study_id,Study Class,Treatment Focus (Study level),Total N Randomized,Intervention Group,Treatment Focus (Arm level),Treatment Focus Subclass (Arm level),N Completed Outcome Measurement,N Completed Outcome Measurement Detail,Publication Treatment Name,NCPTSD Treatment Name,Psychotherapy,Psychotherapy Subclass,Pharmacotherapy,Pharmacotherapy Subclass,CIH,CIH Subclass,Nonpharm Biologic,Nonpharm Cognitive Therapy,Control,Other,Collaborative Care,Format,Delivery Method,Arm N Randomized,Outcome Assessment Type,PTSD Outcome Measure,PTSD Outcome Measure Detail,Analysis Type,Method for Handling Missing Data,Statistical Analysis Method,Assessment Point Category,Follow-up Assessment in Weeks,Measure Score Detail,Measure Score Mean,Measure Score Standard Deviation,Measure Score Type of Variance Measure,Measure Score Variance Value or Lower Bound,Measure Score Variance Upper Bound,Score Difference from Baseline Detail,Score Difference from Baseline,Score Difference from Baseline Standard Deviation,Score Difference from Baseline 95% CI Lower Bound,Score Difference from Baseline 95% CI Upper Bound,Effect Size 1 Detail,Effect Size 1 Type,Effect Size 1 Value,Effect Size 1 Type of Variance Measure,Effect Size 1 Variance Value or Lower Bound,Effect Size 1 Variance Upper Bound,Effect Size 1 p value,Effect Size 2 Detail,Effect Size 2 Type,Effect Size 2 Value,Effect Size 2 Type of Variance Measure,Effect Size 2 Variance Value or Lower Bound,Effect Size 2 Variance Upper Bound,Effect Size 2 p value,Diagnostic Change Definition 1,Percent Achieved Diagnostic Change Definition 1,Additional Defs of Diagnostic Change,Clinically Meaningful Response Definition 1,Percent Achieved Clinically Meaningful Response Definition 1,Additional Defs of Clinically Meaningful Response,Military Status (Study level),Active Duty Military Percent (Study level),Veteran Percent (Study level),Community Percent (Study level),Female Percent (Study level),Female Percent Detail  (Study level),Male Percent (Study level),Trauma Type (Study level),Trauma Detail (Study level),Risk of Bias Rating (Study level),Citation,PTSDPubs ID,Year Added to PTSD-Repository
acarturk2016_HTQ_A_0_NA,Psychotherapy,PTSD,98,A,PTSD,,,,EMDR Recent Traumatic Episode Protocol,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,49,Self report,HTQ,HTQ (Arabic version),,,"Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change",End of Treatment,0,,1.42,,SE,0.07,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7449,,0.2551,Terrorism/political violence/forced displacement,,Medium,"Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.",45262,2019
acarturk2016_HTQ_A_4_NA,Psychotherapy,PTSD,98,A,PTSD,,,,EMDR Recent Traumatic Episode Protocol,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,49,Self report,HTQ,HTQ (Arabic version),,,"Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change",Assessment at <3 Months,4,,1.57,,SE,0.08,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7449,,0.2551,Terrorism/political violence/forced displacement,,Medium,"Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.",45262,2019
acarturk2016_HTQ_A_Baseline_NA,Psychotherapy,PTSD,98,A,PTSD,,,,EMDR Recent Traumatic Episode Protocol,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,49,Self report,HTQ,HTQ (Arabic version),,,"Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change",Baseline,,,2.63,0.42,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7449,,0.2551,Terrorism/political violence/forced displacement,,Medium,"Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.",45262,2019
acarturk2016_HTQ_B_0_NA,Psychotherapy,PTSD,98,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,49,Self report,HTQ,HTQ (Arabic version),,,"Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change",End of Treatment,0,,2.38,,SE,0.08,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7449,,0.2551,Terrorism/political violence/forced displacement,,Medium,"Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.",45262,2019
acarturk2016_HTQ_B_4_NA,Psychotherapy,PTSD,98,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,49,Self report,HTQ,HTQ (Arabic version),,,"Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change",Assessment at <3 Months,4,,2.38,,SE,0.08,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7449,,0.2551,Terrorism/political violence/forced displacement,,Medium,"Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.",45262,2019
acarturk2016_HTQ_B_Baseline_NA,Psychotherapy,PTSD,98,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,49,Self report,HTQ,HTQ (Arabic version),,,"Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change",Baseline,,,2.47,0.43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7449,,0.2551,Terrorism/political violence/forced displacement,,Medium,"Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.",45262,2019
acarturk2016_IES_A_0_ITT,Psychotherapy,PTSD,98,A,PTSD,,37,,EMDR Recent Traumatic Episode Protocol,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,49,Self report,IES,IES-R (Arabic version),ITT,Imputed,"Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change",End of Treatment,0,,21.36,,SEM,2.76,,,-38.33,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to MINI,0.6122,,,,,Community,,,1,0.7449,,0.2551,Terrorism/political violence/forced displacement,,Medium,"Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.",45262,2019
acarturk2016_IES_A_4_ITT,Psychotherapy,PTSD,98,A,PTSD,,31,,EMDR Recent Traumatic Episode Protocol,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,49,Self report,IES,IES-R (Arabic version),ITT,Imputed,"Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change",Assessment at <3 Months,4,,25.87,,SEM,3.01,,,-33.82,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to MINI,0.4898,,,,,Community,,,1,0.7449,,0.2551,Terrorism/political violence/forced displacement,,Medium,"Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.",45262,2019
acarturk2016_IES_A_Baseline_ITT,Psychotherapy,PTSD,98,A,PTSD,,49,,EMDR Recent Traumatic Episode Protocol,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,49,Self report,IES,IES-R (Arabic version),ITT,Imputed,"Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change",Baseline,,,59.69,13.65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7449,,0.2551,Terrorism/political violence/forced displacement,,Medium,"Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.",45262,2019
acarturk2016_IES_B_0_ITT,Psychotherapy,PTSD,98,B,Control,,33,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,49,Self report,IES,IES-R (Arabic version),ITT,Imputed,"Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change",End of Treatment,0,,59.01,,SEM,2.92,,,-3.54,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to MINI,0.0612,,,,,Community,,,1,0.7449,,0.2551,Terrorism/political violence/forced displacement,,Medium,"Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.",45262,2019
acarturk2016_IES_B_4_ITT,Psychotherapy,PTSD,98,B,Control,,33,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,49,Self report,IES,IES-R (Arabic version),ITT,Imputed,"Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change",Assessment at <3 Months,4,,60.37,,SEM,3.01,,,-2.18,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to MINI,0.0409,,,,,Community,,,1,0.7449,,0.2551,Terrorism/political violence/forced displacement,,Medium,"Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.",45262,2019
acarturk2016_IES_B_Baseline_ITT,Psychotherapy,PTSD,98,B,Control,,49,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,49,Self report,IES,IES-R (Arabic version),ITT,Imputed,"Linear mixed models, omega-squared for PTSD measure score, chi-square for diagnostic change",Baseline,,,62.55,12.46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7449,,0.2551,Terrorism/political violence/forced displacement,,Medium,"Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.",45262,2019
acierno2017_PCL_A_0_Comp,Psychotherapy,PTSD,150,A,PTSD,,55,,PE delivered in-person,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,76,Self report,PCL,PCL-M,Completer,Multiple imputation,Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0379,,0.9621,Combat-related,,Medium,"Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.",45948,2019
acierno2017_PCL_A_0_ITT,Psychotherapy,PTSD,150,A,PTSD,,68,,PE delivered in-person,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,76,Self report,PCL,PCL-M,ITT,Multiple imputation,Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0379,,0.9621,Combat-related,,Medium,"Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.",45948,2019
acierno2017_PCL_A_12_Comp,Psychotherapy,PTSD,150,A,PTSD,,55,,PE delivered in-person,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,76,Self report,PCL,PCL-M,Completer,Multiple imputation,Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0379,,0.9621,Combat-related,,Medium,"Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.",45948,2019
acierno2017_PCL_A_12_ITT,Psychotherapy,PTSD,150,A,PTSD,,68,,PE delivered in-person,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,76,Self report,PCL,PCL-M,ITT,Multiple imputation,Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0379,,0.9621,Combat-related,,Medium,"Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.",45948,2019
acierno2017_PCL_A_26_Comp,Psychotherapy,PTSD,150,A,PTSD,,55,,PE delivered in-person,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,76,Self report,PCL,PCL-M,Completer,Multiple imputation,Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.,Assessment at 6 to <12 Months,26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0379,,0.9621,Combat-related,,Medium,"Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.",45948,2019
acierno2017_PCL_A_26_ITT,Psychotherapy,PTSD,150,A,PTSD,,68,,PE delivered in-person,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,76,Self report,PCL,PCL-M,ITT,Multiple imputation,Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.,Assessment at 6 to <12 Months,26,,,,,,,,,,,,,Slope,-1.9,,,,p<0.0001,,,,,,,,,,,,,,Veteran,,1,,0.0379,,0.9621,Combat-related,,Medium,"Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.",45948,2019
acierno2017_PCL_A_Baseline_Comp,Psychotherapy,PTSD,150,A,PTSD,,55,,PE delivered in-person,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,76,Self report,PCL,PCL-M,Completer,Multiple imputation,Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0379,,0.9621,Combat-related,,Medium,"Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.",45948,2019
acierno2017_PCL_A_Baseline_ITT,Psychotherapy,PTSD,150,A,PTSD,,68,,PE delivered in-person,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,76,Self report,PCL,PCL-M,ITT,Multiple imputation,Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.,Baseline,,,58.3,11.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0379,,0.9621,Combat-related,,Medium,"Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.",45948,2019
acierno2017_PCL_B_0_Comp,Psychotherapy,PTSD,150,B,PTSD,,43,,PE delivered via home-based telehealth,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,74,Self report,PCL,PCL-M,Completer,Multiple imputation,Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0379,,0.9621,Combat-related,,Medium,"Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.",45948,2019
acierno2017_PCL_B_0_ITT,Psychotherapy,PTSD,150,B,PTSD,,64,,PE delivered via home-based telehealth,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,74,Self report,PCL,PCL-M,ITT,Multiple imputation,Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0379,,0.9621,Combat-related,,Medium,"Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.",45948,2019
acierno2017_PCL_B_12_Comp,Psychotherapy,PTSD,150,B,PTSD,,43,,PE delivered via home-based telehealth,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,74,Self report,PCL,PCL-M,Completer,Multiple imputation,Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0379,,0.9621,Combat-related,,Medium,"Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.",45948,2019
acierno2017_PCL_B_12_ITT,Psychotherapy,PTSD,150,B,PTSD,,64,,PE delivered via home-based telehealth,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,74,Self report,PCL,PCL-M,ITT,Multiple imputation,Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0379,,0.9621,Combat-related,,Medium,"Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.",45948,2019
acierno2017_PCL_B_26_Comp,Psychotherapy,PTSD,150,B,PTSD,,43,,PE delivered via home-based telehealth,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,74,Self report,PCL,PCL-M,Completer,Multiple imputation,Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.,Assessment at 6 to <12 Months,26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0379,,0.9621,Combat-related,,Medium,"Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.",45948,2019
acierno2017_PCL_B_26_ITT,Psychotherapy,PTSD,150,B,PTSD,,64,,PE delivered via home-based telehealth,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,74,Self report,PCL,PCL-M,ITT,Multiple imputation,Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.,Assessment at 6 to <12 Months,26,,,,,,,,,,,,,Slope,-1.8,,,,p<0.0001,,,,,,,,,,,,,,Veteran,,1,,0.0379,,0.9621,Combat-related,,Medium,"Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.",45948,2019
acierno2017_PCL_B_Baseline_Comp,Psychotherapy,PTSD,150,B,PTSD,,43,,PE delivered via home-based telehealth,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,74,Self report,PCL,PCL-M,Completer,Multiple imputation,Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0379,,0.9621,Combat-related,,Medium,"Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.",45948,2019
acierno2017_PCL_B_Baseline_ITT,Psychotherapy,PTSD,150,B,PTSD,,64,,PE delivered via home-based telehealth,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,74,Self report,PCL,PCL-M,ITT,Multiple imputation,Mixed effects model; non-inferiority margin (delta) set at 8.8 for PCL and 5 for BDI-II and analyses conducted with per-protocol sample.,Baseline,,,60.1,11.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0379,,0.9621,Combat-related,,Medium,"Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.",45948,2019
adenauer2011_CAPS_A_16_Comp,Psychotherapy,PTSD,34,A,PTSD,,11,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,16,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated-measures ANOVA with Greenhouse-Geisser's correction of the degrees of freedom as needed; post-hoc Tukey's honest significant difference test; Cohen's d effect sizes,Assessment at 3 to <6 Months,16,,52.8,18.8,,,,,-35.2,,,,,Cohen's d,2.21,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.4545,,,,,Community,,,1,0.4412,,0.5588,Terrorism/political violence/forced displacement,,High,"Adenauer H, Catani C, Gola H, et al. Narrative exposure therapy for PTSD increases top-down processing of aversive stimuli -- evidence from a randomized controlled treatment trial. BMC Neurosci. 2011 Dec 19;12:127. doi: 10.1186/1471-2202-12-127. PMID: 22182346.",37889,2019
adenauer2011_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,34,A,PTSD,,11,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,16,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated-measures ANOVA with Greenhouse-Geisser's correction of the degrees of freedom as needed; post-hoc Tukey's honest significant difference test; Cohen's d effect sizes,Baseline,,,88,12.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4412,,0.5588,Terrorism/political violence/forced displacement,,High,"Adenauer H, Catani C, Gola H, et al. Narrative exposure therapy for PTSD increases top-down processing of aversive stimuli -- evidence from a randomized controlled treatment trial. BMC Neurosci. 2011 Dec 19;12:127. doi: 10.1186/1471-2202-12-127. PMID: 22182346.",37889,2019
adenauer2011_CAPS_B_16_Comp,Psychotherapy,PTSD,34,B,Control,,8,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,18,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated-measures ANOVA with Greenhouse-Geisser's correction of the degrees of freedom as needed; post-hoc Tukey's honest significant difference test; Cohen's d effect sizes,Assessment at 3 to <6 Months,16,,87.9,18.5,,,,,15.9,,,,,Cohen's d,-0.97,,,,p=0.11,,,,,,,,Not meeting criteria for PTSD according to CAPS,0,,,,,Community,,,1,0.4412,,0.5588,Terrorism/political violence/forced displacement,,High,"Adenauer H, Catani C, Gola H, et al. Narrative exposure therapy for PTSD increases top-down processing of aversive stimuli -- evidence from a randomized controlled treatment trial. BMC Neurosci. 2011 Dec 19;12:127. doi: 10.1186/1471-2202-12-127. PMID: 22182346.",37889,2019
adenauer2011_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,34,B,Control,,8,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,18,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated-measures ANOVA with Greenhouse-Geisser's correction of the degrees of freedom as needed; post-hoc Tukey's honest significant difference test; Cohen's d effect sizes,Baseline,,,72,13.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4412,,0.5588,Terrorism/political violence/forced displacement,,High,"Adenauer H, Catani C, Gola H, et al. Narrative exposure therapy for PTSD increases top-down processing of aversive stimuli -- evidence from a randomized controlled treatment trial. BMC Neurosci. 2011 Dec 19;12:127. doi: 10.1186/1471-2202-12-127. PMID: 22182346.",37889,2019
ahmadi2015_M-PTSD_A_0_Comp,Mixed: Psychotherapy & CIH,PTSD,48,A,PTSD,,11,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,16,Self report,M-PTSD,M-PTSD (Persian version),Completer,,ANOVA for continuous variables; Tukey's test for multiple comparisons,End of Treatment,0,,,,,,,,-19.4,10.3,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0,,1,Combat-related,,High,"Ahmadi K, Hazrati M, Ahmadizadeh MJ, et al. REM desensitization as a new therapeutic method for post-traumatic stress disorder: a randomized controlled trial. Acta Med Indones. 2015 Apr;47(2):111-9.  PMID: 26260553.",46896,2019
ahmadi2015_M-PTSD_A_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,48,A,PTSD,,11,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,16,Self report,M-PTSD,M-PTSD (Persian version),Completer,,ANOVA for continuous variables; Tukey's test for multiple comparisons,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0,,1,Combat-related,,High,"Ahmadi K, Hazrati M, Ahmadizadeh MJ, et al. REM desensitization as a new therapeutic method for post-traumatic stress disorder: a randomized controlled trial. Acta Med Indones. 2015 Apr;47(2):111-9.  PMID: 26260553.",46896,2019
ahmadi2015_M-PTSD_B_0_Comp,Mixed: Psychotherapy & CIH,PTSD,48,B,PTSD,,10,,REM Desensitization,Rapid Eye Movement (REM) Desentization,No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,16,Self report,M-PTSD,M-PTSD (Persian version),Completer,,ANOVA for continuous variables; Tukey's test for multiple comparisons,End of Treatment,0,,,,,,,,-20,9.5,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0,,1,Combat-related,,High,"Ahmadi K, Hazrati M, Ahmadizadeh MJ, et al. REM desensitization as a new therapeutic method for post-traumatic stress disorder: a randomized controlled trial. Acta Med Indones. 2015 Apr;47(2):111-9.  PMID: 26260553.",46896,2019
ahmadi2015_M-PTSD_B_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,48,B,PTSD,,10,,REM Desensitization,Rapid Eye Movement (REM) Desentization,No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,16,Self report,M-PTSD,M-PTSD (Persian version),Completer,,ANOVA for continuous variables; Tukey's test for multiple comparisons,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0,,1,Combat-related,,High,"Ahmadi K, Hazrati M, Ahmadizadeh MJ, et al. REM desensitization as a new therapeutic method for post-traumatic stress disorder: a randomized controlled trial. Acta Med Indones. 2015 Apr;47(2):111-9.  PMID: 26260553.",46896,2019
ahmadi2015_M-PTSD_C_0_Comp,Mixed: Psychotherapy & CIH,PTSD,48,C,Control,,12,,Control,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,16,Self report,M-PTSD,M-PTSD (Persian version),Completer,,ANOVA for continuous variables; Tukey's test for multiple comparisons,End of Treatment,0,,,,,,,,0.6,5.9,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0,,1,Combat-related,,High,"Ahmadi K, Hazrati M, Ahmadizadeh MJ, et al. REM desensitization as a new therapeutic method for post-traumatic stress disorder: a randomized controlled trial. Acta Med Indones. 2015 Apr;47(2):111-9.  PMID: 26260553.",46896,2019
ahmadi2015_M-PTSD_C_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,48,C,Control,,12,,Control,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,16,Self report,M-PTSD,M-PTSD (Persian version),Completer,,ANOVA for continuous variables; Tukey's test for multiple comparisons,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0,,1,Combat-related,,High,"Ahmadi K, Hazrati M, Ahmadizadeh MJ, et al. REM desensitization as a new therapeutic method for post-traumatic stress disorder: a randomized controlled trial. Acta Med Indones. 2015 Apr;47(2):111-9.  PMID: 26260553.",46896,2019
ahmadizadeh2018_PCL_A_0_ITT,Nonpharmacologic biological,PTSD,65,A,PTSD,,16,,Bilateral rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,22,Self report,PCL,PCL-M,ITT,LOCF,Repeated measures ANOVA; mixed model analysis; Bonferroni correction for pairwise comparisons; chi-squared for clinically meaningful change,End of Treatment,0,,45.81,4.67,,,,SE 2.31,-26.25,,,,,,,,,,p=0.0001,,,,,,,,,,,Change in PCL-M ≥2 standard deviation relative to sample's baseline PCL-M score,0.625,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ahmadizadeh MJ, Rezaei M. Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment post-traumatic stress disorder: a randomized controlled study. Brain Res Bull. 2018;140:334-40. doi: 10.1016/j.brainresbull.2018.06.001. PMID: 29883597.",50480,2019
ahmadizadeh2018_PCL_A_Baseline_ITT,Nonpharmacologic biological,PTSD,65,A,PTSD,,22,,Bilateral rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,22,Self report,PCL,PCL-M,ITT,LOCF,Repeated measures ANOVA; mixed model analysis; Bonferroni correction for pairwise comparisons; chi-squared for clinically meaningful change,Baseline,,,71.26,7.65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ahmadizadeh MJ, Rezaei M. Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment post-traumatic stress disorder: a randomized controlled study. Brain Res Bull. 2018;140:334-40. doi: 10.1016/j.brainresbull.2018.06.001. PMID: 29883597.",50480,2019
ahmadizadeh2018_PCL_B_0_ITT,Nonpharmacologic biological,PTSD,65,B,PTSD,,17,,Unilateral rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,21,Self report,PCL,PCL-M,ITT,LOCF,Repeated measures ANOVA; mixed model analysis; Bonferroni correction for pairwise comparisons; chi-squared for clinically meaningful change,End of Treatment,0,,49.41,6.53,,,,SE 2.55,-21.12,,,,,,,,,,p=0.0001,,,,,,,,,,,Change in PCL-M ≥2 standard deviation relative to sample's baseline PCL-M score,0.4118,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ahmadizadeh MJ, Rezaei M. Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment post-traumatic stress disorder: a randomized controlled study. Brain Res Bull. 2018;140:334-40. doi: 10.1016/j.brainresbull.2018.06.001. PMID: 29883597.",50480,2019
ahmadizadeh2018_PCL_B_Baseline_ITT,Nonpharmacologic biological,PTSD,65,B,PTSD,,21,,Unilateral rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,21,Self report,PCL,PCL-M,ITT,LOCF,Repeated measures ANOVA; mixed model analysis; Bonferroni correction for pairwise comparisons; chi-squared for clinically meaningful change,Baseline,,,70.57,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ahmadizadeh MJ, Rezaei M. Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment post-traumatic stress disorder: a randomized controlled study. Brain Res Bull. 2018;140:334-40. doi: 10.1016/j.brainresbull.2018.06.001. PMID: 29883597.",50480,2019
ahmadizadeh2018_PCL_C_0_ITT,Nonpharmacologic biological,PTSD,65,C,Control,,16,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,22,Self report,PCL,PCL-M,ITT,LOCF,Repeated measures ANOVA; mixed model analysis; Bonferroni correction for pairwise comparisons; chi-squared for clinically meaningful change,End of Treatment,0,,66.93,10.34,,,,,-3.62,,,,,,,,,,,,,,,,,,,,,Change in PCL-M ≥2 standard deviation relative to sample's baseline PCL-M score,0,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ahmadizadeh MJ, Rezaei M. Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment post-traumatic stress disorder: a randomized controlled study. Brain Res Bull. 2018;140:334-40. doi: 10.1016/j.brainresbull.2018.06.001. PMID: 29883597.",50480,2019
ahmadizadeh2018_PCL_C_Baseline_ITT,Nonpharmacologic biological,PTSD,65,C,Control,,22,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,22,Self report,PCL,PCL-M,ITT,LOCF,Repeated measures ANOVA; mixed model analysis; Bonferroni correction for pairwise comparisons; chi-squared for clinically meaningful change,Baseline,,,70.55,9.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ahmadizadeh MJ, Rezaei M. Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment post-traumatic stress disorder: a randomized controlled study. Brain Res Bull. 2018;140:334-40. doi: 10.1016/j.brainresbull.2018.06.001. PMID: 29883597.",50480,2019
ahmadizadeh2019_PCL_A_0_Comp,Nonpharmacologic biological,PTSD,40,A,PTSD,,18,,Transcranial direct current stimulation (tDCS),Transcranial direct current stimulation (tDCS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,20,Self report,PCL,PCL-5,Completer,,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",End of Treatment,0,,37.44,10.77,,,,,-16.95,,,,,,,,,,,,,,,,,,PCL-5 < 33,0.444,,"PCL-5 ≤ 24 on the PCL-5, if reliable change index also exceeds 1.96",0.278,,Community,,,1,0.65,,0.35,,,Medium,"Ahmadizadeh MJ, Rezaei M, Fitzgerald PB. Transcranial direct current stimulation (tDCS) for post-traumatic stress disorder (PTSD): a randomized, double-blinded, controlled trial. Brain research bulletin. 2019;153:273-8. PMID: 31560945.",1545324,2020
ahmadizadeh2019_PCL_A_4_Comp,Nonpharmacologic biological,PTSD,40,A,PTSD,,16,,Transcranial direct current stimulation (tDCS),Transcranial direct current stimulation (tDCS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,20,Self report,PCL,PCL-5,Completer,,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",Assessment at <3 Months,4,,41.28,8.86,,,,,-13.11,,,,,,,,,,,,,,,,,,PCL-5 < 33,,,"PCL-5 ≤ 24 on the PCL-5, if reliable change index also exceeds 1.96",,,Community,,,1,0.65,,0.35,,,Medium,"Ahmadizadeh MJ, Rezaei M, Fitzgerald PB. Transcranial direct current stimulation (tDCS) for post-traumatic stress disorder (PTSD): a randomized, double-blinded, controlled trial. Brain research bulletin. 2019;153:273-8. PMID: 31560945.",1545324,2020
ahmadizadeh2019_PCL_A_Baseline_Comp,Nonpharmacologic biological,PTSD,40,A,PTSD,,20,,Transcranial direct current stimulation (tDCS),Transcranial direct current stimulation (tDCS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,20,Self report,PCL,PCL-5,Completer,,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",Baseline,,,54.39,2.93,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.65,,0.35,,,Medium,"Ahmadizadeh MJ, Rezaei M, Fitzgerald PB. Transcranial direct current stimulation (tDCS) for post-traumatic stress disorder (PTSD): a randomized, double-blinded, controlled trial. Brain research bulletin. 2019;153:273-8. PMID: 31560945.",1545324,2020
ahmadizadeh2019_PCL_B_0_Comp,Nonpharmacologic biological,PTSD,40,B,Control,,16,,Sham transcranial direct current stimulation,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,20,Self report,PCL,PCL-5,Completer,,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",End of Treatment,0,,52.00,11.19,,,,,-2.81,,,,,,,,,,,,,,,,,,PCL-5 < 33,0.125,,"PCL-5 ≤ 24 on the PCL-5, if reliable change index also exceeds 1.96",0.062,,Community,,,1,0.65,,0.35,,,Medium,"Ahmadizadeh MJ, Rezaei M, Fitzgerald PB. Transcranial direct current stimulation (tDCS) for post-traumatic stress disorder (PTSD): a randomized, double-blinded, controlled trial. Brain research bulletin. 2019;153:273-8. PMID: 31560945.",1545324,2020
ahmadizadeh2019_PCL_B_4_Comp,Nonpharmacologic biological,PTSD,40,B,Control,,16,,Sham transcranial direct current stimulation,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,20,Self report,PCL,PCL-5,Completer,,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",Assessment at <3 Months,4,,52.81,5.07,,,,,-2,,,,,,,,,,,,,,,,,,PCL-5 < 33,,,"PCL-5 ≤ 24 on the PCL-5, if reliable change index also exceeds 1.96",,,Community,,,1,0.65,,0.35,,,Medium,"Ahmadizadeh MJ, Rezaei M, Fitzgerald PB. Transcranial direct current stimulation (tDCS) for post-traumatic stress disorder (PTSD): a randomized, double-blinded, controlled trial. Brain research bulletin. 2019;153:273-8. PMID: 31560945.",1545324,2020
ahmadizadeh2019_PCL_B_Baseline_Comp,Nonpharmacologic biological,PTSD,40,B,Control,,20,,Sham transcranial direct current stimulation,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,20,Self report,PCL,PCL-5,Completer,,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",Baseline,,,54.81,2.79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.65,,0.35,,,Medium,"Ahmadizadeh MJ, Rezaei M, Fitzgerald PB. Transcranial direct current stimulation (tDCS) for post-traumatic stress disorder (PTSD): a randomized, double-blinded, controlled trial. Brain research bulletin. 2019;153:273-8. PMID: 31560945.",1545324,2020
ahmadpanah2014_MINI_A_0_ITT,Pharmacotherapy,PTSD,100,A,PTSD,,33,,Prazosin,Prazosin,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,33,Structured Clinical Interview,MINI,MINI,ITT,,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",End of Treatment,0,,3.36,0.78,,,,,-3.64,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.28,,0.72,Mixed,"combat-related, accidents, natural or manmade disasters, other (not specified)",Medium,"Ahmadpanah M, Sabzeiee P, Hosseini SM, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014 2016-09-15;69(4):235-42. doi: http://dx.doi.org/10.1159/000362243. PMID: 24993832.",43996,2019
ahmadpanah2014_MINI_A_Baseline_ITT,Pharmacotherapy,PTSD,100,A,PTSD,,33,,Prazosin,Prazosin,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,33,Structured Clinical Interview,MINI,MINI,ITT,,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",Baseline,,,7,0.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.28,,0.72,Mixed,"combat-related, accidents, natural or manmade disasters, other (not specified)",Medium,"Ahmadpanah M, Sabzeiee P, Hosseini SM, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014 2016-09-15;69(4):235-42. doi: http://dx.doi.org/10.1159/000362243. PMID: 24993832.",43996,2019
ahmadpanah2014_MINI_B_0_ITT,Pharmacotherapy,PTSD,100,B,PTSD,,34,,Hydroxyzine,Hydroxyzine,No,Not Applicable,Yes,Antianxiety: nonbenzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In Person,34,Structured Clinical Interview,MINI,MINI,ITT,,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",End of Treatment,0,,3.58,0.98,,,,,-3.42,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.28,,0.72,Mixed,"combat-related, accidents, natural or manmade disasters, other (not specified)",Medium,"Ahmadpanah M, Sabzeiee P, Hosseini SM, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014 2016-09-15;69(4):235-42. doi: http://dx.doi.org/10.1159/000362243. PMID: 24993832.",43996,2019
ahmadpanah2014_MINI_B_Baseline_ITT,Pharmacotherapy,PTSD,100,B,PTSD,,34,,Hydroxyzine,Hydroxyzine,No,Not Applicable,Yes,Antianxiety: nonbenzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In Person,34,Structured Clinical Interview,MINI,MINI,ITT,,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",Baseline,,,7,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.28,,0.72,Mixed,"combat-related, accidents, natural or manmade disasters, other (not specified)",Medium,"Ahmadpanah M, Sabzeiee P, Hosseini SM, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014 2016-09-15;69(4):235-42. doi: http://dx.doi.org/10.1159/000362243. PMID: 24993832.",43996,2019
ahmadpanah2014_MINI_C_0_ITT,Pharmacotherapy,PTSD,100,C,Control,,33,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,33,Structured Clinical Interview,MINI,MINI,ITT,,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",End of Treatment,0,,5.39,1.29,,,,,-1.61,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.28,,0.72,Mixed,"combat-related, accidents, natural or manmade disasters, other (not specified)",Medium,"Ahmadpanah M, Sabzeiee P, Hosseini SM, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014 2016-09-15;69(4):235-42. doi: http://dx.doi.org/10.1159/000362243. PMID: 24993832.",43996,2019
ahmadpanah2014_MINI_C_Baseline_ITT,Pharmacotherapy,PTSD,100,C,Control,,33,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,33,Structured Clinical Interview,MINI,MINI,ITT,,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",Baseline,,,7,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.28,,0.72,Mixed,"combat-related, accidents, natural or manmade disasters, other (not specified)",Medium,"Ahmadpanah M, Sabzeiee P, Hosseini SM, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014 2016-09-15;69(4):235-42. doi: http://dx.doi.org/10.1159/000362243. PMID: 24993832.",43996,2019
akbarian2015_IES_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,40,A,PTSD,,20,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Group,In Person,20,Self report,IES,IES-R,ITT,LOCF,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",End of Treatment,0,,55.57,4.77,,,,,-10.79,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7857,,0.2143,Mixed,"intimate partner violence, accidents, illness/medical procedure",Medium,"Akbarian F, Bajoghli H, Haghighi M, et al. The effectiveness of cognitive behavioral therapy with respect to psychological symptoms and recovering autobiographical memory in patients suffering from post-traumatic stress disorder. Neuropsychiatr Dis Treat. 2015;11:395-404. doi: 10.2147/NDT.S79581. PMID: 25737635.",43629,2019
akbarian2015_IES_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,40,A,PTSD,,20,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Group,In Person,20,Self report,IES,IES-R,ITT,LOCF,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",Baseline,,,66.36,4.81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7857,,0.2143,Mixed,"intimate partner violence, accidents, illness/medical procedure",Medium,"Akbarian F, Bajoghli H, Haghighi M, et al. The effectiveness of cognitive behavioral therapy with respect to psychological symptoms and recovering autobiographical memory in patients suffering from post-traumatic stress disorder. Neuropsychiatr Dis Treat. 2015;11:395-404. doi: 10.2147/NDT.S79581. PMID: 25737635.",43629,2019
akbarian2015_IES_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,40,B,Control,,20,,Control condition (psychopharmacologic treatment only),Medication as usual,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Self report,IES,IES-R,ITT,LOCF,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",End of Treatment,0,,63.5,5.68,,,,,-0.5,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7857,,0.2143,Mixed,"intimate partner violence, accidents, illness/medical procedure",Medium,"Akbarian F, Bajoghli H, Haghighi M, et al. The effectiveness of cognitive behavioral therapy with respect to psychological symptoms and recovering autobiographical memory in patients suffering from post-traumatic stress disorder. Neuropsychiatr Dis Treat. 2015;11:395-404. doi: 10.2147/NDT.S79581. PMID: 25737635.",43629,2019
akbarian2015_IES_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,40,B,Control,,20,,Control condition (psychopharmacologic treatment only),Medication as usual,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Self report,IES,IES-R,ITT,LOCF,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",Baseline,,,64,5.11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7857,,0.2143,Mixed,"intimate partner violence, accidents, illness/medical procedure",Medium,"Akbarian F, Bajoghli H, Haghighi M, et al. The effectiveness of cognitive behavioral therapy with respect to psychological symptoms and recovering autobiographical memory in patients suffering from post-traumatic stress disorder. Neuropsychiatr Dis Treat. 2015;11:395-404. doi: 10.2147/NDT.S79581. PMID: 25737635.",43629,2019
akuchekian2004_CAPS_A_0_ITT,Pharmacotherapy,PTSD,67,A,PTSD,,32,,Topiramate augmentation,Topiramate augmentation,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,34,Structured Clinical Interview,CAPS,CAPS (11-item severity score),ITT,LOCF,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",End of Treatment,0,,32.75,8.2,,,,,-17.95,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,0,0,,1,Combat-related,,Medium,"Akuchekian S, Amanat S. The Comparison of Topiramate and Placebo in the Treatment of Posttraumatic Stress Disorder: A Randomized, Double- Blind Study. J Res Med Sci. 2004;9(5):240-4.",50403,2019
akuchekian2004_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,67,A,PTSD,,34,,Topiramate augmentation,Topiramate augmentation,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,34,Structured Clinical Interview,CAPS,CAPS (11-item severity score),ITT,LOCF,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",Baseline,,,50.70,7.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,0,0,,1,Combat-related,,Medium,"Akuchekian S, Amanat S. The Comparison of Topiramate and Placebo in the Treatment of Posttraumatic Stress Disorder: A Randomized, Double- Blind Study. J Res Med Sci. 2004;9(5):240-4.",50403,2019
akuchekian2004_CAPS_B_0_ITT,Pharmacotherapy,PTSD,67,B,Control,,30,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,33,Structured Clinical Interview,CAPS,CAPS (11-item severity score),ITT,LOCF,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",End of Treatment,0,,46.62,8.8,,,,,-2.28,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,0,0,,1,Combat-related,,Medium,"Akuchekian S, Amanat S. The Comparison of Topiramate and Placebo in the Treatment of Posttraumatic Stress Disorder: A Randomized, Double- Blind Study. J Res Med Sci. 2004;9(5):240-4.",50403,2019
akuchekian2004_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,67,B,Control,,33,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,33,Structured Clinical Interview,CAPS,CAPS (11-item severity score),ITT,LOCF,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",Baseline,,,48.9,9.13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,0,0,,1,Combat-related,,Medium,"Akuchekian S, Amanat S. The Comparison of Topiramate and Placebo in the Treatment of Posttraumatic Stress Disorder: A Randomized, Double- Blind Study. J Res Med Sci. 2004;9(5):240-4.",50403,2019
aldahadha2012_TSI_A_0_Comp,Psychotherapy,PTSD,51,A,PTSD,,25,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Self report,TSI,TSI,Completer,,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",End of Treatment,0,,43.76,5.11,,,,,-14.72,,,,,,,,,,p<0.0001,,,,,,,,,,,,,,Community,,,1,0.5294,,0.4706,Accidents,,High,"Aldahadha B, Al-Harthy H, Sulaiman S. The Efficacy of Eye Movement Desensitization Reprocessing in Resolving the Trauma Caused by the Road Accidents in the Sultanate of Oman. Journal of Instructional Psychology. 2012;39(3/4):146-58.",1548482,2019
aldahadha2012_TSI_A_4_Comp,Psychotherapy,PTSD,51,A,PTSD,,22,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Self report,TSI,TSI,Completer,,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",Assessment at <3 Months,4,,42.18,5.84,,,,,-16.3,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5294,,0.4706,Accidents,,High,"Aldahadha B, Al-Harthy H, Sulaiman S. The Efficacy of Eye Movement Desensitization Reprocessing in Resolving the Trauma Caused by the Road Accidents in the Sultanate of Oman. Journal of Instructional Psychology. 2012;39(3/4):146-58.",1548482,2019
aldahadha2012_TSI_A_Baseline_Comp,Psychotherapy,PTSD,51,A,PTSD,,25,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Self report,TSI,TSI,Completer,,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",Baseline,,,58.48,6.66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5294,,0.4706,Accidents,,High,"Aldahadha B, Al-Harthy H, Sulaiman S. The Efficacy of Eye Movement Desensitization Reprocessing in Resolving the Trauma Caused by the Road Accidents in the Sultanate of Oman. Journal of Instructional Psychology. 2012;39(3/4):146-58.",1548482,2019
aldahadha2012_TSI_B_0_Comp,Psychotherapy,PTSD,51,B,Control,,22,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,26,Self report,TSI,TSI,Completer,,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",End of Treatment,0,,58.08,6.62,,,,,-1.23,,,,,,,,,,p=0.5397,,,,,,,,,,,,,,Community,,,1,0.5294,,0.4706,Accidents,,High,"Aldahadha B, Al-Harthy H, Sulaiman S. The Efficacy of Eye Movement Desensitization Reprocessing in Resolving the Trauma Caused by the Road Accidents in the Sultanate of Oman. Journal of Instructional Psychology. 2012;39(3/4):146-58.",1548482,2019
aldahadha2012_TSI_B_Baseline_Comp,Psychotherapy,PTSD,51,B,Control,,26,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,26,Self report,TSI,TSI,Completer,,"Group x time (2×3) mixed model analysis
Multiple ANOVA for pre-treatment group differences",Baseline,,,59.31,6.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5294,,0.4706,Accidents,,High,"Aldahadha B, Al-Harthy H, Sulaiman S. The Efficacy of Eye Movement Desensitization Reprocessing in Resolving the Trauma Caused by the Road Accidents in the Sultanate of Oman. Journal of Instructional Psychology. 2012;39(3/4):146-58.",1548482,2019
alghamdi2015_SPTSS_A_0_ITT,Psychotherapy,PTSD,34,A,PTSD,,17,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,17,Self report,SPTSS,SPTSS,ITT,None,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",End of Treatment,0,,,,,,,,-6.65,,-8.05,-5.23,,Hedges' g,0.75,,,,p<0.001,,,,,,,,,,,,,,Community,0,0,1,0,,1,,,Medium,"Alghamdi M, Hunt NC, Thomas SA. The effectiveness of narrative exposure therapy with traumatised firefighters in Saudi Arabia: a randomized controlled study. Behav Res Ther. 2015 Mar;66:64-71. doi: 10.1016/j.brat.2015.01.008. PMID: 25701801.",46524,2020
alghamdi2015_SPTSS_A_12_ITT,Psychotherapy,PTSD,34,A,PTSD,,14,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,17,Self report,SPTSS,SPTSS,ITT,None,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",Assessment at 3 to <6 Months,12,,,,,,,,,,,,reported combined results with waitlist group,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0,,1,,,Medium,"Alghamdi M, Hunt NC, Thomas SA. The effectiveness of narrative exposure therapy with traumatised firefighters in Saudi Arabia: a randomized controlled study. Behav Res Ther. 2015 Mar;66:64-71. doi: 10.1016/j.brat.2015.01.008. PMID: 25701801.",46524,2020
alghamdi2015_SPTSS_A_26_ITT,Psychotherapy,PTSD,34,A,PTSD,,14,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,17,Self report,SPTSS,SPTSS,ITT,None,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",Assessment at 6 to <12 Months,26,,,,,,,,,,,,reported combined results with waitlist group,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0,,1,,,Medium,"Alghamdi M, Hunt NC, Thomas SA. The effectiveness of narrative exposure therapy with traumatised firefighters in Saudi Arabia: a randomized controlled study. Behav Res Ther. 2015 Mar;66:64-71. doi: 10.1016/j.brat.2015.01.008. PMID: 25701801.",46524,2020
alghamdi2015_SPTSS_A_3_ITT,Psychotherapy,PTSD,34,A,PTSD,,17,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,17,Self report,SPTSS,SPTSS,ITT,None,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",Assessment at <3 Months,3,,,,,,,,,,,,reported combined results with waitlist group,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0,,1,,,Medium,"Alghamdi M, Hunt NC, Thomas SA. The effectiveness of narrative exposure therapy with traumatised firefighters in Saudi Arabia: a randomized controlled study. Behav Res Ther. 2015 Mar;66:64-71. doi: 10.1016/j.brat.2015.01.008. PMID: 25701801.",46524,2020
alghamdi2015_SPTSS_A_Baseline_ITT,Psychotherapy,PTSD,34,A,PTSD,,17,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,17,Self report,SPTSS,SPTSS,ITT,None,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0,,1,,,Medium,"Alghamdi M, Hunt NC, Thomas SA. The effectiveness of narrative exposure therapy with traumatised firefighters in Saudi Arabia: a randomized controlled study. Behav Res Ther. 2015 Mar;66:64-71. doi: 10.1016/j.brat.2015.01.008. PMID: 25701801.",46524,2020
alghamdi2015_SPTSS_B_0_ITT,Psychotherapy,PTSD,34,B,Control,,17,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,17,Self report,SPTSS,SPTSS,ITT,None,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",End of Treatment,0,,,,,,,,-0.58,,-2.1,0.96,,Hedges' g,0.04,,,,,,,,,,,,,,,,,,Community,0,0,1,0,,1,,,Medium,"Alghamdi M, Hunt NC, Thomas SA. The effectiveness of narrative exposure therapy with traumatised firefighters in Saudi Arabia: a randomized controlled study. Behav Res Ther. 2015 Mar;66:64-71. doi: 10.1016/j.brat.2015.01.008. PMID: 25701801.",46524,2020
alghamdi2015_SPTSS_B_Baseline_ITT,Psychotherapy,PTSD,34,B,Control,,17,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,17,Self report,SPTSS,SPTSS,ITT,None,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0,,1,,,Medium,"Alghamdi M, Hunt NC, Thomas SA. The effectiveness of narrative exposure therapy with traumatised firefighters in Saudi Arabia: a randomized controlled study. Behav Res Ther. 2015 Mar;66:64-71. doi: 10.1016/j.brat.2015.01.008. PMID: 25701801.",46524,2020
ardani2017_PCL-M_A_0_NA,Pharmacotherapy,PTSD,36,A,PTSD,,,,Rivastigmine augmentation,Rivastigmine augmentation,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Self report,PCL-M,PCL-M,,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",End of Treatment,0,,44.63,7.67,,,,,-3.37,,,,,,,,,,p=0.0001,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ardani AR, Hosseini G, Bordbar MRF, et al. Effect of rivastigmine augmentation in treatment of male patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Clin Psychopharmacol. 2017 Feb;37(1):54-60. doi: 10.1097/jcp.0000000000000624. PMID: 27930500.",47465,2019
ardani2017_PCL-M_A_Baseline_NA,Pharmacotherapy,PTSD,36,A,PTSD,,12,,Rivastigmine augmentation,Rivastigmine augmentation,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Self report,PCL-M,PCL-M,,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",Baseline,,,48.00,7.03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ardani AR, Hosseini G, Bordbar MRF, et al. Effect of rivastigmine augmentation in treatment of male patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Clin Psychopharmacol. 2017 Feb;37(1):54-60. doi: 10.1097/jcp.0000000000000624. PMID: 27930500.",47465,2019
ardani2017_PCL-M_B_0_NA,Pharmacotherapy,PTSD,36,B,Control,,,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,12,Self report,PCL-M,PCL-M,,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",End of Treatment,0,,47.25,6.35,,,,,-3.75,,,,,,,,,,p=0.0001,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ardani AR, Hosseini G, Bordbar MRF, et al. Effect of rivastigmine augmentation in treatment of male patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Clin Psychopharmacol. 2017 Feb;37(1):54-60. doi: 10.1097/jcp.0000000000000624. PMID: 27930500.",47465,2019
ardani2017_PCL-M_B_Baseline_NA,Pharmacotherapy,PTSD,36,B,Control,,12,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,12,Self report,PCL-M,PCL-M,,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",Baseline,,,51.00,4.15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ardani AR, Hosseini G, Bordbar MRF, et al. Effect of rivastigmine augmentation in treatment of male patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Clin Psychopharmacol. 2017 Feb;37(1):54-60. doi: 10.1097/jcp.0000000000000624. PMID: 27930500.",47465,2019
ardani2017_PCL-M_C_0_NA,Pharmacotherapy,PTSD,36,C,Control,,,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,12,Self report,PCL-M,PCL-M,,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",End of Treatment,0,,48.83,6.04,,,,,-3.67,,,,,,,,,,p=0.0001,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ardani AR, Hosseini G, Bordbar MRF, et al. Effect of rivastigmine augmentation in treatment of male patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Clin Psychopharmacol. 2017 Feb;37(1):54-60. doi: 10.1097/jcp.0000000000000624. PMID: 27930500.",47465,2019
ardani2017_PCL-M_C_Baseline_NA,Pharmacotherapy,PTSD,36,C,Control,,12,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,12,Self report,PCL-M,PCL-M,,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",Baseline,,,52.50,2.46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ardani AR, Hosseini G, Bordbar MRF, et al. Effect of rivastigmine augmentation in treatment of male patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Clin Psychopharmacol. 2017 Feb;37(1):54-60. doi: 10.1097/jcp.0000000000000624. PMID: 27930500.",47465,2019
arntz2007_PSS-SR_A_0_Comp,Psychotherapy,PTSD,67,A,PTSD,,21,,Imaginal Exposure + Imagery Rescripting,Imaginal exposure plus imagery rescripting,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Self report,PSS-SR,PSS-SR (Dutch version),Completer,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",End of Treatment,0,,18.52,14.5,,,,,-11.1,,,,,Cohen's d,0.89,,,,,,,,,,,,,,,PSS-SR (Dutch version) score ≤20,0.619,,Community,,,1,0.6567,,0.3433,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)",High,"Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.",30284,2019
arntz2007_PSS-SR_A_0_ITT,Psychotherapy,PTSD,67,A,PTSD,,22,,Imaginal Exposure + Imagery Rescripting,Imaginal exposure plus imagery rescripting,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Self report,PSS-SR,PSS-SR (Dutch version),ITT,LOCF,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",End of Treatment,0,,20.54,13.62,,,,,-8.85,,,,,Cohen's d,0.73,,,,,,,,,,,,,,,PSS-SR (Dutch version) score ≤20,0.5357,,Community,,,1,0.6567,,0.3433,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)",High,"Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.",30284,2019
arntz2007_PSS-SR_A_4_Comp,Psychotherapy,PTSD,67,A,PTSD,,21,,Imaginal Exposure + Imagery Rescripting,Imaginal exposure plus imagery rescripting,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Self report,PSS-SR,PSS-SR (Dutch version),Completer,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",Assessment at <3 Months,4,,20.43,12.7,,,,,-9.19,,,,,Cohen's d,0.75,,,,,,,,,,,,,,,PSS-SR (Dutch version) score ≤20,0.4762,,Community,,,1,0.6567,,0.3433,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)",High,"Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.",30284,2019
arntz2007_PSS-SR_A_4_ITT,Psychotherapy,PTSD,67,A,PTSD,,20,,Imaginal Exposure + Imagery Rescripting,Imaginal exposure plus imagery rescripting,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Self report,PSS-SR,PSS-SR (Dutch version),ITT,LOCF,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",Assessment at <3 Months,4,,21.93,12.02,,,,,-7.46,,,,,Cohen's d,0.63,,,,,,,,,,,,,,,PSS-SR (Dutch version) score ≤20,0.4286,,Community,,,1,0.6567,,0.3433,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)",High,"Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.",30284,2019
arntz2007_PSS-SR_A_Baseline_Comp,Psychotherapy,PTSD,67,A,PTSD,,21,,Imaginal Exposure + Imagery Rescripting,Imaginal exposure plus imagery rescripting,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Self report,PSS-SR,PSS-SR (Dutch version),Completer,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",Baseline,,,29.62,10.86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6567,,0.3433,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)",High,"Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.",30284,2019
arntz2007_PSS-SR_A_Baseline_ITT,Psychotherapy,PTSD,67,A,PTSD,,28,,Imaginal Exposure + Imagery Rescripting,Imaginal exposure plus imagery rescripting,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Self report,PSS-SR,PSS-SR (Dutch version),ITT,LOCF,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",Baseline,,,29.39,10.17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6567,,0.3433,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)",High,"Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.",30284,2019
arntz2007_PSS-SR_B_0_Comp,Psychotherapy,PTSD,67,B,PTSD,,19,,IE,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,39,Self report,PSS-SR,PSS-SR (Dutch version),Completer,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",End of Treatment,0,,17.63,13.76,,,,,-9.9,,,,,Cohen's d,0.8,,,,,,,,,,,,,,,PSS-SR (Dutch version) score ≤20,0.6316,,Community,,,1,0.6567,,0.3433,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)",High,"Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.",30284,2019
arntz2007_PSS-SR_B_0_ITT,Psychotherapy,PTSD,67,B,PTSD,,22,,IE,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,39,Self report,PSS-SR,PSS-SR (Dutch version),ITT,LOCF,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",End of Treatment,0,,18.28,13.25,,,,,-6.75,,,,,Cohen's d,0.56,,,,,,,,,,,,,,,PSS-SR (Dutch version) score ≤20,0.5897,,Community,,,1,0.6567,,0.3433,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)",High,"Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.",30284,2019
arntz2007_PSS-SR_B_4_Comp,Psychotherapy,PTSD,67,B,PTSD,,19,,IE,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,39,Self report,PSS-SR,PSS-SR (Dutch version),Completer,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",Assessment at <3 Months,4,,18.16,14.97,,,,,-9.37,,,,,Cohen's d,0.76,,,,,,,,,,,,,,,PSS-SR (Dutch version) score ≤20,0.5789,,Community,,,1,0.6567,,0.3433,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)",High,"Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.",30284,2019
arntz2007_PSS-SR_B_4_ITT,Psychotherapy,PTSD,67,B,PTSD,,23,,IE,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,39,Self report,PSS-SR,PSS-SR (Dutch version),ITT,LOCF,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",Assessment at <3 Months,4,,18.97,13.93,,,,,-6.06,,,,,Cohen's d,0.51,,,,,,,,,,,,,,,PSS-SR (Dutch version) score ≤20,0.5385,,Community,,,1,0.6567,,0.3433,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)",High,"Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.",30284,2019
arntz2007_PSS-SR_B_Baseline_Comp,Psychotherapy,PTSD,67,B,PTSD,,19,,IE,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,39,Self report,PSS-SR,PSS-SR (Dutch version),Completer,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",Baseline,,,27.53,10.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6567,,0.3433,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)",High,"Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.",30284,2019
arntz2007_PSS-SR_B_Baseline_ITT,Psychotherapy,PTSD,67,B,PTSD,,39,,IE,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,39,Self report,PSS-SR,PSS-SR (Dutch version),ITT,LOCF,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",Baseline,,,25.03,10.88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6567,,0.3433,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)",High,"Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.",30284,2019
arntz2007_PSS-SR_C_0_Comp,Psychotherapy,PTSD,67,C,Control,,17,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,21,Self report,PSS-SR,PSS-SR (Dutch version),Completer,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",End of Treatment,0,,27.47,12.16,,,,,0.53,,,,,Cohen's d,-0.04,,,,p=NS,,,,,,,,,,,PSS-SR (Dutch version) score ≤20,,,Community,,,1,0.6567,,0.3433,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)",High,"Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.",30284,2019
arntz2007_PSS-SR_C_Baseline_Comp,Psychotherapy,PTSD,67,C,Control,,17,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,21,Self report,PSS-SR,PSS-SR (Dutch version),Completer,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",Baseline,,,26.94,12.83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6567,,0.3433,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)",High,"Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. Journal of Behavior Therapy and Experimental Psychiatry. 2007 2016-09-15;38(4):345-70. doi: http://dx.doi.org/10.1016/j.jbtep.2007.10.006. PMID: 18005935.",30284,2019
asukai2010_CAPS_A_0_ITT,Psychotherapy,PTSD,24,A,PTSD,,12,,PE + TAU,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Structured Clinical Interview,CAPS,CAPS,ITT,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",End of Treatment,0,,43.76,,SE,8.43,,,-40.82,,,,,Hedges' g,0.95,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,15-point decrease from CAPS baseline,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.875,,0.125,Mixed,"rape/sexual assault, accidents, community/school violence",Medium,"Asukai N, Saito A, Tsuruta N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: A randomized controlled study. J Trauma Stress. 2010 Dec;23(6):744-50. doi: 10.1002/jts.20589. PMID: 21171135.",84311,2019
asukai2010_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,24,A,PTSD,,12,,PE + TAU,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Structured Clinical Interview,CAPS,CAPS,ITT,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",Baseline,,,84.58,,SE,7.78,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.875,,0.125,Mixed,"rape/sexual assault, accidents, community/school violence",Medium,"Asukai N, Saito A, Tsuruta N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: A randomized controlled study. J Trauma Stress. 2010 Dec;23(6):744-50. doi: 10.1002/jts.20589. PMID: 21171135.",84311,2019
asukai2010_CAPS_B_0_ITT,Psychotherapy,PTSD,24,B,Control,,12,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Structured Clinical Interview,CAPS,CAPS,ITT,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",End of Treatment,0,,84.81,,SE,7.96,,,0.48,,,,,Hedges' g,0.71,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,15-point decrease from CAPS baseline,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.875,,0.125,Mixed,"rape/sexual assault, accidents, community/school violence",Medium,"Asukai N, Saito A, Tsuruta N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: A randomized controlled study. J Trauma Stress. 2010 Dec;23(6):744-50. doi: 10.1002/jts.20589. PMID: 21171135.",84311,2019
asukai2010_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,24,B,Control,,12,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Structured Clinical Interview,CAPS,CAPS,ITT,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",Baseline,,,84.33,,SE,7.78,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.875,,0.125,Mixed,"rape/sexual assault, accidents, community/school violence",Medium,"Asukai N, Saito A, Tsuruta N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: A randomized controlled study. J Trauma Stress. 2010 Dec;23(6):744-50. doi: 10.1002/jts.20589. PMID: 21171135.",84311,2019
asukai2010_IES_A_0_NA,Psychotherapy,PTSD,24,A,PTSD,,,,PE + TAU,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Self report,IES,IES-R (Japanese version),,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",End of Treatment,0,,21.15,,SE,5.53,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.875,,0.125,Mixed,"rape/sexual assault, accidents, community/school violence",Medium,"Asukai N, Saito A, Tsuruta N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: A randomized controlled study. J Trauma Stress. 2010 Dec;23(6):744-50. doi: 10.1002/jts.20589. PMID: 21171135.",84311,2019
asukai2010_IES_A_Baseline_NA,Psychotherapy,PTSD,24,A,PTSD,,,,PE + TAU,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Self report,IES,IES-R (Japanese version),,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",Baseline,,,59.67,,SE,5.06,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.875,,0.125,Mixed,"rape/sexual assault, accidents, community/school violence",Medium,"Asukai N, Saito A, Tsuruta N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: A randomized controlled study. J Trauma Stress. 2010 Dec;23(6):744-50. doi: 10.1002/jts.20589. PMID: 21171135.",84311,2019
asukai2010_IES_B_0_NA,Psychotherapy,PTSD,24,B,Control,,,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Self report,IES,IES-R (Japanese version),,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",End of Treatment,0,,53.75,,SE,5.2,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.875,,0.125,Mixed,"rape/sexual assault, accidents, community/school violence",Medium,"Asukai N, Saito A, Tsuruta N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: A randomized controlled study. J Trauma Stress. 2010 Dec;23(6):744-50. doi: 10.1002/jts.20589. PMID: 21171135.",84311,2019
asukai2010_IES_B_Baseline_NA,Psychotherapy,PTSD,24,B,Control,,,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Self report,IES,IES-R (Japanese version),,,"ANCOVA and Hedges' g for change in mean score between groups, paired t-test for within-group",Baseline,,,59.75,,SE,5.06,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.875,,0.125,Mixed,"rape/sexual assault, accidents, community/school violence",Medium,"Asukai N, Saito A, Tsuruta N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: A randomized controlled study. J Trauma Stress. 2010 Dec;23(6):744-50. doi: 10.1002/jts.20589. PMID: 21171135.",84311,2019
back2019_CAPS_A_0_Comp,Psychotherapy,PTSD+SUD,81,A,PTSD+SUD,Integrated,29,,COPE,Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS-IV,Completer,"multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS-IV score <50,0.828,,,,,Veteran,0,1,0,0.091,,0.909,Mixed,"Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)",Medium,"Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.",51384,2020
back2019_CAPS_A_0_ITT,Psychotherapy,PTSD+SUD,81,A,PTSD+SUD,Integrated,30,,COPE,Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS-IV,ITT,"multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,27.2,19.4,,,,,-51.2,,-59.7,-42.8,,,,,,,,,,,,,,,CAPS-IV score <50,0.593,,,,,Veteran,0,1,0,0.091,,0.909,Mixed,"Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)",Medium,"Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.",51384,2020
back2019_CAPS_A_12_ITT,Psychotherapy,PTSD+SUD,81,A,PTSD+SUD,Integrated,28,,COPE,Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS-IV,ITT,"multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.091,,0.909,Mixed,"Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)",Medium,"Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.",51384,2020
back2019_CAPS_A_26_ITT,Psychotherapy,PTSD+SUD,81,A,PTSD+SUD,Integrated,18,,COPE,Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS-IV,ITT,"multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Assessment at 6 to <12 Months,26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.091,,0.909,Mixed,"Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)",Medium,"Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.",51384,2020
back2019_CAPS_A_Baseline_Comp,Psychotherapy,PTSD+SUD,81,A,PTSD+SUD,Integrated,29,,COPE,Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS-IV,Completer,"multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.091,,0.909,Mixed,"Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)",Medium,"Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.",51384,2020
back2019_CAPS_A_Baseline_ITT,Psychotherapy,PTSD+SUD,81,A,PTSD+SUD,Integrated,54,,COPE,Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS-IV,ITT,"multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,77.4,18.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.091,,0.909,Mixed,"Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)",Medium,"Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.",51384,2020
back2019_CAPS_B_0_Comp,Psychotherapy,PTSD+SUD,81,B,SUD,Not integrated,13,,Relapse Prevention,Relapse Prevention,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,27,Structured Clinical Interview,CAPS,CAPS-IV,Completer,"multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS-IV score <50,0.385,,,,,Veteran,0,1,0,0.091,,0.909,Mixed,"Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)",Medium,"Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.",51384,2020
back2019_CAPS_B_0_ITT,Psychotherapy,PTSD+SUD,81,B,SUD,Not integrated,14,,Relapse Prevention,Relapse Prevention,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,27,Structured Clinical Interview,CAPS,CAPS-IV,ITT,"multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,49.7,25.3,,,,,-35.9,,-48.8,-23,,,,,,,,,,,,,,,CAPS-IV score <50,0.222,,,,,Veteran,0,1,0,0.091,,0.909,Mixed,"Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)",Medium,"Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.",51384,2020
back2019_CAPS_B_12_ITT,Psychotherapy,PTSD+SUD,81,B,SUD,Not integrated,11,,Relapse Prevention,Relapse Prevention,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,27,Structured Clinical Interview,CAPS,CAPS-IV,ITT,"multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.091,,0.909,Mixed,"Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)",Medium,"Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.",51384,2020
back2019_CAPS_B_26_ITT,Psychotherapy,PTSD+SUD,81,B,SUD,Not integrated,12,,Relapse Prevention,Relapse Prevention,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,27,Structured Clinical Interview,CAPS,CAPS-IV,ITT,"multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Assessment at 6 to <12 Months,26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.091,,0.909,Mixed,"Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)",Medium,"Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.",51384,2020
back2019_CAPS_B_Baseline_Comp,Psychotherapy,PTSD+SUD,81,B,SUD,Not integrated,13,,Relapse Prevention,Relapse Prevention,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,27,Structured Clinical Interview,CAPS,CAPS-IV,Completer,"multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.091,,0.909,Mixed,"Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)",Medium,"Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.",51384,2020
back2019_CAPS_B_Baseline_ITT,Psychotherapy,PTSD+SUD,81,B,SUD,Not integrated,27,,Relapse Prevention,Relapse Prevention,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,27,Structured Clinical Interview,CAPS,CAPS-IV,ITT,"multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,84.7,17.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.091,,0.909,Mixed,"Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)",Medium,"Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.",51384,2020
back2019_PCL_A_0_ITT,Psychotherapy,PTSD+SUD,81,A,PTSD+SUD,Integrated,,,COPE,Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Self report,PCL,PCL-M,ITT,"multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,37.6,17.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.091,,0.909,Mixed,"Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)",Medium,"Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.",51384,2020
back2019_PCL_A_Baseline_ITT,Psychotherapy,PTSD+SUD,81,A,PTSD+SUD,Integrated,,,COPE,Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Self report,PCL,PCL-M,ITT,"multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,62.2,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.091,,0.909,Mixed,"Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)",Medium,"Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.",51384,2020
back2019_PCL_B_0_ITT,Psychotherapy,PTSD+SUD,81,B,SUD,Not integrated,,,Relapse Prevention,Relapse Prevention,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,27,Self report,PCL,PCL-M,ITT,"multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,53.1,14.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.091,,0.909,Mixed,"Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)",Medium,"Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.",51384,2020
back2019_PCL_B_Baseline_ITT,Psychotherapy,PTSD+SUD,81,B,SUD,Not integrated,,,Relapse Prevention,Relapse Prevention,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,27,Self report,PCL,PCL-M,ITT,"multilevel model utilizing robust maximum likelihood, uses all available data","PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,64.3,8.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.091,,0.909,Mixed,"Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)",Medium,"Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.",51384,2020
badurabrack2015astudy1_PCL_A_0_ITT,Nonpharmacologic cognitive,PTSD,52,A,PTSD,,14,,Attention Bias Modification,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In Person,27,Self report,PCL,PCL,ITT,Imputed using generalized estimating equations,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,56.57,2.74,,,,,-3.82,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.",44617,2019
badurabrack2015astudy1_PCL_A_Baseline_ITT,Nonpharmacologic cognitive,PTSD,52,A,PTSD,,27,,Attention Bias Modification,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In Person,27,Self report,PCL,PCL,ITT,Imputed using generalized estimating equations,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,60.39,1.77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.",44617,2019
badurabrack2015astudy1_PCL_B_0_ITT,Nonpharmacologic cognitive,PTSD,52,B,PTSD,,15,,Attention Control Training,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In Person,25,Self report,PCL,PCL,ITT,Imputed using generalized estimating equations,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,45.34,3.58,,,,,-12.95,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.",44617,2019
badurabrack2015astudy1_PCL_B_Baseline_ITT,Nonpharmacologic cognitive,PTSD,52,B,PTSD,,27,,Attention Control Training,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In Person,25,Self report,PCL,PCL,ITT,Imputed using generalized estimating equations,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,58.29,1.84,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.",44617,2019
badurabrack2015bstudy2_CAPS_A_0_ITT,Nonpharmacologic cognitive,PTSD,46,A,PTSD,,17,,Attention Bias Modification,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using generalized estimating equations,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,56.19,4.9,,,,,-15.99,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.",44617,2019
badurabrack2015bstudy2_CAPS_A_Baseline_ITT,Nonpharmacologic cognitive,PTSD,46,A,PTSD,,22,,Attention Bias Modification,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using generalized estimating equations,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,72.18,3.53,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.",44617,2019
badurabrack2015bstudy2_CAPS_B_0_ITT,Nonpharmacologic cognitive,PTSD,46,B,PTSD,,15,,Attention Control Training,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In Person,24,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using generalized estimating equations,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,44.13,4.92,,,,,-28.2,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.",44617,2019
badurabrack2015bstudy2_CAPS_B_Baseline_ITT,Nonpharmacologic cognitive,PTSD,46,B,PTSD,,17,,Attention Control Training,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In Person,24,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using generalized estimating equations,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,72.33,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.",44617,2019
badurabrack2015bstudy2_PCL_A_0_ITT,Nonpharmacologic cognitive,PTSD,46,A,PTSD,,,,Attention Bias Modification,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In Person,22,Self report,PCL,PCL-M,ITT,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,50.17,2.96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.",44617,2019
badurabrack2015bstudy2_PCL_A_Baseline_ITT,Nonpharmacologic cognitive,PTSD,46,A,PTSD,,,,Attention Bias Modification,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In Person,22,Self report,PCL,PCL-M,ITT,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,51.68,2.66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.",44617,2019
badurabrack2015bstudy2_PCL_B_0_ITT,Nonpharmacologic cognitive,PTSD,46,B,PTSD,,,,Attention Control Training,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In Person,24,Self report,PCL,PCL-M,ITT,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,45.40,3.22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.",44617,2019
badurabrack2015bstudy2_PCL_B_Baseline_ITT,Nonpharmacologic cognitive,PTSD,46,B,PTSD,,,,Attention Control Training,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In Person,24,Self report,PCL,PCL-M,ITT,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,54.16,1.82,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.",44617,2019
baker1995_CAPS_A_0_ITT,Pharmacotherapy,PTSD,118,A,PTSD,,56,,Brofaromine,Brofaromine,No,Not Applicable,Yes,Antidepressant: MAOI,No,Not Applicable,No,No,No,No,No,Individual,In Person,56,Structured Clinical Interview,CAPS,CAPS,ITT,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,54.86,,,,,,-27.3,,,,,,,,,,p=0.001,,,,,,,,,,,,,,Mixed,0,0.602,0.398,0.193,,0.807,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Baker DG, Diamond BI, Gillette GM, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386-9. doi: 10.1007/BF02246271. PMID: 8657838.",06773,2019
baker1995_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,118,A,PTSD,,56,,Brofaromine,Brofaromine,No,Not Applicable,Yes,Antidepressant: MAOI,No,Not Applicable,No,No,No,No,No,Individual,In Person,56,Structured Clinical Interview,CAPS,CAPS,ITT,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,83.6,17.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.602,0.398,0.193,,0.807,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Baker DG, Diamond BI, Gillette GM, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386-9. doi: 10.1007/BF02246271. PMID: 8657838.",06773,2019
baker1995_CAPS_B_0_ITT,Pharmacotherapy,PTSD,118,B,Control,,58,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,58,Structured Clinical Interview,CAPS,CAPS,ITT,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,54.98,,,,,,-24.68,,,,,,,,,,p=0.001,,,,,,,,,,,,,,Mixed,0,0.602,0.398,0.193,,0.807,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Baker DG, Diamond BI, Gillette GM, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386-9. doi: 10.1007/BF02246271. PMID: 8657838.",06773,2019
baker1995_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,118,B,Control,,58,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,58,Structured Clinical Interview,CAPS,CAPS,ITT,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,83.2,18.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.602,0.398,0.193,,0.807,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Baker DG, Diamond BI, Gillette GM, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386-9. doi: 10.1007/BF02246271. PMID: 8657838.",06773,2019
baker1995_IES_A_0_NA,Pharmacotherapy,PTSD,118,A,PTSD,,,,Brofaromine,Brofaromine,No,Not Applicable,Yes,Antidepressant: MAOI,No,Not Applicable,No,No,No,No,No,Individual,In Person,56,Self report,IES,IES,,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.602,0.398,0.193,,0.807,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Baker DG, Diamond BI, Gillette GM, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386-9. doi: 10.1007/BF02246271. PMID: 8657838.",06773,2019
baker1995_IES_A_Baseline_NA,Pharmacotherapy,PTSD,118,A,PTSD,,,,Brofaromine,Brofaromine,No,Not Applicable,Yes,Antidepressant: MAOI,No,Not Applicable,No,No,No,No,No,Individual,In Person,56,Self report,IES,IES,,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,31.9,7.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.602,0.398,0.193,,0.807,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Baker DG, Diamond BI, Gillette GM, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386-9. doi: 10.1007/BF02246271. PMID: 8657838.",06773,2019
baker1995_IES_B_0_NA,Pharmacotherapy,PTSD,118,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,58,Self report,IES,IES,,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.602,0.398,0.193,,0.807,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Baker DG, Diamond BI, Gillette GM, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386-9. doi: 10.1007/BF02246271. PMID: 8657838.",06773,2019
baker1995_IES_B_Baseline_NA,Pharmacotherapy,PTSD,118,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,58,Self report,IES,IES,,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,32.1,6.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.602,0.398,0.193,,0.807,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Baker DG, Diamond BI, Gillette GM, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386-9. doi: 10.1007/BF02246271. PMID: 8657838.",06773,2019
baniasadi2014_PCL-M_A_0_ITT,Pharmacotherapy,PTSD,37,A,PTSD,,18,,Pregabalin augmentation,Pregabalin,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Self report,PCL-M,PCL-M,ITT,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,48.77,7.01,,,,,-8.06,,,,,,,,,,p=0.0001,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Baniasadi M, Hosseini G, Fayyazi Bordbar MR, et al. Effect of pregabalin augmentation in treatment of patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Psychiatr Pract. 2014 Nov;20(6):419-27. doi: 10.1097/01.pra.0000456590.12998.41. PMID: 25406046.",44618,2019
baniasadi2014_PCL-M_A_Baseline_ITT,Pharmacotherapy,PTSD,37,A,PTSD,,18,,Pregabalin augmentation,Pregabalin,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Self report,PCL-M,PCL-M,ITT,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,56.83,7.66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Baniasadi M, Hosseini G, Fayyazi Bordbar MR, et al. Effect of pregabalin augmentation in treatment of patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Psychiatr Pract. 2014 Nov;20(6):419-27. doi: 10.1097/01.pra.0000456590.12998.41. PMID: 25406046.",44618,2019
baniasadi2014_PCL-M_B_0_ITT,Pharmacotherapy,PTSD,37,B,Control,,19,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Self report,PCL-M,PCL-M,ITT,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,50.79,6.01,,,,,-4.31,,,,,,,,,,p=0.0001,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Baniasadi M, Hosseini G, Fayyazi Bordbar MR, et al. Effect of pregabalin augmentation in treatment of patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Psychiatr Pract. 2014 Nov;20(6):419-27. doi: 10.1097/01.pra.0000456590.12998.41. PMID: 25406046.",44618,2019
baniasadi2014_PCL-M_B_Baseline_ITT,Pharmacotherapy,PTSD,37,B,Control,,19,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Self report,PCL-M,PCL-M,ITT,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,55.10,7.75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Baniasadi M, Hosseini G, Fayyazi Bordbar MR, et al. Effect of pregabalin augmentation in treatment of patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Psychiatr Pract. 2014 Nov;20(6):419-27. doi: 10.1097/01.pra.0000456590.12998.41. PMID: 25406046.",44618,2019
basoglu2005_CAPS_A_0_Comp,Psychotherapy,PTSD,59,A,PTSD,,31,,Modified behavioral treatment,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS (Turkish version),Completer,Excluded,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,44.4,25,,,,,-23.4,,,,,Cohen's d,1.3,,,,p<0.001,,,,,,,,,,,,,,Community,,,1,0.8475,,0.1525,Natural or manmade disasters,,Medium,"Basoglu M, Salcioglu E, Livanou M, et al. Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial. J Trauma Stress. 2005;18(1):1-11. doi: 10.1002/jts.20011. PMID: 16281190.",18886,2019
basoglu2005_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,59,A,PTSD,,31,,Modified behavioral treatment,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS (Turkish version),Completer,Excluded,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,67.8,16.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8475,,0.1525,Natural or manmade disasters,,Medium,"Basoglu M, Salcioglu E, Livanou M, et al. Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial. J Trauma Stress. 2005;18(1):1-11. doi: 10.1002/jts.20011. PMID: 16281190.",18886,2019
basoglu2005_CAPS_B_0_Comp,Psychotherapy,PTSD,59,B,Control,,28,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,28,Structured Clinical Interview,CAPS,CAPS (Turkish version),Completer,Excluded,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,54.7,21.4,,,,,-5.8,,,,,Cohen's d,0.3,,,,p≥0.05,,,,,,,,,,,,,,Community,,,1,0.8475,,0.1525,Natural or manmade disasters,,Medium,"Basoglu M, Salcioglu E, Livanou M, et al. Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial. J Trauma Stress. 2005;18(1):1-11. doi: 10.1002/jts.20011. PMID: 16281190.",18886,2019
basoglu2005_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,59,B,Control,,28,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,28,Structured Clinical Interview,CAPS,CAPS (Turkish version),Completer,Excluded,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,60.5,14.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8475,,0.1525,Natural or manmade disasters,,Medium,"Basoglu M, Salcioglu E, Livanou M, et al. Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial. J Trauma Stress. 2005;18(1):1-11. doi: 10.1002/jts.20011. PMID: 16281190.",18886,2019
basoglu2005_Trau_A_0_NA,Psychotherapy,PTSD,59,A,PTSD,,,,Modified behavioral treatment,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Self report,Traumatic Stress Symptom Checklist,Traumatic Stress Symptom Checklist,,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,25.3,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8475,,0.1525,Natural or manmade disasters,,Medium,"Basoglu M, Salcioglu E, Livanou M, et al. Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial. J Trauma Stress. 2005;18(1):1-11. doi: 10.1002/jts.20011. PMID: 16281190.",18886,2019
basoglu2005_Trau_A_Baseline_NA,Psychotherapy,PTSD,59,A,PTSD,,,,Modified behavioral treatment,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Self report,Traumatic Stress Symptom Checklist,Traumatic Stress Symptom Checklist,,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,42.0,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8475,,0.1525,Natural or manmade disasters,,Medium,"Basoglu M, Salcioglu E, Livanou M, et al. Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial. J Trauma Stress. 2005;18(1):1-11. doi: 10.1002/jts.20011. PMID: 16281190.",18886,2019
basoglu2005_Trau_B_0_NA,Psychotherapy,PTSD,59,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,28,Self report,Traumatic Stress Symptom Checklist,Traumatic Stress Symptom Checklist,,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",End of Treatment,0,,32.6,13.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8475,,0.1525,Natural or manmade disasters,,Medium,"Basoglu M, Salcioglu E, Livanou M, et al. Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial. J Trauma Stress. 2005;18(1):1-11. doi: 10.1002/jts.20011. PMID: 16281190.",18886,2019
basoglu2005_Trau_B_Baseline_NA,Psychotherapy,PTSD,59,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,28,Self report,Traumatic Stress Symptom Checklist,Traumatic Stress Symptom Checklist,,,"PTSD scores: Random intercept and slope mutilevel models utilizing robust maximum likelihood. Effect sizes as regression coefficients standardized to baseline SD of each outcome in total sample.
Diagnostic change: binary logistic regression",Baseline,,,39.9,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8475,,0.1525,Natural or manmade disasters,,Medium,"Basoglu M, Salcioglu E, Livanou M, et al. Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial. J Trauma Stress. 2005;18(1):1-11. doi: 10.1002/jts.20011. PMID: 16281190.",18886,2019
basoglu2007_CAPS_A_0_ITT,Psychotherapy,PTSD,31,A,PTSD,,15,,Behavioral treatment,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,16,Structured Clinical Interview,CAPS,CAPS,ITT,,Repeated measures ANOVA and Cohen's d for change in mean score,End of Treatment,0,,38.7,18.7,,,,,-24.4,,,,,,,,,,,,,,,,,,,,,Very/much improved on CGI-I,,,Community,0,0,1,0.871,,0.129,Natural or manmade disasters,,Medium,"Basoglu M, Salcioglu E, Livanou M. A randomized controlled study of single-session behavioural treatment of earthquake-related post-traumatic stress disorder using an earthquake simulator. Psychological Medicine. 2007;37(2):203-13. doi: 10.1017/S0033291706009123. PMID: 17254365.",29446,2020
basoglu2007_CAPS_A_4_ITT,Psychotherapy,PTSD,31,A,PTSD,,16,,Behavioral treatment,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,16,Structured Clinical Interview,CAPS,CAPS,ITT,,Repeated measures ANOVA and Cohen's d for change in mean score,Assessment at <3 Months,4,,30.2,20.3,,,,,-32.9,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.871,,0.129,Natural or manmade disasters,,Medium,"Basoglu M, Salcioglu E, Livanou M. A randomized controlled study of single-session behavioural treatment of earthquake-related post-traumatic stress disorder using an earthquake simulator. Psychological Medicine. 2007;37(2):203-13. doi: 10.1017/S0033291706009123. PMID: 17254365.",29446,2020
basoglu2007_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,31,A,PTSD,,16,,Behavioral treatment,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,16,Structured Clinical Interview,CAPS,CAPS,ITT,,Repeated measures ANOVA and Cohen's d for change in mean score,Baseline,,,63.1,10.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.871,,0.129,Natural or manmade disasters,,Medium,"Basoglu M, Salcioglu E, Livanou M. A randomized controlled study of single-session behavioural treatment of earthquake-related post-traumatic stress disorder using an earthquake simulator. Psychological Medicine. 2007;37(2):203-13. doi: 10.1017/S0033291706009123. PMID: 17254365.",29446,2020
basoglu2007_CAPS_B_0_ITT,Psychotherapy,PTSD,31,B,Control,,15,,Repeated assessment,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,15,Structured Clinical Interview,CAPS,CAPS,ITT,,Repeated measures ANOVA and Cohen's d for change in mean score,End of Treatment,0,,54.5,16.9,,,,,-7.8,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.871,,0.129,Natural or manmade disasters,,Medium,"Basoglu M, Salcioglu E, Livanou M. A randomized controlled study of single-session behavioural treatment of earthquake-related post-traumatic stress disorder using an earthquake simulator. Psychological Medicine. 2007;37(2):203-13. doi: 10.1017/S0033291706009123. PMID: 17254365.",29446,2020
basoglu2007_CAPS_B_4_ITT,Psychotherapy,PTSD,31,B,Control,,15,,Repeated assessment,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,15,Structured Clinical Interview,CAPS,CAPS,ITT,,Repeated measures ANOVA and Cohen's d for change in mean score,Assessment at <3 Months,4,,49.1,20.3,,,,,-13.2,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.871,,0.129,Natural or manmade disasters,,Medium,"Basoglu M, Salcioglu E, Livanou M. A randomized controlled study of single-session behavioural treatment of earthquake-related post-traumatic stress disorder using an earthquake simulator. Psychological Medicine. 2007;37(2):203-13. doi: 10.1017/S0033291706009123. PMID: 17254365.",29446,2020
basoglu2007_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,31,B,Control,,15,,Repeated assessment,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,15,Structured Clinical Interview,CAPS,CAPS,ITT,,Repeated measures ANOVA and Cohen's d for change in mean score,Baseline,,,62.3,14.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.871,,0.129,Natural or manmade disasters,,Medium,"Basoglu M, Salcioglu E, Livanou M. A randomized controlled study of single-session behavioural treatment of earthquake-related post-traumatic stress disorder using an earthquake simulator. Psychological Medicine. 2007;37(2):203-13. doi: 10.1017/S0033291706009123. PMID: 17254365.",29446,2020
batki2014_PCL_A_0_ITT,Pharmacotherapy,PTSD+SUD,30,A,PTSD+SUD,Not integrated,,,Topiramate,Topiramate,No,Not Applicable,Yes,Mood stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In person,14,Self report,PCL,PCL,ITT,Linear mixed models,Random-intercept linear mixed models,End of Treatment,0,average weeks 1 through 12,42.3,16,,,,difference between baseline and average of weeks 1 through 12,-14.8,,,,average relative change in outcome per week from baseline through week 12,Incidence rate ratio,-1.22,95% CI,-1.84,0.62,p=0.001,,,,,,,,,,,,,,Veteran,0,1,0,0.0667,,0.9333,Mixed,"combat-related, other (""civilian related trauma"")",Medium,"Batki SL, Pennington DL, Lasher B, et al. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial. Alcohol Clin Exp Res. 2014 Aug;38(8):2169-77. doi: 10.1111/acer.12496. PMID: 25092377.",42646,2020
batki2014_PCL_A_Baseline_ITT,Pharmacotherapy,PTSD+SUD,30,A,PTSD+SUD,Not integrated,14,,Topiramate,Topiramate,No,Not Applicable,Yes,Mood stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In person,14,Self report,PCL,PCL,ITT,Linear mixed models,Random-intercept linear mixed models,Baseline,,,57.1,13.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0667,,0.9333,Mixed,"combat-related, other (""civilian related trauma"")",Medium,"Batki SL, Pennington DL, Lasher B, et al. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial. Alcohol Clin Exp Res. 2014 Aug;38(8):2169-77. doi: 10.1111/acer.12496. PMID: 25092377.",42646,2020
batki2014_PCL_B_0_ITT,Pharmacotherapy,PTSD+SUD,30,B,Control,Not integrated,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,16,Self report,PCL,PCL,ITT,Linear mixed models,Random-intercept linear mixed models,End of Treatment,0,average weeks 1 through 12,49.0,16.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0667,,0.9333,Mixed,"combat-related, other (""civilian related trauma"")",Medium,"Batki SL, Pennington DL, Lasher B, et al. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial. Alcohol Clin Exp Res. 2014 Aug;38(8):2169-77. doi: 10.1111/acer.12496. PMID: 25092377.",42646,2020
batki2014_PCL_B_Baseline_ITT,Pharmacotherapy,PTSD+SUD,30,B,Control,Not integrated,16,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,16,Self report,PCL,PCL,ITT,Linear mixed models,Random-intercept linear mixed models,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0667,,0.9333,Mixed,"combat-related, other (""civilian related trauma"")",Medium,"Batki SL, Pennington DL, Lasher B, et al. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial. Alcohol Clin Exp Res. 2014 Aug;38(8):2169-77. doi: 10.1111/acer.12496. PMID: 25092377.",42646,2020
battaglia2016_PCL_A_0_ITT,Other mixed,PTSD+SUD,175,A,PTSD+SUD,Not integrated,62,,MI for smoking cessation + PTSD home telehealth care management program,Motivational Interviewing (MI) for smoking cessation + PTSD home telehealth care management program,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,Yes,Individual,Mixed,89,Self report,PCL,PCL,ITT,,Mean score differences between groups using t-test (nonparametric tests if skewed) and linear regression models,End of Treatment,0,,54.5,13.2,,,,,-2.8,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1371,,0.8629,,,Medium,"Battaglia C, Peterson J, Whitfield E, et al. Integrating motivational interviewing into a home telehealth program for veterans with posttraumatic stress disorder who smoke: a randomized controlled trial. J Clin Psychol. 2016 Mar;72(3):194-206. doi: 10.1002/jclp.22252. PMID: 26783736.",49060,2020
battaglia2016_PCL_A_26_ITT,Other mixed,PTSD+SUD,175,A,PTSD+SUD,Not integrated,61,,MI for smoking cessation + PTSD home telehealth care management program,Motivational Interviewing (MI) for smoking cessation + PTSD home telehealth care management program,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,Yes,Individual,Mixed,89,Self report,PCL,PCL,ITT,,Mean score differences between groups using t-test (nonparametric tests if skewed) and linear regression models,Assessment at 6 to <12 Months,26,,58.4,11.4,,,,,1.1,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1371,,0.8629,,,Medium,"Battaglia C, Peterson J, Whitfield E, et al. Integrating motivational interviewing into a home telehealth program for veterans with posttraumatic stress disorder who smoke: a randomized controlled trial. J Clin Psychol. 2016 Mar;72(3):194-206. doi: 10.1002/jclp.22252. PMID: 26783736.",49060,2020
battaglia2016_PCL_A_Baseline_ITT,Other mixed,PTSD+SUD,175,A,PTSD+SUD,Not integrated,84,,MI for smoking cessation + PTSD home telehealth care management program,Motivational Interviewing (MI) for smoking cessation + PTSD home telehealth care management program,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,Yes,Individual,Mixed,89,Self report,PCL,PCL,ITT,,Mean score differences between groups using t-test (nonparametric tests if skewed) and linear regression models,Baseline,,,57.3,11.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1371,,0.8629,,,Medium,"Battaglia C, Peterson J, Whitfield E, et al. Integrating motivational interviewing into a home telehealth program for veterans with posttraumatic stress disorder who smoke: a randomized controlled trial. J Clin Psychol. 2016 Mar;72(3):194-206. doi: 10.1002/jclp.22252. PMID: 26783736.",49060,2020
battaglia2016_PCL_B_0_ITT,Other mixed,PTSD+SUD,175,B,PTSD,Not integrated,59,,PTSD home telehealth care management program,PTSD home telehealth care management program,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Technology alone,86,Self report,PCL,PCL,ITT,,Mean score differences between groups using t-test (nonparametric tests if skewed) and linear regression models,End of Treatment,0,,55.9,13.5,,,,,-4.5,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1371,,0.8629,,,Medium,"Battaglia C, Peterson J, Whitfield E, et al. Integrating motivational interviewing into a home telehealth program for veterans with posttraumatic stress disorder who smoke: a randomized controlled trial. J Clin Psychol. 2016 Mar;72(3):194-206. doi: 10.1002/jclp.22252. PMID: 26783736.",49060,2020
battaglia2016_PCL_B_26_ITT,Other mixed,PTSD+SUD,175,B,PTSD,Not integrated,59,,PTSD home telehealth care management program,PTSD home telehealth care management program,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Technology alone,86,Self report,PCL,PCL,ITT,,Mean score differences between groups using t-test (nonparametric tests if skewed) and linear regression models,Assessment at 6 to <12 Months,26,,62.4,10.9,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1371,,0.8629,,,Medium,"Battaglia C, Peterson J, Whitfield E, et al. Integrating motivational interviewing into a home telehealth program for veterans with posttraumatic stress disorder who smoke: a randomized controlled trial. J Clin Psychol. 2016 Mar;72(3):194-206. doi: 10.1002/jclp.22252. PMID: 26783736.",49060,2020
battaglia2016_PCL_B_Baseline_ITT,Other mixed,PTSD+SUD,175,B,PTSD,Not integrated,81,,PTSD home telehealth care management program,PTSD home telehealth care management program,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Technology alone,86,Self report,PCL,PCL,ITT,,Mean score differences between groups using t-test (nonparametric tests if skewed) and linear regression models,Baseline,,,60.4,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1371,,0.8629,,,Medium,"Battaglia C, Peterson J, Whitfield E, et al. Integrating motivational interviewing into a home telehealth program for veterans with posttraumatic stress disorder who smoke: a randomized controlled trial. J Clin Psychol. 2016 Mar;72(3):194-206. doi: 10.1002/jclp.22252. PMID: 26783736.",49060,2020
battersby2013_PCL_A_0_ITT,Collaborative care,PTSD,82,A,PTSD,,44,,Flinders Program + Usual Care,Flinders Program,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,Yes,Individual,Mixed,46,Self report,PCL,PCL-M,ITT,Used available data (not imputed),"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",End of Treatment,0,,48.95,10.39,,,,,-4.46,,,,,Cohen's d,-0.42,,,,p<0.01,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,Medium,"Battersby MW, Beattie J, Pols RG, et al. A randomised controlled trial of the Flinders Program™ of chronic condition management in Vietnam veterans with co-morbid alcohol misuse, and psychiatric and medical conditions. Aust N Z J Psychiatry. 2013 May;47(5):451-62. doi: 10.1177/0004867412471977. PMID: 23307806.",,2020
battersby2013_PCL_A_39_ITT,Collaborative care,PTSD,82,A,PTSD,,25,,Flinders Program + Usual Care,Flinders Program,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,Yes,Individual,Mixed,46,Self report,PCL,PCL-M,ITT,Used available data (not imputed),"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",Assessment at 6 to <12 Months,39,,44.04,13.21,,,,,-9.37,,,,,Cohen's d,-0.71,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,Medium,"Battersby MW, Beattie J, Pols RG, et al. A randomised controlled trial of the Flinders Program™ of chronic condition management in Vietnam veterans with co-morbid alcohol misuse, and psychiatric and medical conditions. Aust N Z J Psychiatry. 2013 May;47(5):451-62. doi: 10.1177/0004867412471977. PMID: 23307806.",,2020
battersby2013_PCL_A_Baseline_ITT,Collaborative care,PTSD,82,A,PTSD,,44,,Flinders Program + Usual Care,Flinders Program,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,Yes,Individual,Mixed,46,Self report,PCL,PCL-M,ITT,Used available data (not imputed),"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",Baseline,,,53.41,10.95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,Medium,"Battersby MW, Beattie J, Pols RG, et al. A randomised controlled trial of the Flinders Program™ of chronic condition management in Vietnam veterans with co-morbid alcohol misuse, and psychiatric and medical conditions. Aust N Z J Psychiatry. 2013 May;47(5):451-62. doi: 10.1177/0004867412471977. PMID: 23307806.",,2020
battersby2013_PCL_B_0_ITT,Collaborative care,PTSD,82,B,Control,,28,,Usual care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,31,Self report,PCL,PCL-M,ITT,Used available data (not imputed),"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",End of Treatment,0,,47.00,13.75,,,,,-5.57,,,,,Cohen's d,-0.41,,,,p<0.01,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,Medium,"Battersby MW, Beattie J, Pols RG, et al. A randomised controlled trial of the Flinders Program™ of chronic condition management in Vietnam veterans with co-morbid alcohol misuse, and psychiatric and medical conditions. Aust N Z J Psychiatry. 2013 May;47(5):451-62. doi: 10.1177/0004867412471977. PMID: 23307806.",,2020
battersby2013_PCL_B_Baseline_ITT,Collaborative care,PTSD,82,B,Control,,28,,Usual care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,31,Self report,PCL,PCL-M,ITT,Used available data (not imputed),"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",Baseline,,,52.57,13.03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,Medium,"Battersby MW, Beattie J, Pols RG, et al. A randomised controlled trial of the Flinders Program™ of chronic condition management in Vietnam veterans with co-morbid alcohol misuse, and psychiatric and medical conditions. Aust N Z J Psychiatry. 2013 May;47(5):451-62. doi: 10.1177/0004867412471977. PMID: 23307806.",,2020
beck2009_CAPS_A_0_Comp,Psychotherapy,PTSD,44,A,PTSD,,17,,Group CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,26,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",End of Treatment,0,,28.9,19.9,,,,,-28.4,,,,,,,,,,p<0.05,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.8824,,RCI for CAPS,0.8235,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.8182,,0.1818,Accidents,,High,"Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.",32054,2019
beck2009_CAPS_A_12_Comp,Psychotherapy,PTSD,44,A,PTSD,,15,,Group CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,26,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",Assessment at 3 to <6 Months,12,,19.7,18.8,,,,,-37.6,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.9333,,RCI for CAPS,0.9333,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.8182,,0.1818,Accidents,,High,"Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.",32054,2019
beck2009_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,44,A,PTSD,,17,,Group CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,26,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",Baseline,,,57.3,15.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8182,,0.1818,Accidents,,High,"Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.",32054,2019
beck2009_CAPS_B_0_Comp,Psychotherapy,PTSD,44,B,Control,,16,,Minimum contact,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,18,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",End of Treatment,0,,49.4,27,,,,,-8.4,,,,,,,,,,p<0.05,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.3125,,RCI for CAPS,0.3125,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.8182,,0.1818,Accidents,,High,"Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.",32054,2019
beck2009_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,44,B,Control,,16,,Minimum contact,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,18,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",Baseline,,,57.8,14.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8182,,0.1818,Accidents,,High,"Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.",32054,2019
beck2009_IES_A_0_NA,Psychotherapy,PTSD,44,A,PTSD,,,,Group CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,26,Self report,IES,IES-R,,,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",End of Treatment,0,,0.95,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8182,,0.1818,Accidents,,High,"Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.",32054,2019
beck2009_IES_A_Baseline_NA,Psychotherapy,PTSD,44,A,PTSD,,,,Group CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,26,Self report,IES,IES-R,,,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",Baseline,,,1.75,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8182,,0.1818,Accidents,,High,"Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.",32054,2019
beck2009_IES_B_0_NA,Psychotherapy,PTSD,44,B,Control,,,,Minimum contact,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,18,Self report,IES,IES-R,,,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",End of Treatment,0,,1.91,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8182,,0.1818,Accidents,,High,"Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.",32054,2019
beck2009_IES_B_Baseline_NA,Psychotherapy,PTSD,44,B,Control,,,,Minimum contact,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,18,Self report,IES,IES-R,,,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",Baseline,,,2.10,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8182,,0.1818,Accidents,,High,"Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.",32054,2019
becker2007_CAPS_A_0_ITT,Pharmacotherapy,PTSD,30,A,PTSD,,15,,Bupropion sustained release,Bupropion,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",End of Treatment,0,,,,,,,,-12.33,24.12,,,,,,,,,,,,,,,,,,,,CGI rated at least minimally improved,0.5556,,Mixed,0,0.7857,0.2143,0.2143,,0.7857,Mixed,"combat-related, child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, illness/medical procedure, other (homicide, death/suicide of a loved one)",Medium,"Becker ME, Hertzberg MA, Moore SD, et al. A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Apr;27(2):193-7. doi: 10.1097/JCP.0b013e318032eaed. PMID: 17414245.",31131,2019
becker2007_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,30,A,PTSD,,18,,Bupropion sustained release,Bupropion,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CGI rated at least minimally improved,,,Mixed,0,0.7857,0.2143,0.2143,,0.7857,Mixed,"combat-related, child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, illness/medical procedure, other (homicide, death/suicide of a loved one)",Medium,"Becker ME, Hertzberg MA, Moore SD, et al. A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Apr;27(2):193-7. doi: 10.1097/JCP.0b013e318032eaed. PMID: 17414245.",31131,2019
becker2007_CAPS_B_0_ITT,Pharmacotherapy,PTSD,30,B,Control,,7,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",End of Treatment,0,,,,,,,,-16.99,11.26,,,,,,,,,,,,,,,,,,,,CGI rated at least minimally improved,,,Mixed,0,0.7857,0.2143,0.2143,,0.7857,Mixed,"combat-related, child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, illness/medical procedure, other (homicide, death/suicide of a loved one)",Medium,"Becker ME, Hertzberg MA, Moore SD, et al. A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Apr;27(2):193-7. doi: 10.1097/JCP.0b013e318032eaed. PMID: 17414245.",31131,2019
becker2007_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,30,B,Control,,10,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CGI rated at least minimally improved,,,Mixed,0,0.7857,0.2143,0.2143,,0.7857,Mixed,"combat-related, child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, illness/medical procedure, other (homicide, death/suicide of a loved one)",Medium,"Becker ME, Hertzberg MA, Moore SD, et al. A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Apr;27(2):193-7. doi: 10.1097/JCP.0b013e318032eaed. PMID: 17414245.",31131,2019
beidel2011_CAPS_A_0_Comp,Psychotherapy,PTSD,35,A,PTSD,,13,,Trauma Management Therapy with Exposure Therapy,Trauma Management Therapy with exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,18,Structured Clinical Interview,CAPS,CAPS,Completer,Excluded,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",End of Treatment,0,,69,24,,,,,-15.9,,,,,,,,,,,,,,,,,,,,,CGI-I rated as 1 or 2,0.43,,Veteran,0,1,0,0,,1,Combat-related,,High,"Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar;25(2):224-31. doi: 10.1016/j.janxdis.2010.09.006. PMID: 20951543.",35248,2019
beidel2011_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,35,A,PTSD,,16,,Trauma Management Therapy with Exposure Therapy,Trauma Management Therapy with exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,18,Structured Clinical Interview,CAPS,CAPS,Completer,Excluded,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",Baseline,,,84.9,14.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar;25(2):224-31. doi: 10.1016/j.janxdis.2010.09.006. PMID: 20951543.",35248,2019
beidel2011_CAPS_B_0_Comp,Psychotherapy,PTSD,35,B,PTSD,,12,,Exposure Therapy + psychoeducation,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,17,Structured Clinical Interview,CAPS,CAPS,Completer,Excluded,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",End of Treatment,0,,65.5,20.2,,,,,-25.1,,,,,,,,,,,,,,,,,,,,,CGI-I rated as 1 or 2,0.44,,Veteran,0,1,0,0,,1,Combat-related,,High,"Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar;25(2):224-31. doi: 10.1016/j.janxdis.2010.09.006. PMID: 20951543.",35248,2019
beidel2011_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,35,B,PTSD,,14,,Exposure Therapy + psychoeducation,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,17,Structured Clinical Interview,CAPS,CAPS,Completer,Excluded,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",Baseline,,,90.6,14.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar;25(2):224-31. doi: 10.1016/j.janxdis.2010.09.006. PMID: 20951543.",35248,2019
beidel2011_PCL_A_0_NA,Psychotherapy,PTSD,35,A,PTSD,,,,Trauma Management Therapy with Exposure Therapy,Trauma Management Therapy with exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,18,Self report,PCL,PCL-M,,,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",End of Treatment,0,,60.9,11.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar;25(2):224-31. doi: 10.1016/j.janxdis.2010.09.006. PMID: 20951543.",35248,2019
beidel2011_PCL_A_Baseline_NA,Psychotherapy,PTSD,35,A,PTSD,,,,Trauma Management Therapy with Exposure Therapy,Trauma Management Therapy with exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,18,Self report,PCL,PCL-M,,,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",Baseline,,,67.0,11.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar;25(2):224-31. doi: 10.1016/j.janxdis.2010.09.006. PMID: 20951543.",35248,2019
beidel2011_PCL_B_0_NA,Psychotherapy,PTSD,35,B,PTSD,,,,Exposure Therapy + psychoeducation,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,17,Self report,PCL,PCL-M,,,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",End of Treatment,0,,63.6,11.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar;25(2):224-31. doi: 10.1016/j.janxdis.2010.09.006. PMID: 20951543.",35248,2019
beidel2011_PCL_B_Baseline_NA,Psychotherapy,PTSD,35,B,PTSD,,,,Exposure Therapy + psychoeducation,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,17,Self report,PCL,PCL-M,,,"ANCOVA, effect sizes with Cohen's d and paired sample t-tests",Baseline,,,68.2,8.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar;25(2):224-31. doi: 10.1016/j.janxdis.2010.09.006. PMID: 20951543.",35248,2019
bell2019_PCL_A_0_Comp,Complementary and integrative health (CIH),PTSD,24,A,PTSD,,12,,LORETA z-score neurofeedback,LORETA z-score neurofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,12,Self report,PCL,PCL-5,Completer,Complete case analysis,Nonparametric Mann-Withney U analysis; Cohen's d effect sizes,End of Treatment,0,,18.08,12.65,,,,,-28.09,,,,,Cohen's d,2.09,,,,p=0.003,,,,,,,,,,,,,,Community,0,,1,,,,Mixed,"combat-related, rape/sexual assault, community/school violence, illness/medical procedure, natural or manmade disasters, child other abuse, other (""work-related trauma [e.g. first responders]"")",Medium,"Bell AN, Moss D, Kallmeyer RJ. Healing the neurophysiological roots of trauma: a controlled study examining loreta z-score neurofeedback and HRV biofeedback for chronic PTSD. NeuroRegulation. 2019;6(2):54-70. doi: 10.15540/nr.6.2.54.",,2020
bell2019_PCL_A_Baseline_Comp,Complementary and integrative health (CIH),PTSD,24,A,PTSD,,12,,LORETA z-score neurofeedback,LORETA z-score neurofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,12,Self report,PCL,PCL-5,Completer,Complete case analysis,Nonparametric Mann-Withney U analysis; Cohen's d effect sizes,Baseline,,,46.17,14.23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,,1,,,,Mixed,"combat-related, rape/sexual assault, community/school violence, illness/medical procedure, natural or manmade disasters, child other abuse, other (""work-related trauma [e.g. first responders]"")",Medium,"Bell AN, Moss D, Kallmeyer RJ. Healing the neurophysiological roots of trauma: a controlled study examining loreta z-score neurofeedback and HRV biofeedback for chronic PTSD. NeuroRegulation. 2019;6(2):54-70. doi: 10.15540/nr.6.2.54.",,2020
bell2019_PCL_B_0_Comp,Complementary and integrative health (CIH),PTSD,24,B,Control,,11,,Heart rate variability biofeedback,Heart rate variability biofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,12,Self report,PCL,PCL-5,Completer,Complete case analysis,Nonparametric Mann-Withney U analysis; Cohen's d effect sizes,End of Treatment,0,,31.18,13.53,,,,,-18.64,,,,,Cohen's d,1.4,,,,p=0.006,,,,,,,,,,,,,,Community,0,,1,,,,Mixed,"combat-related, rape/sexual assault, community/school violence, illness/medical procedure, natural or manmade disasters, child other abuse, other (""work-related trauma [e.g. first responders]"")",Medium,"Bell AN, Moss D, Kallmeyer RJ. Healing the neurophysiological roots of trauma: a controlled study examining loreta z-score neurofeedback and HRV biofeedback for chronic PTSD. NeuroRegulation. 2019;6(2):54-70. doi: 10.15540/nr.6.2.54.",,2020
bell2019_PCL_B_Baseline_Comp,Complementary and integrative health (CIH),PTSD,24,B,Control,,11,,Heart rate variability biofeedback,Heart rate variability biofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,12,Self report,PCL,PCL-5,Completer,Complete case analysis,Nonparametric Mann-Withney U analysis; Cohen's d effect sizes,Baseline,,,49.82,10.16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,,1,,,,Mixed,"combat-related, rape/sexual assault, community/school violence, illness/medical procedure, natural or manmade disasters, child other abuse, other (""work-related trauma [e.g. first responders]"")",Medium,"Bell AN, Moss D, Kallmeyer RJ. Healing the neurophysiological roots of trauma: a controlled study examining loreta z-score neurofeedback and HRV biofeedback for chronic PTSD. NeuroRegulation. 2019;6(2):54-70. doi: 10.15540/nr.6.2.54.",,2020
belleville2018_Modi_A_0_ITT,Psychotherapy,PTSD,42,A,PTSD,,16,,Imagery rehearsal therapy + CBT,Imagery rehearsal training (IRT) + trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,22,Self report,Modified PSS-SR,Modified PSS-SR,ITT,"Replaced missing data with average item response for questionnaire; however, data missing because of attrition or questionnaires not completed at all were not replaced.",Mixed-model ANOVA,End of Treatment,0,,21.53,11.84,,,,,-43.4,,,,,,,,,,,,,,,,,,Not fulfilling diagnostic criteria for PTSD according to DSM-IV-TR,,,,,,Community,0,0,1,0.881,,0.119,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Belleville G, Dube-Frenette M, Rousseau A. Efficacy of imagery rehearsal therapy and cognitive behavioral therapy in sexual assault victims with posttraumatic stress disorder: a randomized controlled trial. J Trauma Stress. 2018 Aug;31(4):591-601. doi: 10.1002/jts.22306. PMID: 30070398.",50883,2020
belleville2018_Modi_A_Baseline_ITT,Psychotherapy,PTSD,42,A,PTSD,,22,,Imagery rehearsal therapy + CBT,Imagery rehearsal training (IRT) + trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,22,Self report,Modified PSS-SR,Modified PSS-SR,ITT,"Replaced missing data with average item response for questionnaire; however, data missing because of attrition or questionnaires not completed at all were not replaced.",Mixed-model ANOVA,Baseline,,,64.83,19.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.881,,0.119,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Belleville G, Dube-Frenette M, Rousseau A. Efficacy of imagery rehearsal therapy and cognitive behavioral therapy in sexual assault victims with posttraumatic stress disorder: a randomized controlled trial. J Trauma Stress. 2018 Aug;31(4):591-601. doi: 10.1002/jts.22306. PMID: 30070398.",50883,2020
belleville2018_Modi_B_0_Comp,Psychotherapy,PTSD,42,B,PTSD,,,,CBT only,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,20,Self report,Modified PSS-SR,Modified PSS-SR,Completer,"Replaced missing data with average item response for questionnaire; however, data missing because of attrition or questionnaires not completed at all were not replaced.",Mixed-model ANOVA,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not fulfilling diagnostic criteria for PTSD according to DSM-IV-TR,0.733,,,,,Community,0,0,1,0.881,,0.119,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Belleville G, Dube-Frenette M, Rousseau A. Efficacy of imagery rehearsal therapy and cognitive behavioral therapy in sexual assault victims with posttraumatic stress disorder: a randomized controlled trial. J Trauma Stress. 2018 Aug;31(4):591-601. doi: 10.1002/jts.22306. PMID: 30070398.",50883,2020
belleville2018_Modi_B_0_ITT,Psychotherapy,PTSD,42,B,PTSD,,15,,CBT only,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,20,Self report,Modified PSS-SR,Modified PSS-SR,ITT,"Replaced missing data with average item response for questionnaire; however, data missing because of attrition or questionnaires not completed at all were not replaced.",Mixed-model ANOVA,End of Treatment,0,,30.95,16.12,,,,,-38.2,,,,,,,,,,,,,,,,,,Not fulfilling diagnostic criteria for PTSD according to DSM-IV-TR,,,,,,Community,0,0,1,0.881,,0.119,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Belleville G, Dube-Frenette M, Rousseau A. Efficacy of imagery rehearsal therapy and cognitive behavioral therapy in sexual assault victims with posttraumatic stress disorder: a randomized controlled trial. J Trauma Stress. 2018 Aug;31(4):591-601. doi: 10.1002/jts.22306. PMID: 30070398.",50883,2020
belleville2018_Modi_B_Baseline_Comp,Psychotherapy,PTSD,42,B,PTSD,,,,CBT only,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,20,Self report,Modified PSS-SR,Modified PSS-SR,Completer,"Replaced missing data with average item response for questionnaire; however, data missing because of attrition or questionnaires not completed at all were not replaced.",Mixed-model ANOVA,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.881,,0.119,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Belleville G, Dube-Frenette M, Rousseau A. Efficacy of imagery rehearsal therapy and cognitive behavioral therapy in sexual assault victims with posttraumatic stress disorder: a randomized controlled trial. J Trauma Stress. 2018 Aug;31(4):591-601. doi: 10.1002/jts.22306. PMID: 30070398.",50883,2020
belleville2018_Modi_B_Baseline_ITT,Psychotherapy,PTSD,42,B,PTSD,,20,,CBT only,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,20,Self report,Modified PSS-SR,Modified PSS-SR,ITT,"Replaced missing data with average item response for questionnaire; however, data missing because of attrition or questionnaires not completed at all were not replaced.",Mixed-model ANOVA,Baseline,,,69.15,25.67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.881,,0.119,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Belleville G, Dube-Frenette M, Rousseau A. Efficacy of imagery rehearsal therapy and cognitive behavioral therapy in sexual assault victims with posttraumatic stress disorder: a randomized controlled trial. J Trauma Stress. 2018 Aug;31(4):591-601. doi: 10.1002/jts.22306. PMID: 30070398.",50883,2020
bichescu2007_CIDI_A_26_NA,Psychotherapy,PTSD,18,A,PTSD,,9,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,9,Structured Clinical Interview,CIDI,CIDI,,,Mixed-model ANOVA,Assessment at 6 to <12 Months,26,,5.4,1.3,,,,,-6.4,,,,,Cohen's d,3.15,,,,,,,,,,,,Not meeting PTSD criteria according to the CIDI,0.5556,,,,,Community,,,1,0.0556,,0.9444,Terrorism/political violence/forced displacement,,High,"Bichescu D, Neuner F, Schauer M, et al. Narrative exposure therapy for political imprisonment-related chronic posttraumatic stress disorder and depression. Behav Res Ther. 2007 Sep;45(9):2212-20. doi: 10.1016/j.brat.2006.12.006. PMID: 17288990.",29906,2019
bichescu2007_CIDI_A_Baseline_NA,Psychotherapy,PTSD,18,A,PTSD,,9,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,9,Structured Clinical Interview,CIDI,CIDI,,,Mixed-model ANOVA,Baseline,,,11.8,1.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.0556,,0.9444,Terrorism/political violence/forced displacement,,High,"Bichescu D, Neuner F, Schauer M, et al. Narrative exposure therapy for political imprisonment-related chronic posttraumatic stress disorder and depression. Behav Res Ther. 2007 Sep;45(9):2212-20. doi: 10.1016/j.brat.2006.12.006. PMID: 17288990.",29906,2019
bichescu2007_CIDI_B_26_NA,Psychotherapy,PTSD,18,B,Control,,9,,Psychoeducation,Psychoeducation,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,In Person,9,Structured Clinical Interview,CIDI,CIDI,,,Mixed-model ANOVA,Assessment at 6 to <12 Months,26,,9.9,4.1,,,,,-1.5,,,,,Cohen's d,0.31,,,,,,,,,,,,Not meeting PTSD criteria according to the CIDI,0.1111,,,,,Community,,,1,0.0556,,0.9444,Terrorism/political violence/forced displacement,,High,"Bichescu D, Neuner F, Schauer M, et al. Narrative exposure therapy for political imprisonment-related chronic posttraumatic stress disorder and depression. Behav Res Ther. 2007 Sep;45(9):2212-20. doi: 10.1016/j.brat.2006.12.006. PMID: 17288990.",29906,2019
blanchard2003_CAPS_A_0_C-F,Psychotherapy,PTSD,98,A,PTSD,,26,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,Follow-up completer,,Mixed-model ANOVA,End of Treatment,0,,23.7,26.2,,,,,-45.9,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_CAPS_A_0_C-P,Psychotherapy,PTSD,98,A,PTSD,,27,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,Posttreatment completer,,Mixed-model ANOVA,End of Treatment,0,,23.7,26.2,,,,,-44.5,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to the CAPS,0.7619,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_CAPS_A_12_C-F,Psychotherapy,PTSD,98,A,PTSD,,26,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,Follow-up completer,,Mixed-model ANOVA,Assessment at 3 to <6 Months,12,,22.1,24.8,,,,,-47.5,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to the CAPS,0.8095,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_CAPS_A_Baseline_C-F,Psychotherapy,PTSD,98,A,PTSD,,26,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,Follow-up completer,,Mixed-model ANOVA,Baseline,,,69.6,22.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_CAPS_A_Baseline_C-P,Psychotherapy,PTSD,98,A,PTSD,,27,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,Posttreatment completer,,Mixed-model ANOVA,Baseline,,,68.2,22.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,98,A,PTSD,,37,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,ITT,,Mixed-model ANOVA,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_CAPS_B_0_C-F,Psychotherapy,PTSD,98,B,PTSD,,26,,Supportive psychotherapy,PTSD psychotherapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Structured Clinical Interview,CAPS,CAPS,Follow-up completer,,Mixed-model ANOVA,End of Treatment,0,,41.2,25.5,,,,,-24.7,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_CAPS_B_0_C-P,Psychotherapy,PTSD,98,B,PTSD,,27,,Supportive psychotherapy,PTSD psychotherapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Structured Clinical Interview,CAPS,CAPS,Posttreatment completer,,Mixed-model ANOVA,End of Treatment,0,,40.1,25.7,,,,,-24.9,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to the CAPS,0.4762,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_CAPS_B_12_C-F,Psychotherapy,PTSD,98,B,PTSD,,26,,Supportive psychotherapy,PTSD psychotherapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Structured Clinical Interview,CAPS,CAPS,Follow-up completer,,Mixed-model ANOVA,Assessment at 3 to <6 Months,12,,40.4,29.8,,,,,-25.5,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to the CAPS,0.4286,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_CAPS_B_Baseline_C-F,Psychotherapy,PTSD,98,B,PTSD,,26,,Supportive psychotherapy,PTSD psychotherapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Structured Clinical Interview,CAPS,CAPS,Follow-up completer,,Mixed-model ANOVA,Baseline,,,65.9,26.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_CAPS_B_Baseline_C-P,Psychotherapy,PTSD,98,B,PTSD,,36,,Supportive psychotherapy,PTSD psychotherapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Structured Clinical Interview,CAPS,CAPS,Posttreatment completer,,Mixed-model ANOVA,Baseline,,,65.0,25.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_CAPS_C_0_C-P,Psychotherapy,PTSD,98,C,Control,,24,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,25,Structured Clinical Interview,CAPS,CAPS,Posttreatment completer,,Mixed-model ANOVA,End of Treatment,0,,54.0,25.9,,,,,-11.8,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to the CAPS,0.2381,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_CAPS_C_Baseline_C-P,Psychotherapy,PTSD,98,C,Control,,24,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,25,Structured Clinical Interview,CAPS,CAPS,Posttreatment completer,,Mixed-model ANOVA,Baseline,,,65.8,26.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_CAPS_C_Baseline_ITT,Psychotherapy,PTSD,98,C,Control,,25,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,25,Structured Clinical Interview,CAPS,CAPS,ITT,,Mixed-model ANOVA,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_IES_A_0_Comp,Psychotherapy,PTSD,98,A,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Self report,IES,IES,Completer,,Mixed-model ANOVA,End of Treatment,0,,12.1,14.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_IES_A_12_Comp,Psychotherapy,PTSD,98,A,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Self report,IES,IES,Completer,,Mixed-model ANOVA,Assessment at 3 to <6 Months,12,,12.2,13.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_IES_A_Baseline_Comp,Psychotherapy,PTSD,98,A,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Self report,IES,IES,Completer,,Mixed-model ANOVA,Baseline,,,40.4,13.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_IES_B_0_Comp,Psychotherapy,PTSD,98,B,PTSD,,,,Supportive psychotherapy,PTSD psychotherapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Self report,IES,IES,Completer,,Mixed-model ANOVA,End of Treatment,0,,27.4,19.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_IES_B_12_Comp,Psychotherapy,PTSD,98,B,PTSD,,,,Supportive psychotherapy,PTSD psychotherapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Self report,IES,IES,Completer,,Mixed-model ANOVA,Assessment at 3 to <6 Months,12,,24.0,20.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_IES_B_Baseline_Comp,Psychotherapy,PTSD,98,B,PTSD,,,,Supportive psychotherapy,PTSD psychotherapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Self report,IES,IES,Completer,,Mixed-model ANOVA,Baseline,,,38.7,20.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_IES_C_0_Comp,Psychotherapy,PTSD,98,C,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,25,Self report,IES,IES,Completer,,Mixed-model ANOVA,End of Treatment,0,,36.6,17.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_IES_C_Baseline_Comp,Psychotherapy,PTSD,98,C,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,25,Self report,IES,IES,Completer,,Mixed-model ANOVA,Baseline,,,40.2,15.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_PCL_A_0_Comp,Psychotherapy,PTSD,98,A,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Self report,PCL,PCL,Completer,,Mixed-model ANOVA,End of Treatment,0,,31.3,14.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_PCL_A_12_Comp,Psychotherapy,PTSD,98,A,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Self report,PCL,PCL,Completer,,Mixed-model ANOVA,Assessment at 3 to <6 Months,12,,31.1,14.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_PCL_A_Baseline_Comp,Psychotherapy,PTSD,98,A,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Self report,PCL,PCL,Completer,,Mixed-model ANOVA,Baseline,,,54.4,12.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_PCL_B_0_Comp,Psychotherapy,PTSD,98,B,PTSD,,,,Supportive psychotherapy,PTSD psychotherapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Self report,PCL,PCL,Completer,,Mixed-model ANOVA,End of Treatment,0,,43.8,14.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_PCL_B_12_Comp,Psychotherapy,PTSD,98,B,PTSD,,,,Supportive psychotherapy,PTSD psychotherapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Self report,PCL,PCL,Completer,,Mixed-model ANOVA,Assessment at 3 to <6 Months,12,,40.8,14.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_PCL_B_Baseline_Comp,Psychotherapy,PTSD,98,B,PTSD,,,,Supportive psychotherapy,PTSD psychotherapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Self report,PCL,PCL,Completer,,Mixed-model ANOVA,Baseline,,,55.0,14.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_PCL_C_0_Comp,Psychotherapy,PTSD,98,C,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,25,Self report,PCL,PCL,Completer,,Mixed-model ANOVA,End of Treatment,0,,53.9,14.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
blanchard2003_PCL_C_Baseline_Comp,Psychotherapy,PTSD,98,C,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,25,Self report,PCL,PCL,Completer,,Mixed-model ANOVA,Baseline,,,55.9,13.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7347,,0.2653,Accidents,,Medium,"Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.",25272,2019
boals2015_PCL_A_0_Comp,Psychotherapy,PTSD,70,A,PTSD,,16,,ACT analog,Acceptance and Commitment Therapy (ACT) + expressive writing,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Mixed,26,Self report,PCL,PCL-S,Completer,,Mixed-model ANOVA,End of Treatment,0,,39.06,14.11,,,,,-11.53,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,,,High,"Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.",1548485,2019
boals2015_PCL_A_3_Comp,Psychotherapy,PTSD,70,A,PTSD,,16,,ACT analog,Acceptance and Commitment Therapy (ACT) + expressive writing,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Mixed,26,Self report,PCL,PCL-S,Completer,,Mixed-model ANOVA,Assessment at <3 Months,3,,38.89,15.84,,,,,-11.7,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,,,High,"Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.",1548485,2019
boals2015_PCL_A_Baseline_Comp,Psychotherapy,PTSD,70,A,PTSD,,16,,ACT analog,Acceptance and Commitment Therapy (ACT) + expressive writing,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Mixed,26,Self report,PCL,PCL-S,Completer,,Mixed-model ANOVA,Baseline,,,50.59,14.29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,,,High,"Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.",1548485,2019
boals2015_PCL_B_0_Comp,Psychotherapy,PTSD,70,B,PTSD,,10,,CBT analog,Cognitive behavioral therapy (CBT) + expressive writing,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Mixed,20,Self report,PCL,PCL-S,Completer,,Mixed-model ANOVA,End of Treatment,0,,37.75,12.49,,,,,-11,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,,,High,"Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.",1548485,2019
boals2015_PCL_B_3_Comp,Psychotherapy,PTSD,70,B,PTSD,,10,,CBT analog,Cognitive behavioral therapy (CBT) + expressive writing,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Mixed,20,Self report,PCL,PCL-S,Completer,,Mixed-model ANOVA,Assessment at <3 Months,3,,32,14.22,,,,,-16.75,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,,,High,"Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.",1548485,2019
boals2015_PCL_B_Baseline_Comp,Psychotherapy,PTSD,70,B,PTSD,,10,,CBT analog,Cognitive behavioral therapy (CBT) + expressive writing,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Mixed,20,Self report,PCL,PCL-S,Completer,,Mixed-model ANOVA,Baseline,,,48.75,14.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,,,High,"Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.",1548485,2019
boals2015_PCL_C_0_Comp,Psychotherapy,PTSD,70,C,Control,,22,,Neutral script and writing,Control writing,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Mixed,23,Self report,PCL,PCL-S,Completer,,Mixed-model ANOVA,End of Treatment,0,,38.64,15.75,,,,,-10.06,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,,,High,"Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.",1548485,2019
boals2015_PCL_C_3_Comp,Psychotherapy,PTSD,70,C,Control,,22,,Neutral script and writing,Control writing,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Mixed,23,Self report,PCL,PCL-S,Completer,,Mixed-model ANOVA,Assessment at <3 Months,3,,34.68,14.17,,,,,-14.02,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,,,High,"Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.",1548485,2019
boals2015_PCL_C_Baseline_Comp,Psychotherapy,PTSD,70,C,Control,,22,,Neutral script and writing,Control writing,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Mixed,23,Self report,PCL,PCL-S,Completer,,Mixed-model ANOVA,Baseline,,,48.7,15.47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,,,High,"Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.",1548485,2019
boggio2010_TOP-8_A_0_ITT,Nonpharmacologic biological,PTSD,30,A,PTSD,,9,,High-frequency left rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,TOP-8,TOP-8,ITT,LOCF,Mixed-model ANOVA,End of Treatment,0,,,,,,,,,,,,,,,,,,p=0.0039 (Bonferroni corrected),,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)",Medium,"Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.",33726,2019
boggio2010_TOP-8_A_12_ITT,Nonpharmacologic biological,PTSD,30,A,PTSD,,,,High-frequency left rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,TOP-8,TOP-8,ITT,LOCF,Mixed-model ANOVA,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,p<0.005 (Bonferroni corrected),,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)",Medium,"Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.",33726,2019
boggio2010_TOP-8_A_Baseline_ITT,Nonpharmacologic biological,PTSD,30,A,PTSD,,10,,High-frequency left rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,TOP-8,TOP-8,ITT,LOCF,Mixed-model ANOVA,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)",Medium,"Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.",33726,2019
boggio2010_TOP-8_B_0_ITT,Nonpharmacologic biological,PTSD,30,B,PTSD,,9,,High-frequency Right rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,TOP-8,TOP-8,ITT,LOCF,Mixed-model ANOVA,End of Treatment,0,,,,,,,,,,,,,,,,,,p=0.008 (Bonferroni corrected),,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)",Medium,"Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.",33726,2019
boggio2010_TOP-8_B_12_ITT,Nonpharmacologic biological,PTSD,30,B,PTSD,,,,High-frequency Right rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,TOP-8,TOP-8,ITT,LOCF,Mixed-model ANOVA,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,p<0.005 (Bonferroni corrected),,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)",Medium,"Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.",33726,2019
boggio2010_TOP-8_B_Baseline_ITT,Nonpharmacologic biological,PTSD,30,B,PTSD,,10,,High-frequency Right rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,TOP-8,TOP-8,ITT,LOCF,Mixed-model ANOVA,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)",Medium,"Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.",33726,2019
boggio2010_TOP-8_C_0_ITT,Nonpharmacologic biological,PTSD,30,C,Control,,8,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,10,Structured Clinical Interview,TOP-8,TOP-8,ITT,LOCF,Mixed-model ANOVA,End of Treatment,0,,,,,,,,,,,,,,,,,,p=0.36 (Bonferroni corrected),,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)",Medium,"Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.",33726,2019
boggio2010_TOP-8_C_Baseline_ITT,Nonpharmacologic biological,PTSD,30,C,Control,,10,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,10,Structured Clinical Interview,TOP-8,TOP-8,ITT,LOCF,Mixed-model ANOVA,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)",Medium,"Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.",33726,2019
bohus2013_CAPS_A_0_Comp,Psychotherapy,PTSD,82,A,PTSD,,29,,DBT-PTSD,Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,43,Structured Clinical Interview,CAPS,CAPS,Completer,imputed,Mixed-model ANOVA,End of Treatment,0,,57.24,25.49,,,,,-30.68,,,,,,,,,,,,,,,,,,Not meeting DSM-IV PTSD criteria according to CAPS,,,Reduction of >= 30 points on CAPS score,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_CAPS_A_0_ITT,Psychotherapy,PTSD,82,A,PTSD,,34,,DBT-PTSD,Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,43,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed-model ANOVA,End of Treatment,0,,60.31,26.79,,,,,-27.61,,,,,,,,,,,,,,,,,,Not meeting DSM-IV PTSD criteria according to CAPS,,,Reduction of >= 30 points on CAPS score,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_CAPS_A_12_Comp,Psychotherapy,PTSD,82,A,PTSD,,29,,DBT-PTSD,Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,43,Structured Clinical Interview,CAPS,CAPS,Completer,imputed,Mixed-model ANOVA,Assessment at 3 to <6 Months,12,,54.76,24.05,,,,,-33.16,,,,,,,,,,,,,,,,,,Not meeting DSM-IV PTSD criteria according to CAPS,,,Reduction of >= 30 points on CAPS score,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_CAPS_A_12_ITT,Psychotherapy,PTSD,82,A,PTSD,,29,,DBT-PTSD,Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,43,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed-model ANOVA,Assessment at 3 to <6 Months,12,,58.5,24.2,,,,,,,,,,,,,,,,,,,,,,,Not meeting DSM-IV PTSD criteria according to CAPS,0.3889,,Reduction of >= 30 points on CAPS score,0.3889,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_CAPS_A_6_Comp,Psychotherapy,PTSD,82,A,PTSD,,29,,DBT-PTSD,Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,43,Structured Clinical Interview,CAPS,CAPS,Completer,imputed,Mixed-model ANOVA,Assessment at <3 Months,6,,53.07,21.44,,,,,,,,,,,,,,,,,,,,,,,Not meeting DSM-IV PTSD criteria according to CAPS,,,Reduction of >= 30 points on CAPS score,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_CAPS_A_6_ITT,Psychotherapy,PTSD,82,A,PTSD,,28,,DBT-PTSD,Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,43,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed-model ANOVA,Assessment at <3 Months,6,,57.47,25.66,,,,,-30.45,,,,,,,,,,,,,,,,,,Not meeting DSM-IV PTSD criteria according to CAPS,,,Reduction of >= 30 points on CAPS score,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,82,A,PTSD,,29,,DBT-PTSD,Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,43,Structured Clinical Interview,CAPS,CAPS,Completer,imputed,Mixed-model ANOVA,Baseline,,,87.92,14.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,82,A,PTSD,,36,,DBT-PTSD,Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,43,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed-model ANOVA,Baseline,,,87.92,14.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_CAPS_B_0_Comp,Psychotherapy,PTSD,82,B,Control,,29,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,39,Structured Clinical Interview,CAPS,CAPS,Completer,imputed,Mixed-model ANOVA,End of Treatment,0,,82.73,17.19,,,,,0.1,,,,,,,,,,,,,,,,,,Not meeting DSM-IV PTSD criteria according to CAPS,,,Reduction of >= 30 points on CAPS score,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_CAPS_B_0_ITT,Psychotherapy,PTSD,82,B,Control,,34,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,39,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed-model ANOVA,End of Treatment,0,,83.53,16.5,,,,,0.9,,,,,,,,,,,,,,,,,,Not meeting DSM-IV PTSD criteria according to CAPS,,,Reduction of >= 30 points on CAPS score,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_CAPS_B_12_Comp,Psychotherapy,PTSD,82,B,Control,,29,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,39,Structured Clinical Interview,CAPS,CAPS,Completer,imputed,Mixed-model ANOVA,Assessment at 3 to <6 Months,12,,80.55,19.89,,,,,-2.08,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_CAPS_B_12_ITT,Psychotherapy,PTSD,82,B,Control,,33,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,39,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed-model ANOVA,Assessment at 3 to <6 Months,12,,80.21,19.21,,,,,-2.42,,,,,,,,,,,,,,,,,,Not meeting DSM-IV PTSD criteria according to CAPS,0.1053,,Reduction of >= 30 points on CAPS score,0.0263,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_CAPS_B_6_Comp,Psychotherapy,PTSD,82,B,Control,,29,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,39,Structured Clinical Interview,CAPS,CAPS,Completer,imputed,Mixed-model ANOVA,Assessment at <3 Months,6,,79.03,22.98,,,,,-3.6,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_CAPS_B_6_ITT,Psychotherapy,PTSD,82,B,Control,,32,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,39,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed-model ANOVA,Assessment at <3 Months,6,,79.74,21.67,,,,,-2.89,,,,,,,,,,,,,,,,,,Not meeting DSM-IV PTSD criteria according to CAPS,,,Reduction of >= 30 points on CAPS score,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,82,B,Control,,29,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,39,Structured Clinical Interview,CAPS,CAPS,Completer,imputed,Mixed-model ANOVA,Baseline,,,82.63,18.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,82,B,Control,,38,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,39,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed-model ANOVA,Baseline,,,82.63,18.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_PDS_A_0_Comp,Psychotherapy,PTSD,82,A,PTSD,,,,DBT-PTSD,Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,43,Self report,PDS,PDS,Completer,,Mixed-model ANOVA,End of Treatment,0,,1.61,0.67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_PDS_A_0_ITT,Psychotherapy,PTSD,82,A,PTSD,,,,DBT-PTSD,Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,43,Self report,PDS,PDS,ITT,,Mixed-model ANOVA,End of Treatment,0,,1.61,0.64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_PDS_A_12_Comp,Psychotherapy,PTSD,82,A,PTSD,,,,DBT-PTSD,Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,43,Self report,PDS,PDS,Completer,,Mixed-model ANOVA,Assessment at 3 to <6 Months,12,,1.57,0.67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_PDS_A_12_ITT,Psychotherapy,PTSD,82,A,PTSD,,,,DBT-PTSD,Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,43,Self report,PDS,PDS,ITT,,Mixed-model ANOVA,Assessment at 3 to <6 Months,12,,1.54,0.64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_PDS_A_6_Comp,Psychotherapy,PTSD,82,A,PTSD,,,,DBT-PTSD,Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,43,Self report,PDS,PDS,Completer,,Mixed-model ANOVA,Assessment at <3 Months,6,,1.51,0.35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_PDS_A_6_ITT,Psychotherapy,PTSD,82,A,PTSD,,,,DBT-PTSD,Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,43,Self report,PDS,PDS,ITT,,Mixed-model ANOVA,Assessment at <3 Months,6,,1.58,0.51,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_PDS_A_Baseline_Comp,Psychotherapy,PTSD,82,A,PTSD,,,,DBT-PTSD,Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,43,Self report,PDS,PDS,Completer,,Mixed-model ANOVA,Baseline,,,2.22,0.44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_PDS_A_Baseline_ITT,Psychotherapy,PTSD,82,A,PTSD,,,,DBT-PTSD,Dialectical Behavior Therapy (DBT) +  trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,43,Self report,PDS,PDS,ITT,,Mixed-model ANOVA,Baseline,,,2.22,0.44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_PDS_B_0_Comp,Psychotherapy,PTSD,82,B,Control,,,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,39,Self report,PDS,PDS,Completer,,Mixed-model ANOVA,End of Treatment,0,,2.02,0.47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_PDS_B_0_ITT,Psychotherapy,PTSD,82,B,Control,,,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,39,Self report,PDS,PDS,ITT,,Mixed-model ANOVA,End of Treatment,0,,2.09,0.46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_PDS_B_12_Comp,Psychotherapy,PTSD,82,B,Control,,,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,39,Self report,PDS,PDS,Completer,,Mixed-model ANOVA,Assessment at 3 to <6 Months,12,,1.90,0.44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_PDS_B_12_ITT,Psychotherapy,PTSD,82,B,Control,,,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,39,Self report,PDS,PDS,ITT,,Mixed-model ANOVA,Assessment at 3 to <6 Months,12,,1.97,0.44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_PDS_B_6_Comp,Psychotherapy,PTSD,82,B,Control,,,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,39,Self report,PDS,PDS,Completer,,Mixed-model ANOVA,Assessment at <3 Months,6,,1.97,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_PDS_B_6_ITT,Psychotherapy,PTSD,82,B,Control,,,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,39,Self report,PDS,PDS,ITT,,Mixed-model ANOVA,Assessment at <3 Months,6,,2.00,0.49,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_PDS_B_Baseline_Comp,Psychotherapy,PTSD,82,B,Control,,,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,39,Self report,PDS,PDS,Completer,,Mixed-model ANOVA,Baseline,,,2.09,0.45,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bohus2013_PDS_B_Baseline_ITT,Psychotherapy,PTSD,82,B,Control,,,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,39,Self report,PDS,PDS,ITT,,Mixed-model ANOVA,Baseline,,,2.09,0.45,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.",41533,2019
bomyea2015_CAPS_A_0_Comp,Nonpharmacologic cognitive,PTSD,42,A,PTSD,,13,,High Interference Control Training,Interference control training,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,Completer,,Mixed-model ANOVA,End of Treatment,0,,33.77,15.67,,,,,-27.23,,,,,Cohen's d,1.85,,,,p<0.00,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.77,,≥80% reduction in total PTSD symptoms,0.85,,Community,,,1,1,,0,Rape/sexual assault,,Medium,"Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33-42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901.",44517,2019
bomyea2015_CAPS_A_0_ITT,Nonpharmacologic cognitive,PTSD,42,A,PTSD,,22,,High Interference Control Training,Interference control training,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed-model ANOVA,End of Treatment,0,,45.32,19.92,,,,,-16.09,,,,,Cohen's d,0.92,,,,p<0.00,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.45,,≥80% reduction in total PTSD symptoms,0.5,,Community,,,1,1,,0,Rape/sexual assault,,Medium,"Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33-42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901.",44517,2019
bomyea2015_CAPS_A_Baseline_Comp,Nonpharmacologic cognitive,PTSD,42,A,PTSD,,13,,High Interference Control Training,Interference control training,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,Completer,,Mixed-model ANOVA,Baseline,,,61,13.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Rape/sexual assault,,Medium,"Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33-42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901.",44517,2019
bomyea2015_CAPS_A_Baseline_ITT,Nonpharmacologic cognitive,PTSD,42,A,PTSD,,22,,High Interference Control Training,Interference control training,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed-model ANOVA,Baseline,,,61.41,12.54,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Rape/sexual assault,,Medium,"Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33-42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901.",44517,2019
bomyea2015_CAPS_B_0_Comp,Nonpharmacologic cognitive,PTSD,42,B,Control,,8,,Low Interference Control Training,Interference control training,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,,Mixed-model ANOVA,End of Treatment,0,,45.88,20.55,,,,,-22.12,,,,,Cohen's d,1.1,,,,p<0.01,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.63,,≥80% reduction in total PTSD symptoms,0.75,,Community,,,1,1,,0,Rape/sexual assault,,Medium,"Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33-42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901.",44517,2019
bomyea2015_CAPS_B_0_ITT,Nonpharmacologic cognitive,PTSD,42,B,Control,,20,,Low Interference Control Training,Interference control training,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed-model ANOVA,End of Treatment,0,,58.5,18.61,,,,,-8.85,,,,,Cohen's d,0.52,,,,p<0.05,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.3,,≥80% reduction in total PTSD symptoms,0.3,,Community,,,1,1,,0,Rape/sexual assault,,Medium,"Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33-42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901.",44517,2019
bomyea2015_CAPS_B_Baseline_Comp,Nonpharmacologic cognitive,PTSD,42,B,Control,,8,,Low Interference Control Training,Interference control training,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,,Mixed-model ANOVA,Baseline,,,68,19.86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Rape/sexual assault,,Medium,"Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33-42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901.",44517,2019
bomyea2015_CAPS_B_Baseline_ITT,Nonpharmacologic cognitive,PTSD,42,B,Control,,20,,Low Interference Control Training,Interference control training,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed-model ANOVA,Baseline,,,67.35,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Rape/sexual assault,,Medium,"Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33-42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901.",44517,2019
bormann2008_CAPS_A_0_ITT,Complementary and integrative health (CIH),PTSD,29,A,PTSD,,14,,Mantram,Mantram Repetition,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,14,Structured Clinical Interview,CAPS,CAPS,ITT,,Mixed-model ANOVA,End of Treatment,0,,,,,,,,-4.79,7.45,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0,,1,Combat-related,,Medium,"Bormann JE, Thorp S, Wetherell JL, et al. A spiritually based group intervention for combat veterans with posttraumatic stress disorder: feasibility study. J Holist Nurs. 2008 Jun;26(2):109-16. doi: 10.1177/0898010107311276. PMID: 18356284.",30929,2019
bormann2008_CAPS_A_Baseline_ITT,Complementary and integrative health (CIH),PTSD,29,A,PTSD,,14,,Mantram,Mantram Repetition,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,14,Structured Clinical Interview,CAPS,CAPS,ITT,,Mixed-model ANOVA,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0,,1,Combat-related,,Medium,"Bormann JE, Thorp S, Wetherell JL, et al. A spiritually based group intervention for combat veterans with posttraumatic stress disorder: feasibility study. J Holist Nurs. 2008 Jun;26(2):109-16. doi: 10.1177/0898010107311276. PMID: 18356284.",30929,2019
bormann2008_CAPS_B_0_ITT,Complementary and integrative health (CIH),PTSD,29,B,Control,,15,,Usual care delayed-treatment,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,15,Structured Clinical Interview,CAPS,CAPS,ITT,,Mixed-model ANOVA,End of Treatment,0,,,,,,,,-2.64,5.44,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0,,1,Combat-related,,Medium,"Bormann JE, Thorp S, Wetherell JL, et al. A spiritually based group intervention for combat veterans with posttraumatic stress disorder: feasibility study. J Holist Nurs. 2008 Jun;26(2):109-16. doi: 10.1177/0898010107311276. PMID: 18356284.",30929,2019
bormann2008_CAPS_B_Baseline_ITT,Complementary and integrative health (CIH),PTSD,29,B,Control,,15,,Usual care delayed-treatment,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,15,Structured Clinical Interview,CAPS,CAPS,ITT,,Mixed-model ANOVA,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0,,1,Combat-related,,Medium,"Bormann JE, Thorp S, Wetherell JL, et al. A spiritually based group intervention for combat veterans with posttraumatic stress disorder: feasibility study. J Holist Nurs. 2008 Jun;26(2):109-16. doi: 10.1177/0898010107311276. PMID: 18356284.",30929,2019
bormann2013_CAPS_A_0_ITT,Complementary and integrative health (CIH),PTSD,146,A,PTSD,,66,,Mantram Repetition Program + TAU,Mantram Repetition,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,71,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed,Mixed-model ANOVA,End of Treatment,0,,66.16,23.58,,,,,-16.92,,,,,,,,,,,,,,,,,,,,,≥10-point reduction on CAPS and CAPS score ≤45,0.24,,Veteran,,1,,0.0274,,0.9726,Combat-related,,Low,"Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.",38465,2019
bormann2013_CAPS_A_6_ITT,Complementary and integrative health (CIH),PTSD,146,A,PTSD,,66,,Mantram Repetition Program + TAU,Mantram Repetition,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,71,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed,Mixed-model ANOVA,Assessment at <3 Months,6,,61.82,23.53,,,,,-21.26,,,,,,,,,,,,,,,,,,,,,≥10-point reduction on CAPS and CAPS score ≤45,,,Veteran,,1,,0.0274,,0.9726,Combat-related,,Low,"Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.",38465,2019
bormann2013_CAPS_A_Baseline_ITT,Complementary and integrative health (CIH),PTSD,146,A,PTSD,,69,,Mantram Repetition Program + TAU,Mantram Repetition,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,71,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed,Mixed-model ANOVA,Baseline,,,83.08,16.17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0274,,0.9726,Combat-related,,Low,"Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.",38465,2019
bormann2013_CAPS_B_0_ITT,Complementary and integrative health (CIH),PTSD,146,B,Control,,70,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,75,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed,Mixed-model ANOVA,End of Treatment,0,,72.59,24.97,,,,,-10.24,,,,,,,,,,,,,,,,,,,,,≥10-point reduction on CAPS and CAPS score ≤45,0.12,,Veteran,,1,,0.0274,,0.9726,Combat-related,,Low,"Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.",38465,2019
bormann2013_CAPS_B_Baseline_ITT,Complementary and integrative health (CIH),PTSD,146,B,Control,,73,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,75,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed,Mixed-model ANOVA,Baseline,,,82.83,19.44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0274,,0.9726,Combat-related,,Low,"Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.",38465,2019
bormann2013_PCL_A_0_NA,Complementary and integrative health (CIH),PTSD,146,A,PTSD,,,,Mantram Repetition Program + TAU,Mantram Repetition,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,71,Self report,PCL,PCL,,,Mixed-model ANOVA,End of Treatment,0,,55.77,14.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0274,,0.9726,Combat-related,,Low,"Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.",38465,2019
bormann2013_PCL_A_Baseline_NA,Complementary and integrative health (CIH),PTSD,146,A,PTSD,,,,Mantram Repetition Program + TAU,Mantram Repetition,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,71,Self report,PCL,PCL,,,Mixed-model ANOVA,Baseline,,,61.39,11.62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0274,,0.9726,Combat-related,,Low,"Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.",38465,2019
bormann2013_PCL_B_0_NA,Complementary and integrative health (CIH),PTSD,146,B,Control,,,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,75,Self report,PCL,PCL,,,Mixed-model ANOVA,End of Treatment,0,,60.23,12.17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0274,,0.9726,Combat-related,,Low,"Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.",38465,2019
bormann2013_PCL_B_Baseline_NA,Complementary and integrative health (CIH),PTSD,146,B,Control,,,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,In Person,75,Self report,PCL,PCL,,,Mixed-model ANOVA,Baseline,,,62.70,10.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0274,,0.9726,Combat-related,,Low,"Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.",38465,2019
bradshaw2014_CAPS_A_0_ITT,Psychotherapy,PTSD,10,A,PTSD,,5,,Observed and  Experiential Integration - Switching component,Observed and  Experiential Integration - Switching component,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,5,Structured Clinical Interview,CAPS,CAPS,ITT,,Mixed-model ANOVA,End of Treatment,0,,21,7.38,,,,,-50.4,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8,,0.2,Mixed,"rape/sexual assault, intimate partner violence, accidents, community/school violence",High,"Bradshaw RA, McDonald MJ, Grace R, et al. A randomized clinical trial of Observed and Experiential Integration (OEI): a simple, innovative intervention for affect regulation in clients with PTSD. Traumatology (Tallahass Fla). 2014 Sep;20(3):161-71. doi: 10.1037/h0099401.",45231,2019
bradshaw2014_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,10,A,PTSD,,5,,Observed and  Experiential Integration - Switching component,Observed and  Experiential Integration - Switching component,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,5,Structured Clinical Interview,CAPS,CAPS,ITT,,Mixed-model ANOVA,Baseline,,,71.4,18.24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8,,0.2,Mixed,"rape/sexual assault, intimate partner violence, accidents, community/school violence",High,"Bradshaw RA, McDonald MJ, Grace R, et al. A randomized clinical trial of Observed and Experiential Integration (OEI): a simple, innovative intervention for affect regulation in clients with PTSD. Traumatology (Tallahass Fla). 2014 Sep;20(3):161-71. doi: 10.1037/h0099401.",45231,2019
bradshaw2014_CAPS_B_0_ITT,Psychotherapy,PTSD,10,B,Control,,5,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,5,Structured Clinical Interview,CAPS,CAPS,ITT,,Mixed-model ANOVA,End of Treatment,0,,85.2,27.67,,,,,-2.2,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8,,0.2,Mixed,"rape/sexual assault, intimate partner violence, accidents, community/school violence",High,"Bradshaw RA, McDonald MJ, Grace R, et al. A randomized clinical trial of Observed and Experiential Integration (OEI): a simple, innovative intervention for affect regulation in clients with PTSD. Traumatology (Tallahass Fla). 2014 Sep;20(3):161-71. doi: 10.1037/h0099401.",45231,2019
bradshaw2014_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,10,B,Control,,5,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,5,Structured Clinical Interview,CAPS,CAPS,ITT,,Mixed-model ANOVA,Baseline,,,87.4,16.21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8,,0.2,Mixed,"rape/sexual assault, intimate partner violence, accidents, community/school violence",High,"Bradshaw RA, McDonald MJ, Grace R, et al. A randomized clinical trial of Observed and Experiential Integration (OEI): a simple, innovative intervention for affect regulation in clients with PTSD. Traumatology (Tallahass Fla). 2014 Sep;20(3):161-71. doi: 10.1037/h0099401.",45231,2019
brady2000_CAPS_A_0_ITT,Pharmacotherapy,PTSD,187,A,PTSD,,93,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,94,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,Mixed-model ANOVA,End of Treatment,0,,43.4,28.1,,,,SEM 2.8,-33,,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 score and CGI-I score of 1 or 2,0.53,,Community,,,1,0.733,,0.267,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)",Medium,"Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.",22232,2019
brady2000_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,187,A,PTSD,,93,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,94,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,Mixed-model ANOVA,Baseline,,,76.6,17.5,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 score and CGI-I score of 1 or 2,,,Community,,,1,0.733,,0.267,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)",Medium,"Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.",22232,2019
brady2000_CAPS_B_0_ITT,Pharmacotherapy,PTSD,187,B,Control,,90,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,93,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,Mixed-model ANOVA,End of Treatment,0,,51.9,28.7,,,,SEM 2.9,-23.2,,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 score and CGI-I score of 1 or 2,0.32,,Community,,,1,0.733,,0.267,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)",Medium,"Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.",22232,2019
brady2000_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,187,B,Control,,90,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,93,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,Mixed-model ANOVA,Baseline,,,75.1,17.7,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 score and CGI-I score of 1 or 2,,,Community,,,1,0.733,,0.267,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)",Medium,"Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.",22232,2019
brady2000_DTS_A_0_NA,Pharmacotherapy,PTSD,187,A,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,94,Self report,DTS,DTS,,,Mixed-model ANOVA,End of Treatment,0,,43.2,29.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.733,,0.267,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)",Medium,"Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.",22232,2019
brady2000_DTS_A_Baseline_NA,Pharmacotherapy,PTSD,187,A,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,94,Self report,DTS,DTS,,,Mixed-model ANOVA,Baseline,,,71.9,24.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.733,,0.267,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)",Medium,"Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.",22232,2019
brady2000_DTS_B_0_NA,Pharmacotherapy,PTSD,187,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,93,Self report,DTS,DTS,,,Mixed-model ANOVA,End of Treatment,0,,52.2,31.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.733,,0.267,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)",Medium,"Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.",22232,2019
brady2000_DTS_B_Baseline_NA,Pharmacotherapy,PTSD,187,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,93,Self report,DTS,DTS,,,Mixed-model ANOVA,Baseline,,,68.5,27.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.733,,0.267,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)",Medium,"Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.",22232,2019
brady2000_IES_A_0_NA,Pharmacotherapy,PTSD,187,A,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,94,Self report,IES,IES,,,Mixed-model ANOVA,End of Treatment,0,,21.0,17.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.733,,0.267,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)",Medium,"Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.",22232,2019
brady2000_IES_A_Baseline_NA,Pharmacotherapy,PTSD,187,A,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,94,Self report,IES,IES,,,Mixed-model ANOVA,Baseline,,,37.7,15.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.733,,0.267,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)",Medium,"Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.",22232,2019
brady2000_IES_B_0_NA,Pharmacotherapy,PTSD,187,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,93,Self report,IES,IES,,,Mixed-model ANOVA,End of Treatment,0,,24.5,17.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.733,,0.267,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)",Medium,"Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.",22232,2019
brady2000_IES_B_Baseline_NA,Pharmacotherapy,PTSD,187,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,93,Self report,IES,IES,,,Mixed-model ANOVA,Baseline,,,36.7,15.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.733,,0.267,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)",Medium,"Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.",22232,2019
brady2005_CAPS_A_0_ITT,Pharmacotherapy,PTSD+SUD,94,A,PTSD+SUD,Not integrated,49,,Sertraline + CBT for alcohol dependence,Cognitive behavioral therapy (CBT) for alcohol use + sertraline,Yes,Non-TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In person,49,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed-model ANOVA and ANCOVA analyses take into account missing data,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS total score (baseline to end of treatment) and score ≤2 on CAPS question 20 (with or without alcohol treatment response),0.7105,,Community,,,1,0.457,,0.543,Mixed,"rape/sexual assault, accidents, community/school violence, other (childhood trauma not specified)",Medium,"Brady KT, Sonne SC, Anton RF, et al. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005 Mar;29(3):395-401. doi: 10.1097/01.ALC.0000156129.98265.57. PMID: 15770115.",27416,2020
brady2005_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD+SUD,94,A,PTSD+SUD,Not integrated,49,,Sertraline + CBT for alcohol dependence,Cognitive behavioral therapy (CBT) for alcohol use + sertraline,Yes,Non-TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In person,49,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed-model ANOVA and ANCOVA analyses take into account missing data,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,60.1,18.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.457,,0.543,Mixed,"rape/sexual assault, accidents, community/school violence, other (childhood trauma not specified)",Medium,"Brady KT, Sonne SC, Anton RF, et al. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005 Mar;29(3):395-401. doi: 10.1097/01.ALC.0000156129.98265.57. PMID: 15770115.",27416,2020
brady2005_CAPS_B_0_ITT,Pharmacotherapy,PTSD+SUD,94,B,Control,Not integrated,45,,Placebo + CBT for alcohol dependence,Cognitive behavioral therapy (CBT) for alcohol use,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,45,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed-model ANOVA and ANCOVA analyses take into account missing data,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,0.6316,,,,,Community,,,1,0.457,,0.543,Mixed,"rape/sexual assault, accidents, community/school violence, other (childhood trauma not specified)",Medium,"Brady KT, Sonne SC, Anton RF, et al. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005 Mar;29(3):395-401. doi: 10.1097/01.ALC.0000156129.98265.57. PMID: 15770115.",27416,2020
brady2005_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD+SUD,94,B,Control,Not integrated,45,,Placebo + CBT for alcohol dependence,Cognitive behavioral therapy (CBT) for alcohol use,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,45,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed-model ANOVA and ANCOVA analyses take into account missing data,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,57.6,20.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.457,,0.543,Mixed,"rape/sexual assault, accidents, community/school violence, other (childhood trauma not specified)",Medium,"Brady KT, Sonne SC, Anton RF, et al. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005 Mar;29(3):395-401. doi: 10.1097/01.ALC.0000156129.98265.57. PMID: 15770115.",27416,2020
braun1990_IES_A_0_NA,Pharmacotherapy,PTSD,16,A,PTSD,,,,Alprazolam,Alprazolam,No,Not Applicable,Yes,Antianxiety: benzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In Person,16,Self report,IES,IES,,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,24.8,7.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement",High,"Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J. Clin. Psychiatry. 1990 Jun;51(6):236-8.  PMID: 2189869.",02466,2019
braun1990_IES_A_Baseline_NA,Pharmacotherapy,PTSD,16,A,PTSD,,,,Alprazolam,Alprazolam,No,Not Applicable,Yes,Antianxiety: benzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In Person,16,Self report,IES,IES,,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,28.1,6.07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement",High,"Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J. Clin. Psychiatry. 1990 Jun;51(6):236-8.  PMID: 2189869.",02466,2019
braun1990_IES_B_0_NA,Pharmacotherapy,PTSD,16,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,16,Self report,IES,IES,,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,26.4,6.99,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement",High,"Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J. Clin. Psychiatry. 1990 Jun;51(6):236-8.  PMID: 2189869.",02466,2019
braun1990_IES_B_Baseline_NA,Pharmacotherapy,PTSD,16,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,16,Self report,IES,IES,,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,26.7,11.26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement",High,"Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J. Clin. Psychiatry. 1990 Jun;51(6):236-8.  PMID: 2189869.",02466,2019
braun1990_PSS_A_0_Comp,Pharmacotherapy,PTSD,16,A,PTSD,,10,,Alprazolam,Alprazolam,No,Not Applicable,Yes,Antianxiety: benzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In Person,16,Self report,PSS,PSS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,26.6,7.44,,,,,-4.3,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement",High,"Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J. Clin. Psychiatry. 1990 Jun;51(6):236-8.  PMID: 2189869.",02466,2019
braun1990_PSS_A_Baseline_Comp,Pharmacotherapy,PTSD,16,A,PTSD,,10,,Alprazolam,Alprazolam,No,Not Applicable,Yes,Antianxiety: benzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In Person,16,Self report,PSS,PSS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,30.9,8.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement",High,"Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J. Clin. Psychiatry. 1990 Jun;51(6):236-8.  PMID: 2189869.",02466,2019
braun1990_PSS_B_0_Comp,Pharmacotherapy,PTSD,16,B,Control,,10,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,16,Self report,PSS,PSS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,28.8,8.16,,,,,-1.2,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement",High,"Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J. Clin. Psychiatry. 1990 Jun;51(6):236-8.  PMID: 2189869.",02466,2019
braun1990_PSS_B_Baseline_Comp,Pharmacotherapy,PTSD,16,B,Control,,10,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,16,Self report,PSS,PSS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,30,9.34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement",High,"Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J. Clin. Psychiatry. 1990 Jun;51(6):236-8.  PMID: 2189869.",02466,2019
bremner2017_CAPS_A_0_Comp,Mixed: Psychotherapy & CIH,PTSD,26,A,PTSD,,9,,MBSR,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,17,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,28,20,,,,,-28,,,,,,,,,,p=0.016,,,,,,,,,,,,,,Veteran,,1,,0,,1,Combat-related,,Medium,"Bremner JD, Mishra S, Campanella C, et al. A pilot study of the effects of mindfulness-based stress reduction on post-traumatic stress disorder symptoms and brain response to traumatic reminders of combat in Operation Enduring Freedom/Operation Iraqi Freedom combat veterans with post-traumatic stress disorder. Front Psychiatry. 2017 Aug 25;8:157. doi: 10.3389/fpsyt.2017.00157. PMID: 28890702.",49077,2019
bremner2017_CAPS_A_26_Comp,Mixed: Psychotherapy & CIH,PTSD,26,A,PTSD,,9,,MBSR,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,17,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,,,,,,,,,,,"""these effects [end of treatment] persisted at the 6-month followup period""",,,,,,,,,,,,,,,,,,,,Veteran,,1,,0,,1,Combat-related,,Medium,"Bremner JD, Mishra S, Campanella C, et al. A pilot study of the effects of mindfulness-based stress reduction on post-traumatic stress disorder symptoms and brain response to traumatic reminders of combat in Operation Enduring Freedom/Operation Iraqi Freedom combat veterans with post-traumatic stress disorder. Front Psychiatry. 2017 Aug 25;8:157. doi: 10.3389/fpsyt.2017.00157. PMID: 28890702.",49077,2019
bremner2017_CAPS_A_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,26,A,PTSD,,9,,MBSR,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,17,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,56,29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0,,1,Combat-related,,Medium,"Bremner JD, Mishra S, Campanella C, et al. A pilot study of the effects of mindfulness-based stress reduction on post-traumatic stress disorder symptoms and brain response to traumatic reminders of combat in Operation Enduring Freedom/Operation Iraqi Freedom combat veterans with post-traumatic stress disorder. Front Psychiatry. 2017 Aug 25;8:157. doi: 10.3389/fpsyt.2017.00157. PMID: 28890702.",49077,2019
bremner2017_CAPS_B_0_Comp,Mixed: Psychotherapy & CIH,PTSD,26,B,PTSD,,8,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,9,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,43,15,,,,,-8,,,,,,,,,,p>0.05,,,,,,,,,,,,,,Veteran,,1,,0,,1,Combat-related,,Medium,"Bremner JD, Mishra S, Campanella C, et al. A pilot study of the effects of mindfulness-based stress reduction on post-traumatic stress disorder symptoms and brain response to traumatic reminders of combat in Operation Enduring Freedom/Operation Iraqi Freedom combat veterans with post-traumatic stress disorder. Front Psychiatry. 2017 Aug 25;8:157. doi: 10.3389/fpsyt.2017.00157. PMID: 28890702.",49077,2019
bremner2017_CAPS_B_26_Comp,Mixed: Psychotherapy & CIH,PTSD,26,B,PTSD,,8,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,9,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,,,,,,,,,,,"""these effects [end of treatment] persisted at the 6-month followup period""",,,,,,,,,,,,,,,,,,,,Veteran,,1,,0,,1,Combat-related,,Medium,"Bremner JD, Mishra S, Campanella C, et al. A pilot study of the effects of mindfulness-based stress reduction on post-traumatic stress disorder symptoms and brain response to traumatic reminders of combat in Operation Enduring Freedom/Operation Iraqi Freedom combat veterans with post-traumatic stress disorder. Front Psychiatry. 2017 Aug 25;8:157. doi: 10.3389/fpsyt.2017.00157. PMID: 28890702.",49077,2019
bremner2017_CAPS_B_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,26,B,PTSD,,8,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,9,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,51,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0,,1,Combat-related,,Medium,"Bremner JD, Mishra S, Campanella C, et al. A pilot study of the effects of mindfulness-based stress reduction on post-traumatic stress disorder symptoms and brain response to traumatic reminders of combat in Operation Enduring Freedom/Operation Iraqi Freedom combat veterans with post-traumatic stress disorder. Front Psychiatry. 2017 Aug 25;8:157. doi: 10.3389/fpsyt.2017.00157. PMID: 28890702.",49077,2019
brom1989_IES_A_0_NA,Mixed: Psychotherapy & CIH,PTSD,112,A,PTSD,,,,Trauma Desensitization,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Self report,IES,IES,,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,28,19.5,,,,,-19.4,,,,,,,,,,p<0.05,,,,,,,,,,,,,,Community,,,1,0.79,,0.21,Mixed,"accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)",High,"Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.",03090,2019
brom1989_IES_A_12_NA,Mixed: Psychotherapy & CIH,PTSD,112,A,PTSD,,,,Trauma Desensitization,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Self report,IES,IES,,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 3 to <6 Months,12,,31.3,21.1,,,,,-16.1,,,,,,,,,,p<0.05,,,,,,,,,,,,,,Community,,,1,0.79,,0.21,Mixed,"accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)",High,"Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.",03090,2019
brom1989_IES_A_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,112,A,PTSD,,,,Trauma Desensitization,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Self report,IES,IES,,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,47.4,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.79,,0.21,Mixed,"accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)",High,"Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.",03090,2019
brom1989_IES_B_0_NA,Mixed: Psychotherapy & CIH,PTSD,112,B,PTSD,,,,Hypnotherapy,Hypnotherapy,No,Not Applicable,No,Not Applicable,Yes,Clinical hypnosis,No,No,No,No,No,Individual,In Person,29,Self report,IES,IES,,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,33.7,22.9,,,,,-17.1,,,,,,,,,,p<0.05,,,,,,,,,,,,,,Community,,,1,0.79,,0.21,Mixed,"accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)",High,"Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.",03090,2019
brom1989_IES_B_12_NA,Mixed: Psychotherapy & CIH,PTSD,112,B,PTSD,,,,Hypnotherapy,Hypnotherapy,No,Not Applicable,No,Not Applicable,Yes,Clinical hypnosis,No,No,No,No,No,Individual,In Person,29,Self report,IES,IES,,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 3 to <6 Months,12,,31.7,22,,,,,-19.1,,,,,,,,,,p<0.05,,,,,,,,,,,,,,Community,,,1,0.79,,0.21,Mixed,"accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)",High,"Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.",03090,2019
brom1989_IES_B_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,112,B,PTSD,,,,Hypnotherapy,Hypnotherapy,No,Not Applicable,No,Not Applicable,Yes,Clinical hypnosis,No,No,No,No,No,Individual,In Person,29,Self report,IES,IES,,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,50.8,11.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.79,,0.21,Mixed,"accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)",High,"Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.",03090,2019
brom1989_IES_C_0_NA,Mixed: Psychotherapy & CIH,PTSD,112,C,PTSD,,,,Psychodynamic therapy,Psychodynamic psychotherapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Self report,IES,IES,,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,32.7,16.5,,,,,-13.6,,,,,,,,,,p<0.05,,,,,,,,,,,,,,Community,,,1,0.79,,0.21,Mixed,"accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)",High,"Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.",03090,2019
brom1989_IES_C_12_NA,Mixed: Psychotherapy & CIH,PTSD,112,C,PTSD,,,,Psychodynamic therapy,Psychodynamic psychotherapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Self report,IES,IES,,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 3 to <6 Months,12,,27,17,,,,,-19.3,,,,,,,,,,p<0.05,,,,,,,,,,,,,,Community,,,1,0.79,,0.21,Mixed,"accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)",High,"Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.",03090,2019
brom1989_IES_C_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,112,C,PTSD,,,,Psychodynamic therapy,Psychodynamic psychotherapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Self report,IES,IES,,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,46.3,13.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.79,,0.21,Mixed,"accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)",High,"Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.",03090,2019
brom1989_IES_D_0_NA,Mixed: Psychotherapy & CIH,PTSD,112,D,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,23,Self report,IES,IES,,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,46.5,15.2,,,,,-4.6,,,,,,,,,,p>0.05,,,,,,,,,,,,,,Community,,,1,0.79,,0.21,Mixed,"accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)",High,"Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.",03090,2019
brom1989_IES_D_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,112,D,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,23,Self report,IES,IES,,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,51.1,14.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.79,,0.21,Mixed,"accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)",High,"Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.",03090,2019
brom2017_CAPS_A_0_ITT,Complementary and integrative health (CIH),PTSD,63,A,PTSD,,28,,Somatic Experiencing,Somatic Experiencing,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Individual,In Person,33,Structured Clinical Interview,CAPS,CAPS (Hebrew version),ITT,Maximum likelihood imputation using unstructured covariance matrix,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,36.31,29.02,,,,,-32.06,,,,,Cohen's d,1.26,,,,"p=""significant""",,,,,,,,Not meeting criteria for PTSD according to CAPS,,,,,,Community,,,1,0.507,,0.493,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence terrorism/political violence/forced displacement, other (death or injury of family member, threat)",Medium,"Brom D, Stokar Y, Lawi C, et al. Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 Jun;30(3):304-12. doi: 10.1002/jts.22189. PMID: 28585761.",48274,2019
brom2017_CAPS_A_Baseline_ITT,Complementary and integrative health (CIH),PTSD,63,A,PTSD,,33,,Somatic Experiencing,Somatic Experiencing,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Individual,In Person,33,Structured Clinical Interview,CAPS,CAPS (Hebrew version),ITT,Maximum likelihood imputation using unstructured covariance matrix,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,68.37,20.05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.507,,0.493,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence terrorism/political violence/forced displacement, other (death or injury of family member, threat)",Medium,"Brom D, Stokar Y, Lawi C, et al. Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 Jun;30(3):304-12. doi: 10.1002/jts.22189. PMID: 28585761.",48274,2019
brom2017_CAPS_B_0_ITT,Complementary and integrative health (CIH),PTSD,63,B,Control,,30,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,30,Structured Clinical Interview,CAPS,CAPS (Hebrew version),ITT,Maximum likelihood imputation using unstructured covariance matrix,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,58.62,29.58,,,,,-9.31,,,,,Cohen's d,0.38,,,,p=NS,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,,,,Community,,,1,0.507,,0.493,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence terrorism/political violence/forced displacement, other (death or injury of family member, threat)",Medium,"Brom D, Stokar Y, Lawi C, et al. Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 Jun;30(3):304-12. doi: 10.1002/jts.22189. PMID: 28585761.",48274,2019
brom2017_CAPS_B_Baseline_ITT,Complementary and integrative health (CIH),PTSD,63,B,Control,,30,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,30,Structured Clinical Interview,CAPS,CAPS (Hebrew version),ITT,Maximum likelihood imputation using unstructured covariance matrix,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,67.93,20.43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.507,,0.493,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence terrorism/political violence/forced displacement, other (death or injury of family member, threat)",Medium,"Brom D, Stokar Y, Lawi C, et al. Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 Jun;30(3):304-12. doi: 10.1002/jts.22189. PMID: 28585761.",48274,2019
brom2017_PDS_A_0_NA,Complementary and integrative health (CIH),PTSD,63,A,PTSD,,,,Somatic Experiencing,Somatic Experiencing,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Individual,In Person,33,Self report,PDS,PDS (Hebrew version),,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,21.36,,SE,2.18,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.507,,0.493,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence terrorism/political violence/forced displacement, other (death or injury of family member, threat)",Medium,"Brom D, Stokar Y, Lawi C, et al. Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 Jun;30(3):304-12. doi: 10.1002/jts.22189. PMID: 28585761.",48274,2019
brom2017_PDS_A_Baseline_NA,Complementary and integrative health (CIH),PTSD,63,A,PTSD,,,,Somatic Experiencing,Somatic Experiencing,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Individual,In Person,33,Self report,PDS,PDS (Hebrew version),,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,34.13,,SE,1.6,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.507,,0.493,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence terrorism/political violence/forced displacement, other (death or injury of family member, threat)",Medium,"Brom D, Stokar Y, Lawi C, et al. Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 Jun;30(3):304-12. doi: 10.1002/jts.22189. PMID: 28585761.",48274,2019
brom2017_PDS_B_0_NA,Complementary and integrative health (CIH),PTSD,63,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,30,Self report,PDS,PDS (Hebrew version),,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,32.50,,SE,2.19,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.507,,0.493,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence terrorism/political violence/forced displacement, other (death or injury of family member, threat)",Medium,"Brom D, Stokar Y, Lawi C, et al. Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 Jun;30(3):304-12. doi: 10.1002/jts.22189. PMID: 28585761.",48274,2019
brom2017_PDS_B_Baseline_NA,Complementary and integrative health (CIH),PTSD,63,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,30,Self report,PDS,PDS (Hebrew version),,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,34.08,,SE,1.73,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.507,,0.493,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence terrorism/political violence/forced displacement, other (death or injury of family member, threat)",Medium,"Brom D, Stokar Y, Lawi C, et al. Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 Jun;30(3):304-12. doi: 10.1002/jts.22189. PMID: 28585761.",48274,2019
brunet2018_CAPS_A_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,61,A,PTSD,,15,,Propranolol + traumatic memory reactivation,Propranolol + imaginal exposure (experimental paradigm),Yes,TF,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,48.00,26.88,,,,,-26.87,,,,,Cohen's d,1.64,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.407,,Decrease of ≥10 on PCL-S,,,Community,,,1,0.5833,,0.4167,Mixed,"combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)",Medium,"Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.",49661,2019
brunet2018_CAPS_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,61,A,PTSD,,30,,Propranolol + traumatic memory reactivation,Propranolol + imaginal exposure (experimental paradigm),Yes,TF,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation using Markov Chain Monte Carlo algorithm and LOCF for outcomes with large amounts of missing data (not pre-defined),"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,47.16,25.36,,,,,-28.91,,,,,Cohen's d,1.76,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,Decrease of ≥10 on PCL-S,0.6333,,Community,,,1,0.5833,,0.4167,Mixed,"combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)",Medium,"Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.",49661,2019
brunet2018_CAPS_A_26_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,61,A,PTSD,,9,,Propranolol + traumatic memory reactivation,Propranolol + imaginal exposure (experimental paradigm),Yes,TF,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation using Markov Chain Monte Carlo algorithm and LOCF for outcomes with large amounts of missing data (not pre-defined),"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,52.0,,,,,,-24.07,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,Decrease of ≥10 on PCL-S,,,Community,,,1,0.5833,,0.4167,Mixed,"combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)",Medium,"Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.",49661,2019
brunet2018_CAPS_A_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,61,A,PTSD,,15,,Propranolol + traumatic memory reactivation,Propranolol + imaginal exposure (experimental paradigm),Yes,TF,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,74.87,16.92,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,Decrease of ≥10 on PCL-S,,,Community,,,1,0.5833,,0.4167,Mixed,"combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)",Medium,"Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.",49661,2019
brunet2018_CAPS_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,61,A,PTSD,,30,,Propranolol + traumatic memory reactivation,Propranolol + imaginal exposure (experimental paradigm),Yes,TF,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation using Markov Chain Monte Carlo algorithm and LOCF for outcomes with large amounts of missing data (not pre-defined),"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,76.07,16.98,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,Decrease of ≥10 on PCL-S,,,Community,,,1,0.5833,,0.4167,Mixed,"combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)",Medium,"Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.",49661,2019
brunet2018_CAPS_B_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,61,B,Control,,15,,Placebo + traumatic memory reactivation,Imaginal exposure (experimental paradigm) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,65.31,19.06,,,,,-10.82,,,,,Cohen's d,0.72,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.197,,Decrease of ≥10 on PCL-S,,,Community,,,1,0.5833,,0.4167,Mixed,"combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)",Medium,"Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.",49661,2019
brunet2018_CAPS_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,61,B,Control,,30,,Placebo + traumatic memory reactivation,Imaginal exposure (experimental paradigm) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation using Markov Chain Monte Carlo algorithm and LOCF for outcomes with large amounts of missing data (not pre-defined),"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,53.69,26.95,,,,,-17.35,,,,,Cohen's d,1.25,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,Decrease of ≥10 on PCL-S,0.3333,,Community,,,1,0.5833,,0.4167,Mixed,"combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)",Medium,"Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.",49661,2019
brunet2018_CAPS_B_26_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,61,B,Control,,5,,Placebo + traumatic memory reactivation,Imaginal exposure (experimental paradigm) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation using Markov Chain Monte Carlo algorithm and LOCF for outcomes with large amounts of missing data (not pre-defined),"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,69.2,,,,,,-1.84,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,Decrease of ≥10 on PCL-S,,,Community,,,1,0.5833,,0.4167,Mixed,"combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)",Medium,"Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.",49661,2019
brunet2018_CAPS_B_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,61,B,Control,,15,,Placebo + traumatic memory reactivation,Imaginal exposure (experimental paradigm) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,76.13,12.86,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,Decrease of ≥10 on PCL-S,,,Community,,,1,0.5833,,0.4167,Mixed,"combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)",Medium,"Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.",49661,2019
brunet2018_CAPS_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,61,B,Control,,30,,Placebo + traumatic memory reactivation,Imaginal exposure (experimental paradigm) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation using Markov Chain Monte Carlo algorithm and LOCF for outcomes with large amounts of missing data (not pre-defined),"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,71.04,14.68,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,Decrease of ≥10 on PCL-S,,,Community,,,1,0.5833,,0.4167,Mixed,"combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)",Medium,"Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.",49661,2019
brunet2018_PCL_A_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,61,A,PTSD,,,,Propranolol + traumatic memory reactivation,Propranolol + imaginal exposure (experimental paradigm),Yes,TF,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PCL,PCL-S,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,38.07,16.73,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5833,,0.4167,Mixed,"combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)",Medium,"Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.",49661,2019
brunet2018_PCL_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,61,A,PTSD,,,,Propranolol + traumatic memory reactivation,Propranolol + imaginal exposure (experimental paradigm),Yes,TF,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PCL,PCL-S,ITT,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,36.60,18.46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5833,,0.4167,Mixed,"combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)",Medium,"Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.",49661,2019
brunet2018_PCL_A_26_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,61,A,PTSD,,,,Propranolol + traumatic memory reactivation,Propranolol + imaginal exposure (experimental paradigm),Yes,TF,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PCL,PCL-S,ITT,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,38.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5833,,0.4167,Mixed,"combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)",Medium,"Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.",49661,2019
brunet2018_PCL_A_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,61,A,PTSD,,,,Propranolol + traumatic memory reactivation,Propranolol + imaginal exposure (experimental paradigm),Yes,TF,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PCL,PCL-S,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,61.73,7.94,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5833,,0.4167,Mixed,"combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)",Medium,"Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.",49661,2019
brunet2018_PCL_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,61,A,PTSD,,,,Propranolol + traumatic memory reactivation,Propranolol + imaginal exposure (experimental paradigm),Yes,TF,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PCL,PCL-S,ITT,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,61.81,9.31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5833,,0.4167,Mixed,"combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)",Medium,"Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.",49661,2019
brunet2018_PCL_B_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,61,B,Control,,,,Placebo + traumatic memory reactivation,Imaginal exposure (experimental paradigm) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,31,Self report,PCL,PCL-S,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,55.71,13.79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5833,,0.4167,Mixed,"combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)",Medium,"Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.",49661,2019
brunet2018_PCL_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,61,B,Control,,,,Placebo + traumatic memory reactivation,Imaginal exposure (experimental paradigm) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,31,Self report,PCL,PCL-S,ITT,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,51.20,18.62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5833,,0.4167,Mixed,"combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)",Medium,"Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.",49661,2019
brunet2018_PCL_B_26_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,61,B,Control,,,,Placebo + traumatic memory reactivation,Imaginal exposure (experimental paradigm) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,31,Self report,PCL,PCL-S,ITT,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,69.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5833,,0.4167,Mixed,"combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)",Medium,"Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.",49661,2019
brunet2018_PCL_B_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,61,B,Control,,,,Placebo + traumatic memory reactivation,Imaginal exposure (experimental paradigm) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,31,Self report,PCL,PCL-S,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,61.27,8.79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5833,,0.4167,Mixed,"combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)",Medium,"Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.",49661,2019
brunet2018_PCL_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,61,B,Control,,,,Placebo + traumatic memory reactivation,Imaginal exposure (experimental paradigm) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,31,Self report,PCL,PCL-S,ITT,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,56.96,11.83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5833,,0.4167,Mixed,"combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)",Medium,"Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.",49661,2019
bryant2003_CAPS_A_0_Comp,Psychotherapy,PTSD,58,A,PTSD,,15,,Prolonged Imaginal Exposure with Cognitive Restructuring,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,10.33,9.75,,,,,-22.4,,,,,Hedges' g,2.47,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-2,0.87,,CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10,,,Community,,,1,0.52,,0.48,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.",25807,2019
bryant2003_CAPS_A_0_ITT,Psychotherapy,PTSD,58,A,PTSD,,20,,Prolonged Imaginal Exposure with Cognitive Restructuring,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS intensity,ITT,LOCF,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,15.9,13.36,,,,,-16.8,,,,,Hedges' g,1.58,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-2,0.65,,CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10,,,Community,,,1,0.52,,0.48,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.",25807,2019
bryant2003_CAPS_A_26_Comp,Psychotherapy,PTSD,58,A,PTSD,,15,,Prolonged Imaginal Exposure with Cognitive Restructuring,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,8.53,10.25,,,,,-24.2,,,,,Hedges' g,2.6,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-2,0.8,,CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10,0.6,,Community,,,1,0.52,,0.48,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.",25807,2019
bryant2003_CAPS_A_26_ITT,Psychotherapy,PTSD,58,A,PTSD,,20,,Prolonged Imaginal Exposure with Cognitive Restructuring,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS intensity,ITT,LOCF,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,15.7,14.79,,,,,-17,,,,,Hedges' g,1.49,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-2,0.6,,CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10,0.4,,Community,,,1,0.52,,0.48,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.",25807,2019
bryant2003_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,58,A,PTSD,,15,,Prolonged Imaginal Exposure with Cognitive Restructuring,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,32.73,7.88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.52,,0.48,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.",25807,2019
bryant2003_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,58,A,PTSD,,20,,Prolonged Imaginal Exposure with Cognitive Restructuring,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS intensity,ITT,LOCF,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,32.70,7.51,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.52,,0.48,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.",25807,2019
bryant2003_CAPS_B_0_Comp,Psychotherapy,PTSD,58,B,PTSD,,15,,Imaginal Exposure,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,14,7.96,,,,,-16.07,,,,,Hedges' g,1.96,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-2,0.67,,CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10,,,Community,,,1,0.52,,0.48,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.",25807,2019
bryant2003_CAPS_B_0_ITT,Psychotherapy,PTSD,58,B,PTSD,,20,,Imaginal Exposure,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS intensity,ITT,LOCF,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,19.15,11.12,,,,,-13.35,,,,,Hedges' g,1.25,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-2,0.5,,CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10,,,Community,,,1,0.52,,0.48,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.",25807,2019
bryant2003_CAPS_B_26_Comp,Psychotherapy,PTSD,58,B,PTSD,,15,,Imaginal Exposure,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,16.67,10.49,,,,,-14,,,,,Hedges' g,1.5,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-2,0.67,,CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10,0.2,,Community,,,1,0.52,,0.48,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.",25807,2019
bryant2003_CAPS_B_26_ITT,Psychotherapy,PTSD,58,B,PTSD,,20,,Imaginal Exposure,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS intensity,ITT,LOCF,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,20.7,12,,,,,-11.8,,,,,Hedges' g,1.05,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-2,0.5,,CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10,0.15,,Community,,,1,0.52,,0.48,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.",25807,2019
bryant2003_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,58,B,PTSD,,15,,Imaginal Exposure,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,30.67,7.94,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.52,,0.48,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.",25807,2019
bryant2003_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,58,B,PTSD,,20,,Imaginal Exposure,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS intensity,ITT,LOCF,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,32.5,8.71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.52,,0.48,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.",25807,2019
bryant2003_CAPS_C_0_Comp,Psychotherapy,PTSD,58,C,PTSD,,15,,Supportive Counseling,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,23.73,12.94,,,,,-8.14,,,,,Hedges' g,0.77,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-2,0.4,,CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10,,,Community,,,1,0.52,,0.48,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.",25807,2019
bryant2003_CAPS_C_0_ITT,Psychotherapy,PTSD,58,C,PTSD,,18,,Supportive Counseling,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS intensity,ITT,LOCF,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,28,15.31,,,,,-4.83,,,,,Hedges' g,0.41,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-2,0.33,,CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10,,,Community,,,1,0.52,,0.48,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.",25807,2019
bryant2003_CAPS_C_26_Comp,Psychotherapy,PTSD,58,C,PTSD,,15,,Supportive Counseling,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,26.4,10.24,,,,,-5.47,,,,,Hedges' g,0.6,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-2,0.27,,CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10,0,,Community,,,1,0.52,,0.48,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.",25807,2019
bryant2003_CAPS_C_26_ITT,Psychotherapy,PTSD,58,C,PTSD,,18,,Supportive Counseling,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS intensity,ITT,LOCF,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,30.28,12.89,,,,,-2.55,,,,,Hedges' g,0.24,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-2,0.22,,CAPS intensity score plus CAPS frequency score <19 and BDI-2 score <10,0,,Community,,,1,0.52,,0.48,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.",25807,2019
bryant2003_CAPS_C_Baseline_Comp,Psychotherapy,PTSD,58,C,PTSD,,15,,Supportive Counseling,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,31.87,7.49,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.52,,0.48,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.",25807,2019
bryant2003_CAPS_C_Baseline_ITT,Psychotherapy,PTSD,58,C,PTSD,,18,,Supportive Counseling,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS intensity,ITT,LOCF,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,32.83,8.01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.52,,0.48,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.",25807,2019
bryant2008_CAPS_A_0_Comp,Psychotherapy,PTSD,118,A,PTSD,,21,,Imaginal Exposure,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,59.94,32.36,,,,difference from the ITT Baseline,-27.94,,,,,,,,,,,,,,,,,,CAPS <19,0.48,,CAPS <19 and BDI <10,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_A_0_ITT,Psychotherapy,PTSD,118,A,PTSD,,23,,Imaginal Exposure,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,55.5,33.83,,,,,-17.79,,,,,,,,,,,,,,,,,,CAPS <19,0.37,,CAPS <19 and BDI <10,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_A_26_Comp,Psychotherapy,PTSD,118,A,PTSD,,21,,Imaginal Exposure,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,46.81,29.1,,,,difference from the ITT Baseline,-26.48,,,,,,,,,,,,,,,,,,CAPS <19,0.57,,CAPS <19 and BDI <10,0.14,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_A_26_ITT,Psychotherapy,PTSD,118,A,PTSD,,21,,Imaginal Exposure,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,59.95,32.36,,,,,-13.35,,,,,,,,,,,,,,,,,,CAPS <19,0.25,,CAPS <19 and BDI <10,0.1,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,118,A,PTSD,,21,,Imaginal Exposure,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,118,A,PTSD,,31,,Imaginal Exposure,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,73.29,18.82,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_B_0_Comp,Psychotherapy,PTSD,118,B,PTSD,,22,,In vivo exposure,In vivo exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,49.55,23.28,,,,difference from the ITT Baseline,-27.24,,,,,,,,,,,,,,,,,,CAPS <19,0.45,,CAPS <19 and BDI <10,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_B_0_ITT,Psychotherapy,PTSD,118,B,PTSD,,22,,In vivo exposure,In vivo exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,55.96,24.56,,,,,-20.83,,,,,,,,,,,,,,,,,,CAPS <19,0.35,,CAPS <19 and BDI <10,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_B_26_Comp,Psychotherapy,PTSD,118,B,PTSD,,21,,In vivo exposure,In vivo exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,52.53,30.92,,,,difference from the ITT Baseline,-24.26,,,,,,,,,,,,,,,,,,CAPS <19,0.38,,CAPS <19 and BDI <10,0.24,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_B_26_ITT,Psychotherapy,PTSD,118,B,PTSD,,21,,In vivo exposure,In vivo exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,59.32,29.62,,,,,-17.47,,,,,,,,,,,,,,,,,,CAPS <19,0.31,,CAPS <19 and BDI <10,0.18,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,118,B,PTSD,,22,,In vivo exposure,In vivo exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,118,B,PTSD,,28,,In vivo exposure,In vivo exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,76.79,15.53,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_C_0_Comp,Psychotherapy,PTSD,118,C,PTSD,,21,,Imaginal exposure + In vivo exposure,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,36.95,30.57,,,,difference from the ITT Baseline,-39.11,,,,,,,,,,,,,,,,,,CAPS <19,0.52,,CAPS <19 and BDI <10,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_C_0_ITT,Psychotherapy,PTSD,118,C,PTSD,,21,,Imaginal exposure + In vivo exposure,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,55.39,37.45,,,,,-20.67,,,,,,,,,,,,,,,,,,CAPS <19,0.41,,CAPS <19 and BDI <10,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_C_26_Comp,Psychotherapy,PTSD,118,C,PTSD,,21,,Imaginal exposure + In vivo exposure,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,38.43,28.6,,,,difference from the ITT Baseline,-37.63,,,,,,,,,,,,,,,,,,CAPS <19,0.57,,CAPS <19 and BDI <10,0.24,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_C_26_ITT,Psychotherapy,PTSD,118,C,PTSD,,21,,Imaginal exposure + In vivo exposure,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,56.39,35.87,,,,,-19.67,,,,,,,,,,,,,,,,,,CAPS <19,0.37,,CAPS <19 and BDI <10,0.16,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_C_Baseline_Comp,Psychotherapy,PTSD,118,C,PTSD,,21,,Imaginal exposure + In vivo exposure,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_C_Baseline_ITT,Psychotherapy,PTSD,118,C,PTSD,,31,,Imaginal exposure + In vivo exposure,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,76.06,19.19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_D_0_Comp,Psychotherapy,PTSD,118,D,PTSD,,24,,Imaginal exposure + In vivo exposure + Cognitive restructuring,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,21.71,18.42,,,,difference from the ITT Baseline,-49.64,,,,,,,,,,,,,,,,,,CAPS <19,0.79,,CAPS <19 and BDI <10,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_D_0_ITT,Psychotherapy,PTSD,118,D,PTSD,,24,,Imaginal exposure + In vivo exposure + Cognitive restructuring,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,29.86,27.11,,,,,-41.49,,,,,,,,,,,,,,,,,,CAPS <19,0.65,,CAPS <19 and BDI <10,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_D_26_Comp,Psychotherapy,PTSD,118,D,PTSD,,21,,Imaginal exposure + In vivo exposure + Cognitive restructuring,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,23.71,19.46,,,,difference from the ITT Baseline,-47.64,,,,,,,,,,,,,,,,,,CAPS <19,0.86,,CAPS <19 and BDI <10,0.46,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_D_26_ITT,Psychotherapy,PTSD,118,D,PTSD,,21,,Imaginal exposure + In vivo exposure + Cognitive restructuring,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,32.86,27.44,,,,,-38.49,,,,,,,,,,,,,,,,,,CAPS <19,0.69,,CAPS <19 and BDI <10,0.36,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_D_Baseline_Comp,Psychotherapy,PTSD,118,D,PTSD,,24,,Imaginal exposure + In vivo exposure + Cognitive restructuring,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2008_CAPS_D_Baseline_ITT,Psychotherapy,PTSD,118,D,PTSD,,28,,Imaginal exposure + In vivo exposure + Cognitive restructuring,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,71.35,17.28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.",31196,2019
bryant2011_PSS-I_A_0_ITT,Psychotherapy,PTSD,28,A,PTSD,,16,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,16,Structured Clinical Interview,PSS-I,PSS-I,ITT,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,4.1,8,,,,,-22.7,,,,,,,,,,,,,,,,,,,,,CAPS score <19 and BDI-II score <10,,,Community,,,1,0.9643,,0.0357,Terrorism/political violence/forced displacement,,Medium,"Bryant RA, Ekassawin S, Chakkraband MLS, et al. A randomized controlled effectiveness trial of cognitive behavior therapy for post-traumatic stress disorder in terrorist-affected people in Thailand. World Psychiatry. 2011 Oct;10(3):205-9.  PMID: 21991280.",37395,2019
bryant2011_PSS-I_A_12_ITT,Psychotherapy,PTSD,28,A,PTSD,,16,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,16,Structured Clinical Interview,PSS-I,PSS-I,ITT,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 3 to <6 Months,12,,7.5,11.1,,,,,-19.3,,,,,Hedges' g,1.78,95% CI,0.96,2.6,,,,,,,,,,,,CAPS score <19 and BDI-II score <10,0.75,,Community,,,1,0.9643,,0.0357,Terrorism/political violence/forced displacement,,Medium,"Bryant RA, Ekassawin S, Chakkraband MLS, et al. A randomized controlled effectiveness trial of cognitive behavior therapy for post-traumatic stress disorder in terrorist-affected people in Thailand. World Psychiatry. 2011 Oct;10(3):205-9.  PMID: 21991280.",37395,2019
bryant2011_PSS-I_A_Baseline_ITT,Psychotherapy,PTSD,28,A,PTSD,,16,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,16,Structured Clinical Interview,PSS-I,PSS-I,ITT,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,26.8,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.9643,,0.0357,Terrorism/political violence/forced displacement,,Medium,"Bryant RA, Ekassawin S, Chakkraband MLS, et al. A randomized controlled effectiveness trial of cognitive behavior therapy for post-traumatic stress disorder in terrorist-affected people in Thailand. World Psychiatry. 2011 Oct;10(3):205-9.  PMID: 21991280.",37395,2019
bryant2011_PSS-I_B_0_ITT,Psychotherapy,PTSD,28,B,Control,,12,,TAU,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Structured Clinical Interview,PSS-I,PSS-I,ITT,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,12.3,8.4,,,,,-10.4,,,,,,,,,,,,,,,,,,,,,CAPS score <19 and BDI-II score <10,,,Community,,,1,0.9643,,0.0357,Terrorism/political violence/forced displacement,,Medium,"Bryant RA, Ekassawin S, Chakkraband MLS, et al. A randomized controlled effectiveness trial of cognitive behavior therapy for post-traumatic stress disorder in terrorist-affected people in Thailand. World Psychiatry. 2011 Oct;10(3):205-9.  PMID: 21991280.",37395,2019
bryant2011_PSS-I_B_12_ITT,Psychotherapy,PTSD,28,B,Control,,12,,TAU,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Structured Clinical Interview,PSS-I,PSS-I,ITT,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 3 to <6 Months,12,,15.2,13.1,,,,,-7.5,,,,,Hedges' g,0.57,95% CI,0.25,1.38,,,,,,,,,,,,CAPS score <19 and BDI-II score <10,0.33,,Community,,,1,0.9643,,0.0357,Terrorism/political violence/forced displacement,,Medium,"Bryant RA, Ekassawin S, Chakkraband MLS, et al. A randomized controlled effectiveness trial of cognitive behavior therapy for post-traumatic stress disorder in terrorist-affected people in Thailand. World Psychiatry. 2011 Oct;10(3):205-9.  PMID: 21991280.",37395,2019
bryant2011_PSS-I_B_Baseline_ITT,Psychotherapy,PTSD,28,B,Control,,12,,TAU,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Structured Clinical Interview,PSS-I,PSS-I,ITT,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,22.7,12.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.9643,,0.0357,Terrorism/political violence/forced displacement,,Medium,"Bryant RA, Ekassawin S, Chakkraband MLS, et al. A randomized controlled effectiveness trial of cognitive behavior therapy for post-traumatic stress disorder in terrorist-affected people in Thailand. World Psychiatry. 2011 Oct;10(3):205-9.  PMID: 21991280.",37395,2019
bryant2013_CAPS_A_0_Comp,Psychotherapy,PTSD,70,A,PTSD,,30,,Emotion Regulation Training + CBT,Emotion Regulation Training followed by trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Structured Clinical Interview,CAPS,CAPS-2,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,34.36,27.95,,,,,-39.39,,,,,,,,,,,,,,,,,,CAPS score <19,,,CAPS score <19 and BDI-II score <10,,,Community,,,1,0.5429,,0.4571,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.",40045,2019
bryant2013_CAPS_A_0_ITT,Psychotherapy,PTSD,70,A,PTSD,,21,,Emotion Regulation Training + CBT,Emotion Regulation Training followed by trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Structured Clinical Interview,CAPS,CAPS-2,ITT,imputed,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,32.43,21.61,,,,,-41.32,,,,,,,,,,,,,,,,,,CAPS score <19,0.81,,CAPS score <19 and BDI-II score <10,,,Community,,,1,0.5429,,0.4571,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.",40045,2019
bryant2013_CAPS_A_26_Comp,Psychotherapy,PTSD,70,A,PTSD,,21,,Emotion Regulation Training + CBT,Emotion Regulation Training followed by trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Structured Clinical Interview,CAPS,CAPS-2,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,27.81,23.49,,,,,-45.94,,,,,,,,,,,,,,,,,,CAPS score <19,,,CAPS score <19 and BDI-II score <10,,,Community,,,1,0.5429,,0.4571,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.",40045,2019
bryant2013_CAPS_A_26_ITT,Psychotherapy,PTSD,70,A,PTSD,,36,,Emotion Regulation Training + CBT,Emotion Regulation Training followed by trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Structured Clinical Interview,CAPS,CAPS-2,ITT,imputed,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,37.47,23.49,,,,,-36.28,,,,,,,,,,,,,,,,,,CAPS score <19,0.72,,CAPS score <19 and BDI-II score <10,0.31,,Community,,,1,0.5429,,0.4571,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.",40045,2019
bryant2013_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,70,A,PTSD,,30,,Emotion Regulation Training + CBT,Emotion Regulation Training followed by trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Structured Clinical Interview,CAPS,CAPS-2,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,73.75,17.79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5429,,0.4571,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.",40045,2019
bryant2013_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,70,A,PTSD,,36,,Emotion Regulation Training + CBT,Emotion Regulation Training followed by trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Structured Clinical Interview,CAPS,CAPS-2,ITT,imputed,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,73.75,17.79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5429,,0.4571,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.",40045,2019
bryant2013_CAPS_B_0_Comp,Psychotherapy,PTSD,70,B,PTSD,,21,,Supportive counseling + CBT,Supportive counseling followed by trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,34,Structured Clinical Interview,CAPS,CAPS-2,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,31,29.42,,,,,-36.69,,,,,,,,,,,,,,,,,,CAPS score <19,,,CAPS score <19 and BDI-II score <10,,,Community,,,1,0.5429,,0.4571,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.",40045,2019
bryant2013_CAPS_B_0_ITT,Psychotherapy,PTSD,70,B,PTSD,,21,,Supportive counseling + CBT,Supportive counseling followed by trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,34,Structured Clinical Interview,CAPS,CAPS-2,ITT,imputed,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",End of Treatment,0,,38.76,20.81,,,,,-28.93,,,,,,,,,,,,,,,,,,CAPS score <19,0.74,,CAPS score <19 and BDI-II score <10,,,Community,,,1,0.5429,,0.4571,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.",40045,2019
bryant2013_CAPS_B_26_Comp,Psychotherapy,PTSD,70,B,PTSD,,11,,Supportive counseling + CBT,Supportive counseling followed by trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,34,Structured Clinical Interview,CAPS,CAPS-2,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,34.63,29.73,,,,,-33.06,,,,,,,,,,,,,,,,,,CAPS score <19,,,CAPS score <19 and BDI-II score <10,,,Community,,,1,0.5429,,0.4571,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.",40045,2019
bryant2013_CAPS_B_26_ITT,Psychotherapy,PTSD,70,B,PTSD,,11,,Supportive counseling + CBT,Supportive counseling followed by trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,34,Structured Clinical Interview,CAPS,CAPS-2,ITT,imputed,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Assessment at 6 to <12 Months,26,,47.54,22.45,,,,,-20.15,,,,,,,,,,,,,,,,,,CAPS score <19,0.5,,CAPS score <19 and BDI-II score <10,0.12,,Community,,,1,0.5429,,0.4571,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.",40045,2019
bryant2013_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,70,B,PTSD,,21,,Supportive counseling + CBT,Supportive counseling followed by trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,34,Structured Clinical Interview,CAPS,CAPS-2,Completer,,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,67.69,16.26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5429,,0.4571,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.",40045,2019
bryant2013_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,70,B,PTSD,,34,,Supportive counseling + CBT,Supportive counseling followed by trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,34,Structured Clinical Interview,CAPS,CAPS-2,ITT,imputed,"ANOVA or ANCOVA for continuous variables, chi-squared analysis for dichotomous variables",Baseline,,,67.69,16.26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5429,,0.4571,Mixed,"accidents, community/school violence",Medium,"Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.",40045,2019
bryant2019_CAPS_A_0_Comp,Psychotherapy,PTSD,100,A,PTSD,,,,CBT with prolonged exposure,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Structured Clinical Interview,CAPS,CAPS,Completer,Models that handle missing data by calculating estimates of trajectories,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not fulfilling diagnostic criteria for PTSD,0.5926,,,,,Community,0,0,1,0.23,,0.77,"Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,Medium,"Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.",51039,2020
bryant2019_CAPS_A_0_ITT,Psychotherapy,PTSD,100,A,PTSD,,27,,CBT with prolonged exposure,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Structured Clinical Interview,CAPS,CAPS,ITT,Models that handle missing data by calculating estimates of trajectories,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",End of Treatment,0,,,,,,,,-38.4,,-46.1,-30.7,,,,,,,,,,,,,,,Not fulfilling diagnostic criteria for PTSD,,,,,,Community,0,0,1,0.23,,0.77,"Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,Medium,"Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.",51039,2020
bryant2019_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,100,A,PTSD,,,,CBT with prolonged exposure,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Structured Clinical Interview,CAPS,CAPS,Completer,Models that handle missing data by calculating estimates of trajectories,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.23,,0.77,"Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,Medium,"Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.",51039,2020
bryant2019_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,100,A,PTSD,,33,,CBT with prolonged exposure,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Structured Clinical Interview,CAPS,CAPS,ITT,Models that handle missing data by calculating estimates of trajectories,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",Baseline,,,80.4,14.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.23,,0.77,"Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,Medium,"Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.",51039,2020
bryant2019_CAPS_B_0_Comp,Psychotherapy,PTSD,100,B,PTSD,,,,CBT with brief exposure,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Structured Clinical Interview,CAPS,CAPS,Completer,Models that handle missing data by calculating estimates of trajectories,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not fulfilling diagnostic criteria for PTSD,0.7586,,,,,Community,0,0,1,0.23,,0.77,"Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,Medium,"Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.",51039,2020
bryant2019_CAPS_B_0_ITT,Psychotherapy,PTSD,100,B,PTSD,,29,,CBT with brief exposure,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Structured Clinical Interview,CAPS,CAPS,ITT,Models that handle missing data by calculating estimates of trajectories,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",End of Treatment,0,,,,,,,,-39.7,,-47.2,-32.1,,,,,,,,,,,,,,,Not fulfilling diagnostic criteria for PTSD,,,,,,Community,0,0,1,0.23,,0.77,"Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,Medium,"Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.",51039,2020
bryant2019_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,100,B,PTSD,,,,CBT with brief exposure,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Structured Clinical Interview,CAPS,CAPS,Completer,Models that handle missing data by calculating estimates of trajectories,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.23,,0.77,"Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,Medium,"Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.",51039,2020
bryant2019_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,100,B,PTSD,,33,,CBT with brief exposure,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Structured Clinical Interview,CAPS,CAPS,ITT,Models that handle missing data by calculating estimates of trajectories,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",Baseline,,,70.5,18.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.23,,0.77,"Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,Medium,"Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.",51039,2020
bryant2019_CAPS_C_0_Comp,Psychotherapy,PTSD,100,C,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,34,Structured Clinical Interview,CAPS,CAPS,Completer,Models that handle missing data by calculating estimates of trajectories,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not fulfilling diagnostic criteria for PTSD,0.1071,,,,,Community,0,0,1,0.23,,0.77,"Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,Medium,"Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.",51039,2020
bryant2019_CAPS_C_0_ITT,Psychotherapy,PTSD,100,C,Control,,27,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,34,Structured Clinical Interview,CAPS,CAPS,ITT,Models that handle missing data by calculating estimates of trajectories,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",End of Treatment,0,,,,,,,,-11.9,,-19.5,-4.4,,,,,,,,,,,,,,,Not fulfilling diagnostic criteria for PTSD,,,,,,Community,0,0,1,0.23,,0.77,"Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,Medium,"Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.",51039,2020
bryant2019_CAPS_C_Baseline_Comp,Psychotherapy,PTSD,100,C,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,34,Structured Clinical Interview,CAPS,CAPS,Completer,Models that handle missing data by calculating estimates of trajectories,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.23,,0.77,"Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,Medium,"Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.",51039,2020
bryant2019_CAPS_C_Baseline_ITT,Psychotherapy,PTSD,100,C,Control,,34,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,34,Structured Clinical Interview,CAPS,CAPS,ITT,Models that handle missing data by calculating estimates of trajectories,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",Baseline,,,75.0,16.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.23,,0.77,"Other (emergency service personnel including police, firefighters, and paramedics; exposure to fatality)",,Medium,"Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.",51039,2020
buhmann2016_HTQ_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,280,A,PTSD,,55,,CBT + sertraline and/or mianserin,Trauma-focused cognitive behavioral therapy (TF-CBT) + sertraline and/or mianserin,Yes,TF,Yes,Mixed,No,Not Applicable,No,No,No,No,No,Individual,In Person,71,Self report,HTQ,HTQ,ITT,Imputed using full information maximum likelihood,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",End of Treatment,0,,3.2,0.7,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4101,,0.5899,Terrorism/political violence/forced displacement,,Medium,"Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.",46863,2019
buhmann2016_HTQ_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,280,A,PTSD,,71,,CBT + sertraline and/or mianserin,Trauma-focused cognitive behavioral therapy (TF-CBT) + sertraline and/or mianserin,Yes,TF,Yes,Mixed,No,Not Applicable,No,No,No,No,No,Individual,In Person,71,Self report,HTQ,HTQ,ITT,Imputed using full information maximum likelihood,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",Baseline,,,3.2,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4101,,0.5899,Terrorism/political violence/forced displacement,,Medium,"Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.",46863,2019
buhmann2016_HTQ_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,280,B,PTSD,,52,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,70,Self report,HTQ,HTQ,ITT,Imputed using full information maximum likelihood,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",End of Treatment,0,,3.3,0.7,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4101,,0.5899,Terrorism/political violence/forced displacement,,Medium,"Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.",46863,2019
buhmann2016_HTQ_B_26_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,280,B,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,70,Self report,HTQ,HTQ,ITT,Imputed using full information maximum likelihood,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",Assessment at 6 to <12 Months,26,,3.18,,,,,,-0.12,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4101,,0.5899,Terrorism/political violence/forced displacement,,Medium,"Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.",46863,2019
buhmann2016_HTQ_B_68_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,280,B,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,70,Self report,HTQ,HTQ,ITT,Imputed using full information maximum likelihood,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",Assessment at ≥12 Months,68,,3.30,,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4101,,0.5899,Terrorism/political violence/forced displacement,,Medium,"Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.",46863,2019
buhmann2016_HTQ_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,280,B,PTSD,,70,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,70,Self report,HTQ,HTQ,ITT,Imputed using full information maximum likelihood,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",Baseline,,,3.3,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4101,,0.5899,Terrorism/political violence/forced displacement,,Medium,"Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.",46863,2019
buhmann2016_HTQ_C_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,280,C,PTSD,,62,,Sertraline and/or mianserin,Sertraline and/or mianserin,No,Not Applicable,Yes,Mixed,No,Not Applicable,No,No,No,No,No,Individual,In Person,71,Self report,HTQ,HTQ,ITT,Imputed using full information maximum likelihood,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",End of Treatment,0,,3.2,0.6,,,,,-0.1,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4101,,0.5899,Terrorism/political violence/forced displacement,,Medium,"Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.",46863,2019
buhmann2016_HTQ_C_26_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,280,C,PTSD,,,,Sertraline and/or mianserin,Sertraline and/or mianserin,No,Not Applicable,Yes,Mixed,No,Not Applicable,No,No,No,No,No,Individual,In Person,71,Self report,HTQ,HTQ,ITT,Imputed using full information maximum likelihood,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",Assessment at 6 to <12 Months,26,,3.09,,,,,,-0.21,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4101,,0.5899,Terrorism/political violence/forced displacement,,Medium,"Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.",46863,2019
buhmann2016_HTQ_C_68_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,280,C,PTSD,,,,Sertraline and/or mianserin,Sertraline and/or mianserin,No,Not Applicable,Yes,Mixed,No,Not Applicable,No,No,No,No,No,Individual,In Person,71,Self report,HTQ,HTQ,ITT,Imputed using full information maximum likelihood,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",Assessment at ≥12 Months,68,,2.91,,,,,,-0.39,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4101,,0.5899,Terrorism/political violence/forced displacement,,Medium,"Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.",46863,2019
buhmann2016_HTQ_C_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,280,C,PTSD,,71,,Sertraline and/or mianserin,Sertraline and/or mianserin,No,Not Applicable,Yes,Mixed,No,Not Applicable,No,No,No,No,No,Individual,In Person,71,Self report,HTQ,HTQ,ITT,Imputed using full information maximum likelihood,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",Baseline,,,3.3,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4101,,0.5899,Terrorism/political violence/forced displacement,,Medium,"Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.",46863,2019
buhmann2016_HTQ_D_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,280,D,Control,,48,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,68,Self report,HTQ,HTQ,ITT,Imputed using full information maximum likelihood,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",End of Treatment,0,,3.2,0.5,,,,,-0.1,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4101,,0.5899,Terrorism/political violence/forced displacement,,Medium,"Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.",46863,2019
buhmann2016_HTQ_D_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,280,D,Control,,68,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,68,Self report,HTQ,HTQ,ITT,Imputed using full information maximum likelihood,"Hierarchical linear mixed models, time x treatment interactions, 
Wald test and Cohen’s (d)",Baseline,,,3.3,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4101,,0.5899,Terrorism/political violence/forced displacement,,Medium,"Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.",46863,2019
butler2018_Inte_A_0_NA,Psychotherapy,PTSD,20,A,PTSD,,,,EMDR + PMR + group psychoeducation,Eye Movement Desensitization and Reprocessing (EMDR) + progressive muscle relaxation (PMR) + group psychoeducation,Yes,TF,No,Not Applicable,Yes,Relaxation,No,No,No,Yes,No,Individual,In person,11,Self report,Interpretation of PTSD Symptoms Inventory,Interpretation of PTSD Symptoms Inventory,,,Repeated measures ANOVA,End of Treatment,0,,3.2,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0,,1,Combat-related,,High,"Butler O, Willmund G, Gleich T, et al. Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav. 2018 May;8(5):e00956. doi: 10.1002/brb3.956. PMID: 29761009.",,2020
butler2018_Inte_A_Baseline_NA,Psychotherapy,PTSD,20,A,PTSD,,,,EMDR + PMR + group psychoeducation,Eye Movement Desensitization and Reprocessing (EMDR) + progressive muscle relaxation (PMR) + group psychoeducation,Yes,TF,No,Not Applicable,Yes,Relaxation,No,No,No,Yes,No,Individual,In person,11,Self report,Interpretation of PTSD Symptoms Inventory,Interpretation of PTSD Symptoms Inventory,,,Repeated measures ANOVA,Baseline,,,3.8,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0,,1,Combat-related,,High,"Butler O, Willmund G, Gleich T, et al. Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav. 2018 May;8(5):e00956. doi: 10.1002/brb3.956. PMID: 29761009.",,2020
butler2018_Inte_B_0_NA,Psychotherapy,PTSD,20,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,9,Self report,Interpretation of PTSD Symptoms Inventory,Interpretation of PTSD Symptoms Inventory,,,Repeated measures ANOVA,End of Treatment,0,,3.0,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0,,1,Combat-related,,High,"Butler O, Willmund G, Gleich T, et al. Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav. 2018 May;8(5):e00956. doi: 10.1002/brb3.956. PMID: 29761009.",,2020
butler2018_Inte_B_Baseline_NA,Psychotherapy,PTSD,20,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,9,Self report,Interpretation of PTSD Symptoms Inventory,Interpretation of PTSD Symptoms Inventory,,,Repeated measures ANOVA,Baseline,,,3.2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0,,1,Combat-related,,High,"Butler O, Willmund G, Gleich T, et al. Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav. 2018 May;8(5):e00956. doi: 10.1002/brb3.956. PMID: 29761009.",,2020
butler2018_PDS_A_0_NA,Psychotherapy,PTSD,20,A,PTSD,,9,,EMDR + PMR + group psychoeducation,Eye Movement Desensitization and Reprocessing (EMDR) + progressive muscle relaxation (PMR) + group psychoeducation,Yes,TF,No,Not Applicable,Yes,Relaxation,No,No,No,Yes,No,Individual,In person,11,Self report,PDS,PDS,,Pairwise deletion,Repeated measures ANOVA,End of Treatment,0,,28.1,12,,,,,-6.3,,,,,,,,,,p=0.029,,,,,,,,,,,,,,Active Duty Military,1,0,0,0,,1,Combat-related,,High,"Butler O, Willmund G, Gleich T, et al. Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav. 2018 May;8(5):e00956. doi: 10.1002/brb3.956. PMID: 29761009.",,2020
butler2018_PDS_A_Baseline_NA,Psychotherapy,PTSD,20,A,PTSD,,9,,EMDR + PMR + group psychoeducation,Eye Movement Desensitization and Reprocessing (EMDR) + progressive muscle relaxation (PMR) + group psychoeducation,Yes,TF,No,Not Applicable,Yes,Relaxation,No,No,No,Yes,No,Individual,In person,11,Self report,PDS,PDS,,Pairwise deletion,Repeated measures ANOVA,Baseline,,,34.4,7.28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0,,1,Combat-related,,High,"Butler O, Willmund G, Gleich T, et al. Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav. 2018 May;8(5):e00956. doi: 10.1002/brb3.956. PMID: 29761009.",,2020
butler2018_PDS_B_0_NA,Psychotherapy,PTSD,20,B,Control,,7,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,9,Self report,PDS,PDS,,Pairwise deletion,Repeated measures ANOVA,End of Treatment,0,,24.0,14.5,,,,,-7.2,,,,,,,,,,p=0.031,,,,,,,,,,,,,,Active Duty Military,1,0,0,0,,1,Combat-related,,High,"Butler O, Willmund G, Gleich T, et al. Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav. 2018 May;8(5):e00956. doi: 10.1002/brb3.956. PMID: 29761009.",,2020
butler2018_PDS_B_Baseline_NA,Psychotherapy,PTSD,20,B,Control,,7,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,9,Self report,PDS,PDS,,Pairwise deletion,Repeated measures ANOVA,Baseline,,,31.2,14.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0,,1,Combat-related,,High,"Butler O, Willmund G, Gleich T, et al. Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav. 2018 May;8(5):e00956. doi: 10.1002/brb3.956. PMID: 29761009.",,2020
butollo2016_IES_A_0_Comp,Psychotherapy,PTSD,141,A,PTSD,,,,Dialogical Exposure Therapy,Dialogical Exposure Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Self report,IES,IES-R,Completer,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",End of Treatment,0,,36.35,31.89,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_IES_A_0_ITT,Psychotherapy,PTSD,141,A,PTSD,,,,Dialogical Exposure Therapy,Dialogical Exposure Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Self report,IES,IES-R,ITT,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",End of Treatment,0,,40.06,32.31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_IES_A_103.9_Comp,Psychotherapy,PTSD,141,A,PTSD,,,,Dialogical Exposure Therapy,Dialogical Exposure Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Self report,IES,IES-R,Completer,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Assessment at ≥12 Months,103.9,,30.18,29.26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_IES_A_26_Comp,Psychotherapy,PTSD,141,A,PTSD,,,,Dialogical Exposure Therapy,Dialogical Exposure Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Self report,IES,IES-R,Completer,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Assessment at 6 to <12 Months,26,,32.31,29.48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_IES_A_26_ITT,Psychotherapy,PTSD,141,A,PTSD,,,,Dialogical Exposure Therapy,Dialogical Exposure Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Self report,IES,IES-R,ITT,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Assessment at 6 to <12 Months,26,,36.47,30.69,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_IES_A_Baseline_Comp,Psychotherapy,PTSD,141,A,PTSD,,,,Dialogical Exposure Therapy,Dialogical Exposure Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Self report,IES,IES-R,Completer,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Baseline,,,69.16,16.09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_IES_A_Baseline_ITT,Psychotherapy,PTSD,141,A,PTSD,,,,Dialogical Exposure Therapy,Dialogical Exposure Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Self report,IES,IES-R,ITT,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Baseline,,,69.22,16.07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_IES_B_0_Comp,Psychotherapy,PTSD,141,B,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,67,Self report,IES,IES-R,Completer,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",End of Treatment,0,,20.07,22.42,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_IES_B_0_ITT,Psychotherapy,PTSD,141,B,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,67,Self report,IES,IES-R,ITT,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",End of Treatment,0,,27.96,28.98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_IES_B_103.9_Comp,Psychotherapy,PTSD,141,B,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,67,Self report,IES,IES-R,Completer,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Assessment at ≥12 Months,103.9,,22.13,22.78,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_IES_B_26_Comp,Psychotherapy,PTSD,141,B,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,67,Self report,IES,IES-R,Completer,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Assessment at 6 to <12 Months,26,,22.38,22.91,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_IES_B_26_ITT,Psychotherapy,PTSD,141,B,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,67,Self report,IES,IES-R,ITT,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Assessment at 6 to <12 Months,26,,29.91,28.77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_IES_B_Baseline_Comp,Psychotherapy,PTSD,141,B,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,67,Self report,IES,IES-R,Completer,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Baseline,,,65.75,19.08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_IES_B_Baseline_ITT,Psychotherapy,PTSD,141,B,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,67,Self report,IES,IES-R,ITT,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Baseline,,,66.76,19.36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_PDS_A_0_Comp,Psychotherapy,PTSD,141,A,PTSD,,,≤65,Dialogical Exposure Therapy,Dialogical Exposure Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Self report,PDS,PDS,Completer,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",End of Treatment,0,,17.22,13.73,,,,,-12.7,,,,,Hedges' g,0.98,,,,,,,,,,,,PDS <18,,,RCI for PDS,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_PDS_A_0_ITT,Psychotherapy,PTSD,141,A,PTSD,,72,,Dialogical Exposure Therapy,Dialogical Exposure Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Self report,PDS,PDS,ITT,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",End of Treatment,0,,18.79,14.02,,,,,-11.29,,,,,Hedges' g,0.93,,,,,,,,,,,,PDS <18,0.527,,RCI for PDS,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_PDS_A_103.9_Comp,Psychotherapy,PTSD,141,A,PTSD,,17,,Dialogical Exposure Therapy,Dialogical Exposure Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Self report,PDS,PDS,Completer,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Assessment at ≥12 Months,103.9,,14.08,13.06,,,,,-15.84,,,,,Hedges' g,1.28,,,,,,,,,,,,PDS <18,0.7231,,RCI for PDS,0.6667,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_PDS_A_26_Comp,Psychotherapy,PTSD,141,A,PTSD,,,≤65,Dialogical Exposure Therapy,Dialogical Exposure Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Self report,PDS,PDS,Completer,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Assessment at 6 to <12 Months,26,,15.06,13.24,,,,,-14.86,,,,,Hedges' g,1.19,,,,,,,,,,,,PDS <18,,,RCI for PDS,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_PDS_A_26_ITT,Psychotherapy,PTSD,141,A,PTSD,,48,,Dialogical Exposure Therapy,Dialogical Exposure Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Self report,PDS,PDS,ITT,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Assessment at 6 to <12 Months,26,,16.88,13.83,,,,,-13.2,,,,,Hedges' g,1.1,,,,,,,,,,,,PDS <18,0.5946,,RCI for PDS,0.5211,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_PDS_A_Baseline_Comp,Psychotherapy,PTSD,141,A,PTSD,,,≤65,Dialogical Exposure Therapy,Dialogical Exposure Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Self report,PDS,PDS,Completer,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Baseline,,,29.92,9.98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_PDS_A_Baseline_ITT,Psychotherapy,PTSD,141,A,PTSD,,71,,Dialogical Exposure Therapy,Dialogical Exposure Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Self report,PDS,PDS,ITT,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Baseline,,,30.08,9.89,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_PDS_B_0_Comp,Psychotherapy,PTSD,141,B,PTSD,,57,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,67,Self report,PDS,PDS,Completer,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",End of Treatment,0,,14.11,11.83,,,,,-14.85,,,,,Hedges' g,1.35,,,,,,,,,,,,PDS <18,,,RCI for PDS,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_PDS_B_0_ITT,Psychotherapy,PTSD,141,B,PTSD,,67,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,67,Self report,PDS,PDS,ITT,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",End of Treatment,0,,15.93,12.36,,,,,-12.63,,,,,Hedges' g,1.12,,,,,,,,,,,,PDS <18,0.6119,,RCI for PDS,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_PDS_B_103.9_Comp,Psychotherapy,PTSD,141,B,PTSD,,19,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,67,Self report,PDS,PDS,Completer,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Assessment at ≥12 Months,103.9,,14.09,12.61,,,,,-14.87,,,,,Hedges' g,1.3,,,,,,,,,,,,PDS <18,0.7018,,RCI for PDS,0.6429,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_PDS_B_26_Comp,Psychotherapy,PTSD,141,B,PTSD,,,≤57,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,67,Self report,PDS,PDS,Completer,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Assessment at 6 to <12 Months,26,,14.30,12.4,,,,,-14.66,,,,,Hedges' g,1.27,,,,,,,,,,,,PDS <18,,,RCI for PDS,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_PDS_B_26_ITT,Psychotherapy,PTSD,141,B,PTSD,,52,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,67,Self report,PDS,PDS,ITT,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Assessment at 6 to <12 Months,26,,16.03,13.17,,,,,-12.53,,,,,Hedges' g,1.07,,,,,,,,,,,,PDS <18,0.6418,,RCI for PDS,0.561,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_PDS_B_Baseline_Comp,Psychotherapy,PTSD,141,B,PTSD,,,≤57,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,67,Self report,PDS,PDS,Completer,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Baseline,,,28.96,10.14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butollo2016_PDS_B_Baseline_ITT,Psychotherapy,PTSD,141,B,PTSD,,66,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,67,Self report,PDS,PDS,ITT,LOCF,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Baseline,,,28.56,10.15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6596,,0.4404,Mixed,"accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)",High,"Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.",45076,2020
butterfield2001_DTS_A_0_NA,Pharmacotherapy,PTSD,15,A,PTSD,,,,Olanzapine,Olanzapine,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,DTS,DTS,,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",End of Treatment,0,,57.4,35.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.9333,,0.0667,Mixed,"MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])",Medium,"Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.",23547,2019
butterfield2001_DTS_A_Baseline_NA,Pharmacotherapy,PTSD,15,A,PTSD,,,,Olanzapine,Olanzapine,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,DTS,DTS,,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Baseline,,,91.6,25.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.9333,,0.0667,Mixed,"MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])",Medium,"Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.",23547,2019
butterfield2001_DTS_B_0_NA,Pharmacotherapy,PTSD,15,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,5,Self report,DTS,DTS,,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",End of Treatment,0,,56.0,36.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.9333,,0.0667,Mixed,"MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])",Medium,"Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.",23547,2019
butterfield2001_DTS_B_Baseline_NA,Pharmacotherapy,PTSD,15,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,5,Self report,DTS,DTS,,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Baseline,,,95.8,16.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.9333,,0.0667,Mixed,"MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])",Medium,"Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.",23547,2019
butterfield2001_SI-PTSD_A_0_ITT,Pharmacotherapy,PTSD,15,A,PTSD,,10,,Olanzapine,Olanzapine,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",End of Treatment,0,,19.2,8.7,,,,,-20.5,,,,,,,,,,,,,,,,,,,,,CGI score of 1 or 2,0.6,,Veteran,0,1,0,0.9333,,0.0667,Mixed,"MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])",Medium,"Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.",23547,2019
butterfield2001_SI-PTSD_A_Baseline_ITT,Pharmacotherapy,PTSD,15,A,PTSD,,10,,Olanzapine,Olanzapine,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Baseline,,,39.7,9.7,,,,,,,,,,,,,,,,,,,,,,,,,,CGI score of 1 or 2,,,Veteran,0,1,0,0.9333,,0.0667,Mixed,"MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])",Medium,"Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.",23547,2019
butterfield2001_SI-PTSD_B_0_ITT,Pharmacotherapy,PTSD,15,B,Control,,5,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,5,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",End of Treatment,0,,17.0,17.5,,,,,-28.9,,,,,,,,,,,,,,,,,,,,,CGI score of 1 or 2,0.6,,Veteran,0,1,0,0.9333,,0.0667,Mixed,"MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])",Medium,"Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.",23547,2019
butterfield2001_SI-PTSD_B_Baseline_ITT,Pharmacotherapy,PTSD,15,B,Control,,5,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,5,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Baseline,,,45.9,8.2,,,,,,,,,,,,,,,,,,,,,,,,,,CGI score of 1 or 2,,,Veteran,0,1,0,0.9333,,0.0667,Mixed,"MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])",Medium,"Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.",23547,2019
butterfield2001_SPRINT_A_0_NA,Pharmacotherapy,PTSD,15,A,PTSD,,,,Olanzapine,Olanzapine,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,SPRINT,SPRINT,,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",End of Treatment,0,,17.9,7.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.9333,,0.0667,Mixed,"MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])",Medium,"Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.",23547,2019
butterfield2001_SPRINT_A_Baseline_NA,Pharmacotherapy,PTSD,15,A,PTSD,,,,Olanzapine,Olanzapine,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,SPRINT,SPRINT,,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Baseline,,,31.5,5.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.9333,,0.0667,Mixed,"MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])",Medium,"Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.",23547,2019
butterfield2001_SPRINT_B_0_NA,Pharmacotherapy,PTSD,15,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,5,Self report,SPRINT,SPRINT,,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",End of Treatment,0,,20.5,11.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.9333,,0.0667,Mixed,"MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])",Medium,"Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.",23547,2019
butterfield2001_SPRINT_B_Baseline_NA,Pharmacotherapy,PTSD,15,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,5,Self report,SPRINT,SPRINT,,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Baseline,,,34.8,2.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.9333,,0.0667,Mixed,"MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])",Medium,"Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.",23547,2019
butterfield2001_TOP-8_A_0_NA,Pharmacotherapy,PTSD,15,A,PTSD,,,,Olanzapine,Olanzapine,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,TOP-8,TOP-8,,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",End of Treatment,0,,12.6,6.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.9333,,0.0667,Mixed,"MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])",Medium,"Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.",23547,2019
butterfield2001_TOP-8_A_Baseline_NA,Pharmacotherapy,PTSD,15,A,PTSD,,,,Olanzapine,Olanzapine,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,TOP-8,TOP-8,,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Baseline,,,19.3,4.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.9333,,0.0667,Mixed,"MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])",Medium,"Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.",23547,2019
butterfield2001_TOP-8_B_0_NA,Pharmacotherapy,PTSD,15,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,5,Structured Clinical Interview,TOP-8,TOP-8,,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",End of Treatment,0,,10.5,8.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.9333,,0.0667,Mixed,"MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])",Medium,"Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.",23547,2019
butterfield2001_TOP-8_B_Baseline_NA,Pharmacotherapy,PTSD,15,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,5,Structured Clinical Interview,TOP-8,TOP-8,,,"MANOVA, repeated measures ANOVA, and t-test for change in mean score; chi-square for diagnostic change and clinically meaningful response",Baseline,,,21.8,3.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.9333,,0.0667,Mixed,"MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])",Medium,"Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.",23547,2019
capone2018_CAPS_A_0_ITT,Psychotherapy,PTSD+SUD,44,A,PTSD+SUD,Integrated,19,,Integrated CBT,Integrated Cognitive Behavioral Therapy (ICBT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,21,Structured Clinical Interview,CAPS,CAPS-4,ITT,Maximum likelihood method,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,61.67,18.27,,,,,-15.16,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0455,,0.9545,Mixed,"MST, combat-related, child sexual abuse, rape/sexual assault",Medium,"Capone C, Presseau C, Saunders E, et al. Is integrated CBT effective in reducing PTSD symptoms and substance use in Iraq and Afghanistan veterans? Results from a randomized clinical trial. Cognit Ther Res. 2018;42(6):735-46. doi: 10.1007/s10608-018-9931-8.",50582,2020
capone2018_CAPS_A_12_ITT,Psychotherapy,PTSD+SUD,44,A,PTSD+SUD,Integrated,15,,Integrated CBT,Integrated Cognitive Behavioral Therapy (ICBT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,21,Structured Clinical Interview,CAPS,CAPS-4,ITT,Maximum likelihood method,Covariance pattern (unstructured) general linear mixed models,Assessment at 3 to <6 Months,12,,66.07,17.6,,,,,-10.26,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0455,,0.9545,Mixed,"MST, combat-related, child sexual abuse, rape/sexual assault",Medium,"Capone C, Presseau C, Saunders E, et al. Is integrated CBT effective in reducing PTSD symptoms and substance use in Iraq and Afghanistan veterans? Results from a randomized clinical trial. Cognit Ther Res. 2018;42(6):735-46. doi: 10.1007/s10608-018-9931-8.",50582,2020
capone2018_CAPS_A_Baseline_ITT,Psychotherapy,PTSD+SUD,44,A,PTSD+SUD,Integrated,21,,Integrated CBT,Integrated Cognitive Behavioral Therapy (ICBT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,21,Structured Clinical Interview,CAPS,CAPS-4,ITT,Maximum likelihood method,Covariance pattern (unstructured) general linear mixed models,Baseline,,,76.33,14.71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0455,,0.9545,Mixed,"MST, combat-related, child sexual abuse, rape/sexual assault",Medium,"Capone C, Presseau C, Saunders E, et al. Is integrated CBT effective in reducing PTSD symptoms and substance use in Iraq and Afghanistan veterans? Results from a randomized clinical trial. Cognit Ther Res. 2018;42(6):735-46. doi: 10.1007/s10608-018-9931-8.",50582,2020
capone2018_CAPS_B_0_ITT,Psychotherapy,PTSD+SUD,44,B,Control,Not integrated,19,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,23,Structured Clinical Interview,CAPS,CAPS-4,ITT,Maximum likelihood method,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,69.42,26.26,,,,,-9.36,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0455,,0.9545,Mixed,"MST, combat-related, child sexual abuse, rape/sexual assault",Medium,"Capone C, Presseau C, Saunders E, et al. Is integrated CBT effective in reducing PTSD symptoms and substance use in Iraq and Afghanistan veterans? Results from a randomized clinical trial. Cognit Ther Res. 2018;42(6):735-46. doi: 10.1007/s10608-018-9931-8.",50582,2020
capone2018_CAPS_B_12_ITT,Psychotherapy,PTSD+SUD,44,B,Control,Not integrated,16,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,23,Structured Clinical Interview,CAPS,CAPS-4,ITT,Maximum likelihood method,Covariance pattern (unstructured) general linear mixed models,Assessment at 3 to <6 Months,12,,62.27,26.26,,,,,-16.51,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0455,,0.9545,Mixed,"MST, combat-related, child sexual abuse, rape/sexual assault",Medium,"Capone C, Presseau C, Saunders E, et al. Is integrated CBT effective in reducing PTSD symptoms and substance use in Iraq and Afghanistan veterans? Results from a randomized clinical trial. Cognit Ther Res. 2018;42(6):735-46. doi: 10.1007/s10608-018-9931-8.",50582,2020
capone2018_CAPS_B_Baseline_ITT,Psychotherapy,PTSD+SUD,44,B,Control,Not integrated,23,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,23,Structured Clinical Interview,CAPS,CAPS-4,ITT,Maximum likelihood method,Covariance pattern (unstructured) general linear mixed models,Baseline,,,78.78,16.62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0455,,0.9545,Mixed,"MST, combat-related, child sexual abuse, rape/sexual assault",Medium,"Capone C, Presseau C, Saunders E, et al. Is integrated CBT effective in reducing PTSD symptoms and substance use in Iraq and Afghanistan veterans? Results from a randomized clinical trial. Cognit Ther Res. 2018;42(6):735-46. doi: 10.1007/s10608-018-9931-8.",50582,2020
carey2012_CAPS_A_0_Comp,Pharmacotherapy,PTSD,34,A,PTSD,,14,,Olanzapine,Olanzapine,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,33.6,28.2,,,,,-45.8,,,,,,,,,,,,,,,,,,CAPS score <50,0.7143,,>50% reduction from baseline on CAPS,0.7143,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6071,,0.3929,Mixed,"intimate partner violence, community/school violence",Medium,"Carey P, Suliman S, Ganesan K, et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012 Jul;27(4):386-91. doi: 10.1002/hup.2238. PMID: 22730105.",38996,2019
carey2012_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,34,A,PTSD,,,,Olanzapine,Olanzapine,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF,Covariance pattern (unstructured) general linear mixed models,Baseline,,,79.4,16,,,,,,,,,,,,,,,,,,,,,,,CAPS score <50,,,>50% reduction from baseline on CAPS,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6071,,0.3929,Mixed,"intimate partner violence, community/school violence",Medium,"Carey P, Suliman S, Ganesan K, et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012 Jul;27(4):386-91. doi: 10.1002/hup.2238. PMID: 22730105.",38996,2019
carey2012_CAPS_B_0_Comp,Pharmacotherapy,PTSD,34,B,Control,,14,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,62.3,31.9,,,,,-19.3,,,,,,,,,,,,,,,,,,CAPS score <50,0.2143,,>50% reduction from baseline on CAPS,0.2143,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6071,,0.3929,Mixed,"intimate partner violence, community/school violence",Medium,"Carey P, Suliman S, Ganesan K, et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012 Jul;27(4):386-91. doi: 10.1002/hup.2238. PMID: 22730105.",38996,2019
carey2012_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,34,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF,Covariance pattern (unstructured) general linear mixed models,Baseline,,,81.6,11.3,,,,,,,,,,,,,,,,,,,,,,,CAPS score <50,,,>50% reduction from baseline on CAPS,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6071,,0.3929,Mixed,"intimate partner violence, community/school violence",Medium,"Carey P, Suliman S, Ganesan K, et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012 Jul;27(4):386-91. doi: 10.1002/hup.2238. PMID: 22730105.",38996,2019
carey2012_DTS_A_0_NA,Pharmacotherapy,PTSD,34,A,PTSD,,,,Olanzapine,Olanzapine,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,DTS,DTS,,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,37.9,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6071,,0.3929,Mixed,"intimate partner violence, community/school violence",Medium,"Carey P, Suliman S, Ganesan K, et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012 Jul;27(4):386-91. doi: 10.1002/hup.2238. PMID: 22730105.",38996,2019
carey2012_DTS_A_Baseline_NA,Pharmacotherapy,PTSD,34,A,PTSD,,,,Olanzapine,Olanzapine,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,DTS,DTS,,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,75,16.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6071,,0.3929,Mixed,"intimate partner violence, community/school violence",Medium,"Carey P, Suliman S, Ganesan K, et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012 Jul;27(4):386-91. doi: 10.1002/hup.2238. PMID: 22730105.",38996,2019
carey2012_DTS_B_0_NA,Pharmacotherapy,PTSD,34,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Self report,DTS,DTS,,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,75.8,34.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6071,,0.3929,Mixed,"intimate partner violence, community/school violence",Medium,"Carey P, Suliman S, Ganesan K, et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012 Jul;27(4):386-91. doi: 10.1002/hup.2238. PMID: 22730105.",38996,2019
carey2012_DTS_B_Baseline_NA,Pharmacotherapy,PTSD,34,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Self report,DTS,DTS,,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,88.1,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6071,,0.3929,Mixed,"intimate partner violence, community/school violence",Medium,"Carey P, Suliman S, Ganesan K, et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012 Jul;27(4):386-91. doi: 10.1002/hup.2238. PMID: 22730105.",38996,2019
carlson1998_CAPS_A_0_Comp,Mixed: Psychotherapy & CIH,PTSD,35,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.7778,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_CAPS_A_12_Comp,Mixed: Psychotherapy & CIH,PTSD,35,A,PTSD,,9,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,Covariance pattern (unstructured) general linear mixed models,Assessment at 3 to <6 Months,12,,13.6,11.9,,,,,-27.2,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_CAPS_A_39_Comp,Mixed: Psychotherapy & CIH,PTSD,35,A,PTSD,,8,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS overall,Completer,,Covariance pattern (unstructured) general linear mixed models,Assessment at 6 to <12 Months,39,,36.9,28.6,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_CAPS_A_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,35,A,PTSD,,10,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,40.8,10.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_CAPS_B_0_Comp,Mixed: Psychotherapy & CIH,PTSD,35,B,PTSD,,,,Biofeedback-assisted relaxation,Biofeedback-assisted relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.2222,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_CAPS_B_12_Comp,Mixed: Psychotherapy & CIH,PTSD,35,B,PTSD,,9,,Biofeedback-assisted relaxation,Biofeedback-assisted relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,Covariance pattern (unstructured) general linear mixed models,Assessment at 3 to <6 Months,12,,34.0,8.5,,,,,-6.8,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_CAPS_B_39_Comp,Mixed: Psychotherapy & CIH,PTSD,35,B,PTSD,,4,,Biofeedback-assisted relaxation,Biofeedback-assisted relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS overall,Completer,,Covariance pattern (unstructured) general linear mixed models,Assessment at 6 to <12 Months,39,,67.8,24.7,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_CAPS_B_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,35,B,PTSD,,13,,Biofeedback-assisted relaxation,Biofeedback-assisted relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,40.8,8.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_CAPS_C_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,35,C,Control,,12,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,42.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_IES_A_0_NA,Mixed: Psychotherapy & CIH,PTSD,35,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,IES,IES,,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,35.2,22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_IES_A_12_NA,Mixed: Psychotherapy & CIH,PTSD,35,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,IES,IES,,,Covariance pattern (unstructured) general linear mixed models,Assessment at 3 to <6 Months,12,,29.1,22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_IES_A_39_NA,Mixed: Psychotherapy & CIH,PTSD,35,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,IES,IES,,,Covariance pattern (unstructured) general linear mixed models,Assessment at 6 to <12 Months,39,,34.8,28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_IES_A_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,35,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,IES,IES,,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,52.5,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_IES_B_0_NA,Mixed: Psychotherapy & CIH,PTSD,35,B,PTSD,,,,Biofeedback-assisted relaxation,Biofeedback-assisted relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,13,Self report,IES,IES,,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,44.5,17.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_IES_B_12_NA,Mixed: Psychotherapy & CIH,PTSD,35,B,PTSD,,,,Biofeedback-assisted relaxation,Biofeedback-assisted relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,13,Self report,IES,IES,,,Covariance pattern (unstructured) general linear mixed models,Assessment at 3 to <6 Months,12,,45.7,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_IES_B_39_NA,Mixed: Psychotherapy & CIH,PTSD,35,B,PTSD,,,,Biofeedback-assisted relaxation,Biofeedback-assisted relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,13,Self report,IES,IES,,,Covariance pattern (unstructured) general linear mixed models,Assessment at 6 to <12 Months,39,,47.0,23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_IES_B_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,35,B,PTSD,,,,Biofeedback-assisted relaxation,Biofeedback-assisted relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,13,Self report,IES,IES,,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,52.9,9.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_IES_C_0_NA,Mixed: Psychotherapy & CIH,PTSD,35,C,Control,,,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Self report,IES,IES,,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,38.7,16.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_IES_C_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,35,C,Control,,,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Self report,IES,IES,,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,52.8,11.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_M-PTSD_A_0_NA,Mixed: Psychotherapy & CIH,PTSD,35,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,M-PTSD,M-PTSD,,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,92.8,20.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_M-PTSD_A_12_NA,Mixed: Psychotherapy & CIH,PTSD,35,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,M-PTSD,M-PTSD,,,Covariance pattern (unstructured) general linear mixed models,Assessment at 3 to <6 Months,12,,92.4,17.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_M-PTSD_A_39_NA,Mixed: Psychotherapy & CIH,PTSD,35,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,M-PTSD,M-PTSD,,,Covariance pattern (unstructured) general linear mixed models,Assessment at 6 to <12 Months,39,,97.8,29.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_M-PTSD_A_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,35,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,M-PTSD,M-PTSD,,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,117.5,14.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_M-PTSD_B_0_NA,Mixed: Psychotherapy & CIH,PTSD,35,B,PTSD,,,,Biofeedback-assisted relaxation,Biofeedback-assisted relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,13,Self report,M-PTSD,M-PTSD,,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,114.2,17.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_M-PTSD_B_12_NA,Mixed: Psychotherapy & CIH,PTSD,35,B,PTSD,,,,Biofeedback-assisted relaxation,Biofeedback-assisted relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,13,Self report,M-PTSD,M-PTSD,,,Covariance pattern (unstructured) general linear mixed models,Assessment at 3 to <6 Months,12,,110.6,18.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_M-PTSD_B_39_NA,Mixed: Psychotherapy & CIH,PTSD,35,B,PTSD,,,,Biofeedback-assisted relaxation,Biofeedback-assisted relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,13,Self report,M-PTSD,M-PTSD,,,Covariance pattern (unstructured) general linear mixed models,Assessment at 6 to <12 Months,39,,127.0,12.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_M-PTSD_B_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,35,B,PTSD,,,,Biofeedback-assisted relaxation,Biofeedback-assisted relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,13,Self report,M-PTSD,M-PTSD,,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,119.4,18.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_M-PTSD_C_0_NA,Mixed: Psychotherapy & CIH,PTSD,35,C,Control,,,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Self report,M-PTSD,M-PTSD,,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,112.9,21.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_M-PTSD_C_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,35,C,Control,,,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Self report,M-PTSD,M-PTSD,,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,117.9,17.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_PSS-SR_A_0_NA,Mixed: Psychotherapy & CIH,PTSD,35,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,PSS-SR,PSS-SR,,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,3.0,2.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_PSS-SR_A_12_NA,Mixed: Psychotherapy & CIH,PTSD,35,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,PSS-SR,PSS-SR,,,Covariance pattern (unstructured) general linear mixed models,Assessment at 3 to <6 Months,12,,2.1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_PSS-SR_A_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,35,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,PSS-SR,PSS-SR,,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,7.3,2.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_PSS-SR_B_0_NA,Mixed: Psychotherapy & CIH,PTSD,35,B,PTSD,,,,Biofeedback-assisted relaxation,Biofeedback-assisted relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,13,Self report,PSS-SR,PSS-SR,,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,4.7,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_PSS-SR_B_12_NA,Mixed: Psychotherapy & CIH,PTSD,35,B,PTSD,,,,Biofeedback-assisted relaxation,Biofeedback-assisted relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,13,Self report,PSS-SR,PSS-SR,,,Covariance pattern (unstructured) general linear mixed models,Assessment at 3 to <6 Months,12,,5.1,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_PSS-SR_B_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,35,B,PTSD,,,,Biofeedback-assisted relaxation,Biofeedback-assisted relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,13,Self report,PSS-SR,PSS-SR,,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,6.8,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_PSS-SR_C_0_NA,Mixed: Psychotherapy & CIH,PTSD,35,C,Control,,,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Self report,PSS-SR,PSS-SR,,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,6.2,2.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlson1998_PSS-SR_C_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,35,C,Control,,,,TAU waitlist,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Self report,PSS-SR,PSS-SR,,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,7.5,1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.",13921,2019
carlsson2018_HTQ_A_0_ITT,Psychotherapy,PTSD,140,A,PTSD,,62,,SIT,Stress Inoculation Training (SIT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,70,Self report,HTQ,HTQ,ITT,Imputed,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,3.1,,SE,0.08,,SE 0.06,-0.08,,,,,Effect size,0.19,,,,p=0.19,,,,,,,,,,,,,,Community,,,1,0.4365,,0.5635,Terrorism/political violence/forced displacement,,Medium,"Carlsson J, Sonne C, Vindbjerg E, et al. Stress management versus cognitive restructuring in trauma-affected refugees‚Äö√Ñ√Æa pragmatic randomised study. Psychiatry Res. 2018 Aug;266:116-23. doi: 10.1016/j.psychres.2018.05.015. PMID: 29859498",1519484,2019
carlsson2018_HTQ_A_Baseline_ITT,Psychotherapy,PTSD,140,A,PTSD,,62,,SIT,Stress Inoculation Training (SIT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,70,Self report,HTQ,HTQ,ITT,Imputed,Covariance pattern (unstructured) general linear mixed models,Baseline,,,3.18,,SE,0.06,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4365,,0.5635,Terrorism/political violence/forced displacement,,Medium,"Carlsson J, Sonne C, Vindbjerg E, et al. Stress management versus cognitive restructuring in trauma-affected refugees‚Äö√Ñ√Æa pragmatic randomised study. Psychiatry Res. 2018 Aug;266:116-23. doi: 10.1016/j.psychres.2018.05.015. PMID: 29859498",1519484,2019
carlsson2018_HTQ_B_0_ITT,Psychotherapy,PTSD,140,B,PTSD,,64,,CR,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,70,Self report,HTQ,HTQ,ITT,Imputed,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,3.06,,SE,0.07,,SE 0.07,-0.15,,,,,Effect size,0.35,,,,p=0.03,,,,,,,,,,,,,,Community,,,1,0.4365,,0.5635,Terrorism/political violence/forced displacement,,Medium,"Carlsson J, Sonne C, Vindbjerg E, et al. Stress management versus cognitive restructuring in trauma-affected refugees‚Äö√Ñ√Æa pragmatic randomised study. Psychiatry Res. 2018 Aug;266:116-23. doi: 10.1016/j.psychres.2018.05.015. PMID: 29859498",1519484,2019
carlsson2018_HTQ_B_Baseline_ITT,Psychotherapy,PTSD,140,B,PTSD,,64,,CR,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,70,Self report,HTQ,HTQ,ITT,Imputed,Covariance pattern (unstructured) general linear mixed models,Baseline,,,3.21,,SE,0.05,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4365,,0.5635,Terrorism/political violence/forced displacement,,Medium,"Carlsson J, Sonne C, Vindbjerg E, et al. Stress management versus cognitive restructuring in trauma-affected refugees‚Äö√Ñ√Æa pragmatic randomised study. Psychiatry Res. 2018 Aug;266:116-23. doi: 10.1016/j.psychres.2018.05.015. PMID: 29859498",1519484,2019
carr2012_IES_A_0_ITT,Complementary and integrative health (CIH),PTSD,17,A,PTSD,,8,,Music Therapy,Music therapy,No,Not Applicable,No,Not Applicable,Yes,Creative therapies,No,No,No,No,No,Group,In Person,9,Self report,IES,IES-R,ITT,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,30.87,10.6,,,,,-21.82,,,,,LSM,-24.5,95% CI,-32.3,16.69,p=0.0001,,,,,,,,,,,,,,Community,,,1,0.5625,,0.4375,Mixed,"child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement, other (torture)",Medium,"Carr C, D'Ardenne P, Sloboda A, et al. Group music therapy for patients with persistent post-traumatic stress disorder -- an exploratory randomized controlled trial with mixed methods evaluation. Psychol Psychother. 2012 Jun;85(2):179-202. doi: 10.1111/j.2044-8341.2011.02026.x. PMID: 22903909.",39454,2019
carr2012_IES_A_Baseline_ITT,Complementary and integrative health (CIH),PTSD,17,A,PTSD,,8,,Music Therapy,Music therapy,No,Not Applicable,No,Not Applicable,Yes,Creative therapies,No,No,No,No,No,Group,In Person,9,Self report,IES,IES-R,ITT,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,52.69,13.82,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5625,,0.4375,Mixed,"child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement, other (torture)",Medium,"Carr C, D'Ardenne P, Sloboda A, et al. Group music therapy for patients with persistent post-traumatic stress disorder -- an exploratory randomized controlled trial with mixed methods evaluation. Psychol Psychother. 2012 Jun;85(2):179-202. doi: 10.1111/j.2044-8341.2011.02026.x. PMID: 22903909.",39454,2019
carr2012_IES_B_0_ITT,Complementary and integrative health (CIH),PTSD,17,B,Control,,8,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,8,Self report,IES,IES-R,ITT,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,53.12,9.2,,,,,-5.66,,,,,LSM,-4.32,95% CI,-12.06,3.42,p=0.2286,,,,,,,,,,,,,,Community,,,1,0.5625,,0.4375,Mixed,"child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement, other (torture)",Medium,"Carr C, D'Ardenne P, Sloboda A, et al. Group music therapy for patients with persistent post-traumatic stress disorder -- an exploratory randomized controlled trial with mixed methods evaluation. Psychol Psychother. 2012 Jun;85(2):179-202. doi: 10.1111/j.2044-8341.2011.02026.x. PMID: 22903909.",39454,2019
carr2012_IES_B_Baseline_ITT,Complementary and integrative health (CIH),PTSD,17,B,Control,,8,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,8,Self report,IES,IES-R,ITT,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,58.78,10.98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5625,,0.4375,Mixed,"child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement, other (torture)",Medium,"Carr C, D'Ardenne P, Sloboda A, et al. Group music therapy for patients with persistent post-traumatic stress disorder -- an exploratory randomized controlled trial with mixed methods evaluation. Psychol Psychother. 2012 Jun;85(2):179-202. doi: 10.1111/j.2044-8341.2011.02026.x. PMID: 22903909.",39454,2019
carter2013_CAPS_A_0_Comp,Complementary and integrative health (CIH),PTSD,31,A,PTSD,,14,assessment conducted 6 weeks post intervention,Sudarshan Kriya Yoga,Yoga,No,Not Applicable,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Group,In Person,16,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,42.1,18.2,,,,,-14.2,,,,,,,,,,p<0.01,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,Medium,"Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.",46976,2019
carter2013_CAPS_A_26_Comp,Complementary and integrative health (CIH),PTSD,31,A,PTSD,,14,,Sudarshan Kriya Yoga,Yoga,No,Not Applicable,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Group,In Person,16,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF,Covariance pattern (unstructured) general linear mixed models,Assessment at 6 to <12 Months,26,,26.2,14.8,,,,,-30.1,,,,,Partial eta-squared,0.89,,,,p<0.00,compared to end-of-treatment,,,,,,p<0.01,,,,,,,Veteran,0,1,0,0,,1,,,Medium,"Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.",46976,2019
carter2013_CAPS_A_Baseline_Comp,Complementary and integrative health (CIH),PTSD,31,A,PTSD,,14,,Sudarshan Kriya Yoga,Yoga,No,Not Applicable,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Group,In Person,16,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF,Covariance pattern (unstructured) general linear mixed models,Baseline,,,56.3,12.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,Medium,"Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.",46976,2019
carter2013_CAPS_B_0_Comp,Complementary and integrative health (CIH),PTSD,31,B,Control,,11,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,15,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,56.6,18.9,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,Medium,"Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.",46976,2019
carter2013_CAPS_B_Baseline_Comp,Complementary and integrative health (CIH),PTSD,31,B,Control,,11,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,15,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF,Covariance pattern (unstructured) general linear mixed models,Baseline,,,56.6,18.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,Medium,"Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.",46976,2019
carter2013_PCL_A_0_NA,Complementary and integrative health (CIH),PTSD,31,A,PTSD,,,,Sudarshan Kriya Yoga,Yoga,No,Not Applicable,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Group,In Person,16,Self report,PCL,PCL-M,,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,35.6,11.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,Medium,"Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.",46976,2019
carter2013_PCL_A_Baseline_NA,Complementary and integrative health (CIH),PTSD,31,A,PTSD,,,,Sudarshan Kriya Yoga,Yoga,No,Not Applicable,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Group,In Person,16,Self report,PCL,PCL-M,,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,53.0,13.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,Medium,"Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.",46976,2019
carter2013_PCL_B_0_NA,Complementary and integrative health (CIH),PTSD,31,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,15,Self report,PCL,PCL-M,,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,37.9,12.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,Medium,"Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.",46976,2019
carter2013_PCL_B_Baseline_NA,Complementary and integrative health (CIH),PTSD,31,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,15,Self report,PCL,PCL-M,,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,51.2,12.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,Medium,"Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.",46976,2019
castillo2016_CAPS_A_0_ITT,Psychotherapy,PTSD,86,A,PTSD,,31,,Group-delivered Cognitive/Exposure Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,44,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using SAS Proc Multiple imputation,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,47.23,16.42,,,,,-24.37,,,,,Cohen's d,1.72,,,,p<0.001,,,,,,,,CAPS total score ≤45,0.5186,,≥10-point decrease on total CAPS score,0.7738,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,,1,,1,,0,Mixed,"MST, combat-related, other (not specified)",Medium,"Castillo DT, Chee CL, Nason E, et al. Group-delivered cognitive/exposure therapy for PTSD in women veterans: a randomized controlled trial. Psychol Trauma. 2016 May;8(3):404-12. doi: 10.1037/tra0000111. PMID: 26854355.",44771,2019
castillo2016_CAPS_A_12_ITT,Psychotherapy,PTSD,86,A,PTSD,,31,,Group-delivered Cognitive/Exposure Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,44,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using SAS Proc Multiple imputation,Covariance pattern (unstructured) general linear mixed models,Assessment at 3 to <6 Months,12,,49.43,19.07,,,,,-22.17,,,,compared to post-treatment,,,,,,p=0.62,,,,,,,,CAPS total score ≤45,0.4376,,≥10-point decrease on total CAPS score,0.6771,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,,1,,1,,0,Mixed,"MST, combat-related, other (not specified)",Medium,"Castillo DT, Chee CL, Nason E, et al. Group-delivered cognitive/exposure therapy for PTSD in women veterans: a randomized controlled trial. Psychol Trauma. 2016 May;8(3):404-12. doi: 10.1037/tra0000111. PMID: 26854355.",44771,2019
castillo2016_CAPS_A_26_ITT,Psychotherapy,PTSD,86,A,PTSD,,31,,Group-delivered Cognitive/Exposure Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,44,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using SAS Proc Multiple imputation,Covariance pattern (unstructured) general linear mixed models,Assessment at 6 to <12 Months,26,,49.04,17.54,,,,,-22.56,,,,compared to post-treatment,,,,,,p=0.54,,,,,,,,CAPS total score ≤45,0.4629,,≥10-point decrease on total CAPS score,0.731,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,,1,,1,,0,Mixed,"MST, combat-related, other (not specified)",Medium,"Castillo DT, Chee CL, Nason E, et al. Group-delivered cognitive/exposure therapy for PTSD in women veterans: a randomized controlled trial. Psychol Trauma. 2016 May;8(3):404-12. doi: 10.1037/tra0000111. PMID: 26854355.",44771,2019
castillo2016_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,86,A,PTSD,,42,,Group-delivered Cognitive/Exposure Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,44,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using SAS Proc Multiple imputation,Covariance pattern (unstructured) general linear mixed models,Baseline,,,71.6,10.32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,1,,0,Mixed,"MST, combat-related, other (not specified)",Medium,"Castillo DT, Chee CL, Nason E, et al. Group-delivered cognitive/exposure therapy for PTSD in women veterans: a randomized controlled trial. Psychol Trauma. 2016 May;8(3):404-12. doi: 10.1037/tra0000111. PMID: 26854355.",44771,2019
castillo2016_CAPS_B_0_ITT,Psychotherapy,PTSD,86,B,Control,,35,,Waitlist with minimal intervention,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Mixed,42,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using SAS Proc Multiple imputation,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,70.61,19.82,,,,,-3.38,,,,,,,,,,p=0.37,,,,,,,,CAPS total score ≤45,,,≥10-point decrease on total CAPS score,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,,1,,1,,0,Mixed,"MST, combat-related, other (not specified)",Medium,"Castillo DT, Chee CL, Nason E, et al. Group-delivered cognitive/exposure therapy for PTSD in women veterans: a randomized controlled trial. Psychol Trauma. 2016 May;8(3):404-12. doi: 10.1037/tra0000111. PMID: 26854355.",44771,2019
castillo2016_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,86,B,Control,,42,,Waitlist with minimal intervention,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Mixed,42,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using SAS Proc Multiple imputation,Covariance pattern (unstructured) general linear mixed models,Baseline,,,73.99,10.62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,1,,0,Mixed,"MST, combat-related, other (not specified)",Medium,"Castillo DT, Chee CL, Nason E, et al. Group-delivered cognitive/exposure therapy for PTSD in women veterans: a randomized controlled trial. Psychol Trauma. 2016 May;8(3):404-12. doi: 10.1037/tra0000111. PMID: 26854355.",44771,2019
celik2011_CAPS_A_0_Comp,Pharmacotherapy,PTSD,50,A,PTSD,,22,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,CAPS,CAPS-2,Completer,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,35.6,9.6,,,,,-10.3,12.8,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 score and CGI-I rating of 1 or 2,0.318,,Community,,,1,,,,Combat-related,,High,"Celik C, Ozdemir B, Ozmenler KN, et al. Efficacy of paroxetine and amitriptyline in posttraumatic stress disorder: an open-label comparative study. Klinik Psikofarmakol B√ºlteni. 2011 Sep;21(3):179-85. doi: 10.5455/bcp.20110627111141.",1519639,2019
celik2011_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,50,A,PTSD,,22,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,CAPS,CAPS-2,Completer,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,45.9,10.2,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 score and CGI-I rating of 1 or 2,,,Community,,,1,,,,Combat-related,,High,"Celik C, Ozdemir B, Ozmenler KN, et al. Efficacy of paroxetine and amitriptyline in posttraumatic stress disorder: an open-label comparative study. Klinik Psikofarmakol B√ºlteni. 2011 Sep;21(3):179-85. doi: 10.5455/bcp.20110627111141.",1519639,2019
celik2011_CAPS_B_0_Comp,Pharmacotherapy,PTSD,50,B,PTSD,,20,,Amitriptyline,Amitriptyline,No,Not Applicable,Yes,Antidepressant: TCA,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,CAPS,CAPS-2,Completer,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,29.6,11.9,,,,,-20.2,16.7,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 score and CGI-I rating of 1 or 2,0.55,,Community,,,1,,,,Combat-related,,High,"Celik C, Ozdemir B, Ozmenler KN, et al. Efficacy of paroxetine and amitriptyline in posttraumatic stress disorder: an open-label comparative study. Klinik Psikofarmakol B√ºlteni. 2011 Sep;21(3):179-85. doi: 10.5455/bcp.20110627111141.",1519639,2019
celik2011_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,50,B,PTSD,,20,,Amitriptyline,Amitriptyline,No,Not Applicable,Yes,Antidepressant: TCA,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,CAPS,CAPS-2,Completer,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,49.7,12.7,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 score and CGI-I rating of 1 or 2,,,Community,,,1,,,,Combat-related,,High,"Celik C, Ozdemir B, Ozmenler KN, et al. Efficacy of paroxetine and amitriptyline in posttraumatic stress disorder: an open-label comparative study. Klinik Psikofarmakol B√ºlteni. 2011 Sep;21(3):179-85. doi: 10.5455/bcp.20110627111141.",1519639,2019
chard2005_CAPS_A_0_Comp,Psychotherapy,PTSD,71,A,PTSD,,28,,CPT for sexual abuse survivor,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,36,Structured Clinical Interview,CAPS,CAPS one-week,Completer,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,9,11.04,,,,,-56.46,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-SX,0.9286,,MPSS score ≤20 and BDI-II ≤10,0.7857,,Community,,,1,1,,0,Child sexual abuse,,Medium,Chard KM. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J Consult Clin Psychol. 2005 Oct;73(5):965-71. doi: 10.1037/0022-006X.73.5.965. PMID: 16287396.,27944,2019
chard2005_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,71,A,PTSD,,36,,CPT for sexual abuse survivor,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,36,Structured Clinical Interview,CAPS,CAPS one-week,Completer,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,65.46,26.39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,Chard KM. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J Consult Clin Psychol. 2005 Oct;73(5):965-71. doi: 10.1037/0022-006X.73.5.965. PMID: 16287396.,27944,2019
chard2005_CAPS_B_0_Comp,Psychotherapy,PTSD,71,B,Control,,27,,Minimal attention waitlist,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Telephone,35,Structured Clinical Interview,CAPS,CAPS one-week,Completer,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,62.96,30.68,,,,,-5.34,,,,,,,,,,p=NS,,,,,,,,Not meeting criteria for PTSD according to CAPS-SX,0.2593,,MPSS score ≤20 and BDI-II ≤10,0.037,,Community,,,1,1,,0,Child sexual abuse,,Medium,Chard KM. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J Consult Clin Psychol. 2005 Oct;73(5):965-71. doi: 10.1037/0022-006X.73.5.965. PMID: 16287396.,27944,2019
chard2005_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,71,B,Control,,35,,Minimal attention waitlist,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Telephone,35,Structured Clinical Interview,CAPS,CAPS one-week,Completer,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,68.3,23.67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,Chard KM. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J Consult Clin Psychol. 2005 Oct;73(5):965-71. doi: 10.1037/0022-006X.73.5.965. PMID: 16287396.,27944,2019
chard2005_MPSS_A_0_NA,Psychotherapy,PTSD,71,A,PTSD,,,,CPT for sexual abuse survivor,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,36,Self report,MPSS,MPSS,,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,7.54,9.51,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,Chard KM. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J Consult Clin Psychol. 2005 Oct;73(5):965-71. doi: 10.1037/0022-006X.73.5.965. PMID: 16287396.,27944,2019
chard2005_MPSS_A_Baseline_NA,Psychotherapy,PTSD,71,A,PTSD,,,,CPT for sexual abuse survivor,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,36,Self report,MPSS,MPSS,,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,57.57,22.85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,Chard KM. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J Consult Clin Psychol. 2005 Oct;73(5):965-71. doi: 10.1037/0022-006X.73.5.965. PMID: 16287396.,27944,2019
chard2005_MPSS_B_0_NA,Psychotherapy,PTSD,71,B,Control,,,,Minimal attention waitlist,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Telephone,35,Self report,MPSS,MPSS,,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,57.70,27.47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,Chard KM. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J Consult Clin Psychol. 2005 Oct;73(5):965-71. doi: 10.1037/0022-006X.73.5.965. PMID: 16287396.,27944,2019
chard2005_MPSS_B_Baseline_NA,Psychotherapy,PTSD,71,B,Control,,,,Minimal attention waitlist,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Telephone,35,Self report,MPSS,MPSS,,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,57.52,24.74,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,Chard KM. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J Consult Clin Psychol. 2005 Oct;73(5):965-71. doi: 10.1037/0022-006X.73.5.965. PMID: 16287396.,27944,2019
chung2004_CAPS_A_0_Comp,Pharmacotherapy,PTSD,113,A,PTSD,,51,,Mirtazapine,Mirtazapine,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS-2,Completer,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,58.4,,,,,,-44.8,19.7,,,,,,,,,p=0.0001,,,,,,,,,,,≥30% decrease in CAPS-2 score,0.8824,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0,,1,Combat-related,,High,"Chung MY, Min KH, Jun YJ, et al. Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial. Hum Psychopharmacol. 2004 Oct;19(7):489-94. doi: 10.1002/hup.615. PMID: 15378676.",26712,2019
chung2004_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,113,A,PTSD,,51,,Mirtazapine,Mirtazapine,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS-2,Completer,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,103.2,24.4,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 score,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0,,1,Combat-related,,High,"Chung MY, Min KH, Jun YJ, et al. Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial. Hum Psychopharmacol. 2004 Oct;19(7):489-94. doi: 10.1002/hup.615. PMID: 15378676.",26712,2019
chung2004_CAPS_B_0_Comp,Pharmacotherapy,PTSD,113,B,PTSD,,49,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS-2,Completer,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,55.6,,,,,,-33.2,20.4,,,,,,,,,p=0.0001,,,,,,,,,,,≥30% decrease in CAPS-2 score,0.6939,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0,,1,Combat-related,,High,"Chung MY, Min KH, Jun YJ, et al. Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial. Hum Psychopharmacol. 2004 Oct;19(7):489-94. doi: 10.1002/hup.615. PMID: 15378676.",26712,2019
chung2004_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,113,B,PTSD,,49,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS-2,Completer,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,88.8,23.9,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 score,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0,,1,Combat-related,,High,"Chung MY, Min KH, Jun YJ, et al. Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial. Hum Psychopharmacol. 2004 Oct;19(7):489-94. doi: 10.1002/hup.615. PMID: 15378676.",26712,2019
church2013_PCL_A_0_Comp,Psychotherapy,PTSD,59,A,PTSD,,29,,Emotional Freedom Technique,Emotional Freedom Technique (EFT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PCL,PCL-M,Completer,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,39.41,,SE,2.7,,,-22.6,,,,,,,,,,p<0.003,,,,,,,,PCL-M <50,0.8967,,,,,Veteran,0,1,0,0.1017,,0.8983,,,Medium,"Church D, Hawk C, Brooks AJ, et al. Psychological trauma symptom improvement in veterans using Emotional Freedom Techniques. J Nerv Ment Dis. 2013 Feb;201(2):153-60. doi: 10.1097/NMD.0b013e31827f6351. PMID: 23364126.",40000,2019
church2013_PCL_A_Baseline_Comp,Psychotherapy,PTSD,59,A,PTSD,,29,,Emotional Freedom Technique,Emotional Freedom Technique (EFT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PCL,PCL-M,Completer,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,62.01,,SE,2.1,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1017,,0.8983,,,Medium,"Church D, Hawk C, Brooks AJ, et al. Psychological trauma symptom improvement in veterans using Emotional Freedom Techniques. J Nerv Ment Dis. 2013 Feb;201(2):153-60. doi: 10.1097/NMD.0b013e31827f6351. PMID: 23364126.",40000,2019
church2013_PCL_B_0_Comp,Psychotherapy,PTSD,59,B,Control,,25,,Standard of care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,29,Self report,PCL,PCL-M,Completer,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,63.23,,SE,2,,,0.52,,,,,,,,,,p=NS,,,,,,,,PCL-M <50,0.04,,,,,Veteran,0,1,0,0.1017,,0.8983,,,Medium,"Church D, Hawk C, Brooks AJ, et al. Psychological trauma symptom improvement in veterans using Emotional Freedom Techniques. J Nerv Ment Dis. 2013 Feb;201(2):153-60. doi: 10.1097/NMD.0b013e31827f6351. PMID: 23364126.",40000,2019
church2013_PCL_B_Baseline_Comp,Psychotherapy,PTSD,59,B,Control,,25,,Standard of care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,29,Self report,PCL,PCL-M,Completer,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,62.71,,SE,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1017,,0.8983,,,Medium,"Church D, Hawk C, Brooks AJ, et al. Psychological trauma symptom improvement in veterans using Emotional Freedom Techniques. J Nerv Ment Dis. 2013 Feb;201(2):153-60. doi: 10.1097/NMD.0b013e31827f6351. PMID: 23364126.",40000,2019
classen2001_TSC-40_A_0_NA,Psychotherapy,PTSD,58,A,PTSD,,,,Trauma-focused or Present-focused group therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,,Self report,TSC-40,TSC-40,,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,,,,,,,-8.1,17,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,"Sexual orientation
Heterosexual: 82.69%
Lesbian: 9.62%
Bisexual: 7.69%",0,Child sexual abuse,,High,"Classen CC, Koopman C, Nevill-Manning K, et al. A preliminary report comparing trauma-focused and present-focused group therapy against a wait-listed condition among childhood sexual abuse survivors with PTSD. J Aggress Maltreat Trauma. 2001 Jun;4(2):265-88. doi: 10.1300/J146v04n02_12.",16145,2019
classen2001_TSC-40_B_0_NA,Psychotherapy,PTSD,58,B,Control,,33,,Waitlist,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,,Self report,TSC-40,TSC-40,,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,,,,,,,-3.8,14.1,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,"Sexual orientation
Heterosexual: 82.69%
Lesbian: 9.62%
Bisexual: 7.69%",0,Child sexual abuse,,High,"Classen CC, Koopman C, Nevill-Manning K, et al. A preliminary report comparing trauma-focused and present-focused group therapy against a wait-listed condition among childhood sexual abuse survivors with PTSD. J Aggress Maltreat Trauma. 2001 Jun;4(2):265-88. doi: 10.1300/J146v04n02_12.",16145,2019
classen2001_TSC-40_B_Baseline_NA,Psychotherapy,PTSD,58,B,Control,,33,,Waitlist,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,,Self report,TSC-40,TSC-40,,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,"Sexual orientation
Heterosexual: 82.69%
Lesbian: 9.62%
Bisexual: 7.69%",0,Child sexual abuse,,High,"Classen CC, Koopman C, Nevill-Manning K, et al. A preliminary report comparing trauma-focused and present-focused group therapy against a wait-listed condition among childhood sexual abuse survivors with PTSD. J Aggress Maltreat Trauma. 2001 Jun;4(2):265-88. doi: 10.1300/J146v04n02_12.",16145,2019
cloitre2002_CAPS_A_0_Comp,Psychotherapy,PTSD,58,A,PTSD,,22,,STAIR + modified PE,Skills Training in Affect and Interpersonal Regulation (STAIR) plus modified Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,Completer,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,31,25.2,,,,,-38,,,,,,,,,,"p=""significant""",,,,,,,,Not meeting criteria for PTSD according to CAPS,0.7727,,"MPSS score <20, STAI-S score <40, and BDI score <10",0.4545,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse",Medium,"Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.",24762,2019
cloitre2002_CAPS_A_0_ITT,Psychotherapy,PTSD,58,A,PTSD,,31,,STAIR + modified PE,Skills Training in Affect and Interpersonal Regulation (STAIR) plus modified Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,,,,,,,,,,,,,,,,,"p=""significant""",,,,,,,,Not meeting criteria for PTSD according to CAPS,,,"MPSS score <20, STAI-S score <40, and BDI score <10",,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse",Medium,"Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.",24762,2019
cloitre2002_CAPS_A_12_Comp,Psychotherapy,PTSD,58,A,PTSD,,20,,STAIR + modified PE,Skills Training in Affect and Interpersonal Regulation (STAIR) plus modified Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,Completer,,Covariance pattern (unstructured) general linear mixed models,Assessment at 3 to <6 Months,12,,26,17.4,,,,,-43,,,,compared to posttreatment,,,,,,p=0.04,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,"MPSS score <20, STAI-S score <40, and BDI score <10",,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse",Medium,"Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.",24762,2019
cloitre2002_CAPS_A_39_Comp,Psychotherapy,PTSD,58,A,PTSD,,17,,STAIR + modified PE,Skills Training in Affect and Interpersonal Regulation (STAIR) plus modified Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,Completer,,Covariance pattern (unstructured) general linear mixed models,Assessment at 6 to <12 Months,39,,22,14.5,,,,,-47,,,,compared to posttreatment,,,,,,p=0.01,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,"MPSS score <20, STAI-S score <40, and BDI score <10",,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse",Medium,"Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.",24762,2019
cloitre2002_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,58,A,PTSD,,22,,STAIR + modified PE,Skills Training in Affect and Interpersonal Regulation (STAIR) plus modified Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,Completer,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,69,16.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse",Medium,"Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.",24762,2019
cloitre2002_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,58,A,PTSD,,31,,STAIR + modified PE,Skills Training in Affect and Interpersonal Regulation (STAIR) plus modified Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Covariance pattern (unstructured) general linear mixed models,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse",Medium,"Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.",24762,2019
cloitre2002_CAPS_B_0_Comp,Psychotherapy,PTSD,58,B,Control,,24,,Minimal attention,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,27,Structured Clinical Interview,CAPS,CAPS,Completer,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,62,22.7,,,,,-7,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.25,,"MPSS score <20, STAI-S score <40, and BDI score <10",0.0417,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse",Medium,"Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.",24762,2019
cloitre2002_CAPS_B_0_ITT,Psychotherapy,PTSD,58,B,Control,,27,,Minimal attention,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,27,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,"MPSS score <20, STAI-S score <40, and BDI score <10",,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse",Medium,"Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.",24762,2019
cloitre2002_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,58,B,Control,,24,,Minimal attention,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,27,Structured Clinical Interview,CAPS,CAPS,Completer,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,69,16.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse",Medium,"Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.",24762,2019
cloitre2002_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,58,B,Control,,27,,Minimal attention,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,27,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Covariance pattern (unstructured) general linear mixed models,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse",Medium,"Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.",24762,2019
cloitre2002_MPSS_A_0_Comp,Psychotherapy,PTSD,58,A,PTSD,,,,STAIR + modified PE,Skills Training in Affect and Interpersonal Regulation (STAIR) plus modified Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Self report,MPSS,MPSS,Completer,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,29,27.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse",Medium,"Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.",24762,2019
cloitre2002_MPSS_A_Baseline_Comp,Psychotherapy,PTSD,58,A,PTSD,,,,STAIR + modified PE,Skills Training in Affect and Interpersonal Regulation (STAIR) plus modified Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Self report,MPSS,MPSS,Completer,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,69,16.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse",Medium,"Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.",24762,2019
cloitre2002_MPSS_B_0_Comp,Psychotherapy,PTSD,58,B,Control,,,,Minimal attention,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,27,Self report,MPSS,MPSS,Completer,,Covariance pattern (unstructured) general linear mixed models,End of Treatment,0,,58,28.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse",Medium,"Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.",24762,2019
cloitre2002_MPSS_B_Baseline_Comp,Psychotherapy,PTSD,58,B,Control,,,,Minimal attention,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,27,Self report,MPSS,MPSS,Completer,,Covariance pattern (unstructured) general linear mixed models,Baseline,,,73,18.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse",Medium,"Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.",24762,2019
cloitre2010_CAPS_A_0_ITT,Psychotherapy,PTSD,104,A,PTSD,,28,,STAIR + Exposure Treatment,Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Structured Clinical Interview,CAPS,CAPS,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,32.70,19.37,,,,,-30.38,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to the CAPS,0.61,,CAPS score <20,0.27,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_CAPS_A_12_ITT,Psychotherapy,PTSD,104,A,PTSD,,25,,STAIR + Exposure Treatment,Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Structured Clinical Interview,CAPS,CAPS,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 3 to <6 Months,12,,24.66,18.47,,,,,-38.42,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to the CAPS,,,CAPS score <20,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_CAPS_A_26_ITT,Psychotherapy,PTSD,104,A,PTSD,,23,,STAIR + Exposure Treatment,Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Structured Clinical Interview,CAPS,CAPS,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 6 to <12 Months,26,,20.44,19.01,,,,,-42.64,,,,,Cohen's d,2.29,,,,,,,,,,,,Not meeting criteria for PTSD according to the CAPS,0.55,,CAPS score <20,0.24,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,104,A,PTSD,,33,,STAIR + Exposure Treatment,Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Structured Clinical Interview,CAPS,CAPS,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,63.08,18.29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_CAPS_B_0_ITT,Psychotherapy,PTSD,104,B,PTSD,,28,,STAIR + Supportive Counseling,Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,38,Structured Clinical Interview,CAPS,CAPS,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,32.32,23.04,,,,,-32.02,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to the CAPS,0.47,,CAPS score <20,0.24,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_CAPS_B_12_ITT,Psychotherapy,PTSD,104,B,PTSD,,26,,STAIR + Supportive Counseling,Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,38,Structured Clinical Interview,CAPS,CAPS,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 3 to <6 Months,12,,31.88,22.98,,,,,-32.46,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to the CAPS,,,CAPS score <20,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_CAPS_B_26_ITT,Psychotherapy,PTSD,104,B,PTSD,,23,,STAIR + Supportive Counseling,Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,38,Structured Clinical Interview,CAPS,CAPS,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 6 to <12 Months,26,,32.51,22.69,,,,,-31.83,,,,,Cohen's d,1.72,,,,,,,,,,,,Not meeting criteria for PTSD according to the CAPS,0.37,,CAPS score <20,0.13,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,104,B,PTSD,,38,,STAIR + Supportive Counseling,Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,38,Structured Clinical Interview,CAPS,CAPS,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,64.34,21.15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_CAPS_C_0_ITT,Psychotherapy,PTSD,104,C,PTSD,,20,,Supportive Counseling + Exposure Treatment,Supportive counseling + exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Structured Clinical Interview,CAPS,CAPS,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,39.72,18.34,,,,,-24.78,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to the CAPS,0.33,,CAPS score <20,0.06,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_CAPS_C_12_ITT,Psychotherapy,PTSD,104,C,PTSD,,20,,Supportive Counseling + Exposure Treatment,Supportive counseling + exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Structured Clinical Interview,CAPS,CAPS,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 3 to <6 Months,12,,39.71,17.59,,,,,-24.79,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to the CAPS,0.29,,CAPS score <20,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_CAPS_C_26_ITT,Psychotherapy,PTSD,104,C,PTSD,,20,,Supportive Counseling + Exposure Treatment,Supportive counseling + exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Structured Clinical Interview,CAPS,CAPS,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 6 to <12 Months,26,,28.56,21,,,,,-35.94,,,,,Cohen's d,1.94,,,,,,,,,,,,Not meeting criteria for PTSD according to the CAPS,0.21,,CAPS score <20,0,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_CAPS_C_Baseline_ITT,Psychotherapy,PTSD,104,C,PTSD,,33,,Supportive Counseling + Exposure Treatment,Supportive counseling + exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Structured Clinical Interview,CAPS,CAPS,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,64.50,15.86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_Gene_A_0_ITT,Psychotherapy,PTSD,104,A,PTSD,,,,STAIR + Exposure Treatment,Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Self report,General Expectancy for Negative Mood Regulation Scale,General Expectancy for Negative Mood Regulation Scale,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,110.5,16.17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_Gene_A_12_ITT,Psychotherapy,PTSD,104,A,PTSD,,,,STAIR + Exposure Treatment,Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Self report,General Expectancy for Negative Mood Regulation Scale,General Expectancy for Negative Mood Regulation Scale,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 3 to <6 Months,12,,108.5,17.86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_Gene_A_26_ITT,Psychotherapy,PTSD,104,A,PTSD,,,,STAIR + Exposure Treatment,Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Self report,General Expectancy for Negative Mood Regulation Scale,General Expectancy for Negative Mood Regulation Scale,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 6 to <12 Months,26,,113.7,15.99,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_Gene_A_Baseline_ITT,Psychotherapy,PTSD,104,A,PTSD,,,,STAIR + Exposure Treatment,Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Self report,General Expectancy for Negative Mood Regulation Scale,General Expectancy for Negative Mood Regulation Scale,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,90.6,14.68,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_Gene_B_0_ITT,Psychotherapy,PTSD,104,B,PTSD,,,,STAIR + Supportive Counseling,Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,38,Self report,General Expectancy for Negative Mood Regulation Scale,General Expectancy for Negative Mood Regulation Scale,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,105.7,16.77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_Gene_B_12_ITT,Psychotherapy,PTSD,104,B,PTSD,,,,STAIR + Supportive Counseling,Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,38,Self report,General Expectancy for Negative Mood Regulation Scale,General Expectancy for Negative Mood Regulation Scale,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 3 to <6 Months,12,,99.6,19.08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_Gene_B_26_ITT,Psychotherapy,PTSD,104,B,PTSD,,,,STAIR + Supportive Counseling,Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,38,Self report,General Expectancy for Negative Mood Regulation Scale,General Expectancy for Negative Mood Regulation Scale,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 6 to <12 Months,26,,105.4,15.95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_Gene_B_Baseline_ITT,Psychotherapy,PTSD,104,B,PTSD,,,,STAIR + Supportive Counseling,Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,38,Self report,General Expectancy for Negative Mood Regulation Scale,General Expectancy for Negative Mood Regulation Scale,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,91.5,16.12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_Gene_C_0_ITT,Psychotherapy,PTSD,104,C,PTSD,,,,Supportive Counseling + Exposure Treatment,Supportive counseling + exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Self report,General Expectancy for Negative Mood Regulation Scale,General Expectancy for Negative Mood Regulation Scale,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,105.8,17.11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_Gene_C_12_ITT,Psychotherapy,PTSD,104,C,PTSD,,,,Supportive Counseling + Exposure Treatment,Supportive counseling + exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Self report,General Expectancy for Negative Mood Regulation Scale,General Expectancy for Negative Mood Regulation Scale,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 3 to <6 Months,12,,101.2,21.82,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_Gene_C_26_ITT,Psychotherapy,PTSD,104,C,PTSD,,,,Supportive Counseling + Exposure Treatment,Supportive counseling + exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Self report,General Expectancy for Negative Mood Regulation Scale,General Expectancy for Negative Mood Regulation Scale,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 6 to <12 Months,26,,106.8,17.63,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_Gene_C_Baseline_ITT,Psychotherapy,PTSD,104,C,PTSD,,,,Supportive Counseling + Exposure Treatment,Supportive counseling + exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Self report,General Expectancy for Negative Mood Regulation Scale,General Expectancy for Negative Mood Regulation Scale,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,90.2,17.18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_PSS-SR_A_0_ITT,Psychotherapy,PTSD,104,A,PTSD,,,,STAIR + Exposure Treatment,Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Self report,PSS-SR,PSS-SR,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,14.0,11.46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_PSS-SR_A_12_ITT,Psychotherapy,PTSD,104,A,PTSD,,,,STAIR + Exposure Treatment,Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Self report,PSS-SR,PSS-SR,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 3 to <6 Months,12,,12.5,11.41,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_PSS-SR_A_26_ITT,Psychotherapy,PTSD,104,A,PTSD,,,,STAIR + Exposure Treatment,Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Self report,PSS-SR,PSS-SR,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 6 to <12 Months,26,,8.9,9.83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_PSS-SR_A_Baseline_ITT,Psychotherapy,PTSD,104,A,PTSD,,,,STAIR + Exposure Treatment,Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Self report,PSS-SR,PSS-SR,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,36.7,12.87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_PSS-SR_B_0_ITT,Psychotherapy,PTSD,104,B,PTSD,,,,STAIR + Supportive Counseling,Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,38,Self report,PSS-SR,PSS-SR,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,14.5,12.79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_PSS-SR_B_12_ITT,Psychotherapy,PTSD,104,B,PTSD,,,,STAIR + Supportive Counseling,Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,38,Self report,PSS-SR,PSS-SR,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 3 to <6 Months,12,,17.3,10.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_PSS-SR_B_26_ITT,Psychotherapy,PTSD,104,B,PTSD,,,,STAIR + Supportive Counseling,Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,38,Self report,PSS-SR,PSS-SR,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 6 to <12 Months,26,,13.7,13.64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_PSS-SR_B_Baseline_ITT,Psychotherapy,PTSD,104,B,PTSD,,,,STAIR + Supportive Counseling,Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,38,Self report,PSS-SR,PSS-SR,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,39.9,12.65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_PSS-SR_C_0_ITT,Psychotherapy,PTSD,104,C,PTSD,,,,Supportive Counseling + Exposure Treatment,Supportive counseling + exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Self report,PSS-SR,PSS-SR,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,19.0,9.83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_PSS-SR_C_12_ITT,Psychotherapy,PTSD,104,C,PTSD,,,,Supportive Counseling + Exposure Treatment,Supportive counseling + exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Self report,PSS-SR,PSS-SR,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 3 to <6 Months,12,,21.4,11.54,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_PSS-SR_C_26_ITT,Psychotherapy,PTSD,104,C,PTSD,,,,Supportive Counseling + Exposure Treatment,Supportive counseling + exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Self report,PSS-SR,PSS-SR,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 6 to <12 Months,26,,20.5,13.56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
cloitre2010_PSS-SR_C_Baseline_ITT,Psychotherapy,PTSD,104,C,PTSD,,,,Supportive Counseling + Exposure Treatment,Supportive counseling + exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Self report,PSS-SR,PSS-SR,ITT,"Imputed (continuous outcomes), LOCF (categorical outcomes)","Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,38.2,11.14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")",Medium,"Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.",34562,2020
coffey2006_IES_A_0_Comp,Psychotherapy,PTSD,43,A,PTSD,,8,,Imaginal Exposure,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,IES,IES-R,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,24.1,13.1,,,,,-23,,,,,,,,,,p=0.002,,,,,,,,,,,,,,Community,,,1,0.6744,,0.3256,Mixed,"child physical abuse, child sexual abuse",High,"Coffey SF, Stasiewicz PR, Hughes PM, et al. Trauma-focused imaginal exposure for individuals with comorbid posttraumatic stress disorder and alcohol dependence: revealing mechanisms of alcohol craving in a cue reactivity paradigm. Psychol Addict Behav. 2006 Dec;20(4):425-35. doi: 10.1037/0893-164X.20.4.425. PMID: 17176177.",34482,2019
coffey2006_IES_A_Baseline_Comp,Psychotherapy,PTSD,43,A,PTSD,,,,Imaginal Exposure,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,IES,IES-R,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,47.1,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6744,,0.3256,Mixed,"child physical abuse, child sexual abuse",High,"Coffey SF, Stasiewicz PR, Hughes PM, et al. Trauma-focused imaginal exposure for individuals with comorbid posttraumatic stress disorder and alcohol dependence: revealing mechanisms of alcohol craving in a cue reactivity paradigm. Psychol Addict Behav. 2006 Dec;20(4):425-35. doi: 10.1037/0893-164X.20.4.425. PMID: 17176177.",34482,2019
coffey2006_IES_B_0_Comp,Psychotherapy,PTSD,43,B,Control,,9,,Relaxation,Relaxation,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Self report,IES,IES-R,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,45,15.4,,,,,-1.7,,,,,,,,,,p=NS,,,,,,,,,,,,,,Community,,,1,0.6744,,0.3256,Mixed,"child physical abuse, child sexual abuse",High,"Coffey SF, Stasiewicz PR, Hughes PM, et al. Trauma-focused imaginal exposure for individuals with comorbid posttraumatic stress disorder and alcohol dependence: revealing mechanisms of alcohol craving in a cue reactivity paradigm. Psychol Addict Behav. 2006 Dec;20(4):425-35. doi: 10.1037/0893-164X.20.4.425. PMID: 17176177.",34482,2019
coffey2006_IES_B_Baseline_Comp,Psychotherapy,PTSD,43,B,Control,,,,Relaxation,Relaxation,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Self report,IES,IES-R,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,46.7,13.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6744,,0.3256,Mixed,"child physical abuse, child sexual abuse",High,"Coffey SF, Stasiewicz PR, Hughes PM, et al. Trauma-focused imaginal exposure for individuals with comorbid posttraumatic stress disorder and alcohol dependence: revealing mechanisms of alcohol craving in a cue reactivity paradigm. Psychol Addict Behav. 2006 Dec;20(4):425-35. doi: 10.1037/0893-164X.20.4.425. PMID: 17176177.",34482,2019
coffey2016_IES_A_0_ITT,Psychotherapy,PTSD,126,A,PTSD+SUD,Not integrated,35,,"Modified PE with trauma-focused motivational enhancement session, plus standard SUD TAU",Motivational enhancement session followed by modified Prolonged Exposure (PE) + standard substance use treatment as usual,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,40,Self report,IES,IES-R,ITT,Maximum likelihood imputation using multilevel mixed-effects models,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,20.49,,95% CI,14.77,26.2,,-34.46,,,,,,,,,,,,,,,,,,,,,≥2 standard deviation decrease from pooled mean on IES-R (20.23),0.6,,Community,,,1,0.4603,,0.5397,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters",Medium,"Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.",48230,2019
coffey2016_IES_A_12_ITT,Psychotherapy,PTSD,126,A,PTSD+SUD,Not integrated,29,,"Modified PE with trauma-focused motivational enhancement session, plus standard SUD TAU",Motivational enhancement session followed by modified Prolonged Exposure (PE) + standard substance use treatment as usual,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,40,Self report,IES,IES-R,ITT,Maximum likelihood imputation using multilevel mixed-effects models,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 3 to <6 Months,12,,19.1,,95% CI,13.01,25.18,,-35.85,,,,,,,,,,,,,,,,,,,,,≥2 standard deviation decrease from pooled mean on IES-R (20.23),,,Community,,,1,0.4603,,0.5397,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters",Medium,"Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.",48230,2019
coffey2016_IES_A_26_ITT,Psychotherapy,PTSD,126,A,PTSD+SUD,Not integrated,31,,"Modified PE with trauma-focused motivational enhancement session, plus standard SUD TAU",Motivational enhancement session followed by modified Prolonged Exposure (PE) + standard substance use treatment as usual,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,40,Self report,IES,IES-R,ITT,Maximum likelihood imputation using multilevel mixed-effects models,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 6 to <12 Months,26,,20.48,,95% CI,14.53,26.42,,-34.47,,,,,,,,,,,,,,,,,,,,,≥2 standard deviation decrease from pooled mean on IES-R (20.23),,,Community,,,1,0.4603,,0.5397,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters",Medium,"Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.",48230,2019
coffey2016_IES_A_Baseline_ITT,Psychotherapy,PTSD,126,A,PTSD+SUD,Not integrated,40,,"Modified PE with trauma-focused motivational enhancement session, plus standard SUD TAU",Motivational enhancement session followed by modified Prolonged Exposure (PE) + standard substance use treatment as usual,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,40,Self report,IES,IES-R,ITT,Maximum likelihood imputation using multilevel mixed-effects models,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,54.95,,95% CI,49.51,60.39,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4603,,0.5397,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters",Medium,"Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.",48230,2019
coffey2016_IES_B_0_ITT,Psychotherapy,PTSD,126,B,PTSD+SUD,Not integrated,33,,Modified PE plus standard SUD TAU,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,45,Self report,IES,IES-R,ITT,Maximum likelihood imputation using multilevel mixed-effects models,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,16.2,,95% CI,10.48,21.92,,-32.36,,,,,,,,,,,,,,,,,,,,,≥2 standard deviation decrease from pooled mean on IES-R (20.23),0.7576,,Community,,,1,0.4603,,0.5397,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters",Medium,"Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.",48230,2019
coffey2016_IES_B_12_ITT,Psychotherapy,PTSD,126,B,PTSD+SUD,Not integrated,32,,Modified PE plus standard SUD TAU,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,45,Self report,IES,IES-R,ITT,Maximum likelihood imputation using multilevel mixed-effects models,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 3 to <6 Months,12,,14.11,,95% CI,8.33,19.9,,-34.45,,,,,,,,,,,,,,,,,,,,,≥2 standard deviation decrease from pooled mean on IES-R (20.23),,,Community,,,1,0.4603,,0.5397,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters",Medium,"Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.",48230,2019
coffey2016_IES_B_26_ITT,Psychotherapy,PTSD,126,B,PTSD+SUD,Not integrated,35,,Modified PE plus standard SUD TAU,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,45,Self report,IES,IES-R,ITT,Maximum likelihood imputation using multilevel mixed-effects models,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 6 to <12 Months,26,,16.45,,95% CI,10.85,22.06,,-32.11,,,,,,,,,,,,,,,,,,,,,≥2 standard deviation decrease from pooled mean on IES-R (20.23),,,Community,,,1,0.4603,,0.5397,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters",Medium,"Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.",48230,2019
coffey2016_IES_B_Baseline_ITT,Psychotherapy,PTSD,126,B,PTSD+SUD,Not integrated,43,,Modified PE plus standard SUD TAU,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,45,Self report,IES,IES-R,ITT,Maximum likelihood imputation using multilevel mixed-effects models,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,48.56,,95% CI,43.43,53.68,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4603,,0.5397,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters",Medium,"Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.",48230,2019
coffey2016_IES_C_0_ITT,Psychotherapy,PTSD,126,C,SUD,,36,,Healthy lifestyle sessions plus standard SUD TAU,Healthy lifetsyle session +  substance use treatment as usual,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,41,Self report,IES,IES-R,ITT,Maximum likelihood imputation using multilevel mixed-effects models,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,27.4,,95% CI,21.8,33.01,,-23.62,,,,,,,,,,,,,,,,,,,,,≥2 standard deviation decrease from pooled mean on IES-R (20.23),0.4444,,Community,,,1,0.4603,,0.5397,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters",Medium,"Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.",48230,2019
coffey2016_IES_C_12_ITT,Psychotherapy,PTSD,126,C,SUD,,32,,Healthy lifestyle sessions plus standard SUD TAU,Healthy lifetsyle session +  substance use treatment as usual,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,41,Self report,IES,IES-R,ITT,Maximum likelihood imputation using multilevel mixed-effects models,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 3 to <6 Months,12,,26,,95% CI,20.15,31.85,,-25.02,,,,,,,,,,,,,,,,,,,,,≥2 standard deviation decrease from pooled mean on IES-R (20.23),,,Community,,,1,0.4603,,0.5397,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters",Medium,"Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.",48230,2019
coffey2016_IES_C_26_ITT,Psychotherapy,PTSD,126,C,SUD,,32,,Healthy lifestyle sessions plus standard SUD TAU,Healthy lifetsyle session +  substance use treatment as usual,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,41,Self report,IES,IES-R,ITT,Maximum likelihood imputation using multilevel mixed-effects models,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 6 to <12 Months,26,,26.5,,95% CI,20.52,32.5,,-24.52,,,,,,,,,,,,,,,,,,,,,≥2 standard deviation decrease from pooled mean on IES-R (20.23),,,Community,,,1,0.4603,,0.5397,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters",Medium,"Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.",48230,2019
coffey2016_IES_C_Baseline_ITT,Psychotherapy,PTSD,126,C,SUD,,41,,Healthy lifestyle sessions plus standard SUD TAU,Healthy lifetsyle session +  substance use treatment as usual,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,41,Self report,IES,IES-R,ITT,Maximum likelihood imputation using multilevel mixed-effects models,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,51.02,,95% CI,45.65,56.4,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4603,,0.5397,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters",Medium,"Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.",48230,2019
cohen2004_CAPS_A_0_Comp,Nonpharmacologic biological,PTSD,29,A,PTSD,,8,,Low frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_CAPS_A_2_Comp,Nonpharmacologic biological,PTSD,29,A,PTSD,,8,,Low frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at <3 Months,2,calculated score 84.5,87.9,17.5,,,,,-2,6.4,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_CAPS_A_Baseline_Comp,Nonpharmacologic biological,PTSD,29,A,PTSD,,8,,Low frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,87.9,17.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_CAPS_B_0_Comp,Nonpharmacologic biological,PTSD,29,B,PTSD,,10,,High frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,11,Structured Clinical Interview,CAPS,CAPS,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_CAPS_B_2_Comp,Nonpharmacologic biological,PTSD,29,B,PTSD,,10,,High frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,11,Structured Clinical Interview,CAPS,CAPS,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at <3 Months,2,,64,16.1,,,,,-30.5,11.6,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_CAPS_B_Baseline_Comp,Nonpharmacologic biological,PTSD,29,B,PTSD,,10,,High frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,11,Structured Clinical Interview,CAPS,CAPS,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,94.5,15.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_CAPS_C_0_Comp,Nonpharmacologic biological,PTSD,29,C,Control,,6,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Structured Clinical Interview,CAPS,CAPS,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_CAPS_C_2_Comp,Nonpharmacologic biological,PTSD,29,C,Control,,6,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Structured Clinical Interview,CAPS,CAPS,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at <3 Months,2,,74.9,9.7,,,,,-9.8,17.3,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_CAPS_C_Baseline_Comp,Nonpharmacologic biological,PTSD,29,C,Control,,6,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Structured Clinical Interview,CAPS,CAPS,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,84.3,19.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_PCL_A_0_NA,Nonpharmacologic biological,PTSD,29,A,PTSD,,,,Low frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Self report,PCL,PCL,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,56.0,9.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_PCL_A_2_NA,Nonpharmacologic biological,PTSD,29,A,PTSD,,,,Low frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Self report,PCL,PCL,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at <3 Months,2,,58.7,9.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_PCL_A_Baseline_NA,Nonpharmacologic biological,PTSD,29,A,PTSD,,,,Low frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Self report,PCL,PCL,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,62.5,7.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_PCL_B_0_NA,Nonpharmacologic biological,PTSD,29,B,PTSD,,,,High frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,11,Self report,PCL,PCL,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,43.5,8.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_PCL_B_2_NA,Nonpharmacologic biological,PTSD,29,B,PTSD,,,,High frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,11,Self report,PCL,PCL,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at <3 Months,2,,46.3,10.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_PCL_B_Baseline_NA,Nonpharmacologic biological,PTSD,29,B,PTSD,,,,High frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,11,Self report,PCL,PCL,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,63.2,13.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_PCL_C_0_NA,Nonpharmacologic biological,PTSD,29,C,Control,,,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Self report,PCL,PCL,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,55.0,4.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_PCL_C_2_NA,Nonpharmacologic biological,PTSD,29,C,Control,,,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Self report,PCL,PCL,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at <3 Months,2,,53.0,5.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_PCL_C_Baseline_NA,Nonpharmacologic biological,PTSD,29,C,Control,,,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Self report,PCL,PCL,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,56.8,3.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_TOP-8_A_0_NA,Nonpharmacologic biological,PTSD,29,A,PTSD,,,,Low frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,TOP-8,TOP-8,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,19.5,4.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_TOP-8_A_2_NA,Nonpharmacologic biological,PTSD,29,A,PTSD,,,,Low frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,TOP-8,TOP-8,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at <3 Months,2,,21.0,3.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_TOP-8_A_Baseline_NA,Nonpharmacologic biological,PTSD,29,A,PTSD,,,,Low frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,TOP-8,TOP-8,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,22.9,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_TOP-8_B_0_NA,Nonpharmacologic biological,PTSD,29,B,PTSD,,,,High frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,11,Structured Clinical Interview,TOP-8,TOP-8,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,12.9,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_TOP-8_B_2_NA,Nonpharmacologic biological,PTSD,29,B,PTSD,,,,High frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,11,Structured Clinical Interview,TOP-8,TOP-8,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at <3 Months,2,,17.2,6.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_TOP-8_B_Baseline_NA,Nonpharmacologic biological,PTSD,29,B,PTSD,,,,High frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,11,Structured Clinical Interview,TOP-8,TOP-8,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,22.3,6.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_TOP-8_C_0_NA,Nonpharmacologic biological,PTSD,29,C,Control,,,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Structured Clinical Interview,TOP-8,TOP-8,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,18.0,3.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_TOP-8_C_2_NA,Nonpharmacologic biological,PTSD,29,C,Control,,,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Structured Clinical Interview,TOP-8,TOP-8,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at <3 Months,2,,15.6,3.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
cohen2004_TOP-8_C_Baseline_NA,Nonpharmacologic biological,PTSD,29,C,Control,,,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Structured Clinical Interview,TOP-8,TOP-8,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,18.3,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.29,,0.71,Mixed,"combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)",High,"Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.",26291,2019
connor1999_DTS_A_0_NA,Pharmacotherapy,PTSD,54,A,PTSD,,,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,27,Self report,DTS,DTS,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,24.8,25.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.91,,0.09,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters. other (traumatic bereavement, father in intensive care unit, witnessed emotional abuse)",Medium,"Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999 Jul;175:17-22.  PMID: 10621763.",21108,2019
connor1999_DTS_A_Baseline_NA,Pharmacotherapy,PTSD,54,A,PTSD,,,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,27,Self report,DTS,DTS,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,73.7,20.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.91,,0.09,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters. other (traumatic bereavement, father in intensive care unit, witnessed emotional abuse)",Medium,"Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999 Jul;175:17-22.  PMID: 10621763.",21108,2019
connor1999_DTS_B_0_NA,Pharmacotherapy,PTSD,54,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,27,Self report,DTS,DTS,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,52.1,30.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.91,,0.09,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters. other (traumatic bereavement, father in intensive care unit, witnessed emotional abuse)",Medium,"Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999 Jul;175:17-22.  PMID: 10621763.",21108,2019
connor1999_DTS_B_Baseline_NA,Pharmacotherapy,PTSD,54,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,27,Self report,DTS,DTS,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,79.4,22.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.91,,0.09,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters. other (traumatic bereavement, father in intensive care unit, witnessed emotional abuse)",Medium,"Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999 Jul;175:17-22.  PMID: 10621763.",21108,2019
connor1999_SI-PTSD_A_0_ITT,Pharmacotherapy,PTSD,54,A,PTSD,,25,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,27,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,10.1,9.8,,,,,-23.9,,,,,,,,,,,,,,,,,,,,,CGI score of 1 or 2,0.8519,Additional definitions of Clinically Meaningful Response reported in the study,Community,0,0,1,0.91,,0.09,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters. other (traumatic bereavement, father in intensive care unit, witnessed emotional abuse)",Medium,"Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999 Jul;175:17-22.  PMID: 10621763.",21108,2019
connor1999_SI-PTSD_A_Baseline_ITT,Pharmacotherapy,PTSD,54,A,PTSD,,25,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,27,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,34.0,8.8,,,,,,,,,,,,,,,,,,,,,,,,,,CGI score of 1 or 2,,Additional definitions of Clinically Meaningful Response reported in the study,Community,0,0,1,0.91,,0.09,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters. other (traumatic bereavement, father in intensive care unit, witnessed emotional abuse)",Medium,"Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999 Jul;175:17-22.  PMID: 10621763.",21108,2019
connor1999_SI-PTSD_B_0_ITT,Pharmacotherapy,PTSD,54,B,Control,,22,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,27,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,20.5,12.6,,,,,-14,,,,,,,,,,,,,,,,,,,,,CGI score of 1 or 2,0.6154,Additional definitions of Clinically Meaningful Response reported in the study,Community,0,0,1,0.91,,0.09,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters. other (traumatic bereavement, father in intensive care unit, witnessed emotional abuse)",Medium,"Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999 Jul;175:17-22.  PMID: 10621763.",21108,2019
connor1999_SI-PTSD_B_Baseline_ITT,Pharmacotherapy,PTSD,54,B,Control,,22,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,27,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,35.4,8.2,,,,,,,,,,,,,,,,,,,,,,,,,,CGI score of 1 or 2,,Additional definitions of Clinically Meaningful Response reported in the study,Community,0,0,1,0.91,,0.09,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters. other (traumatic bereavement, father in intensive care unit, witnessed emotional abuse)",Medium,"Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999 Jul;175:17-22.  PMID: 10621763.",21108,2019
connor2006_DTS_A_0_NA,Pharmacotherapy,PTSD,18,A,PTSD,,,,Tiagabine,Tiagabine,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,DTS,DTS,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,22.9,25.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7308,,0.2692,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)",High,"Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.",29324,2019
connor2006_DTS_A_Baseline_NA,Pharmacotherapy,PTSD,18,A,PTSD,,,,Tiagabine,Tiagabine,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,DTS,DTS,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,39.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7308,,0.2692,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)",High,"Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.",29324,2019
connor2006_DTS_B_0_NA,Pharmacotherapy,PTSD,18,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Self report,DTS,DTS,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,23.0,28.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7308,,0.2692,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)",High,"Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.",29324,2019
connor2006_DTS_B_Baseline_NA,Pharmacotherapy,PTSD,18,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Self report,DTS,DTS,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,26.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7308,,0.2692,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)",High,"Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.",29324,2019
connor2006_SI-PTSD_A_0_ITT,Pharmacotherapy,PTSD,18,A,PTSD,,6,,Tiagabine,Tiagabine,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,15.7,11.7,,,,,,,,,,,,,,,,,,,,,,,,,,DTS score ≤17,0.6667,,Community,,,1,0.7308,,0.2692,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)",High,"Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.",29324,2019
connor2006_SI-PTSD_A_Baseline_ITT,Pharmacotherapy,PTSD,18,A,PTSD,,10,,Tiagabine,Tiagabine,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DTS score ≤17,,,Community,,,1,0.7308,,0.2692,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)",High,"Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.",29324,2019
connor2006_SI-PTSD_B_0_ITT,Pharmacotherapy,PTSD,18,B,Control,,7,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,12.8,15.4,,,,,,,,,,,,,,,,,,,,,,,,,,DTS score ≤17,0,,Community,,,1,0.7308,,0.2692,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)",High,"Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.",29324,2019
connor2006_SI-PTSD_B_Baseline_ITT,Pharmacotherapy,PTSD,18,B,Control,,8,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DTS score ≤17,,,Community,,,1,0.7308,,0.2692,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)",High,"Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.",29324,2019
connor2006_SPRINT_A_0_NA,Pharmacotherapy,PTSD,18,A,PTSD,,,,Tiagabine,Tiagabine,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,SPRINT,SPRINT,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,combined groups,6.6,6.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7308,,0.2692,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)",High,"Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.",29324,2019
connor2006_SPRINT_A_Baseline_NA,Pharmacotherapy,PTSD,18,A,PTSD,,,,Tiagabine,Tiagabine,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,SPRINT,SPRINT,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,9.2,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7308,,0.2692,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)",High,"Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.",29324,2019
connor2006_SPRINT_B_0_NA,Pharmacotherapy,PTSD,18,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Self report,SPRINT,SPRINT,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,combined groups,5.8,7.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7308,,0.2692,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)",High,"Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.",29324,2019
connor2006_SPRINT_B_Baseline_NA,Pharmacotherapy,PTSD,18,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Self report,SPRINT,SPRINT,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,9.2,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7308,,0.2692,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)",High,"Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.",29324,2019
cook2010_CAPS_A_0_Comp,Psychotherapy,PTSD,124,A,PTSD,,39,,Imagery Rehearsal,Imagery Rehearsal Training (IRT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,61,Structured Clinical Interview,CAPS,CAPS,Completer,Mixed effects model,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,72.9,20.46,,,,,-7.36,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.",84153,2019
cook2010_CAPS_A_0_ITT,Psychotherapy,PTSD,124,A,PTSD,,45,,Imagery Rehearsal,Imagery Rehearsal Training (IRT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,61,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed effects model,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,74.04,20.36,,,,,-7.3,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.",84153,2019
cook2010_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,124,A,PTSD,,39,,Imagery Rehearsal,Imagery Rehearsal Training (IRT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,61,Structured Clinical Interview,CAPS,CAPS,Completer,Mixed effects model,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,81.38,14.96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.",84153,2019
cook2010_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,124,A,PTSD,,61,,Imagery Rehearsal,Imagery Rehearsal Training (IRT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,61,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed effects model,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,81.34,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.",84153,2019
cook2010_CAPS_B_0_Comp,Psychotherapy,PTSD,124,B,PTSD,,51,,Sleep and nightmare management,Sleep and nightmare management,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Structured Clinical Interview,CAPS,CAPS,Completer,Mixed effects model,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,74.16,18.97,,,,,-6.1,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.",84153,2019
cook2010_CAPS_B_0_ITT,Psychotherapy,PTSD,124,B,PTSD,,56,,Sleep and nightmare management,Sleep and nightmare management,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed effects model,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,74.85,19.52,,,,,-4.63,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.",84153,2019
cook2010_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,124,B,PTSD,,51,,Sleep and nightmare management,Sleep and nightmare management,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Structured Clinical Interview,CAPS,CAPS,Completer,Mixed effects model,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,80.26,1527,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.",84153,2019
cook2010_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,124,B,PTSD,,63,,Sleep and nightmare management,Sleep and nightmare management,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed effects model,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,79.48,15.27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.",84153,2019
cook2010_PCL_A_0_ITT,Psychotherapy,PTSD,124,A,PTSD,,,,Imagery Rehearsal,Imagery Rehearsal Training (IRT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,61,Self report,PCL,PCL-M,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,58.83,13.56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.",84153,2019
cook2010_PCL_A_12_ITT,Psychotherapy,PTSD,124,A,PTSD,,,,Imagery Rehearsal,Imagery Rehearsal Training (IRT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,61,Self report,PCL,PCL-M,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 3 to <6 Months,12,,60.13,12.16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.",84153,2019
cook2010_PCL_A_26_ITT,Psychotherapy,PTSD,124,A,PTSD,,,,Imagery Rehearsal,Imagery Rehearsal Training (IRT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,61,Self report,PCL,PCL-M,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 6 to <12 Months,26,,59.05,11.87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.",84153,2019
cook2010_PCL_A_Baseline_ITT,Psychotherapy,PTSD,124,A,PTSD,,,,Imagery Rehearsal,Imagery Rehearsal Training (IRT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,61,Self report,PCL,PCL-M,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,62.73,10.18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.",84153,2019
cook2010_PCL_B_0_ITT,Psychotherapy,PTSD,124,B,PTSD,,,,Sleep and nightmare management,Sleep and nightmare management,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Self report,PCL,PCL-M,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,60.96,11.43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.",84153,2019
cook2010_PCL_B_12_ITT,Psychotherapy,PTSD,124,B,PTSD,,,,Sleep and nightmare management,Sleep and nightmare management,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Self report,PCL,PCL-M,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 3 to <6 Months,12,,61.13,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.",84153,2019
cook2010_PCL_B_26_ITT,Psychotherapy,PTSD,124,B,PTSD,,,,Sleep and nightmare management,Sleep and nightmare management,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Self report,PCL,PCL-M,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at 6 to <12 Months,26,,59.64,12.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.",84153,2019
cook2010_PCL_B_Baseline_ITT,Psychotherapy,PTSD,124,B,PTSD,,,,Sleep and nightmare management,Sleep and nightmare management,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Self report,PCL,PCL-M,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,65.06,9.48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.",84153,2019
cottraux2008_PCL_A_0_Comp,Psychotherapy,PTSD,60,A,PTSD,,27,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Self report,PCL,PCL,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,46.22,14.11,,,,,-15.18,12.9,,,,,,,,,,,,,,,,,,,,PCL <44,0.3704,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.7619,,0.2381,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)",Medium,"Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.",30573,2019
cottraux2008_PCL_A_0_ITT,Psychotherapy,PTSD,60,A,PTSD,,30,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Self report,PCL,PCL,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,,,,,,,-13.5,13.2,,,,,,,,,,,,,,,,,,,,PCL <44,0.3333,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.7619,,0.2381,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)",Medium,"Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.",30573,2019
cottraux2008_PCL_A_104_Comp,Psychotherapy,PTSD,60,A,PTSD,,16,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Self report,PCL,PCL,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at ≥12 Months,104,,42.56,16.58,,,,,-18.56,14.91,,,,,,,,,,,,,,,,,,,,PCL <44,0.5,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.7619,,0.2381,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)",Medium,"Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.",30573,2019
cottraux2008_PCL_A_52_Comp,Psychotherapy,PTSD,60,A,PTSD,,24,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Self report,PCL,PCL,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at ≥12 Months,52,,44.62,15.2,,,,,-16.75,14.94,,,,,,,,,,,,,,,,,,,,PCL <44,0.5,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.7619,,0.2381,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)",Medium,"Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.",30573,2019
cottraux2008_PCL_A_Baseline_Comp,Psychotherapy,PTSD,60,A,PTSD,,27,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Self report,PCL,PCL,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,61.37,9.48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7619,,0.2381,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)",Medium,"Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.",30573,2019
cottraux2008_PCL_A_Baseline_ITT,Psychotherapy,PTSD,60,A,PTSD,,31,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Self report,PCL,PCL,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7619,,0.2381,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)",Medium,"Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.",30573,2019
cottraux2008_PCL_B_0_Comp,Psychotherapy,PTSD,60,B,Control,,15,,Rogerian supportive therapy,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Self report,PCL,PCL,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,46.93,13.44,,,,,-12.06,13.86,,,,,,,,,,,,,,,,,,,,PCL <44,0.2667,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.7619,,0.2381,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)",Medium,"Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.",30573,2019
cottraux2008_PCL_B_0_ITT,Psychotherapy,PTSD,60,B,Control,,28,,Rogerian supportive therapy,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Self report,PCL,PCL,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,,,,,,,-6.3,12.9,,,,,,,,,,,,,,,,,,,,PCL <44,0.1429,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.7619,,0.2381,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)",Medium,"Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.",30573,2019
cottraux2008_PCL_B_104_Comp,Psychotherapy,PTSD,60,B,Control,,9,,Rogerian supportive therapy,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Self report,PCL,PCL,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at ≥12 Months,104,,42.77,12.82,,,,,-18.11,14.18,,,,,,,,,,,,,,,,,,,,PCL <44,0.4444,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.7619,,0.2381,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)",Medium,"Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.",30573,2019
cottraux2008_PCL_B_52_Comp,Psychotherapy,PTSD,60,B,Control,,14,,Rogerian supportive therapy,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Self report,PCL,PCL,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Assessment at ≥12 Months,52,,46.85,12.96,,,,,-12,10.5,,,,,,,,,,,,,,,,,,,,PCL <44,0.5,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.7619,,0.2381,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)",Medium,"Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.",30573,2019
cottraux2008_PCL_B_Baseline_Comp,Psychotherapy,PTSD,60,B,Control,,15,,Rogerian supportive therapy,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Self report,PCL,PCL,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,59,7.79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7619,,0.2381,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)",Medium,"Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.",30573,2019
cottraux2008_PCL_B_Baseline_ITT,Psychotherapy,PTSD,60,B,Control,,29,,Rogerian supportive therapy,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Self report,PCL,PCL,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7619,,0.2381,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)",Medium,"Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.",30573,2019
davidson1990_IES_A_0_Comp,Pharmacotherapy,PTSD,46,A,PTSD,,,,Amitriptyline,Amitriptyline,No,Not Applicable,Yes,Antidepressant: TCA,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Self report,IES,IES,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,25.0,11.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,High,"Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.",00912,2019
davidson1990_IES_A_0_I,Pharmacotherapy,PTSD,46,A,PTSD,,,,Amitriptyline,Amitriptyline,No,Not Applicable,Yes,Antidepressant: TCA,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Self report,IES,IES,Efficacy/ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,27.4,11.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,High,"Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.",00912,2019
davidson1990_IES_A_Baseline_Comp,Pharmacotherapy,PTSD,46,A,PTSD,,,,Amitriptyline,Amitriptyline,No,Not Applicable,Yes,Antidepressant: TCA,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Self report,IES,IES,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,31.8,8.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,High,"Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.",00912,2019
davidson1990_IES_A_Baseline_I,Pharmacotherapy,PTSD,46,A,PTSD,,,,Amitriptyline,Amitriptyline,No,Not Applicable,Yes,Antidepressant: TCA,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Self report,IES,IES,Efficacy/ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,33.1,8.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,High,"Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.",00912,2019
davidson1990_IES_B_0_Comp,Pharmacotherapy,PTSD,46,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,21,Self report,IES,IES,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,33.7,6.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,High,"Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.",00912,2019
davidson1990_IES_B_0_I,Pharmacotherapy,PTSD,46,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,21,Self report,IES,IES,Efficacy/ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,34.1,6.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,High,"Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.",00912,2019
davidson1990_IES_B_Baseline_Comp,Pharmacotherapy,PTSD,46,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,21,Self report,IES,IES,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,36.6,5.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,High,"Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.",00912,2019
davidson1990_IES_B_Baseline_I,Pharmacotherapy,PTSD,46,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,21,Self report,IES,IES,Efficacy/ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,36.8,5.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,High,"Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.",00912,2019
davidson1990_SI-PTSD_A_0_Comp,Pharmacotherapy,PTSD,46,A,PTSD,,17,,Amitriptyline,Amitriptyline,No,Not Applicable,Yes,Antidepressant: TCA,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,SI-PTSD,SI-PTSD,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,15.2,8.3,,,,,-7.2,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SI-PTSD,,,≥50% decrease on SI-PTSD,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,,,,Combat-related,,High,"Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.",00912,2019
davidson1990_SI-PTSD_A_0_I,Pharmacotherapy,PTSD,46,A,PTSD,,22,,Amitriptyline,Amitriptyline,No,Not Applicable,Yes,Antidepressant: TCA,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,SI-PTSD,SI-PTSD,Efficacy/ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,17.9,9.1,,,,,-6.2,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SI-PTSD,0.3636,,≥50% decrease on SI-PTSD,0.2727,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,,,,Combat-related,,High,"Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.",00912,2019
davidson1990_SI-PTSD_A_Baseline_Comp,Pharmacotherapy,PTSD,46,A,PTSD,,17,,Amitriptyline,Amitriptyline,No,Not Applicable,Yes,Antidepressant: TCA,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,SI-PTSD,SI-PTSD,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,22.4,7.8,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SI-PTSD,,,≥50% decrease on SI-PTSD,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,,,,Combat-related,,High,"Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.",00912,2019
davidson1990_SI-PTSD_A_Baseline_I,Pharmacotherapy,PTSD,46,A,PTSD,,22,,Amitriptyline,Amitriptyline,No,Not Applicable,Yes,Antidepressant: TCA,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,SI-PTSD,SI-PTSD,Efficacy/ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,24.1,8.4,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SI-PTSD,,,≥50% decrease on SI-PTSD,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,,,,Combat-related,,High,"Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.",00912,2019
davidson1990_SI-PTSD_B_0_Comp,Pharmacotherapy,PTSD,46,B,Control,,16,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,21,Structured Clinical Interview,SI-PTSD,SI-PTSD,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,20.3,7.5,,,,,-5.2,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SI-PTSD,,,≥50% decrease on SI-PTSD,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,,,,Combat-related,,High,"Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.",00912,2019
davidson1990_SI-PTSD_B_0_I,Pharmacotherapy,PTSD,46,B,Control,,18,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,21,Structured Clinical Interview,SI-PTSD,SI-PTSD,Efficacy/ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,20.8,7.2,,,,,-5.6,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SI-PTSD,0.2778,,≥50% decrease on SI-PTSD,0.1667,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,,,,Combat-related,,High,"Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.",00912,2019
davidson1990_SI-PTSD_B_Baseline_Comp,Pharmacotherapy,PTSD,46,B,Control,,16,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,21,Structured Clinical Interview,SI-PTSD,SI-PTSD,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,25.5,7.4,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SI-PTSD,,,≥50% decrease on SI-PTSD,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,,,,Combat-related,,High,"Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.",00912,2019
davidson1990_SI-PTSD_B_Baseline_I,Pharmacotherapy,PTSD,46,B,Control,,18,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,21,Structured Clinical Interview,SI-PTSD,SI-PTSD,Efficacy/ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,26.4,7.5,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SI-PTSD,,,≥50% decrease on SI-PTSD,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,,,,Combat-related,,High,"Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.",00912,2019
davidson2001_CAPS_A_0_ITT,Pharmacotherapy,PTSD,208,A,PTSD,,98,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,100,Structured Clinical Interview,CAPS,CAPS-2,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,40.9,,,,,,-33,,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 score and CGI-I score of 1 or 2 (very much improved or much improved),0.6,,Community,,,1,0.7788,,0.2212,Mixed,"accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")",Medium,"Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.",23358,2019
davidson2001_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,208,A,PTSD,,100,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,100,Structured Clinical Interview,CAPS,CAPS-2,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,73.9,16.2,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 score and CGI-I score of 1 or 2 (very much improved or much improved),,,Community,,,1,0.7788,,0.2212,Mixed,"accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")",Medium,"Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.",23358,2019
davidson2001_CAPS_B_0_ITT,Pharmacotherapy,PTSD,208,B,Control,,104,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,108,Structured Clinical Interview,CAPS,CAPS-2,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,47.3,,,,,,-26.2,2.3,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 score and CGI-I score of 1 or 2 (very much improved or much improved),0.38,,Community,,,1,0.7788,,0.2212,Mixed,"accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")",Medium,"Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.",23358,2019
davidson2001_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,208,B,Control,,108,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,108,Structured Clinical Interview,CAPS,CAPS-2,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,73.5,16.1,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 score and CGI-I score of 1 or 2 (very much improved or much improved),,,Community,,,1,0.7788,,0.2212,Mixed,"accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")",Medium,"Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.",23358,2019
davidson2001_DTS_A_0_NA,Pharmacotherapy,PTSD,208,A,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,100,Self report,DTS,DTS,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7788,,0.2212,Mixed,"accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")",Medium,"Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.",23358,2019
davidson2001_DTS_A_Baseline_NA,Pharmacotherapy,PTSD,208,A,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,100,Self report,DTS,DTS,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,74.5,26.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7788,,0.2212,Mixed,"accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")",Medium,"Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.",23358,2019
davidson2001_DTS_B_0_NA,Pharmacotherapy,PTSD,208,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,108,Self report,DTS,DTS,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7788,,0.2212,Mixed,"accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")",Medium,"Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.",23358,2019
davidson2001_DTS_B_Baseline_NA,Pharmacotherapy,PTSD,208,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,108,Self report,DTS,DTS,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,73.8,26.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7788,,0.2212,Mixed,"accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")",Medium,"Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.",23358,2019
davidson2001_IES_A_0_NA,Pharmacotherapy,PTSD,208,A,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,100,Self report,IES,IES,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7788,,0.2212,Mixed,"accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")",Medium,"Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.",23358,2019
davidson2001_IES_A_Baseline_NA,Pharmacotherapy,PTSD,208,A,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,100,Self report,IES,IES,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,38.5,15.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7788,,0.2212,Mixed,"accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")",Medium,"Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.",23358,2019
davidson2001_IES_B_0_NA,Pharmacotherapy,PTSD,208,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,108,Self report,IES,IES,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7788,,0.2212,Mixed,"accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")",Medium,"Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.",23358,2019
davidson2001_IES_B_Baseline_NA,Pharmacotherapy,PTSD,208,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,108,Self report,IES,IES,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,40.0,14.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7788,,0.2212,Mixed,"accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")",Medium,"Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.",23358,2019
davidson2003_DTS_A_0_ITT,Pharmacotherapy,PTSD,29,A,PTSD,,,,Mirtazapine,Mirtazapine,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Self report,DTS,DTS,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,54.1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,65.00% of 8-week completers,,Mixed,"child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)",Medium,"Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.",25290,2019
davidson2003_DTS_A_Baseline_ITT,Pharmacotherapy,PTSD,29,A,PTSD,,,,Mirtazapine,Mirtazapine,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Self report,DTS,DTS,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,74.8,36.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,65.00% of 8-week completers,,Mixed,"child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)",Medium,"Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.",25290,2019
davidson2003_DTS_B_0_ITT,Pharmacotherapy,PTSD,29,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,9,Self report,DTS,DTS,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,82.6,27.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,65.00% of 8-week completers,,Mixed,"child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)",Medium,"Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.",25290,2019
davidson2003_DTS_B_Baseline_ITT,Pharmacotherapy,PTSD,29,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,9,Self report,DTS,DTS,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,93.8,29.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,65.00% of 8-week completers,,Mixed,"child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)",Medium,"Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.",25290,2019
davidson2003_SI-PTSD_A_0_Comp,Pharmacotherapy,PTSD,29,A,PTSD,,14,,Mirtazapine,Mirtazapine,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,SI-PTSD,SI-PTSD,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"SPRINT Global item rated 1 or 2 (""very much improved"" or ""much improved"")",0.7857,,Community,,,1,,65.00% of 8-week completers,,Mixed,"child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)",Medium,"Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.",25290,2019
davidson2003_SI-PTSD_A_0_ITT,Pharmacotherapy,PTSD,29,A,PTSD,,17,,Mirtazapine,Mirtazapine,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,17.4,4,,,,,-17.3,,,,,,,,,,,,,,,,,,,,,"SPRINT Global item rated 1 or 2 (""very much improved"" or ""much improved"")",0.6471,,Community,,,1,,65.00% of 8-week completers,,Mixed,"child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)",Medium,"Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.",25290,2019
davidson2003_SI-PTSD_A_Baseline_Comp,Pharmacotherapy,PTSD,29,A,PTSD,,14,,Mirtazapine,Mirtazapine,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,SI-PTSD,SI-PTSD,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"SPRINT Global item rated 1 or 2 (""very much improved"" or ""much improved"")",,,Community,,,1,,65.00% of 8-week completers,,Mixed,"child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)",Medium,"Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.",25290,2019
davidson2003_SI-PTSD_A_Baseline_ITT,Pharmacotherapy,PTSD,29,A,PTSD,,17,,Mirtazapine,Mirtazapine,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,34.7,7,,,,,,,,,,,,,,,,,,,,,,,,,,"SPRINT Global item rated 1 or 2 (""very much improved"" or ""much improved"")",,,Community,,,1,,65.00% of 8-week completers,,Mixed,"child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)",Medium,"Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.",25290,2019
davidson2003_SI-PTSD_B_0_Comp,Pharmacotherapy,PTSD,29,B,Control,,6,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,9,Structured Clinical Interview,SI-PTSD,SI-PTSD,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"SPRINT Global item rated 1 or 2 (""very much improved"" or ""much improved"")",0.1667,,Community,,,1,,65.00% of 8-week completers,,Mixed,"child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)",Medium,"Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.",25290,2019
davidson2003_SI-PTSD_B_0_ITT,Pharmacotherapy,PTSD,29,B,Control,,9,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,9,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,32.9,12.7,,,,,-5.5,,,,,,,,,,,,,,,,,,,,,"SPRINT Global item rated 1 or 2 (""very much improved"" or ""much improved"")",0.2222,,Community,,,1,,65.00% of 8-week completers,,Mixed,"child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)",Medium,"Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.",25290,2019
davidson2003_SI-PTSD_B_Baseline_Comp,Pharmacotherapy,PTSD,29,B,Control,,6,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,9,Structured Clinical Interview,SI-PTSD,SI-PTSD,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"SPRINT Global item rated 1 or 2 (""very much improved"" or ""much improved"")",,,Community,,,1,,65.00% of 8-week completers,,Mixed,"child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)",Medium,"Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.",25290,2019
davidson2003_SI-PTSD_B_Baseline_ITT,Pharmacotherapy,PTSD,29,B,Control,,9,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,9,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,38.4,6.7,,,,,,,,,,,,,,,,,,,,,,,,,,"SPRINT Global item rated 1 or 2 (""very much improved"" or ""much improved"")",,,Community,,,1,,65.00% of 8-week completers,,Mixed,"child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)",Medium,"Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.",25290,2019
davidson2003_SPRINT_A_0_ITT,Pharmacotherapy,PTSD,29,A,PTSD,,,,Mirtazapine,Mirtazapine,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Self report,SPRINT,SPRINT,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,12.4,8.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,65.00% of 8-week completers,,Mixed,"child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)",Medium,"Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.",25290,2019
davidson2003_SPRINT_A_Baseline_ITT,Pharmacotherapy,PTSD,29,A,PTSD,,,,Mirtazapine,Mirtazapine,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Self report,SPRINT,SPRINT,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,21.7,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,65.00% of 8-week completers,,Mixed,"child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)",Medium,"Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.",25290,2019
davidson2003_SPRINT_B_0_ITT,Pharmacotherapy,PTSD,29,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,9,Self report,SPRINT,SPRINT,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,19.4,8.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,65.00% of 8-week completers,,Mixed,"child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)",Medium,"Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.",25290,2019
davidson2003_SPRINT_B_Baseline_ITT,Pharmacotherapy,PTSD,29,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,9,Self report,SPRINT,SPRINT,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,25.0,4.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,65.00% of 8-week completers,,Mixed,"child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)",Medium,"Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.",25290,2019
davidson2006a_CAPS_A_0_Comp,Pharmacotherapy,PTSD,329,A,PTSD,,112,,Venlafaxine extended release,Venlafaxine,No,Not Applicable,Yes,Antidepressant: SNRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,161,Structured Clinical Interview,CAPS,CAPS-SX17,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,,,,,,,-59.2,23.76,,,,,,,,,,,,,,,,,,,,CAPS-SX17 score ≤20,0.447,,Community,,,1,0.541,,0.459,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, natural or manmade disasters, other (nonsexual abuse, witnessing unexpected death)",Medium,"Davidson JRT, Baldwin DV, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65. doi: 10.1001/archpsyc.63.10.1158. PMID: 17015818.",28838,2019
davidson2006a_CAPS_A_0_ITT,Pharmacotherapy,PTSD,329,A,PTSD,,161,,Venlafaxine extended release,Venlafaxine,No,Not Applicable,Yes,Antidepressant: SNRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,161,Structured Clinical Interview,CAPS,CAPS-SX17,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,29.2,26.09,,,,,-51.7,27.16,,,,,,,,,,,,,,,,,,,,CAPS-SX17 score ≤20,0.509,,Community,,,1,0.541,,0.459,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, natural or manmade disasters, other (nonsexual abuse, witnessing unexpected death)",Medium,"Davidson JRT, Baldwin DV, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65. doi: 10.1001/archpsyc.63.10.1158. PMID: 17015818.",28838,2019
davidson2006a_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,329,A,PTSD,,112,,Venlafaxine extended release,Venlafaxine,No,Not Applicable,Yes,Antidepressant: SNRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,161,Structured Clinical Interview,CAPS,CAPS-SX17,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS-SX17 score ≤20,,,Community,,,1,0.541,,0.459,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, natural or manmade disasters, other (nonsexual abuse, witnessing unexpected death)",Medium,"Davidson JRT, Baldwin DV, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65. doi: 10.1001/archpsyc.63.10.1158. PMID: 17015818.",28838,2019
davidson2006a_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,329,A,PTSD,,161,,Venlafaxine extended release,Venlafaxine,No,Not Applicable,Yes,Antidepressant: SNRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,161,Structured Clinical Interview,CAPS,CAPS-SX17,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,81.0,14.62,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS-SX17 score ≤20,,,Community,,,1,0.541,,0.459,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, natural or manmade disasters, other (nonsexual abuse, witnessing unexpected death)",Medium,"Davidson JRT, Baldwin DV, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65. doi: 10.1001/archpsyc.63.10.1158. PMID: 17015818.",28838,2019
davidson2006a_CAPS_B_0_Comp,Pharmacotherapy,PTSD,329,B,Control,,112,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,168,Structured Clinical Interview,CAPS,CAPS-SX17,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,,,,,,,-54,23.63,,,,,,,,,,,,,,,,,,,,CAPS-SX17 score ≤20,0.333,,Community,,,1,0.541,,0.459,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, natural or manmade disasters, other (nonsexual abuse, witnessing unexpected death)",Medium,"Davidson JRT, Baldwin DV, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65. doi: 10.1001/archpsyc.63.10.1158. PMID: 17015818.",28838,2019
davidson2006a_CAPS_B_0_ITT,Pharmacotherapy,PTSD,329,B,Control,,168,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,168,Structured Clinical Interview,CAPS,CAPS-SX17,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,38.1,29.11,,,,,-43.9,28.93,,,,,,,,,,,,,,,,,,,,CAPS-SX17 score ≤20,0.375,,Community,,,1,0.541,,0.459,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, natural or manmade disasters, other (nonsexual abuse, witnessing unexpected death)",Medium,"Davidson JRT, Baldwin DV, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65. doi: 10.1001/archpsyc.63.10.1158. PMID: 17015818.",28838,2019
davidson2006a_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,329,B,Control,,112,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,168,Structured Clinical Interview,CAPS,CAPS-SX17,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS-SX17 score ≤20,,,Community,,,1,0.541,,0.459,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, natural or manmade disasters, other (nonsexual abuse, witnessing unexpected death)",Medium,"Davidson JRT, Baldwin DV, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65. doi: 10.1001/archpsyc.63.10.1158. PMID: 17015818.",28838,2019
davidson2006a_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,329,B,Control,,168,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,168,Structured Clinical Interview,CAPS,CAPS-SX17,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,82.9,15.5,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS-SX17 score ≤20,,,Community,,,1,0.541,,0.459,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, natural or manmade disasters, other (nonsexual abuse, witnessing unexpected death)",Medium,"Davidson JRT, Baldwin DV, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65. doi: 10.1001/archpsyc.63.10.1158. PMID: 17015818.",28838,2019
davidson2006b_CAPS_A_0_ITT,Pharmacotherapy,PTSD,538,A,PTSD,,179,,Venlafaxine extended release,Venlafaxine,No,Not Applicable,Yes,Antidepressant: SNRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,179,Structured Clinical Interview,CAPS,CAPS-SX17,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,42.49,,,,,,-41.51,,-45.66,-37.36,,,,,,,,,,,,,,,,,,CAPS-SX17 score ≤20,,,Community,,,1,,,,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (""unexpected death"")",Medium,"Davidson JRT, Rothbaum BO, Tucker PM, et al. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006 Jun 1;26(3):259-67. doi: 10.1097/01.jcp.0000222514.71390.c1. PMID: 16702890.",28788,2019
davidson2006b_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,538,A,PTSD,,179,,Venlafaxine extended release,Venlafaxine,No,Not Applicable,Yes,Antidepressant: SNRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,179,Structured Clinical Interview,CAPS,CAPS-SX17,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,84.0,14.97,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS-SX17 score ≤20,,,Community,,,1,,,,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (""unexpected death"")",Medium,"Davidson JRT, Rothbaum BO, Tucker PM, et al. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006 Jun 1;26(3):259-67. doi: 10.1097/01.jcp.0000222514.71390.c1. PMID: 16702890.",28788,2019
davidson2006b_CAPS_B_0_ITT,Pharmacotherapy,PTSD,538,B,PTSD,,173,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,173,Structured Clinical Interview,CAPS,CAPS-SX17,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,42.56,,,,,,-39.44,,-43.67,-35.21,,,,,,,,,,,,,,,,,,CAPS-SX17 score ≤20,,,Community,,,1,,,,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (""unexpected death"")",Medium,"Davidson JRT, Rothbaum BO, Tucker PM, et al. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006 Jun 1;26(3):259-67. doi: 10.1097/01.jcp.0000222514.71390.c1. PMID: 16702890.",28788,2019
davidson2006b_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,538,B,PTSD,,173,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,173,Structured Clinical Interview,CAPS,CAPS-SX17,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,82.0,15.49,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS-SX17 score ≤20,,,Community,,,1,,,,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (""unexpected death"")",Medium,"Davidson JRT, Rothbaum BO, Tucker PM, et al. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006 Jun 1;26(3):259-67. doi: 10.1097/01.jcp.0000222514.71390.c1. PMID: 16702890.",28788,2019
davidson2006b_CAPS_C_0_ITT,Pharmacotherapy,PTSD,538,C,Control,,179,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,179,Structured Clinical Interview,CAPS,CAPS-SX17,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,47.43,,,,,,-34.17,,-38.33,-30.01,,,,,,,,,,,,,,,,,,CAPS-SX17 score ≤20,,,Community,,,1,,,,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (""unexpected death"")",Medium,"Davidson JRT, Rothbaum BO, Tucker PM, et al. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006 Jun 1;26(3):259-67. doi: 10.1097/01.jcp.0000222514.71390.c1. PMID: 16702890.",28788,2019
davidson2006b_CAPS_C_Baseline_ITT,Pharmacotherapy,PTSD,538,C,Control,,179,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,179,Structured Clinical Interview,CAPS,CAPS-SX17,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,81.6,14.66,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS-SX17 score ≤20,,,Community,,,1,,,,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (""unexpected death"")",Medium,"Davidson JRT, Rothbaum BO, Tucker PM, et al. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006 Jun 1;26(3):259-67. doi: 10.1097/01.jcp.0000222514.71390.c1. PMID: 16702890.",28788,2019
davidson2007_CAPS_A_0_Comp,Pharmacotherapy,PTSD,232,A,PTSD,,105,,Tiagabine,Tiagabine,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,116,Structured Clinical Interview,CAPS,CAPS,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,51.7,,,,,,-30.7,25.1,,,,,,,,,,,,,,,,,,,,CAPS total score <20,0.16,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.66,,0.34,Mixed,"rape/sexual assault, community/school violence, accidents, combat-related, natural or manmade disasters, other (non-specified)",Medium,"Davidson JR, Brady K, Mellman TA, et al. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. J Clin Psychopharmacol. 2007 Feb;27(1):85-8. doi: 10.1097/JCP.0b013e31802e5115. PMID: 17224720.",29658,2019
davidson2007_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,232,A,PTSD,,116,,Tiagabine,Tiagabine,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,116,Structured Clinical Interview,CAPS,CAPS,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,82.4,15.8,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS total score <20,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.66,,0.34,Mixed,"rape/sexual assault, community/school violence, accidents, combat-related, natural or manmade disasters, other (non-specified)",Medium,"Davidson JR, Brady K, Mellman TA, et al. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. J Clin Psychopharmacol. 2007 Feb;27(1):85-8. doi: 10.1097/JCP.0b013e31802e5115. PMID: 17224720.",29658,2019
davidson2007_CAPS_B_0_Comp,Pharmacotherapy,PTSD,232,B,Control,,97,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,116,Structured Clinical Interview,CAPS,CAPS,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,52.5,,,,,,-30.2,26.3,,,,,,,,,,,,,,,,,,,,CAPS total score <20,0.14,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.66,,0.34,Mixed,"rape/sexual assault, community/school violence, accidents, combat-related, natural or manmade disasters, other (non-specified)",Medium,"Davidson JR, Brady K, Mellman TA, et al. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. J Clin Psychopharmacol. 2007 Feb;27(1):85-8. doi: 10.1097/JCP.0b013e31802e5115. PMID: 17224720.",29658,2019
davidson2007_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,232,B,Control,,116,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,116,Structured Clinical Interview,CAPS,CAPS,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,82.7,14.4,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS total score <20,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.66,,0.34,Mixed,"rape/sexual assault, community/school violence, accidents, combat-related, natural or manmade disasters, other (non-specified)",Medium,"Davidson JR, Brady K, Mellman TA, et al. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. J Clin Psychopharmacol. 2007 Feb;27(1):85-8. doi: 10.1097/JCP.0b013e31802e5115. PMID: 17224720.",29658,2019
davis2004_CAPS_A_0_ITT,Pharmacotherapy,PTSD,42,A,PTSD,,26,,Nefazodone,Nefazodone,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,27,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,61.9,,,,,,-19.1,24,,,,,,,,,,,,,,,,,,,,≥30% improvement in CAPS Total Score for patients who completed at least 4 weeks of treatment,0.4737,,Mixed,0,0.9762,0.0238,0.0238,,0.9762,Mixed,"combat-related, rape/sexual assault",High,"Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291-7.  PMID: 15118483.",26401,2019
davis2004_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,42,A,PTSD,,26,,Nefazodone,Nefazodone,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,27,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,81.0,20,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% improvement in CAPS Total Score for patients who completed at least 4 weeks of treatment,,,Mixed,0,0.9762,0.0238,0.0238,,0.9762,Mixed,"combat-related, rape/sexual assault",High,"Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291-7.  PMID: 15118483.",26401,2019
davis2004_CAPS_B_0_ITT,Pharmacotherapy,PTSD,42,B,Control,,15,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,15,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,69.7,,,,,,-13.5,25,,,,,,,,,,,,,,,,,,,,≥30% improvement in CAPS Total Score for patients who completed at least 4 weeks of treatment,0.4166,,Mixed,0,0.9762,0.0238,0.0238,,0.9762,Mixed,"combat-related, rape/sexual assault",High,"Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291-7.  PMID: 15118483.",26401,2019
davis2004_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,42,B,Control,,15,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,15,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,83.2,17,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% improvement in CAPS Total Score for patients who completed at least 4 weeks of treatment,,,Mixed,0,0.9762,0.0238,0.0238,,0.9762,Mixed,"combat-related, rape/sexual assault",High,"Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291-7.  PMID: 15118483.",26401,2019
davis2004_PCL_A_0_NA,Pharmacotherapy,PTSD,42,A,PTSD,,,,Nefazodone,Nefazodone,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,27,Self report,PCL,PCL,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.9762,0.0238,0.0238,,0.9762,Mixed,"combat-related, rape/sexual assault",High,"Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291-7.  PMID: 15118483.",26401,2019
davis2004_PCL_A_Baseline_NA,Pharmacotherapy,PTSD,42,A,PTSD,,,,Nefazodone,Nefazodone,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,27,Self report,PCL,PCL,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,64.1,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.9762,0.0238,0.0238,,0.9762,Mixed,"combat-related, rape/sexual assault",High,"Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291-7.  PMID: 15118483.",26401,2019
davis2004_PCL_B_0_NA,Pharmacotherapy,PTSD,42,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,15,Self report,PCL,PCL,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.9762,0.0238,0.0238,,0.9762,Mixed,"combat-related, rape/sexual assault",High,"Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291-7.  PMID: 15118483.",26401,2019
davis2004_PCL_B_Baseline_NA,Pharmacotherapy,PTSD,42,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,15,Self report,PCL,PCL,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,61.5,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.9762,0.0238,0.0238,,0.9762,Mixed,"combat-related, rape/sexual assault",High,"Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291-7.  PMID: 15118483.",26401,2019
davis2008a_CAPS_A_0_ITT,Pharmacotherapy,PTSD,36,A,PTSD,,18,,Guanfacine,Guanfacine,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,66.94,29.87,,,,,-15.12,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0571,,0.9429,Combat-related,,Medium,"Davis LL, Ward C, Rasmusson A, et al. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008;41(1):8-18.  PMID: 18362867.",34102,2019
davis2008a_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,36,A,PTSD,,18,,Guanfacine,Guanfacine,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,82.06,16.81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0571,,0.9429,Combat-related,,Medium,"Davis LL, Ward C, Rasmusson A, et al. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008;41(1):8-18.  PMID: 18362867.",34102,2019
davis2008a_CAPS_B_0_ITT,Pharmacotherapy,PTSD,36,B,Control,,17,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,74.82,29.26,,,,,-13.59,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0571,,0.9429,Combat-related,,Medium,"Davis LL, Ward C, Rasmusson A, et al. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008;41(1):8-18.  PMID: 18362867.",34102,2019
davis2008a_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,36,B,Control,,17,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,88.41,17.87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0571,,0.9429,Combat-related,,Medium,"Davis LL, Ward C, Rasmusson A, et al. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008;41(1):8-18.  PMID: 18362867.",34102,2019
davis2008a_DTS_A_0_NA,Pharmacotherapy,PTSD,36,A,PTSD,,,,Guanfacine,Guanfacine,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Self report,DTS,DTS,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,75.11,32.51,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0571,,0.9429,Combat-related,,Medium,"Davis LL, Ward C, Rasmusson A, et al. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008;41(1):8-18.  PMID: 18362867.",34102,2019
davis2008a_DTS_A_Baseline_NA,Pharmacotherapy,PTSD,36,A,PTSD,,,,Guanfacine,Guanfacine,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Self report,DTS,DTS,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,92.33,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0571,,0.9429,Combat-related,,Medium,"Davis LL, Ward C, Rasmusson A, et al. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008;41(1):8-18.  PMID: 18362867.",34102,2019
davis2008a_DTS_B_0_NA,Pharmacotherapy,PTSD,36,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,18,Self report,DTS,DTS,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,82.59,31.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0571,,0.9429,Combat-related,,Medium,"Davis LL, Ward C, Rasmusson A, et al. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008;41(1):8-18.  PMID: 18362867.",34102,2019
davis2008a_DTS_B_Baseline_NA,Pharmacotherapy,PTSD,36,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,18,Self report,DTS,DTS,,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,100.77,24.74,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0571,,0.9429,Combat-related,,Medium,"Davis LL, Ward C, Rasmusson A, et al. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008;41(1):8-18.  PMID: 18362867.",34102,2019
davis2008b_CAPS_A_0_Comp,Pharmacotherapy,PTSD,85,A,PTSD,,34,,Divalproex,Divalproex,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,44,Structured Clinical Interview,CAPS,CAPS,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>30% PTSD scores,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.0244,,0.9756,Mixed,"combat-related, other (non-specified)",Low,"Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347",30463,2019
davis2008b_CAPS_A_0_ITT,Pharmacotherapy,PTSD,85,A,PTSD,,41,,Divalproex,Divalproex,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,44,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,60.1,24.1,,,,,-15.1,,,,,,,,,,,,,,,,,,,,,>30% PTSD scores,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.0244,,0.9756,Mixed,"combat-related, other (non-specified)",Low,"Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347",30463,2019
davis2008b_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,85,A,PTSD,,34,,Divalproex,Divalproex,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,44,Structured Clinical Interview,CAPS,CAPS,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>30% PTSD scores,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.0244,,0.9756,Mixed,"combat-related, other (non-specified)",Low,"Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347",30463,2019
davis2008b_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,85,A,PTSD,,41,,Divalproex,Divalproex,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,44,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,75.2,19.1,,,,,,,,,,,,,,,,,,,,,,,,,,>30% PTSD scores,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.0244,,0.9756,Mixed,"combat-related, other (non-specified)",Low,"Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347",30463,2019
davis2008b_CAPS_B_0_Comp,Pharmacotherapy,PTSD,85,B,Control,,34,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,44,Structured Clinical Interview,CAPS,CAPS,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>30% PTSD scores,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.0244,,0.9756,Mixed,"combat-related, other (non-specified)",Low,"Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347",30463,2019
davis2008b_CAPS_B_0_ITT,Pharmacotherapy,PTSD,85,B,Control,,41,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,44,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,60.8,26.6,,,,,-16.5,,,,,,,,,,,,,,,,,,,,,>30% PTSD scores,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.0244,,0.9756,Mixed,"combat-related, other (non-specified)",Low,"Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347",30463,2019
davis2008b_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,85,B,Control,,34,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,44,Structured Clinical Interview,CAPS,CAPS,Completer,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>30% PTSD scores,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.0244,,0.9756,Mixed,"combat-related, other (non-specified)",Low,"Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347",30463,2019
davis2008b_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,85,B,Control,,41,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,44,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,77.3,15.3,,,,,,,,,,,,,,,,,,,,,,,,,,>30% PTSD scores,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.0244,,0.9756,Mixed,"combat-related, other (non-specified)",Low,"Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347",30463,2019
davis2008b_TOP-8_A_0_ITT,Pharmacotherapy,PTSD,85,A,PTSD,,,,Divalproex,Divalproex,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,44,Self report,TOP-8,TOP-8,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,15.4,6.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0244,,0.9756,Mixed,"combat-related, other (non-specified)",Low,"Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347",30463,2019
davis2008b_TOP-8_A_Baseline_ITT,Pharmacotherapy,PTSD,85,A,PTSD,,,,Divalproex,Divalproex,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,44,Self report,TOP-8,TOP-8,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,19.4,5.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0244,,0.9756,Mixed,"combat-related, other (non-specified)",Low,"Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347",30463,2019
davis2008b_TOP-8_B_0_ITT,Pharmacotherapy,PTSD,85,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,44,Self report,TOP-8,TOP-8,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",End of Treatment,0,,15.8,6.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0244,,0.9756,Mixed,"combat-related, other (non-specified)",Low,"Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347",30463,2019
davis2008b_TOP-8_B_Baseline_ITT,Pharmacotherapy,PTSD,85,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,44,Self report,TOP-8,TOP-8,ITT,,"Continuous outcomes: longitudinal mixed-effects models, Cohen's d effect sizes; Categorical outcomes: logistic regression and likelihood ratio tests",Baseline,,,19.7,4.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0244,,0.9756,Mixed,"combat-related, other (non-specified)",Low,"Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347",30463,2019
davis2018b_CAPS_A_0_mI,Pharmacotherapy,PTSD,214,A,PTSD,,65,,MBSR,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In person,107,Structured Clinical Interview,CAPS,CAPS-IV,Modified ITT (patients attending ≥1 therapy sessions),,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.",End of Treatment,0,,59.1,27.1,,,,,-25.2,,,,,,,,,,,,,,,,,,"CAPS-IV ≤45 (""remission"")",0.307,,≥30% reduction in CAPS-IV score,0.452,,Veteran,0,1,0,0.162,,0.838,Mixed,"Combat-related; Rape/sexual assault; Other (noncombat military, civilian)",Low,"Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..",51046,2020
davis2018b_CAPS_A_8_mI,Pharmacotherapy,PTSD,214,A,PTSD,,61,,MBSR,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In person,107,Structured Clinical Interview,CAPS,CAPS-IV,Modified ITT (patients attending ≥1 therapy sessions),,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.",Assessment at <3 Months,8,,64.8,30.8,,,,,-19.5,,,,,,,,,,,,,,,,,,"CAPS-IV ≤45 (""remission"")",,,≥30% reduction in CAPS-IV score,,,Veteran,0,1,0,0.162,,0.838,Mixed,"Combat-related; Rape/sexual assault; Other (noncombat military, civilian)",Low,"Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..",51046,2020
davis2018b_CAPS_A_Baseline_mI,Pharmacotherapy,PTSD,214,A,PTSD,,96,,MBSR,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In person,107,Structured Clinical Interview,CAPS,CAPS-IV,Modified ITT (patients attending ≥1 therapy sessions),,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.",Baseline,,,84.3,19.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.162,,0.838,Mixed,"Combat-related; Rape/sexual assault; Other (noncombat military, civilian)",Low,"Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..",51046,2020
davis2018b_CAPS_B_0_mI,Pharmacotherapy,PTSD,214,B,Control,,77,,Present-centered group therapy,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,107,Structured Clinical Interview,CAPS,CAPS-IV,Modified ITT (patients attending ≥1 therapy sessions),,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.",End of Treatment,0,,64.5,28.2,,,,,-16.2,,,,,,,,,,,,,,,,,,"CAPS-IV ≤45 (""remission"")",0.273,,≥30% reduction in CAPS-IV score,0.377,,Veteran,0,1,0,0.162,,0.838,Mixed,"Combat-related; Rape/sexual assault; Other (noncombat military, civilian)",Low,"Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..",51046,2020
davis2018b_CAPS_B_8_mI,Pharmacotherapy,PTSD,214,B,Control,,69,,Present-centered group therapy,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,107,Structured Clinical Interview,CAPS,CAPS-IV,Modified ITT (patients attending ≥1 therapy sessions),,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.",Assessment at <3 Months,8,,62.9,28.3,,,,,-17.8,,,,,,,,,,,,,,,,,,"CAPS-IV ≤45 (""remission"")",,,≥30% reduction in CAPS-IV score,,,Veteran,0,1,0,0.162,,0.838,Mixed,"Combat-related; Rape/sexual assault; Other (noncombat military, civilian)",Low,"Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..",51046,2020
davis2018b_CAPS_B_Baseline_mI,Pharmacotherapy,PTSD,214,B,Control,,95,,Present-centered group therapy,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,107,Structured Clinical Interview,CAPS,CAPS-IV,Modified ITT (patients attending ≥1 therapy sessions),,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.",Baseline,,,80.7,16.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.162,,0.838,Mixed,"Combat-related; Rape/sexual assault; Other (noncombat military, civilian)",Low,"Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..",51046,2020
davis2018b_PCL_A_0_mI,Pharmacotherapy,PTSD,214,A,PTSD,,,,MBSR,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In person,107,Self report,PCL,PCL,Modified ITT (patients attending ≥1 therapy sessions),,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.",End of Treatment,0,,53.8,17.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.162,,0.838,Mixed,"Combat-related; Rape/sexual assault; Other (noncombat military, civilian)",Low,"Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..",51046,2020
davis2018b_PCL_A_8_mI,Pharmacotherapy,PTSD,214,A,PTSD,,,,MBSR,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In person,107,Self report,PCL,PCL,Modified ITT (patients attending ≥1 therapy sessions),,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.",Assessment at <3 Months,8,,56.2,16.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.162,,0.838,Mixed,"Combat-related; Rape/sexual assault; Other (noncombat military, civilian)",Low,"Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..",51046,2020
davis2018b_PCL_A_Baseline_mI,Pharmacotherapy,PTSD,214,A,PTSD,,,,MBSR,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In person,107,Self report,PCL,PCL,Modified ITT (patients attending ≥1 therapy sessions),,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.",Baseline,,,63.1,12.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.162,,0.838,Mixed,"Combat-related; Rape/sexual assault; Other (noncombat military, civilian)",Low,"Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..",51046,2020
davis2018b_PCL_B_0_mI,Pharmacotherapy,PTSD,214,B,Control,,,,Present-centered group therapy,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,107,Self report,PCL,PCL,Modified ITT (patients attending ≥1 therapy sessions),,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.",End of Treatment,0,,52.6,14.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.162,,0.838,Mixed,"Combat-related; Rape/sexual assault; Other (noncombat military, civilian)",Low,"Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..",51046,2020
davis2018b_PCL_B_8_mI,Pharmacotherapy,PTSD,214,B,Control,,,,Present-centered group therapy,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,107,Self report,PCL,PCL,Modified ITT (patients attending ≥1 therapy sessions),,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.",Assessment at <3 Months,8,,53.8,15.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.162,,0.838,Mixed,"Combat-related; Rape/sexual assault; Other (noncombat military, civilian)",Low,"Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..",51046,2020
davis2018b_PCL_B_Baseline_mI,Pharmacotherapy,PTSD,214,B,Control,,,,Present-centered group therapy,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,107,Self report,PCL,PCL,Modified ITT (patients attending ≥1 therapy sessions),,"Mixed-effects linear regression analysis used. Each model included up to four repeated assessments of CAPS-IV as the dependent variable (baseline and weeks 3, 6, and 9). Likelihood ratio tests examined treatment by time interaction.",Baseline,,,58.7,12.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.162,,0.838,Mixed,"Combat-related; Rape/sexual assault; Other (noncombat military, civilian)",Low,"Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..",51046,2020
davis2020_CAPS_A_0_Comp,Pharmacotherapy,PTSD,212,A,PTSD,,70,,Holistic yoga program,Yoga,No,Not Applicable,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Mixed,In person,108,Structured Clinical Interview,CAPS,CAPS-5,Completer,,Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups,End of Treatment,0,,25.8,12.1,,,,,-11.3,,,,,,,,,,,,,,,,,,PTSD diagnosis based on CAPS,0.4,,,,,Mixed,,,0.086,0.34,,0.66,Mixed,"MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)",Medium,"Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,2020
davis2020_CAPS_A_30.3_Comp,Pharmacotherapy,PTSD,212,A,PTSD,,67,,Holistic yoga program,Yoga,No,Not Applicable,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Mixed,In person,108,Structured Clinical Interview,CAPS,CAPS-5,Completer,,Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups,Assessment at 6 to <12 Months,30.3,,27.5,13.2,,,,,-9.6,,,,,,,,,,,,,,,,,,PTSD diagnosis based on CAPS,0.403,,,,,Mixed,,,0.086,0.34,,0.66,Mixed,"MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)",Medium,"Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,2020
davis2020_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,212,A,PTSD,,108,,Holistic yoga program,Yoga,No,Not Applicable,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Mixed,In person,108,Structured Clinical Interview,CAPS,CAPS-5,Completer,,Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups,Baseline,,,37.1,8.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0.086,0.34,,0.66,Mixed,"MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)",Medium,"Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,2020
davis2020_CAPS_B_0_Comp,Pharmacotherapy,PTSD,212,B,Control,,70,,Wellness lifestyle program,Wellness lifestyle program,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Mixed,In person,101,Structured Clinical Interview,CAPS,CAPS-5,Completer,,Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups,End of Treatment,0,,31.0,13,,,,,-5,,,,,,,,,,,,,,,,,,PTSD diagnosis based on CAPS,0.314,,,,,Mixed,,,0.086,0.34,,0.66,Mixed,"MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)",Medium,"Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,2020
davis2020_CAPS_B_30.3_Comp,Pharmacotherapy,PTSD,212,B,Control,,65,,Wellness lifestyle program,Wellness lifestyle program,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Mixed,In person,101,Structured Clinical Interview,CAPS,CAPS-5,Completer,,Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups,Assessment at 6 to <12 Months,30.3,,27.9,12.8,,,,,-8.1,,,,,,,,,,,,,,,,,,PTSD diagnosis based on CAPS,0.415,,,,,Mixed,,,0.086,0.34,,0.66,Mixed,"MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)",Medium,"Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,2020
davis2020_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,212,B,Control,,101,,Wellness lifestyle program,Wellness lifestyle program,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Mixed,In person,101,Structured Clinical Interview,CAPS,CAPS-5,Completer,,Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups,Baseline,,,36.0,8.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0.086,0.34,,0.66,Mixed,"MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)",Medium,"Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,2020
davis2020_PCL_A_0_Comp,Pharmacotherapy,PTSD,212,A,PTSD,,,,Holistic yoga program,Yoga,No,Not Applicable,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Mixed,In person,108,Self report,PCL,PCL-5,Completer,,Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups,End of Treatment,0,,33.0,17.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0.086,0.34,,0.66,Mixed,"MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)",Medium,"Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,2020
davis2020_PCL_A_30.3_Comp,Pharmacotherapy,PTSD,212,A,PTSD,,,,Holistic yoga program,Yoga,No,Not Applicable,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Mixed,In person,108,Self report,PCL,PCL-5,Completer,,Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups,Assessment at 6 to <12 Months,30.3,,37.0,17.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0.086,0.34,,0.66,Mixed,"MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)",Medium,"Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,2020
davis2020_PCL_A_Baseline_Comp,Pharmacotherapy,PTSD,212,A,PTSD,,,,Holistic yoga program,Yoga,No,Not Applicable,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Mixed,In person,108,Self report,PCL,PCL-5,Completer,,Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups,Baseline,,,45.2,12.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0.086,0.34,,0.66,Mixed,"MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)",Medium,"Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,2020
davis2020_PCL_B_0_Comp,Pharmacotherapy,PTSD,212,B,Control,,,,Wellness lifestyle program,Wellness lifestyle program,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Mixed,In person,101,Self report,PCL,PCL-5,Completer,,Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups,End of Treatment,0,,40.2,15.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0.086,0.34,,0.66,Mixed,"MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)",Medium,"Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,2020
davis2020_PCL_B_30.3_Comp,Pharmacotherapy,PTSD,212,B,Control,,,,Wellness lifestyle program,Wellness lifestyle program,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Mixed,In person,101,Self report,PCL,PCL-5,Completer,,Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups,Assessment at 6 to <12 Months,30.3,,37.9,17.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0.086,0.34,,0.66,Mixed,"MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)",Medium,"Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,2020
davis2020_PCL_B_Baseline_Comp,Pharmacotherapy,PTSD,212,B,Control,,,,Wellness lifestyle program,Wellness lifestyle program,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Mixed,In person,101,Self report,PCL,PCL-5,Completer,,Constrained longitudinal data analysis model incorporating the baseline outcome as a dependent variable and assuming a common baseline mean across groups,Baseline,,,45.1,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0.086,0.34,,0.66,Mixed,"MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)",Medium,"Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.",,2020
decker2018_PCL_A_0_Comp,Mixed: Psychotherapy & CIH,PTSD,38,A,PTSD,,,,Art therapy + CPT,Art therapy + Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,Yes,Creative therapies,No,No,No,No,No,Individual,In person,19,Self report,PCL,PCL-M,Completer,,ANOVA with repeated measures,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0323,,0.9677,Combat-related,,High,"Decker KP, Deaver SP, Abbey V, et al. Quantitatively improved treatment outcomes for combat-associated PTSD with adjunctive art therapy: randomized controlled trial. Art Therapy. 2018;35(4):184-94. doi: 10.1080/07421656.2018.1540822.",,2020
decker2018_PCL_A_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,38,A,PTSD,,16,,Art therapy + CPT,Art therapy + Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,Yes,Creative therapies,No,No,No,No,No,Individual,In person,19,Self report,PCL,PCL-M,Completer,,ANOVA with repeated measures,Baseline,,,71.2,7.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0323,,0.9677,Combat-related,,High,"Decker KP, Deaver SP, Abbey V, et al. Quantitatively improved treatment outcomes for combat-associated PTSD with adjunctive art therapy: randomized controlled trial. Art Therapy. 2018;35(4):184-94. doi: 10.1080/07421656.2018.1540822.",,2020
decker2018_PCL_B_0_Comp,Mixed: Psychotherapy & CIH,PTSD,38,B,PTSD,,,,Supportive psychotherapy + CPT,Supportive psychotherapy + Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,19,Self report,PCL,PCL-M,Completer,,ANOVA with repeated measures,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0323,,0.9677,Combat-related,,High,"Decker KP, Deaver SP, Abbey V, et al. Quantitatively improved treatment outcomes for combat-associated PTSD with adjunctive art therapy: randomized controlled trial. Art Therapy. 2018;35(4):184-94. doi: 10.1080/07421656.2018.1540822.",,2020
decker2018_PCL_B_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,38,B,PTSD,,15,,Supportive psychotherapy + CPT,Supportive psychotherapy + Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,19,Self report,PCL,PCL-M,Completer,,ANOVA with repeated measures,Baseline,,,65.1,8.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0323,,0.9677,Combat-related,,High,"Decker KP, Deaver SP, Abbey V, et al. Quantitatively improved treatment outcomes for combat-associated PTSD with adjunctive art therapy: randomized controlled trial. Art Therapy. 2018;35(4):184-94. doi: 10.1080/07421656.2018.1540822.",,2020
dedert2019_CAPS_A_0_ITT,Psychotherapy,PTSD+SUD,40,A,PTSD+SUD,Integrated,11,,CPT + smoking cessation,Cognitive Processing Therapy (CPT) + smoking cessation,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,15,Structured Clinical Interview,CAPS,CAPS-5,ITT,Imputed and maximum likelihood methods,Mixed random and fixed effect regression models.,End of Treatment,0,,34.1,13.3,,,,,-9.82,14.30,,,,Cohen's d,0.687,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.825,,0.175,,,High,"Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,2020
dedert2019_CAPS_A_26_ITT,Psychotherapy,PTSD+SUD,40,A,PTSD+SUD,Integrated,12,,CPT + smoking cessation,Cognitive Processing Therapy (CPT) + smoking cessation,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,15,Structured Clinical Interview,CAPS,CAPS-5,ITT,Imputed and maximum likelihood methods,Mixed random and fixed effect regression models.,Assessment at 6 to <12 Months,26,,36.6,15.3,,,,,-6.3,11.9,,,,Cohen's d,0.529,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.825,,0.175,,,High,"Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,2020
dedert2019_CAPS_A_Baseline_ITT,Psychotherapy,PTSD+SUD,40,A,PTSD+SUD,Integrated,15,,CPT + smoking cessation,Cognitive Processing Therapy (CPT) + smoking cessation,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,15,Structured Clinical Interview,CAPS,CAPS-5,ITT,Imputed and maximum likelihood methods,Mixed random and fixed effect regression models.,Baseline,,,43.9,8.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.825,,0.175,,,High,"Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,2020
dedert2019_CAPS_B_0_ITT,Psychotherapy,PTSD+SUD,40,B,SUD,Not integrated,17,,Present-focused smoking cessation,Smoking cessation,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,25,Structured Clinical Interview,CAPS,CAPS-5,ITT,Imputed and maximum likelihood methods,Mixed random and fixed effect regression models.,End of Treatment,0,,32.4,20.4,,,,,-3.82,13.34,,,,Cohen's d,0.687,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.825,,0.175,,,High,"Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,2020
dedert2019_CAPS_B_26_ITT,Psychotherapy,PTSD+SUD,40,B,SUD,Not integrated,19,,Present-focused smoking cessation,Smoking cessation,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,25,Structured Clinical Interview,CAPS,CAPS-5,ITT,Imputed and maximum likelihood methods,Mixed random and fixed effect regression models.,Assessment at 6 to <12 Months,26,,35.1,17.9,,,,,-1.17,13.98,,,,Cohen's d,0.084,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.825,,0.175,,,High,"Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,2020
dedert2019_CAPS_B_Baseline_ITT,Psychotherapy,PTSD+SUD,40,B,SUD,Not integrated,25,,Present-focused smoking cessation,Smoking cessation,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,25,Structured Clinical Interview,CAPS,CAPS-5,ITT,Imputed and maximum likelihood methods,Mixed random and fixed effect regression models.,Baseline,,,36.2,10.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.825,,0.175,,,High,"Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,2020
dedert2019_PCL_A_0_ITT,Psychotherapy,PTSD+SUD,40,A,PTSD+SUD,Integrated,,,CPT + smoking cessation,Cognitive Processing Therapy (CPT) + smoking cessation,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,15,Self report,PCL,PCL-5,ITT,Imputed and maximum likelihood methods,Mixed random and fixed effect regression models.,End of Treatment,0,,33.0,17.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.825,,0.175,,,High,"Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,2020
dedert2019_PCL_A_26_ITT,Psychotherapy,PTSD+SUD,40,A,PTSD+SUD,Integrated,,,CPT + smoking cessation,Cognitive Processing Therapy (CPT) + smoking cessation,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,15,Self report,PCL,PCL-5,ITT,Imputed and maximum likelihood methods,Mixed random and fixed effect regression models.,Assessment at 6 to <12 Months,26,,42.6,18.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.825,,0.175,,,High,"Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,2020
dedert2019_PCL_A_Baseline_ITT,Psychotherapy,PTSD+SUD,40,A,PTSD+SUD,Integrated,,,CPT + smoking cessation,Cognitive Processing Therapy (CPT) + smoking cessation,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,15,Self report,PCL,PCL-5,ITT,Imputed and maximum likelihood methods,Mixed random and fixed effect regression models.,Baseline,,,55.1,11.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.825,,0.175,,,High,"Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,2020
dedert2019_PCL_B_0_ITT,Psychotherapy,PTSD+SUD,40,B,SUD,Not integrated,,,Present-focused smoking cessation,Smoking cessation,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,25,Self report,PCL,PCL-5,ITT,Imputed and maximum likelihood methods,Mixed random and fixed effect regression models.,End of Treatment,0,,38.5,21.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.825,,0.175,,,High,"Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,2020
dedert2019_PCL_B_26_ITT,Psychotherapy,PTSD+SUD,40,B,SUD,Not integrated,,,Present-focused smoking cessation,Smoking cessation,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,25,Self report,PCL,PCL-5,ITT,Imputed and maximum likelihood methods,Mixed random and fixed effect regression models.,Assessment at 6 to <12 Months,26,,43.5,23.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.825,,0.175,,,High,"Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,2020
dedert2019_PCL_B_Baseline_ITT,Psychotherapy,PTSD+SUD,40,B,SUD,Not integrated,,,Present-focused smoking cessation,Smoking cessation,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,25,Self report,PCL,PCL-5,ITT,Imputed and maximum likelihood methods,Mixed random and fixed effect regression models.,Baseline,,,46.0,16.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.825,,0.175,,,High,"Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.",,2020
dekleine2012_CAPS_A_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,75,A,PTSD,,24,,PE + D-cycloserine,Prolonged Exposure (PE) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,33,Structured Clinical Interview,CAPS,CAPS-1 (Dutch version),Completer,,Mixed random and fixed effect regression models.,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,≥10 points decrease in CAPS-1 score,0.875,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.806,,0.194,Mixed,"combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")",Medium,"de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.",38434,2019
dekleine2012_CAPS_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,75,A,PTSD,,24,,PE + D-cycloserine,Prolonged Exposure (PE) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,33,Structured Clinical Interview,CAPS,CAPS-1 (Dutch version),ITT,"LOCF for dichotomous outcomes, mixed models for continuous outcomes",Mixed random and fixed effect regression models.,End of Treatment,0,,34.33,,SE,6.46,,,-27.42,,,,,,,,,,,,,,,,,,,,,≥10 points decrease in CAPS-1 score,0.6364,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.806,,0.194,Mixed,"combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")",Medium,"de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.",38434,2019
dekleine2012_CAPS_A_12_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,75,A,PTSD,,,,PE + D-cycloserine,Prolonged Exposure (PE) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,33,Structured Clinical Interview,CAPS,CAPS-1 (Dutch version),Completer,,Mixed random and fixed effect regression models.,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,≥10 points decrease in CAPS-1 score,0.9583,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.806,,0.194,Mixed,"combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")",Medium,"de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.",38434,2019
dekleine2012_CAPS_A_12_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,75,A,PTSD,,,,PE + D-cycloserine,Prolonged Exposure (PE) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,33,Structured Clinical Interview,CAPS,CAPS-1 (Dutch version),ITT,"LOCF for dichotomous outcomes, mixed models for continuous outcomes",Mixed random and fixed effect regression models.,Assessment at 3 to <6 Months,12,,30.28,,SE,6.26,,,-31.47,,,,,,,,,,,,,,,,,,,,,≥10 points decrease in CAPS-1 score,0.697,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.806,,0.194,Mixed,"combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")",Medium,"de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.",38434,2019
dekleine2012_CAPS_A_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,75,A,PTSD,,24,,PE + D-cycloserine,Prolonged Exposure (PE) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,33,Structured Clinical Interview,CAPS,CAPS-1 (Dutch version),Completer,,Mixed random and fixed effect regression models.,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,≥10 points decrease in CAPS-1 score,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.806,,0.194,Mixed,"combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")",Medium,"de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.",38434,2019
dekleine2012_CAPS_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,75,A,PTSD,,33,,PE + D-cycloserine,Prolonged Exposure (PE) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,33,Structured Clinical Interview,CAPS,CAPS-1 (Dutch version),ITT,"LOCF for dichotomous outcomes, mixed models for continuous outcomes",Mixed random and fixed effect regression models.,Baseline,,,61.75,,SE,2.92,,,,,,,,,,,,,,,,,,,,,,,,≥10 points decrease in CAPS-1 score,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.806,,0.194,Mixed,"combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")",Medium,"de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.",38434,2019
dekleine2012_CAPS_B_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,75,B,PTSD,,21,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,34,Structured Clinical Interview,CAPS,CAPS-1 (Dutch version),Completer,,Mixed random and fixed effect regression models.,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,≥10 points decrease in CAPS-1 score,0.619,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.806,,0.194,Mixed,"combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")",Medium,"de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.",38434,2019
dekleine2012_CAPS_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,75,B,PTSD,,21,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,34,Structured Clinical Interview,CAPS,CAPS-1 (Dutch version),ITT,"LOCF for dichotomous outcomes, mixed models for continuous outcomes",Mixed random and fixed effect regression models.,End of Treatment,0,,53.65,6.55,SE,6.55,,,-20.17,,,,,,,,,,,,,,,,,,,,,≥10 points decrease in CAPS-1 score,0.3824,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.806,,0.194,Mixed,"combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")",Medium,"de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.",38434,2019
dekleine2012_CAPS_B_12_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,75,B,PTSD,,,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,34,Structured Clinical Interview,CAPS,CAPS-1 (Dutch version),Completer,,Mixed random and fixed effect regression models.,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,≥10 points decrease in CAPS-1 score,0.7143,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.806,,0.194,Mixed,"combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")",Medium,"de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.",38434,2019
dekleine2012_CAPS_B_12_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,75,B,PTSD,,,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,34,Structured Clinical Interview,CAPS,CAPS-1 (Dutch version),ITT,"LOCF for dichotomous outcomes, mixed models for continuous outcomes",Mixed random and fixed effect regression models.,Assessment at 3 to <6 Months,12,,43.52,,SE,6.22,,,-30.3,,,,,,,,,,,,,,,,,,,,,≥10 points decrease in CAPS-1 score,0.5,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.806,,0.194,Mixed,"combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")",Medium,"de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.",38434,2019
dekleine2012_CAPS_B_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,75,B,PTSD,,21,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,34,Structured Clinical Interview,CAPS,CAPS-1 (Dutch version),Completer,,Mixed random and fixed effect regression models.,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,≥10 points decrease in CAPS-1 score,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.806,,0.194,Mixed,"combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")",Medium,"de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.",38434,2019
dekleine2012_CAPS_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,75,B,PTSD,,34,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,34,Structured Clinical Interview,CAPS,CAPS-1 (Dutch version),ITT,"LOCF for dichotomous outcomes, mixed models for continuous outcomes",Mixed random and fixed effect regression models.,Baseline,,,73.82,,SE,2.88,,,,,,,,,,,,,,,,,,,,,,,,≥10 points decrease in CAPS-1 score,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.806,,0.194,Mixed,"combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")",Medium,"de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.",38434,2019
dekleine2012_PSS-SR_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,75,A,PTSD,,,,PE + D-cycloserine,Prolonged Exposure (PE) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,33,Self report,PSS-SR,PSS-SR (Dutch version),ITT,,Mixed random and fixed effect regression models.,End of Treatment,0,,11.80,,SE,2.59,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.806,,0.194,Mixed,"combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")",Medium,"de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.",38434,2019
dekleine2012_PSS-SR_A_12_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,75,A,PTSD,,,,PE + D-cycloserine,Prolonged Exposure (PE) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,33,Self report,PSS-SR,PSS-SR (Dutch version),ITT,,Mixed random and fixed effect regression models.,Assessment at 3 to <6 Months,12,,12.40,,SE,2.68,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.806,,0.194,Mixed,"combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")",Medium,"de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.",38434,2019
dekleine2012_PSS-SR_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,75,A,PTSD,,,,PE + D-cycloserine,Prolonged Exposure (PE) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,33,Self report,PSS-SR,PSS-SR (Dutch version),ITT,,Mixed random and fixed effect regression models.,Baseline,,,26.05,,SE,1.43,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.806,,0.194,Mixed,"combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")",Medium,"de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.",38434,2019
dekleine2012_PSS-SR_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,75,B,PTSD,,,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,34,Self report,PSS-SR,PSS-SR (Dutch version),ITT,,Mixed random and fixed effect regression models.,End of Treatment,0,,18.41,,SE,2.59,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.806,,0.194,Mixed,"combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")",Medium,"de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.",38434,2019
dekleine2012_PSS-SR_B_12_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,75,B,PTSD,,,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,34,Self report,PSS-SR,PSS-SR (Dutch version),ITT,,Mixed random and fixed effect regression models.,Assessment at 3 to <6 Months,12,,15.28,,SE,2.63,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.806,,0.194,Mixed,"combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")",Medium,"de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.",38434,2019
dekleine2012_PSS-SR_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,75,B,PTSD,,,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,34,Self report,PSS-SR,PSS-SR (Dutch version),ITT,,Mixed random and fixed effect regression models.,Baseline,,,28.34,,SE,1.43,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.806,,0.194,Mixed,"combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")",Medium,"de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.",38434,2019
devilly1998_M-PTSD_A_0_Comp,Psychotherapy,PTSD,51,A,PTSD,,12,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Self report,M-PTSD,M-PTSD,Completer,,Mixed random and fixed effect regression models.,End of Treatment,0,,110.42,27.72,,,,,-10,,,,,,,,,,,,,,,,,,,,,RCI for M-PTSD,0.6667,,Veteran,0,1,0,0,,1,Combat-related,,High,"Devilly GJ, Spence SH, Rapee RM. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav. Ther. 1998 Summer;29(3):435-55. doi: 10.1016/S0005-7894(98)80042-7.",20740,2019
devilly1998_M-PTSD_A_26_Comp,Psychotherapy,PTSD,51,A,PTSD,,9,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Self report,M-PTSD,M-PTSD,Completer,,Mixed random and fixed effect regression models.,Assessment at 6 to <12 Months,26,,115,33.26,,,,,-5.42,,,,,,,,,,,,,,,,,,,,,RCI for M-PTSD,0.3333,,Veteran,0,1,0,0,,1,Combat-related,,High,"Devilly GJ, Spence SH, Rapee RM. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav. Ther. 1998 Summer;29(3):435-55. doi: 10.1016/S0005-7894(98)80042-7.",20740,2019
devilly1998_M-PTSD_A_Baseline_Comp,Psychotherapy,PTSD,51,A,PTSD,,12,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Self report,M-PTSD,M-PTSD,Completer,,Mixed random and fixed effect regression models.,Baseline,,,102.42,26.48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Devilly GJ, Spence SH, Rapee RM. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav. Ther. 1998 Summer;29(3):435-55. doi: 10.1016/S0005-7894(98)80042-7.",20740,2019
devilly1998_M-PTSD_B_0_Comp,Psychotherapy,PTSD,51,B,PTSD,,12,,Reactive Eye Dilation Desensitization and Reprocessing,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,16,Self report,M-PTSD,M-PTSD,Completer,,Mixed random and fixed effect regression models.,End of Treatment,0,,118.58,22.64,,,,,-4.59,,,,,,,,,,,,,,,,,,,,,RCI for M-PTSD,0.4167,,Veteran,0,1,0,0,,1,Combat-related,,High,"Devilly GJ, Spence SH, Rapee RM. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav. Ther. 1998 Summer;29(3):435-55. doi: 10.1016/S0005-7894(98)80042-7.",20740,2019
devilly1998_M-PTSD_B_26_Comp,Psychotherapy,PTSD,51,B,PTSD,,9,,Reactive Eye Dilation Desensitization and Reprocessing,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,16,Self report,M-PTSD,M-PTSD,Completer,,Mixed random and fixed effect regression models.,Assessment at 6 to <12 Months,26,,122.44,21.05,,,,,-0.73,,,,,,,,,,,,,,,,,,,,,RCI for M-PTSD,0.3333,,Veteran,0,1,0,0,,1,Combat-related,,High,"Devilly GJ, Spence SH, Rapee RM. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav. Ther. 1998 Summer;29(3):435-55. doi: 10.1016/S0005-7894(98)80042-7.",20740,2019
devilly1998_M-PTSD_B_Baseline_Comp,Psychotherapy,PTSD,51,B,PTSD,,12,,Reactive Eye Dilation Desensitization and Reprocessing,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,16,Self report,M-PTSD,M-PTSD,Completer,,Mixed random and fixed effect regression models.,Baseline,,,123.17,18.93,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Devilly GJ, Spence SH, Rapee RM. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav. Ther. 1998 Summer;29(3):435-55. doi: 10.1016/S0005-7894(98)80042-7.",20740,2019
devilly1998_M-PTSD_C_Baseline_Comp,Psychotherapy,PTSD,51,C,Control,,,,Standard Psychiatric Support,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,16,Self report,M-PTSD,M-PTSD,Completer,,Mixed random and fixed effect regression models.,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Devilly GJ, Spence SH, Rapee RM. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav. Ther. 1998 Summer;29(3):435-55. doi: 10.1016/S0005-7894(98)80042-7.",20740,2019
difede2014_CAPS_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,25,A,PTSD,,13,,Exposure therapy with virtual reality plus D-cycloserine,Virtual reality exposure therapy (VRET) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed random and fixed effect regression models.,End of Treatment,0,,32.38,28.55,,,,,-49.24,,,,,,,,,,,,,,,,,,,,,"CAPS total score of ≤20 and minimal or no impairment in social, occupational and other important areas of functioning (CAPS items F21 and F22 ≤1)",0.4615,,Community,,,1,0.24,,0.76,Terrorism/political violence/forced displacement,,Medium,"Difede J, Cukor J, Wyka KE, et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology. 2014 Apr;39(5):1052-108. doi: 10.1038/npp.2013.317. PMID: 24217129.",41641,2019
difede2014_CAPS_A_26_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,25,A,PTSD,,13,,Exposure therapy with virtual reality plus D-cycloserine,Virtual reality exposure therapy (VRET) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed random and fixed effect regression models.,Assessment at 6 to <12 Months,26,,24.15,26.48,,,,,-57.47,,,,,,,,,,,,,,,,,,,,,"CAPS total score of ≤20 and minimal or no impairment in social, occupational and other important areas of functioning (CAPS items F21 and F22 ≤1)",0.6923,,Community,,,1,0.24,,0.76,Terrorism/political violence/forced displacement,,Medium,"Difede J, Cukor J, Wyka KE, et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology. 2014 Apr;39(5):1052-108. doi: 10.1038/npp.2013.317. PMID: 24217129.",41641,2019
difede2014_CAPS_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,25,A,PTSD,,13,,Exposure therapy with virtual reality plus D-cycloserine,Virtual reality exposure therapy (VRET) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed random and fixed effect regression models.,Baseline,,,81.62,22.13,,,,,,,,,,,,,,,,,,,,,,,,,,"CAPS total score of ≤20 and minimal or no impairment in social, occupational and other important areas of functioning (CAPS items F21 and F22 ≤1)",,,Community,,,1,0.24,,0.76,Terrorism/political violence/forced displacement,,Medium,"Difede J, Cukor J, Wyka KE, et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology. 2014 Apr;39(5):1052-108. doi: 10.1038/npp.2013.317. PMID: 24217129.",41641,2019
difede2014_CAPS_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,25,B,PTSD,,12,,Exposure therapy with virtual reality plus placebo,Virtual reality exposure therapy (VRET) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,12,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed random and fixed effect regression models.,End of Treatment,0,,42.17,20.75,,,,,-32.91,,,,,,,,,,,,,,,,,,,,,"CAPS total score of ≤20 and minimal or no impairment in social, occupational and other important areas of functioning (CAPS items F21 and F22 ≤1)",0.0833,,Community,,,1,0.24,,0.76,Terrorism/political violence/forced displacement,,Medium,"Difede J, Cukor J, Wyka KE, et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology. 2014 Apr;39(5):1052-108. doi: 10.1038/npp.2013.317. PMID: 24217129.",41641,2019
difede2014_CAPS_B_26_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,25,B,PTSD,,12,,Exposure therapy with virtual reality plus placebo,Virtual reality exposure therapy (VRET) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,12,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed random and fixed effect regression models.,Assessment at 6 to <12 Months,26,,45.92,25.66,,,,,-29.16,,,,,,,,,,,,,,,,,,,,,"CAPS total score of ≤20 and minimal or no impairment in social, occupational and other important areas of functioning (CAPS items F21 and F22 ≤1)",0.1667,,Community,,,1,0.24,,0.76,Terrorism/political violence/forced displacement,,Medium,"Difede J, Cukor J, Wyka KE, et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology. 2014 Apr;39(5):1052-108. doi: 10.1038/npp.2013.317. PMID: 24217129.",41641,2019
difede2014_CAPS_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,25,B,PTSD,,12,,Exposure therapy with virtual reality plus placebo,Virtual reality exposure therapy (VRET) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,12,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed random and fixed effect regression models.,Baseline,,,75.08,23.8,,,,,,,,,,,,,,,,,,,,,,,,,,"CAPS total score of ≤20 and minimal or no impairment in social, occupational and other important areas of functioning (CAPS items F21 and F22 ≤1)",,,Community,,,1,0.24,,0.76,Terrorism/political violence/forced displacement,,Medium,"Difede J, Cukor J, Wyka KE, et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology. 2014 Apr;39(5):1052-108. doi: 10.1038/npp.2013.317. PMID: 24217129.",41641,2019
dorrepaal2012_DTS_A_0_Comp,Psychotherapy,PTSD,71,A,PTSD,,31,,Group CBT,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,38,Self report,DTS,DTS,Completer,,Mixed random and fixed effect regression models.,End of Treatment,0,,66.7,29.4,,,,,-24.7,27.3,,,,Cohen's d,1.09,,,,p=0.000,,,,,,,,,,,≥1 standard deviation decrease from baseline on DTS (equivalent to 22.5 points),0.5484,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse",High,"Dorrepaal E, Thomaes K, Smit JH, et al. Stabilizing group treatment for complex posttraumatic stress disorder related to child abuse based on psychoeducation and cognitive behavioural therapy: a multisite randomized controlled trial. Psychother Psychosom. 2012;81(4):217-25. doi: 10.1159/000335044. PMID: 22585094.",39141,2019
dorrepaal2012_DTS_A_0_ITT,Psychotherapy,PTSD,71,A,PTSD,,38,,Group CBT,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,38,Self report,DTS,DTS,ITT,LOCF,Mixed random and fixed effect regression models.,End of Treatment,0,,69.6,27.4,,,,,-20.2,26.4,,,,Cohen's d,1,,,,p=0.000,,,,,,,,,,,≥1 standard deviation decrease from baseline on DTS (equivalent to 22.5 points),0.4474,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse",High,"Dorrepaal E, Thomaes K, Smit JH, et al. Stabilizing group treatment for complex posttraumatic stress disorder related to child abuse based on psychoeducation and cognitive behavioural therapy: a multisite randomized controlled trial. Psychother Psychosom. 2012;81(4):217-25. doi: 10.1159/000335044. PMID: 22585094.",39141,2019
dorrepaal2012_DTS_A_Baseline_Comp,Psychotherapy,PTSD,71,A,PTSD,,31,,Group CBT,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,38,Self report,DTS,DTS,Completer,,Mixed random and fixed effect regression models.,Baseline,,,91.4,21.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse",High,"Dorrepaal E, Thomaes K, Smit JH, et al. Stabilizing group treatment for complex posttraumatic stress disorder related to child abuse based on psychoeducation and cognitive behavioural therapy: a multisite randomized controlled trial. Psychother Psychosom. 2012;81(4):217-25. doi: 10.1159/000335044. PMID: 22585094.",39141,2019
dorrepaal2012_DTS_A_Baseline_ITT,Psychotherapy,PTSD,71,A,PTSD,,38,,Group CBT,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,38,Self report,DTS,DTS,ITT,LOCF,Mixed random and fixed effect regression models.,Baseline,,,89.8,20.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse",High,"Dorrepaal E, Thomaes K, Smit JH, et al. Stabilizing group treatment for complex posttraumatic stress disorder related to child abuse based on psychoeducation and cognitive behavioural therapy: a multisite randomized controlled trial. Psychother Psychosom. 2012;81(4):217-25. doi: 10.1159/000335044. PMID: 22585094.",39141,2019
dorrepaal2012_DTS_B_0_Comp,Psychotherapy,PTSD,71,B,Control,,29,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,33,Self report,DTS,DTS,Completer,,Mixed random and fixed effect regression models.,End of Treatment,0,,65.5,30.3,,,,,-14.9,22.2,,,,Cohen's d,0.65,,,,p=0.001,,,,,,,,,,,≥1 standard deviation decrease from baseline on DTS (equivalent to 22.5 points),0.2414,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse",High,"Dorrepaal E, Thomaes K, Smit JH, et al. Stabilizing group treatment for complex posttraumatic stress disorder related to child abuse based on psychoeducation and cognitive behavioural therapy: a multisite randomized controlled trial. Psychother Psychosom. 2012;81(4):217-25. doi: 10.1159/000335044. PMID: 22585094.",39141,2019
dorrepaal2012_DTS_B_0_ITT,Psychotherapy,PTSD,71,B,Control,,33,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,33,Self report,DTS,DTS,ITT,LOCF,Mixed random and fixed effect regression models.,End of Treatment,0,,66.5,29.8,,,,,-13.1,21.3,,,,Cohen's d,0.61,,,,p=0.001,,,,,,,,,,,≥1 standard deviation decrease from baseline on DTS (equivalent to 22.5 points),0.2121,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse",High,"Dorrepaal E, Thomaes K, Smit JH, et al. Stabilizing group treatment for complex posttraumatic stress disorder related to child abuse based on psychoeducation and cognitive behavioural therapy: a multisite randomized controlled trial. Psychother Psychosom. 2012;81(4):217-25. doi: 10.1159/000335044. PMID: 22585094.",39141,2019
dorrepaal2012_DTS_B_Baseline_Comp,Psychotherapy,PTSD,71,B,Control,,29,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,33,Self report,DTS,DTS,Completer,,Mixed random and fixed effect regression models.,Baseline,,,80.5,23.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse",High,"Dorrepaal E, Thomaes K, Smit JH, et al. Stabilizing group treatment for complex posttraumatic stress disorder related to child abuse based on psychoeducation and cognitive behavioural therapy: a multisite randomized controlled trial. Psychother Psychosom. 2012;81(4):217-25. doi: 10.1159/000335044. PMID: 22585094.",39141,2019
dorrepaal2012_DTS_B_Baseline_ITT,Psychotherapy,PTSD,71,B,Control,,33,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,33,Self report,DTS,DTS,ITT,LOCF,Mixed random and fixed effect regression models.,Baseline,,,79.6,23.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse",High,"Dorrepaal E, Thomaes K, Smit JH, et al. Stabilizing group treatment for complex posttraumatic stress disorder related to child abuse based on psychoeducation and cognitive behavioural therapy: a multisite randomized controlled trial. Psychother Psychosom. 2012;81(4):217-25. doi: 10.1159/000335044. PMID: 22585094.",39141,2019
dowd2020_CAPS_A_0_ITT,Pharmacotherapy,PTSD,25,A,PTSD,,7,,Eszopiclone,Eszopiclone,No,Not Applicable,Yes,Antianxiety: nonbenzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In person,13,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF (Modified ITT included only participants who had completed at least one dose),0,End of Treatment,0,,40,20.13,,,,,-25,,,,,,,,,,p=0.005,,,,,,,,CAPS score >45,,,,,,Mixed,,0.04,0.96,0.4,,0.6,Mixed,Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (observed violence to or death of a loved one),High,"Dowd SM, Zalta AK, Burgess HJ, et al. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World j. 2020 Mar 19;10(3):21-8. doi: https://dx.doi.org/10.5498/wjp.v10.i3.21. PMID: 32257848.",,2020
dowd2020_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,25,A,PTSD,,13,,Eszopiclone,Eszopiclone,No,Not Applicable,Yes,Antianxiety: nonbenzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In person,13,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF (Modified ITT included only participants who had completed at least one dose),0,Baseline,,,65,22.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.04,0.96,0.4,,0.6,Mixed,Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (observed violence to or death of a loved one),High,"Dowd SM, Zalta AK, Burgess HJ, et al. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World j. 2020 Mar 19;10(3):21-8. doi: https://dx.doi.org/10.5498/wjp.v10.i3.21. PMID: 32257848.",,2020
dowd2020_CAPS_B_0_ITT,Pharmacotherapy,PTSD,25,B,Control,,9,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,12,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF (Modified ITT included only participants who had completed at least one dose),0,End of Treatment,0,41 ± 16.94,,,,,,,-23,,,,,,,,,,p=0.002,,,,,,,,CAPS score >45,,,,,,Mixed,,0.04,0.96,0.4,,0.6,Mixed,Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (observed violence to or death of a loved one),High,"Dowd SM, Zalta AK, Burgess HJ, et al. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World j. 2020 Mar 19;10(3):21-8. doi: https://dx.doi.org/10.5498/wjp.v10.i3.21. PMID: 32257848.",,2020
dowd2020_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,25,B,Control,,12,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,12,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF (Modified ITT included only participants who had completed at least one dose),0,Baseline,,,64,10.93,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.04,0.96,0.4,,0.6,Mixed,Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (observed violence to or death of a loved one),High,"Dowd SM, Zalta AK, Burgess HJ, et al. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World j. 2020 Mar 19;10(3):21-8. doi: https://dx.doi.org/10.5498/wjp.v10.i3.21. PMID: 32257848.",,2020
dowd2020_SPRINT_A_0_ITT,Pharmacotherapy,PTSD,25,A,PTSD,,,,Eszopiclone,Eszopiclone,No,Not Applicable,Yes,Antianxiety: nonbenzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In person,13,Structured Clinical Interview,SPRINT,SPRINT,ITT,LOCF (Modified ITT included only participants who had completed at least one dose),0,End of Treatment,0,,13,6.58,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.04,0.96,0.4,,0.6,Mixed,Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (observed violence to or death of a loved one),High,"Dowd SM, Zalta AK, Burgess HJ, et al. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World j. 2020 Mar 19;10(3):21-8. doi: https://dx.doi.org/10.5498/wjp.v10.i3.21. PMID: 32257848.",,2020
dowd2020_SPRINT_A_Baseline_ITT,Pharmacotherapy,PTSD,25,A,PTSD,,,,Eszopiclone,Eszopiclone,No,Not Applicable,Yes,Antianxiety: nonbenzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In person,13,Structured Clinical Interview,SPRINT,SPRINT,ITT,LOCF (Modified ITT included only participants who had completed at least one dose),0,Baseline,,,22,5.55,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.04,0.96,0.4,,0.6,Mixed,Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (observed violence to or death of a loved one),High,"Dowd SM, Zalta AK, Burgess HJ, et al. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World j. 2020 Mar 19;10(3):21-8. doi: https://dx.doi.org/10.5498/wjp.v10.i3.21. PMID: 32257848.",,2020
dowd2020_SPRINT_B_0_ITT,Pharmacotherapy,PTSD,25,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,12,Structured Clinical Interview,SPRINT,SPRINT,ITT,LOCF (Modified ITT included only participants who had completed at least one dose),0,End of Treatment,0,,14,4.79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.04,0.96,0.4,,0.6,Mixed,Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (observed violence to or death of a loved one),High,"Dowd SM, Zalta AK, Burgess HJ, et al. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World j. 2020 Mar 19;10(3):21-8. doi: https://dx.doi.org/10.5498/wjp.v10.i3.21. PMID: 32257848.",,2020
dowd2020_SPRINT_B_Baseline_ITT,Pharmacotherapy,PTSD,25,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,12,Structured Clinical Interview,SPRINT,SPRINT,ITT,LOCF (Modified ITT included only participants who had completed at least one dose),0,Baseline,,,24,3.61,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.04,0.96,0.4,,0.6,Mixed,Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (observed violence to or death of a loved one),High,"Dowd SM, Zalta AK, Burgess HJ, et al. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World j. 2020 Mar 19;10(3):21-8. doi: https://dx.doi.org/10.5498/wjp.v10.i3.21. PMID: 32257848.",,2020
duberstein2018_MPSS_A_0_ITT,Psychotherapy,PTSD,161,A,PTSD,,66,,IPT-T,Interpersonal Psychotherapy (IPT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,83,Self report,MPSS,MPSS,ITT,Weighted generalized estimating equations assuming data missing at random,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,47.6,33.1,,,,,-20.3,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,Child sexual abuse,,Medium,"Duberstein PR, Ward EA, Chaudron LH, et al. Effectiveness of interpersonal psychotherapy-trauma for depressed women with childhood abuse histories. J Consult Clin Psychol. 2018 Oct;86(10):868-78. doi: 10.1037/ccp0000335. PMID: 30265045.",51365,2020
duberstein2018_MPSS_A_52_ITT,Psychotherapy,PTSD,161,A,PTSD,,41,,IPT-T,Interpersonal Psychotherapy (IPT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,83,Self report,MPSS,MPSS,ITT,Weighted generalized estimating equations assuming data missing at random,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at ≥12 Months,52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,Child sexual abuse,,Medium,"Duberstein PR, Ward EA, Chaudron LH, et al. Effectiveness of interpersonal psychotherapy-trauma for depressed women with childhood abuse histories. J Consult Clin Psychol. 2018 Oct;86(10):868-78. doi: 10.1037/ccp0000335. PMID: 30265045.",51365,2020
duberstein2018_MPSS_A_Baseline_ITT,Psychotherapy,PTSD,161,A,PTSD,,83,,IPT-T,Interpersonal Psychotherapy (IPT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,83,Self report,MPSS,MPSS,ITT,Weighted generalized estimating equations assuming data missing at random,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,67.9,31.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,Child sexual abuse,,Medium,"Duberstein PR, Ward EA, Chaudron LH, et al. Effectiveness of interpersonal psychotherapy-trauma for depressed women with childhood abuse histories. J Consult Clin Psychol. 2018 Oct;86(10):868-78. doi: 10.1037/ccp0000335. PMID: 30265045.",51365,2020
duberstein2018_MPSS_B_0_ITT,Psychotherapy,PTSD,161,B,PTSD,,56,,Clinic Psychotherapy,Psychotherapy as usual,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,78,Self report,MPSS,MPSS,ITT,Weighted generalized estimating equations assuming data missing at random,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,58.9,37.4,,,,,-14.6,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,Child sexual abuse,,Medium,"Duberstein PR, Ward EA, Chaudron LH, et al. Effectiveness of interpersonal psychotherapy-trauma for depressed women with childhood abuse histories. J Consult Clin Psychol. 2018 Oct;86(10):868-78. doi: 10.1037/ccp0000335. PMID: 30265045.",51365,2020
duberstein2018_MPSS_B_52_ITT,Psychotherapy,PTSD,161,B,PTSD,,30,,Clinic Psychotherapy,Psychotherapy as usual,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,78,Self report,MPSS,MPSS,ITT,Weighted generalized estimating equations assuming data missing at random,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at ≥12 Months,52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,Child sexual abuse,,Medium,"Duberstein PR, Ward EA, Chaudron LH, et al. Effectiveness of interpersonal psychotherapy-trauma for depressed women with childhood abuse histories. J Consult Clin Psychol. 2018 Oct;86(10):868-78. doi: 10.1037/ccp0000335. PMID: 30265045.",51365,2020
duberstein2018_MPSS_B_Baseline_ITT,Psychotherapy,PTSD,161,B,PTSD,,78,,Clinic Psychotherapy,Psychotherapy as usual,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,78,Self report,MPSS,MPSS,ITT,Weighted generalized estimating equations assuming data missing at random,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,73.5,32.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,Child sexual abuse,,Medium,"Duberstein PR, Ward EA, Chaudron LH, et al. Effectiveness of interpersonal psychotherapy-trauma for depressed women with childhood abuse histories. J Consult Clin Psychol. 2018 Oct;86(10):868-78. doi: 10.1037/ccp0000335. PMID: 30265045.",51365,2020
duffy2007_PDS_A_0_Comp,Psychotherapy,PTSD,58,A,PTSD,,20,,Cognitive Therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Self report,PDS,PDS,Completer,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,15.1,9.9,,,,,-19.6,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Community,,,1,0.3966,,0.6034,Mixed,"terrorism/political violence/forced displacement, community/school violence, accidents",Medium,"Duffy M, Gillespie K, Clark DM. Post-traumatic stress disorder in the context of terrorism and other civil conflict in Northern Ireland: randomised controlled trial. BMJ. 2007 Jun 2;334(7604):1147-50. doi: 10.1136/bmj.39021.846852.BE. PMID: 17495988.",29736,2019
duffy2007_PDS_A_0_ITT,Psychotherapy,PTSD,58,A,PTSD,,29,,Cognitive Therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Self report,PDS,PDS,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,21.8,14.4,,,,,-12.9,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Community,,,1,0.3966,,0.6034,Mixed,"terrorism/political violence/forced displacement, community/school violence, accidents",Medium,"Duffy M, Gillespie K, Clark DM. Post-traumatic stress disorder in the context of terrorism and other civil conflict in Northern Ireland: randomised controlled trial. BMJ. 2007 Jun 2;334(7604):1147-50. doi: 10.1136/bmj.39021.846852.BE. PMID: 17495988.",29736,2019
duffy2007_PDS_A_Baseline_ITT,Psychotherapy,PTSD,58,A,PTSD,,29,,Cognitive Therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Self report,PDS,PDS,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,34.7,7.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.3966,,0.6034,Mixed,"terrorism/political violence/forced displacement, community/school violence, accidents",Medium,"Duffy M, Gillespie K, Clark DM. Post-traumatic stress disorder in the context of terrorism and other civil conflict in Northern Ireland: randomised controlled trial. BMJ. 2007 Jun 2;334(7604):1147-50. doi: 10.1136/bmj.39021.846852.BE. PMID: 17495988.",29736,2019
duffy2007_PDS_B_0_Comp,Psychotherapy,PTSD,58,B,Control,,25,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,29,Self report,PDS,PDS,Completer,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,33.1,9.9,,,,,-3.7,,,,,,,,,,p=NS,,,,,,,,,,,,,,Community,,,1,0.3966,,0.6034,Mixed,"terrorism/political violence/forced displacement, community/school violence, accidents",Medium,"Duffy M, Gillespie K, Clark DM. Post-traumatic stress disorder in the context of terrorism and other civil conflict in Northern Ireland: randomised controlled trial. BMJ. 2007 Jun 2;334(7604):1147-50. doi: 10.1136/bmj.39021.846852.BE. PMID: 17495988.",29736,2019
duffy2007_PDS_B_0_ITT,Psychotherapy,PTSD,58,B,Control,,29,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,29,Self report,PDS,PDS,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,33.4,11.6,,,,,-3.4,,,,,,,,,,p=NS,,,,,,,,,,,,,,Community,,,1,0.3966,,0.6034,Mixed,"terrorism/political violence/forced displacement, community/school violence, accidents",Medium,"Duffy M, Gillespie K, Clark DM. Post-traumatic stress disorder in the context of terrorism and other civil conflict in Northern Ireland: randomised controlled trial. BMJ. 2007 Jun 2;334(7604):1147-50. doi: 10.1136/bmj.39021.846852.BE. PMID: 17495988.",29736,2019
duffy2007_PDS_B_Baseline_ITT,Psychotherapy,PTSD,58,B,Control,,29,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,29,Self report,PDS,PDS,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,36.8,6.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.3966,,0.6034,Mixed,"terrorism/political violence/forced displacement, community/school violence, accidents",Medium,"Duffy M, Gillespie K, Clark DM. Post-traumatic stress disorder in the context of terrorism and other civil conflict in Northern Ireland: randomised controlled trial. BMJ. 2007 Jun 2;334(7604):1147-50. doi: 10.1136/bmj.39021.846852.BE. PMID: 17495988.",29736,2019
dunlop2017_CAPS_A_0_Comp,Pharmacotherapy,PTSD,128,A,PTSD,,47,,GSK561679 investigational drug,GSK561679 investigational drug,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Structured Clinical Interview,CAPS,CAPS (past week total score),Completer,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,46.4,,,,,,-30,25.3,,,,Cohen's d,1.8,,,,p=0.001,,,,,,,,,,,>50% decrease in total CAPS score from baseline,,Additional definitions of Clinically Meaningful Response reported in the study,,,,,1,,0,Mixed,"combat-related, other (unspecified child abuse, unspecified)",Medium,"Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974",49315,2019
dunlop2017_CAPS_A_0_ITT,Pharmacotherapy,PTSD,128,A,PTSD,,,,GSK561679 investigational drug,GSK561679 investigational drug,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Structured Clinical Interview,CAPS,CAPS (past week total score),ITT,Restricted maximum likelihood estimation with dichotomous outcomes imputed as negative/ nonresponsive to treatment.,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>50% decrease in total CAPS score from baseline,0.2222,Additional definitions of Clinically Meaningful Response reported in the study,,,,,1,,0,Mixed,"combat-related, other (unspecified child abuse, unspecified)",Medium,"Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974",49315,2019
dunlop2017_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,128,A,PTSD,,47,,GSK561679 investigational drug,GSK561679 investigational drug,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Structured Clinical Interview,CAPS,CAPS (past week total score),Completer,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,76.4,14.1,,,,,,,,,,,,,,,,,,,,,,,,,,>50% decrease in total CAPS score from baseline,,Additional definitions of Clinically Meaningful Response reported in the study,,,,,1,,0,Mixed,"combat-related, other (unspecified child abuse, unspecified)",Medium,"Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974",49315,2019
dunlop2017_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,128,A,PTSD,,63,,GSK561679 investigational drug,GSK561679 investigational drug,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Structured Clinical Interview,CAPS,CAPS (past week total score),ITT,Restricted maximum likelihood estimation with dichotomous outcomes imputed as negative/ nonresponsive to treatment.,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,77.5,14.3,,,,,,,,,,,,,,,,,,,,,,,,,,>50% decrease in total CAPS score from baseline,,Additional definitions of Clinically Meaningful Response reported in the study,,,,,1,,0,Mixed,"combat-related, other (unspecified child abuse, unspecified)",Medium,"Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974",49315,2019
dunlop2017_CAPS_B_0_Comp,Pharmacotherapy,PTSD,128,B,Control,,49,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,65,Structured Clinical Interview,CAPS,CAPS (past week total score),Completer,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,42.0,,,,,,-30.4,23.1,,,,Cohen's d,1.7,,,,p=0.001,,,,,,,,,,,>50% decrease in total CAPS score from baseline,,Additional definitions of Clinically Meaningful Response reported in the study,,,,,1,,0,Mixed,"combat-related, other (unspecified child abuse, unspecified)",Medium,"Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974",49315,2019
dunlop2017_CAPS_B_0_ITT,Pharmacotherapy,PTSD,128,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,65,Structured Clinical Interview,CAPS,CAPS (past week total score),ITT,Restricted maximum likelihood estimation with dichotomous outcomes imputed as negative/ nonresponsive to treatment.,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>50% decrease in total CAPS score from baseline,0.2769,Additional definitions of Clinically Meaningful Response reported in the study,,,,,1,,0,Mixed,"combat-related, other (unspecified child abuse, unspecified)",Medium,"Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974",49315,2019
dunlop2017_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,128,B,Control,,49,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,65,Structured Clinical Interview,CAPS,CAPS (past week total score),Completer,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,72.4,17.9,,,,,,,,,,,,,,,,,,,,,,,,,,>50% decrease in total CAPS score from baseline,,Additional definitions of Clinically Meaningful Response reported in the study,,,,,1,,0,Mixed,"combat-related, other (unspecified child abuse, unspecified)",Medium,"Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974",49315,2019
dunlop2017_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,128,B,Control,,65,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,65,Structured Clinical Interview,CAPS,CAPS (past week total score),ITT,Restricted maximum likelihood estimation with dichotomous outcomes imputed as negative/ nonresponsive to treatment.,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,74.8,17.6,,,,,,,,,,,,,,,,,,,,,,,,,,>50% decrease in total CAPS score from baseline,,Additional definitions of Clinically Meaningful Response reported in the study,,,,,1,,0,Mixed,"combat-related, other (unspecified child abuse, unspecified)",Medium,"Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974",49315,2019
dunlop2017_PSS-SR_A_0_Comp,Pharmacotherapy,PTSD,128,A,PTSD,,,,GSK561679 investigational drug,GSK561679 investigational drug,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Self report,PSS-SR,PSS-SR,Completer,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Mixed,"combat-related, other (unspecified child abuse, unspecified)",Medium,"Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974",49315,2019
dunlop2017_PSS-SR_A_0_ITT,Pharmacotherapy,PTSD,128,A,PTSD,,,,GSK561679 investigational drug,GSK561679 investigational drug,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Self report,PSS-SR,PSS-SR,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Mixed,"combat-related, other (unspecified child abuse, unspecified)",Medium,"Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974",49315,2019
dunlop2017_PSS-SR_A_Baseline_Comp,Pharmacotherapy,PTSD,128,A,PTSD,,,,GSK561679 investigational drug,GSK561679 investigational drug,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Self report,PSS-SR,PSS-SR,Completer,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,32.3,5.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Mixed,"combat-related, other (unspecified child abuse, unspecified)",Medium,"Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974",49315,2019
dunlop2017_PSS-SR_A_Baseline_ITT,Pharmacotherapy,PTSD,128,A,PTSD,,,,GSK561679 investigational drug,GSK561679 investigational drug,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Self report,PSS-SR,PSS-SR,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,31.1,7.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Mixed,"combat-related, other (unspecified child abuse, unspecified)",Medium,"Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974",49315,2019
dunlop2017_PSS-SR_B_0_Comp,Pharmacotherapy,PTSD,128,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,65,Self report,PSS-SR,PSS-SR,Completer,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Mixed,"combat-related, other (unspecified child abuse, unspecified)",Medium,"Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974",49315,2019
dunlop2017_PSS-SR_B_0_ITT,Pharmacotherapy,PTSD,128,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,65,Self report,PSS-SR,PSS-SR,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Mixed,"combat-related, other (unspecified child abuse, unspecified)",Medium,"Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974",49315,2019
dunlop2017_PSS-SR_B_Baseline_Comp,Pharmacotherapy,PTSD,128,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,65,Self report,PSS-SR,PSS-SR,Completer,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,29.9,9.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Mixed,"combat-related, other (unspecified child abuse, unspecified)",Medium,"Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974",49315,2019
dunlop2017_PSS-SR_B_Baseline_ITT,Pharmacotherapy,PTSD,128,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,65,Self report,PSS-SR,PSS-SR,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,30.0,9.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Mixed,"combat-related, other (unspecified child abuse, unspecified)",Medium,"Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974",49315,2019
dunne2012_IES_A_0_NA,Psychotherapy,PTSD,26,A,PTSD,,,,Trauma-focused CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,IES,IES-R,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,19.92,10.43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5,,0.5,Accidents,,High,"Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.",39572,2019
dunne2012_IES_A_Baseline_NA,Psychotherapy,PTSD,26,A,PTSD,,,,Trauma-focused CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,IES,IES-R,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,34.77,12.93,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5,,0.5,Accidents,,High,"Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.",39572,2019
dunne2012_IES_B_0_NA,Psychotherapy,PTSD,26,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,13,Self report,IES,IES-R,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,22.23,11.93,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5,,0.5,Accidents,,High,"Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.",39572,2019
dunne2012_IES_B_Baseline_NA,Psychotherapy,PTSD,26,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,13,Self report,IES,IES-R,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,32.62,11.92,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5,,0.5,Accidents,,High,"Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.",39572,2019
dunne2012_PDS_A_0_ITT,Psychotherapy,PTSD,26,A,PTSD,,12,,Trauma-focused CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PDS,PDS,ITT,LOCF,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,15.62,8.16,,,,,-5.77,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SCID,0.6154,,RCI of 7.8 on PDS,0.3077,,Community,,,1,0.5,,0.5,Accidents,,High,"Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.",39572,2019
dunne2012_PDS_A_26_ITT,Psychotherapy,PTSD,26,A,PTSD,,11,,Trauma-focused CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PDS,PDS,ITT,LOCF,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,26,,14.85,7.63,,,,,-6.54,,,,,,,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to SCID,0.6923,,RCI of 7.8 on PDS,0.3846,,Community,,,1,0.5,,0.5,Accidents,,High,"Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.",39572,2019
dunne2012_PDS_A_Baseline_ITT,Psychotherapy,PTSD,26,A,PTSD,,13,,Trauma-focused CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PDS,PDS,ITT,LOCF,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,21.39,8.93,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5,,0.5,Accidents,,High,"Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.",39572,2019
dunne2012_PDS_B_0_ITT,Psychotherapy,PTSD,26,B,Control,,12,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,13,Self report,PDS,PDS,ITT,LOCF,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,23.31,7.97,,,,,0,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SCID,0.0769,,RCI of 7.8 on PDS,0,,Community,,,1,0.5,,0.5,Accidents,,High,"Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.",39572,2019
dunne2012_PDS_B_Baseline_ITT,Psychotherapy,PTSD,26,B,Control,,13,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,13,Self report,PDS,PDS,ITT,LOCF,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,23.31,7.75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5,,0.5,Accidents,,High,"Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.",39572,2019
echeburua1996_SS-PTSD_A_0_ITT,Mixed: Psychotherapy & CIH,PTSD,20,A,PTSD,,10,,Cognitive Restructuring and coping-skills training,Cognitive restructuring and coping-skills training,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,SS-PTSD,Scale of Severity of Posttraumatic Stress Disorder Symptoms,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,12,6.94,,,,,-24.7,,,,,,,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,0.8,,,,,Community,,,1,1,,0,Rape/sexual assault,,High,"Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.",07521,2019
echeburua1996_SS-PTSD_A_26_ITT,Mixed: Psychotherapy & CIH,PTSD,20,A,PTSD,,10,,Cognitive Restructuring and coping-skills training,Cognitive restructuring and coping-skills training,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,SS-PTSD,Scale of Severity of Posttraumatic Stress Disorder Symptoms,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,26,,6,3.62,,,,,-30.7,,,,,,,,,,p<0.05,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,1,,,,,Community,,,1,1,,0,Rape/sexual assault,,High,"Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.",07521,2019
echeburua1996_SS-PTSD_A_4_ITT,Mixed: Psychotherapy & CIH,PTSD,20,A,PTSD,,10,,Cognitive Restructuring and coping-skills training,Cognitive restructuring and coping-skills training,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,SS-PTSD,Scale of Severity of Posttraumatic Stress Disorder Symptoms,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at <3 Months,4,,8,4.42,,,,,-28.7,,,,,,,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,1,,,,,Community,,,1,1,,0,Rape/sexual assault,,High,"Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.",07521,2019
echeburua1996_SS-PTSD_A_52_ITT,Mixed: Psychotherapy & CIH,PTSD,20,A,PTSD,,10,,Cognitive Restructuring and coping-skills training,Cognitive restructuring and coping-skills training,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,SS-PTSD,Scale of Severity of Posttraumatic Stress Disorder Symptoms,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at ≥12 Months,52,,5,2.49,,,,,-31.7,,,,,,,,,,p<0.01,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,1,,,,,Community,,,1,1,,0,Rape/sexual assault,,High,"Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.",07521,2019
echeburua1996_SS-PTSD_A_Baseline_ITT,Mixed: Psychotherapy & CIH,PTSD,20,A,PTSD,,10,,Cognitive Restructuring and coping-skills training,Cognitive restructuring and coping-skills training,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,SS-PTSD,Scale of Severity of Posttraumatic Stress Disorder Symptoms,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,36.7,8.59,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Rape/sexual assault,,High,"Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.",07521,2019
echeburua1996_SS-PTSD_B_0_ITT,Mixed: Psychotherapy & CIH,PTSD,20,B,PTSD,,10,,Progressive muscular relaxation,Progressive muscle relaxation (PMR),No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,10,Self report,SS-PTSD,Scale of Severity of Posttraumatic Stress Disorder Symptoms,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,18.7,9.2,,,,,-15.6,,,,,,,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,0.5,,,,,Community,,,1,1,,0,Rape/sexual assault,,High,"Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.",07521,2019
echeburua1996_SS-PTSD_B_26_ITT,Mixed: Psychotherapy & CIH,PTSD,20,B,PTSD,,10,,Progressive muscular relaxation,Progressive muscle relaxation (PMR),No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,10,Self report,SS-PTSD,Scale of Severity of Posttraumatic Stress Disorder Symptoms,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,26,,10.3,6.7,,,,,-24,,,,,,,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,0.9,,,,,Community,,,1,1,,0,Rape/sexual assault,,High,"Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.",07521,2019
echeburua1996_SS-PTSD_B_4_ITT,Mixed: Psychotherapy & CIH,PTSD,20,B,PTSD,,10,,Progressive muscular relaxation,Progressive muscle relaxation (PMR),No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,10,Self report,SS-PTSD,Scale of Severity of Posttraumatic Stress Disorder Symptoms,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at <3 Months,4,,14,8.34,,,,,-20.3,,,,,,,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,0.8,,,,,Community,,,1,1,,0,Rape/sexual assault,,High,"Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.",07521,2019
echeburua1996_SS-PTSD_B_52_ITT,Mixed: Psychotherapy & CIH,PTSD,20,B,PTSD,,10,,Progressive muscular relaxation,Progressive muscle relaxation (PMR),No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,10,Self report,SS-PTSD,Scale of Severity of Posttraumatic Stress Disorder Symptoms,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at ≥12 Months,52,,10.5,7.16,,,,,-23.8,,,,,,,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,0.8,,,,,Community,,,1,1,,0,Rape/sexual assault,,High,"Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.",07521,2019
echeburua1996_SS-PTSD_B_Baseline_ITT,Mixed: Psychotherapy & CIH,PTSD,20,B,PTSD,,10,,Progressive muscular relaxation,Progressive muscle relaxation (PMR),No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,10,Self report,SS-PTSD,Scale of Severity of Posttraumatic Stress Disorder Symptoms,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,34.3,7.54,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Rape/sexual assault,,High,"Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.",07521,2019
ehlers2003_CAPS_A_0_Comp,Psychotherapy,PTSD,85,A,PTSD,,28,,Cognitive Therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,10.2,9.4,,,,,-16.5,,,,,Cohen's d,2.28,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS.,0.8571,Additional definitions of Diagnostic Change reported in the study,≥50% decrease on PDS,0.8214,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_CAPS_A_0_ITT,Psychotherapy,PTSD,85,A,PTSD,,,,Cognitive Therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS intensity,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS.,0.8571,Additional definitions of Diagnostic Change reported in the study,≥50% decrease on PDS,0.8214,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_CAPS_A_39_Comp,Psychotherapy,PTSD,85,A,PTSD,,28,,Cognitive Therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,39,,9.7,9.5,,,,,-17,,,,,Cohen's d,2.37,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS.,0.8571,Additional definitions of Diagnostic Change reported in the study,≥50% decrease on PDS,0.8929,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_CAPS_A_39_ITT,Psychotherapy,PTSD,85,A,PTSD,,,,Cognitive Therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS intensity,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,39,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS.,0.8571,Additional definitions of Diagnostic Change reported in the study,≥50% decrease on PDS,0.8929,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,85,A,PTSD,,28,,Cognitive Therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,26.7,7.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_CAPS_B_0_Comp,Psychotherapy,PTSD,85,B,Control,,25,,Self-help booklet,Self-help booklet,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,28,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,19.6,9,,,,,-7.1,,,,,Cohen's d,1.11,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS.,0.24,Additional definitions of Diagnostic Change reported in the study,≥50% decrease on PDS,0.28,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_CAPS_B_0_ITT,Psychotherapy,PTSD,85,B,Control,,,,Self-help booklet,Self-help booklet,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,28,Structured Clinical Interview,CAPS,CAPS intensity,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS.,0.2143,Additional definitions of Diagnostic Change reported in the study,≥50% decrease on PDS,0.25,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_CAPS_B_39_Comp,Psychotherapy,PTSD,85,B,Control,,25,,Self-help booklet,Self-help booklet,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,28,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,39,,18.6,10.1,,,,,-8.1,,,,,Cohen's d,1.28,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS.,0.28,Additional definitions of Diagnostic Change reported in the study,≥50% decrease on PDS,0.28,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_CAPS_B_39_ITT,Psychotherapy,PTSD,85,B,Control,,,,Self-help booklet,Self-help booklet,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,28,Structured Clinical Interview,CAPS,CAPS intensity,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,39,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS.,0.25,Additional definitions of Diagnostic Change reported in the study,≥50% decrease on PDS,0.25,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,85,B,Control,,25,,Self-help booklet,Self-help booklet,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,28,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,26.7,7.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_CAPS_C_0_Comp,Psychotherapy,PTSD,85,C,Control,,27,,Repeated assessments,Assessment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,22.4,11.9,,,,,-3.5,,,,,Cohen's d,0.52,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS.,0.2963,Additional definitions of Diagnostic Change reported in the study,≥50% decrease on PDS,0.2222,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_CAPS_C_0_ITT,Psychotherapy,PTSD,85,C,Control,,,,Repeated assessments,Assessment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS intensity,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS.,0.2759,Additional definitions of Diagnostic Change reported in the study,≥50% decrease on PDS,0.2069,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_CAPS_C_39_Comp,Psychotherapy,PTSD,85,C,Control,,27,,Repeated assessments,Assessment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,39,,17,13.8,,,,,-8.9,,,,,Cohen's d,1,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS.,0.4615,Additional definitions of Diagnostic Change reported in the study,≥50% decrease on PDS,0.4231,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_CAPS_C_39_ITT,Psychotherapy,PTSD,85,C,Control,,,,Repeated assessments,Assessment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS intensity,ITT,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,39,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS.,0.4483,Additional definitions of Diagnostic Change reported in the study,≥50% decrease on PDS,0.4138,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_CAPS_C_Baseline_Comp,Psychotherapy,PTSD,85,C,Control,,27,,Repeated assessments,Assessment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS intensity,Completer,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,25.9,10.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_PDS_A_0_NA,Psychotherapy,PTSD,85,A,PTSD,,,,Cognitive Therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Self report,PDS,PDS frequency,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,8.3,9.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_PDS_A_39_NA,Psychotherapy,PTSD,85,A,PTSD,,,,Cognitive Therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Self report,PDS,PDS frequency,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,39,,8.7,8.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_PDS_A_Baseline_NA,Psychotherapy,PTSD,85,A,PTSD,,,,Cognitive Therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Self report,PDS,PDS frequency,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,26.2,7.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_PDS_B_0_NA,Psychotherapy,PTSD,85,B,Control,,,,Self-help booklet,Self-help booklet,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,28,Self report,PDS,PDS frequency,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,19.9,7.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_PDS_B_39_NA,Psychotherapy,PTSD,85,B,Control,,,,Self-help booklet,Self-help booklet,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,28,Self report,PDS,PDS frequency,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,39,,20.0,7.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_PDS_B_Baseline_NA,Psychotherapy,PTSD,85,B,Control,,,,Self-help booklet,Self-help booklet,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,28,Self report,PDS,PDS frequency,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,27.9,7.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_PDS_C_0_NA,Psychotherapy,PTSD,85,C,Control,,,,Repeated assessments,Assessment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,29,Self report,PDS,PDS frequency,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,22.6,11.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_PDS_C_39_NA,Psychotherapy,PTSD,85,C,Control,,,,Repeated assessments,Assessment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,29,Self report,PDS,PDS frequency,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,39,,19.4,12.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2003_PDS_C_Baseline_NA,Psychotherapy,PTSD,85,C,Control,,,,Repeated assessments,Assessment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,29,Self report,PDS,PDS frequency,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,27.0,9.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Accidents,,Medium,"Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.",25861,2019
ehlers2014_CAPS_A_0_ITT,Psychotherapy,PTSD,121,A,PTSD,,30,,Intensive Cognitive Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,"Main analysis: NR
PTSD diagnostic change (for missing CAPS): PDS score or CAPS LOCF",Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,32.22,27.2,,,,,-46.5,,,,,Cohen's d,1.95,,,,,,,,,,,,"Not meeting criteria for PTSD according to DSM-IV ""1-2"" scoring rule",0.7333,,CAPS score <20,0.4667,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_CAPS_A_27_ITT,Psychotherapy,PTSD,121,A,PTSD,,30,,Intensive Cognitive Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,"Main analysis: NR
PTSD diagnostic change (for missing CAPS): PDS score or CAPS LOCF",Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,27,,35.56,26.26,,,,,-43.16,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to DSM-IV ""1-2"" scoring rule",0.7333,,CAPS score <20,0.4,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_CAPS_A_40_ITT,Psychotherapy,PTSD,121,A,PTSD,,30,,Intensive Cognitive Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,"Main analysis: NR
PTSD diagnostic change (for missing CAPS): PDS score or CAPS LOCF",Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,40,,35.33,35.11,,,,,-43.39,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to DSM-IV ""1-2"" scoring rule",0.6667,,CAPS score <20,0.5333,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,121,A,PTSD,,30,,Intensive Cognitive Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,"Main analysis: NR
PTSD diagnostic change (for missing CAPS): PDS score or CAPS LOCF",Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,78.72,19.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_CAPS_B_0_ITT,Psychotherapy,PTSD,121,B,PTSD,,31,,Standard Cognitive Therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,ITT,"Main analysis: NR
PTSD diagnostic change (for missing CAPS): PDS score or CAPS LOCF",Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,26.97,28.68,,,,,-43.63,,,,,Cohen's d,1.95,,,,,,,,,,,,"Not meeting criteria for PTSD according to DSM-IV ""1-2"" scoring rule",0.7742,,CAPS score <20,0.5161,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_CAPS_B_27_ITT,Psychotherapy,PTSD,121,B,PTSD,,31,,Standard Cognitive Therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,ITT,"Main analysis: NR
PTSD diagnostic change (for missing CAPS): PDS score or CAPS LOCF",Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,27,,20.86,25.23,,,,,-49.74,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to DSM-IV ""1-2"" scoring rule",0.7419,,CAPS score <20,0.6774,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_CAPS_B_40_ITT,Psychotherapy,PTSD,121,B,PTSD,,30,,Standard Cognitive Therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,ITT,"Main analysis: NR
PTSD diagnostic change (for missing CAPS): PDS score or CAPS LOCF",Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,40,,20.96,27.71,,,,,-49.64,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to DSM-IV ""1-2"" scoring rule",0.7419,,CAPS score <20,0.7419,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,121,B,PTSD,,31,,Standard Cognitive Therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,ITT,"Main analysis: NR
PTSD diagnostic change (for missing CAPS): PDS score or CAPS LOCF",Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,70.6,13.45,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_CAPS_C_0_ITT,Psychotherapy,PTSD,121,C,PTSD,,30,,Emotion-focused supportive therapy,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,"Main analysis: NR
PTSD diagnostic change (for missing CAPS): PDS score or CAPS LOCF",Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,47.88,31.77,,,,,-26.72,,,,,Cohen's d,1.07,,,,,,,,,,,,"Not meeting criteria for PTSD according to DSM-IV ""1-2"" scoring rule",0.4333,,CAPS score <20,0.2,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_CAPS_C_27_ITT,Psychotherapy,PTSD,121,C,PTSD,,30,,Emotion-focused supportive therapy,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,"Main analysis: NR
PTSD diagnostic change (for missing CAPS): PDS score or CAPS LOCF",Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,27,,49.32,32.46,,,,,-25.28,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to DSM-IV ""1-2"" scoring rule",0.3667,,CAPS score <20,0.1667,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_CAPS_C_40_ITT,Psychotherapy,PTSD,121,C,PTSD,,30,,Emotion-focused supportive therapy,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,"Main analysis: NR
PTSD diagnostic change (for missing CAPS): PDS score or CAPS LOCF",Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,40,,49.04,38.01,,,,,-25.56,,,,,,,,,,,,,,,,,,"Not meeting criteria for PTSD according to DSM-IV ""1-2"" scoring rule",0.4,,CAPS score <20,0.2667,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_CAPS_C_Baseline_ITT,Psychotherapy,PTSD,121,C,PTSD,,30,,Emotion-focused supportive therapy,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,"Main analysis: NR
PTSD diagnostic change (for missing CAPS): PDS score or CAPS LOCF",Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,74.6,15.39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_CAPS_D_0_ITT,Psychotherapy,PTSD,121,D,Control,,30,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,30,Structured Clinical Interview,CAPS,CAPS,ITT,"Main analysis: NR
PTSD diagnostic change (for missing CAPS): PDS score or CAPS LOCF",Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,65.28,20.64,,,,,-4.67,,,,,Cohen's d,0.26,,,,,,,,,,,,"Not meeting criteria for PTSD according to DSM-IV ""1-2"" scoring rule",0.0667,,CAPS score <20,0.0333,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_CAPS_D_Baseline_ITT,Psychotherapy,PTSD,121,D,Control,,30,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,30,Structured Clinical Interview,CAPS,CAPS,ITT,"Main analysis: NR
PTSD diagnostic change (for missing CAPS): PDS score or CAPS LOCF",Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,69.95,14.17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_PDS_A_0_NA,Psychotherapy,PTSD,121,A,PTSD,,,,Intensive Cognitive Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PDS,PDS,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,11.98,9.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_PDS_A_27_NA,Psychotherapy,PTSD,121,A,PTSD,,,,Intensive Cognitive Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PDS,PDS,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,27,,10.61,8.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_PDS_A_40_NA,Psychotherapy,PTSD,121,A,PTSD,,,,Intensive Cognitive Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PDS,PDS,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,40,,13.03,13.99,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_PDS_A_Baseline_NA,Psychotherapy,PTSD,121,A,PTSD,,,,Intensive Cognitive Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PDS,PDS,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,33.21,7.66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_PDS_B_0_NA,Psychotherapy,PTSD,121,B,PTSD,,,,Standard Cognitive Therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Self report,PDS,PDS,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,32.44,6.94,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_PDS_B_27_NA,Psychotherapy,PTSD,121,B,PTSD,,,,Standard Cognitive Therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Self report,PDS,PDS,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,27,,8.68,9.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_PDS_B_40_NA,Psychotherapy,PTSD,121,B,PTSD,,,,Standard Cognitive Therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Self report,PDS,PDS,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,40,,9.63,11.26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_PDS_B_Baseline_NA,Psychotherapy,PTSD,121,B,PTSD,,,,Standard Cognitive Therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Self report,PDS,PDS,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,32.44,6.94,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_PDS_C_0_NA,Psychotherapy,PTSD,121,C,PTSD,,,,Emotion-focused supportive therapy,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PDS,PDS,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,34.26,7.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_PDS_C_27_NA,Psychotherapy,PTSD,121,C,PTSD,,,,Emotion-focused supportive therapy,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PDS,PDS,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,27,,13.67,9.86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_PDS_C_40_NA,Psychotherapy,PTSD,121,C,PTSD,,,,Emotion-focused supportive therapy,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PDS,PDS,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Assessment at 6 to <12 Months,40,,20.94,15.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_PDS_C_Baseline_NA,Psychotherapy,PTSD,121,C,PTSD,,,,Emotion-focused supportive therapy,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PDS,PDS,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,34.26,7.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_PDS_D_0_NA,Psychotherapy,PTSD,121,D,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,30,Self report,PDS,PDS,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,End of Treatment,0,,32.46,7.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
ehlers2014_PDS_D_Baseline_NA,Psychotherapy,PTSD,121,D,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,30,Self report,PDS,PDS,,,Multivariable weighted generalized estimating equations; weights computed using logistic regression models,Baseline,,,32.46,7.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5868,,0.4132,Mixed,"child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)",Low,"Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.",41886,2019
elbogen2019_CAPS_A_0_Comp,Nonpharmacologic cognitive,PTSD,112,A,PTSD,,41,,Cognitive Applications for Life Management,Cognitive Applications for Life Management,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In person,57,Structured Clinical Interview,CAPS,CAPS,Completer,listwise deletion,Exploratory regression models of difference scores,End of Treatment,0,,60.33,25.14,,,,,-15.2,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,0.098,,0.902,,,Medium,"Elbogen EB, Dennis PA, Van Voorhees E,E., et al. Cognitive rehabilitation with mobile technology and social support for veterans with TBI and PTSD: a randomized clinical trial. J Head Trauma Rehabil. 2018. doi:http://dx.doi.org/10.1097/htr.0000000000000435. PMID: 30169439",51118,2020
elbogen2019_CAPS_A_0_ITT,Nonpharmacologic cognitive,PTSD,112,A,PTSD,,41,,Cognitive Applications for Life Management,Cognitive Applications for Life Management,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In person,57,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Exploratory regression models of difference scores,End of Treatment,0,,64.63,23.92,,,,,-10.67,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.098,,0.902,,,Medium,"Elbogen EB, Dennis PA, Van Voorhees E,E., et al. Cognitive rehabilitation with mobile technology and social support for veterans with TBI and PTSD: a randomized clinical trial. J Head Trauma Rehabil. 2018. doi:http://dx.doi.org/10.1097/htr.0000000000000435. PMID: 30169439",51118,2020
elbogen2019_CAPS_A_Baseline_Comp,Nonpharmacologic cognitive,PTSD,112,A,PTSD,,41,,Cognitive Applications for Life Management,Cognitive Applications for Life Management,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In person,57,Structured Clinical Interview,CAPS,CAPS,Completer,listwise deletion,Exploratory regression models of difference scores,Baseline,,,74.88,16.85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.098,,0.902,,,Medium,"Elbogen EB, Dennis PA, Van Voorhees E,E., et al. Cognitive rehabilitation with mobile technology and social support for veterans with TBI and PTSD: a randomized clinical trial. J Head Trauma Rehabil. 2018. doi:http://dx.doi.org/10.1097/htr.0000000000000435. PMID: 30169439",51118,2020
elbogen2019_CAPS_A_Baseline_ITT,Nonpharmacologic cognitive,PTSD,112,A,PTSD,,57,,Cognitive Applications for Life Management,Cognitive Applications for Life Management,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In person,57,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Exploratory regression models of difference scores,Baseline,,,75.30,16.68,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.098,,0.902,,,Medium,"Elbogen EB, Dennis PA, Van Voorhees E,E., et al. Cognitive rehabilitation with mobile technology and social support for veterans with TBI and PTSD: a randomized clinical trial. J Head Trauma Rehabil. 2018. doi:http://dx.doi.org/10.1097/htr.0000000000000435. PMID: 30169439",51118,2020
elbogen2019_CAPS_B_0_Comp,Nonpharmacologic cognitive,PTSD,112,B,Control,,48,,Control,Control,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,55,Structured Clinical Interview,CAPS,CAPS,Completer,listwise deletion,Exploratory regression models of difference scores,End of Treatment,0,,67.64,24.05,,,,,-8.37,,,,,,,,,,p=0.002,,,,,,,,,,,,,,Veteran,0,1,0,0.098,,0.902,,,Medium,"Elbogen EB, Dennis PA, Van Voorhees E,E., et al. Cognitive rehabilitation with mobile technology and social support for veterans with TBI and PTSD: a randomized clinical trial. J Head Trauma Rehabil. 2018. doi:http://dx.doi.org/10.1097/htr.0000000000000435. PMID: 30169439",51118,2020
elbogen2019_CAPS_B_0_ITT,Nonpharmacologic cognitive,PTSD,112,B,Control,,48,,Control,Control,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,55,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Exploratory regression models of difference scores,End of Treatment,0,,68.82,23.55,,,,,-7.16,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.098,,0.902,,,Medium,"Elbogen EB, Dennis PA, Van Voorhees E,E., et al. Cognitive rehabilitation with mobile technology and social support for veterans with TBI and PTSD: a randomized clinical trial. J Head Trauma Rehabil. 2018. doi:http://dx.doi.org/10.1097/htr.0000000000000435. PMID: 30169439",51118,2020
elbogen2019_CAPS_B_Baseline_Comp,Nonpharmacologic cognitive,PTSD,112,B,Control,,48,,Control,Control,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,55,Structured Clinical Interview,CAPS,CAPS,Completer,listwise deletion,Exploratory regression models of difference scores,Baseline,,,76.54,18.07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.098,,0.902,,,Medium,"Elbogen EB, Dennis PA, Van Voorhees E,E., et al. Cognitive rehabilitation with mobile technology and social support for veterans with TBI and PTSD: a randomized clinical trial. J Head Trauma Rehabil. 2018. doi:http://dx.doi.org/10.1097/htr.0000000000000435. PMID: 30169439",51118,2020
elbogen2019_CAPS_B_Baseline_ITT,Nonpharmacologic cognitive,PTSD,112,B,Control,,55,,Control,Control,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,55,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Exploratory regression models of difference scores,Baseline,,,75.98,18.06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.098,,0.902,,,Medium,"Elbogen EB, Dennis PA, Van Voorhees E,E., et al. Cognitive rehabilitation with mobile technology and social support for veterans with TBI and PTSD: a randomized clinical trial. J Head Trauma Rehabil. 2018. doi:http://dx.doi.org/10.1097/htr.0000000000000435. PMID: 30169439",51118,2020
engel2014_CAPS_A_12_ITT,Complementary and integrative health (CIH),PTSD,55,A,PTSD,,19,,Acupuncture + Usual PTSD care,Acupuncture,No,Not Applicable,No,Not Applicable,Yes,Acupuncture,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS,ITT,Markov Chain Monte Carlo Method Imputation,Exploratory regression models of difference scores,Assessment at 3 to <6 Months,12,,41.2,27,,,,,-35,20.26,,,,Cohen's d,1.6,95% CI,1.4,1.8,p<0.0001,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.309,,0.691,,,Medium,"Engel CC, Cordova EH, Benedek DM, et al. Randomized effectiveness trial of a brief course of acupuncture for posttraumatic stress disorder. Med Care. 2014 Dec;52(12 Suppl 5):S57-64. doi: 10.1097/mlr.0000000000000237. PMID: 25397825.",43160,2019
engel2014_CAPS_A_Baseline_ITT,Complementary and integrative health (CIH),PTSD,55,A,PTSD,,28,,Acupuncture + Usual PTSD care,Acupuncture,No,Not Applicable,No,Not Applicable,Yes,Acupuncture,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS,ITT,Markov Chain Monte Carlo Method Imputation,Exploratory regression models of difference scores,Baseline,,,76.2,14.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.309,,0.691,,,Medium,"Engel CC, Cordova EH, Benedek DM, et al. Randomized effectiveness trial of a brief course of acupuncture for posttraumatic stress disorder. Med Care. 2014 Dec;52(12 Suppl 5):S57-64. doi: 10.1097/mlr.0000000000000237. PMID: 25397825.",43160,2019
engel2014_CAPS_B_12_ITT,Complementary and integrative health (CIH),PTSD,55,B,Control,,24,,Usual Care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,27,Structured Clinical Interview,CAPS,CAPS,ITT,Markov Chain Monte Carlo Method Imputation,Exploratory regression models of difference scores,Assessment at 3 to <6 Months,12,,59.2,22.9,,,,,-10.9,20.8,,,,Cohen's d,0.5,95% CI,0.3,0.7,p<0.0001,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.309,,0.691,,,Medium,"Engel CC, Cordova EH, Benedek DM, et al. Randomized effectiveness trial of a brief course of acupuncture for posttraumatic stress disorder. Med Care. 2014 Dec;52(12 Suppl 5):S57-64. doi: 10.1097/mlr.0000000000000237. PMID: 25397825.",43160,2019
engel2014_CAPS_B_Baseline_ITT,Complementary and integrative health (CIH),PTSD,55,B,Control,,27,,Usual Care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,27,Structured Clinical Interview,CAPS,CAPS,ITT,Markov Chain Monte Carlo Method Imputation,Exploratory regression models of difference scores,Baseline,,,70,18.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.309,,0.691,,,Medium,"Engel CC, Cordova EH, Benedek DM, et al. Randomized effectiveness trial of a brief course of acupuncture for posttraumatic stress disorder. Med Care. 2014 Dec;52(12 Suppl 5):S57-64. doi: 10.1097/mlr.0000000000000237. PMID: 25397825.",43160,2019
engel2014_PCL_A_0_NA,Complementary and integrative health (CIH),PTSD,55,A,PTSD,,,,Acupuncture + Usual PTSD care,Acupuncture,No,Not Applicable,No,Not Applicable,Yes,Acupuncture,No,No,No,No,No,Individual,In Person,28,Self report,PCL,PCL,,,Exploratory regression models of difference scores,End of Treatment,0,,38.8,11.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.309,,0.691,,,Medium,"Engel CC, Cordova EH, Benedek DM, et al. Randomized effectiveness trial of a brief course of acupuncture for posttraumatic stress disorder. Med Care. 2014 Dec;52(12 Suppl 5):S57-64. doi: 10.1097/mlr.0000000000000237. PMID: 25397825.",43160,2019
engel2014_PCL_A_12_NA,Complementary and integrative health (CIH),PTSD,55,A,PTSD,,,,Acupuncture + Usual PTSD care,Acupuncture,No,Not Applicable,No,Not Applicable,Yes,Acupuncture,No,No,No,No,No,Individual,In Person,28,Self report,PCL,PCL,,,Exploratory regression models of difference scores,Assessment at 3 to <6 Months,12,,38.7,15.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.309,,0.691,,,Medium,"Engel CC, Cordova EH, Benedek DM, et al. Randomized effectiveness trial of a brief course of acupuncture for posttraumatic stress disorder. Med Care. 2014 Dec;52(12 Suppl 5):S57-64. doi: 10.1097/mlr.0000000000000237. PMID: 25397825.",43160,2019
engel2014_PCL_A_8_NA,Complementary and integrative health (CIH),PTSD,55,A,PTSD,,,,Acupuncture + Usual PTSD care,Acupuncture,No,Not Applicable,No,Not Applicable,Yes,Acupuncture,No,No,No,No,No,Individual,In Person,28,Self report,PCL,PCL,,,Exploratory regression models of difference scores,Assessment at <3 Months,8,,37.8,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.309,,0.691,,,Medium,"Engel CC, Cordova EH, Benedek DM, et al. Randomized effectiveness trial of a brief course of acupuncture for posttraumatic stress disorder. Med Care. 2014 Dec;52(12 Suppl 5):S57-64. doi: 10.1097/mlr.0000000000000237. PMID: 25397825.",43160,2019
engel2014_PCL_A_Baseline_NA,Complementary and integrative health (CIH),PTSD,55,A,PTSD,,,,Acupuncture + Usual PTSD care,Acupuncture,No,Not Applicable,No,Not Applicable,Yes,Acupuncture,No,No,No,No,No,Individual,In Person,28,Self report,PCL,PCL,,,Exploratory regression models of difference scores,Baseline,,,58.1,11.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.309,,0.691,,,Medium,"Engel CC, Cordova EH, Benedek DM, et al. Randomized effectiveness trial of a brief course of acupuncture for posttraumatic stress disorder. Med Care. 2014 Dec;52(12 Suppl 5):S57-64. doi: 10.1097/mlr.0000000000000237. PMID: 25397825.",43160,2019
engel2014_PCL_B_0_NA,Complementary and integrative health (CIH),PTSD,55,B,Control,,,,Usual Care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,27,Self report,PCL,PCL,,,Exploratory regression models of difference scores,End of Treatment,0,,51.5,12.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.309,,0.691,,,Medium,"Engel CC, Cordova EH, Benedek DM, et al. Randomized effectiveness trial of a brief course of acupuncture for posttraumatic stress disorder. Med Care. 2014 Dec;52(12 Suppl 5):S57-64. doi: 10.1097/mlr.0000000000000237. PMID: 25397825.",43160,2019
engel2014_PCL_B_12_NA,Complementary and integrative health (CIH),PTSD,55,B,Control,,,,Usual Care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,27,Self report,PCL,PCL,,,Exploratory regression models of difference scores,Assessment at 3 to <6 Months,12,,45.8,13.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.309,,0.691,,,Medium,"Engel CC, Cordova EH, Benedek DM, et al. Randomized effectiveness trial of a brief course of acupuncture for posttraumatic stress disorder. Med Care. 2014 Dec;52(12 Suppl 5):S57-64. doi: 10.1097/mlr.0000000000000237. PMID: 25397825.",43160,2019
engel2014_PCL_B_8_NA,Complementary and integrative health (CIH),PTSD,55,B,Control,,,,Usual Care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,27,Self report,PCL,PCL,,,Exploratory regression models of difference scores,Assessment at <3 Months,8,,53.8,14.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.309,,0.691,,,Medium,"Engel CC, Cordova EH, Benedek DM, et al. Randomized effectiveness trial of a brief course of acupuncture for posttraumatic stress disorder. Med Care. 2014 Dec;52(12 Suppl 5):S57-64. doi: 10.1097/mlr.0000000000000237. PMID: 25397825.",43160,2019
engel2014_PCL_B_Baseline_NA,Complementary and integrative health (CIH),PTSD,55,B,Control,,,,Usual Care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,27,Self report,PCL,PCL,,,Exploratory regression models of difference scores,Baseline,,,55.4,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.309,,0.691,,,Medium,"Engel CC, Cordova EH, Benedek DM, et al. Randomized effectiveness trial of a brief course of acupuncture for posttraumatic stress disorder. Med Care. 2014 Dec;52(12 Suppl 5):S57-64. doi: 10.1097/mlr.0000000000000237. PMID: 25397825.",43160,2019
engel2015_PCL_A_0_ITT,Other mixed,PTSD,80,A,PTSD,,29,,Delivery of Self Training and Education for Stressful Situations-Primary Care version,Delivery of Self Training and Education for Stressful Situations-Primary Care version,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,43,Self report,PCL,PCL-C,ITT,Imputed,Exploratory regression models of difference scores,End of Treatment,0,,50.72,18.76,,,,,-7.28,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.6,0.4,,0.1875,,0.8125,Mixed,"combat-related, MST",Medium,"Engel CC, Litz B, Magruder KM, et al. Delivery of self training and education for stressful situations (DESTRESS-PC): a randomized trial of nurse assisted online self-management for PTSD in primary care. Gen Hosp Psychiatry. 2015 Jul-Aug;37(4):323-8. doi: 10.1016/j.genhosppsych.2015.04.007. PMID: 25929985.",44647,2019
engel2015_PCL_A_12_ITT,Other mixed,PTSD,80,A,PTSD,,30,,Delivery of Self Training and Education for Stressful Situations-Primary Care version,Delivery of Self Training and Education for Stressful Situations-Primary Care version,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,43,Self report,PCL,PCL-C,ITT,Imputed,Exploratory regression models of difference scores,Assessment at 3 to <6 Months,12,,43.8,18.33,,,,,-14.2,,,,,Treatment effect,0.47,,,,,,,,,,,,,,,,,,Mixed,0.6,0.4,,0.1875,,0.8125,Mixed,"combat-related, MST",Medium,"Engel CC, Litz B, Magruder KM, et al. Delivery of self training and education for stressful situations (DESTRESS-PC): a randomized trial of nurse assisted online self-management for PTSD in primary care. Gen Hosp Psychiatry. 2015 Jul-Aug;37(4):323-8. doi: 10.1016/j.genhosppsych.2015.04.007. PMID: 25929985.",44647,2019
engel2015_PCL_A_18_ITT,Other mixed,PTSD,80,A,PTSD,,31,,Delivery of Self Training and Education for Stressful Situations-Primary Care version,Delivery of Self Training and Education for Stressful Situations-Primary Care version,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,43,Self report,PCL,PCL-C,ITT,Imputed,Exploratory regression models of difference scores,Assessment at 3 to <6 Months,18,,44.58,16.43,,,,,-13.42,,,,,Treatment effect,0.08,,,,,,,,,,,,,,,,,,Mixed,0.6,0.4,,0.1875,,0.8125,Mixed,"combat-related, MST",Medium,"Engel CC, Litz B, Magruder KM, et al. Delivery of self training and education for stressful situations (DESTRESS-PC): a randomized trial of nurse assisted online self-management for PTSD in primary care. Gen Hosp Psychiatry. 2015 Jul-Aug;37(4):323-8. doi: 10.1016/j.genhosppsych.2015.04.007. PMID: 25929985.",44647,2019
engel2015_PCL_A_Baseline_ITT,Other mixed,PTSD,80,A,PTSD,,40,,Delivery of Self Training and Education for Stressful Situations-Primary Care version,Delivery of Self Training and Education for Stressful Situations-Primary Care version,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,43,Self report,PCL,PCL-C,ITT,Imputed,Exploratory regression models of difference scores,Baseline,,,58,9.95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.6,0.4,,0.1875,,0.8125,Mixed,"combat-related, MST",Medium,"Engel CC, Litz B, Magruder KM, et al. Delivery of self training and education for stressful situations (DESTRESS-PC): a randomized trial of nurse assisted online self-management for PTSD in primary care. Gen Hosp Psychiatry. 2015 Jul-Aug;37(4):323-8. doi: 10.1016/j.genhosppsych.2015.04.007. PMID: 25929985.",44647,2019
engel2015_PCL_B_0_ITT,Other mixed,PTSD,80,B,Control,,29,,Optimized usual PTSD care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,37,Self report,PCL,PCL-C,ITT,Imputed,Exploratory regression models of difference scores,End of Treatment,0,,48.52,13.97,,,,,-5.96,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.6,0.4,,0.1875,,0.8125,Mixed,"combat-related, MST",Medium,"Engel CC, Litz B, Magruder KM, et al. Delivery of self training and education for stressful situations (DESTRESS-PC): a randomized trial of nurse assisted online self-management for PTSD in primary care. Gen Hosp Psychiatry. 2015 Jul-Aug;37(4):323-8. doi: 10.1016/j.genhosppsych.2015.04.007. PMID: 25929985.",44647,2019
engel2015_PCL_B_12_ITT,Other mixed,PTSD,80,B,Control,,25,,Optimized usual PTSD care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,37,Self report,PCL,PCL-C,ITT,Imputed,Exploratory regression models of difference scores,Assessment at 3 to <6 Months,12,,47.36,17.45,,,,,-7.12,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.6,0.4,,0.1875,,0.8125,Mixed,"combat-related, MST",Medium,"Engel CC, Litz B, Magruder KM, et al. Delivery of self training and education for stressful situations (DESTRESS-PC): a randomized trial of nurse assisted online self-management for PTSD in primary care. Gen Hosp Psychiatry. 2015 Jul-Aug;37(4):323-8. doi: 10.1016/j.genhosppsych.2015.04.007. PMID: 25929985.",44647,2019
engel2015_PCL_B_18_ITT,Other mixed,PTSD,80,B,Control,,27,,Optimized usual PTSD care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,37,Self report,PCL,PCL-C,ITT,Imputed,Exploratory regression models of difference scores,Assessment at 3 to <6 Months,18,,42.74,14.42,,,,,-11.74,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.6,0.4,,0.1875,,0.8125,Mixed,"combat-related, MST",Medium,"Engel CC, Litz B, Magruder KM, et al. Delivery of self training and education for stressful situations (DESTRESS-PC): a randomized trial of nurse assisted online self-management for PTSD in primary care. Gen Hosp Psychiatry. 2015 Jul-Aug;37(4):323-8. doi: 10.1016/j.genhosppsych.2015.04.007. PMID: 25929985.",44647,2019
engel2015_PCL_B_Baseline_ITT,Other mixed,PTSD,80,B,Control,,33,,Optimized usual PTSD care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,37,Self report,PCL,PCL-C,ITT,Imputed,Exploratory regression models of difference scores,Baseline,,,54.48,11.23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.6,0.4,,0.1875,,0.8125,Mixed,"combat-related, MST",Medium,"Engel CC, Litz B, Magruder KM, et al. Delivery of self training and education for stressful situations (DESTRESS-PC): a randomized trial of nurse assisted online self-management for PTSD in primary care. Gen Hosp Psychiatry. 2015 Jul-Aug;37(4):323-8. doi: 10.1016/j.genhosppsych.2015.04.007. PMID: 25929985.",44647,2019
engel2016_PDS_A_0_ITT,Collaborative care,PTSD,666,A,PTSD,,292,,Centrally assisted collaborative telecare,Centrally assisted collaborative telecare,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,Yes,Individual,Phone,332,Self report,PDS,PDS,ITT,Mixed effects model,Exploratory regression models of difference scores,End of Treatment,0,,23.33,,,,,SE 0.68,-6.07,,,,,,,,,,,,,,,,,,,,,>50% reduction in PDS score,0.25,,Active Duty Military,1,0,0,0.1907,,0.8093,,,Low,"Engel CC, Jaycox LH, Freed MC, et al. Centrally assisted collaborative telecare for posttraumatic stress disorder and depression among military personnel attending primary care: a randomized clinical trial. JAMA Intern Med. 2016 Jul 1;176(7):948-56. doi: 10.1001/jamainternmed.2016.2402. PMID: 27294447.",45003,2019
engel2016_PDS_A_Baseline_ITT,Collaborative care,PTSD,666,A,PTSD,,332,,Centrally assisted collaborative telecare,Centrally assisted collaborative telecare,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,Yes,Individual,Phone,332,Self report,PDS,PDS,ITT,Mixed effects model,Exploratory regression models of difference scores,Baseline,,,29.4,9.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.1907,,0.8093,,,Low,"Engel CC, Jaycox LH, Freed MC, et al. Centrally assisted collaborative telecare for posttraumatic stress disorder and depression among military personnel attending primary care: a randomized clinical trial. JAMA Intern Med. 2016 Jul 1;176(7):948-56. doi: 10.1001/jamainternmed.2016.2402. PMID: 27294447.",45003,2019
engel2016_PDS_B_0_ITT,Collaborative care,PTSD,666,B,Control,,288,,Re-Engineering Systems of Primary Care Treatment in the Military,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,334,Self report,PDS,PDS,ITT,Mixed effects model,Exploratory regression models of difference scores,End of Treatment,0,,25.36,,,,,SE 0.72,-3.54,,,,,,,,,,,,,,,,,,,,,>50% reduction in PDS score,0.1701,,Active Duty Military,1,0,0,0.1907,,0.8093,,,Low,"Engel CC, Jaycox LH, Freed MC, et al. Centrally assisted collaborative telecare for posttraumatic stress disorder and depression among military personnel attending primary care: a randomized clinical trial. JAMA Intern Med. 2016 Jul 1;176(7):948-56. doi: 10.1001/jamainternmed.2016.2402. PMID: 27294447.",45003,2019
engel2016_PDS_B_Baseline_ITT,Collaborative care,PTSD,666,B,Control,,334,,Re-Engineering Systems of Primary Care Treatment in the Military,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,334,Self report,PDS,PDS,ITT,Mixed effects model,Exploratory regression models of difference scores,Baseline,,,28.9,8.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.1907,,0.8093,,,Low,"Engel CC, Jaycox LH, Freed MC, et al. Centrally assisted collaborative telecare for posttraumatic stress disorder and depression among military personnel attending primary care: a randomized clinical trial. JAMA Intern Med. 2016 Jul 1;176(7):948-56. doi: 10.1001/jamainternmed.2016.2402. PMID: 27294447.",45003,2019
falsetti2008_MPSS_A_0_ITT,Psychotherapy,PTSD,60,A,PTSD,,14,,Multiple Channel Exposure Therapy,Multiple Channel Exposure Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Self report,MPSS,MPSS,ITT,LOCF,Exploratory regression models of difference scores,End of Treatment,0,,43.71,29.34,,,,,-18.37,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.73,Additional definitions of Diagnostic Change reported in the study,CAPS score <65,0.68,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault, community/school violence, natural or manmade disasters",High,"Falsetti SA, Resnick HS, Davis JL. Multiple channel exposure therapy for women with PTSD and comorbid panic attacks. Cogn Behav Ther. 2008;37(2):117-30. doi: 10.1080/16506070801969088. PMID: 18470742.",82073,2019
falsetti2008_MPSS_A_Baseline_ITT,Psychotherapy,PTSD,60,A,PTSD,,29,,Multiple Channel Exposure Therapy,Multiple Channel Exposure Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Self report,MPSS,MPSS,ITT,LOCF,Exploratory regression models of difference scores,Baseline,,,62.08,21.39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault, community/school violence, natural or manmade disasters",High,"Falsetti SA, Resnick HS, Davis JL. Multiple channel exposure therapy for women with PTSD and comorbid panic attacks. Cogn Behav Ther. 2008;37(2):117-30. doi: 10.1080/16506070801969088. PMID: 18470742.",82073,2019
falsetti2008_MPSS_B_0_ITT,Psychotherapy,PTSD,60,B,Control,,23,,Waitlist,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,31,Self report,MPSS,MPSS,ITT,LOCF,Exploratory regression models of difference scores,End of Treatment,0,,67.32,26.43,,,,,-6.47,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.26,Additional definitions of Diagnostic Change reported in the study,CAPS score <65,0.36,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault, community/school violence, natural or manmade disasters",High,"Falsetti SA, Resnick HS, Davis JL. Multiple channel exposure therapy for women with PTSD and comorbid panic attacks. Cogn Behav Ther. 2008;37(2):117-30. doi: 10.1080/16506070801969088. PMID: 18470742.",82073,2019
falsetti2008_MPSS_B_Baseline_ITT,Psychotherapy,PTSD,60,B,Control,,31,,Waitlist,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,31,Self report,MPSS,MPSS,ITT,LOCF,Exploratory regression models of difference scores,Baseline,,,73.79,19.63,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault, community/school violence, natural or manmade disasters",High,"Falsetti SA, Resnick HS, Davis JL. Multiple channel exposure therapy for women with PTSD and comorbid panic attacks. Cogn Behav Ther. 2008;37(2):117-30. doi: 10.1080/16506070801969088. PMID: 18470742.",82073,2019
fani2009_CAPS_A_0_Comp,Pharmacotherapy,PTSD,43,A,PTSD,,8,,Paroxetine controlled release,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,Completer,,Exploratory regression models of difference scores,End of Treatment,0,,32.25,31.61,,,,,-55.13,,,,,,,,,,p=0.001,,,,,,,,,,,,,,Community,,,1,0.556,,0.444,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, other (witnessing trauma)",High,"Fani N, Kitayama N, Ashraf A, et al. Neuropsychological functioning in patients with posttraumatic stress disorder following short-term paroxetine treatment. Psychopharmacol Bull. 2009 Jan 1;42(1):53-68.  PMID: 19204651.",47120,2019
fani2009_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,43,A,PTSD,,8,,Paroxetine controlled release,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,Completer,,Exploratory regression models of difference scores,Baseline,,,87.38,10.38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.556,,0.444,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, other (witnessing trauma)",High,"Fani N, Kitayama N, Ashraf A, et al. Neuropsychological functioning in patients with posttraumatic stress disorder following short-term paroxetine treatment. Psychopharmacol Bull. 2009 Jan 1;42(1):53-68.  PMID: 19204651.",47120,2019
fani2009_CAPS_B_0_Comp,Pharmacotherapy,PTSD,43,B,Control,,10,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,Completer,,Exploratory regression models of difference scores,End of Treatment,0,,23.7,17.47,,,,,-33.7,,,,,,,,,,p=0.001,,,,,,,,,,,,,,Community,,,1,0.556,,0.444,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, other (witnessing trauma)",High,"Fani N, Kitayama N, Ashraf A, et al. Neuropsychological functioning in patients with posttraumatic stress disorder following short-term paroxetine treatment. Psychopharmacol Bull. 2009 Jan 1;42(1):53-68.  PMID: 19204651.",47120,2019
fani2009_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,43,B,Control,,10,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,Completer,,Exploratory regression models of difference scores,Baseline,,,57.4,27.52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.556,,0.444,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, other (witnessing trauma)",High,"Fani N, Kitayama N, Ashraf A, et al. Neuropsychological functioning in patients with posttraumatic stress disorder following short-term paroxetine treatment. Psychopharmacol Bull. 2009 Jan 1;42(1):53-68.  PMID: 19204651.",47120,2019
fecteau1999_CAPS_A_0_Comp,Psychotherapy,PTSD,21,A,PTSD,,10,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Structured Clinical Interview,CAPS,CAPS-2,Completer,,Exploratory regression models of difference scores,End of Treatment,0,,37.5,30.4,,,,,-33.4,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-2,0.5,,RCI for CAPS-2 score ( ≥11.09 point decrease),0.8,,Community,,,1,0.7,,0.3,Accidents,,Medium,"Fecteau GW, Nicki RM. Cognitive behavioural treatment of post traumatic stress disorder after motor vehicle accident. Behav. Cogn. Psychother. 1999 Jul;27(3):201-14.",21968,2019
fecteau1999_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,21,A,PTSD,,10,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Structured Clinical Interview,CAPS,CAPS-2,Completer,,Exploratory regression models of difference scores,Baseline,,,70.9,16.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Accidents,,Medium,"Fecteau GW, Nicki RM. Cognitive behavioural treatment of post traumatic stress disorder after motor vehicle accident. Behav. Cogn. Psychother. 1999 Jul;27(3):201-14.",21968,2019
fecteau1999_CAPS_B_0_Comp,Psychotherapy,PTSD,21,B,Control,,10,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,10,Structured Clinical Interview,CAPS,CAPS-2,Completer,,Exploratory regression models of difference scores,End of Treatment,0,,74.6,24.7,,,,,-2.7,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-2,0,,RCI for CAPS-2 score ( ≥11.09 point decrease),0.2,,Community,,,1,0.7,,0.3,Accidents,,Medium,"Fecteau GW, Nicki RM. Cognitive behavioural treatment of post traumatic stress disorder after motor vehicle accident. Behav. Cogn. Psychother. 1999 Jul;27(3):201-14.",21968,2019
fecteau1999_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,21,B,Control,,10,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,10,Structured Clinical Interview,CAPS,CAPS-2,Completer,,Exploratory regression models of difference scores,Baseline,,,77.3,22.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Accidents,,Medium,"Fecteau GW, Nicki RM. Cognitive behavioural treatment of post traumatic stress disorder after motor vehicle accident. Behav. Cogn. Psychother. 1999 Jul;27(3):201-14.",21968,2019
fecteau1999_IES_A_0_NA,Psychotherapy,PTSD,21,A,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,IES,IES,,,Exploratory regression models of difference scores,End of Treatment,0,,15.5,19.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Accidents,,Medium,"Fecteau GW, Nicki RM. Cognitive behavioural treatment of post traumatic stress disorder after motor vehicle accident. Behav. Cogn. Psychother. 1999 Jul;27(3):201-14.",21968,2019
fecteau1999_IES_A_Baseline_NA,Psychotherapy,PTSD,21,A,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,IES,IES,,,Exploratory regression models of difference scores,Baseline,,,45.1,14.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Accidents,,Medium,"Fecteau GW, Nicki RM. Cognitive behavioural treatment of post traumatic stress disorder after motor vehicle accident. Behav. Cogn. Psychother. 1999 Jul;27(3):201-14.",21968,2019
fecteau1999_IES_B_0_NA,Psychotherapy,PTSD,21,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,10,Self report,IES,IES,,,Exploratory regression models of difference scores,End of Treatment,0,,48.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Accidents,,Medium,"Fecteau GW, Nicki RM. Cognitive behavioural treatment of post traumatic stress disorder after motor vehicle accident. Behav. Cogn. Psychother. 1999 Jul;27(3):201-14.",21968,2019
fecteau1999_IES_B_Baseline_NA,Psychotherapy,PTSD,21,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,10,Self report,IES,IES,,,Exploratory regression models of difference scores,Baseline,,,51.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Accidents,,Medium,"Fecteau GW, Nicki RM. Cognitive behavioural treatment of post traumatic stress disorder after motor vehicle accident. Behav. Cogn. Psychother. 1999 Jul;27(3):201-14.",21968,2019
feder2014_IES-R_A_0_ITT,Pharmacotherapy,PTSD,41,A,PTSD,,22,,Ketamine hydrochloride,Ketamine,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Self report,IES-R,IES-R,ITT,,Exploratory regression models of difference scores,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CGI-I,,,Community,,,1,0.4634,,0.5366,Mixed,"combat-related. rape/sexual assault, accidents, community/school violence, other (fire, witnessed assault or death, witnessed 9/11 attacks)",High,"Feder A, Parides MK, Murrough JW, et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2014 Jun;71(6):681-8. doi: 10.1001/jamapsychiatry.2014.62. PMID: 24740528.",42218,2019
feder2014_IES-R_A_Baseline_ITT,Pharmacotherapy,PTSD,41,A,PTSD,,22,,Ketamine hydrochloride,Ketamine,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Self report,IES-R,IES-R,ITT,,Exploratory regression models of difference scores,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CGI-I,,,Community,,,1,0.4634,,0.5366,Mixed,"combat-related. rape/sexual assault, accidents, community/school violence, other (fire, witnessed assault or death, witnessed 9/11 attacks)",High,"Feder A, Parides MK, Murrough JW, et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2014 Jun;71(6):681-8. doi: 10.1001/jamapsychiatry.2014.62. PMID: 24740528.",42218,2019
feder2014_IES-R_B_0_ITT,Pharmacotherapy,PTSD,41,B,Control,,19,,Midazolam,Midazolam,No,Not Applicable,Yes,Antianxiety: benzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Self report,IES-R,IES-R,ITT,,Exploratory regression models of difference scores,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CGI-I,,,Community,,,1,0.4634,,0.5366,Mixed,"combat-related. rape/sexual assault, accidents, community/school violence, other (fire, witnessed assault or death, witnessed 9/11 attacks)",High,"Feder A, Parides MK, Murrough JW, et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2014 Jun;71(6):681-8. doi: 10.1001/jamapsychiatry.2014.62. PMID: 24740528.",42218,2019
feder2014_IES-R_B_Baseline_ITT,Pharmacotherapy,PTSD,41,B,Control,,19,,Midazolam,Midazolam,No,Not Applicable,Yes,Antianxiety: benzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Self report,IES-R,IES-R,ITT,,Exploratory regression models of difference scores,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CGI-I,,,Community,,,1,0.4634,,0.5366,Mixed,"combat-related. rape/sexual assault, accidents, community/school violence, other (fire, witnessed assault or death, witnessed 9/11 attacks)",High,"Feder A, Parides MK, Murrough JW, et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2014 Jun;71(6):681-8. doi: 10.1001/jamapsychiatry.2014.62. PMID: 24740528.",42218,2019
feng2019_CAPS_A_0_ITT,Other mixed,PTSD,240,A,PTSD,,49,,Sertraline + simulated TEAS,Sertraline + simulated transcutaneous electrical acupoint stimulation,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,Yes,No,No,Individual,In person,60,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",End of Treatment,0,,42.0,12.4,,,,,-28.3,,,,,Cohen's d,2.32,,,,,,,,,,,,CAPS score ≤20,0.0333,,≥30% reduction on CAPS from baseline,0.6333,,Community,0,0,1,0.7042,,0.2958,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)",High,"Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.",,2020
feng2019_CAPS_A_Baseline_ITT,Other mixed,PTSD,240,A,PTSD,,60,,Sertraline + simulated TEAS,Sertraline + simulated transcutaneous electrical acupoint stimulation,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,Yes,No,No,Individual,In person,60,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",Baseline,,,70.3,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.7042,,0.2958,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)",High,"Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.",,2020
feng2019_CAPS_B_0_ITT,Other mixed,PTSD,240,B,PTSD,,47,,CBT + simulated TEAS,Trauma-focused cognitive behavioral therapy (TF+CBT) + simulated transcutaneous electrical acupoint stimulation,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,60,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",End of Treatment,0,,46.0,13.2,,,,,-25.3,,,,,Cohen's d,1.788,,,,,,,,,,,,CAPS score ≤20,0.0167,,≥30% reduction on CAPS from baseline,0.6,,Community,0,0,1,0.7042,,0.2958,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)",High,"Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.",,2020
feng2019_CAPS_B_Baseline_ITT,Other mixed,PTSD,240,B,PTSD,,60,,CBT + simulated TEAS,Trauma-focused cognitive behavioral therapy (TF+CBT) + simulated transcutaneous electrical acupoint stimulation,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,60,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",Baseline,,,71.3,15.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.7042,,0.2958,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)",High,"Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.",,2020
feng2019_CAPS_C_0_ITT,Other mixed,PTSD,240,C,PTSD,,53,,CBT + active TEAS,Trauma-focused cognitive behavioral therapy (TF+CBT) + active transcutaneous electrical acupoint stimulation,Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,60,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",End of Treatment,0,,34.3,12.6,,,,,-37,,,,,Cohen's d,2.972,,,,,,,,,,,,CAPS score ≤20,0.15,,≥30% reduction on CAPS from baseline,0.85,,Community,0,0,1,0.7042,,0.2958,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)",High,"Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.",,2020
feng2019_CAPS_C_Baseline_ITT,Other mixed,PTSD,240,C,PTSD,,60,,CBT + active TEAS,Trauma-focused cognitive behavioral therapy (TF+CBT) + active transcutaneous electrical acupoint stimulation,Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,60,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",Baseline,,,71.3,12.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.7042,,0.2958,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)",High,"Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.",,2020
feng2019_CAPS_D_0_ITT,Other mixed,PTSD,240,D,PTSD,,55,,Sertraline + CBT + active TEAS,Sertraline + trauma-focused cognitive behavioral therapy (TF+CBT) + active transcutaneous electrical acupoint stimulation,Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,Yes,No,No,No,No,Individual,In person,60,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",End of Treatment,0,,29.0,11,,,,,-44.6,,,,,Cohen's d,3.431,,,,,,,,,,,,CAPS score ≤20,0.25,,≥30% reduction on CAPS from baseline,0.95,,Community,0,0,1,0.7042,,0.2958,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)",High,"Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.",,2020
feng2019_CAPS_D_Baseline_ITT,Other mixed,PTSD,240,D,PTSD,,60,,Sertraline + CBT + active TEAS,Sertraline + trauma-focused cognitive behavioral therapy (TF+CBT) + active transcutaneous electrical acupoint stimulation,Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,Yes,No,No,No,No,Individual,In person,60,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",Baseline,,,73.6,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.7042,,0.2958,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)",High,"Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.",,2020
feng2019_PCL_A_0_ITT,Other mixed,PTSD,240,A,PTSD,,,,Sertraline + simulated TEAS,Sertraline + simulated transcutaneous electrical acupoint stimulation,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,Yes,No,No,Individual,In person,60,Self report,PCL,PCL-C,ITT,LOCF,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",End of Treatment,0,,35.4,7.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.7042,,0.2958,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)",High,"Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.",,2020
feng2019_PCL_A_Baseline_ITT,Other mixed,PTSD,240,A,PTSD,,,,Sertraline + simulated TEAS,Sertraline + simulated transcutaneous electrical acupoint stimulation,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,Yes,No,No,Individual,In person,60,Self report,PCL,PCL-C,ITT,LOCF,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",Baseline,,,62.7,8.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.7042,,0.2958,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)",High,"Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.",,2020
feng2019_PCL_B_0_ITT,Other mixed,PTSD,240,B,PTSD,,,,CBT + simulated TEAS,Trauma-focused cognitive behavioral therapy (TF+CBT) + simulated transcutaneous electrical acupoint stimulation,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,60,Self report,PCL,PCL-C,ITT,LOCF,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",End of Treatment,0,,39.7,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.7042,,0.2958,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)",High,"Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.",,2020
feng2019_PCL_B_Baseline_ITT,Other mixed,PTSD,240,B,PTSD,,,,CBT + simulated TEAS,Trauma-focused cognitive behavioral therapy (TF+CBT) + simulated transcutaneous electrical acupoint stimulation,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,60,Self report,PCL,PCL-C,ITT,LOCF,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",Baseline,,,64.5,7.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.7042,,0.2958,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)",High,"Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.",,2020
feng2019_PCL_C_0_ITT,Other mixed,PTSD,240,C,PTSD,,,,CBT + active TEAS,Trauma-focused cognitive behavioral therapy (TF+CBT) + active transcutaneous electrical acupoint stimulation,Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,60,Self report,PCL,PCL-C,ITT,LOCF,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",End of Treatment,0,,30.1,5.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.7042,,0.2958,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)",High,"Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.",,2020
feng2019_PCL_C_Baseline_ITT,Other mixed,PTSD,240,C,PTSD,,,,CBT + active TEAS,Trauma-focused cognitive behavioral therapy (TF+CBT) + active transcutaneous electrical acupoint stimulation,Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,60,Self report,PCL,PCL-C,ITT,LOCF,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",Baseline,,,63.9,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.7042,,0.2958,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)",High,"Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.",,2020
feng2019_PCL_D_0_ITT,Other mixed,PTSD,240,D,PTSD,,,,Sertraline + CBT + active TEAS,Sertraline + trauma-focused cognitive behavioral therapy (TF+CBT) + active transcutaneous electrical acupoint stimulation,Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,Yes,No,No,No,No,Individual,In person,60,Self report,PCL,PCL-C,ITT,LOCF,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",End of Treatment,0,,23.9,7.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.7042,,0.2958,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)",High,"Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.",,2020
feng2019_PCL_D_Baseline_ITT,Other mixed,PTSD,240,D,PTSD,,,,Sertraline + CBT + active TEAS,Sertraline + trauma-focused cognitive behavioral therapy (TF+CBT) + active transcutaneous electrical acupoint stimulation,Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,Yes,No,No,No,No,Individual,In person,60,Self report,PCL,PCL-C,ITT,LOCF,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",Baseline,,,62.4,9.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.7042,,0.2958,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)",High,"Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.",,2020
feske2008_PDS_A_0_Comp,Psychotherapy,PTSD,27,A,PTSD,,9,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PDS,PDS-I,Completer,,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",End of Treatment,0,,19.22,11.61,,,,,-15.67,,,,,,,,,,,,,,,,,,,,,RCI ≥1.96,0.6667,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, community/school violence",High,Feske U. Treating low-income and minority women with posttraumatic stress disorder: a pilot study comparing prolonged exposure and treatment as usual conducted by community therapists. J Interpers Violence. 2008 Aug;23(8):1027-40. doi: 10.1177/0886260507313967. PMID: 18292398.,82117,2019
feske2008_PDS_A_8_Comp,Psychotherapy,PTSD,27,A,PTSD,,9,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PDS,PDS-I,Completer,,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",Assessment at <3 Months,8,,18.78,10.7,,,,,-16.11,,,,,,,,,,,,,,,,,,,,,RCI ≥1.96,0.7778,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, community/school violence",High,Feske U. Treating low-income and minority women with posttraumatic stress disorder: a pilot study comparing prolonged exposure and treatment as usual conducted by community therapists. J Interpers Violence. 2008 Aug;23(8):1027-40. doi: 10.1177/0886260507313967. PMID: 18292398.,82117,2019
feske2008_PDS_A_Baseline_Comp,Psychotherapy,PTSD,27,A,PTSD,,9,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PDS,PDS-I,Completer,,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",Baseline,,,34.89,7.64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, community/school violence",High,Feske U. Treating low-income and minority women with posttraumatic stress disorder: a pilot study comparing prolonged exposure and treatment as usual conducted by community therapists. J Interpers Violence. 2008 Aug;23(8):1027-40. doi: 10.1177/0886260507313967. PMID: 18292398.,82117,2019
feske2008_PDS_B_0_Comp,Psychotherapy,PTSD,27,B,Control,,12,,TAU,Psychotherapy as usual,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,14,Self report,PDS,PDS-I,Completer,,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",End of Treatment,0,,30.42,7.43,,,,,-4.75,,,,,,,,,,,,,,,,,,,,,RCI ≥1.96,0.25,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, community/school violence",High,Feske U. Treating low-income and minority women with posttraumatic stress disorder: a pilot study comparing prolonged exposure and treatment as usual conducted by community therapists. J Interpers Violence. 2008 Aug;23(8):1027-40. doi: 10.1177/0886260507313967. PMID: 18292398.,82117,2019
feske2008_PDS_B_8_Comp,Psychotherapy,PTSD,27,B,Control,,12,,TAU,Psychotherapy as usual,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,14,Self report,PDS,PDS-I,Completer,,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",Assessment at <3 Months,8,,30.5,9.05,,,,,-4.67,,,,,,,,,,,,,,,,,,,,,RCI ≥1.96,0.25,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, community/school violence",High,Feske U. Treating low-income and minority women with posttraumatic stress disorder: a pilot study comparing prolonged exposure and treatment as usual conducted by community therapists. J Interpers Violence. 2008 Aug;23(8):1027-40. doi: 10.1177/0886260507313967. PMID: 18292398.,82117,2019
feske2008_PDS_B_Baseline_Comp,Psychotherapy,PTSD,27,B,Control,,12,,TAU,Psychotherapy as usual,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In Person,14,Self report,PDS,PDS-I,Completer,,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",Baseline,,,35.17,8.31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, community/school violence",High,Feske U. Treating low-income and minority women with posttraumatic stress disorder: a pilot study comparing prolonged exposure and treatment as usual conducted by community therapists. J Interpers Violence. 2008 Aug;23(8):1027-40. doi: 10.1177/0886260507313967. PMID: 18292398.,82117,2019
flanagan2018_CAPS_A_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,17,A,PTSD,,6,,PE + oxytocin,Prolonged Exposure (PE) + oxytocin,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,8,Structured Clinical Interview,CAPS,CAPS-5,Completer,,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.588,0.412,0.177,,0.823,Mixed,"combat-related, rape/sexual assault, accidents, terrorism/political violence/forced displacement, other (assault)",High,"Flanagan JC, Sippel LM, Wahlquist A, et al. Augmenting prolonged exposure therapy for PTSD with intranasal oxytocin: a randomized, placebo-controlled pilot trial. J Psychiatr Res. 2018 Mar;98:64-9. doi: 10.1016/j.jpsychires.2017.12.014. PMID: 29294429.",49583,2019
flanagan2018_CAPS_A_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,17,A,PTSD,,8,,PE + oxytocin,Prolonged Exposure (PE) + oxytocin,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,8,Structured Clinical Interview,CAPS,CAPS-5,Completer,,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",Baseline,,,39.56,13.85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.588,0.412,0.177,,0.823,Mixed,"combat-related, rape/sexual assault, accidents, terrorism/political violence/forced displacement, other (assault)",High,"Flanagan JC, Sippel LM, Wahlquist A, et al. Augmenting prolonged exposure therapy for PTSD with intranasal oxytocin: a randomized, placebo-controlled pilot trial. J Psychiatr Res. 2018 Mar;98:64-9. doi: 10.1016/j.jpsychires.2017.12.014. PMID: 29294429.",49583,2019
flanagan2018_CAPS_B_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,17,B,PTSD,,7,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,9,Structured Clinical Interview,CAPS,CAPS-5,Completer,,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.588,0.412,0.177,,0.823,Mixed,"combat-related, rape/sexual assault, accidents, terrorism/political violence/forced displacement, other (assault)",High,"Flanagan JC, Sippel LM, Wahlquist A, et al. Augmenting prolonged exposure therapy for PTSD with intranasal oxytocin: a randomized, placebo-controlled pilot trial. J Psychiatr Res. 2018 Mar;98:64-9. doi: 10.1016/j.jpsychires.2017.12.014. PMID: 29294429.",49583,2019
flanagan2018_CAPS_B_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,17,B,PTSD,,9,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,9,Structured Clinical Interview,CAPS,CAPS-5,Completer,,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",Baseline,,,39.00,6.32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.588,0.412,0.177,,0.823,Mixed,"combat-related, rape/sexual assault, accidents, terrorism/political violence/forced displacement, other (assault)",High,"Flanagan JC, Sippel LM, Wahlquist A, et al. Augmenting prolonged exposure therapy for PTSD with intranasal oxytocin: a randomized, placebo-controlled pilot trial. J Psychiatr Res. 2018 Mar;98:64-9. doi: 10.1016/j.jpsychires.2017.12.014. PMID: 29294429.",49583,2019
flanagan2018_PCL_A_0_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,17,A,PTSD,,,,PE + oxytocin,Prolonged Exposure (PE) + oxytocin,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,8,Self report,PCL,PCL-5,,,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",End of Treatment,0,,31.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.588,0.412,0.177,,0.823,Mixed,"combat-related, rape/sexual assault, accidents, terrorism/political violence/forced displacement, other (assault)",High,"Flanagan JC, Sippel LM, Wahlquist A, et al. Augmenting prolonged exposure therapy for PTSD with intranasal oxytocin: a randomized, placebo-controlled pilot trial. J Psychiatr Res. 2018 Mar;98:64-9. doi: 10.1016/j.jpsychires.2017.12.014. PMID: 29294429.",49583,2019
flanagan2018_PCL_A_Baseline_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,17,A,PTSD,,,,PE + oxytocin,Prolonged Exposure (PE) + oxytocin,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,8,Self report,PCL,PCL-5,,,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",Baseline,,,53.11,15.12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.588,0.412,0.177,,0.823,Mixed,"combat-related, rape/sexual assault, accidents, terrorism/political violence/forced displacement, other (assault)",High,"Flanagan JC, Sippel LM, Wahlquist A, et al. Augmenting prolonged exposure therapy for PTSD with intranasal oxytocin: a randomized, placebo-controlled pilot trial. J Psychiatr Res. 2018 Mar;98:64-9. doi: 10.1016/j.jpsychires.2017.12.014. PMID: 29294429.",49583,2019
flanagan2018_PCL_B_0_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,17,B,PTSD,,,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,9,Self report,PCL,PCL-5,,,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",End of Treatment,0,,40.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.588,0.412,0.177,,0.823,Mixed,"combat-related, rape/sexual assault, accidents, terrorism/political violence/forced displacement, other (assault)",High,"Flanagan JC, Sippel LM, Wahlquist A, et al. Augmenting prolonged exposure therapy for PTSD with intranasal oxytocin: a randomized, placebo-controlled pilot trial. J Psychiatr Res. 2018 Mar;98:64-9. doi: 10.1016/j.jpsychires.2017.12.014. PMID: 29294429.",49583,2019
flanagan2018_PCL_B_Baseline_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,17,B,PTSD,,,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,9,Self report,PCL,PCL-5,,,"ANCOVA for continuous variables, chi-squared test for dichotomous variables",Baseline,,,52.50,12.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.588,0.412,0.177,,0.823,Mixed,"combat-related, rape/sexual assault, accidents, terrorism/political violence/forced displacement, other (assault)",High,"Flanagan JC, Sippel LM, Wahlquist A, et al. Augmenting prolonged exposure therapy for PTSD with intranasal oxytocin: a randomized, placebo-controlled pilot trial. J Psychiatr Res. 2018 Mar;98:64-9. doi: 10.1016/j.jpsychires.2017.12.014. PMID: 29294429.",49583,2019
foa1991_PSS-I_A_0_Comp,Psychotherapy,PTSD,55,A,PTSD,,14,,SIT,Stress Inoculation Training (SIT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Analyses of end of treatment data using n=45 completers; analyses of followup data using n=27 with followup data (no data for wait list plus lost to followup).,End of Treatment,0,,11.07,3.97,,,,,-13.41,,,,,,,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,0.5,,Posttreatment (followup) scores >2 standard deviations below mean of pretreatment sample,0.7143,,Community,,,1,1,,0,Rape/sexual assault,,High,"Foa EB, Rothbaum BO, Riggs DS, et al. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991 Oct;59(5):715-23.  PMID: 1955605.",02437,2019
foa1991_PSS-I_A_12_Comp,Psychotherapy,PTSD,55,A,PTSD,,9,,SIT,Stress Inoculation Training (SIT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Analyses of end of treatment data using n=45 completers; analyses of followup data using n=27 with followup data (no data for wait list plus lost to followup).,Assessment at 3 to <6 Months,12,,12.33,9.59,,,,-12.15 (NR) (compared to mean score for n=14 with end of treatment assessments); -11.97 (NR) (compared to mean score for n=9 with followup assessments),,,,,,,,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,0.5556,,Posttreatment (followup) scores >2 standard deviations below mean of pretreatment sample,0.6667,,Community,,,1,1,,0,Rape/sexual assault,,High,"Foa EB, Rothbaum BO, Riggs DS, et al. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991 Oct;59(5):715-23.  PMID: 1955605.",02437,2019
foa1991_PSS-I_A_Baseline_Comp,Psychotherapy,PTSD,55,A,PTSD,,14,,SIT,Stress Inoculation Training (SIT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Analyses of end of treatment data using n=45 completers; analyses of followup data using n=27 with followup data (no data for wait list plus lost to followup).,Baseline,,,24.48,6.62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Rape/sexual assault,,High,"Foa EB, Rothbaum BO, Riggs DS, et al. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991 Oct;59(5):715-23.  PMID: 1955605.",02437,2019
foa1991_PSS-I_B_0_Comp,Psychotherapy,PTSD,55,B,PTSD,,10,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,14,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Analyses of end of treatment data using n=45 completers; analyses of followup data using n=27 with followup data (no data for wait list plus lost to followup).,End of Treatment,0,,15.4,11.09,,,,,-10.38,,,,,,,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,0.4,,Posttreatment (followup) scores >2 standard deviations below mean of pretreatment sample,0.4,,Community,,,1,1,,0,Rape/sexual assault,,High,"Foa EB, Rothbaum BO, Riggs DS, et al. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991 Oct;59(5):715-23.  PMID: 1955605.",02437,2019
foa1991_PSS-I_B_12_Comp,Psychotherapy,PTSD,55,B,PTSD,,9,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,14,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Analyses of end of treatment data using n=45 completers; analyses of followup data using n=27 with followup data (no data for wait list plus lost to followup).,Assessment at 3 to <6 Months,12,,10.44,8.22,,,,-15.34 (NR) (compared to mean score for n=10 with end of treatment assessments); -14.57 (NR) (compared to mean score for n=9 with followup assessments),,,,,,,,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,0.5556,,Posttreatment (followup) scores >2 standard deviations below mean of pretreatment sample,0.0556,,Community,,,1,1,,0,Rape/sexual assault,,High,"Foa EB, Rothbaum BO, Riggs DS, et al. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991 Oct;59(5):715-23.  PMID: 1955605.",02437,2019
foa1991_PSS-I_B_Baseline_Comp,Psychotherapy,PTSD,55,B,PTSD,,10,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,14,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Analyses of end of treatment data using n=45 completers; analyses of followup data using n=27 with followup data (no data for wait list plus lost to followup).,Baseline,,,25.78,5.01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Rape/sexual assault,,High,"Foa EB, Rothbaum BO, Riggs DS, et al. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991 Oct;59(5):715-23.  PMID: 1955605.",02437,2019
foa1991_PSS-I_C_0_Comp,Psychotherapy,PTSD,55,C,PTSD,,11,,Supportive Counseling,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,14,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Analyses of end of treatment data using n=45 completers; analyses of followup data using n=27 with followup data (no data for wait list plus lost to followup).,End of Treatment,0,,18.09,7.13,,,,,-6.3,,,,,,,,,,p<0.002,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,0.0909,,Posttreatment (followup) scores >2 standard deviations below mean of pretreatment sample,0.1818,,Community,,,1,1,,0,Rape/sexual assault,,High,"Foa EB, Rothbaum BO, Riggs DS, et al. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991 Oct;59(5):715-23.  PMID: 1955605.",02437,2019
foa1991_PSS-I_C_12_Comp,Psychotherapy,PTSD,55,C,PTSD,,9,,Supportive Counseling,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,14,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Analyses of end of treatment data using n=45 completers; analyses of followup data using n=27 with followup data (no data for wait list plus lost to followup).,Assessment at 3 to <6 Months,12,,16.11,9.37,,,,-8.28 (NR) (compared to mean score for n=11 with end of treatment assessments); -9.14 (NR) (compared to mean score for n=9 with followup assessments),,,,,,,,,,,p<0.002,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,0.4444,,Posttreatment (followup) scores >2 standard deviations below mean of pretreatment sample,0.3333,,Community,,,1,1,,0,Rape/sexual assault,,High,"Foa EB, Rothbaum BO, Riggs DS, et al. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991 Oct;59(5):715-23.  PMID: 1955605.",02437,2019
foa1991_PSS-I_C_Baseline_Comp,Psychotherapy,PTSD,55,C,PTSD,,11,,Supportive Counseling,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,14,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Analyses of end of treatment data using n=45 completers; analyses of followup data using n=27 with followup data (no data for wait list plus lost to followup).,Baseline,,,24.39,6.62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Rape/sexual assault,,High,"Foa EB, Rothbaum BO, Riggs DS, et al. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991 Oct;59(5):715-23.  PMID: 1955605.",02437,2019
foa1991_PSS-I_D_0_Comp,Psychotherapy,PTSD,55,D,Control,,10,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,,,10,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Analyses of end of treatment data using n=45 completers; analyses of followup data using n=27 with followup data (no data for wait list plus lost to followup).,End of Treatment,0,,19.5,7.18,,,,,-4.93,,,,,,,,,,p<0.02,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,0,,Posttreatment (followup) scores >2 standard deviations below mean of pretreatment sample,0.2,,Community,,,1,1,,0,Rape/sexual assault,,High,"Foa EB, Rothbaum BO, Riggs DS, et al. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991 Oct;59(5):715-23.  PMID: 1955605.",02437,2019
foa1991_PSS-I_D_Baseline_Comp,Psychotherapy,PTSD,55,D,Control,,10,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,,,10,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Analyses of end of treatment data using n=45 completers; analyses of followup data using n=27 with followup data (no data for wait list plus lost to followup).,Baseline,,,24.43,4.64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Rape/sexual assault,,High,"Foa EB, Rothbaum BO, Riggs DS, et al. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991 Oct;59(5):715-23.  PMID: 1955605.",02437,2019
foa1999_PSS-I_A_0_Comp,Psychotherapy,PTSD,96,A,PTSD,,23,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,PSS-I,PSS-I,Completer,"mean of the scores at the assessment points preceding and following the missing assessment, or LOCF",ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,End of Treatment,0,,11.7,7.32,,,,,-17.78,,,,,,,,,,,,,,,,,,No longer met diagnostic criteria for PTSD on the PSS-I,0.6522,,PSS-I score <20,0.5652,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_A_0_ITT,Psychotherapy,PTSD,96,A,PTSD,,25,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,PSS-I,PSS-I,ITT,LOCF,ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,No longer met diagnostic criteria for PTSD on the PSS-I,0.6,,PSS-I score <20,0.52,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_A_12_Comp,Psychotherapy,PTSD,96,A,PTSD,,19,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,PSS-I,PSS-I,Completer,"mean of the scores at the assessment points preceding and following the missing assessment, or LOCF",ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,Assessment at 3 to <6 Months,12,,11.84,9.01,,,,,-17.64,,,,,,,,,,,,,,,,,,No longer met diagnostic criteria for PTSD on the PSS-I,,,PSS-I score <20,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_A_26_Comp,Psychotherapy,PTSD,96,A,PTSD,,19,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,PSS-I,PSS-I,Completer,"mean of the scores at the assessment points preceding and following the missing assessment, or LOCF",ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,Assessment at 6 to <12 Months,26,,11.16,7.38,,,,,-18.32,,,,,,,,,,,,,,,,,,No longer met diagnostic criteria for PTSD on the PSS-I,,,PSS-I score <20,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_A_52_Comp,Psychotherapy,PTSD,96,A,PTSD,,16,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,PSS-I,PSS-I,Completer,"mean of the scores at the assessment points preceding and following the missing assessment, or LOCF",ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,Assessment at ≥12 Months,52,,10.69,8.96,,,,,-18.79,,,,,,,,,,,,,,,,,,No longer met diagnostic criteria for PTSD on the PSS-I,0.6522,,PSS-I score <20,0.5217,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_A_Baseline_Comp,Psychotherapy,PTSD,96,A,PTSD,,23,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,PSS-I,PSS-I,Completer,"mean of the scores at the assessment points preceding and following the missing assessment, or LOCF",ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,Baseline,,,29.48,9.94,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_A_Baseline_ITT,Psychotherapy,PTSD,96,A,PTSD,,25,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,PSS-I,PSS-I,ITT,LOCF,ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_B_0_Comp,Psychotherapy,PTSD,96,B,PTSD,,19,,SIT,Stress Inoculation Training (SIT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,26,Structured Clinical Interview,PSS-I,PSS-I,Completer,"mean of the scores at the assessment points preceding and following the missing assessment, or LOCF",ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,End of Treatment,0,,12.89,8.96,,,,,-16.53,,,,,,,,,,,,,,,,,,No longer met diagnostic criteria for PTSD on the PSS-I,0.5789,,PSS-I score <20,0.4211,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_B_0_ITT,Psychotherapy,PTSD,96,B,PTSD,,26,,SIT,Stress Inoculation Training (SIT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,26,Structured Clinical Interview,PSS-I,PSS-I,ITT,LOCF,ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,No longer met diagnostic criteria for PTSD on the PSS-I,0.4231,,PSS-I score <20,0.3077,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_B_12_Comp,Psychotherapy,PTSD,96,B,PTSD,,16,,SIT,Stress Inoculation Training (SIT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,26,Structured Clinical Interview,PSS-I,PSS-I,Completer,"mean of the scores at the assessment points preceding and following the missing assessment, or LOCF",ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,Assessment at 3 to <6 Months,12,,15.06,13.33,,,,,-14.36,,,,,,,,,,,,,,,,,,No longer met diagnostic criteria for PTSD on the PSS-I,,,PSS-I score <20,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_B_26_Comp,Psychotherapy,PTSD,96,B,PTSD,,17,,SIT,Stress Inoculation Training (SIT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,26,Structured Clinical Interview,PSS-I,PSS-I,Completer,"mean of the scores at the assessment points preceding and following the missing assessment, or LOCF",ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,Assessment at 6 to <12 Months,26,,11.24,11.86,,,,,-18.18,,,,,,,,,,,,,,,,,,No longer met diagnostic criteria for PTSD on the PSS-I,,,PSS-I score <20,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_B_52_Comp,Psychotherapy,PTSD,96,B,PTSD,,14,,SIT,Stress Inoculation Training (SIT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,26,Structured Clinical Interview,PSS-I,PSS-I,Completer,"mean of the scores at the assessment points preceding and following the missing assessment, or LOCF",ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,Assessment at ≥12 Months,52,,12.64,14.71,,,,,-16.78,,,,,,,,,,,,,,,,,,No longer met diagnostic criteria for PTSD on the PSS-I,0.6842,,PSS-I score <20,0.4211,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_B_Baseline_Comp,Psychotherapy,PTSD,96,B,PTSD,,19,,SIT,Stress Inoculation Training (SIT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,26,Structured Clinical Interview,PSS-I,PSS-I,Completer,"mean of the scores at the assessment points preceding and following the missing assessment, or LOCF",ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,Baseline,,,29.42,8.69,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_B_Baseline_ITT,Psychotherapy,PTSD,96,B,PTSD,,26,,SIT,Stress Inoculation Training (SIT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,26,Structured Clinical Interview,PSS-I,PSS-I,ITT,LOCF,ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_C_0_Comp,Psychotherapy,PTSD,96,C,PTSD,,22,,PE + SIT,Prolonged Exposure (PE) + Stress Inoculation Training (SIT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,PSS-I,PSS-I,Completer,"mean of the scores at the assessment points preceding and following the missing assessment, or LOCF",ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,End of Treatment,0,,13.55,9.35,,,,,-16.4,,,,,,,,,,,,,,,,,,No longer met diagnostic criteria for PTSD on the PSS-I,0.5455,,PSS-I score <20,0.3636,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_C_0_ITT,Psychotherapy,PTSD,96,C,PTSD,,30,,PE + SIT,Prolonged Exposure (PE) + Stress Inoculation Training (SIT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,PSS-I,PSS-I,ITT,LOCF,ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,No longer met diagnostic criteria for PTSD on the PSS-I,0.4,,PSS-I score <20,0.2667,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_C_12_Comp,Psychotherapy,PTSD,96,C,PTSD,,20,,PE + SIT,Prolonged Exposure (PE) + Stress Inoculation Training (SIT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,PSS-I,PSS-I,Completer,"mean of the scores at the assessment points preceding and following the missing assessment, or LOCF",ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,Assessment at 3 to <6 Months,12,,11.45,9.03,,,,,-18.5,,,,,,,,,,,,,,,,,,No longer met diagnostic criteria for PTSD on the PSS-I,,,PSS-I score <20,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_C_26_Comp,Psychotherapy,PTSD,96,C,PTSD,,18,,PE + SIT,Prolonged Exposure (PE) + Stress Inoculation Training (SIT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,PSS-I,PSS-I,Completer,"mean of the scores at the assessment points preceding and following the missing assessment, or LOCF",ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,Assessment at 6 to <12 Months,26,,13.17,10.98,,,,,-16.78,,,,,,,,,,,,,,,,,,No longer met diagnostic criteria for PTSD on the PSS-I,,,PSS-I score <20,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_C_52_Comp,Psychotherapy,PTSD,96,C,PTSD,,16,,PE + SIT,Prolonged Exposure (PE) + Stress Inoculation Training (SIT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,PSS-I,PSS-I,Completer,"mean of the scores at the assessment points preceding and following the missing assessment, or LOCF",ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,Assessment at ≥12 Months,52,,12.56,12.25,,,,,-17.39,,,,,,,,,,,,,,,,,,No longer met diagnostic criteria for PTSD on the PSS-I,0.6818,,PSS-I score <20,0.3636,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_C_Baseline_Comp,Psychotherapy,PTSD,96,C,PTSD,,22,,PE + SIT,Prolonged Exposure (PE) + Stress Inoculation Training (SIT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,PSS-I,PSS-I,Completer,"mean of the scores at the assessment points preceding and following the missing assessment, or LOCF",ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,Baseline,,,29.95,6.97,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_C_Baseline_ITT,Psychotherapy,PTSD,96,C,PTSD,,30,,PE + SIT,Prolonged Exposure (PE) + Stress Inoculation Training (SIT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,PSS-I,PSS-I,ITT,LOCF,ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_D_0_Comp,Psychotherapy,PTSD,96,D,Control,,15,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,15,Structured Clinical Interview,PSS-I,PSS-I,Completer,"mean of the scores at the assessment points preceding and following the missing assessment, or LOCF",ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,End of Treatment,0,,26.93,8.47,,,,,-6,,,,,,,,,,,,,,,,,,No longer met diagnostic criteria for PTSD on the PSS-I,0,,PSS-I score <20,0,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_D_0_ITT,Psychotherapy,PTSD,96,D,Control,,15,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,15,Structured Clinical Interview,PSS-I,PSS-I,ITT,LOCF,ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,No longer met diagnostic criteria for PTSD on the PSS-I,0,,PSS-I score <20,0,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_D_Baseline_Comp,Psychotherapy,PTSD,96,D,Control,,15,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,15,Structured Clinical Interview,PSS-I,PSS-I,Completer,"mean of the scores at the assessment points preceding and following the missing assessment, or LOCF",ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,Baseline,,,32.93,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa1999_PSS-I_D_Baseline_ITT,Psychotherapy,PTSD,96,D,Control,,15,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,15,Structured Clinical Interview,PSS-I,PSS-I,ITT,LOCF,ANCOVAs (following significant MANCOVA) with simple comparisons; repeated measures ANCOVAs for followup assessment periods; chi-squared for categorical outcomes.,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",Medium,"Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.",09724,2019
foa2005_PSS-I_A_0_Comp,Psychotherapy,PTSD,104,A,PTSD,,44,,PE + CR,Prolonged Exposure (PE) plus cognitive restructuring,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,74,Structured Clinical Interview,PSS-I,PSS-I,Completer,,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,9.3,9.2,,,,,-21.6,,,,,Cohen's d,2.39,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child sexual abuse",Medium,"Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.",27946,2019
foa2005_PSS-I_A_0_ITT,Psychotherapy,PTSD,104,A,PTSD,,74,,PE + CR,Prolonged Exposure (PE) plus cognitive restructuring,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,74,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Substitution for posttreatment; for follow-up assessments, used mean of preceding and following scores if available, otherwise LOCF.","Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,16.8,13.2,,,,,-14.3,,,,,Cohen's d,1.3,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child sexual abuse",Medium,"Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.",27946,2019
foa2005_PSS-I_A_12_Comp,Psychotherapy,PTSD,104,A,PTSD,,42,,PE + CR,Prolonged Exposure (PE) plus cognitive restructuring,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,74,Structured Clinical Interview,PSS-I,PSS-I,Completer,,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 3 to <6 Months,12,,7.7,7.8,,,,,-23.2,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child sexual abuse",Medium,"Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.",27946,2019
foa2005_PSS-I_A_26_Comp,Psychotherapy,PTSD,104,A,PTSD,,42,,PE + CR,Prolonged Exposure (PE) plus cognitive restructuring,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,74,Structured Clinical Interview,PSS-I,PSS-I,Completer,,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 6 to <12 Months,26,,8.4,9.1,,,,,-22.5,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child sexual abuse",Medium,"Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.",27946,2019
foa2005_PSS-I_A_52_Comp,Psychotherapy,PTSD,104,A,PTSD,,42,,PE + CR,Prolonged Exposure (PE) plus cognitive restructuring,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,74,Structured Clinical Interview,PSS-I,PSS-I,Completer,,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at ≥12 Months,52,,7.6,8.8,,,,,-23.3,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child sexual abuse",Medium,"Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.",27946,2019
foa2005_PSS-I_A_Baseline_Comp,Psychotherapy,PTSD,104,A,PTSD,,44,,PE + CR,Prolonged Exposure (PE) plus cognitive restructuring,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,74,Structured Clinical Interview,PSS-I,PSS-I,Completer,,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,30.9,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child sexual abuse",Medium,"Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.",27946,2019
foa2005_PSS-I_A_Baseline_ITT,Psychotherapy,PTSD,104,A,PTSD,,74,,PE + CR,Prolonged Exposure (PE) plus cognitive restructuring,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,74,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Substitution for posttreatment; for follow-up assessments, used mean of preceding and following scores if available, otherwise LOCF.","Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,31.1,8.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child sexual abuse",Medium,"Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.",27946,2019
foa2005_PSS-I_B_0_Comp,Psychotherapy,PTSD,104,B,PTSD,,52,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,79,Structured Clinical Interview,PSS-I,PSS-I,Completer,,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,9.3,8.4,,,,,-23.9,,,,,Cohen's d,3.31,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child sexual abuse",Medium,"Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.",27946,2019
foa2005_PSS-I_B_0_ITT,Psychotherapy,PTSD,104,B,PTSD,,79,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,79,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Substitution for posttreatment; for follow-up assessments, used mean of preceding and following scores if available, otherwise LOCF.","Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,17.9,14.5,,,,,-16.1,,,,,Cohen's d,1.37,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child sexual abuse",Medium,"Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.",27946,2019
foa2005_PSS-I_B_12_Comp,Psychotherapy,PTSD,104,B,PTSD,,47,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,79,Structured Clinical Interview,PSS-I,PSS-I,Completer,,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 3 to <6 Months,12,,8,7.6,,,,,-25.2,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child sexual abuse",Medium,"Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.",27946,2019
foa2005_PSS-I_B_26_Comp,Psychotherapy,PTSD,104,B,PTSD,,47,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,79,Structured Clinical Interview,PSS-I,PSS-I,Completer,,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 6 to <12 Months,26,,8.9,8.8,,,,,-24.3,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child sexual abuse",Medium,"Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.",27946,2019
foa2005_PSS-I_B_52_Comp,Psychotherapy,PTSD,104,B,PTSD,,47,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,79,Structured Clinical Interview,PSS-I,PSS-I,Completer,,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at ≥12 Months,52,,8.9,8.7,,,,,-24.3,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child sexual abuse",Medium,"Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.",27946,2019
foa2005_PSS-I_B_Baseline_Comp,Psychotherapy,PTSD,104,B,PTSD,,52,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,79,Structured Clinical Interview,PSS-I,PSS-I,Completer,,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,33.2,5.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child sexual abuse",Medium,"Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.",27946,2019
foa2005_PSS-I_B_Baseline_ITT,Psychotherapy,PTSD,104,B,PTSD,,79,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,79,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Substitution for posttreatment; for follow-up assessments, used mean of preceding and following scores if available, otherwise LOCF.","Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,34,5.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child sexual abuse",Medium,"Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.",27946,2019
foa2005_PSS-I_C_0_Comp,Psychotherapy,PTSD,104,C,Control,,25,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,26,Structured Clinical Interview,PSS-I,PSS-I,Completer,,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,26.2,9.4,,,,,-6.8,,,,,Cohen's d,0.86,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child sexual abuse",Medium,"Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.",27946,2019
foa2005_PSS-I_C_0_ITT,Psychotherapy,PTSD,104,C,Control,,26,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,26,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Substitution for posttreatment; for follow-up assessments, used mean of preceding and following scores if available, otherwise LOCF.","Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,26.8,9.6,,,,,-6.5,,,,,Cohen's d,0.8,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child sexual abuse",Medium,"Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.",27946,2019
foa2005_PSS-I_C_Baseline_Comp,Psychotherapy,PTSD,104,C,Control,,25,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,26,Structured Clinical Interview,PSS-I,PSS-I,Completer,,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,33,6.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child sexual abuse",Medium,"Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.",27946,2019
foa2005_PSS-I_C_Baseline_ITT,Psychotherapy,PTSD,104,C,Control,,26,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,26,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Substitution for posttreatment; for follow-up assessments, used mean of preceding and following scores if available, otherwise LOCF.","Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,33.3,6.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child sexual abuse",Medium,"Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.",27946,2019
foa2013_PSS-I_A_0_ITT,Psychotherapy,PTSD+SUD,165,A,PTSD+SUD,Not integrated,23,,PE + naltrexone,Prolonged Exposure (PE) + naltrexone,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In person,40,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Models, no replacement or imputation","Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,12.2,,95% CI,8.2,16.1,,-19.1,,-23.1,-15.09,,,,,,,,,,,,,,,,,,≤10 on PSS-I at 6 months after end of treatment,,,Mixed,0,0.1152,0.8848,0.3455,,0.6545,Mixed,Combat-related; Rape/sexual assault; Community/school violence; Other (not specified),High,"Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268. PMID: 23925619.",40905,2020
foa2013_PSS-I_A_26_ITT,Psychotherapy,PTSD+SUD,165,A,PTSD+SUD,Not integrated,22,,PE + naltrexone,Prolonged Exposure (PE) + naltrexone,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In person,40,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Models, no replacement or imputation","Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 6 to <12 Months,26,,7.9,,95% CI,4.1,11.8,,,,,,,,,,,,,,,,,,,,,,,≤10 on PSS-I at 6 months after end of treatment,0.7,,Mixed,0,0.1152,0.8848,0.3455,,0.6545,Mixed,Combat-related; Rape/sexual assault; Community/school violence; Other (not specified),High,"Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268. PMID: 23925619.",40905,2020
foa2013_PSS-I_A_Baseline_ITT,Psychotherapy,PTSD+SUD,165,A,PTSD+SUD,Not integrated,40,,PE + naltrexone,Prolonged Exposure (PE) + naltrexone,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In person,40,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Models, no replacement or imputation","Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,30.3,,95% CI,27.7,32.9,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.1152,0.8848,0.3455,,0.6545,Mixed,Combat-related; Rape/sexual assault; Community/school violence; Other (not specified),High,"Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268. PMID: 23925619.",40905,2020
foa2013_PSS-I_B_0_ITT,Psychotherapy,PTSD+SUD,165,B,PTSD+SUD,Not integrated,24,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,40,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Models, no replacement or imputation","Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,13.3,,95% CI,9.3,17.3,,-16.1,,-20.8,-11.3,,,,,,,,,,,,,,,,,,≤10 on PSS-I at 6 months after end of treatment,,,Mixed,0,0.1152,0.8848,0.3455,,0.6545,Mixed,Combat-related; Rape/sexual assault; Community/school violence; Other (not specified),High,"Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268. PMID: 23925619.",40905,2020
foa2013_PSS-I_B_26_ITT,Psychotherapy,PTSD+SUD,165,B,PTSD+SUD,Not integrated,22,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,40,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Models, no replacement or imputation","Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 6 to <12 Months,26,,10.8,,95% CI,6.3,15.2,,,,,,,,,,,,,,,,,,,,,,,≤10 on PSS-I at 6 months after end of treatment,0.55,,Mixed,0,0.1152,0.8848,0.3455,,0.6545,Mixed,Combat-related; Rape/sexual assault; Community/school violence; Other (not specified),High,"Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268. PMID: 23925619.",40905,2020
foa2013_PSS-I_B_Baseline_ITT,Psychotherapy,PTSD+SUD,165,B,PTSD+SUD,Not integrated,40,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,40,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Models, no replacement or imputation","Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,27.7,,95% CI,24.7,30.8,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.1152,0.8848,0.3455,,0.6545,Mixed,Combat-related; Rape/sexual assault; Community/school violence; Other (not specified),High,"Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268. PMID: 23925619.",40905,2020
foa2013_PSS-I_C_0_ITT,Psychotherapy,PTSD+SUD,165,C,SUD,Not integrated,20,,Supportive counseling + naltrexone,Supportive counseling + naltrexone,Yes,Non-TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In person,42,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Models, no replacement or imputation","Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,15.3,,95% CI,12.2,18.3,,-12.4,,-15.79,-8.97,,,,,,,,,,,,,,,,,,≤10 on PSS-I at 6 months after end of treatment,,,Mixed,0,0.1152,0.8848,0.3455,,0.6545,Mixed,Combat-related; Rape/sexual assault; Community/school violence; Other (not specified),High,"Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268. PMID: 23925619.",40905,2020
foa2013_PSS-I_C_26_ITT,Psychotherapy,PTSD+SUD,165,C,SUD,Not integrated,19,,Supportive counseling + naltrexone,Supportive counseling + naltrexone,Yes,Non-TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In person,42,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Models, no replacement or imputation","Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 6 to <12 Months,26,,10.9,,95% CI,7.2,14.6,,,,,,,,,,,,,,,,,,,,,,,≤10 on PSS-I at 6 months after end of treatment,0.439,,Mixed,0,0.1152,0.8848,0.3455,,0.6545,Mixed,Combat-related; Rape/sexual assault; Community/school violence; Other (not specified),High,"Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268. PMID: 23925619.",40905,2020
foa2013_PSS-I_C_Baseline_ITT,Psychotherapy,PTSD+SUD,165,C,SUD,Not integrated,42,,Supportive counseling + naltrexone,Supportive counseling + naltrexone,Yes,Non-TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In person,42,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Models, no replacement or imputation","Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,27.1,,95% CI,24.7,30.8,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.1152,0.8848,0.3455,,0.6545,Mixed,Combat-related; Rape/sexual assault; Community/school violence; Other (not specified),High,"Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268. PMID: 23925619.",40905,2020
foa2013_PSS-I_D_0_ITT,Psychotherapy,PTSD+SUD,165,D,SUD,Not integrated,26,,Supportive counseling + placebo,Supportive counseling + placebo,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,43,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Models, no replacement or imputation","Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,15.5,,95% CI,12.4,18.6,,-11.6,,-14.1,-9.1,,,,,,,,,,,,,,,,,,≤10 on PSS-I at 6 months after end of treatment,,,Mixed,0,0.1152,0.8848,0.3455,,0.6545,Mixed,Combat-related; Rape/sexual assault; Community/school violence; Other (not specified),High,"Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268. PMID: 23925619.",40905,2020
foa2013_PSS-I_D_26_ITT,Psychotherapy,PTSD+SUD,165,D,SUD,Not integrated,30,,Supportive counseling + placebo,Supportive counseling + placebo,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,43,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Models, no replacement or imputation","Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 6 to <12 Months,26,,11.1,,95% CI,8.2,14.1,,,,,,,,,,,,,,,,,,,,,,,≤10 on PSS-I at 6 months after end of treatment,0.372,,Mixed,0,0.1152,0.8848,0.3455,,0.6545,Mixed,Combat-related; Rape/sexual assault; Community/school violence; Other (not specified),High,"Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268. PMID: 23925619.",40905,2020
foa2013_PSS-I_D_Baseline_ITT,Psychotherapy,PTSD+SUD,165,D,SUD,Not integrated,43,,Supportive counseling + placebo,Supportive counseling + placebo,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,43,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Models, no replacement or imputation","Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,27.5,,95% CI,25.4,29.6,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.1152,0.8848,0.3455,,0.6545,Mixed,Combat-related; Rape/sexual assault; Community/school violence; Other (not specified),High,"Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268. PMID: 23925619.",40905,2020
foa2017_PSS-I_A_0_ITT,Psychotherapy,PTSD+SUD,142,A,PTSD+SUD,Integrated,64,,PE + smoking cessation counseling + varenicline,Prolonged Exposure (PE) + smoking cessation counseling + varenicline,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In person,72,Structured Clinical Interview,PSS-I,PSS-I,ITT,Model,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,11.5,,,,,,-16,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.3944,,0.6056,Mixed,"Combat-related; Child sexual abuse; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (imprisonment, torture, other)",Medium,"Foa EB, Asnaani A, Rosenfield D, et al. Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: a randomized controlled trial. J Consult Clin Psychol. 2017 Sep;85(9):862-72. doi: 10.1037/ccp0000213. PMID: 28569519.",48569,2020
foa2017_PSS-I_A_12_ITT,Psychotherapy,PTSD+SUD,142,A,PTSD+SUD,Integrated,63,,PE + smoking cessation counseling + varenicline,Prolonged Exposure (PE) + smoking cessation counseling + varenicline,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In person,72,Structured Clinical Interview,PSS-I,PSS-I,ITT,Model,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 3 to <6 Months,12,,10.8,,,,,,-16.7,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.3944,,0.6056,Mixed,"Combat-related; Child sexual abuse; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (imprisonment, torture, other)",Medium,"Foa EB, Asnaani A, Rosenfield D, et al. Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: a randomized controlled trial. J Consult Clin Psychol. 2017 Sep;85(9):862-72. doi: 10.1037/ccp0000213. PMID: 28569519.",48569,2020
foa2017_PSS-I_A_Baseline_ITT,Psychotherapy,PTSD+SUD,142,A,PTSD+SUD,Integrated,72,,PE + smoking cessation counseling + varenicline,Prolonged Exposure (PE) + smoking cessation counseling + varenicline,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In person,72,Structured Clinical Interview,PSS-I,PSS-I,ITT,Model,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,27.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.3944,,0.6056,Mixed,"Combat-related; Child sexual abuse; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (imprisonment, torture, other)",Medium,"Foa EB, Asnaani A, Rosenfield D, et al. Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: a randomized controlled trial. J Consult Clin Psychol. 2017 Sep;85(9):862-72. doi: 10.1037/ccp0000213. PMID: 28569519.",48569,2020
foa2017_PSS-I_B_0_ITT,Psychotherapy,PTSD+SUD,142,B,SUD,Not integrated,64,,Smoking cessation counseling + varenicline,Smoking cessation counseling + varenicline,Yes,Non-TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In person,70,Structured Clinical Interview,PSS-I,PSS-I,ITT,Model,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,19.3,,,,,,-9.6,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.3944,,0.6056,Mixed,"Combat-related; Child sexual abuse; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (imprisonment, torture, other)",Medium,"Foa EB, Asnaani A, Rosenfield D, et al. Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: a randomized controlled trial. J Consult Clin Psychol. 2017 Sep;85(9):862-72. doi: 10.1037/ccp0000213. PMID: 28569519.",48569,2020
foa2017_PSS-I_B_12_ITT,Psychotherapy,PTSD+SUD,142,B,SUD,Not integrated,62,,Smoking cessation counseling + varenicline,Smoking cessation counseling + varenicline,Yes,Non-TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In person,70,Structured Clinical Interview,PSS-I,PSS-I,ITT,Model,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 3 to <6 Months,12,,16.8,,,,,,-12.1,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.3944,,0.6056,Mixed,"Combat-related; Child sexual abuse; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (imprisonment, torture, other)",Medium,"Foa EB, Asnaani A, Rosenfield D, et al. Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: a randomized controlled trial. J Consult Clin Psychol. 2017 Sep;85(9):862-72. doi: 10.1037/ccp0000213. PMID: 28569519.",48569,2020
foa2017_PSS-I_B_Baseline_ITT,Psychotherapy,PTSD+SUD,142,B,SUD,Not integrated,70,,Smoking cessation counseling + varenicline,Smoking cessation counseling + varenicline,Yes,Non-TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In person,70,Structured Clinical Interview,PSS-I,PSS-I,ITT,Model,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,28.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.3944,,0.6056,Mixed,"Combat-related; Child sexual abuse; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (imprisonment, torture, other)",Medium,"Foa EB, Asnaani A, Rosenfield D, et al. Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: a randomized controlled trial. J Consult Clin Psychol. 2017 Sep;85(9):862-72. doi: 10.1037/ccp0000213. PMID: 28569519.",48569,2020
foa2018_PCL_A_0_ITT,Psychotherapy,PTSD,370,A,PTSD,,,,Massed PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Self report,PCL,PCL-S,ITT,Linear mixed models and generalized linear models using available data (no imputation),"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,41.95,,95% CI,40.04,43.86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PCL_A_12_ITT,Psychotherapy,PTSD,370,A,PTSD,,,,Massed PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Self report,PCL,PCL-S,ITT,Linear mixed models and generalized linear models using available data (no imputation),"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 3 to <6 Months,12,,42.80,,95% CI,40.94,44.65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PCL_A_2_ITT,Psychotherapy,PTSD,370,A,PTSD,,,,Massed PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Self report,PCL,PCL-S,ITT,Linear mixed models and generalized linear models using available data (no imputation),"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at <3 Months,2,,42.09,,95% CI,40.24,43.94,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PCL_A_26_ITT,Psychotherapy,PTSD,370,A,PTSD,,,,Massed PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Self report,PCL,PCL-S,ITT,Linear mixed models and generalized linear models using available data (no imputation),"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 6 to <12 Months,26,,43.78,,95% CI,41.26,46.31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PCL_A_Baseline_ITT,Psychotherapy,PTSD,370,A,PTSD,,,,Massed PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Self report,PCL,PCL-S,ITT,Linear mixed models and generalized linear models using available data (no imputation),"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,56.47,,95% CI,54.46,58.48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PCL_B_0_ITT,Psychotherapy,PTSD,370,B,PTSD,,,,Spaced PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Self report,PCL,PCL-S,ITT,Linear mixed models and generalized linear models using available data (no imputation),"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,40.98,,95% CI,38.95,43.02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PCL_B_12_ITT,Psychotherapy,PTSD,370,B,PTSD,,,,Spaced PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Self report,PCL,PCL-S,ITT,Linear mixed models and generalized linear models using available data (no imputation),"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 3 to <6 Months,12,,42.25,,95% CI,40.26,44.24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PCL_B_2_ITT,Psychotherapy,PTSD,370,B,PTSD,,,,Spaced PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Self report,PCL,PCL-S,ITT,Linear mixed models and generalized linear models using available data (no imputation),"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at <3 Months,2,,41.20,,95% CI,39.21,43.18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PCL_B_26_ITT,Psychotherapy,PTSD,370,B,PTSD,,,,Spaced PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Self report,PCL,PCL-S,ITT,Linear mixed models and generalized linear models using available data (no imputation),"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 6 to <12 Months,26,,43.72,,95% CI,41.13,46.31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PCL_B_Baseline_ITT,Psychotherapy,PTSD,370,B,PTSD,,,,Spaced PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Self report,PCL,PCL-S,ITT,Linear mixed models and generalized linear models using available data (no imputation),"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,55.37,,95% CI,53.4,57.34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PCL_C_0_ITT,Psychotherapy,PTSD,370,C,PTSD,,,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Self report,PCL,PCL-S,ITT,Linear mixed models and generalized linear models using available data (no imputation),"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,43.45,,95% CI,41.51,45.38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PCL_C_12_ITT,Psychotherapy,PTSD,370,C,PTSD,,,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Self report,PCL,PCL-S,ITT,Linear mixed models and generalized linear models using available data (no imputation),"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 3 to <6 Months,12,,43.67,,95% CI,41.48,45.87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PCL_C_2_ITT,Psychotherapy,PTSD,370,C,PTSD,,,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Self report,PCL,PCL-S,ITT,Linear mixed models and generalized linear models using available data (no imputation),"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at <3 Months,2,,43.48,,95% CI,41.56,45.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PCL_C_26_ITT,Psychotherapy,PTSD,370,C,PTSD,,,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Self report,PCL,PCL-S,ITT,Linear mixed models and generalized linear models using available data (no imputation),"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 6 to <12 Months,26,,43.94,,95% CI,40.71,47.16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PCL_C_Baseline_ITT,Psychotherapy,PTSD,370,C,PTSD,,,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Self report,PCL,PCL-S,ITT,Linear mixed models and generalized linear models using available data (no imputation),"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,54.77,,95% CI,52.82,56.73,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PCL_D_0_ITT,Psychotherapy,PTSD,370,D,Control,,,,Minimal contact,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,40,Self report,PCL,PCL-S,ITT,Linear mixed models and generalized linear models using available data (no imputation),"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,51.58,,95% CI,48.72,54.45,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PCL_D_12_ITT,Psychotherapy,PTSD,370,D,Control,,,,Minimal contact,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,40,Self report,PCL,PCL-S,ITT,Linear mixed models and generalized linear models using available data (no imputation),"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PCL_D_2_ITT,Psychotherapy,PTSD,370,D,Control,,,,Minimal contact,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,40,Self report,PCL,PCL-S,ITT,Linear mixed models and generalized linear models using available data (no imputation),"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at <3 Months,2,,49.25,,95% CI,46.35,52.14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PCL_D_26_ITT,Psychotherapy,PTSD,370,D,Control,,,,Minimal contact,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,40,Self report,PCL,PCL-S,ITT,Linear mixed models and generalized linear models using available data (no imputation),"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 6 to <12 Months,26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PCL_D_Baseline_ITT,Psychotherapy,PTSD,370,D,Control,,,,Minimal contact,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,40,Self report,PCL,PCL-S,ITT,Linear mixed models and generalized linear models using available data (no imputation),"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,55.38,,95% CI,52.52,58.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_A_0_I-H1,Psychotherapy,PTSD,370,A,PTSD,,63,,Massed PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 1""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_A_0_I-H2,Psychotherapy,PTSD,370,A,PTSD,,93,,Massed PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 2""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,18.80,,95% CI,17.51,20.09,,-6.4,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.455,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_A_12_I-H2,Psychotherapy,PTSD,370,A,PTSD,,65,,Massed PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 2""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 3 to <6 Months,12,,18.88,,95% CI,17.7,20.07,,-6.32,,-8.89,-3.74,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.428,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_A_2_I-H1,Psychotherapy,PTSD,370,A,PTSD,,59,,Massed PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 1""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at <3 Months,2,,17.62,,95% CI,16.12,19.11,,-7.13,,-8.96,-5.3,,Cohen's d,1.04,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to PSS-I,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_A_2_I-H2,Psychotherapy,PTSD,370,A,PTSD,,85,,Massed PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 2""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at <3 Months,2,,18.82,,95% CI,17.59,20.04,,-6.38,,-9,-3.77,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.45,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_A_26_I-H2,Psychotherapy,PTSD,370,A,PTSD,,56,,Massed PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 2""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 6 to <12 Months,26,,18.97,,95% CI,17.17,20.78,,-6.23,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.397,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_A_Baseline_I-H1,Psychotherapy,PTSD,370,A,PTSD,,75,,Massed PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 1""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,24.74,,95% CI,23.41,26.08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_A_Baseline_I-H2,Psychotherapy,PTSD,370,A,PTSD,,110,,Massed PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 2""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,25.20,,95% CI,23.81,26.59,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_B_0_I-H2,Psychotherapy,PTSD,370,B,PTSD,,79,,Spaced PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 2""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,17.96,,95% CI,16.6,19.33,,-7.35,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.486,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_B_0_I-H3,Psychotherapy,PTSD,370,B,PTSD,,79,,Spaced PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 3""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,18.46,,95% CI,17.12,19.81,,-7.21,,-8.9,-5.52,,Cohen's d,0.84,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to PSS-I,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_B_12_I-H2,Psychotherapy,PTSD,370,B,PTSD,,63,,Spaced PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 2""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 3 to <6 Months,12,,18.34,,95% CI,17.04,19.64,,-6.97,,-9.62,-4.31,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.433,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_B_2_I-H2,Psychotherapy,PTSD,370,B,PTSD,,76,,Spaced PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 2""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at <3 Months,2,,18.03,,95% CI,16.71,19.34,,-7.29,,-9.95,-4.61,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.477,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_B_26_I-H2,Psychotherapy,PTSD,370,B,PTSD,,49,,Spaced PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 2""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 6 to <12 Months,26,,18.77,,95% CI,16.88,20.67,,-6.54,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.373,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_B_Baseline_I-H2,Psychotherapy,PTSD,370,B,PTSD,,109,,Spaced PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 2""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,25.31,,95% CI,23.95,26.66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_B_Baseline_I-H3,Psychotherapy,PTSD,370,B,PTSD,,109,,Spaced PE Therapy,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 3""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,25.67,,95% CI,24.41,26.94,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_C_0_I-H3,Psychotherapy,PTSD,370,C,PTSD,,86,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 3""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,18.65,,95% CI,17.33,19.96,,-7.31,,-8.96,-5.64,,Cohen's d,0.87,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.403,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_C_12_I-H3,Psychotherapy,PTSD,370,C,PTSD,,69,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 3""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 3 to <6 Months,12,,18.91,,95% CI,17.73,20.09,,-7.05,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.398,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_C_2_I-H3,Psychotherapy,PTSD,370,C,PTSD,,77,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 3""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at <3 Months,2,,18.69,,95% CI,17.44,19.94,,-7.27,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.403,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_C_26_I-H3,Psychotherapy,PTSD,370,C,PTSD,,53,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 3""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at 6 to <12 Months,26,,19.21,,95% CI,17.41,21.01,,-6.75,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.392,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_C_Baseline_I-H3,Psychotherapy,PTSD,370,C,PTSD,,107,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,110,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 3""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,25.96,,95% CI,24.69,27.23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_D_0_I-H1,Psychotherapy,PTSD,370,D,Control,,40,,Minimal contact,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,40,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 1""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",End of Treatment,0,,23.06,,95% CI,21.23,24.89,,-1.77,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.2,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_D_2_I-H1,Psychotherapy,PTSD,370,D,Control,,39,,Minimal contact,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,40,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 1""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Assessment at <3 Months,2,,21.41,,95% CI,19.56,23.26,,-3.43,,-5.78,-1.07,,Cohen's d,0.33,,,,p=0.004,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.229,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
foa2018_PSS-I_D_Baseline_I-H1,Psychotherapy,PTSD,370,D,Control,,40,,Minimal contact,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,40,Structured Clinical Interview,PSS-I,PSS-I,"ITT; ""Hypothesis 1""",Mixed models using available data without imputation,"Mixed factorial ANOVAs with independent samples t-tests for pairwise comparisons; follow-up assessments analyzed separately (posttreatment, 3-, 6-, and 12-month follow-ups).",Baseline,,,24.83,,95% CI,23,26.66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1202,,0.8798,Mixed,"combat-related, other (not specified)",Medium,"Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.",49595,2020
fonzo2017_CAPS_A_0_ITT,Psychotherapy,PTSD,66,A,PTSD,,25,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized linear mixed models using available data (no imputation),"Generalized linear mixed effect, Cohen's d for change in mean scores",End of Treatment,0,,29.6,21.26,,,,,-36.73,,,,,,,,,,,,,,,,,,CAPS ≤20,0.4,,,,,,,,,0.6515,,0.3485,Mixed,"combat-related, illness/medical procedure, community/school violence, natural or manmade disasters, rape/sexual assault",Medium,"Fonzo GA, Goodkind MS, Oathes DJ, et al. PTSD psychotherapy outcome predicted by brain activation during emotional reactivity and regulation. Am J Psychiatry. 2017 Dec 1;174(12):1163-74. doi: 10.1176/appi.ajp.2017.16091072. PMID: 28715908.",48700,2019
fonzo2017_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,66,A,PTSD,,36,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized linear mixed models using available data (no imputation),"Generalized linear mixed effect, Cohen's d for change in mean scores",Baseline,,,66.33,15.17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.6515,,0.3485,Mixed,"combat-related, illness/medical procedure, community/school violence, natural or manmade disasters, rape/sexual assault",Medium,"Fonzo GA, Goodkind MS, Oathes DJ, et al. PTSD psychotherapy outcome predicted by brain activation during emotional reactivity and regulation. Am J Psychiatry. 2017 Dec 1;174(12):1163-74. doi: 10.1176/appi.ajp.2017.16091072. PMID: 28715908.",48700,2019
fonzo2017_CAPS_B_0_ITT,Psychotherapy,PTSD,66,B,Control,,26,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,30,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized linear mixed models using available data (no imputation),"Generalized linear mixed effect, Cohen's d for change in mean scores",End of Treatment,0,,64.23,21.77,,,,,-7.14,,,,,,,,,,,,,,,,,,CAPS ≤20,0,,,,,,,,,0.6515,,0.3485,Mixed,"combat-related, illness/medical procedure, community/school violence, natural or manmade disasters, rape/sexual assault",Medium,"Fonzo GA, Goodkind MS, Oathes DJ, et al. PTSD psychotherapy outcome predicted by brain activation during emotional reactivity and regulation. Am J Psychiatry. 2017 Dec 1;174(12):1163-74. doi: 10.1176/appi.ajp.2017.16091072. PMID: 28715908.",48700,2019
fonzo2017_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,66,B,Control,,30,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,30,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized linear mixed models using available data (no imputation),"Generalized linear mixed effect, Cohen's d for change in mean scores",Baseline,,,71.37,14.99,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.6515,,0.3485,Mixed,"combat-related, illness/medical procedure, community/school violence, natural or manmade disasters, rape/sexual assault",Medium,"Fonzo GA, Goodkind MS, Oathes DJ, et al. PTSD psychotherapy outcome predicted by brain activation during emotional reactivity and regulation. Am J Psychiatry. 2017 Dec 1;174(12):1163-74. doi: 10.1176/appi.ajp.2017.16091072. PMID: 28715908.",48700,2019
fonzo2017_PCL_A_0_NA,Psychotherapy,PTSD,66,A,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Self report,PCL,PCL-C,,,"Generalized linear mixed effect, Cohen's d for change in mean scores",End of Treatment,0,,26.13,7.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.6515,,0.3485,Mixed,"combat-related, illness/medical procedure, community/school violence, natural or manmade disasters, rape/sexual assault",Medium,"Fonzo GA, Goodkind MS, Oathes DJ, et al. PTSD psychotherapy outcome predicted by brain activation during emotional reactivity and regulation. Am J Psychiatry. 2017 Dec 1;174(12):1163-74. doi: 10.1176/appi.ajp.2017.16091072. PMID: 28715908.",48700,2019
fonzo2017_PCL_A_Baseline_NA,Psychotherapy,PTSD,66,A,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Self report,PCL,PCL-C,,,"Generalized linear mixed effect, Cohen's d for change in mean scores",Baseline,,,56.16,10.61,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.6515,,0.3485,Mixed,"combat-related, illness/medical procedure, community/school violence, natural or manmade disasters, rape/sexual assault",Medium,"Fonzo GA, Goodkind MS, Oathes DJ, et al. PTSD psychotherapy outcome predicted by brain activation during emotional reactivity and regulation. Am J Psychiatry. 2017 Dec 1;174(12):1163-74. doi: 10.1176/appi.ajp.2017.16091072. PMID: 28715908.",48700,2019
fonzo2017_PCL_B_0_NA,Psychotherapy,PTSD,66,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,30,Self report,PCL,PCL-C,,,"Generalized linear mixed effect, Cohen's d for change in mean scores",End of Treatment,0,,49.00,13.35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.6515,,0.3485,Mixed,"combat-related, illness/medical procedure, community/school violence, natural or manmade disasters, rape/sexual assault",Medium,"Fonzo GA, Goodkind MS, Oathes DJ, et al. PTSD psychotherapy outcome predicted by brain activation during emotional reactivity and regulation. Am J Psychiatry. 2017 Dec 1;174(12):1163-74. doi: 10.1176/appi.ajp.2017.16091072. PMID: 28715908.",48700,2019
fonzo2017_PCL_B_Baseline_NA,Psychotherapy,PTSD,66,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,30,Self report,PCL,PCL-C,,,"Generalized linear mixed effect, Cohen's d for change in mean scores",Baseline,,,57.36,12.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.6515,,0.3485,Mixed,"combat-related, illness/medical procedure, community/school violence, natural or manmade disasters, rape/sexual assault",Medium,"Fonzo GA, Goodkind MS, Oathes DJ, et al. PTSD psychotherapy outcome predicted by brain activation during emotional reactivity and regulation. Am J Psychiatry. 2017 Dec 1;174(12):1163-74. doi: 10.1176/appi.ajp.2017.16091072. PMID: 28715908.",48700,2019
forbes2012_CAPS_A_0_Comp,Psychotherapy,PTSD,59,A,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,Completer,,"Repeated measures ANOVA, Hedges' g effect size",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to the CAPS using the 1(intensity)/2(frequency) rule,0.375,,,,,Veteran,0,1,0,0.0339,,0.9661,"Combat-related (described as ""military-related"")",,Medium,"Forbes D, Lloyd D, Nixon RDV, et al. A multisite randomized controlled effectiveness trial of cognitive processing therapy for military-related posttraumatic stress disorder. J Anxiety Disord. 2012 Apr;26(3):442-52. doi: 10.1016/j.janxdis.2012.01.006. PMID: 22366446..",38353,2019
forbes2012_CAPS_A_0_ITT,Psychotherapy,PTSD,59,A,PTSD,,30,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation,"Repeated measures ANOVA, Hedges' g effect size",End of Treatment,0,,48.03,27.89,,,,,-27.5,,,,,,,,,,,,,,,,,,,,,>12-point reduction in CAPS score,0.667,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.0339,,0.9661,"Combat-related (described as ""military-related"")",,Medium,"Forbes D, Lloyd D, Nixon RDV, et al. A multisite randomized controlled effectiveness trial of cognitive processing therapy for military-related posttraumatic stress disorder. J Anxiety Disord. 2012 Apr;26(3):442-52. doi: 10.1016/j.janxdis.2012.01.006. PMID: 22366446..",38353,2019
forbes2012_CAPS_A_20_ITT,Psychotherapy,PTSD,59,A,PTSD,,30,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation,"Repeated measures ANOVA, Hedges' g effect size",Assessment at 3 to <6 Months,20,,45.3,28.15,,,,,-30.23,,,,,,,,,,,,,,,,,,,,,>12-point reduction in CAPS score,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.0339,,0.9661,"Combat-related (described as ""military-related"")",,Medium,"Forbes D, Lloyd D, Nixon RDV, et al. A multisite randomized controlled effectiveness trial of cognitive processing therapy for military-related posttraumatic stress disorder. J Anxiety Disord. 2012 Apr;26(3):442-52. doi: 10.1016/j.janxdis.2012.01.006. PMID: 22366446..",38353,2019
forbes2012_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,59,A,PTSD,,30,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation,"Repeated measures ANOVA, Hedges' g effect size",Baseline,,,75.53,16.35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0339,,0.9661,"Combat-related (described as ""military-related"")",,Medium,"Forbes D, Lloyd D, Nixon RDV, et al. A multisite randomized controlled effectiveness trial of cognitive processing therapy for military-related posttraumatic stress disorder. J Anxiety Disord. 2012 Apr;26(3):442-52. doi: 10.1016/j.janxdis.2012.01.006. PMID: 22366446..",38353,2019
forbes2012_CAPS_B_0_Comp,Psychotherapy,PTSD,59,B,PTSD,,,,TAU,Psychotherapy as usual,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,,In Person,29,Structured Clinical Interview,CAPS,CAPS,Completer,,"Repeated measures ANOVA, Hedges' g effect size",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to the CAPS using the 1(intensity)/2(frequency) rule,0.1304,,,,,Veteran,0,1,0,0.0339,,0.9661,"Combat-related (described as ""military-related"")",,Medium,"Forbes D, Lloyd D, Nixon RDV, et al. A multisite randomized controlled effectiveness trial of cognitive processing therapy for military-related posttraumatic stress disorder. J Anxiety Disord. 2012 Apr;26(3):442-52. doi: 10.1016/j.janxdis.2012.01.006. PMID: 22366446..",38353,2019
forbes2012_CAPS_B_0_ITT,Psychotherapy,PTSD,59,B,PTSD,,29,,TAU,Psychotherapy as usual,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,,In Person,29,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation,"Repeated measures ANOVA, Hedges' g effect size",End of Treatment,0,,57.73,20.01,,,,,-6.82,,,,,,,,,,,,,,,,,,,,,>12-point reduction in CAPS score,0.3448,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.0339,,0.9661,"Combat-related (described as ""military-related"")",,Medium,"Forbes D, Lloyd D, Nixon RDV, et al. A multisite randomized controlled effectiveness trial of cognitive processing therapy for military-related posttraumatic stress disorder. J Anxiety Disord. 2012 Apr;26(3):442-52. doi: 10.1016/j.janxdis.2012.01.006. PMID: 22366446..",38353,2019
forbes2012_CAPS_B_20_ITT,Psychotherapy,PTSD,59,B,PTSD,,29,,TAU,Psychotherapy as usual,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,,In Person,29,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation,"Repeated measures ANOVA, Hedges' g effect size",Assessment at 3 to <6 Months,20,,52.55,18.93,,,,,-12,,,,,,,,,,,,,,,,,,,,,>12-point reduction in CAPS score,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.0339,,0.9661,"Combat-related (described as ""military-related"")",,Medium,"Forbes D, Lloyd D, Nixon RDV, et al. A multisite randomized controlled effectiveness trial of cognitive processing therapy for military-related posttraumatic stress disorder. J Anxiety Disord. 2012 Apr;26(3):442-52. doi: 10.1016/j.janxdis.2012.01.006. PMID: 22366446..",38353,2019
forbes2012_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,59,B,PTSD,,29,,TAU,Psychotherapy as usual,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,,In Person,29,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation,"Repeated measures ANOVA, Hedges' g effect size",Baseline,,,64.55,19.46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0339,,0.9661,"Combat-related (described as ""military-related"")",,Medium,"Forbes D, Lloyd D, Nixon RDV, et al. A multisite randomized controlled effectiveness trial of cognitive processing therapy for military-related posttraumatic stress disorder. J Anxiety Disord. 2012 Apr;26(3):442-52. doi: 10.1016/j.janxdis.2012.01.006. PMID: 22366446..",38353,2019
forbes2012_PCL_A_0_NA,Psychotherapy,PTSD,59,A,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PCL,PCL,,,"Repeated measures ANOVA, Hedges' g effect size",End of Treatment,0,,45.67,16.66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0339,,0.9661,"Combat-related (described as ""military-related"")",,Medium,"Forbes D, Lloyd D, Nixon RDV, et al. A multisite randomized controlled effectiveness trial of cognitive processing therapy for military-related posttraumatic stress disorder. J Anxiety Disord. 2012 Apr;26(3):442-52. doi: 10.1016/j.janxdis.2012.01.006. PMID: 22366446..",38353,2019
forbes2012_PCL_A_20_NA,Psychotherapy,PTSD,59,A,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PCL,PCL,,,"Repeated measures ANOVA, Hedges' g effect size",Assessment at 3 to <6 Months,20,,41.13,17.51,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0339,,0.9661,"Combat-related (described as ""military-related"")",,Medium,"Forbes D, Lloyd D, Nixon RDV, et al. A multisite randomized controlled effectiveness trial of cognitive processing therapy for military-related posttraumatic stress disorder. J Anxiety Disord. 2012 Apr;26(3):442-52. doi: 10.1016/j.janxdis.2012.01.006. PMID: 22366446..",38353,2019
forbes2012_PCL_A_Baseline_NA,Psychotherapy,PTSD,59,A,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PCL,PCL,,,"Repeated measures ANOVA, Hedges' g effect size",Baseline,,,61.63,11.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0339,,0.9661,"Combat-related (described as ""military-related"")",,Medium,"Forbes D, Lloyd D, Nixon RDV, et al. A multisite randomized controlled effectiveness trial of cognitive processing therapy for military-related posttraumatic stress disorder. J Anxiety Disord. 2012 Apr;26(3):442-52. doi: 10.1016/j.janxdis.2012.01.006. PMID: 22366446..",38353,2019
forbes2012_PCL_B_0_NA,Psychotherapy,PTSD,59,B,PTSD,,,,TAU,Psychotherapy as usual,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,,In Person,29,Self report,PCL,PCL,,,"Repeated measures ANOVA, Hedges' g effect size",End of Treatment,0,,53.84,11.11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0339,,0.9661,"Combat-related (described as ""military-related"")",,Medium,"Forbes D, Lloyd D, Nixon RDV, et al. A multisite randomized controlled effectiveness trial of cognitive processing therapy for military-related posttraumatic stress disorder. J Anxiety Disord. 2012 Apr;26(3):442-52. doi: 10.1016/j.janxdis.2012.01.006. PMID: 22366446..",38353,2019
forbes2012_PCL_B_20_NA,Psychotherapy,PTSD,59,B,PTSD,,,,TAU,Psychotherapy as usual,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,,In Person,29,Self report,PCL,PCL,,,"Repeated measures ANOVA, Hedges' g effect size",Assessment at 3 to <6 Months,20,,49.11,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0339,,0.9661,"Combat-related (described as ""military-related"")",,Medium,"Forbes D, Lloyd D, Nixon RDV, et al. A multisite randomized controlled effectiveness trial of cognitive processing therapy for military-related posttraumatic stress disorder. J Anxiety Disord. 2012 Apr;26(3):442-52. doi: 10.1016/j.janxdis.2012.01.006. PMID: 22366446..",38353,2019
forbes2012_PCL_B_Baseline_NA,Psychotherapy,PTSD,59,B,PTSD,,,,TAU,Psychotherapy as usual,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,,In Person,29,Self report,PCL,PCL,,,"Repeated measures ANOVA, Hedges' g effect size",Baseline,,,57.45,12.55,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0339,,0.9661,"Combat-related (described as ""military-related"")",,Medium,"Forbes D, Lloyd D, Nixon RDV, et al. A multisite randomized controlled effectiveness trial of cognitive processing therapy for military-related posttraumatic stress disorder. J Anxiety Disord. 2012 Apr;26(3):442-52. doi: 10.1016/j.janxdis.2012.01.006. PMID: 22366446..",38353,2019
ford2018_CAPS_A_0_Comp,Psychotherapy,PTSD,31,A,PTSD,,11,,Trauma Affect Regulation: Guide for Education and Therapy,Trauma Affect Regulation: Guide for Education and Therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,CAPS,CAPS,Completer,,"Cohen's d for change in mean score, chi-square test for diagnostic change and clinically meaningful response",End of Treatment,0,,51.82,33.25,,,,,-38.7,29.91,,,,Cohen's d,2.54,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.5455,,>12-point reduction on CAPS,0.7273,,Mixed,,,0,0,,1,Combat-related,,High,"Ford JD, Grasso DJ, Greene CA, et al. Randomized clinical trial pilot study of prolonged exposure versus present centred affect regulation therapy for PTSD and anger problems with male military combat veterans. Clin Psychol Psychother. 2018 Sep;25(5):641-9. doi: 10.1002/cpp.2194. PMID: 29687524.",50258,2019
ford2018_CAPS_A_16_Comp,Psychotherapy,PTSD,31,A,PTSD,,8,,Trauma Affect Regulation: Guide for Education and Therapy,Trauma Affect Regulation: Guide for Education and Therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,CAPS,CAPS,Completer,,"Cohen's d for change in mean score, chi-square test for diagnostic change and clinically meaningful response",Assessment at 3 to <6 Months,16,,58.37,,,,,,-33.13,36.24,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,>12-point reduction on CAPS,0.375,,Mixed,,,0,0,,1,Combat-related,,High,"Ford JD, Grasso DJ, Greene CA, et al. Randomized clinical trial pilot study of prolonged exposure versus present centred affect regulation therapy for PTSD and anger problems with male military combat veterans. Clin Psychol Psychother. 2018 Sep;25(5):641-9. doi: 10.1002/cpp.2194. PMID: 29687524.",50258,2019
ford2018_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,31,A,PTSD,,11,,Trauma Affect Regulation: Guide for Education and Therapy,Trauma Affect Regulation: Guide for Education and Therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,CAPS,CAPS,Completer,,"Cohen's d for change in mean score, chi-square test for diagnostic change and clinically meaningful response",Baseline,,,91.5,15.73,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0,,1,Combat-related,,High,"Ford JD, Grasso DJ, Greene CA, et al. Randomized clinical trial pilot study of prolonged exposure versus present centred affect regulation therapy for PTSD and anger problems with male military combat veterans. Clin Psychol Psychother. 2018 Sep;25(5):641-9. doi: 10.1002/cpp.2194. PMID: 29687524.",50258,2019
ford2018_CAPS_B_0_Comp,Psychotherapy,PTSD,31,B,PTSD,,5,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,14,Structured Clinical Interview,CAPS,CAPS,Completer,,"Cohen's d for change in mean score, chi-square test for diagnostic change and clinically meaningful response",End of Treatment,0,,52.6,30.43,,,,,-11.6,34.23,,,,Cohen's d,0.5,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.6,,>12-point reduction on CAPS,0.4,,Mixed,,,0,0,,1,Combat-related,,High,"Ford JD, Grasso DJ, Greene CA, et al. Randomized clinical trial pilot study of prolonged exposure versus present centred affect regulation therapy for PTSD and anger problems with male military combat veterans. Clin Psychol Psychother. 2018 Sep;25(5):641-9. doi: 10.1002/cpp.2194. PMID: 29687524.",50258,2019
ford2018_CAPS_B_16_Comp,Psychotherapy,PTSD,31,B,PTSD,,5,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,14,Structured Clinical Interview,CAPS,CAPS,Completer,,"Cohen's d for change in mean score, chi-square test for diagnostic change and clinically meaningful response",Assessment at 3 to <6 Months,16,,47.4,,,,,,-16.8,29.12,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,>12-point reduction on CAPS,0.4,,Mixed,,,0,0,,1,Combat-related,,High,"Ford JD, Grasso DJ, Greene CA, et al. Randomized clinical trial pilot study of prolonged exposure versus present centred affect regulation therapy for PTSD and anger problems with male military combat veterans. Clin Psychol Psychother. 2018 Sep;25(5):641-9. doi: 10.1002/cpp.2194. PMID: 29687524.",50258,2019
ford2018_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,31,B,PTSD,,5,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,14,Structured Clinical Interview,CAPS,CAPS,Completer,,"Cohen's d for change in mean score, chi-square test for diagnostic change and clinically meaningful response",Baseline,,,64.2,11.56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0,,1,Combat-related,,High,"Ford JD, Grasso DJ, Greene CA, et al. Randomized clinical trial pilot study of prolonged exposure versus present centred affect regulation therapy for PTSD and anger problems with male military combat veterans. Clin Psychol Psychother. 2018 Sep;25(5):641-9. doi: 10.1002/cpp.2194. PMID: 29687524.",50258,2019
fortney2015_PDS_A_26_ITT,Collaborative care,PTSD,265,A,PTSD,,112,,Telemedicine Outreach for PTSD,Telemedicine Outreach for PTSD (TOP),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,Yes,Individual,Phone,133,Self report,PDS,PDS,ITT,study states that missing data were not imputed,Bivariate analyses: unpaired 2-tailed t-tests and Pearson chi-squared tests; multivariate analyses: maximum likelihood to estimate beta coefficients and SEs. Continuously specified dependent variables used a normal distribution and identify link; dichotomously specified dependent variables used a binomial distribution and logit link and exponentiated the beta coefficients to obtain odds ratios.,Assessment at 6 to <12 Months,26,,,,,,,,-5.31,10.91,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.102,,0.898,Combat-related,,Medium,"Fortney JC, Pyne JM, Kimbrell TA, et al. Telemedicine-based collaborative care for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Jan;72(1):58-67. doi: 10.1001/jamapsychiatry.2014.1575. PMID: 25409287.",43084,2019
fortney2015_PDS_A_52_ITT,Collaborative care,PTSD,265,A,PTSD,,111,,Telemedicine Outreach for PTSD,Telemedicine Outreach for PTSD (TOP),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,Yes,Individual,Phone,133,Self report,PDS,PDS,ITT,study states that missing data were not imputed,Bivariate analyses: unpaired 2-tailed t-tests and Pearson chi-squared tests; multivariate analyses: maximum likelihood to estimate beta coefficients and SEs. Continuously specified dependent variables used a normal distribution and identify link; dichotomously specified dependent variables used a binomial distribution and logit link and exponentiated the beta coefficients to obtain odds ratios.,Assessment at ≥12 Months,52,,,,,,,,-4.17,9.82,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.102,,0.898,Combat-related,,Medium,"Fortney JC, Pyne JM, Kimbrell TA, et al. Telemedicine-based collaborative care for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Jan;72(1):58-67. doi: 10.1001/jamapsychiatry.2014.1575. PMID: 25409287.",43084,2019
fortney2015_PDS_A_Baseline_ITT,Collaborative care,PTSD,265,A,PTSD,,133,,Telemedicine Outreach for PTSD,Telemedicine Outreach for PTSD (TOP),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,Yes,Individual,Phone,133,Self report,PDS,PDS,ITT,study states that missing data were not imputed,Bivariate analyses: unpaired 2-tailed t-tests and Pearson chi-squared tests; multivariate analyses: maximum likelihood to estimate beta coefficients and SEs. Continuously specified dependent variables used a normal distribution and identify link; dichotomously specified dependent variables used a binomial distribution and logit link and exponentiated the beta coefficients to obtain odds ratios.,Baseline,,,35,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.102,,0.898,Combat-related,,Medium,"Fortney JC, Pyne JM, Kimbrell TA, et al. Telemedicine-based collaborative care for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Jan;72(1):58-67. doi: 10.1001/jamapsychiatry.2014.1575. PMID: 25409287.",43084,2019
fortney2015_PDS_B_26_ITT,Collaborative care,PTSD,265,B,Control,,,,Usual care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,132,Self report,PDS,PDS,ITT,study states that missing data were not imputed,Bivariate analyses: unpaired 2-tailed t-tests and Pearson chi-squared tests; multivariate analyses: maximum likelihood to estimate beta coefficients and SEs. Continuously specified dependent variables used a normal distribution and identify link; dichotomously specified dependent variables used a binomial distribution and logit link and exponentiated the beta coefficients to obtain odds ratios.,Assessment at 6 to <12 Months,26,,,,,,,,-1.07,7.73,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.102,,0.898,Combat-related,,Medium,"Fortney JC, Pyne JM, Kimbrell TA, et al. Telemedicine-based collaborative care for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Jan;72(1):58-67. doi: 10.1001/jamapsychiatry.2014.1575. PMID: 25409287.",43084,2019
fortney2015_PDS_B_52_ITT,Collaborative care,PTSD,265,B,Control,,,,Usual care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,132,Self report,PDS,PDS,ITT,study states that missing data were not imputed,Bivariate analyses: unpaired 2-tailed t-tests and Pearson chi-squared tests; multivariate analyses: maximum likelihood to estimate beta coefficients and SEs. Continuously specified dependent variables used a normal distribution and identify link; dichotomously specified dependent variables used a binomial distribution and logit link and exponentiated the beta coefficients to obtain odds ratios.,Assessment at ≥12 Months,52,,,,,,,,-1.32,8.79,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.102,,0.898,Combat-related,,Medium,"Fortney JC, Pyne JM, Kimbrell TA, et al. Telemedicine-based collaborative care for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Jan;72(1):58-67. doi: 10.1001/jamapsychiatry.2014.1575. PMID: 25409287.",43084,2019
fortney2015_PDS_B_Baseline_ITT,Collaborative care,PTSD,265,B,Control,,132,,Usual care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,132,Self report,PDS,PDS,ITT,study states that missing data were not imputed,Bivariate analyses: unpaired 2-tailed t-tests and Pearson chi-squared tests; multivariate analyses: maximum likelihood to estimate beta coefficients and SEs. Continuously specified dependent variables used a normal distribution and identify link; dichotomously specified dependent variables used a binomial distribution and logit link and exponentiated the beta coefficients to obtain odds ratios.,Baseline,,,33.5,8.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.102,,0.898,Combat-related,,Medium,"Fortney JC, Pyne JM, Kimbrell TA, et al. Telemedicine-based collaborative care for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Jan;72(1):58-67. doi: 10.1001/jamapsychiatry.2014.1575. PMID: 25409287.",43084,2019
franklin2017_CAPS_A_0_ITT,Psychotherapy,PTSD,27,A,PTSD,,3,,Telehealth PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,12,Structured Clinical Interview,CAPS,CAPS,ITT,,Mixed models with repeated measures for each outcome,End of Treatment,0,,38.3,17.9,,,,,-31.4,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,Additional definitions of Diagnostic Change reported in the study,,,,Veteran,0,1,0,0.074,,0.926,,,High,"Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.",50424,2019
franklin2017_CAPS_A_4_ITT,Psychotherapy,PTSD,27,A,PTSD,,3,,Telehealth PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,12,Structured Clinical Interview,CAPS,CAPS,ITT,,Mixed models with repeated measures for each outcome,Assessment at <3 Months,4,,24.3,3.1,,,,,-45.4,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,Additional definitions of Diagnostic Change reported in the study,,,,Veteran,0,1,0,0.074,,0.926,,,High,"Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.",50424,2019
franklin2017_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,27,A,PTSD,,12,,Telehealth PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,12,Structured Clinical Interview,CAPS,CAPS,ITT,,Mixed models with repeated measures for each outcome,Baseline,,,69.7,14.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.074,,0.926,,,High,"Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.",50424,2019
franklin2017_CAPS_B_0_ITT,Psychotherapy,PTSD,27,B,PTSD,,3,,PE delivered via computer-based teleconferencing,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,7,Structured Clinical Interview,CAPS,CAPS,ITT,,Mixed models with repeated measures for each outcome,End of Treatment,0,,49.3,20.8,,,,,-25,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,Additional definitions of Diagnostic Change reported in the study,,,,Veteran,0,1,0,0.074,,0.926,,,High,"Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.",50424,2019
franklin2017_CAPS_B_4_ITT,Psychotherapy,PTSD,27,B,PTSD,,3,,PE delivered via computer-based teleconferencing,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,7,Structured Clinical Interview,CAPS,CAPS,ITT,,Mixed models with repeated measures for each outcome,Assessment at <3 Months,4,,43.7,15.4,,,,,-30.6,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.333,Additional definitions of Diagnostic Change reported in the study,,,,Veteran,0,1,0,0.074,,0.926,,,High,"Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.",50424,2019
franklin2017_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,27,B,PTSD,,7,,PE delivered via computer-based teleconferencing,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,7,Structured Clinical Interview,CAPS,CAPS,ITT,,Mixed models with repeated measures for each outcome,Baseline,,,74.3,14.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.074,,0.926,,,High,"Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.",50424,2019
franklin2017_CAPS_C_0_ITT,Psychotherapy,PTSD,27,C,Control,,7,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,8,Structured Clinical Interview,CAPS,CAPS,ITT,,Mixed models with repeated measures for each outcome,End of Treatment,0,,61.4,16.8,,,,,0.3,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,Additional definitions of Diagnostic Change reported in the study,,,,Veteran,0,1,0,0.074,,0.926,,,High,"Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.",50424,2019
franklin2017_CAPS_C_4_ITT,Psychotherapy,PTSD,27,C,Control,,7,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,8,Structured Clinical Interview,CAPS,CAPS,ITT,,Mixed models with repeated measures for each outcome,Assessment at <3 Months,4,,58.3,17.9,,,,,-2.8,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.286,Additional definitions of Diagnostic Change reported in the study,,,,Veteran,0,1,0,0.074,,0.926,,,High,"Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.",50424,2019
franklin2017_CAPS_C_Baseline_ITT,Psychotherapy,PTSD,27,C,Control,,8,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,8,Structured Clinical Interview,CAPS,CAPS,ITT,,Mixed models with repeated measures for each outcome,Baseline,,,61.1,9.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.074,,0.926,,,High,"Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.",50424,2019
franklin2017_PDS_A_0_NA,Psychotherapy,PTSD,27,A,PTSD,,,,Telehealth PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,12,Self report,PDS,PDS,,,Mixed models with repeated measures for each outcome,End of Treatment,0,,15.0,12.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.074,,0.926,,,High,"Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.",50424,2019
franklin2017_PDS_A_4_NA,Psychotherapy,PTSD,27,A,PTSD,,,,Telehealth PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,12,Self report,PDS,PDS,,,Mixed models with repeated measures for each outcome,Assessment at <3 Months,4,,11.7,7.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.074,,0.926,,,High,"Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.",50424,2019
franklin2017_PDS_A_Baseline_NA,Psychotherapy,PTSD,27,A,PTSD,,,,Telehealth PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,12,Self report,PDS,PDS,,,Mixed models with repeated measures for each outcome,Baseline,,,37.4,7.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.074,,0.926,,,High,"Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.",50424,2019
franklin2017_PDS_B_0_NA,Psychotherapy,PTSD,27,B,PTSD,,,,PE delivered via computer-based teleconferencing,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,7,Self report,PDS,PDS,,,Mixed models with repeated measures for each outcome,End of Treatment,0,,26.7,3.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.074,,0.926,,,High,"Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.",50424,2019
franklin2017_PDS_B_4_NA,Psychotherapy,PTSD,27,B,PTSD,,,,PE delivered via computer-based teleconferencing,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,7,Self report,PDS,PDS,,,Mixed models with repeated measures for each outcome,Assessment at <3 Months,4,,22.0,13.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.074,,0.926,,,High,"Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.",50424,2019
franklin2017_PDS_B_Baseline_NA,Psychotherapy,PTSD,27,B,PTSD,,,,PE delivered via computer-based teleconferencing,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,7,Self report,PDS,PDS,,,Mixed models with repeated measures for each outcome,Baseline,,,35.9,9.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.074,,0.926,,,High,"Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.",50424,2019
franklin2017_PDS_C_0_NA,Psychotherapy,PTSD,27,C,Control,,,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,8,Self report,PDS,PDS,,,Mixed models with repeated measures for each outcome,End of Treatment,0,,37.3,6.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.074,,0.926,,,High,"Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.",50424,2019
franklin2017_PDS_C_4_NA,Psychotherapy,PTSD,27,C,Control,,,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,8,Self report,PDS,PDS,,,Mixed models with repeated measures for each outcome,Assessment at <3 Months,4,,32.6,4.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.074,,0.926,,,High,"Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.",50424,2019
franklin2017_PDS_C_Baseline_NA,Psychotherapy,PTSD,27,C,Control,,,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,8,Self report,PDS,PDS,,,Mixed models with repeated measures for each outcome,Baseline,,,35.9,5.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.074,,0.926,,,High,"Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.",50424,2019
friedman2007_CAPS_A_0_ITT,Pharmacotherapy,PTSD,169,A,PTSD,,84,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,86,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,Mixed models with repeated measures for each outcome,End of Treatment,0,,,,,,,,-13.1,3.0,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2,0.3452,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.2282,,0.7718,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (injury, fire, seeing someone hurt or die, ""miscellaneous"")",Medium,"Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007 May;68(5):711-20. PMID: 17503980.",29522,2019
friedman2007_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,169,A,PTSD,,84,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,86,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,Mixed models with repeated measures for each outcome,Baseline,,,72.1,19.1,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.2282,,0.7718,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (injury, fire, seeing someone hurt or die, ""miscellaneous"")",Medium,"Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007 May;68(5):711-20. PMID: 17503980.",29522,2019
friedman2007_CAPS_B_0_ITT,Pharmacotherapy,PTSD,169,B,Control,,82,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,83,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,Mixed models with repeated measures for each outcome,End of Treatment,0,,,,,,,,-15.4,3.1,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2,0.4268,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.2282,,0.7718,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (injury, fire, seeing someone hurt or die, ""miscellaneous"")",Medium,"Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007 May;68(5):711-20. PMID: 17503980.",29522,2019
friedman2007_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,169,B,Control,,82,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,83,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,Mixed models with repeated measures for each outcome,Baseline,,,73.8,19.8,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.2282,,0.7718,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (injury, fire, seeing someone hurt or die, ""miscellaneous"")",Medium,"Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007 May;68(5):711-20. PMID: 17503980.",29522,2019
friedman2007_DTS_A_0_NA,Pharmacotherapy,PTSD,169,A,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,86,Self report,DTS,DTS,,,Mixed models with repeated measures for each outcome,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2282,,0.7718,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (injury, fire, seeing someone hurt or die, ""miscellaneous"")",Medium,"Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007 May;68(5):711-20. PMID: 17503980.",29522,2019
friedman2007_DTS_A_Baseline_NA,Pharmacotherapy,PTSD,169,A,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,86,Self report,DTS,DTS,,,Mixed models with repeated measures for each outcome,Baseline,,,77.2,27.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2282,,0.7718,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (injury, fire, seeing someone hurt or die, ""miscellaneous"")",Medium,"Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007 May;68(5):711-20. PMID: 17503980.",29522,2019
friedman2007_DTS_B_0_NA,Pharmacotherapy,PTSD,169,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,83,Self report,DTS,DTS,,,Mixed models with repeated measures for each outcome,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2282,,0.7718,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (injury, fire, seeing someone hurt or die, ""miscellaneous"")",Medium,"Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007 May;68(5):711-20. PMID: 17503980.",29522,2019
friedman2007_DTS_B_Baseline_NA,Pharmacotherapy,PTSD,169,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,83,Self report,DTS,DTS,,,Mixed models with repeated measures for each outcome,Baseline,,,80.4,27.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2282,,0.7718,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (injury, fire, seeing someone hurt or die, ""miscellaneous"")",Medium,"Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007 May;68(5):711-20. PMID: 17503980.",29522,2019
friedman2007_IES_A_0_NA,Pharmacotherapy,PTSD,169,A,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,86,Self report,IES,IES,,,Mixed models with repeated measures for each outcome,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2282,,0.7718,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (injury, fire, seeing someone hurt or die, ""miscellaneous"")",Medium,"Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007 May;68(5):711-20. PMID: 17503980.",29522,2019
friedman2007_IES_A_Baseline_NA,Pharmacotherapy,PTSD,169,A,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,86,Self report,IES,IES,,,Mixed models with repeated measures for each outcome,Baseline,,,40.7,15.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2282,,0.7718,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (injury, fire, seeing someone hurt or die, ""miscellaneous"")",Medium,"Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007 May;68(5):711-20. PMID: 17503980.",29522,2019
friedman2007_IES_B_0_NA,Pharmacotherapy,PTSD,169,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,83,Self report,IES,IES,,,Mixed models with repeated measures for each outcome,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2282,,0.7718,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (injury, fire, seeing someone hurt or die, ""miscellaneous"")",Medium,"Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007 May;68(5):711-20. PMID: 17503980.",29522,2019
friedman2007_IES_B_Baseline_NA,Pharmacotherapy,PTSD,169,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,83,Self report,IES,IES,,,Mixed models with repeated measures for each outcome,Baseline,,,43.4,15.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2282,,0.7718,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (injury, fire, seeing someone hurt or die, ""miscellaneous"")",Medium,"Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007 May;68(5):711-20. PMID: 17503980.",29522,2019
friedman2007_M-PTSD_A_0_NA,Pharmacotherapy,PTSD,169,A,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,86,Self report,M-PTSD,M-PTSD,,,Mixed models with repeated measures for each outcome,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2282,,0.7718,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (injury, fire, seeing someone hurt or die, ""miscellaneous"")",Medium,"Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007 May;68(5):711-20. PMID: 17503980.",29522,2019
friedman2007_M-PTSD_A_Baseline_NA,Pharmacotherapy,PTSD,169,A,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,86,Self report,M-PTSD,M-PTSD,,,Mixed models with repeated measures for each outcome,Baseline,,,115.8,15.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2282,,0.7718,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (injury, fire, seeing someone hurt or die, ""miscellaneous"")",Medium,"Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007 May;68(5):711-20. PMID: 17503980.",29522,2019
friedman2007_M-PTSD_B_0_NA,Pharmacotherapy,PTSD,169,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,83,Self report,M-PTSD,M-PTSD,,,Mixed models with repeated measures for each outcome,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2282,,0.7718,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (injury, fire, seeing someone hurt or die, ""miscellaneous"")",Medium,"Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007 May;68(5):711-20. PMID: 17503980.",29522,2019
friedman2007_M-PTSD_B_Baseline_NA,Pharmacotherapy,PTSD,169,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,83,Self report,M-PTSD,M-PTSD,,,Mixed models with repeated measures for each outcome,Baseline,,,118.1,16.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2282,,0.7718,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (injury, fire, seeing someone hurt or die, ""miscellaneous"")",Medium,"Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007 May;68(5):711-20. PMID: 17503980.",29522,2019
frommberger2004_CAPS_A_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,21,A,PTSD,,,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Structured Clinical Interview,CAPS,CAPS,Completer,Excluded,Two-factor repeated measures ANOVA,End of Treatment,0,,36.1,12.1,,,,,-28.9,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5714,,0.4286,Mixed,"rape/sexual assault, accidents, community/school violence",High,"Frommberger UH, Stieglitz R-D, Nyberg E, et al. Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder (PTSD): a pilot study. Int. J. Psychiatry Clin. Pract. 2004;8(1):19-24. doi: 10.1080/13651500310004803. PMID: 24937579.",27144,2019
frommberger2004_CAPS_A_26_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,21,A,PTSD,,,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Structured Clinical Interview,CAPS,CAPS,Completer,Excluded,Two-factor repeated measures ANOVA,Assessment at 6 to <12 Months,26,,53.6,,,,,,-11.4,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5714,,0.4286,Mixed,"rape/sexual assault, accidents, community/school violence",High,"Frommberger UH, Stieglitz R-D, Nyberg E, et al. Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder (PTSD): a pilot study. Int. J. Psychiatry Clin. Pract. 2004;8(1):19-24. doi: 10.1080/13651500310004803. PMID: 24937579.",27144,2019
frommberger2004_CAPS_A_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,21,A,PTSD,,11,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Structured Clinical Interview,CAPS,CAPS,Completer,Excluded,Two-factor repeated measures ANOVA,Baseline,,,65.0,13.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5714,,0.4286,Mixed,"rape/sexual assault, accidents, community/school violence",High,"Frommberger UH, Stieglitz R-D, Nyberg E, et al. Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder (PTSD): a pilot study. Int. J. Psychiatry Clin. Pract. 2004;8(1):19-24. doi: 10.1080/13651500310004803. PMID: 24937579.",27144,2019
frommberger2004_CAPS_B_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,21,B,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,Completer,Excluded,Two-factor repeated measures ANOVA,End of Treatment,0,,34.8,15,,,,,-35.7,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5714,,0.4286,Mixed,"rape/sexual assault, accidents, community/school violence",High,"Frommberger UH, Stieglitz R-D, Nyberg E, et al. Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder (PTSD): a pilot study. Int. J. Psychiatry Clin. Pract. 2004;8(1):19-24. doi: 10.1080/13651500310004803. PMID: 24937579.",27144,2019
frommberger2004_CAPS_B_26_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,21,B,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,Completer,Excluded,Two-factor repeated measures ANOVA,Assessment at 6 to <12 Months,26,,23.0,,,,,,-47.5,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5714,,0.4286,Mixed,"rape/sexual assault, accidents, community/school violence",High,"Frommberger UH, Stieglitz R-D, Nyberg E, et al. Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder (PTSD): a pilot study. Int. J. Psychiatry Clin. Pract. 2004;8(1):19-24. doi: 10.1080/13651500310004803. PMID: 24937579.",27144,2019
frommberger2004_CAPS_B_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,21,B,PTSD,,10,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,Completer,Excluded,Two-factor repeated measures ANOVA,Baseline,,,70.5,7.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5714,,0.4286,Mixed,"rape/sexual assault, accidents, community/school violence",High,"Frommberger UH, Stieglitz R-D, Nyberg E, et al. Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder (PTSD): a pilot study. Int. J. Psychiatry Clin. Pract. 2004;8(1):19-24. doi: 10.1080/13651500310004803. PMID: 24937579.",27144,2019
frommberger2004_PSS_A_0_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,21,A,PTSD,,,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,PSS,PSS,,,Two-factor repeated measures ANOVA,End of Treatment,0,,25.1,11.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5714,,0.4286,Mixed,"rape/sexual assault, accidents, community/school violence",High,"Frommberger UH, Stieglitz R-D, Nyberg E, et al. Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder (PTSD): a pilot study. Int. J. Psychiatry Clin. Pract. 2004;8(1):19-24. doi: 10.1080/13651500310004803. PMID: 24937579.",27144,2019
frommberger2004_PSS_A_26_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,21,A,PTSD,,,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,PSS,PSS,,,Two-factor repeated measures ANOVA,Assessment at 6 to <12 Months,26,,26.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5714,,0.4286,Mixed,"rape/sexual assault, accidents, community/school violence",High,"Frommberger UH, Stieglitz R-D, Nyberg E, et al. Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder (PTSD): a pilot study. Int. J. Psychiatry Clin. Pract. 2004;8(1):19-24. doi: 10.1080/13651500310004803. PMID: 24937579.",27144,2019
frommberger2004_PSS_A_Baseline_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,21,A,PTSD,,,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,PSS,PSS,,,Two-factor repeated measures ANOVA,Baseline,,,34.1,9.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5714,,0.4286,Mixed,"rape/sexual assault, accidents, community/school violence",High,"Frommberger UH, Stieglitz R-D, Nyberg E, et al. Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder (PTSD): a pilot study. Int. J. Psychiatry Clin. Pract. 2004;8(1):19-24. doi: 10.1080/13651500310004803. PMID: 24937579.",27144,2019
frommberger2004_PSS_B_0_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,21,B,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,PSS,PSS,,,Two-factor repeated measures ANOVA,End of Treatment,0,,15.0,5.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5714,,0.4286,Mixed,"rape/sexual assault, accidents, community/school violence",High,"Frommberger UH, Stieglitz R-D, Nyberg E, et al. Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder (PTSD): a pilot study. Int. J. Psychiatry Clin. Pract. 2004;8(1):19-24. doi: 10.1080/13651500310004803. PMID: 24937579.",27144,2019
frommberger2004_PSS_B_26_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,21,B,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,PSS,PSS,,,Two-factor repeated measures ANOVA,Assessment at 6 to <12 Months,26,,13.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5714,,0.4286,Mixed,"rape/sexual assault, accidents, community/school violence",High,"Frommberger UH, Stieglitz R-D, Nyberg E, et al. Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder (PTSD): a pilot study. Int. J. Psychiatry Clin. Pract. 2004;8(1):19-24. doi: 10.1080/13651500310004803. PMID: 24937579.",27144,2019
frommberger2004_PSS_B_Baseline_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,21,B,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,PSS,PSS,,,Two-factor repeated measures ANOVA,Baseline,,,34.5,4.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5714,,0.4286,Mixed,"rape/sexual assault, accidents, community/school violence",High,"Frommberger UH, Stieglitz R-D, Nyberg E, et al. Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder (PTSD): a pilot study. Int. J. Psychiatry Clin. Pract. 2004;8(1):19-24. doi: 10.1080/13651500310004803. PMID: 24937579.",27144,2019
frueh2007_PCL_A_0_Comp,Psychotherapy,PTSD,38,A,PTSD,,9,,Telehealth CBT,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,17,Self report,PCL,PCL-M,Completer,Excluded,"T-test or nonparametric Wilcoxon rank sum test for posttreatment change in mean score, pooled t-test for 3-month followup change-from-baseline score",End of Treatment,0,,68.11,11,,,,,1.78,11,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Frueh BC, Monnier J, Yim E, et al. A randomized trial of telepsychiatry for post-traumatic stress disorder. J. Telemed. Telecare. 2007 Apr 1;13(3):142-7. doi: 10.1258/135763307780677604. PMID: 17519056.",29644,2019
frueh2007_PCL_A_12_Comp,Psychotherapy,PTSD,38,A,PTSD,,7,,Telehealth CBT,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,17,Self report,PCL,PCL-M,Completer,Excluded,"T-test or nonparametric Wilcoxon rank sum test for posttreatment change in mean score, pooled t-test for 3-month followup change-from-baseline score",Assessment at 3 to <6 Months,12,,61.43,14.6,,,,,-2.67,11,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Frueh BC, Monnier J, Yim E, et al. A randomized trial of telepsychiatry for post-traumatic stress disorder. J. Telemed. Telecare. 2007 Apr 1;13(3):142-7. doi: 10.1258/135763307780677604. PMID: 17519056.",29644,2019
frueh2007_PCL_A_Baseline_Comp,Psychotherapy,PTSD,38,A,PTSD,,17,,Telehealth CBT,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,17,Self report,PCL,PCL-M,Completer,Excluded,"T-test or nonparametric Wilcoxon rank sum test for posttreatment change in mean score, pooled t-test for 3-month followup change-from-baseline score",Baseline,,,67,9.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Frueh BC, Monnier J, Yim E, et al. A randomized trial of telepsychiatry for post-traumatic stress disorder. J. Telemed. Telecare. 2007 Apr 1;13(3):142-7. doi: 10.1258/135763307780677604. PMID: 17519056.",29644,2019
frueh2007_PCL_B_0_Comp,Psychotherapy,PTSD,38,B,PTSD,,12,,CBT in-person,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,21,Self report,PCL,PCL-M,Completer,Excluded,"T-test or nonparametric Wilcoxon rank sum test for posttreatment change in mean score, pooled t-test for 3-month followup change-from-baseline score",End of Treatment,0,,56.58,10.1,,,,,-2.58,11.3,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Frueh BC, Monnier J, Yim E, et al. A randomized trial of telepsychiatry for post-traumatic stress disorder. J. Telemed. Telecare. 2007 Apr 1;13(3):142-7. doi: 10.1258/135763307780677604. PMID: 17519056.",29644,2019
frueh2007_PCL_B_12_Comp,Psychotherapy,PTSD,38,B,PTSD,,9,,CBT in-person,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,21,Self report,PCL,PCL-M,Completer,Excluded,"T-test or nonparametric Wilcoxon rank sum test for posttreatment change in mean score, pooled t-test for 3-month followup change-from-baseline score",Assessment at 3 to <6 Months,12,,60.56,9.8,,,,,0.22,11,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Frueh BC, Monnier J, Yim E, et al. A randomized trial of telepsychiatry for post-traumatic stress disorder. J. Telemed. Telecare. 2007 Apr 1;13(3):142-7. doi: 10.1258/135763307780677604. PMID: 17519056.",29644,2019
frueh2007_PCL_B_Baseline_Comp,Psychotherapy,PTSD,38,B,PTSD,,21,,CBT in-person,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,21,Self report,PCL,PCL-M,Completer,Excluded,"T-test or nonparametric Wilcoxon rank sum test for posttreatment change in mean score, pooled t-test for 3-month followup change-from-baseline score",Baseline,,,62.38,12.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Frueh BC, Monnier J, Yim E, et al. A randomized trial of telepsychiatry for post-traumatic stress disorder. J. Telemed. Telecare. 2007 Apr 1;13(3):142-7. doi: 10.1258/135763307780677604. PMID: 17519056.",29644,2019
galovski2012_CAPS_A_0_Comp,Psychotherapy,PTSD,100,A,PTSD,,33,,Modified CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Structured Clinical Interview,CAPS,CAPS,Completer,,Hierarchical linear modeling,End of Treatment,0,,,,,,,,-49.7,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.69,,0.31,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence",Medium,"Galovski TE, Blain LM, Mott JM, et al. Manualized therapy for PTSD: flexing the structure of cognitive processing therapy. J Consult Clin Psychol. 2012 Dec;80(6):968-81. doi: 10.1037/a0030600. PMID: 23106761.",39611,2019
galovski2012_CAPS_A_0_ITT,Psychotherapy,PTSD,100,A,PTSD,,,34 to 48,Modified CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Structured Clinical Interview,CAPS,CAPS,ITT,,Hierarchical linear modeling,End of Treatment,0,,26.96,,SEM,3.88,,,-47.49,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.69,,0.31,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence",Medium,"Galovski TE, Blain LM, Mott JM, et al. Manualized therapy for PTSD: flexing the structure of cognitive processing therapy. J Consult Clin Psychol. 2012 Dec;80(6):968-81. doi: 10.1037/a0030600. PMID: 23106761.",39611,2019
galovski2012_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,100,A,PTSD,,33,,Modified CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Structured Clinical Interview,CAPS,CAPS,Completer,,Hierarchical linear modeling,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.69,,0.31,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence",Medium,"Galovski TE, Blain LM, Mott JM, et al. Manualized therapy for PTSD: flexing the structure of cognitive processing therapy. J Consult Clin Psychol. 2012 Dec;80(6):968-81. doi: 10.1037/a0030600. PMID: 23106761.",39611,2019
galovski2012_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,100,A,PTSD,,,49 to 53,Modified CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Structured Clinical Interview,CAPS,CAPS,ITT,,Hierarchical linear modeling,Baseline,,,74.45,,SEM,2.42,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.69,,0.31,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence",Medium,"Galovski TE, Blain LM, Mott JM, et al. Manualized therapy for PTSD: flexing the structure of cognitive processing therapy. J Consult Clin Psychol. 2012 Dec;80(6):968-81. doi: 10.1037/a0030600. PMID: 23106761.",39611,2019
galovski2012_CAPS_B_0_Comp,Psychotherapy,PTSD,100,B,Control,,36,,Symptom monitoring,Symptom monitoring,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,47,Structured Clinical Interview,CAPS,CAPS,Completer,,Hierarchical linear modeling,End of Treatment,0,,,,,,,,-15.3,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.69,,0.31,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence",Medium,"Galovski TE, Blain LM, Mott JM, et al. Manualized therapy for PTSD: flexing the structure of cognitive processing therapy. J Consult Clin Psychol. 2012 Dec;80(6):968-81. doi: 10.1037/a0030600. PMID: 23106761.",39611,2019
galovski2012_CAPS_B_0_ITT,Psychotherapy,PTSD,100,B,Control,,,32 to 37,Symptom monitoring,Symptom monitoring,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,47,Structured Clinical Interview,CAPS,CAPS,ITT,,Hierarchical linear modeling,End of Treatment,0,,61.18,3.98,,,,,-15.82,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.69,,0.31,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence",Medium,"Galovski TE, Blain LM, Mott JM, et al. Manualized therapy for PTSD: flexing the structure of cognitive processing therapy. J Consult Clin Psychol. 2012 Dec;80(6):968-81. doi: 10.1037/a0030600. PMID: 23106761.",39611,2019
galovski2012_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,100,B,Control,,37,,Symptom monitoring,Symptom monitoring,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,47,Structured Clinical Interview,CAPS,CAPS,Completer,,Hierarchical linear modeling,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.69,,0.31,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence",Medium,"Galovski TE, Blain LM, Mott JM, et al. Manualized therapy for PTSD: flexing the structure of cognitive processing therapy. J Consult Clin Psychol. 2012 Dec;80(6):968-81. doi: 10.1037/a0030600. PMID: 23106761.",39611,2019
galovski2012_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,100,B,Control,,,41 to 47,Symptom monitoring,Symptom monitoring,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,47,Structured Clinical Interview,CAPS,CAPS,ITT,,Hierarchical linear modeling,Baseline,,,77,,SEM,2.57,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.69,,0.31,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence",Medium,"Galovski TE, Blain LM, Mott JM, et al. Manualized therapy for PTSD: flexing the structure of cognitive processing therapy. J Consult Clin Psychol. 2012 Dec;80(6):968-81. doi: 10.1037/a0030600. PMID: 23106761.",39611,2019
galovski2012_PDS_A_0_ITT,Psychotherapy,PTSD,100,A,PTSD,,,,Modified CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Self report,PDS,PDS,ITT,,Hierarchical linear modeling,End of Treatment,0,,11.63,,SEM,2.01,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.69,,0.31,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence",Medium,"Galovski TE, Blain LM, Mott JM, et al. Manualized therapy for PTSD: flexing the structure of cognitive processing therapy. J Consult Clin Psychol. 2012 Dec;80(6):968-81. doi: 10.1037/a0030600. PMID: 23106761.",39611,2019
galovski2012_PDS_A_Baseline_ITT,Psychotherapy,PTSD,100,A,PTSD,,,,Modified CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Self report,PDS,PDS,ITT,,Hierarchical linear modeling,Baseline,,,31.88,,SEM,1.25,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.69,,0.31,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence",Medium,"Galovski TE, Blain LM, Mott JM, et al. Manualized therapy for PTSD: flexing the structure of cognitive processing therapy. J Consult Clin Psychol. 2012 Dec;80(6):968-81. doi: 10.1037/a0030600. PMID: 23106761.",39611,2019
galovski2012_PDS_B_0_ITT,Psychotherapy,PTSD,100,B,Control,,,,Symptom monitoring,Symptom monitoring,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,47,Self report,PDS,PDS,ITT,,Hierarchical linear modeling,End of Treatment,0,,26.81,,SEM,2.07,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.69,,0.31,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence",Medium,"Galovski TE, Blain LM, Mott JM, et al. Manualized therapy for PTSD: flexing the structure of cognitive processing therapy. J Consult Clin Psychol. 2012 Dec;80(6):968-81. doi: 10.1037/a0030600. PMID: 23106761.",39611,2019
galovski2012_PDS_B_Baseline_ITT,Psychotherapy,PTSD,100,B,Control,,,,Symptom monitoring,Symptom monitoring,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,47,Self report,PDS,PDS,ITT,,Hierarchical linear modeling,Baseline,,,35.28,,SEM,1.34,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.69,,0.31,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence",Medium,"Galovski TE, Blain LM, Mott JM, et al. Manualized therapy for PTSD: flexing the structure of cognitive processing therapy. J Consult Clin Psychol. 2012 Dec;80(6):968-81. doi: 10.1037/a0030600. PMID: 23106761.",39611,2019
galovski2016_CAPS_A_0_ITT,Mixed: Psychotherapy & CIH,PTSD,92,A,PTSD,,26,,Sleep-directed hypnosis + CPT,Sleep-directed hypnosis followed by Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,Yes,Clinical hypnosis,No,No,No,No,No,Individual,In Person,44,Structured Clinical Interview,CAPS,CAPS total score without sleep item (D-1),ITT,,Multilevel approach to longitudinal data analysis with NLME package from R; effect size differences in change between assessment intervals as difference in rates of change between study conditions (independent samples),End of Treatment,0,,22.66,17.77,,,,,-49.82,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence",High,"Galovski TE, Harik JM, Blain LM, et al. Augmenting cognitive processing therapy to improve sleep impairment in PTSD: a randomized controlled trial. J Consult Clin Psychol. 2016 Feb;84(2):167-77. doi: 10.1037/ccp0000059. PMID: 26689303.",44664,2019
galovski2016_CAPS_A_12_ITT,Mixed: Psychotherapy & CIH,PTSD,92,A,PTSD,,26,,Sleep-directed hypnosis + CPT,Sleep-directed hypnosis followed by Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,Yes,Clinical hypnosis,No,No,No,No,No,Individual,In Person,44,Structured Clinical Interview,CAPS,CAPS total score without sleep item (D-1),ITT,,Multilevel approach to longitudinal data analysis with NLME package from R; effect size differences in change between assessment intervals as difference in rates of change between study conditions (independent samples),Assessment at 3 to <6 Months,12,,27.87,27.26,,,,,-44.61,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence",High,"Galovski TE, Harik JM, Blain LM, et al. Augmenting cognitive processing therapy to improve sleep impairment in PTSD: a randomized controlled trial. J Consult Clin Psychol. 2016 Feb;84(2):167-77. doi: 10.1037/ccp0000059. PMID: 26689303.",44664,2019
galovski2016_CAPS_A_Baseline_ITT,Mixed: Psychotherapy & CIH,PTSD,92,A,PTSD,,26,,Sleep-directed hypnosis + CPT,Sleep-directed hypnosis followed by Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,Yes,Clinical hypnosis,No,No,No,No,No,Individual,In Person,44,Structured Clinical Interview,CAPS,CAPS total score without sleep item (D-1),ITT,,Multilevel approach to longitudinal data analysis with NLME package from R; effect size differences in change between assessment intervals as difference in rates of change between study conditions (independent samples),Baseline,,,72.48,15.01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence",High,"Galovski TE, Harik JM, Blain LM, et al. Augmenting cognitive processing therapy to improve sleep impairment in PTSD: a randomized controlled trial. J Consult Clin Psychol. 2016 Feb;84(2):167-77. doi: 10.1037/ccp0000059. PMID: 26689303.",44664,2019
galovski2016_CAPS_B_0_ITT,Mixed: Psychotherapy & CIH,PTSD,92,B,PTSD,,25,,Sleep and symptom monitoring + CPT,Sleep and symptom monitoring followed by Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,48,Structured Clinical Interview,CAPS,CAPS total score without sleep item (D-1),ITT,,Multilevel approach to longitudinal data analysis with NLME package from R; effect size differences in change between assessment intervals as difference in rates of change between study conditions (independent samples),End of Treatment,0,,23.4,22.45,,,,,-45.83,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence",High,"Galovski TE, Harik JM, Blain LM, et al. Augmenting cognitive processing therapy to improve sleep impairment in PTSD: a randomized controlled trial. J Consult Clin Psychol. 2016 Feb;84(2):167-77. doi: 10.1037/ccp0000059. PMID: 26689303.",44664,2019
galovski2016_CAPS_B_12_ITT,Mixed: Psychotherapy & CIH,PTSD,92,B,PTSD,,25,,Sleep and symptom monitoring + CPT,Sleep and symptom monitoring followed by Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,48,Structured Clinical Interview,CAPS,CAPS total score without sleep item (D-1),ITT,,Multilevel approach to longitudinal data analysis with NLME package from R; effect size differences in change between assessment intervals as difference in rates of change between study conditions (independent samples),Assessment at 3 to <6 Months,12,,27.63,26.91,,,,,-41.6,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence",High,"Galovski TE, Harik JM, Blain LM, et al. Augmenting cognitive processing therapy to improve sleep impairment in PTSD: a randomized controlled trial. J Consult Clin Psychol. 2016 Feb;84(2):167-77. doi: 10.1037/ccp0000059. PMID: 26689303.",44664,2019
galovski2016_CAPS_B_Baseline_ITT,Mixed: Psychotherapy & CIH,PTSD,92,B,PTSD,,25,,Sleep and symptom monitoring + CPT,Sleep and symptom monitoring followed by Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,48,Structured Clinical Interview,CAPS,CAPS total score without sleep item (D-1),ITT,,Multilevel approach to longitudinal data analysis with NLME package from R; effect size differences in change between assessment intervals as difference in rates of change between study conditions (independent samples),Baseline,,,69.23,15.74,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence",High,"Galovski TE, Harik JM, Blain LM, et al. Augmenting cognitive processing therapy to improve sleep impairment in PTSD: a randomized controlled trial. J Consult Clin Psychol. 2016 Feb;84(2):167-77. doi: 10.1037/ccp0000059. PMID: 26689303.",44664,2019
gamito2010_CAPS_A_0_NA,Psychotherapy,PTSD,10,A,PTSD,,4,,Virtual reality exposure therapy,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,5,Structured Clinical Interview,CAPS,CAPS,,,Repeated measures ANOVA,End of Treatment,0,,,,,,,-8%,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Gamito P, Oliveira J, Rosa P, et al. PTSD elderly war veterans: a clinical controlled pilot study. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):43-8. doi: 10.1089/cyber.2009.0237. PMID: 20528292.",33784,2019
gamito2010_CAPS_A_Baseline_NA,Psychotherapy,PTSD,10,A,PTSD,,5,,Virtual reality exposure therapy,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,5,Structured Clinical Interview,CAPS,CAPS,,,Repeated measures ANOVA,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Gamito P, Oliveira J, Rosa P, et al. PTSD elderly war veterans: a clinical controlled pilot study. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):43-8. doi: 10.1089/cyber.2009.0237. PMID: 20528292.",33784,2019
gamito2010_CAPS_B_0_NA,Psychotherapy,PTSD,10,B,PTSD,,2,,Imaginal Exposure,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,2,Structured Clinical Interview,CAPS,CAPS,,,Repeated measures ANOVA,End of Treatment,0,,,,,,,-1%,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Gamito P, Oliveira J, Rosa P, et al. PTSD elderly war veterans: a clinical controlled pilot study. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):43-8. doi: 10.1089/cyber.2009.0237. PMID: 20528292.",33784,2019
gamito2010_CAPS_B_Baseline_NA,Psychotherapy,PTSD,10,B,PTSD,,2,,Imaginal Exposure,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,2,Structured Clinical Interview,CAPS,CAPS,,,Repeated measures ANOVA,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Gamito P, Oliveira J, Rosa P, et al. PTSD elderly war veterans: a clinical controlled pilot study. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):43-8. doi: 10.1089/cyber.2009.0237. PMID: 20528292.",33784,2019
gamito2010_CAPS_C_0_NA,Psychotherapy,PTSD,10,C,Control,,3,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,3,Structured Clinical Interview,CAPS,CAPS,,,Repeated measures ANOVA,End of Treatment,0,,-0.06,,,,,-6%,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Gamito P, Oliveira J, Rosa P, et al. PTSD elderly war veterans: a clinical controlled pilot study. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):43-8. doi: 10.1089/cyber.2009.0237. PMID: 20528292.",33784,2019
gamito2010_CAPS_C_Baseline_NA,Psychotherapy,PTSD,10,C,Control,,3,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,3,Structured Clinical Interview,CAPS,CAPS,,,Repeated measures ANOVA,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Gamito P, Oliveira J, Rosa P, et al. PTSD elderly war veterans: a clinical controlled pilot study. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):43-8. doi: 10.1089/cyber.2009.0237. PMID: 20528292.",33784,2019
gapen2016_DTS_A_0_NA,Complementary and integrative health (CIH),PTSD,23,A,PTSD,,9,,Neurofeedback,Neurofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,12,Self report,DTS,DTS,,Restricted maximum likelihood estimation,Multilevel growth curve analyses; hierarchical linear and non-linear modeling with restricted maximum likelihood estimation. Effect size (d) computed by procedures defined by Feingold (2009) from growth curve analyses.,End of Treatment,0,,,,,,,,-12.99,,,,,d,-0.45,,,,p=0.056,,,,,,,,,,,,,,Community,,,1,0.6522,,0.3478,Mixed,"child physical abuse, child sexual abuse, child other abuse, other (not specified)",High,"Gapen MA, van der Kolk BA, Hamlin E, et al. A pilot study of neurofeedback for chronic PTSD. Appl Psychophysiol Biofeedback. 2016 Sep;41(3):251-61. doi: 10.1007/s10484-015-9326-5. PMID: 26782083.",44803,2019
gapen2016_DTS_A_Baseline_NA,Complementary and integrative health (CIH),PTSD,23,A,PTSD,,12,,Neurofeedback,Neurofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,12,Self report,DTS,DTS,,Restricted maximum likelihood estimation,Multilevel growth curve analyses; hierarchical linear and non-linear modeling with restricted maximum likelihood estimation. Effect size (d) computed by procedures defined by Feingold (2009) from growth curve analyses.,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6522,,0.3478,Mixed,"child physical abuse, child sexual abuse, child other abuse, other (not specified)",High,"Gapen MA, van der Kolk BA, Hamlin E, et al. A pilot study of neurofeedback for chronic PTSD. Appl Psychophysiol Biofeedback. 2016 Sep;41(3):251-61. doi: 10.1007/s10484-015-9326-5. PMID: 26782083.",44803,2019
gapen2016_DTS_B_0_NA,Complementary and integrative health (CIH),PTSD,23,B,PTSD,,8,,Neurofeedback,Neurofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,11,Self report,DTS,DTS,,Restricted maximum likelihood estimation,Multilevel growth curve analyses; hierarchical linear and non-linear modeling with restricted maximum likelihood estimation. Effect size (d) computed by procedures defined by Feingold (2009) from growth curve analyses.,End of Treatment,0,,,,,,,,-24.29,,,,,d,-1.15,,,,p=0.002,,,,,,,,,,,,,,Community,,,1,0.6522,,0.3478,Mixed,"child physical abuse, child sexual abuse, child other abuse, other (not specified)",High,"Gapen MA, van der Kolk BA, Hamlin E, et al. A pilot study of neurofeedback for chronic PTSD. Appl Psychophysiol Biofeedback. 2016 Sep;41(3):251-61. doi: 10.1007/s10484-015-9326-5. PMID: 26782083.",44803,2019
gapen2016_DTS_B_Baseline_NA,Complementary and integrative health (CIH),PTSD,23,B,PTSD,,11,,Neurofeedback,Neurofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,11,Self report,DTS,DTS,,Restricted maximum likelihood estimation,Multilevel growth curve analyses; hierarchical linear and non-linear modeling with restricted maximum likelihood estimation. Effect size (d) computed by procedures defined by Feingold (2009) from growth curve analyses.,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6522,,0.3478,Mixed,"child physical abuse, child sexual abuse, child other abuse, other (not specified)",High,"Gapen MA, van der Kolk BA, Hamlin E, et al. A pilot study of neurofeedback for chronic PTSD. Appl Psychophysiol Biofeedback. 2016 Sep;41(3):251-61. doi: 10.1007/s10484-015-9326-5. PMID: 26782083.",44803,2019
gelkopf2013_SASRQ_A_0_Comp,Complementary and integrative health (CIH),PTSD,42,A,PTSD,,22,,Nature Adventure Rehabilitation,Recreational therapy,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Group,In Person,22,Self report,SASRQ,Modified Stanford Acute Stress Reaction Questionnaire,Completer,No missing values,Repeated measures ANOVA for change in mean score,End of Treatment,0,,105.37,21.5,,,,,-9.68,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Gelkopf M, Hasson-Ohayon I, Bikman M, et al. Nature adventure rehabilitation for combat-related posttraumatic chronic stress disorder: a randomized control trial. Psychiatry Res. 2013 Oct 30;209(3):485-93. doi: 10.1016/j.psychres.2013.01.026. PMID: 23541513.",40581,2019
gelkopf2013_SASRQ_A_Baseline_Comp,Complementary and integrative health (CIH),PTSD,42,A,PTSD,,22,,Nature Adventure Rehabilitation,Recreational therapy,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Group,In Person,22,Self report,SASRQ,Modified Stanford Acute Stress Reaction Questionnaire,Completer,No missing values,Repeated measures ANOVA for change in mean score,Baseline,,,115.05,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Gelkopf M, Hasson-Ohayon I, Bikman M, et al. Nature adventure rehabilitation for combat-related posttraumatic chronic stress disorder: a randomized control trial. Psychiatry Res. 2013 Oct 30;209(3):485-93. doi: 10.1016/j.psychres.2013.01.026. PMID: 23541513.",40581,2019
gelkopf2013_SASRQ_B_0_Comp,Complementary and integrative health (CIH),PTSD,42,B,Control,,20,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,20,Self report,SASRQ,Modified Stanford Acute Stress Reaction Questionnaire,Completer,No missing values,Repeated measures ANOVA for change in mean score,End of Treatment,0,,113.6,19.2,,,,,2.35,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Gelkopf M, Hasson-Ohayon I, Bikman M, et al. Nature adventure rehabilitation for combat-related posttraumatic chronic stress disorder: a randomized control trial. Psychiatry Res. 2013 Oct 30;209(3):485-93. doi: 10.1016/j.psychres.2013.01.026. PMID: 23541513.",40581,2019
gelkopf2013_SASRQ_B_Baseline_Comp,Complementary and integrative health (CIH),PTSD,42,B,Control,,20,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,20,Self report,SASRQ,Modified Stanford Acute Stress Reaction Questionnaire,Completer,No missing values,Repeated measures ANOVA for change in mean score,Baseline,,,111.25,26.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Gelkopf M, Hasson-Ohayon I, Bikman M, et al. Nature adventure rehabilitation for combat-related posttraumatic chronic stress disorder: a randomized control trial. Psychiatry Res. 2013 Oct 30;209(3):485-93. doi: 10.1016/j.psychres.2013.01.026. PMID: 23541513.",40581,2019
geronilla2016_PCL_A_0_ITT,Psychotherapy,PTSD,58,A,PTSD,,27,,Emotional Freedom Technique,Emotional Freedom Technique (EFT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,32,Self report,PCL,PCL-M,ITT,Linear mixed-effects model,Linear mixed-effects model for change in mean score,End of Treatment,0,,34,10.3,,,,,-31,,,,,,,,,,p<0.0045 (with Bonferroni correction),,,,,,,,PCL-M <50,0.963,,,,,Veteran,0,1,0,0.1207,,0.8793,,,High,"Geronilla L, Minewiser L, Mollon P, et al. EFT (Emotional Freedom Techniques) remediates PTSD and psychological symptoms in veterans: A randomized controlled replication trial. Energy Psychology. 2016;8(2):29.",1549292,2019
geronilla2016_PCL_A_12_ITT,Psychotherapy,PTSD,58,A,PTSD,,25,,Emotional Freedom Technique,Emotional Freedom Technique (EFT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,32,Self report,PCL,PCL-M,ITT,Linear mixed-effects model,Linear mixed-effects model for change in mean score,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,PCL-M <50,,,,,,Veteran,0,1,0,0.1207,,0.8793,,,High,"Geronilla L, Minewiser L, Mollon P, et al. EFT (Emotional Freedom Techniques) remediates PTSD and psychological symptoms in veterans: A randomized controlled replication trial. Energy Psychology. 2016;8(2):29.",1549292,2019
geronilla2016_PCL_A_26_ITT,Psychotherapy,PTSD,58,A,PTSD,,23,,Emotional Freedom Technique,Emotional Freedom Technique (EFT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,32,Self report,PCL,PCL-M,ITT,Linear mixed-effects model,Linear mixed-effects model for change in mean score,Assessment at 6 to <12 Months,26,,,,,,,,,,,,,,,,,,,,,,,,,,PCL-M <50,,,,,,Veteran,0,1,0,0.1207,,0.8793,,,High,"Geronilla L, Minewiser L, Mollon P, et al. EFT (Emotional Freedom Techniques) remediates PTSD and psychological symptoms in veterans: A randomized controlled replication trial. Energy Psychology. 2016;8(2):29.",1549292,2019
geronilla2016_PCL_A_Baseline_ITT,Psychotherapy,PTSD,58,A,PTSD,,32,,Emotional Freedom Technique,Emotional Freedom Technique (EFT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,32,Self report,PCL,PCL-M,ITT,Linear mixed-effects model,Linear mixed-effects model for change in mean score,Baseline,,,65,8.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1207,,0.8793,,,High,"Geronilla L, Minewiser L, Mollon P, et al. EFT (Emotional Freedom Techniques) remediates PTSD and psychological symptoms in veterans: A randomized controlled replication trial. Energy Psychology. 2016;8(2):29.",1549292,2019
geronilla2016_PCL_B_0_ITT,Psychotherapy,PTSD,58,B,Control,,22,,TAU waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,26,Self report,PCL,PCL-M,ITT,Linear mixed-effects model,Linear mixed-effects model for change in mean score,End of Treatment,0,,63,10.4,,,,,-4,,,,,,,,,,p=NS,,,,,,,,PCL-M <50,0.0909,,,,,Veteran,0,1,0,0.1207,,0.8793,,,High,"Geronilla L, Minewiser L, Mollon P, et al. EFT (Emotional Freedom Techniques) remediates PTSD and psychological symptoms in veterans: A randomized controlled replication trial. Energy Psychology. 2016;8(2):29.",1549292,2019
geronilla2016_PCL_B_Baseline_ITT,Psychotherapy,PTSD,58,B,Control,,26,,TAU waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,26,Self report,PCL,PCL-M,ITT,Linear mixed-effects model,Linear mixed-effects model for change in mean score,Baseline,,,67,7.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1207,,0.8793,,,High,"Geronilla L, Minewiser L, Mollon P, et al. EFT (Emotional Freedom Techniques) remediates PTSD and psychological symptoms in veterans: A randomized controlled replication trial. Energy Psychology. 2016;8(2):29.",1549292,2019
gersons2000_DSM_A_0_ITT,Psychotherapy,PTSD,44,A,PTSD,,22,,Brief Eclectic Psychotherapy,Brief Eclectic Psychotherapy (BEP),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Clinical diagnosis,DSM,Number of DSM-III-R PTSD symptoms,ITT,,Difference in followup scores,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,0.9091,,<6 PTSD symptoms,0.7727,,Community,,,1,0.119,,0.881,Other (occupational events),,Medium,"Gersons BP, Carlier IV, Lamberts RD, et al. Randomized clinical trial of brief eclectic psychotherapy for police officers with posttraumatic stress disorder. J Trauma Stress. 2000 Apr;13(2):333-47. doi: 10.1023/A:1007793803627. PMID: 10838679..",15124,2019
gersons2000_DSM_A_12_ITT,Psychotherapy,PTSD,44,A,PTSD,,22,,Brief Eclectic Psychotherapy,Brief Eclectic Psychotherapy (BEP),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Clinical diagnosis,DSM,Number of DSM-III-R PTSD symptoms,ITT,,Difference in followup scores,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,0.9545,,<6 PTSD symptoms,0.9091,,Community,,,1,0.119,,0.881,Other (occupational events),,Medium,"Gersons BP, Carlier IV, Lamberts RD, et al. Randomized clinical trial of brief eclectic psychotherapy for police officers with posttraumatic stress disorder. J Trauma Stress. 2000 Apr;13(2):333-47. doi: 10.1023/A:1007793803627. PMID: 10838679..",15124,2019
gersons2000_DSM_A_Baseline_ITT,Psychotherapy,PTSD,44,A,PTSD,,22,,Brief Eclectic Psychotherapy,Brief Eclectic Psychotherapy (BEP),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Clinical diagnosis,DSM,Number of DSM-III-R PTSD symptoms,ITT,,Difference in followup scores,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.119,,0.881,Other (occupational events),,Medium,"Gersons BP, Carlier IV, Lamberts RD, et al. Randomized clinical trial of brief eclectic psychotherapy for police officers with posttraumatic stress disorder. J Trauma Stress. 2000 Apr;13(2):333-47. doi: 10.1023/A:1007793803627. PMID: 10838679..",15124,2019
gersons2000_DSM_B_0_ITT,Psychotherapy,PTSD,44,B,Control,,20,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,20,Clinical diagnosis,DSM,Number of DSM-III-R PTSD symptoms,ITT,,Difference in followup scores,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,0.5,,<6 PTSD symptoms,0.15,,Community,,,1,0.119,,0.881,Other (occupational events),,Medium,"Gersons BP, Carlier IV, Lamberts RD, et al. Randomized clinical trial of brief eclectic psychotherapy for police officers with posttraumatic stress disorder. J Trauma Stress. 2000 Apr;13(2):333-47. doi: 10.1023/A:1007793803627. PMID: 10838679..",15124,2019
gersons2000_DSM_B_12_ITT,Psychotherapy,PTSD,44,B,Control,,20,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,20,Clinical diagnosis,DSM,Number of DSM-III-R PTSD symptoms,ITT,,Difference in followup scores,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,0.35,,<6 PTSD symptoms,0.3,,Community,,,1,0.119,,0.881,Other (occupational events),,Medium,"Gersons BP, Carlier IV, Lamberts RD, et al. Randomized clinical trial of brief eclectic psychotherapy for police officers with posttraumatic stress disorder. J Trauma Stress. 2000 Apr;13(2):333-47. doi: 10.1023/A:1007793803627. PMID: 10838679..",15124,2019
gersons2000_DSM_B_Baseline_ITT,Psychotherapy,PTSD,44,B,Control,,20,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,20,Clinical diagnosis,DSM,Number of DSM-III-R PTSD symptoms,ITT,,Difference in followup scores,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.119,,0.881,Other (occupational events),,Medium,"Gersons BP, Carlier IV, Lamberts RD, et al. Randomized clinical trial of brief eclectic psychotherapy for police officers with posttraumatic stress disorder. J Trauma Stress. 2000 Apr;13(2):333-47. doi: 10.1023/A:1007793803627. PMID: 10838679..",15124,2019
ghafoori2017_PCL_A_0_ITT,Psychotherapy,PTSD,71,A,PTSD,,47,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,47,Self report,PCL,PCL-5,ITT,Mixed effects model,Mixed-effects model for repeated measures; Cohen's d to estimate effect size.,End of Treatment,0,,24.2,15.4,,,,,-29.3,,,,,Cohen's d,2.83,,,,,,,,,,,,,,,,,,Community,,,1,0.831,,0.169,Mixed,"natural or manmade disaster, accidents, rape/sexual assault, community/school violence, illness/medical procedure, combat-related, terrorism/political violence/forced displacement",High,"Ghafoori B, Hansen MC, Garibay E, et al. Feasibility of training frontline therapists in prolonged exposure: a randomized controlled pilot study of treatment of complex trauma in diverse victims of crime and violence. J Nerv Ment Dis. 2017 Apr;205(4):283-93. doi: 10.1097/NMD.0000000000000659. PMID: 28157725.",1523171,2019
ghafoori2017_PCL_A_Baseline_ITT,Psychotherapy,PTSD,71,A,PTSD,,47,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,47,Self report,PCL,PCL-5,ITT,Mixed effects model,Mixed-effects model for repeated measures; Cohen's d to estimate effect size.,Baseline,,,53.5,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.831,,0.169,Mixed,"natural or manmade disaster, accidents, rape/sexual assault, community/school violence, illness/medical procedure, combat-related, terrorism/political violence/forced displacement",High,"Ghafoori B, Hansen MC, Garibay E, et al. Feasibility of training frontline therapists in prolonged exposure: a randomized controlled pilot study of treatment of complex trauma in diverse victims of crime and violence. J Nerv Ment Dis. 2017 Apr;205(4):283-93. doi: 10.1097/NMD.0000000000000659. PMID: 28157725.",1523171,2019
ghafoori2017_PCL_B_0_ITT,Psychotherapy,PTSD,71,B,PTSD,,24,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,24,Self report,PCL,PCL-5,ITT,Mixed effects model,Mixed-effects model for repeated measures; Cohen's d to estimate effect size.,End of Treatment,0,,24.9,16.4,,,,,-36.3,,,,,Cohen's d,2.856,,,,,,,,,,,,,,,,,,Community,,,1,0.831,,0.169,Mixed,"natural or manmade disaster, accidents, rape/sexual assault, community/school violence, illness/medical procedure, combat-related, terrorism/political violence/forced displacement",High,"Ghafoori B, Hansen MC, Garibay E, et al. Feasibility of training frontline therapists in prolonged exposure: a randomized controlled pilot study of treatment of complex trauma in diverse victims of crime and violence. J Nerv Ment Dis. 2017 Apr;205(4):283-93. doi: 10.1097/NMD.0000000000000659. PMID: 28157725.",1523171,2019
ghafoori2017_PCL_B_Baseline_ITT,Psychotherapy,PTSD,71,B,PTSD,,24,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,24,Self report,PCL,PCL-5,ITT,Mixed effects model,Mixed-effects model for repeated measures; Cohen's d to estimate effect size.,Baseline,,,61.2,11.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.831,,0.169,Mixed,"natural or manmade disaster, accidents, rape/sexual assault, community/school violence, illness/medical procedure, combat-related, terrorism/political violence/forced displacement",High,"Ghafoori B, Hansen MC, Garibay E, et al. Feasibility of training frontline therapists in prolonged exposure: a randomized controlled pilot study of treatment of complex trauma in diverse victims of crime and violence. J Nerv Ment Dis. 2017 Apr;205(4):283-93. doi: 10.1097/NMD.0000000000000659. PMID: 28157725.",1523171,2019
goldstein2018_CAPS_A_0_ITT,Complementary and integrative health (CIH),PTSD,47,A,PTSD,,16,,Integrative Exercise,Exercise,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Group,In Person,21,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed-effects model,"Mixed effects model, Cohen's d",End of Treatment,0,,34.2,19.62,,,,,-30.64,17,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.1915,,0.8085,,,Low,"Goldstein LA, Mehling WE, Metzler TJ, et al. Veterans group exercise: a randomized pilot trial of an integrative exercise program for veterans with posttraumatic stress. J Affect Disord. 2018 Feb;227:345-52. doi: 10.1016/j.jad.2017.11.002. PMID: 29145076.",49403,2019
goldstein2018_CAPS_A_Baseline_ITT,Complementary and integrative health (CIH),PTSD,47,A,PTSD,,21,,Integrative Exercise,Exercise,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Group,In Person,21,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed-effects model,"Mixed effects model, Cohen's d",Baseline,,,64.25,20.54,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.1915,,0.8085,,,Low,"Goldstein LA, Mehling WE, Metzler TJ, et al. Veterans group exercise: a randomized pilot trial of an integrative exercise program for veterans with posttraumatic stress. J Affect Disord. 2018 Feb;227:345-52. doi: 10.1016/j.jad.2017.11.002. PMID: 29145076.",49403,2019
goldstein2018_CAPS_B_0_ITT,Complementary and integrative health (CIH),PTSD,47,B,Control,,22,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,26,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed-effects model,"Mixed effects model, Cohen's d",End of Treatment,0,,44.23,23.62,,,,,-14.27,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.1915,,0.8085,,,Low,"Goldstein LA, Mehling WE, Metzler TJ, et al. Veterans group exercise: a randomized pilot trial of an integrative exercise program for veterans with posttraumatic stress. J Affect Disord. 2018 Feb;227:345-52. doi: 10.1016/j.jad.2017.11.002. PMID: 29145076.",49403,2019
goldstein2018_CAPS_B_Baseline_ITT,Complementary and integrative health (CIH),PTSD,47,B,Control,,26,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,26,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed-effects model,"Mixed effects model, Cohen's d",Baseline,,,58.5,14.19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.1915,,0.8085,,,Low,"Goldstein LA, Mehling WE, Metzler TJ, et al. Veterans group exercise: a randomized pilot trial of an integrative exercise program for veterans with posttraumatic stress. J Affect Disord. 2018 Feb;227:345-52. doi: 10.1016/j.jad.2017.11.002. PMID: 29145076.",49403,2019
golier2012_CAPS_A_0_Comp,Pharmacotherapy,PTSD,9,A,PTSD,,4,,Mifepristone,Mifepristone,No,Not Applicable,Yes,Steroids,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS-2,Completer,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,43.50,19.49,,,,,-25.25,,,,,,,,,,,,,,,,,,Not meeting diagnostic criteria for PTSD,,,≥12-point reduction in total CAPS-2 score,0.75,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,,,,Combat-related,,Medium,"Golier JA, Caramanica K, Demaria R, et al. A pilot study of mifepristone in combat-related PTSD. Depress Res Treat. 2012;2012:393251. doi: 10.1155/2012/393251. PMID: 22611490.",39051,2019
golier2012_CAPS_A_4_Comp,Pharmacotherapy,PTSD,9,A,PTSD,,4,,Mifepristone,Mifepristone,No,Not Applicable,Yes,Steroids,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS-2,Completer,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Assessment at <3 Months,4,,44.00,24.12,,,,,-24.75,,,,,,,,,,p=0.039,,,,,,,,Not meeting diagnostic criteria for PTSD,0.75,,≥12-point reduction in total CAPS-2 score,1,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,,,,Combat-related,,Medium,"Golier JA, Caramanica K, Demaria R, et al. A pilot study of mifepristone in combat-related PTSD. Depress Res Treat. 2012;2012:393251. doi: 10.1155/2012/393251. PMID: 22611490.",39051,2019
golier2012_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,9,A,PTSD,,4,,Mifepristone,Mifepristone,No,Not Applicable,Yes,Steroids,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS-2,Completer,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,68.75,10.24,,,,,,,,,,,,,,,,,,,,,,,Not meeting diagnostic criteria for PTSD,,,≥12-point reduction in total CAPS-2 score,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,,,,Combat-related,,Medium,"Golier JA, Caramanica K, Demaria R, et al. A pilot study of mifepristone in combat-related PTSD. Depress Res Treat. 2012;2012:393251. doi: 10.1155/2012/393251. PMID: 22611490.",39051,2019
golier2012_CAPS_B_0_Comp,Pharmacotherapy,PTSD,9,B,Control,,4,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS-2,Completer,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,56.50,31.89,,,,,-11.75,,,,,,,,,,,,,,,,,,Not meeting diagnostic criteria for PTSD,,,≥12-point reduction in total CAPS-2 score,0.5,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,,,,Combat-related,,Medium,"Golier JA, Caramanica K, Demaria R, et al. A pilot study of mifepristone in combat-related PTSD. Depress Res Treat. 2012;2012:393251. doi: 10.1155/2012/393251. PMID: 22611490.",39051,2019
golier2012_CAPS_B_4_Comp,Pharmacotherapy,PTSD,9,B,Control,,4,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS-2,Completer,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Assessment at <3 Months,4,,65.25,18.86,,,,,-3,,,,,,,,,,p>0.05,,,,,,,,Not meeting diagnostic criteria for PTSD,0.25,,≥12-point reduction in total CAPS-2 score,0.25,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,,,,Combat-related,,Medium,"Golier JA, Caramanica K, Demaria R, et al. A pilot study of mifepristone in combat-related PTSD. Depress Res Treat. 2012;2012:393251. doi: 10.1155/2012/393251. PMID: 22611490.",39051,2019
golier2012_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,9,B,Control,,4,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS-2,Completer,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,68.25,8.77,,,,,,,,,,,,,,,,,,,,,,,Not meeting diagnostic criteria for PTSD,,,≥12-point reduction in total CAPS-2 score,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,,,,Combat-related,,Medium,"Golier JA, Caramanica K, Demaria R, et al. A pilot study of mifepristone in combat-related PTSD. Depress Res Treat. 2012;2012:393251. doi: 10.1155/2012/393251. PMID: 22611490.",39051,2019
golier2012_PCL_A_0_NA,Pharmacotherapy,PTSD,9,A,PTSD,,,,Mifepristone,Mifepristone,No,Not Applicable,Yes,Steroids,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL,,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,46.75,11.79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Golier JA, Caramanica K, Demaria R, et al. A pilot study of mifepristone in combat-related PTSD. Depress Res Treat. 2012;2012:393251. doi: 10.1155/2012/393251. PMID: 22611490.",39051,2019
golier2012_PCL_A_4_NA,Pharmacotherapy,PTSD,9,A,PTSD,,,,Mifepristone,Mifepristone,No,Not Applicable,Yes,Steroids,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL,,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Assessment at <3 Months,4,,49.25,15.59,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Golier JA, Caramanica K, Demaria R, et al. A pilot study of mifepristone in combat-related PTSD. Depress Res Treat. 2012;2012:393251. doi: 10.1155/2012/393251. PMID: 22611490.",39051,2019
golier2012_PCL_A_Baseline_NA,Pharmacotherapy,PTSD,9,A,PTSD,,,,Mifepristone,Mifepristone,No,Not Applicable,Yes,Steroids,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL,,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,60.00,10.83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Golier JA, Caramanica K, Demaria R, et al. A pilot study of mifepristone in combat-related PTSD. Depress Res Treat. 2012;2012:393251. doi: 10.1155/2012/393251. PMID: 22611490.",39051,2019
golier2012_PCL_B_0_NA,Pharmacotherapy,PTSD,9,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL,,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,54.25,24.17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Golier JA, Caramanica K, Demaria R, et al. A pilot study of mifepristone in combat-related PTSD. Depress Res Treat. 2012;2012:393251. doi: 10.1155/2012/393251. PMID: 22611490.",39051,2019
golier2012_PCL_B_4_NA,Pharmacotherapy,PTSD,9,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL,,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Assessment at <3 Months,4,,56.25,16.68,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Golier JA, Caramanica K, Demaria R, et al. A pilot study of mifepristone in combat-related PTSD. Depress Res Treat. 2012;2012:393251. doi: 10.1155/2012/393251. PMID: 22611490.",39051,2019
golier2012_PCL_B_Baseline_NA,Pharmacotherapy,PTSD,9,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL,,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,63.25,11.41,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Golier JA, Caramanica K, Demaria R, et al. A pilot study of mifepristone in combat-related PTSD. Depress Res Treat. 2012;2012:393251. doi: 10.1155/2012/393251. PMID: 22611490.",39051,2019
gray2019a_PCL_A_0_ITT,Psychotherapy,PTSD,74,A,PTSD,,,,Reconsolidation of Traumatic Memories,Reconsolidation of Traumatic Memories (RTM),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,37,Self report,PCL,PCL-M,ITT,LOCF,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,31.5,15.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"MST, combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (not specified)",Medium,"Gray R, Budden-Potts D, Bourke F. Reconsolidation of traumatic memories for PTSD: a randomized controlled trial of 74 male veterans. Psychother Res. 2017 Dec 14:1-19. doi: 10.1080/10503307.2017.1408973. PMID: 29241423.",49545,2020
gray2019a_PCL_A_Baseline_ITT,Psychotherapy,PTSD,74,A,PTSD,,,,Reconsolidation of Traumatic Memories,Reconsolidation of Traumatic Memories (RTM),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,37,Self report,PCL,PCL-M,ITT,LOCF,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,62.9,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"MST, combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (not specified)",Medium,"Gray R, Budden-Potts D, Bourke F. Reconsolidation of traumatic memories for PTSD: a randomized controlled trial of 74 male veterans. Psychother Res. 2017 Dec 14:1-19. doi: 10.1080/10503307.2017.1408973. PMID: 29241423.",49545,2020
gray2019a_PCL_B_0_ITT,Psychotherapy,PTSD,74,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,37,Self report,PCL,PCL-M,ITT,LOCF,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,63.0,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"MST, combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (not specified)",Medium,"Gray R, Budden-Potts D, Bourke F. Reconsolidation of traumatic memories for PTSD: a randomized controlled trial of 74 male veterans. Psychother Res. 2017 Dec 14:1-19. doi: 10.1080/10503307.2017.1408973. PMID: 29241423.",49545,2020
gray2019a_PCL_B_Baseline_ITT,Psychotherapy,PTSD,74,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,37,Self report,PCL,PCL-M,ITT,LOCF,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,66.2,9.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"MST, combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (not specified)",Medium,"Gray R, Budden-Potts D, Bourke F. Reconsolidation of traumatic memories for PTSD: a randomized controlled trial of 74 male veterans. Psychother Res. 2017 Dec 14:1-19. doi: 10.1080/10503307.2017.1408973. PMID: 29241423.",49545,2020
gray2019a_PSS-I_A_0_ITT,Psychotherapy,PTSD,74,A,PTSD,,37,,Reconsolidation of Traumatic Memories,Reconsolidation of Traumatic Memories (RTM),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,37,Structured Clinical Interview,PSS-I,PSS-I,ITT,LOCF,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,12.9,12.9,,,,,-24.4,,,,,Hedges' g,-2.35,95% CI,-2.94,-1.76,p<0.001,,,,,,,,Not meeting criteria for PTSD according to DSM-IV and PSS-I score ≤20,,Additional definitions of Diagnostic Change reported in the study,,,,Veteran,0,1,0,0,,1,Mixed,"MST, combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (not specified)",Medium,"Gray R, Budden-Potts D, Bourke F. Reconsolidation of traumatic memories for PTSD: a randomized controlled trial of 74 male veterans. Psychother Res. 2017 Dec 14:1-19. doi: 10.1080/10503307.2017.1408973. PMID: 29241423.",49545,2020
gray2019a_PSS-I_A_6_ITT,Psychotherapy,PTSD,74,A,PTSD,,37,,Reconsolidation of Traumatic Memories,Reconsolidation of Traumatic Memories (RTM),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,37,Structured Clinical Interview,PSS-I,PSS-I,ITT,LOCF,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Assessment at <3 Months,6,,17.4,14.3,,,,,-19.9,,,,,Hedges' g,-1.77,95% CI,-2.31,-1.23,p<0.001,,,,,,,,Not meeting criteria for PTSD according to DSM-IV and PSS-I score ≤20,,Additional definitions of Diagnostic Change reported in the study,,,,Veteran,0,1,0,0,,1,Mixed,"MST, combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (not specified)",Medium,"Gray R, Budden-Potts D, Bourke F. Reconsolidation of traumatic memories for PTSD: a randomized controlled trial of 74 male veterans. Psychother Res. 2017 Dec 14:1-19. doi: 10.1080/10503307.2017.1408973. PMID: 29241423.",49545,2020
gray2019a_PSS-I_A_Baseline_ITT,Psychotherapy,PTSD,74,A,PTSD,,37,,Reconsolidation of Traumatic Memories,Reconsolidation of Traumatic Memories (RTM),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,37,Structured Clinical Interview,PSS-I,PSS-I,ITT,LOCF,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,37.3,6.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"MST, combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (not specified)",Medium,"Gray R, Budden-Potts D, Bourke F. Reconsolidation of traumatic memories for PTSD: a randomized controlled trial of 74 male veterans. Psychother Res. 2017 Dec 14:1-19. doi: 10.1080/10503307.2017.1408973. PMID: 29241423.",49545,2020
gray2019a_PSS-I_B_0_ITT,Psychotherapy,PTSD,74,B,Control,,37,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,37,Structured Clinical Interview,PSS-I,PSS-I,ITT,LOCF,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,37.1,9.3,,,,,-2.6,,,,,Hedges' g,-0.31,95% CI,-0.77,0.15,p=0.018,,,,,,,,Not meeting criteria for PTSD according to DSM-IV and PSS-I score ≤20,,Additional definitions of Diagnostic Change reported in the study,,,,Veteran,0,1,0,0,,1,Mixed,"MST, combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (not specified)",Medium,"Gray R, Budden-Potts D, Bourke F. Reconsolidation of traumatic memories for PTSD: a randomized controlled trial of 74 male veterans. Psychother Res. 2017 Dec 14:1-19. doi: 10.1080/10503307.2017.1408973. PMID: 29241423.",49545,2020
gray2019a_PSS-I_B_Baseline_ITT,Psychotherapy,PTSD,74,B,Control,,37,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,37,Structured Clinical Interview,PSS-I,PSS-I,ITT,LOCF,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,39.7,6.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"MST, combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (not specified)",Medium,"Gray R, Budden-Potts D, Bourke F. Reconsolidation of traumatic memories for PTSD: a randomized controlled trial of 74 male veterans. Psychother Res. 2017 Dec 14:1-19. doi: 10.1080/10503307.2017.1408973. PMID: 29241423.",49545,2020
hall2019a_PCL_A_0_I,Complementary and integrative health (CIH),PTSD,54,A,PTSD,,31,,Warrior Wellness,Exercise,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In person,36,Self report,PCL,PCL-5,ITT (limited to participants with follow-up data),None (no missing data),"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,35.87,,,,,SE 2.4,-7.1,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.9074,,0.0926,,,Medium,"Hall KS, Morey MC, Bosworth HB, et al. Pilot randomized controlled trial of exercise training for older veterans with PTSD. J Behav Med. 2019 Jul 1doi: 10.1007/s10865-019-00073-w. PMID: 31264055.",52094,2020
hall2019a_PCL_A_Baseline_I,Complementary and integrative health (CIH),PTSD,54,A,PTSD,,31,,Warrior Wellness,Exercise,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In person,36,Self report,PCL,PCL-5,ITT (limited to participants with follow-up data),None (no missing data),"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,42.97,,SE,2.5,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.9074,,0.0926,,,Medium,"Hall KS, Morey MC, Bosworth HB, et al. Pilot randomized controlled trial of exercise training for older veterans with PTSD. J Behav Med. 2019 Jul 1doi: 10.1007/s10865-019-00073-w. PMID: 31264055.",52094,2020
hall2019a_PCL_B_0_I,Complementary and integrative health (CIH),PTSD,54,B,Control,,17,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,18,Self report,PCL,PCL-5,ITT (limited to participants with follow-up data),None (no missing data),"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,38.19,,,,,SE 2.3,-2.87,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.9074,,0.0926,,,Medium,"Hall KS, Morey MC, Bosworth HB, et al. Pilot randomized controlled trial of exercise training for older veterans with PTSD. J Behav Med. 2019 Jul 1doi: 10.1007/s10865-019-00073-w. PMID: 31264055.",52094,2020
hall2019a_PCL_B_Baseline_I,Complementary and integrative health (CIH),PTSD,54,B,Control,,17,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,18,Self report,PCL,PCL-5,ITT (limited to participants with follow-up data),None (no missing data),"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,41.06,,SE,3.5,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.9074,,0.0926,,,Medium,"Hall KS, Morey MC, Bosworth HB, et al. Pilot randomized controlled trial of exercise training for older veterans with PTSD. J Behav Med. 2019 Jul 1doi: 10.1007/s10865-019-00073-w. PMID: 31264055.",52094,2020
hamner2009_CAPS_A_0_ITT,Pharmacotherapy,PTSD,29,A,PTSD,,15,,Divalproex,Divalproex,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,16,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,78.34,,,,,,1.67,15.96,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0345,,0.9655,Mixed,"combat-related, MST",High,"Hamner MB, Faldowski RA, Robert S, et al. A preliminary controlled trial of divalproex in posttraumatic stress disorder. Ann Clin Psychiatry. 2009 Apr-Jun;21(2):89-94. PMID: 19439158.",33535,2019
hamner2009_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,29,A,PTSD,,15,,Divalproex,Divalproex,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,16,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,76.67,23.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0345,,0.9655,Mixed,"combat-related, MST",High,"Hamner MB, Faldowski RA, Robert S, et al. A preliminary controlled trial of divalproex in posttraumatic stress disorder. Ann Clin Psychiatry. 2009 Apr-Jun;21(2):89-94. PMID: 19439158.",33535,2019
hamner2009_CAPS_B_0_ITT,Pharmacotherapy,PTSD,29,B,Control,,13,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,67.47,,,,,,-10.15,23.88,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0345,,0.9655,Mixed,"combat-related, MST",High,"Hamner MB, Faldowski RA, Robert S, et al. A preliminary controlled trial of divalproex in posttraumatic stress disorder. Ann Clin Psychiatry. 2009 Apr-Jun;21(2):89-94. PMID: 19439158.",33535,2019
hamner2009_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,29,B,Control,,13,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,77.62,21.19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0345,,0.9655,Mixed,"combat-related, MST",High,"Hamner MB, Faldowski RA, Robert S, et al. A preliminary controlled trial of divalproex in posttraumatic stress disorder. Ann Clin Psychiatry. 2009 Apr-Jun;21(2):89-94. PMID: 19439158.",33535,2019
hamner2009_IES_A_0_NA,Pharmacotherapy,PTSD,29,A,PTSD,,,,Divalproex,Divalproex,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,16,Self report,IES,IES,,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0345,,0.9655,Mixed,"combat-related, MST",High,"Hamner MB, Faldowski RA, Robert S, et al. A preliminary controlled trial of divalproex in posttraumatic stress disorder. Ann Clin Psychiatry. 2009 Apr-Jun;21(2):89-94. PMID: 19439158.",33535,2019
hamner2009_IES_A_Baseline_NA,Pharmacotherapy,PTSD,29,A,PTSD,,,,Divalproex,Divalproex,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,16,Self report,IES,IES,,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,44.33,19.49,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0345,,0.9655,Mixed,"combat-related, MST",High,"Hamner MB, Faldowski RA, Robert S, et al. A preliminary controlled trial of divalproex in posttraumatic stress disorder. Ann Clin Psychiatry. 2009 Apr-Jun;21(2):89-94. PMID: 19439158.",33535,2019
hamner2009_IES_B_0_NA,Pharmacotherapy,PTSD,29,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,13,Self report,IES,IES,,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0345,,0.9655,Mixed,"combat-related, MST",High,"Hamner MB, Faldowski RA, Robert S, et al. A preliminary controlled trial of divalproex in posttraumatic stress disorder. Ann Clin Psychiatry. 2009 Apr-Jun;21(2):89-94. PMID: 19439158.",33535,2019
hamner2009_IES_B_Baseline_NA,Pharmacotherapy,PTSD,29,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,13,Self report,IES,IES,,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,42.42,14.48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0345,,0.9655,Mixed,"combat-related, MST",High,"Hamner MB, Faldowski RA, Robert S, et al. A preliminary controlled trial of divalproex in posttraumatic stress disorder. Ann Clin Psychiatry. 2009 Apr-Jun;21(2):89-94. PMID: 19439158.",33535,2019
hamner2019_CAPS_A_0_ITT,Pharmacotherapy,PTSD,24,A,PTSD,,8,,Ziprasidone augmentation,Ziprasidone augmentation,No,Not Applicable,Yes,Mixed SSRI & antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In person,9,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,59.71,22.1,,,,,-3.29,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,High,"Hamner MB, Hernandez-Tejada MA, Zuschlag ZD, et al. Ziprasidone augmentation of SSRI antidepressants in posttraumatic stress disorder: a randomized, placebo-controlled pilot study of augmentation therapy. J Clin Psychopharmacol. 2019 Mar/Apr;39(2):153-7. doi: 10.1097/JCP.0000000000001000. PMID: 30640209.",51867,2020
hamner2019_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,24,A,PTSD,,8,,Ziprasidone augmentation,Ziprasidone augmentation,No,Not Applicable,Yes,Mixed SSRI & antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In person,9,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,63.00,12.383,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,High,"Hamner MB, Hernandez-Tejada MA, Zuschlag ZD, et al. Ziprasidone augmentation of SSRI antidepressants in posttraumatic stress disorder: a randomized, placebo-controlled pilot study of augmentation therapy. J Clin Psychopharmacol. 2019 Mar/Apr;39(2):153-7. doi: 10.1097/JCP.0000000000001000. PMID: 30640209.",51867,2020
hamner2019_CAPS_B_0_ITT,Pharmacotherapy,PTSD,24,B,Control,,14,,Placebo augmentation,Placebo,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,Yes,No,No,Individual,In person,15,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,52.25,20.69,,,,,-13.25,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,High,"Hamner MB, Hernandez-Tejada MA, Zuschlag ZD, et al. Ziprasidone augmentation of SSRI antidepressants in posttraumatic stress disorder: a randomized, placebo-controlled pilot study of augmentation therapy. J Clin Psychopharmacol. 2019 Mar/Apr;39(2):153-7. doi: 10.1097/JCP.0000000000001000. PMID: 30640209.",51867,2020
hamner2019_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,24,B,Control,,14,,Placebo augmentation,Placebo,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,Yes,No,No,Individual,In person,15,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,65.50,15.77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,High,"Hamner MB, Hernandez-Tejada MA, Zuschlag ZD, et al. Ziprasidone augmentation of SSRI antidepressants in posttraumatic stress disorder: a randomized, placebo-controlled pilot study of augmentation therapy. J Clin Psychopharmacol. 2019 Mar/Apr;39(2):153-7. doi: 10.1097/JCP.0000000000001000. PMID: 30640209.",51867,2020
hanling2016_CAPS_A_0_C-I1,Nonpharmacologic biological,PTSD,42,A,PTSD,,27,,Stellate Ganglion Block,Stellate ganglion block (SGB),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,27,Structured Clinical Interview,CAPS,CAPS,"Completer; ""First Injection""",Participants with missing assessments excluded from analysis,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,74.22,20.93,,,,,-12.74,,,,Overall time effect,,,,,,p<0.001,Difference between first and second injections,,,,,,p<0.05,,,,,,,Mixed,0.881,0.119,0,0.1905,,0.8095,Mixed,"combat-related, other (noncombat unspecified)",Medium,"Hanling SR, Hickey A, Lesnik I, et al. Stellate Ganglion Block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):494-500. doi: 10.1097/aap.0000000000000402. PMID: 27187898.",46472,2019
hanling2016_CAPS_A_0_C-I2,Nonpharmacologic biological,PTSD,42,A,PTSD,,18,,Stellate Ganglion Block,Stellate ganglion block (SGB),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,27,Structured Clinical Interview,CAPS,CAPS,"Completer; ""Second Injection""",Participants with missing assessments excluded from analysis,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,66.28,24.86,,,,,-20.69,,,,Overall time effect,,,,,,p<0.05,Difference between first and second injections,,,,,,p<0.05,,,,,,,Mixed,0.881,0.119,0,0.1905,,0.8095,Mixed,"combat-related, other (noncombat unspecified)",Medium,"Hanling SR, Hickey A, Lesnik I, et al. Stellate Ganglion Block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):494-500. doi: 10.1097/aap.0000000000000402. PMID: 27187898.",46472,2019
hanling2016_CAPS_A_4_C-I1,Nonpharmacologic biological,PTSD,42,A,PTSD,,27,,Stellate Ganglion Block,Stellate ganglion block (SGB),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,27,Structured Clinical Interview,CAPS,CAPS,"Completer; ""First Injection""",Participants with missing assessments excluded from analysis,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Assessment at <3 Months,4,,80.41,20.59,,,,,-6.56,,,,Overall time effect,,,,,,p<0.001,,,,,,,,,,,,,,Mixed,0.881,0.119,0,0.1905,,0.8095,Mixed,"combat-related, other (noncombat unspecified)",Medium,"Hanling SR, Hickey A, Lesnik I, et al. Stellate Ganglion Block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):494-500. doi: 10.1097/aap.0000000000000402. PMID: 27187898.",46472,2019
hanling2016_CAPS_A_4_C-I2,Nonpharmacologic biological,PTSD,42,A,PTSD,,18,,Stellate Ganglion Block,Stellate ganglion block (SGB),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,27,Structured Clinical Interview,CAPS,CAPS,"Completer; ""Second Injection""",Participants with missing assessments excluded from analysis,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Assessment at <3 Months,4,,76.36,18.57,,,,,-10.6,,,,Overall time effect,,,,,,p<0.05,,,,,,,,,,,,,,Mixed,0.881,0.119,0,0.1905,,0.8095,Mixed,"combat-related, other (noncombat unspecified)",Medium,"Hanling SR, Hickey A, Lesnik I, et al. Stellate Ganglion Block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):494-500. doi: 10.1097/aap.0000000000000402. PMID: 27187898.",46472,2019
hanling2016_CAPS_A_Baseline_Comp,Nonpharmacologic biological,PTSD,42,A,PTSD,,27,,Stellate Ganglion Block,Stellate ganglion block (SGB),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,27,Structured Clinical Interview,CAPS,CAPS,Completer,Participants with missing assessments excluded from analysis,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,86.96,14.16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.881,0.119,0,0.1905,,0.8095,Mixed,"combat-related, other (noncombat unspecified)",Medium,"Hanling SR, Hickey A, Lesnik I, et al. Stellate Ganglion Block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):494-500. doi: 10.1097/aap.0000000000000402. PMID: 27187898.",46472,2019
hanling2016_CAPS_B_0_C-I1,Nonpharmacologic biological,PTSD,42,B,Control,,15,,Sham stellate ganglion block,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,15,Structured Clinical Interview,CAPS,CAPS,"Completer; ""First Injection""",Participants with missing assessments excluded from analysis,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,75.07,22.72,,,,,-11.33,,,,Overall time effect,,,,,,p<0.001,,,,,,,,,,,,,,Mixed,0.881,0.119,0,0.1905,,0.8095,Mixed,"combat-related, other (noncombat unspecified)",Medium,"Hanling SR, Hickey A, Lesnik I, et al. Stellate Ganglion Block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):494-500. doi: 10.1097/aap.0000000000000402. PMID: 27187898.",46472,2019
hanling2016_CAPS_B_0_C-I2,Nonpharmacologic biological,PTSD,42,B,Control,,12,,Sham stellate ganglion block,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,15,Structured Clinical Interview,CAPS,CAPS,"Completer; ""Second Injection""",Participants with missing assessments excluded from analysis,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,74.00,18.8,,,,,-12.4,,,,Overall time effect,,,,,,p<0.05,,,,,,,,,,,,,,Mixed,0.881,0.119,0,0.1905,,0.8095,Mixed,"combat-related, other (noncombat unspecified)",Medium,"Hanling SR, Hickey A, Lesnik I, et al. Stellate Ganglion Block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):494-500. doi: 10.1097/aap.0000000000000402. PMID: 27187898.",46472,2019
hanling2016_CAPS_B_4_C-I1,Nonpharmacologic biological,PTSD,42,B,Control,,14,,Sham stellate ganglion block,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,15,Structured Clinical Interview,CAPS,CAPS,"Completer; ""First Injection""",Participants with missing assessments excluded from analysis,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Assessment at <3 Months,4,,77.64,20.18,,,,,-8.76,,,,Overall time effect,,,,,,p<0.001,,,,,,,,,,,,,,Mixed,0.881,0.119,0,0.1905,,0.8095,Mixed,"combat-related, other (noncombat unspecified)",Medium,"Hanling SR, Hickey A, Lesnik I, et al. Stellate Ganglion Block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):494-500. doi: 10.1097/aap.0000000000000402. PMID: 27187898.",46472,2019
hanling2016_CAPS_B_4_C-I2,Nonpharmacologic biological,PTSD,42,B,Control,,14,,Sham stellate ganglion block,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,15,Structured Clinical Interview,CAPS,CAPS,"Completer; ""Second Injection""",Participants with missing assessments excluded from analysis,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Assessment at <3 Months,4,,78.67,5.45,,,,,-7.73,,,,Overall time effect,,,,,,p<0.05,,,,,,,,,,,,,,Mixed,0.881,0.119,0,0.1905,,0.8095,Mixed,"combat-related, other (noncombat unspecified)",Medium,"Hanling SR, Hickey A, Lesnik I, et al. Stellate Ganglion Block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):494-500. doi: 10.1097/aap.0000000000000402. PMID: 27187898.",46472,2019
hanling2016_CAPS_B_Baseline_Comp,Nonpharmacologic biological,PTSD,42,B,Control,,15,,Sham stellate ganglion block,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,15,Structured Clinical Interview,CAPS,CAPS,Completer,Participants with missing assessments excluded from analysis,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,86.40,14.77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.881,0.119,0,0.1905,,0.8095,Mixed,"combat-related, other (noncombat unspecified)",Medium,"Hanling SR, Hickey A, Lesnik I, et al. Stellate Ganglion Block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):494-500. doi: 10.1097/aap.0000000000000402. PMID: 27187898.",46472,2019
hanling2016_PCL_A_0_NA,Nonpharmacologic biological,PTSD,42,A,PTSD,,,,Stellate Ganglion Block,Stellate ganglion block (SGB),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,27,Self report,PCL,PCL,,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,63.23,13.78,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.881,0.119,0,0.1905,,0.8095,Mixed,"combat-related, other (noncombat unspecified)",Medium,"Hanling SR, Hickey A, Lesnik I, et al. Stellate Ganglion Block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):494-500. doi: 10.1097/aap.0000000000000402. PMID: 27187898.",46472,2019
hanling2016_PCL_A_4_NA,Nonpharmacologic biological,PTSD,42,A,PTSD,,,,Stellate Ganglion Block,Stellate ganglion block (SGB),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,27,Self report,PCL,PCL,,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Assessment at <3 Months,4,,64.89,12.57,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.881,0.119,0,0.1905,,0.8095,Mixed,"combat-related, other (noncombat unspecified)",Medium,"Hanling SR, Hickey A, Lesnik I, et al. Stellate Ganglion Block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):494-500. doi: 10.1097/aap.0000000000000402. PMID: 27187898.",46472,2019
hanling2016_PCL_A_Baseline_NA,Nonpharmacologic biological,PTSD,42,A,PTSD,,,,Stellate Ganglion Block,Stellate ganglion block (SGB),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,27,Self report,PCL,PCL,,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,66.85,9.81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.881,0.119,0,0.1905,,0.8095,Mixed,"combat-related, other (noncombat unspecified)",Medium,"Hanling SR, Hickey A, Lesnik I, et al. Stellate Ganglion Block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):494-500. doi: 10.1097/aap.0000000000000402. PMID: 27187898.",46472,2019
hanling2016_PCL_B_0_NA,Nonpharmacologic biological,PTSD,42,B,Control,,,,Sham stellate ganglion block,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,15,Self report,PCL,PCL,,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,60.07,11.47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.881,0.119,0,0.1905,,0.8095,Mixed,"combat-related, other (noncombat unspecified)",Medium,"Hanling SR, Hickey A, Lesnik I, et al. Stellate Ganglion Block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):494-500. doi: 10.1097/aap.0000000000000402. PMID: 27187898.",46472,2019
hanling2016_PCL_B_4_NA,Nonpharmacologic biological,PTSD,42,B,Control,,,,Sham stellate ganglion block,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,15,Self report,PCL,PCL,,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Assessment at <3 Months,4,,61.77,12.42,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.881,0.119,0,0.1905,,0.8095,Mixed,"combat-related, other (noncombat unspecified)",Medium,"Hanling SR, Hickey A, Lesnik I, et al. Stellate Ganglion Block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):494-500. doi: 10.1097/aap.0000000000000402. PMID: 27187898.",46472,2019
hanling2016_PCL_B_Baseline_NA,Nonpharmacologic biological,PTSD,42,B,Control,,,,Sham stellate ganglion block,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,15,Self report,PCL,PCL,,,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,64.20,12.21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.881,0.119,0,0.1905,,0.8095,Mixed,"combat-related, other (noncombat unspecified)",Medium,"Hanling SR, Hickey A, Lesnik I, et al. Stellate Ganglion Block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):494-500. doi: 10.1097/aap.0000000000000402. PMID: 27187898.",46472,2019
harb2019_PCL_A_0_ITT,Psychotherapy,PTSD,108,A,PTSD,,,,IR + CBT-I,Imagery Rehearsal Training (IRT) + Cognitive Behavioral Therapy for Insomnia (CBT-I),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,53,Self report,PCL,PCL-M,ITT,Linear mixed-effects models assuming missing at random,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.139,,0.861,Combat-related,,Low,"Harb GC, Cook JM, Phelps AJ, et al. Randomized controlled trial of imagery rehearsal for posttraumatic nightmares in combat veterans. J Clin Sleep Med. 2019 May 15;15(5):757-67. doi: 10.5664/jcsm.7770. PMID: 31053215.",,2020
harb2019_PCL_A_Baseline_ITT,Psychotherapy,PTSD,108,A,PTSD,,41,,IR + CBT-I,Imagery Rehearsal Training (IRT) + Cognitive Behavioral Therapy for Insomnia (CBT-I),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,53,Self report,PCL,PCL-M,ITT,Linear mixed-effects models assuming missing at random,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,65.8,9.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.139,,0.861,Combat-related,,Low,"Harb GC, Cook JM, Phelps AJ, et al. Randomized controlled trial of imagery rehearsal for posttraumatic nightmares in combat veterans. J Clin Sleep Med. 2019 May 15;15(5):757-67. doi: 10.5664/jcsm.7770. PMID: 31053215.",,2020
harb2019_PCL_B_0_ITT,Psychotherapy,PTSD,108,B,PTSD,,,,CBT-I,Cognitive Behavioral Therapy for Insomnia (CBT-I),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,55,Self report,PCL,PCL-M,ITT,Linear mixed-effects models assuming missing at random,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.139,,0.861,Combat-related,,Low,"Harb GC, Cook JM, Phelps AJ, et al. Randomized controlled trial of imagery rehearsal for posttraumatic nightmares in combat veterans. J Clin Sleep Med. 2019 May 15;15(5):757-67. doi: 10.5664/jcsm.7770. PMID: 31053215.",,2020
harb2019_PCL_B_Baseline_ITT,Psychotherapy,PTSD,108,B,PTSD,,55,,CBT-I,Cognitive Behavioral Therapy for Insomnia (CBT-I),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,55,Self report,PCL,PCL-M,ITT,Linear mixed-effects models assuming missing at random,"Independent samples t-test for change in mean scores, chi-square for PTSD diagnostic change and clinically meaningful response",Baseline,,,63.2,10.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.139,,0.861,Combat-related,,Low,"Harb GC, Cook JM, Phelps AJ, et al. Randomized controlled trial of imagery rehearsal for posttraumatic nightmares in combat veterans. J Clin Sleep Med. 2019 May 15;15(5):757-67. doi: 10.5664/jcsm.7770. PMID: 31053215.",,2020
harris2018_CAPS_A_0_Comp,Mixed: Psychotherapy & CIH,PTSD,138,A,PTSD,,40,,Building Spiritual Strength,Building Spiritual Strength,No,Not Applicable,No,Not Applicable,Yes,Spirituality,No,No,No,No,No,Group,In Person,71,Structured Clinical Interview,CAPS,CAPS,Completer,"Generalized linear mixed models: used available data
Repeated measures ANOVA: NR",Mixed effects regression modeling to compare groups across all 3 time points; repeated measures ANOVA for pre-post group differences; chi-square test for clinically meaningful response,End of Treatment,0,,37.7,22.04,,,,,-23.61,,,,,Cohen's d,0.92,,,,,,,,,,,,,,,>10-point reduction on CAPS score,0.7,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.2391,,0.7609,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (adverse childhood experiences, not specified)",Medium,"Harris JI, Usset T, Voecks C, et al. Spiritually integrated care for PTSD: a randomized controlled trial of ‚Äö√Ñ√∫Building Spiritual Strength‚Äö√Ñ√π. Psychiatry Res. 2018 Jun 20;267:420-8. doi: 10.1016/j.psychres.2018.06.045. PMID: 29980120.",50585,2019
harris2018_CAPS_A_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,138,A,PTSD,,71,,Building Spiritual Strength,Building Spiritual Strength,No,Not Applicable,No,Not Applicable,Yes,Spirituality,No,No,No,No,No,Group,In Person,71,Structured Clinical Interview,CAPS,CAPS,Completer,"Generalized linear mixed models: used available data
Repeated measures ANOVA: NR",Mixed effects regression modeling to compare groups across all 3 time points; repeated measures ANOVA for pre-post group differences; chi-square test for clinically meaningful response,Baseline,,,61.31,21.02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2391,,0.7609,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (adverse childhood experiences, not specified)",Medium,"Harris JI, Usset T, Voecks C, et al. Spiritually integrated care for PTSD: a randomized controlled trial of ‚Äö√Ñ√∫Building Spiritual Strength‚Äö√Ñ√π. Psychiatry Res. 2018 Jun 20;267:420-8. doi: 10.1016/j.psychres.2018.06.045. PMID: 29980120.",50585,2019
harris2018_CAPS_B_0_Comp,Mixed: Psychotherapy & CIH,PTSD,138,B,PTSD,,41,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,67,Structured Clinical Interview,CAPS,CAPS,Completer,"Generalized linear mixed models: used available data
Repeated measures ANOVA: NR",Mixed effects regression modeling to compare groups across all 3 time points; repeated measures ANOVA for pre-post group differences; chi-square test for clinically meaningful response,End of Treatment,0,,43.37,22.87,,,,,-17.75,,,,,Cohen's d,1.06,,,,,,,,,,,,,,,>10-point reduction on CAPS score,0.6829,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.2391,,0.7609,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (adverse childhood experiences, not specified)",Medium,"Harris JI, Usset T, Voecks C, et al. Spiritually integrated care for PTSD: a randomized controlled trial of ‚Äö√Ñ√∫Building Spiritual Strength‚Äö√Ñ√π. Psychiatry Res. 2018 Jun 20;267:420-8. doi: 10.1016/j.psychres.2018.06.045. PMID: 29980120.",50585,2019
harris2018_CAPS_B_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,138,B,PTSD,,67,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,67,Structured Clinical Interview,CAPS,CAPS,Completer,"Generalized linear mixed models: used available data
Repeated measures ANOVA: NR",Mixed effects regression modeling to compare groups across all 3 time points; repeated measures ANOVA for pre-post group differences; chi-square test for clinically meaningful response,Baseline,,,61.12,17.44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2391,,0.7609,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (adverse childhood experiences, not specified)",Medium,"Harris JI, Usset T, Voecks C, et al. Spiritually integrated care for PTSD: a randomized controlled trial of ‚Äö√Ñ√∫Building Spiritual Strength‚Äö√Ñ√π. Psychiatry Res. 2018 Jun 20;267:420-8. doi: 10.1016/j.psychres.2018.06.045. PMID: 29980120.",50585,2019
harris2018_PCL_A_0_NA,Mixed: Psychotherapy & CIH,PTSD,138,A,PTSD,,,,Building Spiritual Strength,Building Spiritual Strength,No,Not Applicable,No,Not Applicable,Yes,Spirituality,No,No,No,No,No,Group,In Person,71,Self report,PCL,PCL-C,,,Mixed effects regression modeling to compare groups across all 3 time points; repeated measures ANOVA for pre-post group differences; chi-square test for clinically meaningful response,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2391,,0.7609,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (adverse childhood experiences, not specified)",Medium,"Harris JI, Usset T, Voecks C, et al. Spiritually integrated care for PTSD: a randomized controlled trial of ‚Äö√Ñ√∫Building Spiritual Strength‚Äö√Ñ√π. Psychiatry Res. 2018 Jun 20;267:420-8. doi: 10.1016/j.psychres.2018.06.045. PMID: 29980120.",50585,2019
harris2018_PCL_A_8_NA,Mixed: Psychotherapy & CIH,PTSD,138,A,PTSD,,,,Building Spiritual Strength,Building Spiritual Strength,No,Not Applicable,No,Not Applicable,Yes,Spirituality,No,No,No,No,No,Group,In Person,71,Self report,PCL,PCL-C,,,Mixed effects regression modeling to compare groups across all 3 time points; repeated measures ANOVA for pre-post group differences; chi-square test for clinically meaningful response,Assessment at <3 Months,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2391,,0.7609,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (adverse childhood experiences, not specified)",Medium,"Harris JI, Usset T, Voecks C, et al. Spiritually integrated care for PTSD: a randomized controlled trial of ‚Äö√Ñ√∫Building Spiritual Strength‚Äö√Ñ√π. Psychiatry Res. 2018 Jun 20;267:420-8. doi: 10.1016/j.psychres.2018.06.045. PMID: 29980120.",50585,2019
harris2018_PCL_A_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,138,A,PTSD,,,,Building Spiritual Strength,Building Spiritual Strength,No,Not Applicable,No,Not Applicable,Yes,Spirituality,No,No,No,No,No,Group,In Person,71,Self report,PCL,PCL-C,,,Mixed effects regression modeling to compare groups across all 3 time points; repeated measures ANOVA for pre-post group differences; chi-square test for clinically meaningful response,Baseline,,,58.51,11.24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2391,,0.7609,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (adverse childhood experiences, not specified)",Medium,"Harris JI, Usset T, Voecks C, et al. Spiritually integrated care for PTSD: a randomized controlled trial of ‚Äö√Ñ√∫Building Spiritual Strength‚Äö√Ñ√π. Psychiatry Res. 2018 Jun 20;267:420-8. doi: 10.1016/j.psychres.2018.06.045. PMID: 29980120.",50585,2019
harris2018_PCL_B_0_NA,Mixed: Psychotherapy & CIH,PTSD,138,B,PTSD,,,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,67,Self report,PCL,PCL-C,,,Mixed effects regression modeling to compare groups across all 3 time points; repeated measures ANOVA for pre-post group differences; chi-square test for clinically meaningful response,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2391,,0.7609,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (adverse childhood experiences, not specified)",Medium,"Harris JI, Usset T, Voecks C, et al. Spiritually integrated care for PTSD: a randomized controlled trial of ‚Äö√Ñ√∫Building Spiritual Strength‚Äö√Ñ√π. Psychiatry Res. 2018 Jun 20;267:420-8. doi: 10.1016/j.psychres.2018.06.045. PMID: 29980120.",50585,2019
harris2018_PCL_B_8_NA,Mixed: Psychotherapy & CIH,PTSD,138,B,PTSD,,,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,67,Self report,PCL,PCL-C,,,Mixed effects regression modeling to compare groups across all 3 time points; repeated measures ANOVA for pre-post group differences; chi-square test for clinically meaningful response,Assessment at <3 Months,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2391,,0.7609,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (adverse childhood experiences, not specified)",Medium,"Harris JI, Usset T, Voecks C, et al. Spiritually integrated care for PTSD: a randomized controlled trial of ‚Äö√Ñ√∫Building Spiritual Strength‚Äö√Ñ√π. Psychiatry Res. 2018 Jun 20;267:420-8. doi: 10.1016/j.psychres.2018.06.045. PMID: 29980120.",50585,2019
harris2018_PCL_B_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,138,B,PTSD,,,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,67,Self report,PCL,PCL-C,,,Mixed effects regression modeling to compare groups across all 3 time points; repeated measures ANOVA for pre-post group differences; chi-square test for clinically meaningful response,Baseline,,,55.12,10.83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2391,,0.7609,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (adverse childhood experiences, not specified)",Medium,"Harris JI, Usset T, Voecks C, et al. Spiritually integrated care for PTSD: a randomized controlled trial of ‚Äö√Ñ√∫Building Spiritual Strength‚Äö√Ñ√π. Psychiatry Res. 2018 Jun 20;267:420-8. doi: 10.1016/j.psychres.2018.06.045. PMID: 29980120.",50585,2019
henseldittmann2011_CAPS_A_0_ITT,Psychotherapy,PTSD,28,A,PTSD,,11,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed effects models with available data (no imputation or replacement),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,76.73,26.19,,,,,-19.74,,,,,Cohen's d,0.91,,,,,,,,,,,,Not fulfilling criteria for PTSD,0.1818,,,,,Community,,,1,,,,Terrorism/political violence/forced displacement,,High,"Hensel-Dittmann D, Schauer M, Ruf M, et al. Treatment of traumatized victims of war and torture: a randomized controlled comparison of narrative exposure therapy and stress inoculation training. Psychother Psychosom. 2011 Oct;80(6):345-52. doi: 10.1159/000327253. PMID: 21829046.",37590,2019
henseldittmann2011_CAPS_A_26_ITT,Psychotherapy,PTSD,28,A,PTSD,,12,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed effects models with available data (no imputation or replacement),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Assessment at 6 to <12 Months,26,,72.33,18.1,,,,,-24.14,,,,,Cohen's d,1.42,95% CI,0.57,2.27,p<0.05,,,,,,,,Not fulfilling criteria for PTSD,0.1667,,,,,Community,,,1,,,,Terrorism/political violence/forced displacement,,High,"Hensel-Dittmann D, Schauer M, Ruf M, et al. Treatment of traumatized victims of war and torture: a randomized controlled comparison of narrative exposure therapy and stress inoculation training. Psychother Psychosom. 2011 Oct;80(6):345-52. doi: 10.1159/000327253. PMID: 21829046.",37590,2019
henseldittmann2011_CAPS_A_52_ITT,Psychotherapy,PTSD,28,A,PTSD,,8,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed effects models with available data (no imputation or replacement),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Assessment at ≥12 Months,52,,64.12,23.95,,,,,-32.35,,,,,Cohen's d,1.59,95% CI,0.62,2.57,p<0.05,,,,,,,,Not fulfilling criteria for PTSD,0.375,,,,,Community,,,1,,,,Terrorism/political violence/forced displacement,,High,"Hensel-Dittmann D, Schauer M, Ruf M, et al. Treatment of traumatized victims of war and torture: a randomized controlled comparison of narrative exposure therapy and stress inoculation training. Psychother Psychosom. 2011 Oct;80(6):345-52. doi: 10.1159/000327253. PMID: 21829046.",37590,2019
henseldittmann2011_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,28,A,PTSD,,15,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed effects models with available data (no imputation or replacement),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,96.47,15.89,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Terrorism/political violence/forced displacement,,High,"Hensel-Dittmann D, Schauer M, Ruf M, et al. Treatment of traumatized victims of war and torture: a randomized controlled comparison of narrative exposure therapy and stress inoculation training. Psychother Psychosom. 2011 Oct;80(6):345-52. doi: 10.1159/000327253. PMID: 21829046.",37590,2019
henseldittmann2011_CAPS_B_0_ITT,Psychotherapy,PTSD,28,B,PTSD,,10,,SIT,Stress Inoculation Training (SIT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed effects models with available data (no imputation or replacement),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,82.6,18.8,,,,,-2.55,,,,,Cohen's d,0.16,,,,,,,,,,,,Not fulfilling criteria for PTSD,0,,,,,Community,,,1,,,,Terrorism/political violence/forced displacement,,High,"Hensel-Dittmann D, Schauer M, Ruf M, et al. Treatment of traumatized victims of war and torture: a randomized controlled comparison of narrative exposure therapy and stress inoculation training. Psychother Psychosom. 2011 Oct;80(6):345-52. doi: 10.1159/000327253. PMID: 21829046.",37590,2019
henseldittmann2011_CAPS_B_26_ITT,Psychotherapy,PTSD,28,B,PTSD,,10,,SIT,Stress Inoculation Training (SIT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed effects models with available data (no imputation or replacement),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Assessment at 6 to <12 Months,26,,82.7,26.16,,,,,-2.45,,,,,Cohen's d,0.12,95% CI,-0.71,0.94,p>0.05,,,,,,,,Not fulfilling criteria for PTSD,0.2,,,,,Community,,,1,,,,Terrorism/political violence/forced displacement,,High,"Hensel-Dittmann D, Schauer M, Ruf M, et al. Treatment of traumatized victims of war and torture: a randomized controlled comparison of narrative exposure therapy and stress inoculation training. Psychother Psychosom. 2011 Oct;80(6):345-52. doi: 10.1159/000327253. PMID: 21829046.",37590,2019
henseldittmann2011_CAPS_B_52_ITT,Psychotherapy,PTSD,28,B,PTSD,,7,,SIT,Stress Inoculation Training (SIT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed effects models with available data (no imputation or replacement),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Assessment at ≥12 Months,52,,80.14,33.88,,,,,-5.01,,,,,Cohen's d,0.19,95% CI,-0.73,1.12,p>0.05,,,,,,,,Not fulfilling criteria for PTSD,0.2857,,,,,Community,,,1,,,,Terrorism/political violence/forced displacement,,High,"Hensel-Dittmann D, Schauer M, Ruf M, et al. Treatment of traumatized victims of war and torture: a randomized controlled comparison of narrative exposure therapy and stress inoculation training. Psychother Psychosom. 2011 Oct;80(6):345-52. doi: 10.1159/000327253. PMID: 21829046.",37590,2019
henseldittmann2011_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,28,B,PTSD,,13,,SIT,Stress Inoculation Training (SIT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed effects models with available data (no imputation or replacement),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,85.15,12.95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Terrorism/political violence/forced displacement,,High,"Hensel-Dittmann D, Schauer M, Ruf M, et al. Treatment of traumatized victims of war and torture: a randomized controlled comparison of narrative exposure therapy and stress inoculation training. Psychother Psychosom. 2011 Oct;80(6):345-52. doi: 10.1159/000327253. PMID: 21829046.",37590,2019
herescolevy2002_CAPS_A_0_Comp,Pharmacotherapy,PTSD,11,A,PTSD,,10,,D-cycloserine,D-cycloserine,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,Completer,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,54.6,12.1,,,,,-4.4,,,,,,,,,,p=0.03,,,,,,,,,,,,,,Community,,,1,0.1818,,0.8182,Mixed,"accidents, terrorism/political violence/forced displacement, other (physical abuse)",Medium,"Heresco-Levy U, Kremer I, Javitt DC, et al. Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2002 Dec;5(4):301-7. doi: 10.1017/S1461145702003061. PMID: 12466030.",25345,2019
herescolevy2002_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,11,A,PTSD,,11,,D-cycloserine,D-cycloserine,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,Completer,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,59.0,14.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1818,,0.8182,Mixed,"accidents, terrorism/political violence/forced displacement, other (physical abuse)",Medium,"Heresco-Levy U, Kremer I, Javitt DC, et al. Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2002 Dec;5(4):301-7. doi: 10.1017/S1461145702003061. PMID: 12466030.",25345,2019
herescolevy2002_CAPS_B_0_Comp,Pharmacotherapy,PTSD,11,B,Control,,8,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Structured Clinical Interview,CAPS,CAPS,Completer,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,52.3,3,,,,,-6.8,,,,,,,,,,p=0.03,,,,,,,,,,,,,,Community,,,1,0.1818,,0.8182,Mixed,"accidents, terrorism/political violence/forced displacement, other (physical abuse)",Medium,"Heresco-Levy U, Kremer I, Javitt DC, et al. Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2002 Dec;5(4):301-7. doi: 10.1017/S1461145702003061. PMID: 12466030.",25345,2019
herescolevy2002_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,11,B,Control,,11,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Structured Clinical Interview,CAPS,CAPS,Completer,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,59.1,7.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1818,,0.8182,Mixed,"accidents, terrorism/political violence/forced displacement, other (physical abuse)",Medium,"Heresco-Levy U, Kremer I, Javitt DC, et al. Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2002 Dec;5(4):301-7. doi: 10.1017/S1461145702003061. PMID: 12466030.",25345,2019
herescolevy2002_M-PTSD_A_0_NA,Pharmacotherapy,PTSD,11,A,PTSD,,,,D-cycloserine,D-cycloserine,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,M-PTSD,M-PTSD,,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,99.7,12.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1818,,0.8182,Mixed,"accidents, terrorism/political violence/forced displacement, other (physical abuse)",Medium,"Heresco-Levy U, Kremer I, Javitt DC, et al. Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2002 Dec;5(4):301-7. doi: 10.1017/S1461145702003061. PMID: 12466030.",25345,2019
herescolevy2002_M-PTSD_A_Baseline_NA,Pharmacotherapy,PTSD,11,A,PTSD,,,,D-cycloserine,D-cycloserine,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,M-PTSD,M-PTSD,,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,108.3,11.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1818,,0.8182,Mixed,"accidents, terrorism/political violence/forced displacement, other (physical abuse)",Medium,"Heresco-Levy U, Kremer I, Javitt DC, et al. Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2002 Dec;5(4):301-7. doi: 10.1017/S1461145702003061. PMID: 12466030.",25345,2019
herescolevy2002_M-PTSD_B_0_NA,Pharmacotherapy,PTSD,11,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Self report,M-PTSD,M-PTSD,,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,96.7,8.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1818,,0.8182,Mixed,"accidents, terrorism/political violence/forced displacement, other (physical abuse)",Medium,"Heresco-Levy U, Kremer I, Javitt DC, et al. Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2002 Dec;5(4):301-7. doi: 10.1017/S1461145702003061. PMID: 12466030.",25345,2019
herescolevy2002_M-PTSD_B_Baseline_NA,Pharmacotherapy,PTSD,11,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Self report,M-PTSD,M-PTSD,,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,109.3,13.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1818,,0.8182,Mixed,"accidents, terrorism/political violence/forced displacement, other (physical abuse)",Medium,"Heresco-Levy U, Kremer I, Javitt DC, et al. Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2002 Dec;5(4):301-7. doi: 10.1017/S1461145702003061. PMID: 12466030.",25345,2019
herescolevy2009_CAPS_A_0_ITT,Pharmacotherapy,PTSD,22,A,PTSD,,21,,D-serine,D-serine,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,21,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed-model approach permits analysis of cases with missing data at either follow-up point.,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,65.16,19.63,,,,,-17.95,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1364,,0.8636,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement, other (not specified)",Medium,"Heresco-Levy U, Vass A, Bloch B, et al. Pilot controlled trial of D-serine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2009 Oct;12(9):1275-82. doi: 10.1017/S1461145709000339. PMID: 19366490.",33582,2019
herescolevy2009_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,22,A,PTSD,,21,,D-serine,D-serine,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,21,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed-model approach permits analysis of cases with missing data at either follow-up point.,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,83.11,17.31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1364,,0.8636,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement, other (not specified)",Medium,"Heresco-Levy U, Vass A, Bloch B, et al. Pilot controlled trial of D-serine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2009 Oct;12(9):1275-82. doi: 10.1017/S1461145709000339. PMID: 19366490.",33582,2019
herescolevy2009_CAPS_B_0_ITT,Pharmacotherapy,PTSD,22,B,Control,,22,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed-model approach permits analysis of cases with missing data at either follow-up point.,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,66.33,21.97,,,,,-15.58,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1364,,0.8636,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement, other (not specified)",Medium,"Heresco-Levy U, Vass A, Bloch B, et al. Pilot controlled trial of D-serine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2009 Oct;12(9):1275-82. doi: 10.1017/S1461145709000339. PMID: 19366490.",33582,2019
herescolevy2009_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,22,B,Control,,22,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed-model approach permits analysis of cases with missing data at either follow-up point.,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,81.91,21.97,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1364,,0.8636,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement, other (not specified)",Medium,"Heresco-Levy U, Vass A, Bloch B, et al. Pilot controlled trial of D-serine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2009 Oct;12(9):1275-82. doi: 10.1017/S1461145709000339. PMID: 19366490.",33582,2019
herescolevy2009_M-PTSD_A_0_NA,Pharmacotherapy,PTSD,22,A,PTSD,,,,D-serine,D-serine,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,21,Self report,M-PTSD,M-PTSD,,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,106.30,21.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1364,,0.8636,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement, other (not specified)",Medium,"Heresco-Levy U, Vass A, Bloch B, et al. Pilot controlled trial of D-serine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2009 Oct;12(9):1275-82. doi: 10.1017/S1461145709000339. PMID: 19366490.",33582,2019
herescolevy2009_M-PTSD_A_Baseline_NA,Pharmacotherapy,PTSD,22,A,PTSD,,,,D-serine,D-serine,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,21,Self report,M-PTSD,M-PTSD,,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,116.80,13.78,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1364,,0.8636,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement, other (not specified)",Medium,"Heresco-Levy U, Vass A, Bloch B, et al. Pilot controlled trial of D-serine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2009 Oct;12(9):1275-82. doi: 10.1017/S1461145709000339. PMID: 19366490.",33582,2019
herescolevy2009_M-PTSD_B_0_NA,Pharmacotherapy,PTSD,22,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,22,Self report,M-PTSD,M-PTSD,,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,112.0,21.81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1364,,0.8636,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement, other (not specified)",Medium,"Heresco-Levy U, Vass A, Bloch B, et al. Pilot controlled trial of D-serine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2009 Oct;12(9):1275-82. doi: 10.1017/S1461145709000339. PMID: 19366490.",33582,2019
herescolevy2009_M-PTSD_B_Baseline_NA,Pharmacotherapy,PTSD,22,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,22,Self report,M-PTSD,M-PTSD,,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,115.00,19.68,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1364,,0.8636,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement, other (not specified)",Medium,"Heresco-Levy U, Vass A, Bloch B, et al. Pilot controlled trial of D-serine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2009 Oct;12(9):1275-82. doi: 10.1017/S1461145709000339. PMID: 19366490.",33582,2019
hertzberg1999_SI-PTSD_A_0_Comp,Pharmacotherapy,PTSD,15,A,PTSD,,10,,Lamotrigine,Lamotrigine,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Structured Clinical Interview,SI-PTSD,SI-PTSD,Completer,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,34.3,,,,,,-10.5,,,,,,,,,,,,,,,,,,,,,Score 1 or 2 on the Duke Global Rating for PTSD-Improvement (very much improved or much improved),0.5,,Mixed,0,0.71,0.29,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, other (abduction)",High,"Hertzberg MA, Butterfield MI, Feldman ME, et al. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol psychiatry. 1999 May 1;45(9):1226-9. PMID: 10331117.",09744,2019
hertzberg1999_SI-PTSD_A_Baseline_Comp,Pharmacotherapy,PTSD,15,A,PTSD,,10,,Lamotrigine,Lamotrigine,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Structured Clinical Interview,SI-PTSD,SI-PTSD,Completer,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,44.8,,,,,,,,,,,,,,,,,,,,,,,,,,,Score 1 or 2 on the Duke Global Rating for PTSD-Improvement (very much improved or much improved),,,Mixed,0,0.71,0.29,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, other (abduction)",High,"Hertzberg MA, Butterfield MI, Feldman ME, et al. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol psychiatry. 1999 May 1;45(9):1226-9. PMID: 10331117.",09744,2019
hertzberg1999_SI-PTSD_B_0_Comp,Pharmacotherapy,PTSD,15,B,Control,,4,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,4,Structured Clinical Interview,SI-PTSD,SI-PTSD,Completer,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,34.5,,,,,,-8.5,,,,,,,,,,,,,,,,,,,,,Score 1 or 2 on the Duke Global Rating for PTSD-Improvement (very much improved or much improved),0.25,,Mixed,0,0.71,0.29,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, other (abduction)",High,"Hertzberg MA, Butterfield MI, Feldman ME, et al. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol psychiatry. 1999 May 1;45(9):1226-9. PMID: 10331117.",09744,2019
hertzberg1999_SI-PTSD_B_Baseline_Comp,Pharmacotherapy,PTSD,15,B,Control,,4,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,4,Structured Clinical Interview,SI-PTSD,SI-PTSD,Completer,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,43.0,,,,,,,,,,,,,,,,,,,,,,,,,,,Score 1 or 2 on the Duke Global Rating for PTSD-Improvement (very much improved or much improved),,,Mixed,0,0.71,0.29,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, other (abduction)",High,"Hertzberg MA, Butterfield MI, Feldman ME, et al. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol psychiatry. 1999 May 1;45(9):1226-9. PMID: 10331117.",09744,2019
hertzberg2000_DTS_A_0_ITT,Pharmacotherapy,PTSD,12,A,PTSD,,,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,6,Self report,DTS,DTS,ITT,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,103,23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Hertzberg MA, Feldman ME, Beckham JC, et al. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry. 2000 Jun;12(2):101-5. doi: 10.1023/A:1009076231175. PMID: 10907802.",22432,2019
hertzberg2000_DTS_A_Baseline_ITT,Pharmacotherapy,PTSD,12,A,PTSD,,,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,6,Self report,DTS,DTS,ITT,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,106,27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Hertzberg MA, Feldman ME, Beckham JC, et al. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry. 2000 Jun;12(2):101-5. doi: 10.1023/A:1009076231175. PMID: 10907802.",22432,2019
hertzberg2000_DTS_B_0_ITT,Pharmacotherapy,PTSD,12,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,6,Self report,DTS,DTS,ITT,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,102,26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Hertzberg MA, Feldman ME, Beckham JC, et al. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry. 2000 Jun;12(2):101-5. doi: 10.1023/A:1009076231175. PMID: 10907802.",22432,2019
hertzberg2000_DTS_B_Baseline_ITT,Pharmacotherapy,PTSD,12,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,6,Self report,DTS,DTS,ITT,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,111,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Hertzberg MA, Feldman ME, Beckham JC, et al. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry. 2000 Jun;12(2):101-5. doi: 10.1023/A:1009076231175. PMID: 10907802.",22432,2019
hertzberg2000_SI-PTSD_A_0_ITT,Pharmacotherapy,PTSD,12,A,PTSD,,6,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,6,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,47,8,,,,,-1,,,,,,,,,,,,,,,,,,,,,Duke Global Rating for PTSD score of 1 or 2 (1  very much improved; 2   much improved),0.1667,,Veteran,0,1,0,0,,1,Combat-related,,High,"Hertzberg MA, Feldman ME, Beckham JC, et al. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry. 2000 Jun;12(2):101-5. doi: 10.1023/A:1009076231175. PMID: 10907802.",22432,2019
hertzberg2000_SI-PTSD_A_Baseline_ITT,Pharmacotherapy,PTSD,12,A,PTSD,,6,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,6,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,48,9,,,,,,,,,,,,,,,,,,,,,,,,,,Duke Global Rating for PTSD score of 1 or 2 (1  very much improved; 2   much improved),,,Veteran,0,1,0,0,,1,Combat-related,,High,"Hertzberg MA, Feldman ME, Beckham JC, et al. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry. 2000 Jun;12(2):101-5. doi: 10.1023/A:1009076231175. PMID: 10907802.",22432,2019
hertzberg2000_SI-PTSD_B_0_ITT,Pharmacotherapy,PTSD,12,B,Control,,6,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,6,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,42,11,,,,,-1,,,,,,,,,,,,,,,,,,,,,Duke Global Rating for PTSD score of 1 or 2 (1  very much improved; 2   much improved),0.3333,,Veteran,0,1,0,0,,1,Combat-related,,High,"Hertzberg MA, Feldman ME, Beckham JC, et al. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry. 2000 Jun;12(2):101-5. doi: 10.1023/A:1009076231175. PMID: 10907802.",22432,2019
hertzberg2000_SI-PTSD_B_Baseline_ITT,Pharmacotherapy,PTSD,12,B,Control,,6,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,6,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,43,10,,,,,,,,,,,,,,,,,,,,,,,,,,Duke Global Rating for PTSD score of 1 or 2 (1  very much improved; 2   much improved),,,Veteran,0,1,0,0,,1,Combat-related,,High,"Hertzberg MA, Feldman ME, Beckham JC, et al. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry. 2000 Jun;12(2):101-5. doi: 10.1023/A:1009076231175. PMID: 10907802.",22432,2019
hien2004_CAPS_A_0_ITT,Psychotherapy,PTSD+SUD,96,A,PTSD+SUD,Integrated,41,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,-0.11,0.59,,,,,-0.14,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,,,Medium,"Hien DA, Cohen LR, Miele GM, et al. Promising treatments for women with comorbid PTSD and substance use disorders. Am J Psychiatry. 2004 Aug;161(8):1426-32. doi: 10.1176/appi.ajp.161.8.1426. PMID: 15285969.",26661,2020
hien2004_CAPS_A_26_ITT,Psychotherapy,PTSD+SUD,96,A,PTSD+SUD,Integrated,41,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Assessment at 6 to <12 Months,26,,-0.10,0.67,,,,,-0.13,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,,,Medium,"Hien DA, Cohen LR, Miele GM, et al. Promising treatments for women with comorbid PTSD and substance use disorders. Am J Psychiatry. 2004 Aug;161(8):1426-32. doi: 10.1176/appi.ajp.161.8.1426. PMID: 15285969.",26661,2020
hien2004_CAPS_A_39_ITT,Psychotherapy,PTSD+SUD,96,A,PTSD+SUD,Integrated,41,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Assessment at 6 to <12 Months,39,,-0.02,0.63,,,,,-0.05,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,,,Medium,"Hien DA, Cohen LR, Miele GM, et al. Promising treatments for women with comorbid PTSD and substance use disorders. Am J Psychiatry. 2004 Aug;161(8):1426-32. doi: 10.1176/appi.ajp.161.8.1426. PMID: 15285969.",26661,2020
hien2004_CAPS_A_Baseline_ITT,Psychotherapy,PTSD+SUD,96,A,PTSD+SUD,Integrated,41,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,0.03,0.81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,,,Medium,"Hien DA, Cohen LR, Miele GM, et al. Promising treatments for women with comorbid PTSD and substance use disorders. Am J Psychiatry. 2004 Aug;161(8):1426-32. doi: 10.1176/appi.ajp.161.8.1426. PMID: 15285969.",26661,2020
hien2004_CAPS_B_0_ITT,Psychotherapy,PTSD+SUD,96,B,SUD,Not integrated,34,,Relapse Prevention,Relapse Prevention,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,-0.17,0.65,,,,,-0.03,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,,,Medium,"Hien DA, Cohen LR, Miele GM, et al. Promising treatments for women with comorbid PTSD and substance use disorders. Am J Psychiatry. 2004 Aug;161(8):1426-32. doi: 10.1176/appi.ajp.161.8.1426. PMID: 15285969.",26661,2020
hien2004_CAPS_B_26_ITT,Psychotherapy,PTSD+SUD,96,B,SUD,Not integrated,34,,Relapse Prevention,Relapse Prevention,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Assessment at 6 to <12 Months,26,,-0.24,0.78,,,,,-0.1,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,,,Medium,"Hien DA, Cohen LR, Miele GM, et al. Promising treatments for women with comorbid PTSD and substance use disorders. Am J Psychiatry. 2004 Aug;161(8):1426-32. doi: 10.1176/appi.ajp.161.8.1426. PMID: 15285969.",26661,2020
hien2004_CAPS_B_39_ITT,Psychotherapy,PTSD+SUD,96,B,SUD,Not integrated,34,,Relapse Prevention,Relapse Prevention,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Assessment at 6 to <12 Months,39,,-0.25,0.86,,,,,-0.11,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,,,Medium,"Hien DA, Cohen LR, Miele GM, et al. Promising treatments for women with comorbid PTSD and substance use disorders. Am J Psychiatry. 2004 Aug;161(8):1426-32. doi: 10.1176/appi.ajp.161.8.1426. PMID: 15285969.",26661,2020
hien2004_CAPS_B_Baseline_ITT,Psychotherapy,PTSD+SUD,96,B,SUD,Not integrated,34,,Relapse Prevention,Relapse Prevention,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,-0.14,0.59,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,,,Medium,"Hien DA, Cohen LR, Miele GM, et al. Promising treatments for women with comorbid PTSD and substance use disorders. Am J Psychiatry. 2004 Aug;161(8):1426-32. doi: 10.1176/appi.ajp.161.8.1426. PMID: 15285969.",26661,2020
hien2009_CAPS_A_0_ITT,Psychotherapy,PTSD+SUD,353,A,PTSD+SUD,Integrated,108,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,176,Structured Clinical Interview,CAPS,CAPS,ITT,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,31.7,23.4,,,,,-29.9,,,,,,,,,,p<0.001,,,,,,,,,,,≥30 point decrease from baseline CAPS score,0.477,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_CAPS_A_0_mA,Psychotherapy,PTSD+SUD,353,A,PTSD+SUD,Integrated,103,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,176,Structured Clinical Interview,CAPS,CAPS,Minimal attendence,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,32.0,23.8,,,,,-31.3,,,,,,,,,,,,,,,,,,,,,≥30 point decrease from baseline CAPS score,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_CAPS_A_52_ITT,Psychotherapy,PTSD+SUD,353,A,PTSD+SUD,Integrated,108,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,176,Structured Clinical Interview,CAPS,CAPS,ITT,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Assessment at ≥12 Months,52,,24.3,22.1,,,,,-37.3,,,,,,,,,,,,,,,,,,,,,≥30 point decrease from baseline CAPS score,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_CAPS_A_52_mA,Psychotherapy,PTSD+SUD,353,A,PTSD+SUD,Integrated,103,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,176,Structured Clinical Interview,CAPS,CAPS,Minimal attendence,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Assessment at ≥12 Months,52,,24.1,21.9,,,,,-39.2,,,,,,,,,,,,,,,,,,,,,≥30 point decrease from baseline CAPS score,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_CAPS_A_Baseline_ITT,Psychotherapy,PTSD+SUD,353,A,PTSD+SUD,Integrated,176,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,176,Structured Clinical Interview,CAPS,CAPS,ITT,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,61.6,19.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_CAPS_A_Baseline_mA,Psychotherapy,PTSD+SUD,353,A,PTSD+SUD,Integrated,103,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,176,Structured Clinical Interview,CAPS,CAPS,Minimal attendence,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,63.3,19.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_CAPS_B_0_ITT,Psychotherapy,PTSD+SUD,353,B,SUD,Not integrated,113,,Women's Health Education,Women's Health Education,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,177,Structured Clinical Interview,CAPS,CAPS,ITT,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,32.7,23.4,,,,,-31.5,,,,,,,,,,,,,,,,,,,,,≥30 point decrease from baseline CAPS score,0.459,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_CAPS_B_0_mA,Psychotherapy,PTSD+SUD,353,B,SUD,Not integrated,96,,Women's Health Education,Women's Health Education,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,177,Structured Clinical Interview,CAPS,CAPS,Minimal attendence,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,34.9,22.8,,,,,-28.8,,,,,,,,,,,,,,,,,,,,,≥30 point decrease from baseline CAPS score,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_CAPS_B_52_ITT,Psychotherapy,PTSD+SUD,353,B,SUD,Not integrated,102,,Women's Health Education,Women's Health Education,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,177,Structured Clinical Interview,CAPS,CAPS,ITT,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Assessment at ≥12 Months,52,,27.1,23.4,,,,,-37.1,,,,,,,,,,,,,,,,,,,,,≥30 point decrease from baseline CAPS score,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_CAPS_B_52_mA,Psychotherapy,PTSD+SUD,353,B,SUD,Not integrated,96,,Women's Health Education,Women's Health Education,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,177,Structured Clinical Interview,CAPS,CAPS,Minimal attendence,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Assessment at ≥12 Months,52,,27.0,22.8,,,,,-36.7,,,,,,,,,,,,,,,,,,,,,≥30 point decrease from baseline CAPS score,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_CAPS_B_Baseline_ITT,Psychotherapy,PTSD+SUD,353,B,SUD,Not integrated,177,,Women's Health Education,Women's Health Education,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,177,Structured Clinical Interview,CAPS,CAPS,ITT,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,64.2,19.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_CAPS_B_Baseline_mA,Psychotherapy,PTSD+SUD,353,B,SUD,Not integrated,96,,Women's Health Education,Women's Health Education,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,177,Structured Clinical Interview,CAPS,CAPS,Minimal attendence,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,63.7,20.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_PSS-SR_A_0_ITT,Psychotherapy,PTSD+SUD,353,A,PTSD+SUD,Integrated,,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,176,Self report,PSS-SR,PSS-SR,ITT,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,32.7,13.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_PSS-SR_A_0_mA,Psychotherapy,PTSD+SUD,353,A,PTSD+SUD,Integrated,,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,176,Self report,PSS-SR,PSS-SR,Minimal attendence,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,32.6,14.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_PSS-SR_A_52_ITT,Psychotherapy,PTSD+SUD,353,A,PTSD+SUD,Integrated,,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,176,Self report,PSS-SR,PSS-SR,ITT,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Assessment at ≥12 Months,52,scores at 12 months,29.2,14.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_PSS-SR_A_52_mA,Psychotherapy,PTSD+SUD,353,A,PTSD+SUD,Integrated,,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,176,Self report,PSS-SR,PSS-SR,Minimal attendence,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Assessment at ≥12 Months,52,"Scores averaged over follow-up period, end of treatment to 12 months",29.8,12.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_PSS-SR_A_Baseline_ITT,Psychotherapy,PTSD+SUD,353,A,PTSD+SUD,Integrated,,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,176,Self report,PSS-SR,PSS-SR,ITT,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,45.4,15.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_PSS-SR_A_Baseline_mA,Psychotherapy,PTSD+SUD,353,A,PTSD+SUD,Integrated,,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,176,Self report,PSS-SR,PSS-SR,Minimal attendence,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,45.8,15.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_PSS-SR_B_0_ITT,Psychotherapy,PTSD+SUD,353,B,SUD,Not integrated,,,Women's Health Education,Women's Health Education,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,177,Self report,PSS-SR,PSS-SR,ITT,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,33.8,15.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_PSS-SR_B_0_mA,Psychotherapy,PTSD+SUD,353,B,SUD,Not integrated,,,Women's Health Education,Women's Health Education,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,177,Self report,PSS-SR,PSS-SR,Minimal attendence,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",End of Treatment,0,,34.9,15.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_PSS-SR_B_52_ITT,Psychotherapy,PTSD+SUD,353,B,SUD,Not integrated,,,Women's Health Education,Women's Health Education,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,177,Self report,PSS-SR,PSS-SR,ITT,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Assessment at ≥12 Months,52,scores at 12 months,29.1,15.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_PSS-SR_B_52_mA,Psychotherapy,PTSD+SUD,353,B,SUD,Not integrated,,,Women's Health Education,Women's Health Education,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,177,Self report,PSS-SR,PSS-SR,Minimal attendence,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Assessment at ≥12 Months,52,"Scores averaged over follow-up period, end of treatment to 12 months",31.7,14.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_PSS-SR_B_Baseline_ITT,Psychotherapy,PTSD+SUD,353,B,SUD,Not integrated,,,Women's Health Education,Women's Health Education,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,177,Self report,PSS-SR,PSS-SR,ITT,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,45.6,15.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hien2009_PSS-SR_B_Baseline_mA,Psychotherapy,PTSD+SUD,353,B,SUD,Not integrated,,,Women's Health Education,Women's Health Education,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,177,Self report,PSS-SR,PSS-SR,Minimal attendence,generalized estimating equations (assumption of data missing at random),"Mixed effects model, post-hoc Tukey test, Cohen's d for change in mean score",Baseline,,,47.0,15.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")",Medium,"Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.",85825,2020
hijazi2014_HTQ_A_16_ITT,Psychotherapy,PTSD,63,A,PTSD,,36,,Brief NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,41,Self report,HTQ,"HTQ - Part D (Arabic translation), mean item score",ITT,Multiple imputation,"Mixed design repeated measures ANOVA with paired t-tests, within-condition effect size using Cohen's d, between-condition effect size calculated as (Brief NET follow-up mean minus baseline mean) - (control follow-up mean minus baseline mean) / standard dviation of pooled change scores",Assessment at 3 to <6 Months,16,,2.55,0.66,,,,,-0.24,,,,,Cohen's d,-0.5,,,,p<0.01,,,,,,,,,,,,,,Community,,,1,0.556,,0.444,Mixed,"terrorism/political violence/forced displacement, rape/sexual assault, combat-related",Medium,"Hijazi AM, Lumley MA, Ziadni MS, et al. Brief narrative exposure therapy for posttraumatic stress in Iraqi refugees: a preliminary randomized clinical trial. J Trauma Stress. 2014 Jun;27(3):314-22. doi: 10.1002/jts.21922. PMID: 24866253.",42387,2019
hijazi2014_HTQ_A_8_ITT,Psychotherapy,PTSD,63,A,PTSD,,38,,Brief NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,41,Self report,HTQ,"HTQ - Part D (Arabic translation), mean item score",ITT,Multiple imputation,"Mixed design repeated measures ANOVA with paired t-tests, within-condition effect size using Cohen's d, between-condition effect size calculated as (Brief NET follow-up mean minus baseline mean) - (control follow-up mean minus baseline mean) / standard dviation of pooled change scores",Assessment at <3 Months,8,,2.6,0.66,,,,,-0.19,,,,,Cohen's d,-0.39,,,,p<0.01,,,,,,,,,,,,,,Community,,,1,0.556,,0.444,Mixed,"terrorism/political violence/forced displacement, rape/sexual assault, combat-related",Medium,"Hijazi AM, Lumley MA, Ziadni MS, et al. Brief narrative exposure therapy for posttraumatic stress in Iraqi refugees: a preliminary randomized clinical trial. J Trauma Stress. 2014 Jun;27(3):314-22. doi: 10.1002/jts.21922. PMID: 24866253.",42387,2019
hijazi2014_HTQ_A_Baseline_ITT,Psychotherapy,PTSD,63,A,PTSD,,41,,Brief NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,41,Self report,HTQ,"HTQ - Part D (Arabic translation), mean item score",ITT,Multiple imputation,"Mixed design repeated measures ANOVA with paired t-tests, within-condition effect size using Cohen's d, between-condition effect size calculated as (Brief NET follow-up mean minus baseline mean) - (control follow-up mean minus baseline mean) / standard dviation of pooled change scores",Baseline,,,2.79,0.49,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.556,,0.444,Mixed,"terrorism/political violence/forced displacement, rape/sexual assault, combat-related",Medium,"Hijazi AM, Lumley MA, Ziadni MS, et al. Brief narrative exposure therapy for posttraumatic stress in Iraqi refugees: a preliminary randomized clinical trial. J Trauma Stress. 2014 Jun;27(3):314-22. doi: 10.1002/jts.21922. PMID: 24866253.",42387,2019
hijazi2014_HTQ_B_16_ITT,Psychotherapy,PTSD,63,B,Control,,21,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,22,Self report,HTQ,"HTQ - Part D (Arabic translation), mean item score",ITT,Multiple imputation,"Mixed design repeated measures ANOVA with paired t-tests, within-condition effect size using Cohen's d, between-condition effect size calculated as (Brief NET follow-up mean minus baseline mean) - (control follow-up mean minus baseline mean) / standard dviation of pooled change scores",Assessment at 3 to <6 Months,16,,2.65,0.52,,,,,-0.11,,,,,Cohen's d,-0.26,,,,p=NS,,,,,,,,,,,,,,Community,,,1,0.556,,0.444,Mixed,"terrorism/political violence/forced displacement, rape/sexual assault, combat-related",Medium,"Hijazi AM, Lumley MA, Ziadni MS, et al. Brief narrative exposure therapy for posttraumatic stress in Iraqi refugees: a preliminary randomized clinical trial. J Trauma Stress. 2014 Jun;27(3):314-22. doi: 10.1002/jts.21922. PMID: 24866253.",42387,2019
hijazi2014_HTQ_B_8_ITT,Psychotherapy,PTSD,63,B,Control,,21,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,22,Self report,HTQ,"HTQ - Part D (Arabic translation), mean item score",ITT,Multiple imputation,"Mixed design repeated measures ANOVA with paired t-tests, within-condition effect size using Cohen's d, between-condition effect size calculated as (Brief NET follow-up mean minus baseline mean) - (control follow-up mean minus baseline mean) / standard dviation of pooled change scores",Assessment at <3 Months,8,,2.76,0.48,,,,,0,,,,,Cohen's d,-0.01,,,,p=NS,,,,,,,,,,,,,,Community,,,1,0.556,,0.444,Mixed,"terrorism/political violence/forced displacement, rape/sexual assault, combat-related",Medium,"Hijazi AM, Lumley MA, Ziadni MS, et al. Brief narrative exposure therapy for posttraumatic stress in Iraqi refugees: a preliminary randomized clinical trial. J Trauma Stress. 2014 Jun;27(3):314-22. doi: 10.1002/jts.21922. PMID: 24866253.",42387,2019
hijazi2014_HTQ_B_Baseline_ITT,Psychotherapy,PTSD,63,B,Control,,22,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,22,Self report,HTQ,"HTQ - Part D (Arabic translation), mean item score",ITT,Multiple imputation,"Mixed design repeated measures ANOVA with paired t-tests, within-condition effect size using Cohen's d, between-condition effect size calculated as (Brief NET follow-up mean minus baseline mean) - (control follow-up mean minus baseline mean) / standard dviation of pooled change scores",Baseline,,,2.76,0.44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.556,,0.444,Mixed,"terrorism/political violence/forced displacement, rape/sexual assault, combat-related",Medium,"Hijazi AM, Lumley MA, Ziadni MS, et al. Brief narrative exposure therapy for posttraumatic stress in Iraqi refugees: a preliminary randomized clinical trial. J Trauma Stress. 2014 Jun;27(3):314-22. doi: 10.1002/jts.21922. PMID: 24866253.",42387,2019
hinton2009_CAPS_A_0_NA,Psychotherapy,PTSD,24,A,PTSD,,12,,Culturally sensitive CBT,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,12,Structured Clinical Interview,CAPS,CAPS,,No missing data,Repeated measures ANOVA,End of Treatment,0,,46.83,17.17,,,,,-28.58,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5833,,0.4167,Terrorism/political violence/forced displacement,,Medium,"Hinton DE, Hofmann SG, Pollack MH, et al. Mechanisms of efficacy of CBT for Cambodian refugees with PTSD: improvement in emotion regulation and orthostatic blood pressure response. CNS Neurosci Ther. 2009 Fall;15(3):255-63. doi: 10.1111/j.1755-5949.2009.00100.x. PMID: 19691545.",33298,2019
hinton2009_CAPS_A_12_NA,Psychotherapy,PTSD,24,A,PTSD,,12,,Culturally sensitive CBT,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,12,Structured Clinical Interview,CAPS,CAPS,,No missing data,Repeated measures ANOVA,Assessment at 3 to <6 Months,12,,44.75,14.85,,,,,-30.66,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5833,,0.4167,Terrorism/political violence/forced displacement,,Medium,"Hinton DE, Hofmann SG, Pollack MH, et al. Mechanisms of efficacy of CBT for Cambodian refugees with PTSD: improvement in emotion regulation and orthostatic blood pressure response. CNS Neurosci Ther. 2009 Fall;15(3):255-63. doi: 10.1111/j.1755-5949.2009.00100.x. PMID: 19691545.",33298,2019
hinton2009_CAPS_A_Baseline_NA,Psychotherapy,PTSD,24,A,PTSD,,12,,Culturally sensitive CBT,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,12,Structured Clinical Interview,CAPS,CAPS,,No missing data,Repeated measures ANOVA,Baseline,,,75.41,13.47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5833,,0.4167,Terrorism/political violence/forced displacement,,Medium,"Hinton DE, Hofmann SG, Pollack MH, et al. Mechanisms of efficacy of CBT for Cambodian refugees with PTSD: improvement in emotion regulation and orthostatic blood pressure response. CNS Neurosci Ther. 2009 Fall;15(3):255-63. doi: 10.1111/j.1755-5949.2009.00100.x. PMID: 19691545.",33298,2019
hinton2009_CAPS_B_0_NA,Psychotherapy,PTSD,24,B,Control,,12,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Structured Clinical Interview,CAPS,CAPS,,No missing data,Repeated measures ANOVA,End of Treatment,0,,74.25,9.43,,,,,-3,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5833,,0.4167,Terrorism/political violence/forced displacement,,Medium,"Hinton DE, Hofmann SG, Pollack MH, et al. Mechanisms of efficacy of CBT for Cambodian refugees with PTSD: improvement in emotion regulation and orthostatic blood pressure response. CNS Neurosci Ther. 2009 Fall;15(3):255-63. doi: 10.1111/j.1755-5949.2009.00100.x. PMID: 19691545.",33298,2019
hinton2009_CAPS_B_Baseline_NA,Psychotherapy,PTSD,24,B,Control,,12,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Structured Clinical Interview,CAPS,CAPS,,No missing data,Repeated measures ANOVA,Baseline,,,77.25,11.47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5833,,0.4167,Terrorism/political violence/forced displacement,,Medium,"Hinton DE, Hofmann SG, Pollack MH, et al. Mechanisms of efficacy of CBT for Cambodian refugees with PTSD: improvement in emotion regulation and orthostatic blood pressure response. CNS Neurosci Ther. 2009 Fall;15(3):255-63. doi: 10.1111/j.1755-5949.2009.00100.x. PMID: 19691545.",33298,2019
hinton2011_PCL_A_0_NA,Psychotherapy,PTSD,24,A,PTSD,,12,,Culturally adapted CBT,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,12,Self report,PCL,PCL,,No missing data,"Repeated-measure ANOVAs, unpaired t-tests, and Cohen's d effect sizes",End of Treatment,0,,39.1,15.1,,,,,-30.7,,,,,Cohen's d,2.6,,,,,,,,,,,,,,,≥10-point change in PCL score,,,Community,,,1,1,,0,,,Medium,"Hinton DE, Hofmann SG, Rivera E, et al. Culturally adapted CBT (CA-CBT) for Latino women with treatment-resistant PTSD: a pilot study comparing CA-CBT to applied muscle relaxation. Behav Res Ther. 2011 Apr;49(4):275-80. doi: 10.1016/j.brat.2011.01.005. PMID: 21333272.",36143,2019
hinton2011_PCL_A_12_NA,Psychotherapy,PTSD,24,A,PTSD,,12,,Culturally adapted CBT,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,12,Self report,PCL,PCL,,No missing data,"Repeated-measure ANOVAs, unpaired t-tests, and Cohen's d effect sizes",Assessment at 3 to <6 Months,12,,36.4,12.7,,,,,-33.4,,,,,,,,,,,,,,,,,,,,,≥10-point change in PCL score,1,,Community,,,1,1,,0,,,Medium,"Hinton DE, Hofmann SG, Rivera E, et al. Culturally adapted CBT (CA-CBT) for Latino women with treatment-resistant PTSD: a pilot study comparing CA-CBT to applied muscle relaxation. Behav Res Ther. 2011 Apr;49(4):275-80. doi: 10.1016/j.brat.2011.01.005. PMID: 21333272.",36143,2019
hinton2011_PCL_A_Baseline_NA,Psychotherapy,PTSD,24,A,PTSD,,12,,Culturally adapted CBT,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,12,Self report,PCL,PCL,,No missing data,"Repeated-measure ANOVAs, unpaired t-tests, and Cohen's d effect sizes",Baseline,,,69.8,6.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,,,Medium,"Hinton DE, Hofmann SG, Rivera E, et al. Culturally adapted CBT (CA-CBT) for Latino women with treatment-resistant PTSD: a pilot study comparing CA-CBT to applied muscle relaxation. Behav Res Ther. 2011 Apr;49(4):275-80. doi: 10.1016/j.brat.2011.01.005. PMID: 21333272.",36143,2019
hinton2011_PCL_B_0_NA,Psychotherapy,PTSD,24,B,PTSD,,12,,Applied muscle relaxation,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Group,In Person,12,Self report,PCL,PCL,,No missing data,"Repeated-measure ANOVAs, unpaired t-tests, and Cohen's d effect sizes",End of Treatment,0,,61.6,13.2,,,,,-9.5,,,,,Cohen's d,0.8,,,,,,,,,,,,,,,≥10-point change in PCL score,,,Community,,,1,1,,0,,,Medium,"Hinton DE, Hofmann SG, Rivera E, et al. Culturally adapted CBT (CA-CBT) for Latino women with treatment-resistant PTSD: a pilot study comparing CA-CBT to applied muscle relaxation. Behav Res Ther. 2011 Apr;49(4):275-80. doi: 10.1016/j.brat.2011.01.005. PMID: 21333272.",36143,2019
hinton2011_PCL_B_12_NA,Psychotherapy,PTSD,24,B,PTSD,,12,,Applied muscle relaxation,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Group,In Person,12,Self report,PCL,PCL,,No missing data,"Repeated-measure ANOVAs, unpaired t-tests, and Cohen's d effect sizes",Assessment at 3 to <6 Months,12,,58.9,14.7,,,,,-12.2,,,,,,,,,,,,,,,,,,,,,≥10-point change in PCL score,0.3333,,Community,,,1,1,,0,,,Medium,"Hinton DE, Hofmann SG, Rivera E, et al. Culturally adapted CBT (CA-CBT) for Latino women with treatment-resistant PTSD: a pilot study comparing CA-CBT to applied muscle relaxation. Behav Res Ther. 2011 Apr;49(4):275-80. doi: 10.1016/j.brat.2011.01.005. PMID: 21333272.",36143,2019
hinton2011_PCL_B_Baseline_NA,Psychotherapy,PTSD,24,B,PTSD,,12,,Applied muscle relaxation,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Group,In Person,12,Self report,PCL,PCL,,No missing data,"Repeated-measure ANOVAs, unpaired t-tests, and Cohen's d effect sizes",Baseline,,,71.1,7.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,,,Medium,"Hinton DE, Hofmann SG, Rivera E, et al. Culturally adapted CBT (CA-CBT) for Latino women with treatment-resistant PTSD: a pilot study comparing CA-CBT to applied muscle relaxation. Behav Res Ther. 2011 Apr;49(4):275-80. doi: 10.1016/j.brat.2011.01.005. PMID: 21333272.",36143,2019
hoffart2013_PSS-I_A_0_ITT,Psychotherapy,PTSD,65,A,PTSD,,31,,PE using imagery exposure,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,PSS-I,PSS-I (Norwegian version),ITT,Pretreatment ratings substituted for missing posttreatment ratings,"Repeated measures ANOVA, Hedges' g effect size",End of Treatment,0,,19.9,13.76,,,,,-15.29,,,,,Hedges' g,-1.27,95% CI,-0.76,-1.78,,,,,,,,,,,,,,,Community,,,1,0.5846,,0.4154,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence",Medium,"Hoffart A, Øktedalen T, Langkaas TF, et al. Alliance and outcome in varying imagery procedures for PTSD: a study of within-person processes. J Couns Psychol. 2013 Oct;60(4):471-82. doi: 10.1037/a0033604. PMID: 23957768.",44042,2019
hoffart2013_PSS-I_A_Baseline_ITT,Psychotherapy,PTSD,65,A,PTSD,,31,,PE using imagery exposure,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,PSS-I,PSS-I (Norwegian version),ITT,Pretreatment ratings substituted for missing posttreatment ratings,"Repeated measures ANOVA, Hedges' g effect size",Baseline,,,35.19,8.24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5846,,0.4154,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence",Medium,"Hoffart A, Øktedalen T, Langkaas TF, et al. Alliance and outcome in varying imagery procedures for PTSD: a study of within-person processes. J Couns Psychol. 2013 Oct;60(4):471-82. doi: 10.1037/a0033604. PMID: 23957768.",44042,2019
hoffart2013_PSS-I_B_0_ITT,Psychotherapy,PTSD,65,B,PTSD,,34,,PE using imagery rescripting,Prolonged Exposure (PE) with imagery rescripting,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,34,Structured Clinical Interview,PSS-I,PSS-I (Norwegian version),ITT,Pretreatment ratings substituted for missing posttreatment ratings,"Repeated measures ANOVA, Hedges' g effect size",End of Treatment,0,,22.71,14.27,,,,,-10.61,,,,,Hedges' g,-0.83,95% CI,-0.46,-1.2,,,,,,,,,,,,,,,Community,,,1,0.5846,,0.4154,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence",Medium,"Hoffart A, Øktedalen T, Langkaas TF, et al. Alliance and outcome in varying imagery procedures for PTSD: a study of within-person processes. J Couns Psychol. 2013 Oct;60(4):471-82. doi: 10.1037/a0033604. PMID: 23957768.",44042,2019
hoffart2013_PSS-I_B_Baseline_ITT,Psychotherapy,PTSD,65,B,PTSD,,34,,PE using imagery rescripting,Prolonged Exposure (PE) with imagery rescripting,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,34,Structured Clinical Interview,PSS-I,PSS-I (Norwegian version),ITT,Pretreatment ratings substituted for missing posttreatment ratings,"Repeated measures ANOVA, Hedges' g effect size",Baseline,,,33.32,6.88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5846,,0.4154,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence",Medium,"Hoffart A, Øktedalen T, Langkaas TF, et al. Alliance and outcome in varying imagery procedures for PTSD: a study of within-person processes. J Couns Psychol. 2013 Oct;60(4):471-82. doi: 10.1037/a0033604. PMID: 23957768.",44042,2019
hogberg2007_IES_A_0_Comp,Psychotherapy,PTSD,24,A,PTSD,,12,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,IES,IES,Completer,Excluded,"Fisher's exact test for primary outcome, Mann-Whitney U-test for between-group secondary outcomes, Wilcoxon for within-group for secondary outcomes",End of Treatment,0,,23.2,17.4,,,,,-16.1,,,,,,,,,,p<0.05,,,,,,,,Not meeting criteria for PTSD according to SCID,0.6667,,,,,Community,,,1,0.2083,,0.7917,Mixed,"accidents, community/school violence",Medium,"Hogberg G, Pagani M, Sundin O, et al. On treatment with eye movement desensitization and reprocessing of chronic post-traumatic stress disorder in public transportation workers--a randomized controlled trial. Nord J Psychiatry. 2007;61(1):54-61. doi:  10.1080/08039480601129408. PMID: 17365790.",38652,2019
hogberg2007_IES_A_Baseline_Comp,Psychotherapy,PTSD,24,A,PTSD,,12,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,IES,IES,Completer,Excluded,"Fisher's exact test for primary outcome, Mann-Whitney U-test for between-group secondary outcomes, Wilcoxon for within-group for secondary outcomes",Baseline,,,39.3,17.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.2083,,0.7917,Mixed,"accidents, community/school violence",Medium,"Hogberg G, Pagani M, Sundin O, et al. On treatment with eye movement desensitization and reprocessing of chronic post-traumatic stress disorder in public transportation workers--a randomized controlled trial. Nord J Psychiatry. 2007;61(1):54-61. doi:  10.1080/08039480601129408. PMID: 17365790.",38652,2019
hogberg2007_IES_B_0_Comp,Psychotherapy,PTSD,24,B,Control,,9,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,11,Self report,IES,IES,Completer,Excluded,"Fisher's exact test for primary outcome, Mann-Whitney U-test for between-group secondary outcomes, Wilcoxon for within-group for secondary outcomes",End of Treatment,0,,34,16.2,,,,,-5.1,,,,,,,,,,p<0.05,,,,,,,,Not meeting criteria for PTSD according to SCID,0.1111,,,,,Community,,,1,0.2083,,0.7917,Mixed,"accidents, community/school violence",Medium,"Hogberg G, Pagani M, Sundin O, et al. On treatment with eye movement desensitization and reprocessing of chronic post-traumatic stress disorder in public transportation workers--a randomized controlled trial. Nord J Psychiatry. 2007;61(1):54-61. doi:  10.1080/08039480601129408. PMID: 17365790.",38652,2019
hogberg2007_IES_B_Baseline_Comp,Psychotherapy,PTSD,24,B,Control,,8,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,11,Self report,IES,IES,Completer,Excluded,"Fisher's exact test for primary outcome, Mann-Whitney U-test for between-group secondary outcomes, Wilcoxon for within-group for secondary outcomes",Baseline,,,39.1,12.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.2083,,0.7917,Mixed,"accidents, community/school violence",Medium,"Hogberg G, Pagani M, Sundin O, et al. On treatment with eye movement desensitization and reprocessing of chronic post-traumatic stress disorder in public transportation workers--a randomized controlled trial. Nord J Psychiatry. 2007;61(1):54-61. doi:  10.1080/08039480601129408. PMID: 17365790.",38652,2019
hollifield2007_PSS-SR_A_0_Comp,Mixed: Psychotherapy & CIH,PTSD,84,A,PTSD,,19,,Acupuncture,Acupuncture,No,Not Applicable,No,Not Applicable,Yes,Acupuncture,No,No,No,No,No,Individual,In Person,29,Self report,PSS-SR,PSS-SR,Completer,,MANOVA was used to compute 3 planned contrasts to compare each pairwise combination of study groups in both intent-to-treat and treatment completion models. Cohen's d for within-group treatment effect sizes using change from baseline.,End of Treatment,0,,14.3,12.1,,,,,-17,,,,,Cohen's d,1.63,,,,p<0.01,,,,,,,,PSS-SR score ≤16,0.6842,,,,,Community,,,1,0.6786,,0.3214,,,Medium,"Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.",29609,2019
hollifield2007_PSS-SR_A_0_ITT,Mixed: Psychotherapy & CIH,PTSD,84,A,PTSD,,24,,Acupuncture,Acupuncture,No,Not Applicable,No,Not Applicable,Yes,Acupuncture,No,No,No,No,No,Individual,In Person,29,Self report,PSS-SR,PSS-SR,ITT,LOCF,MANOVA was used to compute 3 planned contrasts to compare each pairwise combination of study groups in both intent-to-treat and treatment completion models. Cohen's d for within-group treatment effect sizes using change from baseline.,End of Treatment,0,,15.65,12.54,,,,,-15.68,,,,,Cohen's d,1.29,,,,p>0.01,,,,,,,,PSS-SR score ≤16,0.625,,,,,Community,,,1,0.6786,,0.3214,,,Medium,"Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.",29609,2019
hollifield2007_PSS-SR_A_12_Comp,Mixed: Psychotherapy & CIH,PTSD,84,A,PTSD,,19,,Acupuncture,Acupuncture,No,Not Applicable,No,Not Applicable,Yes,Acupuncture,No,No,No,No,No,Individual,In Person,29,Self report,PSS-SR,PSS-SR,Completer,,MANOVA was used to compute 3 planned contrasts to compare each pairwise combination of study groups in both intent-to-treat and treatment completion models. Cohen's d for within-group treatment effect sizes using change from baseline.,Assessment at 3 to <6 Months,12,,14,9.9,,,,,-17.3,,,,,Cohen's d,1.88,,,,p<0.01,,,,,,,,PSS-SR score ≤16,0.6842,,,,,Community,,,1,0.6786,,0.3214,,,Medium,"Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.",29609,2019
hollifield2007_PSS-SR_A_12_ITT,Mixed: Psychotherapy & CIH,PTSD,84,A,PTSD,,24,,Acupuncture,Acupuncture,No,Not Applicable,No,Not Applicable,Yes,Acupuncture,No,No,No,No,No,Individual,In Person,29,Self report,PSS-SR,PSS-SR,ITT,LOCF,MANOVA was used to compute 3 planned contrasts to compare each pairwise combination of study groups in both intent-to-treat and treatment completion models. Cohen's d for within-group treatment effect sizes using change from baseline.,Assessment at 3 to <6 Months,12,,15.42,12.54,,,,,-15.91,,,,,Cohen's d,1.4,,,,p<0.01,,,,,,,,PSS-SR score ≤16,0.625,,,,,Community,,,1,0.6786,,0.3214,,,Medium,"Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.",29609,2019
hollifield2007_PSS-SR_A_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,84,A,PTSD,,19,,Acupuncture,Acupuncture,No,Not Applicable,No,Not Applicable,Yes,Acupuncture,No,No,No,No,No,Individual,In Person,29,Self report,PSS-SR,PSS-SR,Completer,,MANOVA was used to compute 3 planned contrasts to compare each pairwise combination of study groups in both intent-to-treat and treatment completion models. Cohen's d for within-group treatment effect sizes using change from baseline.,Baseline,,,31.3,8.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6786,,0.3214,,,Medium,"Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.",29609,2019
hollifield2007_PSS-SR_A_Baseline_ITT,Mixed: Psychotherapy & CIH,PTSD,84,A,PTSD,,24,,Acupuncture,Acupuncture,No,Not Applicable,No,Not Applicable,Yes,Acupuncture,No,No,No,No,No,Individual,In Person,29,Self report,PSS-SR,PSS-SR,ITT,LOCF,MANOVA was used to compute 3 planned contrasts to compare each pairwise combination of study groups in both intent-to-treat and treatment completion models. Cohen's d for within-group treatment effect sizes using change from baseline.,Baseline,,,31.33,10.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6786,,0.3214,,,Medium,"Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.",29609,2019
hollifield2007_PSS-SR_B_0_Comp,Mixed: Psychotherapy & CIH,PTSD,84,B,PTSD,,21,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Self report,PSS-SR,PSS-SR,Completer,,MANOVA was used to compute 3 planned contrasts to compare each pairwise combination of study groups in both intent-to-treat and treatment completion models. Cohen's d for within-group treatment effect sizes using change from baseline.,End of Treatment,0,,17.5,8.3,,,,,-14.5,,,,,Cohen's d,1.95,,,,p<0.01,,,,,,,,PSS-SR score ≤16,0.4286,,,,,Community,,,1,0.6786,,0.3214,,,Medium,"Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.",29609,2019
hollifield2007_PSS-SR_B_0_ITT,Mixed: Psychotherapy & CIH,PTSD,84,B,PTSD,,25,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Self report,PSS-SR,PSS-SR,ITT,LOCF,MANOVA was used to compute 3 planned contrasts to compare each pairwise combination of study groups in both intent-to-treat and treatment completion models. Cohen's d for within-group treatment effect sizes using change from baseline.,End of Treatment,0,,20.02,10.56,,,,,-12.5,,,,,Cohen's d,1.42,,,,p<0.01,,,,,,,,PSS-SR score ≤16,0.36,,,,,Community,,,1,0.6786,,0.3214,,,Medium,"Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.",29609,2019
hollifield2007_PSS-SR_B_12_Comp,Mixed: Psychotherapy & CIH,PTSD,84,B,PTSD,,21,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Self report,PSS-SR,PSS-SR,Completer,,MANOVA was used to compute 3 planned contrasts to compare each pairwise combination of study groups in both intent-to-treat and treatment completion models. Cohen's d for within-group treatment effect sizes using change from baseline.,Assessment at 3 to <6 Months,12,,13.5,9.5,,,,,-18.5,,,,,Cohen's d,2.28,,,,p<0.01,,,,,,,,PSS-SR score ≤16,0.619,,,,,Community,,,1,0.6786,,0.3214,,,Medium,"Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.",29609,2019
hollifield2007_PSS-SR_B_12_ITT,Mixed: Psychotherapy & CIH,PTSD,84,B,PTSD,,25,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Self report,PSS-SR,PSS-SR,ITT,LOCF,MANOVA was used to compute 3 planned contrasts to compare each pairwise combination of study groups in both intent-to-treat and treatment completion models. Cohen's d for within-group treatment effect sizes using change from baseline.,Assessment at 3 to <6 Months,12,,16.68,12.2,,,,,-15.84,,,,,Cohen's d,1.61,,,,p<0.01,,,,,,,,PSS-SR score ≤16,0.52,,,,,Community,,,1,0.6786,,0.3214,,,Medium,"Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.",29609,2019
hollifield2007_PSS-SR_B_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,84,B,PTSD,,21,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Self report,PSS-SR,PSS-SR,Completer,,MANOVA was used to compute 3 planned contrasts to compare each pairwise combination of study groups in both intent-to-treat and treatment completion models. Cohen's d for within-group treatment effect sizes using change from baseline.,Baseline,,,32,6.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6786,,0.3214,,,Medium,"Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.",29609,2019
hollifield2007_PSS-SR_B_Baseline_ITT,Mixed: Psychotherapy & CIH,PTSD,84,B,PTSD,,25,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Self report,PSS-SR,PSS-SR,ITT,LOCF,MANOVA was used to compute 3 planned contrasts to compare each pairwise combination of study groups in both intent-to-treat and treatment completion models. Cohen's d for within-group treatment effect sizes using change from baseline.,Baseline,,,32.52,6.63,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6786,,0.3214,,,Medium,"Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.",29609,2019
hollifield2007_PSS-SR_C_0_Comp,Mixed: Psychotherapy & CIH,PTSD,84,C,Control,,21,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,27,Self report,PSS-SR,PSS-SR,Completer,,MANOVA was used to compute 3 planned contrasts to compare each pairwise combination of study groups in both intent-to-treat and treatment completion models. Cohen's d for within-group treatment effect sizes using change from baseline.,End of Treatment,0,,27.5,12.5,,,,,-1.6,,,,,Cohen's d,0.15,,,,p=NS,,,,,,,,PSS-SR score ≤16,0.1905,,,,,Community,,,1,0.6786,,0.3214,,,Medium,"Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.",29609,2019
hollifield2007_PSS-SR_C_0_ITT,Mixed: Psychotherapy & CIH,PTSD,84,C,Control,,24,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,27,Self report,PSS-SR,PSS-SR,ITT,LOCF,MANOVA was used to compute 3 planned contrasts to compare each pairwise combination of study groups in both intent-to-treat and treatment completion models. Cohen's d for within-group treatment effect sizes using change from baseline.,End of Treatment,0,,27.92,12.33,,,,,-2.87,,,,,Cohen's d,0.26,,,,p>0.05,,,,,,,,PSS-SR score ≤16,0.1667,,,,,Community,,,1,0.6786,,0.3214,,,Medium,"Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.",29609,2019
hollifield2007_PSS-SR_C_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,84,C,Control,,21,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,27,Self report,PSS-SR,PSS-SR,Completer,,MANOVA was used to compute 3 planned contrasts to compare each pairwise combination of study groups in both intent-to-treat and treatment completion models. Cohen's d for within-group treatment effect sizes using change from baseline.,Baseline,,,29.1,8.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6786,,0.3214,,,Medium,"Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.",29609,2019
hollifield2007_PSS-SR_C_Baseline_ITT,Mixed: Psychotherapy & CIH,PTSD,84,C,Control,,24,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,27,Self report,PSS-SR,PSS-SR,ITT,LOCF,MANOVA was used to compute 3 planned contrasts to compare each pairwise combination of study groups in both intent-to-treat and treatment completion models. Cohen's d for within-group treatment effect sizes using change from baseline.,Baseline,,,30.79,9.54,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6786,,0.3214,,,Medium,"Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.",29609,2019
hyer1996_M-PTSD_A_0_NA,Complementary and integrative health (CIH),PTSD,219,A,PTSD,,108,,Outward Bound Experience adjunctive with TAU,Recreational therapy,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In Person,108,Self report,M-PTSD,M-PTSD,,,ANCOVA using 4 groups (2 locations x 2 treatments),End of Treatment,0,,122.62,,,,,,0.44,,,,,,,,,,p=NS,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Hyer L, Boyd S, Scurfield R, et al. Effects of Outward Bound experience as an adjunct to inpatient PTSD treatment of war veterans. J Clin Psychol. 1996 May;52(3):263-78. doi: 10.1002/(SICI)1097-4679(199605)52:3<263::AID-JCLP3>3.0.CO;2-T. PMID: 8835688.",08065,2019
hyer1996_M-PTSD_A_Baseline_NA,Complementary and integrative health (CIH),PTSD,219,A,PTSD,,108,,Outward Bound Experience adjunctive with TAU,Recreational therapy,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In Person,108,Self report,M-PTSD,M-PTSD,,,ANCOVA using 4 groups (2 locations x 2 treatments),Baseline,,,122.18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Hyer L, Boyd S, Scurfield R, et al. Effects of Outward Bound experience as an adjunct to inpatient PTSD treatment of war veterans. J Clin Psychol. 1996 May;52(3):263-78. doi: 10.1002/(SICI)1097-4679(199605)52:3<263::AID-JCLP3>3.0.CO;2-T. PMID: 8835688.",08065,2019
hyer1996_M-PTSD_B_0_NA,Complementary and integrative health (CIH),PTSD,219,B,Control,,111,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,111,Self report,M-PTSD,M-PTSD,,,ANCOVA using 4 groups (2 locations x 2 treatments),End of Treatment,0,,119.84,,,,,,-1.66,,,,,,,,,,p=NS,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Hyer L, Boyd S, Scurfield R, et al. Effects of Outward Bound experience as an adjunct to inpatient PTSD treatment of war veterans. J Clin Psychol. 1996 May;52(3):263-78. doi: 10.1002/(SICI)1097-4679(199605)52:3<263::AID-JCLP3>3.0.CO;2-T. PMID: 8835688.",08065,2019
hyer1996_M-PTSD_B_Baseline_NA,Complementary and integrative health (CIH),PTSD,219,B,Control,,111,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,111,Self report,M-PTSD,M-PTSD,,,ANCOVA using 4 groups (2 locations x 2 treatments),Baseline,,,121.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Hyer L, Boyd S, Scurfield R, et al. Effects of Outward Bound experience as an adjunct to inpatient PTSD treatment of war veterans. J Clin Psychol. 1996 May;52(3):263-78. doi: 10.1002/(SICI)1097-4679(199605)52:3<263::AID-JCLP3>3.0.CO;2-T. PMID: 8835688.",08065,2019
isserles2013_CAPS_A_0_Comp,Nonpharmacologic biological,PTSD,30,A,PTSD,,8,,DTMS with traumatic experience,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,Completer,,ANCOVA using 4 groups (2 locations x 2 treatments),End of Treatment,0,,60,,,,,SE 8.7,-28,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.2308,,0.7692,Mixed,"combat-related, other (not specified)",Medium,"Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study. Brain Stimul. 2013 May;6(3):377-83. doi: 10.1016/j.brs.2012.07.008. PMID: 22921765.",39466,2019
isserles2013_CAPS_A_0_ITT,Nonpharmacologic biological,PTSD,30,A,PTSD,,10,,DTMS with traumatic experience,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,ITT,,ANCOVA using 4 groups (2 locations x 2 treatments),End of Treatment,0,,61,,SE,8.8,,SE 7.4,-24.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.2308,,0.7692,Mixed,"combat-related, other (not specified)",Medium,"Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study. Brain Stimul. 2013 May;6(3):377-83. doi: 10.1016/j.brs.2012.07.008. PMID: 22921765.",39466,2019
isserles2013_CAPS_A_0_T,Nonpharmacologic biological,PTSD,30,A,PTSD,,9,,DTMS with traumatic experience,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,Treatment criterion,,ANCOVA using 4 groups (2 locations x 2 treatments),End of Treatment,0,,61,,,,,SE 7.7,-27,,,,,,,,,,p=0.0003,,,,,,,,,,,≥50% improvement on total CAPS score,0.4444,,,,,,0.2308,,0.7692,Mixed,"combat-related, other (not specified)",Medium,"Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study. Brain Stimul. 2013 May;6(3):377-83. doi: 10.1016/j.brs.2012.07.008. PMID: 22921765.",39466,2019
isserles2013_CAPS_A_Baseline_T,Nonpharmacologic biological,PTSD,30,A,PTSD,,9,,DTMS with traumatic experience,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,Treatment criterion,,ANCOVA using 4 groups (2 locations x 2 treatments),Baseline,,,88.0,16.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.2308,,0.7692,Mixed,"combat-related, other (not specified)",Medium,"Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study. Brain Stimul. 2013 May;6(3):377-83. doi: 10.1016/j.brs.2012.07.008. PMID: 22921765.",39466,2019
isserles2013_CAPS_B_0_Comp,Nonpharmacologic biological,PTSD,30,B,PTSD,,8,,DTMS with positive experience,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,Completer,,ANCOVA using 4 groups (2 locations x 2 treatments),End of Treatment,0,,75.9,,,,,,-9.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.2308,,0.7692,Mixed,"combat-related, other (not specified)",Medium,"Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study. Brain Stimul. 2013 May;6(3):377-83. doi: 10.1016/j.brs.2012.07.008. PMID: 22921765.",39466,2019
isserles2013_CAPS_B_0_ITT,Nonpharmacologic biological,PTSD,30,B,PTSD,,10,,DTMS with positive experience,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,ITT,,ANCOVA using 4 groups (2 locations x 2 treatments),End of Treatment,0,,77.9,,,,,,-7.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.2308,,0.7692,Mixed,"combat-related, other (not specified)",Medium,"Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study. Brain Stimul. 2013 May;6(3):377-83. doi: 10.1016/j.brs.2012.07.008. PMID: 22921765.",39466,2019
isserles2013_CAPS_B_0_T,Nonpharmacologic biological,PTSD,30,B,PTSD,,8,,DTMS with positive experience,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,Treatment criterion,,ANCOVA using 4 groups (2 locations x 2 treatments),End of Treatment,0,,75.9,,,,,,-9.9,,,,,,,,,,p=0.164,,,,,,,,,,,≥50% improvement on total CAPS score,0.125,,,,,,0.2308,,0.7692,Mixed,"combat-related, other (not specified)",Medium,"Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study. Brain Stimul. 2013 May;6(3):377-83. doi: 10.1016/j.brs.2012.07.008. PMID: 22921765.",39466,2019
isserles2013_CAPS_B_Baseline_T,Nonpharmacologic biological,PTSD,30,B,PTSD,,8,,DTMS with positive experience,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,Treatment criterion,,ANCOVA using 4 groups (2 locations x 2 treatments),Baseline,,,85.8,15.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.2308,,0.7692,Mixed,"combat-related, other (not specified)",Medium,"Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study. Brain Stimul. 2013 May;6(3):377-83. doi: 10.1016/j.brs.2012.07.008. PMID: 22921765.",39466,2019
isserles2013_CAPS_C_0_Comp,Nonpharmacologic biological,PTSD,30,C,Control,,9,,DTMS with positive experience,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,Completer,,ANCOVA using 4 groups (2 locations x 2 treatments),End of Treatment,0,,75.8,,,,,,-10.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.2308,,0.7692,Mixed,"combat-related, other (not specified)",Medium,"Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study. Brain Stimul. 2013 May;6(3):377-83. doi: 10.1016/j.brs.2012.07.008. PMID: 22921765.",39466,2019
isserles2013_CAPS_C_0_ITT,Nonpharmacologic biological,PTSD,30,C,Control,,10,,DTMS with positive experience,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,ITT,,ANCOVA using 4 groups (2 locations x 2 treatments),End of Treatment,0,,77,,,,,,-9.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.2308,,0.7692,Mixed,"combat-related, other (not specified)",Medium,"Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study. Brain Stimul. 2013 May;6(3):377-83. doi: 10.1016/j.brs.2012.07.008. PMID: 22921765.",39466,2019
isserles2013_CAPS_C_0_T,Nonpharmacologic biological,PTSD,30,C,Control,,9,,DTMS with positive experience,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,Treatment criterion,,ANCOVA using 4 groups (2 locations x 2 treatments),End of Treatment,0,,75.8,,,,,,-10.3,,,,,,,,,,p=0.122,,,,,,,,,,,≥50% improvement on total CAPS score,0,,,,,,0.2308,,0.7692,Mixed,"combat-related, other (not specified)",Medium,"Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study. Brain Stimul. 2013 May;6(3):377-83. doi: 10.1016/j.brs.2012.07.008. PMID: 22921765.",39466,2019
isserles2013_CAPS_C_Baseline_T,Nonpharmacologic biological,PTSD,30,C,Control,,9,,DTMS with positive experience,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,Treatment criterion,,ANCOVA using 4 groups (2 locations x 2 treatments),Baseline,,,86.1,27.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.2308,,0.7692,Mixed,"combat-related, other (not specified)",Medium,"Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study. Brain Stimul. 2013 May;6(3):377-83. doi: 10.1016/j.brs.2012.07.008. PMID: 22921765.",39466,2019
ivarsson2014_IES_A_0_NA,Psychotherapy,PTSD,62,A,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Technology Assisted,31,Self report,IES,IES-R,,,Continuous outcomes: linear mixed-effects model fitted with full information maximum-likelihood estimation. Standard difference in average trajectories (d) for growth models and 95% confidence intervals for traditional Cohen's d. Categorical outcomes: logistic regression fitted with maximum likelihood.,End of Treatment,0,,30.96,16.06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.823,,0.177,Mixed,"intimate partner violence, accidents, illness/medical procedure, combat-related, natural or manmade disasters, community/school violence, other (torture, multiple stressors)",Medium,"Ivarsson D, Blom M, Hesser H, et al. Guided internet-delivered cognitive behavior therapy for post-traumatic stress disorder: a randomized controlled trial. Internet Interv. 2014 March;1(1):33-40. doi: 10.1016/j.invent.2014.03.002.",44101,2019
ivarsson2014_IES_A_Baseline_NA,Psychotherapy,PTSD,62,A,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Technology Assisted,31,Self report,IES,IES-R,,,Continuous outcomes: linear mixed-effects model fitted with full information maximum-likelihood estimation. Standard difference in average trajectories (d) for growth models and 95% confidence intervals for traditional Cohen's d. Categorical outcomes: logistic regression fitted with maximum likelihood.,Baseline,,,54.65,13.16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.823,,0.177,Mixed,"intimate partner violence, accidents, illness/medical procedure, combat-related, natural or manmade disasters, community/school violence, other (torture, multiple stressors)",Medium,"Ivarsson D, Blom M, Hesser H, et al. Guided internet-delivered cognitive behavior therapy for post-traumatic stress disorder: a randomized controlled trial. Internet Interv. 2014 March;1(1):33-40. doi: 10.1016/j.invent.2014.03.002.",44101,2019
ivarsson2014_IES_B_0_NA,Psychotherapy,PTSD,62,B,Control,,,,Minimal support control,Internet control intervention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Technology Alone,31,Self report,IES,IES-R,,,Continuous outcomes: linear mixed-effects model fitted with full information maximum-likelihood estimation. Standard difference in average trajectories (d) for growth models and 95% confidence intervals for traditional Cohen's d. Categorical outcomes: logistic regression fitted with maximum likelihood.,End of Treatment,0,,49.19,18.09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.823,,0.177,Mixed,"intimate partner violence, accidents, illness/medical procedure, combat-related, natural or manmade disasters, community/school violence, other (torture, multiple stressors)",Medium,"Ivarsson D, Blom M, Hesser H, et al. Guided internet-delivered cognitive behavior therapy for post-traumatic stress disorder: a randomized controlled trial. Internet Interv. 2014 March;1(1):33-40. doi: 10.1016/j.invent.2014.03.002.",44101,2019
ivarsson2014_IES_B_Baseline_NA,Psychotherapy,PTSD,62,B,Control,,,,Minimal support control,Internet control intervention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Technology Alone,31,Self report,IES,IES-R,,,Continuous outcomes: linear mixed-effects model fitted with full information maximum-likelihood estimation. Standard difference in average trajectories (d) for growth models and 95% confidence intervals for traditional Cohen's d. Categorical outcomes: logistic regression fitted with maximum likelihood.,Baseline,,,54.87,15.48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.823,,0.177,Mixed,"intimate partner violence, accidents, illness/medical procedure, combat-related, natural or manmade disasters, community/school violence, other (torture, multiple stressors)",Medium,"Ivarsson D, Blom M, Hesser H, et al. Guided internet-delivered cognitive behavior therapy for post-traumatic stress disorder: a randomized controlled trial. Internet Interv. 2014 March;1(1):33-40. doi: 10.1016/j.invent.2014.03.002.",44101,2019
ivarsson2014_PDS_A_0_ITT,Psychotherapy,PTSD,62,A,PTSD,,28,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Technology Assisted,31,Self report,PDS,PDS,ITT,"Imputed, Missing at random assumption",Continuous outcomes: linear mixed-effects model fitted with full information maximum-likelihood estimation. Standard difference in average trajectories (d) for growth models and 95% confidence intervals for traditional Cohen's d. Categorical outcomes: logistic regression fitted with maximum likelihood.,End of Treatment,0,,17.32,9.86,,,,,-14.58,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.815,,CGI-Improvement score of much improved or very much improved,0.63,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.823,,0.177,Mixed,"intimate partner violence, accidents, illness/medical procedure, combat-related, natural or manmade disasters, community/school violence, other (torture, multiple stressors)",Medium,"Ivarsson D, Blom M, Hesser H, et al. Guided internet-delivered cognitive behavior therapy for post-traumatic stress disorder: a randomized controlled trial. Internet Interv. 2014 March;1(1):33-40. doi: 10.1016/j.invent.2014.03.002.",44101,2019
ivarsson2014_PDS_A_52_ITT,Psychotherapy,PTSD,62,A,PTSD,,22,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Technology Assisted,31,Self report,PDS,PDS,ITT,"Imputed, Missing at random assumption",Continuous outcomes: linear mixed-effects model fitted with full information maximum-likelihood estimation. Standard difference in average trajectories (d) for growth models and 95% confidence intervals for traditional Cohen's d. Categorical outcomes: logistic regression fitted with maximum likelihood.,Assessment at ≥12 Months,52,,13,10.76,,,,,-18.9,,,,,Cohen's d,2.03,95% CI,1.27,2.72,p<0.01,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.613,,CGI-Improvement score of much improved or very much improved,0.484,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.823,,0.177,Mixed,"intimate partner violence, accidents, illness/medical procedure, combat-related, natural or manmade disasters, community/school violence, other (torture, multiple stressors)",Medium,"Ivarsson D, Blom M, Hesser H, et al. Guided internet-delivered cognitive behavior therapy for post-traumatic stress disorder: a randomized controlled trial. Internet Interv. 2014 March;1(1):33-40. doi: 10.1016/j.invent.2014.03.002.",44101,2019
ivarsson2014_PDS_A_Baseline_ITT,Psychotherapy,PTSD,62,A,PTSD,,31,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Technology Assisted,31,Self report,PDS,PDS,ITT,"Imputed, Missing at random assumption",Continuous outcomes: linear mixed-effects model fitted with full information maximum-likelihood estimation. Standard difference in average trajectories (d) for growth models and 95% confidence intervals for traditional Cohen's d. Categorical outcomes: logistic regression fitted with maximum likelihood.,Baseline,,,31.9,6.52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.823,,0.177,Mixed,"intimate partner violence, accidents, illness/medical procedure, combat-related, natural or manmade disasters, community/school violence, other (torture, multiple stressors)",Medium,"Ivarsson D, Blom M, Hesser H, et al. Guided internet-delivered cognitive behavior therapy for post-traumatic stress disorder: a randomized controlled trial. Internet Interv. 2014 March;1(1):33-40. doi: 10.1016/j.invent.2014.03.002.",44101,2019
ivarsson2014_PDS_B_0_ITT,Psychotherapy,PTSD,62,B,Control,,26,,Minimal support control,Internet control intervention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Technology Alone,31,Self report,PDS,PDS,ITT,"Imputed, Missing at random assumption",Continuous outcomes: linear mixed-effects model fitted with full information maximum-likelihood estimation. Standard difference in average trajectories (d) for growth models and 95% confidence intervals for traditional Cohen's d. Categorical outcomes: logistic regression fitted with maximum likelihood.,End of Treatment,0,,25.04,11.14,,,,,-4.8,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.389,,CGI-Improvement score of much improved or very much improved,0.138,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.823,,0.177,Mixed,"intimate partner violence, accidents, illness/medical procedure, combat-related, natural or manmade disasters, community/school violence, other (torture, multiple stressors)",Medium,"Ivarsson D, Blom M, Hesser H, et al. Guided internet-delivered cognitive behavior therapy for post-traumatic stress disorder: a randomized controlled trial. Internet Interv. 2014 March;1(1):33-40. doi: 10.1016/j.invent.2014.03.002.",44101,2019
ivarsson2014_PDS_B_Baseline_ITT,Psychotherapy,PTSD,62,B,Control,,31,,Minimal support control,Internet control intervention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Technology Alone,31,Self report,PDS,PDS,ITT,"Imputed, Missing at random assumption",Continuous outcomes: linear mixed-effects model fitted with full information maximum-likelihood estimation. Standard difference in average trajectories (d) for growth models and 95% confidence intervals for traditional Cohen's d. Categorical outcomes: logistic regression fitted with maximum likelihood.,Baseline,,,29.84,8.77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.823,,0.177,Mixed,"intimate partner violence, accidents, illness/medical procedure, combat-related, natural or manmade disasters, community/school violence, other (torture, multiple stressors)",Medium,"Ivarsson D, Blom M, Hesser H, et al. Guided internet-delivered cognitive behavior therapy for post-traumatic stress disorder: a randomized controlled trial. Internet Interv. 2014 March;1(1):33-40. doi: 10.1016/j.invent.2014.03.002.",44101,2019
jacob2014_CAPS_A_0_ITT,Psychotherapy,PTSD,76,A,PTSD,,37,,NET,Narrative Exposure Therapy (NET) + Interpersonal Psychotherapy (IPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,38,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANOVA for change in mean score,End of Treatment,0,,61.47,23.72,,,,,-13.69,,,,,Cohen's d,0.66,95% CI,-4.01,5.33,p<0.001,,,,,,,,Not meeting criteria for PTSD according to DSM-IV-TR,0.2632,,RCI of 17.68 points on CAPS,,,Community,,,1,0.9211,,0.0789,Mixed,"rape/sexual assault, terrorism/political violence/forced displacement",Medium,"Jacob N, Neuner F, Maedl A, et al. Dissemination of psychotherapy for trauma spectrum disorders in postconflict settings: a randomized controlled trial in Rwanda. Psychother Psychosom. 2014 Nov;83(6):354-63. doi: 10.1159/000365114. PMID: 25323203.",43991,2019
jacob2014_CAPS_A_39_ITT,Psychotherapy,PTSD,76,A,PTSD,,37,,NET,Narrative Exposure Therapy (NET) + Interpersonal Psychotherapy (IPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,38,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANOVA for change in mean score,Assessment at 6 to <12 Months,39,,46,26.96,,,,,-33.16,,,,,Cohen's d,1.47,95% CI,-3.62,6.55,p<0.001,,,,,,,,Not meeting criteria for PTSD according to DSM-IV-TR,0.5789,,RCI of 17.68 points on CAPS,0.7632,,Community,,,1,0.9211,,0.0789,Mixed,"rape/sexual assault, terrorism/political violence/forced displacement",Medium,"Jacob N, Neuner F, Maedl A, et al. Dissemination of psychotherapy for trauma spectrum disorders in postconflict settings: a randomized controlled trial in Rwanda. Psychother Psychosom. 2014 Nov;83(6):354-63. doi: 10.1159/000365114. PMID: 25323203.",43991,2019
jacob2014_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,76,A,PTSD,,38,,NET,Narrative Exposure Therapy (NET) + Interpersonal Psychotherapy (IPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,38,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANOVA for change in mean score,Baseline,,,75.16,18.02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.9211,,0.0789,Mixed,"rape/sexual assault, terrorism/political violence/forced displacement",Medium,"Jacob N, Neuner F, Maedl A, et al. Dissemination of psychotherapy for trauma spectrum disorders in postconflict settings: a randomized controlled trial in Rwanda. Psychother Psychosom. 2014 Nov;83(6):354-63. doi: 10.1159/000365114. PMID: 25323203.",43991,2019
jacob2014_CAPS_B_0_ITT,Psychotherapy,PTSD,76,B,Control,,36,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,38,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANOVA for change in mean score,End of Treatment,0,,66.68,16.51,,,,,-5.64,,,,,Cohen's d,0.36,95% CI,-3.14,3.86,p=0.030,,,,,,,,Not meeting criteria for PTSD according to DSM-IV-TR,0.0526,,RCI of 17.68 points on CAPS,,,Community,,,1,0.9211,,0.0789,Mixed,"rape/sexual assault, terrorism/political violence/forced displacement",Medium,"Jacob N, Neuner F, Maedl A, et al. Dissemination of psychotherapy for trauma spectrum disorders in postconflict settings: a randomized controlled trial in Rwanda. Psychother Psychosom. 2014 Nov;83(6):354-63. doi: 10.1159/000365114. PMID: 25323203.",43991,2019
jacob2014_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,76,B,Control,,38,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,38,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANOVA for change in mean score,Baseline,,,72.32,15.02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.9211,,0.0789,Mixed,"rape/sexual assault, terrorism/political violence/forced displacement",Medium,"Jacob N, Neuner F, Maedl A, et al. Dissemination of psychotherapy for trauma spectrum disorders in postconflict settings: a randomized controlled trial in Rwanda. Psychother Psychosom. 2014 Nov;83(6):354-63. doi: 10.1159/000365114. PMID: 25323203.",43991,2019
jak2019_PCL_A_0_ITT,Psychotherapy,PTSD,100,A,PTSD,,23,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,49,Self report,PCL,PCL-S,ITT,Full information maximum likelihood method,ANOVA for change in mean score,End of Treatment,0,,41.04,16.66,,,,,-20.02,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.11,,0.89,,,Low,"Jak AJ, Jurick S, Crocker LD, et al. SMART-CPT for veterans with comorbid post-traumatic stress disorder and history of traumatic brain injury: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):333-41. doi: 10.1136/jnnp-2018-319315. PMID: 30554135.",51464,2020
jak2019_PCL_A_12_ITT,Psychotherapy,PTSD,100,A,PTSD,,15,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,49,Self report,PCL,PCL-S,ITT,Full information maximum likelihood method,ANOVA for change in mean score,Assessment at 3 to <6 Months,12,,37.73,14.27,,,,,-23.33,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.11,,0.89,,,Low,"Jak AJ, Jurick S, Crocker LD, et al. SMART-CPT for veterans with comorbid post-traumatic stress disorder and history of traumatic brain injury: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):333-41. doi: 10.1136/jnnp-2018-319315. PMID: 30554135.",51464,2020
jak2019_PCL_A_Baseline_ITT,Psychotherapy,PTSD,100,A,PTSD,,49,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,49,Self report,PCL,PCL-S,ITT,Full information maximum likelihood method,ANOVA for change in mean score,Baseline,,,61.06,9.92,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.11,,0.89,,,Low,"Jak AJ, Jurick S, Crocker LD, et al. SMART-CPT for veterans with comorbid post-traumatic stress disorder and history of traumatic brain injury: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):333-41. doi: 10.1136/jnnp-2018-319315. PMID: 30554135.",51464,2020
jak2019_PCL_B_0_ITT,Psychotherapy,PTSD,100,B,PTSD,,26,,SMART-CPT,Cognitive Processing Therapy (CPT) adapted for traumatic brain injury (TBI),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,51,Self report,PCL,PCL-S,ITT,Full information maximum likelihood method,ANOVA for change in mean score,End of Treatment,0,,30.44,17.66,,,,,-27.19,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.11,,0.89,,,Low,"Jak AJ, Jurick S, Crocker LD, et al. SMART-CPT for veterans with comorbid post-traumatic stress disorder and history of traumatic brain injury: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):333-41. doi: 10.1136/jnnp-2018-319315. PMID: 30554135.",51464,2020
jak2019_PCL_B_12_ITT,Psychotherapy,PTSD,100,B,PTSD,,20,,SMART-CPT,Cognitive Processing Therapy (CPT) adapted for traumatic brain injury (TBI),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,51,Self report,PCL,PCL-S,ITT,Full information maximum likelihood method,ANOVA for change in mean score,Assessment at 3 to <6 Months,12,,42.10,13.97,,,,,-15.53,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.11,,0.89,,,Low,"Jak AJ, Jurick S, Crocker LD, et al. SMART-CPT for veterans with comorbid post-traumatic stress disorder and history of traumatic brain injury: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):333-41. doi: 10.1136/jnnp-2018-319315. PMID: 30554135.",51464,2020
jak2019_PCL_B_Baseline_ITT,Psychotherapy,PTSD,100,B,PTSD,,51,,SMART-CPT,Cognitive Processing Therapy (CPT) adapted for traumatic brain injury (TBI),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,51,Self report,PCL,PCL-S,ITT,Full information maximum likelihood method,ANOVA for change in mean score,Baseline,,,57.63,11.17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.11,,0.89,,,Low,"Jak AJ, Jurick S, Crocker LD, et al. SMART-CPT for veterans with comorbid post-traumatic stress disorder and history of traumatic brain injury: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):333-41. doi: 10.1136/jnnp-2018-319315. PMID: 30554135.",51464,2020
jensen1994_M-PTSD_A_0_NA,Psychotherapy,PTSD,25,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,M-PTSD,M-PTSD,,,ANCOVA for change in mean score,End of Treatment,0,,129.31,13.39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,High,Jensen JA. An investigation of Eye Movement Desensitization Reprocessing (EMD/R) as a treatment for posttraumatic stress disorder (PTSD) symptoms of Vietnam combat veterans. Behav Ther. 1994 Spring;25(2):311-25. doi: 10.1016/S0005-7894(05)80290-4.,04669,2019
jensen1994_M-PTSD_A_Baseline_NA,Psychotherapy,PTSD,25,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,M-PTSD,M-PTSD,,,ANCOVA for change in mean score,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,High,Jensen JA. An investigation of Eye Movement Desensitization Reprocessing (EMD/R) as a treatment for posttraumatic stress disorder (PTSD) symptoms of Vietnam combat veterans. Behav Ther. 1994 Spring;25(2):311-25. doi: 10.1016/S0005-7894(05)80290-4.,04669,2019
jensen1994_M-PTSD_B_0_NA,Psychotherapy,PTSD,25,B,Control,,,,Control,Control,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Self report,M-PTSD,M-PTSD,,,ANCOVA for change in mean score,End of Treatment,0,,124.50,12.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,High,Jensen JA. An investigation of Eye Movement Desensitization Reprocessing (EMD/R) as a treatment for posttraumatic stress disorder (PTSD) symptoms of Vietnam combat veterans. Behav Ther. 1994 Spring;25(2):311-25. doi: 10.1016/S0005-7894(05)80290-4.,04669,2019
jensen1994_M-PTSD_B_Baseline_NA,Psychotherapy,PTSD,25,B,Control,,,,Control,Control,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Self report,M-PTSD,M-PTSD,,,ANCOVA for change in mean score,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,High,Jensen JA. An investigation of Eye Movement Desensitization Reprocessing (EMD/R) as a treatment for posttraumatic stress disorder (PTSD) symptoms of Vietnam combat veterans. Behav Ther. 1994 Spring;25(2):311-25. doi: 10.1016/S0005-7894(05)80290-4.,04669,2019
jensen1994_SI-PTSD_A_0_NA,Psychotherapy,PTSD,25,A,PTSD,,13,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,SI-PTSD,SI-PTSD,,,ANCOVA for change in mean score,End of Treatment,0,,35.69,12,,,,,5.77,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,High,Jensen JA. An investigation of Eye Movement Desensitization Reprocessing (EMD/R) as a treatment for posttraumatic stress disorder (PTSD) symptoms of Vietnam combat veterans. Behav Ther. 1994 Spring;25(2):311-25. doi: 10.1016/S0005-7894(05)80290-4.,04669,2019
jensen1994_SI-PTSD_A_Baseline_NA,Psychotherapy,PTSD,25,A,PTSD,,13,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,SI-PTSD,SI-PTSD,,,ANCOVA for change in mean score,Baseline,,,29.92,11.14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,High,Jensen JA. An investigation of Eye Movement Desensitization Reprocessing (EMD/R) as a treatment for posttraumatic stress disorder (PTSD) symptoms of Vietnam combat veterans. Behav Ther. 1994 Spring;25(2):311-25. doi: 10.1016/S0005-7894(05)80290-4.,04669,2019
jensen1994_SI-PTSD_B_0_NA,Psychotherapy,PTSD,25,B,Control,,12,,Control,Control,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Structured Clinical Interview,SI-PTSD,SI-PTSD,,,ANCOVA for change in mean score,End of Treatment,0,,46.92,10.22,,,,,9.84,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,High,Jensen JA. An investigation of Eye Movement Desensitization Reprocessing (EMD/R) as a treatment for posttraumatic stress disorder (PTSD) symptoms of Vietnam combat veterans. Behav Ther. 1994 Spring;25(2):311-25. doi: 10.1016/S0005-7894(05)80290-4.,04669,2019
jensen1994_SI-PTSD_B_Baseline_NA,Psychotherapy,PTSD,25,B,Control,,12,,Control,Control,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Structured Clinical Interview,SI-PTSD,SI-PTSD,,,ANCOVA for change in mean score,Baseline,,,37.08,9.22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,High,Jensen JA. An investigation of Eye Movement Desensitization Reprocessing (EMD/R) as a treatment for posttraumatic stress disorder (PTSD) symptoms of Vietnam combat veterans. Behav Ther. 1994 Spring;25(2):311-25. doi: 10.1016/S0005-7894(05)80290-4.,04669,2019
jespersen2012_PTSD-8_A_0_Comp,Complementary and integrative health (CIH),PTSD,19,A,PTSD,,9,,Relaxation music at bedtime,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,Technology Alone,10,Self report,PTSD-8,PTSD-8,Completer,,Wilcoxon Signed-Rank test,End of Treatment,0,,,,,,,,,,,,,,,,,,p>0.05,,,,,,,,,,,,,,Community,,,1,0.6,completers only,0.4,,,High,"Jespersen KV, Vuust P. The effect of relaxation music listening on sleep quality in traumatized refugees: a pilot study. J Music Ther. 2012;49(2):205-29.  PMID: 26753218.",1548481,2019
jespersen2012_PTSD-8_A_Baseline_Comp,Complementary and integrative health (CIH),PTSD,19,A,PTSD,,10,,Relaxation music at bedtime,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,Technology Alone,10,Self report,PTSD-8,PTSD-8,Completer,,Wilcoxon Signed-Rank test,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6,completers only,0.4,,,High,"Jespersen KV, Vuust P. The effect of relaxation music listening on sleep quality in traumatized refugees: a pilot study. J Music Ther. 2012;49(2):205-29.  PMID: 26753218.",1548481,2019
jespersen2012_PTSD-8_B_0_Comp,Complementary and integrative health (CIH),PTSD,19,B,Control,,6,,Ergonomic pillow,Ergonomic pillow,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Technology Alone,9,Self report,PTSD-8,PTSD-8,Completer,,Wilcoxon Signed-Rank test,End of Treatment,0,,,,,,,,,,,,,,,,,,p>0.05,,,,,,,,,,,,,,Community,,,1,0.6,completers only,0.4,,,High,"Jespersen KV, Vuust P. The effect of relaxation music listening on sleep quality in traumatized refugees: a pilot study. J Music Ther. 2012;49(2):205-29.  PMID: 26753218.",1548481,2019
jespersen2012_PTSD-8_B_Baseline_Comp,Complementary and integrative health (CIH),PTSD,19,B,Control,,9,,Ergonomic pillow,Ergonomic pillow,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Technology Alone,9,Self report,PTSD-8,PTSD-8,Completer,,Wilcoxon Signed-Rank test,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6,completers only,0.4,,,High,"Jespersen KV, Vuust P. The effect of relaxation music listening on sleep quality in traumatized refugees: a pilot study. J Music Ther. 2012;49(2):205-29.  PMID: 26753218.",1548481,2019
jindani2015_PCL_A_0_Comp,Complementary and integrative health (CIH),PTSD,80,A,PTSD,,29,,Kundalini Yoga,Yoga,No,Not Applicable,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Group,In Person,59,Self report,PCL,PCL-17,Completer,,ANCOVA with partial eta-squared effect sizes.,End of Treatment,0,,41.8,12,,,,,-17.7,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8875,,0.1125,Mixed,"rape/sexual assault, child sexual abuse, intimate partner violence, terrorism/political violence/forced displacement, illness/medical procedure, accidents, other (emotional abuse, systemic discrimination, compassion fatigue)",High,"Jindani FA, Turner N, Khalsa SBS. A yoga intervention for posttraumatic stress: a preliminary randomized control trial. Evid Based Complement Alternat Med. 2015;2015:351746. doi: 10.1155/2015/351746. PMID: 26366179.",48111,2019
jindani2015_PCL_A_Baseline_Comp,Complementary and integrative health (CIH),PTSD,80,A,PTSD,,29,,Kundalini Yoga,Yoga,No,Not Applicable,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Group,In Person,59,Self report,PCL,PCL-17,Completer,,ANCOVA with partial eta-squared effect sizes.,Baseline,,,59.5,9.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8875,,0.1125,Mixed,"rape/sexual assault, child sexual abuse, intimate partner violence, terrorism/political violence/forced displacement, illness/medical procedure, accidents, other (emotional abuse, systemic discrimination, compassion fatigue)",High,"Jindani FA, Turner N, Khalsa SBS. A yoga intervention for posttraumatic stress: a preliminary randomized control trial. Evid Based Complement Alternat Med. 2015;2015:351746. doi: 10.1155/2015/351746. PMID: 26366179.",48111,2019
jindani2015_PCL_B_0_Comp,Complementary and integrative health (CIH),PTSD,80,B,Control,,21,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,21,Self report,PCL,PCL-17,Completer,,ANCOVA with partial eta-squared effect sizes.,End of Treatment,0,,55.4,13.5,,,,,0.3,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8875,,0.1125,Mixed,"rape/sexual assault, child sexual abuse, intimate partner violence, terrorism/political violence/forced displacement, illness/medical procedure, accidents, other (emotional abuse, systemic discrimination, compassion fatigue)",High,"Jindani FA, Turner N, Khalsa SBS. A yoga intervention for posttraumatic stress: a preliminary randomized control trial. Evid Based Complement Alternat Med. 2015;2015:351746. doi: 10.1155/2015/351746. PMID: 26366179.",48111,2019
jindani2015_PCL_B_Baseline_Comp,Complementary and integrative health (CIH),PTSD,80,B,Control,,21,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,21,Self report,PCL,PCL-17,Completer,,ANCOVA with partial eta-squared effect sizes.,Baseline,,,55.1,11.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8875,,0.1125,Mixed,"rape/sexual assault, child sexual abuse, intimate partner violence, terrorism/political violence/forced displacement, illness/medical procedure, accidents, other (emotional abuse, systemic discrimination, compassion fatigue)",High,"Jindani FA, Turner N, Khalsa SBS. A yoga intervention for posttraumatic stress: a preliminary randomized control trial. Evid Based Complement Alternat Med. 2015;2015:351746. doi: 10.1155/2015/351746. PMID: 26366179.",48111,2019
johnson2011_CAPS_A_0_Comp,Other mixed,PTSD,70,A,PTSD,,19,,Helping to Overcome PTSD through Empowerment,Helping to Overcome PTSD through Empowerment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,In Person,35,Structured Clinical Interview,CAPS,CAPS,Completer,Hierarchical linear modeling,"Hierarchical linear modeling, Cohen's d for change in mean scores, chi-square, odds ratio, and relative risk for binary outcomes",End of Treatment,0,,21.16,17.17,,,,,-28.84,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,RCI for CAPS (equivalent to ≥21-points in ITT and ≥22-point in completers),0.647,,Community,,,1,1,,0,Intimate partner violence,,Medium,"Johnson DM, Zlotnick C, Perez SK. Cognitive behavioral treatment of PTSD in residents of battered women's shelters: results of a randomized clinical trial. J Consult Clin Psychol. 2011 Aug;79(4):542-51. doi: 10.1037/a0023822. PMID: 21787052.",37002,2019
johnson2011_CAPS_A_0_ITT,Other mixed,PTSD,70,A,PTSD,,34,,Helping to Overcome PTSD through Empowerment,Helping to Overcome PTSD through Empowerment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,In Person,35,Structured Clinical Interview,CAPS,CAPS,ITT,Hierarchical linear modeling,"Hierarchical linear modeling, Cohen's d for change in mean scores, chi-square, odds ratio, and relative risk for binary outcomes",End of Treatment,0,,24.76,18.47,,,,,-28.58,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,RCI for CAPS (equivalent to ≥21-points in ITT and ≥22-point in completers),0.632,,Community,,,1,1,,0,Intimate partner violence,,Medium,"Johnson DM, Zlotnick C, Perez SK. Cognitive behavioral treatment of PTSD in residents of battered women's shelters: results of a randomized clinical trial. J Consult Clin Psychol. 2011 Aug;79(4):542-51. doi: 10.1037/a0023822. PMID: 21787052.",37002,2019
johnson2011_CAPS_A_12_Comp,Other mixed,PTSD,70,A,PTSD,,19,,Helping to Overcome PTSD through Empowerment,Helping to Overcome PTSD through Empowerment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,In Person,35,Structured Clinical Interview,CAPS,CAPS,Completer,Hierarchical linear modeling,"Hierarchical linear modeling, Cohen's d for change in mean scores, chi-square, odds ratio, and relative risk for binary outcomes",Assessment at 3 to <6 Months,12,,16.32,20.2,,,,,-33.68,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.158,,RCI for CAPS (equivalent to ≥21-points in ITT and ≥22-point in completers),,,Community,,,1,1,,0,Intimate partner violence,,Medium,"Johnson DM, Zlotnick C, Perez SK. Cognitive behavioral treatment of PTSD in residents of battered women's shelters: results of a randomized clinical trial. J Consult Clin Psychol. 2011 Aug;79(4):542-51. doi: 10.1037/a0023822. PMID: 21787052.",37002,2019
johnson2011_CAPS_A_12_ITT,Other mixed,PTSD,70,A,PTSD,,33,,Helping to Overcome PTSD through Empowerment,Helping to Overcome PTSD through Empowerment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,In Person,35,Structured Clinical Interview,CAPS,CAPS,ITT,Hierarchical linear modeling,"Hierarchical linear modeling, Cohen's d for change in mean scores, chi-square, odds ratio, and relative risk for binary outcomes",Assessment at 3 to <6 Months,12,,21.15,24.79,,,,,-32.19,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,RCI for CAPS (equivalent to ≥21-points in ITT and ≥22-point in completers),,,Community,,,1,1,,0,Intimate partner violence,,Medium,"Johnson DM, Zlotnick C, Perez SK. Cognitive behavioral treatment of PTSD in residents of battered women's shelters: results of a randomized clinical trial. J Consult Clin Psychol. 2011 Aug;79(4):542-51. doi: 10.1037/a0023822. PMID: 21787052.",37002,2019
johnson2011_CAPS_A_26_Comp,Other mixed,PTSD,70,A,PTSD,,19,,Helping to Overcome PTSD through Empowerment,Helping to Overcome PTSD through Empowerment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,In Person,35,Structured Clinical Interview,CAPS,CAPS,Completer,Hierarchical linear modeling,"Hierarchical linear modeling, Cohen's d for change in mean scores, chi-square, odds ratio, and relative risk for binary outcomes",Assessment at 6 to <12 Months,26,,14.79,16.63,,,,,-35.21,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,RCI for CAPS (equivalent to ≥21-points in ITT and ≥22-point in completers),,,Community,,,1,1,,0,Intimate partner violence,,Medium,"Johnson DM, Zlotnick C, Perez SK. Cognitive behavioral treatment of PTSD in residents of battered women's shelters: results of a randomized clinical trial. J Consult Clin Psychol. 2011 Aug;79(4):542-51. doi: 10.1037/a0023822. PMID: 21787052.",37002,2019
johnson2011_CAPS_A_26_ITT,Other mixed,PTSD,70,A,PTSD,,32,,Helping to Overcome PTSD through Empowerment,Helping to Overcome PTSD through Empowerment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,In Person,35,Structured Clinical Interview,CAPS,CAPS,ITT,Hierarchical linear modeling,"Hierarchical linear modeling, Cohen's d for change in mean scores, chi-square, odds ratio, and relative risk for binary outcomes",Assessment at 6 to <12 Months,26,,18.62,18.84,,,,,-34.72,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,RCI for CAPS (equivalent to ≥21-points in ITT and ≥22-point in completers),,,Community,,,1,1,,0,Intimate partner violence,,Medium,"Johnson DM, Zlotnick C, Perez SK. Cognitive behavioral treatment of PTSD in residents of battered women's shelters: results of a randomized clinical trial. J Consult Clin Psychol. 2011 Aug;79(4):542-51. doi: 10.1037/a0023822. PMID: 21787052.",37002,2019
johnson2011_CAPS_A_Baseline_Comp,Other mixed,PTSD,70,A,PTSD,,19,,Helping to Overcome PTSD through Empowerment,Helping to Overcome PTSD through Empowerment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,In Person,35,Structured Clinical Interview,CAPS,CAPS,Completer,Hierarchical linear modeling,"Hierarchical linear modeling, Cohen's d for change in mean scores, chi-square, odds ratio, and relative risk for binary outcomes",Baseline,,,50,22.61,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Intimate partner violence,,Medium,"Johnson DM, Zlotnick C, Perez SK. Cognitive behavioral treatment of PTSD in residents of battered women's shelters: results of a randomized clinical trial. J Consult Clin Psychol. 2011 Aug;79(4):542-51. doi: 10.1037/a0023822. PMID: 21787052.",37002,2019
johnson2011_CAPS_A_Baseline_ITT,Other mixed,PTSD,70,A,PTSD,,35,,Helping to Overcome PTSD through Empowerment,Helping to Overcome PTSD through Empowerment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,In Person,35,Structured Clinical Interview,CAPS,CAPS,ITT,Hierarchical linear modeling,"Hierarchical linear modeling, Cohen's d for change in mean scores, chi-square, odds ratio, and relative risk for binary outcomes",Baseline,,,53.34,24.29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Intimate partner violence,,Medium,"Johnson DM, Zlotnick C, Perez SK. Cognitive behavioral treatment of PTSD in residents of battered women's shelters: results of a randomized clinical trial. J Consult Clin Psychol. 2011 Aug;79(4):542-51. doi: 10.1037/a0023822. PMID: 21787052.",37002,2019
johnson2011_CAPS_B_0_Comp,Other mixed,PTSD,70,B,Control,,33,,Standard shelter service,Standard shelter service,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,35,Structured Clinical Interview,CAPS,CAPS,Completer,Hierarchical linear modeling,"Hierarchical linear modeling, Cohen's d for change in mean scores, chi-square, odds ratio, and relative risk for binary outcomes",End of Treatment,0,,40.97,28.59,,,,,-20.88,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,RCI for CAPS (equivalent to ≥21-points in ITT and ≥22-point in completers),,,Community,,,1,1,,0,Intimate partner violence,,Medium,"Johnson DM, Zlotnick C, Perez SK. Cognitive behavioral treatment of PTSD in residents of battered women's shelters: results of a randomized clinical trial. J Consult Clin Psychol. 2011 Aug;79(4):542-51. doi: 10.1037/a0023822. PMID: 21787052.",37002,2019
johnson2011_CAPS_B_0_ITT,Other mixed,PTSD,70,B,Control,,34,,Standard shelter service,Standard shelter service,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,35,Structured Clinical Interview,CAPS,CAPS,ITT,Hierarchical linear modeling,"Hierarchical linear modeling, Cohen's d for change in mean scores, chi-square, odds ratio, and relative risk for binary outcomes",End of Treatment,0,,42.38,29.33,,,,,-20.31,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,RCI for CAPS (equivalent to ≥21-points in ITT and ≥22-point in completers),,,Community,,,1,1,,0,Intimate partner violence,,Medium,"Johnson DM, Zlotnick C, Perez SK. Cognitive behavioral treatment of PTSD in residents of battered women's shelters: results of a randomized clinical trial. J Consult Clin Psychol. 2011 Aug;79(4):542-51. doi: 10.1037/a0023822. PMID: 21787052.",37002,2019
johnson2011_CAPS_B_12_Comp,Other mixed,PTSD,70,B,Control,,33,,Standard shelter service,Standard shelter service,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,35,Structured Clinical Interview,CAPS,CAPS,Completer,Hierarchical linear modeling,"Hierarchical linear modeling, Cohen's d for change in mean scores, chi-square, odds ratio, and relative risk for binary outcomes",Assessment at 3 to <6 Months,12,,31.27,22.01,,,,,-31.42,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.455,,RCI for CAPS (equivalent to ≥21-points in ITT and ≥22-point in completers),,,Community,,,1,1,,0,Intimate partner violence,,Medium,"Johnson DM, Zlotnick C, Perez SK. Cognitive behavioral treatment of PTSD in residents of battered women's shelters: results of a randomized clinical trial. J Consult Clin Psychol. 2011 Aug;79(4):542-51. doi: 10.1037/a0023822. PMID: 21787052.",37002,2019
johnson2011_CAPS_B_12_ITT,Other mixed,PTSD,70,B,Control,,33,,Standard shelter service,Standard shelter service,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,35,Structured Clinical Interview,CAPS,CAPS,ITT,Hierarchical linear modeling,"Hierarchical linear modeling, Cohen's d for change in mean scores, chi-square, odds ratio, and relative risk for binary outcomes",Assessment at 3 to <6 Months,12,,31.27,22.01,,,,,-31.42,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,RCI for CAPS (equivalent to ≥21-points in ITT and ≥22-point in completers),,,Community,,,1,1,,0,Intimate partner violence,,Medium,"Johnson DM, Zlotnick C, Perez SK. Cognitive behavioral treatment of PTSD in residents of battered women's shelters: results of a randomized clinical trial. J Consult Clin Psychol. 2011 Aug;79(4):542-51. doi: 10.1037/a0023822. PMID: 21787052.",37002,2019
johnson2011_CAPS_B_26_Comp,Other mixed,PTSD,70,B,Control,,33,,Standard shelter service,Standard shelter service,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,35,Structured Clinical Interview,CAPS,CAPS,Completer,Hierarchical linear modeling,"Hierarchical linear modeling, Cohen's d for change in mean scores, chi-square, odds ratio, and relative risk for binary outcomes",Assessment at 6 to <12 Months,26,,26.82,26.18,,,,,-35.03,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,RCI for CAPS (equivalent to ≥21-points in ITT and ≥22-point in completers),,,Community,,,1,1,,0,Intimate partner violence,,Medium,"Johnson DM, Zlotnick C, Perez SK. Cognitive behavioral treatment of PTSD in residents of battered women's shelters: results of a randomized clinical trial. J Consult Clin Psychol. 2011 Aug;79(4):542-51. doi: 10.1037/a0023822. PMID: 21787052.",37002,2019
johnson2011_CAPS_B_26_ITT,Other mixed,PTSD,70,B,Control,,34,,Standard shelter service,Standard shelter service,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,35,Structured Clinical Interview,CAPS,CAPS,ITT,Hierarchical linear modeling,"Hierarchical linear modeling, Cohen's d for change in mean scores, chi-square, odds ratio, and relative risk for binary outcomes",Assessment at 6 to <12 Months,26,,26.56,25.83,,,,,-36.13,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,RCI for CAPS (equivalent to ≥21-points in ITT and ≥22-point in completers),,,Community,,,1,1,,0,Intimate partner violence,,Medium,"Johnson DM, Zlotnick C, Perez SK. Cognitive behavioral treatment of PTSD in residents of battered women's shelters: results of a randomized clinical trial. J Consult Clin Psychol. 2011 Aug;79(4):542-51. doi: 10.1037/a0023822. PMID: 21787052.",37002,2019
johnson2011_CAPS_B_Baseline_Comp,Other mixed,PTSD,70,B,Control,,33,,Standard shelter service,Standard shelter service,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,35,Structured Clinical Interview,CAPS,CAPS,Completer,Hierarchical linear modeling,"Hierarchical linear modeling, Cohen's d for change in mean scores, chi-square, odds ratio, and relative risk for binary outcomes",Baseline,,,61.85,25.66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Intimate partner violence,,Medium,"Johnson DM, Zlotnick C, Perez SK. Cognitive behavioral treatment of PTSD in residents of battered women's shelters: results of a randomized clinical trial. J Consult Clin Psychol. 2011 Aug;79(4):542-51. doi: 10.1037/a0023822. PMID: 21787052.",37002,2019
johnson2011_CAPS_B_Baseline_ITT,Other mixed,PTSD,70,B,Control,,35,,Standard shelter service,Standard shelter service,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,35,Structured Clinical Interview,CAPS,CAPS,ITT,Hierarchical linear modeling,"Hierarchical linear modeling, Cohen's d for change in mean scores, chi-square, odds ratio, and relative risk for binary outcomes",Baseline,,,62.69,25.38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Intimate partner violence,,Medium,"Johnson DM, Zlotnick C, Perez SK. Cognitive behavioral treatment of PTSD in residents of battered women's shelters: results of a randomized clinical trial. J Consult Clin Psychol. 2011 Aug;79(4):542-51. doi: 10.1037/a0023822. PMID: 21787052.",37002,2019
johnson2018_PCL_A_0_ITT,Complementary and integrative health (CIH),PTSD,29,A,PTSD,,19,,Therapeutic horseback riding,Therapeutic horseback riding,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In Person,15,Self report,PCL,PCL-M,ITT,,"Repeated measures ANOVA, t-tests for difference scores",End of Treatment,0,,47,14.67,,,,,-10.72,,,,,,,,,,p<0.01,,,,,,,,,,,,,,Veteran,,1,,,,,,,High,"Johnson RA, Albright DL, Marzolf JR, et al. Effects of therapeutic horseback riding on post-traumatic stress disorder in military veterans. Mil Med Res. 2018 Jan;5(1):3. doi: 10.1186/s40779-018-0149-6. PMID: 29502529.",49720,2019
johnson2018_PCL_A_Baseline_ITT,Complementary and integrative health (CIH),PTSD,29,A,PTSD,,28,,Therapeutic horseback riding,Therapeutic horseback riding,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In Person,15,Self report,PCL,PCL-M,ITT,,"Repeated measures ANOVA, t-tests for difference scores",Baseline,,,57.72,14.63,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,,,,,,High,"Johnson RA, Albright DL, Marzolf JR, et al. Effects of therapeutic horseback riding on post-traumatic stress disorder in military veterans. Mil Med Res. 2018 Jan;5(1):3. doi: 10.1186/s40779-018-0149-6. PMID: 29502529.",49720,2019
johnson2018_PCL_B_0_ITT,Complementary and integrative health (CIH),PTSD,29,B,Control,,13,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,14,Self report,PCL,PCL-M,ITT,,"Repeated measures ANOVA, t-tests for difference scores",End of Treatment,0,,59.23,14.29,,,,,0.87,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,,,,,,High,"Johnson RA, Albright DL, Marzolf JR, et al. Effects of therapeutic horseback riding on post-traumatic stress disorder in military veterans. Mil Med Res. 2018 Jan;5(1):3. doi: 10.1186/s40779-018-0149-6. PMID: 29502529.",49720,2019
johnson2018_PCL_B_Baseline_ITT,Complementary and integrative health (CIH),PTSD,29,B,Control,,14,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,14,Self report,PCL,PCL-M,ITT,,"Repeated measures ANOVA, t-tests for difference scores",Baseline,,,58.36,16.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,,,,,,High,"Johnson RA, Albright DL, Marzolf JR, et al. Effects of therapeutic horseback riding on post-traumatic stress disorder in military veterans. Mil Med Res. 2018 Jan;5(1):3. doi: 10.1186/s40779-018-0149-6. PMID: 29502529.",49720,2019
jung2013_CAPS_A_0_Comp,Psychotherapy,PTSD,34,A,PTSD,,14,,CR and Imagery Modification,Cognitive restructuring and imagery modification,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated-measures ANOVA for change in mean scores,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS for DSM-IV,,,RCI for CAPS (corresponding to 19.62 points),,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013 Jun;82(4):213-20. doi: 10.1159/000348450. PMID: 23712073.",41611,2019
jung2013_CAPS_A_0_ITT,Psychotherapy,PTSD,34,A,PTSD,,17,,CR and Imagery Modification,Cognitive restructuring and imagery modification,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,CAPS,CAPS,ITT,,Repeated-measures ANOVA for change in mean scores,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS for DSM-IV,,,RCI for CAPS (corresponding to 19.62 points),,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013 Jun;82(4):213-20. doi: 10.1159/000348450. PMID: 23712073.",41611,2019
jung2013_CAPS_A_3_Comp,Psychotherapy,PTSD,34,A,PTSD,,14,,CR and Imagery Modification,Cognitive restructuring and imagery modification,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated-measures ANOVA for change in mean scores,Assessment at <3 Months,3,,60.9,23.3,,,,,-19.7,,,,,Cohen's d,0.9,95% CI,0.12,1.68,p≤0.001,,,,,,,,Not meeting criteria for PTSD according to CAPS for DSM-IV,0.3571,,RCI for CAPS (corresponding to 19.62 points),0.5,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013 Jun;82(4):213-20. doi: 10.1159/000348450. PMID: 23712073.",41611,2019
jung2013_CAPS_A_3_ITT,Psychotherapy,PTSD,34,A,PTSD,,17,,CR and Imagery Modification,Cognitive restructuring and imagery modification,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,CAPS,CAPS,ITT,,Repeated-measures ANOVA for change in mean scores,Assessment at <3 Months,3,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS for DSM-IV,,,RCI for CAPS (corresponding to 19.62 points),,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013 Jun;82(4):213-20. doi: 10.1159/000348450. PMID: 23712073.",41611,2019
jung2013_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,34,A,PTSD,,17,,CR and Imagery Modification,Cognitive restructuring and imagery modification,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,CAPS,CAPS,ITT,,Repeated-measures ANOVA for change in mean scores,Baseline,,,80.6,20.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013 Jun;82(4):213-20. doi: 10.1159/000348450. PMID: 23712073.",41611,2019
jung2013_CAPS_B_0_Comp,Psychotherapy,PTSD,34,B,Control,,14,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,17,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated-measures ANOVA for change in mean scores,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS for DSM-IV,,,RCI for CAPS (corresponding to 19.62 points),,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013 Jun;82(4):213-20. doi: 10.1159/000348450. PMID: 23712073.",41611,2019
jung2013_CAPS_B_0_ITT,Psychotherapy,PTSD,34,B,Control,,17,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,17,Structured Clinical Interview,CAPS,CAPS,ITT,,Repeated-measures ANOVA for change in mean scores,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS for DSM-IV,,,RCI for CAPS (corresponding to 19.62 points),,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013 Jun;82(4):213-20. doi: 10.1159/000348450. PMID: 23712073.",41611,2019
jung2013_CAPS_B_3_Comp,Psychotherapy,PTSD,34,B,Control,,14,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,17,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated-measures ANOVA for change in mean scores,Assessment at <3 Months,3,,80.4,18.3,,,,,-2.2,,,,,Cohen's d,0.12,95% CI,-0.62,0.86,p=NS,,,,,,,,Not meeting criteria for PTSD according to CAPS for DSM-IV,0.0714,,RCI for CAPS (corresponding to 19.62 points),0.0714,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013 Jun;82(4):213-20. doi: 10.1159/000348450. PMID: 23712073.",41611,2019
jung2013_CAPS_B_3_ITT,Psychotherapy,PTSD,34,B,Control,,17,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,17,Structured Clinical Interview,CAPS,CAPS,ITT,,Repeated-measures ANOVA for change in mean scores,Assessment at <3 Months,3,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS for DSM-IV,,,RCI for CAPS (corresponding to 19.62 points),,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013 Jun;82(4):213-20. doi: 10.1159/000348450. PMID: 23712073.",41611,2019
jung2013_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,34,B,Control,,17,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,17,Structured Clinical Interview,CAPS,CAPS,ITT,,Repeated-measures ANOVA for change in mean scores,Baseline,,,82.6,16.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013 Jun;82(4):213-20. doi: 10.1159/000348450. PMID: 23712073.",41611,2019
jung2013_PDS_A_0_ITT,Psychotherapy,PTSD,34,A,PTSD,,,,CR and Imagery Modification,Cognitive restructuring and imagery modification,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Self report,PDS,PDS,ITT,,Repeated-measures ANOVA for change in mean scores,End of Treatment,0,,24.4,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013 Jun;82(4):213-20. doi: 10.1159/000348450. PMID: 23712073.",41611,2019
jung2013_PDS_A_3_ITT,Psychotherapy,PTSD,34,A,PTSD,,,,CR and Imagery Modification,Cognitive restructuring and imagery modification,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Self report,PDS,PDS,ITT,,Repeated-measures ANOVA for change in mean scores,Assessment at <3 Months,3,,24.4,10.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013 Jun;82(4):213-20. doi: 10.1159/000348450. PMID: 23712073.",41611,2019
jung2013_PDS_A_Baseline_ITT,Psychotherapy,PTSD,34,A,PTSD,,,,CR and Imagery Modification,Cognitive restructuring and imagery modification,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Self report,PDS,PDS,ITT,,Repeated-measures ANOVA for change in mean scores,Baseline,,,30.2,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013 Jun;82(4):213-20. doi: 10.1159/000348450. PMID: 23712073.",41611,2019
jung2013_PDS_B_0_ITT,Psychotherapy,PTSD,34,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,17,Self report,PDS,PDS,ITT,,Repeated-measures ANOVA for change in mean scores,End of Treatment,0,,32.5,8.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013 Jun;82(4):213-20. doi: 10.1159/000348450. PMID: 23712073.",41611,2019
jung2013_PDS_B_3_ITT,Psychotherapy,PTSD,34,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,17,Self report,PDS,PDS,ITT,,Repeated-measures ANOVA for change in mean scores,Assessment at <3 Months,3,,33.8,9.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013 Jun;82(4):213-20. doi: 10.1159/000348450. PMID: 23712073.",41611,2019
jung2013_PDS_B_Baseline_ITT,Psychotherapy,PTSD,34,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,17,Self report,PDS,PDS,ITT,,Repeated-measures ANOVA for change in mean scores,Baseline,,,33.6,9.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013 Jun;82(4):213-20. doi: 10.1159/000348450. PMID: 23712073.",41611,2019
kaplan1996_IES_A_0_Comp,Pharmacotherapy,PTSD,17,A,PTSD,,,,Inositol,Inositol,No,Not Applicable,Yes,Supplement,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,IES,IES (Hebrew version),Completer,,Repeated-measures ANOVA for change in mean scores,End of Treatment,0,,32.0,11,,,,,-3.76,6.42,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.3846,,0.6154,Mixed,"combat-related, accidents, community/school violence, other (not specified)",High,"Kaplan Z, Amir M, Swartz M, et al. Inositol treatment of post-traumatic stress disorder. Anxiety. 1996;2(1):51-2. doi: 10.1002/(SICI)1522-7154(1996)2:1<51::AID-ANXI8>3.0.CO;2-G. PMID: 9160600.",06980,2019
kaplan1996_IES_A_Baseline_Comp,Pharmacotherapy,PTSD,17,A,PTSD,,,,Inositol,Inositol,No,Not Applicable,Yes,Supplement,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,IES,IES (Hebrew version),Completer,,Repeated-measures ANOVA for change in mean scores,Baseline,,,35.8,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.3846,,0.6154,Mixed,"combat-related, accidents, community/school violence, other (not specified)",High,"Kaplan Z, Amir M, Swartz M, et al. Inositol treatment of post-traumatic stress disorder. Anxiety. 1996;2(1):51-2. doi: 10.1002/(SICI)1522-7154(1996)2:1<51::AID-ANXI8>3.0.CO;2-G. PMID: 9160600.",06980,2019
kaplan1996_IES_B_0_Comp,Pharmacotherapy,PTSD,17,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Self report,IES,IES (Hebrew version),Completer,,Repeated-measures ANOVA for change in mean scores,End of Treatment,0,,35.3,15,,,,,-0.38,8.46,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.3846,,0.6154,Mixed,"combat-related, accidents, community/school violence, other (not specified)",High,"Kaplan Z, Amir M, Swartz M, et al. Inositol treatment of post-traumatic stress disorder. Anxiety. 1996;2(1):51-2. doi: 10.1002/(SICI)1522-7154(1996)2:1<51::AID-ANXI8>3.0.CO;2-G. PMID: 9160600.",06980,2019
kaplan1996_IES_B_Baseline_Comp,Pharmacotherapy,PTSD,17,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Self report,IES,IES (Hebrew version),Completer,,Repeated-measures ANOVA for change in mean scores,Baseline,,,34.9,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.3846,,0.6154,Mixed,"combat-related, accidents, community/school violence, other (not specified)",High,"Kaplan Z, Amir M, Swartz M, et al. Inositol treatment of post-traumatic stress disorder. Anxiety. 1996;2(1):51-2. doi: 10.1002/(SICI)1522-7154(1996)2:1<51::AID-ANXI8>3.0.CO;2-G. PMID: 9160600.",06980,2019
karatzias2011_CAPS_A_0_ITT,Psychotherapy,PTSD,46,A,PTSD,,13,,Emotional Freedom Technique,Emotional Freedom Technique (EFT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Structured Clinical Interview,CAPS,CAPS,ITT,BOCF and LOCF,ANOVA for change in mean score,End of Treatment,0,,40.5,26.3,,,,,-22,,,,,Cohen's d,1,,,,,,,,,,,,,,,≥2 standard deviation change in CAPS score,0.3913,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5652,,0.4348,Mixed,"accidents, community/school violence, other (not specified)",High,"Karatzias A, Power KG, Brown KW, et al. A controlled comparison of the effectiveness and efficiency of two psychological therapies for posttraumatic stress disorder: Eye Movement Desensitization and Reprocessing vs. Emotional Freedom Techniques. J. Nerv. Ment. Dis. 2011 Jun;199(6):372-8. doi: 10.1097/NMD.0b013e31821cd262. PMID: 21629014.",36614,2019
karatzias2011_CAPS_A_12_ITT,Psychotherapy,PTSD,46,A,PTSD,,12,,Emotional Freedom Technique,Emotional Freedom Technique (EFT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Structured Clinical Interview,CAPS,CAPS,ITT,BOCF and LOCF,ANOVA for change in mean score,Assessment at 3 to <6 Months,12,,38.7,28.6,,,,,-23.8,,,,,Cohen's d,1,,,,,,,,,,,,,,,≥2 standard deviation change in CAPS score,0.3913,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5652,,0.4348,Mixed,"accidents, community/school violence, other (not specified)",High,"Karatzias A, Power KG, Brown KW, et al. A controlled comparison of the effectiveness and efficiency of two psychological therapies for posttraumatic stress disorder: Eye Movement Desensitization and Reprocessing vs. Emotional Freedom Techniques. J. Nerv. Ment. Dis. 2011 Jun;199(6):372-8. doi: 10.1097/NMD.0b013e31821cd262. PMID: 21629014.",36614,2019
karatzias2011_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,46,A,PTSD,,23,,Emotional Freedom Technique,Emotional Freedom Technique (EFT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Structured Clinical Interview,CAPS,CAPS,ITT,BOCF and LOCF,ANOVA for change in mean score,Baseline,,,62.5,14.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5652,,0.4348,Mixed,"accidents, community/school violence, other (not specified)",High,"Karatzias A, Power KG, Brown KW, et al. A controlled comparison of the effectiveness and efficiency of two psychological therapies for posttraumatic stress disorder: Eye Movement Desensitization and Reprocessing vs. Emotional Freedom Techniques. J. Nerv. Ment. Dis. 2011 Jun;199(6):372-8. doi: 10.1097/NMD.0b013e31821cd262. PMID: 21629014.",36614,2019
karatzias2011_CAPS_B_0_ITT,Psychotherapy,PTSD,46,B,PTSD,,13,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Structured Clinical Interview,CAPS,CAPS,ITT,BOCF and LOCF,ANOVA for change in mean score,End of Treatment,0,,42.7,30.1,,,,,-25.1,,,,,Cohen's d,1.1,,,,,,,,,,,,,,,≥2 standard deviation change in CAPS score,0.4348,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5652,,0.4348,Mixed,"accidents, community/school violence, other (not specified)",High,"Karatzias A, Power KG, Brown KW, et al. A controlled comparison of the effectiveness and efficiency of two psychological therapies for posttraumatic stress disorder: Eye Movement Desensitization and Reprocessing vs. Emotional Freedom Techniques. J. Nerv. Ment. Dis. 2011 Jun;199(6):372-8. doi: 10.1097/NMD.0b013e31821cd262. PMID: 21629014.",36614,2019
karatzias2011_CAPS_B_12_ITT,Psychotherapy,PTSD,46,B,PTSD,,11,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Structured Clinical Interview,CAPS,CAPS,ITT,BOCF and LOCF,ANOVA for change in mean score,Assessment at 3 to <6 Months,12,,43.8,30.5,,,,,-24,,,,,Cohen's d,1,,,,,,,,,,,,,,,≥2 standard deviation change in CAPS score,0.3478,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5652,,0.4348,Mixed,"accidents, community/school violence, other (not specified)",High,"Karatzias A, Power KG, Brown KW, et al. A controlled comparison of the effectiveness and efficiency of two psychological therapies for posttraumatic stress disorder: Eye Movement Desensitization and Reprocessing vs. Emotional Freedom Techniques. J. Nerv. Ment. Dis. 2011 Jun;199(6):372-8. doi: 10.1097/NMD.0b013e31821cd262. PMID: 21629014.",36614,2019
karatzias2011_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,46,B,PTSD,,23,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Structured Clinical Interview,CAPS,CAPS,ITT,BOCF and LOCF,ANOVA for change in mean score,Baseline,,,67.8,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5652,,0.4348,Mixed,"accidents, community/school violence, other (not specified)",High,"Karatzias A, Power KG, Brown KW, et al. A controlled comparison of the effectiveness and efficiency of two psychological therapies for posttraumatic stress disorder: Eye Movement Desensitization and Reprocessing vs. Emotional Freedom Techniques. J. Nerv. Ment. Dis. 2011 Jun;199(6):372-8. doi: 10.1097/NMD.0b013e31821cd262. PMID: 21629014.",36614,2019
karatzias2011_PCL_A_0_NA,Psychotherapy,PTSD,46,A,PTSD,,,,Emotional Freedom Technique,Emotional Freedom Technique (EFT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Self report,PCL,PCL-C,,,ANOVA for change in mean score,End of Treatment,0,,42.0,16.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5652,,0.4348,Mixed,"accidents, community/school violence, other (not specified)",High,"Karatzias A, Power KG, Brown KW, et al. A controlled comparison of the effectiveness and efficiency of two psychological therapies for posttraumatic stress disorder: Eye Movement Desensitization and Reprocessing vs. Emotional Freedom Techniques. J. Nerv. Ment. Dis. 2011 Jun;199(6):372-8. doi: 10.1097/NMD.0b013e31821cd262. PMID: 21629014.",36614,2019
karatzias2011_PCL_A_12_NA,Psychotherapy,PTSD,46,A,PTSD,,,,Emotional Freedom Technique,Emotional Freedom Technique (EFT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Self report,PCL,PCL-C,,,ANOVA for change in mean score,Assessment at 3 to <6 Months,12,,41.0,18.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5652,,0.4348,Mixed,"accidents, community/school violence, other (not specified)",High,"Karatzias A, Power KG, Brown KW, et al. A controlled comparison of the effectiveness and efficiency of two psychological therapies for posttraumatic stress disorder: Eye Movement Desensitization and Reprocessing vs. Emotional Freedom Techniques. J. Nerv. Ment. Dis. 2011 Jun;199(6):372-8. doi: 10.1097/NMD.0b013e31821cd262. PMID: 21629014.",36614,2019
karatzias2011_PCL_A_Baseline_NA,Psychotherapy,PTSD,46,A,PTSD,,,,Emotional Freedom Technique,Emotional Freedom Technique (EFT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Self report,PCL,PCL-C,,,ANOVA for change in mean score,Baseline,,,57.8,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5652,,0.4348,Mixed,"accidents, community/school violence, other (not specified)",High,"Karatzias A, Power KG, Brown KW, et al. A controlled comparison of the effectiveness and efficiency of two psychological therapies for posttraumatic stress disorder: Eye Movement Desensitization and Reprocessing vs. Emotional Freedom Techniques. J. Nerv. Ment. Dis. 2011 Jun;199(6):372-8. doi: 10.1097/NMD.0b013e31821cd262. PMID: 21629014.",36614,2019
karatzias2011_PCL_B_0_NA,Psychotherapy,PTSD,46,B,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Self report,PCL,PCL-C,,,ANOVA for change in mean score,End of Treatment,0,,41.6,21.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5652,,0.4348,Mixed,"accidents, community/school violence, other (not specified)",High,"Karatzias A, Power KG, Brown KW, et al. A controlled comparison of the effectiveness and efficiency of two psychological therapies for posttraumatic stress disorder: Eye Movement Desensitization and Reprocessing vs. Emotional Freedom Techniques. J. Nerv. Ment. Dis. 2011 Jun;199(6):372-8. doi: 10.1097/NMD.0b013e31821cd262. PMID: 21629014.",36614,2019
karatzias2011_PCL_B_12_NA,Psychotherapy,PTSD,46,B,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Self report,PCL,PCL-C,,,ANOVA for change in mean score,Assessment at 3 to <6 Months,12,,43.1,21.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5652,,0.4348,Mixed,"accidents, community/school violence, other (not specified)",High,"Karatzias A, Power KG, Brown KW, et al. A controlled comparison of the effectiveness and efficiency of two psychological therapies for posttraumatic stress disorder: Eye Movement Desensitization and Reprocessing vs. Emotional Freedom Techniques. J. Nerv. Ment. Dis. 2011 Jun;199(6):372-8. doi: 10.1097/NMD.0b013e31821cd262. PMID: 21629014.",36614,2019
karatzias2011_PCL_B_Baseline_NA,Psychotherapy,PTSD,46,B,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Self report,PCL,PCL-C,,,ANOVA for change in mean score,Baseline,,,59.3,11.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5652,,0.4348,Mixed,"accidents, community/school violence, other (not specified)",High,"Karatzias A, Power KG, Brown KW, et al. A controlled comparison of the effectiveness and efficiency of two psychological therapies for posttraumatic stress disorder: Eye Movement Desensitization and Reprocessing vs. Emotional Freedom Techniques. J. Nerv. Ment. Dis. 2011 Jun;199(6):372-8. doi: 10.1097/NMD.0b013e31821cd262. PMID: 21629014.",36614,2019
karatzias2019_PCL_A_0_ITT,Psychotherapy,PTSD,29,A,PTSD,,12,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,15,Self report,PCL,PCL-5,ITT,LOCF,ANOVA for change in mean score,End of Treatment,0,,28.50,18.77,,,,,-20.79,,,,,,,,,,,,,,,,,,PCL-5 <38,0.6,,,,,,,,,0.62,,0.38,,,Medium,"Karatzias T, Brown M, Taggart L, et al. A mixed-methods, randomized controlled feasibility trial of Eye Movement Desensitization and Reprocessing (EMDR) plus Standard Care (SC) versus SC alone for DSM-5 Posttraumatic Stress Disorder (PTSD) in adults with intellectual disabilities. J Appl Res Intellect Disabil. 2019 Jul;32(4):806-18. doi: 10.1111/jar.12570. PMID: 30714684.",52277,2020
karatzias2019_PCL_A_12_ITT,Psychotherapy,PTSD,29,A,PTSD,,9,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,15,Self report,PCL,PCL-5,ITT,LOCF,ANOVA for change in mean score,Assessment at 3 to <6 Months,12,,31.14,16.38,,,,,-18.15,,,,,,,,,,,,,,,,,,PCL-5 <38,0.4667,,,,,,,,,0.62,,0.38,,,Medium,"Karatzias T, Brown M, Taggart L, et al. A mixed-methods, randomized controlled feasibility trial of Eye Movement Desensitization and Reprocessing (EMDR) plus Standard Care (SC) versus SC alone for DSM-5 Posttraumatic Stress Disorder (PTSD) in adults with intellectual disabilities. J Appl Res Intellect Disabil. 2019 Jul;32(4):806-18. doi: 10.1111/jar.12570. PMID: 30714684.",52277,2020
karatzias2019_PCL_A_Baseline_ITT,Psychotherapy,PTSD,29,A,PTSD,,15,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,15,Self report,PCL,PCL-5,ITT,LOCF,ANOVA for change in mean score,Baseline,,,49.29,12.66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.62,,0.38,,,Medium,"Karatzias T, Brown M, Taggart L, et al. A mixed-methods, randomized controlled feasibility trial of Eye Movement Desensitization and Reprocessing (EMDR) plus Standard Care (SC) versus SC alone for DSM-5 Posttraumatic Stress Disorder (PTSD) in adults with intellectual disabilities. J Appl Res Intellect Disabil. 2019 Jul;32(4):806-18. doi: 10.1111/jar.12570. PMID: 30714684.",52277,2020
karatzias2019_PCL_B_0_ITT,Psychotherapy,PTSD,29,B,Control,,13,,Standard care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,14,Self report,PCL,PCL-5,ITT,LOCF,ANOVA for change in mean score,End of Treatment,0,,35.14,13,,,,,-10,,,,,,,,,,,,,,,,,,PCL-5 <38,0.2857,,,,,,,,,0.62,,0.38,,,Medium,"Karatzias T, Brown M, Taggart L, et al. A mixed-methods, randomized controlled feasibility trial of Eye Movement Desensitization and Reprocessing (EMDR) plus Standard Care (SC) versus SC alone for DSM-5 Posttraumatic Stress Disorder (PTSD) in adults with intellectual disabilities. J Appl Res Intellect Disabil. 2019 Jul;32(4):806-18. doi: 10.1111/jar.12570. PMID: 30714684.",52277,2020
karatzias2019_PCL_B_12_ITT,Psychotherapy,PTSD,29,B,Control,,10,,Standard care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,14,Self report,PCL,PCL-5,ITT,LOCF,ANOVA for change in mean score,Assessment at 3 to <6 Months,12,,36.43,13.83,,,,,-8.71,,,,,,,,,,,,,,,,,,PCL-5 <38,0.2857,,,,,,,,,0.62,,0.38,,,Medium,"Karatzias T, Brown M, Taggart L, et al. A mixed-methods, randomized controlled feasibility trial of Eye Movement Desensitization and Reprocessing (EMDR) plus Standard Care (SC) versus SC alone for DSM-5 Posttraumatic Stress Disorder (PTSD) in adults with intellectual disabilities. J Appl Res Intellect Disabil. 2019 Jul;32(4):806-18. doi: 10.1111/jar.12570. PMID: 30714684.",52277,2020
karatzias2019_PCL_B_Baseline_ITT,Psychotherapy,PTSD,29,B,Control,,14,,Standard care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,14,Self report,PCL,PCL-5,ITT,LOCF,ANOVA for change in mean score,Baseline,,,45.14,13.31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.62,,0.38,,,Medium,"Karatzias T, Brown M, Taggart L, et al. A mixed-methods, randomized controlled feasibility trial of Eye Movement Desensitization and Reprocessing (EMDR) plus Standard Care (SC) versus SC alone for DSM-5 Posttraumatic Stress Disorder (PTSD) in adults with intellectual disabilities. J Appl Res Intellect Disabil. 2019 Jul;32(4):806-18. doi: 10.1111/jar.12570. PMID: 30714684.",52277,2020
katz1994_CAPS_A_0_ITT,Pharmacotherapy,PTSD,64,A,PTSD,,33,,Brofaromine,Brofaromine,No,Not Applicable,Yes,Antidepressant: MAOI,No,Not Applicable,No,No,No,No,No,Individual,In Person,33,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANOVA for change in mean score,End of Treatment,0,,46.3,29.7,,,,,-33.6,25.4,,,,,,,,,,,,,,,,,CAPS score <36,0.5455,,CGI-I score of 1 (very much improved),,,Community,,,1,0.2444,,0.7556,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (not specified)",High,"Katz RJ, Lott MH, Arbus P, et al. Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic. Anxiety. 1994;1(4):169-74.  PMID: 9160569.",05306,2019
katz1994_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,64,A,PTSD,,33,,Brofaromine,Brofaromine,No,Not Applicable,Yes,Antidepressant: MAOI,No,Not Applicable,No,No,No,No,No,Individual,In Person,33,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANOVA for change in mean score,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS score <36,,,CGI-I score of 1 (very much improved),,,Community,,,1,0.2444,,0.7556,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (not specified)",High,"Katz RJ, Lott MH, Arbus P, et al. Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic. Anxiety. 1994;1(4):169-74.  PMID: 9160569.",05306,2019
katz1994_CAPS_B_0_ITT,Pharmacotherapy,PTSD,64,B,Control,,31,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANOVA for change in mean score,End of Treatment,0,,57.1,23.7,,,,,-26.7,24.0,,,,,,,,,,,,,,,,,CAPS score <36,0.2581,,CGI-I score of 1 (very much improved),,,Community,,,1,0.2444,,0.7556,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (not specified)",High,"Katz RJ, Lott MH, Arbus P, et al. Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic. Anxiety. 1994;1(4):169-74.  PMID: 9160569.",05306,2019
katz1994_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,64,B,Control,,31,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANOVA for change in mean score,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS score <36,,,CGI-I score of 1 (very much improved),,,Community,,,1,0.2444,,0.7556,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (not specified)",High,"Katz RJ, Lott MH, Arbus P, et al. Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic. Anxiety. 1994;1(4):169-74.  PMID: 9160569.",05306,2019
katz2014_PCL_A_0_Comp,Psychotherapy,PTSD,51,A,PTSD,,16,,Holographic reprocessing,Holographic reprocessing,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Self report,PCL,PCL,Completer,,mixed designed ANOVA with post-hoc comparisons,End of Treatment,0,,32.77,9.95,,,,,-21.54,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,1,,0,Mixed,"MST, rape/sexual assault, child sexual abuse, intimate partner violence",High,"Katz LS, Douglas S, Zaleski K, et al. Comparing holographic reprocessing and prolonged exposure for women veterans with sexual trauma: a pilot randomized trial. J Contemp Psychother. 2014 Mar;44(1):9-19. doi: 10.1007/s10879-013-9248-6.",1548483,2019
katz2014_PCL_A_Baseline_Comp,Psychotherapy,PTSD,51,A,PTSD,,16,,Holographic reprocessing,Holographic reprocessing,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Self report,PCL,PCL,Completer,,mixed designed ANOVA with post-hoc comparisons,Baseline,,,54.31,13.57,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,1,,0,Mixed,"MST, rape/sexual assault, child sexual abuse, intimate partner violence",High,"Katz LS, Douglas S, Zaleski K, et al. Comparing holographic reprocessing and prolonged exposure for women veterans with sexual trauma: a pilot randomized trial. J Contemp Psychother. 2014 Mar;44(1):9-19. doi: 10.1007/s10879-013-9248-6.",1548483,2019
katz2014_PCL_B_0_Comp,Psychotherapy,PTSD,51,B,PTSD,,10,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Self report,PCL,PCL,Completer,,mixed designed ANOVA with post-hoc comparisons,End of Treatment,0,,47.9,22.69,,,,,-18.3,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,1,,0,Mixed,"MST, rape/sexual assault, child sexual abuse, intimate partner violence",High,"Katz LS, Douglas S, Zaleski K, et al. Comparing holographic reprocessing and prolonged exposure for women veterans with sexual trauma: a pilot randomized trial. J Contemp Psychother. 2014 Mar;44(1):9-19. doi: 10.1007/s10879-013-9248-6.",1548483,2019
katz2014_PCL_B_Baseline_Comp,Psychotherapy,PTSD,51,B,PTSD,,10,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Self report,PCL,PCL,Completer,,mixed designed ANOVA with post-hoc comparisons,Baseline,,,66.2,12.87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,1,,0,Mixed,"MST, rape/sexual assault, child sexual abuse, intimate partner violence",High,"Katz LS, Douglas S, Zaleski K, et al. Comparing holographic reprocessing and prolonged exposure for women veterans with sexual trauma: a pilot randomized trial. J Contemp Psychother. 2014 Mar;44(1):9-19. doi: 10.1007/s10879-013-9248-6.",1548483,2019
katz2014_PCL_C_0_Comp,Psychotherapy,PTSD,51,C,PTSD,,11,,Person-centered therapy,Person centered Therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Self report,PCL,PCL,Completer,,mixed designed ANOVA with post-hoc comparisons,End of Treatment,0,,49.13,23.4,,,,,-2.5,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,1,,0,Mixed,"MST, rape/sexual assault, child sexual abuse, intimate partner violence",High,"Katz LS, Douglas S, Zaleski K, et al. Comparing holographic reprocessing and prolonged exposure for women veterans with sexual trauma: a pilot randomized trial. J Contemp Psychother. 2014 Mar;44(1):9-19. doi: 10.1007/s10879-013-9248-6.",1548483,2019
katz2014_PCL_C_Baseline_Comp,Psychotherapy,PTSD,51,C,PTSD,,11,,Person-centered therapy,Person centered Therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Self report,PCL,PCL,Completer,,mixed designed ANOVA with post-hoc comparisons,Baseline,,,51.63,17.76,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,1,,0,Mixed,"MST, rape/sexual assault, child sexual abuse, intimate partner violence",High,"Katz LS, Douglas S, Zaleski K, et al. Comparing holographic reprocessing and prolonged exposure for women veterans with sexual trauma: a pilot randomized trial. J Contemp Psychother. 2014 Mar;44(1):9-19. doi: 10.1007/s10879-013-9248-6.",1548483,2019
keane1989_MMPI_A_0_NA,Psychotherapy,PTSD,24,A,PTSD,,11,,Implosive therapy,Implosive Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,MMPI,MMPI - PTSD subscale,,,Two-way univariate repeated measures ANOVA with two-tailed t-tests; chi-squared analyses for categorical variables,End of Treatment,0,,28.8,15,,,,,-7.6,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Keane TM, Fairbank JA, Caddell JM, et al. Implosive (flooding) therapy reduces symptoms of PTSD in Vietnam combat veterans. Behav Ther. 1989 Spring;20(2):245-60. doi: 10.1016/S0005-7894(89)80072-3.",01015,2019
keane1989_MMPI_A_26_NA,Psychotherapy,PTSD,24,A,PTSD,,11,,Implosive therapy,Implosive Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,MMPI,MMPI - PTSD subscale,,,Two-way univariate repeated measures ANOVA with two-tailed t-tests; chi-squared analyses for categorical variables,Assessment at 6 to <12 Months,26,,29.1,15.5,,,,,-7.3,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Keane TM, Fairbank JA, Caddell JM, et al. Implosive (flooding) therapy reduces symptoms of PTSD in Vietnam combat veterans. Behav Ther. 1989 Spring;20(2):245-60. doi: 10.1016/S0005-7894(89)80072-3.",01015,2019
keane1989_MMPI_A_Baseline_NA,Psychotherapy,PTSD,24,A,PTSD,,11,,Implosive therapy,Implosive Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,MMPI,MMPI - PTSD subscale,,,Two-way univariate repeated measures ANOVA with two-tailed t-tests; chi-squared analyses for categorical variables,Baseline,,,36.4,10.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Keane TM, Fairbank JA, Caddell JM, et al. Implosive (flooding) therapy reduces symptoms of PTSD in Vietnam combat veterans. Behav Ther. 1989 Spring;20(2):245-60. doi: 10.1016/S0005-7894(89)80072-3.",01015,2019
keane1989_MMPI_B_0_NA,Psychotherapy,PTSD,24,B,Control,,13,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,13,Self report,MMPI,MMPI - PTSD subscale,,,Two-way univariate repeated measures ANOVA with two-tailed t-tests; chi-squared analyses for categorical variables,End of Treatment,0,,31.9,12,,,,,-4.6,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Keane TM, Fairbank JA, Caddell JM, et al. Implosive (flooding) therapy reduces symptoms of PTSD in Vietnam combat veterans. Behav Ther. 1989 Spring;20(2):245-60. doi: 10.1016/S0005-7894(89)80072-3.",01015,2019
keane1989_MMPI_B_Baseline_NA,Psychotherapy,PTSD,24,B,Control,,13,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,13,Self report,MMPI,MMPI - PTSD subscale,,,Two-way univariate repeated measures ANOVA with two-tailed t-tests; chi-squared analyses for categorical variables,Baseline,,,36.5,6.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Keane TM, Fairbank JA, Caddell JM, et al. Implosive (flooding) therapy reduces symptoms of PTSD in Vietnam combat veterans. Behav Ther. 1989 Spring;20(2):245-60. doi: 10.1016/S0005-7894(89)80072-3.",01015,2019
kearney2013_PCL_A_0_Comp,Complementary and integrative health (CIH),PTSD,47,A,PTSD,,21,,MBSR,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,25,Self report,PCL,PCL,Completer,,Cohen's d for change in mean scores,End of Treatment,0,,52,13.1,,,,,-7,,,,,,,,,,,,,,,,,,,,,≥10-point change on PCL,,,Veteran,,1,,0.2128,,0.7872,,,Medium,"Kearney DJ, McDermott K, Malte C, et al. Effects of participation in a mindfulness program for veterans with posttraumatic stress disorder: a randomized controlled pilot study. J Clin Psychol. 2013 Jan;69(1):14-27. doi: 10.1002/jclp.21911. PMID: 22930491.",39341,2019
kearney2013_PCL_A_0_ITT,Complementary and integrative health (CIH),PTSD,47,A,PTSD,,25,,MBSR,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,25,Self report,PCL,PCL,ITT,,Cohen's d for change in mean scores,End of Treatment,0,,52.45,13,,,,,-7.43,,,,,Cohen's d,-0.63,95% CI,-1.22,-0.05,p=0.035,,,,,,,,,,,≥10-point change on PCL,0.3478,,Veteran,,1,,0.2128,,0.7872,,,Medium,"Kearney DJ, McDermott K, Malte C, et al. Effects of participation in a mindfulness program for veterans with posttraumatic stress disorder: a randomized controlled pilot study. J Clin Psychol. 2013 Jan;69(1):14-27. doi: 10.1002/jclp.21911. PMID: 22930491.",39341,2019
kearney2013_PCL_A_16_Comp,Complementary and integrative health (CIH),PTSD,47,A,PTSD,,21,,MBSR,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,25,Self report,PCL,PCL,Completer,,Cohen's d for change in mean scores,Assessment at 3 to <6 Months,16,,54,14.8,,,,,-5,,,,,,,,,,,,,,,,,,,,,≥10-point change on PCL,,,Veteran,,1,,0.2128,,0.7872,,,Medium,"Kearney DJ, McDermott K, Malte C, et al. Effects of participation in a mindfulness program for veterans with posttraumatic stress disorder: a randomized controlled pilot study. J Clin Psychol. 2013 Jan;69(1):14-27. doi: 10.1002/jclp.21911. PMID: 22930491.",39341,2019
kearney2013_PCL_A_16_ITT,Complementary and integrative health (CIH),PTSD,47,A,PTSD,,25,,MBSR,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,25,Self report,PCL,PCL,ITT,,Cohen's d for change in mean scores,Assessment at 3 to <6 Months,16,,54.43,15,,,,,-5.45,,,,,,,,,,p>0.05,,,,,,,,,,,≥10-point change on PCL,0.3913,,Veteran,,1,,0.2128,,0.7872,,,Medium,"Kearney DJ, McDermott K, Malte C, et al. Effects of participation in a mindfulness program for veterans with posttraumatic stress disorder: a randomized controlled pilot study. J Clin Psychol. 2013 Jan;69(1):14-27. doi: 10.1002/jclp.21911. PMID: 22930491.",39341,2019
kearney2013_PCL_A_Baseline_Comp,Complementary and integrative health (CIH),PTSD,47,A,PTSD,,21,,MBSR,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,25,Self report,PCL,PCL,Completer,,Cohen's d for change in mean scores,Baseline,,,59,11.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.2128,,0.7872,,,Medium,"Kearney DJ, McDermott K, Malte C, et al. Effects of participation in a mindfulness program for veterans with posttraumatic stress disorder: a randomized controlled pilot study. J Clin Psychol. 2013 Jan;69(1):14-27. doi: 10.1002/jclp.21911. PMID: 22930491.",39341,2019
kearney2013_PCL_A_Baseline_ITT,Complementary and integrative health (CIH),PTSD,47,A,PTSD,,25,,MBSR,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,25,Self report,PCL,PCL,ITT,,Cohen's d for change in mean scores,Baseline,,,59.88,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.2128,,0.7872,,,Medium,"Kearney DJ, McDermott K, Malte C, et al. Effects of participation in a mindfulness program for veterans with posttraumatic stress disorder: a randomized controlled pilot study. J Clin Psychol. 2013 Jan;69(1):14-27. doi: 10.1002/jclp.21911. PMID: 22930491.",39341,2019
kearney2013_PCL_B_0_ITT,Complementary and integrative health (CIH),PTSD,47,B,Control,,22,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,22,Self report,PCL,PCL,ITT,,Cohen's d for change in mean scores,End of Treatment,0,,58.5,11,,,,,-4.4,,,,,,,,,,p>0.05,,,,,,,,,,,≥10-point change on PCL,0.25,,Veteran,,1,,0.2128,,0.7872,,,Medium,"Kearney DJ, McDermott K, Malte C, et al. Effects of participation in a mindfulness program for veterans with posttraumatic stress disorder: a randomized controlled pilot study. J Clin Psychol. 2013 Jan;69(1):14-27. doi: 10.1002/jclp.21911. PMID: 22930491.",39341,2019
kearney2013_PCL_B_16_ITT,Complementary and integrative health (CIH),PTSD,47,B,Control,,22,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,22,Self report,PCL,PCL,ITT,,Cohen's d for change in mean scores,Assessment at 3 to <6 Months,16,,60.16,13,,,,,-2.75,,,,,,,,,,p>0.05,,,,,,,,,,,≥10-point change on PCL,0.2632,,Veteran,,1,,0.2128,,0.7872,,,Medium,"Kearney DJ, McDermott K, Malte C, et al. Effects of participation in a mindfulness program for veterans with posttraumatic stress disorder: a randomized controlled pilot study. J Clin Psychol. 2013 Jan;69(1):14-27. doi: 10.1002/jclp.21911. PMID: 22930491.",39341,2019
kearney2013_PCL_B_Baseline_Comp,Complementary and integrative health (CIH),PTSD,47,B,Control,,22,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,22,Self report,PCL,PCL,Completer,,Cohen's d for change in mean scores,Baseline,,,62.91,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.2128,,0.7872,,,Medium,"Kearney DJ, McDermott K, Malte C, et al. Effects of participation in a mindfulness program for veterans with posttraumatic stress disorder: a randomized controlled pilot study. J Clin Psychol. 2013 Jan;69(1):14-27. doi: 10.1002/jclp.21911. PMID: 22930491.",39341,2019
kearney2013_PCL_B_Baseline_ITT,Complementary and integrative health (CIH),PTSD,47,B,Control,,22,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,22,Self report,PCL,PCL,ITT,,Cohen's d for change in mean scores,Baseline,,,62.91,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.2128,,0.7872,,,Medium,"Kearney DJ, McDermott K, Malte C, et al. Effects of participation in a mindfulness program for veterans with posttraumatic stress disorder: a randomized controlled pilot study. J Clin Psychol. 2013 Jan;69(1):14-27. doi: 10.1002/jclp.21911. PMID: 22930491.",39341,2019
kearney2016_PSS-I_A_0_Comp,Complementary and integrative health (CIH),PTSD,55,A,PTSD,,19,,MBSR + TAU,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In person,26,Structured Clinical Interview,PSS-I,PSS-I,Completer,Linear mixed-effects models,Cohen's d for change in mean scores,End of Treatment,0,,19.1,9.1,,,,,-9.2,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1455,,0.8545,,,Medium,"Kearney DJ, Simpson TL, Malte CA, et al. Mindfulness-based stress reduction in addition to usual care is associated with improvements in pain, fatigue, and cognitive failures among veterans with Gulf War illness. Am J Med. 2016 Feb;129(2):204-14. doi: 10.1016/j.amjmed.2015.09.015. PMID: 26519614.",45996,2020
kearney2016_PSS-I_A_0_ITT,Complementary and integrative health (CIH),PTSD,55,A,PTSD,,21,,MBSR + TAU,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In person,26,Structured Clinical Interview,PSS-I,PSS-I,ITT,Linear mixed-effects models,Cohen's d for change in mean scores,End of Treatment,0,,20.7,9.1,,,,,-8.3,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1455,,0.8545,,,Medium,"Kearney DJ, Simpson TL, Malte CA, et al. Mindfulness-based stress reduction in addition to usual care is associated with improvements in pain, fatigue, and cognitive failures among veterans with Gulf War illness. Am J Med. 2016 Feb;129(2):204-14. doi: 10.1016/j.amjmed.2015.09.015. PMID: 26519614.",45996,2020
kearney2016_PSS-I_A_26_Comp,Complementary and integrative health (CIH),PTSD,55,A,PTSD,,19,,MBSR + TAU,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In person,26,Structured Clinical Interview,PSS-I,PSS-I,Completer,Linear mixed-effects models,Cohen's d for change in mean scores,Assessment at 6 to <12 Months,26,,20.4,11.5,,,,,-7.9,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1455,,0.8545,,,Medium,"Kearney DJ, Simpson TL, Malte CA, et al. Mindfulness-based stress reduction in addition to usual care is associated with improvements in pain, fatigue, and cognitive failures among veterans with Gulf War illness. Am J Med. 2016 Feb;129(2):204-14. doi: 10.1016/j.amjmed.2015.09.015. PMID: 26519614.",45996,2020
kearney2016_PSS-I_A_26_ITT,Complementary and integrative health (CIH),PTSD,55,A,PTSD,,22,,MBSR + TAU,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In person,26,Structured Clinical Interview,PSS-I,PSS-I,ITT,Linear mixed-effects models,Cohen's d for change in mean scores,Assessment at 6 to <12 Months,26,,21.7,10.8,,,,,-7.3,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1455,,0.8545,,,Medium,"Kearney DJ, Simpson TL, Malte CA, et al. Mindfulness-based stress reduction in addition to usual care is associated with improvements in pain, fatigue, and cognitive failures among veterans with Gulf War illness. Am J Med. 2016 Feb;129(2):204-14. doi: 10.1016/j.amjmed.2015.09.015. PMID: 26519614.",45996,2020
kearney2016_PSS-I_A_Baseline_Comp,Complementary and integrative health (CIH),PTSD,55,A,PTSD,,19,,MBSR + TAU,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In person,26,Structured Clinical Interview,PSS-I,PSS-I,Completer,Linear mixed-effects models,Cohen's d for change in mean scores,Baseline,,,28.3,12.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1455,,0.8545,,,Medium,"Kearney DJ, Simpson TL, Malte CA, et al. Mindfulness-based stress reduction in addition to usual care is associated with improvements in pain, fatigue, and cognitive failures among veterans with Gulf War illness. Am J Med. 2016 Feb;129(2):204-14. doi: 10.1016/j.amjmed.2015.09.015. PMID: 26519614.",45996,2020
kearney2016_PSS-I_A_Baseline_ITT,Complementary and integrative health (CIH),PTSD,55,A,PTSD,,26,,MBSR + TAU,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In person,26,Structured Clinical Interview,PSS-I,PSS-I,ITT,Linear mixed-effects models,Cohen's d for change in mean scores,Baseline,,,29.0,11.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1455,,0.8545,,,Medium,"Kearney DJ, Simpson TL, Malte CA, et al. Mindfulness-based stress reduction in addition to usual care is associated with improvements in pain, fatigue, and cognitive failures among veterans with Gulf War illness. Am J Med. 2016 Feb;129(2):204-14. doi: 10.1016/j.amjmed.2015.09.015. PMID: 26519614.",45996,2020
kearney2016_PSS-I_B_0_ITT,Complementary and integrative health (CIH),PTSD,55,B,Control,,26,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,29,Structured Clinical Interview,PSS-I,PSS-I,ITT,Linear mixed-effects models,Cohen's d for change in mean scores,End of Treatment,0,,24.7,10.2,,,,,-1.5,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1455,,0.8545,,,Medium,"Kearney DJ, Simpson TL, Malte CA, et al. Mindfulness-based stress reduction in addition to usual care is associated with improvements in pain, fatigue, and cognitive failures among veterans with Gulf War illness. Am J Med. 2016 Feb;129(2):204-14. doi: 10.1016/j.amjmed.2015.09.015. PMID: 26519614.",45996,2020
kearney2016_PSS-I_B_26_ITT,Complementary and integrative health (CIH),PTSD,55,B,Control,,23,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,29,Structured Clinical Interview,PSS-I,PSS-I,ITT,Linear mixed-effects models,Cohen's d for change in mean scores,Assessment at 6 to <12 Months,26,,23.6,10.7,,,,,-2.6,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1455,,0.8545,,,Medium,"Kearney DJ, Simpson TL, Malte CA, et al. Mindfulness-based stress reduction in addition to usual care is associated with improvements in pain, fatigue, and cognitive failures among veterans with Gulf War illness. Am J Med. 2016 Feb;129(2):204-14. doi: 10.1016/j.amjmed.2015.09.015. PMID: 26519614.",45996,2020
kearney2016_PSS-I_B_Baseline_ITT,Complementary and integrative health (CIH),PTSD,55,B,Control,,29,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,29,Structured Clinical Interview,PSS-I,PSS-I,ITT,Linear mixed-effects models,Cohen's d for change in mean scores,Baseline,,,26.2,10.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1455,,0.8545,,,Medium,"Kearney DJ, Simpson TL, Malte CA, et al. Mindfulness-based stress reduction in addition to usual care is associated with improvements in pain, fatigue, and cognitive failures among veterans with Gulf War illness. Am J Med. 2016 Feb;129(2):204-14. doi: 10.1016/j.amjmed.2015.09.015. PMID: 26519614.",45996,2020
kehleforbes2019_PCL_A_0_ITT,Psychotherapy,PTSD+SUD,183,A,PTSD+SUD,Integrated,,,Integrated MET + PE,Integrated Motivational Enhancement Therapy (MET) + Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,95,Self report,PCL,PCL,ITT,Mixed-effects regression analyses,Cohen's d for change in mean scores,End of Treatment,0,,55.50,17.57,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0765,,0.9235,,,Medium,"Kehle-Forbes SM, Chen S, Polusny MA, et al. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders. Drug Alcohol Depend. 2019 Dec 1;205:107647. doi: 10.1016/j.drugalcdep.2019.107647. PMID: 31675546.",,2020
kehleforbes2019_PCL_A_26_ITT,Psychotherapy,PTSD+SUD,183,A,PTSD+SUD,Integrated,,,Integrated MET + PE,Integrated Motivational Enhancement Therapy (MET) + Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,95,Self report,PCL,PCL,ITT,Mixed-effects regression analyses,Cohen's d for change in mean scores,Assessment at 6 to <12 Months,26,,56.57,17.96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0765,,0.9235,,,Medium,"Kehle-Forbes SM, Chen S, Polusny MA, et al. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders. Drug Alcohol Depend. 2019 Dec 1;205:107647. doi: 10.1016/j.drugalcdep.2019.107647. PMID: 31675546.",,2020
kehleforbes2019_PCL_A_Baseline_ITT,Psychotherapy,PTSD+SUD,183,A,PTSD+SUD,Integrated,,,Integrated MET + PE,Integrated Motivational Enhancement Therapy (MET) + Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,95,Self report,PCL,PCL,ITT,Mixed-effects regression analyses,Cohen's d for change in mean scores,Baseline,,,62.5,11.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0765,,0.9235,,,Medium,"Kehle-Forbes SM, Chen S, Polusny MA, et al. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders. Drug Alcohol Depend. 2019 Dec 1;205:107647. doi: 10.1016/j.drugalcdep.2019.107647. PMID: 31675546.",,2020
kehleforbes2019_PCL_B_0_ITT,Psychotherapy,PTSD+SUD,183,B,PTSD+SUD,Not integrated,,,Phased MET + PE,Phased Motivational Enhancement Therapy (MET) + Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,88,Self report,PCL,PCL,ITT,Mixed-effects regression analyses,Cohen's d for change in mean scores,End of Treatment,0,,54.12,17.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0765,,0.9235,,,Medium,"Kehle-Forbes SM, Chen S, Polusny MA, et al. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders. Drug Alcohol Depend. 2019 Dec 1;205:107647. doi: 10.1016/j.drugalcdep.2019.107647. PMID: 31675546.",,2020
kehleforbes2019_PCL_B_26_ITT,Psychotherapy,PTSD+SUD,183,B,PTSD+SUD,Not integrated,,,Phased MET + PE,Phased Motivational Enhancement Therapy (MET) + Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,88,Self report,PCL,PCL,ITT,Mixed-effects regression analyses,Cohen's d for change in mean scores,Assessment at 6 to <12 Months,26,,53.39,17.22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0765,,0.9235,,,Medium,"Kehle-Forbes SM, Chen S, Polusny MA, et al. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders. Drug Alcohol Depend. 2019 Dec 1;205:107647. doi: 10.1016/j.drugalcdep.2019.107647. PMID: 31675546.",,2020
kehleforbes2019_PCL_B_Baseline_ITT,Psychotherapy,PTSD+SUD,183,B,PTSD+SUD,Not integrated,,,Phased MET + PE,Phased Motivational Enhancement Therapy (MET) + Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,88,Self report,PCL,PCL,ITT,Mixed-effects regression analyses,Cohen's d for change in mean scores,Baseline,,,63.6,10.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0765,,0.9235,,,Medium,"Kehle-Forbes SM, Chen S, Polusny MA, et al. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders. Drug Alcohol Depend. 2019 Dec 1;205:107647. doi: 10.1016/j.drugalcdep.2019.107647. PMID: 31675546.",,2020
kehleforbes2019_PSS-I_A_0_ITT,Psychotherapy,PTSD+SUD,183,A,PTSD+SUD,Integrated,80,,Integrated MET + PE,Integrated Motivational Enhancement Therapy (MET) + Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,95,Structured Clinical Interview,PSS-I,PSS-I,ITT,Mixed-effects regression analyses,Cohen's d for change in mean scores,End of Treatment,0,,26.01,12.79,,,,,-9.79,,,,Endpoint difference,Cohen's d,0.99,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0765,,0.9235,,,Medium,"Kehle-Forbes SM, Chen S, Polusny MA, et al. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders. Drug Alcohol Depend. 2019 Dec 1;205:107647. doi: 10.1016/j.drugalcdep.2019.107647. PMID: 31675546.",,2020
kehleforbes2019_PSS-I_A_Baseline_ITT,Psychotherapy,PTSD+SUD,183,A,PTSD+SUD,Integrated,95,,Integrated MET + PE,Integrated Motivational Enhancement Therapy (MET) + Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,95,Structured Clinical Interview,PSS-I,PSS-I,ITT,Mixed-effects regression analyses,Cohen's d for change in mean scores,Baseline,,,35.8,6.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0765,,0.9235,,,Medium,"Kehle-Forbes SM, Chen S, Polusny MA, et al. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders. Drug Alcohol Depend. 2019 Dec 1;205:107647. doi: 10.1016/j.drugalcdep.2019.107647. PMID: 31675546.",,2020
kehleforbes2019_PSS-I_B_0_ITT,Psychotherapy,PTSD+SUD,183,B,PTSD+SUD,Not integrated,77,,Phased MET + PE,Phased Motivational Enhancement Therapy (MET) + Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,88,Structured Clinical Interview,PSS-I,PSS-I,ITT,Mixed-effects regression analyses,Cohen's d for change in mean scores,End of Treatment,0,,26.43,12.7,,,,,-10.47,,,,Endpoint difference,Cohen's d,1.05,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0765,,0.9235,,,Medium,"Kehle-Forbes SM, Chen S, Polusny MA, et al. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders. Drug Alcohol Depend. 2019 Dec 1;205:107647. doi: 10.1016/j.drugalcdep.2019.107647. PMID: 31675546.",,2020
kehleforbes2019_PSS-I_B_Baseline_ITT,Psychotherapy,PTSD+SUD,183,B,PTSD+SUD,Not integrated,88,,Phased MET + PE,Phased Motivational Enhancement Therapy (MET) + Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,88,Structured Clinical Interview,PSS-I,PSS-I,ITT,Mixed-effects regression analyses,Cohen's d for change in mean scores,Baseline,,,36.9,6.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0765,,0.9235,,,Medium,"Kehle-Forbes SM, Chen S, Polusny MA, et al. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders. Drug Alcohol Depend. 2019 Dec 1;205:107647. doi: 10.1016/j.drugalcdep.2019.107647. PMID: 31675546.",,2020
kent2011_PDS_A_0_ITT,Psychotherapy,PTSD,39,A,PTSD,,20,,Resilience-oriented treatment,Resilience-oriented treatment,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,20,Self report,PDS,PDS,ITT,BOCF,Repeated measures ANOVA with t-tests for within-group change; Cohen's d effect sizes,End of Treatment,0,,23,12.23,,,,,-12.9,,,,,,,,,,p<0.02,,,,,,,,,,,,,,Veteran,0,1,0,0.33,,0.67,Mixed,"combat-related, child physical abuse, child other abuse, rape/sexual assault, accidents, community/school violence",Medium,"Kent M, Davis MC, Stark SL, et al. A resilience-oriented treatment for posttraumatic stress disorder: results of a preliminary randomized clinical trial. J Trauma Stress. 2011 Oct;24(5):591-5. doi: 10.1002/jts.20685. PMID: 21898603.",85582,2019
kent2011_PDS_A_Baseline_ITT,Psychotherapy,PTSD,39,A,PTSD,,20,,Resilience-oriented treatment,Resilience-oriented treatment,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,20,Self report,PDS,PDS,ITT,BOCF,Repeated measures ANOVA with t-tests for within-group change; Cohen's d effect sizes,Baseline,,,35.9,9.49,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.33,,0.67,Mixed,"combat-related, child physical abuse, child other abuse, rape/sexual assault, accidents, community/school violence",Medium,"Kent M, Davis MC, Stark SL, et al. A resilience-oriented treatment for posttraumatic stress disorder: results of a preliminary randomized clinical trial. J Trauma Stress. 2011 Oct;24(5):591-5. doi: 10.1002/jts.20685. PMID: 21898603.",85582,2019
kent2011_PDS_B_0_ITT,Psychotherapy,PTSD,39,B,Control,,19,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,19,Self report,PDS,PDS,ITT,BOCF,Repeated measures ANOVA with t-tests for within-group change; Cohen's d effect sizes,End of Treatment,0,,36.9,9.65,,,,,-0.63,,,,,,,,,,p>0.09,,,,,,,,,,,,,,Veteran,0,1,0,0.33,,0.67,Mixed,"combat-related, child physical abuse, child other abuse, rape/sexual assault, accidents, community/school violence",Medium,"Kent M, Davis MC, Stark SL, et al. A resilience-oriented treatment for posttraumatic stress disorder: results of a preliminary randomized clinical trial. J Trauma Stress. 2011 Oct;24(5):591-5. doi: 10.1002/jts.20685. PMID: 21898603.",85582,2019
kent2011_PDS_B_Baseline_ITT,Psychotherapy,PTSD,39,B,Control,,19,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,19,Self report,PDS,PDS,ITT,BOCF,Repeated measures ANOVA with t-tests for within-group change; Cohen's d effect sizes,Baseline,,,37.53,9.77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.33,,0.67,Mixed,"combat-related, child physical abuse, child other abuse, rape/sexual assault, accidents, community/school violence",Medium,"Kent M, Davis MC, Stark SL, et al. A resilience-oriented treatment for posttraumatic stress disorder: results of a preliminary randomized clinical trial. J Trauma Stress. 2011 Oct;24(5):591-5. doi: 10.1002/jts.20685. PMID: 21898603.",85582,2019
kip2013_PCL_A_0_Comp,Psychotherapy,PTSD,57,A,PTSD,,26,,Accelerated Resolution Therapy,Accelerated Resolution Therapy (ART),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Self report,PCL,PCL-M,Completer,,ANCOVA for change in mean scores,End of Treatment,0,,40.2,,,,,,-17.2,13.4,,,,,,,,,,,,,,,,,,,,≥10-point reduction on PCL-M,0.6538,,Mixed,0.2982,0.7018,0,0.193,,0.807,Mixed,"MST, combat-related, community/school violence",Medium,"Kip KE, Rosenzweig L, Hernandez DF, et al. Randomized controlled trial of Accelerated Resolution Therapy (ART) for symptoms of combat-related post-traumatic stress disorder (PTSD). Mil Med. 2013 Dec;178(12):1298-309. doi: 10.7205/MILMED-D-13-00298. PMID: 24306011.",88001,2019
kip2013_PCL_A_0_ITT,Psychotherapy,PTSD,57,A,PTSD,,29,,Accelerated Resolution Therapy,Accelerated Resolution Therapy (ART),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Self report,PCL,PCL-M,ITT,assume mean difference of 0 from baseline to post-treatment assessment,ANCOVA for change in mean scores,End of Treatment,0,,42,,,,,,-15.4,13.7,,,,,,,,,,,,,,,,,,,,≥10-point reduction on PCL-M,0.5862,,Mixed,0.2982,0.7018,0,0.193,,0.807,Mixed,"MST, combat-related, community/school violence",Medium,"Kip KE, Rosenzweig L, Hernandez DF, et al. Randomized controlled trial of Accelerated Resolution Therapy (ART) for symptoms of combat-related post-traumatic stress disorder (PTSD). Mil Med. 2013 Dec;178(12):1298-309. doi: 10.7205/MILMED-D-13-00298. PMID: 24306011.",88001,2019
kip2013_PCL_A_Baseline_ITT,Psychotherapy,PTSD,57,A,PTSD,,29,,Accelerated Resolution Therapy,Accelerated Resolution Therapy (ART),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Self report,PCL,PCL-M,ITT,assume mean difference of 0 from baseline to post-treatment assessment,ANCOVA for change in mean scores,Baseline,,,57.4,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.2982,0.7018,0,0.193,,0.807,Mixed,"MST, combat-related, community/school violence",Medium,"Kip KE, Rosenzweig L, Hernandez DF, et al. Randomized controlled trial of Accelerated Resolution Therapy (ART) for symptoms of combat-related post-traumatic stress disorder (PTSD). Mil Med. 2013 Dec;178(12):1298-309. doi: 10.7205/MILMED-D-13-00298. PMID: 24306011.",88001,2019
kip2013_PCL_B_0_Comp,Psychotherapy,PTSD,57,B,Control,,24,,Attention Control,Fitness/career assessment and planning,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,28,Self report,PCL,PCL-M,Completer,,ANCOVA for change in mean scores,End of Treatment,0,,53.9,,,,,,-2.5,6,,,,,,,,,,,,,,,,,,,,≥10-point reduction on PCL-M,0.125,,Mixed,0.2982,0.7018,0,0.193,,0.807,Mixed,"MST, combat-related, community/school violence",Medium,"Kip KE, Rosenzweig L, Hernandez DF, et al. Randomized controlled trial of Accelerated Resolution Therapy (ART) for symptoms of combat-related post-traumatic stress disorder (PTSD). Mil Med. 2013 Dec;178(12):1298-309. doi: 10.7205/MILMED-D-13-00298. PMID: 24306011.",88001,2019
kip2013_PCL_B_0_ITT,Psychotherapy,PTSD,57,B,Control,,28,,Attention Control,Fitness/career assessment and planning,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,28,Self report,PCL,PCL-M,ITT,assume mean difference of 0 from baseline to post-treatment assessment,ANCOVA for change in mean scores,End of Treatment,0,,54.3,,,,,,-2.1,5.6,,,,,,,,,,,,,,,,,,,,≥10-point reduction on PCL-M,0.1071,,Mixed,0.2982,0.7018,0,0.193,,0.807,Mixed,"MST, combat-related, community/school violence",Medium,"Kip KE, Rosenzweig L, Hernandez DF, et al. Randomized controlled trial of Accelerated Resolution Therapy (ART) for symptoms of combat-related post-traumatic stress disorder (PTSD). Mil Med. 2013 Dec;178(12):1298-309. doi: 10.7205/MILMED-D-13-00298. PMID: 24306011.",88001,2019
kip2013_PCL_B_Baseline_ITT,Psychotherapy,PTSD,57,B,Control,,28,,Attention Control,Fitness/career assessment and planning,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,28,Self report,PCL,PCL-M,ITT,assume mean difference of 0 from baseline to post-treatment assessment,ANCOVA for change in mean scores,Baseline,,,56.4,15.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.2982,0.7018,0,0.193,,0.807,Mixed,"MST, combat-related, community/school violence",Medium,"Kip KE, Rosenzweig L, Hernandez DF, et al. Randomized controlled trial of Accelerated Resolution Therapy (ART) for symptoms of combat-related post-traumatic stress disorder (PTSD). Mil Med. 2013 Dec;178(12):1298-309. doi: 10.7205/MILMED-D-13-00298. PMID: 24306011.",88001,2019
knaevelsrud2015_PDS_A_0_Comp,Psychotherapy,PTSD,159,A,PTSD,,47,,Interapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Technology Assisted,79,Self report,PDS,PDS,Completer,,"ANOVA, chi-squared test",End of Treatment,0,,13.96,10.75,,,,,-16.91,,,,,,,,,,p<0.05,,,,,,,,PDS score <20,0.6596,,PDS score <20,0.617,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.7233,,0.2767,Mixed,"terrorism/political violence/forced displacement, rape/sexual assault, community/school violence",High,"Knaevelsrud C, Brand J, Lange A, et al. Web-based psychotherapy for posttraumatic stress disorder in war-traumatized Arab patients: randomized controlled trial. J Med Internet Res. 2015 Mar 20;17(3):e71. doi: 10.2196/jmir.3582. PMID: 25799024.",46782,2019
knaevelsrud2015_PDS_A_0_ITT,Psychotherapy,PTSD,159,A,PTSD,,79,,Interapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Technology Assisted,79,Self report,PDS,PDS,ITT,LOCF,"ANOVA, chi-squared test",End of Treatment,0,,20.29,12.45,,,,,-10.06,,,,,,,,,,p<0.05,,,,,,,,PDS score <20,,,PDS score <20,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.7233,,0.2767,Mixed,"terrorism/political violence/forced displacement, rape/sexual assault, community/school violence",High,"Knaevelsrud C, Brand J, Lange A, et al. Web-based psychotherapy for posttraumatic stress disorder in war-traumatized Arab patients: randomized controlled trial. J Med Internet Res. 2015 Mar 20;17(3):e71. doi: 10.2196/jmir.3582. PMID: 25799024.",46782,2019
knaevelsrud2015_PDS_A_12_Comp,Psychotherapy,PTSD,159,A,PTSD,,28,,Interapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Technology Assisted,79,Self report,PDS,PDS,Completer,,"ANOVA, chi-squared test",Assessment at 3 to <6 Months,12,,10.89,7.91,,,,,-19.98,,,,,,,,,,p<0.05,,,,,,,,PDS score <20,0.8571,,PDS score <20,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.7233,,0.2767,Mixed,"terrorism/political violence/forced displacement, rape/sexual assault, community/school violence",High,"Knaevelsrud C, Brand J, Lange A, et al. Web-based psychotherapy for posttraumatic stress disorder in war-traumatized Arab patients: randomized controlled trial. J Med Internet Res. 2015 Mar 20;17(3):e71. doi: 10.2196/jmir.3582. PMID: 25799024.",46782,2019
knaevelsrud2015_PDS_A_12_ITT,Psychotherapy,PTSD,159,A,PTSD,,79,,Interapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Technology Assisted,79,Self report,PDS,PDS,ITT,LOCF,"ANOVA, chi-squared test",Assessment at 3 to <6 Months,12,,20.87,12.37,,,,,-9.48,,,,,,,,,,p<0.05,,,,,,,,PDS score <20,,,PDS score <20,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.7233,,0.2767,Mixed,"terrorism/political violence/forced displacement, rape/sexual assault, community/school violence",High,"Knaevelsrud C, Brand J, Lange A, et al. Web-based psychotherapy for posttraumatic stress disorder in war-traumatized Arab patients: randomized controlled trial. J Med Internet Res. 2015 Mar 20;17(3):e71. doi: 10.2196/jmir.3582. PMID: 25799024.",46782,2019
knaevelsrud2015_PDS_A_Baseline_Comp,Psychotherapy,PTSD,159,A,PTSD,,47,,Interapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Technology Assisted,79,Self report,PDS,PDS,Completer,,"ANOVA, chi-squared test",Baseline,,,30.87,8.13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7233,,0.2767,Mixed,"terrorism/political violence/forced displacement, rape/sexual assault, community/school violence",High,"Knaevelsrud C, Brand J, Lange A, et al. Web-based psychotherapy for posttraumatic stress disorder in war-traumatized Arab patients: randomized controlled trial. J Med Internet Res. 2015 Mar 20;17(3):e71. doi: 10.2196/jmir.3582. PMID: 25799024.",46782,2019
knaevelsrud2015_PDS_A_Baseline_ITT,Psychotherapy,PTSD,159,A,PTSD,,79,,Interapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Technology Assisted,79,Self report,PDS,PDS,ITT,LOCF,"ANOVA, chi-squared test",Baseline,,,30.35,8.16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7233,,0.2767,Mixed,"terrorism/political violence/forced displacement, rape/sexual assault, community/school violence",High,"Knaevelsrud C, Brand J, Lange A, et al. Web-based psychotherapy for posttraumatic stress disorder in war-traumatized Arab patients: randomized controlled trial. J Med Internet Res. 2015 Mar 20;17(3):e71. doi: 10.2196/jmir.3582. PMID: 25799024.",46782,2019
knaevelsrud2015_PDS_B_0_Comp,Psychotherapy,PTSD,159,B,Control,,47,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,80,Self report,PDS,PDS,Completer,,"ANOVA, chi-squared test",End of Treatment,0,,31,8.36,,,,,-0.81,,,,,,,,,,p>0.05,,,,,,,,PDS score <20,0.1064,,PDS score <20,0.0213,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.7233,,0.2767,Mixed,"terrorism/political violence/forced displacement, rape/sexual assault, community/school violence",High,"Knaevelsrud C, Brand J, Lange A, et al. Web-based psychotherapy for posttraumatic stress disorder in war-traumatized Arab patients: randomized controlled trial. J Med Internet Res. 2015 Mar 20;17(3):e71. doi: 10.2196/jmir.3582. PMID: 25799024.",46782,2019
knaevelsrud2015_PDS_B_0_ITT,Psychotherapy,PTSD,159,B,Control,,80,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,80,Self report,PDS,PDS,ITT,LOCF,"ANOVA, chi-squared test",End of Treatment,0,,30.17,8.7,,,,,-0.48,,,,,,,,,,p>0.05,,,,,,,,PDS score <20,,,PDS score <20,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.7233,,0.2767,Mixed,"terrorism/political violence/forced displacement, rape/sexual assault, community/school violence",High,"Knaevelsrud C, Brand J, Lange A, et al. Web-based psychotherapy for posttraumatic stress disorder in war-traumatized Arab patients: randomized controlled trial. J Med Internet Res. 2015 Mar 20;17(3):e71. doi: 10.2196/jmir.3582. PMID: 25799024.",46782,2019
knaevelsrud2015_PDS_B_Baseline_Comp,Psychotherapy,PTSD,159,B,Control,,47,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,80,Self report,PDS,PDS,Completer,,"ANOVA, chi-squared test",Baseline,,,31.81,7.13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7233,,0.2767,Mixed,"terrorism/political violence/forced displacement, rape/sexual assault, community/school violence",High,"Knaevelsrud C, Brand J, Lange A, et al. Web-based psychotherapy for posttraumatic stress disorder in war-traumatized Arab patients: randomized controlled trial. J Med Internet Res. 2015 Mar 20;17(3):e71. doi: 10.2196/jmir.3582. PMID: 25799024.",46782,2019
knaevelsrud2015_PDS_B_Baseline_ITT,Psychotherapy,PTSD,159,B,Control,,80,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,80,Self report,PDS,PDS,ITT,LOCF,"ANOVA, chi-squared test",Baseline,,,30.65,8.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7233,,0.2767,Mixed,"terrorism/political violence/forced displacement, rape/sexual assault, community/school violence",High,"Knaevelsrud C, Brand J, Lange A, et al. Web-based psychotherapy for posttraumatic stress disorder in war-traumatized Arab patients: randomized controlled trial. J Med Internet Res. 2015 Mar 20;17(3):e71. doi: 10.2196/jmir.3582. PMID: 25799024.",46782,2019
knaevelsrud2017_PDS_A_0_ITT,Psychotherapy,PTSD,94,A,PTSD,,41,,Integrative Testimonial Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Technology Assisted,47,Self report,PDS,PDS,ITT,Linear mixed-effects model,Linear mixed-effects and Cohen's d for change in mean score,End of Treatment,0,,15.19,,SE,1.35,,,-7.56,,,,,Cohen's d,0.84,,,,,,,,,,,,,,,,,,Community,,,1,0.6489,,0.3511,Terrorism/political violence/forced displacement,,Medium,"Knaevelsrud C, Böttche M, Pietrzak RH, et al. Efficacy and feasibility of a therapist-guided internet-based intervention for older persons with childhood traumatization: a randomized controlled trial. Am J Geriatr Psychiatry. 2017 Aug;25(8):878-88. doi: 10.1016/j.jagp.2017.02.024. PMID: 28365000.",47282,2019
knaevelsrud2017_PDS_A_12_ITT,Psychotherapy,PTSD,94,A,PTSD,,38,,Integrative Testimonial Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Technology Assisted,47,Self report,PDS,PDS,ITT,Linear mixed-effects model,Linear mixed-effects and Cohen's d for change in mean score,Assessment at 3 to <6 Months,12,,14.93,,SE,1.38,,,-7.82,,,,from posttreatment to 3-month followup,Cohen's d,0.03,95% CI,-0.38,0.43,,,,,,,,,,,,,,,Community,,,1,0.6489,,0.3511,Terrorism/political violence/forced displacement,,Medium,"Knaevelsrud C, Böttche M, Pietrzak RH, et al. Efficacy and feasibility of a therapist-guided internet-based intervention for older persons with childhood traumatization: a randomized controlled trial. Am J Geriatr Psychiatry. 2017 Aug;25(8):878-88. doi: 10.1016/j.jagp.2017.02.024. PMID: 28365000.",47282,2019
knaevelsrud2017_PDS_A_26_ITT,Psychotherapy,PTSD,94,A,PTSD,,36,,Integrative Testimonial Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Technology Assisted,47,Self report,PDS,PDS,ITT,Linear mixed-effects model,Linear mixed-effects and Cohen's d for change in mean score,Assessment at 6 to <12 Months,26,,12.26,,SE,1.4,,,-10.49,,,,from posttreatment to 6-month followup,Cohen's d,0.31,95% CI,-0.09,0.72,,,,,,,,,,,,,,,Community,,,1,0.6489,,0.3511,Terrorism/political violence/forced displacement,,Medium,"Knaevelsrud C, Böttche M, Pietrzak RH, et al. Efficacy and feasibility of a therapist-guided internet-based intervention for older persons with childhood traumatization: a randomized controlled trial. Am J Geriatr Psychiatry. 2017 Aug;25(8):878-88. doi: 10.1016/j.jagp.2017.02.024. PMID: 28365000.",47282,2019
knaevelsrud2017_PDS_A_52_ITT,Psychotherapy,PTSD,94,A,PTSD,,37,,Integrative Testimonial Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Technology Assisted,47,Self report,PDS,PDS,ITT,Linear mixed-effects model,Linear mixed-effects and Cohen's d for change in mean score,Assessment at ≥12 Months,52,,13.81,,SE,1.39,,,-8.94,,,,from posttreatment to 12-month followup,Cohen's d,0.15,95% CI,-0.26,0.55,,,,,,,,,,,,,,,Community,,,1,0.6489,,0.3511,Terrorism/political violence/forced displacement,,Medium,"Knaevelsrud C, Böttche M, Pietrzak RH, et al. Efficacy and feasibility of a therapist-guided internet-based intervention for older persons with childhood traumatization: a randomized controlled trial. Am J Geriatr Psychiatry. 2017 Aug;25(8):878-88. doi: 10.1016/j.jagp.2017.02.024. PMID: 28365000.",47282,2019
knaevelsrud2017_PDS_A_Baseline_ITT,Psychotherapy,PTSD,94,A,PTSD,,47,,Integrative Testimonial Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Technology Assisted,47,Self report,PDS,PDS,ITT,Linear mixed-effects model,Linear mixed-effects and Cohen's d for change in mean score,Baseline,,,22.75,,SE,1.29,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6489,,0.3511,Terrorism/political violence/forced displacement,,Medium,"Knaevelsrud C, Böttche M, Pietrzak RH, et al. Efficacy and feasibility of a therapist-guided internet-based intervention for older persons with childhood traumatization: a randomized controlled trial. Am J Geriatr Psychiatry. 2017 Aug;25(8):878-88. doi: 10.1016/j.jagp.2017.02.024. PMID: 28365000.",47282,2019
knaevelsrud2017_PDS_B_0_ITT,Psychotherapy,PTSD,94,B,Control,,44,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,47,Self report,PDS,PDS,ITT,Linear mixed-effects model,Linear mixed-effects and Cohen's d for change in mean score,End of Treatment,0,,19.02,,SE,1.34,,,-2.85,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6489,,0.3511,Terrorism/political violence/forced displacement,,Medium,"Knaevelsrud C, Böttche M, Pietrzak RH, et al. Efficacy and feasibility of a therapist-guided internet-based intervention for older persons with childhood traumatization: a randomized controlled trial. Am J Geriatr Psychiatry. 2017 Aug;25(8):878-88. doi: 10.1016/j.jagp.2017.02.024. PMID: 28365000.",47282,2019
knaevelsrud2017_PDS_B_Baseline_ITT,Psychotherapy,PTSD,94,B,Control,,47,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,47,Self report,PDS,PDS,ITT,Linear mixed-effects model,Linear mixed-effects and Cohen's d for change in mean score,Baseline,,,21.87,,SE,1.29,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6489,,0.3511,Terrorism/political violence/forced displacement,,Medium,"Knaevelsrud C, Böttche M, Pietrzak RH, et al. Efficacy and feasibility of a therapist-guided internet-based intervention for older persons with childhood traumatization: a randomized controlled trial. Am J Geriatr Psychiatry. 2017 Aug;25(8):878-88. doi: 10.1016/j.jagp.2017.02.024. PMID: 28365000.",47282,2019
koochaki2018_PSS_A_0_Comp,Psychotherapy,PTSD,90,A,PTSD,,42,,CBT for PTSD + routine care counseling,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,45,Self report,PSS,PSS,Completer,,Linear mixed-effects and Cohen's d for change in mean score,End of Treatment,0,,4.547,2.297,,,,,-3.548,,,,,,,,,,p=significant,,,,,,,,,,,,,,,,,,1,,0,Illness/medical procedure,,Medium,"Koochaki M, Mahmoodi Z, Esmaelzadeh–Saeieh S, et al. Effects of cognitive-behavioral counseling on posttraumatic stress disorder in mothers with infants hospitalized at neonatal intensive care units: a randomized controlled trial. Iran J Psychiatry Behav Sci. 2018;12(4):e65159. doi: 10.5812/ijpbs.65159.",,2020
koochaki2018_PSS_A_3_Comp,Psychotherapy,PTSD,90,A,PTSD,,42,,CBT for PTSD + routine care counseling,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,45,Self report,PSS,PSS,Completer,,Linear mixed-effects and Cohen's d for change in mean score,Assessment at <3 Months,3,,5.000,2.447,,,,,-3.095,,,,,,,,,,p=0.000,,,,,,,,,,,,,,,,,,1,,0,Illness/medical procedure,,Medium,"Koochaki M, Mahmoodi Z, Esmaelzadeh–Saeieh S, et al. Effects of cognitive-behavioral counseling on posttraumatic stress disorder in mothers with infants hospitalized at neonatal intensive care units: a randomized controlled trial. Iran J Psychiatry Behav Sci. 2018;12(4):e65159. doi: 10.5812/ijpbs.65159.",,2020
koochaki2018_PSS_A_Baseline_Comp,Psychotherapy,PTSD,90,A,PTSD,,42,,CBT for PTSD + routine care counseling,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,45,Self report,PSS,PSS,Completer,,Linear mixed-effects and Cohen's d for change in mean score,Baseline,,,8.095,5.202,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Illness/medical procedure,,Medium,"Koochaki M, Mahmoodi Z, Esmaelzadeh–Saeieh S, et al. Effects of cognitive-behavioral counseling on posttraumatic stress disorder in mothers with infants hospitalized at neonatal intensive care units: a randomized controlled trial. Iran J Psychiatry Behav Sci. 2018;12(4):e65159. doi: 10.5812/ijpbs.65159.",,2020
koochaki2018_PSS_B_0_Comp,Psychotherapy,PTSD,90,B,Control,,39,,PTSD educational packet + routine care counseling,PTSD educational packet + routine care counseling,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,45,Self report,PSS,PSS,Completer,,Linear mixed-effects and Cohen's d for change in mean score,End of Treatment,0,,6.564,4.29,,,,,-0.256,,,,,,,,,,p=significant,,,,,,,,,,,,,,,,,,1,,0,Illness/medical procedure,,Medium,"Koochaki M, Mahmoodi Z, Esmaelzadeh–Saeieh S, et al. Effects of cognitive-behavioral counseling on posttraumatic stress disorder in mothers with infants hospitalized at neonatal intensive care units: a randomized controlled trial. Iran J Psychiatry Behav Sci. 2018;12(4):e65159. doi: 10.5812/ijpbs.65159.",,2020
koochaki2018_PSS_B_3_Comp,Psychotherapy,PTSD,90,B,Control,,39,,PTSD educational packet + routine care counseling,PTSD educational packet + routine care counseling,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,45,Self report,PSS,PSS,Completer,,Linear mixed-effects and Cohen's d for change in mean score,Assessment at <3 Months,3,,14.205,4.856,,,,,7.385,,,,,,,,,,p=0.033,,,,,,,,,,,,,,,,,,1,,0,Illness/medical procedure,,Medium,"Koochaki M, Mahmoodi Z, Esmaelzadeh–Saeieh S, et al. Effects of cognitive-behavioral counseling on posttraumatic stress disorder in mothers with infants hospitalized at neonatal intensive care units: a randomized controlled trial. Iran J Psychiatry Behav Sci. 2018;12(4):e65159. doi: 10.5812/ijpbs.65159.",,2020
koochaki2018_PSS_B_Baseline_Comp,Psychotherapy,PTSD,90,B,Control,,39,,PTSD educational packet + routine care counseling,PTSD educational packet + routine care counseling,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,45,Self report,PSS,PSS,Completer,,Linear mixed-effects and Cohen's d for change in mean score,Baseline,,,6.820,4.297,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Illness/medical procedure,,Medium,"Koochaki M, Mahmoodi Z, Esmaelzadeh–Saeieh S, et al. Effects of cognitive-behavioral counseling on posttraumatic stress disorder in mothers with infants hospitalized at neonatal intensive care units: a randomized controlled trial. Iran J Psychiatry Behav Sci. 2018;12(4):e65159. doi: 10.5812/ijpbs.65159.",,2020
kosten1991_IES_A_0_ITT,Pharmacotherapy,PTSD,60,A,PTSD,,19,,Phenelzine,Phenelzine,No,Not Applicable,Yes,Antidepressant: MAOI,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Self report,IES,IES,ITT,LOCF,Linear mixed-effects and Cohen's d for change in mean score,End of Treatment,0,,17.0,11.3,,,,,-13.6,,,,,,,,,,,,,,,,,,,,,Improved rating on 5-point global assessment,0.6842,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Kosten TR, Frank JB, Dan E, et al. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis. 1991;179(6):366-70. PMID: 2051152.",02658,2019
kosten1991_IES_A_Baseline_ITT,Pharmacotherapy,PTSD,60,A,PTSD,,19,,Phenelzine,Phenelzine,No,Not Applicable,Yes,Antidepressant: MAOI,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Self report,IES,IES,ITT,LOCF,Linear mixed-effects and Cohen's d for change in mean score,Baseline,,,30.6,15.2,,,,,,,,,,,,,,,,,,,,,,,,,,Improved rating on 5-point global assessment,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Kosten TR, Frank JB, Dan E, et al. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis. 1991;179(6):366-70. PMID: 2051152.",02658,2019
kosten1991_IES_B_0_ITT,Pharmacotherapy,PTSD,60,B,PTSD,,23,,Imipramine,Imipramine,No,Not Applicable,Yes,Antidepressant: TCA,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Self report,IES,IES,ITT,LOCF,Linear mixed-effects and Cohen's d for change in mean score,End of Treatment,0,,27.4,16.3,,,,,-19.8,,,,,,,,,,,,,,,,,,,,,Improved rating on 5-point global assessment,0.6522,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Kosten TR, Frank JB, Dan E, et al. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis. 1991;179(6):366-70. PMID: 2051152.",02658,2019
kosten1991_IES_B_Baseline_ITT,Pharmacotherapy,PTSD,60,B,PTSD,,23,,Imipramine,Imipramine,No,Not Applicable,Yes,Antidepressant: TCA,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Self report,IES,IES,ITT,LOCF,Linear mixed-effects and Cohen's d for change in mean score,Baseline,,,36.5,16.7,,,,,,,,,,,,,,,,,,,,,,,,,,Improved rating on 5-point global assessment,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Kosten TR, Frank JB, Dan E, et al. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis. 1991;179(6):366-70. PMID: 2051152.",02658,2019
kosten1991_IES_C_0_ITT,Pharmacotherapy,PTSD,60,C,Control,,18,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,18,Self report,IES,IES,ITT,LOCF,Linear mixed-effects and Cohen's d for change in mean score,End of Treatment,0,,31.3,15,,,,,-1.3,,,,,,,,,,,,,,,,,,,,,Improved rating on 5-point global assessment,0.2778,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Kosten TR, Frank JB, Dan E, et al. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis. 1991;179(6):366-70. PMID: 2051152.",02658,2019
kosten1991_IES_C_Baseline_ITT,Pharmacotherapy,PTSD,60,C,Control,,18,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,18,Self report,IES,IES,ITT,LOCF,Linear mixed-effects and Cohen's d for change in mean score,Baseline,,,33.0,13.4,,,,,,,,,,,,,,,,,,,,,,,,,,Improved rating on 5-point global assessment,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Kosten TR, Frank JB, Dan E, et al. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis. 1991;179(6):366-70. PMID: 2051152.",02658,2019
kozel2018_CAPS_A_0_ITT,Other mixed,PTSD,103,A,PTSD,,31,(assessed after 9 sessions of CPT),rTMS + CPT,Transcranial magnetic stimulation (TMS) + Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,54,Structured Clinical Interview,CAPS,CAPS,ITT,Restricted maximum likelihood estimator,Mixed linear model and Cohen's d for change in mean scores,End of Treatment,0,,45.95,4.04,,,,,-28.77,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_CAPS_A_12_ITT,Other mixed,PTSD,103,A,PTSD,,29,,rTMS + CPT,Transcranial magnetic stimulation (TMS) + Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,54,Structured Clinical Interview,CAPS,CAPS,ITT,Restricted maximum likelihood estimator,Mixed linear model and Cohen's d for change in mean scores,Assessment at 3 to <6 Months,12,,30.32,4.07,,,,,-44.96,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_CAPS_A_26_ITT,Other mixed,PTSD,103,A,PTSD,,31,,rTMS + CPT,Transcranial magnetic stimulation (TMS) + Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,54,Structured Clinical Interview,CAPS,CAPS,ITT,Restricted maximum likelihood estimator,Mixed linear model and Cohen's d for change in mean scores,Assessment at 6 to <12 Months,26,,27.51,4.04,,,,,-47.77,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_CAPS_A_4_ITT,Other mixed,PTSD,103,A,PTSD,,31,,rTMS + CPT,Transcranial magnetic stimulation (TMS) + Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,54,Structured Clinical Interview,CAPS,CAPS,ITT,Restricted maximum likelihood estimator,Mixed linear model and Cohen's d for change in mean scores,Assessment at <3 Months,4,,31.11,4.04,,,,,-44.17,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_CAPS_A_Baseline_ITT,Other mixed,PTSD,103,A,PTSD,,54,,rTMS + CPT,Transcranial magnetic stimulation (TMS) + Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,54,Structured Clinical Interview,CAPS,CAPS,ITT,Restricted maximum likelihood estimator,Mixed linear model and Cohen's d for change in mean scores,Baseline,,,75.28,3.24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_CAPS_B_0_ITT,Other mixed,PTSD,103,B,Control,,30,(assessed after 9 sessions of CPT),Sham rTMS + CPT,Cognitive Processing Therapy (CPT) + sham,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,46,Structured Clinical Interview,CAPS,CAPS,ITT,Restricted maximum likelihood estimator,Mixed linear model and Cohen's d for change in mean scores,End of Treatment,0,,53.86,4.66,,,,,-20.02,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_CAPS_B_12_ITT,Other mixed,PTSD,103,B,Control,,28,,Sham rTMS + CPT,Cognitive Processing Therapy (CPT) + sham,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,46,Structured Clinical Interview,CAPS,CAPS,ITT,Restricted maximum likelihood estimator,Mixed linear model and Cohen's d for change in mean scores,Assessment at 3 to <6 Months,12,,40.68,4.49,,,,,-33.2,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_CAPS_B_26_ITT,Other mixed,PTSD,103,B,Control,,28,,Sham rTMS + CPT,Cognitive Processing Therapy (CPT) + sham,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,46,Structured Clinical Interview,CAPS,CAPS,ITT,Restricted maximum likelihood estimator,Mixed linear model and Cohen's d for change in mean scores,Assessment at 6 to <12 Months,26,,37.57,4.49,,,,,-36.31,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_CAPS_B_4_ITT,Other mixed,PTSD,103,B,Control,,30,,Sham rTMS + CPT,Cognitive Processing Therapy (CPT) + sham,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,46,Structured Clinical Interview,CAPS,CAPS,ITT,Restricted maximum likelihood estimator,Mixed linear model and Cohen's d for change in mean scores,Assessment at <3 Months,4,,38.29,4.46,,,,,-35.59,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_CAPS_B_Baseline_ITT,Other mixed,PTSD,103,B,Control,,49,,Sham rTMS + CPT,Cognitive Processing Therapy (CPT) + sham,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,46,Structured Clinical Interview,CAPS,CAPS,ITT,Restricted maximum likelihood estimator,Mixed linear model and Cohen's d for change in mean scores,Baseline,,,73.88,3.51,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_M-PTSD_A_0_NA,Other mixed,PTSD,103,A,PTSD,,,,rTMS + CPT,Transcranial magnetic stimulation (TMS) + Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,54,Self report,M-PTSD,M-PTSD,,,Mixed linear model and Cohen's d for change in mean scores,End of Treatment,0,,93.10,,SEM,3.17,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_M-PTSD_A_12_NA,Other mixed,PTSD,103,A,PTSD,,,,rTMS + CPT,Transcranial magnetic stimulation (TMS) + Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,54,Self report,M-PTSD,M-PTSD,,,Mixed linear model and Cohen's d for change in mean scores,Assessment at 3 to <6 Months,12,,83.46,,SEM,3.27,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_M-PTSD_A_26_NA,Other mixed,PTSD,103,A,PTSD,,,,rTMS + CPT,Transcranial magnetic stimulation (TMS) + Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,54,Self report,M-PTSD,M-PTSD,,,Mixed linear model and Cohen's d for change in mean scores,Assessment at 6 to <12 Months,26,,78.97,,SEM,3.15,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_M-PTSD_A_4_NA,Other mixed,PTSD,103,A,PTSD,,,,rTMS + CPT,Transcranial magnetic stimulation (TMS) + Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,54,Self report,M-PTSD,M-PTSD,,,Mixed linear model and Cohen's d for change in mean scores,Assessment at <3 Months,4,,85.58,,SEM,3.17,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_M-PTSD_A_Baseline_NA,Other mixed,PTSD,103,A,PTSD,,,,rTMS + CPT,Transcranial magnetic stimulation (TMS) + Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,54,Self report,M-PTSD,M-PTSD,,,Mixed linear model and Cohen's d for change in mean scores,Baseline,,,107.01,,SEM,2.67,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_M-PTSD_B_0_NA,Other mixed,PTSD,103,B,Control,,,,Sham rTMS + CPT,Cognitive Processing Therapy (CPT) + sham,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,46,Self report,M-PTSD,M-PTSD,,,Mixed linear model and Cohen's d for change in mean scores,End of Treatment,0,,97.28,,SEM,3.58,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_M-PTSD_B_12_NA,Other mixed,PTSD,103,B,Control,,,,Sham rTMS + CPT,Cognitive Processing Therapy (CPT) + sham,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,46,Self report,M-PTSD,M-PTSD,,,Mixed linear model and Cohen's d for change in mean scores,Assessment at 3 to <6 Months,12,,88.98,,SEM,3.49,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_M-PTSD_B_26_NA,Other mixed,PTSD,103,B,Control,,,,Sham rTMS + CPT,Cognitive Processing Therapy (CPT) + sham,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,46,Self report,M-PTSD,M-PTSD,,,Mixed linear model and Cohen's d for change in mean scores,Assessment at 6 to <12 Months,26,,90.58,,SEM,3.47,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_M-PTSD_B_4_NA,Other mixed,PTSD,103,B,Control,,,,Sham rTMS + CPT,Cognitive Processing Therapy (CPT) + sham,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,46,Self report,M-PTSD,M-PTSD,,,Mixed linear model and Cohen's d for change in mean scores,Assessment at <3 Months,4,,91.71,,SEM,3.46,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_M-PTSD_B_Baseline_NA,Other mixed,PTSD,103,B,Control,,,,Sham rTMS + CPT,Cognitive Processing Therapy (CPT) + sham,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,46,Self report,M-PTSD,M-PTSD,,,Mixed linear model and Cohen's d for change in mean scores,Baseline,,,108.25,,SEM,2.9,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_PCL_A_0_NA,Other mixed,PTSD,103,A,PTSD,,,,rTMS + CPT,Transcranial magnetic stimulation (TMS) + Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,54,Self report,PCL,PCL,,,Mixed linear model and Cohen's d for change in mean scores,End of Treatment,0,,39.25,,SEM,2.2,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_PCL_A_12_NA,Other mixed,PTSD,103,A,PTSD,,,,rTMS + CPT,Transcranial magnetic stimulation (TMS) + Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,54,Self report,PCL,PCL,,,Mixed linear model and Cohen's d for change in mean scores,Assessment at 3 to <6 Months,12,,32.86,,SEM,2.29,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_PCL_A_26_NA,Other mixed,PTSD,103,A,PTSD,,,,rTMS + CPT,Transcranial magnetic stimulation (TMS) + Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,54,Self report,PCL,PCL,,,Mixed linear model and Cohen's d for change in mean scores,Assessment at 6 to <12 Months,26,,30.87,,SEM,2.15,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_PCL_A_4_NA,Other mixed,PTSD,103,A,PTSD,,,,rTMS + CPT,Transcranial magnetic stimulation (TMS) + Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,54,Self report,PCL,PCL,,,Mixed linear model and Cohen's d for change in mean scores,Assessment at <3 Months,4,,34.80,,SEM,2.21,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_PCL_A_Baseline_NA,Other mixed,PTSD,103,A,PTSD,,,,rTMS + CPT,Transcranial magnetic stimulation (TMS) + Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,54,Self report,PCL,PCL,,,Mixed linear model and Cohen's d for change in mean scores,Baseline,,,55.93,,SEM,1.83,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_PCL_B_0_NA,Other mixed,PTSD,103,B,Control,,,,Sham rTMS + CPT,Cognitive Processing Therapy (CPT) + sham,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,46,Self report,PCL,PCL,,,Mixed linear model and Cohen's d for change in mean scores,End of Treatment,0,,42.35,,SEM,2.53,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_PCL_B_12_NA,Other mixed,PTSD,103,B,Control,,,,Sham rTMS + CPT,Cognitive Processing Therapy (CPT) + sham,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,46,Self report,PCL,PCL,,,Mixed linear model and Cohen's d for change in mean scores,Assessment at 3 to <6 Months,12,,37.04,,SEM,2.48,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_PCL_B_26_NA,Other mixed,PTSD,103,B,Control,,,,Sham rTMS + CPT,Cognitive Processing Therapy (CPT) + sham,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,46,Self report,PCL,PCL,,,Mixed linear model and Cohen's d for change in mean scores,Assessment at 6 to <12 Months,26,,38.08,,SEM,2.46,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_PCL_B_4_NA,Other mixed,PTSD,103,B,Control,,,,Sham rTMS + CPT,Cognitive Processing Therapy (CPT) + sham,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,46,Self report,PCL,PCL,,,Mixed linear model and Cohen's d for change in mean scores,Assessment at <3 Months,4,,38.78,,SEM,2.45,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2018_PCL_B_Baseline_NA,Other mixed,PTSD,103,B,Control,,,,Sham rTMS + CPT,Cognitive Processing Therapy (CPT) + sham,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,46,Self report,PCL,PCL,,,Mixed linear model and Cohen's d for change in mean scores,Baseline,,,52.82,,SEM,2.05,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,Medium,"Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.",49858,2019
kozel2019_CAPS_A_0_Comp,Other mixed,PTSD,35,A,PTSD,,14,,rTMS 1 Hz,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,17,Structured Clinical Interview,CAPS,CAPS-5,Completer,No missing data,Mixed linear model and Cohen's d for change in mean scores,End of Treatment,0,,39,18,,,,,-9.4,,-18,-1.1,,,,,,,p=0.03,,,,,,,,CAPS-5 criteria for PTSD not met,0.2143,Additional definitions of Diagnostic Change reported in the study,30% reduction in CAPS-5 score,0.2857,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.2857,,0.7143,,,Medium,"Kozel FA, Van Trees K, Larson V, et al. One hertz versus ten hertz repetitive TMS treatment of PTSD: a randomized clinical trial. Psychiatry Res. 2019 Mar;273:153-62. doi: 10.1016/j.psychres.2019.01.004. PMID: 30641346.",51540,2020
kozel2019_CAPS_A_Baseline_Comp,Other mixed,PTSD,35,A,PTSD,,14,,rTMS 1 Hz,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,17,Structured Clinical Interview,CAPS,CAPS-5,Completer,No missing data,Mixed linear model and Cohen's d for change in mean scores,Baseline,,,48,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2857,,0.7143,,,Medium,"Kozel FA, Van Trees K, Larson V, et al. One hertz versus ten hertz repetitive TMS treatment of PTSD: a randomized clinical trial. Psychiatry Res. 2019 Mar;273:153-62. doi: 10.1016/j.psychres.2019.01.004. PMID: 30641346.",51540,2020
kozel2019_CAPS_B_0_Comp,Other mixed,PTSD,35,B,PTSD,,13,,rTMS 10 Hz,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,18,Structured Clinical Interview,CAPS,CAPS-5,Completer,No missing data,Mixed linear model and Cohen's d for change in mean scores,End of Treatment,0,,40,21,,,,,-11,,-18,-3.9,,,,,,,p=0.006,,,,,,,,CAPS-5 criteria for PTSD not met,0.3333,Additional definitions of Diagnostic Change reported in the study,30% reduction in CAPS-5 score,0.3077,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.2857,,0.7143,,,Medium,"Kozel FA, Van Trees K, Larson V, et al. One hertz versus ten hertz repetitive TMS treatment of PTSD: a randomized clinical trial. Psychiatry Res. 2019 Mar;273:153-62. doi: 10.1016/j.psychres.2019.01.004. PMID: 30641346.",51540,2020
kozel2019_CAPS_B_Baseline_Comp,Other mixed,PTSD,35,B,PTSD,,13,,rTMS 10 Hz,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,18,Structured Clinical Interview,CAPS,CAPS-5,Completer,No missing data,Mixed linear model and Cohen's d for change in mean scores,Baseline,,,48,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2857,,0.7143,,,Medium,"Kozel FA, Van Trees K, Larson V, et al. One hertz versus ten hertz repetitive TMS treatment of PTSD: a randomized clinical trial. Psychiatry Res. 2019 Mar;273:153-62. doi: 10.1016/j.psychres.2019.01.004. PMID: 30641346.",51540,2020
kozel2019_PCL_A_0_Comp,Other mixed,PTSD,35,A,PTSD,,,,rTMS 1 Hz,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,17,Self report,PCL,PCL-5,Completer,No missing data,Mixed linear model and Cohen's d for change in mean scores,End of Treatment,0,,42,19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2857,,0.7143,,,Medium,"Kozel FA, Van Trees K, Larson V, et al. One hertz versus ten hertz repetitive TMS treatment of PTSD: a randomized clinical trial. Psychiatry Res. 2019 Mar;273:153-62. doi: 10.1016/j.psychres.2019.01.004. PMID: 30641346.",51540,2020
kozel2019_PCL_A_Baseline_Comp,Other mixed,PTSD,35,A,PTSD,,,,rTMS 1 Hz,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,17,Self report,PCL,PCL-5,Completer,No missing data,Mixed linear model and Cohen's d for change in mean scores,Baseline,,,59,8.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2857,,0.7143,,,Medium,"Kozel FA, Van Trees K, Larson V, et al. One hertz versus ten hertz repetitive TMS treatment of PTSD: a randomized clinical trial. Psychiatry Res. 2019 Mar;273:153-62. doi: 10.1016/j.psychres.2019.01.004. PMID: 30641346.",51540,2020
kozel2019_PCL_B_0_Comp,Other mixed,PTSD,35,B,PTSD,,,,rTMS 10 Hz,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,18,Self report,PCL,PCL-5,Completer,No missing data,Mixed linear model and Cohen's d for change in mean scores,End of Treatment,0,,38,21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2857,,0.7143,,,Medium,"Kozel FA, Van Trees K, Larson V, et al. One hertz versus ten hertz repetitive TMS treatment of PTSD: a randomized clinical trial. Psychiatry Res. 2019 Mar;273:153-62. doi: 10.1016/j.psychres.2019.01.004. PMID: 30641346.",51540,2020
kozel2019_PCL_B_Baseline_Comp,Other mixed,PTSD,35,B,PTSD,,,,rTMS 10 Hz,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,18,Self report,PCL,PCL-5,Completer,No missing data,Mixed linear model and Cohen's d for change in mean scores,Baseline,,,60,8.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2857,,0.7143,,,Medium,"Kozel FA, Van Trees K, Larson V, et al. One hertz versus ten hertz repetitive TMS treatment of PTSD: a randomized clinical trial. Psychiatry Res. 2019 Mar;273:153-62. doi: 10.1016/j.psychres.2019.01.004. PMID: 30641346.",51540,2020
krakow2000_PSS_A_0_Comp,Psychotherapy,PTSD,169,A,PTSD,,39,,Imagery rehearsal,Imagery Rehearsal Training (IRT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,87,Self report,PSS,"PSS (PSS-I at baseline, PSS-SR at end of treatment)",Completer,None,Mixed linear model and Cohen's d for change in mean scores,End of Treatment,0,,15.00,10.29,,,,,-12.6,,,,,Cohen's d,1.2,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters",High,"Krakow BJ, Hollifield M, Schrader R, et al. A controlled study of imagery rehearsal for chronic nightmares in sexual assault survivors with PTSD: a preliminary report. Journal of Traumatic Stress. 2000 Oct;13(4):589-609. doi: 10.1023/A:1007854015481. PMID: 11109233.",15539,2020
krakow2000_PSS_A_Baseline_Comp,Psychotherapy,PTSD,169,A,PTSD,,43,,Imagery rehearsal,Imagery Rehearsal Training (IRT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,87,Self report,PSS,"PSS (PSS-I at baseline, PSS-SR at end of treatment)",Completer,None,Mixed linear model and Cohen's d for change in mean scores,Baseline,,,27.60,10.64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters",High,"Krakow BJ, Hollifield M, Schrader R, et al. A controlled study of imagery rehearsal for chronic nightmares in sexual assault survivors with PTSD: a preliminary report. Journal of Traumatic Stress. 2000 Oct;13(4):589-609. doi: 10.1023/A:1007854015481. PMID: 11109233.",15539,2020
krakow2000_PSS_B_0_Comp,Psychotherapy,PTSD,169,B,Control,,41,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,82,Self report,PSS,"PSS (PSS-I at baseline, PSS-SR at end of treatment)",Completer,None,Mixed linear model and Cohen's d for change in mean scores,End of Treatment,0,,25.71,12.64,,,,,-3.48,,,,,Cohen's d,0.28,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters",High,"Krakow BJ, Hollifield M, Schrader R, et al. A controlled study of imagery rehearsal for chronic nightmares in sexual assault survivors with PTSD: a preliminary report. Journal of Traumatic Stress. 2000 Oct;13(4):589-609. doi: 10.1023/A:1007854015481. PMID: 11109233.",15539,2020
krakow2000_PSS_B_Baseline_Comp,Psychotherapy,PTSD,169,B,Control,,48,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,82,Self report,PSS,"PSS (PSS-I at baseline, PSS-SR at end of treatment)",Completer,None,Mixed linear model and Cohen's d for change in mean scores,Baseline,,,29.19,12.09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters",High,"Krakow BJ, Hollifield M, Schrader R, et al. A controlled study of imagery rehearsal for chronic nightmares in sexual assault survivors with PTSD: a preliminary report. Journal of Traumatic Stress. 2000 Oct;13(4):589-609. doi: 10.1023/A:1007854015481. PMID: 11109233.",15539,2020
krupnick2008_CAPS_A_0_ITT,Psychotherapy,PTSD,48,A,PTSD,,20,,IPT,Interpersonal Psychotherapy (IPT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,32,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed,"Mixed linear regression for change  in mean score, chi-square test for diagnostic change",End of Treatment,0,,40.62,,,,,,-24.54,16.92,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to the CAPS,0.7,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, other (interpersonal trauma)",High,"Krupnick JL, Green BL, Stockton P, et al. Group interpersonal psychotherapy for low-income women with posttraumatic stress disorder. Psychother Res. 2008 Sep;18(5):497-507. doi: 10.1080/10503300802183678. PMID: 18816001.",32335,2019
krupnick2008_CAPS_A_16_ITT,Psychotherapy,PTSD,48,A,PTSD,,26,,IPT,Interpersonal Psychotherapy (IPT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,32,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed,"Mixed linear regression for change  in mean score, chi-square test for diagnostic change",Assessment at 3 to <6 Months,16,,38.53,,,,,,-26.63,20.54,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to the CAPS,0.7692,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, other (interpersonal trauma)",High,"Krupnick JL, Green BL, Stockton P, et al. Group interpersonal psychotherapy for low-income women with posttraumatic stress disorder. Psychother Res. 2008 Sep;18(5):497-507. doi: 10.1080/10503300802183678. PMID: 18816001.",32335,2019
krupnick2008_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,48,A,PTSD,,32,,IPT,Interpersonal Psychotherapy (IPT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,32,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed,"Mixed linear regression for change  in mean score, chi-square test for diagnostic change",Baseline,,,65.16,20.92,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, other (interpersonal trauma)",High,"Krupnick JL, Green BL, Stockton P, et al. Group interpersonal psychotherapy for low-income women with posttraumatic stress disorder. Psychother Res. 2008 Sep;18(5):497-507. doi: 10.1080/10503300802183678. PMID: 18816001.",32335,2019
krupnick2008_CAPS_B_0_ITT,Psychotherapy,PTSD,48,B,Control,,7,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,16,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed,"Mixed linear regression for change  in mean score, chi-square test for diagnostic change",End of Treatment,0,,56.86,,,,,Adjusted: -5.8 (SE 3.30),-5.78,12.23,,,,,,,,,p<0.10,,,,,,,,Not meeting criteria for PTSD according to the CAPS,0.2857,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, other (interpersonal trauma)",High,"Krupnick JL, Green BL, Stockton P, et al. Group interpersonal psychotherapy for low-income women with posttraumatic stress disorder. Psychother Res. 2008 Sep;18(5):497-507. doi: 10.1080/10503300802183678. PMID: 18816001.",32335,2019
krupnick2008_CAPS_B_16_ITT,Psychotherapy,PTSD,48,B,Control,,10,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,16,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed,"Mixed linear regression for change  in mean score, chi-square test for diagnostic change",Assessment at 3 to <6 Months,16,,36.01,,,,,Adjusted: -21.2 (SE 4.40),-18.89,18.17,,,,,,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to the CAPS,0.5,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, other (interpersonal trauma)",High,"Krupnick JL, Green BL, Stockton P, et al. Group interpersonal psychotherapy for low-income women with posttraumatic stress disorder. Psychother Res. 2008 Sep;18(5):497-507. doi: 10.1080/10503300802183678. PMID: 18816001.",32335,2019
krupnick2008_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,48,B,Control,,16,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,16,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed,"Mixed linear regression for change  in mean score, chi-square test for diagnostic change",Baseline,,,62.64,16.57,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, other (interpersonal trauma)",High,"Krupnick JL, Green BL, Stockton P, et al. Group interpersonal psychotherapy for low-income women with posttraumatic stress disorder. Psychother Res. 2008 Sep;18(5):497-507. doi: 10.1080/10503300802183678. PMID: 18816001.",32335,2019
krupnick2017_PCL_A_0_ITT,Psychotherapy,PTSD,34,A,PTSD,,6,,Warriors Internet Recovery & Education + TAU,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Technology Assisted,18,Self report,PCL,PCL-M average item score,ITT,Random effects mixed model,Cohen's d for change in mean score,End of Treatment,0,,3.58,0.4,,,,,-0.02,,,,,Cohen's d,1.23,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0882,,0.9118,Mixed,"MST, combat-related",High,"Krupnick JL, Green BL, Amdur RL, et al. An internet-based writing intervention for PTSD in veterans: a feasibility and pilot effectiveness trial. Psychol Trauma. 2017 Jul;9(4):461-70. doi: 10.1037/tra0000176. PMID: 27607767.",45679,2019
krupnick2017_PCL_A_12_ITT,Psychotherapy,PTSD,34,A,PTSD,,4,,Warriors Internet Recovery & Education + TAU,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Technology Assisted,18,Self report,PCL,PCL-M average item score,ITT,Random effects mixed model,Cohen's d for change in mean score,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,Cohen's d,1.93,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0882,,0.9118,Mixed,"MST, combat-related",High,"Krupnick JL, Green BL, Amdur RL, et al. An internet-based writing intervention for PTSD in veterans: a feasibility and pilot effectiveness trial. Psychol Trauma. 2017 Jul;9(4):461-70. doi: 10.1037/tra0000176. PMID: 27607767.",45679,2019
krupnick2017_PCL_A_Baseline_ITT,Psychotherapy,PTSD,34,A,PTSD,,16,,Warriors Internet Recovery & Education + TAU,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Technology Assisted,18,Self report,PCL,PCL-M average item score,ITT,Random effects mixed model,Cohen's d for change in mean score,Baseline,,,3.6,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0882,,0.9118,Mixed,"MST, combat-related",High,"Krupnick JL, Green BL, Amdur RL, et al. An internet-based writing intervention for PTSD in veterans: a feasibility and pilot effectiveness trial. Psychol Trauma. 2017 Jul;9(4):461-70. doi: 10.1037/tra0000176. PMID: 27607767.",45679,2019
krupnick2017_PCL_B_0_ITT,Psychotherapy,PTSD,34,B,Control,,12,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,16,Self report,PCL,PCL-M average item score,ITT,Random effects mixed model,Cohen's d for change in mean score,End of Treatment,0,,3.91,0.4,,,,,0.01,,,,,Cohen's d,0.06,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0882,,0.9118,Mixed,"MST, combat-related",High,"Krupnick JL, Green BL, Amdur RL, et al. An internet-based writing intervention for PTSD in veterans: a feasibility and pilot effectiveness trial. Psychol Trauma. 2017 Jul;9(4):461-70. doi: 10.1037/tra0000176. PMID: 27607767.",45679,2019
krupnick2017_PCL_B_12_ITT,Psychotherapy,PTSD,34,B,Control,,10,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,16,Self report,PCL,PCL-M average item score,ITT,Random effects mixed model,Cohen's d for change in mean score,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,Cohen's d,0.45,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0882,,0.9118,Mixed,"MST, combat-related",High,"Krupnick JL, Green BL, Amdur RL, et al. An internet-based writing intervention for PTSD in veterans: a feasibility and pilot effectiveness trial. Psychol Trauma. 2017 Jul;9(4):461-70. doi: 10.1037/tra0000176. PMID: 27607767.",45679,2019
krupnick2017_PCL_B_Baseline_ITT,Psychotherapy,PTSD,34,B,Control,,15,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,16,Self report,PCL,PCL-M average item score,ITT,Random effects mixed model,Cohen's d for change in mean score,Baseline,,,3.9,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0882,,0.9118,Mixed,"MST, combat-related",High,"Krupnick JL, Green BL, Amdur RL, et al. An internet-based writing intervention for PTSD in veterans: a feasibility and pilot effectiveness trial. Psychol Trauma. 2017 Jul;9(4):461-70. doi: 10.1037/tra0000176. PMID: 27607767.",45679,2019
krystal2011_CAPS_A_0_ITT,Pharmacotherapy,PTSD,296,A,PTSD,,123,,Risperidone augmentation,Risperidone augmentation,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,147,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed models with generalized least squares,Cohen's d for change in mean score,End of Treatment,0,,64.43,,,,,,-16.3,,,,,,,,,,,,,,,,,,,,,CAPS score <20,0.05,,Veteran,0,1,0,0.09,,0.91,Mixed,"combat-related, other (physical or sexual abuse)",Low,"Krystal JH, Rosenheck RA, Cramer JA, et al. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA. 2011;306(5):493-502. doi: 10.1001/jama.2011.1080. PMID: 21813427.",36863,2019
krystal2011_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,296,A,PTSD,,133,,Risperidone augmentation,Risperidone augmentation,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,147,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed models with generalized least squares,Cohen's d for change in mean score,Baseline,,,78.2,15,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS score <20,,,Veteran,0,1,0,0.09,,0.91,Mixed,"combat-related, other (physical or sexual abuse)",Low,"Krystal JH, Rosenheck RA, Cramer JA, et al. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA. 2011;306(5):493-502. doi: 10.1001/jama.2011.1080. PMID: 21813427.",36863,2019
krystal2011_CAPS_B_0_ITT,Pharmacotherapy,PTSD,296,B,Control,,124,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,149,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed models with generalized least squares,Cohen's d for change in mean score,End of Treatment,0,,67.16,,,,,,-12.5,,,,,,,,,,,,,,,,,,,,,CAPS score <20,0.04,,Veteran,0,1,0,0.09,,0.91,Mixed,"combat-related, other (physical or sexual abuse)",Low,"Krystal JH, Rosenheck RA, Cramer JA, et al. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA. 2011;306(5):493-502. doi: 10.1001/jama.2011.1080. PMID: 21813427.",36863,2019
krystal2011_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,296,B,Control,,134,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,149,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed models with generalized least squares,Cohen's d for change in mean score,Baseline,,,78.2,14.7,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS score <20,,,Veteran,0,1,0,0.09,,0.91,Mixed,"combat-related, other (physical or sexual abuse)",Low,"Krystal JH, Rosenheck RA, Cramer JA, et al. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA. 2011;306(5):493-502. doi: 10.1001/jama.2011.1080. PMID: 21813427.",36863,2019
kubany2004_CAPS_A_0_Comp,Psychotherapy,PTSD,107,A,PTSD,,45,,Cognitive trauma therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,46,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA with Bonferroni correction; effect size as difference between group means divided by the standard deviation for the delayed therapy condition (Intervention B),End of Treatment,0,,15.8,14.4,,,,,-57.1,,,,,,,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to DSM-IV,0.913,,Distressing event questionnaire score ≤25 and BDI score ≤10,,,,,,,1,,0,Intimate partner violence,,Medium,"Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.",26300,2019
kubany2004_CAPS_A_0_ITT,Psychotherapy,PTSD,107,A,PTSD,,63,,Cognitive trauma therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,46,Structured Clinical Interview,CAPS,CAPS,ITT,baseline values for nonstarters and noncompleters,ANOVA with Bonferroni correction; effect size as difference between group means divided by the standard deviation for the delayed therapy condition (Intervention B),End of Treatment,0,,33.3,32.8,,,,,-41.1,,,,,,,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to DSM-IV,,,Distressing event questionnaire score ≤25 and BDI score ≤10,,,,,,,1,,0,Intimate partner violence,,Medium,"Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.",26300,2019
kubany2004_CAPS_A_12_Comp,Psychotherapy,PTSD,107,A,PTSD,,34,,Cognitive trauma therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,46,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA with Bonferroni correction; effect size as difference between group means divided by the standard deviation for the delayed therapy condition (Intervention B),Assessment at 3 to <6 Months,12,,17.7,19.7,,,,,-55.2,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-IV,,,Distressing event questionnaire score ≤25 and BDI score ≤10,,,,,,,1,,0,Intimate partner violence,,Medium,"Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.",26300,2019
kubany2004_CAPS_A_26_Comp,Psychotherapy,PTSD,107,A,PTSD,,32,,Cognitive trauma therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,46,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA with Bonferroni correction; effect size as difference between group means divided by the standard deviation for the delayed therapy condition (Intervention B),Assessment at 6 to <12 Months,26,,22.8,23.7,,,,,-50.1,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-IV,,,Distressing event questionnaire score ≤25 and BDI score ≤10,,,,,,,1,,0,Intimate partner violence,,Medium,"Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.",26300,2019
kubany2004_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,107,A,PTSD,,46,,Cognitive trauma therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,46,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA with Bonferroni correction; effect size as difference between group means divided by the standard deviation for the delayed therapy condition (Intervention B),Baseline,,,72.9,18.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Intimate partner violence,,Medium,"Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.",26300,2019
kubany2004_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,107,A,PTSD,,63,,Cognitive trauma therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,46,Structured Clinical Interview,CAPS,CAPS,ITT,baseline values for nonstarters and noncompleters,ANOVA with Bonferroni correction; effect size as difference between group means divided by the standard deviation for the delayed therapy condition (Intervention B),Baseline,,,74.4,19.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Intimate partner violence,,Medium,"Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.",26300,2019
kubany2004_CAPS_B_0_Comp,Psychotherapy,PTSD,107,B,Control,,40,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,40,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA with Bonferroni correction; effect size as difference between group means divided by the standard deviation for the delayed therapy condition (Intervention B),End of Treatment,0,,71.9,23.8,,,,,-5.6,,,,,,,,,,p=NS,,,,,,,,Not meeting criteria for PTSD according to DSM-IV,,,Distressing event questionnaire score ≤25 and BDI score ≤10,,,,,,,1,,0,Intimate partner violence,,Medium,"Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.",26300,2019
kubany2004_CAPS_B_0_ITT,Psychotherapy,PTSD,107,B,Control,,62,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,40,Structured Clinical Interview,CAPS,CAPS,ITT,baseline values for nonstarters and noncompleters,ANOVA with Bonferroni correction; effect size as difference between group means divided by the standard deviation for the delayed therapy condition (Intervention B),End of Treatment,0,,74.1,21.9,,,,,-3.9,,,,,,,,,,p=NS,,,,,,,,Not meeting criteria for PTSD according to DSM-IV,,,Distressing event questionnaire score ≤25 and BDI score ≤10,,,,,,,1,,0,Intimate partner violence,,Medium,"Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.",26300,2019
kubany2004_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,107,B,Control,,40,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,40,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA with Bonferroni correction; effect size as difference between group means divided by the standard deviation for the delayed therapy condition (Intervention B),Baseline,,,77.5,21.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Intimate partner violence,,Medium,"Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.",26300,2019
kubany2004_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,107,B,Control,,62,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,40,Structured Clinical Interview,CAPS,CAPS,ITT,baseline values for nonstarters and noncompleters,ANOVA with Bonferroni correction; effect size as difference between group means divided by the standard deviation for the delayed therapy condition (Intervention B),Baseline,,,78,20.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Intimate partner violence,,Medium,"Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.",26300,2019
kubany2004_Dist_A_0_Comp,Psychotherapy,PTSD,107,A,PTSD,,,,Cognitive trauma therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,46,Self report,Distressing Event Questionnaire,Distressing Event Questionnaire,Completer,,ANOVA with Bonferroni correction; effect size as difference between group means divided by the standard deviation for the delayed therapy condition (Intervention B),End of Treatment,0,,16.8,16.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Intimate partner violence,,Medium,"Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.",26300,2019
kubany2004_Dist_A_0_ITT,Psychotherapy,PTSD,107,A,PTSD,,,,Cognitive trauma therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,46,Self report,Distressing Event Questionnaire,Distressing Event Questionnaire,ITT,,ANOVA with Bonferroni correction; effect size as difference between group means divided by the standard deviation for the delayed therapy condition (Intervention B),End of Treatment,0,,27.9,24.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Intimate partner violence,,Medium,"Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.",26300,2019
kubany2004_Dist_A_Baseline_Comp,Psychotherapy,PTSD,107,A,PTSD,,,,Cognitive trauma therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,46,Self report,Distressing Event Questionnaire,Distressing Event Questionnaire,Completer,,ANOVA with Bonferroni correction; effect size as difference between group means divided by the standard deviation for the delayed therapy condition (Intervention B),Baseline,,,55.4,12.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Intimate partner violence,,Medium,"Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.",26300,2019
kubany2004_Dist_A_Baseline_ITT,Psychotherapy,PTSD,107,A,PTSD,,,,Cognitive trauma therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,46,Self report,Distressing Event Questionnaire,Distressing Event Questionnaire,ITT,,ANOVA with Bonferroni correction; effect size as difference between group means divided by the standard deviation for the delayed therapy condition (Intervention B),Baseline,,,56.5,13.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Intimate partner violence,,Medium,"Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.",26300,2019
kubany2004_Dist_B_0_Comp,Psychotherapy,PTSD,107,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,40,Self report,Distressing Event Questionnaire,Distressing Event Questionnaire,Completer,,ANOVA with Bonferroni correction; effect size as difference between group means divided by the standard deviation for the delayed therapy condition (Intervention B),End of Treatment,0,,52.0,15.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Intimate partner violence,,Medium,"Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.",26300,2019
kubany2004_Dist_B_0_ITT,Psychotherapy,PTSD,107,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,40,Self report,Distressing Event Questionnaire,Distressing Event Questionnaire,ITT,,ANOVA with Bonferroni correction; effect size as difference between group means divided by the standard deviation for the delayed therapy condition (Intervention B),End of Treatment,0,,52.7,16.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Intimate partner violence,,Medium,"Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.",26300,2019
kubany2004_Dist_B_Baseline_Comp,Psychotherapy,PTSD,107,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,40,Self report,Distressing Event Questionnaire,Distressing Event Questionnaire,Completer,,ANOVA with Bonferroni correction; effect size as difference between group means divided by the standard deviation for the delayed therapy condition (Intervention B),Baseline,,,57.5,15.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Intimate partner violence,,Medium,"Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.",26300,2019
kubany2004_Dist_B_Baseline_ITT,Psychotherapy,PTSD,107,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,40,Self report,Distressing Event Questionnaire,Distressing Event Questionnaire,ITT,,ANOVA with Bonferroni correction; effect size as difference between group means divided by the standard deviation for the delayed therapy condition (Intervention B),Baseline,,,58.0,15.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,0,Intimate partner violence,,Medium,"Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.",26300,2019
kuckertz2014_PCL_A_0_Comp,Nonpharmacologic cognitive,PTSD,37,A,PTSD,,12,,Attention Bias Modification,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In Person,20,Self report,PCL,PCL-M,Completer,linear mixed effects models using available data,Linear mixed effects models,End of Treatment,0,,42.83,12.04,,,,,-20.25,,,,,Cohen's d,3.17,,,,p=0.0003,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.069,,0.931,,,Medium,"Kuckertz JM, Amir N, Boffa JW, et al. The effectiveness of an attention bias modification program as an adjunctive treatment for post-traumatic stress disorder. Behav Res Ther. 2014 Dec;63:25-35. doi: 10.1016/j.brat.2014.09.002. PMID: 25277496.",43075,2019
kuckertz2014_PCL_A_Baseline_Comp,Nonpharmacologic cognitive,PTSD,37,A,PTSD,,12,,Attention Bias Modification,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In Person,20,Self report,PCL,PCL-M,Completer,linear mixed effects models using available data,Linear mixed effects models,Baseline,,,63.08,9.13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.069,,0.931,,,Medium,"Kuckertz JM, Amir N, Boffa JW, et al. The effectiveness of an attention bias modification program as an adjunctive treatment for post-traumatic stress disorder. Behav Res Ther. 2014 Dec;63:25-35. doi: 10.1016/j.brat.2014.09.002. PMID: 25277496.",43075,2019
kuckertz2014_PCL_B_0_Comp,Nonpharmacologic cognitive,PTSD,37,B,Control,,17,,Attention Control Condition,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In Person,17,Self report,PCL,PCL-M,Completer,linear mixed effects models using available data,Linear mixed effects models,End of Treatment,0,,51.65,14.72,,,,,-10.06,,,,,Cohen's d,1.81,,,,p=0.002,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.069,,0.931,,,Medium,"Kuckertz JM, Amir N, Boffa JW, et al. The effectiveness of an attention bias modification program as an adjunctive treatment for post-traumatic stress disorder. Behav Res Ther. 2014 Dec;63:25-35. doi: 10.1016/j.brat.2014.09.002. PMID: 25277496.",43075,2019
kuckertz2014_PCL_B_Baseline_Comp,Nonpharmacologic cognitive,PTSD,37,B,Control,,17,,Attention Control Condition,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,In Person,17,Self report,PCL,PCL-M,Completer,linear mixed effects models using available data,Linear mixed effects models,Baseline,,,61.71,9.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.069,,0.931,,,Medium,"Kuckertz JM, Amir N, Boffa JW, et al. The effectiveness of an attention bias modification program as an adjunctive treatment for post-traumatic stress disorder. Behav Res Ther. 2014 Dec;63:25-35. doi: 10.1016/j.brat.2014.09.002. PMID: 25277496.",43075,2019
lang2019_CAPS_A_0_Comp,Complementary and integrative health (CIH),PTSD,37,A,PTSD,,14,,Compassion meditation,Compassion meditation,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In person,17,Structured Clinical Interview,CAPS,CAPS,Completer,,Linear mixed effects models,End of Treatment,0,,20.4,11.8,,,,,-15.4,,,,,Cohen's d,1.19,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.25,,0.75,Mixed,"combat-related; Accidents; Community/ school violence; Other (sudden violent death, causing serious harm to another)",Medium,"Lang AJ, Malaktaris AL, Casmar P, et al. Compassion meditation for posttraumatic stress disorder in veterans: a randomized proof of concept study. J Trauma Stress. 2019 Apr;32(2):299-309. doi: 10.1002/jts.22397. PMID: 30929283.",51896,2020
lang2019_CAPS_A_Baseline_Comp,Complementary and integrative health (CIH),PTSD,37,A,PTSD,,14,,Compassion meditation,Compassion meditation,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In person,17,Structured Clinical Interview,CAPS,CAPS,Completer,,Linear mixed effects models,Baseline,,,35.8,13.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.25,,0.75,Mixed,"combat-related; Accidents; Community/ school violence; Other (sudden violent death, causing serious harm to another)",Medium,"Lang AJ, Malaktaris AL, Casmar P, et al. Compassion meditation for posttraumatic stress disorder in veterans: a randomized proof of concept study. J Trauma Stress. 2019 Apr;32(2):299-309. doi: 10.1002/jts.22397. PMID: 30929283.",51896,2020
lang2019_CAPS_B_0_Comp,Complementary and integrative health (CIH),PTSD,37,B,PTSD,,14,,Veteran.calm,Veteran.calm,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,20,Structured Clinical Interview,CAPS,CAPS,Completer,,Linear mixed effects models,End of Treatment,0,,35.3,7.7,,,,,-2.6,,,,,,0.26,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.25,,0.75,Mixed,"combat-related; Accidents; Community/ school violence; Other (sudden violent death, causing serious harm to another)",Medium,"Lang AJ, Malaktaris AL, Casmar P, et al. Compassion meditation for posttraumatic stress disorder in veterans: a randomized proof of concept study. J Trauma Stress. 2019 Apr;32(2):299-309. doi: 10.1002/jts.22397. PMID: 30929283.",51896,2020
lang2019_CAPS_B_Baseline_Comp,Complementary and integrative health (CIH),PTSD,37,B,PTSD,,14,,Veteran.calm,Veteran.calm,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,20,Structured Clinical Interview,CAPS,CAPS,Completer,,Linear mixed effects models,Baseline,,,37.9,11.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.25,,0.75,Mixed,"combat-related; Accidents; Community/ school violence; Other (sudden violent death, causing serious harm to another)",Medium,"Lang AJ, Malaktaris AL, Casmar P, et al. Compassion meditation for posttraumatic stress disorder in veterans: a randomized proof of concept study. J Trauma Stress. 2019 Apr;32(2):299-309. doi: 10.1002/jts.22397. PMID: 30929283.",51896,2020
lang2019_PCL_A_0_Comp,Complementary and integrative health (CIH),PTSD,37,A,PTSD,,,,Compassion meditation,Compassion meditation,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In person,17,Self report,PCL,PCL-5,Completer,,Linear mixed effects models,End of Treatment,0,estimated from Figure 3,22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.25,,0.75,Mixed,"combat-related; Accidents; Community/ school violence; Other (sudden violent death, causing serious harm to another)",Medium,"Lang AJ, Malaktaris AL, Casmar P, et al. Compassion meditation for posttraumatic stress disorder in veterans: a randomized proof of concept study. J Trauma Stress. 2019 Apr;32(2):299-309. doi: 10.1002/jts.22397. PMID: 30929283.",51896,2020
lang2019_PCL_A_Baseline_Comp,Complementary and integrative health (CIH),PTSD,37,A,PTSD,,,,Compassion meditation,Compassion meditation,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In person,17,Self report,PCL,PCL-5,Completer,,Linear mixed effects models,Baseline,,estimated from Figure 3,49,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.25,,0.75,Mixed,"combat-related; Accidents; Community/ school violence; Other (sudden violent death, causing serious harm to another)",Medium,"Lang AJ, Malaktaris AL, Casmar P, et al. Compassion meditation for posttraumatic stress disorder in veterans: a randomized proof of concept study. J Trauma Stress. 2019 Apr;32(2):299-309. doi: 10.1002/jts.22397. PMID: 30929283.",51896,2020
lang2019_PCL_B_0_Comp,Complementary and integrative health (CIH),PTSD,37,B,PTSD,,,,Veteran.calm,Veteran.calm,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,20,Self report,PCL,PCL-5,Completer,,Linear mixed effects models,End of Treatment,0,estimated from Figure 3,37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.25,,0.75,Mixed,"combat-related; Accidents; Community/ school violence; Other (sudden violent death, causing serious harm to another)",Medium,"Lang AJ, Malaktaris AL, Casmar P, et al. Compassion meditation for posttraumatic stress disorder in veterans: a randomized proof of concept study. J Trauma Stress. 2019 Apr;32(2):299-309. doi: 10.1002/jts.22397. PMID: 30929283.",51896,2020
lang2019_PCL_B_Baseline_Comp,Complementary and integrative health (CIH),PTSD,37,B,PTSD,,,,Veteran.calm,Veteran.calm,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,20,Self report,PCL,PCL-5,Completer,,Linear mixed effects models,Baseline,,estimated from Figure 3,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.25,,0.75,Mixed,"combat-related; Accidents; Community/ school violence; Other (sudden violent death, causing serious harm to another)",Medium,"Lang AJ, Malaktaris AL, Casmar P, et al. Compassion meditation for posttraumatic stress disorder in veterans: a randomized proof of concept study. J Trauma Stress. 2019 Apr;32(2):299-309. doi: 10.1002/jts.22397. PMID: 30929283.",51896,2020
langkaas2017_PSS-I_A_0_ITT,Psychotherapy,PTSD,65,A,PTSD,,31,,Imagery Rescription,Imagery rescripting,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,34,Structured Clinical Interview,PSS-I,PSS-I,ITT,,Repeated measures linear mixed model,End of Treatment,0,,21.9,14.13,,,,,-11.3,,,,,Hedges' g,0.9,95% CI,0.49,1.3,,,,,,,,,,,,≥8-point change on PSS-I,,,Community,,,1,0.5846,,0.4154,Mixed,"rape/sexual assault, accidents, community/school violence, other (war-related)",Medium,"Langkaas TF, Hoffart A, Øktedalen T, et al. Exposure and non-fear emotions: a randomized controlled study of exposure-based and rescripting-based imagery in PTSD treatment. Behav Res Ther. 2017 Oct;97:33-42. doi: 10.1016/j.brat.2017.06.007. PMID: 28689041.",48570,2019
langkaas2017_PSS-I_A_52_ITT,Psychotherapy,PTSD,65,A,PTSD,,31,,Imagery Rescription,Imagery rescripting,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,34,Structured Clinical Interview,PSS-I,PSS-I,ITT,,Repeated measures linear mixed model,Assessment at ≥12 Months,52,,23.5,15.13,,,,,-9.7,,,,,Hedges' g,0.77,95% CI,0.28,1.25,,,,,,,,,,,,≥8-point change on PSS-I,,,Community,,,1,0.5846,,0.4154,Mixed,"rape/sexual assault, accidents, community/school violence, other (war-related)",Medium,"Langkaas TF, Hoffart A, Øktedalen T, et al. Exposure and non-fear emotions: a randomized controlled study of exposure-based and rescripting-based imagery in PTSD treatment. Behav Res Ther. 2017 Oct;97:33-42. doi: 10.1016/j.brat.2017.06.007. PMID: 28689041.",48570,2019
langkaas2017_PSS-I_A_Baseline_ITT,Psychotherapy,PTSD,65,A,PTSD,,34,,Imagery Rescription,Imagery rescripting,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,34,Structured Clinical Interview,PSS-I,PSS-I,ITT,,Repeated measures linear mixed model,Baseline,,,33.2,6.91,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5846,,0.4154,Mixed,"rape/sexual assault, accidents, community/school violence, other (war-related)",Medium,"Langkaas TF, Hoffart A, Øktedalen T, et al. Exposure and non-fear emotions: a randomized controlled study of exposure-based and rescripting-based imagery in PTSD treatment. Behav Res Ther. 2017 Oct;97:33-42. doi: 10.1016/j.brat.2017.06.007. PMID: 28689041.",48570,2019
langkaas2017_PSS-I_B_0_ITT,Psychotherapy,PTSD,65,B,PTSD,,30,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,33,Structured Clinical Interview,PSS-I,PSS-I,ITT,,Repeated measures linear mixed model,End of Treatment,0,,19.7,13.92,,,,,-15.2,,,,,Hedges' g,1.24,95% CI,0.73,1.75,,,,,,,,,,,,≥8-point change on PSS-I,,,Community,,,1,0.5846,,0.4154,Mixed,"rape/sexual assault, accidents, community/school violence, other (war-related)",Medium,"Langkaas TF, Hoffart A, Øktedalen T, et al. Exposure and non-fear emotions: a randomized controlled study of exposure-based and rescripting-based imagery in PTSD treatment. Behav Res Ther. 2017 Oct;97:33-42. doi: 10.1016/j.brat.2017.06.007. PMID: 28689041.",48570,2019
langkaas2017_PSS-I_B_52_ITT,Psychotherapy,PTSD,65,B,PTSD,,27,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,33,Structured Clinical Interview,PSS-I,PSS-I,ITT,,Repeated measures linear mixed model,Assessment at ≥12 Months,52,,22.9,15.74,,,,,-12,,,,,Hedges' g,0.88,95% CI,0.4,1.36,,,,,,,,,,,,≥8-point change on PSS-I,,,Community,,,1,0.5846,,0.4154,Mixed,"rape/sexual assault, accidents, community/school violence, other (war-related)",Medium,"Langkaas TF, Hoffart A, Øktedalen T, et al. Exposure and non-fear emotions: a randomized controlled study of exposure-based and rescripting-based imagery in PTSD treatment. Behav Res Ther. 2017 Oct;97:33-42. doi: 10.1016/j.brat.2017.06.007. PMID: 28689041.",48570,2019
langkaas2017_PSS-I_B_Baseline_ITT,Psychotherapy,PTSD,65,B,PTSD,,33,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,33,Structured Clinical Interview,PSS-I,PSS-I,ITT,,Repeated measures linear mixed model,Baseline,,,34.9,8.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5846,,0.4154,Mixed,"rape/sexual assault, accidents, community/school violence, other (war-related)",Medium,"Langkaas TF, Hoffart A, Øktedalen T, et al. Exposure and non-fear emotions: a randomized controlled study of exposure-based and rescripting-based imagery in PTSD treatment. Behav Res Ther. 2017 Oct;97:33-42. doi: 10.1016/j.brat.2017.06.007. PMID: 28689041.",48570,2019
lee2002_IES_A_0_NA,Psychotherapy,PTSD,27,A,PTSD,,,,SIT with PE,Stress Inoculation Training (SIT) plus Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Self report,IES,IES,,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),End of Treatment,0,,23.17,18.99,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,,,0.4583,,0.5417,Mixed,"combat-related, rape/sexual assault, accidents, other (murder)",High,"Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.",24570,2019
lee2002_IES_A_12_NA,Psychotherapy,PTSD,27,A,PTSD,,,,SIT with PE,Stress Inoculation Training (SIT) plus Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Self report,IES,IES,,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Assessment at 3 to <6 Months,12,,19,18.73,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,,,0.4583,,0.5417,Mixed,"combat-related, rape/sexual assault, accidents, other (murder)",High,"Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.",24570,2019
lee2002_IES_A_Baseline_NA,Psychotherapy,PTSD,27,A,PTSD,,,,SIT with PE,Stress Inoculation Training (SIT) plus Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Self report,IES,IES,,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Baseline,,,55.75,8.21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,,,0.4583,,0.5417,Mixed,"combat-related, rape/sexual assault, accidents, other (murder)",High,"Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.",24570,2019
lee2002_IES_B_0_NA,Psychotherapy,PTSD,27,B,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Self report,IES,IES,,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),End of Treatment,0,,30.25,20.21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,,,0.4583,,0.5417,Mixed,"combat-related, rape/sexual assault, accidents, other (murder)",High,"Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.",24570,2019
lee2002_IES_B_12_NA,Psychotherapy,PTSD,27,B,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Self report,IES,IES,,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Assessment at 3 to <6 Months,12,,32.92,19.98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,,,0.4583,,0.5417,Mixed,"combat-related, rape/sexual assault, accidents, other (murder)",High,"Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.",24570,2019
lee2002_IES_B_Baseline_NA,Psychotherapy,PTSD,27,B,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Self report,IES,IES,,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Baseline,,,54.92,9.08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,,,0.4583,,0.5417,Mixed,"combat-related, rape/sexual assault, accidents, other (murder)",High,"Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.",24570,2019
lee2002_MMPI_A_0_NA,Psychotherapy,PTSD,27,A,PTSD,,,,SIT with PE,Stress Inoculation Training (SIT) plus Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Self report,MMPI,MMPI - Keane's PTSD Scale,,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),End of Treatment,0,,54.86,15.65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,,,0.4583,,0.5417,Mixed,"combat-related, rape/sexual assault, accidents, other (murder)",High,"Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.",24570,2019
lee2002_MMPI_A_12_NA,Psychotherapy,PTSD,27,A,PTSD,,,,SIT with PE,Stress Inoculation Training (SIT) plus Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Self report,MMPI,MMPI - Keane's PTSD Scale,,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Assessment at 3 to <6 Months,12,,54.33,9.36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,,,0.4583,,0.5417,Mixed,"combat-related, rape/sexual assault, accidents, other (murder)",High,"Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.",24570,2019
lee2002_MMPI_A_Baseline_NA,Psychotherapy,PTSD,27,A,PTSD,,,,SIT with PE,Stress Inoculation Training (SIT) plus Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Self report,MMPI,MMPI - Keane's PTSD Scale,,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Baseline,,,72.58,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,,,0.4583,,0.5417,Mixed,"combat-related, rape/sexual assault, accidents, other (murder)",High,"Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.",24570,2019
lee2002_MMPI_B_0_NA,Psychotherapy,PTSD,27,B,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Self report,MMPI,MMPI - Keane's PTSD Scale,,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),End of Treatment,0,,65.75,17.43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,,,0.4583,,0.5417,Mixed,"combat-related, rape/sexual assault, accidents, other (murder)",High,"Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.",24570,2019
lee2002_MMPI_B_12_NA,Psychotherapy,PTSD,27,B,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Self report,MMPI,MMPI - Keane's PTSD Scale,,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Assessment at 3 to <6 Months,12,,70.75,18.89,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,,,0.4583,,0.5417,Mixed,"combat-related, rape/sexual assault, accidents, other (murder)",High,"Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.",24570,2019
lee2002_MMPI_B_Baseline_NA,Psychotherapy,PTSD,27,B,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Self report,MMPI,MMPI - Keane's PTSD Scale,,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Baseline,,,81.08,15.96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,,,0.4583,,0.5417,Mixed,"combat-related, rape/sexual assault, accidents, other (murder)",High,"Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.",24570,2019
lee2002_SI-PTSD_A_0_Comp,Psychotherapy,PTSD,27,A,PTSD,,12,,SIT with PE,Stress Inoculation Training (SIT) plus Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Structured Clinical Interview,SI-PTSD,SI-PTSD,Completer,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),End of Treatment,0,,17,12.92,,,,,-20.58,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SI-PTSD,0.75,,IES <37 (2 standard deviations below pretreatment mean),0.6667,,Mixed,0,,,0.4583,,0.5417,Mixed,"combat-related, rape/sexual assault, accidents, other (murder)",High,"Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.",24570,2019
lee2002_SI-PTSD_A_12_Comp,Psychotherapy,PTSD,27,A,PTSD,,12,,SIT with PE,Stress Inoculation Training (SIT) plus Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Structured Clinical Interview,SI-PTSD,SI-PTSD,Completer,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Assessment at 3 to <6 Months,12,,14.17,12.15,,,,,-23.41,,,,,Cohen's d,2.48,,,,,,,,,,,,Not meeting criteria for PTSD according to SI-PTSD,0.8333,,IES <37 (2 standard deviations below pretreatment mean),0.5,,Mixed,0,,,0.4583,,0.5417,Mixed,"combat-related, rape/sexual assault, accidents, other (murder)",High,"Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.",24570,2019
lee2002_SI-PTSD_A_Baseline_Comp,Psychotherapy,PTSD,27,A,PTSD,,12,,SIT with PE,Stress Inoculation Training (SIT) plus Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Structured Clinical Interview,SI-PTSD,SI-PTSD,Completer,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Baseline,,,37.58,5.47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,,,0.4583,,0.5417,Mixed,"combat-related, rape/sexual assault, accidents, other (murder)",High,"Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.",24570,2019
lee2002_SI-PTSD_B_0_Comp,Psychotherapy,PTSD,27,B,PTSD,,12,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Structured Clinical Interview,SI-PTSD,SI-PTSD,Completer,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),End of Treatment,0,,25.08,13.27,,,,,-17.17,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SI-PTSD,0.8333,,IES <37 (2 standard deviations below pretreatment mean),0.6667,,Mixed,0,,,0.4583,,0.5417,Mixed,"combat-related, rape/sexual assault, accidents, other (murder)",High,"Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.",24570,2019
lee2002_SI-PTSD_B_12_Comp,Psychotherapy,PTSD,27,B,PTSD,,12,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Structured Clinical Interview,SI-PTSD,SI-PTSD,Completer,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Assessment at 3 to <6 Months,12,,24.33,12.03,,,,,-17.92,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SI-PTSD,0.8333,,IES <37 (2 standard deviations below pretreatment mean),0.9167,,Mixed,0,,,0.4583,,0.5417,Mixed,"combat-related, rape/sexual assault, accidents, other (murder)",High,"Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.",24570,2019
lee2002_SI-PTSD_B_Baseline_Comp,Psychotherapy,PTSD,27,B,PTSD,,12,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Structured Clinical Interview,SI-PTSD,SI-PTSD,Completer,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Baseline,,,42.25,8.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,,,0.4583,,0.5417,Mixed,"combat-related, rape/sexual assault, accidents, other (murder)",High,"Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.",24570,2019
lely2019_CAPS_A_0_ITT,Psychotherapy,PTSD,33,A,PTSD,,15,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,18,Structured Clinical Interview,CAPS,CAPS,ITT,Piecewise mixed-effects growth model,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),End of Treatment,0,,64.29,26.6,,,,,-6.96,,,,,,,,,,,,,,,,,,CAPS score ≤40 and decrease of ≥10 points in CAPS score,0.143,,≥10 points decrease in CAPS score,0.5,,Community,0,0,1,0.2727,,0.7273,Mixed,"intimate partner violence, terrorism/political violence/forced displacement, other (unspecified child abuse, persecution)",Medium,"Lely JCG, Knipscheer JW, Moerbeek M, et al. Randomised controlled trial comparing narrative exposure therapy with present-centred therapy for older patients with post-traumatic stress disorder. Br J Psychiatry. 2019 Jun;214(6):369-77. doi: 10.1192/bjp.2019.59. PMID: 30957736.",,2020
lely2019_CAPS_A_16_ITT,Psychotherapy,PTSD,33,A,PTSD,,15,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,18,Structured Clinical Interview,CAPS,CAPS,ITT,Piecewise mixed-effects growth model,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Assessment at 3 to <6 Months,16,,54.64,26.42,,,,,-16.61,,,,,,,,,,,,,,,,,,CAPS score ≤40 and decrease of ≥10 points in CAPS score,0.286,,≥10 points decrease in CAPS score,0.429,,Community,0,0,1,0.2727,,0.7273,Mixed,"intimate partner violence, terrorism/political violence/forced displacement, other (unspecified child abuse, persecution)",Medium,"Lely JCG, Knipscheer JW, Moerbeek M, et al. Randomised controlled trial comparing narrative exposure therapy with present-centred therapy for older patients with post-traumatic stress disorder. Br J Psychiatry. 2019 Jun;214(6):369-77. doi: 10.1192/bjp.2019.59. PMID: 30957736.",,2020
lely2019_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,33,A,PTSD,,18,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,18,Structured Clinical Interview,CAPS,CAPS,ITT,Piecewise mixed-effects growth model,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Baseline,,,71.25,25.17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.2727,,0.7273,Mixed,"intimate partner violence, terrorism/political violence/forced displacement, other (unspecified child abuse, persecution)",Medium,"Lely JCG, Knipscheer JW, Moerbeek M, et al. Randomised controlled trial comparing narrative exposure therapy with present-centred therapy for older patients with post-traumatic stress disorder. Br J Psychiatry. 2019 Jun;214(6):369-77. doi: 10.1192/bjp.2019.59. PMID: 30957736.",,2020
lely2019_CAPS_B_0_ITT,Psychotherapy,PTSD,33,B,PTSD,,12,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,15,Structured Clinical Interview,CAPS,CAPS,ITT,Piecewise mixed-effects growth model,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),End of Treatment,0,,49.83,21.71,,,,,-18.38,,,,,,,,,,,,,,,,,,CAPS score ≤40 and decrease of ≥10 points in CAPS score,0.167,,≥10 points decrease in CAPS score,0.417,,Community,0,0,1,0.2727,,0.7273,Mixed,"intimate partner violence, terrorism/political violence/forced displacement, other (unspecified child abuse, persecution)",Medium,"Lely JCG, Knipscheer JW, Moerbeek M, et al. Randomised controlled trial comparing narrative exposure therapy with present-centred therapy for older patients with post-traumatic stress disorder. Br J Psychiatry. 2019 Jun;214(6):369-77. doi: 10.1192/bjp.2019.59. PMID: 30957736.",,2020
lely2019_CAPS_B_16_ITT,Psychotherapy,PTSD,33,B,PTSD,,12,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,15,Structured Clinical Interview,CAPS,CAPS,ITT,Piecewise mixed-effects growth model,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Assessment at 3 to <6 Months,16,,59.17,28.4,,,,,-9.04,,,,,,,,,,,,,,,,,,CAPS score ≤40 and decrease of ≥10 points in CAPS score,0.083,,≥10 points decrease in CAPS score,0.417,,Community,0,0,1,0.2727,,0.7273,Mixed,"intimate partner violence, terrorism/political violence/forced displacement, other (unspecified child abuse, persecution)",Medium,"Lely JCG, Knipscheer JW, Moerbeek M, et al. Randomised controlled trial comparing narrative exposure therapy with present-centred therapy for older patients with post-traumatic stress disorder. Br J Psychiatry. 2019 Jun;214(6):369-77. doi: 10.1192/bjp.2019.59. PMID: 30957736.",,2020
lely2019_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,33,B,PTSD,,15,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,15,Structured Clinical Interview,CAPS,CAPS,ITT,Piecewise mixed-effects growth model,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Baseline,,,68.21,19.95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.2727,,0.7273,Mixed,"intimate partner violence, terrorism/political violence/forced displacement, other (unspecified child abuse, persecution)",Medium,"Lely JCG, Knipscheer JW, Moerbeek M, et al. Randomised controlled trial comparing narrative exposure therapy with present-centred therapy for older patients with post-traumatic stress disorder. Br J Psychiatry. 2019 Jun;214(6):369-77. doi: 10.1192/bjp.2019.59. PMID: 30957736.",,2020
leong2020_CAPS_A_0_ITT,Nonpharmacologic biological,PTSD,31,A,PTSD,,11,,Low-frequency repetitive transcranial magnetic stimulation (rTMS),Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,11,Structured Clinical Interview,CAPS,CAPS-IV,ITT,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),End of Treatment,0,,59.80,35.83,,,,,-12.47,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.8276,,0.1724,Mixed,"Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)",High,"Leong K, Chan P, Ong L, et al. A Randomized Sham-controlled Trial of 1-Hz and 10-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) of the Right Dorsolateral Prefrontal Cortex in Civilian Post-traumatic Stress Disorder. Can J Psychiatry. 2020 May 07:706743720923064. doi: https://dx.doi.org/10.1177/0706743720923064. PMID: 32379487.",,2020
leong2020_CAPS_A_12_ITT,Nonpharmacologic biological,PTSD,31,A,PTSD,,10,,Low-frequency repetitive transcranial magnetic stimulation (rTMS),Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,11,Structured Clinical Interview,CAPS,CAPS-IV,ITT,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Assessment at 3 to <6 Months,12,,55.40,29.2,,,,,-16.87,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.8276,,0.1724,Mixed,"Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)",High,"Leong K, Chan P, Ong L, et al. A Randomized Sham-controlled Trial of 1-Hz and 10-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) of the Right Dorsolateral Prefrontal Cortex in Civilian Post-traumatic Stress Disorder. Can J Psychiatry. 2020 May 07:706743720923064. doi: https://dx.doi.org/10.1177/0706743720923064. PMID: 32379487.",,2020
leong2020_CAPS_A_Baseline_ITT,Nonpharmacologic biological,PTSD,31,A,PTSD,,11,,Low-frequency repetitive transcranial magnetic stimulation (rTMS),Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,11,Structured Clinical Interview,CAPS,CAPS-IV,ITT,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Baseline,,,72.27,25.34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.8276,,0.1724,Mixed,"Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)",High,"Leong K, Chan P, Ong L, et al. A Randomized Sham-controlled Trial of 1-Hz and 10-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) of the Right Dorsolateral Prefrontal Cortex in Civilian Post-traumatic Stress Disorder. Can J Psychiatry. 2020 May 07:706743720923064. doi: https://dx.doi.org/10.1177/0706743720923064. PMID: 32379487.",,2020
leong2020_CAPS_B_0_ITT,Nonpharmacologic biological,PTSD,31,B,PTSD,,9,,High-frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,10,Structured Clinical Interview,CAPS,CAPS-IV,ITT,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),End of Treatment,0,,74.00,30.97,,,,,4.56,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.8276,,0.1724,Mixed,"Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)",High,"Leong K, Chan P, Ong L, et al. A Randomized Sham-controlled Trial of 1-Hz and 10-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) of the Right Dorsolateral Prefrontal Cortex in Civilian Post-traumatic Stress Disorder. Can J Psychiatry. 2020 May 07:706743720923064. doi: https://dx.doi.org/10.1177/0706743720923064. PMID: 32379487.",,2020
leong2020_CAPS_B_12_ITT,Nonpharmacologic biological,PTSD,31,B,PTSD,,9,,High-frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,10,Structured Clinical Interview,CAPS,CAPS-IV,ITT,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Assessment at 3 to <6 Months,12,70.55 + 27.98,,,,,,,1.11,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.8276,,0.1724,Mixed,"Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)",High,"Leong K, Chan P, Ong L, et al. A Randomized Sham-controlled Trial of 1-Hz and 10-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) of the Right Dorsolateral Prefrontal Cortex in Civilian Post-traumatic Stress Disorder. Can J Psychiatry. 2020 May 07:706743720923064. doi: https://dx.doi.org/10.1177/0706743720923064. PMID: 32379487.",,2020
leong2020_CAPS_B_Baseline_ITT,Nonpharmacologic biological,PTSD,31,B,PTSD,,10,,High-frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,10,Structured Clinical Interview,CAPS,CAPS-IV,ITT,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Baseline,,,69.44,18.29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.8276,,0.1724,Mixed,"Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)",High,"Leong K, Chan P, Ong L, et al. A Randomized Sham-controlled Trial of 1-Hz and 10-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) of the Right Dorsolateral Prefrontal Cortex in Civilian Post-traumatic Stress Disorder. Can J Psychiatry. 2020 May 07:706743720923064. doi: https://dx.doi.org/10.1177/0706743720923064. PMID: 32379487.",,2020
leong2020_CAPS_C_0_ITT,Nonpharmacologic biological,PTSD,31,C,Control,,9,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS-IV,ITT,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),End of Treatment,0,,65.12,14.97,,,,,9.9,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.8276,,0.1724,Mixed,"Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)",High,"Leong K, Chan P, Ong L, et al. A Randomized Sham-controlled Trial of 1-Hz and 10-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) of the Right Dorsolateral Prefrontal Cortex in Civilian Post-traumatic Stress Disorder. Can J Psychiatry. 2020 May 07:706743720923064. doi: https://dx.doi.org/10.1177/0706743720923064. PMID: 32379487.",,2020
leong2020_CAPS_C_12_ITT,Nonpharmacologic biological,PTSD,31,C,Control,,4,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS-IV,ITT,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Assessment at 3 to <6 Months,12,,71.50,19.97,,,,,16.28,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.8276,,0.1724,Mixed,"Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)",High,"Leong K, Chan P, Ong L, et al. A Randomized Sham-controlled Trial of 1-Hz and 10-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) of the Right Dorsolateral Prefrontal Cortex in Civilian Post-traumatic Stress Disorder. Can J Psychiatry. 2020 May 07:706743720923064. doi: https://dx.doi.org/10.1177/0706743720923064. PMID: 32379487.",,2020
leong2020_CAPS_C_Baseline_ITT,Nonpharmacologic biological,PTSD,31,C,Control,,10,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS-IV,ITT,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Baseline,,,55.22,13.17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.8276,,0.1724,Mixed,"Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)",High,"Leong K, Chan P, Ong L, et al. A Randomized Sham-controlled Trial of 1-Hz and 10-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) of the Right Dorsolateral Prefrontal Cortex in Civilian Post-traumatic Stress Disorder. Can J Psychiatry. 2020 May 07:706743720923064. doi: https://dx.doi.org/10.1177/0706743720923064. PMID: 32379487.",,2020
leong2020_PCL_A_0_ITT,Nonpharmacologic biological,PTSD,31,A,PTSD,,,,Low-frequency repetitive transcranial magnetic stimulation (rTMS),Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,11,Self report,PCL,PCL-C,ITT,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),End of Treatment,0,,48.10,23.54,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.8276,,0.1724,Mixed,"Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)",High,"Leong K, Chan P, Ong L, et al. A Randomized Sham-controlled Trial of 1-Hz and 10-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) of the Right Dorsolateral Prefrontal Cortex in Civilian Post-traumatic Stress Disorder. Can J Psychiatry. 2020 May 07:706743720923064. doi: https://dx.doi.org/10.1177/0706743720923064. PMID: 32379487.",,2020
leong2020_PCL_A_12_ITT,Nonpharmacologic biological,PTSD,31,A,PTSD,,,,Low-frequency repetitive transcranial magnetic stimulation (rTMS),Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,11,Self report,PCL,PCL-C,ITT,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Assessment at 3 to <6 Months,12,,48.66,17.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.8276,,0.1724,Mixed,"Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)",High,"Leong K, Chan P, Ong L, et al. A Randomized Sham-controlled Trial of 1-Hz and 10-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) of the Right Dorsolateral Prefrontal Cortex in Civilian Post-traumatic Stress Disorder. Can J Psychiatry. 2020 May 07:706743720923064. doi: https://dx.doi.org/10.1177/0706743720923064. PMID: 32379487.",,2020
leong2020_PCL_A_Baseline_ITT,Nonpharmacologic biological,PTSD,31,A,PTSD,,,,Low-frequency repetitive transcranial magnetic stimulation (rTMS),Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,11,Self report,PCL,PCL-C,ITT,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Baseline,,,59.40,16.44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.8276,,0.1724,Mixed,"Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)",High,"Leong K, Chan P, Ong L, et al. A Randomized Sham-controlled Trial of 1-Hz and 10-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) of the Right Dorsolateral Prefrontal Cortex in Civilian Post-traumatic Stress Disorder. Can J Psychiatry. 2020 May 07:706743720923064. doi: https://dx.doi.org/10.1177/0706743720923064. PMID: 32379487.",,2020
leong2020_PCL_B_0_ITT,Nonpharmacologic biological,PTSD,31,B,PTSD,,,,High-frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,10,Self report,PCL,PCL-C,ITT,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),End of Treatment,0,,53.44,22.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.8276,,0.1724,Mixed,"Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)",High,"Leong K, Chan P, Ong L, et al. A Randomized Sham-controlled Trial of 1-Hz and 10-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) of the Right Dorsolateral Prefrontal Cortex in Civilian Post-traumatic Stress Disorder. Can J Psychiatry. 2020 May 07:706743720923064. doi: https://dx.doi.org/10.1177/0706743720923064. PMID: 32379487.",,2020
leong2020_PCL_B_12_ITT,Nonpharmacologic biological,PTSD,31,B,PTSD,,,,High-frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,10,Self report,PCL,PCL-C,ITT,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Assessment at 3 to <6 Months,12,,57.12,14.77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.8276,,0.1724,Mixed,"Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)",High,"Leong K, Chan P, Ong L, et al. A Randomized Sham-controlled Trial of 1-Hz and 10-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) of the Right Dorsolateral Prefrontal Cortex in Civilian Post-traumatic Stress Disorder. Can J Psychiatry. 2020 May 07:706743720923064. doi: https://dx.doi.org/10.1177/0706743720923064. PMID: 32379487.",,2020
leong2020_PCL_B_Baseline_ITT,Nonpharmacologic biological,PTSD,31,B,PTSD,,,,High-frequency rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,10,Self report,PCL,PCL-C,ITT,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Baseline,,,65.33,11.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.8276,,0.1724,Mixed,"Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)",High,"Leong K, Chan P, Ong L, et al. A Randomized Sham-controlled Trial of 1-Hz and 10-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) of the Right Dorsolateral Prefrontal Cortex in Civilian Post-traumatic Stress Disorder. Can J Psychiatry. 2020 May 07:706743720923064. doi: https://dx.doi.org/10.1177/0706743720923064. PMID: 32379487.",,2020
leong2020_PCL_C_0_ITT,Nonpharmacologic biological,PTSD,31,C,Control,,,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,10,Self report,PCL,PCL-C,ITT,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),End of Treatment,0,,52.14,10.05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.8276,,0.1724,Mixed,"Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)",High,"Leong K, Chan P, Ong L, et al. A Randomized Sham-controlled Trial of 1-Hz and 10-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) of the Right Dorsolateral Prefrontal Cortex in Civilian Post-traumatic Stress Disorder. Can J Psychiatry. 2020 May 07:706743720923064. doi: https://dx.doi.org/10.1177/0706743720923064. PMID: 32379487.",,2020
leong2020_PCL_C_12_ITT,Nonpharmacologic biological,PTSD,31,C,Control,,,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,10,Self report,PCL,PCL-C,ITT,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Assessment at 3 to <6 Months,12,,52.66,13.44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.8276,,0.1724,Mixed,"Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)",High,"Leong K, Chan P, Ong L, et al. A Randomized Sham-controlled Trial of 1-Hz and 10-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) of the Right Dorsolateral Prefrontal Cortex in Civilian Post-traumatic Stress Disorder. Can J Psychiatry. 2020 May 07:706743720923064. doi: https://dx.doi.org/10.1177/0706743720923064. PMID: 32379487.",,2020
leong2020_PCL_C_Baseline_ITT,Nonpharmacologic biological,PTSD,31,C,Control,,,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,10,Self report,PCL,PCL-C,ITT,,MANCOVA followed by univariate tests of between-subjects effects (F tests with eta-squared),Baseline,,,61.62,7.96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.8276,,0.1724,Mixed,"Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)",High,"Leong K, Chan P, Ong L, et al. A Randomized Sham-controlled Trial of 1-Hz and 10-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) of the Right Dorsolateral Prefrontal Cortex in Civilian Post-traumatic Stress Disorder. Can J Psychiatry. 2020 May 07:706743720923064. doi: https://dx.doi.org/10.1177/0706743720923064. PMID: 32379487.",,2020
lewis2017_CAPS_A_0_ITT,Other mixed,PTSD,42,A,PTSD,,15,,Internet-based guided self-help,Internet-based guided self-help,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,21,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation (100 replicate datasets) using values sampled uniformly between missing at random and LOCF,Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,End of Treatment,0,,17.93,12.25,,,,,-18.06,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.595,,0.405,Mixed,"accidents, illness/medical procedure, rape/sexual assault, terrorism/political violence/forced displacement, community/school violence",Medium,"Lewis CE, Farewell D, Groves V, et al. Internet-based guided self-help for posttraumatic stress disorder (PTSD): randomized controlled trial. Depress Anxiety. 2017 Jun;34(6):555-65. doi: 10.1002/da.22645. PMID: 28557299.",48301,2019
lewis2017_CAPS_A_12_ITT,Other mixed,PTSD,42,A,PTSD,,13,,Internet-based guided self-help,Internet-based guided self-help,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,21,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation (100 replicate datasets) using values sampled uniformly between missing at random and LOCF,Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,Assessment at 3 to <6 Months,12,,15.77,13.01,,,,,-20.22,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.595,,0.405,Mixed,"accidents, illness/medical procedure, rape/sexual assault, terrorism/political violence/forced displacement, community/school violence",Medium,"Lewis CE, Farewell D, Groves V, et al. Internet-based guided self-help for posttraumatic stress disorder (PTSD): randomized controlled trial. Depress Anxiety. 2017 Jun;34(6):555-65. doi: 10.1002/da.22645. PMID: 28557299.",48301,2019
lewis2017_CAPS_A_4_ITT,Other mixed,PTSD,42,A,PTSD,,14,,Internet-based guided self-help,Internet-based guided self-help,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,21,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation (100 replicate datasets) using values sampled uniformly between missing at random and LOCF,Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,Assessment at <3 Months,4,,16.47,13.22,,,,,-19.52,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.595,,0.405,Mixed,"accidents, illness/medical procedure, rape/sexual assault, terrorism/political violence/forced displacement, community/school violence",Medium,"Lewis CE, Farewell D, Groves V, et al. Internet-based guided self-help for posttraumatic stress disorder (PTSD): randomized controlled trial. Depress Anxiety. 2017 Jun;34(6):555-65. doi: 10.1002/da.22645. PMID: 28557299.",48301,2019
lewis2017_CAPS_A_Baseline_ITT,Other mixed,PTSD,42,A,PTSD,,21,,Internet-based guided self-help,Internet-based guided self-help,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,21,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation (100 replicate datasets) using values sampled uniformly between missing at random and LOCF,Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,Baseline,,,35.99,6.29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.595,,0.405,Mixed,"accidents, illness/medical procedure, rape/sexual assault, terrorism/political violence/forced displacement, community/school violence",Medium,"Lewis CE, Farewell D, Groves V, et al. Internet-based guided self-help for posttraumatic stress disorder (PTSD): randomized controlled trial. Depress Anxiety. 2017 Jun;34(6):555-65. doi: 10.1002/da.22645. PMID: 28557299.",48301,2019
lewis2017_CAPS_B_0_ITT,Other mixed,PTSD,42,B,Control,,17,,Delayed treatment,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,21,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation (100 replicate datasets) using values sampled uniformly between missing at random and LOCF,Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,End of Treatment,0,,36.53,7.1,,,,,-0.59,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.595,,0.405,Mixed,"accidents, illness/medical procedure, rape/sexual assault, terrorism/political violence/forced displacement, community/school violence",Medium,"Lewis CE, Farewell D, Groves V, et al. Internet-based guided self-help for posttraumatic stress disorder (PTSD): randomized controlled trial. Depress Anxiety. 2017 Jun;34(6):555-65. doi: 10.1002/da.22645. PMID: 28557299.",48301,2019
lewis2017_CAPS_B_4_ITT,Other mixed,PTSD,42,B,Control,,18,,Delayed treatment,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,21,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation (100 replicate datasets) using values sampled uniformly between missing at random and LOCF,Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,Assessment at <3 Months,4,,33.63,8.42,,,,,-3.49,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.595,,0.405,Mixed,"accidents, illness/medical procedure, rape/sexual assault, terrorism/political violence/forced displacement, community/school violence",Medium,"Lewis CE, Farewell D, Groves V, et al. Internet-based guided self-help for posttraumatic stress disorder (PTSD): randomized controlled trial. Depress Anxiety. 2017 Jun;34(6):555-65. doi: 10.1002/da.22645. PMID: 28557299.",48301,2019
lewis2017_CAPS_B_Baseline_ITT,Other mixed,PTSD,42,B,Control,,21,,Delayed treatment,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,21,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation (100 replicate datasets) using values sampled uniformly between missing at random and LOCF,Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,Baseline,,,37.12,6.95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.595,,0.405,Mixed,"accidents, illness/medical procedure, rape/sexual assault, terrorism/political violence/forced displacement, community/school violence",Medium,"Lewis CE, Farewell D, Groves V, et al. Internet-based guided self-help for posttraumatic stress disorder (PTSD): randomized controlled trial. Depress Anxiety. 2017 Jun;34(6):555-65. doi: 10.1002/da.22645. PMID: 28557299.",48301,2019
li2017_IES-R_A_0_ITT,Pharmacotherapy,PTSD,72,A,PTSD,,36,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Self report,IES-R,IES-R,ITT,,Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,End of Treatment,0,,,,,,,,-24.3,,-32.1,-14.3,,,,,,,,,,,,,,,,,,≥30% reduction in IES-R total scores,1,,Mixed,0.375,,0.625,0.125,,0.875,Mixed,"combat-related, other (chemical burn)",Low,"Li W, Ma YB, Yang Q, et al. Effect and safety of sertraline for treat posttraumatic stress disorder: a multicenter randomised controlled study. Int. J. Psychiatry Clin. Pract. 2017 Jun;21(2):151-5. doi: 10.1080/13651501.2017.1291838. PMID: 28266242.",49934,2019
li2017_IES-R_A_Baseline_ITT,Pharmacotherapy,PTSD,72,A,PTSD,,36,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,36,Self report,IES-R,IES-R,ITT,,Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,Baseline,,,64.8,4.1,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% reduction in IES-R total scores,,,Mixed,0.375,,0.625,0.125,,0.875,Mixed,"combat-related, other (chemical burn)",Low,"Li W, Ma YB, Yang Q, et al. Effect and safety of sertraline for treat posttraumatic stress disorder: a multicenter randomised controlled study. Int. J. Psychiatry Clin. Pract. 2017 Jun;21(2):151-5. doi: 10.1080/13651501.2017.1291838. PMID: 28266242.",49934,2019
li2017_IES-R_B_0_ITT,Pharmacotherapy,PTSD,72,B,Control,,36,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,36,Self report,IES-R,IES-R,ITT,,Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,End of Treatment,0,,,,,,,,-18.1,,-25.7,-11.8,,,,,,,,,,,,,,,,,,≥30% reduction in IES-R total scores,0.6944,,Mixed,0.375,,0.625,0.125,,0.875,Mixed,"combat-related, other (chemical burn)",Low,"Li W, Ma YB, Yang Q, et al. Effect and safety of sertraline for treat posttraumatic stress disorder: a multicenter randomised controlled study. Int. J. Psychiatry Clin. Pract. 2017 Jun;21(2):151-5. doi: 10.1080/13651501.2017.1291838. PMID: 28266242.",49934,2019
li2017_IES-R_B_Baseline_ITT,Pharmacotherapy,PTSD,72,B,Control,,36,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,36,Self report,IES-R,IES-R,ITT,,Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,Baseline,,,63.9,3.7,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% reduction in IES-R total scores,,,Mixed,0.375,,0.625,0.125,,0.875,Mixed,"combat-related, other (chemical burn)",Low,"Li W, Ma YB, Yang Q, et al. Effect and safety of sertraline for treat posttraumatic stress disorder: a multicenter randomised controlled study. Int. J. Psychiatry Clin. Pract. 2017 Jun;21(2):151-5. doi: 10.1080/13651501.2017.1291838. PMID: 28266242.",49934,2019
lindauer2005_SI-PTSD_A_0_Comp,Psychotherapy,PTSD,24,A,PTSD,,7,,BEP,Brief Eclectic Psychotherapy (BEP),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,12,Structured Clinical Interview,SI-PTSD,SI-PTSD subscales,Completer,,Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Diagnosis by SI-PTSD,,,,,,Community,0,0,1,0.5417,,0.4583,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (unspecified)",Medium,"Lindauer RJ, Gersons BP, van Meijel EP, et al. Effects of brief eclectic psychotherapy in patients with posttraumatic stress disorder: randomized clinical trial. Journal of traumatic stress. 2005 Jun;18(3):205-12. doi: 10.1002/jts.20029. PMID: 16281214.",19181,2020
lindauer2005_SI-PTSD_A_0_ITT,Psychotherapy,PTSD,24,A,PTSD,,12,,BEP,Brief Eclectic Psychotherapy (BEP),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,12,Structured Clinical Interview,SI-PTSD,SI-PTSD subscales,ITT,,Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Diagnosis by SI-PTSD,0.8333,,,,,Community,0,0,1,0.5417,,0.4583,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (unspecified)",Medium,"Lindauer RJ, Gersons BP, van Meijel EP, et al. Effects of brief eclectic psychotherapy in patients with posttraumatic stress disorder: randomized clinical trial. Journal of traumatic stress. 2005 Jun;18(3):205-12. doi: 10.1002/jts.20029. PMID: 16281214.",19181,2020
lindauer2005_SI-PTSD_A_Baseline_Comp,Psychotherapy,PTSD,24,A,PTSD,,7,,BEP,Brief Eclectic Psychotherapy (BEP),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,12,Structured Clinical Interview,SI-PTSD,SI-PTSD subscales,Completer,,Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.5417,,0.4583,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (unspecified)",Medium,"Lindauer RJ, Gersons BP, van Meijel EP, et al. Effects of brief eclectic psychotherapy in patients with posttraumatic stress disorder: randomized clinical trial. Journal of traumatic stress. 2005 Jun;18(3):205-12. doi: 10.1002/jts.20029. PMID: 16281214.",19181,2020
lindauer2005_SI-PTSD_A_Baseline_ITT,Psychotherapy,PTSD,24,A,PTSD,,12,,BEP,Brief Eclectic Psychotherapy (BEP),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,12,Structured Clinical Interview,SI-PTSD,SI-PTSD subscales,ITT,,Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.5417,,0.4583,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (unspecified)",Medium,"Lindauer RJ, Gersons BP, van Meijel EP, et al. Effects of brief eclectic psychotherapy in patients with posttraumatic stress disorder: randomized clinical trial. Journal of traumatic stress. 2005 Jun;18(3):205-12. doi: 10.1002/jts.20029. PMID: 16281214.",19181,2020
lindauer2005_SI-PTSD_B_0_Comp,Psychotherapy,PTSD,24,B,Control,,11,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Structured Clinical Interview,SI-PTSD,SI-PTSD subscales,Completer,,Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Diagnosis by SI-PTSD,,,,,,Community,0,0,1,0.5417,,0.4583,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (unspecified)",Medium,"Lindauer RJ, Gersons BP, van Meijel EP, et al. Effects of brief eclectic psychotherapy in patients with posttraumatic stress disorder: randomized clinical trial. Journal of traumatic stress. 2005 Jun;18(3):205-12. doi: 10.1002/jts.20029. PMID: 16281214.",19181,2020
lindauer2005_SI-PTSD_B_0_ITT,Psychotherapy,PTSD,24,B,Control,,12,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Structured Clinical Interview,SI-PTSD,SI-PTSD subscales,ITT,,Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Diagnosis by SI-PTSD,0.25,,,,,Community,0,0,1,0.5417,,0.4583,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (unspecified)",Medium,"Lindauer RJ, Gersons BP, van Meijel EP, et al. Effects of brief eclectic psychotherapy in patients with posttraumatic stress disorder: randomized clinical trial. Journal of traumatic stress. 2005 Jun;18(3):205-12. doi: 10.1002/jts.20029. PMID: 16281214.",19181,2020
lindauer2005_SI-PTSD_B_Baseline_Comp,Psychotherapy,PTSD,24,B,Control,,11,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Structured Clinical Interview,SI-PTSD,SI-PTSD subscales,Completer,,Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.5417,,0.4583,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (unspecified)",Medium,"Lindauer RJ, Gersons BP, van Meijel EP, et al. Effects of brief eclectic psychotherapy in patients with posttraumatic stress disorder: randomized clinical trial. Journal of traumatic stress. 2005 Jun;18(3):205-12. doi: 10.1002/jts.20029. PMID: 16281214.",19181,2020
lindauer2005_SI-PTSD_B_Baseline_ITT,Psychotherapy,PTSD,24,B,Control,,12,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Structured Clinical Interview,SI-PTSD,SI-PTSD subscales,ITT,,Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.5417,,0.4583,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (unspecified)",Medium,"Lindauer RJ, Gersons BP, van Meijel EP, et al. Effects of brief eclectic psychotherapy in patients with posttraumatic stress disorder: randomized clinical trial. Journal of traumatic stress. 2005 Jun;18(3):205-12. doi: 10.1002/jts.20029. PMID: 16281214.",19181,2020
lindley2007_CAPS_A_0_Comp,Pharmacotherapy,PTSD,40,A,PTSD,,9,,Topiramate,Topiramate,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,"Continuous outcomes: available data used to calculate slope of change in score over time (interpolation for missing data points)
Clinically meaningful response: LOCF",Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,End of Treatment,0,,,,,,,,,,,,,Slope of CAPS (change in score/time in weeks),-2.09,SD,3,,,,,,,,,,,,,≥50% decrease in CAPS score,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0,,1,Combat-related,,High,"Lindley SE, Carlson EB, Hill K. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Dec;27(6):677-81. doi: 10.1097/jcp.0b013e31815a43ee. PMID: 18004136..",50965,2019
lindley2007_CAPS_A_0_ITT,Pharmacotherapy,PTSD,40,A,PTSD,,20,,Topiramate,Topiramate,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,ITT,"Continuous outcomes: available data used to calculate slope of change in score over time (interpolation for missing data points)
Clinically meaningful response: LOCF",Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,≥50% decrease in CAPS score,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0,,1,Combat-related,,High,"Lindley SE, Carlson EB, Hill K. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Dec;27(6):677-81. doi: 10.1097/jcp.0b013e31815a43ee. PMID: 18004136..",50965,2019
lindley2007_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,40,A,PTSD,,9,,Topiramate,Topiramate,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,"Continuous outcomes: available data used to calculate slope of change in score over time (interpolation for missing data points)
Clinically meaningful response: LOCF",Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,≥50% decrease in CAPS score,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0,,1,Combat-related,,High,"Lindley SE, Carlson EB, Hill K. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Dec;27(6):677-81. doi: 10.1097/jcp.0b013e31815a43ee. PMID: 18004136..",50965,2019
lindley2007_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,40,A,PTSD,,20,,Topiramate,Topiramate,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,ITT,"Continuous outcomes: available data used to calculate slope of change in score over time (interpolation for missing data points)
Clinically meaningful response: LOCF",Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,Baseline,,,62.1,12.9,,,,,,,,,,,,,,,,,,,,,,,,,,≥50% decrease in CAPS score,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0,,1,Combat-related,,High,"Lindley SE, Carlson EB, Hill K. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Dec;27(6):677-81. doi: 10.1097/jcp.0b013e31815a43ee. PMID: 18004136..",50965,2019
lindley2007_CAPS_B_0_Comp,Pharmacotherapy,PTSD,40,B,Control,,15,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,"Continuous outcomes: available data used to calculate slope of change in score over time (interpolation for missing data points)
Clinically meaningful response: LOCF",Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,End of Treatment,0,,,,,,,,,,,,,Slope of CAPS (change in score/time in weeks),-0.3,SD,3.07,,,,,,,,,,,,,≥50% decrease in CAPS score,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0,,1,Combat-related,,High,"Lindley SE, Carlson EB, Hill K. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Dec;27(6):677-81. doi: 10.1097/jcp.0b013e31815a43ee. PMID: 18004136..",50965,2019
lindley2007_CAPS_B_0_ITT,Pharmacotherapy,PTSD,40,B,Control,,20,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,ITT,"Continuous outcomes: available data used to calculate slope of change in score over time (interpolation for missing data points)
Clinically meaningful response: LOCF",Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,≥50% decrease in CAPS score,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0,,1,Combat-related,,High,"Lindley SE, Carlson EB, Hill K. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Dec;27(6):677-81. doi: 10.1097/jcp.0b013e31815a43ee. PMID: 18004136..",50965,2019
lindley2007_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,40,B,Control,,15,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,"Continuous outcomes: available data used to calculate slope of change in score over time (interpolation for missing data points)
Clinically meaningful response: LOCF",Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,≥50% decrease in CAPS score,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0,,1,Combat-related,,High,"Lindley SE, Carlson EB, Hill K. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Dec;27(6):677-81. doi: 10.1097/jcp.0b013e31815a43ee. PMID: 18004136..",50965,2019
lindley2007_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,40,B,Control,,20,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,ITT,"Continuous outcomes: available data used to calculate slope of change in score over time (interpolation for missing data points)
Clinically meaningful response: LOCF",Differences in means; standard regression adjustment for effect modification and random effects to account for intra-participant and intra-therapist measurement correlations,Baseline,,,61.0,22.2,,,,,,,,,,,,,,,,,,,,,,,,,,≥50% decrease in CAPS score,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0,,1,Combat-related,,High,"Lindley SE, Carlson EB, Hill K. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Dec;27(6):677-81. doi: 10.1097/jcp.0b013e31815a43ee. PMID: 18004136..",50965,2019
littleton2016_PSS-I_A_0_Comp,Other mixed,PTSD,87,A,PTSD,,23,,From Survivor to Thriver,From Survivor to Thriver,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,46,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Residual difference score model for change in mean scores,End of Treatment,0,,11.2,5.8,,,,,-12.5,,,,,Cohen's d,2.22,,,,p<0.001,,,,,,,,,,,RCI for PSS-I,0.7391,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, intimate partner violence",High,"Littleton HL, Grills AE, Kline KD, et al. The From Survivor to Thriver program: RCT of an online therapist-facilitated program for rape-related PTSD. J Anxiety Disord. 2016 Oct;43:41-51. doi: 10.1016/j.janxdis.2016.07.010. PMID: 27513363.",45583,2019
littleton2016_PSS-I_A_0_ITT,Other mixed,PTSD,87,A,PTSD,,46,,From Survivor to Thriver,From Survivor to Thriver,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,46,Structured Clinical Interview,PSS-I,PSS-I,ITT,Imputed using R package mice,Residual difference score model for change in mean scores,End of Treatment,0,,,,,,,,,,,,,Cohen's d,0.88,,,,,,,,,,,,,,,RCI for PSS-I,,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, intimate partner violence",High,"Littleton HL, Grills AE, Kline KD, et al. The From Survivor to Thriver program: RCT of an online therapist-facilitated program for rape-related PTSD. J Anxiety Disord. 2016 Oct;43:41-51. doi: 10.1016/j.janxdis.2016.07.010. PMID: 27513363.",45583,2019
littleton2016_PSS-I_A_12_Comp,Other mixed,PTSD,87,A,PTSD,,20,,From Survivor to Thriver,From Survivor to Thriver,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,46,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Residual difference score model for change in mean scores,Assessment at 3 to <6 Months,12,,7.9,6.3,,,,,-15.8,,,,,Cohen's d,2.6,,,,,,,,,,,,,,,RCI for PSS-I,0.8,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, intimate partner violence",High,"Littleton HL, Grills AE, Kline KD, et al. The From Survivor to Thriver program: RCT of an online therapist-facilitated program for rape-related PTSD. J Anxiety Disord. 2016 Oct;43:41-51. doi: 10.1016/j.janxdis.2016.07.010. PMID: 27513363.",45583,2019
littleton2016_PSS-I_A_12_ITT,Other mixed,PTSD,87,A,PTSD,,46,,From Survivor to Thriver,From Survivor to Thriver,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,46,Structured Clinical Interview,PSS-I,PSS-I,ITT,Imputed using R package mice,Residual difference score model for change in mean scores,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,Cohen's d,1.8,,,,,,,,,,,,,,,RCI for PSS-I,,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, intimate partner violence",High,"Littleton HL, Grills AE, Kline KD, et al. The From Survivor to Thriver program: RCT of an online therapist-facilitated program for rape-related PTSD. J Anxiety Disord. 2016 Oct;43:41-51. doi: 10.1016/j.janxdis.2016.07.010. PMID: 27513363.",45583,2019
littleton2016_PSS-I_A_Baseline_Comp,Other mixed,PTSD,87,A,PTSD,,38,,From Survivor to Thriver,From Survivor to Thriver,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,46,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Residual difference score model for change in mean scores,Baseline,,,23.7,6.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, intimate partner violence",High,"Littleton HL, Grills AE, Kline KD, et al. The From Survivor to Thriver program: RCT of an online therapist-facilitated program for rape-related PTSD. J Anxiety Disord. 2016 Oct;43:41-51. doi: 10.1016/j.janxdis.2016.07.010. PMID: 27513363.",45583,2019
littleton2016_PSS-I_A_Baseline_ITT,Other mixed,PTSD,87,A,PTSD,,46,,From Survivor to Thriver,From Survivor to Thriver,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,46,Structured Clinical Interview,PSS-I,PSS-I,ITT,Imputed using R package mice,Residual difference score model for change in mean scores,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, intimate partner violence",High,"Littleton HL, Grills AE, Kline KD, et al. The From Survivor to Thriver program: RCT of an online therapist-facilitated program for rape-related PTSD. J Anxiety Disord. 2016 Oct;43:41-51. doi: 10.1016/j.janxdis.2016.07.010. PMID: 27513363.",45583,2019
littleton2016_PSS-I_B_0_Comp,Other mixed,PTSD,87,B,Control,,28,,Psychoeducation website,Psychoeducation,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Alone,41,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Residual difference score model for change in mean scores,End of Treatment,0,,10.4,8.5,,,,,-12.6,,,,,Cohen's d,1.1,,,,p<0.001,,,,,,,,,,,RCI for PSS-I,0.75,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, intimate partner violence",High,"Littleton HL, Grills AE, Kline KD, et al. The From Survivor to Thriver program: RCT of an online therapist-facilitated program for rape-related PTSD. J Anxiety Disord. 2016 Oct;43:41-51. doi: 10.1016/j.janxdis.2016.07.010. PMID: 27513363.",45583,2019
littleton2016_PSS-I_B_0_ITT,Other mixed,PTSD,87,B,Control,,41,,Psychoeducation website,Psychoeducation,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Alone,41,Structured Clinical Interview,PSS-I,PSS-I,ITT,Imputed using R package mice,Residual difference score model for change in mean scores,End of Treatment,0,,,,,,,,,,,,,Cohen's d,0.86,,,,,,,,,,,,,,,RCI for PSS-I,,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, intimate partner violence",High,"Littleton HL, Grills AE, Kline KD, et al. The From Survivor to Thriver program: RCT of an online therapist-facilitated program for rape-related PTSD. J Anxiety Disord. 2016 Oct;43:41-51. doi: 10.1016/j.janxdis.2016.07.010. PMID: 27513363.",45583,2019
littleton2016_PSS-I_B_12_Comp,Other mixed,PTSD,87,B,Control,,21,,Psychoeducation website,Psychoeducation,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Alone,41,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Residual difference score model for change in mean scores,Assessment at 3 to <6 Months,12,,6.8,5.7,,,,,-16.2,,,,,Cohen's d,2.26,,,,,,,,,,,,,,,RCI for PSS-I,0.7143,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, intimate partner violence",High,"Littleton HL, Grills AE, Kline KD, et al. The From Survivor to Thriver program: RCT of an online therapist-facilitated program for rape-related PTSD. J Anxiety Disord. 2016 Oct;43:41-51. doi: 10.1016/j.janxdis.2016.07.010. PMID: 27513363.",45583,2019
littleton2016_PSS-I_B_12_ITT,Other mixed,PTSD,87,B,Control,,,,Psychoeducation website,Psychoeducation,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Alone,41,Structured Clinical Interview,PSS-I,PSS-I,ITT,Imputed using R package mice,Residual difference score model for change in mean scores,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,Cohen's d,1.8,,,,,,,,,,,,,,,RCI for PSS-I,,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, intimate partner violence",High,"Littleton HL, Grills AE, Kline KD, et al. The From Survivor to Thriver program: RCT of an online therapist-facilitated program for rape-related PTSD. J Anxiety Disord. 2016 Oct;43:41-51. doi: 10.1016/j.janxdis.2016.07.010. PMID: 27513363.",45583,2019
littleton2016_PSS-I_B_Baseline_Comp,Other mixed,PTSD,87,B,Control,,35,,Psychoeducation website,Psychoeducation,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Alone,41,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Residual difference score model for change in mean scores,Baseline,,,23,7.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, intimate partner violence",High,"Littleton HL, Grills AE, Kline KD, et al. The From Survivor to Thriver program: RCT of an online therapist-facilitated program for rape-related PTSD. J Anxiety Disord. 2016 Oct;43:41-51. doi: 10.1016/j.janxdis.2016.07.010. PMID: 27513363.",45583,2019
littleton2016_PSS-I_B_Baseline_ITT,Other mixed,PTSD,87,B,Control,,41,,Psychoeducation website,Psychoeducation,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Alone,41,Structured Clinical Interview,PSS-I,PSS-I,ITT,Imputed using R package mice,Residual difference score model for change in mean scores,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, child physical abuse, rape/sexual assault, intimate partner violence",High,"Littleton HL, Grills AE, Kline KD, et al. The From Survivor to Thriver program: RCT of an online therapist-facilitated program for rape-related PTSD. J Anxiety Disord. 2016 Oct;43:41-51. doi: 10.1016/j.janxdis.2016.07.010. PMID: 27513363.",45583,2019
litz2012_CAPS_A_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,A,PTSD,,9,,D-cycloserine + brief exposure therapy,D-cycloserine plus imaginal exposure,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS,Completer,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.3333,,≥10 point decrease in CAPS score,0.3,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2012_CAPS_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,A,PTSD,,13,,D-cycloserine + brief exposure therapy,D-cycloserine plus imaginal exposure,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS,ITT,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",End of Treatment,0,,72.33,28.63,,,,,2.48,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,≥10 point decrease in CAPS score,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2012_CAPS_A_12_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,A,PTSD,,9,,D-cycloserine + brief exposure therapy,D-cycloserine plus imaginal exposure,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS,Completer,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Assessment at 3 to <6 Months,12,,62.57,26.65,,,,,-7.28,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,≥10 point decrease in CAPS score,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2012_CAPS_A_26_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,A,PTSD,,9,,D-cycloserine + brief exposure therapy,D-cycloserine plus imaginal exposure,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS,Completer,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Assessment at 6 to <12 Months,26,,62.20,32.17,,,,,-7.65,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,≥10 point decrease in CAPS score,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2012_CAPS_A_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,A,PTSD,,9,,D-cycloserine + brief exposure therapy,D-cycloserine plus imaginal exposure,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS,Completer,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,≥10 point decrease in CAPS score,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2012_CAPS_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,A,PTSD,,13,,D-cycloserine + brief exposure therapy,D-cycloserine plus imaginal exposure,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS,ITT,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Baseline,,,69.85,23.24,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,≥10 point decrease in CAPS score,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2012_CAPS_B_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,B,Control,,11,,Placebo + brief exposure therapy,Imaginal exposure (experimental paradigm),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS,Completer,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.3636,,≥10 point decrease in CAPS score,0.7,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2012_CAPS_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,B,Control,,13,,Placebo + brief exposure therapy,Imaginal exposure (experimental paradigm),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS,ITT,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",End of Treatment,0,,53.73,26.22,,,,,-19.65,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,≥10 point decrease in CAPS score,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2012_CAPS_B_12_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,B,Control,,11,,Placebo + brief exposure therapy,Imaginal exposure (experimental paradigm),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS,Completer,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Assessment at 3 to <6 Months,12,,58.20,26.17,,,,,-15.18,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,≥10 point decrease in CAPS score,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2012_CAPS_B_26_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,B,Control,,11,,Placebo + brief exposure therapy,Imaginal exposure (experimental paradigm),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS,Completer,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Assessment at 6 to <12 Months,26,,55.50,27.02,,,,,-17.88,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,≥10 point decrease in CAPS score,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2012_CAPS_B_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,B,Control,,11,,Placebo + brief exposure therapy,Imaginal exposure (experimental paradigm),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS,Completer,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,≥10 point decrease in CAPS score,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2012_CAPS_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,B,Control,,13,,Placebo + brief exposure therapy,Imaginal exposure (experimental paradigm),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Structured Clinical Interview,CAPS,CAPS,ITT,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Baseline,,,73.38,16.35,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,≥10 point decrease in CAPS score,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2012_PCL_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,A,PTSD,,,,D-cycloserine + brief exposure therapy,D-cycloserine plus imaginal exposure,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PCL,PCL-M,ITT,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",End of Treatment,0,,34.11,21.09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2012_PCL_A_12_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,A,PTSD,,,,D-cycloserine + brief exposure therapy,D-cycloserine plus imaginal exposure,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PCL,PCL-M,Completer,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Assessment at 3 to <6 Months,12,,33.29,14.68,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2012_PCL_A_26_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,A,PTSD,,,,D-cycloserine + brief exposure therapy,D-cycloserine plus imaginal exposure,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PCL,PCL-M,Completer,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Assessment at 6 to <12 Months,26,,29.20,13.16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2012_PCL_A_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,A,PTSD,,,,D-cycloserine + brief exposure therapy,D-cycloserine plus imaginal exposure,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PCL,PCL-M,Completer,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2012_PCL_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,A,PTSD,,,,D-cycloserine + brief exposure therapy,D-cycloserine plus imaginal exposure,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PCL,PCL-M,ITT,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Baseline,,,37.85,8.76,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2012_PCL_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,B,Control,,,,Placebo + brief exposure therapy,Imaginal exposure (experimental paradigm),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PCL,PCL-M,ITT,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",End of Treatment,0,,24.18,14.95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2012_PCL_B_12_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,B,Control,,,,Placebo + brief exposure therapy,Imaginal exposure (experimental paradigm),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PCL,PCL-M,Completer,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Assessment at 3 to <6 Months,12,,26.91,16.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2012_PCL_B_26_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,B,Control,,,,Placebo + brief exposure therapy,Imaginal exposure (experimental paradigm),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PCL,PCL-M,Completer,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Assessment at 6 to <12 Months,26,,27.25,15.83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2012_PCL_B_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,B,Control,,,,Placebo + brief exposure therapy,Imaginal exposure (experimental paradigm),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PCL,PCL-M,Completer,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
litz2012_PCL_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,B,Control,,,,Placebo + brief exposure therapy,Imaginal exposure (experimental paradigm),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PCL,PCL-M,ITT,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Baseline,,,39.00,8.77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.",38885,2019
liu2019_CAPS_A_0_Comp,Psychotherapy,PTSD,207,A,PTSD,,65,,CPT by videoconference,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,103,Structured Clinical Interview,CAPS,CAPS,Completer,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",End of Treatment,0,,61.3,27,,,,,-9.1,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_CAPS_A_0_ITT,Psychotherapy,PTSD,207,A,PTSD,,80,,CPT by videoconference,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,103,Structured Clinical Interview,CAPS,CAPS,ITT,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",End of Treatment,0,,62.1,27.5,,,,,-9.2,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_CAPS_A_26_Comp,Psychotherapy,PTSD,207,A,PTSD,,,,CPT by videoconference,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,103,Structured Clinical Interview,CAPS,CAPS,Completer,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Assessment at 6 to <12 Months,26,,56.1,29,,,,,-14.3,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_CAPS_A_26_ITT,Psychotherapy,PTSD,207,A,PTSD,,66,,CPT by videoconference,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,103,Structured Clinical Interview,CAPS,CAPS,ITT,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Assessment at 6 to <12 Months,26,,56.6,28.5,,,,,-14.7,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,207,A,PTSD,,65,,CPT by videoconference,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,103,Structured Clinical Interview,CAPS,CAPS,Completer,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Baseline,,,70.4,16.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,207,A,PTSD,,103,,CPT by videoconference,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,103,Structured Clinical Interview,CAPS,CAPS,ITT,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Baseline,,,71.3,17.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_CAPS_B_0_Comp,Psychotherapy,PTSD,207,B,PTSD,,73,,CPT in person,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,104,Structured Clinical Interview,CAPS,CAPS,Completer,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",End of Treatment,0,,52.2,26.9,,,,,-20.3,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_CAPS_B_0_ITT,Psychotherapy,PTSD,207,B,PTSD,,74,,CPT in person,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,104,Structured Clinical Interview,CAPS,CAPS,ITT,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",End of Treatment,0,,53.4,26.2,,,,,-19.1,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_CAPS_B_26_Comp,Psychotherapy,PTSD,207,B,PTSD,,,,CPT in person,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,104,Structured Clinical Interview,CAPS,CAPS,Completer,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Assessment at 6 to <12 Months,26,,57.3,27,,,,,-15.2,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_CAPS_B_26_ITT,Psychotherapy,PTSD,207,B,PTSD,,62,,CPT in person,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,104,Structured Clinical Interview,CAPS,CAPS,ITT,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Assessment at 6 to <12 Months,26,,57.3,26.9,,,,,-15.2,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,207,B,PTSD,,73,,CPT in person,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,104,Structured Clinical Interview,CAPS,CAPS,Completer,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Baseline,,,72.5,18.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,207,B,PTSD,,104,,CPT in person,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,104,Structured Clinical Interview,CAPS,CAPS,ITT,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Baseline,,,72.5,18.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_PCL_A_0_Comp,Psychotherapy,PTSD,207,A,PTSD,,,,CPT by videoconference,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,103,Self report,PCL,PCL-S,Completer,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",End of Treatment,0,,51.3,16.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_PCL_A_0_ITT,Psychotherapy,PTSD,207,A,PTSD,,,,CPT by videoconference,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,103,Self report,PCL,PCL-S,ITT,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",End of Treatment,0,,51.3,16.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_PCL_A_26_Comp,Psychotherapy,PTSD,207,A,PTSD,,,,CPT by videoconference,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,103,Self report,PCL,PCL-S,Completer,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Assessment at 6 to <12 Months,26,,47.5,16.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_PCL_A_26_ITT,Psychotherapy,PTSD,207,A,PTSD,,,,CPT by videoconference,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,103,Self report,PCL,PCL-S,ITT,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Assessment at 6 to <12 Months,26,,48.3,17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_PCL_A_Baseline_Comp,Psychotherapy,PTSD,207,A,PTSD,,,,CPT by videoconference,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,103,Self report,PCL,PCL-S,Completer,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Baseline,,,59.4,13.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_PCL_A_Baseline_ITT,Psychotherapy,PTSD,207,A,PTSD,,,,CPT by videoconference,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,103,Self report,PCL,PCL-S,ITT,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Baseline,,,59.1,13.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_PCL_B_0_Comp,Psychotherapy,PTSD,207,B,PTSD,,,,CPT in person,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,104,Self report,PCL,PCL-S,Completer,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",End of Treatment,0,,50.5,16.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_PCL_B_0_ITT,Psychotherapy,PTSD,207,B,PTSD,,,,CPT in person,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,104,Self report,PCL,PCL-S,ITT,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",End of Treatment,0,,49.3,16.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_PCL_B_26_Comp,Psychotherapy,PTSD,207,B,PTSD,,,,CPT in person,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,104,Self report,PCL,PCL-S,Completer,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Assessment at 6 to <12 Months,26,,54.0,15.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_PCL_B_26_ITT,Psychotherapy,PTSD,207,B,PTSD,,,,CPT in person,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,104,Self report,PCL,PCL-S,ITT,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Assessment at 6 to <12 Months,26,,51.5,16.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_PCL_B_Baseline_Comp,Psychotherapy,PTSD,207,B,PTSD,,,,CPT in person,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,104,Self report,PCL,PCL-S,Completer,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Baseline,,,59.4,12.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
liu2019_PCL_B_Baseline_ITT,Psychotherapy,PTSD,207,B,PTSD,,,,CPT in person,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,104,Self report,PCL,PCL-S,ITT,linear mixed-effects model,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Baseline,,,58.5,12.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.226,,0.774,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")",High,"Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.",,2020
ludascher2015_IES-R_A_0_Comp,Pharmacotherapy,PTSD,30,A,PTSD,,27,,Hydrocortisone,Hydrocortisone,No,Not Applicable,Yes,Steroids,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,IES-R,IES-R,Completer,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault, child physical abuse, child other abuse",High,"Ludascher P, Schmahl C, Feldmann RE, Jr., et al. No evidence for differential dose effects of hydrocortisone on intrusive memories in female patients with complex post-traumatic stress disorder--a randomized, double-blind, placebo-controlled, crossover study. J Psychopharmacol. 2015 Oct;29(10):1077-84. doi: 10.1177/0269881115592339. PMID: 26152322.",49607,2019
ludascher2015_IES-R_A_Baseline_Comp,Pharmacotherapy,PTSD,30,A,PTSD,,27,,Hydrocortisone,Hydrocortisone,No,Not Applicable,Yes,Steroids,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,IES-R,IES-R,Completer,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault, child physical abuse, child other abuse",High,"Ludascher P, Schmahl C, Feldmann RE, Jr., et al. No evidence for differential dose effects of hydrocortisone on intrusive memories in female patients with complex post-traumatic stress disorder--a randomized, double-blind, placebo-controlled, crossover study. J Psychopharmacol. 2015 Oct;29(10):1077-84. doi: 10.1177/0269881115592339. PMID: 26152322.",49607,2019
ludascher2015_IES-R_B_0_Comp,Pharmacotherapy,PTSD,30,B,PTSD,,27,,Hydrocortisone,Hydrocortisone,No,Not Applicable,Yes,Steroids,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,IES-R,IES-R,Completer,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault, child physical abuse, child other abuse",High,"Ludascher P, Schmahl C, Feldmann RE, Jr., et al. No evidence for differential dose effects of hydrocortisone on intrusive memories in female patients with complex post-traumatic stress disorder--a randomized, double-blind, placebo-controlled, crossover study. J Psychopharmacol. 2015 Oct;29(10):1077-84. doi: 10.1177/0269881115592339. PMID: 26152322.",49607,2019
ludascher2015_IES-R_B_Baseline_Comp,Pharmacotherapy,PTSD,30,B,PTSD,,27,,Hydrocortisone,Hydrocortisone,No,Not Applicable,Yes,Steroids,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,IES-R,IES-R,Completer,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault, child physical abuse, child other abuse",High,"Ludascher P, Schmahl C, Feldmann RE, Jr., et al. No evidence for differential dose effects of hydrocortisone on intrusive memories in female patients with complex post-traumatic stress disorder--a randomized, double-blind, placebo-controlled, crossover study. J Psychopharmacol. 2015 Oct;29(10):1077-84. doi: 10.1177/0269881115592339. PMID: 26152322.",49607,2019
ludascher2015_IES-R_C_0_Comp,Pharmacotherapy,PTSD,30,C,Control,,27,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,30,Self report,IES-R,IES-R,Completer,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault, child physical abuse, child other abuse",High,"Ludascher P, Schmahl C, Feldmann RE, Jr., et al. No evidence for differential dose effects of hydrocortisone on intrusive memories in female patients with complex post-traumatic stress disorder--a randomized, double-blind, placebo-controlled, crossover study. J Psychopharmacol. 2015 Oct;29(10):1077-84. doi: 10.1177/0269881115592339. PMID: 26152322.",49607,2019
ludascher2015_IES-R_C_Baseline_Comp,Pharmacotherapy,PTSD,30,C,Control,,27,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,30,Self report,IES-R,IES-R,Completer,,"Multi-level regression analyses with full maximum likelihood estimation, Hedge's g effect sizes",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault, child physical abuse, child other abuse",High,"Ludascher P, Schmahl C, Feldmann RE, Jr., et al. No evidence for differential dose effects of hydrocortisone on intrusive memories in female patients with complex post-traumatic stress disorder--a randomized, double-blind, placebo-controlled, crossover study. J Psychopharmacol. 2015 Oct;29(10):1077-84. doi: 10.1177/0269881115592339. PMID: 26152322.",49607,2019
maguen2017_PCL_A_0_Comp,Psychotherapy,PTSD,33,A,PTSD,,15,,Impact of Killing,Impact of Killing,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Self report,PCL,PCL-M,Completer,,Linear regression model and paired t-tests for change in mean scores (omega-squared),End of Treatment,0,,41.3,11.2,,,,,-7.33,,-14.71,-0.05,,,,,,,p=0.0512,,,,,,,,,,,,,,Veteran,,1,,0,,1,Combat-related,,Medium,"Maguen S, Burkman KM, Madden E, et al. Impact of killing in war: a randomized, controlled pilot trial. J Clin Psychol. 2017 Sep;73(9):997-1012. doi: 10.1002/jclp.22471. PMID: 28294318.",47285,2019
maguen2017_PCL_A_Baseline_Comp,Psychotherapy,PTSD,33,A,PTSD,,17,,Impact of Killing,Impact of Killing,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Self report,PCL,PCL-M,Completer,,Linear regression model and paired t-tests for change in mean scores (omega-squared),Baseline,,,48.6,14.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0,,1,Combat-related,,Medium,"Maguen S, Burkman KM, Madden E, et al. Impact of killing in war: a randomized, controlled pilot trial. J Clin Psychol. 2017 Sep;73(9):997-1012. doi: 10.1002/jclp.22471. PMID: 28294318.",47285,2019
maguen2017_PCL_B_0_Comp,Psychotherapy,PTSD,33,B,Control,,15,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,16,Self report,PCL,PCL-M,Completer,,Linear regression model and paired t-tests for change in mean scores (omega-squared),End of Treatment,0,,50.7,10.6,,,,,-2.13,,-5.97,-1.71,,,,,,,p=0.2534,,,,,,,,,,,,,,Veteran,,1,,0,,1,Combat-related,,Medium,"Maguen S, Burkman KM, Madden E, et al. Impact of killing in war: a randomized, controlled pilot trial. J Clin Psychol. 2017 Sep;73(9):997-1012. doi: 10.1002/jclp.22471. PMID: 28294318.",47285,2019
maguen2017_PCL_B_Baseline_Comp,Psychotherapy,PTSD,33,B,Control,,16,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,16,Self report,PCL,PCL-M,Completer,,Linear regression model and paired t-tests for change in mean scores (omega-squared),Baseline,,,52.9,11.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0,,1,Combat-related,,Medium,"Maguen S, Burkman KM, Madden E, et al. Impact of killing in war: a randomized, controlled pilot trial. J Clin Psychol. 2017 Sep;73(9):997-1012. doi: 10.1002/jclp.22471. PMID: 28294318.",47285,2019
mahabir2016_IES-R_A_0_NA,Pharmacotherapy,PTSD,41,A,PTSD,,19,,Propranolol,Propranolol,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Self report,IES-R,IES-R,,,Linear regression model and paired t-tests for change in mean scores (omega-squared),End of Treatment,0,,75.9,,,,,,-11.9,16.9,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7317,,0.2683,Mixed,"accidents, rape/sexual assault, combat-related, community/school violence, other (non-specified)",Medium,"Mahabir M, Ashbaugh AR, Saumier D, et al. Propranolol's impact on cognitive performance in post-traumatic stress disorder. J Affect Disord. 2016 Mar 1;192:98-103. doi: 10.1016/j.jad.2015.11.051. PMID: 26707354.",46886,2019
mahabir2016_IES-R_A_Baseline_NA,Pharmacotherapy,PTSD,41,A,PTSD,,20,,Propranolol,Propranolol,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Self report,IES-R,IES-R,,,Linear regression model and paired t-tests for change in mean scores (omega-squared),Baseline,,,87.8,16.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7317,,0.2683,Mixed,"accidents, rape/sexual assault, combat-related, community/school violence, other (non-specified)",Medium,"Mahabir M, Ashbaugh AR, Saumier D, et al. Propranolol's impact on cognitive performance in post-traumatic stress disorder. J Affect Disord. 2016 Mar 1;192:98-103. doi: 10.1016/j.jad.2015.11.051. PMID: 26707354.",46886,2019
mahabir2016_IES-R_B_0_NA,Pharmacotherapy,PTSD,41,B,Control,,21,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,21,Self report,IES-R,IES-R,,,Linear regression model and paired t-tests for change in mean scores (omega-squared),End of Treatment,0,,73.3,,,,,,-10.4,13.4,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7317,,0.2683,Mixed,"accidents, rape/sexual assault, combat-related, community/school violence, other (non-specified)",Medium,"Mahabir M, Ashbaugh AR, Saumier D, et al. Propranolol's impact on cognitive performance in post-traumatic stress disorder. J Affect Disord. 2016 Mar 1;192:98-103. doi: 10.1016/j.jad.2015.11.051. PMID: 26707354.",46886,2019
mahabir2016_IES-R_B_Baseline_NA,Pharmacotherapy,PTSD,41,B,Control,,21,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,21,Self report,IES-R,IES-R,,,Linear regression model and paired t-tests for change in mean scores (omega-squared),Baseline,,,83.7,11.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7317,,0.2683,Mixed,"accidents, rape/sexual assault, combat-related, community/school violence, other (non-specified)",Medium,"Mahabir M, Ashbaugh AR, Saumier D, et al. Propranolol's impact on cognitive performance in post-traumatic stress disorder. J Affect Disord. 2016 Mar 1;192:98-103. doi: 10.1016/j.jad.2015.11.051. PMID: 26707354.",46886,2019
maieritsch2016_CAPS_A_0_ITT,Psychotherapy,PTSD,90,A,PTSD,,25,,CPT via Telehealth,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,45,Structured Clinical Interview,CAPS,CAPS,ITT,,"Paired t-test with Cohen's d for within-group changes, and linear mixed effects model with unstructured correlation structure for longitudinal effects",End of Treatment,0,,51.2,28.3,,,,,-30.3,,,,,Cohen's d,-1.4,,,,p<0.05,,,,,,,,CAPS score <45,,,,,,Veteran,,1,,0.067,,0.933,Mixed,"MST, combat-related, community/school violence",High,"Maieritsch KP, Smith TL, Hessinger JD, et al. Randomized controlled equivalence trial comparing videoconference and in person delivery of cognitive processing therapy for PTSD. J Telemed Telecare. 2016 Jun;22(4):238-43. doi: 10.1177/1357633x15596109. PMID: 26231819.",45182,2019
maieritsch2016_CAPS_A_12_ITT,Psychotherapy,PTSD,90,A,PTSD,,,,CPT via Telehealth,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,45,Structured Clinical Interview,CAPS,CAPS,ITT,,"Paired t-test with Cohen's d for within-group changes, and linear mixed effects model with unstructured correlation structure for longitudinal effects",Assessment at 3 to <6 Months,12,Adjusted mean,50.02,,SE,4.4,,difference from adjusted mean at baseline,-31.48,,,,,,,,,,p<0.05,,,,,,,,CAPS score <45,,,,,,Veteran,,1,,0.067,,0.933,Mixed,"MST, combat-related, community/school violence",High,"Maieritsch KP, Smith TL, Hessinger JD, et al. Randomized controlled equivalence trial comparing videoconference and in person delivery of cognitive processing therapy for PTSD. J Telemed Telecare. 2016 Jun;22(4):238-43. doi: 10.1177/1357633x15596109. PMID: 26231819.",45182,2019
maieritsch2016_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,90,A,PTSD,,45,,CPT via Telehealth,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,45,Structured Clinical Interview,CAPS,CAPS,ITT,,"Paired t-test with Cohen's d for within-group changes, and linear mixed effects model with unstructured correlation structure for longitudinal effects",Baseline,,,81.5,15.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.067,,0.933,Mixed,"MST, combat-related, community/school violence",High,"Maieritsch KP, Smith TL, Hessinger JD, et al. Randomized controlled equivalence trial comparing videoconference and in person delivery of cognitive processing therapy for PTSD. J Telemed Telecare. 2016 Jun;22(4):238-43. doi: 10.1177/1357633x15596109. PMID: 26231819.",45182,2019
maieritsch2016_CAPS_B_0_ITT,Psychotherapy,PTSD,90,B,PTSD,,26,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,45,Structured Clinical Interview,CAPS,CAPS,ITT,,"Paired t-test with Cohen's d for within-group changes, and linear mixed effects model with unstructured correlation structure for longitudinal effects",End of Treatment,0,,50.7,22.1,,,,,-32.1,,,,,Cohen's d,-0.9,,,,p<0.05,,,,,,,,CAPS score <45,,,,,,Veteran,,1,,0.067,,0.933,Mixed,"MST, combat-related, community/school violence",High,"Maieritsch KP, Smith TL, Hessinger JD, et al. Randomized controlled equivalence trial comparing videoconference and in person delivery of cognitive processing therapy for PTSD. J Telemed Telecare. 2016 Jun;22(4):238-43. doi: 10.1177/1357633x15596109. PMID: 26231819.",45182,2019
maieritsch2016_CAPS_B_12_ITT,Psychotherapy,PTSD,90,B,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,45,Structured Clinical Interview,CAPS,CAPS,ITT,,"Paired t-test with Cohen's d for within-group changes, and linear mixed effects model with unstructured correlation structure for longitudinal effects",Assessment at 3 to <6 Months,12,Adjusted mean,48.24,,SE,4.2,,difference from adjusted mean at baseline,-30.36,,,,,,,,,,p<0.05,,,,,,,,CAPS score <45,,,,,,Veteran,,1,,0.067,,0.933,Mixed,"MST, combat-related, community/school violence",High,"Maieritsch KP, Smith TL, Hessinger JD, et al. Randomized controlled equivalence trial comparing videoconference and in person delivery of cognitive processing therapy for PTSD. J Telemed Telecare. 2016 Jun;22(4):238-43. doi: 10.1177/1357633x15596109. PMID: 26231819.",45182,2019
maieritsch2016_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,90,B,PTSD,,45,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,45,Structured Clinical Interview,CAPS,CAPS,ITT,,"Paired t-test with Cohen's d for within-group changes, and linear mixed effects model with unstructured correlation structure for longitudinal effects",Baseline,,,78.6,15.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.067,,0.933,Mixed,"MST, combat-related, community/school violence",High,"Maieritsch KP, Smith TL, Hessinger JD, et al. Randomized controlled equivalence trial comparing videoconference and in person delivery of cognitive processing therapy for PTSD. J Telemed Telecare. 2016 Jun;22(4):238-43. doi: 10.1177/1357633x15596109. PMID: 26231819.",45182,2019
maieritsch2016_PCL_A_0_NA,Psychotherapy,PTSD,90,A,PTSD,,,,CPT via Telehealth,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,45,Self report,PCL,PCL,,,"Paired t-test with Cohen's d for within-group changes, and linear mixed effects model with unstructured correlation structure for longitudinal effects",End of Treatment,0,,47.1,16.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.067,,0.933,Mixed,"MST, combat-related, community/school violence",High,"Maieritsch KP, Smith TL, Hessinger JD, et al. Randomized controlled equivalence trial comparing videoconference and in person delivery of cognitive processing therapy for PTSD. J Telemed Telecare. 2016 Jun;22(4):238-43. doi: 10.1177/1357633x15596109. PMID: 26231819.",45182,2019
maieritsch2016_PCL_A_12_NA,Psychotherapy,PTSD,90,A,PTSD,,,,CPT via Telehealth,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,45,Self report,PCL,PCL,,,"Paired t-test with Cohen's d for within-group changes, and linear mixed effects model with unstructured correlation structure for longitudinal effects",Assessment at 3 to <6 Months,12,Adjusted means,45.13,,SE,2.5,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.067,,0.933,Mixed,"MST, combat-related, community/school violence",High,"Maieritsch KP, Smith TL, Hessinger JD, et al. Randomized controlled equivalence trial comparing videoconference and in person delivery of cognitive processing therapy for PTSD. J Telemed Telecare. 2016 Jun;22(4):238-43. doi: 10.1177/1357633x15596109. PMID: 26231819.",45182,2019
maieritsch2016_PCL_A_Baseline_NA,Psychotherapy,PTSD,90,A,PTSD,,,,CPT via Telehealth,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,45,Self report,PCL,PCL,,,"Paired t-test with Cohen's d for within-group changes, and linear mixed effects model with unstructured correlation structure for longitudinal effects",Baseline,,,60.7,10.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.067,,0.933,Mixed,"MST, combat-related, community/school violence",High,"Maieritsch KP, Smith TL, Hessinger JD, et al. Randomized controlled equivalence trial comparing videoconference and in person delivery of cognitive processing therapy for PTSD. J Telemed Telecare. 2016 Jun;22(4):238-43. doi: 10.1177/1357633x15596109. PMID: 26231819.",45182,2019
maieritsch2016_PCL_B_0_NA,Psychotherapy,PTSD,90,B,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,45,Self report,PCL,PCL,,,"Paired t-test with Cohen's d for within-group changes, and linear mixed effects model with unstructured correlation structure for longitudinal effects",End of Treatment,0,,50.7,22.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.067,,0.933,Mixed,"MST, combat-related, community/school violence",High,"Maieritsch KP, Smith TL, Hessinger JD, et al. Randomized controlled equivalence trial comparing videoconference and in person delivery of cognitive processing therapy for PTSD. J Telemed Telecare. 2016 Jun;22(4):238-43. doi: 10.1177/1357633x15596109. PMID: 26231819.",45182,2019
maieritsch2016_PCL_B_12_NA,Psychotherapy,PTSD,90,B,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,45,Self report,PCL,PCL,,,"Paired t-test with Cohen's d for within-group changes, and linear mixed effects model with unstructured correlation structure for longitudinal effects",Assessment at 3 to <6 Months,12,,45.94,,SE,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.067,,0.933,Mixed,"MST, combat-related, community/school violence",High,"Maieritsch KP, Smith TL, Hessinger JD, et al. Randomized controlled equivalence trial comparing videoconference and in person delivery of cognitive processing therapy for PTSD. J Telemed Telecare. 2016 Jun;22(4):238-43. doi: 10.1177/1357633x15596109. PMID: 26231819.",45182,2019
maieritsch2016_PCL_B_Baseline_NA,Psychotherapy,PTSD,90,B,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,45,Self report,PCL,PCL,,,"Paired t-test with Cohen's d for within-group changes, and linear mixed effects model with unstructured correlation structure for longitudinal effects",Baseline,,,60.1,10.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.067,,0.933,Mixed,"MST, combat-related, community/school violence",High,"Maieritsch KP, Smith TL, Hessinger JD, et al. Randomized controlled equivalence trial comparing videoconference and in person delivery of cognitive processing therapy for PTSD. J Telemed Telecare. 2016 Jun;22(4):238-43. doi: 10.1177/1357633x15596109. PMID: 26231819.",45182,2019
manteghi2014_CAPS_A_0_Comp,Pharmacotherapy,PTSD,40,A,PTSD,,13,,Citalopram + baclofen,Citalopram + baclofen,No,Not Applicable,Yes,Mixed,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,,"Paired t-test with Cohen's d for within-group changes, and linear mixed effects model with unstructured correlation structure for longitudinal effects",End of Treatment,0,,38,11.69,,,,,-23,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Manteghi AA, Hebrani P, Mortezania M, et al. Baclofen add-on to citalopram in treatment of posttraumatic stress disorder. J Clin Psychopharmacol. 2014 Apr;34(2):240-3. doi: 10.1097/jcp.0000000000000089. PMID: 24525635.",42065,2019
manteghi2014_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,40,A,PTSD,,13,,Citalopram + baclofen,Citalopram + baclofen,No,Not Applicable,Yes,Mixed,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,,"Paired t-test with Cohen's d for within-group changes, and linear mixed effects model with unstructured correlation structure for longitudinal effects",Baseline,,,61,16.06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Manteghi AA, Hebrani P, Mortezania M, et al. Baclofen add-on to citalopram in treatment of posttraumatic stress disorder. J Clin Psychopharmacol. 2014 Apr;34(2):240-3. doi: 10.1097/jcp.0000000000000089. PMID: 24525635.",42065,2019
manteghi2014_CAPS_B_0_Comp,Pharmacotherapy,PTSD,40,B,Control,,10,,Citalopram + placebo,Citalopram + placebo,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,,"Paired t-test with Cohen's d for within-group changes, and linear mixed effects model with unstructured correlation structure for longitudinal effects",End of Treatment,0,,46.2,7.89,,,,,-15.6,,,,,,,,,,p=significant,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Manteghi AA, Hebrani P, Mortezania M, et al. Baclofen add-on to citalopram in treatment of posttraumatic stress disorder. J Clin Psychopharmacol. 2014 Apr;34(2):240-3. doi: 10.1097/jcp.0000000000000089. PMID: 24525635.",42065,2019
manteghi2014_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,40,B,Control,,10,,Citalopram + placebo,Citalopram + placebo,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,,"Paired t-test with Cohen's d for within-group changes, and linear mixed effects model with unstructured correlation structure for longitudinal effects",Baseline,,,61.8,14.38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Manteghi AA, Hebrani P, Mortezania M, et al. Baclofen add-on to citalopram in treatment of posttraumatic stress disorder. J Clin Psychopharmacol. 2014 Apr;34(2):240-3. doi: 10.1097/jcp.0000000000000089. PMID: 24525635.",42065,2019
marcus1997_IES_A_0_NA,Psychotherapy,PTSD,67,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,IES,IES,,,"t-test for change in mean score, chi-square test for diagnostic change",End of Treatment,0,,17.89,16.46,,,,,-27.5,20.17,,,,Cohen's d,2.03,,,,p=0.009,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,0.77,,,,,Community,,,1,0.791,,0.209,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disaster",High,"Marcus SV, Marquis P, Sakai CE. Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy (Chic). 1997;34(3):307-15. doi: 10.1037/h0087791.",09960,2019
marcus1997_IES_A_12_NA,Psychotherapy,PTSD,67,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,IES,IES,,,"t-test for change in mean score, chi-square test for diagnostic change",Assessment at 3 to <6 Months,12,,12.32,14.63,,,,,-33.77,,,,,Cohen's d,0.36,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,,,,,,Community,,,1,0.791,,0.209,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disaster",High,"Marcus SV, Marquis P, Sakai CE. Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy (Chic). 1997;34(3):307-15. doi: 10.1037/h0087791.",09960,2019
marcus1997_IES_A_26_NA,Psychotherapy,PTSD,67,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,IES,IES,,,"t-test for change in mean score, chi-square test for diagnostic change",Assessment at 6 to <12 Months,26,,11.45,14.58,,,,,-34.64,,,,,Cohen's d,0.41,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,,,,,,Community,,,1,0.791,,0.209,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disaster",High,"Marcus SV, Marquis P, Sakai CE. Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy (Chic). 1997;34(3):307-15. doi: 10.1037/h0087791.",09960,2019
marcus1997_IES_A_Baseline_NA,Psychotherapy,PTSD,67,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,IES,IES,,,"t-test for change in mean score, chi-square test for diagnostic change",Baseline,,,46.09,10.65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.791,,0.209,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disaster",High,"Marcus SV, Marquis P, Sakai CE. Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy (Chic). 1997;34(3):307-15. doi: 10.1037/h0087791.",09960,2019
marcus1997_IES_B_0_NA,Psychotherapy,PTSD,67,B,Control,,,,Standard care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,,Self report,IES,IES,,,"t-test for change in mean score, chi-square test for diagnostic change",End of Treatment,0,,35,20.24,,,,,-13.42,18.83,,,,Cohen's d,0.89,,,,p=0.009,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,0.5,,,,,Community,,,1,0.791,,0.209,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disaster",High,"Marcus SV, Marquis P, Sakai CE. Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy (Chic). 1997;34(3):307-15. doi: 10.1037/h0087791.",09960,2019
marcus1997_IES_B_12_NA,Psychotherapy,PTSD,67,B,Control,,,,Standard care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,,Self report,IES,IES,,,"t-test for change in mean score, chi-square test for diagnostic change",Assessment at 3 to <6 Months,12,,33,20.82,,,,,-16.7,,,,,Cohen's d,0.1,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,,,,,,Community,,,1,0.791,,0.209,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disaster",High,"Marcus SV, Marquis P, Sakai CE. Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy (Chic). 1997;34(3):307-15. doi: 10.1037/h0087791.",09960,2019
marcus1997_IES_B_26_NA,Psychotherapy,PTSD,67,B,Control,,,,Standard care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,,Self report,IES,IES,,,"t-test for change in mean score, chi-square test for diagnostic change",Assessment at 6 to <12 Months,26,,27.64,21.07,,,,,-22.06,,,,,Cohen's d,0.36,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,,,,,,Community,,,1,0.791,,0.209,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disaster",High,"Marcus SV, Marquis P, Sakai CE. Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy (Chic). 1997;34(3):307-15. doi: 10.1037/h0087791.",09960,2019
marcus1997_IES_B_Baseline_NA,Psychotherapy,PTSD,67,B,Control,,,,Standard care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,,Self report,IES,IES,,,"t-test for change in mean score, chi-square test for diagnostic change",Baseline,,,49.7,11.71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.791,,0.209,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disaster",High,"Marcus SV, Marquis P, Sakai CE. Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy (Chic). 1997;34(3):307-15. doi: 10.1037/h0087791.",09960,2019
marcus1997_MPSS_A_0_NA,Psychotherapy,PTSD,67,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,MPSS,MPSS,,,"t-test for change in mean score, chi-square test for diagnostic change",End of Treatment,0,,24.50,21.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.791,,0.209,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disaster",High,"Marcus SV, Marquis P, Sakai CE. Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy (Chic). 1997;34(3):307-15. doi: 10.1037/h0087791.",09960,2019
marcus1997_MPSS_A_12_NA,Psychotherapy,PTSD,67,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,MPSS,MPSS,,,"t-test for change in mean score, chi-square test for diagnostic change",Assessment at 3 to <6 Months,12,,17.25,21.08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.791,,0.209,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disaster",High,"Marcus SV, Marquis P, Sakai CE. Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy (Chic). 1997;34(3):307-15. doi: 10.1037/h0087791.",09960,2019
marcus1997_MPSS_A_26_NA,Psychotherapy,PTSD,67,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,MPSS,MPSS,,,"t-test for change in mean score, chi-square test for diagnostic change",Assessment at 6 to <12 Months,26,,15.95,17.79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.791,,0.209,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disaster",High,"Marcus SV, Marquis P, Sakai CE. Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy (Chic). 1997;34(3):307-15. doi: 10.1037/h0087791.",09960,2019
marcus1997_MPSS_A_Baseline_NA,Psychotherapy,PTSD,67,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,MPSS,MPSS,,,"t-test for change in mean score, chi-square test for diagnostic change",Baseline,,,66.45,20.09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.791,,0.209,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disaster",High,"Marcus SV, Marquis P, Sakai CE. Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy (Chic). 1997;34(3):307-15. doi: 10.1037/h0087791.",09960,2019
marcus1997_MPSS_B_0_NA,Psychotherapy,PTSD,67,B,Control,,,,Standard care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,,Self report,MPSS,MPSS,,,"t-test for change in mean score, chi-square test for diagnostic change",End of Treatment,0,,44.26,30.02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.791,,0.209,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disaster",High,"Marcus SV, Marquis P, Sakai CE. Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy (Chic). 1997;34(3):307-15. doi: 10.1037/h0087791.",09960,2019
marcus1997_MPSS_B_12_NA,Psychotherapy,PTSD,67,B,Control,,,,Standard care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,,Self report,MPSS,MPSS,,,"t-test for change in mean score, chi-square test for diagnostic change",Assessment at 3 to <6 Months,12,,42.21,27.19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.791,,0.209,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disaster",High,"Marcus SV, Marquis P, Sakai CE. Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy (Chic). 1997;34(3):307-15. doi: 10.1037/h0087791.",09960,2019
marcus1997_MPSS_B_26_NA,Psychotherapy,PTSD,67,B,Control,,,,Standard care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,,Self report,MPSS,MPSS,,,"t-test for change in mean score, chi-square test for diagnostic change",Assessment at 6 to <12 Months,26,,43.50,35.12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.791,,0.209,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disaster",High,"Marcus SV, Marquis P, Sakai CE. Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy (Chic). 1997;34(3):307-15. doi: 10.1037/h0087791.",09960,2019
marcus1997_MPSS_B_Baseline_NA,Psychotherapy,PTSD,67,B,Control,,,,Standard care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,,Self report,MPSS,MPSS,,,"t-test for change in mean score, chi-square test for diagnostic change",Baseline,,,72.09,17.62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.791,,0.209,Mixed,"rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disaster",High,"Marcus SV, Marquis P, Sakai CE. Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy (Chic). 1997;34(3):307-15. doi: 10.1037/h0087791.",09960,2019
margolies2013_PSS-SR_A_0_Comp,Psychotherapy,PTSD,40,A,PTSD,,15,,CBT-I + IRT,Cognitive Behavioral Therapy for Insomnia (CBT-I) + Imagery Rehearsal Training (IRT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,20,Self report,PSS-SR,PSS-SR,Completer,BOCF,"t-test for change in mean score, chi-square test for diagnostic change",End of Treatment,0,,39.8,11.4,,,,,-2,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1,,0.9,,,High,"Margolies SO, Rybarczyk B, Vrana SR, et al. Efficacy of a cognitive-behavioral treatment for insomnia and nightmares in Afghanistan and Iraq veterans with PTSD. Journal of Clinical Psychology. 2013 Oct;69(10):1026-42. doi: 10.1002/jclp.21970. PMID: 23629959.",40515,2020
margolies2013_PSS-SR_A_Baseline_Comp,Psychotherapy,PTSD,40,A,PTSD,,15,,CBT-I + IRT,Cognitive Behavioral Therapy for Insomnia (CBT-I) + Imagery Rehearsal Training (IRT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,20,Self report,PSS-SR,PSS-SR,Completer,BOCF,"t-test for change in mean score, chi-square test for diagnostic change",Baseline,,,41.8,14.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1,,0.9,,,High,"Margolies SO, Rybarczyk B, Vrana SR, et al. Efficacy of a cognitive-behavioral treatment for insomnia and nightmares in Afghanistan and Iraq veterans with PTSD. Journal of Clinical Psychology. 2013 Oct;69(10):1026-42. doi: 10.1002/jclp.21970. PMID: 23629959.",40515,2020
margolies2013_PSS-SR_B_0_Comp,Psychotherapy,PTSD,40,B,Control,,12,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,20,Self report,PSS-SR,PSS-SR,Completer,BOCF,"t-test for change in mean score, chi-square test for diagnostic change",End of Treatment,0,,47.1,9.7,,,,,13.6,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1,,0.9,,,High,"Margolies SO, Rybarczyk B, Vrana SR, et al. Efficacy of a cognitive-behavioral treatment for insomnia and nightmares in Afghanistan and Iraq veterans with PTSD. Journal of Clinical Psychology. 2013 Oct;69(10):1026-42. doi: 10.1002/jclp.21970. PMID: 23629959.",40515,2020
margolies2013_PSS-SR_B_Baseline_Comp,Psychotherapy,PTSD,40,B,Control,,12,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,20,Self report,PSS-SR,PSS-SR,Completer,BOCF,"t-test for change in mean score, chi-square test for diagnostic change",Baseline,,,33.5,13.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1,,0.9,,,High,"Margolies SO, Rybarczyk B, Vrana SR, et al. Efficacy of a cognitive-behavioral treatment for insomnia and nightmares in Afghanistan and Iraq veterans with PTSD. Journal of Clinical Psychology. 2013 Oct;69(10):1026-42. doi: 10.1002/jclp.21970. PMID: 23629959.",40515,2020
markowitz2015a_CAPS_A_0_ITT,Psychotherapy,PTSD,110,A,PTSD,,28,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,38,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputations for missing values using Markov Chain Monte Carlo method; participants with missing followup CAPS scores were categorized as nonresponders and nonremitters,Longitudinal mixed effects models; chi-squared for response and remission rates,End of Treatment,0,,37.5,28.8,,,,,-31.6,,,,,Cohen's d,1.88,,,,,,,,,,,,,,,>30% decrease from baseline CAPS,0.4737,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, other (child abuse unspecified, interpersonal, not specified)",Medium,"Markowitz JC, Petkova E, Neria Y, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015 May;172(5):430-40. doi: 10.1176/appi.ajp.2014.14070908. PMID: 25677355.",43409,2019
markowitz2015a_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,110,A,PTSD,,37,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,38,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputations for missing values using Markov Chain Monte Carlo method; participants with missing followup CAPS scores were categorized as nonresponders and nonremitters,Longitudinal mixed effects models; chi-squared for response and remission rates,Baseline,,,72.1,18.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, other (child abuse unspecified, interpersonal, not specified)",Medium,"Markowitz JC, Petkova E, Neria Y, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015 May;172(5):430-40. doi: 10.1176/appi.ajp.2014.14070908. PMID: 25677355.",43409,2019
markowitz2015a_CAPS_B_0_ITT,Psychotherapy,PTSD,110,B,PTSD,,36,,Interpersonal Psychotherapy,Interpersonal Psychotherapy (IPT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,40,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputations for missing values using Markov Chain Monte Carlo method; participants with missing followup CAPS scores were categorized as nonresponders and nonremitters,Longitudinal mixed effects models; chi-squared for response and remission rates,End of Treatment,0,,39.8,24.3,,,,,-28.6,,,,,Cohen's d,1.69,,,,,,,,,,,,,,,>30% decrease from baseline CAPS,0.625,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, other (child abuse unspecified, interpersonal, not specified)",Medium,"Markowitz JC, Petkova E, Neria Y, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015 May;172(5):430-40. doi: 10.1176/appi.ajp.2014.14070908. PMID: 25677355.",43409,2019
markowitz2015a_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,110,B,PTSD,,40,,Interpersonal Psychotherapy,Interpersonal Psychotherapy (IPT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,40,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputations for missing values using Markov Chain Monte Carlo method; participants with missing followup CAPS scores were categorized as nonresponders and nonremitters,Longitudinal mixed effects models; chi-squared for response and remission rates,Baseline,,,68.9,16.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, other (child abuse unspecified, interpersonal, not specified)",Medium,"Markowitz JC, Petkova E, Neria Y, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015 May;172(5):430-40. doi: 10.1176/appi.ajp.2014.14070908. PMID: 25677355.",43409,2019
markowitz2015a_CAPS_C_0_ITT,Psychotherapy,PTSD,110,C,PTSD,,24,,Relaxation Therapy,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,32,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputations for missing values using Markov Chain Monte Carlo method; participants with missing followup CAPS scores were categorized as nonresponders and nonremitters,Longitudinal mixed effects models; chi-squared for response and remission rates,End of Treatment,0,,46.5,31,,,,,-22.3,,,,,Cohen's d,1.32,,,,,,,,,,,,,,,>30% decrease from baseline CAPS,0.375,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, other (child abuse unspecified, interpersonal, not specified)",Medium,"Markowitz JC, Petkova E, Neria Y, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015 May;172(5):430-40. doi: 10.1176/appi.ajp.2014.14070908. PMID: 25677355.",43409,2019
markowitz2015a_CAPS_C_Baseline_ITT,Psychotherapy,PTSD,110,C,PTSD,,30,,Relaxation Therapy,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,32,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputations for missing values using Markov Chain Monte Carlo method; participants with missing followup CAPS scores were categorized as nonresponders and nonremitters,Longitudinal mixed effects models; chi-squared for response and remission rates,Baseline,,,68.9,16.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, other (child abuse unspecified, interpersonal, not specified)",Medium,"Markowitz JC, Petkova E, Neria Y, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015 May;172(5):430-40. doi: 10.1176/appi.ajp.2014.14070908. PMID: 25677355.",43409,2019
markowitz2015a_PSS-SR_A_0_NA,Psychotherapy,PTSD,110,A,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,38,Self report,PSS-SR,PSS-SR,,,Longitudinal mixed effects models; chi-squared for response and remission rates,End of Treatment,0,,34.1,26.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, other (child abuse unspecified, interpersonal, not specified)",Medium,"Markowitz JC, Petkova E, Neria Y, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015 May;172(5):430-40. doi: 10.1176/appi.ajp.2014.14070908. PMID: 25677355.",43409,2019
markowitz2015a_PSS-SR_A_Baseline_NA,Psychotherapy,PTSD,110,A,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,38,Self report,PSS-SR,PSS-SR,,,Longitudinal mixed effects models; chi-squared for response and remission rates,Baseline,,,77.7,22.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, other (child abuse unspecified, interpersonal, not specified)",Medium,"Markowitz JC, Petkova E, Neria Y, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015 May;172(5):430-40. doi: 10.1176/appi.ajp.2014.14070908. PMID: 25677355.",43409,2019
markowitz2015a_PSS-SR_B_0_NA,Psychotherapy,PTSD,110,B,PTSD,,,,Interpersonal Psychotherapy,Interpersonal Psychotherapy (IPT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,40,Self report,PSS-SR,PSS-SR,,,Longitudinal mixed effects models; chi-squared for response and remission rates,End of Treatment,0,,41.7,26.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, other (child abuse unspecified, interpersonal, not specified)",Medium,"Markowitz JC, Petkova E, Neria Y, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015 May;172(5):430-40. doi: 10.1176/appi.ajp.2014.14070908. PMID: 25677355.",43409,2019
markowitz2015a_PSS-SR_B_Baseline_NA,Psychotherapy,PTSD,110,B,PTSD,,,,Interpersonal Psychotherapy,Interpersonal Psychotherapy (IPT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,40,Self report,PSS-SR,PSS-SR,,,Longitudinal mixed effects models; chi-squared for response and remission rates,Baseline,,,74.3,20.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, other (child abuse unspecified, interpersonal, not specified)",Medium,"Markowitz JC, Petkova E, Neria Y, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015 May;172(5):430-40. doi: 10.1176/appi.ajp.2014.14070908. PMID: 25677355.",43409,2019
markowitz2015a_PSS-SR_C_0_NA,Psychotherapy,PTSD,110,C,PTSD,,,,Relaxation Therapy,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,32,Self report,PSS-SR,PSS-SR,,,Longitudinal mixed effects models; chi-squared for response and remission rates,End of Treatment,0,,64.7,27.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, other (child abuse unspecified, interpersonal, not specified)",Medium,"Markowitz JC, Petkova E, Neria Y, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015 May;172(5):430-40. doi: 10.1176/appi.ajp.2014.14070908. PMID: 25677355.",43409,2019
markowitz2015a_PSS-SR_C_Baseline_NA,Psychotherapy,PTSD,110,C,PTSD,,,,Relaxation Therapy,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,32,Self report,PSS-SR,PSS-SR,,,Longitudinal mixed effects models; chi-squared for response and remission rates,Baseline,,,83.2,15.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, other (child abuse unspecified, interpersonal, not specified)",Medium,"Markowitz JC, Petkova E, Neria Y, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015 May;172(5):430-40. doi: 10.1176/appi.ajp.2014.14070908. PMID: 25677355.",43409,2019
marks1998_CAPS_A_0_Comp,Psychotherapy,PTSD,87,A,PTSD,,20,,Exposure Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Structured Clinical Interview,CAPS,CAPS-2 severity,Completer,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,1.5,1.4,,,,,-1.1,,,,,Standardized mean change,1,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-2,0.75,,"≥2 standard deviations improvement from baseline on total of 3 clusters on CAPS (reexperiencing, avoidance, and arousal)",,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement",Medium,"Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.",09640,2019
marks1998_CAPS_A_12_Comp,Psychotherapy,PTSD,87,A,PTSD,,13,,Exposure Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Structured Clinical Interview,CAPS,CAPS-2 severity,Completer,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Assessment at 3 to <6 Months,12,,0.5,0.5,,,,,-2.1,,,,,Standardized mean change,2,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-2,,,,,,Community,,,1,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement",Medium,"Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.",09640,2019
marks1998_CAPS_A_26_Comp,Psychotherapy,PTSD,87,A,PTSD,,12,,Exposure Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Structured Clinical Interview,CAPS,CAPS-2 severity,Completer,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Assessment at 6 to <12 Months,26,,0.5,0.5,,,,,-2.1,,,,,Standardized mean change,2,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-2,,,,,,Community,,,1,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement",Medium,"Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.",09640,2019
marks1998_CAPS_A_4_Comp,Psychotherapy,PTSD,87,A,PTSD,,16,,Exposure Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Structured Clinical Interview,CAPS,CAPS-2 severity,Completer,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Assessment at <3 Months,4,,1.1,1.2,,,,,-1.5,,,,,Standardized mean change,1,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-2,,,,,,Community,,,1,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement",Medium,"Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.",09640,2019
marks1998_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,87,A,PTSD,,20,,Exposure Therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Structured Clinical Interview,CAPS,CAPS-2 severity,Completer,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,2.6,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement",Medium,"Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.",09640,2019
marks1998_CAPS_B_0_Comp,Psychotherapy,PTSD,87,B,PTSD,,19,,CR,Cognitive restructuring,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Structured Clinical Interview,CAPS,CAPS-2 severity,Completer,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,1.6,1.2,,,,,-1.6,,,,,Standardized mean change,1,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-2,0.65,,"≥2 standard deviations improvement from baseline on total of 3 clusters on CAPS (reexperiencing, avoidance, and arousal)",,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement",Medium,"Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.",09640,2019
marks1998_CAPS_B_12_Comp,Psychotherapy,PTSD,87,B,PTSD,,13,,CR,Cognitive restructuring,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Structured Clinical Interview,CAPS,CAPS-2 severity,Completer,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Assessment at 3 to <6 Months,12,,1.5,0.9,,,,,-1.7,,,,,Standardized mean change,2,,,,,,,,,,,,,,,,,,Community,,,1,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement",Medium,"Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.",09640,2019
marks1998_CAPS_B_26_Comp,Psychotherapy,PTSD,87,B,PTSD,,12,,CR,Cognitive restructuring,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Structured Clinical Interview,CAPS,CAPS-2 severity,Completer,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Assessment at 6 to <12 Months,26,,1.5,0.9,,,,,-1.7,,,,,Standardized mean change,2,,,,,,,,,,,,,,,,,,Community,,,1,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement",Medium,"Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.",09640,2019
marks1998_CAPS_B_4_Comp,Psychotherapy,PTSD,87,B,PTSD,,14,,CR,Cognitive restructuring,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Structured Clinical Interview,CAPS,CAPS-2 severity,Completer,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Assessment at <3 Months,4,,1.8,1.2,,,,,-1.4,,,,,Standardized mean change,1,,,,,,,,,,,,,,,,,,Community,,,1,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement",Medium,"Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.",09640,2019
marks1998_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,87,B,PTSD,,18,,CR,Cognitive restructuring,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Structured Clinical Interview,CAPS,CAPS-2 severity,Completer,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,3.2,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement",Medium,"Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.",09640,2019
marks1998_CAPS_C_0_Comp,Psychotherapy,PTSD,87,C,PTSD,,20,,Exposure combined with CR,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,24,Structured Clinical Interview,CAPS,CAPS-2 severity,Completer,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,2,1.2,,,,,-1.1,,,,,Standardized mean change,1,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-2,0.63,,"≥2 standard deviations improvement from baseline on total of 3 clusters on CAPS (reexperiencing, avoidance, and arousal)",,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement",Medium,"Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.",09640,2019
marks1998_CAPS_C_12_Comp,Psychotherapy,PTSD,87,C,PTSD,,14,,Exposure combined with CR,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,24,Structured Clinical Interview,CAPS,CAPS-2 severity,Completer,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Assessment at 3 to <6 Months,12,,1.1,1,,,,,-2,,,,,Standardized mean change,2,,,,,,,,,,,,,,,,,,Community,,,1,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement",Medium,"Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.",09640,2019
marks1998_CAPS_C_26_Comp,Psychotherapy,PTSD,87,C,PTSD,,11,,Exposure combined with CR,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,24,Structured Clinical Interview,CAPS,CAPS-2 severity,Completer,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Assessment at 6 to <12 Months,26,,0.8,0.7,,,,,-2.3,,,,,Standardized mean change,2,,,,,,,,,,,,,,,,,,Community,,,1,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement",Medium,"Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.",09640,2019
marks1998_CAPS_C_4_Comp,Psychotherapy,PTSD,87,C,PTSD,,18,,Exposure combined with CR,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,24,Structured Clinical Interview,CAPS,CAPS-2 severity,Completer,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Assessment at <3 Months,4,,1.6,1.5,,,,,-1.5,,,,,Standardized mean change,2,,,,,,,,,,,,,,,,,,Community,,,1,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement",Medium,"Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.",09640,2019
marks1998_CAPS_C_Baseline_Comp,Psychotherapy,PTSD,87,C,PTSD,,19,,Exposure combined with CR,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,24,Structured Clinical Interview,CAPS,CAPS-2 severity,Completer,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,3.1,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement",Medium,"Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.",09640,2019
marks1998_CAPS_D_0_Comp,Psychotherapy,PTSD,87,D,PTSD,,18,,Relaxation,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,21,Structured Clinical Interview,CAPS,CAPS-2 severity,Completer,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,1.7,1.3,,,,,-1,,,,,Standardized mean change,1,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-2,0.55,,"≥2 standard deviations improvement from baseline on total of 3 clusters on CAPS (reexperiencing, avoidance, and arousal)",0.15,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement",Medium,"Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.",09640,2019
marks1998_CAPS_D_12_Comp,Psychotherapy,PTSD,87,D,PTSD,,13,,Relaxation,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,21,Structured Clinical Interview,CAPS,CAPS-2 severity,Completer,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Assessment at 3 to <6 Months,12,,1.5,1.1,,,,,-1.2,,,,,Standardized mean change,1,,,,,,,,,,,,,,,,,,Community,,,1,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement",Medium,"Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.",09640,2019
marks1998_CAPS_D_4_Comp,Psychotherapy,PTSD,87,D,PTSD,,16,,Relaxation,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,21,Structured Clinical Interview,CAPS,CAPS-2 severity,Completer,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Assessment at <3 Months,4,,1.8,1.1,,,,,-0.9,,,,,Standardized mean change,1,,,,,,,,,,,,,,,,,,Community,,,1,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement",Medium,"Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.",09640,2019
marks1998_CAPS_D_Baseline_Comp,Psychotherapy,PTSD,87,D,PTSD,,20,,Relaxation,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,21,Structured Clinical Interview,CAPS,CAPS-2 severity,Completer,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,2.7,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.36,,0.64,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement",Medium,"Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.",09640,2019
marshall2001_CAPS_A_0_ITT,Pharmacotherapy,PTSD,563,A,PTSD,,182,,Paroxetine (flexible dose),Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,187,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,,,,,,,-37.9,28.7,,,,,,,,,,,,,,,,,,,,CGI-I score of 1 or 2,0.544,,Community,,,1,0.6842,,0.3158,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, witnessing injury or death)",Medium,"Marshall RD, Beebe KL, Oldham M, et al. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry. 2001;158(12):1982-8. doi: 10.1176/appi.ajp.158.12.1982. PMID: 11729013.",23882,2019
marshall2001_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,563,A,PTSD,,182,,Paroxetine (flexible dose),Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,187,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,74.3,15.6,,,,,,,,,,,,,,,,,,,,,,,,,,CGI-I score of 1 or 2,,,Community,,,1,0.6842,,0.3158,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, witnessing injury or death)",Medium,"Marshall RD, Beebe KL, Oldham M, et al. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry. 2001;158(12):1982-8. doi: 10.1176/appi.ajp.158.12.1982. PMID: 11729013.",23882,2019
marshall2001_CAPS_B_0_ITT,Pharmacotherapy,PTSD,563,B,PTSD,,183,,Paroxetine (fixed dose),Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,188,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,,,,,,,-39.6,25.7,,,,,,,,,,,,,,,,,,,,CGI-I score of 1 or 2,0.6175,,Community,,,1,0.6842,,0.3158,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, witnessing injury or death)",Medium,"Marshall RD, Beebe KL, Oldham M, et al. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry. 2001;158(12):1982-8. doi: 10.1176/appi.ajp.158.12.1982. PMID: 11729013.",23882,2019
marshall2001_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,563,B,PTSD,,183,,Paroxetine (fixed dose),Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,188,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,75.3,16.1,,,,,,,,,,,,,,,,,,,,,,,,,,CGI-I score of 1 or 2,,,Community,,,1,0.6842,,0.3158,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, witnessing injury or death)",Medium,"Marshall RD, Beebe KL, Oldham M, et al. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry. 2001;158(12):1982-8. doi: 10.1176/appi.ajp.158.12.1982. PMID: 11729013.",23882,2019
marshall2001_CAPS_C_0_ITT,Pharmacotherapy,PTSD,563,C,Control,,186,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,188,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,,,,,,,-25.3,25.8,,,,,,,,,,,,,,,,,,,,CGI-I score of 1 or 2,0.3602,,Community,,,1,0.6842,,0.3158,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, witnessing injury or death)",Medium,"Marshall RD, Beebe KL, Oldham M, et al. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry. 2001;158(12):1982-8. doi: 10.1176/appi.ajp.158.12.1982. PMID: 11729013.",23882,2019
marshall2001_CAPS_C_Baseline_ITT,Pharmacotherapy,PTSD,563,C,Control,,186,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,188,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,74.4,15.9,,,,,,,,,,,,,,,,,,,,,,,,,,CGI-I score of 1 or 2,,,Community,,,1,0.6842,,0.3158,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, witnessing injury or death)",Medium,"Marshall RD, Beebe KL, Oldham M, et al. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry. 2001;158(12):1982-8. doi: 10.1176/appi.ajp.158.12.1982. PMID: 11729013.",23882,2019
marshall2007_CAPS_A_0_Comp,Pharmacotherapy,PTSD,63,A,PTSD,,17,,Paroxetine (flexible dose),Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,CAPS,CAPS,Completer,"Only observed data used, except in cases of nonignorable missing data in which case the model included the measure of missing behavior in the model",ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,55.6,33.4,,,,,-27.2,,,,,,,,,,p=0.001,,,,,,,,,,,CGI-I (threshold NR),,,Community,,,1,0.6731,,0.3269,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing events, fire)",High,"Marshall RD, Lewis-Fernández R, Blanco C, et al. A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults. Depress Anxiety. 2007;24(2):77-84. doi: 10.1002/da.20176. PMID: 16892419.",29847,2019
marshall2007_CAPS_A_0_ITT,Pharmacotherapy,PTSD,63,A,PTSD,,,,Paroxetine (flexible dose),Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,CAPS,CAPS,ITT,"Only observed data used, except in cases of nonignorable missing data in which case the model included the measure of missing behavior in the model",ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CGI-I (threshold NR),0.56,,Community,,,1,0.6731,,0.3269,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing events, fire)",High,"Marshall RD, Lewis-Fernández R, Blanco C, et al. A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults. Depress Anxiety. 2007;24(2):77-84. doi: 10.1002/da.20176. PMID: 16892419.",29847,2019
marshall2007_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,63,A,PTSD,,25,,Paroxetine (flexible dose),Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,CAPS,CAPS,Completer,"Only observed data used, except in cases of nonignorable missing data in which case the model included the measure of missing behavior in the model",ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,82.8,25.4,,,,,,,,,,,,,,,,,,,,,,,,,,CGI-I (threshold NR),,,Community,,,1,0.6731,,0.3269,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing events, fire)",High,"Marshall RD, Lewis-Fernández R, Blanco C, et al. A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults. Depress Anxiety. 2007;24(2):77-84. doi: 10.1002/da.20176. PMID: 16892419.",29847,2019
marshall2007_CAPS_B_0_Comp,Pharmacotherapy,PTSD,63,B,Control,,13,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,27,Structured Clinical Interview,CAPS,CAPS,Completer,"Only observed data used, except in cases of nonignorable missing data in which case the model included the measure of missing behavior in the model",ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,62.8,40.8,,,,,-21.4,,,,,,,,,,p=0.50,,,,,,,,,,,CGI-I (threshold NR),,,Community,,,1,0.6731,,0.3269,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing events, fire)",High,"Marshall RD, Lewis-Fernández R, Blanco C, et al. A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults. Depress Anxiety. 2007;24(2):77-84. doi: 10.1002/da.20176. PMID: 16892419.",29847,2019
marshall2007_CAPS_B_0_ITT,Pharmacotherapy,PTSD,63,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,27,Structured Clinical Interview,CAPS,CAPS,ITT,"Only observed data used, except in cases of nonignorable missing data in which case the model included the measure of missing behavior in the model",ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CGI-I (threshold NR),0.2222,,Community,,,1,0.6731,,0.3269,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing events, fire)",High,"Marshall RD, Lewis-Fernández R, Blanco C, et al. A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults. Depress Anxiety. 2007;24(2):77-84. doi: 10.1002/da.20176. PMID: 16892419.",29847,2019
marshall2007_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,63,B,Control,,27,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,27,Structured Clinical Interview,CAPS,CAPS,Completer,"Only observed data used, except in cases of nonignorable missing data in which case the model included the measure of missing behavior in the model",ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,84.2,26.7,,,,,,,,,,,,,,,,,,,,,,,,,,CGI-I (threshold NR),,,Community,,,1,0.6731,,0.3269,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing events, fire)",High,"Marshall RD, Lewis-Fernández R, Blanco C, et al. A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults. Depress Anxiety. 2007;24(2):77-84. doi: 10.1002/da.20176. PMID: 16892419.",29847,2019
martenyi2002_CAPS_A_0_ITT,Pharmacotherapy,PTSD,301,A,PTSD,,226,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,226,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,45.9,,,,,,-34.6,28.1,,,,,,,,,,,,,,,,,,,,≥50% decrease in TOP-8 total score,0.599,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0,0.4817,0.5183,0.19,,0.81,Mixed,"combat-related, other (""victim of war or witness of war event,"" ""witness of another person's death"")",Medium,"Martenyi F, Brown EB, Zhang H, et al. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry. 2002;63(3):199-206.  PMID: 11926718",24911,2019
martenyi2002_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,301,A,PTSD,,226,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,226,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,80.5,16,,,,,,,,,,,,,,,,,,,,,,,,,,≥50% decrease in TOP-8 total score,,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0,0.4817,0.5183,0.19,,0.81,Mixed,"combat-related, other (""victim of war or witness of war event,"" ""witness of another person's death"")",Medium,"Martenyi F, Brown EB, Zhang H, et al. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry. 2002;63(3):199-206.  PMID: 11926718",24911,2019
martenyi2002_CAPS_B_0_ITT,Pharmacotherapy,PTSD,301,B,Control,,75,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,75,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,54.5,,,,,,-26.8,26.1,,,,,,,,,,,,,,,,,,,,≥50% decrease in TOP-8 total score,0.438,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0,0.4817,0.5183,0.19,,0.81,Mixed,"combat-related, other (""victim of war or witness of war event,"" ""witness of another person's death"")",Medium,"Martenyi F, Brown EB, Zhang H, et al. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry. 2002;63(3):199-206.  PMID: 11926718",24911,2019
martenyi2002_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,301,B,Control,,75,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,75,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,81.3,14.1,,,,,,,,,,,,,,,,,,,,,,,,,,≥50% decrease in TOP-8 total score,,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0,0.4817,0.5183,0.19,,0.81,Mixed,"combat-related, other (""victim of war or witness of war event,"" ""witness of another person's death"")",Medium,"Martenyi F, Brown EB, Zhang H, et al. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry. 2002;63(3):199-206.  PMID: 11926718",24911,2019
martenyi2002_DTS_A_0_NA,Pharmacotherapy,PTSD,301,A,PTSD,,,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,226,Self report,DTS,DTS,,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.4817,0.5183,0.19,,0.81,Mixed,"combat-related, other (""victim of war or witness of war event,"" ""witness of another person's death"")",Medium,"Martenyi F, Brown EB, Zhang H, et al. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry. 2002;63(3):199-206.  PMID: 11926718",24911,2019
martenyi2002_DTS_A_Baseline_NA,Pharmacotherapy,PTSD,301,A,PTSD,,,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,226,Self report,DTS,DTS,,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,75.6,22.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.4817,0.5183,0.19,,0.81,Mixed,"combat-related, other (""victim of war or witness of war event,"" ""witness of another person's death"")",Medium,"Martenyi F, Brown EB, Zhang H, et al. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry. 2002;63(3):199-206.  PMID: 11926718",24911,2019
martenyi2002_DTS_B_0_NA,Pharmacotherapy,PTSD,301,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,75,Self report,DTS,DTS,,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.4817,0.5183,0.19,,0.81,Mixed,"combat-related, other (""victim of war or witness of war event,"" ""witness of another person's death"")",Medium,"Martenyi F, Brown EB, Zhang H, et al. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry. 2002;63(3):199-206.  PMID: 11926718",24911,2019
martenyi2002_DTS_B_Baseline_NA,Pharmacotherapy,PTSD,301,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,75,Self report,DTS,DTS,,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,76.2,22.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.4817,0.5183,0.19,,0.81,Mixed,"combat-related, other (""victim of war or witness of war event,"" ""witness of another person's death"")",Medium,"Martenyi F, Brown EB, Zhang H, et al. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry. 2002;63(3):199-206.  PMID: 11926718",24911,2019
martenyi2002_TOP-8_A_0_NA,Pharmacotherapy,PTSD,301,A,PTSD,,,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,226,Structured Clinical Interview,TOP-8,TOP-8,,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.4817,0.5183,0.19,,0.81,Mixed,"combat-related, other (""victim of war or witness of war event,"" ""witness of another person's death"")",Medium,"Martenyi F, Brown EB, Zhang H, et al. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry. 2002;63(3):199-206.  PMID: 11926718",24911,2019
martenyi2002_TOP-8_A_Baseline_NA,Pharmacotherapy,PTSD,301,A,PTSD,,,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,226,Structured Clinical Interview,TOP-8,TOP-8,,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,19.5,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.4817,0.5183,0.19,,0.81,Mixed,"combat-related, other (""victim of war or witness of war event,"" ""witness of another person's death"")",Medium,"Martenyi F, Brown EB, Zhang H, et al. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry. 2002;63(3):199-206.  PMID: 11926718",24911,2019
martenyi2002_TOP-8_B_0_NA,Pharmacotherapy,PTSD,301,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,75,Structured Clinical Interview,TOP-8,TOP-8,,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.4817,0.5183,0.19,,0.81,Mixed,"combat-related, other (""victim of war or witness of war event,"" ""witness of another person's death"")",Medium,"Martenyi F, Brown EB, Zhang H, et al. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry. 2002;63(3):199-206.  PMID: 11926718",24911,2019
martenyi2002_TOP-8_B_Baseline_NA,Pharmacotherapy,PTSD,301,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,75,Structured Clinical Interview,TOP-8,TOP-8,,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,19.1,3.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.4817,0.5183,0.19,,0.81,Mixed,"combat-related, other (""victim of war or witness of war event,"" ""witness of another person's death"")",Medium,"Martenyi F, Brown EB, Zhang H, et al. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry. 2002;63(3):199-206.  PMID: 11926718",24911,2019
martenyi2007_CAPS_A_0_ITT,Pharmacotherapy,PTSD,411,A,PTSD,,113,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,163,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,34.8,,,,,,-42.9,23.1,,,,,,,,,,,,,,,,,,,,"Not fulfilling DSM-IV criteria for PTSD and
≥50% decrease in TOP-8 and CGI-S ≤ 2",0.4049,,,,,,0.7153,,0.2847,Mixed,"combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)",Medium,"Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.",29532,2019
martenyi2007_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,411,A,PTSD,,113,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,163,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,77.7,15.7,,,,,,,,,,,,,,,,,,,,,,,,,,"Not fulfilling DSM-IV criteria for PTSD and
≥50% decrease in TOP-8 and CGI-S ≤ 2",,,,,,,0.7153,,0.2847,Mixed,"combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)",Medium,"Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.",29532,2019
martenyi2007_CAPS_B_0_ITT,Pharmacotherapy,PTSD,411,B,PTSD,,120,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,160,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,35.5,,,,,,-42.8,27.9,,,,,,,,,,,,,,,,,,,,"Not fulfilling DSM-IV criteria for PTSD and
≥50% decrease in TOP-8 and CGI-S ≤ 2",0.3875,,,,,,0.7153,,0.2847,Mixed,"combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)",Medium,"Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.",29532,2019
martenyi2007_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,411,B,PTSD,,120,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,160,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,78.3,16,,,,,,,,,,,,,,,,,,,,,,,,,,"Not fulfilling DSM-IV criteria for PTSD and
≥50% decrease in TOP-8 and CGI-S ≤ 2",,,,,,,0.7153,,0.2847,Mixed,"combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)",Medium,"Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.",29532,2019
martenyi2007_CAPS_C_0_ITT,Pharmacotherapy,PTSD,411,C,Control,,64,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,88,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,38.6,,,,,,-36.6,25.7,,,,,,,,,,,,,,,,,,,,"Not fulfilling DSM-IV criteria for PTSD and
≥50% decrease in TOP-8 and CGI-S ≤ 2",0.375,,,,,,0.7153,,0.2847,Mixed,"combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)",Medium,"Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.",29532,2019
martenyi2007_CAPS_C_Baseline_ITT,Pharmacotherapy,PTSD,411,C,Control,,64,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,88,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,75.2,16.1,,,,,,,,,,,,,,,,,,,,,,,,,,"Not fulfilling DSM-IV criteria for PTSD and
≥50% decrease in TOP-8 and CGI-S ≤ 2",,,,,,,0.7153,,0.2847,Mixed,"combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)",Medium,"Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.",29532,2019
martenyi2007_DTS_A_0_NA,Pharmacotherapy,PTSD,411,A,PTSD,,,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,163,Self report,DTS,DTS,,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.7153,,0.2847,Mixed,"combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)",Medium,"Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.",29532,2019
martenyi2007_DTS_A_Baseline_NA,Pharmacotherapy,PTSD,411,A,PTSD,,,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,163,Self report,DTS,DTS,,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,74.62,23.46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.7153,,0.2847,Mixed,"combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)",Medium,"Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.",29532,2019
martenyi2007_DTS_B_0_NA,Pharmacotherapy,PTSD,411,B,PTSD,,,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,160,Self report,DTS,DTS,,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.7153,,0.2847,Mixed,"combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)",Medium,"Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.",29532,2019
martenyi2007_DTS_B_Baseline_NA,Pharmacotherapy,PTSD,411,B,PTSD,,,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,160,Self report,DTS,DTS,,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,69.71,24.96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.7153,,0.2847,Mixed,"combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)",Medium,"Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.",29532,2019
martenyi2007_DTS_C_0_NA,Pharmacotherapy,PTSD,411,C,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,88,Self report,DTS,DTS,,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.7153,,0.2847,Mixed,"combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)",Medium,"Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.",29532,2019
martenyi2007_DTS_C_Baseline_NA,Pharmacotherapy,PTSD,411,C,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,88,Self report,DTS,DTS,,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,66.27,22.79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.7153,,0.2847,Mixed,"combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)",Medium,"Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.",29532,2019
martenyi2007_TOP-8_A_0_NA,Pharmacotherapy,PTSD,411,A,PTSD,,,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,163,Structured Clinical Interview,TOP-8,TOP-8,,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.7153,,0.2847,Mixed,"combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)",Medium,"Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.",29532,2019
martenyi2007_TOP-8_A_Baseline_NA,Pharmacotherapy,PTSD,411,A,PTSD,,,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,163,Structured Clinical Interview,TOP-8,TOP-8,,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,19.01,4.38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.7153,,0.2847,Mixed,"combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)",Medium,"Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.",29532,2019
martenyi2007_TOP-8_B_0_NA,Pharmacotherapy,PTSD,411,B,PTSD,,,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,160,Structured Clinical Interview,TOP-8,TOP-8,,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.7153,,0.2847,Mixed,"combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)",Medium,"Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.",29532,2019
martenyi2007_TOP-8_B_Baseline_NA,Pharmacotherapy,PTSD,411,B,PTSD,,,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,160,Structured Clinical Interview,TOP-8,TOP-8,,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,18.64,4.22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.7153,,0.2847,Mixed,"combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)",Medium,"Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.",29532,2019
martenyi2007_TOP-8_C_0_NA,Pharmacotherapy,PTSD,411,C,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,88,Structured Clinical Interview,TOP-8,TOP-8,,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.7153,,0.2847,Mixed,"combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)",Medium,"Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.",29532,2019
martenyi2007_TOP-8_C_Baseline_NA,Pharmacotherapy,PTSD,411,C,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,88,Structured Clinical Interview,TOP-8,TOP-8,,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,17.99,4.09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.7153,,0.2847,Mixed,"combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)",Medium,"Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.",29532,2019
mathew2011_CAPS_A_0_I,Pharmacotherapy,PTSD,47,A,PTSD,,22,,GR205171 investigational drug,GR205171 investigational drug,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,ITT (all randomized patients),LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,≥50% reduction in CAPS score,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5897,,0.4103,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death)",Medium,"Mathew SJ, Vythilingam M, Murrough JW, et al. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur. Neuropsychopharmacol. 2011;21(3):221-9. doi: 10.1016/j.euroneuro.2010.11.012. PMID: 21194898.",35587,2019
mathew2011_CAPS_A_0_mI,Pharmacotherapy,PTSD,47,A,PTSD,,20,,GR205171 investigational drug,GR205171 investigational drug,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,mITT (randomized patients who received ≥1 dose and had CAPS scores at baseline and week 1),LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,43.5,,SE,5.1,,SE 5.1,-31.7,,,,,,,,,,,,,,,,,,,,,≥50% reduction in CAPS score,0.4,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5897,,0.4103,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death)",Medium,"Mathew SJ, Vythilingam M, Murrough JW, et al. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur. Neuropsychopharmacol. 2011;21(3):221-9. doi: 10.1016/j.euroneuro.2010.11.012. PMID: 21194898.",35587,2019
mathew2011_CAPS_A_Baseline_I,Pharmacotherapy,PTSD,47,A,PTSD,,22,,GR205171 investigational drug,GR205171 investigational drug,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,ITT (all randomized patients),LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,≥50% reduction in CAPS score,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5897,,0.4103,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death)",Medium,"Mathew SJ, Vythilingam M, Murrough JW, et al. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur. Neuropsychopharmacol. 2011;21(3):221-9. doi: 10.1016/j.euroneuro.2010.11.012. PMID: 21194898.",35587,2019
mathew2011_CAPS_A_Baseline_mI,Pharmacotherapy,PTSD,47,A,PTSD,,20,,GR205171 investigational drug,GR205171 investigational drug,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,mITT (randomized patients who received ≥1 dose and had CAPS scores at baseline and week 1),LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,72.7,12.1,,,,,,,,,,,,,,,,,,,,,,,,,,≥50% reduction in CAPS score,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5897,,0.4103,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death)",Medium,"Mathew SJ, Vythilingam M, Murrough JW, et al. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur. Neuropsychopharmacol. 2011;21(3):221-9. doi: 10.1016/j.euroneuro.2010.11.012. PMID: 21194898.",35587,2019
mathew2011_CAPS_B_0_I,Pharmacotherapy,PTSD,47,B,Control,,25,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,25,Structured Clinical Interview,CAPS,CAPS,ITT (all randomized patients),LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,≥50% reduction in CAPS score,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5897,,0.4103,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death)",Medium,"Mathew SJ, Vythilingam M, Murrough JW, et al. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur. Neuropsychopharmacol. 2011;21(3):221-9. doi: 10.1016/j.euroneuro.2010.11.012. PMID: 21194898.",35587,2019
mathew2011_CAPS_B_0_mI,Pharmacotherapy,PTSD,47,B,Control,,19,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,25,Structured Clinical Interview,CAPS,CAPS,mITT (randomized patients who received ≥1 dose and had CAPS scores at baseline and week 1),LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,51.1,,SE,5.7,,SE 5.7,-25.2,,,,,,,,,,,,,,,,,,,,,≥50% reduction in CAPS score,0.2105,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5897,,0.4103,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death)",Medium,"Mathew SJ, Vythilingam M, Murrough JW, et al. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur. Neuropsychopharmacol. 2011;21(3):221-9. doi: 10.1016/j.euroneuro.2010.11.012. PMID: 21194898.",35587,2019
mathew2011_CAPS_B_Baseline_I,Pharmacotherapy,PTSD,47,B,Control,,25,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,25,Structured Clinical Interview,CAPS,CAPS,ITT (all randomized patients),LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,≥50% reduction in CAPS score,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5897,,0.4103,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death)",Medium,"Mathew SJ, Vythilingam M, Murrough JW, et al. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur. Neuropsychopharmacol. 2011;21(3):221-9. doi: 10.1016/j.euroneuro.2010.11.012. PMID: 21194898.",35587,2019
mathew2011_CAPS_B_Baseline_mI,Pharmacotherapy,PTSD,47,B,Control,,19,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,25,Structured Clinical Interview,CAPS,CAPS,mITT (randomized patients who received ≥1 dose and had CAPS scores at baseline and week 1),LOCF,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,73.6,15.6,,,,,,,,,,,,,,,,,,,,,,,,,,≥50% reduction in CAPS score,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5897,,0.4103,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death)",Medium,"Mathew SJ, Vythilingam M, Murrough JW, et al. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur. Neuropsychopharmacol. 2011;21(3):221-9. doi: 10.1016/j.euroneuro.2010.11.012. PMID: 21194898.",35587,2019
mathew2011_DTS_A_0_mI,Pharmacotherapy,PTSD,47,A,PTSD,,,,GR205171 investigational drug,GR205171 investigational drug,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Self report,DTS,DTS,mITT,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5897,,0.4103,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death)",Medium,"Mathew SJ, Vythilingam M, Murrough JW, et al. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur. Neuropsychopharmacol. 2011;21(3):221-9. doi: 10.1016/j.euroneuro.2010.11.012. PMID: 21194898.",35587,2019
mathew2011_DTS_A_Baseline_mI,Pharmacotherapy,PTSD,47,A,PTSD,,,,GR205171 investigational drug,GR205171 investigational drug,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Self report,DTS,DTS,mITT,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,74.5,22.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5897,,0.4103,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death)",Medium,"Mathew SJ, Vythilingam M, Murrough JW, et al. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur. Neuropsychopharmacol. 2011;21(3):221-9. doi: 10.1016/j.euroneuro.2010.11.012. PMID: 21194898.",35587,2019
mathew2011_DTS_B_0_mI,Pharmacotherapy,PTSD,47,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,25,Self report,DTS,DTS,mITT,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5897,,0.4103,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death)",Medium,"Mathew SJ, Vythilingam M, Murrough JW, et al. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur. Neuropsychopharmacol. 2011;21(3):221-9. doi: 10.1016/j.euroneuro.2010.11.012. PMID: 21194898.",35587,2019
mathew2011_DTS_B_Baseline_mI,Pharmacotherapy,PTSD,47,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,25,Self report,DTS,DTS,mITT,,ANOVA; ANCOVA; Effect size (standardized mean change) calculated as mean change from week 0 divided by SD of change,Baseline,,,71.9,20.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5897,,0.4103,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death)",Medium,"Mathew SJ, Vythilingam M, Murrough JW, et al. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur. Neuropsychopharmacol. 2011;21(3):221-9. doi: 10.1016/j.euroneuro.2010.11.012. PMID: 21194898.",35587,2019
maxwell2016_MPSS_A_0_NA,Psychotherapy,PTSD,18,A,PTSD,,8,,Group memory specificity training,Memory specificity training,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,9,Self report,MPSS,MPSS,,No missing data,Cohen's d,End of Treatment,0,,49,26.6,,,,,-14.5,,,,,,,,,,,,,,,,,,,,,RCI for the MPSS,0.875,,Community,,,1,0.8125,,0.1875,Mixed,"rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence, other (military-related, not specified)",Medium,"Maxwell K, Callahan JL, Holtz P, et al. Comparative study of group treatments for posttraumatic stress disorder. Psychotherapy (Chic). 2016 Dec;53(4):433-45. doi: 10.1037/pst0000032. PMID: 26390014.",50402,2019
maxwell2016_MPSS_A_12_NA,Psychotherapy,PTSD,18,A,PTSD,,8,,Group memory specificity training,Memory specificity training,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,9,Self report,MPSS,MPSS,,No missing data,Cohen's d,Assessment at 3 to <6 Months,12,,33.5,25.39,,,,,-30,,,,,,,,,,,,,,,,,,,,,RCI for the MPSS,,,Community,,,1,0.8125,,0.1875,Mixed,"rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence, other (military-related, not specified)",Medium,"Maxwell K, Callahan JL, Holtz P, et al. Comparative study of group treatments for posttraumatic stress disorder. Psychotherapy (Chic). 2016 Dec;53(4):433-45. doi: 10.1037/pst0000032. PMID: 26390014.",50402,2019
maxwell2016_MPSS_A_Baseline_NA,Psychotherapy,PTSD,18,A,PTSD,,8,,Group memory specificity training,Memory specificity training,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,9,Self report,MPSS,MPSS,,No missing data,Cohen's d,Baseline,,,63.5,18.37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8125,,0.1875,Mixed,"rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence, other (military-related, not specified)",Medium,"Maxwell K, Callahan JL, Holtz P, et al. Comparative study of group treatments for posttraumatic stress disorder. Psychotherapy (Chic). 2016 Dec;53(4):433-45. doi: 10.1037/pst0000032. PMID: 26390014.",50402,2019
maxwell2016_MPSS_B_0_NA,Psychotherapy,PTSD,18,B,PTSD,,8,,Group CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,9,Self report,MPSS,MPSS,,No missing data,Cohen's d,End of Treatment,0,,38.13,15.06,,,,,-16,,,,,,,,,,,,,,,,,,,,,RCI for the MPSS,0.875,,Community,,,1,0.8125,,0.1875,Mixed,"rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence, other (military-related, not specified)",Medium,"Maxwell K, Callahan JL, Holtz P, et al. Comparative study of group treatments for posttraumatic stress disorder. Psychotherapy (Chic). 2016 Dec;53(4):433-45. doi: 10.1037/pst0000032. PMID: 26390014.",50402,2019
maxwell2016_MPSS_B_12_NA,Psychotherapy,PTSD,18,B,PTSD,,8,,Group CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,9,Self report,MPSS,MPSS,,No missing data,Cohen's d,Assessment at 3 to <6 Months,12,,25.13,23.31,,,,,-29,,,,,,,,,,,,,,,,,,,,,RCI for the MPSS,,,Community,,,1,0.8125,,0.1875,Mixed,"rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence, other (military-related, not specified)",Medium,"Maxwell K, Callahan JL, Holtz P, et al. Comparative study of group treatments for posttraumatic stress disorder. Psychotherapy (Chic). 2016 Dec;53(4):433-45. doi: 10.1037/pst0000032. PMID: 26390014.",50402,2019
maxwell2016_MPSS_B_Baseline_NA,Psychotherapy,PTSD,18,B,PTSD,,8,,Group CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,9,Self report,MPSS,MPSS,,No missing data,Cohen's d,Baseline,,,54.13,24.87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8125,,0.1875,Mixed,"rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence, other (military-related, not specified)",Medium,"Maxwell K, Callahan JL, Holtz P, et al. Comparative study of group treatments for posttraumatic stress disorder. Psychotherapy (Chic). 2016 Dec;53(4):433-45. doi: 10.1037/pst0000032. PMID: 26390014.",50402,2019
mccall2018_PCL_A_0_ITT,Pharmacotherapy,PTSD,20,A,PTSD,,10,,Prazosin,Prazosin,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In person,10,Self report,PCL,PCL (minus sleep),ITT,Models assumed data were missing at random,Cohen's d,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.1,0.9,0.85,,0.15,Mixed,"combat-related, other (not specified)",High,"McCall WV, Pillai A, Case D, et al. A pilot, randomized clinical trial of bedtime doses of prazosin versus placebo in suicidal posttraumatic stress disorder patients with nightmares. J Clin Psychopharmacol. 2018 Dec;38(6):618-21. doi: 10.1097/JCP.0000000000000968. PMID: 30335633.",51299,2020
mccall2018_PCL_A_Baseline_ITT,Pharmacotherapy,PTSD,20,A,PTSD,,10,,Prazosin,Prazosin,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In person,10,Self report,PCL,PCL (minus sleep),ITT,Models assumed data were missing at random,Cohen's d,Baseline,,,56.9,10.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.1,0.9,0.85,,0.15,Mixed,"combat-related, other (not specified)",High,"McCall WV, Pillai A, Case D, et al. A pilot, randomized clinical trial of bedtime doses of prazosin versus placebo in suicidal posttraumatic stress disorder patients with nightmares. J Clin Psychopharmacol. 2018 Dec;38(6):618-21. doi: 10.1097/JCP.0000000000000968. PMID: 30335633.",51299,2020
mccall2018_PCL_B_0_ITT,Pharmacotherapy,PTSD,20,B,Control,,10,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,10,Self report,PCL,PCL (minus sleep),ITT,Models assumed data were missing at random,Cohen's d,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.1,0.9,0.85,,0.15,Mixed,"combat-related, other (not specified)",High,"McCall WV, Pillai A, Case D, et al. A pilot, randomized clinical trial of bedtime doses of prazosin versus placebo in suicidal posttraumatic stress disorder patients with nightmares. J Clin Psychopharmacol. 2018 Dec;38(6):618-21. doi: 10.1097/JCP.0000000000000968. PMID: 30335633.",51299,2020
mccall2018_PCL_B_Baseline_ITT,Pharmacotherapy,PTSD,20,B,Control,,10,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,10,Self report,PCL,PCL (minus sleep),ITT,Models assumed data were missing at random,Cohen's d,Baseline,,,58.9,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.1,0.9,0.85,,0.15,Mixed,"combat-related, other (not specified)",High,"McCall WV, Pillai A, Case D, et al. A pilot, randomized clinical trial of bedtime doses of prazosin versus placebo in suicidal posttraumatic stress disorder patients with nightmares. J Clin Psychopharmacol. 2018 Dec;38(6):618-21. doi: 10.1097/JCP.0000000000000968. PMID: 30335633.",51299,2020
mcdonagh2005_CAPS_A_0_Comp,Psychotherapy,PTSD,74,A,PTSD,,17,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,End of Treatment,0,,38.5,27.7,,,,,-28.6,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.471,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.",27712,2019
mcdonagh2005_CAPS_A_0_ITT,Psychotherapy,PTSD,74,A,PTSD,,29,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,End of Treatment,0,,53.1,28.8,,,,,-16.8,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.276,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.",27712,2019
mcdonagh2005_CAPS_A_12_Comp,Psychotherapy,PTSD,74,A,PTSD,,17,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at 3 to <6 Months,12,,32.8,20.4,,,,,-34.3,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.824,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.",27712,2019
mcdonagh2005_CAPS_A_26_Comp,Psychotherapy,PTSD,74,A,PTSD,,17,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at 6 to <12 Months,26,,31.9,27.8,,,,,-35.2,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.765,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.",27712,2019
mcdonagh2005_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,74,A,PTSD,,17,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Baseline,,,67.1,18.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.",27712,2019
mcdonagh2005_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,74,A,PTSD,,29,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Baseline,,,69.9,16.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.",27712,2019
mcdonagh2005_CAPS_B_0_Comp,Psychotherapy,PTSD,74,B,PTSD,,20,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,End of Treatment,0,,44.9,22.1,,,,,-22.6,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.35,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.",27712,2019
mcdonagh2005_CAPS_B_0_ITT,Psychotherapy,PTSD,74,B,PTSD,,22,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,End of Treatment,0,,47.2,22.4,,,,,-20.5,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.318,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.",27712,2019
mcdonagh2005_CAPS_B_12_Comp,Psychotherapy,PTSD,74,B,PTSD,,17,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at 3 to <6 Months,12,,32.8,20.4,,,,,-34.7,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.421,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.",27712,2019
mcdonagh2005_CAPS_B_26_Comp,Psychotherapy,PTSD,74,B,PTSD,,17,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at 6 to <12 Months,26,,43.3,23.4,,,,,-24.2,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.421,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.",27712,2019
mcdonagh2005_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,74,B,PTSD,,20,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Baseline,,,67.5,15.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.",27712,2019
mcdonagh2005_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,74,B,PTSD,,22,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Baseline,,,67.7,14.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.",27712,2019
mcdonagh2005_CAPS_C_0_Comp,Psychotherapy,PTSD,74,C,Control,,20,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,23,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,End of Treatment,0,,62.5,17,,,,,-7.5,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.2,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.",27712,2019
mcdonagh2005_CAPS_C_0_ITT,Psychotherapy,PTSD,74,C,Control,,23,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,23,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,End of Treatment,0,,65.5,18.6,,,,,-6.5,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.174,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.",27712,2019
mcdonagh2005_CAPS_C_Baseline_Comp,Psychotherapy,PTSD,74,C,Control,,20,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,23,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Baseline,,,70,16.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.",27712,2019
mcdonagh2005_CAPS_C_Baseline_ITT,Psychotherapy,PTSD,74,C,Control,,23,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,23,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Baseline,,,72,17.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,Medium,"McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.",27712,2019
mcfall2010_CAPS_A_77.9_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD+SUD,943,A,PTSD+SUD,Integrated,389,,Integrated Care,Integrated care,Yes,Non-TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In person,472,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at ≥12 Months,77.9,,68.3,,,,,,-7.2,,-9.1,-5.2,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,0.0636,,0.9364,"Other (""related to military service"")",,Medium,"McFall ME, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA. 2010 Dec 8;304(22):2485-93. doi: 10.1001/jama.2010.1769. PMID: 21139110.",35450,2020
mcfall2010_CAPS_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD+SUD,943,A,PTSD+SUD,Integrated,472,,Integrated Care,Integrated care,Yes,Non-TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In person,472,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Baseline,,,75.5,,95% CI,73.8,77.2,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0636,,0.9364,"Other (""related to military service"")",,Medium,"McFall ME, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA. 2010 Dec 8;304(22):2485-93. doi: 10.1001/jama.2010.1769. PMID: 21139110.",35450,2020
mcfall2010_CAPS_B_77.9_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD+SUD,943,B,SUD,Not integrated,392,,Smoking Cessation Clinic,Smoking cessation,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,471,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at ≥12 Months,77.9,,67.9,,,,,,-7,,-9,-5,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,0.0636,,0.9364,"Other (""related to military service"")",,Medium,"McFall ME, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA. 2010 Dec 8;304(22):2485-93. doi: 10.1001/jama.2010.1769. PMID: 21139110.",35450,2020
mcfall2010_CAPS_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD+SUD,943,B,SUD,Not integrated,471,,Smoking Cessation Clinic,Smoking cessation,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,471,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Baseline,,,74.9,,95% CI,73.3,76.6,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0636,,0.9364,"Other (""related to military service"")",,Medium,"McFall ME, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA. 2010 Dec 8;304(22):2485-93. doi: 10.1001/jama.2010.1769. PMID: 21139110.",35450,2020
mcfall2010_PCL_A_12_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD+SUD,943,A,PTSD+SUD,Integrated,,,Integrated Care,Integrated care,Yes,Non-TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In person,472,Self report,PCL,PCL,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at 3 to <6 Months,12,,57.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0636,,0.9364,"Other (""related to military service"")",,Medium,"McFall ME, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA. 2010 Dec 8;304(22):2485-93. doi: 10.1001/jama.2010.1769. PMID: 21139110.",35450,2020
mcfall2010_PCL_A_26_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD+SUD,943,A,PTSD+SUD,Integrated,,,Integrated Care,Integrated care,Yes,Non-TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In person,472,Self report,PCL,PCL,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at 6 to <12 Months,26,,61.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0636,,0.9364,"Other (""related to military service"")",,Medium,"McFall ME, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA. 2010 Dec 8;304(22):2485-93. doi: 10.1001/jama.2010.1769. PMID: 21139110.",35450,2020
mcfall2010_PCL_A_39_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD+SUD,943,A,PTSD+SUD,Integrated,,,Integrated Care,Integrated care,Yes,Non-TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In person,472,Self report,PCL,PCL,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at 6 to <12 Months,39,,58.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0636,,0.9364,"Other (""related to military service"")",,Medium,"McFall ME, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA. 2010 Dec 8;304(22):2485-93. doi: 10.1001/jama.2010.1769. PMID: 21139110.",35450,2020
mcfall2010_PCL_A_52_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD+SUD,943,A,PTSD+SUD,Integrated,,,Integrated Care,Integrated care,Yes,Non-TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In person,472,Self report,PCL,PCL,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at ≥12 Months,52,,58.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0636,,0.9364,"Other (""related to military service"")",,Medium,"McFall ME, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA. 2010 Dec 8;304(22):2485-93. doi: 10.1001/jama.2010.1769. PMID: 21139110.",35450,2020
mcfall2010_PCL_A_65_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD+SUD,943,A,PTSD+SUD,Integrated,,,Integrated Care,Integrated care,Yes,Non-TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In person,472,Self report,PCL,PCL,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at ≥12 Months,65,,57.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0636,,0.9364,"Other (""related to military service"")",,Medium,"McFall ME, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA. 2010 Dec 8;304(22):2485-93. doi: 10.1001/jama.2010.1769. PMID: 21139110.",35450,2020
mcfall2010_PCL_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD+SUD,943,A,PTSD+SUD,Integrated,,,Integrated Care,Integrated care,Yes,Non-TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In person,472,Self report,PCL,PCL,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Baseline,,,59.6,,95% CI,58.6,60.7,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0636,,0.9364,"Other (""related to military service"")",,Medium,"McFall ME, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA. 2010 Dec 8;304(22):2485-93. doi: 10.1001/jama.2010.1769. PMID: 21139110.",35450,2020
mcfall2010_PCL_B_12_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD+SUD,943,B,SUD,Not integrated,,,Smoking Cessation Clinic,Smoking cessation,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,471,Self report,PCL,PCL,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at 3 to <6 Months,12,,58.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0636,,0.9364,"Other (""related to military service"")",,Medium,"McFall ME, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA. 2010 Dec 8;304(22):2485-93. doi: 10.1001/jama.2010.1769. PMID: 21139110.",35450,2020
mcfall2010_PCL_B_26_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD+SUD,943,B,SUD,Not integrated,,,Smoking Cessation Clinic,Smoking cessation,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,471,Self report,PCL,PCL,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at 6 to <12 Months,26,,61.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0636,,0.9364,"Other (""related to military service"")",,Medium,"McFall ME, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA. 2010 Dec 8;304(22):2485-93. doi: 10.1001/jama.2010.1769. PMID: 21139110.",35450,2020
mcfall2010_PCL_B_39_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD+SUD,943,B,SUD,Not integrated,,,Smoking Cessation Clinic,Smoking cessation,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,471,Self report,PCL,PCL,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at 6 to <12 Months,39,,58.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0636,,0.9364,"Other (""related to military service"")",,Medium,"McFall ME, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA. 2010 Dec 8;304(22):2485-93. doi: 10.1001/jama.2010.1769. PMID: 21139110.",35450,2020
mcfall2010_PCL_B_52_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD+SUD,943,B,SUD,Not integrated,,,Smoking Cessation Clinic,Smoking cessation,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,471,Self report,PCL,PCL,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at ≥12 Months,52,,57.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0636,,0.9364,"Other (""related to military service"")",,Medium,"McFall ME, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA. 2010 Dec 8;304(22):2485-93. doi: 10.1001/jama.2010.1769. PMID: 21139110.",35450,2020
mcfall2010_PCL_B_65_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD+SUD,943,B,SUD,Not integrated,,,Smoking Cessation Clinic,Smoking cessation,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,471,Self report,PCL,PCL,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at ≥12 Months,65,,58.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0636,,0.9364,"Other (""related to military service"")",,Medium,"McFall ME, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA. 2010 Dec 8;304(22):2485-93. doi: 10.1001/jama.2010.1769. PMID: 21139110.",35450,2020
mcfall2010_PCL_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD+SUD,943,B,SUD,Not integrated,,,Smoking Cessation Clinic,Smoking cessation,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,471,Self report,PCL,PCL,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Baseline,,,58.9,,95% CI,57.7,60,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0636,,0.9364,"Other (""related to military service"")",,Medium,"McFall ME, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA. 2010 Dec 8;304(22):2485-93. doi: 10.1001/jama.2010.1769. PMID: 21139110.",35450,2020
mcgovern2011_CAPS_A_0_ITT,Psychotherapy,PTSD+SUD,53,A,PTSD+SUD,Integrated,,,Integrated CBT + Standard Care,Integrated Cognitive Behavioral Therapy (ICBT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,32,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,End of Treatment,0,,36.08,19.19,,,,,-39.67,,,,,,,,,,,,,,,,,,Not fulfilling criteria for PTSD according to CAPS,0.6923,,,,,Community,0,0,1,0.566,,0.434,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents",Medium,"McGovern MP, Lambert-Harris C, Alterman AI, et al. A randomized controlled trial comparing integrated cognitive behavioral therapy versus individual addiction counseling for co-occurring substance use and posttraumatic stress disorders. J Dual Diagn. 2011 Jan 1;7(4):207-27. doi: 10.1080/15504263.2011.620425. PMID: 22383864.",85821,2020
mcgovern2011_CAPS_A_12_ITT,Psychotherapy,PTSD+SUD,53,A,PTSD+SUD,Integrated,,,Integrated CBT + Standard Care,Integrated Cognitive Behavioral Therapy (ICBT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,32,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at 3 to <6 Months,12,,46.50,21.75,,,,,-29.25,,,,,,,,,,,,,,,,,,Not fulfilling criteria for PTSD according to CAPS,0.5,,,,,Community,0,0,1,0.566,,0.434,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents",Medium,"McGovern MP, Lambert-Harris C, Alterman AI, et al. A randomized controlled trial comparing integrated cognitive behavioral therapy versus individual addiction counseling for co-occurring substance use and posttraumatic stress disorders. J Dual Diagn. 2011 Jan 1;7(4):207-27. doi: 10.1080/15504263.2011.620425. PMID: 22383864.",85821,2020
mcgovern2011_CAPS_A_Baseline_ITT,Psychotherapy,PTSD+SUD,53,A,PTSD+SUD,Integrated,32,,Integrated CBT + Standard Care,Integrated Cognitive Behavioral Therapy (ICBT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,32,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Baseline,,,75.75,19.94,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.566,,0.434,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents",Medium,"McGovern MP, Lambert-Harris C, Alterman AI, et al. A randomized controlled trial comparing integrated cognitive behavioral therapy versus individual addiction counseling for co-occurring substance use and posttraumatic stress disorders. J Dual Diagn. 2011 Jan 1;7(4):207-27. doi: 10.1080/15504263.2011.620425. PMID: 22383864.",85821,2020
mcgovern2011_CAPS_B_0_ITT,Psychotherapy,PTSD+SUD,53,B,PTSD+SUD,Not integrated,,,Individual Addiction Counseling + Standard Care,Addiction Counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,21,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,End of Treatment,0,,52.60,21.86,,,,,-31.5,,,,,,,,,,,,,,,,,,Not fulfilling criteria for PTSD according to CAPS,0.5,,,,,Community,0,0,1,0.566,,0.434,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents",Medium,"McGovern MP, Lambert-Harris C, Alterman AI, et al. A randomized controlled trial comparing integrated cognitive behavioral therapy versus individual addiction counseling for co-occurring substance use and posttraumatic stress disorders. J Dual Diagn. 2011 Jan 1;7(4):207-27. doi: 10.1080/15504263.2011.620425. PMID: 22383864.",85821,2020
mcgovern2011_CAPS_B_12_ITT,Psychotherapy,PTSD+SUD,53,B,PTSD+SUD,Not integrated,10,,Individual Addiction Counseling + Standard Care,Addiction Counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,21,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at 3 to <6 Months,12,,49.75,28.64,,,,,-34.35,,,,,,,,,,,,,,,,,,Not fulfilling criteria for PTSD according to CAPS,0.75,,,,,Community,0,0,1,0.566,,0.434,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents",Medium,"McGovern MP, Lambert-Harris C, Alterman AI, et al. A randomized controlled trial comparing integrated cognitive behavioral therapy versus individual addiction counseling for co-occurring substance use and posttraumatic stress disorders. J Dual Diagn. 2011 Jan 1;7(4):207-27. doi: 10.1080/15504263.2011.620425. PMID: 22383864.",85821,2020
mcgovern2011_CAPS_B_Baseline_ITT,Psychotherapy,PTSD+SUD,53,B,PTSD+SUD,Not integrated,21,,Individual Addiction Counseling + Standard Care,Addiction Counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,21,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized estimating equations,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Baseline,,,84.10,22.57,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.566,,0.434,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents",Medium,"McGovern MP, Lambert-Harris C, Alterman AI, et al. A randomized controlled trial comparing integrated cognitive behavioral therapy versus individual addiction counseling for co-occurring substance use and posttraumatic stress disorders. J Dual Diagn. 2011 Jan 1;7(4):207-27. doi: 10.1080/15504263.2011.620425. PMID: 22383864.",85821,2020
mcgovern2015_CAPS_A_0_ITT,Psychotherapy,PTSD+SUD,221,A,PTSD+SUD,Integrated,58,,Integrated CBT + Standard Care,Integrated Cognitive Behavioral Therapy (ICBT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,73,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized linear models,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,End of Treatment,0,,46.81,24.81,,,,,-29.9,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.593,,0.407,Mixed,"child sexual abuse, community/school violence, other (not specified)",Medium,"McGovern MP, Lambert-Harris C, Xie H, et al. A randomized controlled trial of treatments for co-occurring substance use disorders and post-traumatic stress disorder. Addiction. 2015 Jul;110(7):1194-204. doi: 10.1111/add.12943. PMID: 25846251.",44027,2020
mcgovern2015_CAPS_A_Baseline_ITT,Psychotherapy,PTSD+SUD,221,A,PTSD+SUD,Integrated,73,,Integrated CBT + Standard Care,Integrated Cognitive Behavioral Therapy (ICBT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,73,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized linear models,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Baseline,,,76.71,18.13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.593,,0.407,Mixed,"child sexual abuse, community/school violence, other (not specified)",Medium,"McGovern MP, Lambert-Harris C, Xie H, et al. A randomized controlled trial of treatments for co-occurring substance use disorders and post-traumatic stress disorder. Addiction. 2015 Jul;110(7):1194-204. doi: 10.1111/add.12943. PMID: 25846251.",44027,2020
mcgovern2015_CAPS_B_0_ITT,Psychotherapy,PTSD+SUD,221,B,PTSD+SUD,Not integrated,61,,Individual Addiction Counseling + Standard Care,Addiction Counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,75,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized linear models,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,End of Treatment,0,,49.62,25.71,,,,,-29.17,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.593,,0.407,Mixed,"child sexual abuse, community/school violence, other (not specified)",Medium,"McGovern MP, Lambert-Harris C, Xie H, et al. A randomized controlled trial of treatments for co-occurring substance use disorders and post-traumatic stress disorder. Addiction. 2015 Jul;110(7):1194-204. doi: 10.1111/add.12943. PMID: 25846251.",44027,2020
mcgovern2015_CAPS_B_Baseline_ITT,Psychotherapy,PTSD+SUD,221,B,PTSD+SUD,Not integrated,75,,Individual Addiction Counseling + Standard Care,Addiction Counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,75,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized linear models,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Baseline,,,78.79,21.36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.593,,0.407,Mixed,"child sexual abuse, community/school violence, other (not specified)",Medium,"McGovern MP, Lambert-Harris C, Xie H, et al. A randomized controlled trial of treatments for co-occurring substance use disorders and post-traumatic stress disorder. Addiction. 2015 Jul;110(7):1194-204. doi: 10.1111/add.12943. PMID: 25846251.",44027,2020
mcgovern2015_CAPS_C_0_ITT,Psychotherapy,PTSD+SUD,221,C,Control,Not integrated,53,,Standard Care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Control,No,No,Individual,In person,73,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized linear models,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,End of Treatment,0,,52.60,26.46,,,,,-23.91,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.593,,0.407,Mixed,"child sexual abuse, community/school violence, other (not specified)",Medium,"McGovern MP, Lambert-Harris C, Xie H, et al. A randomized controlled trial of treatments for co-occurring substance use disorders and post-traumatic stress disorder. Addiction. 2015 Jul;110(7):1194-204. doi: 10.1111/add.12943. PMID: 25846251.",44027,2020
mcgovern2015_CAPS_C_Baseline_ITT,Psychotherapy,PTSD+SUD,221,C,Control,Not integrated,73,,Standard Care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Control,No,No,Individual,In person,73,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized linear models,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Baseline,,,76.51,20.83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.593,,0.407,Mixed,"child sexual abuse, community/school violence, other (not specified)",Medium,"McGovern MP, Lambert-Harris C, Xie H, et al. A randomized controlled trial of treatments for co-occurring substance use disorders and post-traumatic stress disorder. Addiction. 2015 Jul;110(7):1194-204. doi: 10.1111/add.12943. PMID: 25846251.",44027,2020
mcguirestanbury2020_CAPS_A_0_ITT,Psychotherapy,PTSD,20,A,PTSD,,10,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,10,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,End of Treatment,0,,22.57,21.68,,,,,-64.14,,,,,Cohen's d,0.64,,,,p<0.05,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Natural or manmade disasters; Other (childhood trauma, not specified)",Medium,"McGuire Stanbury TM, Drummond PD, Laugharne J, et al. Comparative Efficiency of EMDR and Prolonged Exposure in Treating Posttraumatic Stress Disorder: A Randomized Trial. Journal of EMDR Practice and Research. 2020;14(1):2-12. doi: 10.1891/1933-3196.14.1.2.",,2020
mcguirestanbury2020_CAPS_A_12_ITT,Psychotherapy,PTSD,20,A,PTSD,,10,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,10,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at 3 to <6 Months,12,,21.43,21.17,,,,,-65.28,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Natural or manmade disasters; Other (childhood trauma, not specified)",Medium,"McGuire Stanbury TM, Drummond PD, Laugharne J, et al. Comparative Efficiency of EMDR and Prolonged Exposure in Treating Posttraumatic Stress Disorder: A Randomized Trial. Journal of EMDR Practice and Research. 2020;14(1):2-12. doi: 10.1891/1933-3196.14.1.2.",,2020
mcguirestanbury2020_CAPS_A_26_ITT,Psychotherapy,PTSD,20,A,PTSD,,7,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,10,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at 6 to <12 Months,26,,38.57,23.88,,,,,-48.14,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Natural or manmade disasters; Other (childhood trauma, not specified)",Medium,"McGuire Stanbury TM, Drummond PD, Laugharne J, et al. Comparative Efficiency of EMDR and Prolonged Exposure in Treating Posttraumatic Stress Disorder: A Randomized Trial. Journal of EMDR Practice and Research. 2020;14(1):2-12. doi: 10.1891/1933-3196.14.1.2.",,2020
mcguirestanbury2020_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,20,A,PTSD,,10,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,10,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Baseline,,,86.71,22.85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Natural or manmade disasters; Other (childhood trauma, not specified)",Medium,"McGuire Stanbury TM, Drummond PD, Laugharne J, et al. Comparative Efficiency of EMDR and Prolonged Exposure in Treating Posttraumatic Stress Disorder: A Randomized Trial. Journal of EMDR Practice and Research. 2020;14(1):2-12. doi: 10.1891/1933-3196.14.1.2.",,2020
mcguirestanbury2020_CAPS_B_0_ITT,Psychotherapy,PTSD,20,B,PTSD,,10,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,10,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,End of Treatment,0,,17.13,16.23,,,,,-60.75,,,,,,,,,,p<0.05,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Natural or manmade disasters; Other (childhood trauma, not specified)",Medium,"McGuire Stanbury TM, Drummond PD, Laugharne J, et al. Comparative Efficiency of EMDR and Prolonged Exposure in Treating Posttraumatic Stress Disorder: A Randomized Trial. Journal of EMDR Practice and Research. 2020;14(1):2-12. doi: 10.1891/1933-3196.14.1.2.",,2020
mcguirestanbury2020_CAPS_B_12_ITT,Psychotherapy,PTSD,20,B,PTSD,,10,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,10,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at 3 to <6 Months,12,,18.38,13.26,,,,,-59.5,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Natural or manmade disasters; Other (childhood trauma, not specified)",Medium,"McGuire Stanbury TM, Drummond PD, Laugharne J, et al. Comparative Efficiency of EMDR and Prolonged Exposure in Treating Posttraumatic Stress Disorder: A Randomized Trial. Journal of EMDR Practice and Research. 2020;14(1):2-12. doi: 10.1891/1933-3196.14.1.2.",,2020
mcguirestanbury2020_CAPS_B_26_ITT,Psychotherapy,PTSD,20,B,PTSD,,8,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,10,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at 6 to <12 Months,26,,24.38,11.03,,,,,-53.5,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Natural or manmade disasters; Other (childhood trauma, not specified)",Medium,"McGuire Stanbury TM, Drummond PD, Laugharne J, et al. Comparative Efficiency of EMDR and Prolonged Exposure in Treating Posttraumatic Stress Disorder: A Randomized Trial. Journal of EMDR Practice and Research. 2020;14(1):2-12. doi: 10.1891/1933-3196.14.1.2.",,2020
mcguirestanbury2020_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,20,B,PTSD,,10,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,10,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Baseline,,,77.88,13.07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Natural or manmade disasters; Other (childhood trauma, not specified)",Medium,"McGuire Stanbury TM, Drummond PD, Laugharne J, et al. Comparative Efficiency of EMDR and Prolonged Exposure in Treating Posttraumatic Stress Disorder: A Randomized Trial. Journal of EMDR Practice and Research. 2020;14(1):2-12. doi: 10.1891/1933-3196.14.1.2.",,2020
mcguirestanbury2020_PCL_A_0_ITT,Psychotherapy,PTSD,20,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,10,Self report,PCL,PCL-C,ITT,Imputation,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,End of Treatment,0,,34.4,13.95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Natural or manmade disasters; Other (childhood trauma, not specified)",Medium,"McGuire Stanbury TM, Drummond PD, Laugharne J, et al. Comparative Efficiency of EMDR and Prolonged Exposure in Treating Posttraumatic Stress Disorder: A Randomized Trial. Journal of EMDR Practice and Research. 2020;14(1):2-12. doi: 10.1891/1933-3196.14.1.2.",,2020
mcguirestanbury2020_PCL_A_12_ITT,Psychotherapy,PTSD,20,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,10,Self report,PCL,PCL-C,ITT,Imputation,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at 3 to <6 Months,12,,36.1,17.14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Natural or manmade disasters; Other (childhood trauma, not specified)",Medium,"McGuire Stanbury TM, Drummond PD, Laugharne J, et al. Comparative Efficiency of EMDR and Prolonged Exposure in Treating Posttraumatic Stress Disorder: A Randomized Trial. Journal of EMDR Practice and Research. 2020;14(1):2-12. doi: 10.1891/1933-3196.14.1.2.",,2020
mcguirestanbury2020_PCL_A_26_ITT,Psychotherapy,PTSD,20,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,10,Self report,PCL,PCL-C,ITT,Imputation,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at 6 to <12 Months,26,,33.7,15.07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Natural or manmade disasters; Other (childhood trauma, not specified)",Medium,"McGuire Stanbury TM, Drummond PD, Laugharne J, et al. Comparative Efficiency of EMDR and Prolonged Exposure in Treating Posttraumatic Stress Disorder: A Randomized Trial. Journal of EMDR Practice and Research. 2020;14(1):2-12. doi: 10.1891/1933-3196.14.1.2.",,2020
mcguirestanbury2020_PCL_A_Baseline_ITT,Psychotherapy,PTSD,20,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,10,Self report,PCL,PCL-C,ITT,Imputation,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Baseline,,,59,16.63,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Natural or manmade disasters; Other (childhood trauma, not specified)",Medium,"McGuire Stanbury TM, Drummond PD, Laugharne J, et al. Comparative Efficiency of EMDR and Prolonged Exposure in Treating Posttraumatic Stress Disorder: A Randomized Trial. Journal of EMDR Practice and Research. 2020;14(1):2-12. doi: 10.1891/1933-3196.14.1.2.",,2020
mcguirestanbury2020_PCL_B_0_ITT,Psychotherapy,PTSD,20,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,10,Self report,PCL,PCL-C,ITT,Imputation,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,End of Treatment,0,,34.9,12.13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Natural or manmade disasters; Other (childhood trauma, not specified)",Medium,"McGuire Stanbury TM, Drummond PD, Laugharne J, et al. Comparative Efficiency of EMDR and Prolonged Exposure in Treating Posttraumatic Stress Disorder: A Randomized Trial. Journal of EMDR Practice and Research. 2020;14(1):2-12. doi: 10.1891/1933-3196.14.1.2.",,2020
mcguirestanbury2020_PCL_B_12_ITT,Psychotherapy,PTSD,20,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,10,Self report,PCL,PCL-C,ITT,Imputation,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at 3 to <6 Months,12,,35.9,17.62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Natural or manmade disasters; Other (childhood trauma, not specified)",Medium,"McGuire Stanbury TM, Drummond PD, Laugharne J, et al. Comparative Efficiency of EMDR and Prolonged Exposure in Treating Posttraumatic Stress Disorder: A Randomized Trial. Journal of EMDR Practice and Research. 2020;14(1):2-12. doi: 10.1891/1933-3196.14.1.2.",,2020
mcguirestanbury2020_PCL_B_26_ITT,Psychotherapy,PTSD,20,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,10,Self report,PCL,PCL-C,ITT,Imputation,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Assessment at 6 to <12 Months,26,,28.1,8.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Natural or manmade disasters; Other (childhood trauma, not specified)",Medium,"McGuire Stanbury TM, Drummond PD, Laugharne J, et al. Comparative Efficiency of EMDR and Prolonged Exposure in Treating Posttraumatic Stress Disorder: A Randomized Trial. Journal of EMDR Practice and Research. 2020;14(1):2-12. doi: 10.1891/1933-3196.14.1.2.",,2020
mcguirestanbury2020_PCL_B_Baseline_ITT,Psychotherapy,PTSD,20,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,10,Self report,PCL,PCL-C,ITT,Imputation,Repeated measures ANOVA with post hoc analyses (Tukey) for continuous outcomes; chi-squared for categorical outcomes.,Baseline,,,53.4,12.55,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Natural or manmade disasters; Other (childhood trauma, not specified)",Medium,"McGuire Stanbury TM, Drummond PD, Laugharne J, et al. Comparative Efficiency of EMDR and Prolonged Exposure in Treating Posttraumatic Stress Disorder: A Randomized Trial. Journal of EMDR Practice and Research. 2020;14(1):2-12. doi: 10.1891/1933-3196.14.1.2.",,2020
mclay2011_CAPS_A_0_NA,Psychotherapy,PTSD,20,A,PTSD,,10,,Virtual reality-graded exposure therapy,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,,,"Two-way ANOVA, chi-squared with Yates correction",End of Treatment,0,,48.1,36.9,,,,,-35.4,24.7,,,,,,,,,,,,,,,,,,,,≥30% reduction in CAPS score,0.7,,Active Duty Military,1,0,0,0.05,,0.95,Combat-related,,High,"McLay RN, Wood DP, Webb-Murphy JA, et al. A randomized, controlled trial of virtual reality-graded exposure therapy for post-traumatic stress disorder in active duty service members with combat-related post-traumatic stress disorder. Cyberpsychol Behav Soc Netw. 2011 Apr;14(4):223-9. doi: 10.1089/cyber.2011.0003. PMID: 21332375.",36339,2019
mclay2011_CAPS_A_Baseline_NA,Psychotherapy,PTSD,20,A,PTSD,,10,,Virtual reality-graded exposure therapy,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,,,"Two-way ANOVA, chi-squared with Yates correction",Baseline,,,83.5,18.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.05,,0.95,Combat-related,,High,"McLay RN, Wood DP, Webb-Murphy JA, et al. A randomized, controlled trial of virtual reality-graded exposure therapy for post-traumatic stress disorder in active duty service members with combat-related post-traumatic stress disorder. Cyberpsychol Behav Soc Netw. 2011 Apr;14(4):223-9. doi: 10.1089/cyber.2011.0003. PMID: 21332375.",36339,2019
mclay2011_CAPS_B_0_NA,Psychotherapy,PTSD,20,B,Control,,9,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,,,"Two-way ANOVA, chi-squared with Yates correction",End of Treatment,0,,72.3,33.8,,,,,-9.4,26.6,,,,,,,,,,,,,,,,,,,,≥30% reduction in CAPS score,0.1111,,Active Duty Military,1,0,0,0.05,,0.95,Combat-related,,High,"McLay RN, Wood DP, Webb-Murphy JA, et al. A randomized, controlled trial of virtual reality-graded exposure therapy for post-traumatic stress disorder in active duty service members with combat-related post-traumatic stress disorder. Cyberpsychol Behav Soc Netw. 2011 Apr;14(4):223-9. doi: 10.1089/cyber.2011.0003. PMID: 21332375.",36339,2019
mclay2011_CAPS_B_Baseline_NA,Psychotherapy,PTSD,20,B,Control,,10,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,,,"Two-way ANOVA, chi-squared with Yates correction",Baseline,,,82.8,13.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.05,,0.95,Combat-related,,High,"McLay RN, Wood DP, Webb-Murphy JA, et al. A randomized, controlled trial of virtual reality-graded exposure therapy for post-traumatic stress disorder in active duty service members with combat-related post-traumatic stress disorder. Cyberpsychol Behav Soc Netw. 2011 Apr;14(4):223-9. doi: 10.1089/cyber.2011.0003. PMID: 21332375.",36339,2019
mclay2017_CAPS_A_0_ITT,Psychotherapy,PTSD,81,A,PTSD,,42,,Virtual reality exposure therapy,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,43,Structured Clinical Interview,CAPS,CAPS,ITT,Listwise deletion,"Repeated-measures ANOVA, two separate analyses: 1) change from pretreatment to posttreatment, 2) pretreatment, posttreatment, and 3-month followup.",End of Treatment,0,,65.7,28.4,,,,,-9.2,26.7,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS score,0.3095,Additional definitions of Clinically Meaningful Response reported in the study,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"McLay RN, Baird A, Webb-Murphy J, et al. A randomized, head-to-head study of virtual reality exposuretherapy for posttraumatic stress disorder. Cyberpsychol Behav Soc Netw. 2017 Apr;20(4):218-24. doi: 10.1089/cyber.2016.0554. PMID: 28394217.",36339,2019
mclay2017_CAPS_A_12_ITT,Psychotherapy,PTSD,81,A,PTSD,,33,,Virtual reality exposure therapy,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,43,Structured Clinical Interview,CAPS,CAPS,ITT,Listwise deletion,"Repeated-measures ANOVA, two separate analyses: 1) change from pretreatment to posttreatment, 2) pretreatment, posttreatment, and 3-month followup.",Assessment at 3 to <6 Months,12,,58.2,29.2,,,,,-11,24.4,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS score,0.303,Additional definitions of Clinically Meaningful Response reported in the study,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"McLay RN, Baird A, Webb-Murphy J, et al. A randomized, head-to-head study of virtual reality exposuretherapy for posttraumatic stress disorder. Cyberpsychol Behav Soc Netw. 2017 Apr;20(4):218-24. doi: 10.1089/cyber.2016.0554. PMID: 28394217.",36339,2019
mclay2017_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,81,A,PTSD,,42,,Virtual reality exposure therapy,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,43,Structured Clinical Interview,CAPS,CAPS,ITT,Listwise deletion,"Repeated-measures ANOVA, two separate analyses: 1) change from pretreatment to posttreatment, 2) pretreatment, posttreatment, and 3-month followup.",Baseline,,,76.8,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"McLay RN, Baird A, Webb-Murphy J, et al. A randomized, head-to-head study of virtual reality exposuretherapy for posttraumatic stress disorder. Cyberpsychol Behav Soc Netw. 2017 Apr;20(4):218-24. doi: 10.1089/cyber.2016.0554. PMID: 28394217.",36339,2019
mclay2017_CAPS_B_0_ITT,Psychotherapy,PTSD,81,B,Control,,43,,Control exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,38,Structured Clinical Interview,CAPS,CAPS,ITT,Listwise deletion,"Repeated-measures ANOVA, two separate analyses: 1) change from pretreatment to posttreatment, 2) pretreatment, posttreatment, and 3-month followup.",End of Treatment,0,,56.8,25.1,,,,,-18.4,28.6,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS score,0.3721,Additional definitions of Clinically Meaningful Response reported in the study,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"McLay RN, Baird A, Webb-Murphy J, et al. A randomized, head-to-head study of virtual reality exposuretherapy for posttraumatic stress disorder. Cyberpsychol Behav Soc Netw. 2017 Apr;20(4):218-24. doi: 10.1089/cyber.2016.0554. PMID: 28394217.",36339,2019
mclay2017_CAPS_B_12_ITT,Psychotherapy,PTSD,81,B,Control,,33,,Control exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,38,Structured Clinical Interview,CAPS,CAPS,ITT,Listwise deletion,"Repeated-measures ANOVA, two separate analyses: 1) change from pretreatment to posttreatment, 2) pretreatment, posttreatment, and 3-month followup.",Assessment at 3 to <6 Months,12,,62.6,28,,,,,-18,33.7,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS score,0.3636,Additional definitions of Clinically Meaningful Response reported in the study,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"McLay RN, Baird A, Webb-Murphy J, et al. A randomized, head-to-head study of virtual reality exposuretherapy for posttraumatic stress disorder. Cyberpsychol Behav Soc Netw. 2017 Apr;20(4):218-24. doi: 10.1089/cyber.2016.0554. PMID: 28394217.",36339,2019
mclay2017_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,81,B,Control,,43,,Control exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,38,Structured Clinical Interview,CAPS,CAPS,ITT,Listwise deletion,"Repeated-measures ANOVA, two separate analyses: 1) change from pretreatment to posttreatment, 2) pretreatment, posttreatment, and 3-month followup.",Baseline,,,74.5,16.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"McLay RN, Baird A, Webb-Murphy J, et al. A randomized, head-to-head study of virtual reality exposuretherapy for posttraumatic stress disorder. Cyberpsychol Behav Soc Netw. 2017 Apr;20(4):218-24. doi: 10.1089/cyber.2016.0554. PMID: 28394217.",36339,2019
mcrae2004_CAPS_A_0_NA,Pharmacotherapy,PTSD,37,A,PTSD,,13,,Nefazodone,Nefazodone,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS-2 (17-item total severity score),,,"Repeated-measures ANOVA, two separate analyses: 1) change from pretreatment to posttreatment, 2) pretreatment, posttreatment, and 3-month followup.",End of Treatment,0,,28.77,22.2,,,,,-40.08,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7692,,0.2308,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",High,"McRae AL, Brady KT, Mellman TA, et al. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004;19(3):190-6. doi: 10.1002/da.20008. PMID: 15129422.",26720,2019
mcrae2004_CAPS_A_Baseline_NA,Pharmacotherapy,PTSD,37,A,PTSD,,13,,Nefazodone,Nefazodone,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS-2 (17-item total severity score),,,"Repeated-measures ANOVA, two separate analyses: 1) change from pretreatment to posttreatment, 2) pretreatment, posttreatment, and 3-month followup.",Baseline,,,68.85,7.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7692,,0.2308,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",High,"McRae AL, Brady KT, Mellman TA, et al. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004;19(3):190-6. doi: 10.1002/da.20008. PMID: 15129422.",26720,2019
mcrae2004_CAPS_B_0_NA,Pharmacotherapy,PTSD,37,B,PTSD,,13,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Structured Clinical Interview,CAPS,CAPS-2 (17-item total severity score),,,"Repeated-measures ANOVA, two separate analyses: 1) change from pretreatment to posttreatment, 2) pretreatment, posttreatment, and 3-month followup.",End of Treatment,0,,29.08,25.4,,,,,-44.69,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7692,,0.2308,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",High,"McRae AL, Brady KT, Mellman TA, et al. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004;19(3):190-6. doi: 10.1002/da.20008. PMID: 15129422.",26720,2019
mcrae2004_CAPS_B_Baseline_NA,Pharmacotherapy,PTSD,37,B,PTSD,,13,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Structured Clinical Interview,CAPS,CAPS-2 (17-item total severity score),,,"Repeated-measures ANOVA, two separate analyses: 1) change from pretreatment to posttreatment, 2) pretreatment, posttreatment, and 3-month followup.",Baseline,,,73.77,16.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7692,,0.2308,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",High,"McRae AL, Brady KT, Mellman TA, et al. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004;19(3):190-6. doi: 10.1002/da.20008. PMID: 15129422.",26720,2019
mcrae2004_DTS_A_0_NA,Pharmacotherapy,PTSD,37,A,PTSD,,,,Nefazodone,Nefazodone,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Self report,DTS,DTS,,,"Repeated-measures ANOVA, two separate analyses: 1) change from pretreatment to posttreatment, 2) pretreatment, posttreatment, and 3-month followup.",End of Treatment,0,,33.31,24.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7692,,0.2308,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",High,"McRae AL, Brady KT, Mellman TA, et al. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004;19(3):190-6. doi: 10.1002/da.20008. PMID: 15129422.",26720,2019
mcrae2004_DTS_A_Baseline_NA,Pharmacotherapy,PTSD,37,A,PTSD,,,,Nefazodone,Nefazodone,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Self report,DTS,DTS,,,"Repeated-measures ANOVA, two separate analyses: 1) change from pretreatment to posttreatment, 2) pretreatment, posttreatment, and 3-month followup.",Baseline,,,73.46,13.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7692,,0.2308,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",High,"McRae AL, Brady KT, Mellman TA, et al. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004;19(3):190-6. doi: 10.1002/da.20008. PMID: 15129422.",26720,2019
mcrae2004_DTS_B_0_NA,Pharmacotherapy,PTSD,37,B,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Self report,DTS,DTS,,,"Repeated-measures ANOVA, two separate analyses: 1) change from pretreatment to posttreatment, 2) pretreatment, posttreatment, and 3-month followup.",End of Treatment,0,,35.92,29.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7692,,0.2308,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",High,"McRae AL, Brady KT, Mellman TA, et al. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004;19(3):190-6. doi: 10.1002/da.20008. PMID: 15129422.",26720,2019
mcrae2004_DTS_B_Baseline_NA,Pharmacotherapy,PTSD,37,B,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Self report,DTS,DTS,,,"Repeated-measures ANOVA, two separate analyses: 1) change from pretreatment to posttreatment, 2) pretreatment, posttreatment, and 3-month followup.",Baseline,,,67.31,20.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7692,,0.2308,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",High,"McRae AL, Brady KT, Mellman TA, et al. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004;19(3):190-6. doi: 10.1002/da.20008. PMID: 15129422.",26720,2019
mcrae2004_TOP-8_A_0_NA,Pharmacotherapy,PTSD,37,A,PTSD,,,,Nefazodone,Nefazodone,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,TOP-8,TOP-8,,,"Repeated-measures ANOVA, two separate analyses: 1) change from pretreatment to posttreatment, 2) pretreatment, posttreatment, and 3-month followup.",End of Treatment,0,,5.54,4.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7692,,0.2308,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",High,"McRae AL, Brady KT, Mellman TA, et al. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004;19(3):190-6. doi: 10.1002/da.20008. PMID: 15129422.",26720,2019
mcrae2004_TOP-8_A_Baseline_NA,Pharmacotherapy,PTSD,37,A,PTSD,,,,Nefazodone,Nefazodone,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,TOP-8,TOP-8,,,"Repeated-measures ANOVA, two separate analyses: 1) change from pretreatment to posttreatment, 2) pretreatment, posttreatment, and 3-month followup.",Baseline,,,16.23,4.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7692,,0.2308,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",High,"McRae AL, Brady KT, Mellman TA, et al. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004;19(3):190-6. doi: 10.1002/da.20008. PMID: 15129422.",26720,2019
mcrae2004_TOP-8_B_0_NA,Pharmacotherapy,PTSD,37,B,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Structured Clinical Interview,TOP-8,TOP-8,,,"Repeated-measures ANOVA, two separate analyses: 1) change from pretreatment to posttreatment, 2) pretreatment, posttreatment, and 3-month followup.",End of Treatment,0,,5.62,6.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7692,,0.2308,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",High,"McRae AL, Brady KT, Mellman TA, et al. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004;19(3):190-6. doi: 10.1002/da.20008. PMID: 15129422.",26720,2019
mcrae2004_TOP-8_B_Baseline_NA,Pharmacotherapy,PTSD,37,B,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Structured Clinical Interview,TOP-8,TOP-8,,,"Repeated-measures ANOVA, two separate analyses: 1) change from pretreatment to posttreatment, 2) pretreatment, posttreatment, and 3-month followup.",Baseline,,,17.46,4.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7692,,0.2308,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",High,"McRae AL, Brady KT, Mellman TA, et al. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004;19(3):190-6. doi: 10.1002/da.20008. PMID: 15129422.",26720,2019
meredith2016_CAPS_A_0_ITT,Collaborative care,PTSD,404,A,PTSD,,129,,Collaborative Care,Collaborative care,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,Yes,Individual,Mixed,206,Structured Clinical Interview,CAPS,CAPS,ITT,Sequential imputation,Linear mixed-effect model,End of Treatment,0,,46.9,,95% CI,42.8,50.9,,-24.2,,,,,,,,,,p<0.0001,,,,,,,,Not meeting criteria for PTSD according to past month CAPS,0.567,,,,,Community,,,1,0.8056,,0.1944,,,Medium,"Meredith LS, Eisenman DP, Han B, et al. Impact of collaborative care for underserved patients with PTSD in primary care: a randomized controlled trial. J Gen Intern Med. 2016 May;31(5):509-17. doi: 10.1007/s11606-016-3588-3. PMID: 26850413.",44675,2019
meredith2016_CAPS_A_Baseline_ITT,Collaborative care,PTSD,404,A,PTSD,,184,,Collaborative Care,Collaborative care,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,Yes,Individual,Mixed,206,Structured Clinical Interview,CAPS,CAPS,ITT,Sequential imputation,Linear mixed-effect model,Baseline,,,71.1,,95% CI,67.9,74.3,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8056,,0.1944,,,Medium,"Meredith LS, Eisenman DP, Han B, et al. Impact of collaborative care for underserved patients with PTSD in primary care: a randomized controlled trial. J Gen Intern Med. 2016 May;31(5):509-17. doi: 10.1007/s11606-016-3588-3. PMID: 26850413.",44675,2019
meredith2016_CAPS_B_0_ITT,Collaborative care,PTSD,404,B,Control,,140,,Minimally Enhanced Usual Care,Minimally enhanced usual care,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Mixed,198,Structured Clinical Interview,CAPS,CAPS,ITT,Sequential imputation,Linear mixed-effect model,End of Treatment,0,,44.2,,95% CI,41.2,47.1,,-26.8,,,,,,,,,,p<0.0001,,,,,,,,Not meeting criteria for PTSD according to past month CAPS,0.606,,,,,Community,,,1,0.8056,,0.1944,,,Medium,"Meredith LS, Eisenman DP, Han B, et al. Impact of collaborative care for underserved patients with PTSD in primary care: a randomized controlled trial. J Gen Intern Med. 2016 May;31(5):509-17. doi: 10.1007/s11606-016-3588-3. PMID: 26850413.",44675,2019
meredith2016_CAPS_B_Baseline_ITT,Collaborative care,PTSD,404,B,Control,,171,,Minimally Enhanced Usual Care,Minimally enhanced usual care,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Mixed,198,Structured Clinical Interview,CAPS,CAPS,ITT,Sequential imputation,Linear mixed-effect model,Baseline,,,71,,95% CI,67.9,74.2,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8056,,0.1944,,,Medium,"Meredith LS, Eisenman DP, Han B, et al. Impact of collaborative care for underserved patients with PTSD in primary care: a randomized controlled trial. J Gen Intern Med. 2016 May;31(5):509-17. doi: 10.1007/s11606-016-3588-3. PMID: 26850413.",44675,2019
mills2012_CAPS_A_0_ITT,Psychotherapy,PTSD+SUD,103,A,PTSD+SUD,Integrated,41,,COPE + Usual Treatment,Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,55,Structured Clinical Interview,CAPS,CAPS,ITT,Markov chain Monte Carlo method of Multiple imputation,Linear mixed-effect model,End of Treatment,0,,67.85,,95% CI,59.93,75.77,,-23.28,,,,,,,,,,,,,,,,,,Not meeting DSM-IV-TR criteria for PTSD on CAPS,0.1455,,RCI < -1.96,,,Community,,,1,0.621,,0.379,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)",Medium,"Mills KL, Teesson M, Back SE, et al. Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):690-9. doi: 10.1001/jama.2012.9071. PMID: 22893166..",39123,2020
mills2012_CAPS_A_39_ITT,Psychotherapy,PTSD+SUD,103,A,PTSD+SUD,Integrated,39,,COPE + Usual Treatment,Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,55,Structured Clinical Interview,CAPS,CAPS,ITT,Markov chain Monte Carlo method of Multiple imputation,Linear mixed-effect model,Assessment at 6 to <12 Months,39,,52.89,,95% CI,43.72,62.06,,-38.24,,-47.93,-28.54,,,,,,,p<0.001,,,,,,,,Not meeting DSM-IV-TR criteria for PTSD on CAPS,0.4364,,RCI < -1.96,0.4909,,Community,,,1,0.621,,0.379,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)",Medium,"Mills KL, Teesson M, Back SE, et al. Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):690-9. doi: 10.1001/jama.2012.9071. PMID: 22893166..",39123,2020
mills2012_CAPS_A_Baseline_ITT,Psychotherapy,PTSD+SUD,103,A,PTSD+SUD,Integrated,55,,COPE + Usual Treatment,Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,55,Structured Clinical Interview,CAPS,CAPS,ITT,Markov chain Monte Carlo method of Multiple imputation,Linear mixed-effect model,Baseline,,,91.13,,95% CI,87.03,95.23,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.621,,0.379,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)",Medium,"Mills KL, Teesson M, Back SE, et al. Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):690-9. doi: 10.1001/jama.2012.9071. PMID: 22893166..",39123,2020
mills2012_CAPS_B_0_ITT,Psychotherapy,PTSD+SUD,103,B,SUD,Not integrated,41,,Usual Treatment,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,48,Structured Clinical Interview,CAPS,CAPS,ITT,Markov chain Monte Carlo method of Multiple imputation,Linear mixed-effect model,End of Treatment,0,,73.38,,95% CI,66.79,79.97,,-16,,,,,,,,,,,,,,,,,,Not meeting DSM-IV-TR criteria for PTSD on CAPS,0.1042,,RCI < -1.96,,,Community,,,1,0.621,,0.379,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)",Medium,"Mills KL, Teesson M, Back SE, et al. Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):690-9. doi: 10.1001/jama.2012.9071. PMID: 22893166..",39123,2020
mills2012_CAPS_B_39_ITT,Psychotherapy,PTSD+SUD,103,B,SUD,Not integrated,38,,Usual Treatment,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,48,Structured Clinical Interview,CAPS,CAPS,ITT,Markov chain Monte Carlo method of Multiple imputation,Linear mixed-effect model,Assessment at 6 to <12 Months,39,,67.23,,95% CI,59.21,75.25,,-22.14,,-30.33,-13.95,,,,,,,p<0.001,,,,,,,,Not meeting DSM-IV-TR criteria for PTSD on CAPS,0.2083,,,,,Community,,,1,0.621,,0.379,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)",Medium,"Mills KL, Teesson M, Back SE, et al. Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):690-9. doi: 10.1001/jama.2012.9071. PMID: 22893166..",39123,2020
mills2012_CAPS_B_Baseline_ITT,Psychotherapy,PTSD+SUD,103,B,SUD,Not integrated,48,,Usual Treatment,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,48,Structured Clinical Interview,CAPS,CAPS,ITT,Markov chain Monte Carlo method of Multiple imputation,Linear mixed-effect model,Baseline,,,89.38,,95% CI,84.7,94.06,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.621,,0.379,Mixed,"combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)",Medium,"Mills KL, Teesson M, Back SE, et al. Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):690-9. doi: 10.1001/jama.2012.9071. PMID: 22893166..",39123,2020
mithoefer2011_CAPS_A_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,23,A,PTSD,,12,,MDMA-assisted psychotherapy,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Structured Clinical Interview,CAPS,CAPS,Completer,,Linear mixed-effect model,End of Treatment,0,,25.5,,SEM,9.4,,,-53.7,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-IV,0.8333,,>30% reduction in CAPS from baseline,0.8333,,Community,,,1,0.85,,0.15,Mixed,"combat-related, child physical abuse, child sexual abuse, child other abuse, rape/sexual assault, community/school violence, other (family violence)",Medium,"Mithoefer MC, Wagner MT, Mithoefer AT, et al. The safety and efficacy of ±3,4-psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. [Erratum appears in J Psychopharmacol. 2011;25(6):852.] J Psychopharmacol. 2010 June;25(4):439-52. doi: 10.1177/0269881110378371.",35036,2019
mithoefer2011_CAPS_A_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,23,A,PTSD,,12,,MDMA-assisted psychotherapy,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Structured Clinical Interview,CAPS,CAPS,Completer,,Linear mixed-effect model,Baseline,,,79.2,23.6,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-IV,,,>30% reduction in CAPS from baseline,,,Community,,,1,0.85,,0.15,Mixed,"combat-related, child physical abuse, child sexual abuse, child other abuse, rape/sexual assault, community/school violence, other (family violence)",Medium,"Mithoefer MC, Wagner MT, Mithoefer AT, et al. The safety and efficacy of ±3,4-psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. [Erratum appears in J Psychopharmacol. 2011;25(6):852.] J Psychopharmacol. 2010 June;25(4):439-52. doi: 10.1177/0269881110378371.",35036,2019
mithoefer2011_CAPS_B_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,23,B,PTSD,,8,,Placebo-assisted psychotherapy,Trauma-focused psychotherapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Structured Clinical Interview,CAPS,CAPS,Completer,,Linear mixed-effect model,End of Treatment,0,,59.1,,SEM,9.4,,,-20.5,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-IV,0.25,,>30% reduction in CAPS from baseline,0.25,,Community,,,1,0.85,,0.15,Mixed,"combat-related, child physical abuse, child sexual abuse, child other abuse, rape/sexual assault, community/school violence, other (family violence)",Medium,"Mithoefer MC, Wagner MT, Mithoefer AT, et al. The safety and efficacy of ±3,4-psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. [Erratum appears in J Psychopharmacol. 2011;25(6):852.] J Psychopharmacol. 2010 June;25(4):439-52. doi: 10.1177/0269881110378371.",35036,2019
mithoefer2011_CAPS_B_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,23,B,PTSD,,8,,Placebo-assisted psychotherapy,Trauma-focused psychotherapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Structured Clinical Interview,CAPS,CAPS,Completer,,Linear mixed-effect model,Baseline,,,79.6,22,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-IV,,,>30% reduction in CAPS from baseline,,,Community,,,1,0.85,,0.15,Mixed,"combat-related, child physical abuse, child sexual abuse, child other abuse, rape/sexual assault, community/school violence, other (family violence)",Medium,"Mithoefer MC, Wagner MT, Mithoefer AT, et al. The safety and efficacy of ±3,4-psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. [Erratum appears in J Psychopharmacol. 2011;25(6):852.] J Psychopharmacol. 2010 June;25(4):439-52. doi: 10.1177/0269881110378371.",35036,2019
mithoefer2011_IES_A_0_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,23,A,PTSD,,,,MDMA-assisted psychotherapy,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Self report,IES,IES-R,,,Linear mixed-effect model,End of Treatment,0,,18.2,,SE,4.1,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.85,,0.15,Mixed,"combat-related, child physical abuse, child sexual abuse, child other abuse, rape/sexual assault, community/school violence, other (family violence)",Medium,"Mithoefer MC, Wagner MT, Mithoefer AT, et al. The safety and efficacy of ±3,4-psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. [Erratum appears in J Psychopharmacol. 2011;25(6):852.] J Psychopharmacol. 2010 June;25(4):439-52. doi: 10.1177/0269881110378371.",35036,2019
mithoefer2011_IES_A_8_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,23,A,PTSD,,,,MDMA-assisted psychotherapy,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Self report,IES,IES-R,,,Linear mixed-effect model,Assessment at <3 Months,8,,15.0,,SE,5,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.85,,0.15,Mixed,"combat-related, child physical abuse, child sexual abuse, child other abuse, rape/sexual assault, community/school violence, other (family violence)",Medium,"Mithoefer MC, Wagner MT, Mithoefer AT, et al. The safety and efficacy of ±3,4-psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. [Erratum appears in J Psychopharmacol. 2011;25(6):852.] J Psychopharmacol. 2010 June;25(4):439-52. doi: 10.1177/0269881110378371.",35036,2019
mithoefer2011_IES_A_Baseline_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,23,A,PTSD,,,,MDMA-assisted psychotherapy,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Self report,IES,IES-R,,,Linear mixed-effect model,Baseline,,,44.9,,SEM,4.3,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.85,,0.15,Mixed,"combat-related, child physical abuse, child sexual abuse, child other abuse, rape/sexual assault, community/school violence, other (family violence)",Medium,"Mithoefer MC, Wagner MT, Mithoefer AT, et al. The safety and efficacy of ±3,4-psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. [Erratum appears in J Psychopharmacol. 2011;25(6):852.] J Psychopharmacol. 2010 June;25(4):439-52. doi: 10.1177/0269881110378371.",35036,2019
mithoefer2011_IES_B_0_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,23,B,PTSD,,,,Placebo-assisted psychotherapy,Trauma-focused psychotherapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Self report,IES,IES-R,,,Linear mixed-effect model,End of Treatment,0,,38.28,,SE,5,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.85,,0.15,Mixed,"combat-related, child physical abuse, child sexual abuse, child other abuse, rape/sexual assault, community/school violence, other (family violence)",Medium,"Mithoefer MC, Wagner MT, Mithoefer AT, et al. The safety and efficacy of ±3,4-psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. [Erratum appears in J Psychopharmacol. 2011;25(6):852.] J Psychopharmacol. 2010 June;25(4):439-52. doi: 10.1177/0269881110378371.",35036,2019
mithoefer2011_IES_B_8_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,23,B,PTSD,,,,Placebo-assisted psychotherapy,Trauma-focused psychotherapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Self report,IES,IES-R,,,Linear mixed-effect model,Assessment at <3 Months,8,,32.6,,SE,6.1,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.85,,0.15,Mixed,"combat-related, child physical abuse, child sexual abuse, child other abuse, rape/sexual assault, community/school violence, other (family violence)",Medium,"Mithoefer MC, Wagner MT, Mithoefer AT, et al. The safety and efficacy of ±3,4-psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. [Erratum appears in J Psychopharmacol. 2011;25(6):852.] J Psychopharmacol. 2010 June;25(4):439-52. doi: 10.1177/0269881110378371.",35036,2019
mithoefer2011_IES_B_Baseline_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,23,B,PTSD,,,,Placebo-assisted psychotherapy,Trauma-focused psychotherapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Self report,IES,IES-R,,,Linear mixed-effect model,Baseline,,,45.1,,SEM,5.3,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.85,,0.15,Mixed,"combat-related, child physical abuse, child sexual abuse, child other abuse, rape/sexual assault, community/school violence, other (family violence)",Medium,"Mithoefer MC, Wagner MT, Mithoefer AT, et al. The safety and efficacy of ±3,4-psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. [Erratum appears in J Psychopharmacol. 2011;25(6):852.] J Psychopharmacol. 2010 June;25(4):439-52. doi: 10.1177/0269881110378371.",35036,2019
mithoefer2018_CAPS_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,A,PTSD,,12,,MDMA-assisted psychotherapy,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Structured Clinical Interview,CAPS,CAPS-IV,ITT,,Linear mixed-effect model,End of Treatment,0,,45.3,33.8,,,,,-44.3,28.7,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-IV,0.5833,,>30% decrease in CAPS-IV,0.6667,,Mixed,0,0.8462,0.1538,0.2692,,0.7308,Mixed,"combat-related, other (firefighter/police officer)",High,"Mithoefer MC, Mithoefer AT, Feduccia AA, et al. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry. 2018 Jun;5(6):486-97. doi: 10.1016/S2215-0366(18)30135-4. PMID: 29728331.",50277,2019
mithoefer2018_CAPS_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,A,PTSD,,12,,MDMA-assisted psychotherapy,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Structured Clinical Interview,CAPS,CAPS-IV,ITT,,Linear mixed-effect model,Baseline,,,89.7,17.3,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-IV,,,>30% decrease in CAPS-IV,,,Mixed,0,0.8462,0.1538,0.2692,,0.7308,Mixed,"combat-related, other (firefighter/police officer)",High,"Mithoefer MC, Mithoefer AT, Feduccia AA, et al. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry. 2018 Jun;5(6):486-97. doi: 10.1016/S2215-0366(18)30135-4. PMID: 29728331.",50277,2019
mithoefer2018_CAPS_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,B,PTSD,,7,,MDMA-assisted psychotherapy,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,No,No,No,Individual,In Person,7,Structured Clinical Interview,CAPS,CAPS-IV,ITT,,Linear mixed-effect model,End of Treatment,0,,24.1,17.2,,,,,-58.3,9.8,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-IV,0.8571,,>30% decrease in CAPS-IV,1,,Mixed,0,0.8462,0.1538,0.2692,,0.7308,Mixed,"combat-related, other (firefighter/police officer)",High,"Mithoefer MC, Mithoefer AT, Feduccia AA, et al. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry. 2018 Jun;5(6):486-97. doi: 10.1016/S2215-0366(18)30135-4. PMID: 29728331.",50277,2019
mithoefer2018_CAPS_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,B,PTSD,,7,,MDMA-assisted psychotherapy,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,No,No,No,Individual,In Person,7,Structured Clinical Interview,CAPS,CAPS-IV,ITT,,Linear mixed-effect model,Baseline,,,82.4,17.3,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-IV,,,>30% decrease in CAPS-IV,,,Mixed,0,0.8462,0.1538,0.2692,,0.7308,Mixed,"combat-related, other (firefighter/police officer)",High,"Mithoefer MC, Mithoefer AT, Feduccia AA, et al. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry. 2018 Jun;5(6):486-97. doi: 10.1016/S2215-0366(18)30135-4. PMID: 29728331.",50277,2019
mithoefer2018_CAPS_C_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,C,PTSD,,7,,Low-dose MDMA-assisted psychotherapy,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,7,Structured Clinical Interview,CAPS,CAPS-IV,ITT,,Linear mixed-effect model,End of Treatment,0,,76.0,23.4,,,,,-11.4,12.7,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-IV,0.2857,,>30% decrease in CAPS-IV,0.2857,,Mixed,0,0.8462,0.1538,0.2692,,0.7308,Mixed,"combat-related, other (firefighter/police officer)",High,"Mithoefer MC, Mithoefer AT, Feduccia AA, et al. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry. 2018 Jun;5(6):486-97. doi: 10.1016/S2215-0366(18)30135-4. PMID: 29728331.",50277,2019
mithoefer2018_CAPS_C_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,C,PTSD,,7,,Low-dose MDMA-assisted psychotherapy,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,7,Structured Clinical Interview,CAPS,CAPS-IV,ITT,,Linear mixed-effect model,Baseline,,,87.4,14.1,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-IV,,,>30% decrease in CAPS-IV,,,Mixed,0,0.8462,0.1538,0.2692,,0.7308,Mixed,"combat-related, other (firefighter/police officer)",High,"Mithoefer MC, Mithoefer AT, Feduccia AA, et al. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry. 2018 Jun;5(6):486-97. doi: 10.1016/S2215-0366(18)30135-4. PMID: 29728331.",50277,2019
miyahira2012_CAPS_A_0_Comp,Psychotherapy,PTSD,42,A,PTSD,,10,,CBT with virtual reality exposure,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA,End of Treatment,0,,58.9,23.29,,,,,-13.3,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,,,,Combat-related,,High,"Miyahira SD, Folen RA, Hoffman HG, et al. The effectiveness of VR exposure therapy for PTSD in returning warfighters. Stud Health Technol Inform. 2012;181:128-32.  PMID: 22954842.",43675,2019
miyahira2012_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,42,A,PTSD,,10,,CBT with virtual reality exposure,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA,Baseline,,,72.2,17.07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,,,,Combat-related,,High,"Miyahira SD, Folen RA, Hoffman HG, et al. The effectiveness of VR exposure therapy for PTSD in returning warfighters. Stud Health Technol Inform. 2012;181:128-32.  PMID: 22954842.",43675,2019
miyahira2012_CAPS_B_0_Comp,Psychotherapy,PTSD,42,B,Control,,12,,Minimal attention,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,13,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA,End of Treatment,0,,71.17,25.41,,,,,-3.83,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,,,,Combat-related,,High,"Miyahira SD, Folen RA, Hoffman HG, et al. The effectiveness of VR exposure therapy for PTSD in returning warfighters. Stud Health Technol Inform. 2012;181:128-32.  PMID: 22954842.",43675,2019
miyahira2012_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,42,B,Control,,12,,Minimal attention,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,13,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA,Baseline,,,75,19.29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,,,,Combat-related,,High,"Miyahira SD, Folen RA, Hoffman HG, et al. The effectiveness of VR exposure therapy for PTSD in returning warfighters. Stud Health Technol Inform. 2012;181:128-32.  PMID: 22954842.",43675,2019
miyahira2012_PDS_A_0_NA,Psychotherapy,PTSD,42,A,PTSD,,,,CBT with virtual reality exposure,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Self report,PDS,PDS,,,Repeated measures ANOVA,End of Treatment,0,,27.3,13.29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,,,,Combat-related,,High,"Miyahira SD, Folen RA, Hoffman HG, et al. The effectiveness of VR exposure therapy for PTSD in returning warfighters. Stud Health Technol Inform. 2012;181:128-32.  PMID: 22954842.",43675,2019
miyahira2012_PDS_A_Baseline_NA,Psychotherapy,PTSD,42,A,PTSD,,,,CBT with virtual reality exposure,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Self report,PDS,PDS,,,Repeated measures ANOVA,Baseline,,,33.4,9.88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,,,,Combat-related,,High,"Miyahira SD, Folen RA, Hoffman HG, et al. The effectiveness of VR exposure therapy for PTSD in returning warfighters. Stud Health Technol Inform. 2012;181:128-32.  PMID: 22954842.",43675,2019
miyahira2012_PDS_B_0_NA,Psychotherapy,PTSD,42,B,Control,,,,Minimal attention,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,13,Self report,PDS,PDS,,,Repeated measures ANOVA,End of Treatment,0,,25.25,12.02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,,,,Combat-related,,High,"Miyahira SD, Folen RA, Hoffman HG, et al. The effectiveness of VR exposure therapy for PTSD in returning warfighters. Stud Health Technol Inform. 2012;181:128-32.  PMID: 22954842.",43675,2019
miyahira2012_PDS_B_Baseline_NA,Psychotherapy,PTSD,42,B,Control,,,,Minimal attention,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,13,Self report,PDS,PDS,,,Repeated measures ANOVA,Baseline,,,30.75,10.38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,,,,Combat-related,,High,"Miyahira SD, Folen RA, Hoffman HG, et al. The effectiveness of VR exposure therapy for PTSD in returning warfighters. Stud Health Technol Inform. 2012;181:128-32.  PMID: 22954842.",43675,2019
monson2006_CAPS_A_0_ITT,Psychotherapy,PTSD,60,A,PTSD,,24,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,random regression models,"Random regression modeling and Hedges' g for change in mean score, chi-square test for diagnostic change and clinically meaningful response",End of Treatment,0,LSM 52.14,,,SE,3.9,,,-24.59,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.4,,>12-point change in total CAPS,0.5,,Veteran,0,1,0,0.1,,0.9,Other (military-related),,Medium,"Monson CM, Schnurr PP, Resick PA, et al. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. J Consult Clin Psychol. 2006 Oct;74(5):898-907. doi: 10.1037/0022-006X.74.5.898. PMID: 17032094.",28862,2019
monson2006_CAPS_A_4_ITT,Psychotherapy,PTSD,60,A,PTSD,,23,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,random regression models,"Random regression modeling and Hedges' g for change in mean score, chi-square test for diagnostic change and clinically meaningful response",Assessment at <3 Months,4,LSM 58.13,,,SE,3.7,,,-18.6,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.3,,>12-point change in total CAPS,0.4667,,Veteran,0,1,0,0.1,,0.9,Other (military-related),,Medium,"Monson CM, Schnurr PP, Resick PA, et al. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. J Consult Clin Psychol. 2006 Oct;74(5):898-907. doi: 10.1037/0022-006X.74.5.898. PMID: 17032094.",28862,2019
monson2006_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,60,A,PTSD,,30,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,random regression models,"Random regression modeling and Hedges' g for change in mean score, chi-square test for diagnostic change and clinically meaningful response",Baseline,,LSM 76.73,,,SE,2.6,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1,,0.9,Other (military-related),,Medium,"Monson CM, Schnurr PP, Resick PA, et al. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. J Consult Clin Psychol. 2006 Oct;74(5):898-907. doi: 10.1037/0022-006X.74.5.898. PMID: 17032094.",28862,2019
monson2006_CAPS_B_0_ITT,Psychotherapy,PTSD,60,B,Control,,27,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,30,Structured Clinical Interview,CAPS,CAPS,ITT,random regression models,"Random regression modeling and Hedges' g for change in mean score, chi-square test for diagnostic change and clinically meaningful response",End of Treatment,0,LSM 76.03,,,SE,3.7,,,-3.07,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.0333,,>12-point change in total CAPS,0.1,,Veteran,0,1,0,0.1,,0.9,Other (military-related),,Medium,"Monson CM, Schnurr PP, Resick PA, et al. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. J Consult Clin Psychol. 2006 Oct;74(5):898-907. doi: 10.1037/0022-006X.74.5.898. PMID: 17032094.",28862,2019
monson2006_CAPS_B_4_ITT,Psychotherapy,PTSD,60,B,Control,,26,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,30,Structured Clinical Interview,CAPS,CAPS,ITT,random regression models,"Random regression modeling and Hedges' g for change in mean score, chi-square test for diagnostic change and clinically meaningful response",Assessment at <3 Months,4,LSM 74.37,,,SE,4.3,,,-4.73,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.0333,,>12-point change in total CAPS,0.3,,Veteran,0,1,0,0.1,,0.9,Other (military-related),,Medium,"Monson CM, Schnurr PP, Resick PA, et al. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. J Consult Clin Psychol. 2006 Oct;74(5):898-907. doi: 10.1037/0022-006X.74.5.898. PMID: 17032094.",28862,2019
monson2006_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,60,B,Control,,30,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,30,Structured Clinical Interview,CAPS,CAPS,ITT,random regression models,"Random regression modeling and Hedges' g for change in mean score, chi-square test for diagnostic change and clinically meaningful response",Baseline,,LSM 79.10,,,SE,3.5,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1,,0.9,Other (military-related),,Medium,"Monson CM, Schnurr PP, Resick PA, et al. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. J Consult Clin Psychol. 2006 Oct;74(5):898-907. doi: 10.1037/0022-006X.74.5.898. PMID: 17032094.",28862,2019
monson2006_PCL_A_0_ITT,Psychotherapy,PTSD,60,A,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PCL,PCL,ITT,,"Random regression modeling and Hedges' g for change in mean score, chi-square test for diagnostic change and clinically meaningful response",End of Treatment,0,,44.62,,SE,2.2,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1,,0.9,Other (military-related),,Medium,"Monson CM, Schnurr PP, Resick PA, et al. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. J Consult Clin Psychol. 2006 Oct;74(5):898-907. doi: 10.1037/0022-006X.74.5.898. PMID: 17032094.",28862,2019
monson2006_PCL_A_4_ITT,Psychotherapy,PTSD,60,A,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PCL,PCL,ITT,,"Random regression modeling and Hedges' g for change in mean score, chi-square test for diagnostic change and clinically meaningful response",Assessment at <3 Months,4,,45.55,,SE,2.4,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1,,0.9,Other (military-related),,Medium,"Monson CM, Schnurr PP, Resick PA, et al. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. J Consult Clin Psychol. 2006 Oct;74(5):898-907. doi: 10.1037/0022-006X.74.5.898. PMID: 17032094.",28862,2019
monson2006_PCL_A_Baseline_ITT,Psychotherapy,PTSD,60,A,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PCL,PCL,ITT,,"Random regression modeling and Hedges' g for change in mean score, chi-square test for diagnostic change and clinically meaningful response",Baseline,,,60.66,,SE,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1,,0.9,Other (military-related),,Medium,"Monson CM, Schnurr PP, Resick PA, et al. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. J Consult Clin Psychol. 2006 Oct;74(5):898-907. doi: 10.1037/0022-006X.74.5.898. PMID: 17032094.",28862,2019
monson2006_PCL_B_0_ITT,Psychotherapy,PTSD,60,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,30,Self report,PCL,PCL,ITT,,"Random regression modeling and Hedges' g for change in mean score, chi-square test for diagnostic change and clinically meaningful response",End of Treatment,0,,56.38,,SE,2,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1,,0.9,Other (military-related),,Medium,"Monson CM, Schnurr PP, Resick PA, et al. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. J Consult Clin Psychol. 2006 Oct;74(5):898-907. doi: 10.1037/0022-006X.74.5.898. PMID: 17032094.",28862,2019
monson2006_PCL_B_4_ITT,Psychotherapy,PTSD,60,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,30,Self report,PCL,PCL,ITT,,"Random regression modeling and Hedges' g for change in mean score, chi-square test for diagnostic change and clinically meaningful response",Assessment at <3 Months,4,,57.23,,SE,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1,,0.9,Other (military-related),,Medium,"Monson CM, Schnurr PP, Resick PA, et al. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. J Consult Clin Psychol. 2006 Oct;74(5):898-907. doi: 10.1037/0022-006X.74.5.898. PMID: 17032094.",28862,2019
monson2006_PCL_B_Baseline_ITT,Psychotherapy,PTSD,60,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,30,Self report,PCL,PCL,ITT,,"Random regression modeling and Hedges' g for change in mean score, chi-square test for diagnostic change and clinically meaningful response",Baseline,,,61.50,,SE,1.8,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1,,0.9,Other (military-related),,Medium,"Monson CM, Schnurr PP, Resick PA, et al. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. J Consult Clin Psychol. 2006 Oct;74(5):898-907. doi: 10.1037/0022-006X.74.5.898. PMID: 17032094.",28862,2019
monson2012a_CAPS_A_0_ITT,Psychotherapy,PTSD,80,A,PTSD,,16,,Cognitive Behavioral Couple Therapy,Cognitive Behavioral Conjoint Therapy (CBCT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Couple,In Person,20,Structured Clinical Interview,CAPS,CAPS,ITT,multilevel models using available data,Least-squares means difference (estimated usng multilevel models) and independent samples t-test for change in mean scores,End of Treatment,0,,33.45,,95% CI,22.03,44.87,,-35.42,,-47.84,-23,,Hedges' g,1.82,95% CI,1,2.62,,,,,,,,,Not meeting criteria for PTSD according to DSM-IV-TR criteria and CAPS <45,0.8125,,CAPS ≥10-point decrease from baseline,0.8125,,Mixed,,0.225,0.775,0.75,,0.25,Mixed,"rape/sexual assault, child sexual abuse, accidents, illness/medical procedure, combat-related, community/school violence, other (not specified)",Medium,"Monson CM, Fredman SJ, Macdonald A, et al. Effect of cognitive-behavioral couple therapy for PTSD: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):700-9. doi: 10.1001/jama.2012.9307. PMID: 22893167.",39124,2019
monson2012a_CAPS_A_12_Comp,Psychotherapy,PTSD,80,A,PTSD,,13,,Cognitive Behavioral Couple Therapy,Cognitive Behavioral Conjoint Therapy (CBCT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Couple,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,,Least-squares means difference (estimated usng multilevel models) and independent samples t-test for change in mean scores,Assessment at 3 to <6 Months,12,,28.45,,,,,from posttreatment,-5,,-14.36,4.36,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-IV-TR criteria and CAPS <45,0.7143,,CAPS ≥10-point decrease from baseline,0.7143,,Mixed,,0.225,0.775,0.75,,0.25,Mixed,"rape/sexual assault, child sexual abuse, accidents, illness/medical procedure, combat-related, community/school violence, other (not specified)",Medium,"Monson CM, Fredman SJ, Macdonald A, et al. Effect of cognitive-behavioral couple therapy for PTSD: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):700-9. doi: 10.1001/jama.2012.9307. PMID: 22893167.",39124,2019
monson2012a_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,80,A,PTSD,,20,,Cognitive Behavioral Couple Therapy,Cognitive Behavioral Conjoint Therapy (CBCT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Couple,In Person,20,Structured Clinical Interview,CAPS,CAPS,ITT,multilevel models using available data,Least-squares means difference (estimated usng multilevel models) and independent samples t-test for change in mean scores,Baseline,,,68.87,,95% CI,62.12,75.61,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.225,0.775,0.75,,0.25,Mixed,"rape/sexual assault, child sexual abuse, accidents, illness/medical procedure, combat-related, community/school violence, other (not specified)",Medium,"Monson CM, Fredman SJ, Macdonald A, et al. Effect of cognitive-behavioral couple therapy for PTSD: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):700-9. doi: 10.1001/jama.2012.9307. PMID: 22893167.",39124,2019
monson2012a_CAPS_B_0_ITT,Psychotherapy,PTSD,80,B,Control,,19,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,20,Structured Clinical Interview,CAPS,CAPS,ITT,multilevel models using available data,Least-squares means difference (estimated usng multilevel models) and independent samples t-test for change in mean scores,End of Treatment,0,,60.82,,95% CI,49.87,71.78,,-12.2,,-21.51,-2.89,,Hedges' g,0.57,95% CI,0.12,1,,,,,,,,,Not meeting criteria for PTSD according to DSM-IV-TR criteria and CAPS <45,0.2105,,CAPS ≥10-point decrease from baseline,0.6316,,Mixed,,0.225,0.775,0.75,,0.25,Mixed,"rape/sexual assault, child sexual abuse, accidents, illness/medical procedure, combat-related, community/school violence, other (not specified)",Medium,"Monson CM, Fredman SJ, Macdonald A, et al. Effect of cognitive-behavioral couple therapy for PTSD: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):700-9. doi: 10.1001/jama.2012.9307. PMID: 22893167.",39124,2019
monson2012a_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,80,B,Control,,20,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,20,Structured Clinical Interview,CAPS,CAPS,ITT,multilevel models using available data,Least-squares means difference (estimated usng multilevel models) and independent samples t-test for change in mean scores,Baseline,,,73.03,,95% CI,66.29,79.76,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.225,0.775,0.75,,0.25,Mixed,"rape/sexual assault, child sexual abuse, accidents, illness/medical procedure, combat-related, community/school violence, other (not specified)",Medium,"Monson CM, Fredman SJ, Macdonald A, et al. Effect of cognitive-behavioral couple therapy for PTSD: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):700-9. doi: 10.1001/jama.2012.9307. PMID: 22893167.",39124,2019
monson2012a_PCL_A_0_NA,Psychotherapy,PTSD,80,A,PTSD,,,,Cognitive Behavioral Couple Therapy,Cognitive Behavioral Conjoint Therapy (CBCT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Couple,In Person,20,Self report,PCL,PCL,,,Least-squares means difference (estimated usng multilevel models) and independent samples t-test for change in mean scores,End of Treatment,0,,30.38,,95% CI,22.81,37.96,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.225,0.775,0.75,,0.25,Mixed,"rape/sexual assault, child sexual abuse, accidents, illness/medical procedure, combat-related, community/school violence, other (not specified)",Medium,"Monson CM, Fredman SJ, Macdonald A, et al. Effect of cognitive-behavioral couple therapy for PTSD: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):700-9. doi: 10.1001/jama.2012.9307. PMID: 22893167.",39124,2019
monson2012a_PCL_A_Baseline_NA,Psychotherapy,PTSD,80,A,PTSD,,,,Cognitive Behavioral Couple Therapy,Cognitive Behavioral Conjoint Therapy (CBCT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Couple,In Person,20,Self report,PCL,PCL,,,Least-squares means difference (estimated usng multilevel models) and independent samples t-test for change in mean scores,Baseline,,,49.92,,95% CI,45.12,54.71,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.225,0.775,0.75,,0.25,Mixed,"rape/sexual assault, child sexual abuse, accidents, illness/medical procedure, combat-related, community/school violence, other (not specified)",Medium,"Monson CM, Fredman SJ, Macdonald A, et al. Effect of cognitive-behavioral couple therapy for PTSD: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):700-9. doi: 10.1001/jama.2012.9307. PMID: 22893167.",39124,2019
monson2012a_PCL_B_0_NA,Psychotherapy,PTSD,80,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,20,Self report,PCL,PCL,,,Least-squares means difference (estimated usng multilevel models) and independent samples t-test for change in mean scores,End of Treatment,0,,46.80,,95% CI,39.61,53.99,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.225,0.775,0.75,,0.25,Mixed,"rape/sexual assault, child sexual abuse, accidents, illness/medical procedure, combat-related, community/school violence, other (not specified)",Medium,"Monson CM, Fredman SJ, Macdonald A, et al. Effect of cognitive-behavioral couple therapy for PTSD: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):700-9. doi: 10.1001/jama.2012.9307. PMID: 22893167.",39124,2019
monson2012a_PCL_B_Baseline_NA,Psychotherapy,PTSD,80,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,20,Self report,PCL,PCL,,,Least-squares means difference (estimated usng multilevel models) and independent samples t-test for change in mean scores,Baseline,,,57.89,,95% CI,53.1,62.67,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.225,0.775,0.75,,0.25,Mixed,"rape/sexual assault, child sexual abuse, accidents, illness/medical procedure, combat-related, community/school violence, other (not specified)",Medium,"Monson CM, Fredman SJ, Macdonald A, et al. Effect of cognitive-behavioral couple therapy for PTSD: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):700-9. doi: 10.1001/jama.2012.9307. PMID: 22893167.",39124,2019
moradi2014_IES_A_0_NA,Psychotherapy,PTSD,24,A,PTSD,,12,,Group memory specificity training,Memory specificity training,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,12,Self report,IES,IES-R (Farsi version),,,"Mixed ANOVAs, Cohen's d effect size",End of Treatment,0,,,,,,,,,,,,,Cohen's d,6.99,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Moradi AR, Moshirpanahi S, Parhon H, et al. A pilot randomized controlled trial investigating the efficacy of Memory Specificity Training in improving symptoms of posttraumatic stress disorder. Behav Res Ther. 2014 May;56:68-74. doi: 10.1016/j.brat.2014.03.002. PMID: 24705337.",46541,2019
moradi2014_IES_A_12_NA,Psychotherapy,PTSD,24,A,PTSD,,12,,Group memory specificity training,Memory specificity training,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,12,Self report,IES,IES-R (Farsi version),,,"Mixed ANOVAs, Cohen's d effect size",Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Moradi AR, Moshirpanahi S, Parhon H, et al. A pilot randomized controlled trial investigating the efficacy of Memory Specificity Training in improving symptoms of posttraumatic stress disorder. Behav Res Ther. 2014 May;56:68-74. doi: 10.1016/j.brat.2014.03.002. PMID: 24705337.",46541,2019
moradi2014_IES_A_Baseline_NA,Psychotherapy,PTSD,24,A,PTSD,,12,,Group memory specificity training,Memory specificity training,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,12,Self report,IES,IES-R (Farsi version),,,"Mixed ANOVAs, Cohen's d effect size",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Moradi AR, Moshirpanahi S, Parhon H, et al. A pilot randomized controlled trial investigating the efficacy of Memory Specificity Training in improving symptoms of posttraumatic stress disorder. Behav Res Ther. 2014 May;56:68-74. doi: 10.1016/j.brat.2014.03.002. PMID: 24705337.",46541,2019
moradi2014_IES_B_0_NA,Psychotherapy,PTSD,24,B,Control,,12,,Control,Assessment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Self report,IES,IES-R (Farsi version),,,"Mixed ANOVAs, Cohen's d effect size",End of Treatment,0,,,,,,,,,,,,Cohen's d <0.001,,,,,,p=NS,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Moradi AR, Moshirpanahi S, Parhon H, et al. A pilot randomized controlled trial investigating the efficacy of Memory Specificity Training in improving symptoms of posttraumatic stress disorder. Behav Res Ther. 2014 May;56:68-74. doi: 10.1016/j.brat.2014.03.002. PMID: 24705337.",46541,2019
moradi2014_IES_B_12_NA,Psychotherapy,PTSD,24,B,Control,,12,,Control,Assessment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Self report,IES,IES-R (Farsi version),,,"Mixed ANOVAs, Cohen's d effect size",Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Moradi AR, Moshirpanahi S, Parhon H, et al. A pilot randomized controlled trial investigating the efficacy of Memory Specificity Training in improving symptoms of posttraumatic stress disorder. Behav Res Ther. 2014 May;56:68-74. doi: 10.1016/j.brat.2014.03.002. PMID: 24705337.",46541,2019
moradi2014_IES_B_Baseline_NA,Psychotherapy,PTSD,24,B,Control,,12,,Control,Assessment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,12,Self report,IES,IES-R (Farsi version),,,"Mixed ANOVAs, Cohen's d effect size",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Moradi AR, Moshirpanahi S, Parhon H, et al. A pilot randomized controlled trial investigating the efficacy of Memory Specificity Training in improving symptoms of posttraumatic stress disorder. Behav Res Ther. 2014 May;56:68-74. doi: 10.1016/j.brat.2014.03.002. PMID: 24705337.",46541,2019
morath2014_CAPS_A_0_NA,Psychotherapy,PTSD,34,A,PTSD,,17,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,CAPS,CAPS,,,Linear mixed model for change in mean scores,End of Treatment,0,,58.65,24.93,,,,,-33.76,,,,,Hedges' g,1.61,,,,"p=""significant""",,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Terrorism/political violence/forced displacement,,Medium,"Morath J, Gola H, Sommershof A, et al. The effect of trauma-focused therapy on the altered T cell distribution in individuals with PTSD: evidence from a randomized controlled trial. J Psychiatr Res. 2014 Jul;54:1-10. doi: 10.1016/j.jpsychires.2014.03.016. PMID: 24726027.",49697,2019
morath2014_CAPS_A_52_NA,Psychotherapy,PTSD,34,A,PTSD,,16,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,CAPS,CAPS,,,Linear mixed model for change in mean scores,Assessment at ≥12 Months,52,,51.88,24.52,,,,,-40.53,,,,,Hedges' g,1.96,,,,"p=""significant""",,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Terrorism/political violence/forced displacement,,Medium,"Morath J, Gola H, Sommershof A, et al. The effect of trauma-focused therapy on the altered T cell distribution in individuals with PTSD: evidence from a randomized controlled trial. J Psychiatr Res. 2014 Jul;54:1-10. doi: 10.1016/j.jpsychires.2014.03.016. PMID: 24726027.",49697,2019
morath2014_CAPS_A_Baseline_NA,Psychotherapy,PTSD,34,A,PTSD,,17,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,CAPS,CAPS,,,Linear mixed model for change in mean scores,Baseline,,,92.41,14.95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Terrorism/political violence/forced displacement,,Medium,"Morath J, Gola H, Sommershof A, et al. The effect of trauma-focused therapy on the altered T cell distribution in individuals with PTSD: evidence from a randomized controlled trial. J Psychiatr Res. 2014 Jul;54:1-10. doi: 10.1016/j.jpsychires.2014.03.016. PMID: 24726027.",49697,2019
morath2014_CAPS_B_0_NA,Psychotherapy,PTSD,34,B,Control,,17,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,17,Structured Clinical Interview,CAPS,CAPS,,,Linear mixed model for change in mean scores,End of Treatment,0,,74.59,20.42,,,,,-2.29,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Terrorism/political violence/forced displacement,,Medium,"Morath J, Gola H, Sommershof A, et al. The effect of trauma-focused therapy on the altered T cell distribution in individuals with PTSD: evidence from a randomized controlled trial. J Psychiatr Res. 2014 Jul;54:1-10. doi: 10.1016/j.jpsychires.2014.03.016. PMID: 24726027.",49697,2019
morath2014_CAPS_B_Baseline_NA,Psychotherapy,PTSD,34,B,Control,,17,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,17,Structured Clinical Interview,CAPS,CAPS,,,Linear mixed model for change in mean scores,Baseline,,,76.88,15.95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7,,0.3,Terrorism/political violence/forced displacement,,Medium,"Morath J, Gola H, Sommershof A, et al. The effect of trauma-focused therapy on the altered T cell distribution in individuals with PTSD: evidence from a randomized controlled trial. J Psychiatr Res. 2014 Jul;54:1-10. doi: 10.1016/j.jpsychires.2014.03.016. PMID: 24726027.",49697,2019
morland2014_CAPS_A_0_Comp,Psychotherapy,PTSD,125,A,PTSD,,42,,Group CPT-cognitive only delivered via videoteleconferencing,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,Video,61,Structured Clinical Interview,CAPS,CAPS,Completer,,Mixed effects model and Cohen's d for change in mean score,End of Treatment,0,,55.9,19.6,,,,,-15.2,,,,,,,,,,"p=""significant""",,,,,,,,CAPS <65,,,>10-point reduction on CAPS,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Morland LA, Mackintosh M-A, Greene CJ, et al. Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. J Clin Psychiatry. 2014;75(5):470-6. doi: 10.4088/JCP.13m08842. PMID: 24922484.",42407,2019
morland2014_CAPS_A_0_ITT,Psychotherapy,PTSD,125,A,PTSD,,48,,Group CPT-cognitive only delivered via videoteleconferencing,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,Video,61,Structured Clinical Interview,CAPS,CAPS,ITT,imputed using Markov Chain Monte Carlo method,Mixed effects model and Cohen's d for change in mean score,End of Treatment,0,,55.6,18.8,,,,,-16.4,,,,,,,,,,"p=""significant""",,,,,,,,CAPS <65,,,>10-point reduction on CAPS,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Morland LA, Mackintosh M-A, Greene CJ, et al. Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. J Clin Psychiatry. 2014;75(5):470-6. doi: 10.4088/JCP.13m08842. PMID: 24922484.",42407,2019
morland2014_CAPS_A_12_Comp,Psychotherapy,PTSD,125,A,PTSD,,41,,Group CPT-cognitive only delivered via videoteleconferencing,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,Video,61,Structured Clinical Interview,CAPS,CAPS,Completer,,Mixed effects model and Cohen's d for change in mean score,Assessment at 3 to <6 Months,12,,54.4,19.2,,,,,-16.7,,,,,,,,,,"p=""significant""",,,,,,,,CAPS <65,,,>10-point reduction on CAPS,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Morland LA, Mackintosh M-A, Greene CJ, et al. Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. J Clin Psychiatry. 2014;75(5):470-6. doi: 10.4088/JCP.13m08842. PMID: 24922484.",42407,2019
morland2014_CAPS_A_12_ITT,Psychotherapy,PTSD,125,A,PTSD,,46,,Group CPT-cognitive only delivered via videoteleconferencing,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,Video,61,Structured Clinical Interview,CAPS,CAPS,ITT,imputed using Markov Chain Monte Carlo method,Mixed effects model and Cohen's d for change in mean score,Assessment at 3 to <6 Months,12,,53.7,19,,,,,-18.3,,,,,,,,,,"p=""significant""",,,,,,,,CAPS <65,,,>10-point reduction on CAPS,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Morland LA, Mackintosh M-A, Greene CJ, et al. Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. J Clin Psychiatry. 2014;75(5):470-6. doi: 10.4088/JCP.13m08842. PMID: 24922484.",42407,2019
morland2014_CAPS_A_26_Comp,Psychotherapy,PTSD,125,A,PTSD,,40,,Group CPT-cognitive only delivered via videoteleconferencing,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,Video,61,Structured Clinical Interview,CAPS,CAPS,Completer,,Mixed effects model and Cohen's d for change in mean score,Assessment at 6 to <12 Months,26,,56.5,18.7,,,,,-14.6,,,,,,,,,,"p=""significant""",,,,,,,,CAPS <65,,,>10-point reduction on CAPS,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Morland LA, Mackintosh M-A, Greene CJ, et al. Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. J Clin Psychiatry. 2014;75(5):470-6. doi: 10.4088/JCP.13m08842. PMID: 24922484.",42407,2019
morland2014_CAPS_A_26_ITT,Psychotherapy,PTSD,125,A,PTSD,,44,,Group CPT-cognitive only delivered via videoteleconferencing,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,Video,61,Structured Clinical Interview,CAPS,CAPS,ITT,imputed using Markov Chain Monte Carlo method,Mixed effects model and Cohen's d for change in mean score,Assessment at 6 to <12 Months,26,,56.2,18,,,,,-15.8,,,,,,,,,,"p=""significant""",,,,,,,,CAPS <65,,,>10-point reduction on CAPS,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Morland LA, Mackintosh M-A, Greene CJ, et al. Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. J Clin Psychiatry. 2014;75(5):470-6. doi: 10.4088/JCP.13m08842. PMID: 24922484.",42407,2019
morland2014_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,125,A,PTSD,,43,,Group CPT-cognitive only delivered via videoteleconferencing,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,Video,61,Structured Clinical Interview,CAPS,CAPS,Completer,,Mixed effects model and Cohen's d for change in mean score,Baseline,,,71.1,14.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Morland LA, Mackintosh M-A, Greene CJ, et al. Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. J Clin Psychiatry. 2014;75(5):470-6. doi: 10.4088/JCP.13m08842. PMID: 24922484.",42407,2019
morland2014_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,125,A,PTSD,,57,,Group CPT-cognitive only delivered via videoteleconferencing,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,Video,61,Structured Clinical Interview,CAPS,CAPS,ITT,imputed using Markov Chain Monte Carlo method,Mixed effects model and Cohen's d for change in mean score,Baseline,,,72,14.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Morland LA, Mackintosh M-A, Greene CJ, et al. Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. J Clin Psychiatry. 2014;75(5):470-6. doi: 10.4088/JCP.13m08842. PMID: 24922484.",42407,2019
morland2014_CAPS_B_0_Comp,Psychotherapy,PTSD,125,B,PTSD,,47,,In person group CPT-cognitive only,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,64,Structured Clinical Interview,CAPS,CAPS,Completer,,Mixed effects model and Cohen's d for change in mean score,End of Treatment,0,,60.5,20.9,,,,,-8.5,,,,,,,,,,"p=""significant""",,,,,,,,CAPS <65,,,>10-point reduction on CAPS,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Morland LA, Mackintosh M-A, Greene CJ, et al. Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. J Clin Psychiatry. 2014;75(5):470-6. doi: 10.4088/JCP.13m08842. PMID: 24922484.",42407,2019
morland2014_CAPS_B_0_ITT,Psychotherapy,PTSD,125,B,PTSD,,52,,In person group CPT-cognitive only,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,64,Structured Clinical Interview,CAPS,CAPS,ITT,imputed using Markov Chain Monte Carlo method,Mixed effects model and Cohen's d for change in mean score,End of Treatment,0,,58.7,21,,,,,-10.2,,,,,,,,,,"p=""significant""",,,,,,,,CAPS <65,,,>10-point reduction on CAPS,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Morland LA, Mackintosh M-A, Greene CJ, et al. Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. J Clin Psychiatry. 2014;75(5):470-6. doi: 10.4088/JCP.13m08842. PMID: 24922484.",42407,2019
morland2014_CAPS_B_12_Comp,Psychotherapy,PTSD,125,B,PTSD,,43,,In person group CPT-cognitive only,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,64,Structured Clinical Interview,CAPS,CAPS,Completer,,Mixed effects model and Cohen's d for change in mean score,Assessment at 3 to <6 Months,12,,57.4,19.7,,,,,-11.6,,,,,,,,,,"p=""significant""",,,,,,,,CAPS <65,,,>10-point reduction on CAPS,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Morland LA, Mackintosh M-A, Greene CJ, et al. Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. J Clin Psychiatry. 2014;75(5):470-6. doi: 10.4088/JCP.13m08842. PMID: 24922484.",42407,2019
morland2014_CAPS_B_12_ITT,Psychotherapy,PTSD,125,B,PTSD,,48,,In person group CPT-cognitive only,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,64,Structured Clinical Interview,CAPS,CAPS,ITT,imputed using Markov Chain Monte Carlo method,Mixed effects model and Cohen's d for change in mean score,Assessment at 3 to <6 Months,12,,57.6,19.7,,,,,-11.3,,,,,,,,,,"p=""significant""",,,,,,,,CAPS <65,,,>10-point reduction on CAPS,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Morland LA, Mackintosh M-A, Greene CJ, et al. Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. J Clin Psychiatry. 2014;75(5):470-6. doi: 10.4088/JCP.13m08842. PMID: 24922484.",42407,2019
morland2014_CAPS_B_26_Comp,Psychotherapy,PTSD,125,B,PTSD,,38,,In person group CPT-cognitive only,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,64,Structured Clinical Interview,CAPS,CAPS,Completer,,Mixed effects model and Cohen's d for change in mean score,Assessment at 6 to <12 Months,26,,57.8,18.7,,,,,-11.2,,,,,,,,,,"p=""significant""",,,,,,,,CAPS <65,,,>10-point reduction on CAPS,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Morland LA, Mackintosh M-A, Greene CJ, et al. Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. J Clin Psychiatry. 2014;75(5):470-6. doi: 10.4088/JCP.13m08842. PMID: 24922484.",42407,2019
morland2014_CAPS_B_26_ITT,Psychotherapy,PTSD,125,B,PTSD,,43,,In person group CPT-cognitive only,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,64,Structured Clinical Interview,CAPS,CAPS,ITT,imputed using Markov Chain Monte Carlo method,Mixed effects model and Cohen's d for change in mean score,Assessment at 6 to <12 Months,26,,57.7,19.8,,,,,-11.2,,,,,,,,,,"p=""significant""",,,,,,,,CAPS <65,,,>10-point reduction on CAPS,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Morland LA, Mackintosh M-A, Greene CJ, et al. Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. J Clin Psychiatry. 2014;75(5):470-6. doi: 10.4088/JCP.13m08842. PMID: 24922484.",42407,2019
morland2014_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,125,B,PTSD,,48,,In person group CPT-cognitive only,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,64,Structured Clinical Interview,CAPS,CAPS,Completer,,Mixed effects model and Cohen's d for change in mean score,Baseline,,,69,13.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Morland LA, Mackintosh M-A, Greene CJ, et al. Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. J Clin Psychiatry. 2014;75(5):470-6. doi: 10.4088/JCP.13m08842. PMID: 24922484.",42407,2019
morland2014_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,125,B,PTSD,,62,,In person group CPT-cognitive only,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,64,Structured Clinical Interview,CAPS,CAPS,ITT,imputed using Markov Chain Monte Carlo method,Mixed effects model and Cohen's d for change in mean score,Baseline,,,68.9,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Morland LA, Mackintosh M-A, Greene CJ, et al. Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. J Clin Psychiatry. 2014;75(5):470-6. doi: 10.4088/JCP.13m08842. PMID: 24922484.",42407,2019
morland2015_CAPS_A_0_Comp,Psychotherapy,PTSD,126,A,PTSD,,43,,CPT by video teleconferencing,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,63,Structured Clinical Interview,CAPS,CAPS,Completer,"""same approach""",Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,End of Treatment,0,,44,,95% CI,35.3,52.8,,-23.2,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.17,0.83,1,,0,,,Medium,"Morland LA, Mackintosh MA, Rosen CS, et al. Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015 Nov;32(11):811-20. doi: 10.1002/da.22397. PMID: 26243685.",44260,2019
morland2015_CAPS_A_0_ITT,Psychotherapy,PTSD,126,A,PTSD,,43,,CPT by video teleconferencing,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,63,Structured Clinical Interview,CAPS,CAPS,ITT,Multiply imputed using the Markov Chain Monte Carlo method with 20 data sets,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,End of Treatment,0,,50.5,,95% CI,39.9,61,,-17.1,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.17,0.83,1,,0,,,Medium,"Morland LA, Mackintosh MA, Rosen CS, et al. Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015 Nov;32(11):811-20. doi: 10.1002/da.22397. PMID: 26243685.",44260,2019
morland2015_CAPS_A_12_Comp,Psychotherapy,PTSD,126,A,PTSD,,38,,CPT by video teleconferencing,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,63,Structured Clinical Interview,CAPS,CAPS,Completer,"""same approach""",Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Assessment at 3 to <6 Months,12,,45.4,,95% CI,35.8,52.8,,-21.8,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.17,0.83,1,,0,,,Medium,"Morland LA, Mackintosh MA, Rosen CS, et al. Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015 Nov;32(11):811-20. doi: 10.1002/da.22397. PMID: 26243685.",44260,2019
morland2015_CAPS_A_12_ITT,Psychotherapy,PTSD,126,A,PTSD,,38,,CPT by video teleconferencing,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,63,Structured Clinical Interview,CAPS,CAPS,ITT,Multiply imputed using the Markov Chain Monte Carlo method with 20 data sets,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Assessment at 3 to <6 Months,12,,50.9,,95% CI,40.1,61.7,,-16.7,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.17,0.83,1,,0,,,Medium,"Morland LA, Mackintosh MA, Rosen CS, et al. Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015 Nov;32(11):811-20. doi: 10.1002/da.22397. PMID: 26243685.",44260,2019
morland2015_CAPS_A_26_Comp,Psychotherapy,PTSD,126,A,PTSD,,43,,CPT by video teleconferencing,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,63,Structured Clinical Interview,CAPS,CAPS,Completer,"""same approach""",Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Assessment at 6 to <12 Months,26,,46.5,,95% CI,35.3,57.7,,-20.7,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.17,0.83,1,,0,,,Medium,"Morland LA, Mackintosh MA, Rosen CS, et al. Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015 Nov;32(11):811-20. doi: 10.1002/da.22397. PMID: 26243685.",44260,2019
morland2015_CAPS_A_26_ITT,Psychotherapy,PTSD,126,A,PTSD,,43,,CPT by video teleconferencing,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,63,Structured Clinical Interview,CAPS,CAPS,ITT,Multiply imputed using the Markov Chain Monte Carlo method with 20 data sets,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Assessment at 6 to <12 Months,26,,46.5,,95% CI,35.3,57.7,,-21.1,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.17,0.83,1,,0,,,Medium,"Morland LA, Mackintosh MA, Rosen CS, et al. Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015 Nov;32(11):811-20. doi: 10.1002/da.22397. PMID: 26243685.",44260,2019
morland2015_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,126,A,PTSD,,48,,CPT by video teleconferencing,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,63,Structured Clinical Interview,CAPS,CAPS,Completer,"""same approach""",Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Baseline,,,67.2,,95% CI,61.4,72.1,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.17,0.83,1,,0,,,Medium,"Morland LA, Mackintosh MA, Rosen CS, et al. Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015 Nov;32(11):811-20. doi: 10.1002/da.22397. PMID: 26243685.",44260,2019
morland2015_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,126,A,PTSD,,61,,CPT by video teleconferencing,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,63,Structured Clinical Interview,CAPS,CAPS,ITT,Multiply imputed using the Markov Chain Monte Carlo method with 20 data sets,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Baseline,,,67.6,,95% CI,62.7,72.5,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.17,0.83,1,,0,,,Medium,"Morland LA, Mackintosh MA, Rosen CS, et al. Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015 Nov;32(11):811-20. doi: 10.1002/da.22397. PMID: 26243685.",44260,2019
morland2015_CAPS_B_0_Comp,Psychotherapy,PTSD,126,B,PTSD,,49,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Structured Clinical Interview,CAPS,CAPS,Completer,"""same approach""",Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,End of Treatment,0,,48.6,,95% CI,41.1,56.1,,-18.1,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.17,0.83,1,,0,,,Medium,"Morland LA, Mackintosh MA, Rosen CS, et al. Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015 Nov;32(11):811-20. doi: 10.1002/da.22397. PMID: 26243685.",44260,2019
morland2015_CAPS_B_0_ITT,Psychotherapy,PTSD,126,B,PTSD,,49,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Structured Clinical Interview,CAPS,CAPS,ITT,Multiply imputed using the Markov Chain Monte Carlo method with 20 data sets,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,End of Treatment,0,,53.6,,95% CI,43.9,63.3,,13.7,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.17,0.83,1,,0,,,Medium,"Morland LA, Mackintosh MA, Rosen CS, et al. Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015 Nov;32(11):811-20. doi: 10.1002/da.22397. PMID: 26243685.",44260,2019
morland2015_CAPS_B_12_Comp,Psychotherapy,PTSD,126,B,PTSD,,45,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Structured Clinical Interview,CAPS,CAPS,Completer,"""same approach""",Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Assessment at 3 to <6 Months,12,,49.4,,95% CI,41.1,57.6,,-17.3,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.17,0.83,1,,0,,,Medium,"Morland LA, Mackintosh MA, Rosen CS, et al. Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015 Nov;32(11):811-20. doi: 10.1002/da.22397. PMID: 26243685.",44260,2019
morland2015_CAPS_B_12_ITT,Psychotherapy,PTSD,126,B,PTSD,,45,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Structured Clinical Interview,CAPS,CAPS,ITT,Multiply imputed using the Markov Chain Monte Carlo method with 20 data sets,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Assessment at 3 to <6 Months,12,,54.5,,95% CI,44.7,64.4,,-12.8,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.17,0.83,1,,0,,,Medium,"Morland LA, Mackintosh MA, Rosen CS, et al. Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015 Nov;32(11):811-20. doi: 10.1002/da.22397. PMID: 26243685.",44260,2019
morland2015_CAPS_B_26_Comp,Psychotherapy,PTSD,126,B,PTSD,,41,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Structured Clinical Interview,CAPS,CAPS,Completer,"""same approach""",Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Assessment at 6 to <12 Months,26,,52.3,,95% CI,39.6,65,,-14.4,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.17,0.83,1,,0,,,Medium,"Morland LA, Mackintosh MA, Rosen CS, et al. Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015 Nov;32(11):811-20. doi: 10.1002/da.22397. PMID: 26243685.",44260,2019
morland2015_CAPS_B_26_ITT,Psychotherapy,PTSD,126,B,PTSD,,41,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Structured Clinical Interview,CAPS,CAPS,ITT,Multiply imputed using the Markov Chain Monte Carlo method with 20 data sets,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Assessment at 6 to <12 Months,26,,52.3,,95% CI,39.6,65,,-15,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.17,0.83,1,,0,,,Medium,"Morland LA, Mackintosh MA, Rosen CS, et al. Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015 Nov;32(11):811-20. doi: 10.1002/da.22397. PMID: 26243685.",44260,2019
morland2015_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,126,B,PTSD,,50,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Structured Clinical Interview,CAPS,CAPS,Completer,"""same approach""",Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Baseline,,,66.7,,95% CI,61.4,72.1,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.17,0.83,1,,0,,,Medium,"Morland LA, Mackintosh MA, Rosen CS, et al. Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015 Nov;32(11):811-20. doi: 10.1002/da.22397. PMID: 26243685.",44260,2019
morland2015_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,126,B,PTSD,,63,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,63,Structured Clinical Interview,CAPS,CAPS,ITT,Multiply imputed using the Markov Chain Monte Carlo method with 20 data sets,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Baseline,,,67.3,,95% CI,62.5,71.2,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.17,0.83,1,,0,,,Medium,"Morland LA, Mackintosh MA, Rosen CS, et al. Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015 Nov;32(11):811-20. doi: 10.1002/da.22397. PMID: 26243685.",44260,2019
morland2019_CAPS_A_0_ITT,Psychotherapy,PTSD,175,A,PTSD,,45,,In-home in-person PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,58,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,End of Treatment,0,,20.6,12.86,,,,,-21.2,,,,,Cohen's d,1.08,,,,p=NR,,,,,,,,Not fulfilling criteria for PTSD according to CAPS-5,0.5517,,,,,Veteran,0,1,0,0.251,,0.749,,,Medium,"Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",,2020
morland2019_CAPS_A_26_ITT,Psychotherapy,PTSD,175,A,PTSD,,35,,In-home in-person PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,58,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Assessment at 6 to <12 Months,26,,20.6,12.86,,,,,-19.6,,,,,Cohen's d,0.96,,,,p=NR,,,,,,,,Not fulfilling criteria for PTSD according to CAPS-5,0.5328,,,,,Veteran,0,1,0,0.251,,0.749,,,Medium,"Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",,2020
morland2019_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,175,A,PTSD,,58,,In-home in-person PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,58,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Baseline,,,41.8,6.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.251,,0.749,,,Medium,"Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",,2020
morland2019_CAPS_B_0_ITT,Psychotherapy,PTSD,175,B,PTSD,,41,,Home-based telehealth PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,58,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,End of Treatment,0,,21.5,14.77,,,,,-20,,,,,Cohen's d,1.02,,,,p=NR,,,,,,,,Not fulfilling criteria for PTSD according to CAPS-5,0.5448,,,,,Veteran,0,1,0,0.251,,0.749,,,Medium,"Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",,2020
morland2019_CAPS_B_26_ITT,Psychotherapy,PTSD,175,B,PTSD,,33,,Home-based telehealth PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,58,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Assessment at 6 to <12 Months,26,,24.9,14.2,,,,,-16.6,,,,,Cohen's d,0.85,,,,p=NR,,,,,,,,Not fulfilling criteria for PTSD according to CAPS-5,0.4897,,,,,Veteran,0,1,0,0.251,,0.749,,,Medium,"Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",,2020
morland2019_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,175,B,PTSD,,58,,Home-based telehealth PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,58,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Baseline,,,41.5,7.93,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.251,,0.749,,,Medium,"Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",,2020
morland2019_CAPS_C_0_ITT,Psychotherapy,PTSD,175,C,PTSD,,39,,Office-based telehealth PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,59,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,End of Treatment,0,,21.6,15.1,,,,,-19,,,,,Cohen's d,0.96,,,,p=NR,,,,,,,,Not fulfilling criteria for PTSD according to CAPS-5,0.622,,,,,Veteran,0,1,0,0.251,,0.749,,,Medium,"Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",,2020
morland2019_CAPS_C_26_ITT,Psychotherapy,PTSD,175,C,PTSD,,34,,Office-based telehealth PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,59,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Assessment at 6 to <12 Months,26,,23.7,14.14,,,,,-16.9,,,,,Cohen's d,0.84,,,,p=NR,,,,,,,,Not fulfilling criteria for PTSD according to CAPS-5,0.4831,,,,,Veteran,0,1,0,0.251,,0.749,,,Medium,"Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",,2020
morland2019_CAPS_C_Baseline_ITT,Psychotherapy,PTSD,175,C,PTSD,,59,,Office-based telehealth PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,59,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Baseline,,,40.6,8.32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.251,,0.749,,,Medium,"Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",,2020
morland2019_PCL_A_0_ITT,Psychotherapy,PTSD,175,A,PTSD,,,,In-home in-person PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,58,Self report,PCL,PCL-5,ITT,Multiple imputation,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,End of Treatment,0,,27.8,19.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.251,,0.749,,,Medium,"Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",,2020
morland2019_PCL_A_26_ITT,Psychotherapy,PTSD,175,A,PTSD,,,,In-home in-person PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,58,Self report,PCL,PCL-5,ITT,Multiple imputation,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Assessment at 6 to <12 Months,26,,32.1,18.32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.251,,0.749,,,Medium,"Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",,2020
morland2019_PCL_A_Baseline_ITT,Psychotherapy,PTSD,175,A,PTSD,,,,In-home in-person PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,58,Self report,PCL,PCL-5,ITT,Multiple imputation,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Baseline,,,54.7,9.82,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.251,,0.749,,,Medium,"Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",,2020
morland2019_PCL_B_0_ITT,Psychotherapy,PTSD,175,B,PTSD,,,,Home-based telehealth PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,58,Self report,PCL,PCL-5,ITT,Multiple imputation,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,End of Treatment,0,,20.1,21.34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.251,,0.749,,,Medium,"Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",,2020
morland2019_PCL_B_26_ITT,Psychotherapy,PTSD,175,B,PTSD,,,,Home-based telehealth PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,58,Self report,PCL,PCL-5,ITT,Multiple imputation,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Assessment at 6 to <12 Months,26,,32.4,20.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.251,,0.749,,,Medium,"Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",,2020
morland2019_PCL_B_Baseline_ITT,Psychotherapy,PTSD,175,B,PTSD,,,,Home-based telehealth PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,58,Self report,PCL,PCL-5,ITT,Multiple imputation,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Baseline,,,53.4,10.48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.251,,0.749,,,Medium,"Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",,2020
morland2019_PCL_C_0_ITT,Psychotherapy,PTSD,175,C,PTSD,,,,Office-based telehealth PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,59,Self report,PCL,PCL-5,ITT,Multiple imputation,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,End of Treatment,0,,31.6,22.21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.251,,0.749,,,Medium,"Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",,2020
morland2019_PCL_C_26_ITT,Psychotherapy,PTSD,175,C,PTSD,,,,Office-based telehealth PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,59,Self report,PCL,PCL-5,ITT,Multiple imputation,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Assessment at 6 to <12 Months,26,,33.3,19.67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.251,,0.749,,,Medium,"Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",,2020
morland2019_PCL_C_Baseline_ITT,Psychotherapy,PTSD,175,C,PTSD,,,,Office-based telehealth PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,59,Self report,PCL,PCL-5,ITT,Multiple imputation,Mixed effects modeling approach to estimate differences in CAPS score between groups. Cohen's d for effect sizes.,Baseline,,,53.1,11.57,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.251,,0.749,,,Medium,"Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.",,2020
mueser2008_CAPS_A_0_ITT,Psychotherapy,PTSD,108,A,PTSD,,54,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,54,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using maximum likelihood estimation,Covariance pattern models,End of Treatment,0,,55.53,27.92,,,,,-18.93,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.6111,,,,,Community,,,1,0.787,,0.213,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",Medium,"Mueser KT, Rosenberg SD, Xie HY, et al. A randomized controlled trial of cognitive-behavioral treatment for posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol. 2008 Apr;76(2):259-71. doi: 10.1037/0022-006X.76.2.259. PMID: 18377122.",30794,2019
mueser2008_CAPS_A_12_ITT,Psychotherapy,PTSD,108,A,PTSD,,54,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,54,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using maximum likelihood estimation,Covariance pattern models,Assessment at 3 to <6 Months,12,,55.1,25.96,,,,,-19.36,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.6481,,,,,Community,,,1,0.787,,0.213,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",Medium,"Mueser KT, Rosenberg SD, Xie HY, et al. A randomized controlled trial of cognitive-behavioral treatment for posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol. 2008 Apr;76(2):259-71. doi: 10.1037/0022-006X.76.2.259. PMID: 18377122.",30794,2019
mueser2008_CAPS_A_26_ITT,Psychotherapy,PTSD,108,A,PTSD,,54,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,54,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using maximum likelihood estimation,Covariance pattern models,Assessment at 6 to <12 Months,26,,57.48,25.34,,,,,-16.98,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.5556,,,,,Community,,,1,0.787,,0.213,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",Medium,"Mueser KT, Rosenberg SD, Xie HY, et al. A randomized controlled trial of cognitive-behavioral treatment for posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol. 2008 Apr;76(2):259-71. doi: 10.1037/0022-006X.76.2.259. PMID: 18377122.",30794,2019
mueser2008_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,108,A,PTSD,,54,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,54,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using maximum likelihood estimation,Covariance pattern models,Baseline,,,74.46,17.56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.787,,0.213,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",Medium,"Mueser KT, Rosenberg SD, Xie HY, et al. A randomized controlled trial of cognitive-behavioral treatment for posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol. 2008 Apr;76(2):259-71. doi: 10.1037/0022-006X.76.2.259. PMID: 18377122.",30794,2019
mueser2008_CAPS_B_0_ITT,Psychotherapy,PTSD,108,B,Control,,54,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,54,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using maximum likelihood estimation,Covariance pattern models,End of Treatment,0,,67.78,26.84,,,,,-8.37,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.6111,,,,,Community,,,1,0.787,,0.213,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",Medium,"Mueser KT, Rosenberg SD, Xie HY, et al. A randomized controlled trial of cognitive-behavioral treatment for posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol. 2008 Apr;76(2):259-71. doi: 10.1037/0022-006X.76.2.259. PMID: 18377122.",30794,2019
mueser2008_CAPS_B_12_ITT,Psychotherapy,PTSD,108,B,Control,,54,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,54,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using maximum likelihood estimation,Covariance pattern models,Assessment at 3 to <6 Months,12,,64.8,28.25,,,,,-11.35,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.5,,,,,Community,,,1,0.787,,0.213,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",Medium,"Mueser KT, Rosenberg SD, Xie HY, et al. A randomized controlled trial of cognitive-behavioral treatment for posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol. 2008 Apr;76(2):259-71. doi: 10.1037/0022-006X.76.2.259. PMID: 18377122.",30794,2019
mueser2008_CAPS_B_26_ITT,Psychotherapy,PTSD,108,B,Control,,54,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,54,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using maximum likelihood estimation,Covariance pattern models,Assessment at 6 to <12 Months,26,,70.9,24.15,,,,,-5.25,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.6852,,,,,Community,,,1,0.787,,0.213,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",Medium,"Mueser KT, Rosenberg SD, Xie HY, et al. A randomized controlled trial of cognitive-behavioral treatment for posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol. 2008 Apr;76(2):259-71. doi: 10.1037/0022-006X.76.2.259. PMID: 18377122.",30794,2019
mueser2008_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,108,B,Control,,54,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,54,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using maximum likelihood estimation,Covariance pattern models,Baseline,,,76.15,17.07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.787,,0.213,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)",Medium,"Mueser KT, Rosenberg SD, Xie HY, et al. A randomized controlled trial of cognitive-behavioral treatment for posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol. 2008 Apr;76(2):259-71. doi: 10.1037/0022-006X.76.2.259. PMID: 18377122.",30794,2019
mueser2015_CAPS_A_0_ITT,Psychotherapy,PTSD,201,A,PTSD,,86,,CBT for severe mental illness,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,104,Structured Clinical Interview,CAPS,CAPS (Schizophrenia version),ITT,,General mixed-effects linear regression model,End of Treatment,0,,63.55,27.14,,,,,-22.51,,,,,,,,,,,,,,,,,,Not meeting PTSD criteria according to the CAPS,0.3605,,,,,Community,,,1,0.6866,,0.3134,,,High,"Mueser KT, Gottlieb JD, Xie H, et al. Evaluation of cognitive restructuring for post-traumatic stress disorder in people with severe mental illness. Br J Psychiatry. 2015 Jun;206(6):501-8. doi: 10.1192/bjp.bp.114.147926. PMID: 25858178.",43698,2019
mueser2015_CAPS_A_26_ITT,Psychotherapy,PTSD,201,A,PTSD,,82,,CBT for severe mental illness,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,104,Structured Clinical Interview,CAPS,CAPS (Schizophrenia version),ITT,,General mixed-effects linear regression model,Assessment at 6 to <12 Months,26,,63.23,28.96,,,,,-22.83,,,,,,,,,,,,,,,,,,Not meeting PTSD criteria according to the CAPS,0.3659,,,,,Community,,,1,0.6866,,0.3134,,,High,"Mueser KT, Gottlieb JD, Xie H, et al. Evaluation of cognitive restructuring for post-traumatic stress disorder in people with severe mental illness. Br J Psychiatry. 2015 Jun;206(6):501-8. doi: 10.1192/bjp.bp.114.147926. PMID: 25858178.",43698,2019
mueser2015_CAPS_A_52_ITT,Psychotherapy,PTSD,201,A,PTSD,,83,,CBT for severe mental illness,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,104,Structured Clinical Interview,CAPS,CAPS (Schizophrenia version),ITT,,General mixed-effects linear regression model,Assessment at ≥12 Months,52,,60.62,28.14,,,,,-25.44,,,,,,,,,,,,,,,,,,Not meeting PTSD criteria according to the CAPS,0.4096,,,,,Community,,,1,0.6866,,0.3134,,,High,"Mueser KT, Gottlieb JD, Xie H, et al. Evaluation of cognitive restructuring for post-traumatic stress disorder in people with severe mental illness. Br J Psychiatry. 2015 Jun;206(6):501-8. doi: 10.1192/bjp.bp.114.147926. PMID: 25858178.",43698,2019
mueser2015_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,201,A,PTSD,,104,,CBT for severe mental illness,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,104,Structured Clinical Interview,CAPS,CAPS (Schizophrenia version),ITT,,General mixed-effects linear regression model,Baseline,,,86.06,13.46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6866,,0.3134,,,High,"Mueser KT, Gottlieb JD, Xie H, et al. Evaluation of cognitive restructuring for post-traumatic stress disorder in people with severe mental illness. Br J Psychiatry. 2015 Jun;206(6):501-8. doi: 10.1192/bjp.bp.114.147926. PMID: 25858178.",43698,2019
mueser2015_CAPS_B_0_ITT,Psychotherapy,PTSD,201,B,PTSD,,75,,Brief Treatment,Psychoeducation,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,97,Structured Clinical Interview,CAPS,CAPS (Schizophrenia version),ITT,,General mixed-effects linear regression model,End of Treatment,0,,70.38,25.01,,,,,-15.38,,,,,,,,,,,,,,,,,,Not meeting PTSD criteria according to the CAPS,0.2667,,,,,Community,,,1,0.6866,,0.3134,,,High,"Mueser KT, Gottlieb JD, Xie H, et al. Evaluation of cognitive restructuring for post-traumatic stress disorder in people with severe mental illness. Br J Psychiatry. 2015 Jun;206(6):501-8. doi: 10.1192/bjp.bp.114.147926. PMID: 25858178.",43698,2019
mueser2015_CAPS_B_26_ITT,Psychotherapy,PTSD,201,B,PTSD,,68,,Brief Treatment,Psychoeducation,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,97,Structured Clinical Interview,CAPS,CAPS (Schizophrenia version),ITT,,General mixed-effects linear regression model,Assessment at 6 to <12 Months,26,,70.17,24.69,,,,,-15.59,,,,,,,,,,,,,,,,,,Not meeting PTSD criteria according to the CAPS,0.2353,,,,,Community,,,1,0.6866,,0.3134,,,High,"Mueser KT, Gottlieb JD, Xie H, et al. Evaluation of cognitive restructuring for post-traumatic stress disorder in people with severe mental illness. Br J Psychiatry. 2015 Jun;206(6):501-8. doi: 10.1192/bjp.bp.114.147926. PMID: 25858178.",43698,2019
mueser2015_CAPS_B_52_ITT,Psychotherapy,PTSD,201,B,PTSD,,73,,Brief Treatment,Psychoeducation,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,97,Structured Clinical Interview,CAPS,CAPS (Schizophrenia version),ITT,,General mixed-effects linear regression model,Assessment at ≥12 Months,52,,65.9,,,,,,-19.86,,,,,,,,,,,,,,,,,,Not meeting PTSD criteria according to the CAPS,0.3014,,,,,Community,,,1,0.6866,,0.3134,,,High,"Mueser KT, Gottlieb JD, Xie H, et al. Evaluation of cognitive restructuring for post-traumatic stress disorder in people with severe mental illness. Br J Psychiatry. 2015 Jun;206(6):501-8. doi: 10.1192/bjp.bp.114.147926. PMID: 25858178.",43698,2019
mueser2015_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,201,B,PTSD,,97,,Brief Treatment,Psychoeducation,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,97,Structured Clinical Interview,CAPS,CAPS (Schizophrenia version),ITT,,General mixed-effects linear regression model,Baseline,,,85.76,13.11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6866,,0.3134,,,High,"Mueser KT, Gottlieb JD, Xie H, et al. Evaluation of cognitive restructuring for post-traumatic stress disorder in people with severe mental illness. Br J Psychiatry. 2015 Jun;206(6):501-8. doi: 10.1192/bjp.bp.114.147926. PMID: 25858178.",43698,2019
nacasch2011_PSS-I_A_0_ITT,Psychotherapy,PTSD,30,A,PTSD,,13,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Structured Clinical Interview,PSS-I,PSS-I,ITT,Mixed-effects models,Mixed-effects models mixed with an unstructured covariance structure; Cohen's d effect sizes.,End of Treatment,0,,18.9,9.1,,,,,-18.2,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0667,,0.9333,Mixed,"combat-related, terrorism/political violence",Medium,"Nacasch N, Foa EB, Huppert JD, et al. Prolonged exposure therapy for combat- and terror-related posttraumatic stress disorder: a randomized control comparison with treatment as usual. J Clin Psychiatry. 2011 Sep;72(9):1174-80. doi: 10.4088/JCP.09m05682blu. PMID: 21208581.",35512,2019
nacasch2011_PSS-I_A_52_ITT,Psychotherapy,PTSD,30,A,PTSD,,13,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Structured Clinical Interview,PSS-I,PSS-I,ITT,Mixed-effects models,Mixed-effects models mixed with an unstructured covariance structure; Cohen's d effect sizes.,Assessment at ≥12 Months,52,,16.3,10.4,,,,,-20.8,,,,,,,,,,p<0.0001,,,,,,,,,,,,,,Veteran,0,1,0,0.0667,,0.9333,Mixed,"combat-related, terrorism/political violence",Medium,"Nacasch N, Foa EB, Huppert JD, et al. Prolonged exposure therapy for combat- and terror-related posttraumatic stress disorder: a randomized control comparison with treatment as usual. J Clin Psychiatry. 2011 Sep;72(9):1174-80. doi: 10.4088/JCP.09m05682blu. PMID: 21208581.",35512,2019
nacasch2011_PSS-I_A_Baseline_ITT,Psychotherapy,PTSD,30,A,PTSD,,15,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Structured Clinical Interview,PSS-I,PSS-I,ITT,Mixed-effects models,Mixed-effects models mixed with an unstructured covariance structure; Cohen's d effect sizes.,Baseline,,,37.1,3.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0667,,0.9333,Mixed,"combat-related, terrorism/political violence",Medium,"Nacasch N, Foa EB, Huppert JD, et al. Prolonged exposure therapy for combat- and terror-related posttraumatic stress disorder: a randomized control comparison with treatment as usual. J Clin Psychiatry. 2011 Sep;72(9):1174-80. doi: 10.4088/JCP.09m05682blu. PMID: 21208581.",35512,2019
nacasch2011_PSS-I_B_0_ITT,Psychotherapy,PTSD,30,B,Control,,13,,TAU,Treatment as usual (TAU),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,15,Structured Clinical Interview,PSS-I,PSS-I,ITT,Mixed-effects models,Mixed-effects models mixed with an unstructured covariance structure; Cohen's d effect sizes.,End of Treatment,0,,35,8.9,,,,,-1.8,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0667,,0.9333,Mixed,"combat-related, terrorism/political violence",Medium,"Nacasch N, Foa EB, Huppert JD, et al. Prolonged exposure therapy for combat- and terror-related posttraumatic stress disorder: a randomized control comparison with treatment as usual. J Clin Psychiatry. 2011 Sep;72(9):1174-80. doi: 10.4088/JCP.09m05682blu. PMID: 21208581.",35512,2019
nacasch2011_PSS-I_B_52_ITT,Psychotherapy,PTSD,30,B,Control,,9,,TAU,Treatment as usual (TAU),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,15,Structured Clinical Interview,PSS-I,PSS-I,ITT,Mixed-effects models,Mixed-effects models mixed with an unstructured covariance structure; Cohen's d effect sizes.,Assessment at ≥12 Months,52,,35.4,7.6,,,,,-1.4,,,,,,,,,,p=0.44,,,,,,,,,,,,,,Veteran,0,1,0,0.0667,,0.9333,Mixed,"combat-related, terrorism/political violence",Medium,"Nacasch N, Foa EB, Huppert JD, et al. Prolonged exposure therapy for combat- and terror-related posttraumatic stress disorder: a randomized control comparison with treatment as usual. J Clin Psychiatry. 2011 Sep;72(9):1174-80. doi: 10.4088/JCP.09m05682blu. PMID: 21208581.",35512,2019
nacasch2011_PSS-I_B_Baseline_ITT,Psychotherapy,PTSD,30,B,Control,,15,,TAU,Treatment as usual (TAU),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,15,Structured Clinical Interview,PSS-I,PSS-I,ITT,Mixed-effects models,Mixed-effects models mixed with an unstructured covariance structure; Cohen's d effect sizes.,Baseline,,,36.8,6.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0667,,0.9333,Mixed,"combat-related, terrorism/political violence",Medium,"Nacasch N, Foa EB, Huppert JD, et al. Prolonged exposure therapy for combat- and terror-related posttraumatic stress disorder: a randomized control comparison with treatment as usual. J Clin Psychiatry. 2011 Sep;72(9):1174-80. doi: 10.4088/JCP.09m05682blu. PMID: 21208581.",35512,2019
nacasch2015_PSS-I_A_0_ITT,Psychotherapy,PTSD,39,A,PTSD,,20,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,PSS-I,PSS-I,ITT,,"Noninferiority margin determined using RCI: 7 points on PSS-I , between-group effect size Cohen's d <0.2; additional analysis using multilevel linear models. Cohen's d  effect size for between-group differences using raw data and pooled variance as well as estimates of d from mixed-effects repeated measures models.",End of Treatment,0,,13.3,9.52,,,,,-18.9,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,0.3846,,0.6154,Mixed,"combat-related, rape/sexual assault, child sexual abuse, community/school violence, terrorism/political violence/forced displacement, accidents",Medium,"Nacasch N, Huppert JD, Su Y-J, et al. Are 60-minute prolonged exposure sessions with 20-minute imaginal exposure to traumatic memories sufficient to successfully treat PTSD? A randomized nonininferiority clinical trial. Behav Ther. 2015 May;46(3):328-41. doi: 10.1016/j.beth.2014.12.002. PMID: 25892169.",43927,2019
nacasch2015_PSS-I_A_26_ITT,Psychotherapy,PTSD,39,A,PTSD,,14,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,PSS-I,PSS-I,ITT,,"Noninferiority margin determined using RCI: 7 points on PSS-I , between-group effect size Cohen's d <0.2; additional analysis using multilevel linear models. Cohen's d  effect size for between-group differences using raw data and pooled variance as well as estimates of d from mixed-effects repeated measures models.",Assessment at 6 to <12 Months,26,,13.57,9.26,,,,,-18.63,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3846,,0.6154,Mixed,"combat-related, rape/sexual assault, child sexual abuse, community/school violence, terrorism/political violence/forced displacement, accidents",Medium,"Nacasch N, Huppert JD, Su Y-J, et al. Are 60-minute prolonged exposure sessions with 20-minute imaginal exposure to traumatic memories sufficient to successfully treat PTSD? A randomized nonininferiority clinical trial. Behav Ther. 2015 May;46(3):328-41. doi: 10.1016/j.beth.2014.12.002. PMID: 25892169.",43927,2019
nacasch2015_PSS-I_A_Baseline_ITT,Psychotherapy,PTSD,39,A,PTSD,,20,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,PSS-I,PSS-I,ITT,,"Noninferiority margin determined using RCI: 7 points on PSS-I , between-group effect size Cohen's d <0.2; additional analysis using multilevel linear models. Cohen's d  effect size for between-group differences using raw data and pooled variance as well as estimates of d from mixed-effects repeated measures models.",Baseline,,,32.2,5.96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3846,,0.6154,Mixed,"combat-related, rape/sexual assault, child sexual abuse, community/school violence, terrorism/political violence/forced displacement, accidents",Medium,"Nacasch N, Huppert JD, Su Y-J, et al. Are 60-minute prolonged exposure sessions with 20-minute imaginal exposure to traumatic memories sufficient to successfully treat PTSD? A randomized nonininferiority clinical trial. Behav Ther. 2015 May;46(3):328-41. doi: 10.1016/j.beth.2014.12.002. PMID: 25892169.",43927,2019
nacasch2015_PSS-I_B_0_ITT,Psychotherapy,PTSD,39,B,PTSD,,17,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Structured Clinical Interview,PSS-I,PSS-I,ITT,,"Noninferiority margin determined using RCI: 7 points on PSS-I , between-group effect size Cohen's d <0.2; additional analysis using multilevel linear models. Cohen's d  effect size for between-group differences using raw data and pooled variance as well as estimates of d from mixed-effects repeated measures models.",End of Treatment,0,,12.24,8.02,,,,,-19.78,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,0.3846,,0.6154,Mixed,"combat-related, rape/sexual assault, child sexual abuse, community/school violence, terrorism/political violence/forced displacement, accidents",Medium,"Nacasch N, Huppert JD, Su Y-J, et al. Are 60-minute prolonged exposure sessions with 20-minute imaginal exposure to traumatic memories sufficient to successfully treat PTSD? A randomized nonininferiority clinical trial. Behav Ther. 2015 May;46(3):328-41. doi: 10.1016/j.beth.2014.12.002. PMID: 25892169.",43927,2019
nacasch2015_PSS-I_B_26_ITT,Psychotherapy,PTSD,39,B,PTSD,,15,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Structured Clinical Interview,PSS-I,PSS-I,ITT,,"Noninferiority margin determined using RCI: 7 points on PSS-I , between-group effect size Cohen's d <0.2; additional analysis using multilevel linear models. Cohen's d  effect size for between-group differences using raw data and pooled variance as well as estimates of d from mixed-effects repeated measures models.",Assessment at 6 to <12 Months,26,,12.2,7.78,,,,,-19.38,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3846,,0.6154,Mixed,"combat-related, rape/sexual assault, child sexual abuse, community/school violence, terrorism/political violence/forced displacement, accidents",Medium,"Nacasch N, Huppert JD, Su Y-J, et al. Are 60-minute prolonged exposure sessions with 20-minute imaginal exposure to traumatic memories sufficient to successfully treat PTSD? A randomized nonininferiority clinical trial. Behav Ther. 2015 May;46(3):328-41. doi: 10.1016/j.beth.2014.12.002. PMID: 25892169.",43927,2019
nacasch2015_PSS-I_B_Baseline_ITT,Psychotherapy,PTSD,39,B,PTSD,,19,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Structured Clinical Interview,PSS-I,PSS-I,ITT,,"Noninferiority margin determined using RCI: 7 points on PSS-I , between-group effect size Cohen's d <0.2; additional analysis using multilevel linear models. Cohen's d  effect size for between-group differences using raw data and pooled variance as well as estimates of d from mixed-effects repeated measures models.",Baseline,,,31.58,6.38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3846,,0.6154,Mixed,"combat-related, rape/sexual assault, child sexual abuse, community/school violence, terrorism/political violence/forced displacement, accidents",Medium,"Nacasch N, Huppert JD, Su Y-J, et al. Are 60-minute prolonged exposure sessions with 20-minute imaginal exposure to traumatic memories sufficient to successfully treat PTSD? A randomized nonininferiority clinical trial. Behav Ther. 2015 May;46(3):328-41. doi: 10.1016/j.beth.2014.12.002. PMID: 25892169.",43927,2019
najavits2018_PCL_A_0_ITT,Psychotherapy,PTSD+SUD,52,A,PTSD+SUD,Integrated,19,,Creating Change,Creating Change,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,26,Self report,PCL,PCL,ITT,"Multiple imputation, Little's test for MCAR nonsignificant","Noninferiority margin determined using RCI: 7 points on PSS-I , between-group effect size Cohen's d <0.2; additional analysis using multilevel linear models. Cohen's d  effect size for between-group differences using raw data and pooled variance as well as estimates of d from mixed-effects repeated measures models.",End of Treatment,0,,45.98,15.59,,,,,-4.39,,,,,,,,,,,,,,,,,,Not meeting DSM-IV criteria on MINI,0.6,,,,,Veteran,0,1,0,0.2692,,0.7308,Mixed,"combat-related, rape/sexual assault, other (NR)",Medium,"Najavits LM, Krinsley K, Waring ME, et al. A randomized controlled trial for veterans with PTSD and substance use disorder: creating change versus seeking safety. Subst Use Misuse. 2018 Sep 19;53(11):1788-800. doi: 10.1080/10826084.2018.1432653. PMID: 29461920.",49779,2020
najavits2018_PCL_A_12_ITT,Psychotherapy,PTSD+SUD,52,A,PTSD+SUD,Integrated,12,,Creating Change,Creating Change,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,26,Self report,PCL,PCL,ITT,"Multiple imputation, Little's test for MCAR nonsignificant","Noninferiority margin determined using RCI: 7 points on PSS-I , between-group effect size Cohen's d <0.2; additional analysis using multilevel linear models. Cohen's d  effect size for between-group differences using raw data and pooled variance as well as estimates of d from mixed-effects repeated measures models.",Assessment at 3 to <6 Months,12,,45.85,16.67,,,,,-4.52,,,,,,,,,,,,,,,,,,Not meeting DSM-IV criteria on MINI,0.66,,,,,Veteran,0,1,0,0.2692,,0.7308,Mixed,"combat-related, rape/sexual assault, other (NR)",Medium,"Najavits LM, Krinsley K, Waring ME, et al. A randomized controlled trial for veterans with PTSD and substance use disorder: creating change versus seeking safety. Subst Use Misuse. 2018 Sep 19;53(11):1788-800. doi: 10.1080/10826084.2018.1432653. PMID: 29461920.",49779,2020
najavits2018_PCL_A_Baseline_ITT,Psychotherapy,PTSD+SUD,52,A,PTSD+SUD,Integrated,26,,Creating Change,Creating Change,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,26,Self report,PCL,PCL,ITT,"Multiple imputation, Little's test for MCAR nonsignificant","Noninferiority margin determined using RCI: 7 points on PSS-I , between-group effect size Cohen's d <0.2; additional analysis using multilevel linear models. Cohen's d  effect size for between-group differences using raw data and pooled variance as well as estimates of d from mixed-effects repeated measures models.",Baseline,,,50.37,14.09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2692,,0.7308,Mixed,"combat-related, rape/sexual assault, other (NR)",Medium,"Najavits LM, Krinsley K, Waring ME, et al. A randomized controlled trial for veterans with PTSD and substance use disorder: creating change versus seeking safety. Subst Use Misuse. 2018 Sep 19;53(11):1788-800. doi: 10.1080/10826084.2018.1432653. PMID: 29461920.",49779,2020
najavits2018_PCL_B_0_ITT,Psychotherapy,PTSD+SUD,52,B,PTSD+SUD,Integrated,22,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,26,Self report,PCL,PCL,ITT,"Multiple imputation, Little's test for MCAR nonsignificant","Noninferiority margin determined using RCI: 7 points on PSS-I , between-group effect size Cohen's d <0.2; additional analysis using multilevel linear models. Cohen's d  effect size for between-group differences using raw data and pooled variance as well as estimates of d from mixed-effects repeated measures models.",End of Treatment,0,,48.83,16.27,,,,,-3.92,,,,,,,,,,,,,,,,,,Not meeting DSM-IV criteria on MINI,0.54,,,,,Veteran,0,1,0,0.2692,,0.7308,Mixed,"combat-related, rape/sexual assault, other (NR)",Medium,"Najavits LM, Krinsley K, Waring ME, et al. A randomized controlled trial for veterans with PTSD and substance use disorder: creating change versus seeking safety. Subst Use Misuse. 2018 Sep 19;53(11):1788-800. doi: 10.1080/10826084.2018.1432653. PMID: 29461920.",49779,2020
najavits2018_PCL_B_12_ITT,Psychotherapy,PTSD+SUD,52,B,PTSD+SUD,Integrated,20,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,26,Self report,PCL,PCL,ITT,"Multiple imputation, Little's test for MCAR nonsignificant","Noninferiority margin determined using RCI: 7 points on PSS-I , between-group effect size Cohen's d <0.2; additional analysis using multilevel linear models. Cohen's d  effect size for between-group differences using raw data and pooled variance as well as estimates of d from mixed-effects repeated measures models.",Assessment at 3 to <6 Months,12,,42.43,12.44,,,,,-10.32,,,,,,,,,,,,,,,,,,Not meeting DSM-IV criteria on MINI,0.59,,,,,Veteran,0,1,0,0.2692,,0.7308,Mixed,"combat-related, rape/sexual assault, other (NR)",Medium,"Najavits LM, Krinsley K, Waring ME, et al. A randomized controlled trial for veterans with PTSD and substance use disorder: creating change versus seeking safety. Subst Use Misuse. 2018 Sep 19;53(11):1788-800. doi: 10.1080/10826084.2018.1432653. PMID: 29461920.",49779,2020
najavits2018_PCL_B_Baseline_ITT,Psychotherapy,PTSD+SUD,52,B,PTSD+SUD,Integrated,26,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,26,Self report,PCL,PCL,ITT,"Multiple imputation, Little's test for MCAR nonsignificant","Noninferiority margin determined using RCI: 7 points on PSS-I , between-group effect size Cohen's d <0.2; additional analysis using multilevel linear models. Cohen's d  effect size for between-group differences using raw data and pooled variance as well as estimates of d from mixed-effects repeated measures models.",Baseline,,,52.75,12.41,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.2692,,0.7308,Mixed,"combat-related, rape/sexual assault, other (NR)",Medium,"Najavits LM, Krinsley K, Waring ME, et al. A randomized controlled trial for veterans with PTSD and substance use disorder: creating change versus seeking safety. Subst Use Misuse. 2018 Sep 19;53(11):1788-800. doi: 10.1080/10826084.2018.1432653. PMID: 29461920.",49779,2020
nam2013_CAPS_A_0_Comp,Nonpharmacologic biological,PTSD,18,A,PTSD,,7,,rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,9,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.625,,0.375,Mixed,"intimate partner violence, accidents, community/school violence",Medium,"Nam D-H, Pae C-U, Chae J-H. Low-frequency, repetitive transcranial magnetic stimulation for the treatment of patients with posttraumatic stress disorder: a double-blind, sham-controlled study. Clin Psychopharmacol Neurosci. 2013 Aug;11(2):96-102. doi: 10.9758/cpn.2013.11.2.96. PMID: 24023554.",46490,2019
nam2013_CAPS_A_Baseline_Comp,Nonpharmacologic biological,PTSD,18,A,PTSD,,7,,rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,9,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,Baseline,,,106.14,4.02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.625,,0.375,Mixed,"intimate partner violence, accidents, community/school violence",Medium,"Nam D-H, Pae C-U, Chae J-H. Low-frequency, repetitive transcranial magnetic stimulation for the treatment of patients with posttraumatic stress disorder: a double-blind, sham-controlled study. Clin Psychopharmacol Neurosci. 2013 Aug;11(2):96-102. doi: 10.9758/cpn.2013.11.2.96. PMID: 24023554.",46490,2019
nam2013_CAPS_B_0_Comp,Nonpharmacologic biological,PTSD,18,B,Control,,9,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,9,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.625,,0.375,Mixed,"intimate partner violence, accidents, community/school violence",Medium,"Nam D-H, Pae C-U, Chae J-H. Low-frequency, repetitive transcranial magnetic stimulation for the treatment of patients with posttraumatic stress disorder: a double-blind, sham-controlled study. Clin Psychopharmacol Neurosci. 2013 Aug;11(2):96-102. doi: 10.9758/cpn.2013.11.2.96. PMID: 24023554.",46490,2019
nam2013_CAPS_B_Baseline_Comp,Nonpharmacologic biological,PTSD,18,B,Control,,9,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,9,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,Baseline,,,104.44,6.98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.625,,0.375,Mixed,"intimate partner violence, accidents, community/school violence",Medium,"Nam D-H, Pae C-U, Chae J-H. Low-frequency, repetitive transcranial magnetic stimulation for the treatment of patients with posttraumatic stress disorder: a double-blind, sham-controlled study. Clin Psychopharmacol Neurosci. 2013 Aug;11(2):96-102. doi: 10.9758/cpn.2013.11.2.96. PMID: 24023554.",46490,2019
naylor2015_CAPS_A_0_Comp,Pharmacotherapy,PTSD,16,A,PTSD,,5,,Aripiprazole augmentation,Aripiprazole,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,End of Treatment,0,,63.80,,SE,11.74,,SE 14.98,-29.6,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3571,,0.6429,Combat-related,,High,"Naylor JC, Kilts JD, Bradford DW, et al. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment. Int. Clin Psychopharmacol. 2015;30(3):167-74. doi: 10.1097/YIC.0000000000000061. PMID: 25647451.",46407,2019
naylor2015_CAPS_A_0_ITT,Pharmacotherapy,PTSD,16,A,PTSD,,7,,Aripiprazole augmentation,Aripiprazole,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF and mixed-effects model using all available data,ANOVA,End of Treatment,0,,72.00,,SE,10.32,,SE 12.74,-18.6,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3571,,0.6429,Combat-related,,High,"Naylor JC, Kilts JD, Bradford DW, et al. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment. Int. Clin Psychopharmacol. 2015;30(3):167-74. doi: 10.1097/YIC.0000000000000061. PMID: 25647451.",46407,2019
naylor2015_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,16,A,PTSD,,5,,Aripiprazole augmentation,Aripiprazole,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,Baseline,,,93.40,,SE,4.6,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3571,,0.6429,Combat-related,,High,"Naylor JC, Kilts JD, Bradford DW, et al. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment. Int. Clin Psychopharmacol. 2015;30(3):167-74. doi: 10.1097/YIC.0000000000000061. PMID: 25647451.",46407,2019
naylor2015_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,16,A,PTSD,,7,,Aripiprazole augmentation,Aripiprazole,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF and mixed-effects model using all available data,ANOVA,Baseline,,,90.60,,SE,3.9,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3571,,0.6429,Combat-related,,High,"Naylor JC, Kilts JD, Bradford DW, et al. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment. Int. Clin Psychopharmacol. 2015;30(3):167-74. doi: 10.1097/YIC.0000000000000061. PMID: 25647451.",46407,2019
naylor2015_CAPS_B_0_Comp,Pharmacotherapy,PTSD,16,B,Control,,7,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,End of Treatment,0,,72.71,,SE,7.95,,SE 4.51,-9.58,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3571,,0.6429,Combat-related,,High,"Naylor JC, Kilts JD, Bradford DW, et al. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment. Int. Clin Psychopharmacol. 2015;30(3):167-74. doi: 10.1097/YIC.0000000000000061. PMID: 25647451.",46407,2019
naylor2015_CAPS_B_0_ITT,Pharmacotherapy,PTSD,16,B,Control,,7,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF and mixed-effects model using all available data,ANOVA,End of Treatment,0,,72.71,,SE,7.95,,SE 4.51,-9.58,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3571,,0.6429,Combat-related,,High,"Naylor JC, Kilts JD, Bradford DW, et al. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment. Int. Clin Psychopharmacol. 2015;30(3):167-74. doi: 10.1097/YIC.0000000000000061. PMID: 25647451.",46407,2019
naylor2015_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,16,B,Control,,7,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,Baseline,,,82.29,,SE,7.22,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3571,,0.6429,Combat-related,,High,"Naylor JC, Kilts JD, Bradford DW, et al. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment. Int. Clin Psychopharmacol. 2015;30(3):167-74. doi: 10.1097/YIC.0000000000000061. PMID: 25647451.",46407,2019
naylor2015_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,16,B,Control,,7,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF and mixed-effects model using all available data,ANOVA,Baseline,,,82.29,,SE,7.22,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3571,,0.6429,Combat-related,,High,"Naylor JC, Kilts JD, Bradford DW, et al. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment. Int. Clin Psychopharmacol. 2015;30(3):167-74. doi: 10.1097/YIC.0000000000000061. PMID: 25647451.",46407,2019
naylor2015_PCL_A_0_Comp,Pharmacotherapy,PTSD,16,A,PTSD,,,,Aripiprazole augmentation,Aripiprazole,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL,Completer,,ANOVA,End of Treatment,0,,48.60,,SE,8.54,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3571,,0.6429,Combat-related,,High,"Naylor JC, Kilts JD, Bradford DW, et al. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment. Int. Clin Psychopharmacol. 2015;30(3):167-74. doi: 10.1097/YIC.0000000000000061. PMID: 25647451.",46407,2019
naylor2015_PCL_A_0_ITT,Pharmacotherapy,PTSD,16,A,PTSD,,,,Aripiprazole augmentation,Aripiprazole,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL,ITT,,ANOVA,End of Treatment,0,,49.29,,SE,5.92,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3571,,0.6429,Combat-related,,High,"Naylor JC, Kilts JD, Bradford DW, et al. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment. Int. Clin Psychopharmacol. 2015;30(3):167-74. doi: 10.1097/YIC.0000000000000061. PMID: 25647451.",46407,2019
naylor2015_PCL_A_Baseline_Comp,Pharmacotherapy,PTSD,16,A,PTSD,,,,Aripiprazole augmentation,Aripiprazole,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL,Completer,,ANOVA,Baseline,,,63.20,,SE,6.03,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3571,,0.6429,Combat-related,,High,"Naylor JC, Kilts JD, Bradford DW, et al. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment. Int. Clin Psychopharmacol. 2015;30(3):167-74. doi: 10.1097/YIC.0000000000000061. PMID: 25647451.",46407,2019
naylor2015_PCL_A_Baseline_ITT,Pharmacotherapy,PTSD,16,A,PTSD,,,,Aripiprazole augmentation,Aripiprazole,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL,ITT,,ANOVA,Baseline,,,60.57,,SE,4.51,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3571,,0.6429,Combat-related,,High,"Naylor JC, Kilts JD, Bradford DW, et al. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment. Int. Clin Psychopharmacol. 2015;30(3):167-74. doi: 10.1097/YIC.0000000000000061. PMID: 25647451.",46407,2019
naylor2015_PCL_B_0_Comp,Pharmacotherapy,PTSD,16,B,Control,,,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Self report,PCL,PCL,Completer,,ANOVA,End of Treatment,0,,61.08,,SE,5.67,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3571,,0.6429,Combat-related,,High,"Naylor JC, Kilts JD, Bradford DW, et al. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment. Int. Clin Psychopharmacol. 2015;30(3):167-74. doi: 10.1097/YIC.0000000000000061. PMID: 25647451.",46407,2019
naylor2015_PCL_B_0_ITT,Pharmacotherapy,PTSD,16,B,Control,,,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Self report,PCL,PCL,ITT,,ANOVA,End of Treatment,0,,61.08,,SE,5.67,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3571,,0.6429,Combat-related,,High,"Naylor JC, Kilts JD, Bradford DW, et al. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment. Int. Clin Psychopharmacol. 2015;30(3):167-74. doi: 10.1097/YIC.0000000000000061. PMID: 25647451.",46407,2019
naylor2015_PCL_B_Baseline_Comp,Pharmacotherapy,PTSD,16,B,Control,,,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Self report,PCL,PCL,Completer,,ANOVA,Baseline,,,60.5,,SE,5.46,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3571,,0.6429,Combat-related,,High,"Naylor JC, Kilts JD, Bradford DW, et al. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment. Int. Clin Psychopharmacol. 2015;30(3):167-74. doi: 10.1097/YIC.0000000000000061. PMID: 25647451.",46407,2019
naylor2015_PCL_B_Baseline_ITT,Pharmacotherapy,PTSD,16,B,Control,,,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Self report,PCL,PCL,ITT,,ANOVA,Baseline,,,60.50,,SE,5.46,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3571,,0.6429,Combat-related,,High,"Naylor JC, Kilts JD, Bradford DW, et al. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment. Int. Clin Psychopharmacol. 2015;30(3):167-74. doi: 10.1097/YIC.0000000000000061. PMID: 25647451.",46407,2019
neuner2008_PDS_A_0_ITT,Psychotherapy,PTSD,277,A,PTSD,,86,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,111,Self report,PDS,PDS,ITT,Excluded,Linear mixed-effects model,End of Treatment,0,,5.4,6.6,,,,,-20.5,,,,,Cohen's d,1.4,,,,,,,,,,,,Not meeting criteria for PTSD according to clinical interview,,,,,,Community,,,1,0.5126,,0.4874,Terrorism/political violence/forced displacement,,Medium,"Neuner F, Onyut PL, Ertl V, et al. Treatment of posttraumatic stress disorder by trained lay counselors in an African refugee settlement: a randomized controlled trial. J Consult Clin Psychol. 2008 Aug;76(4):686-94. doi: 10.1037/0022-006X.76.4.686. PMID: 18665696.",31216,2019
neuner2008_PDS_A_26_ITT,Psychotherapy,PTSD,277,A,PTSD,,56,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,111,Self report,PDS,PDS,ITT,Excluded,Linear mixed-effects model,Assessment at 6 to <12 Months,26,,6.1,6.8,,,,,-19.8,,,,,Cohen's d,1.4,,,,,,,,,,,,Not meeting criteria for PTSD according to clinical interview,0.6977,,,,,Community,,,1,0.5126,,0.4874,Terrorism/political violence/forced displacement,,Medium,"Neuner F, Onyut PL, Ertl V, et al. Treatment of posttraumatic stress disorder by trained lay counselors in an African refugee settlement: a randomized controlled trial. J Consult Clin Psychol. 2008 Aug;76(4):686-94. doi: 10.1037/0022-006X.76.4.686. PMID: 18665696.",31216,2019
neuner2008_PDS_A_Baseline_ITT,Psychotherapy,PTSD,277,A,PTSD,,111,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,111,Self report,PDS,PDS,ITT,Excluded,Linear mixed-effects model,Baseline,,,25.9,13.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5126,,0.4874,Terrorism/political violence/forced displacement,,Medium,"Neuner F, Onyut PL, Ertl V, et al. Treatment of posttraumatic stress disorder by trained lay counselors in an African refugee settlement: a randomized controlled trial. J Consult Clin Psychol. 2008 Aug;76(4):686-94. doi: 10.1037/0022-006X.76.4.686. PMID: 18665696.",31216,2019
neuner2008_PDS_B_0_ITT,Psychotherapy,PTSD,277,B,PTSD,,85,,Trauma counseling,Trauma counseling,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,111,Self report,PDS,PDS,ITT,Excluded,Linear mixed-effects model,End of Treatment,0,,5.3,5.7,,,,,-21.4,,,,,Cohen's d,1.5,,,,,,,,,,,,Not meeting criteria for PTSD according to clinical interview,,,,,,Community,,,1,0.5126,,0.4874,Terrorism/political violence/forced displacement,,Medium,"Neuner F, Onyut PL, Ertl V, et al. Treatment of posttraumatic stress disorder by trained lay counselors in an African refugee settlement: a randomized controlled trial. J Consult Clin Psychol. 2008 Aug;76(4):686-94. doi: 10.1037/0022-006X.76.4.686. PMID: 18665696.",31216,2019
neuner2008_PDS_B_26_ITT,Psychotherapy,PTSD,277,B,PTSD,,53,,Trauma counseling,Trauma counseling,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,111,Self report,PDS,PDS,ITT,Excluded,Linear mixed-effects model,Assessment at 6 to <12 Months,26,,5,6.6,,,,,-21.7,,,,,Cohen's d,1.5,,,,,,,,,,,,Not meeting criteria for PTSD according to clinical interview,0.6522,,,,,Community,,,1,0.5126,,0.4874,Terrorism/political violence/forced displacement,,Medium,"Neuner F, Onyut PL, Ertl V, et al. Treatment of posttraumatic stress disorder by trained lay counselors in an African refugee settlement: a randomized controlled trial. J Consult Clin Psychol. 2008 Aug;76(4):686-94. doi: 10.1037/0022-006X.76.4.686. PMID: 18665696.",31216,2019
neuner2008_PDS_B_Baseline_ITT,Psychotherapy,PTSD,277,B,PTSD,,111,,Trauma counseling,Trauma counseling,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,111,Self report,PDS,PDS,ITT,Excluded,Linear mixed-effects model,Baseline,,,26.7,12.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5126,,0.4874,Terrorism/political violence/forced displacement,,Medium,"Neuner F, Onyut PL, Ertl V, et al. Treatment of posttraumatic stress disorder by trained lay counselors in an African refugee settlement: a randomized controlled trial. J Consult Clin Psychol. 2008 Aug;76(4):686-94. doi: 10.1037/0022-006X.76.4.686. PMID: 18665696.",31216,2019
neuner2008_PDS_C_26_ITT,Psychotherapy,PTSD,277,C,Control,,19,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,,,55,Self report,PDS,PDS,ITT,Excluded,Linear mixed-effects model,Assessment at 6 to <12 Months,26,,10.1,8.1,,,,,-11.2,,,,,Cohen's d,0.8,,,,,,,,,,,,Not meeting criteria for PTSD according to clinical interview,0.3684,,,,,Community,,,1,0.5126,,0.4874,Terrorism/political violence/forced displacement,,Medium,"Neuner F, Onyut PL, Ertl V, et al. Treatment of posttraumatic stress disorder by trained lay counselors in an African refugee settlement: a randomized controlled trial. J Consult Clin Psychol. 2008 Aug;76(4):686-94. doi: 10.1037/0022-006X.76.4.686. PMID: 18665696.",31216,2019
neuner2008_PDS_C_Baseline_ITT,Psychotherapy,PTSD,277,C,Control,,55,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,,,55,Self report,PDS,PDS,ITT,Excluded,Linear mixed-effects model,Baseline,,,21.3,10.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5126,,0.4874,Terrorism/political violence/forced displacement,,Medium,"Neuner F, Onyut PL, Ertl V, et al. Treatment of posttraumatic stress disorder by trained lay counselors in an African refugee settlement: a randomized controlled trial. J Consult Clin Psychol. 2008 Aug;76(4):686-94. doi: 10.1037/0022-006X.76.4.686. PMID: 18665696.",31216,2019
neuner2010_PDS_A_0_ITT,Psychotherapy,PTSD,32,A,PTSD,,14,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,16,Self report,PDS,PDS,ITT,Excluded,Mixed effects model,End of Treatment,0,,26,9.2,,,,,-12.9,,,,,Cohen's d,1.6,,,,,,,,,,,,Not meeting criteria for PTSD according to PDS,0.0714,,RCI corresponding to ≥10-point reduction on PDS,0.625,,Community,,,1,0.3125,,0.6875,Terrorism/political violence/forced displacement,,Medium,"Neuner F, Kurreck S, Ruf M, et al. Can asylum-seekers with posttraumatic stress disorder be successfully treated? A randomized controlled pilot study. Cogn Behav Ther. 2010;39(2):81-91. doi: 10.1080/16506070903121042. PMID: 19816834.",33877,2019
neuner2010_PDS_A_Baseline_ITT,Psychotherapy,PTSD,32,A,PTSD,,16,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,16,Self report,PDS,PDS,ITT,Excluded,Mixed effects model,Baseline,,,38.9,6.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.3125,,0.6875,Terrorism/political violence/forced displacement,,Medium,"Neuner F, Kurreck S, Ruf M, et al. Can asylum-seekers with posttraumatic stress disorder be successfully treated? A randomized controlled pilot study. Cogn Behav Ther. 2010;39(2):81-91. doi: 10.1080/16506070903121042. PMID: 19816834.",33877,2019
neuner2010_PDS_B_0_ITT,Psychotherapy,PTSD,32,B,Control,,16,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,,,16,Self report,PDS,PDS,ITT,Excluded,Mixed effects model,End of Treatment,0,,24.1,6.1,,,,,-2.8,,,,,Cohen's d,0.4,,,,,,,,,,,,Not meeting criteria for PTSD according to PDS,0,,RCI corresponding to ≥10-point reduction on PDS,0.1875,,Community,,,1,0.3125,,0.6875,Terrorism/political violence/forced displacement,,Medium,"Neuner F, Kurreck S, Ruf M, et al. Can asylum-seekers with posttraumatic stress disorder be successfully treated? A randomized controlled pilot study. Cogn Behav Ther. 2010;39(2):81-91. doi: 10.1080/16506070903121042. PMID: 19816834.",33877,2019
neuner2010_PDS_B_Baseline_ITT,Psychotherapy,PTSD,32,B,Control,,16,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,,,16,Self report,PDS,PDS,ITT,Excluded,Mixed effects model,Baseline,,,36.9,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.3125,,0.6875,Terrorism/political violence/forced displacement,,Medium,"Neuner F, Kurreck S, Ruf M, et al. Can asylum-seekers with posttraumatic stress disorder be successfully treated? A randomized controlled pilot study. Cogn Behav Ther. 2010;39(2):81-91. doi: 10.1080/16506070903121042. PMID: 19816834.",33877,2019
neylan2006_CAPS_A_0_ITT,Pharmacotherapy,PTSD,63,A,PTSD,,29,,Guanfacine,Guanfacine,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed with linear mixed modeling,Mixed effects model,End of Treatment,0,,62.7,18.9,,,,,-4.4,,,,,,,,,,p=0.01,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,Medium,"Neylan TC, Lenoci M, Samuelson KW, et al. No improvement of posttraumatic stress disorder symptoms with guanfacine treatment. Am J Psychiatry. 2006 Dec;163(12):2186-8. doi: 10.1176/appi.ajp.163.12.2186. PMID: 17151174.",28964,2019
neylan2006_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,63,A,PTSD,,29,,Guanfacine,Guanfacine,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed with linear mixed modeling,Mixed effects model,Baseline,,,67.1,20.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,Medium,"Neylan TC, Lenoci M, Samuelson KW, et al. No improvement of posttraumatic stress disorder symptoms with guanfacine treatment. Am J Psychiatry. 2006 Dec;163(12):2186-8. doi: 10.1176/appi.ajp.163.12.2186. PMID: 17151174.",28964,2019
neylan2006_CAPS_B_0_ITT,Pharmacotherapy,PTSD,63,B,Control,,34,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,34,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed with linear mixed modeling,Mixed effects model,End of Treatment,0,,63.3,22.9,,,,,-6.1,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,Medium,"Neylan TC, Lenoci M, Samuelson KW, et al. No improvement of posttraumatic stress disorder symptoms with guanfacine treatment. Am J Psychiatry. 2006 Dec;163(12):2186-8. doi: 10.1176/appi.ajp.163.12.2186. PMID: 17151174.",28964,2019
neylan2006_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,63,B,Control,,34,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,34,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed with linear mixed modeling,Mixed effects model,Baseline,,,69.4,20.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,Medium,"Neylan TC, Lenoci M, Samuelson KW, et al. No improvement of posttraumatic stress disorder symptoms with guanfacine treatment. Am J Psychiatry. 2006 Dec;163(12):2186-8. doi: 10.1176/appi.ajp.163.12.2186. PMID: 17151174.",28964,2019
neylan2006_IES_A_0_NA,Pharmacotherapy,PTSD,63,A,PTSD,,,,Guanfacine,Guanfacine,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Self report,IES,IES-R,,,Mixed effects model,End of Treatment,0,,1.79,0.76,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,Medium,"Neylan TC, Lenoci M, Samuelson KW, et al. No improvement of posttraumatic stress disorder symptoms with guanfacine treatment. Am J Psychiatry. 2006 Dec;163(12):2186-8. doi: 10.1176/appi.ajp.163.12.2186. PMID: 17151174.",28964,2019
neylan2006_IES_A_Baseline_NA,Pharmacotherapy,PTSD,63,A,PTSD,,,,Guanfacine,Guanfacine,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Self report,IES,IES-R,,,Mixed effects model,Baseline,,,2.03,0.59,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,Medium,"Neylan TC, Lenoci M, Samuelson KW, et al. No improvement of posttraumatic stress disorder symptoms with guanfacine treatment. Am J Psychiatry. 2006 Dec;163(12):2186-8. doi: 10.1176/appi.ajp.163.12.2186. PMID: 17151174.",28964,2019
neylan2006_IES_B_0_NA,Pharmacotherapy,PTSD,63,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,34,Self report,IES,IES-R,,,Mixed effects model,End of Treatment,0,,1.77,0.78,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,Medium,"Neylan TC, Lenoci M, Samuelson KW, et al. No improvement of posttraumatic stress disorder symptoms with guanfacine treatment. Am J Psychiatry. 2006 Dec;163(12):2186-8. doi: 10.1176/appi.ajp.163.12.2186. PMID: 17151174.",28964,2019
neylan2006_IES_B_Baseline_NA,Pharmacotherapy,PTSD,63,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,34,Self report,IES,IES-R,,,Mixed effects model,Baseline,,,2.22,0.77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,Medium,"Neylan TC, Lenoci M, Samuelson KW, et al. No improvement of posttraumatic stress disorder symptoms with guanfacine treatment. Am J Psychiatry. 2006 Dec;163(12):2186-8. doi: 10.1176/appi.ajp.163.12.2186. PMID: 17151174.",28964,2019
nidich2018_CAPS_A_0_C,Mixed: Psychotherapy & CIH,PTSD,202,A,PTSD,,,,Transcendental meditation,Transcendental meditation,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,,,68,Structured Clinical Interview,CAPS,CAPS,Completer (those attending ≥8 sessions),,Mixed effects model,End of Treatment,0,,,,,,,,-17.3,,-24.4,-10.3,,Cohen's d,0.97,,,,,,,,,,,,,,,≥10 point decrease on CAPS,,,Veteran,0,1,0,0.1683,,0.8317,Mixed,MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness),Low,"Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.",51386,2020
nidich2018_CAPS_A_0_ITT,Mixed: Psychotherapy & CIH,PTSD,202,A,PTSD,,53,,Transcendental meditation,Transcendental meditation,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,,,68,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,Mixed effects model,End of Treatment,0,,64.4,33,,,,,-16.1,,-22.6,-9.5,,Cohen's d,0.9,,,,p<0.0001,,,,,,,,,,,≥10 point decrease on CAPS,0.612,,Veteran,0,1,0,0.1683,,0.8317,Mixed,MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness),Low,"Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.",51386,2020
nidich2018_CAPS_A_Baseline_C,Mixed: Psychotherapy & CIH,PTSD,202,A,PTSD,,51,,Transcendental meditation,Transcendental meditation,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,,,68,Structured Clinical Interview,CAPS,CAPS,Completer (those attending ≥8 sessions),,Mixed effects model,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1683,,0.8317,Mixed,MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness),Low,"Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.",51386,2020
nidich2018_CAPS_A_Baseline_ITT,Mixed: Psychotherapy & CIH,PTSD,202,A,PTSD,,68,,Transcendental meditation,Transcendental meditation,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,,,68,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,Mixed effects model,Baseline,,,80.5,17.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1683,,0.8317,Mixed,MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness),Low,"Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.",51386,2020
nidich2018_CAPS_B_0_C,Mixed: Psychotherapy & CIH,PTSD,202,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,68,Structured Clinical Interview,CAPS,CAPS,Completer (those attending ≥8 sessions),,Mixed effects model,End of Treatment,0,,,,,,,,-13.7,,-22.2,-5.2,,Cohen's d,0.77,,,,,,,,,,,,,,,≥10 point decrease on CAPS,,,Veteran,0,1,0,0.1683,,0.8317,Mixed,MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness),Low,"Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.",51386,2020
nidich2018_CAPS_B_0_ITT,Mixed: Psychotherapy & CIH,PTSD,202,B,PTSD,,57,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,68,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,Mixed effects model,End of Treatment,0,,69.5,31.5,,,,,-11.2,,-17.4,5,,Cohen's d,0.63,,,,p=0.0006,,,,,,,,,,,≥10 point decrease on CAPS,0.415,,Veteran,0,1,0,0.1683,,0.8317,Mixed,MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness),Low,"Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.",51386,2020
nidich2018_CAPS_B_Baseline_C,Mixed: Psychotherapy & CIH,PTSD,202,B,PTSD,,42,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,68,Structured Clinical Interview,CAPS,CAPS,Completer (those attending ≥8 sessions),,Mixed effects model,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1683,,0.8317,Mixed,MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness),Low,"Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.",51386,2020
nidich2018_CAPS_B_Baseline_ITT,Mixed: Psychotherapy & CIH,PTSD,202,B,PTSD,,68,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,68,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,Mixed effects model,Baseline,,,80.6,16.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1683,,0.8317,Mixed,MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness),Low,"Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.",51386,2020
nidich2018_CAPS_C_0_C,Mixed: Psychotherapy & CIH,PTSD,202,C,Control,,,,PTSD health education,PTSD health education,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,66,Structured Clinical Interview,CAPS,CAPS,Completer (those attending ≥8 sessions),,Mixed effects model,End of Treatment,0,,,,,,,,-2.4,,-9.1,4.4,,Cohen's d,0.13,,,,,,,,,,,,,,,≥10 point decrease on CAPS,,,Veteran,0,1,0,0.1683,,0.8317,Mixed,MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness),Low,"Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.",51386,2020
nidich2018_CAPS_C_0_ITT,Mixed: Psychotherapy & CIH,PTSD,202,C,Control,,56,,PTSD health education,PTSD health education,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,66,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,Mixed effects model,End of Treatment,0,,75.1,26.5,,,,,-2.5,,-8.2,3.2,,Cohen's d,0.14,,,,,,,,,,,,,,,≥10 point decrease on CAPS,0.323,,Veteran,0,1,0,0.1683,,0.8317,Mixed,MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness),Low,"Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.",51386,2020
nidich2018_CAPS_C_Baseline_C,Mixed: Psychotherapy & CIH,PTSD,202,C,Control,,43,,PTSD health education,PTSD health education,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,66,Structured Clinical Interview,CAPS,CAPS,Completer (those attending ≥8 sessions),,Mixed effects model,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1683,,0.8317,Mixed,MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness),Low,"Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.",51386,2020
nidich2018_CAPS_C_Baseline_ITT,Mixed: Psychotherapy & CIH,PTSD,202,C,Control,,66,,PTSD health education,PTSD health education,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,66,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,Mixed effects model,Baseline,,,77.6,18.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1683,,0.8317,Mixed,MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness),Low,"Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.",51386,2020
nidich2018_PCL_A_0_NA,Mixed: Psychotherapy & CIH,PTSD,202,A,PTSD,,,,Transcendental meditation,Transcendental meditation,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,,,68,Self report,PCL,PCL-M,,,Mixed effects model,End of Treatment,0,,46.9,18.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1683,,0.8317,Mixed,MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness),Low,"Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.",51386,2020
nidich2018_PCL_A_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,202,A,PTSD,,,,Transcendental meditation,Transcendental meditation,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,,,68,Self report,PCL,PCL-M,,,Mixed effects model,Baseline,,,60.5,12.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1683,,0.8317,Mixed,MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness),Low,"Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.",51386,2020
nidich2018_PCL_B_0_NA,Mixed: Psychotherapy & CIH,PTSD,202,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,68,Self report,PCL,PCL-M,,,Mixed effects model,End of Treatment,0,,50.6,18.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1683,,0.8317,Mixed,MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness),Low,"Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.",51386,2020
nidich2018_PCL_B_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,202,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,68,Self report,PCL,PCL-M,,,Mixed effects model,Baseline,,,61.3,11.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1683,,0.8317,Mixed,MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness),Low,"Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.",51386,2020
nidich2018_PCL_C_0_NA,Mixed: Psychotherapy & CIH,PTSD,202,C,Control,,,,PTSD health education,PTSD health education,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,66,Self report,PCL,PCL-M,,,Mixed effects model,End of Treatment,0,,55.2,15.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1683,,0.8317,Mixed,MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness),Low,"Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.",51386,2020
nidich2018_PCL_C_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,202,C,Control,,,,PTSD health education,PTSD health education,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In person,66,Self report,PCL,PCL-M,,,Mixed effects model,Baseline,,,58.8,12.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1683,,0.8317,Mixed,MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness),Low,"Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.",51386,2020
nijdam2012_IES_A_0_NA,Psychotherapy,PTSD,140,A,PTSD,,,,Brief eclectic psychotherapy,Brief Eclectic Psychotherapy (BEP),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,70,Self report,IES,IES-R,,,"Mixed linear models for differences between groups, t-test for clinical characteristics, Cohen's d for effect sizes, and Fisher's exact test for diagnostic change.",End of Treatment,0,,38.0,34.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.564,,0.436,Mixed,"rape/sexual assault, accidents, natural or manmade disasters, community/school violence, other (war-related)",Medium,"Nijdam MJ, Gersons BP, Reitsma JB, et al. Brief eclectic psychotherapy v. Eye Movement Desensitization and Reprocessing therapy for post-traumatic stress disorder: randomised controlled trial. Br J Psychiatry. 2012 Mar;200(3):224-31. doi: 10.1192/bjp.bp.111.099234. PMID: 22322458.",38273,2019
nijdam2012_IES_A_Baseline_NA,Psychotherapy,PTSD,140,A,PTSD,,,,Brief eclectic psychotherapy,Brief Eclectic Psychotherapy (BEP),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,70,Self report,IES,IES-R,,,"Mixed linear models for differences between groups, t-test for clinical characteristics, Cohen's d for effect sizes, and Fisher's exact test for diagnostic change.",Baseline,,,79.9,16.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.564,,0.436,Mixed,"rape/sexual assault, accidents, natural or manmade disasters, community/school violence, other (war-related)",Medium,"Nijdam MJ, Gersons BP, Reitsma JB, et al. Brief eclectic psychotherapy v. Eye Movement Desensitization and Reprocessing therapy for post-traumatic stress disorder: randomised controlled trial. Br J Psychiatry. 2012 Mar;200(3):224-31. doi: 10.1192/bjp.bp.111.099234. PMID: 22322458.",38273,2019
nijdam2012_IES_B_0_NA,Psychotherapy,PTSD,140,B,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,70,Self report,IES,IES-R,,,"Mixed linear models for differences between groups, t-test for clinical characteristics, Cohen's d for effect sizes, and Fisher's exact test for diagnostic change.",End of Treatment,0,,28.5,29.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.564,,0.436,Mixed,"rape/sexual assault, accidents, natural or manmade disasters, community/school violence, other (war-related)",Medium,"Nijdam MJ, Gersons BP, Reitsma JB, et al. Brief eclectic psychotherapy v. Eye Movement Desensitization and Reprocessing therapy for post-traumatic stress disorder: randomised controlled trial. Br J Psychiatry. 2012 Mar;200(3):224-31. doi: 10.1192/bjp.bp.111.099234. PMID: 22322458.",38273,2019
nijdam2012_IES_B_Baseline_NA,Psychotherapy,PTSD,140,B,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,70,Self report,IES,IES-R,,,"Mixed linear models for differences between groups, t-test for clinical characteristics, Cohen's d for effect sizes, and Fisher's exact test for diagnostic change.",Baseline,,,72.8,20.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.564,,0.436,Mixed,"rape/sexual assault, accidents, natural or manmade disasters, community/school violence, other (war-related)",Medium,"Nijdam MJ, Gersons BP, Reitsma JB, et al. Brief eclectic psychotherapy v. Eye Movement Desensitization and Reprocessing therapy for post-traumatic stress disorder: randomised controlled trial. Br J Psychiatry. 2012 Mar;200(3):224-31. doi: 10.1192/bjp.bp.111.099234. PMID: 22322458.",38273,2019
nijdam2012_SI-PTSD_A_0_ITT,Psychotherapy,PTSD,140,A,PTSD,,42,,Brief eclectic psychotherapy,Brief Eclectic Psychotherapy (BEP),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,70,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,Mixed linear models used to calculate estimates when data were missing at certain assessments.,"Mixed linear models for differences between groups, t-test for clinical characteristics, Cohen's d for effect sizes, and Fisher's exact test for diagnostic change.",End of Treatment,0,,20.5,12.79,,,,,-19.61,,,,,Cohen's d,1.95,,,,,,,,,,,,Not meeting criteria for PTSD according to SI-PTSD,0.857,,,,,Community,,,1,0.564,,0.436,Mixed,"rape/sexual assault, accidents, natural or manmade disasters, community/school violence, other (war-related)",Medium,"Nijdam MJ, Gersons BP, Reitsma JB, et al. Brief eclectic psychotherapy v. Eye Movement Desensitization and Reprocessing therapy for post-traumatic stress disorder: randomised controlled trial. Br J Psychiatry. 2012 Mar;200(3):224-31. doi: 10.1192/bjp.bp.111.099234. PMID: 22322458.",38273,2019
nijdam2012_SI-PTSD_A_Baseline_ITT,Psychotherapy,PTSD,140,A,PTSD,,70,,Brief eclectic psychotherapy,Brief Eclectic Psychotherapy (BEP),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,70,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,Mixed linear models used to calculate estimates when data were missing at certain assessments.,"Mixed linear models for differences between groups, t-test for clinical characteristics, Cohen's d for effect sizes, and Fisher's exact test for diagnostic change.",Baseline,,,40.11,6.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.564,,0.436,Mixed,"rape/sexual assault, accidents, natural or manmade disasters, community/school violence, other (war-related)",Medium,"Nijdam MJ, Gersons BP, Reitsma JB, et al. Brief eclectic psychotherapy v. Eye Movement Desensitization and Reprocessing therapy for post-traumatic stress disorder: randomised controlled trial. Br J Psychiatry. 2012 Mar;200(3):224-31. doi: 10.1192/bjp.bp.111.099234. PMID: 22322458.",38273,2019
nijdam2012_SI-PTSD_B_0_ITT,Psychotherapy,PTSD,140,B,PTSD,,48,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,70,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,Mixed linear models used to calculate estimates when data were missing at certain assessments.,"Mixed linear models for differences between groups, t-test for clinical characteristics, Cohen's d for effect sizes, and Fisher's exact test for diagnostic change.",End of Treatment,0,,17.67,11.06,,,,,-21.73,,,,,Cohen's d,2.43,,,,,,,,,,,,Not meeting criteria for PTSD according to SI-PTSD,0.937,,,,,Community,,,1,0.564,,0.436,Mixed,"rape/sexual assault, accidents, natural or manmade disasters, community/school violence, other (war-related)",Medium,"Nijdam MJ, Gersons BP, Reitsma JB, et al. Brief eclectic psychotherapy v. Eye Movement Desensitization and Reprocessing therapy for post-traumatic stress disorder: randomised controlled trial. Br J Psychiatry. 2012 Mar;200(3):224-31. doi: 10.1192/bjp.bp.111.099234. PMID: 22322458.",38273,2019
nijdam2012_SI-PTSD_B_Baseline_ITT,Psychotherapy,PTSD,140,B,PTSD,,70,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,70,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,Mixed linear models used to calculate estimates when data were missing at certain assessments.,"Mixed linear models for differences between groups, t-test for clinical characteristics, Cohen's d for effect sizes, and Fisher's exact test for diagnostic change.",Baseline,,,39.4,6.16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.564,,0.436,Mixed,"rape/sexual assault, accidents, natural or manmade disasters, community/school violence, other (war-related)",Medium,"Nijdam MJ, Gersons BP, Reitsma JB, et al. Brief eclectic psychotherapy v. Eye Movement Desensitization and Reprocessing therapy for post-traumatic stress disorder: randomised controlled trial. Br J Psychiatry. 2012 Mar;200(3):224-31. doi: 10.1192/bjp.bp.111.099234. PMID: 22322458.",38273,2019
niles2012_CAPS_A_0_Comp,Complementary and integrative health (CIH),PTSD,33,A,PTSD,,13,,Mindfulness,Mindfulness,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Individual,Mixed,17,Structured Clinical Interview,CAPS,CAPS,Completer,,"Repeated measures ANOVA, post-hoc comparisons",End of Treatment,0,,47.46,18.29,,,,,-13.46,,,,,Partial eta-squared,0.502,,,,p=0.005,,,,,,,,,,,20-point change on CAPS,0.385,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0,,1,Combat-related,,High,"Niles BL, Klunk-Gillis J, Ryngala DJ, et al. Comparing mindfulness and psychoeducation treatments for combat-related PTSD using a telehealth approach. Psychol Trauma. 2012 Sep;4(5):538-47. doi: 10.1037/a0026161",37920,2019
niles2012_CAPS_A_Baseline_Comp,Complementary and integrative health (CIH),PTSD,33,A,PTSD,,17,,Mindfulness,Mindfulness,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Individual,Mixed,17,Structured Clinical Interview,CAPS,CAPS,Completer,,"Repeated measures ANOVA, post-hoc comparisons",Baseline,,,60.92,19.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Niles BL, Klunk-Gillis J, Ryngala DJ, et al. Comparing mindfulness and psychoeducation treatments for combat-related PTSD using a telehealth approach. Psychol Trauma. 2012 Sep;4(5):538-47. doi: 10.1037/a0026161",37920,2019
niles2012_CAPS_B_0_Comp,Complementary and integrative health (CIH),PTSD,33,B,Control,,14,,Psychoeducation,Psychoeducation,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Mixed,16,Structured Clinical Interview,CAPS,CAPS,Completer,,"Repeated measures ANOVA, post-hoc comparisons",End of Treatment,0,,74,22.95,,,,,1.5,,,,,Partial eta-squared,0.007,,,,p=0.765,,,,,,,,,,,20-point change on CAPS,0.071,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0,,1,Combat-related,,High,"Niles BL, Klunk-Gillis J, Ryngala DJ, et al. Comparing mindfulness and psychoeducation treatments for combat-related PTSD using a telehealth approach. Psychol Trauma. 2012 Sep;4(5):538-47. doi: 10.1037/a0026161",37920,2019
niles2012_CAPS_B_Baseline_Comp,Complementary and integrative health (CIH),PTSD,33,B,Control,,16,,Psychoeducation,Psychoeducation,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Mixed,16,Structured Clinical Interview,CAPS,CAPS,Completer,,"Repeated measures ANOVA, post-hoc comparisons",Baseline,,,72.5,19.66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Niles BL, Klunk-Gillis J, Ryngala DJ, et al. Comparing mindfulness and psychoeducation treatments for combat-related PTSD using a telehealth approach. Psychol Trauma. 2012 Sep;4(5):538-47. doi: 10.1037/a0026161",37920,2019
niles2012_PCL_A_0_NA,Complementary and integrative health (CIH),PTSD,33,A,PTSD,,,,Mindfulness,Mindfulness,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Individual,Mixed,17,Self report,PCL,PCL-M,,,"Repeated measures ANOVA, post-hoc comparisons",End of Treatment,0,,42.75,11.35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Niles BL, Klunk-Gillis J, Ryngala DJ, et al. Comparing mindfulness and psychoeducation treatments for combat-related PTSD using a telehealth approach. Psychol Trauma. 2012 Sep;4(5):538-47. doi: 10.1037/a0026161",37920,2019
niles2012_PCL_A_6_NA,Complementary and integrative health (CIH),PTSD,33,A,PTSD,,,,Mindfulness,Mindfulness,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Individual,Mixed,17,Self report,PCL,PCL-M,,,"Repeated measures ANOVA, post-hoc comparisons",Assessment at <3 Months,6,,50.75,12.27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Niles BL, Klunk-Gillis J, Ryngala DJ, et al. Comparing mindfulness and psychoeducation treatments for combat-related PTSD using a telehealth approach. Psychol Trauma. 2012 Sep;4(5):538-47. doi: 10.1037/a0026161",37920,2019
niles2012_PCL_A_Baseline_NA,Complementary and integrative health (CIH),PTSD,33,A,PTSD,,,,Mindfulness,Mindfulness,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Individual,Mixed,17,Self report,PCL,PCL-M,,,"Repeated measures ANOVA, post-hoc comparisons",Baseline,,,52.75,12.29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Niles BL, Klunk-Gillis J, Ryngala DJ, et al. Comparing mindfulness and psychoeducation treatments for combat-related PTSD using a telehealth approach. Psychol Trauma. 2012 Sep;4(5):538-47. doi: 10.1037/a0026161",37920,2019
niles2012_PCL_B_0_NA,Complementary and integrative health (CIH),PTSD,33,B,Control,,,,Psychoeducation,Psychoeducation,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Mixed,16,Self report,PCL,PCL-M,,,"Repeated measures ANOVA, post-hoc comparisons",End of Treatment,0,,64.42,10.84,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Niles BL, Klunk-Gillis J, Ryngala DJ, et al. Comparing mindfulness and psychoeducation treatments for combat-related PTSD using a telehealth approach. Psychol Trauma. 2012 Sep;4(5):538-47. doi: 10.1037/a0026161",37920,2019
niles2012_PCL_B_6_NA,Complementary and integrative health (CIH),PTSD,33,B,Control,,,,Psychoeducation,Psychoeducation,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Mixed,16,Self report,PCL,PCL-M,,,"Repeated measures ANOVA, post-hoc comparisons",Assessment at <3 Months,6,,61.33,11.39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Niles BL, Klunk-Gillis J, Ryngala DJ, et al. Comparing mindfulness and psychoeducation treatments for combat-related PTSD using a telehealth approach. Psychol Trauma. 2012 Sep;4(5):538-47. doi: 10.1037/a0026161",37920,2019
niles2012_PCL_B_Baseline_NA,Complementary and integrative health (CIH),PTSD,33,B,Control,,,,Psychoeducation,Psychoeducation,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Mixed,16,Self report,PCL,PCL-M,,,"Repeated measures ANOVA, post-hoc comparisons",Baseline,,,63.08,10.85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Niles BL, Klunk-Gillis J, Ryngala DJ, et al. Comparing mindfulness and psychoeducation treatments for combat-related PTSD using a telehealth approach. Psychol Trauma. 2012 Sep;4(5):538-47. doi: 10.1037/a0026161",37920,2019
noohi2017_IES_A_0_NA,Complementary and integrative health (CIH),PTSD,30,A,PTSD,,,,Neurofeedback,Neurofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,15,Self report,IES,IES-R,,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,30.4,6.23,,,,,-16.8,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0,,1,Combat-related,,High,"Noohi S, Miraghaie AM, Arabi A, et al. Effectiveness of neuro-feedback treatment with alpha/theta method on PTSD symptoms and their executing function. Biomed Res. 2017;28(5):2019-27.",47468,2019
noohi2017_IES_A_6.3_NA,Complementary and integrative health (CIH),PTSD,30,A,PTSD,,,,Neurofeedback,Neurofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,15,Self report,IES,IES-R,,,Repeated measures ANOVA for change in mean scores,Assessment at <3 Months,6.3,,30.46,5.2,,,,,-16.74,,,,,Eta-squared,0.55,,,,p<0.01,,,,,,,,,,,,,,Community,,,1,0,,1,Combat-related,,High,"Noohi S, Miraghaie AM, Arabi A, et al. Effectiveness of neuro-feedback treatment with alpha/theta method on PTSD symptoms and their executing function. Biomed Res. 2017;28(5):2019-27.",47468,2019
noohi2017_IES_A_Baseline_NA,Complementary and integrative health (CIH),PTSD,30,A,PTSD,,15,,Neurofeedback,Neurofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,15,Self report,IES,IES-R,,,Repeated measures ANOVA for change in mean scores,Baseline,,,47.2,7.63,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0,,1,Combat-related,,High,"Noohi S, Miraghaie AM, Arabi A, et al. Effectiveness of neuro-feedback treatment with alpha/theta method on PTSD symptoms and their executing function. Biomed Res. 2017;28(5):2019-27.",47468,2019
noohi2017_IES_B_0_NA,Complementary and integrative health (CIH),PTSD,30,B,Control,,,,Control,Control,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,15,Self report,IES,IES-R,,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,51.14,5.37,,,,,0.07,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0,,1,Combat-related,,High,"Noohi S, Miraghaie AM, Arabi A, et al. Effectiveness of neuro-feedback treatment with alpha/theta method on PTSD symptoms and their executing function. Biomed Res. 2017;28(5):2019-27.",47468,2019
noohi2017_IES_B_6.3_NA,Complementary and integrative health (CIH),PTSD,30,B,Control,,,,Control,Control,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,15,Self report,IES,IES-R,,,Repeated measures ANOVA for change in mean scores,Assessment at <3 Months,6.3,,51.21,6.25,,,,,0.14,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0,,1,Combat-related,,High,"Noohi S, Miraghaie AM, Arabi A, et al. Effectiveness of neuro-feedback treatment with alpha/theta method on PTSD symptoms and their executing function. Biomed Res. 2017;28(5):2019-27.",47468,2019
noohi2017_IES_B_Baseline_NA,Complementary and integrative health (CIH),PTSD,30,B,Control,,15,,Control,Control,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,15,Self report,IES,IES-R,,,Repeated measures ANOVA for change in mean scores,Baseline,,,51.07,5.37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0,,1,Combat-related,,High,"Noohi S, Miraghaie AM, Arabi A, et al. Effectiveness of neuro-feedback treatment with alpha/theta method on PTSD symptoms and their executing function. Biomed Res. 2017;28(5):2019-27.",47468,2019
nordbrandt2020_HTQ_A_0_Comp,Complementary and integrative health (CIH),PTSD,318,A,PTSD,,63,,Basic body awareness therapy + TAU,Exercise,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In person,105,Self report,HTQ,HTQ,Completer,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,3.02,,SE,0.08,,SE 0.06,-0.21,,,,,,,,,,p=0.0006,,,,,,,,,,,,,,Community,0,0,1,0.528,,0.472,Mixed,"combat-related, rape/sexual assault, terrorism/political violence/forced dsplacement, other (""violence from relatives"")",Medium,"Nordbrandt MS, Sonne C, Mortensen EL, et al. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-A pragmatic randomised controlled trial. PLoS ONE [Electronic Resource]. 2020;15(3):e0230300. doi: https://dx.doi.org/10.1371/journal.pone.0230300. PMID: 32163509.",,2020
nordbrandt2020_HTQ_A_0_ITT,Complementary and integrative health (CIH),PTSD,318,A,PTSD,,83,,Basic body awareness therapy + TAU,Exercise,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In person,105,Self report,HTQ,HTQ,ITT,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,3.00,,SE,0.07,,SE 0.06,-0.17,,,,,,,,,,p=0.0024,,,,,,,,,,,,,,Community,0,0,1,0.528,,0.472,Mixed,"combat-related, rape/sexual assault, terrorism/political violence/forced dsplacement, other (""violence from relatives"")",Medium,"Nordbrandt MS, Sonne C, Mortensen EL, et al. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-A pragmatic randomised controlled trial. PLoS ONE [Electronic Resource]. 2020;15(3):e0230300. doi: https://dx.doi.org/10.1371/journal.pone.0230300. PMID: 32163509.",,2020
nordbrandt2020_HTQ_A_Baseline_Comp,Complementary and integrative health (CIH),PTSD,318,A,PTSD,,63,,Basic body awareness therapy + TAU,Exercise,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In person,105,Self report,HTQ,HTQ,Completer,,Repeated measures ANOVA for change in mean scores,Baseline,,,3.22,,SE,0.05,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.528,,0.472,Mixed,"combat-related, rape/sexual assault, terrorism/political violence/forced dsplacement, other (""violence from relatives"")",Medium,"Nordbrandt MS, Sonne C, Mortensen EL, et al. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-A pragmatic randomised controlled trial. PLoS ONE [Electronic Resource]. 2020;15(3):e0230300. doi: https://dx.doi.org/10.1371/journal.pone.0230300. PMID: 32163509.",,2020
nordbrandt2020_HTQ_A_Baseline_ITT,Complementary and integrative health (CIH),PTSD,318,A,PTSD,,105,,Basic body awareness therapy + TAU,Exercise,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In person,105,Self report,HTQ,HTQ,ITT,,Repeated measures ANOVA for change in mean scores,Baseline,,,3.17,,SE,0.04,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.528,,0.472,Mixed,"combat-related, rape/sexual assault, terrorism/political violence/forced dsplacement, other (""violence from relatives"")",Medium,"Nordbrandt MS, Sonne C, Mortensen EL, et al. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-A pragmatic randomised controlled trial. PLoS ONE [Electronic Resource]. 2020;15(3):e0230300. doi: https://dx.doi.org/10.1371/journal.pone.0230300. PMID: 32163509.",,2020
nordbrandt2020_HTQ_B_0_Comp,Complementary and integrative health (CIH),PTSD,318,B,PTSD,,61,,Mixed physical activity + TAU,Exercise,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In person,109,Self report,HTQ,HTQ,Completer,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,3.02,,SE,0.08,,SE 0.07,-0.19,,,,,,,,,,p=0.0100,,,,,,,,,,,,,,Community,0,0,1,0.528,,0.472,Mixed,"combat-related, rape/sexual assault, terrorism/political violence/forced dsplacement, other (""violence from relatives"")",Medium,"Nordbrandt MS, Sonne C, Mortensen EL, et al. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-A pragmatic randomised controlled trial. PLoS ONE [Electronic Resource]. 2020;15(3):e0230300. doi: https://dx.doi.org/10.1371/journal.pone.0230300. PMID: 32163509.",,2020
nordbrandt2020_HTQ_B_0_ITT,Complementary and integrative health (CIH),PTSD,318,B,PTSD,,77,,Mixed physical activity + TAU,Exercise,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In person,109,Self report,HTQ,HTQ,ITT,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,2.97,,SE,0.07,,SE 0.07,-0.21,,,,,,,,,,p=0.0015,,,,,,,,,,,,,,Community,0,0,1,0.528,,0.472,Mixed,"combat-related, rape/sexual assault, terrorism/political violence/forced dsplacement, other (""violence from relatives"")",Medium,"Nordbrandt MS, Sonne C, Mortensen EL, et al. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-A pragmatic randomised controlled trial. PLoS ONE [Electronic Resource]. 2020;15(3):e0230300. doi: https://dx.doi.org/10.1371/journal.pone.0230300. PMID: 32163509.",,2020
nordbrandt2020_HTQ_B_Baseline_Comp,Complementary and integrative health (CIH),PTSD,318,B,PTSD,,61,,Mixed physical activity + TAU,Exercise,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In person,109,Self report,HTQ,HTQ,Completer,,Repeated measures ANOVA for change in mean scores,Baseline,,,3.21,,SE,0.06,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.528,,0.472,Mixed,"combat-related, rape/sexual assault, terrorism/political violence/forced dsplacement, other (""violence from relatives"")",Medium,"Nordbrandt MS, Sonne C, Mortensen EL, et al. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-A pragmatic randomised controlled trial. PLoS ONE [Electronic Resource]. 2020;15(3):e0230300. doi: https://dx.doi.org/10.1371/journal.pone.0230300. PMID: 32163509.",,2020
nordbrandt2020_HTQ_B_Baseline_ITT,Complementary and integrative health (CIH),PTSD,318,B,PTSD,,109,,Mixed physical activity + TAU,Exercise,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In person,109,Self report,HTQ,HTQ,ITT,,Repeated measures ANOVA for change in mean scores,Baseline,,,3.18,,SE,0.04,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.528,,0.472,Mixed,"combat-related, rape/sexual assault, terrorism/political violence/forced dsplacement, other (""violence from relatives"")",Medium,"Nordbrandt MS, Sonne C, Mortensen EL, et al. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-A pragmatic randomised controlled trial. PLoS ONE [Electronic Resource]. 2020;15(3):e0230300. doi: https://dx.doi.org/10.1371/journal.pone.0230300. PMID: 32163509.",,2020
nordbrandt2020_HTQ_C_0_Comp,Complementary and integrative health (CIH),PTSD,318,C,Control,,81,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,104,Self report,HTQ,HTQ,Completer,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,2.96,,SE,0.06,,SE 0.06,-0.21,,,,,,,,,,p=0.0003,,,,,,,,,,,,,,Community,0,0,1,0.528,,0.472,Mixed,"combat-related, rape/sexual assault, terrorism/political violence/forced dsplacement, other (""violence from relatives"")",Medium,"Nordbrandt MS, Sonne C, Mortensen EL, et al. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-A pragmatic randomised controlled trial. PLoS ONE [Electronic Resource]. 2020;15(3):e0230300. doi: https://dx.doi.org/10.1371/journal.pone.0230300. PMID: 32163509.",,2020
nordbrandt2020_HTQ_C_0_ITT,Complementary and integrative health (CIH),PTSD,318,C,Control,,104,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,104,Self report,HTQ,HTQ,ITT,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,2.96,,SE,0.06,,SE 0.06,-0.21,,,,,,,,,,p=0.0003,,,,,,,,,,,,,,Community,0,0,1,0.528,,0.472,Mixed,"combat-related, rape/sexual assault, terrorism/political violence/forced dsplacement, other (""violence from relatives"")",Medium,"Nordbrandt MS, Sonne C, Mortensen EL, et al. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-A pragmatic randomised controlled trial. PLoS ONE [Electronic Resource]. 2020;15(3):e0230300. doi: https://dx.doi.org/10.1371/journal.pone.0230300. PMID: 32163509.",,2020
nordbrandt2020_HTQ_C_Baseline_Comp,Complementary and integrative health (CIH),PTSD,318,C,Control,,104,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,104,Self report,HTQ,HTQ,Completer,,Repeated measures ANOVA for change in mean scores,Baseline,,,3.17,,SE,0.04,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.528,,0.472,Mixed,"combat-related, rape/sexual assault, terrorism/political violence/forced dsplacement, other (""violence from relatives"")",Medium,"Nordbrandt MS, Sonne C, Mortensen EL, et al. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-A pragmatic randomised controlled trial. PLoS ONE [Electronic Resource]. 2020;15(3):e0230300. doi: https://dx.doi.org/10.1371/journal.pone.0230300. PMID: 32163509.",,2020
nordbrandt2020_HTQ_C_Baseline_ITT,Complementary and integrative health (CIH),PTSD,318,C,Control,,104,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,104,Self report,HTQ,HTQ,ITT,,Repeated measures ANOVA for change in mean scores,Baseline,,,3.17,,SE,0.04,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.528,,0.472,Mixed,"combat-related, rape/sexual assault, terrorism/political violence/forced dsplacement, other (""violence from relatives"")",Medium,"Nordbrandt MS, Sonne C, Mortensen EL, et al. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-A pragmatic randomised controlled trial. PLoS ONE [Electronic Resource]. 2020;15(3):e0230300. doi: https://dx.doi.org/10.1371/journal.pone.0230300. PMID: 32163509.",,2020
norman2019_CAPS_A_0_Comp,Psychotherapy,PTSD+SUD,119,A,PTSD+SUD,Integrated,,,Concurrent Treatment for PTSD and Substance Use Disorder Prolonged Exposure (COPE),Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,Completer,Imputation,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS score <12,0.2222,,,,,Veteran,0,1,0,0.1008,,0.8992,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters",Medium,"Norman SB, Trim R, Haller M, et al. Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Apr 24;76(8):791-9. doi: 10.1001/jamapsychiatry.2019.0638. PMID: 31017639.",52065,2020
norman2019_CAPS_A_0_ITT,Psychotherapy,PTSD+SUD,119,A,PTSD+SUD,Integrated,36,,Concurrent Treatment for PTSD and Substance Use Disorder Prolonged Exposure (COPE),Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,ITT,Imputation,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,25.8,,95% CI,22.1,29.6,,-17.4,,,,,,,,,,,,,,,,,,CAPS score <12,,,,,,Veteran,0,1,0,0.1008,,0.8992,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters",Medium,"Norman SB, Trim R, Haller M, et al. Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Apr 24;76(8):791-9. doi: 10.1001/jamapsychiatry.2019.0638. PMID: 31017639.",52065,2020
norman2019_CAPS_A_12_Comp,Psychotherapy,PTSD+SUD,119,A,PTSD+SUD,Integrated,,,Concurrent Treatment for PTSD and Substance Use Disorder Prolonged Exposure (COPE),Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,Completer,Imputation,Repeated measures ANOVA for change in mean scores,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS score <12,0.25,,,,,Veteran,0,1,0,0.1008,,0.8992,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters",Medium,"Norman SB, Trim R, Haller M, et al. Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Apr 24;76(8):791-9. doi: 10.1001/jamapsychiatry.2019.0638. PMID: 31017639.",52065,2020
norman2019_CAPS_A_12_ITT,Psychotherapy,PTSD+SUD,119,A,PTSD+SUD,Integrated,40,,Concurrent Treatment for PTSD and Substance Use Disorder Prolonged Exposure (COPE),Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,ITT,Imputation,Repeated measures ANOVA for change in mean scores,Assessment at 3 to <6 Months,12,,26.4,,95% CI,22.6,30.3,,-16.8,,,,,,,,,,,,,,,,,,CAPS score <12,,,,,,Veteran,0,1,0,0.1008,,0.8992,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters",Medium,"Norman SB, Trim R, Haller M, et al. Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Apr 24;76(8):791-9. doi: 10.1001/jamapsychiatry.2019.0638. PMID: 31017639.",52065,2020
norman2019_CAPS_A_26_Comp,Psychotherapy,PTSD+SUD,119,A,PTSD+SUD,Integrated,,,Concurrent Treatment for PTSD and Substance Use Disorder Prolonged Exposure (COPE),Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,Completer,Imputation,Repeated measures ANOVA for change in mean scores,Assessment at 6 to <12 Months,26,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS score <12,0.3333,,,,,Veteran,0,1,0,0.1008,,0.8992,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters",Medium,"Norman SB, Trim R, Haller M, et al. Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Apr 24;76(8):791-9. doi: 10.1001/jamapsychiatry.2019.0638. PMID: 31017639.",52065,2020
norman2019_CAPS_A_26_ITT,Psychotherapy,PTSD+SUD,119,A,PTSD+SUD,Integrated,30,,Concurrent Treatment for PTSD and Substance Use Disorder Prolonged Exposure (COPE),Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,ITT,Imputation,Repeated measures ANOVA for change in mean scores,Assessment at 6 to <12 Months,26,,22.5,,95% CI,18.2,26.8,,-20.7,,,,,,,,,,,,,,,,,,CAPS score <12,,,,,,Veteran,0,1,0,0.1008,,0.8992,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters",Medium,"Norman SB, Trim R, Haller M, et al. Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Apr 24;76(8):791-9. doi: 10.1001/jamapsychiatry.2019.0638. PMID: 31017639.",52065,2020
norman2019_CAPS_A_Baseline_Comp,Psychotherapy,PTSD+SUD,119,A,PTSD+SUD,Integrated,,,Concurrent Treatment for PTSD and Substance Use Disorder Prolonged Exposure (COPE),Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,Completer,Imputation,Repeated measures ANOVA for change in mean scores,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1008,,0.8992,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters",Medium,"Norman SB, Trim R, Haller M, et al. Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Apr 24;76(8):791-9. doi: 10.1001/jamapsychiatry.2019.0638. PMID: 31017639.",52065,2020
norman2019_CAPS_A_Baseline_ITT,Psychotherapy,PTSD+SUD,119,A,PTSD+SUD,Integrated,63,,Concurrent Treatment for PTSD and Substance Use Disorder Prolonged Exposure (COPE),Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,ITT,Imputation,Repeated measures ANOVA for change in mean scores,Baseline,,,43.2,,95% CI,40,46.4,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1008,,0.8992,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters",Medium,"Norman SB, Trim R, Haller M, et al. Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Apr 24;76(8):791-9. doi: 10.1001/jamapsychiatry.2019.0638. PMID: 31017639.",52065,2020
norman2019_CAPS_B_0_Comp,Psychotherapy,PTSD+SUD,119,B,PTSD+SUD,Integrated,,,Seeking Safety (SS),Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,56,Structured Clinical Interview,CAPS,CAPS-5,Completer,Imputation,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS score <12,0.0682,,,,,Veteran,0,1,0,0.1008,,0.8992,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters",Medium,"Norman SB, Trim R, Haller M, et al. Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Apr 24;76(8):791-9. doi: 10.1001/jamapsychiatry.2019.0638. PMID: 31017639.",52065,2020
norman2019_CAPS_B_0_ITT,Psychotherapy,PTSD+SUD,119,B,PTSD+SUD,Integrated,44,,Seeking Safety (SS),Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,56,Structured Clinical Interview,CAPS,CAPS-5,ITT,Imputation,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,32.9,,95% CI,29.3,36.6,,-9.2,,,,,,,,,,,,,,,,,,CAPS score <12,,,,,,Veteran,0,1,0,0.1008,,0.8992,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters",Medium,"Norman SB, Trim R, Haller M, et al. Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Apr 24;76(8):791-9. doi: 10.1001/jamapsychiatry.2019.0638. PMID: 31017639.",52065,2020
norman2019_CAPS_B_12_Comp,Psychotherapy,PTSD+SUD,119,B,PTSD+SUD,Integrated,,,Seeking Safety (SS),Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,56,Structured Clinical Interview,CAPS,CAPS-5,Completer,Imputation,Repeated measures ANOVA for change in mean scores,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS score <12,0.0606,,,,,Veteran,0,1,0,0.1008,,0.8992,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters",Medium,"Norman SB, Trim R, Haller M, et al. Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Apr 24;76(8):791-9. doi: 10.1001/jamapsychiatry.2019.0638. PMID: 31017639.",52065,2020
norman2019_CAPS_B_12_ITT,Psychotherapy,PTSD+SUD,119,B,PTSD+SUD,Integrated,33,,Seeking Safety (SS),Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,56,Structured Clinical Interview,CAPS,CAPS-5,ITT,Imputation,Repeated measures ANOVA for change in mean scores,Assessment at 3 to <6 Months,12,,31.0,,95% CI,27,35.1,,-11.1,,,,,,,,,,,,,,,,,,CAPS score <12,,,,,,Veteran,0,1,0,0.1008,,0.8992,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters",Medium,"Norman SB, Trim R, Haller M, et al. Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Apr 24;76(8):791-9. doi: 10.1001/jamapsychiatry.2019.0638. PMID: 31017639.",52065,2020
norman2019_CAPS_B_26_Comp,Psychotherapy,PTSD+SUD,119,B,PTSD+SUD,Integrated,,,Seeking Safety (SS),Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,56,Structured Clinical Interview,CAPS,CAPS-5,Completer,Imputation,Repeated measures ANOVA for change in mean scores,Assessment at 6 to <12 Months,26,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS score <12,0.1471,,,,,Veteran,0,1,0,0.1008,,0.8992,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters",Medium,"Norman SB, Trim R, Haller M, et al. Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Apr 24;76(8):791-9. doi: 10.1001/jamapsychiatry.2019.0638. PMID: 31017639.",52065,2020
norman2019_CAPS_B_26_ITT,Psychotherapy,PTSD+SUD,119,B,PTSD+SUD,Integrated,34,,Seeking Safety (SS),Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,56,Structured Clinical Interview,CAPS,CAPS-5,ITT,Imputation,Repeated measures ANOVA for change in mean scores,Assessment at 6 to <12 Months,26,,29.8,,95% CI,25.6,33.9,,-12.3,,,,,,,,,,,,,,,,,,CAPS score <12,,,,,,Veteran,0,1,0,0.1008,,0.8992,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters",Medium,"Norman SB, Trim R, Haller M, et al. Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Apr 24;76(8):791-9. doi: 10.1001/jamapsychiatry.2019.0638. PMID: 31017639.",52065,2020
norman2019_CAPS_B_Baseline_Comp,Psychotherapy,PTSD+SUD,119,B,PTSD+SUD,Integrated,,,Seeking Safety (SS),Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,56,Structured Clinical Interview,CAPS,CAPS-5,Completer,Imputation,Repeated measures ANOVA for change in mean scores,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1008,,0.8992,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters",Medium,"Norman SB, Trim R, Haller M, et al. Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Apr 24;76(8):791-9. doi: 10.1001/jamapsychiatry.2019.0638. PMID: 31017639.",52065,2020
norman2019_CAPS_B_Baseline_ITT,Psychotherapy,PTSD+SUD,119,B,PTSD+SUD,Integrated,56,,Seeking Safety (SS),Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,56,Structured Clinical Interview,CAPS,CAPS-5,ITT,Imputation,Repeated measures ANOVA for change in mean scores,Baseline,,,42.1,,95% CI,38.7,45.5,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1008,,0.8992,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters",Medium,"Norman SB, Trim R, Haller M, et al. Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Apr 24;76(8):791-9. doi: 10.1001/jamapsychiatry.2019.0638. PMID: 31017639.",52065,2020
numata2014_IES-R_A_0_ITT,Pharmacotherapy,PTSD,43,A,PTSD,,20,,Saikokeishikankyoto,Saikokeishikankyoto,No,Not Applicable,No,Not Applicable,Yes,Natural products,No,No,No,No,No,Individual,In Person,21,Self report,IES-R,IES-R,ITT,"LOCF (""if a patient dropped out, all outcome measures were assessed within a week"")",Repeated measures ANOVA for change in mean scores,End of Treatment,0,,25.5,17,,,,,-24.1,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Community,,,1,0.4884,,0.5116,Natural or manmade disasters,,Medium,"Numata T, GunFan S, Takayama S, et al. Treatment of posttraumatic stress disorder using the traditional Japanese herbal medicine saikokeishikankyoto: a randomized, observer-blinded, controlled trial in survivors of the great East Japan earthquake and tsunami. Evid Based Complement Alternat Med. 2014;2014:683293. doi: 10.1155/2014/683293. PMID: 24790634.",46973,2019
numata2014_IES-R_A_Baseline_ITT,Pharmacotherapy,PTSD,43,A,PTSD,,21,,Saikokeishikankyoto,Saikokeishikankyoto,No,Not Applicable,No,Not Applicable,Yes,Natural products,No,No,No,No,No,Individual,In Person,21,Self report,IES-R,IES-R,ITT,,Repeated measures ANOVA for change in mean scores,Baseline,,,49.6,11.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4884,,0.5116,Natural or manmade disasters,,Medium,"Numata T, GunFan S, Takayama S, et al. Treatment of posttraumatic stress disorder using the traditional Japanese herbal medicine saikokeishikankyoto: a randomized, observer-blinded, controlled trial in survivors of the great East Japan earthquake and tsunami. Evid Based Complement Alternat Med. 2014;2014:683293. doi: 10.1155/2014/683293. PMID: 24790634.",46973,2019
numata2014_IES-R_B_0_ITT,Pharmacotherapy,PTSD,43,B,Control,,22,,Control,Control,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,22,Self report,IES-R,IES-R,ITT,"LOCF (""if a patient dropped out, all outcome measures were assessed within a week"")",Repeated measures ANOVA for change in mean scores,End of Treatment,0,,39.3,12.4,,,,,-4.4,,,,,,,,,,p≥0.05,,,,,,,,,,,,,,Community,,,1,0.4884,,0.5116,Natural or manmade disasters,,Medium,"Numata T, GunFan S, Takayama S, et al. Treatment of posttraumatic stress disorder using the traditional Japanese herbal medicine saikokeishikankyoto: a randomized, observer-blinded, controlled trial in survivors of the great East Japan earthquake and tsunami. Evid Based Complement Alternat Med. 2014;2014:683293. doi: 10.1155/2014/683293. PMID: 24790634.",46973,2019
numata2014_IES-R_B_Baseline_ITT,Pharmacotherapy,PTSD,43,B,Control,,22,,Control,Control,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,22,Self report,IES-R,IES-R,ITT,,Repeated measures ANOVA for change in mean scores,Baseline,,,43.7,13.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4884,,0.5116,Natural or manmade disasters,,Medium,"Numata T, GunFan S, Takayama S, et al. Treatment of posttraumatic stress disorder using the traditional Japanese herbal medicine saikokeishikankyoto: a randomized, observer-blinded, controlled trial in survivors of the great East Japan earthquake and tsunami. Evid Based Complement Alternat Med. 2014;2014:683293. doi: 10.1155/2014/683293. PMID: 24790634.",46973,2019
oehen2013_CAPS_A_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,14,A,PTSD,,8,,MDMA-assisted psychotherapy,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,No,No,No,Individual,In Person,9,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,50.8,19.7,,,,,-15.6,18.1,,,,,,,,,p=0.002,,,,,,,,Not meeting criteria for PTSD,0,,"Investigators' and patients' subjective impression of improvement and
CAPS score change >15 points and CAPS item #25 <3 and overall CAPS score <50",0.5,,Community,,,1,0.8333,,0.1667,Mixed,"child sexual abuse, rape/sexual assault, accidents, illness/medical procedure",High,"Oehen P, Traber R, Widmer V, et al. A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J Psychopharmacol. 2013 Jan;27(1):40-52. doi: 10.1177/0269881112464827. PMID: 23118021.",41195,2019
oehen2013_CAPS_A_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,14,A,PTSD,,8,,MDMA-assisted psychotherapy,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,No,No,No,Individual,In Person,9,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA for change in mean scores,Baseline,,,66.4,13.6,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD,,,"Investigators' and patients' subjective impression of improvement and
CAPS score change >15 points and CAPS item #25 <3 and overall CAPS score <50",,,Community,,,1,0.8333,,0.1667,Mixed,"child sexual abuse, rape/sexual assault, accidents, illness/medical procedure",High,"Oehen P, Traber R, Widmer V, et al. A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J Psychopharmacol. 2013 Jan;27(1):40-52. doi: 10.1177/0269881112464827. PMID: 23118021.",41195,2019
oehen2013_CAPS_B_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,14,B,PTSD,,4,,Low-dose MDMA-assisted psychotherapy,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,5,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,66.5,7.6,,,,,3.2,15.3,,,,,,,,,p=0.475,,,,,,,,Not meeting criteria for PTSD,,,"Investigators' and patients' subjective impression of improvement and
CAPS score change >15 points and CAPS item #25 <3 and overall CAPS score <50",0,,Community,,,1,0.8333,,0.1667,Mixed,"child sexual abuse, rape/sexual assault, accidents, illness/medical procedure",High,"Oehen P, Traber R, Widmer V, et al. A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J Psychopharmacol. 2013 Jan;27(1):40-52. doi: 10.1177/0269881112464827. PMID: 23118021.",41195,2019
oehen2013_CAPS_B_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,14,B,PTSD,,4,,Low-dose MDMA-assisted psychotherapy,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,5,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA for change in mean scores,Baseline,,,63.4,7.9,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD,,,"Investigators' and patients' subjective impression of improvement and
CAPS score change >15 points and CAPS item #25 <3 and overall CAPS score <50",,,Community,,,1,0.8333,,0.1667,Mixed,"child sexual abuse, rape/sexual assault, accidents, illness/medical procedure",High,"Oehen P, Traber R, Widmer V, et al. A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J Psychopharmacol. 2013 Jan;27(1):40-52. doi: 10.1177/0269881112464827. PMID: 23118021.",41195,2019
oehen2013_PDS_A_0_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,14,A,PTSD,,,,MDMA-assisted psychotherapy,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,No,No,No,Individual,In Person,9,Self report,PDS,PDS,,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,21.4,11.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8333,,0.1667,Mixed,"child sexual abuse, rape/sexual assault, accidents, illness/medical procedure",High,"Oehen P, Traber R, Widmer V, et al. A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J Psychopharmacol. 2013 Jan;27(1):40-52. doi: 10.1177/0269881112464827. PMID: 23118021.",41195,2019
oehen2013_PDS_A_Baseline_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,14,A,PTSD,,,,MDMA-assisted psychotherapy,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,No,No,No,Individual,In Person,9,Self report,PDS,PDS,,,Repeated measures ANOVA for change in mean scores,Baseline,,,30,6.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8333,,0.1667,Mixed,"child sexual abuse, rape/sexual assault, accidents, illness/medical procedure",High,"Oehen P, Traber R, Widmer V, et al. A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J Psychopharmacol. 2013 Jan;27(1):40-52. doi: 10.1177/0269881112464827. PMID: 23118021.",41195,2019
oehen2013_PDS_B_0_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,14,B,PTSD,,,,Low-dose MDMA-assisted psychotherapy,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,5,Self report,PDS,PDS,,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,30.8,6.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8333,,0.1667,Mixed,"child sexual abuse, rape/sexual assault, accidents, illness/medical procedure",High,"Oehen P, Traber R, Widmer V, et al. A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J Psychopharmacol. 2013 Jan;27(1):40-52. doi: 10.1177/0269881112464827. PMID: 23118021.",41195,2019
oehen2013_PDS_B_Baseline_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,14,B,PTSD,,,,Low-dose MDMA-assisted psychotherapy,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,5,Self report,PDS,PDS,,,Repeated measures ANOVA for change in mean scores,Baseline,,,23.5,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8333,,0.1667,Mixed,"child sexual abuse, rape/sexual assault, accidents, illness/medical procedure",High,"Oehen P, Traber R, Widmer V, et al. A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J Psychopharmacol. 2013 Jan;27(1):40-52. doi: 10.1177/0269881112464827. PMID: 23118021.",41195,2019
önder2006_CAPS_A_0_ITT,Pharmacotherapy,PTSD,103,A,PTSD,,38,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,38,Structured Clinical Interview,CAPS,CAPS (17-item total severity score),ITT,LOCF,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,41.5,3.2,,,,,-42.1,,,,,,,,,,,,,,,,,,,,,≥50% decline in total CAPS score,0.7632,,Community,,,1,0.5049,,0.4951,Natural or manmade disasters,,High,"Önder E, Tural Ü, Aker AT. A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake. Eur Psychiatry. 2006 Apr;21(3):174-9. doi: 10.1016/j.eurpsy.2005.03.007. PMID: 15964747.",28188,2019
önder2006_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,103,A,PTSD,,38,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,38,Structured Clinical Interview,CAPS,CAPS (17-item total severity score),ITT,LOCF,Repeated measures ANOVA for change in mean scores,Baseline,,,83.6,5.1,,,,,,,,,,,,,,,,,,,,,,,,,,≥50% decline in total CAPS score,,,Community,,,1,0.5049,,0.4951,Natural or manmade disasters,,High,"Önder E, Tural Ü, Aker AT. A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake. Eur Psychiatry. 2006 Apr;21(3):174-9. doi: 10.1016/j.eurpsy.2005.03.007. PMID: 15964747.",28188,2019
önder2006_CAPS_B_0_ITT,Pharmacotherapy,PTSD,103,B,PTSD,,35,,Moclobemide,Moclobemide,No,Not Applicable,Yes,Antidepressant: MAOI,No,Not Applicable,No,No,No,No,No,Individual,In Person,35,Structured Clinical Interview,CAPS,CAPS (17-item total severity score),ITT,LOCF,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,43.9,2.8,,,,,-41,,,,,,,,,,,,,,,,,,,,,≥50% decline in total CAPS score,0.6286,,Community,,,1,0.5049,,0.4951,Natural or manmade disasters,,High,"Önder E, Tural Ü, Aker AT. A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake. Eur Psychiatry. 2006 Apr;21(3):174-9. doi: 10.1016/j.eurpsy.2005.03.007. PMID: 15964747.",28188,2019
önder2006_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,103,B,PTSD,,35,,Moclobemide,Moclobemide,No,Not Applicable,Yes,Antidepressant: MAOI,No,Not Applicable,No,No,No,No,No,Individual,In Person,35,Structured Clinical Interview,CAPS,CAPS (17-item total severity score),ITT,LOCF,Repeated measures ANOVA for change in mean scores,Baseline,,,84.9,13.4,,,,,,,,,,,,,,,,,,,,,,,,,,≥50% decline in total CAPS score,,,Community,,,1,0.5049,,0.4951,Natural or manmade disasters,,High,"Önder E, Tural Ü, Aker AT. A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake. Eur Psychiatry. 2006 Apr;21(3):174-9. doi: 10.1016/j.eurpsy.2005.03.007. PMID: 15964747.",28188,2019
önder2006_CAPS_C_0_ITT,Pharmacotherapy,PTSD,103,C,PTSD,,30,,Tianeptine,Tianeptine,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS (17-item total severity score),ITT,LOCF,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,39.7,4.2,,,,,-42.4,,,,,,,,,,,,,,,,,,,,,≥50% decline in total CAPS score,0.7667,,Community,,,1,0.5049,,0.4951,Natural or manmade disasters,,High,"Önder E, Tural Ü, Aker AT. A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake. Eur Psychiatry. 2006 Apr;21(3):174-9. doi: 10.1016/j.eurpsy.2005.03.007. PMID: 15964747.",28188,2019
önder2006_CAPS_C_Baseline_ITT,Pharmacotherapy,PTSD,103,C,PTSD,,30,,Tianeptine,Tianeptine,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS (17-item total severity score),ITT,LOCF,Repeated measures ANOVA for change in mean scores,Baseline,,,82.1,18.8,,,,,,,,,,,,,,,,,,,,,,,,,,≥50% decline in total CAPS score,,,Community,,,1,0.5049,,0.4951,Natural or manmade disasters,,High,"Önder E, Tural Ü, Aker AT. A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake. Eur Psychiatry. 2006 Apr;21(3):174-9. doi: 10.1016/j.eurpsy.2005.03.007. PMID: 15964747.",28188,2019
orang2018_PSS-I_A_0_Comp,Psychotherapy,PTSD,45,A,PTSD,,17,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,24,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,12.52,10.03,,,,,-13.42,,,,,Hedges' g,1.6,,,,,,,,,,,,PSS-I <15,,,Reliable change index,,,Community,0,0,1,1,,0,Intimate partner violence,,High,"Orang T, Ayoughi S, Moran JK, et al. The efficacy of narrative exposure therapy in a sample of Iranian women exposed to ongoing intimate partner violence-a randomized controlled trial. Clin Psychol Psychother. 2018 Nov;25(6):827-41. doi: 10.1002/cpp.2318. PMID: 30079583.",,2020
orang2018_PSS-I_A_12_Comp,Psychotherapy,PTSD,45,A,PTSD,,17,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,24,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Repeated measures ANOVA for change in mean scores,Assessment at 3 to <6 Months,12,,12.58,8.7,,,,,-13.36,,,,,Hedges' g,1.77,,,,,,,,,,,,PSS-I <15,0.7059,,Reliable change index,0.4706,,Community,0,0,1,1,,0,Intimate partner violence,,High,"Orang T, Ayoughi S, Moran JK, et al. The efficacy of narrative exposure therapy in a sample of Iranian women exposed to ongoing intimate partner violence-a randomized controlled trial. Clin Psychol Psychother. 2018 Nov;25(6):827-41. doi: 10.1002/cpp.2318. PMID: 30079583.",,2020
orang2018_PSS-I_A_Baseline_Comp,Psychotherapy,PTSD,45,A,PTSD,,17,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,24,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Repeated measures ANOVA for change in mean scores,Baseline,,,25.94,5.65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,Intimate partner violence,,High,"Orang T, Ayoughi S, Moran JK, et al. The efficacy of narrative exposure therapy in a sample of Iranian women exposed to ongoing intimate partner violence-a randomized controlled trial. Clin Psychol Psychother. 2018 Nov;25(6):827-41. doi: 10.1002/cpp.2318. PMID: 30079583.",,2020
orang2018_PSS-I_B_0_Comp,Psychotherapy,PTSD,45,B,PTSD,,17,,TAU,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,21,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,20.70,6.86,,,,,-6.71,,,,,Hedges' g,1.02,,,,,,,,,,,,PSS-I <15,,,Reliable change index,,,Community,0,0,1,1,,0,Intimate partner violence,,High,"Orang T, Ayoughi S, Moran JK, et al. The efficacy of narrative exposure therapy in a sample of Iranian women exposed to ongoing intimate partner violence-a randomized controlled trial. Clin Psychol Psychother. 2018 Nov;25(6):827-41. doi: 10.1002/cpp.2318. PMID: 30079583.",,2020
orang2018_PSS-I_B_12_Comp,Psychotherapy,PTSD,45,B,PTSD,,17,,TAU,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,21,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Repeated measures ANOVA for change in mean scores,Assessment at 3 to <6 Months,12,,19.52,7.23,,,,,-7.89,,,,,Hedges' g,1.16,,,,,,,,,,,,PSS-I <15,0.2941,,Reliable change index,0.1176,,Community,0,0,1,1,,0,Intimate partner violence,,High,"Orang T, Ayoughi S, Moran JK, et al. The efficacy of narrative exposure therapy in a sample of Iranian women exposed to ongoing intimate partner violence-a randomized controlled trial. Clin Psychol Psychother. 2018 Nov;25(6):827-41. doi: 10.1002/cpp.2318. PMID: 30079583.",,2020
orang2018_PSS-I_B_Baseline_Comp,Psychotherapy,PTSD,45,B,PTSD,,17,,TAU,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,21,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Repeated measures ANOVA for change in mean scores,Baseline,,,27.41,5.87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,Intimate partner violence,,High,"Orang T, Ayoughi S, Moran JK, et al. The efficacy of narrative exposure therapy in a sample of Iranian women exposed to ongoing intimate partner violence-a randomized controlled trial. Clin Psychol Psychother. 2018 Nov;25(6):827-41. doi: 10.1002/cpp.2318. PMID: 30079583.",,2020
otalora2018_CAPS_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,28,A,PTSD,,12,,Psychotherapy + higher-dose MDMA,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,No,No,No,Individual,In person,13,Structured Clinical Interview,CAPS,CAPS-IV,ITT,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,64.3,33.6,,,,,-26.3,29.5,,,,,,,,,,,,,,,,,Not fulfilling diagnostic criteria for PTSD according to CAPS-IV,0.417,,≥30% improvement on total CAPS-IV score,0.5,,Community,0,0,1,0.679,,0.321,Mixed,"Combat-related; Child physical abuse; Child sexual abuse; Accidents; Community/school violence; Other (ritual abuse, witnessing a crime)",Medium,"Ot'alora GM, Grigsby J, Poulter B, et al. 3,4-methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized phase 2 controlled trial. J Psychopharmacol. 2018 Dec;32(12):1295-307. doi: 10.1177/0269881118806297. PMID: 30371148.",51494,2020
otalora2018_CAPS_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,28,A,PTSD,,13,,Psychotherapy + higher-dose MDMA,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,No,No,No,Individual,In person,13,Structured Clinical Interview,CAPS,CAPS-IV,ITT,,Repeated measures ANOVA for change in mean scores,Baseline,,,93.5,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.679,,0.321,Mixed,"Combat-related; Child physical abuse; Child sexual abuse; Accidents; Community/school violence; Other (ritual abuse, witnessing a crime)",Medium,"Ot'alora GM, Grigsby J, Poulter B, et al. 3,4-methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized phase 2 controlled trial. J Psychopharmacol. 2018 Dec;32(12):1295-307. doi: 10.1177/0269881118806297. PMID: 30371148.",51494,2020
otalora2018_CAPS_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,28,B,PTSD,,9,,Psychotherapy + lower-dose MDMA,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,No,No,No,Individual,In person,9,Structured Clinical Interview,CAPS,CAPS-IV,ITT,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,70.0,28.2,,,,,-24.4,24.2,,,,,,,,,,,,,,,,,Not fulfilling diagnostic criteria for PTSD according to CAPS-IV,0.3333,,≥30% improvement on total CAPS-IV score,0.556,,Community,0,0,1,0.679,,0.321,Mixed,"Combat-related; Child physical abuse; Child sexual abuse; Accidents; Community/school violence; Other (ritual abuse, witnessing a crime)",Medium,"Ot'alora GM, Grigsby J, Poulter B, et al. 3,4-methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized phase 2 controlled trial. J Psychopharmacol. 2018 Dec;32(12):1295-307. doi: 10.1177/0269881118806297. PMID: 30371148.",51494,2020
otalora2018_CAPS_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,28,B,PTSD,,9,,Psychotherapy + lower-dose MDMA,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,No,No,No,Individual,In person,9,Structured Clinical Interview,CAPS,CAPS-IV,ITT,,Repeated measures ANOVA for change in mean scores,Baseline,,,94.4,20.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.679,,0.321,Mixed,"Combat-related; Child physical abuse; Child sexual abuse; Accidents; Community/school violence; Other (ritual abuse, witnessing a crime)",Medium,"Ot'alora GM, Grigsby J, Poulter B, et al. 3,4-methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized phase 2 controlled trial. J Psychopharmacol. 2018 Dec;32(12):1295-307. doi: 10.1177/0269881118806297. PMID: 30371148.",51494,2020
otalora2018_CAPS_C_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,28,C,Control,,5,,Psychotherapy + control dose MDMA,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,No,No,No,Individual,In person,6,Structured Clinical Interview,CAPS,CAPS-IV,ITT,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,73.3,24.5,,,,,-11.5,21.2,,,,,,,,,,,,,,,,,Not fulfilling diagnostic criteria for PTSD according to CAPS-IV,0.333,,≥30% improvement on total CAPS-IV score,0.167,,Community,0,0,1,0.679,,0.321,Mixed,"Combat-related; Child physical abuse; Child sexual abuse; Accidents; Community/school violence; Other (ritual abuse, witnessing a crime)",Medium,"Ot'alora GM, Grigsby J, Poulter B, et al. 3,4-methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized phase 2 controlled trial. J Psychopharmacol. 2018 Dec;32(12):1295-307. doi: 10.1177/0269881118806297. PMID: 30371148.",51494,2020
otalora2018_CAPS_C_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,28,C,Control,,6,,Psychotherapy + control dose MDMA,MDMA-assisted psychotherapy,Yes,Non-TF,Yes,Psychostimulant,No,Not Applicable,No,No,No,No,No,Individual,In person,6,Structured Clinical Interview,CAPS,CAPS-IV,ITT,,Repeated measures ANOVA for change in mean scores,Baseline,,,84.8,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.679,,0.321,Mixed,"Combat-related; Child physical abuse; Child sexual abuse; Accidents; Community/school violence; Other (ritual abuse, witnessing a crime)",Medium,"Ot'alora GM, Grigsby J, Poulter B, et al. 3,4-methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized phase 2 controlled trial. J Psychopharmacol. 2018 Dec;32(12):1295-307. doi: 10.1177/0269881118806297. PMID: 30371148.",51494,2020
padala2006_CAPS_A_0_NA,Pharmacotherapy,PTSD,20,A,PTSD,,11,,Risperidone,Risperidone,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Structured Clinical Interview,CAPS,CAPS-2,,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,,,,,,,,,,,,,,,,,p=significant,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child physical abuse, community/school violence, other (violent death of a loved one)",High,"Padala PR, Madison J, Monnahan M, et al. Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. Int Clin Psychopharmacol. 2006 Sep;21(5):275-80. PMID: 16877898.",50966,2019
padala2006_CAPS_A_Baseline_NA,Pharmacotherapy,PTSD,20,A,PTSD,,11,,Risperidone,Risperidone,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Structured Clinical Interview,CAPS,CAPS-2,,,Repeated measures ANOVA for change in mean scores,Baseline,,,79.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child physical abuse, community/school violence, other (violent death of a loved one)",High,"Padala PR, Madison J, Monnahan M, et al. Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. Int Clin Psychopharmacol. 2006 Sep;21(5):275-80. PMID: 16877898.",50966,2019
padala2006_CAPS_B_0_NA,Pharmacotherapy,PTSD,20,B,Control,,9,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,9,Structured Clinical Interview,CAPS,CAPS-2,,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,,,,,,,,,,,,,,,,,p=significant,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child physical abuse, community/school violence, other (violent death of a loved one)",High,"Padala PR, Madison J, Monnahan M, et al. Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. Int Clin Psychopharmacol. 2006 Sep;21(5):275-80. PMID: 16877898.",50966,2019
padala2006_CAPS_B_Baseline_NA,Pharmacotherapy,PTSD,20,B,Control,,9,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,9,Structured Clinical Interview,CAPS,CAPS-2,,,Repeated measures ANOVA for change in mean scores,Baseline,,,80.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child physical abuse, community/school violence, other (violent death of a loved one)",High,"Padala PR, Madison J, Monnahan M, et al. Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. Int Clin Psychopharmacol. 2006 Sep;21(5):275-80. PMID: 16877898.",50966,2019
padala2006_TOP-8_A_0_NA,Pharmacotherapy,PTSD,20,A,PTSD,,,,Risperidone,Risperidone,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Structured Clinical Interview,TOP-8,TOP-8,,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child physical abuse, community/school violence, other (violent death of a loved one)",High,"Padala PR, Madison J, Monnahan M, et al. Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. Int Clin Psychopharmacol. 2006 Sep;21(5):275-80. PMID: 16877898.",50966,2019
padala2006_TOP-8_A_Baseline_NA,Pharmacotherapy,PTSD,20,A,PTSD,,,,Risperidone,Risperidone,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Structured Clinical Interview,TOP-8,TOP-8,,,Repeated measures ANOVA for change in mean scores,Baseline,,,20.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child physical abuse, community/school violence, other (violent death of a loved one)",High,"Padala PR, Madison J, Monnahan M, et al. Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. Int Clin Psychopharmacol. 2006 Sep;21(5):275-80. PMID: 16877898.",50966,2019
padala2006_TOP-8_B_0_NA,Pharmacotherapy,PTSD,20,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,9,Structured Clinical Interview,TOP-8,TOP-8,,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child physical abuse, community/school violence, other (violent death of a loved one)",High,"Padala PR, Madison J, Monnahan M, et al. Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. Int Clin Psychopharmacol. 2006 Sep;21(5):275-80. PMID: 16877898.",50966,2019
padala2006_TOP-8_B_Baseline_NA,Pharmacotherapy,PTSD,20,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,9,Structured Clinical Interview,TOP-8,TOP-8,,,Repeated measures ANOVA for change in mean scores,Baseline,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, intimate partner violence, child physical abuse, community/school violence, other (violent death of a loved one)",High,"Padala PR, Madison J, Monnahan M, et al. Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. Int Clin Psychopharmacol. 2006 Sep;21(5):275-80. PMID: 16877898.",50966,2019
panahi2011_IES-R_A_0_Comp,Pharmacotherapy,PTSD,70,A,PTSD,,32,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,35,Self report,IES-R,IES-R,Completer,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,,,,,,,-24.8,2.0,,,,,,,,,,,,,,,,,,,,≥30% reduction in IES-R total score,1,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.6857,0.3143,0,0,,1,Combat-related,,Low,"Panahi Y, Moghaddam BR, Sahebkar A, et al. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder. Psychol Med. 2011;41(10):2159-66. doi: 10.1017/S0033291711000201. PMID: 21349225.",36061,2019
panahi2011_IES-R_A_0_ITT,Pharmacotherapy,PTSD,70,A,PTSD,,35,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,35,Self report,IES-R,IES-R,ITT,LOCF,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,,,,,,,-22.7,7.3,,,,,,,,,,,,,,,,,,,,≥30% reduction in IES-R total score,,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.6857,0.3143,0,0,,1,Combat-related,,Low,"Panahi Y, Moghaddam BR, Sahebkar A, et al. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder. Psychol Med. 2011;41(10):2159-66. doi: 10.1017/S0033291711000201. PMID: 21349225.",36061,2019
panahi2011_IES-R_A_0_ITT,Pharmacotherapy,PTSD,70,A,PTSD,,35,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,35,Self report,IES-R,IES-R,ITT,group mean imputation (GMI),Repeated measures ANOVA for change in mean scores,End of Treatment,0,,,,,,,,-24.6,2.1,,,,,,,,,,,,,,,,,,,,≥30% reduction in IES-R total score,1,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.6857,0.3143,0,0,,1,Combat-related,,Low,"Panahi Y, Moghaddam BR, Sahebkar A, et al. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder. Psychol Med. 2011;41(10):2159-66. doi: 10.1017/S0033291711000201. PMID: 21349225.",36061,2019
panahi2011_IES-R_A_Baseline_Comp,Pharmacotherapy,PTSD,70,A,PTSD,,32,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,35,Self report,IES-R,IES-R,Completer,,Repeated measures ANOVA for change in mean scores,Baseline,,,65.4,3.9,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% reduction in IES-R total score,,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.6857,0.3143,0,0,,1,Combat-related,,Low,"Panahi Y, Moghaddam BR, Sahebkar A, et al. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder. Psychol Med. 2011;41(10):2159-66. doi: 10.1017/S0033291711000201. PMID: 21349225.",36061,2019
panahi2011_IES-R_A_Baseline_ITT,Pharmacotherapy,PTSD,70,A,PTSD,,35,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,35,Self report,IES-R,IES-R,ITT,,Repeated measures ANOVA for change in mean scores,Baseline,,,65.3,3.8,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% reduction in IES-R total score,,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.6857,0.3143,0,0,,1,Combat-related,,Low,"Panahi Y, Moghaddam BR, Sahebkar A, et al. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder. Psychol Med. 2011;41(10):2159-66. doi: 10.1017/S0033291711000201. PMID: 21349225.",36061,2019
panahi2011_IES-R_B_0_Comp,Pharmacotherapy,PTSD,70,B,Control,,30,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,35,Self report,IES-R,IES-R,Completer,,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,,,,,,,-20.4,2.2,,,,,,,,,,,,,,,,,,,,≥30% reduction in IES-R total score,0.8,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.6857,0.3143,0,0,,1,Combat-related,,Low,"Panahi Y, Moghaddam BR, Sahebkar A, et al. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder. Psychol Med. 2011;41(10):2159-66. doi: 10.1017/S0033291711000201. PMID: 21349225.",36061,2019
panahi2011_IES-R_B_0_ITT,Pharmacotherapy,PTSD,70,B,Control,,35,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,35,Self report,IES-R,IES-R,ITT,LOCF,Repeated measures ANOVA for change in mean scores,End of Treatment,0,,,,,,,,-17.5,7.5,,,,,,,,,,,,,,,,,,,,≥30% reduction in IES-R total score,,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.6857,0.3143,0,0,,1,Combat-related,,Low,"Panahi Y, Moghaddam BR, Sahebkar A, et al. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder. Psychol Med. 2011;41(10):2159-66. doi: 10.1017/S0033291711000201. PMID: 21349225.",36061,2019
panahi2011_IES-R_B_0_ITT,Pharmacotherapy,PTSD,70,B,Control,,35,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,35,Self report,IES-R,IES-R,ITT,group mean imputation (GMI),Repeated measures ANOVA for change in mean scores,End of Treatment,0,,,,,,,,-20.4,2.4,,,,,,,,,,,,,,,,,,,,≥30% reduction in IES-R total score,0.8,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.6857,0.3143,0,0,,1,Combat-related,,Low,"Panahi Y, Moghaddam BR, Sahebkar A, et al. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder. Psychol Med. 2011;41(10):2159-66. doi: 10.1017/S0033291711000201. PMID: 21349225.",36061,2019
panahi2011_IES-R_B_Baseline_Comp,Pharmacotherapy,PTSD,70,B,Control,,30,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,35,Self report,IES-R,IES-R,Completer,,Repeated measures ANOVA for change in mean scores,Baseline,,,65.1,5,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% reduction in IES-R total score,,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.6857,0.3143,0,0,,1,Combat-related,,Low,"Panahi Y, Moghaddam BR, Sahebkar A, et al. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder. Psychol Med. 2011;41(10):2159-66. doi: 10.1017/S0033291711000201. PMID: 21349225.",36061,2019
panahi2011_IES-R_B_Baseline_ITT,Pharmacotherapy,PTSD,70,B,Control,,35,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,35,Self report,IES-R,IES-R,ITT,,Repeated measures ANOVA for change in mean scores,Baseline,,,65.1,4.8,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% reduction in IES-R total score,,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.6857,0.3143,0,0,,1,Combat-related,,Low,"Panahi Y, Moghaddam BR, Sahebkar A, et al. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder. Psychol Med. 2011;41(10):2159-66. doi: 10.1017/S0033291711000201. PMID: 21349225.",36061,2019
paunovic2001_CAPS_A_0_Comp,Psychotherapy,PTSD,20,A,PTSD,,,,Exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,End of Treatment,0,,46,23.9,,,,,-52.4,,,,ANOVA treatment effect,,,,,,p<0.01,,,,,,,,,,,,,,Community,,,1,0.1875,,0.8125,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (exposure to toxic substance)",High,"Paunovic N, Öst L-G. Cognitive-behavior therapy vs exposure therapy in the treatment of PTSD in refugees. Behav Res Ther. 2001 Oct;39(10):1183-97. doi: 10.1016/S0005-7967(00)00093-0. PMID: 11579988.",07357,2019
paunovic2001_CAPS_A_26_Comp,Psychotherapy,PTSD,20,A,PTSD,,,,Exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,Assessment at 6 to <12 Months,26,,50.5,23.4,,,,,-47.9,,,,ANOVA treatment effect,,,,,,p<0.01,,,,,,,,,,,,,,Community,,,1,0.1875,,0.8125,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (exposure to toxic substance)",High,"Paunovic N, Öst L-G. Cognitive-behavior therapy vs exposure therapy in the treatment of PTSD in refugees. Behav Res Ther. 2001 Oct;39(10):1183-97. doi: 10.1016/S0005-7967(00)00093-0. PMID: 11579988.",07357,2019
paunovic2001_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,20,A,PTSD,,,,Exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,Baseline,,,98.4,14.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1875,,0.8125,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (exposure to toxic substance)",High,"Paunovic N, Öst L-G. Cognitive-behavior therapy vs exposure therapy in the treatment of PTSD in refugees. Behav Res Ther. 2001 Oct;39(10):1183-97. doi: 10.1016/S0005-7967(00)00093-0. PMID: 11579988.",07357,2019
paunovic2001_CAPS_B_0_Comp,Psychotherapy,PTSD,20,B,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,End of Treatment,0,,49,24.2,,,,,-46.1,,,,ANOVA treatment effect,,,,,,p<0.01,,,,,,,,,,,,,,Community,,,1,0.1875,,0.8125,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (exposure to toxic substance)",High,"Paunovic N, Öst L-G. Cognitive-behavior therapy vs exposure therapy in the treatment of PTSD in refugees. Behav Res Ther. 2001 Oct;39(10):1183-97. doi: 10.1016/S0005-7967(00)00093-0. PMID: 11579988.",07357,2019
paunovic2001_CAPS_B_26_Comp,Psychotherapy,PTSD,20,B,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,Assessment at 6 to <12 Months,26,,52.9,28.2,,,,,-42.2,,,,ANOVA treatment effect,,,,,,p<0.01,,,,,,,,,,,,,,Community,,,1,0.1875,,0.8125,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (exposure to toxic substance)",High,"Paunovic N, Öst L-G. Cognitive-behavior therapy vs exposure therapy in the treatment of PTSD in refugees. Behav Res Ther. 2001 Oct;39(10):1183-97. doi: 10.1016/S0005-7967(00)00093-0. PMID: 11579988.",07357,2019
paunovic2001_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,20,B,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,Baseline,,,95.1,25.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1875,,0.8125,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (exposure to toxic substance)",High,"Paunovic N, Öst L-G. Cognitive-behavior therapy vs exposure therapy in the treatment of PTSD in refugees. Behav Res Ther. 2001 Oct;39(10):1183-97. doi: 10.1016/S0005-7967(00)00093-0. PMID: 11579988.",07357,2019
paunovic2001_PSS-SR_A_0_NA,Psychotherapy,PTSD,20,A,PTSD,,,,Exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,PSS-SR,PSS-SR,,,ANOVA,End of Treatment,0,,18.1,10.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1875,,0.8125,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (exposure to toxic substance)",High,"Paunovic N, Öst L-G. Cognitive-behavior therapy vs exposure therapy in the treatment of PTSD in refugees. Behav Res Ther. 2001 Oct;39(10):1183-97. doi: 10.1016/S0005-7967(00)00093-0. PMID: 11579988.",07357,2019
paunovic2001_PSS-SR_A_26_NA,Psychotherapy,PTSD,20,A,PTSD,,,,Exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,PSS-SR,PSS-SR,,,ANOVA,Assessment at 6 to <12 Months,26,,18.3,9.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1875,,0.8125,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (exposure to toxic substance)",High,"Paunovic N, Öst L-G. Cognitive-behavior therapy vs exposure therapy in the treatment of PTSD in refugees. Behav Res Ther. 2001 Oct;39(10):1183-97. doi: 10.1016/S0005-7967(00)00093-0. PMID: 11579988.",07357,2019
paunovic2001_PSS-SR_A_Baseline_NA,Psychotherapy,PTSD,20,A,PTSD,,,,Exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,PSS-SR,PSS-SR,,,ANOVA,Baseline,,,38.4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1875,,0.8125,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (exposure to toxic substance)",High,"Paunovic N, Öst L-G. Cognitive-behavior therapy vs exposure therapy in the treatment of PTSD in refugees. Behav Res Ther. 2001 Oct;39(10):1183-97. doi: 10.1016/S0005-7967(00)00093-0. PMID: 11579988.",07357,2019
paunovic2001_PSS-SR_B_0_NA,Psychotherapy,PTSD,20,B,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,PSS-SR,PSS-SR,,,ANOVA,End of Treatment,0,,16.8,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1875,,0.8125,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (exposure to toxic substance)",High,"Paunovic N, Öst L-G. Cognitive-behavior therapy vs exposure therapy in the treatment of PTSD in refugees. Behav Res Ther. 2001 Oct;39(10):1183-97. doi: 10.1016/S0005-7967(00)00093-0. PMID: 11579988.",07357,2019
paunovic2001_PSS-SR_B_26_NA,Psychotherapy,PTSD,20,B,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,PSS-SR,PSS-SR,,,ANOVA,Assessment at 6 to <12 Months,26,,18.5,9.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1875,,0.8125,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (exposure to toxic substance)",High,"Paunovic N, Öst L-G. Cognitive-behavior therapy vs exposure therapy in the treatment of PTSD in refugees. Behav Res Ther. 2001 Oct;39(10):1183-97. doi: 10.1016/S0005-7967(00)00093-0. PMID: 11579988.",07357,2019
paunovic2001_PSS-SR_B_Baseline_NA,Psychotherapy,PTSD,20,B,PTSD,,,,CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,PSS-SR,PSS-SR,,,ANOVA,Baseline,,,38.9,9.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1875,,0.8125,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (exposure to toxic substance)",High,"Paunovic N, Öst L-G. Cognitive-behavior therapy vs exposure therapy in the treatment of PTSD in refugees. Behav Res Ther. 2001 Oct;39(10):1183-97. doi: 10.1016/S0005-7967(00)00093-0. PMID: 11579988.",07357,2019
perezdandieu2014_PCL_A_0_NA,Psychotherapy,PTSD,12,A,PTSD+SUD,Not integrated,6,,EMDR + TAU,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,6,Self report,PCL,PCL-S,,,Paired t-tests,End of Treatment,0,,35.17,13.42,,,,,-24.66,,,,,,,,,,p=0.008,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"other (sexual abuse, physical abuse or physical threatening or negligence, emotional abuse)",High,"Perez-Dandieu B, Tapia G. Treating trauma in addiction with EMDR: a pilot study. J Psychoactive Drugs. 2014 Oct-Dec;46(4):303-9. doi: 10.1080/02791072.2014.921744. PMID: 25188700.",1548480,2019
perezdandieu2014_PCL_A_Baseline_NA,Psychotherapy,PTSD,12,A,PTSD+SUD,Not integrated,6,,EMDR + TAU,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,6,Self report,PCL,PCL-S,,,Paired t-tests,Baseline,,,59.83,7.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"other (sexual abuse, physical abuse or physical threatening or negligence, emotional abuse)",High,"Perez-Dandieu B, Tapia G. Treating trauma in addiction with EMDR: a pilot study. J Psychoactive Drugs. 2014 Oct-Dec;46(4):303-9. doi: 10.1080/02791072.2014.921744. PMID: 25188700.",1548480,2019
perezdandieu2014_PCL_B_0_NA,Psychotherapy,PTSD,12,B,Control,,,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,6,Self report,PCL,PCL-S,,,Paired t-tests,End of Treatment,0,,56.5,2.55,,,,,1.83,,,,,,,,,,p=0.389,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"other (sexual abuse, physical abuse or physical threatening or negligence, emotional abuse)",High,"Perez-Dandieu B, Tapia G. Treating trauma in addiction with EMDR: a pilot study. J Psychoactive Drugs. 2014 Oct-Dec;46(4):303-9. doi: 10.1080/02791072.2014.921744. PMID: 25188700.",1548480,2019
perezdandieu2014_PCL_B_Baseline_NA,Psychotherapy,PTSD,12,B,Control,,6,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,6,Self report,PCL,PCL-S,,,Paired t-tests,Baseline,,,54.67,7.53,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"other (sexual abuse, physical abuse or physical threatening or negligence, emotional abuse)",High,"Perez-Dandieu B, Tapia G. Treating trauma in addiction with EMDR: a pilot study. J Psychoactive Drugs. 2014 Oct-Dec;46(4):303-9. doi: 10.1080/02791072.2014.921744. PMID: 25188700.",1548480,2019
petrakis2012_CAPS_A_0_ITT,Pharmacotherapy,PTSD+SUD,88,A,PTSD+SUD,Not integrated,22,,Paroxetine + naltrexone,Paroxetine + naltrexone,No,Not Applicable,Yes,Mixed,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed-effects repeated models,Paired t-tests,End of Treatment,0,,40.02,5.53,,,,,-33.52,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.9205,0.0795,0.0909,,0.9091,,,Medium,"Petrakis IL, Ralevski E, Desai N, et al. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology. 2012 Mar;37(4):996-1004. doi: 10.1038/npp.2011.283. PMID: 22089316.",36777,2019
petrakis2012_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD+SUD,88,A,PTSD+SUD,Not integrated,22,,Paroxetine + naltrexone,Paroxetine + naltrexone,No,Not Applicable,Yes,Mixed,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed-effects repeated models,Paired t-tests,Baseline,,,73.54,5.01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.9205,0.0795,0.0909,,0.9091,,,Medium,"Petrakis IL, Ralevski E, Desai N, et al. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology. 2012 Mar;37(4):996-1004. doi: 10.1038/npp.2011.283. PMID: 22089316.",36777,2019
petrakis2012_CAPS_B_0_ITT,Pharmacotherapy,PTSD+SUD,88,B,PTSD,,20,,Paroxetine + placebo,Paroxetine + placebo,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed-effects repeated models,Paired t-tests,End of Treatment,0,,36.59,5.57,,,,,-33.22,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.9205,0.0795,0.0909,,0.9091,,,Medium,"Petrakis IL, Ralevski E, Desai N, et al. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology. 2012 Mar;37(4):996-1004. doi: 10.1038/npp.2011.283. PMID: 22089316.",36777,2019
petrakis2012_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD+SUD,88,B,PTSD,,20,,Paroxetine + placebo,Paroxetine + placebo,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed-effects repeated models,Paired t-tests,Baseline,,,69.81,5.17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.9205,0.0795,0.0909,,0.9091,,,Medium,"Petrakis IL, Ralevski E, Desai N, et al. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology. 2012 Mar;37(4):996-1004. doi: 10.1038/npp.2011.283. PMID: 22089316.",36777,2019
petrakis2012_CAPS_C_0_ITT,Pharmacotherapy,PTSD+SUD,88,C,PTSD+SUD,Not integrated,22,,Desipramine + naltrexone,Desipramine + naltrexone,No,Not Applicable,Yes,Mixed,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed-effects repeated models,Paired t-tests,End of Treatment,0,,26.75,5.35,,,,,-35.75,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.9205,0.0795,0.0909,,0.9091,,,Medium,"Petrakis IL, Ralevski E, Desai N, et al. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology. 2012 Mar;37(4):996-1004. doi: 10.1038/npp.2011.283. PMID: 22089316.",36777,2019
petrakis2012_CAPS_C_Baseline_ITT,Pharmacotherapy,PTSD+SUD,88,C,PTSD+SUD,Not integrated,22,,Desipramine + naltrexone,Desipramine + naltrexone,No,Not Applicable,Yes,Mixed,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed-effects repeated models,Paired t-tests,Baseline,,,62.50,5.05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.9205,0.0795,0.0909,,0.9091,,,Medium,"Petrakis IL, Ralevski E, Desai N, et al. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology. 2012 Mar;37(4):996-1004. doi: 10.1038/npp.2011.283. PMID: 22089316.",36777,2019
petrakis2012_CAPS_D_0_ITT,Pharmacotherapy,PTSD+SUD,88,D,PTSD,,24,,Desipramine + placebo,Desipramine + placebo,No,Not Applicable,Yes,Antidepressant: TCA,No,Not Applicable,No,No,No,No,No,Individual,In Person,24,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed-effects repeated models,Paired t-tests,End of Treatment,0,,41.39,4.95,,,,,-37.44,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.9205,0.0795,0.0909,,0.9091,,,Medium,"Petrakis IL, Ralevski E, Desai N, et al. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology. 2012 Mar;37(4):996-1004. doi: 10.1038/npp.2011.283. PMID: 22089316.",36777,2019
petrakis2012_CAPS_D_Baseline_ITT,Pharmacotherapy,PTSD+SUD,88,D,PTSD,,24,,Desipramine + placebo,Desipramine + placebo,No,Not Applicable,Yes,Antidepressant: TCA,No,Not Applicable,No,No,No,No,No,Individual,In Person,24,Structured Clinical Interview,CAPS,CAPS,ITT,Mixed-effects repeated models,Paired t-tests,Baseline,,,78.83,4.83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.9205,0.0795,0.0909,,0.9091,,,Medium,"Petrakis IL, Ralevski E, Desai N, et al. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology. 2012 Mar;37(4):996-1004. doi: 10.1038/npp.2011.283. PMID: 22089316.",36777,2019
petrakis2016_CAPS_A_0_ITT,Pharmacotherapy,PTSD+SUD,96,A,PTSD+SUD,Not integrated,50,,Prazosin,Prazosin,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In person,50,Structured Clinical Interview,CAPS,CAPS,ITT,,Paired t-tests,End of Treatment,0,,37.94,37.92,,,,,-33.92,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,,,High,"Petrakis IL, Desai N, Gueorguieva R, et al. Prazosin for veterans with posttraumatic stress disorder and comorbid alcohol dependence: a clinical trial. Alcohol Clin Exp Res. 2016 Jan;40(1):178-86. doi: 10.1111/acer.12926. PMID: 26683790.",44663,2020
petrakis2016_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD+SUD,96,A,PTSD+SUD,Not integrated,50,,Prazosin,Prazosin,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In person,50,Structured Clinical Interview,CAPS,CAPS,ITT,,Paired t-tests,Baseline,,,71.86,24.65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,,,High,"Petrakis IL, Desai N, Gueorguieva R, et al. Prazosin for veterans with posttraumatic stress disorder and comorbid alcohol dependence: a clinical trial. Alcohol Clin Exp Res. 2016 Jan;40(1):178-86. doi: 10.1111/acer.12926. PMID: 26683790.",44663,2020
petrakis2016_CAPS_B_0_ITT,Pharmacotherapy,PTSD+SUD,96,B,Control,Not integrated,46,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,46,Structured Clinical Interview,CAPS,CAPS,ITT,,Paired t-tests,End of Treatment,0,,37.93,41.13,,,,,-37.78,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,,,High,"Petrakis IL, Desai N, Gueorguieva R, et al. Prazosin for veterans with posttraumatic stress disorder and comorbid alcohol dependence: a clinical trial. Alcohol Clin Exp Res. 2016 Jan;40(1):178-86. doi: 10.1111/acer.12926. PMID: 26683790.",44663,2020
petrakis2016_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD+SUD,96,B,Control,Not integrated,46,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,46,Structured Clinical Interview,CAPS,CAPS,ITT,,Paired t-tests,Baseline,,,75.71,26.36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,,,High,"Petrakis IL, Desai N, Gueorguieva R, et al. Prazosin for veterans with posttraumatic stress disorder and comorbid alcohol dependence: a clinical trial. Alcohol Clin Exp Res. 2016 Jan;40(1):178-86. doi: 10.1111/acer.12926. PMID: 26683790.",44663,2020
philip2019a_CAPS_A_0_ITT,Nonpharmacologic biological,PTSD,50,A,PTSD,,,,Intermittent theta-burst transcranial magnetic stimulation,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,25,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputations,Paired t-tests,End of Treatment,0,,38.6,11.4,,,,,-9.3,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.16,,0.84,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (unspecified childhood trauma, ""serious injury, harm, or death you caused to someone else"", ""other very stressful event/experiences"")",Medium,"Philip NS, Barredo J, Aiken E, et al. Theta-burst transcranial magnetic stimulation for posttraumatic stress disorder. Am J Psychiatry. 2019 Jun 24;176(11):939-48. doi: 10.1176/appi.ajp.2019.18101160. PMID: 31230462.",52101,2020
philip2019a_CAPS_A_Baseline_ITT,Nonpharmacologic biological,PTSD,50,A,PTSD,,25,,Intermittent theta-burst transcranial magnetic stimulation,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,25,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputations,Paired t-tests,Baseline,,,47.90,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.16,,0.84,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (unspecified childhood trauma, ""serious injury, harm, or death you caused to someone else"", ""other very stressful event/experiences"")",Medium,"Philip NS, Barredo J, Aiken E, et al. Theta-burst transcranial magnetic stimulation for posttraumatic stress disorder. Am J Psychiatry. 2019 Jun 24;176(11):939-48. doi: 10.1176/appi.ajp.2019.18101160. PMID: 31230462.",52101,2020
philip2019a_CAPS_B_0_ITT,Nonpharmacologic biological,PTSD,50,B,Control,,,,Sham intermittent theta-burst transcranial magnetic stimulation,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,25,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputations,Paired t-tests,End of Treatment,0,,39.4,13.8,,,,,-8,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.16,,0.84,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (unspecified childhood trauma, ""serious injury, harm, or death you caused to someone else"", ""other very stressful event/experiences"")",Medium,"Philip NS, Barredo J, Aiken E, et al. Theta-burst transcranial magnetic stimulation for posttraumatic stress disorder. Am J Psychiatry. 2019 Jun 24;176(11):939-48. doi: 10.1176/appi.ajp.2019.18101160. PMID: 31230462.",52101,2020
philip2019a_CAPS_B_Baseline_ITT,Nonpharmacologic biological,PTSD,50,B,Control,,25,,Sham intermittent theta-burst transcranial magnetic stimulation,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,25,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputations,Paired t-tests,Baseline,,,47.4,10.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.16,,0.84,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (unspecified childhood trauma, ""serious injury, harm, or death you caused to someone else"", ""other very stressful event/experiences"")",Medium,"Philip NS, Barredo J, Aiken E, et al. Theta-burst transcranial magnetic stimulation for posttraumatic stress disorder. Am J Psychiatry. 2019 Jun 24;176(11):939-48. doi: 10.1176/appi.ajp.2019.18101160. PMID: 31230462.",52101,2020
philip2019a_PCL_A_0_ITT,Nonpharmacologic biological,PTSD,50,A,PTSD,,,,Intermittent theta-burst transcranial magnetic stimulation,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,25,Self report,PCL,PCL-5,ITT,Multiple imputations,Paired t-tests,End of Treatment,0,,35.5,13.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.16,,0.84,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (unspecified childhood trauma, ""serious injury, harm, or death you caused to someone else"", ""other very stressful event/experiences"")",Medium,"Philip NS, Barredo J, Aiken E, et al. Theta-burst transcranial magnetic stimulation for posttraumatic stress disorder. Am J Psychiatry. 2019 Jun 24;176(11):939-48. doi: 10.1176/appi.ajp.2019.18101160. PMID: 31230462.",52101,2020
philip2019a_PCL_A_Baseline_ITT,Nonpharmacologic biological,PTSD,50,A,PTSD,,,,Intermittent theta-burst transcranial magnetic stimulation,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,25,Self report,PCL,PCL-5,ITT,Multiple imputations,Paired t-tests,Baseline,,,49.4,9.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.16,,0.84,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (unspecified childhood trauma, ""serious injury, harm, or death you caused to someone else"", ""other very stressful event/experiences"")",Medium,"Philip NS, Barredo J, Aiken E, et al. Theta-burst transcranial magnetic stimulation for posttraumatic stress disorder. Am J Psychiatry. 2019 Jun 24;176(11):939-48. doi: 10.1176/appi.ajp.2019.18101160. PMID: 31230462.",52101,2020
philip2019a_PCL_B_0_ITT,Nonpharmacologic biological,PTSD,50,B,Control,,,,Sham intermittent theta-burst transcranial magnetic stimulation,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,25,Self report,PCL,PCL-5,ITT,Multiple imputations,Paired t-tests,End of Treatment,0,,39.4,16.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.16,,0.84,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (unspecified childhood trauma, ""serious injury, harm, or death you caused to someone else"", ""other very stressful event/experiences"")",Medium,"Philip NS, Barredo J, Aiken E, et al. Theta-burst transcranial magnetic stimulation for posttraumatic stress disorder. Am J Psychiatry. 2019 Jun 24;176(11):939-48. doi: 10.1176/appi.ajp.2019.18101160. PMID: 31230462.",52101,2020
philip2019a_PCL_B_Baseline_ITT,Nonpharmacologic biological,PTSD,50,B,Control,,,,Sham intermittent theta-burst transcranial magnetic stimulation,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,25,Self report,PCL,PCL-5,ITT,Multiple imputations,Paired t-tests,Baseline,,,50.0,11.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.16,,0.84,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (unspecified childhood trauma, ""serious injury, harm, or death you caused to someone else"", ""other very stressful event/experiences"")",Medium,"Philip NS, Barredo J, Aiken E, et al. Theta-burst transcranial magnetic stimulation for posttraumatic stress disorder. Am J Psychiatry. 2019 Jun 24;176(11):939-48. doi: 10.1176/appi.ajp.2019.18101160. PMID: 31230462.",52101,2020
philip2019b_PCL_A_0_ITT,Nonpharmacologic biological,PTSD,23,A,PTSD,,10,,Synchronized TMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,10,Self report,PCL,PCL-5,ITT,,Paired t-tests,End of Treatment,0,,,,,,,SE 3.30,-17.22,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,0.22,,0.78,,,High,"Philip NS, Aiken EE, Kelley ME, et al. Synchronized transcranial magnetic stimulation for posttraumatic stress disorder and comorbid major depression. Brain Stimulation. 2019 Sep-Oct;12(5):1335-7. doi: http://dx.doi.org/10.1016/j.brs.2019.06.010. PMID: 31204205.",1511859,2020
philip2019b_PCL_A_Baseline_ITT,Nonpharmacologic biological,PTSD,23,A,PTSD,,10,,Synchronized TMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,10,Self report,PCL,PCL-5,ITT,,Paired t-tests,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.22,,0.78,,,High,"Philip NS, Aiken EE, Kelley ME, et al. Synchronized transcranial magnetic stimulation for posttraumatic stress disorder and comorbid major depression. Brain Stimulation. 2019 Sep-Oct;12(5):1335-7. doi: http://dx.doi.org/10.1016/j.brs.2019.06.010. PMID: 31204205.",1511859,2020
philip2019b_PCL_B_0_ITT,Nonpharmacologic biological,PTSD,23,B,Control,,13,,Sham synchronized TMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,13,Self report,PCL,PCL-5,ITT,,Paired t-tests,End of Treatment,0,,,,,,,SE 2.41,-10.1,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,0.22,,0.78,,,High,"Philip NS, Aiken EE, Kelley ME, et al. Synchronized transcranial magnetic stimulation for posttraumatic stress disorder and comorbid major depression. Brain Stimulation. 2019 Sep-Oct;12(5):1335-7. doi: http://dx.doi.org/10.1016/j.brs.2019.06.010. PMID: 31204205.",1511859,2020
philip2019b_PCL_B_Baseline_ITT,Nonpharmacologic biological,PTSD,23,B,Control,,13,,Sham synchronized TMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,13,Self report,PCL,PCL-5,ITT,,Paired t-tests,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.22,,0.78,,,High,"Philip NS, Aiken EE, Kelley ME, et al. Synchronized transcranial magnetic stimulation for posttraumatic stress disorder and comorbid major depression. Brain Stimulation. 2019 Sep-Oct;12(5):1335-7. doi: http://dx.doi.org/10.1016/j.brs.2019.06.010. PMID: 31204205.",1511859,2020
polak2015_IES_A_0_ITT,Psychotherapy,PTSD,8,A,PTSD,,4,,Trauma-focused CBT with breathing biofeedback,Trauma-focused cognitive behavioral therapy (TF-CBT) with breathing biofeedback,Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,4,Self report,IES,IES-R,ITT,Restricted maximum likelihood estimation,Linear mixed-effects model,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.75,,0.25,Mixed,"accidents, other (sexual or physical abuse)",High,"Polak AR, Witteveen AB, Denys D, et al. Breathing biofeedback as an adjunct to exposure in cognitive behavioral therapy hastens the reduction of PTSD symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2015 Mar;40(1):25-31. doi: 10.1007/s10484-015-9268-y. PMID: 25750106.",47793,2019
polak2015_IES_A_Baseline_ITT,Psychotherapy,PTSD,8,A,PTSD,,4,,Trauma-focused CBT with breathing biofeedback,Trauma-focused cognitive behavioral therapy (TF-CBT) with breathing biofeedback,Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,4,Self report,IES,IES-R,ITT,Restricted maximum likelihood estimation,Linear mixed-effects model,Baseline,,Median 45,,,Range,28,62,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.75,,0.25,Mixed,"accidents, other (sexual or physical abuse)",High,"Polak AR, Witteveen AB, Denys D, et al. Breathing biofeedback as an adjunct to exposure in cognitive behavioral therapy hastens the reduction of PTSD symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2015 Mar;40(1):25-31. doi: 10.1007/s10484-015-9268-y. PMID: 25750106.",47793,2019
polak2015_IES_B_0_ITT,Psychotherapy,PTSD,8,B,PTSD,,4,,Trauma-focused CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,4,Self report,IES,IES-R,ITT,Restricted maximum likelihood estimation,Linear mixed-effects model,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.75,,0.25,Mixed,"accidents, other (sexual or physical abuse)",High,"Polak AR, Witteveen AB, Denys D, et al. Breathing biofeedback as an adjunct to exposure in cognitive behavioral therapy hastens the reduction of PTSD symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2015 Mar;40(1):25-31. doi: 10.1007/s10484-015-9268-y. PMID: 25750106.",47793,2019
polak2015_IES_B_Baseline_ITT,Psychotherapy,PTSD,8,B,PTSD,,4,,Trauma-focused CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,4,Self report,IES,IES-R,ITT,Restricted maximum likelihood estimation,Linear mixed-effects model,Baseline,,Median 41.5,,,Range,21,73,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.75,,0.25,Mixed,"accidents, other (sexual or physical abuse)",High,"Polak AR, Witteveen AB, Denys D, et al. Breathing biofeedback as an adjunct to exposure in cognitive behavioral therapy hastens the reduction of PTSD symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2015 Mar;40(1):25-31. doi: 10.1007/s10484-015-9268-y. PMID: 25750106.",47793,2019
polusny2015_CAPS_A_0_ITT,Mixed: Psychotherapy & CIH,PTSD,116,A,PTSD,,52,,MBSR,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,58,Structured Clinical Interview,CAPS,CAPS,ITT,,"Mixed-effects model, Cohen's d for change in mean scores",End of Treatment,0,,56.3,,95% CI,51,61.5,,-13.6,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to 1/2 scoring rule for CAPS,0.4231,,≥10-point reduction on CAPS score,0.6346,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.1552,,0.8448,Mixed,"combat-related, rape/sexual assault, illness/medical procedure, community/school violence, natural or manmade disaster, other (not specified)",Medium,"Polusny MA, Erbes CR, Thuras P, et al. Mindfulness-based stress reduction for posttraumatic stress disorder among veterans: a randomized clinical trial. JAMA. 2015 Aug 4;314(5):456-65. doi: 10.1001/jama.2015.8361. PMID: 26241597.",44257,2019
polusny2015_CAPS_A_8_ITT,Mixed: Psychotherapy & CIH,PTSD,116,A,PTSD,,47,,MBSR,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,58,Structured Clinical Interview,CAPS,CAPS,ITT,,"Mixed-effects model, Cohen's d for change in mean scores",Assessment at <3 Months,8,,49.8,,95% CI,44.3,55.3,,-20.1,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to 1/2 scoring rule for CAPS,0.5319,,≥10-point reduction on CAPS score,0.6383,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.1552,,0.8448,Mixed,"combat-related, rape/sexual assault, illness/medical procedure, community/school violence, natural or manmade disaster, other (not specified)",Medium,"Polusny MA, Erbes CR, Thuras P, et al. Mindfulness-based stress reduction for posttraumatic stress disorder among veterans: a randomized clinical trial. JAMA. 2015 Aug 4;314(5):456-65. doi: 10.1001/jama.2015.8361. PMID: 26241597.",44257,2019
polusny2015_CAPS_A_Baseline_ITT,Mixed: Psychotherapy & CIH,PTSD,116,A,PTSD,,58,,MBSR,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,58,Structured Clinical Interview,CAPS,CAPS,ITT,,"Mixed-effects model, Cohen's d for change in mean scores",Baseline,,,69.9,,95% CI,65,74.8,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1552,,0.8448,Mixed,"combat-related, rape/sexual assault, illness/medical procedure, community/school violence, natural or manmade disaster, other (not specified)",Medium,"Polusny MA, Erbes CR, Thuras P, et al. Mindfulness-based stress reduction for posttraumatic stress disorder among veterans: a randomized clinical trial. JAMA. 2015 Aug 4;314(5):456-65. doi: 10.1001/jama.2015.8361. PMID: 26241597.",44257,2019
polusny2015_CAPS_B_0_ITT,Mixed: Psychotherapy & CIH,PTSD,116,B,PTSD,,57,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,58,Structured Clinical Interview,CAPS,CAPS,ITT,,"Mixed-effects model, Cohen's d for change in mean scores",End of Treatment,0,,51.7,,95% CI,46.5,56.8,,-10.8,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to 1/2 scoring rule for CAPS,0.4386,,≥10-point reduction on CAPS score,0.4912,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.1552,,0.8448,Mixed,"combat-related, rape/sexual assault, illness/medical procedure, community/school violence, natural or manmade disaster, other (not specified)",Medium,"Polusny MA, Erbes CR, Thuras P, et al. Mindfulness-based stress reduction for posttraumatic stress disorder among veterans: a randomized clinical trial. JAMA. 2015 Aug 4;314(5):456-65. doi: 10.1001/jama.2015.8361. PMID: 26241597.",44257,2019
polusny2015_CAPS_B_8_ITT,Mixed: Psychotherapy & CIH,PTSD,116,B,PTSD,,57,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,58,Structured Clinical Interview,CAPS,CAPS,ITT,,"Mixed-effects model, Cohen's d for change in mean scores",Assessment at <3 Months,8,,50.6,,95% CI,45.4,55.8,,-11.9,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to 1/2 scoring rule for CAPS,0.4737,,≥10-point reduction on CAPS score,0.5263,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.1552,,0.8448,Mixed,"combat-related, rape/sexual assault, illness/medical procedure, community/school violence, natural or manmade disaster, other (not specified)",Medium,"Polusny MA, Erbes CR, Thuras P, et al. Mindfulness-based stress reduction for posttraumatic stress disorder among veterans: a randomized clinical trial. JAMA. 2015 Aug 4;314(5):456-65. doi: 10.1001/jama.2015.8361. PMID: 26241597.",44257,2019
polusny2015_CAPS_B_Baseline_ITT,Mixed: Psychotherapy & CIH,PTSD,116,B,PTSD,,58,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,58,Structured Clinical Interview,CAPS,CAPS,ITT,,"Mixed-effects model, Cohen's d for change in mean scores",Baseline,,,62.5,,95% CI,57.6,67.4,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1552,,0.8448,Mixed,"combat-related, rape/sexual assault, illness/medical procedure, community/school violence, natural or manmade disaster, other (not specified)",Medium,"Polusny MA, Erbes CR, Thuras P, et al. Mindfulness-based stress reduction for posttraumatic stress disorder among veterans: a randomized clinical trial. JAMA. 2015 Aug 4;314(5):456-65. doi: 10.1001/jama.2015.8361. PMID: 26241597.",44257,2019
polusny2015_PCL_A_0_NA,Mixed: Psychotherapy & CIH,PTSD,116,A,PTSD,,,,MBSR,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,58,Self report,PCL,PCL,,,"Mixed-effects model, Cohen's d for change in mean scores",End of Treatment,0,,55.7,,95% CI,52.6,58.9,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1552,,0.8448,Mixed,"combat-related, rape/sexual assault, illness/medical procedure, community/school violence, natural or manmade disaster, other (not specified)",Medium,"Polusny MA, Erbes CR, Thuras P, et al. Mindfulness-based stress reduction for posttraumatic stress disorder among veterans: a randomized clinical trial. JAMA. 2015 Aug 4;314(5):456-65. doi: 10.1001/jama.2015.8361. PMID: 26241597.",44257,2019
polusny2015_PCL_A_8_NA,Mixed: Psychotherapy & CIH,PTSD,116,A,PTSD,,,,MBSR,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,58,Self report,PCL,PCL,,,"Mixed-effects model, Cohen's d for change in mean scores",Assessment at <3 Months,8,,54.4,,95% CI,51.2,57.6,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1552,,0.8448,Mixed,"combat-related, rape/sexual assault, illness/medical procedure, community/school violence, natural or manmade disaster, other (not specified)",Medium,"Polusny MA, Erbes CR, Thuras P, et al. Mindfulness-based stress reduction for posttraumatic stress disorder among veterans: a randomized clinical trial. JAMA. 2015 Aug 4;314(5):456-65. doi: 10.1001/jama.2015.8361. PMID: 26241597.",44257,2019
polusny2015_PCL_A_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,116,A,PTSD,,,,MBSR,Mindfulness-based stress reduction (MBSR),No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Group,In Person,58,Self report,PCL,PCL,,,"Mixed-effects model, Cohen's d for change in mean scores",Baseline,,,63.6,,95% CI,60.6,66.7,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1552,,0.8448,Mixed,"combat-related, rape/sexual assault, illness/medical procedure, community/school violence, natural or manmade disaster, other (not specified)",Medium,"Polusny MA, Erbes CR, Thuras P, et al. Mindfulness-based stress reduction for posttraumatic stress disorder among veterans: a randomized clinical trial. JAMA. 2015 Aug 4;314(5):456-65. doi: 10.1001/jama.2015.8361. PMID: 26241597.",44257,2019
polusny2015_PCL_B_0_NA,Mixed: Psychotherapy & CIH,PTSD,116,B,PTSD,,,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,58,Self report,PCL,PCL,,,"Mixed-effects model, Cohen's d for change in mean scores",End of Treatment,0,,55.8,,95% CI,52.7,58.9,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1552,,0.8448,Mixed,"combat-related, rape/sexual assault, illness/medical procedure, community/school violence, natural or manmade disaster, other (not specified)",Medium,"Polusny MA, Erbes CR, Thuras P, et al. Mindfulness-based stress reduction for posttraumatic stress disorder among veterans: a randomized clinical trial. JAMA. 2015 Aug 4;314(5):456-65. doi: 10.1001/jama.2015.8361. PMID: 26241597.",44257,2019
polusny2015_PCL_B_8_NA,Mixed: Psychotherapy & CIH,PTSD,116,B,PTSD,,,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,58,Self report,PCL,PCL,,,"Mixed-effects model, Cohen's d for change in mean scores",Assessment at <3 Months,8,,56.0,,95% CI,52.9,59,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1552,,0.8448,Mixed,"combat-related, rape/sexual assault, illness/medical procedure, community/school violence, natural or manmade disaster, other (not specified)",Medium,"Polusny MA, Erbes CR, Thuras P, et al. Mindfulness-based stress reduction for posttraumatic stress disorder among veterans: a randomized clinical trial. JAMA. 2015 Aug 4;314(5):456-65. doi: 10.1001/jama.2015.8361. PMID: 26241597.",44257,2019
polusny2015_PCL_B_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,116,B,PTSD,,,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,58,Self report,PCL,PCL,,,"Mixed-effects model, Cohen's d for change in mean scores",Baseline,,,58.8,,95% CI,55.7,61.8,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1552,,0.8448,Mixed,"combat-related, rape/sexual assault, illness/medical procedure, community/school violence, natural or manmade disaster, other (not specified)",Medium,"Polusny MA, Erbes CR, Thuras P, et al. Mindfulness-based stress reduction for posttraumatic stress disorder among veterans: a randomized clinical trial. JAMA. 2015 Aug 4;314(5):456-65. doi: 10.1001/jama.2015.8361. PMID: 26241597.",44257,2019
popiel2015_PDS_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,228,A,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,114,Self report,PDS,PDS,ITT,,"Hierarchical linear model for change in mean scores, chi-square and t-test for diagnostic change",Baseline,,,32.6,9.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.2368,,0.7632,Accidents,,High,"Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.",45183,2019
popiel2015_PDS_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,228,B,PTSD,,,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,57,Self report,PDS,PDS,ITT,,"Hierarchical linear model for change in mean scores, chi-square and t-test for diagnostic change",Baseline,,,32.6,8.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.2368,,0.7632,Accidents,,High,"Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.",45183,2019
popiel2015_PDS_C_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,228,C,PTSD,,,,PE + paroxetine,Prolonged Exposure (PE) + paroxetine,Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,57,Self report,PDS,PDS,ITT,,"Hierarchical linear model for change in mean scores, chi-square and t-test for diagnostic change",Baseline,,,30.9,10.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.2368,,0.7632,Accidents,,High,"Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.",45183,2019
popiel2015_SCID_A_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,228,A,PTSD,,89,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,114,Structured Clinical Interview,SCID,SCID-1 P/R Module,Completer,,"Hierarchical linear model for change in mean scores, chi-square and t-test for diagnostic change",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SCID,,Additional definitions of Diagnostic Change reported in the study,,,,Community,,,1,0.2368,,0.7632,Accidents,,High,"Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.",45183,2019
popiel2015_SCID_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,228,A,PTSD,,110,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,114,Structured Clinical Interview,SCID,SCID-1 P/R Module,ITT,Generalized linear mixed model with no imputation of data,"Hierarchical linear model for change in mean scores, chi-square and t-test for diagnostic change",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SCID,0.6545,Additional definitions of Diagnostic Change reported in the study,,,,Community,,,1,0.2368,,0.7632,Accidents,,High,"Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.",45183,2019
popiel2015_SCID_A_52_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,228,A,PTSD,,72,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,114,Structured Clinical Interview,SCID,SCID-1 P/R Module,Completer,,"Hierarchical linear model for change in mean scores, chi-square and t-test for diagnostic change",Assessment at ≥12 Months,52,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SCID,,Additional definitions of Diagnostic Change reported in the study,,,,Community,,,1,0.2368,,0.7632,Accidents,,High,"Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.",45183,2019
popiel2015_SCID_A_52_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,228,A,PTSD,,88,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,114,Structured Clinical Interview,SCID,SCID-1 P/R Module,ITT,Generalized linear mixed model with no imputation of data,"Hierarchical linear model for change in mean scores, chi-square and t-test for diagnostic change",Assessment at ≥12 Months,52,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SCID,,Additional definitions of Diagnostic Change reported in the study,,,,Community,,,1,0.2368,,0.7632,Accidents,,High,"Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.",45183,2019
popiel2015_SCID_A_Baseline_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,228,A,PTSD,,114,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,114,Structured Clinical Interview,SCID,SCID-1 P/R Module,,,"Hierarchical linear model for change in mean scores, chi-square and t-test for diagnostic change",Baseline,,,11.8,2.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.2368,,0.7632,Accidents,,High,"Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.",45183,2019
popiel2015_SCID_B_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,228,B,PTSD,,23,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,57,Structured Clinical Interview,SCID,SCID-1 P/R Module,Completer,,"Hierarchical linear model for change in mean scores, chi-square and t-test for diagnostic change",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SCID,,Additional definitions of Diagnostic Change reported in the study,,,,Community,,,1,0.2368,,0.7632,Accidents,,High,"Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.",45183,2019
popiel2015_SCID_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,228,B,PTSD,,30,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,57,Structured Clinical Interview,SCID,SCID-1 P/R Module,ITT,Generalized linear mixed model with no imputation of data,"Hierarchical linear model for change in mean scores, chi-square and t-test for diagnostic change",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SCID,0.4333,Additional definitions of Diagnostic Change reported in the study,,,,Community,,,1,0.2368,,0.7632,Accidents,,High,"Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.",45183,2019
popiel2015_SCID_B_52_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,228,B,PTSD,,18,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,57,Structured Clinical Interview,SCID,SCID-1 P/R Module,Completer,,"Hierarchical linear model for change in mean scores, chi-square and t-test for diagnostic change",Assessment at ≥12 Months,52,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SCID,,Additional definitions of Diagnostic Change reported in the study,,,,Community,,,1,0.2368,,0.7632,Accidents,,High,"Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.",45183,2019
popiel2015_SCID_B_52_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,228,B,PTSD,,45,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,57,Structured Clinical Interview,SCID,SCID-1 P/R Module,ITT,Generalized linear mixed model with no imputation of data,"Hierarchical linear model for change in mean scores, chi-square and t-test for diagnostic change",Assessment at ≥12 Months,52,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SCID,,Additional definitions of Diagnostic Change reported in the study,,,,Community,,,1,0.2368,,0.7632,Accidents,,High,"Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.",45183,2019
popiel2015_SCID_B_Baseline_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,228,B,PTSD,,57,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,57,Structured Clinical Interview,SCID,SCID-1 P/R Module,,,"Hierarchical linear model for change in mean scores, chi-square and t-test for diagnostic change",Baseline,,,11.7,2.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.2368,,0.7632,Accidents,,High,"Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.",45183,2019
popiel2015_SCID_C_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,228,C,PTSD,,26,,PE + paroxetine,Prolonged Exposure (PE) + paroxetine,Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,57,Structured Clinical Interview,SCID,SCID-1 P/R Module,Completer,,"Hierarchical linear model for change in mean scores, chi-square and t-test for diagnostic change",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SCID,,Additional definitions of Diagnostic Change reported in the study,,,,Community,,,1,0.2368,,0.7632,Accidents,,High,"Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.",45183,2019
popiel2015_SCID_C_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,228,C,PTSD,,39,,PE + paroxetine,Prolonged Exposure (PE) + paroxetine,Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,57,Structured Clinical Interview,SCID,SCID-1 P/R Module,ITT,Generalized linear mixed model with no imputation of data,"Hierarchical linear model for change in mean scores, chi-square and t-test for diagnostic change",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SCID,0.5128,Additional definitions of Diagnostic Change reported in the study,,,,Community,,,1,0.2368,,0.7632,Accidents,,High,"Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.",45183,2019
popiel2015_SCID_C_52_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,228,C,PTSD,,26,,PE + paroxetine,Prolonged Exposure (PE) + paroxetine,Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,57,Structured Clinical Interview,SCID,SCID-1 P/R Module,Completer,,"Hierarchical linear model for change in mean scores, chi-square and t-test for diagnostic change",Assessment at ≥12 Months,52,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SCID,,Additional definitions of Diagnostic Change reported in the study,,,,Community,,,1,0.2368,,0.7632,Accidents,,High,"Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.",45183,2019
popiel2015_SCID_C_52_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,228,C,PTSD,,49,,PE + paroxetine,Prolonged Exposure (PE) + paroxetine,Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,57,Structured Clinical Interview,SCID,SCID-1 P/R Module,ITT,Generalized linear mixed model with no imputation of data,"Hierarchical linear model for change in mean scores, chi-square and t-test for diagnostic change",Assessment at ≥12 Months,52,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to SCID,,Additional definitions of Diagnostic Change reported in the study,,,,Community,,,1,0.2368,,0.7632,Accidents,,High,"Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.",45183,2019
popiel2015_SCID_C_Baseline_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,228,C,PTSD,,57,,PE + paroxetine,Prolonged Exposure (PE) + paroxetine,Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,57,Structured Clinical Interview,SCID,SCID-1 P/R Module,,,"Hierarchical linear model for change in mean scores, chi-square and t-test for diagnostic change",Baseline,,,11.8,2.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.2368,,0.7632,Accidents,,High,"Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.",45183,2019
possemato2016_PCL_A_0_ITT,Other mixed,PTSD,20,A,PTSD,,10,,PTSD Coach mobile application with clinician support,PTSD Coach mobile application,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,10,Self report,PCL,PCL,ITT,Imputation,"ANOVA for change in mean score, chi-square test for clinically meaningful change",End of Treatment,0,,40,10.9,,,,,-11,,,,,Cohen's d,1.4,,,,p≤0.01,,,,,,,,,,,Decrease in PCL ≥10 points,0.7,,Veteran,0,1,0,0.05,,0.95,Other (military-related),,High,"Possemato K, Kuhn E, Johnson E, et al. Using PTSD Coach in primary care with and without clinician support: a pilot randomized controlled trial. General hospital psychiatry. 2016 Jan-Feb;38:94-8. doi: 10.1016/j.genhosppsych.2015.09.005. PMID: 26589765.",44682,2019
possemato2016_PCL_A_Baseline_ITT,Other mixed,PTSD,20,A,PTSD,,10,,PTSD Coach mobile application with clinician support,PTSD Coach mobile application,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,10,Self report,PCL,PCL,ITT,Imputation,"ANOVA for change in mean score, chi-square test for clinically meaningful change",Baseline,,,51,7.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.05,,0.95,Other (military-related),,High,"Possemato K, Kuhn E, Johnson E, et al. Using PTSD Coach in primary care with and without clinician support: a pilot randomized controlled trial. General hospital psychiatry. 2016 Jan-Feb;38:94-8. doi: 10.1016/j.genhosppsych.2015.09.005. PMID: 26589765.",44682,2019
possemato2016_PCL_B_0_ITT,Other mixed,PTSD,20,B,PTSD,,10,,PTSD Coach mobile application without clinician support,PTSD Coach mobile application,No,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Alone,10,Self report,PCL,PCL,ITT,Imputation,"ANOVA for change in mean score, chi-square test for clinically meaningful change",End of Treatment,0,,49.8,18.1,,,,,-6.2,,,,,Cohen's d,0.41,,,,p=0.02,,,,,,,,,,,Decrease in PCL ≥10 points,0.375,,Veteran,0,1,0,0.05,,0.95,Other (military-related),,High,"Possemato K, Kuhn E, Johnson E, et al. Using PTSD Coach in primary care with and without clinician support: a pilot randomized controlled trial. General hospital psychiatry. 2016 Jan-Feb;38:94-8. doi: 10.1016/j.genhosppsych.2015.09.005. PMID: 26589765.",44682,2019
possemato2016_PCL_B_Baseline_ITT,Other mixed,PTSD,20,B,PTSD,,10,,PTSD Coach mobile application without clinician support,PTSD Coach mobile application,No,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Alone,10,Self report,PCL,PCL,ITT,Imputation,"ANOVA for change in mean score, chi-square test for clinically meaningful change",Baseline,,,56,15.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.05,,0.95,Other (military-related),,High,"Possemato K, Kuhn E, Johnson E, et al. Using PTSD Coach in primary care with and without clinician support: a pilot randomized controlled trial. General hospital psychiatry. 2016 Jan-Feb;38:94-8. doi: 10.1016/j.genhosppsych.2015.09.005. PMID: 26589765.",44682,2019
power2002_IES_A_0_NA,Psychotherapy,PTSD,105,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,39,Self report,IES,IES,,,"Factorial ANOVA and Scheffe's test for change in mean score, chi-square test for clinically meaningful response",End of Treatment,0,,11.8,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4167,completers only,0.5833,Mixed,"accidents, rape/sexual assault, community/school violence, other (traumatic death, not specified)",High,"Power K, McGoldrick T, Brown K, et al. A controlled comparison of Eye Movement Desensitization and Reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post‚Äö√Ñ√™traumatic stress disorder. Clin Psychol Psychother. 2002 Sep/Oct;9(5):299-318. doi: 10.1002/cpp.341.
.",25144,2019
power2002_IES_A_Baseline_NA,Psychotherapy,PTSD,105,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,39,Self report,IES,IES,,,"Factorial ANOVA and Scheffe's test for change in mean score, chi-square test for clinically meaningful response",Baseline,,,35.1,4.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4167,completers only,0.5833,Mixed,"accidents, rape/sexual assault, community/school violence, other (traumatic death, not specified)",High,"Power K, McGoldrick T, Brown K, et al. A controlled comparison of Eye Movement Desensitization and Reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post‚Äö√Ñ√™traumatic stress disorder. Clin Psychol Psychother. 2002 Sep/Oct;9(5):299-318. doi: 10.1002/cpp.341.
.",25144,2019
power2002_IES_B_0_NA,Psychotherapy,PTSD,105,B,PTSD,,,,Exposure + cognitive restructuring,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Self report,IES,IES,,,"Factorial ANOVA and Scheffe's test for change in mean score, chi-square test for clinically meaningful response",End of Treatment,0,,19.2,12.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4167,completers only,0.5833,Mixed,"accidents, rape/sexual assault, community/school violence, other (traumatic death, not specified)",High,"Power K, McGoldrick T, Brown K, et al. A controlled comparison of Eye Movement Desensitization and Reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post‚Äö√Ñ√™traumatic stress disorder. Clin Psychol Psychother. 2002 Sep/Oct;9(5):299-318. doi: 10.1002/cpp.341.
.",25144,2019
power2002_IES_B_Baseline_NA,Psychotherapy,PTSD,105,B,PTSD,,,,Exposure + cognitive restructuring,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Self report,IES,IES,,,"Factorial ANOVA and Scheffe's test for change in mean score, chi-square test for clinically meaningful response",Baseline,,,32.7,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4167,completers only,0.5833,Mixed,"accidents, rape/sexual assault, community/school violence, other (traumatic death, not specified)",High,"Power K, McGoldrick T, Brown K, et al. A controlled comparison of Eye Movement Desensitization and Reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post‚Äö√Ñ√™traumatic stress disorder. Clin Psychol Psychother. 2002 Sep/Oct;9(5):299-318. doi: 10.1002/cpp.341.
.",25144,2019
power2002_IES_C_0_NA,Psychotherapy,PTSD,105,C,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,29,Self report,IES,IES,,,"Factorial ANOVA and Scheffe's test for change in mean score, chi-square test for clinically meaningful response",End of Treatment,0,,29.6,8.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4167,completers only,0.5833,Mixed,"accidents, rape/sexual assault, community/school violence, other (traumatic death, not specified)",High,"Power K, McGoldrick T, Brown K, et al. A controlled comparison of Eye Movement Desensitization and Reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post‚Äö√Ñ√™traumatic stress disorder. Clin Psychol Psychother. 2002 Sep/Oct;9(5):299-318. doi: 10.1002/cpp.341.
.",25144,2019
power2002_IES_C_Baseline_NA,Psychotherapy,PTSD,105,C,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,29,Self report,IES,IES,,,"Factorial ANOVA and Scheffe's test for change in mean score, chi-square test for clinically meaningful response",Baseline,,,32.6,6.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4167,completers only,0.5833,Mixed,"accidents, rape/sexual assault, community/school violence, other (traumatic death, not specified)",High,"Power K, McGoldrick T, Brown K, et al. A controlled comparison of Eye Movement Desensitization and Reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post‚Äö√Ñ√™traumatic stress disorder. Clin Psychol Psychother. 2002 Sep/Oct;9(5):299-318. doi: 10.1002/cpp.341.
.",25144,2019
power2002_SI-PTSD_A_0_Comp,Psychotherapy,PTSD,105,A,PTSD,,27,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,39,Structured Clinical Interview,SI-PTSD,SI-PTSD self-report,Completer,,"Factorial ANOVA and Scheffe's test for change in mean score, chi-square test for clinically meaningful response",End of Treatment,0,,16.8,17.2,,,,,-33.8,,,,,Glass' delta,1.8,,,,p<0.001,,,,,,,,,,,≥2 standard deviations from pre-treatment self-reported SI-PTSD mean of dysfunctional population in the direction of functionality,0.6667,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.4167,completers only,0.5833,Mixed,"accidents, rape/sexual assault, community/school violence, other (traumatic death, not specified)",High,"Power K, McGoldrick T, Brown K, et al. A controlled comparison of Eye Movement Desensitization and Reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post‚Äö√Ñ√™traumatic stress disorder. Clin Psychol Psychother. 2002 Sep/Oct;9(5):299-318. doi: 10.1002/cpp.341.
.",25144,2019
power2002_SI-PTSD_A_65_Comp,Psychotherapy,PTSD,105,A,PTSD,,22,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,39,Structured Clinical Interview,SI-PTSD,SI-PTSD self-report,Completer,,"Factorial ANOVA and Scheffe's test for change in mean score, chi-square test for clinically meaningful response",Assessment at ≥12 Months,65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,≥2 standard deviations from pre-treatment self-reported SI-PTSD mean of dysfunctional population in the direction of functionality,0.4091,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.4167,completers only,0.5833,Mixed,"accidents, rape/sexual assault, community/school violence, other (traumatic death, not specified)",High,"Power K, McGoldrick T, Brown K, et al. A controlled comparison of Eye Movement Desensitization and Reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post‚Äö√Ñ√™traumatic stress disorder. Clin Psychol Psychother. 2002 Sep/Oct;9(5):299-318. doi: 10.1002/cpp.341.
.",25144,2019
power2002_SI-PTSD_A_Baseline_Comp,Psychotherapy,PTSD,105,A,PTSD,,39,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,39,Structured Clinical Interview,SI-PTSD,SI-PTSD self-report,Completer,,"Factorial ANOVA and Scheffe's test for change in mean score, chi-square test for clinically meaningful response",Baseline,,,50.6,8.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4167,completers only,0.5833,Mixed,"accidents, rape/sexual assault, community/school violence, other (traumatic death, not specified)",High,"Power K, McGoldrick T, Brown K, et al. A controlled comparison of Eye Movement Desensitization and Reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post‚Äö√Ñ√™traumatic stress disorder. Clin Psychol Psychother. 2002 Sep/Oct;9(5):299-318. doi: 10.1002/cpp.341.
.",25144,2019
power2002_SI-PTSD_B_0_Comp,Psychotherapy,PTSD,105,B,PTSD,,21,,Exposure + cognitive restructuring,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Structured Clinical Interview,SI-PTSD,SI-PTSD self-report,Completer,,"Factorial ANOVA and Scheffe's test for change in mean score, chi-square test for clinically meaningful response",End of Treatment,0,,25.9,17.9,,,,,-20.7,,,,,Glass' delta,1.2,,,,p<0.001,,,,,,,,,,,≥2 standard deviations from pre-treatment self-reported SI-PTSD mean of dysfunctional population in the direction of functionality,0.5238,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.4167,completers only,0.5833,Mixed,"accidents, rape/sexual assault, community/school violence, other (traumatic death, not specified)",High,"Power K, McGoldrick T, Brown K, et al. A controlled comparison of Eye Movement Desensitization and Reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post‚Äö√Ñ√™traumatic stress disorder. Clin Psychol Psychother. 2002 Sep/Oct;9(5):299-318. doi: 10.1002/cpp.341.
.",25144,2019
power2002_SI-PTSD_B_65_Comp,Psychotherapy,PTSD,105,B,PTSD,,17,,Exposure + cognitive restructuring,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Structured Clinical Interview,SI-PTSD,SI-PTSD self-report,Completer,,"Factorial ANOVA and Scheffe's test for change in mean score, chi-square test for clinically meaningful response",Assessment at ≥12 Months,65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,≥2 standard deviations from pre-treatment self-reported SI-PTSD mean of dysfunctional population in the direction of functionality,0.2941,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.4167,completers only,0.5833,Mixed,"accidents, rape/sexual assault, community/school violence, other (traumatic death, not specified)",High,"Power K, McGoldrick T, Brown K, et al. A controlled comparison of Eye Movement Desensitization and Reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post‚Äö√Ñ√™traumatic stress disorder. Clin Psychol Psychother. 2002 Sep/Oct;9(5):299-318. doi: 10.1002/cpp.341.
.",25144,2019
power2002_SI-PTSD_B_Baseline_Comp,Psychotherapy,PTSD,105,B,PTSD,,37,,Exposure + cognitive restructuring,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Structured Clinical Interview,SI-PTSD,SI-PTSD self-report,Completer,,"Factorial ANOVA and Scheffe's test for change in mean score, chi-square test for clinically meaningful response",Baseline,,,46.6,9.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4167,completers only,0.5833,Mixed,"accidents, rape/sexual assault, community/school violence, other (traumatic death, not specified)",High,"Power K, McGoldrick T, Brown K, et al. A controlled comparison of Eye Movement Desensitization and Reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post‚Äö√Ñ√™traumatic stress disorder. Clin Psychol Psychother. 2002 Sep/Oct;9(5):299-318. doi: 10.1002/cpp.341.
.",25144,2019
power2002_SI-PTSD_C_0_Comp,Psychotherapy,PTSD,105,C,Control,,24,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,29,Structured Clinical Interview,SI-PTSD,SI-PTSD self-report,Completer,,"Factorial ANOVA and Scheffe's test for change in mean score, chi-square test for clinically meaningful response",End of Treatment,0,,45.5,16.1,,,,,-2.4,,,,,,,,,,p=NS,,,,,,,,,,,≥2 standard deviations from pre-treatment self-reported SI-PTSD mean of dysfunctional population in the direction of functionality,0.0417,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.4167,completers only,0.5833,Mixed,"accidents, rape/sexual assault, community/school violence, other (traumatic death, not specified)",High,"Power K, McGoldrick T, Brown K, et al. A controlled comparison of Eye Movement Desensitization and Reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post‚Äö√Ñ√™traumatic stress disorder. Clin Psychol Psychother. 2002 Sep/Oct;9(5):299-318. doi: 10.1002/cpp.341.
.",25144,2019
power2002_SI-PTSD_C_Baseline_Comp,Psychotherapy,PTSD,105,C,Control,,29,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,29,Structured Clinical Interview,SI-PTSD,SI-PTSD self-report,Completer,,"Factorial ANOVA and Scheffe's test for change in mean score, chi-square test for clinically meaningful response",Baseline,,,47.9,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.4167,completers only,0.5833,Mixed,"accidents, rape/sexual assault, community/school violence, other (traumatic death, not specified)",High,"Power K, McGoldrick T, Brown K, et al. A controlled comparison of Eye Movement Desensitization and Reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post‚Äö√Ñ√™traumatic stress disorder. Clin Psychol Psychother. 2002 Sep/Oct;9(5):299-318. doi: 10.1002/cpp.341.
.",25144,2019
powers2015_PSS-I_A_0_Comp,Psychotherapy,PTSD,9,A,PTSD,,,,PE + exercise,Prolonged Exposure (PE) + exercise,Yes,TF,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,PSS-I,PSS-I,Completer,,No tests of statistical signficance due to small sample size; between-group effect sizes with Cohen's d,End of Treatment,0,,5.2,,,,,,-36.8,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8889,,0.1111,,,High,"Powers MB, Medina JL, Burns S, et al. Exercise augmentation of exposure therapy for PTSD: rationale and pilot efficacy data. Cogn Behav Ther. 2015;44(4):314-27. doi: 10.1080/16506073.2015.1012740. PMID: 25706090.",43517,2019
powers2015_PSS-I_A_Baseline_Comp,Psychotherapy,PTSD,9,A,PTSD,,,,PE + exercise,Prolonged Exposure (PE) + exercise,Yes,TF,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,PSS-I,PSS-I,Completer,,No tests of statistical signficance due to small sample size; between-group effect sizes with Cohen's d,Baseline,,,42,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8889,,0.1111,,,High,"Powers MB, Medina JL, Burns S, et al. Exercise augmentation of exposure therapy for PTSD: rationale and pilot efficacy data. Cogn Behav Ther. 2015;44(4):314-27. doi: 10.1080/16506073.2015.1012740. PMID: 25706090.",43517,2019
powers2015_PSS-I_B_0_Comp,Psychotherapy,PTSD,9,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,PSS-I,PSS-I,Completer,,No tests of statistical signficance due to small sample size; between-group effect sizes with Cohen's d,End of Treatment,0,,8.25,,,,,,-28.75,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8889,,0.1111,,,High,"Powers MB, Medina JL, Burns S, et al. Exercise augmentation of exposure therapy for PTSD: rationale and pilot efficacy data. Cogn Behav Ther. 2015;44(4):314-27. doi: 10.1080/16506073.2015.1012740. PMID: 25706090.",43517,2019
powers2015_PSS-I_B_Baseline_Comp,Psychotherapy,PTSD,9,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,PSS-I,PSS-I,Completer,,No tests of statistical signficance due to small sample size; between-group effect sizes with Cohen's d,Baseline,,,37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8889,,0.1111,,,High,"Powers MB, Medina JL, Burns S, et al. Exercise augmentation of exposure therapy for PTSD: rationale and pilot efficacy data. Cogn Behav Ther. 2015;44(4):314-27. doi: 10.1080/16506073.2015.1012740. PMID: 25706090.",43517,2019
quinones2015_PCL_A_0_Comp,Mixed: Psychotherapy & CIH,PTSD,100,A,PTSD,,48,,Yoga + supportive therapy,Yoga + supportive therapy,Yes,Non-TF,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Individual,In Person,50,Self report,PCL,PCL-C,Completer,No imputation (lost values did not exceed 5%),"T-test, Cohen's d for within-group change",End of Treatment,0,,38.84,14.91,,,,,-17.46,,,,,Cohen's d,1.15,,,,p<0.001,,,,,,,,,,,,,,Community,,,1,0.27,,0.73,Combat-related,,High,"Quinones N, Maquet YG, Velez DM, et al. Efficacy of a Satyananda yoga intervention for reintegrating adults diagnosed with posttraumatic stress disorder. Int J Yoga Therap. 2015;25(1):89-99. doi: 10.17761/1531-2054-25.1.89. PMID: 26667292.",44694,2019
quinones2015_PCL_A_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,100,A,PTSD,,50,,Yoga + supportive therapy,Yoga + supportive therapy,Yes,Non-TF,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Individual,In Person,50,Self report,PCL,PCL-C,Completer,No imputation (lost values did not exceed 5%),"T-test, Cohen's d for within-group change",Baseline,,,56.3,15.48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.27,,0.73,Combat-related,,High,"Quinones N, Maquet YG, Velez DM, et al. Efficacy of a Satyananda yoga intervention for reintegrating adults diagnosed with posttraumatic stress disorder. Int J Yoga Therap. 2015;25(1):89-99. doi: 10.17761/1531-2054-25.1.89. PMID: 26667292.",44694,2019
quinones2015_PCL_B_0_Comp,Mixed: Psychotherapy & CIH,PTSD,100,B,Control,,42,,Waitlist + supportive therapy,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,50,Self report,PCL,PCL-C,Completer,No imputation (lost values did not exceed 5%),"T-test, Cohen's d for within-group change",End of Treatment,0,,48.26,14.1,,,,,-6.64,,,,,Cohen's d,0.42,,,,p<0.005,,,,,,,,,,,,,,Community,,,1,0.27,,0.73,Combat-related,,High,"Quinones N, Maquet YG, Velez DM, et al. Efficacy of a Satyananda yoga intervention for reintegrating adults diagnosed with posttraumatic stress disorder. Int J Yoga Therap. 2015;25(1):89-99. doi: 10.17761/1531-2054-25.1.89. PMID: 26667292.",44694,2019
quinones2015_PCL_B_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,100,B,Control,,50,,Waitlist + supportive therapy,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,50,Self report,PCL,PCL-C,Completer,No imputation (lost values did not exceed 5%),"T-test, Cohen's d for within-group change",Baseline,,,54.9,17.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.27,,0.73,Combat-related,,High,"Quinones N, Maquet YG, Velez DM, et al. Efficacy of a Satyananda yoga intervention for reintegrating adults diagnosed with posttraumatic stress disorder. Int J Yoga Therap. 2015;25(1):89-99. doi: 10.17761/1531-2054-25.1.89. PMID: 26667292.",44694,2019
raeolmsted2019_CAPS_A_0_Comp,Nonpharmacologic biological,PTSD,113,A,PTSD,,74,,SGB,Stellate ganglion block (SGB),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,74,Structured Clinical Interview,CAPS,CAPS-5 for DSM-5,Completer,Missing data treated as missing atr andom for all analyses. Multiple imputation used for CAPS outcomes.,"T-test, Cohen's d for within-group change",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,No longer meeting CAPS-5 criteria for PTSD diagnosis at 8-week follow-up (among those meeting criteria at baseline),,,Ten-point change in CAPS score from baseline to week 8,,,Active Duty Military,1,0,0,0.115,,0.885,,,Medium,"Rae Olmsted KL, Bartoszek M, Mulvaney S, et al. Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial. JAMA Psychiatry. 2019 Nov 6:1-9. doi: https://dx.doi.org/10.1001/jamapsychiatry.2019.3474. PMID: 31693083.",,2020
raeolmsted2019_CAPS_A_8_Comp,Nonpharmacologic biological,PTSD,113,A,PTSD,,71,,SGB,Stellate ganglion block (SGB),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,74,Structured Clinical Interview,CAPS,CAPS-5 for DSM-5,Completer,Missing data treated as missing atr andom for all analyses. Multiple imputation used for CAPS outcomes.,"T-test, Cohen's d for within-group change",Assessment at <3 Months,8,,25.67,14.13,,,,,-12.16,12.86,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.115,,0.885,,,Medium,"Rae Olmsted KL, Bartoszek M, Mulvaney S, et al. Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial. JAMA Psychiatry. 2019 Nov 6:1-9. doi: https://dx.doi.org/10.1001/jamapsychiatry.2019.3474. PMID: 31693083.",,2020
raeolmsted2019_CAPS_A_Baseline_Comp,Nonpharmacologic biological,PTSD,113,A,PTSD,,74,,SGB,Stellate ganglion block (SGB),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,74,Structured Clinical Interview,CAPS,CAPS-5 for DSM-5,Completer,Missing data treated as missing atr andom for all analyses. Multiple imputation used for CAPS outcomes.,"T-test, Cohen's d for within-group change",Baseline,,,37.61,11.13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.115,,0.885,,,Medium,"Rae Olmsted KL, Bartoszek M, Mulvaney S, et al. Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial. JAMA Psychiatry. 2019 Nov 6:1-9. doi: https://dx.doi.org/10.1001/jamapsychiatry.2019.3474. PMID: 31693083.",,2020
raeolmsted2019_CAPS_B_0_Comp,Nonpharmacologic biological,PTSD,113,B,Control,,39,,Sham SGB,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,39,Structured Clinical Interview,CAPS,CAPS-5 for DSM-5,Completer,Missing data treated as missing atr andom for all analyses. Multiple imputation used for CAPS outcomes.,"T-test, Cohen's d for within-group change",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.115,,0.885,,,Medium,"Rae Olmsted KL, Bartoszek M, Mulvaney S, et al. Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial. JAMA Psychiatry. 2019 Nov 6:1-9. doi: https://dx.doi.org/10.1001/jamapsychiatry.2019.3474. PMID: 31693083.",,2020
raeolmsted2019_CAPS_B_8_Comp,Nonpharmacologic biological,PTSD,113,B,Control,,37,,Sham SGB,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,39,Structured Clinical Interview,CAPS,CAPS-5 for DSM-5,Completer,Missing data treated as missing atr andom for all analyses. Multiple imputation used for CAPS outcomes.,"T-test, Cohen's d for within-group change",Assessment at <3 Months,8,,33.68,15.6,,,,,-5.79,8.19,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.115,,0.885,,,Medium,"Rae Olmsted KL, Bartoszek M, Mulvaney S, et al. Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial. JAMA Psychiatry. 2019 Nov 6:1-9. doi: https://dx.doi.org/10.1001/jamapsychiatry.2019.3474. PMID: 31693083.",,2020
raeolmsted2019_CAPS_B_Baseline_Comp,Nonpharmacologic biological,PTSD,113,B,Control,,39,,Sham SGB,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,39,Structured Clinical Interview,CAPS,CAPS-5 for DSM-5,Completer,Missing data treated as missing atr andom for all analyses. Multiple imputation used for CAPS outcomes.,"T-test, Cohen's d for within-group change",Baseline,,,39.82,14.23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.115,,0.885,,,Medium,"Rae Olmsted KL, Bartoszek M, Mulvaney S, et al. Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial. JAMA Psychiatry. 2019 Nov 6:1-9. doi: https://dx.doi.org/10.1001/jamapsychiatry.2019.3474. PMID: 31693083.",,2020
raeolmsted2019_PCL-5_A_8_Comp,Nonpharmacologic biological,PTSD,113,A,PTSD,,,,SGB,Stellate ganglion block (SGB),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,74,Self report,PCL,PCL-5 for DSM-5,Completer,Missing data treated as missing atr andom for all analyses. Multiple imputation used for CAPS outcomes.,"T-test, Cohen's d for within-group change",Assessment at <3 Months,8,,29.49,19.29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.115,,0.885,,,Medium,"Rae Olmsted KL, Bartoszek M, Mulvaney S, et al. Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial. JAMA Psychiatry. 2019 Nov 6:1-9. doi: https://dx.doi.org/10.1001/jamapsychiatry.2019.3474. PMID: 31693083.",,2020
raeolmsted2019_PCL-5_A_Baseline_Comp,Nonpharmacologic biological,PTSD,113,A,PTSD,,,,SGB,Stellate ganglion block (SGB),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,74,Self report,PCL,PCL-5 for DSM-5,Completer,Missing data treated as missing atr andom for all analyses. Multiple imputation used for CAPS outcomes.,"T-test, Cohen's d for within-group change",Baseline,,,41.54,14.03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.115,,0.885,,,Medium,"Rae Olmsted KL, Bartoszek M, Mulvaney S, et al. Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial. JAMA Psychiatry. 2019 Nov 6:1-9. doi: https://dx.doi.org/10.1001/jamapsychiatry.2019.3474. PMID: 31693083.",,2020
raeolmsted2019_PCL-5_B_8_Comp,Nonpharmacologic biological,PTSD,113,B,Control,,,,Sham SGB,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,39,Self report,PCL,PCL-5 for DSM-5,Completer,Missing data treated as missing atr andom for all analyses. Multiple imputation used for CAPS outcomes.,"T-test, Cohen's d for within-group change",Assessment at <3 Months,8,,38.11,18.23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.115,,0.885,,,Medium,"Rae Olmsted KL, Bartoszek M, Mulvaney S, et al. Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial. JAMA Psychiatry. 2019 Nov 6:1-9. doi: https://dx.doi.org/10.1001/jamapsychiatry.2019.3474. PMID: 31693083.",,2020
raeolmsted2019_PCL-5_B_Baseline_Comp,Nonpharmacologic biological,PTSD,113,B,Control,,,,Sham SGB,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,39,Self report,PCL,PCL-5 for DSM-5,Completer,Missing data treated as missing atr andom for all analyses. Multiple imputation used for CAPS outcomes.,"T-test, Cohen's d for within-group change",Baseline,,,43.23,18.13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.115,,0.885,,,Medium,"Rae Olmsted KL, Bartoszek M, Mulvaney S, et al. Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial. JAMA Psychiatry. 2019 Nov 6:1-9. doi: https://dx.doi.org/10.1001/jamapsychiatry.2019.3474. PMID: 31693083.",,2020
raeolmsted2019_PCL-C_A_8_Comp,Nonpharmacologic biological,PTSD,113,A,PTSD,,,,SGB,Stellate ganglion block (SGB),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,74,Self report,PCL,PCL-C-IV,Completer,Missing data treated as missing atr andom for all analyses. Multiple imputation used for CAPS outcomes.,"T-test, Cohen's d for within-group change",Assessment at <3 Months,8,,42.41,17.47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.115,,0.885,,,Medium,"Rae Olmsted KL, Bartoszek M, Mulvaney S, et al. Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial. JAMA Psychiatry. 2019 Nov 6:1-9. doi: https://dx.doi.org/10.1001/jamapsychiatry.2019.3474. PMID: 31693083.",,2020
raeolmsted2019_PCL-C_A_Baseline_Comp,Nonpharmacologic biological,PTSD,113,A,PTSD,,,,SGB,Stellate ganglion block (SGB),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,74,Self report,PCL,PCL-C-IV,Completer,Missing data treated as missing atr andom for all analyses. Multiple imputation used for CAPS outcomes.,"T-test, Cohen's d for within-group change",Baseline,,,53.30,13.64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.115,,0.885,,,Medium,"Rae Olmsted KL, Bartoszek M, Mulvaney S, et al. Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial. JAMA Psychiatry. 2019 Nov 6:1-9. doi: https://dx.doi.org/10.1001/jamapsychiatry.2019.3474. PMID: 31693083.",,2020
raeolmsted2019_PCL-C_B_8_Comp,Nonpharmacologic biological,PTSD,113,B,Control,,,,Sham SGB,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,39,Self report,PCL,PCL-C-IV,Completer,Missing data treated as missing atr andom for all analyses. Multiple imputation used for CAPS outcomes.,"T-test, Cohen's d for within-group change",Assessment at <3 Months,8,,50.65,17.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.115,,0.885,,,Medium,"Rae Olmsted KL, Bartoszek M, Mulvaney S, et al. Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial. JAMA Psychiatry. 2019 Nov 6:1-9. doi: https://dx.doi.org/10.1001/jamapsychiatry.2019.3474. PMID: 31693083.",,2020
raeolmsted2019_PCL-C_B_Baseline_Comp,Nonpharmacologic biological,PTSD,113,B,Control,,,,Sham SGB,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,39,Self report,PCL,PCL-C-IV,Completer,Missing data treated as missing atr andom for all analyses. Multiple imputation used for CAPS outcomes.,"T-test, Cohen's d for within-group change",Baseline,,,54.95,15.67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.115,,0.885,,,Medium,"Rae Olmsted KL, Bartoszek M, Mulvaney S, et al. Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial. JAMA Psychiatry. 2019 Nov 6:1-9. doi: https://dx.doi.org/10.1001/jamapsychiatry.2019.3474. PMID: 31693083.",,2020
ramaswamy2016_CAPS_A_0_Comp,Pharmacotherapy,PTSD,30,A,PTSD,,12,,Ziprasidone,Ziprasidone,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Structured Clinical Interview,CAPS,CAPS,Completer,Mixed effects models,"T-test, Cohen's d for within-group change",End of Treatment,0,,51.7,8.4,,,,,-28.2,,,,,,,,,,,,,,,,,,,,,≥50% improvement on total CAPS score,0.5,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.8667,,0.1333,Mixed,"rape/sexual assault, community/school violence, other (not specified)",High,"Ramaswamy S, Driscoll D, Smith LM, et al. Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder. Contemp Clin Trials Commun. 2016 Dec;2:1-5. doi: 10.1016/j.conctc.2015.12.003. PMID: 29736440.",1551835,2019
ramaswamy2016_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,30,A,PTSD,,15,,Ziprasidone,Ziprasidone,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Structured Clinical Interview,CAPS,CAPS,Completer,Mixed effects models,"T-test, Cohen's d for within-group change",Baseline,,,79.9,4.6,,,,,,,,,,,,,,,,,,,,,,,,,,≥50% improvement on total CAPS score,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.8667,,0.1333,Mixed,"rape/sexual assault, community/school violence, other (not specified)",High,"Ramaswamy S, Driscoll D, Smith LM, et al. Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder. Contemp Clin Trials Commun. 2016 Dec;2:1-5. doi: 10.1016/j.conctc.2015.12.003. PMID: 29736440.",1551835,2019
ramaswamy2016_CAPS_B_0_Comp,Pharmacotherapy,PTSD,30,B,Control,,13,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,15,Structured Clinical Interview,CAPS,CAPS,Completer,Mixed effects models,"T-test, Cohen's d for within-group change",End of Treatment,0,,53.1,8.3,,,,,-22.3,,,,,,,,,,,,,,,,,,,,,≥50% improvement on total CAPS score,0.5385,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.8667,,0.1333,Mixed,"rape/sexual assault, community/school violence, other (not specified)",High,"Ramaswamy S, Driscoll D, Smith LM, et al. Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder. Contemp Clin Trials Commun. 2016 Dec;2:1-5. doi: 10.1016/j.conctc.2015.12.003. PMID: 29736440.",1551835,2019
ramaswamy2016_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,30,B,Control,,15,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,15,Structured Clinical Interview,CAPS,CAPS,Completer,Mixed effects models,"T-test, Cohen's d for within-group change",Baseline,,,74.5,4.6,,,,,,,,,,,,,,,,,,,,,,,,,,≥50% improvement on total CAPS score,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.8667,,0.1333,Mixed,"rape/sexual assault, community/school violence, other (not specified)",High,"Ramaswamy S, Driscoll D, Smith LM, et al. Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder. Contemp Clin Trials Commun. 2016 Dec;2:1-5. doi: 10.1016/j.conctc.2015.12.003. PMID: 29736440.",1551835,2019
ramaswamy2016_TOP-8_A_0_NA,Pharmacotherapy,PTSD,30,A,PTSD,,,,Ziprasidone,Ziprasidone,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Structured Clinical Interview,TOP-8,TOP-8,,,"T-test, Cohen's d for within-group change",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8667,,0.1333,Mixed,"rape/sexual assault, community/school violence, other (not specified)",High,"Ramaswamy S, Driscoll D, Smith LM, et al. Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder. Contemp Clin Trials Commun. 2016 Dec;2:1-5. doi: 10.1016/j.conctc.2015.12.003. PMID: 29736440.",1551835,2019
ramaswamy2016_TOP-8_A_Baseline_NA,Pharmacotherapy,PTSD,30,A,PTSD,,,,Ziprasidone,Ziprasidone,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Structured Clinical Interview,TOP-8,TOP-8,,,"T-test, Cohen's d for within-group change",Baseline,,,20.0,5.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8667,,0.1333,Mixed,"rape/sexual assault, community/school violence, other (not specified)",High,"Ramaswamy S, Driscoll D, Smith LM, et al. Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder. Contemp Clin Trials Commun. 2016 Dec;2:1-5. doi: 10.1016/j.conctc.2015.12.003. PMID: 29736440.",1551835,2019
ramaswamy2016_TOP-8_B_0_NA,Pharmacotherapy,PTSD,30,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,15,Structured Clinical Interview,TOP-8,TOP-8,,,"T-test, Cohen's d for within-group change",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8667,,0.1333,Mixed,"rape/sexual assault, community/school violence, other (not specified)",High,"Ramaswamy S, Driscoll D, Smith LM, et al. Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder. Contemp Clin Trials Commun. 2016 Dec;2:1-5. doi: 10.1016/j.conctc.2015.12.003. PMID: 29736440.",1551835,2019
ramaswamy2016_TOP-8_B_Baseline_NA,Pharmacotherapy,PTSD,30,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,15,Structured Clinical Interview,TOP-8,TOP-8,,,"T-test, Cohen's d for within-group change",Baseline,,,18.7,4.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8667,,0.1333,Mixed,"rape/sexual assault, community/school violence, other (not specified)",High,"Ramaswamy S, Driscoll D, Smith LM, et al. Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder. Contemp Clin Trials Commun. 2016 Dec;2:1-5. doi: 10.1016/j.conctc.2015.12.003. PMID: 29736440.",1551835,2019
ramaswamy2017_CAPS_A_0_Comp,Pharmacotherapy,PTSD,59,A,PTSD,,25,,Vilazodone,Vilazodone,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,Completer,,"T-test, Cohen's d for within-group change",End of Treatment,0,,57.9,,SE,5.7,,SE 4.4,-17.8,,,,,,,,,,p<0.01,,,,,,,,,,,,,,Veteran,0,1,0,0.0339,,0.9661,Combat-related,,Medium,"Ramaswamy S, Driscoll D, Reist C, et al. A double-blind, placebo-controlled randomized trial of vilazodone in the treatment of posttraumatic stress disorder and comorbid depression. Prim Care Companion CNS Disord. 2017 Aug 24;19(4):17m02138. doi: 10.4088/PCC.17m02138. PMID: 28858440.",49046,2019
ramaswamy2017_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,59,A,PTSD,,29,,Vilazodone,Vilazodone,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,Completer,,"T-test, Cohen's d for within-group change",Baseline,,,75.3,,SE,2.6,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0339,,0.9661,Combat-related,,Medium,"Ramaswamy S, Driscoll D, Reist C, et al. A double-blind, placebo-controlled randomized trial of vilazodone in the treatment of posttraumatic stress disorder and comorbid depression. Prim Care Companion CNS Disord. 2017 Aug 24;19(4):17m02138. doi: 10.4088/PCC.17m02138. PMID: 28858440.",49046,2019
ramaswamy2017_CAPS_B_0_Comp,Pharmacotherapy,PTSD,59,B,Control,,22,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,Completer,,"T-test, Cohen's d for within-group change",End of Treatment,0,,58.0,,SE,4.4,,SE 4.7,-15.1,,,,,,,,,,p<0.01,,,,,,,,,,,,,,Veteran,0,1,0,0.0339,,0.9661,Combat-related,,Medium,"Ramaswamy S, Driscoll D, Reist C, et al. A double-blind, placebo-controlled randomized trial of vilazodone in the treatment of posttraumatic stress disorder and comorbid depression. Prim Care Companion CNS Disord. 2017 Aug 24;19(4):17m02138. doi: 10.4088/PCC.17m02138. PMID: 28858440.",49046,2019
ramaswamy2017_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,59,B,Control,,30,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,Completer,,"T-test, Cohen's d for within-group change",Baseline,,,75.6,,SE,2.4,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0339,,0.9661,Combat-related,,Medium,"Ramaswamy S, Driscoll D, Reist C, et al. A double-blind, placebo-controlled randomized trial of vilazodone in the treatment of posttraumatic stress disorder and comorbid depression. Prim Care Companion CNS Disord. 2017 Aug 24;19(4):17m02138. doi: 10.4088/PCC.17m02138. PMID: 28858440.",49046,2019
ramaswamy2017_PSS-SR_A_0_NA,Pharmacotherapy,PTSD,59,A,PTSD,,,,Vilazodone,Vilazodone,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Structured Clinical Interview,PSS-SR,PSS-SR,,,"T-test, Cohen's d for within-group change",End of Treatment,0,,24.0,,SE,3,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0339,,0.9661,Combat-related,,Medium,"Ramaswamy S, Driscoll D, Reist C, et al. A double-blind, placebo-controlled randomized trial of vilazodone in the treatment of posttraumatic stress disorder and comorbid depression. Prim Care Companion CNS Disord. 2017 Aug 24;19(4):17m02138. doi: 10.4088/PCC.17m02138. PMID: 28858440.",49046,2019
ramaswamy2017_PSS-SR_A_Baseline_NA,Pharmacotherapy,PTSD,59,A,PTSD,,,,Vilazodone,Vilazodone,No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Structured Clinical Interview,PSS-SR,PSS-SR,,,"T-test, Cohen's d for within-group change",Baseline,,,30.0,,SE,1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0339,,0.9661,Combat-related,,Medium,"Ramaswamy S, Driscoll D, Reist C, et al. A double-blind, placebo-controlled randomized trial of vilazodone in the treatment of posttraumatic stress disorder and comorbid depression. Prim Care Companion CNS Disord. 2017 Aug 24;19(4):17m02138. doi: 10.4088/PCC.17m02138. PMID: 28858440.",49046,2019
ramaswamy2017_PSS-SR_B_0_NA,Pharmacotherapy,PTSD,59,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,30,Structured Clinical Interview,PSS-SR,PSS-SR,,,"T-test, Cohen's d for within-group change",End of Treatment,0,,27.3,,SE,2.4,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0339,,0.9661,Combat-related,,Medium,"Ramaswamy S, Driscoll D, Reist C, et al. A double-blind, placebo-controlled randomized trial of vilazodone in the treatment of posttraumatic stress disorder and comorbid depression. Prim Care Companion CNS Disord. 2017 Aug 24;19(4):17m02138. doi: 10.4088/PCC.17m02138. PMID: 28858440.",49046,2019
ramaswamy2017_PSS-SR_B_Baseline_NA,Pharmacotherapy,PTSD,59,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,30,Structured Clinical Interview,PSS-SR,PSS-SR,,,"T-test, Cohen's d for within-group change",Baseline,,,32.1,,SE,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0339,,0.9661,Combat-related,,Medium,"Ramaswamy S, Driscoll D, Reist C, et al. A double-blind, placebo-controlled randomized trial of vilazodone in the treatment of posttraumatic stress disorder and comorbid depression. Prim Care Companion CNS Disord. 2017 Aug 24;19(4):17m02138. doi: 10.4088/PCC.17m02138. PMID: 28858440.",49046,2019
raskind2003_CAPS_A_0_ITT,Pharmacotherapy,PTSD,10,A,PTSD,,10,,Prazosin,Prazosin,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"T-test, Cohen's d for within-group change",End of Treatment,0,,57.3,32.3,,,,,-21.8,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Raskind MA, Peskind ER, Kanter ED, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry. 2003 Feb;160(2):371-3. doi: 10.1176/appi.ajp.160.2.371. PMID: 12562588.",25442,2019
raskind2003_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,10,A,PTSD,,10,,Prazosin,Prazosin,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"T-test, Cohen's d for within-group change",Baseline,,,79.1,17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Raskind MA, Peskind ER, Kanter ED, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry. 2003 Feb;160(2):371-3. doi: 10.1176/appi.ajp.160.2.371. PMID: 12562588.",25442,2019
raskind2003_CAPS_B_0_ITT,Pharmacotherapy,PTSD,10,B,Control,,10,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"T-test, Cohen's d for within-group change",End of Treatment,0,,86.5,30,,,,,2.9,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Raskind MA, Peskind ER, Kanter ED, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry. 2003 Feb;160(2):371-3. doi: 10.1176/appi.ajp.160.2.371. PMID: 12562588.",25442,2019
raskind2003_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,10,B,Control,,10,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"T-test, Cohen's d for within-group change",Baseline,,,83.6,17.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Raskind MA, Peskind ER, Kanter ED, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry. 2003 Feb;160(2):371-3. doi: 10.1176/appi.ajp.160.2.371. PMID: 12562588.",25442,2019
raskind2007_CAPS_A_0_Comp,Pharmacotherapy,PTSD,40,A,PTSD,,17,,Prazosin,Prazosin,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF,"T-test, Cohen's d for within-group change",End of Treatment,0,,63,20,,,,,-13,,,,,,,,,,,,,,,,,,,,,CGI change score of 1 or 2,0.7059,,Veteran,0,1,0,0.05,,0.95,Combat-related,,Medium,"Raskind MA, Peskind ER, Hoff DJ, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007 Apr 15;61(8):928-34. doi: 10.1016/j.biopsych.2006.06.032. PMID: 17069768.",29403,2019
raskind2007_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,40,A,PTSD,,17,,Prazosin,Prazosin,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF,"T-test, Cohen's d for within-group change",Baseline,,,76,22,,,,,,,,,,,,,,,,,,,,,,,,,,CGI change score of 1 or 2,,,Veteran,0,1,0,0.05,,0.95,Combat-related,,Medium,"Raskind MA, Peskind ER, Hoff DJ, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007 Apr 15;61(8):928-34. doi: 10.1016/j.biopsych.2006.06.032. PMID: 17069768.",29403,2019
raskind2007_CAPS_B_0_Comp,Pharmacotherapy,PTSD,40,B,Control,,17,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF,"T-test, Cohen's d for within-group change",End of Treatment,0,,71,22,,,,,-7,,,,,,,,,,,,,,,,,,,,,CGI change score of 1 or 2,0.1176,,Veteran,0,1,0,0.05,,0.95,Combat-related,,Medium,"Raskind MA, Peskind ER, Hoff DJ, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007 Apr 15;61(8):928-34. doi: 10.1016/j.biopsych.2006.06.032. PMID: 17069768.",29403,2019
raskind2007_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,40,B,Control,,17,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF,"T-test, Cohen's d for within-group change",Baseline,,,78,18,,,,,,,,,,,,,,,,,,,,,,,,,,CGI change score of 1 or 2,,,Veteran,0,1,0,0.05,,0.95,Combat-related,,Medium,"Raskind MA, Peskind ER, Hoff DJ, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007 Apr 15;61(8):928-34. doi: 10.1016/j.biopsych.2006.06.032. PMID: 17069768.",29403,2019
raskind2013_CAPS_A_0_ITT,Pharmacotherapy,PTSD,67,A,PTSD,,23,,Prazosin,Prazosin,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,32,Structured Clinical Interview,CAPS,CAPS,ITT,Linear mixed-effects models,"T-test, Cohen's d for within-group change",End of Treatment,0,,52.2,,95% CI,43.8,60.5,,-25.1,,,,,,,,,,,,,,,,,,,,,CAPS score < 20,0.0938,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.9701,0.0299,0,0.1493,,0.8507,Combat-related,,Medium,"Raskind MA, Peterson K, Williams T, et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry. 2013 Sep;170(9):1003-10. doi: 10.1176/appi.ajp.2013.12081133. PMID: 23846759.",41028,2019
raskind2013_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,67,A,PTSD,,32,,Prazosin,Prazosin,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,32,Structured Clinical Interview,CAPS,CAPS,ITT,Linear mixed-effects models,"T-test, Cohen's d for within-group change",Baseline,,,77.3,,95% CI,69.1,85.5,,,,,,,,,,,,,,,,,,,,,,,CAPS score < 20,,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.9701,0.0299,0,0.1493,,0.8507,Combat-related,,Medium,"Raskind MA, Peterson K, Williams T, et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry. 2013 Sep;170(9):1003-10. doi: 10.1176/appi.ajp.2013.12081133. PMID: 23846759.",41028,2019
raskind2013_CAPS_B_0_ITT,Pharmacotherapy,PTSD,67,B,Control,,23,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,35,Structured Clinical Interview,CAPS,CAPS,ITT,Linear mixed-effects models,"T-test, Cohen's d for within-group change",End of Treatment,0,,71.9,,95% CI,63.9,79.8,,-13.8,,,,,,,,,,,,,,,,,,,,,CAPS score < 20,0,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.9701,0.0299,0,0.1493,,0.8507,Combat-related,,Medium,"Raskind MA, Peterson K, Williams T, et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry. 2013 Sep;170(9):1003-10. doi: 10.1176/appi.ajp.2013.12081133. PMID: 23846759.",41028,2019
raskind2013_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,67,B,Control,,35,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,35,Structured Clinical Interview,CAPS,CAPS,ITT,Linear mixed-effects models,"T-test, Cohen's d for within-group change",Baseline,,,85.7,,95% CI,78,93.3,,,,,,,,,,,,,,,,,,,,,,,CAPS score < 20,,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.9701,0.0299,0,0.1493,,0.8507,Combat-related,,Medium,"Raskind MA, Peterson K, Williams T, et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry. 2013 Sep;170(9):1003-10. doi: 10.1176/appi.ajp.2013.12081133. PMID: 23846759.",41028,2019
raskind2018_CAPS_A_0_Comp,Pharmacotherapy,PTSD,304,A,PTSD,,122,,Prazosin,Prazosin,No,Not Applicable,Yes,Adrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,152,Structured Clinical Interview,CAPS,CAPS,Completer,"Missing data excluded 
(sensitivity analysis was conducted using imputation, and ""results were similar."")","T-test, Cohen's d for within-group change",End of Treatment,0,,66.3,24.4,,,,,-14.4,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.023,,0.977,Combat-related,,Medium,"Raskind MA, Peskind ER, Chow B, et al. Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med. 2018 Feb 8;378(6):507-17. doi: 10.1056/NEJMoa1507598. PMID: 29414272.",49659,2019
raskind2018_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,304,A,PTSD,,152,,Prazosin,Prazosin,No,Not Applicable,Yes,Adrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,152,Structured Clinical Interview,CAPS,CAPS,Completer,"Missing data excluded 
(sensitivity analysis was conducted using imputation, and ""results were similar."")","T-test, Cohen's d for within-group change",Baseline,,,80.7,15.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.023,,0.977,Combat-related,,Medium,"Raskind MA, Peskind ER, Chow B, et al. Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med. 2018 Feb 8;378(6):507-17. doi: 10.1056/NEJMoa1507598. PMID: 29414272.",49659,2019
raskind2018_CAPS_B_0_Comp,Pharmacotherapy,PTSD,304,B,Control,,123,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,152,Structured Clinical Interview,CAPS,CAPS,Completer,"Missing data excluded 
(sensitivity analysis was conducted using imputation, and ""results were similar."")","T-test, Cohen's d for within-group change",End of Treatment,0,,64.0,26.9,,,,,-17.9,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.023,,0.977,Combat-related,,Medium,"Raskind MA, Peskind ER, Chow B, et al. Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med. 2018 Feb 8;378(6):507-17. doi: 10.1056/NEJMoa1507598. PMID: 29414272.",49659,2019
raskind2018_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,304,B,Control,,152,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,152,Structured Clinical Interview,CAPS,CAPS,Completer,"Missing data excluded 
(sensitivity analysis was conducted using imputation, and ""results were similar."")","T-test, Cohen's d for within-group change",Baseline,,,81.9,17.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.023,,0.977,Combat-related,,Medium,"Raskind MA, Peskind ER, Chow B, et al. Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med. 2018 Feb 8;378(6):507-17. doi: 10.1056/NEJMoa1507598. PMID: 29414272.",49659,2019
raskind2018_PCL_A_0_NA,Pharmacotherapy,PTSD,304,A,PTSD,,,,Prazosin,Prazosin,No,Not Applicable,Yes,Adrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,152,Self report,PCL,PCL-M,,,"T-test, Cohen's d for within-group change",End of Treatment,0,,54.2,15.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.023,,0.977,Combat-related,,Medium,"Raskind MA, Peskind ER, Chow B, et al. Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med. 2018 Feb 8;378(6):507-17. doi: 10.1056/NEJMoa1507598. PMID: 29414272.",49659,2019
raskind2018_PCL_A_Baseline_NA,Pharmacotherapy,PTSD,304,A,PTSD,,,,Prazosin,Prazosin,No,Not Applicable,Yes,Adrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,152,Self report,PCL,PCL-M,,,"T-test, Cohen's d for within-group change",Baseline,,,62.5,11.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.023,,0.977,Combat-related,,Medium,"Raskind MA, Peskind ER, Chow B, et al. Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med. 2018 Feb 8;378(6):507-17. doi: 10.1056/NEJMoa1507598. PMID: 29414272.",49659,2019
raskind2018_PCL_B_0_NA,Pharmacotherapy,PTSD,304,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,152,Self report,PCL,PCL-M,,,"T-test, Cohen's d for within-group change",End of Treatment,0,,53.9,16.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.023,,0.977,Combat-related,,Medium,"Raskind MA, Peskind ER, Chow B, et al. Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med. 2018 Feb 8;378(6):507-17. doi: 10.1056/NEJMoa1507598. PMID: 29414272.",49659,2019
raskind2018_PCL_B_Baseline_NA,Pharmacotherapy,PTSD,304,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,152,Self report,PCL,PCL-M,,,"T-test, Cohen's d for within-group change",Baseline,,,64.3,12.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.023,,0.977,Combat-related,,Medium,"Raskind MA, Peskind ER, Chow B, et al. Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med. 2018 Feb 8;378(6):507-17. doi: 10.1056/NEJMoa1507598. PMID: 29414272.",49659,2019
rasmusson2017_CAPS_A_0_ITT,Pharmacotherapy,PTSD,112,A,PTSD,,49,,Ganaxolone,Ganaxolone,No,Not Applicable,Yes,Steroids,No,Not Applicable,No,No,No,No,No,Individual,In Person,59,Structured Clinical Interview,CAPS,CAPS,ITT,,"T-test, Cohen's d for within-group change",End of Treatment,0,,,,,,,,-17.6,,-23.6,-11.6,,,,,,,,,,,,,,,,,,CGI-I score of 1 or 2,,,Mixed,,,0.125,0.2143,,0.7857,Mixed,"combat-related, child physical abuse, child sexual abuse, child other abuse",Medium,"Rasmusson AM, Marx CE, Jain S, et al. A randomized controlled trial of ganaxolone in posttraumatic stress disorder. Psychopharmacology (Berl). 2017;234(15):2245-57. doi: 10.1007/s00213-017-4649-y. PMID: 28667510.",48368,2019
rasmusson2017_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,112,A,PTSD,,59,,Ganaxolone,Ganaxolone,No,Not Applicable,Yes,Steroids,No,Not Applicable,No,No,No,No,No,Individual,In Person,59,Structured Clinical Interview,CAPS,CAPS,ITT,,"T-test, Cohen's d for within-group change",Baseline,,,72.2,18.3,,,,,,,,,,,,,,,,,,,,,,,,,,CGI-I score of 1 or 2,,,Mixed,,,0.125,0.2143,,0.7857,Mixed,"combat-related, child physical abuse, child sexual abuse, child other abuse",Medium,"Rasmusson AM, Marx CE, Jain S, et al. A randomized controlled trial of ganaxolone in posttraumatic stress disorder. Psychopharmacology (Berl). 2017;234(15):2245-57. doi: 10.1007/s00213-017-4649-y. PMID: 28667510.",48368,2019
rasmusson2017_CAPS_B_0_ITT,Pharmacotherapy,PTSD,112,B,Control,,50,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,53,Structured Clinical Interview,CAPS,CAPS,ITT,,"T-test, Cohen's d for within-group change",End of Treatment,0,,,,,,,,-15.1,,-21,-9.2,,,,,,,,,,,,,,,,,,CGI-I score of 1 or 2,,,Mixed,,,0.125,0.2143,,0.7857,Mixed,"combat-related, child physical abuse, child sexual abuse, child other abuse",Medium,"Rasmusson AM, Marx CE, Jain S, et al. A randomized controlled trial of ganaxolone in posttraumatic stress disorder. Psychopharmacology (Berl). 2017;234(15):2245-57. doi: 10.1007/s00213-017-4649-y. PMID: 28667510.",48368,2019
rasmusson2017_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,112,B,Control,,53,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,53,Structured Clinical Interview,CAPS,CAPS,ITT,,"T-test, Cohen's d for within-group change",Baseline,,,75.5,17,,,,,,,,,,,,,,,,,,,,,,,,,,CGI-I score of 1 or 2,,,Mixed,,,0.125,0.2143,,0.7857,Mixed,"combat-related, child physical abuse, child sexual abuse, child other abuse",Medium,"Rasmusson AM, Marx CE, Jain S, et al. A randomized controlled trial of ganaxolone in posttraumatic stress disorder. Psychopharmacology (Berl). 2017;234(15):2245-57. doi: 10.1007/s00213-017-4649-y. PMID: 28667510.",48368,2019
rasmusson2017_PCL_A_0_NA,Pharmacotherapy,PTSD,112,A,PTSD,,,,Ganaxolone,Ganaxolone,No,Not Applicable,Yes,Steroids,No,Not Applicable,No,No,No,No,No,Individual,In Person,59,Self report,PCL,PCL,,,"T-test, Cohen's d for within-group change",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0.125,0.2143,,0.7857,Mixed,"combat-related, child physical abuse, child sexual abuse, child other abuse",Medium,"Rasmusson AM, Marx CE, Jain S, et al. A randomized controlled trial of ganaxolone in posttraumatic stress disorder. Psychopharmacology (Berl). 2017;234(15):2245-57. doi: 10.1007/s00213-017-4649-y. PMID: 28667510.",48368,2019
rasmusson2017_PCL_A_Baseline_NA,Pharmacotherapy,PTSD,112,A,PTSD,,,,Ganaxolone,Ganaxolone,No,Not Applicable,Yes,Steroids,No,Not Applicable,No,No,No,No,No,Individual,In Person,59,Self report,PCL,PCL,,,"T-test, Cohen's d for within-group change",Baseline,,,55.6,14.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0.125,0.2143,,0.7857,Mixed,"combat-related, child physical abuse, child sexual abuse, child other abuse",Medium,"Rasmusson AM, Marx CE, Jain S, et al. A randomized controlled trial of ganaxolone in posttraumatic stress disorder. Psychopharmacology (Berl). 2017;234(15):2245-57. doi: 10.1007/s00213-017-4649-y. PMID: 28667510.",48368,2019
rasmusson2017_PCL_B_0_NA,Pharmacotherapy,PTSD,112,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,53,Self report,PCL,PCL,,,"T-test, Cohen's d for within-group change",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0.125,0.2143,,0.7857,Mixed,"combat-related, child physical abuse, child sexual abuse, child other abuse",Medium,"Rasmusson AM, Marx CE, Jain S, et al. A randomized controlled trial of ganaxolone in posttraumatic stress disorder. Psychopharmacology (Berl). 2017;234(15):2245-57. doi: 10.1007/s00213-017-4649-y. PMID: 28667510.",48368,2019
rasmusson2017_PCL_B_Baseline_NA,Pharmacotherapy,PTSD,112,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,53,Self report,PCL,PCL,,,"T-test, Cohen's d for within-group change",Baseline,,,58.9,12.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0.125,0.2143,,0.7857,Mixed,"combat-related, child physical abuse, child sexual abuse, child other abuse",Medium,"Rasmusson AM, Marx CE, Jain S, et al. A randomized controlled trial of ganaxolone in posttraumatic stress disorder. Psychopharmacology (Berl). 2017;234(15):2245-57. doi: 10.1007/s00213-017-4649-y. PMID: 28667510.",48368,2019
rauch2015_CAPS_A_0_Comp,Psychotherapy,PTSD,36,A,PTSD,,11,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVAs with Greenhouse-Geisser corrections and post hoc t-tests,End of Treatment,0,,30,18.4,,,,,-49.2,,,,,Cohen's d,3.16,,,,,,,,,,,,,,,≥10-point reduction in CAPS from baseline,0.9091,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.0833,,0.9167,,,High,"Rauch SAM, King AP, Abelson JL, et al. Biological and symptom changes in posttraumatic stress disorder treatment: a randomized clinical trial. Depress Anxiety. 2015 Mar;32(3):204-12. doi: 10.1002/da.22331. PMID: 25639570.",43645,2019
rauch2015_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,36,A,PTSD,,11,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVAs with Greenhouse-Geisser corrections and post hoc t-tests,Baseline,,,79.2,12.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0833,,0.9167,,,High,"Rauch SAM, King AP, Abelson JL, et al. Biological and symptom changes in posttraumatic stress disorder treatment: a randomized clinical trial. Depress Anxiety. 2015 Mar;32(3):204-12. doi: 10.1002/da.22331. PMID: 25639570.",43645,2019
rauch2015_CAPS_B_0_Comp,Psychotherapy,PTSD,36,B,PTSD,,15,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVAs with Greenhouse-Geisser corrections and post hoc t-tests,End of Treatment,0,,53.6,28.7,,,,,-23.8,,,,,Cohen's d,1.08,,,,,,,,,,,,,,,≥10-point reduction in CAPS from baseline,0.6,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.0833,,0.9167,,,High,"Rauch SAM, King AP, Abelson JL, et al. Biological and symptom changes in posttraumatic stress disorder treatment: a randomized clinical trial. Depress Anxiety. 2015 Mar;32(3):204-12. doi: 10.1002/da.22331. PMID: 25639570.",43645,2019
rauch2015_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,36,B,PTSD,,15,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVAs with Greenhouse-Geisser corrections and post hoc t-tests,Baseline,,,77.4,12.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0833,,0.9167,,,High,"Rauch SAM, King AP, Abelson JL, et al. Biological and symptom changes in posttraumatic stress disorder treatment: a randomized clinical trial. Depress Anxiety. 2015 Mar;32(3):204-12. doi: 10.1002/da.22331. PMID: 25639570.",43645,2019
rauch2019_CAPS_A_0_ITT,Psychotherapy,PTSD,223,A,PTSD,,51,,PE + sertraline,Prolonged Exposure (PE) + sertraline,Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In person,75,Structured Clinical Interview,CAPS,CAPS,ITT,used logistic regression model to evaluate baseline factors predictive of missing week 24 CAPS score and included them as covariates in sensitivity analysis,Repeated measures ANOVAs with Greenhouse-Geisser corrections and post hoc t-tests,End of Treatment,0,,43.3,27.2,,,,,-32.7,,,,,,,,,,p<0.001,,,,,,,,,,,Clinically meaningful change: reduction of ≥20 points in CAPS score or CAPS score ≤35,0.565,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,,,0,0.13,,0.87,Combat-related,,Medium,"Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.",51290,2020
rauch2019_CAPS_A_28.1_ITT,Psychotherapy,PTSD,223,A,PTSD,,49,,PE + sertraline,Prolonged Exposure (PE) + sertraline,Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In person,75,Structured Clinical Interview,CAPS,CAPS,ITT,used logistic regression model to evaluate baseline factors predictive of missing week 24 CAPS score and included them as covariates in sensitivity analysis,Repeated measures ANOVAs with Greenhouse-Geisser corrections and post hoc t-tests,Assessment at 6 to <12 Months,28.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinically meaningful change: reduction of ≥20 points in CAPS score or CAPS score ≤35,,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,,,0,0.13,,0.87,Combat-related,,Medium,"Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.",51290,2020
rauch2019_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,223,A,PTSD,,75,,PE + sertraline,Prolonged Exposure (PE) + sertraline,Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In person,75,Structured Clinical Interview,CAPS,CAPS,ITT,used logistic regression model to evaluate baseline factors predictive of missing week 24 CAPS score and included them as covariates in sensitivity analysis,Repeated measures ANOVAs with Greenhouse-Geisser corrections and post hoc t-tests,Baseline,,,76.0,14.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.13,,0.87,Combat-related,,Medium,"Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.",51290,2020
rauch2019_CAPS_B_0_ITT,Psychotherapy,PTSD,223,B,PTSD,,42,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Structured Clinical Interview,CAPS,CAPS,ITT,used logistic regression model to evaluate baseline factors predictive of missing week 24 CAPS score and included them as covariates in sensitivity analysis,Repeated measures ANOVAs with Greenhouse-Geisser corrections and post hoc t-tests,End of Treatment,0,,51.5,25.3,,,,,-29.4,,,,,,,,,,p<0.001,,,,,,,,,,,Clinically meaningful change: reduction of ≥20 points in CAPS score or CAPS score ≤35,0.522,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,,,0,0.13,,0.87,Combat-related,,Medium,"Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.",51290,2020
rauch2019_CAPS_B_28.1_ITT,Psychotherapy,PTSD,223,B,PTSD,,40,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Structured Clinical Interview,CAPS,CAPS,ITT,used logistic regression model to evaluate baseline factors predictive of missing week 24 CAPS score and included them as covariates in sensitivity analysis,Repeated measures ANOVAs with Greenhouse-Geisser corrections and post hoc t-tests,Assessment at 6 to <12 Months,28.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinically meaningful change: reduction of ≥20 points in CAPS score or CAPS score ≤35,,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,,,0,0.13,,0.87,Combat-related,,Medium,"Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.",51290,2020
rauch2019_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,223,B,PTSD,,74,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Structured Clinical Interview,CAPS,CAPS,ITT,used logistic regression model to evaluate baseline factors predictive of missing week 24 CAPS score and included them as covariates in sensitivity analysis,Repeated measures ANOVAs with Greenhouse-Geisser corrections and post hoc t-tests,Baseline,,,80.9,13.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.13,,0.87,Combat-related,,Medium,"Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.",51290,2020
rauch2019_CAPS_C_0_ITT,Psychotherapy,PTSD,223,C,PTSD,,56,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Structured Clinical Interview,CAPS,CAPS,ITT,used logistic regression model to evaluate baseline factors predictive of missing week 24 CAPS score and included them as covariates in sensitivity analysis,Repeated measures ANOVAs with Greenhouse-Geisser corrections and post hoc t-tests,End of Treatment,0,,41.7,25.7,,,,,-33.8,,,,,,,,,,p<0.001,,,,,,,,,,,Clinically meaningful change: reduction of ≥20 points in CAPS score or CAPS score ≤35,0.62,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,,,0,0.13,,0.87,Combat-related,,Medium,"Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.",51290,2020
rauch2019_CAPS_C_28.1_ITT,Psychotherapy,PTSD,223,C,PTSD,,50,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Structured Clinical Interview,CAPS,CAPS,ITT,used logistic regression model to evaluate baseline factors predictive of missing week 24 CAPS score and included them as covariates in sensitivity analysis,Repeated measures ANOVAs with Greenhouse-Geisser corrections and post hoc t-tests,Assessment at 6 to <12 Months,28.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.13,,0.87,Combat-related,,Medium,"Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.",51290,2020
rauch2019_CAPS_C_Baseline_ITT,Psychotherapy,PTSD,223,C,PTSD,,74,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Structured Clinical Interview,CAPS,CAPS,ITT,used logistic regression model to evaluate baseline factors predictive of missing week 24 CAPS score and included them as covariates in sensitivity analysis,Repeated measures ANOVAs with Greenhouse-Geisser corrections and post hoc t-tests,Baseline,,,75.5,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.13,,0.87,Combat-related,,Medium,"Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.",51290,2020
rauch2019_PCL_A_0_ITT,Psychotherapy,PTSD,223,A,PTSD,,,,PE + sertraline,Prolonged Exposure (PE) + sertraline,Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In person,75,Self report,PCL,PCL Specific Stressor Version,ITT,,Repeated measures ANOVAs with Greenhouse-Geisser corrections and post hoc t-tests,End of Treatment,0,,40.5,19.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.13,,0.87,Combat-related,,Medium,"Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.",51290,2020
rauch2019_PCL_A_Baseline_ITT,Psychotherapy,PTSD,223,A,PTSD,,,,PE + sertraline,Prolonged Exposure (PE) + sertraline,Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In person,75,Self report,PCL,PCL Specific Stressor Version,ITT,,Repeated measures ANOVAs with Greenhouse-Geisser corrections and post hoc t-tests,Baseline,,,56.6,11.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.13,,0.87,Combat-related,,Medium,"Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.",51290,2020
rauch2019_PCL_B_0_ITT,Psychotherapy,PTSD,223,B,PTSD,,,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Self report,PCL,PCL Specific Stressor Version,ITT,,Repeated measures ANOVAs with Greenhouse-Geisser corrections and post hoc t-tests,End of Treatment,0,,42.3,13.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.13,,0.87,Combat-related,,Medium,"Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.",51290,2020
rauch2019_PCL_B_Baseline_ITT,Psychotherapy,PTSD,223,B,PTSD,,,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Self report,PCL,PCL Specific Stressor Version,ITT,,Repeated measures ANOVAs with Greenhouse-Geisser corrections and post hoc t-tests,Baseline,,,59.6,9.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.13,,0.87,Combat-related,,Medium,"Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.",51290,2020
rauch2019_PCL_C_0_ITT,Psychotherapy,PTSD,223,C,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Self report,PCL,PCL Specific Stressor Version,ITT,,Repeated measures ANOVAs with Greenhouse-Geisser corrections and post hoc t-tests,End of Treatment,0,,41.5,16.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.13,,0.87,Combat-related,,Medium,"Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.",51290,2020
rauch2019_PCL_C_Baseline_ITT,Psychotherapy,PTSD,223,C,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In person,74,Self report,PCL,PCL Specific Stressor Version,ITT,,Repeated measures ANOVAs with Greenhouse-Geisser corrections and post hoc t-tests,Baseline,,,56.2,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.13,,0.87,Combat-related,,Medium,"Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.",51290,2020
ready2010_CAPS_A_0_ITT,Psychotherapy,PTSD,11,A,PTSD,,5,,Virtual reality exposure  therapy,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,6,Structured Clinical Interview,CAPS,CAPS,ITT,NR (study states that missing data were not imputed using LOCF),"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",End of Treatment,0,,59.2,32.24,,,,,-31.8,39.1,,,,Cohen's d,0.28,,,,p>0.05,,,,,,,,,,,≥10-point reduction on total CAPS score,0.6,,Veteran,0,1,0,0,,1,Combat-related,,High,"Ready DJ, Gerardi RJ, Backscheider AG, et al. Comparing virtual reality exposure therapy to present-centered therapy with 11 U.S. Vietnam veterans with PTSD. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):49-54.  PMID: 20528293.",34258,2019
ready2010_CAPS_A_26_ITT,Psychotherapy,PTSD,11,A,PTSD,,4,,Virtual reality exposure  therapy,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,6,Structured Clinical Interview,CAPS,CAPS,ITT,NR (study states that missing data were not imputed using LOCF),"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at 6 to <12 Months,26,,64.75,34.08,,,,,-25,28.1,,,,,,,,,p>0.05,,,,,,,,,,,≥10-point reduction on total CAPS score,0.75,,Veteran,0,1,0,0,,1,Combat-related,,High,"Ready DJ, Gerardi RJ, Backscheider AG, et al. Comparing virtual reality exposure therapy to present-centered therapy with 11 U.S. Vietnam veterans with PTSD. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):49-54.  PMID: 20528293.",34258,2019
ready2010_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,11,A,PTSD,,6,,Virtual reality exposure  therapy,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,6,Structured Clinical Interview,CAPS,CAPS,ITT,NR (study states that missing data were not imputed using LOCF),"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Baseline,,,87.83,15.43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Ready DJ, Gerardi RJ, Backscheider AG, et al. Comparing virtual reality exposure therapy to present-centered therapy with 11 U.S. Vietnam veterans with PTSD. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):49-54.  PMID: 20528293.",34258,2019
ready2010_CAPS_B_0_ITT,Psychotherapy,PTSD,11,B,PTSD,,4,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,5,Structured Clinical Interview,CAPS,CAPS,ITT,NR (study states that missing data were not imputed using LOCF),"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",End of Treatment,0,,75.5,22.22,,,,,-23,21.9,,,,,,,,,p>0.05,,,,,,,,,,,≥10-point reduction on total CAPS score,0.5,,Veteran,0,1,0,0,,1,Combat-related,,High,"Ready DJ, Gerardi RJ, Backscheider AG, et al. Comparing virtual reality exposure therapy to present-centered therapy with 11 U.S. Vietnam veterans with PTSD. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):49-54.  PMID: 20528293.",34258,2019
ready2010_CAPS_B_26_ITT,Psychotherapy,PTSD,11,B,PTSD,,5,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,5,Structured Clinical Interview,CAPS,CAPS,ITT,NR (study states that missing data were not imputed using LOCF),"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at 6 to <12 Months,26,,87,6.32,,,,,-13,11.3,,,,,,,,,p>0.05,,,,,,,,,,,≥10-point reduction on total CAPS score,0.75,,Veteran,0,1,0,0,,1,Combat-related,,High,"Ready DJ, Gerardi RJ, Backscheider AG, et al. Comparing virtual reality exposure therapy to present-centered therapy with 11 U.S. Vietnam veterans with PTSD. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):49-54.  PMID: 20528293.",34258,2019
ready2010_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,11,B,PTSD,,5,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,5,Structured Clinical Interview,CAPS,CAPS,ITT,NR (study states that missing data were not imputed using LOCF),"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Baseline,,,101,9.51,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Ready DJ, Gerardi RJ, Backscheider AG, et al. Comparing virtual reality exposure therapy to present-centered therapy with 11 U.S. Vietnam veterans with PTSD. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):49-54.  PMID: 20528293.",34258,2019
ready2018_CAPS_A_0_ITT,Psychotherapy,PTSD,81,A,PTSD,,37,,Group-based exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,41,Structured Clinical Interview,CAPS,CAPS,ITT,BOCF for patients who drop out of treatment and were lost to followup. Left missing for patients who were lost to followup but continued treatment. Imputation for patients who completed treatment,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",End of Treatment,0,,71.73,20.55,,,,,-10.7,,,,,,,,,,,,,,,,,,,,,Reliable change index defined as ≥10-point change on CAPS,0.439,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ready DJ, Mascaro N, Wattenberg MS, et al. A controlled study of group-based exposure therapy with Vietnam-era veterans. J Loss Trauma. 2018;23(6):439-57. doi: 10.1080/15325024.2018.1485268. PMID: 133654049.",,2020
ready2018_CAPS_A_16_ITT,Psychotherapy,PTSD,81,A,PTSD,,40,,Group-based exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,41,Structured Clinical Interview,CAPS,CAPS,ITT,BOCF for patients who drop out of treatment and were lost to followup. Left missing for patients who were lost to followup but continued treatment. Imputation for patients who completed treatment,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at 3 to <6 Months,16,,71.63,20.44,,,,,-10.8,,,,,,,,,,,,,,,,,,,,,Reliable change index defined as ≥10-point change on CAPS,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ready DJ, Mascaro N, Wattenberg MS, et al. A controlled study of group-based exposure therapy with Vietnam-era veterans. J Loss Trauma. 2018;23(6):439-57. doi: 10.1080/15325024.2018.1485268. PMID: 133654049.",,2020
ready2018_CAPS_A_52_ITT,Psychotherapy,PTSD,81,A,PTSD,,35,,Group-based exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,41,Structured Clinical Interview,CAPS,CAPS,ITT,BOCF for patients who drop out of treatment and were lost to followup. Left missing for patients who were lost to followup but continued treatment. Imputation for patients who completed treatment,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at ≥12 Months,52,,69.29,20.71,,,,,-13.14,,,,,,,,,,p<0.01,,,,,,,,,,,Reliable change index defined as ≥10-point change on CAPS,0.4286,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ready DJ, Mascaro N, Wattenberg MS, et al. A controlled study of group-based exposure therapy with Vietnam-era veterans. J Loss Trauma. 2018;23(6):439-57. doi: 10.1080/15325024.2018.1485268. PMID: 133654049.",,2020
ready2018_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,81,A,PTSD,,41,,Group-based exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,41,Structured Clinical Interview,CAPS,CAPS,ITT,BOCF for patients who drop out of treatment and were lost to followup. Left missing for patients who were lost to followup but continued treatment. Imputation for patients who completed treatment,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Baseline,,,82.43,15.09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ready DJ, Mascaro N, Wattenberg MS, et al. A controlled study of group-based exposure therapy with Vietnam-era veterans. J Loss Trauma. 2018;23(6):439-57. doi: 10.1080/15325024.2018.1485268. PMID: 133654049.",,2020
ready2018_CAPS_B_0_ITT,Psychotherapy,PTSD,81,B,PTSD,,36,,PCGT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,40,Structured Clinical Interview,CAPS,CAPS,ITT,BOCF for patients who drop out of treatment and were lost to followup. Left missing for patients who were lost to followup but continued treatment. Imputation for patients who completed treatment,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",End of Treatment,0,,75.43,23.01,,,,,-5.74,,,,,,,,,,,,,,,,,,,,,Reliable change index defined as ≥10-point change on CAPS,0.425,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ready DJ, Mascaro N, Wattenberg MS, et al. A controlled study of group-based exposure therapy with Vietnam-era veterans. J Loss Trauma. 2018;23(6):439-57. doi: 10.1080/15325024.2018.1485268. PMID: 133654049.",,2020
ready2018_CAPS_B_16_ITT,Psychotherapy,PTSD,81,B,PTSD,,38,,PCGT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,40,Structured Clinical Interview,CAPS,CAPS,ITT,BOCF for patients who drop out of treatment and were lost to followup. Left missing for patients who were lost to followup but continued treatment. Imputation for patients who completed treatment,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at 3 to <6 Months,16,,71.13,16.59,,,,,-10.04,,,,,,,,,,,,,,,,,,,,,Reliable change index defined as ≥10-point change on CAPS,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ready DJ, Mascaro N, Wattenberg MS, et al. A controlled study of group-based exposure therapy with Vietnam-era veterans. J Loss Trauma. 2018;23(6):439-57. doi: 10.1080/15325024.2018.1485268. PMID: 133654049.",,2020
ready2018_CAPS_B_52_ITT,Psychotherapy,PTSD,81,B,PTSD,,33,,PCGT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,40,Structured Clinical Interview,CAPS,CAPS,ITT,BOCF for patients who drop out of treatment and were lost to followup. Left missing for patients who were lost to followup but continued treatment. Imputation for patients who completed treatment,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at ≥12 Months,52,,71.03,22.8,,,,,-10.14,,,,,,,,,,p<0.01,,,,,,,,,,,Reliable change index defined as ≥10-point change on CAPS,0.5455,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ready DJ, Mascaro N, Wattenberg MS, et al. A controlled study of group-based exposure therapy with Vietnam-era veterans. J Loss Trauma. 2018;23(6):439-57. doi: 10.1080/15325024.2018.1485268. PMID: 133654049.",,2020
ready2018_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,81,B,PTSD,,40,,PCGT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,40,Structured Clinical Interview,CAPS,CAPS,ITT,BOCF for patients who drop out of treatment and were lost to followup. Left missing for patients who were lost to followup but continued treatment. Imputation for patients who completed treatment,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Baseline,,,71.17,14.31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ready DJ, Mascaro N, Wattenberg MS, et al. A controlled study of group-based exposure therapy with Vietnam-era veterans. J Loss Trauma. 2018;23(6):439-57. doi: 10.1080/15325024.2018.1485268. PMID: 133654049.",,2020
ready2018_PCL_A_0_ITT,Psychotherapy,PTSD,81,A,PTSD,,,,Group-based exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,41,Self report,PCL,PCL-M,ITT,BOCF for patients who drop out of treatment and were lost to followup. Left missing for patients who were lost to followup but continued treatment. Imputation for patients who completed treatment,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",End of Treatment,0,,56.06,13.53,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ready DJ, Mascaro N, Wattenberg MS, et al. A controlled study of group-based exposure therapy with Vietnam-era veterans. J Loss Trauma. 2018;23(6):439-57. doi: 10.1080/15325024.2018.1485268. PMID: 133654049.",,2020
ready2018_PCL_A_16_ITT,Psychotherapy,PTSD,81,A,PTSD,,,,Group-based exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,41,Self report,PCL,PCL-M,ITT,BOCF for patients who drop out of treatment and were lost to followup. Left missing for patients who were lost to followup but continued treatment. Imputation for patients who completed treatment,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at 3 to <6 Months,16,,58.41,11.58,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ready DJ, Mascaro N, Wattenberg MS, et al. A controlled study of group-based exposure therapy with Vietnam-era veterans. J Loss Trauma. 2018;23(6):439-57. doi: 10.1080/15325024.2018.1485268. PMID: 133654049.",,2020
ready2018_PCL_A_52_ITT,Psychotherapy,PTSD,81,A,PTSD,,,,Group-based exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,41,Self report,PCL,PCL-M,ITT,BOCF for patients who drop out of treatment and were lost to followup. Left missing for patients who were lost to followup but continued treatment. Imputation for patients who completed treatment,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at ≥12 Months,52,,57.16,10.77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ready DJ, Mascaro N, Wattenberg MS, et al. A controlled study of group-based exposure therapy with Vietnam-era veterans. J Loss Trauma. 2018;23(6):439-57. doi: 10.1080/15325024.2018.1485268. PMID: 133654049.",,2020
ready2018_PCL_A_Baseline_ITT,Psychotherapy,PTSD,81,A,PTSD,,,,Group-based exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,41,Self report,PCL,PCL-M,ITT,BOCF for patients who drop out of treatment and were lost to followup. Left missing for patients who were lost to followup but continued treatment. Imputation for patients who completed treatment,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Baseline,,,67.40,9.92,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ready DJ, Mascaro N, Wattenberg MS, et al. A controlled study of group-based exposure therapy with Vietnam-era veterans. J Loss Trauma. 2018;23(6):439-57. doi: 10.1080/15325024.2018.1485268. PMID: 133654049.",,2020
ready2018_PCL_B_0_ITT,Psychotherapy,PTSD,81,B,PTSD,,,,PCGT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,40,Self report,PCL,PCL-M,ITT,BOCF for patients who drop out of treatment and were lost to followup. Left missing for patients who were lost to followup but continued treatment. Imputation for patients who completed treatment,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",End of Treatment,0,,59.00,14.43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ready DJ, Mascaro N, Wattenberg MS, et al. A controlled study of group-based exposure therapy with Vietnam-era veterans. J Loss Trauma. 2018;23(6):439-57. doi: 10.1080/15325024.2018.1485268. PMID: 133654049.",,2020
ready2018_PCL_B_16_ITT,Psychotherapy,PTSD,81,B,PTSD,,,,PCGT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,40,Self report,PCL,PCL-M,ITT,BOCF for patients who drop out of treatment and were lost to followup. Left missing for patients who were lost to followup but continued treatment. Imputation for patients who completed treatment,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at 3 to <6 Months,16,,59.91,13.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ready DJ, Mascaro N, Wattenberg MS, et al. A controlled study of group-based exposure therapy with Vietnam-era veterans. J Loss Trauma. 2018;23(6):439-57. doi: 10.1080/15325024.2018.1485268. PMID: 133654049.",,2020
ready2018_PCL_B_52_ITT,Psychotherapy,PTSD,81,B,PTSD,,,,PCGT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,40,Self report,PCL,PCL-M,ITT,BOCF for patients who drop out of treatment and were lost to followup. Left missing for patients who were lost to followup but continued treatment. Imputation for patients who completed treatment,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at ≥12 Months,52,,58.24,9.79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ready DJ, Mascaro N, Wattenberg MS, et al. A controlled study of group-based exposure therapy with Vietnam-era veterans. J Loss Trauma. 2018;23(6):439-57. doi: 10.1080/15325024.2018.1485268. PMID: 133654049.",,2020
ready2018_PCL_B_Baseline_ITT,Psychotherapy,PTSD,81,B,PTSD,,,,PCGT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,40,Self report,PCL,PCL-M,ITT,BOCF for patients who drop out of treatment and were lost to followup. Left missing for patients who were lost to followup but continued treatment. Imputation for patients who completed treatment,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Baseline,,,65.33,11.82,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Ready DJ, Mascaro N, Wattenberg MS, et al. A controlled study of group-based exposure therapy with Vietnam-era veterans. J Loss Trauma. 2018;23(6):439-57. doi: 10.1080/15325024.2018.1485268. PMID: 133654049.",,2020
reeve2020_PCL_A_0_Comp,Complementary and integrative health (CIH),PTSD,40,A,PTSD,,19,,Healing Touch + Standard of care,Healing Touch,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In person,20,Self report,PCL,PCL-5,Completer,,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",End of Treatment,0,,40.21,19.16,,,,,-18.11,18.13,,,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,High,"Reeve K, et al. Examining the impact of a Healing Touch intervention to reduce posttraumatic stress disorder symptoms in combat veterans. Psychological Trauma: Theory, Research, Practice, and Policy. 2020. doi: 10.1037/tra0000591.",,2020
reeve2020_PCL_A_12_Comp,Complementary and integrative health (CIH),PTSD,40,A,PTSD,,19,,Healing Touch + Standard of care,Healing Touch,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In person,20,Self report,PCL,PCL-5,Completer,,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at 3 to <6 Months,12,,43.29,14.79,,,,mean difference,-15.71,8.52,,,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,High,"Reeve K, et al. Examining the impact of a Healing Touch intervention to reduce posttraumatic stress disorder symptoms in combat veterans. Psychological Trauma: Theory, Research, Practice, and Policy. 2020. doi: 10.1037/tra0000591.",,2020
reeve2020_PCL_A_Baseline_Comp,Complementary and integrative health (CIH),PTSD,40,A,PTSD,,19,,Healing Touch + Standard of care,Healing Touch,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In person,20,Self report,PCL,PCL-5,Completer,,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Baseline,,,58.32,12.57,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,High,"Reeve K, et al. Examining the impact of a Healing Touch intervention to reduce posttraumatic stress disorder symptoms in combat veterans. Psychological Trauma: Theory, Research, Practice, and Policy. 2020. doi: 10.1037/tra0000591.",,2020
reeve2020_PCL_B_0_Comp,Complementary and integrative health (CIH),PTSD,40,B,Control,,20,,Standard of care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,20,Self report,PCL,PCL-5,Completer,,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",End of Treatment,0,,56.70,12.52,,,,mean difference,-5,6.782,,,,,,,,,p=0.013,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,High,"Reeve K, et al. Examining the impact of a Healing Touch intervention to reduce posttraumatic stress disorder symptoms in combat veterans. Psychological Trauma: Theory, Research, Practice, and Policy. 2020. doi: 10.1037/tra0000591.",,2020
reeve2020_PCL_B_Baseline_Comp,Complementary and integrative health (CIH),PTSD,40,B,Control,,15,,Standard of care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,20,Self report,PCL,PCL-5,Completer,,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Baseline,,,62.27,13.68,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,,,High,"Reeve K, et al. Examining the impact of a Healing Touch intervention to reduce posttraumatic stress disorder symptoms in combat veterans. Psychological Trauma: Theory, Research, Practice, and Policy. 2020. doi: 10.1037/tra0000591.",,2020
reger2016_CAPS-pm_A_12_ITT,Psychotherapy,PTSD,162,A,PTSD,,24,,PE with virtual reality exposure,Prolonged Exposure (PE) with virtual reality exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS past month,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at 3 to <6 Months,12,,62.71,30.51,,,,,-25.99,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_CAPS-pm_A_26_ITT,Psychotherapy,PTSD,162,A,PTSD,,18,,PE with virtual reality exposure,Prolonged Exposure (PE) with virtual reality exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS past month,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at 6 to <12 Months,26,,59.61,27.51,,,,,-29.09,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_CAPS-pm_A_Baseline_ITT,Psychotherapy,PTSD,162,A,PTSD,,54,,PE with virtual reality exposure,Prolonged Exposure (PE) with virtual reality exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS past month,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Baseline,,,88.70,12.86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_CAPS-pm_B_12_ITT,Psychotherapy,PTSD,162,B,PTSD,,27,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS past month,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at 3 to <6 Months,12,,41.71,25.52,,,,,-43.7,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_CAPS-pm_B_26_ITT,Psychotherapy,PTSD,162,B,PTSD,,24,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS past month,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at 6 to <12 Months,26,,44.92,29.34,,,,,-33.36,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_CAPS-pm_B_Baseline_ITT,Psychotherapy,PTSD,162,B,PTSD,,54,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS past month,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Baseline,,,85.44,14.06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_CAPS-pm_C_Baseline_ITT,Psychotherapy,PTSD,162,C,Control,,54,,Waitlist minimal attention,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,54,Structured Clinical Interview,CAPS,CAPS past month,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Baseline,,,87.61,12.88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_CAPS-pw_A_0_Comp,Psychotherapy,PTSD,162,A,PTSD,,,,PE with virtual reality exposure,Prolonged Exposure (PE) with virtual reality exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS past week,Completer,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Individual reliable change on CAPS (past week) but no clinically significant change (CAPS <52.78),0.2333,Additional definitions of Clinically Meaningful Response reported in the study,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_CAPS-pw_A_0_ITT,Psychotherapy,PTSD,162,A,PTSD,,30,,PE with virtual reality exposure,Prolonged Exposure (PE) with virtual reality exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS past week,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",End of Treatment,0,,57.07,32.32,,,,,-23.37,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_CAPS-pw_A_12_ITT,Psychotherapy,PTSD,162,A,PTSD,,25,,PE with virtual reality exposure,Prolonged Exposure (PE) with virtual reality exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS past week,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at 3 to <6 Months,12,,56.64,31.5,,,,,-23.8,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_CAPS-pw_A_26_ITT,Psychotherapy,PTSD,162,A,PTSD,,18,,PE with virtual reality exposure,Prolonged Exposure (PE) with virtual reality exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS past week,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at 6 to <12 Months,26,,53.50,28.07,,,,,-26.94,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_CAPS-pw_A_Baseline_ITT,Psychotherapy,PTSD,162,A,PTSD,,54,,PE with virtual reality exposure,Prolonged Exposure (PE) with virtual reality exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS past week,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Baseline,,,80.44,16.23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_CAPS-pw_B_0_Comp,Psychotherapy,PTSD,162,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS past week,Completer,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Individual reliable change on CAPS (past week) but no clinically significant change (CAPS <52.78),0.1563,Additional definitions of Clinically Meaningful Response reported in the study,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_CAPS-pw_B_0_ITT,Psychotherapy,PTSD,162,B,PTSD,,32,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS past week,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",End of Treatment,0,,44.28,33.73,,,,,-34,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_CAPS-pw_B_12_ITT,Psychotherapy,PTSD,162,B,PTSD,,27,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS past week,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at 3 to <6 Months,12,,36.63,31.8,,,,,-41.65,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_CAPS-pw_B_26_ITT,Psychotherapy,PTSD,162,B,PTSD,,24,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS past week,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at 6 to <12 Months,26,,38.33,28.49,,,,,-39.95,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_CAPS-pw_B_Baseline_ITT,Psychotherapy,PTSD,162,B,PTSD,,54,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Structured Clinical Interview,CAPS,CAPS past week,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Baseline,,,78.28,16.35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_CAPS-pw_C_0_Comp,Psychotherapy,PTSD,162,C,Control,,,,Waitlist minimal attention,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,54,Structured Clinical Interview,CAPS,CAPS past week,Completer,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Individual reliable change on CAPS (past week) but no clinically significant change (CAPS <52.78),0.1064,Additional definitions of Clinically Meaningful Response reported in the study,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_CAPS-pw_C_0_ITT,Psychotherapy,PTSD,162,C,Control,,47,,Waitlist minimal attention,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,54,Structured Clinical Interview,CAPS,CAPS past week,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",End of Treatment,0,,68.06,24.27,,,,,-10.83,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_CAPS-pw_C_Baseline_ITT,Psychotherapy,PTSD,162,C,Control,,54,,Waitlist minimal attention,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,54,Structured Clinical Interview,CAPS,CAPS past week,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Baseline,,,78.89,16.87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_PCL_A_0_ITT,Psychotherapy,PTSD,162,A,PTSD,,,,PE with virtual reality exposure,Prolonged Exposure (PE) with virtual reality exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Self report,PCL,PCL-C,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",End of Treatment,0,,45.57,15.88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_PCL_A_12_ITT,Psychotherapy,PTSD,162,A,PTSD,,,,PE with virtual reality exposure,Prolonged Exposure (PE) with virtual reality exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Self report,PCL,PCL-C,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at 3 to <6 Months,12,,46.96,15.95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_PCL_A_26_ITT,Psychotherapy,PTSD,162,A,PTSD,,,,PE with virtual reality exposure,Prolonged Exposure (PE) with virtual reality exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Self report,PCL,PCL-C,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at 6 to <12 Months,26,,42.88,15.96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_PCL_A_Baseline_ITT,Psychotherapy,PTSD,162,A,PTSD,,,,PE with virtual reality exposure,Prolonged Exposure (PE) with virtual reality exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Self report,PCL,PCL-C,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Baseline,,,61.85,9.03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_PCL_B_0_ITT,Psychotherapy,PTSD,162,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Self report,PCL,PCL-C,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",End of Treatment,0,,40.63,18.57,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_PCL_B_12_ITT,Psychotherapy,PTSD,162,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Self report,PCL,PCL-C,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at 3 to <6 Months,12,,38.41,17.98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_PCL_B_26_ITT,Psychotherapy,PTSD,162,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Self report,PCL,PCL-C,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Assessment at 6 to <12 Months,26,,40.83,18.56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_PCL_B_Baseline_ITT,Psychotherapy,PTSD,162,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,54,Self report,PCL,PCL-C,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Baseline,,,59.74,9.09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_PCL_C_0_ITT,Psychotherapy,PTSD,162,C,Control,,,,Waitlist minimal attention,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,54,Self report,PCL,PCL-C,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",End of Treatment,0,,53.89,11.77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reger2016_PCL_C_Baseline_ITT,Psychotherapy,PTSD,162,C,Control,,,,Waitlist minimal attention,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,54,Self report,PCL,PCL-C,ITT,Ignored,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Baseline,,,60.30,8.97,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.037,,0.963,Combat-related,,Medium,"Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.",45485,2020
reich2004_CAPS_A_0_ITT,Pharmacotherapy,PTSD,21,A,PTSD,,12,,Risperidone,Risperidone,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",End of Treatment,0,,33.9,,,,,,-29.6,31.5,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse",Medium,"Reich DB, Winternitz S, Hennen J, et al. A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women. J Clin Psychiatry. 2004 Dec;65(12):1601-6. PMID: 15641864.",27284,2019
reich2004_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,21,A,PTSD,,12,,Risperidone,Risperidone,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Baseline,,,63.5,17.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse",Medium,"Reich DB, Winternitz S, Hennen J, et al. A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women. J Clin Psychiatry. 2004 Dec;65(12):1601-6. PMID: 15641864.",27284,2019
reich2004_CAPS_B_0_ITT,Pharmacotherapy,PTSD,21,B,Control,,9,,Control,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,9,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",End of Treatment,0,,47.0,,,,,,-18.6,12.3,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse",Medium,"Reich DB, Winternitz S, Hennen J, et al. A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women. J Clin Psychiatry. 2004 Dec;65(12):1601-6. PMID: 15641864.",27284,2019
reich2004_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,21,B,Control,,9,,Control,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,9,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,"Mixed-design ANOVA, Cohen's d, and dependent sample t-test for change in mean score, Fisher's exact test for clinically meaningful response",Baseline,,,65.6,13.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,Mixed,"child physical abuse, child sexual abuse, child other abuse",Medium,"Reich DB, Winternitz S, Hennen J, et al. A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women. J Clin Psychiatry. 2004 Dec;65(12):1601-6. PMID: 15641864.",27284,2019
reinhardt2018_CAPS-pm_A_0_Comp,Complementary and integrative health (CIH),PTSD,51,A,PTSD,,9,,Kripalu yoga,Yoga,No,Not Applicable,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Group,In Person,26,Structured Clinical Interview,CAPS,CAPS past month,Completer,,"Repeated measures ANOVA, post hoc Tukey's honestly significant difference, and eta-squared effect sizes.",End of Treatment,0,,63.56,25.7,,,,,-9.77,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.1176,,0.8824,,,High,"Reinhardt KM, Noggle Taylor JJ, Johnston J, et al. Kripalu yoga for military veterans With PTSD: a randomized trial. J Clin Psychol. 2018 Jan;74(1):93-108. doi: 10.1002/jclp.22483. PMID: 28524358.",48190,2019
reinhardt2018_CAPS-pm_A_Baseline_Comp,Complementary and integrative health (CIH),PTSD,51,A,PTSD,,9,,Kripalu yoga,Yoga,No,Not Applicable,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Group,In Person,26,Structured Clinical Interview,CAPS,CAPS past month,Completer,,"Repeated measures ANOVA, post hoc Tukey's honestly significant difference, and eta-squared effect sizes.",Baseline,,,73.33,18.28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.1176,,0.8824,,,High,"Reinhardt KM, Noggle Taylor JJ, Johnston J, et al. Kripalu yoga for military veterans With PTSD: a randomized trial. J Clin Psychol. 2018 Jan;74(1):93-108. doi: 10.1002/jclp.22483. PMID: 28524358.",48190,2019
reinhardt2018_CAPS-pm_B_0_Comp,Complementary and integrative health (CIH),PTSD,51,B,Control,,6,,Control,Assessment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In Person,25,Structured Clinical Interview,CAPS,CAPS past month,Completer,,"Repeated measures ANOVA, post hoc Tukey's honestly significant difference, and eta-squared effect sizes.",End of Treatment,0,,67.83,23.04,,,,,-1.34,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.1176,,0.8824,,,High,"Reinhardt KM, Noggle Taylor JJ, Johnston J, et al. Kripalu yoga for military veterans With PTSD: a randomized trial. J Clin Psychol. 2018 Jan;74(1):93-108. doi: 10.1002/jclp.22483. PMID: 28524358.",48190,2019
reinhardt2018_CAPS-pm_B_Baseline_Comp,Complementary and integrative health (CIH),PTSD,51,B,Control,,6,,Control,Assessment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In Person,25,Structured Clinical Interview,CAPS,CAPS past month,Completer,,"Repeated measures ANOVA, post hoc Tukey's honestly significant difference, and eta-squared effect sizes.",Baseline,,,69.17,23.91,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.1176,,0.8824,,,High,"Reinhardt KM, Noggle Taylor JJ, Johnston J, et al. Kripalu yoga for military veterans With PTSD: a randomized trial. J Clin Psychol. 2018 Jan;74(1):93-108. doi: 10.1002/jclp.22483. PMID: 28524358.",48190,2019
reinhardt2018_CAPS-pw_A_0_Comp,Complementary and integrative health (CIH),PTSD,51,A,PTSD,,9,,Kripalu yoga,Yoga,No,Not Applicable,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Group,In Person,26,Structured Clinical Interview,CAPS,CAPS past week,Completer,,"Repeated measures ANOVA, post hoc Tukey's honestly significant difference, and eta-squared effect sizes.",End of Treatment,0,,58.22,26.47,,,,,-12.11,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.1176,,0.8824,,,High,"Reinhardt KM, Noggle Taylor JJ, Johnston J, et al. Kripalu yoga for military veterans With PTSD: a randomized trial. J Clin Psychol. 2018 Jan;74(1):93-108. doi: 10.1002/jclp.22483. PMID: 28524358.",48190,2019
reinhardt2018_CAPS-pw_A_Baseline_Comp,Complementary and integrative health (CIH),PTSD,51,A,PTSD,,9,,Kripalu yoga,Yoga,No,Not Applicable,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Group,In Person,26,Structured Clinical Interview,CAPS,CAPS past week,Completer,,"Repeated measures ANOVA, post hoc Tukey's honestly significant difference, and eta-squared effect sizes.",Baseline,,,70.33,18.55,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.1176,,0.8824,,,High,"Reinhardt KM, Noggle Taylor JJ, Johnston J, et al. Kripalu yoga for military veterans With PTSD: a randomized trial. J Clin Psychol. 2018 Jan;74(1):93-108. doi: 10.1002/jclp.22483. PMID: 28524358.",48190,2019
reinhardt2018_CAPS-pw_B_0_Comp,Complementary and integrative health (CIH),PTSD,51,B,Control,,6,,Control,Assessment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In Person,25,Structured Clinical Interview,CAPS,CAPS past week,Completer,,"Repeated measures ANOVA, post hoc Tukey's honestly significant difference, and eta-squared effect sizes.",End of Treatment,0,,61.17,20.97,,,,,-6.16,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.1176,,0.8824,,,High,"Reinhardt KM, Noggle Taylor JJ, Johnston J, et al. Kripalu yoga for military veterans With PTSD: a randomized trial. J Clin Psychol. 2018 Jan;74(1):93-108. doi: 10.1002/jclp.22483. PMID: 28524358.",48190,2019
reinhardt2018_CAPS-pw_B_Baseline_Comp,Complementary and integrative health (CIH),PTSD,51,B,Control,,6,,Control,Assessment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In Person,25,Structured Clinical Interview,CAPS,CAPS past week,Completer,,"Repeated measures ANOVA, post hoc Tukey's honestly significant difference, and eta-squared effect sizes.",Baseline,,,67.33,22.46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.1176,,0.8824,,,High,"Reinhardt KM, Noggle Taylor JJ, Johnston J, et al. Kripalu yoga for military veterans With PTSD: a randomized trial. J Clin Psychol. 2018 Jan;74(1):93-108. doi: 10.1002/jclp.22483. PMID: 28524358.",48190,2019
reinhardt2018_IES_A_0_NA,Complementary and integrative health (CIH),PTSD,51,A,PTSD,,,,Kripalu yoga,Yoga,No,Not Applicable,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Group,In Person,26,Self report,IES,IES-R,,,"Repeated measures ANOVA, post hoc Tukey's honestly significant difference, and eta-squared effect sizes.",End of Treatment,0,,1.59,1.01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.1176,,0.8824,,,High,"Reinhardt KM, Noggle Taylor JJ, Johnston J, et al. Kripalu yoga for military veterans With PTSD: a randomized trial. J Clin Psychol. 2018 Jan;74(1):93-108. doi: 10.1002/jclp.22483. PMID: 28524358.",48190,2019
reinhardt2018_IES_A_Baseline_NA,Complementary and integrative health (CIH),PTSD,51,A,PTSD,,,,Kripalu yoga,Yoga,No,Not Applicable,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Group,In Person,26,Self report,IES,IES-R,,,"Repeated measures ANOVA, post hoc Tukey's honestly significant difference, and eta-squared effect sizes.",Baseline,,,42.46,22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.1176,,0.8824,,,High,"Reinhardt KM, Noggle Taylor JJ, Johnston J, et al. Kripalu yoga for military veterans With PTSD: a randomized trial. J Clin Psychol. 2018 Jan;74(1):93-108. doi: 10.1002/jclp.22483. PMID: 28524358.",48190,2019
reinhardt2018_IES_B_0_NA,Complementary and integrative health (CIH),PTSD,51,B,Control,,,,Control,Assessment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In Person,25,Self report,IES,IES-R,,,"Repeated measures ANOVA, post hoc Tukey's honestly significant difference, and eta-squared effect sizes.",End of Treatment,0,,2.50,1.44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.1176,,0.8824,,,High,"Reinhardt KM, Noggle Taylor JJ, Johnston J, et al. Kripalu yoga for military veterans With PTSD: a randomized trial. J Clin Psychol. 2018 Jan;74(1):93-108. doi: 10.1002/jclp.22483. PMID: 28524358.",48190,2019
reinhardt2018_IES_B_Baseline_NA,Complementary and integrative health (CIH),PTSD,51,B,Control,,,,Control,Assessment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In Person,25,Self report,IES,IES-R,,,"Repeated measures ANOVA, post hoc Tukey's honestly significant difference, and eta-squared effect sizes.",Baseline,,,50.16,26.18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.1176,,0.8824,,,High,"Reinhardt KM, Noggle Taylor JJ, Johnston J, et al. Kripalu yoga for military veterans With PTSD: a randomized trial. J Clin Psychol. 2018 Jan;74(1):93-108. doi: 10.1002/jclp.22483. PMID: 28524358.",48190,2019
reinhardt2018_PCL_A_0_NA,Complementary and integrative health (CIH),PTSD,51,A,PTSD,,,,Kripalu yoga,Yoga,No,Not Applicable,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Group,In Person,26,Self report,PCL,PCL-M,,,"Repeated measures ANOVA, post hoc Tukey's honestly significant difference, and eta-squared effect sizes.",End of Treatment,0,,43.00,14.28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.1176,,0.8824,,,High,"Reinhardt KM, Noggle Taylor JJ, Johnston J, et al. Kripalu yoga for military veterans With PTSD: a randomized trial. J Clin Psychol. 2018 Jan;74(1):93-108. doi: 10.1002/jclp.22483. PMID: 28524358.",48190,2019
reinhardt2018_PCL_A_Baseline_NA,Complementary and integrative health (CIH),PTSD,51,A,PTSD,,,,Kripalu yoga,Yoga,No,Not Applicable,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Group,In Person,26,Self report,PCL,PCL-M,,,"Repeated measures ANOVA, post hoc Tukey's honestly significant difference, and eta-squared effect sizes.",Baseline,,,51.50,9.68,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.1176,,0.8824,,,High,"Reinhardt KM, Noggle Taylor JJ, Johnston J, et al. Kripalu yoga for military veterans With PTSD: a randomized trial. J Clin Psychol. 2018 Jan;74(1):93-108. doi: 10.1002/jclp.22483. PMID: 28524358.",48190,2019
reinhardt2018_PCL_B_0_NA,Complementary and integrative health (CIH),PTSD,51,B,Control,,,,Control,Assessment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In Person,25,Self report,PCL,PCL-M,,,"Repeated measures ANOVA, post hoc Tukey's honestly significant difference, and eta-squared effect sizes.",End of Treatment,0,,58.00,17.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.1176,,0.8824,,,High,"Reinhardt KM, Noggle Taylor JJ, Johnston J, et al. Kripalu yoga for military veterans With PTSD: a randomized trial. J Clin Psychol. 2018 Jan;74(1):93-108. doi: 10.1002/jclp.22483. PMID: 28524358.",48190,2019
reinhardt2018_PCL_B_Baseline_NA,Complementary and integrative health (CIH),PTSD,51,B,Control,,,,Control,Assessment,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In Person,25,Self report,PCL,PCL-M,,,"Repeated measures ANOVA, post hoc Tukey's honestly significant difference, and eta-squared effect sizes.",Baseline,,,57.00,16.99,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.1176,,0.8824,,,High,"Reinhardt KM, Noggle Taylor JJ, Johnston J, et al. Kripalu yoga for military veterans With PTSD: a randomized trial. J Clin Psychol. 2018 Jan;74(1):93-108. doi: 10.1002/jclp.22483. PMID: 28524358.",48190,2019
resick2002_CAPS_A_0_Comp,Psychotherapy,PTSD,171,A,PTSD,,41,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Structured Clinical Interview,CAPS,CAPS,Completer,,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,End of Treatment,0,,20.66,15.6,,,,,-53.05,,,,,,,,,,p<0.0001,,,,,,,,No longer meeting criteria for PTSD according to the CAPS,0.805,,≤20 on PSS and ≤10 on BDI,0.76,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_CAPS_A_0_ITT,Psychotherapy,PTSD,171,A,PTSD,,62,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF; mixed-effects regression (separate analyses),ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,End of Treatment,0,,39.08,31.12,,,,,-35.68,,,,,,,,,,,,,,,,,,No longer meeting criteria for PTSD according to the CAPS,0.5322,,≤20 on PSS and ≤10 on BDI,0.53,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_CAPS_A_12_Comp,Psychotherapy,PTSD,171,A,PTSD,,37,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Structured Clinical Interview,CAPS,CAPS,Completer,,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Assessment at 3 to <6 Months,12,,26.78,20.03,,,,,-46.93,,,,,,,,,,,,,,,,,,No longer meeting criteria for PTSD according to the CAPS,0.84,,≤20 on PSS and ≤10 on BDI,0.72,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_CAPS_A_12_ITT,Psychotherapy,PTSD,171,A,PTSD,,62,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF; mixed-effects regression (separate analyses),ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Assessment at 3 to <6 Months,12,,42.21,30.13,,,,,-32.55,,,,,,,,,,,,,,,,,,No longer meeting criteria for PTSD according to the CAPS,0.58,,≤20 on PSS and ≤10 on BDI,0.5,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_CAPS_A_39_Comp,Psychotherapy,PTSD,171,A,PTSD,,26,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Structured Clinical Interview,CAPS,CAPS,Completer,,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Assessment at 6 to <12 Months,39,,29.27,23.56,,,,,-44.44,,,,,,,,,,,,,,,,,,No longer meeting criteria for PTSD according to the CAPS,0.81,,≤20 on PSS and ≤10 on BDI,0.64,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_CAPS_A_39_ITT,Psychotherapy,PTSD,171,A,PTSD,,62,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF; mixed-effects regression (separate analyses),ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Assessment at 6 to <12 Months,39,,42.87,31.06,,,,,-31.89,,,,,,,,,,,,,,,,,,No longer meeting criteria for PTSD according to the CAPS,0.55,,≤20 on PSS and ≤10 on BDI,0.45,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,171,A,PTSD,,41,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Structured Clinical Interview,CAPS,CAPS,Completer,,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Baseline,,,73.71,18.47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,171,A,PTSD,,62,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF; mixed-effects regression (separate analyses),ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Baseline,,,74.76,18.77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_CAPS_B_0_Comp,Psychotherapy,PTSD,171,B,PTSD,,40,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Structured Clinical Interview,CAPS,CAPS,Completer,,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,End of Treatment,0,,25.4,23.54,,,,,-51.03,,,,,,,,,,p<0.0001,,,,,,,,No longer meeting criteria for PTSD according to the CAPS,0.825,,≤20 on PSS and ≤10 on BDI,0.58,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_CAPS_B_0_ITT,Psychotherapy,PTSD,171,B,PTSD,,62,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF; mixed-effects regression (separate analyses),ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,End of Treatment,0,,44.89,33.52,,,,,-31.71,,,,,,,,,,,,,,,,,,No longer meeting criteria for PTSD according to the CAPS,0.5322,,≤20 on PSS and ≤10 on BDI,0.37,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_CAPS_B_12_Comp,Psychotherapy,PTSD,171,B,PTSD,,37,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Structured Clinical Interview,CAPS,CAPS,Completer,,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Assessment at 3 to <6 Months,12,,34.27,26.89,,,,,-42.16,,,,,,,,,,,,,,,,,,No longer meeting criteria for PTSD according to the CAPS,0.703,,≤20 on PSS and ≤10 on BDI,0.5,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_CAPS_B_12_ITT,Psychotherapy,PTSD,171,B,PTSD,,62,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF; mixed-effects regression (separate analyses),ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Assessment at 3 to <6 Months,12,,49.16,32.86,,,,,-27.44,,,,,,,,,,,,,,,,,,No longer meeting criteria for PTSD according to the CAPS,0.47,,≤20 on PSS and ≤10 on BDI,0.36,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_CAPS_B_39_Comp,Psychotherapy,PTSD,171,B,PTSD,,26,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Structured Clinical Interview,CAPS,CAPS,Completer,,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Assessment at 6 to <12 Months,39,,24.12,18.78,,,,,-52.31,,,,,Pillai's trace,0.53,,,,p<0.001,,,,,,,,No longer meeting criteria for PTSD according to the CAPS,0.846,,≤20 on PSS and ≤10 on BDI,0.68,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_CAPS_B_39_ITT,Psychotherapy,PTSD,171,B,PTSD,,62,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF; mixed-effects regression (separate analyses),ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Assessment at 6 to <12 Months,39,,46.98,33.68,,,,,-29.62,,,,,Pillai's trace,0.53,,,,p<0.001,,,,,,,,No longer meeting criteria for PTSD according to the CAPS,0.5,,≤20 on PSS and ≤10 on BDI,0.4,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,171,B,PTSD,,40,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Structured Clinical Interview,CAPS,CAPS,Completer,,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Baseline,,,76.43,19.11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,171,B,PTSD,,62,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF; mixed-effects regression (separate analyses),ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Baseline,,,76.6,19.72,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_CAPS_C_0_Comp,Psychotherapy,PTSD,171,C,Control,,40,,Waitlist with minimal attention,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,47,Structured Clinical Interview,CAPS,CAPS,Completer,,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,End of Treatment,0,,69.73,19.19,,,,,-0.15,,,,,,,,,,p=NS,,,,,,,,No longer meeting criteria for PTSD according to the CAPS,,,≤20 on PSS and ≤10 on BDI,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_CAPS_C_0_ITT,Psychotherapy,PTSD,171,C,Control,,47,,Waitlist with minimal attention,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,47,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF; mixed-effects regression (separate analyses),ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,End of Treatment,0,,69.26,18.55,,,,,-0.59,,,,,,,,,,p=NS,,,,,,,,No longer meeting criteria for PTSD according to the CAPS,0.0222,,≤20 on PSS and ≤10 on BDI,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_CAPS_C_Baseline_Comp,Psychotherapy,PTSD,171,C,Control,,40,,Waitlist with minimal attention,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,47,Structured Clinical Interview,CAPS,CAPS,Completer,,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Baseline,,,69.88,19.91,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_CAPS_C_Baseline_ITT,Psychotherapy,PTSD,171,C,Control,,47,,Waitlist with minimal attention,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,47,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF; mixed-effects regression (separate analyses),ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Baseline,,,69.85,19.57,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_PSS_A_0_Comp,Psychotherapy,PTSD,171,A,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Self report,PSS,PSS,Completer,,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,End of Treatment,0,,8.30,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_PSS_A_0_ITT,Psychotherapy,PTSD,171,A,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Self report,PSS,PSS,ITT,LOCF,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,End of Treatment,0,,13.66,11.05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_PSS_A_12_Comp,Psychotherapy,PTSD,171,A,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Self report,PSS,PSS,Completer,,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Assessment at 3 to <6 Months,12,,9.75,9.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_PSS_A_12_ITT,Psychotherapy,PTSD,171,A,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Self report,PSS,PSS,ITT,LOCF,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Assessment at 3 to <6 Months,12,,14.67,11.79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_PSS_A_39_Comp,Psychotherapy,PTSD,171,A,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Self report,PSS,PSS,Completer,,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Assessment at 6 to <12 Months,39,,9.53,9.28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_PSS_A_39_ITT,Psychotherapy,PTSD,171,A,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Self report,PSS,PSS,ITT,LOCF,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Assessment at 6 to <12 Months,39,,15.13,12.03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_PSS_A_Baseline_Comp,Psychotherapy,PTSD,171,A,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Self report,PSS,PSS,Completer,,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Baseline,,,29.22,8.72,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_PSS_A_Baseline_ITT,Psychotherapy,PTSD,171,A,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Self report,PSS,PSS,ITT,LOCF,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Baseline,,,29.55,8.62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_PSS_B_0_Comp,Psychotherapy,PTSD,171,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Self report,PSS,PSS,Completer,,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,End of Treatment,0,,11.80,9.87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_PSS_B_0_ITT,Psychotherapy,PTSD,171,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Self report,PSS,PSS,ITT,LOCF,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,End of Treatment,0,,17.99,13.17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_PSS_B_12_Comp,Psychotherapy,PTSD,171,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Self report,PSS,PSS,Completer,,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Assessment at 3 to <6 Months,12,,12.72,10.98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_PSS_B_12_ITT,Psychotherapy,PTSD,171,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Self report,PSS,PSS,ITT,LOCF,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Assessment at 3 to <6 Months,12,,18.05,13.78,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_PSS_B_39_Comp,Psychotherapy,PTSD,171,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Self report,PSS,PSS,Completer,,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Assessment at 6 to <12 Months,39,,10.23,9.12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_PSS_B_39_ITT,Psychotherapy,PTSD,171,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Self report,PSS,PSS,ITT,LOCF,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Assessment at 6 to <12 Months,39,,18.40,13.98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_PSS_B_Baseline_Comp,Psychotherapy,PTSD,171,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Self report,PSS,PSS,Completer,,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Baseline,,,29.93,8.84,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_PSS_B_Baseline_ITT,Psychotherapy,PTSD,171,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,62,Self report,PSS,PSS,ITT,LOCF,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Baseline,,,30.09,9.18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_PSS_C_0_Comp,Psychotherapy,PTSD,171,C,Control,,,,Waitlist with minimal attention,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,47,Self report,PSS,PSS,Completer,,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,End of Treatment,0,,27.95,8.41,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_PSS_C_0_ITT,Psychotherapy,PTSD,171,C,Control,,,,Waitlist with minimal attention,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,47,Self report,PSS,PSS,ITT,LOCF,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,End of Treatment,0,,27.77,8.12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_PSS_C_Baseline_Comp,Psychotherapy,PTSD,171,C,Control,,,,Waitlist with minimal attention,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,47,Self report,PSS,PSS,Completer,,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Baseline,,,28.94,7.47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2002_PSS_C_Baseline_ITT,Psychotherapy,PTSD,171,C,Control,,,,Waitlist with minimal attention,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,47,Self report,PSS,PSS,ITT,LOCF,ITT with LOCF and completer using MANOVA followed by one-way ANOVA with post hoc Tukey's honestly significant difference test for change in mean scores; ITT using mixed effect regression; chi-square for diagnostic change and clinically meaningful response,Baseline,,,28.70,7.33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child sexual abuse, rape/sexual assault",Medium,"Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.",14652,2019
resick2008_CAPS_A_0_Comp,Psychotherapy,PTSD,162,A,PTSD,,27,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,56,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF for PTSD diagnostic change,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS (frequency ≥1 and severity ≥2),0.7037,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_CAPS_A_0_ITT,Psychotherapy,PTSD,162,A,PTSD,,42,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,56,Structured Clinical Interview,CAPS,CAPS,ITT,"LOCF for PTSD diagnostic change, hierarchical linear modeling estimates missing values for CAPS continuous measure",Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,End of Treatment,0,,34.74,27.62,,,,,-35.45,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS (frequency ≥1 and severity ≥2),0.5472,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_CAPS_A_26_Comp,Psychotherapy,PTSD,162,A,PTSD,,26,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,56,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF for PTSD diagnostic change,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Assessment at 6 to <12 Months,26,,,,,,,,,,,,,Cohen's d,-2.03,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to CAPS (frequency ≥1 and severity ≥2),0.7407,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_CAPS_A_26_ITT,Psychotherapy,PTSD,162,A,PTSD,,45,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,56,Structured Clinical Interview,CAPS,CAPS,ITT,"LOCF for PTSD diagnostic change, hierarchical linear modeling estimates missing values for CAPS continuous measure",Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Assessment at 6 to <12 Months,26,,31.96,28.46,,,,,-38.23,,,,,Cohen's d,-1.68,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to CAPS (frequency ≥1 and severity ≥2),0.6038,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,162,A,PTSD,,27,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,56,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF for PTSD diagnostic change,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,162,A,PTSD,,53,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,56,Structured Clinical Interview,CAPS,CAPS,ITT,"LOCF for PTSD diagnostic change, hierarchical linear modeling estimates missing values for CAPS continuous measure",Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Baseline,,,70.19,15.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_CAPS_B_0_Comp,Psychotherapy,PTSD,162,B,PTSD,,27,,Written account,Written narrative exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,51,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF for PTSD diagnostic change,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS (frequency ≥1 and severity ≥2),0.6333,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_CAPS_B_0_ITT,Psychotherapy,PTSD,162,B,PTSD,,38,,Written account,Written narrative exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,51,Structured Clinical Interview,CAPS,CAPS,ITT,"LOCF for PTSD diagnostic change, hierarchical linear modeling estimates missing values for CAPS continuous measure",Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,End of Treatment,0,,44.76,31.55,,,,,-25.62,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS (frequency ≥1 and severity ≥2),0.42,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_CAPS_B_26_Comp,Psychotherapy,PTSD,162,B,PTSD,,27,,Written account,Written narrative exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,51,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF for PTSD diagnostic change,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Assessment at 6 to <12 Months,26,,,,,,,,,,,,,Cohen's d,-1.98,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to CAPS (frequency ≥1 and severity ≥2),0.7333,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_CAPS_B_26_ITT,Psychotherapy,PTSD,162,B,PTSD,,40,,Written account,Written narrative exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,51,Structured Clinical Interview,CAPS,CAPS,ITT,"LOCF for PTSD diagnostic change, hierarchical linear modeling estimates missing values for CAPS continuous measure",Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Assessment at 6 to <12 Months,26,,35.9,27.09,,,,,-34.48,,,,,Cohen's d,-1.54,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to CAPS (frequency ≥1 and severity ≥2),0.56,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,162,B,PTSD,,30,,Written account,Written narrative exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,51,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF for PTSD diagnostic change,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,162,B,PTSD,,50,,Written account,Written narrative exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,51,Structured Clinical Interview,CAPS,CAPS,ITT,"LOCF for PTSD diagnostic change, hierarchical linear modeling estimates missing values for CAPS continuous measure",Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Baseline,,,70.38,18.65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_CAPS_C_0_Comp,Psychotherapy,PTSD,162,C,PTSD,,29,,CPT-cognitive therapy,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,55,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF for PTSD diagnostic change,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS (frequency ≥1 and severity ≥2),0.7931,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_CAPS_C_0_ITT,Psychotherapy,PTSD,162,C,PTSD,,37,,CPT-cognitive therapy,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,55,Structured Clinical Interview,CAPS,CAPS,ITT,"LOCF for PTSD diagnostic change, hierarchical linear modeling estimates missing values for CAPS continuous measure",Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,End of Treatment,0,,31.32,37,,,,,-42.55,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS (frequency ≥1 and severity ≥2),0.6596,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_CAPS_C_26_Comp,Psychotherapy,PTSD,162,C,PTSD,,29,,CPT-cognitive therapy,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,55,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF for PTSD diagnostic change,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Assessment at 6 to <12 Months,26,,,,,,,,,,,,,Cohen's d,-2.18,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to CAPS (frequency ≥1 and severity ≥2),0.7931,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_CAPS_C_26_ITT,Psychotherapy,PTSD,162,C,PTSD,,36,,CPT-cognitive therapy,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,55,Structured Clinical Interview,CAPS,CAPS,ITT,"LOCF for PTSD diagnostic change, hierarchical linear modeling estimates missing values for CAPS continuous measure",Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Assessment at 6 to <12 Months,26,,31.03,27.57,,,,,-42.84,,,,,Cohen's d,-1.82,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to CAPS (frequency ≥1 and severity ≥2),0.617,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_CAPS_C_Baseline_Comp,Psychotherapy,PTSD,162,C,PTSD,,29,,CPT-cognitive therapy,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,55,Structured Clinical Interview,CAPS,CAPS,Completer,LOCF for PTSD diagnostic change,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_CAPS_C_Baseline_ITT,Psychotherapy,PTSD,162,C,PTSD,,47,,CPT-cognitive therapy,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,55,Structured Clinical Interview,CAPS,CAPS,ITT,"LOCF for PTSD diagnostic change, hierarchical linear modeling estimates missing values for CAPS continuous measure",Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Baseline,,,73.87,21.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_PDS_A_0_ITT,Psychotherapy,PTSD,162,A,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,56,Self report,PDS,PDS,ITT,,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,End of Treatment,0,,13.98,11.77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_PDS_A_26_ITT,Psychotherapy,PTSD,162,A,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,56,Self report,PDS,PDS,ITT,,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Assessment at 6 to <12 Months,26,,12.11,11.94,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_PDS_A_Baseline_ITT,Psychotherapy,PTSD,162,A,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,56,Self report,PDS,PDS,ITT,,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Baseline,,,29.15,9.54,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_PDS_B_0_ITT,Psychotherapy,PTSD,162,B,PTSD,,,,Written account,Written narrative exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,51,Self report,PDS,PDS,ITT,,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,End of Treatment,0,,18.79,15.09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_PDS_B_26_ITT,Psychotherapy,PTSD,162,B,PTSD,,,,Written account,Written narrative exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,51,Self report,PDS,PDS,ITT,,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Assessment at 6 to <12 Months,26,,14.62,12.57,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_PDS_B_Baseline_ITT,Psychotherapy,PTSD,162,B,PTSD,,,,Written account,Written narrative exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,51,Self report,PDS,PDS,ITT,,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Baseline,,,29.35,9.72,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_PDS_C_0_ITT,Psychotherapy,PTSD,162,C,PTSD,,,,CPT-cognitive therapy,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,55,Self report,PDS,PDS,ITT,,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,End of Treatment,0,,12.89,12.06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_PDS_C_26_ITT,Psychotherapy,PTSD,162,C,PTSD,,,,CPT-cognitive therapy,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,55,Self report,PDS,PDS,ITT,,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Assessment at 6 to <12 Months,26,,12.22,11.42,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2008_PDS_C_Baseline_ITT,Psychotherapy,PTSD,162,C,PTSD,,,,CPT-cognitive therapy,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,55,Self report,PDS,PDS,ITT,,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Baseline,,,28.48,9.51,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence",Medium,"Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.",30597,2019
resick2015_PCL_A_0_Comp,Psychotherapy,PTSD,108,A,PTSD,,,,CPT-Cognitive only version,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,56,Self report,PCL,PCL-S,Completer,Imputed,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,End of Treatment,0,,47.8,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.0741,,0.9259,Mixed,"combat-related, child sexual abuse",Medium,"Resick PA, Wachen JS, Mintz J, et al. A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015 Dec;83(6):1058-68. doi: 10.1037/ccp0000016. PMID: 25939018.",43929,2020
resick2015_PCL_A_26_Comp,Psychotherapy,PTSD,108,A,PTSD,,,,CPT-Cognitive only version,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,56,Self report,PCL,PCL-S,Completer,Imputed,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Assessment at 6 to <12 Months,26,,46.8,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.0741,,0.9259,Mixed,"combat-related, child sexual abuse",Medium,"Resick PA, Wachen JS, Mintz J, et al. A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015 Dec;83(6):1058-68. doi: 10.1037/ccp0000016. PMID: 25939018.",43929,2020
resick2015_PCL_A_52_Comp,Psychotherapy,PTSD,108,A,PTSD,,,,CPT-Cognitive only version,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,56,Self report,PCL,PCL-S,Completer,Imputed,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Assessment at ≥12 Months,52,,46.1,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.0741,,0.9259,Mixed,"combat-related, child sexual abuse",Medium,"Resick PA, Wachen JS, Mintz J, et al. A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015 Dec;83(6):1058-68. doi: 10.1037/ccp0000016. PMID: 25939018.",43929,2020
resick2015_PCL_A_Baseline_Comp,Psychotherapy,PTSD,108,A,PTSD,,,,CPT-Cognitive only version,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,56,Self report,PCL,PCL-S,Completer,Imputed,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Baseline,,,59.3,10.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.0741,,0.9259,Mixed,"combat-related, child sexual abuse",Medium,"Resick PA, Wachen JS, Mintz J, et al. A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015 Dec;83(6):1058-68. doi: 10.1037/ccp0000016. PMID: 25939018.",43929,2020
resick2015_PCL_B_0_Comp,Psychotherapy,PTSD,108,B,PTSD,,,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,52,Self report,PCL,PCL-S,Completer,Imputed,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,End of Treatment,0,,51.2,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.0741,,0.9259,Mixed,"combat-related, child sexual abuse",Medium,"Resick PA, Wachen JS, Mintz J, et al. A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015 Dec;83(6):1058-68. doi: 10.1037/ccp0000016. PMID: 25939018.",43929,2020
resick2015_PCL_B_26_Comp,Psychotherapy,PTSD,108,B,PTSD,,,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,52,Self report,PCL,PCL-S,Completer,Imputed,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Assessment at 6 to <12 Months,26,,50.2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.0741,,0.9259,Mixed,"combat-related, child sexual abuse",Medium,"Resick PA, Wachen JS, Mintz J, et al. A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015 Dec;83(6):1058-68. doi: 10.1037/ccp0000016. PMID: 25939018.",43929,2020
resick2015_PCL_B_52_Comp,Psychotherapy,PTSD,108,B,PTSD,,,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,52,Self report,PCL,PCL-S,Completer,Imputed,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Assessment at ≥12 Months,52,,48.6,2.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.0741,,0.9259,Mixed,"combat-related, child sexual abuse",Medium,"Resick PA, Wachen JS, Mintz J, et al. A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015 Dec;83(6):1058-68. doi: 10.1037/ccp0000016. PMID: 25939018.",43929,2020
resick2015_PCL_B_Baseline_Comp,Psychotherapy,PTSD,108,B,PTSD,,,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,52,Self report,PCL,PCL-S,Completer,Imputed,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Baseline,,,58.5,10.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.0741,,0.9259,Mixed,"combat-related, child sexual abuse",Medium,"Resick PA, Wachen JS, Mintz J, et al. A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015 Dec;83(6):1058-68. doi: 10.1037/ccp0000016. PMID: 25939018.",43929,2020
resick2015_PSS-I_A_0_Comp,Psychotherapy,PTSD,108,A,PTSD,,45,,CPT-Cognitive only version,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,56,Structured Clinical Interview,PSS-I,PSS-I,Completer,Imputed,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,End of Treatment,0,,23.0,1.3,,,,,-4.7,,,,,Cohen's d,0.66,,,,p=0.001,,,,,,,,,,,≥10-point change on PCL-S,0.49,,Active Duty Military,1,0,0,0.0741,,0.9259,Mixed,"combat-related, child sexual abuse",Medium,"Resick PA, Wachen JS, Mintz J, et al. A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015 Dec;83(6):1058-68. doi: 10.1037/ccp0000016. PMID: 25939018.",43929,2020
resick2015_PSS-I_A_26_Comp,Psychotherapy,PTSD,108,A,PTSD,,34,,CPT-Cognitive only version,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,56,Structured Clinical Interview,PSS-I,PSS-I,Completer,Imputed,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Assessment at 6 to <12 Months,26,,20.0,1.5,,,,,-7.7,,,,,,,,,,p<0.0001,,,,,,,,,,,≥10-point change on PCL-S,0.59,,Active Duty Military,1,0,0,0.0741,,0.9259,Mixed,"combat-related, child sexual abuse",Medium,"Resick PA, Wachen JS, Mintz J, et al. A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015 Dec;83(6):1058-68. doi: 10.1037/ccp0000016. PMID: 25939018.",43929,2020
resick2015_PSS-I_A_52_Comp,Psychotherapy,PTSD,108,A,PTSD,,26,,CPT-Cognitive only version,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,56,Structured Clinical Interview,PSS-I,PSS-I,Completer,Imputed,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Assessment at ≥12 Months,52,,19.0,1.4,,,,,-8.7,,,,,Cohen's d,1.21,,,,p<0.0001,,,,,,,,,,,≥10-point change on PCL-S,0.56,,Active Duty Military,1,0,0,0.0741,,0.9259,Mixed,"combat-related, child sexual abuse",Medium,"Resick PA, Wachen JS, Mintz J, et al. A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015 Dec;83(6):1058-68. doi: 10.1037/ccp0000016. PMID: 25939018.",43929,2020
resick2015_PSS-I_A_Baseline_Comp,Psychotherapy,PTSD,108,A,PTSD,,56,,CPT-Cognitive only version,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,56,Structured Clinical Interview,PSS-I,PSS-I,Completer,Imputed,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Baseline,,,27.7,7.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.0741,,0.9259,Mixed,"combat-related, child sexual abuse",Medium,"Resick PA, Wachen JS, Mintz J, et al. A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015 Dec;83(6):1058-68. doi: 10.1037/ccp0000016. PMID: 25939018.",43929,2020
resick2015_PSS-I_B_0_Comp,Psychotherapy,PTSD,108,B,PTSD,,49,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,52,Structured Clinical Interview,PSS-I,PSS-I,Completer,Imputed,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,End of Treatment,0,,23.9,1.3,,,,,-3.2,,,,,Cohen's d,0.45,,,,p=0.013,,,,,,,,,,,≥10-point change on PCL-S,0.34,,Active Duty Military,1,0,0,0.0741,,0.9259,Mixed,"combat-related, child sexual abuse",Medium,"Resick PA, Wachen JS, Mintz J, et al. A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015 Dec;83(6):1058-68. doi: 10.1037/ccp0000016. PMID: 25939018.",43929,2020
resick2015_PSS-I_B_26_Comp,Psychotherapy,PTSD,108,B,PTSD,,37,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,52,Structured Clinical Interview,PSS-I,PSS-I,Completer,Imputed,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Assessment at 6 to <12 Months,26,,21.0,1.5,,,,,-6.1,,,,,,,,,,p<0.0001,,,,,,,,,,,≥10-point change on PCL-S,0.41,,Active Duty Military,1,0,0,0.0741,,0.9259,Mixed,"combat-related, child sexual abuse",Medium,"Resick PA, Wachen JS, Mintz J, et al. A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015 Dec;83(6):1058-68. doi: 10.1037/ccp0000016. PMID: 25939018.",43929,2020
resick2015_PSS-I_B_52_Comp,Psychotherapy,PTSD,108,B,PTSD,,28,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,52,Structured Clinical Interview,PSS-I,PSS-I,Completer,Imputed,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Assessment at ≥12 Months,52,,19.9,1.4,,,,,-7.2,,,,,,,,,,p<0.0001,,,,,,,,,,,≥10-point change on PCL-S,0.5,,Active Duty Military,1,0,0,0.0741,,0.9259,Mixed,"combat-related, child sexual abuse",Medium,"Resick PA, Wachen JS, Mintz J, et al. A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015 Dec;83(6):1058-68. doi: 10.1037/ccp0000016. PMID: 25939018.",43929,2020
resick2015_PSS-I_B_Baseline_Comp,Psychotherapy,PTSD,108,B,PTSD,,52,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,52,Structured Clinical Interview,PSS-I,PSS-I,Completer,Imputed,Hierarchical linear modeling for CAPS continuous; linear mixed-effects regression with maximum likelihood estimation for PDS; chi-squared for loss of diagnosis,Baseline,,,27.1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.0741,,0.9259,Mixed,"combat-related, child sexual abuse",Medium,"Resick PA, Wachen JS, Mintz J, et al. A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015 Dec;83(6):1058-68. doi: 10.1037/ccp0000016. PMID: 25939018.",43929,2020
resick2017_PCL_A_0_Comp,Psychotherapy,PTSD,268,A,PTSD,,,,Group CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,133,Self report,PCL,PCL-S,Completer,,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,End of Treatment,0,,47.8,,SE,1.86,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PCL_A_0_ITT,Psychotherapy,PTSD,268,A,PTSD,,,,Group CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,133,Self report,PCL,PCL-S,ITT,,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,End of Treatment,0,,48.9,,SE,1.52,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PCL_A_26_Comp,Psychotherapy,PTSD,268,A,PTSD,,,,Group CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,133,Self report,PCL,PCL-S,Completer,,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,Assessment at 6 to <12 Months,26,,47.6,,SE,2.14,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PCL_A_26_ITT,Psychotherapy,PTSD,268,A,PTSD,,,,Group CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,133,Self report,PCL,PCL-S,ITT,,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,Assessment at 6 to <12 Months,26,,48.7,,SE,1.79,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PCL_A_Baseline_Comp,Psychotherapy,PTSD,268,A,PTSD,,,,Group CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,133,Self report,PCL,PCL-S,Completer,,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,Baseline,,,53.7,,SE,1.25,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PCL_A_Baseline_ITT,Psychotherapy,PTSD,268,A,PTSD,,,,Group CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,133,Self report,PCL,PCL-S,ITT,,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,Baseline,,,55.2,,SE,0.91,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PCL_B_0_Comp,Psychotherapy,PTSD,268,B,PTSD,,,,Individual CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,135,Self report,PCL,PCL-S,Completer,,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,End of Treatment,0,,41.0,,SE,1.77,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PCL_B_0_ITT,Psychotherapy,PTSD,268,B,PTSD,,,,Individual CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,135,Self report,PCL,PCL-S,ITT,,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,End of Treatment,0,,42.5,,SE,1.53,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PCL_B_26_Comp,Psychotherapy,PTSD,268,B,PTSD,,,,Individual CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,135,Self report,PCL,PCL-S,Completer,,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,Assessment at 6 to <12 Months,26,,43.2,,SE,1.96,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PCL_B_26_ITT,Psychotherapy,PTSD,268,B,PTSD,,,,Individual CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,135,Self report,PCL,PCL-S,ITT,,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,Assessment at 6 to <12 Months,26,,44.3,,SE,1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PCL_B_Baseline_Comp,Psychotherapy,PTSD,268,B,PTSD,,,,Individual CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,135,Self report,PCL,PCL-S,Completer,,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,Baseline,,,54.9,,SE,1.18,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PCL_B_Baseline_ITT,Psychotherapy,PTSD,268,B,PTSD,,,,Individual CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,135,Self report,PCL,PCL-S,ITT,,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,Baseline,,,55.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PSS-I_A_0_Comp,Psychotherapy,PTSD,268,A,PTSD,,61,,Group CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,133,Structured Clinical Interview,PSS-I,PSS-I,Completer,general linear mixed regression models,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,End of Treatment,0,,20.6,,SE,1.21,,SE 1.20,-3.7,,,,,Cohen's d,0.6,,,,p=0.003,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.41,,,,,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PSS-I_A_0_ITT,Psychotherapy,PTSD,268,A,PTSD,,82,,Group CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,133,Structured Clinical Interview,PSS-I,PSS-I,ITT,general linear mixed regression models,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,End of Treatment,0,,20.4,,SE,0.98,,SE 0.97,-4,,,,,Cohen's d,0.66,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.37,,"RCI for PSS-I (alpha = 0.62, SD 6.0)",0.17,Additional definitions of Clinically Meaningful Response reported in the study,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PSS-I_A_26_Comp,Psychotherapy,PTSD,268,A,PTSD,,42,,Group CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,133,Structured Clinical Interview,PSS-I,PSS-I,Completer,general linear mixed regression models,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,Assessment at 6 to <12 Months,26,,19.2,,SE,1.31,,SE 1.34,-5.2,,,,,Cohen's d,0.84,,,,p=0.002,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.43,,,,,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PSS-I_A_26_ITT,Psychotherapy,PTSD,268,A,PTSD,,51,,Group CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,133,Structured Clinical Interview,PSS-I,PSS-I,ITT,general linear mixed regression models,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,Assessment at 6 to <12 Months,26,,19.2,,SE,1.13,,SE 1.14,-5.2,,,,,Cohen's d,0.86,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.39,,"RCI for PSS-I (alpha = 0.62, SD 6.0)",0.21,Additional definitions of Clinically Meaningful Response reported in the study,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PSS-I_A_Baseline_Comp,Psychotherapy,PTSD,268,A,PTSD,,73,,Group CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,133,Structured Clinical Interview,PSS-I,PSS-I,Completer,general linear mixed regression models,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,Baseline,,,24.3,,SE,0.72,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PSS-I_A_Baseline_ITT,Psychotherapy,PTSD,268,A,PTSD,,133,,Group CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,133,Structured Clinical Interview,PSS-I,PSS-I,ITT,general linear mixed regression models,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,Baseline,,,24.4,,SE,0.52,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PSS-I_B_0_Comp,Psychotherapy,PTSD,268,B,PTSD,,68,,Individual CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,135,Structured Clinical Interview,PSS-I,PSS-I,Completer,general linear mixed regression models,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,End of Treatment,0,,16,,SE,1.13,,SE 1.13,-8.1,,,,,Cohen's d,1.31,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.52,,,,,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PSS-I_B_0_ITT,Psychotherapy,PTSD,268,B,PTSD,,83,,Individual CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,135,Structured Clinical Interview,PSS-I,PSS-I,ITT,general linear mixed regression models,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,End of Treatment,0,,16.4,,SE,0.98,,SE 0.96,-7.8,,,,,Cohen's d,1.28,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.49,,"RCI for PSS-I (alpha = 0.62, SD 6.0)",0.43,Additional definitions of Clinically Meaningful Response reported in the study,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PSS-I_B_26_Comp,Psychotherapy,PTSD,268,B,PTSD,,52,,Individual CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,135,Structured Clinical Interview,PSS-I,PSS-I,Completer,general linear mixed regression models,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,Assessment at 6 to <12 Months,26,,16.6,,SE,1.2,,SE 1.23,-7.5,,,,,Cohen's d,1.22,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.44,,,,,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PSS-I_B_26_ITT,Psychotherapy,PTSD,268,B,PTSD,,64,,Individual CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,135,Structured Clinical Interview,PSS-I,PSS-I,ITT,general linear mixed regression models,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,Assessment at 6 to <12 Months,26,,17.1,,SE,1.05,,SE 1.06,-7.1,,,,,Cohen's d,1.18,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.43,,"RCI for PSS-I (alpha = 0.62, SD 6.0)",0.39,Additional definitions of Clinically Meaningful Response reported in the study,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PSS-I_B_Baseline_Comp,Psychotherapy,PTSD,268,B,PTSD,,82,,Individual CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,135,Structured Clinical Interview,PSS-I,PSS-I,Completer,general linear mixed regression models,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,Baseline,,,24.1,,SE,0.68,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
resick2017_PSS-I_B_Baseline_ITT,Psychotherapy,PTSD,268,B,PTSD,,135,,Individual CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,135,Structured Clinical Interview,PSS-I,PSS-I,ITT,general linear mixed regression models,General linear mixed regression models with Cohen's d effect sizes for continuous outcomes; generalized linear proportions model for binary data,Baseline,,,24.2,,SE,0.52,,,,,,,,,,,,,,,,,,,,,,,,,,,Active Duty Military,1,0,0,0.09,,0.91,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)",Medium,"Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.",45949,2019
richards1994_IES_A_0_Comp,Psychotherapy,PTSD,14,A,PTSD,,6,,Imaginal exposure followed by live exposure,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,7,Self report,IES,IES-R,Completer,,MANOVA,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,1,,,,,Community,,,1,0.6923,(completers only),0.3077,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters",High,"Richards DA, Lovell K, Marks IM. Post-traumatic stress disorder: evaluation of a behavioral treatment program. J Trauma Stress. 1994 Oct;7(4):669-80. doi: 10.1007/BF02103014. PMID: 7820356.",12187,2019
richards1994_IES_A_12_Comp,Psychotherapy,PTSD,14,A,PTSD,,,,Imaginal exposure followed by live exposure,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,7,Self report,IES,IES-R,Completer,,MANOVA,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,1,,,,,Community,,,1,0.6923,(completers only),0.3077,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters",High,"Richards DA, Lovell K, Marks IM. Post-traumatic stress disorder: evaluation of a behavioral treatment program. J Trauma Stress. 1994 Oct;7(4):669-80. doi: 10.1007/BF02103014. PMID: 7820356.",12187,2019
richards1994_IES_A_26_Comp,Psychotherapy,PTSD,14,A,PTSD,,,,Imaginal exposure followed by live exposure,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,7,Self report,IES,IES-R,Completer,,MANOVA,Assessment at 6 to <12 Months,26,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,1,,,,,Community,,,1,0.6923,(completers only),0.3077,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters",High,"Richards DA, Lovell K, Marks IM. Post-traumatic stress disorder: evaluation of a behavioral treatment program. J Trauma Stress. 1994 Oct;7(4):669-80. doi: 10.1007/BF02103014. PMID: 7820356.",12187,2019
richards1994_IES_A_4_Comp,Psychotherapy,PTSD,14,A,PTSD,,,,Imaginal exposure followed by live exposure,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,7,Self report,IES,IES-R,Completer,,MANOVA,Assessment at <3 Months,4,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,1,,,,,Community,,,1,0.6923,(completers only),0.3077,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters",High,"Richards DA, Lovell K, Marks IM. Post-traumatic stress disorder: evaluation of a behavioral treatment program. J Trauma Stress. 1994 Oct;7(4):669-80. doi: 10.1007/BF02103014. PMID: 7820356.",12187,2019
richards1994_IES_A_52_Comp,Psychotherapy,PTSD,14,A,PTSD,,,,Imaginal exposure followed by live exposure,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,7,Self report,IES,IES-R,Completer,,MANOVA,Assessment at ≥12 Months,52,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,1,,,,,Community,,,1,0.6923,(completers only),0.3077,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters",High,"Richards DA, Lovell K, Marks IM. Post-traumatic stress disorder: evaluation of a behavioral treatment program. J Trauma Stress. 1994 Oct;7(4):669-80. doi: 10.1007/BF02103014. PMID: 7820356.",12187,2019
richards1994_IES_A_Baseline_Comp,Psychotherapy,PTSD,14,A,PTSD,,7,,Imaginal exposure followed by live exposure,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,7,Self report,IES,IES-R,Completer,,MANOVA,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6923,(completers only),0.3077,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters",High,"Richards DA, Lovell K, Marks IM. Post-traumatic stress disorder: evaluation of a behavioral treatment program. J Trauma Stress. 1994 Oct;7(4):669-80. doi: 10.1007/BF02103014. PMID: 7820356.",12187,2019
richards1994_IES_B_0_Comp,Psychotherapy,PTSD,14,B,PTSD,,7,,Live exposure followed by imaginal exposure,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,7,Self report,IES,IES-R,Completer,,MANOVA,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,1,,,,,Community,,,1,0.6923,(completers only),0.3077,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters",High,"Richards DA, Lovell K, Marks IM. Post-traumatic stress disorder: evaluation of a behavioral treatment program. J Trauma Stress. 1994 Oct;7(4):669-80. doi: 10.1007/BF02103014. PMID: 7820356.",12187,2019
richards1994_IES_B_12_Comp,Psychotherapy,PTSD,14,B,PTSD,,,,Live exposure followed by imaginal exposure,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,7,Self report,IES,IES-R,Completer,,MANOVA,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,1,,,,,Community,,,1,0.6923,(completers only),0.3077,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters",High,"Richards DA, Lovell K, Marks IM. Post-traumatic stress disorder: evaluation of a behavioral treatment program. J Trauma Stress. 1994 Oct;7(4):669-80. doi: 10.1007/BF02103014. PMID: 7820356.",12187,2019
richards1994_IES_B_26_Comp,Psychotherapy,PTSD,14,B,PTSD,,,,Live exposure followed by imaginal exposure,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,7,Self report,IES,IES-R,Completer,,MANOVA,Assessment at 6 to <12 Months,26,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,1,,,,,Community,,,1,0.6923,(completers only),0.3077,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters",High,"Richards DA, Lovell K, Marks IM. Post-traumatic stress disorder: evaluation of a behavioral treatment program. J Trauma Stress. 1994 Oct;7(4):669-80. doi: 10.1007/BF02103014. PMID: 7820356.",12187,2019
richards1994_IES_B_4_Comp,Psychotherapy,PTSD,14,B,PTSD,,,,Live exposure followed by imaginal exposure,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,7,Self report,IES,IES-R,Completer,,MANOVA,Assessment at <3 Months,4,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,1,,,,,Community,,,1,0.6923,(completers only),0.3077,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters",High,"Richards DA, Lovell K, Marks IM. Post-traumatic stress disorder: evaluation of a behavioral treatment program. J Trauma Stress. 1994 Oct;7(4):669-80. doi: 10.1007/BF02103014. PMID: 7820356.",12187,2019
richards1994_IES_B_52_Comp,Psychotherapy,PTSD,14,B,PTSD,,,,Live exposure followed by imaginal exposure,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,7,Self report,IES,IES-R,Completer,,MANOVA,Assessment at ≥12 Months,52,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DSM-III-R,1,,,,,Community,,,1,0.6923,(completers only),0.3077,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters",High,"Richards DA, Lovell K, Marks IM. Post-traumatic stress disorder: evaluation of a behavioral treatment program. J Trauma Stress. 1994 Oct;7(4):669-80. doi: 10.1007/BF02103014. PMID: 7820356.",12187,2019
richards1994_IES_B_Baseline_Comp,Psychotherapy,PTSD,14,B,PTSD,,7,,Live exposure followed by imaginal exposure,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,7,Self report,IES,IES-R,Completer,,MANOVA,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6923,(completers only),0.3077,Mixed,"rape/sexual assault, accidents, community/school violence, natural or manmade disasters",High,"Richards DA, Lovell K, Marks IM. Post-traumatic stress disorder: evaluation of a behavioral treatment program. J Trauma Stress. 1994 Oct;7(4):669-80. doi: 10.1007/BF02103014. PMID: 7820356.",12187,2019
robjant2019_PSS-I_A_12_Comp,Psychotherapy,PTSD,92,A,PTSD,,45,,Adapted FORNET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In person,46,Structured Clinical Interview,PSS-I,PSS-I,Completer,Missing values excluded,MANOVA,Assessment at 3 to <6 Months,12,,17.71,13.85,,,,,-21.55,,,,,,,,,,p=significant,,,,,,,,Not meeting DSM-5 criteria on the PSS-I,,,Reliable change index,,,Community,0,0,1,1,,0,Other (former child soldiers),,Medium,"Robjant K, Koebach A, Schmitt S, et al. The treatment of posttraumatic stress symptoms and aggression in female former child soldiers using adapted Narrative Exposure therapy - a RCT in Eastern Democratic Republic of Congo. Behav Res Ther. 2019 Dec;123:103482. doi: 10.1016/j.brat.2019.103482. PMID: 31639529.",,2020
robjant2019_PSS-I_A_39_Comp,Psychotherapy,PTSD,92,A,PTSD,,43,,Adapted FORNET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In person,46,Structured Clinical Interview,PSS-I,PSS-I,Completer,Missing values excluded,MANOVA,Assessment at 6 to <12 Months,39,,12.56,10.55,,,,,-26.7,,,,,,,,,,p=significant,,,,,,,,Not meeting DSM-5 criteria on the PSS-I,0.6512,,Reliable change index,0.8478,,Community,0,0,1,1,,0,Other (former child soldiers),,Medium,"Robjant K, Koebach A, Schmitt S, et al. The treatment of posttraumatic stress symptoms and aggression in female former child soldiers using adapted Narrative Exposure therapy - a RCT in Eastern Democratic Republic of Congo. Behav Res Ther. 2019 Dec;123:103482. doi: 10.1016/j.brat.2019.103482. PMID: 31639529.",,2020
robjant2019_PSS-I_A_Baseline_Comp,Psychotherapy,PTSD,92,A,PTSD,,46,,Adapted FORNET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In person,46,Structured Clinical Interview,PSS-I,PSS-I,Completer,Missing values excluded,MANOVA,Baseline,,,39.26,8.19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,Other (former child soldiers),,Medium,"Robjant K, Koebach A, Schmitt S, et al. The treatment of posttraumatic stress symptoms and aggression in female former child soldiers using adapted Narrative Exposure therapy - a RCT in Eastern Democratic Republic of Congo. Behav Res Ther. 2019 Dec;123:103482. doi: 10.1016/j.brat.2019.103482. PMID: 31639529.",,2020
robjant2019_PSS-I_B_12_Comp,Psychotherapy,PTSD,92,B,Control,,43,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,46,Structured Clinical Interview,PSS-I,PSS-I,Completer,Missing values excluded,MANOVA,Assessment at 3 to <6 Months,12,,31.93,13.41,,,,,-5.74,,,,,,,,,,p=significant,,,,,,,,Not meeting DSM-5 criteria on the PSS-I,,,Reliable change index,,,Community,0,0,1,1,,0,Other (former child soldiers),,Medium,"Robjant K, Koebach A, Schmitt S, et al. The treatment of posttraumatic stress symptoms and aggression in female former child soldiers using adapted Narrative Exposure therapy - a RCT in Eastern Democratic Republic of Congo. Behav Res Ther. 2019 Dec;123:103482. doi: 10.1016/j.brat.2019.103482. PMID: 31639529.",,2020
robjant2019_PSS-I_B_39_Comp,Psychotherapy,PTSD,92,B,Control,,44,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,46,Structured Clinical Interview,PSS-I,PSS-I,Completer,Missing values excluded,MANOVA,Assessment at 6 to <12 Months,39,,29.11,14.17,,,,,-8.56,,,,,,,,,,p=significant,,,,,,,,Not meeting DSM-5 criteria on the PSS-I,0.1364,,Reliable change index,0.4565,,Community,0,0,1,1,,0,Other (former child soldiers),,Medium,"Robjant K, Koebach A, Schmitt S, et al. The treatment of posttraumatic stress symptoms and aggression in female former child soldiers using adapted Narrative Exposure therapy - a RCT in Eastern Democratic Republic of Congo. Behav Res Ther. 2019 Dec;123:103482. doi: 10.1016/j.brat.2019.103482. PMID: 31639529.",,2020
robjant2019_PSS-I_B_Baseline_Comp,Psychotherapy,PTSD,92,B,Control,,46,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,46,Structured Clinical Interview,PSS-I,PSS-I,Completer,Missing values excluded,MANOVA,Baseline,,,37.67,9.67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,Other (former child soldiers),,Medium,"Robjant K, Koebach A, Schmitt S, et al. The treatment of posttraumatic stress symptoms and aggression in female former child soldiers using adapted Narrative Exposure therapy - a RCT in Eastern Democratic Republic of Congo. Behav Res Ther. 2019 Dec;123:103482. doi: 10.1016/j.brat.2019.103482. PMID: 31639529.",,2020
rodgman2016_CAPS_A_0_Comp,Pharmacotherapy,PTSD,8,A,PTSD,,8,,Doxazosin extended release,Doxazosin,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,8,Structured Clinical Interview,CAPS,CAPS,Completer,,MANOVA,End of Treatment,0,,78.6,,SEM,17.3,,,-7,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Rodgman C, Verrico CD, Holst M, et al. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial. J Clin Psychiatry. 2016 May;77(5):e561-5. doi: 10.4088/JCP.14m09681. PMID: 27249080.",49795,2019
rodgman2016_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,8,A,PTSD,,8,,Doxazosin extended release,Doxazosin,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,8,Structured Clinical Interview,CAPS,CAPS,Completer,,MANOVA,Baseline,,,85.6,,SEM,17.3,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Rodgman C, Verrico CD, Holst M, et al. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial. J Clin Psychiatry. 2016 May;77(5):e561-5. doi: 10.4088/JCP.14m09681. PMID: 27249080.",49795,2019
rodgman2016_CAPS_B_0_Comp,Pharmacotherapy,PTSD,8,B,Control,,7,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Structured Clinical Interview,CAPS,CAPS,Completer,,MANOVA,End of Treatment,0,,82.9,,SEM,21.3,,,-13.2,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Rodgman C, Verrico CD, Holst M, et al. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial. J Clin Psychiatry. 2016 May;77(5):e561-5. doi: 10.4088/JCP.14m09681. PMID: 27249080.",49795,2019
rodgman2016_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,8,B,Control,,7,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Structured Clinical Interview,CAPS,CAPS,Completer,,MANOVA,Baseline,,,96.1,,SEM,20.2,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Rodgman C, Verrico CD, Holst M, et al. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial. J Clin Psychiatry. 2016 May;77(5):e561-5. doi: 10.4088/JCP.14m09681. PMID: 27249080.",49795,2019
rodgman2016_PCL_A_0_NA,Pharmacotherapy,PTSD,8,A,PTSD,,,,Doxazosin extended release,Doxazosin,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,8,Self report,PCL,PCL-M,,,MANOVA,End of Treatment,0,,27.5,,SEM,5.82,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Rodgman C, Verrico CD, Holst M, et al. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial. J Clin Psychiatry. 2016 May;77(5):e561-5. doi: 10.4088/JCP.14m09681. PMID: 27249080.",49795,2019
rodgman2016_PCL_A_Baseline_NA,Pharmacotherapy,PTSD,8,A,PTSD,,,,Doxazosin extended release,Doxazosin,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,8,Self report,PCL,PCL-M,,,MANOVA,Baseline,,,43.3,,SEM,7.17,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Rodgman C, Verrico CD, Holst M, et al. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial. J Clin Psychiatry. 2016 May;77(5):e561-5. doi: 10.4088/JCP.14m09681. PMID: 27249080.",49795,2019
rodgman2016_PCL_B_0_NA,Pharmacotherapy,PTSD,8,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Self report,PCL,PCL-M,,,MANOVA,End of Treatment,0,,36.7,,SEM,7.6,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Rodgman C, Verrico CD, Holst M, et al. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial. J Clin Psychiatry. 2016 May;77(5):e561-5. doi: 10.4088/JCP.14m09681. PMID: 27249080.",49795,2019
rodgman2016_PCL_B_Baseline_NA,Pharmacotherapy,PTSD,8,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,8,Self report,PCL,PCL-M,,,MANOVA,Baseline,,,31.3,,SEM,6.53,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Rodgman C, Verrico CD, Holst M, et al. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial. J Clin Psychiatry. 2016 May;77(5):e561-5. doi: 10.4088/JCP.14m09681. PMID: 27249080.",49795,2019
rogers1999_IES_A_0_NA,Psychotherapy,PTSD,12,A,PTSD,,6,,Group EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,6,Self report,IES,IES,,,ANOVA for change in mean score,End of Treatment,0,,29.8,10.4,,,,,-7.5,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,High,"Rogers S, Silver SM, Goss J, et al. A single session, group study of exposure and Eye Movement Desensitization and Reprocessing in treating posttraumatic stress disorder among Vietnam War veterans: preliminary data. J Anxiety Disord. 1999 Jan-Apr;13(1-2):119-30. doi: 10.1016/S0887-6185(98)00043-7. PMID: 10225504.",14686,2019
rogers1999_IES_A_Baseline_NA,Psychotherapy,PTSD,12,A,PTSD,,6,,Group EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,6,Self report,IES,IES,,,ANOVA for change in mean score,Baseline,,,37.3,6.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,High,"Rogers S, Silver SM, Goss J, et al. A single session, group study of exposure and Eye Movement Desensitization and Reprocessing in treating posttraumatic stress disorder among Vietnam War veterans: preliminary data. J Anxiety Disord. 1999 Jan-Apr;13(1-2):119-30. doi: 10.1016/S0887-6185(98)00043-7. PMID: 10225504.",14686,2019
rogers1999_IES_B_0_NA,Psychotherapy,PTSD,12,B,PTSD,,6,,Exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,6,Self report,IES,IES,,,ANOVA for change in mean score,End of Treatment,0,,39.6,6.6,,,,,-1.4,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,High,"Rogers S, Silver SM, Goss J, et al. A single session, group study of exposure and Eye Movement Desensitization and Reprocessing in treating posttraumatic stress disorder among Vietnam War veterans: preliminary data. J Anxiety Disord. 1999 Jan-Apr;13(1-2):119-30. doi: 10.1016/S0887-6185(98)00043-7. PMID: 10225504.",14686,2019
rogers1999_IES_B_Baseline_NA,Psychotherapy,PTSD,12,B,PTSD,,6,,Exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,6,Self report,IES,IES,,,ANOVA for change in mean score,Baseline,,,41,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,,,,Combat-related,,High,"Rogers S, Silver SM, Goss J, et al. A single session, group study of exposure and Eye Movement Desensitization and Reprocessing in treating posttraumatic stress disorder among Vietnam War veterans: preliminary data. J Anxiety Disord. 1999 Jan-Apr;13(1-2):119-30. doi: 10.1016/S0887-6185(98)00043-7. PMID: 10225504.",14686,2019
rosenbaum2015_PCL_A_0_ITT,Complementary and integrative health (CIH),PTSD,81,A,PTSD,,30,,Exercise program,Exercise,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In Person,39,Self report,PCL,PCL-C,ITT,"Analyses used all available data, missing values not imputed",Linear regression models for mean differences; partial eta-squared effect sizes.,End of Treatment,0,,53.7,13.5,,,,,-9.8,,-13.7,-6,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1605,,0.8395,Mixed,"other (trauma experienced through occupation, not specified)",Medium,"Rosenbaum S, Sherrington C, Tiedemann A. Exercise augmentation compared with usual care for post-traumatic stress disorder: a randomized controlled trial. Acta Psychiatr Scand. 2015 May;131(5):350-9. doi: 10.1111/acps.12371. PMID: 25443996.",44069,2019
rosenbaum2015_PCL_A_Baseline_ITT,Complementary and integrative health (CIH),PTSD,81,A,PTSD,,39,,Exercise program,Exercise,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In Person,39,Self report,PCL,PCL-C,ITT,"Analyses used all available data, missing values not imputed",Linear regression models for mean differences; partial eta-squared effect sizes.,Baseline,,,64.5,11.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1605,,0.8395,Mixed,"other (trauma experienced through occupation, not specified)",Medium,"Rosenbaum S, Sherrington C, Tiedemann A. Exercise augmentation compared with usual care for post-traumatic stress disorder: a randomized controlled trial. Acta Psychiatr Scand. 2015 May;131(5):350-9. doi: 10.1111/acps.12371. PMID: 25443996.",44069,2019
rosenbaum2015_PCL_B_0_ITT,Complementary and integrative health (CIH),PTSD,81,B,PTSD,,28,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,42,Self report,PCL,PCL-C,ITT,"Analyses used all available data, missing values not imputed",Linear regression models for mean differences; partial eta-squared effect sizes.,End of Treatment,0,,57.9,14.9,,,,,-4.2,,-7.8,-0.5,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1605,,0.8395,Mixed,"other (trauma experienced through occupation, not specified)",Medium,"Rosenbaum S, Sherrington C, Tiedemann A. Exercise augmentation compared with usual care for post-traumatic stress disorder: a randomized controlled trial. Acta Psychiatr Scand. 2015 May;131(5):350-9. doi: 10.1111/acps.12371. PMID: 25443996.",44069,2019
rosenbaum2015_PCL_B_Baseline_ITT,Complementary and integrative health (CIH),PTSD,81,B,PTSD,,42,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,42,Self report,PCL,PCL-C,ITT,"Analyses used all available data, missing values not imputed",Linear regression models for mean differences; partial eta-squared effect sizes.,Baseline,,,64.2,12.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.1605,,0.8395,Mixed,"other (trauma experienced through occupation, not specified)",Medium,"Rosenbaum S, Sherrington C, Tiedemann A. Exercise augmentation compared with usual care for post-traumatic stress disorder: a randomized controlled trial. Acta Psychiatr Scand. 2015 May;131(5):350-9. doi: 10.1111/acps.12371. PMID: 25443996.",44069,2019
rothbaum1997_IES_A_0_NA,Psychotherapy,PTSD,21,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,IES,IES,,,Wilcoxon Rank Sums test,End of Treatment,0,,12.4,11.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Rape/sexual assault,,Medium,Rothbaum BO. A controlled study of Eye Movement Desensitization and Reprocessing in the treatment of posttraumatic stress disordered sexual assault victims. Bull Menninger Clin. 1997 Summer;61(3):317-34.  PMID: 9260344.,09058,2019
rothbaum1997_IES_A_Baseline_NA,Psychotherapy,PTSD,21,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,IES,IES,,,Wilcoxon Rank Sums test,Baseline,,,47.4,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Rape/sexual assault,,Medium,Rothbaum BO. A controlled study of Eye Movement Desensitization and Reprocessing in the treatment of posttraumatic stress disordered sexual assault victims. Bull Menninger Clin. 1997 Summer;61(3):317-34.  PMID: 9260344.,09058,2019
rothbaum1997_IES_B_0_NA,Psychotherapy,PTSD,21,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,,,10,Self report,IES,IES,,,Wilcoxon Rank Sums test,End of Treatment,0,,45.4,6.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Rape/sexual assault,,Medium,Rothbaum BO. A controlled study of Eye Movement Desensitization and Reprocessing in the treatment of posttraumatic stress disordered sexual assault victims. Bull Menninger Clin. 1997 Summer;61(3):317-34.  PMID: 9260344.,09058,2019
rothbaum1997_IES_B_Baseline_NA,Psychotherapy,PTSD,21,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,,,10,Self report,IES,IES,,,Wilcoxon Rank Sums test,Baseline,,,48.9,8.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Rape/sexual assault,,Medium,Rothbaum BO. A controlled study of Eye Movement Desensitization and Reprocessing in the treatment of posttraumatic stress disordered sexual assault victims. Bull Menninger Clin. 1997 Summer;61(3):317-34.  PMID: 9260344.,09058,2019
rothbaum1997_PSS-I_A_0_Comp,Psychotherapy,PTSD,21,A,PTSD,,10,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Wilcoxon Rank Sums test,End of Treatment,0,,14.3,8.4,,,,,-19,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.9,,,,,Community,,,1,1,,0,Rape/sexual assault,,Medium,Rothbaum BO. A controlled study of Eye Movement Desensitization and Reprocessing in the treatment of posttraumatic stress disordered sexual assault victims. Bull Menninger Clin. 1997 Summer;61(3):317-34.  PMID: 9260344.,09058,2019
rothbaum1997_PSS-I_A_12_Comp,Psychotherapy,PTSD,21,A,PTSD,,10,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Wilcoxon Rank Sums test,Assessment at 3 to <6 Months,12,,9.8,8.7,,,,,-23.5,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,,,,,,Community,,,1,1,,0,Rape/sexual assault,,Medium,Rothbaum BO. A controlled study of Eye Movement Desensitization and Reprocessing in the treatment of posttraumatic stress disordered sexual assault victims. Bull Menninger Clin. 1997 Summer;61(3):317-34.  PMID: 9260344.,09058,2019
rothbaum1997_PSS-I_A_Baseline_Comp,Psychotherapy,PTSD,21,A,PTSD,,10,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Wilcoxon Rank Sums test,Baseline,,,33.3,8.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Rape/sexual assault,,Medium,Rothbaum BO. A controlled study of Eye Movement Desensitization and Reprocessing in the treatment of posttraumatic stress disordered sexual assault victims. Bull Menninger Clin. 1997 Summer;61(3):317-34.  PMID: 9260344.,09058,2019
rothbaum1997_PSS-I_B_0_Comp,Psychotherapy,PTSD,21,B,Control,,8,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,,,10,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Wilcoxon Rank Sums test,End of Treatment,0,,35,5.9,,,,,-4,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.125,,,,,Community,,,1,1,,0,Rape/sexual assault,,Medium,Rothbaum BO. A controlled study of Eye Movement Desensitization and Reprocessing in the treatment of posttraumatic stress disordered sexual assault victims. Bull Menninger Clin. 1997 Summer;61(3):317-34.  PMID: 9260344.,09058,2019
rothbaum1997_PSS-I_B_Baseline_Comp,Psychotherapy,PTSD,21,B,Control,,8,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,,,10,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Wilcoxon Rank Sums test,Baseline,,,39,8.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Rape/sexual assault,,Medium,Rothbaum BO. A controlled study of Eye Movement Desensitization and Reprocessing in the treatment of posttraumatic stress disordered sexual assault victims. Bull Menninger Clin. 1997 Summer;61(3):317-34.  PMID: 9260344.,09058,2019
rothbaum2005_CAPS_A_0_Comp,Psychotherapy,PTSD,72,A,PTSD,,20,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,CAPS and PSS-SR and IES-R,"CAPS + PSS-SR + IES-R (""PTSD Total scores"" as combination of frequency and intensity total scores for all 3 measures)",Completer,,"Multitrait, multimeasure multivariate repeated measure models with Cohen's f-squared effect sizes. Categorical outcomes with Fisher's exact test.",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for diagnosis of PTSD,0.75,,≥50% decrease on CAPS and BDI score ≤10 and STAI-S score ≤40,0.5,,Community,,,1,1,,0,Rape/sexual assault,,Medium,"Rothbaum BO, Astin MC, Marsteller F. Prolonged exposure versus Eye Movement Desensitization and Reprocessing (EMDR) for PTSD rape victims. J Trauma Stress. 2005 Dec;18(6):607-16. doi: 10.1002/jts.20069. PMID: 16382428.",19662,2019
rothbaum2005_CAPS_A_26_Comp,Psychotherapy,PTSD,72,A,PTSD,,19,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,CAPS and PSS-SR and IES-R,"CAPS + PSS-SR + IES-R (""PTSD Total scores"" as combination of frequency and intensity total scores for all 3 measures)",Completer,,"Multitrait, multimeasure multivariate repeated measure models with Cohen's f-squared effect sizes. Categorical outcomes with Fisher's exact test.",Assessment at 6 to <12 Months,26,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for diagnosis of PTSD,0.7368,,≥50% decrease on CAPS and BDI score ≤10 and STAI-S score ≤40,0.3529,,Community,,,1,1,,0,Rape/sexual assault,,Medium,"Rothbaum BO, Astin MC, Marsteller F. Prolonged exposure versus Eye Movement Desensitization and Reprocessing (EMDR) for PTSD rape victims. J Trauma Stress. 2005 Dec;18(6):607-16. doi: 10.1002/jts.20069. PMID: 16382428.",19662,2019
rothbaum2005_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,72,A,PTSD,,20,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,CAPS and PSS-SR and IES-R,"CAPS + PSS-SR + IES-R (""PTSD Total scores"" as combination of frequency and intensity total scores for all 3 measures)",Completer,,"Multitrait, multimeasure multivariate repeated measure models with Cohen's f-squared effect sizes. Categorical outcomes with Fisher's exact test.",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Rape/sexual assault,,Medium,"Rothbaum BO, Astin MC, Marsteller F. Prolonged exposure versus Eye Movement Desensitization and Reprocessing (EMDR) for PTSD rape victims. J Trauma Stress. 2005 Dec;18(6):607-16. doi: 10.1002/jts.20069. PMID: 16382428.",19662,2019
rothbaum2005_CAPS_B_0_Comp,Psychotherapy,PTSD,72,B,PTSD,,20,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Structured Clinical Interview,CAPS and PSS-SR and IES-R,"CAPS + PSS-SR + IES-R (""PTSD Total scores"" as combination of frequency and intensity total scores for all 3 measures)",Completer,,"Multitrait, multimeasure multivariate repeated measure models with Cohen's f-squared effect sizes. Categorical outcomes with Fisher's exact test.",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for diagnosis of PTSD,0.95,,≥50% decrease on CAPS and BDI score ≤10 and STAI-S score ≤40,0.7,,Community,,,1,1,,0,Rape/sexual assault,,Medium,"Rothbaum BO, Astin MC, Marsteller F. Prolonged exposure versus Eye Movement Desensitization and Reprocessing (EMDR) for PTSD rape victims. J Trauma Stress. 2005 Dec;18(6):607-16. doi: 10.1002/jts.20069. PMID: 16382428.",19662,2019
rothbaum2005_CAPS_B_26_Comp,Psychotherapy,PTSD,72,B,PTSD,,18,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Structured Clinical Interview,CAPS and PSS-SR and IES-R,"CAPS + PSS-SR + IES-R (""PTSD Total scores"" as combination of frequency and intensity total scores for all 3 measures)",Completer,,"Multitrait, multimeasure multivariate repeated measure models with Cohen's f-squared effect sizes. Categorical outcomes with Fisher's exact test.",Assessment at 6 to <12 Months,26,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for diagnosis of PTSD,0.9444,,≥50% decrease on CAPS and BDI score ≤10 and STAI-S score ≤40,0.7778,,Community,,,1,1,,0,Rape/sexual assault,,Medium,"Rothbaum BO, Astin MC, Marsteller F. Prolonged exposure versus Eye Movement Desensitization and Reprocessing (EMDR) for PTSD rape victims. J Trauma Stress. 2005 Dec;18(6):607-16. doi: 10.1002/jts.20069. PMID: 16382428.",19662,2019
rothbaum2005_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,72,B,PTSD,,20,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Structured Clinical Interview,CAPS and PSS-SR and IES-R,"CAPS + PSS-SR + IES-R (""PTSD Total scores"" as combination of frequency and intensity total scores for all 3 measures)",Completer,,"Multitrait, multimeasure multivariate repeated measure models with Cohen's f-squared effect sizes. Categorical outcomes with Fisher's exact test.",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Rape/sexual assault,,Medium,"Rothbaum BO, Astin MC, Marsteller F. Prolonged exposure versus Eye Movement Desensitization and Reprocessing (EMDR) for PTSD rape victims. J Trauma Stress. 2005 Dec;18(6):607-16. doi: 10.1002/jts.20069. PMID: 16382428.",19662,2019
rothbaum2005_CAPS_C_0_Comp,Psychotherapy,PTSD,72,C,Control,,20,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,24,Structured Clinical Interview,CAPS and PSS-SR and IES-R,"CAPS + PSS-SR + IES-R (""PTSD Total scores"" as combination of frequency and intensity total scores for all 3 measures)",Completer,,"Multitrait, multimeasure multivariate repeated measure models with Cohen's f-squared effect sizes. Categorical outcomes with Fisher's exact test.",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for diagnosis of PTSD,0.1,,≥50% decrease on CAPS and BDI score ≤10 and STAI-S score ≤40,0,,Community,,,1,1,,0,Rape/sexual assault,,Medium,"Rothbaum BO, Astin MC, Marsteller F. Prolonged exposure versus Eye Movement Desensitization and Reprocessing (EMDR) for PTSD rape victims. J Trauma Stress. 2005 Dec;18(6):607-16. doi: 10.1002/jts.20069. PMID: 16382428.",19662,2019
rothbaum2005_CAPS_C_Baseline_Comp,Psychotherapy,PTSD,72,C,Control,,20,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,24,Structured Clinical Interview,CAPS and PSS-SR and IES-R,"CAPS + PSS-SR + IES-R (""PTSD Total scores"" as combination of frequency and intensity total scores for all 3 measures)",Completer,,"Multitrait, multimeasure multivariate repeated measure models with Cohen's f-squared effect sizes. Categorical outcomes with Fisher's exact test.",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Rape/sexual assault,,Medium,"Rothbaum BO, Astin MC, Marsteller F. Prolonged exposure versus Eye Movement Desensitization and Reprocessing (EMDR) for PTSD rape victims. J Trauma Stress. 2005 Dec;18(6):607-16. doi: 10.1002/jts.20069. PMID: 16382428.",19662,2019
rothbaum2006_SI-PTSD_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,65,A,PTSD,,32,,Sertraline + PE,Sertraline + Prolonged Exposure (PE),Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,34,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,BOCF,"Multitrait, multimeasure multivariate repeated measure models with Cohen's f-squared effect sizes. Categorical outcomes with Fisher's exact test.",End of Treatment,0,,10.2,8.83,,,,,-5.9,7.82,,,,,,,,,p<0.001,,,,,,,,,,,,,,Community,,,1,0.646,,0.354,Mixed,"child sexual abuse, child physical abuse, accidents, combat-related, other (death [not combat-related] of another person)",Medium,"Rothbaum BO, Cahill SP, Foa EB, et al. Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder. J Trauma Stress. 2006 Oct;19(5):625-38. doi: 10.1002/jts.20170. PMID: 17075912.",80288,2019
rothbaum2006_SI-PTSD_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,65,A,PTSD,,34,,Sertraline + PE,Sertraline + Prolonged Exposure (PE),Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,34,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,BOCF,"Multitrait, multimeasure multivariate repeated measure models with Cohen's f-squared effect sizes. Categorical outcomes with Fisher's exact test.",Baseline,,,16.1,10.64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.646,,0.354,Mixed,"child sexual abuse, child physical abuse, accidents, combat-related, other (death [not combat-related] of another person)",Medium,"Rothbaum BO, Cahill SP, Foa EB, et al. Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder. J Trauma Stress. 2006 Oct;19(5):625-38. doi: 10.1002/jts.20170. PMID: 17075912.",80288,2019
rothbaum2006_SI-PTSD_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,65,B,Control,,30,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,BOCF,"Multitrait, multimeasure multivariate repeated measure models with Cohen's f-squared effect sizes. Categorical outcomes with Fisher's exact test.",End of Treatment,0,,14.9,15.27,,,,,-0.3,7.60,,,,,,,,,p=NS,,,,,,,,,,,,,,Community,,,1,0.646,,0.354,Mixed,"child sexual abuse, child physical abuse, accidents, combat-related, other (death [not combat-related] of another person)",Medium,"Rothbaum BO, Cahill SP, Foa EB, et al. Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder. J Trauma Stress. 2006 Oct;19(5):625-38. doi: 10.1002/jts.20170. PMID: 17075912.",80288,2019
rothbaum2006_SI-PTSD_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,65,B,Control,,31,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,31,Structured Clinical Interview,SI-PTSD,SI-PTSD,ITT,BOCF,"Multitrait, multimeasure multivariate repeated measure models with Cohen's f-squared effect sizes. Categorical outcomes with Fisher's exact test.",Baseline,,,14.5,11.65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.646,,0.354,Mixed,"child sexual abuse, child physical abuse, accidents, combat-related, other (death [not combat-related] of another person)",Medium,"Rothbaum BO, Cahill SP, Foa EB, et al. Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder. J Trauma Stress. 2006 Oct;19(5):625-38. doi: 10.1002/jts.20170. PMID: 17075912.",80288,2019
rothbaum2008_CAPS_A_0_ITT,Pharmacotherapy,PTSD,25,A,PTSD,,9,,Risperidone augmentation,Risperidone augmentation,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,14,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Multitrait, multimeasure multivariate repeated measure models with Cohen's f-squared effect sizes. Categorical outcomes with Fisher's exact test.",End of Treatment,0,,38.89,24.44,,,,,-17.11,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8,,0.2,Mixed,"rape/sexual assault, intimate partner violence, accidents, community/school violence, other (stalking, break-in, witnessed killing or suicide attempt)",High,"Rothbaum BO, Killeen TK, Davidson JRT, et al. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J. Clin. Psychiatry. 2008;69(4):520-5. doi: 10.4088/JCP.v69n0402. PMID: 18278987.",30519,2019
rothbaum2008_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,25,A,PTSD,,14,,Risperidone augmentation,Risperidone augmentation,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,14,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Multitrait, multimeasure multivariate repeated measure models with Cohen's f-squared effect sizes. Categorical outcomes with Fisher's exact test.",Baseline,,,56.00,20.91,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8,,0.2,Mixed,"rape/sexual assault, intimate partner violence, accidents, community/school violence, other (stalking, break-in, witnessed killing or suicide attempt)",High,"Rothbaum BO, Killeen TK, Davidson JRT, et al. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J. Clin. Psychiatry. 2008;69(4):520-5. doi: 10.4088/JCP.v69n0402. PMID: 18278987.",30519,2019
rothbaum2008_CAPS_B_0_ITT,Pharmacotherapy,PTSD,25,B,Control,,11,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,11,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Multitrait, multimeasure multivariate repeated measure models with Cohen's f-squared effect sizes. Categorical outcomes with Fisher's exact test.",End of Treatment,0,,36.45,21.04,,,,,-23.55,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8,,0.2,Mixed,"rape/sexual assault, intimate partner violence, accidents, community/school violence, other (stalking, break-in, witnessed killing or suicide attempt)",High,"Rothbaum BO, Killeen TK, Davidson JRT, et al. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J. Clin. Psychiatry. 2008;69(4):520-5. doi: 10.4088/JCP.v69n0402. PMID: 18278987.",30519,2019
rothbaum2008_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,25,B,Control,,11,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,11,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Multitrait, multimeasure multivariate repeated measure models with Cohen's f-squared effect sizes. Categorical outcomes with Fisher's exact test.",Baseline,,,60.00,21.45,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8,,0.2,Mixed,"rape/sexual assault, intimate partner violence, accidents, community/school violence, other (stalking, break-in, witnessed killing or suicide attempt)",High,"Rothbaum BO, Killeen TK, Davidson JRT, et al. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J. Clin. Psychiatry. 2008;69(4):520-5. doi: 10.4088/JCP.v69n0402. PMID: 18278987.",30519,2019
rothbaum2008_DTS_A_0_NA,Pharmacotherapy,PTSD,25,A,PTSD,,,,Risperidone augmentation,Risperidone augmentation,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,14,Self report,DTS,DTS,,,"Multitrait, multimeasure multivariate repeated measure models with Cohen's f-squared effect sizes. Categorical outcomes with Fisher's exact test.",End of Treatment,0,,33.5,27.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8,,0.2,Mixed,"rape/sexual assault, intimate partner violence, accidents, community/school violence, other (stalking, break-in, witnessed killing or suicide attempt)",High,"Rothbaum BO, Killeen TK, Davidson JRT, et al. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J. Clin. Psychiatry. 2008;69(4):520-5. doi: 10.4088/JCP.v69n0402. PMID: 18278987.",30519,2019
rothbaum2008_DTS_A_Baseline_NA,Pharmacotherapy,PTSD,25,A,PTSD,,,,Risperidone augmentation,Risperidone augmentation,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,14,Self report,DTS,DTS,,,"Multitrait, multimeasure multivariate repeated measure models with Cohen's f-squared effect sizes. Categorical outcomes with Fisher's exact test.",Baseline,,,49.4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8,,0.2,Mixed,"rape/sexual assault, intimate partner violence, accidents, community/school violence, other (stalking, break-in, witnessed killing or suicide attempt)",High,"Rothbaum BO, Killeen TK, Davidson JRT, et al. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J. Clin. Psychiatry. 2008;69(4):520-5. doi: 10.4088/JCP.v69n0402. PMID: 18278987.",30519,2019
rothbaum2008_DTS_B_0_NA,Pharmacotherapy,PTSD,25,B,Control,,,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,11,Self report,DTS,DTS,,,"Multitrait, multimeasure multivariate repeated measure models with Cohen's f-squared effect sizes. Categorical outcomes with Fisher's exact test.",End of Treatment,0,,37.3,26.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8,,0.2,Mixed,"rape/sexual assault, intimate partner violence, accidents, community/school violence, other (stalking, break-in, witnessed killing or suicide attempt)",High,"Rothbaum BO, Killeen TK, Davidson JRT, et al. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J. Clin. Psychiatry. 2008;69(4):520-5. doi: 10.4088/JCP.v69n0402. PMID: 18278987.",30519,2019
rothbaum2008_DTS_B_Baseline_NA,Pharmacotherapy,PTSD,25,B,Control,,,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,11,Self report,DTS,DTS,,,"Multitrait, multimeasure multivariate repeated measure models with Cohen's f-squared effect sizes. Categorical outcomes with Fisher's exact test.",Baseline,,,59.9,25.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8,,0.2,Mixed,"rape/sexual assault, intimate partner violence, accidents, community/school violence, other (stalking, break-in, witnessed killing or suicide attempt)",High,"Rothbaum BO, Killeen TK, Davidson JRT, et al. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J. Clin. Psychiatry. 2008;69(4):520-5. doi: 10.4088/JCP.v69n0402. PMID: 18278987.",30519,2019
rothbaum2014_CAPS_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,A,PTSD,,28,,Virtual reality exposure therapy + D-cycloserine,Virtual reality exposure therapy (VRET) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Structured Clinical Interview,CAPS,CAPS,ITT,missing completely at random assumption (Little's test not significant),Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,End of Treatment,0,,65.9,,95% CI,60.2,71.6,,-19.4,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.2143,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_CAPS_A_12_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,A,PTSD,,20,,Virtual reality exposure therapy + D-cycloserine,Virtual reality exposure therapy (VRET) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Structured Clinical Interview,CAPS,CAPS,ITT,missing completely at random assumption (Little's test not significant),Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Assessment at 3 to <6 Months,12,,60.3,,95% CI,54.4,66.2,,-25,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.35,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_CAPS_A_26_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,A,PTSD,,17,,Virtual reality exposure therapy + D-cycloserine,Virtual reality exposure therapy (VRET) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Structured Clinical Interview,CAPS,CAPS,ITT,missing completely at random assumption (Little's test not significant),Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Assessment at 6 to <12 Months,26,,56.0,,95% CI,50.1,62,,-29.3,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.4118,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_CAPS_A_52_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,A,PTSD,,17,,Virtual reality exposure therapy + D-cycloserine,Virtual reality exposure therapy (VRET) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Structured Clinical Interview,CAPS,CAPS,ITT,missing completely at random assumption (Little's test not significant),Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Assessment at ≥12 Months,52,,48.0,,95% CI,41,55,,-37.3,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.5294,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_CAPS_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,A,PTSD,,53,,Virtual reality exposure therapy + D-cycloserine,Virtual reality exposure therapy (VRET) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Structured Clinical Interview,CAPS,CAPS,ITT,missing completely at random assumption (Little's test not significant),Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Baseline,,,85.3,,95% CI,79.3,91.9,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_CAPS_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,B,PTSD,,35,,Virtual reality exposure + alprazolam,Virtual reality exposure therapy (VRET) + alprazolam,Yes,TF,Yes,Antianxiety: benzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In Person,50,Structured Clinical Interview,CAPS,CAPS,ITT,missing completely at random assumption (Little's test not significant),Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,End of Treatment,0,,69.6,,95% CI,63.8,75.4,,-18.4,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.2571,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_CAPS_B_12_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,B,PTSD,,29,,Virtual reality exposure + alprazolam,Virtual reality exposure therapy (VRET) + alprazolam,Yes,TF,Yes,Antianxiety: benzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In Person,50,Structured Clinical Interview,CAPS,CAPS,ITT,missing completely at random assumption (Little's test not significant),Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Assessment at 3 to <6 Months,12,,66.8,,95% CI,59.6,74,,-21.2,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.1724,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_CAPS_B_26_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,B,PTSD,,25,,Virtual reality exposure + alprazolam,Virtual reality exposure therapy (VRET) + alprazolam,Yes,TF,Yes,Antianxiety: benzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In Person,50,Structured Clinical Interview,CAPS,CAPS,ITT,missing completely at random assumption (Little's test not significant),Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Assessment at 6 to <12 Months,26,,63.4,,95% CI,55.4,71,,-24.6,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.24,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_CAPS_B_52_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,B,PTSD,,22,,Virtual reality exposure + alprazolam,Virtual reality exposure therapy (VRET) + alprazolam,Yes,TF,Yes,Antianxiety: benzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In Person,50,Structured Clinical Interview,CAPS,CAPS,ITT,missing completely at random assumption (Little's test not significant),Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Assessment at ≥12 Months,52,,57.2,,95% CI,50.6,63.8,,-30.8,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.3636,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_CAPS_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,B,PTSD,,50,,Virtual reality exposure + alprazolam,Virtual reality exposure therapy (VRET) + alprazolam,Yes,TF,Yes,Antianxiety: benzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In Person,50,Structured Clinical Interview,CAPS,CAPS,ITT,missing completely at random assumption (Little's test not significant),Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Baseline,,,88.0,,95% CI,82.3,93.6,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_CAPS_C_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,C,PTSD,,34,,Virtual reality exposure + placebo,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,53,Structured Clinical Interview,CAPS,CAPS,ITT,missing completely at random assumption (Little's test not significant),Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,End of Treatment,0,,63.8,,95% CI,56.7,70.9,,-18.8,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.2647,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_CAPS_C_12_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,C,PTSD,,23,,Virtual reality exposure + placebo,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,53,Structured Clinical Interview,CAPS,CAPS,ITT,missing completely at random assumption (Little's test not significant),Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Assessment at 3 to <6 Months,12,,51.5,,95% CI,43.6,59.5,,-31.1,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.5217,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_CAPS_C_26_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,C,PTSD,,23,,Virtual reality exposure + placebo,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,53,Structured Clinical Interview,CAPS,CAPS,ITT,missing completely at random assumption (Little's test not significant),Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Assessment at 6 to <12 Months,26,,46.9,,95% CI,38.7,55.1,,-35.7,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.5652,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_CAPS_C_52_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,C,PTSD,,20,,Virtual reality exposure + placebo,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,53,Structured Clinical Interview,CAPS,CAPS,ITT,missing completely at random assumption (Little's test not significant),Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Assessment at ≥12 Months,52,,48.4,,95% CI,41,55.8,,-34.2,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.45,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_CAPS_C_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,C,PTSD,,53,,Virtual reality exposure + placebo,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,53,Structured Clinical Interview,CAPS,CAPS,ITT,missing completely at random assumption (Little's test not significant),Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Baseline,,,82.6,,95% CI,75.8,89.4,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_PSS-SR_A_0_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,A,PTSD,,,,Virtual reality exposure therapy + D-cycloserine,Virtual reality exposure therapy (VRET) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Self report,PSS-SR,PSS-SR,,,Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,End of Treatment,0,,27.1,,95% CI,24.3,29.9,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_PSS-SR_A_12_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,A,PTSD,,,,Virtual reality exposure therapy + D-cycloserine,Virtual reality exposure therapy (VRET) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Self report,PSS-SR,PSS-SR,,,Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Assessment at 3 to <6 Months,12,,25.2,,95% CI,22,28.5,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_PSS-SR_A_26_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,A,PTSD,,,,Virtual reality exposure therapy + D-cycloserine,Virtual reality exposure therapy (VRET) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Self report,PSS-SR,PSS-SR,,,Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Assessment at 6 to <12 Months,26,,24.1,,95% CI,20.5,27.6,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_PSS-SR_A_52_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,A,PTSD,,,,Virtual reality exposure therapy + D-cycloserine,Virtual reality exposure therapy (VRET) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Self report,PSS-SR,PSS-SR,,,Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Assessment at ≥12 Months,52,,22.6,,95% CI,19.1,26.1,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_PSS-SR_A_Baseline_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,A,PTSD,,,,Virtual reality exposure therapy + D-cycloserine,Virtual reality exposure therapy (VRET) + D-cycloserine,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Self report,PSS-SR,PSS-SR,,,Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Baseline,,,32.9,,95% CI,29.7,36.2,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_PSS-SR_B_0_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,B,PTSD,,,,Virtual reality exposure + alprazolam,Virtual reality exposure therapy (VRET) + alprazolam,Yes,TF,Yes,Antianxiety: benzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In Person,50,Self report,PSS-SR,PSS-SR,,,Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,End of Treatment,0,,25.6,,95% CI,22.5,28.7,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_PSS-SR_B_12_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,B,PTSD,,,,Virtual reality exposure + alprazolam,Virtual reality exposure therapy (VRET) + alprazolam,Yes,TF,Yes,Antianxiety: benzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In Person,50,Self report,PSS-SR,PSS-SR,,,Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Assessment at 3 to <6 Months,12,,26.1,,95% CI,22.6,29.4,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_PSS-SR_B_26_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,B,PTSD,,,,Virtual reality exposure + alprazolam,Virtual reality exposure therapy (VRET) + alprazolam,Yes,TF,Yes,Antianxiety: benzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In Person,50,Self report,PSS-SR,PSS-SR,,,Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Assessment at 6 to <12 Months,26,,26.3,,95% CI,22.5,30.1,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_PSS-SR_B_52_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,B,PTSD,,,,Virtual reality exposure + alprazolam,Virtual reality exposure therapy (VRET) + alprazolam,Yes,TF,Yes,Antianxiety: benzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In Person,50,Self report,PSS-SR,PSS-SR,,,Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Assessment at ≥12 Months,52,,24.2,,95% CI,20.8,27.6,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_PSS-SR_B_Baseline_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,B,PTSD,,,,Virtual reality exposure + alprazolam,Virtual reality exposure therapy (VRET) + alprazolam,Yes,TF,Yes,Antianxiety: benzodiazepine,No,Not Applicable,No,No,No,No,No,Individual,In Person,50,Self report,PSS-SR,PSS-SR,,,Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Baseline,,,32.4,,95% CI,26,38.9,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_PSS-SR_C_0_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,C,PTSD,,,,Virtual reality exposure + placebo,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,53,Self report,PSS-SR,PSS-SR,,,Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,End of Treatment,0,,24.2,,95% CI,20.2,28.1,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_PSS-SR_C_12_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,C,PTSD,,,,Virtual reality exposure + placebo,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,53,Self report,PSS-SR,PSS-SR,,,Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Assessment at 3 to <6 Months,12,,21.4,,95% CI,17.1,25.6,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_PSS-SR_C_26_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,C,PTSD,,,,Virtual reality exposure + placebo,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,53,Self report,PSS-SR,PSS-SR,,,Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Assessment at 6 to <12 Months,26,,20.0,,95% CI,15.9,24,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_PSS-SR_C_52_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,C,PTSD,,,,Virtual reality exposure + placebo,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,53,Self report,PSS-SR,PSS-SR,,,Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Assessment at ≥12 Months,52,,21.7,,95% CI,17.9,25.4,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
rothbaum2014_PSS-SR_C_Baseline_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,156,C,PTSD,,,,Virtual reality exposure + placebo,Virtual reality exposure therapy (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,53,Self report,PSS-SR,PSS-SR,,,Piecewise mixed-effect models. Chi-square tests for PTSD diagnostic change.,Baseline,,,32.4,,95% CI,29.1,35.7,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0513,,0.9487,Combat-related,,Medium,"Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.",42150,2019
sack2016_CAPS_A_0_Comp,Psychotherapy,PTSD,139,A,PTSD,,41,,Exposure with eyes fixated and moving,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,47,Structured Clinical Interview,CAPS,CAPS (German version),Completer,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,End of Treatment,0,,21.3,16.5,,,,,-35.5,,,,,Cohen's d 2.22,2.22,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to SCID,,,20-point decrease in CAPS score from baseline to posttreatment,0.8049,,Community,,,1,0.64,,0.36,Mixed,"accidents, natural or manmade disasters, community/school violence, other (sexual trauma)",Medium,"Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.",49086,2019
sack2016_CAPS_A_0_ITT,Psychotherapy,PTSD,139,A,PTSD,,41,,Exposure with eyes fixated and moving,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,47,Structured Clinical Interview,CAPS,CAPS (German version),ITT,Multiple imputation,Linear mixed models with a priori contrasts; Cohen's d effect sizes,End of Treatment,0,,22.8,18.1,,,,,-35.8,,,,,Cohen's d 2.06,2.06,95% CI,1.55,2.57,p<0.001,,,,,,,,Not meeting criteria for PTSD according to SCID,0.8085,,20-point decrease in CAPS score from baseline to posttreatment,,,Community,,,1,0.64,,0.36,Mixed,"accidents, natural or manmade disasters, community/school violence, other (sexual trauma)",Medium,"Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.",49086,2019
sack2016_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,139,A,PTSD,,41,,Exposure with eyes fixated and moving,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,47,Structured Clinical Interview,CAPS,CAPS (German version),Completer,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Baseline,,,56.8,15.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.64,,0.36,Mixed,"accidents, natural or manmade disasters, community/school violence, other (sexual trauma)",Medium,"Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.",49086,2019
sack2016_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,139,A,PTSD,,47,,Exposure with eyes fixated and moving,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,47,Structured Clinical Interview,CAPS,CAPS (German version),ITT,Multiple imputation,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Baseline,,,58.6,16.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.64,,0.36,Mixed,"accidents, natural or manmade disasters, community/school violence, other (sexual trauma)",Medium,"Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.",49086,2019
sack2016_CAPS_B_0_Comp,Psychotherapy,PTSD,139,B,PTSD,,38,,Exposure with eyes fixated and not moving,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,47,Structured Clinical Interview,CAPS,CAPS (German version),Completer,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,End of Treatment,0,,18.5,16.9,,,,,-41.9,,,,,Cohen's d 2.55,2.55,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to SCID,,,20-point decrease in CAPS score from baseline to posttreatment,0.8684,,Community,,,1,0.64,,0.36,Mixed,"accidents, natural or manmade disasters, community/school violence, other (sexual trauma)",Medium,"Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.",49086,2019
sack2016_CAPS_B_0_ITT,Psychotherapy,PTSD,139,B,PTSD,,38,,Exposure with eyes fixated and not moving,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,47,Structured Clinical Interview,CAPS,CAPS (German version),ITT,Multiple imputation,Linear mixed models with a priori contrasts; Cohen's d effect sizes,End of Treatment,0,,20.3,16.4,,,,,-40.5,,,,,Cohen's d 2.58,2.58,95% CI,2.01,3.11,p<0.001,,,,,,,,Not meeting criteria for PTSD according to SCID,0.7872,,20-point decrease in CAPS score from baseline to posttreatment,,,Community,,,1,0.64,,0.36,Mixed,"accidents, natural or manmade disasters, community/school violence, other (sexual trauma)",Medium,"Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.",49086,2019
sack2016_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,139,B,PTSD,,38,,Exposure with eyes fixated and not moving,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,47,Structured Clinical Interview,CAPS,CAPS (German version),Completer,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Baseline,,,60.4,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.64,,0.36,Mixed,"accidents, natural or manmade disasters, community/school violence, other (sexual trauma)",Medium,"Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.",49086,2019
sack2016_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,139,B,PTSD,,47,,Exposure with eyes fixated and not moving,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,47,Structured Clinical Interview,CAPS,CAPS (German version),ITT,Multiple imputation,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Baseline,,,60.8,15.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.64,,0.36,Mixed,"accidents, natural or manmade disasters, community/school violence, other (sexual trauma)",Medium,"Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.",49086,2019
sack2016_CAPS_C_0_Comp,Psychotherapy,PTSD,139,C,PTSD,,37,,Exposure without eye fixation,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,45,Structured Clinical Interview,CAPS,CAPS (German version),Completer,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,End of Treatment,0,,23.7,17.7,,,,,-30.8,,,,,Cohen's d 1.53,1.53,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to SCID,,,20-point decrease in CAPS score from baseline to posttreatment,0.6216,,Community,,,1,0.64,,0.36,Mixed,"accidents, natural or manmade disasters, community/school violence, other (sexual trauma)",Medium,"Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.",49086,2019
sack2016_CAPS_C_0_ITT,Psychotherapy,PTSD,139,C,PTSD,,37,,Exposure without eye fixation,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,45,Structured Clinical Interview,CAPS,CAPS (German version),ITT,Multiple imputation,Linear mixed models with a priori contrasts; Cohen's d effect sizes,End of Treatment,0,,26.6,18.8,,,,,-31,,,,,Cohen's d 1.44,1.44,95% CI,0.97,1.91,p<0.001,,,,,,,,Not meeting criteria for PTSD according to SCID,0.8,,20-point decrease in CAPS score from baseline to posttreatment,,,Community,,,1,0.64,,0.36,Mixed,"accidents, natural or manmade disasters, community/school violence, other (sexual trauma)",Medium,"Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.",49086,2019
sack2016_CAPS_C_Baseline_Comp,Psychotherapy,PTSD,139,C,PTSD,,37,,Exposure without eye fixation,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,45,Structured Clinical Interview,CAPS,CAPS (German version),Completer,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Baseline,,,54.5,22.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.64,,0.36,Mixed,"accidents, natural or manmade disasters, community/school violence, other (sexual trauma)",Medium,"Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.",49086,2019
sack2016_CAPS_C_Baseline_ITT,Psychotherapy,PTSD,139,C,PTSD,,45,,Exposure without eye fixation,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,45,Structured Clinical Interview,CAPS,CAPS (German version),ITT,Multiple imputation,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Baseline,,,57.6,23.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.64,,0.36,Mixed,"accidents, natural or manmade disasters, community/school violence, other (sexual trauma)",Medium,"Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.",49086,2019
sack2016_IES_A_0_ITT,Psychotherapy,PTSD,139,A,PTSD,,,,Exposure with eyes fixated and moving,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,47,Self report,IES,IES,ITT,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,End of Treatment,0,,17.4,13.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.64,,0.36,Mixed,"accidents, natural or manmade disasters, community/school violence, other (sexual trauma)",Medium,"Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.",49086,2019
sack2016_IES_A_Baseline_ITT,Psychotherapy,PTSD,139,A,PTSD,,,,Exposure with eyes fixated and moving,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,47,Self report,IES,IES,ITT,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Baseline,,,39.9,14.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.64,,0.36,Mixed,"accidents, natural or manmade disasters, community/school violence, other (sexual trauma)",Medium,"Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.",49086,2019
sack2016_IES_B_0_ITT,Psychotherapy,PTSD,139,B,PTSD,,,,Exposure with eyes fixated and not moving,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,47,Self report,IES,IES,ITT,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,End of Treatment,0,,18.3,12.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.64,,0.36,Mixed,"accidents, natural or manmade disasters, community/school violence, other (sexual trauma)",Medium,"Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.",49086,2019
sack2016_IES_B_Baseline_ITT,Psychotherapy,PTSD,139,B,PTSD,,,,Exposure with eyes fixated and not moving,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,47,Self report,IES,IES,ITT,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Baseline,,,41.8,15.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.64,,0.36,Mixed,"accidents, natural or manmade disasters, community/school violence, other (sexual trauma)",Medium,"Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.",49086,2019
sack2016_IES_C_0_ITT,Psychotherapy,PTSD,139,C,PTSD,,,,Exposure without eye fixation,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,45,Self report,IES,IES,ITT,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,End of Treatment,0,,16.2,16.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.64,,0.36,Mixed,"accidents, natural or manmade disasters, community/school violence, other (sexual trauma)",Medium,"Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.",49086,2019
sack2016_IES_C_Baseline_ITT,Psychotherapy,PTSD,139,C,PTSD,,,,Exposure without eye fixation,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,45,Self report,IES,IES,ITT,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Baseline,,,41.7,13.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.64,,0.36,Mixed,"accidents, natural or manmade disasters, community/school violence, other (sexual trauma)",Medium,"Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.",49086,2019
sack2017_Scri_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,35,A,PTSD,,35,,Oxytocin + trauma memory reactivation,Oxytocin + exposure (experimental paradigm),No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,35,Self report,Script-Driven Imagery Scale,Script-Driven Imagery Scale,ITT,Linear mixed model,Linear mixed models with a priori contrasts; Cohen's d effect sizes,End of Treatment,0,,2.44,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, child sexual abuse, community/school violence, accidents, natural or manmade disasters, other (""non-sexual violence by a family member"")",Low,"Sack M, Spieler D, Wizelman L, et al. Intranasal oxytocin reduces provoked symptoms in female patients with posttraumatic stress disorder despite exerting sympathomimetic and positive chronotropic effects in a randomized controlled trial. BMC Med. 2017 Feb 17;15:40. doi: 10.1186/s12916-017-0801-0. PMID: 28209155.",47377,2019
sack2017_Scri_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,35,A,PTSD,,35,,Oxytocin + trauma memory reactivation,Oxytocin + exposure (experimental paradigm),No,Not Applicable,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,35,Self report,Script-Driven Imagery Scale,Script-Driven Imagery Scale,ITT,Linear mixed model,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, child sexual abuse, community/school violence, accidents, natural or manmade disasters, other (""non-sexual violence by a family member"")",Low,"Sack M, Spieler D, Wizelman L, et al. Intranasal oxytocin reduces provoked symptoms in female patients with posttraumatic stress disorder despite exerting sympathomimetic and positive chronotropic effects in a randomized controlled trial. BMC Med. 2017 Feb 17;15:40. doi: 10.1186/s12916-017-0801-0. PMID: 28209155.",47377,2019
sack2017_Scri_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,35,B,Control,,35,,Placebo + trauma memory reactivation,Placebo + trauma memory reactivation,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,35,Self report,Script-Driven Imagery Scale,Script-Driven Imagery Scale,ITT,Linear mixed model,Linear mixed models with a priori contrasts; Cohen's d effect sizes,End of Treatment,0,,2.87,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, child sexual abuse, community/school violence, accidents, natural or manmade disasters, other (""non-sexual violence by a family member"")",Low,"Sack M, Spieler D, Wizelman L, et al. Intranasal oxytocin reduces provoked symptoms in female patients with posttraumatic stress disorder despite exerting sympathomimetic and positive chronotropic effects in a randomized controlled trial. BMC Med. 2017 Feb 17;15:40. doi: 10.1186/s12916-017-0801-0. PMID: 28209155.",47377,2019
sack2017_Scri_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,35,B,Control,,35,,Placebo + trauma memory reactivation,Placebo + trauma memory reactivation,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,35,Self report,Script-Driven Imagery Scale,Script-Driven Imagery Scale,ITT,Linear mixed model,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, child sexual abuse, community/school violence, accidents, natural or manmade disasters, other (""non-sexual violence by a family member"")",Low,"Sack M, Spieler D, Wizelman L, et al. Intranasal oxytocin reduces provoked symptoms in female patients with posttraumatic stress disorder despite exerting sympathomimetic and positive chronotropic effects in a randomized controlled trial. BMC Med. 2017 Feb 17;15:40. doi: 10.1186/s12916-017-0801-0. PMID: 28209155.",47377,2019
sannibale2013_CAPS_A_0_ITT,Psychotherapy,PTSD+SUD,62,A,PTSD+SUD,Integrated,24,,Integrated therapy,Integrated cognitive behavioral therapy for PTSD and AUD,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized estimating equations with assumption of data missing at random,Linear mixed models with a priori contrasts; Cohen's d effect sizes,End of Treatment,0,,42.80,26.45,,,,,-25.2,,,,,,,,,,,,,,,,,,Not fulfilling DSM-IV criteria for PTSD according to CAPS,,,CAPS score <37,,Additional definitions of Clinically Meaningful Response reported in the study,Community,0,0,1,0.5323,,0.4677,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, intimate partner violence, accidents, other (""witnessed injury/killing/mutilation"", ""news of someone close"", ""danger of losing life/other"")",Medium,"Sannibale C, Teesson M, Creamer MC, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013 Aug;108(8):1397-410. doi: 10.1111/add.12167. PMID: 25328957.",40190,2020
sannibale2013_CAPS_A_39_ITT,Psychotherapy,PTSD+SUD,62,A,PTSD+SUD,Integrated,26,,Integrated therapy,Integrated cognitive behavioral therapy for PTSD and AUD,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized estimating equations with assumption of data missing at random,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Assessment at 6 to <12 Months,39,,43.40,28.25,,,,,-24.7,,,,,,,,,,,,,,,,,,Not fulfilling DSM-IV criteria for PTSD according to CAPS,,,CAPS score <37,,Additional definitions of Clinically Meaningful Response reported in the study,Community,0,0,1,0.5323,,0.4677,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, intimate partner violence, accidents, other (""witnessed injury/killing/mutilation"", ""news of someone close"", ""danger of losing life/other"")",Medium,"Sannibale C, Teesson M, Creamer MC, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013 Aug;108(8):1397-410. doi: 10.1111/add.12167. PMID: 25328957.",40190,2020
sannibale2013_CAPS_A_5_ITT,Psychotherapy,PTSD+SUD,62,A,PTSD+SUD,Integrated,24,,Integrated therapy,Integrated cognitive behavioral therapy for PTSD and AUD,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized estimating equations with assumption of data missing at random,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Assessment at <3 Months,5,,40.39,23.49,,,,,-27.61,,,,,,,,,,,,,,,,,,Not fulfilling DSM-IV criteria for PTSD according to CAPS,,,CAPS score <37,0.54,Additional definitions of Clinically Meaningful Response reported in the study,Community,0,0,1,0.5323,,0.4677,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, intimate partner violence, accidents, other (""witnessed injury/killing/mutilation"", ""news of someone close"", ""danger of losing life/other"")",Medium,"Sannibale C, Teesson M, Creamer MC, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013 Aug;108(8):1397-410. doi: 10.1111/add.12167. PMID: 25328957.",40190,2020
sannibale2013_CAPS_A_Baseline_ITT,Psychotherapy,PTSD+SUD,62,A,PTSD+SUD,Integrated,33,,Integrated therapy,Integrated cognitive behavioral therapy for PTSD and AUD,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized estimating equations with assumption of data missing at random,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Baseline,,,68.00,23.63,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.5323,,0.4677,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, intimate partner violence, accidents, other (""witnessed injury/killing/mutilation"", ""news of someone close"", ""danger of losing life/other"")",Medium,"Sannibale C, Teesson M, Creamer MC, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013 Aug;108(8):1397-410. doi: 10.1111/add.12167. PMID: 25328957.",40190,2020
sannibale2013_CAPS_B_0_ITT,Psychotherapy,PTSD+SUD,62,B,SUD,Not integrated,22,,Alcohol support,Cognitive behavioral therapy (CBT) for alcohol use,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,29,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized estimating equations with assumption of data missing at random,Linear mixed models with a priori contrasts; Cohen's d effect sizes,End of Treatment,0,,46.71,26.27,,,,,-21.36,,,,,,,,,,,,,,,,,,Not fulfilling DSM-IV criteria for PTSD according to CAPS,,,CAPS score <37,,Additional definitions of Clinically Meaningful Response reported in the study,Community,0,0,1,0.5323,,0.4677,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, intimate partner violence, accidents, other (""witnessed injury/killing/mutilation"", ""news of someone close"", ""danger of losing life/other"")",Medium,"Sannibale C, Teesson M, Creamer MC, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013 Aug;108(8):1397-410. doi: 10.1111/add.12167. PMID: 25328957.",40190,2020
sannibale2013_CAPS_B_39_ITT,Psychotherapy,PTSD+SUD,62,B,SUD,Not integrated,21,,Alcohol support,Cognitive behavioral therapy (CBT) for alcohol use,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,29,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized estimating equations with assumption of data missing at random,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Assessment at 6 to <12 Months,39,,41.19,34.17,,,,,-26.88,,,,,,,,,,,,,,,,,,Not fulfilling DSM-IV criteria for PTSD according to CAPS,,,CAPS score <37,,Additional definitions of Clinically Meaningful Response reported in the study,Community,0,0,1,0.5323,,0.4677,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, intimate partner violence, accidents, other (""witnessed injury/killing/mutilation"", ""news of someone close"", ""danger of losing life/other"")",Medium,"Sannibale C, Teesson M, Creamer MC, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013 Aug;108(8):1397-410. doi: 10.1111/add.12167. PMID: 25328957.",40190,2020
sannibale2013_CAPS_B_5_ITT,Psychotherapy,PTSD+SUD,62,B,SUD,Not integrated,21,,Alcohol support,Cognitive behavioral therapy (CBT) for alcohol use,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,29,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized estimating equations with assumption of data missing at random,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Assessment at <3 Months,5,,49.71,22.9,,,,,-18.36,,,,,,,,,,,,,,,,,,Not fulfilling DSM-IV criteria for PTSD according to CAPS,,,CAPS score <37,0.18,Additional definitions of Clinically Meaningful Response reported in the study,Community,0,0,1,0.5323,,0.4677,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, intimate partner violence, accidents, other (""witnessed injury/killing/mutilation"", ""news of someone close"", ""danger of losing life/other"")",Medium,"Sannibale C, Teesson M, Creamer MC, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013 Aug;108(8):1397-410. doi: 10.1111/add.12167. PMID: 25328957.",40190,2020
sannibale2013_CAPS_B_Baseline_ITT,Psychotherapy,PTSD+SUD,62,B,SUD,Not integrated,29,,Alcohol support,Cognitive behavioral therapy (CBT) for alcohol use,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,29,Structured Clinical Interview,CAPS,CAPS,ITT,Generalized estimating equations with assumption of data missing at random,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Baseline,,,68.07,21.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.5323,,0.4677,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, intimate partner violence, accidents, other (""witnessed injury/killing/mutilation"", ""news of someone close"", ""danger of losing life/other"")",Medium,"Sannibale C, Teesson M, Creamer MC, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013 Aug;108(8):1397-410. doi: 10.1111/add.12167. PMID: 25328957.",40190,2020
sannibale2013_PDS_A_0_ITT,Psychotherapy,PTSD+SUD,62,A,PTSD+SUD,Integrated,,,Integrated therapy,Integrated cognitive behavioral therapy for PTSD and AUD,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Self report,PDS,PDS,ITT,Generalized estimating equations with assumption of data missing at random,Linear mixed models with a priori contrasts; Cohen's d effect sizes,End of Treatment,0,,21.88,14.66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.5323,,0.4677,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, intimate partner violence, accidents, other (""witnessed injury/killing/mutilation"", ""news of someone close"", ""danger of losing life/other"")",Medium,"Sannibale C, Teesson M, Creamer MC, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013 Aug;108(8):1397-410. doi: 10.1111/add.12167. PMID: 25328957.",40190,2020
sannibale2013_PDS_A_39_ITT,Psychotherapy,PTSD+SUD,62,A,PTSD+SUD,Integrated,,,Integrated therapy,Integrated cognitive behavioral therapy for PTSD and AUD,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Self report,PDS,PDS,ITT,Generalized estimating equations with assumption of data missing at random,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Assessment at 6 to <12 Months,39,,22.88,16.68,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.5323,,0.4677,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, intimate partner violence, accidents, other (""witnessed injury/killing/mutilation"", ""news of someone close"", ""danger of losing life/other"")",Medium,"Sannibale C, Teesson M, Creamer MC, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013 Aug;108(8):1397-410. doi: 10.1111/add.12167. PMID: 25328957.",40190,2020
sannibale2013_PDS_A_5_ITT,Psychotherapy,PTSD+SUD,62,A,PTSD+SUD,Integrated,,,Integrated therapy,Integrated cognitive behavioral therapy for PTSD and AUD,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Self report,PDS,PDS,ITT,Generalized estimating equations with assumption of data missing at random,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Assessment at <3 Months,5,,20.88,13.37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.5323,,0.4677,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, intimate partner violence, accidents, other (""witnessed injury/killing/mutilation"", ""news of someone close"", ""danger of losing life/other"")",Medium,"Sannibale C, Teesson M, Creamer MC, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013 Aug;108(8):1397-410. doi: 10.1111/add.12167. PMID: 25328957.",40190,2020
sannibale2013_PDS_A_Baseline_ITT,Psychotherapy,PTSD+SUD,62,A,PTSD+SUD,Integrated,,,Integrated therapy,Integrated cognitive behavioral therapy for PTSD and AUD,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,33,Self report,PDS,PDS,ITT,Generalized estimating equations with assumption of data missing at random,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Baseline,,,33.07,10.43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.5323,,0.4677,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, intimate partner violence, accidents, other (""witnessed injury/killing/mutilation"", ""news of someone close"", ""danger of losing life/other"")",Medium,"Sannibale C, Teesson M, Creamer MC, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013 Aug;108(8):1397-410. doi: 10.1111/add.12167. PMID: 25328957.",40190,2020
sannibale2013_PDS_B_0_ITT,Psychotherapy,PTSD+SUD,62,B,SUD,Not integrated,,,Alcohol support,Cognitive behavioral therapy (CBT) for alcohol use,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,29,Self report,PDS,PDS,ITT,Generalized estimating equations with assumption of data missing at random,Linear mixed models with a priori contrasts; Cohen's d effect sizes,End of Treatment,0,,24.18,14.05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.5323,,0.4677,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, intimate partner violence, accidents, other (""witnessed injury/killing/mutilation"", ""news of someone close"", ""danger of losing life/other"")",Medium,"Sannibale C, Teesson M, Creamer MC, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013 Aug;108(8):1397-410. doi: 10.1111/add.12167. PMID: 25328957.",40190,2020
sannibale2013_PDS_B_39_ITT,Psychotherapy,PTSD+SUD,62,B,SUD,Not integrated,,,Alcohol support,Cognitive behavioral therapy (CBT) for alcohol use,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,29,Self report,PDS,PDS,ITT,Generalized estimating equations with assumption of data missing at random,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Assessment at 6 to <12 Months,39,,20.81,17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.5323,,0.4677,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, intimate partner violence, accidents, other (""witnessed injury/killing/mutilation"", ""news of someone close"", ""danger of losing life/other"")",Medium,"Sannibale C, Teesson M, Creamer MC, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013 Aug;108(8):1397-410. doi: 10.1111/add.12167. PMID: 25328957.",40190,2020
sannibale2013_PDS_B_5_ITT,Psychotherapy,PTSD+SUD,62,B,SUD,Not integrated,,,Alcohol support,Cognitive behavioral therapy (CBT) for alcohol use,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,29,Self report,PDS,PDS,ITT,Generalized estimating equations with assumption of data missing at random,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Assessment at <3 Months,5,,24.48,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.5323,,0.4677,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, intimate partner violence, accidents, other (""witnessed injury/killing/mutilation"", ""news of someone close"", ""danger of losing life/other"")",Medium,"Sannibale C, Teesson M, Creamer MC, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013 Aug;108(8):1397-410. doi: 10.1111/add.12167. PMID: 25328957.",40190,2020
sannibale2013_PDS_B_Baseline_ITT,Psychotherapy,PTSD+SUD,62,B,SUD,Not integrated,,,Alcohol support,Cognitive behavioral therapy (CBT) for alcohol use,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,29,Self report,PDS,PDS,ITT,Generalized estimating equations with assumption of data missing at random,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Baseline,,,31.38,10.43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.5323,,0.4677,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, intimate partner violence, accidents, other (""witnessed injury/killing/mutilation"", ""news of someone close"", ""danger of losing life/other"")",Medium,"Sannibale C, Teesson M, Creamer MC, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013 Aug;108(8):1397-410. doi: 10.1111/add.12167. PMID: 25328957.",40190,2020
santarnecchi2019_CAPS_A_0_Comp,Psychotherapy,PTSD,37,A,PTSD,,14,,Trauma-focused CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,14,Structured Clinical Interview,CAPS,CAPS,Completer,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,End of Treatment,0,,18,,,,,,-28,,,,,,,,,,p<0.05,,,,,,,,,,,,,,Community,0,0,1,0.3871,,0.6129,Natural or manmade disasters,,High,"Santarnecchi E, Bossini L, Vatti G, et al. Psychological and brain connectivity changes following trauma-focused CBT and EMDR treatment in single-episode PTSD patients. Front Psychol. 2019;10:129. doi: 10.3389/fpsyg.2019.00129. PMID: 30858808.",52130,2020
santarnecchi2019_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,37,A,PTSD,,14,,Trauma-focused CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,14,Structured Clinical Interview,CAPS,CAPS,Completer,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Baseline,,,45.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.3871,,0.6129,Natural or manmade disasters,,High,"Santarnecchi E, Bossini L, Vatti G, et al. Psychological and brain connectivity changes following trauma-focused CBT and EMDR treatment in single-episode PTSD patients. Front Psychol. 2019;10:129. doi: 10.3389/fpsyg.2019.00129. PMID: 30858808.",52130,2020
santarnecchi2019_CAPS_B_0_Comp,Psychotherapy,PTSD,37,B,PTSD,,17,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,17,Structured Clinical Interview,CAPS,CAPS,Completer,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,End of Treatment,0,,31,,,,,,-27,,,,,,,,,,p<0.05,,,,,,,,,,,,,,Community,0,0,1,0.3871,,0.6129,Natural or manmade disasters,,High,"Santarnecchi E, Bossini L, Vatti G, et al. Psychological and brain connectivity changes following trauma-focused CBT and EMDR treatment in single-episode PTSD patients. Front Psychol. 2019;10:129. doi: 10.3389/fpsyg.2019.00129. PMID: 30858808.",52130,2020
santarnecchi2019_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,37,B,PTSD,,17,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,17,Structured Clinical Interview,CAPS,CAPS,Completer,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Baseline,,,57.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.3871,,0.6129,Natural or manmade disasters,,High,"Santarnecchi E, Bossini L, Vatti G, et al. Psychological and brain connectivity changes following trauma-focused CBT and EMDR treatment in single-episode PTSD patients. Front Psychol. 2019;10:129. doi: 10.3389/fpsyg.2019.00129. PMID: 30858808.",52130,2020
santarnecchi2019_DTS_A_0_Comp,Psychotherapy,PTSD,37,A,PTSD,,,,Trauma-focused CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,14,Self report,DTS,DTS,Completer,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,End of Treatment,0,,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.3871,,0.6129,Natural or manmade disasters,,High,"Santarnecchi E, Bossini L, Vatti G, et al. Psychological and brain connectivity changes following trauma-focused CBT and EMDR treatment in single-episode PTSD patients. Front Psychol. 2019;10:129. doi: 10.3389/fpsyg.2019.00129. PMID: 30858808.",52130,2020
santarnecchi2019_DTS_A_0_NA,Psychotherapy,PTSD,37,A,PTSD,,,,Trauma-focused CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,14,Self report,DTS,DTS,,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,End of Treatment,0,,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.3871,,0.6129,Natural or manmade disasters,,High,"Santarnecchi E, Bossini L, Vatti G, et al. Psychological and brain connectivity changes following trauma-focused CBT and EMDR treatment in single-episode PTSD patients. Front Psychol. 2019;10:129. doi: 10.3389/fpsyg.2019.00129. PMID: 30858808.",52130,2020
santarnecchi2019_DTS_A_Baseline_Comp,Psychotherapy,PTSD,37,A,PTSD,,,,Trauma-focused CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,14,Self report,DTS,DTS,Completer,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Baseline,,,39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.3871,,0.6129,Natural or manmade disasters,,High,"Santarnecchi E, Bossini L, Vatti G, et al. Psychological and brain connectivity changes following trauma-focused CBT and EMDR treatment in single-episode PTSD patients. Front Psychol. 2019;10:129. doi: 10.3389/fpsyg.2019.00129. PMID: 30858808.",52130,2020
santarnecchi2019_DTS_A_Baseline_NA,Psychotherapy,PTSD,37,A,PTSD,,,,Trauma-focused CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,14,Self report,DTS,DTS,,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Baseline,,,39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.3871,,0.6129,Natural or manmade disasters,,High,"Santarnecchi E, Bossini L, Vatti G, et al. Psychological and brain connectivity changes following trauma-focused CBT and EMDR treatment in single-episode PTSD patients. Front Psychol. 2019;10:129. doi: 10.3389/fpsyg.2019.00129. PMID: 30858808.",52130,2020
santarnecchi2019_DTS_B_0_Comp,Psychotherapy,PTSD,37,B,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,17,Self report,DTS,DTS,Completer,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,End of Treatment,0,,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.3871,,0.6129,Natural or manmade disasters,,High,"Santarnecchi E, Bossini L, Vatti G, et al. Psychological and brain connectivity changes following trauma-focused CBT and EMDR treatment in single-episode PTSD patients. Front Psychol. 2019;10:129. doi: 10.3389/fpsyg.2019.00129. PMID: 30858808.",52130,2020
santarnecchi2019_DTS_B_0_NA,Psychotherapy,PTSD,37,B,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,17,Self report,DTS,DTS,,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,End of Treatment,0,,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.3871,,0.6129,Natural or manmade disasters,,High,"Santarnecchi E, Bossini L, Vatti G, et al. Psychological and brain connectivity changes following trauma-focused CBT and EMDR treatment in single-episode PTSD patients. Front Psychol. 2019;10:129. doi: 10.3389/fpsyg.2019.00129. PMID: 30858808.",52130,2020
santarnecchi2019_DTS_B_Baseline_Comp,Psychotherapy,PTSD,37,B,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,17,Self report,DTS,DTS,Completer,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Baseline,,,45,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.3871,,0.6129,Natural or manmade disasters,,High,"Santarnecchi E, Bossini L, Vatti G, et al. Psychological and brain connectivity changes following trauma-focused CBT and EMDR treatment in single-episode PTSD patients. Front Psychol. 2019;10:129. doi: 10.3389/fpsyg.2019.00129. PMID: 30858808.",52130,2020
santarnecchi2019_DTS_B_Baseline_NA,Psychotherapy,PTSD,37,B,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,17,Self report,DTS,DTS,,,Linear mixed models with a priori contrasts; Cohen's d effect sizes,Baseline,,,45,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.3871,,0.6129,Natural or manmade disasters,,High,"Santarnecchi E, Bossini L, Vatti G, et al. Psychological and brain connectivity changes following trauma-focused CBT and EMDR treatment in single-episode PTSD patients. Front Psychol. 2019;10:129. doi: 10.3389/fpsyg.2019.00129. PMID: 30858808.",52130,2020
sautter2015_CAPS_A_0_ITT,Psychotherapy,PTSD,114,A,PTSD,,22,,Structured Approach Therapy,Structured Approach Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Couple,In Person,58,Structured Clinical Interview,CAPS,CAPS,ITT,All available observations used,General linear mixed models with time flexibly modeled; t tests or Fisher's exact tests for PTSD diagnostic change comparisons,End of Treatment,0,,48.33,,SE,3.71,,,-37.6,,,,Treatment effect,,,,,,p<0.0001,,,,,,,,,,,,,,Veteran,,1,,,"Veterans: 1.75%
Partners: 98.25%",,,,Medium,"Sautter FJ, Glynn SM, Cretu JB, et al. Efficacy of structured approach therapy in reducing PTSD in returning veterans: A randomized clinical trial. Psychol Serv. 2015 Aug;12(3):199-212. doi: 10.1037/ser0000032. PMID: 26213789.",44509,2019
sautter2015_CAPS_A_12_ITT,Psychotherapy,PTSD,114,A,PTSD,,21,,Structured Approach Therapy,Structured Approach Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Couple,In Person,58,Structured Clinical Interview,CAPS,CAPS,ITT,All available observations used,General linear mixed models with time flexibly modeled; t tests or Fisher's exact tests for PTSD diagnostic change comparisons,Assessment at 3 to <6 Months,12,,44.64,,SE,3.78,,,-41.29,,,,Treatment effect,,,,,,p<0.0001,,,,,,,,CAPS <45,0.5172,,,,,Veteran,,1,,,"Veterans: 1.75%
Partners: 98.25%",,,,Medium,"Sautter FJ, Glynn SM, Cretu JB, et al. Efficacy of structured approach therapy in reducing PTSD in returning veterans: A randomized clinical trial. Psychol Serv. 2015 Aug;12(3):199-212. doi: 10.1037/ser0000032. PMID: 26213789.",44509,2019
sautter2015_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,114,A,PTSD,,29,(Veterans only),Structured Approach Therapy,Structured Approach Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Couple,In Person,58,Structured Clinical Interview,CAPS,CAPS,ITT,All available observations used,General linear mixed models with time flexibly modeled; t tests or Fisher's exact tests for PTSD diagnostic change comparisons,Baseline,,,85.93,,SE,3.31,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,,"Veterans: 1.75%
Partners: 98.25%",,,,Medium,"Sautter FJ, Glynn SM, Cretu JB, et al. Efficacy of structured approach therapy in reducing PTSD in returning veterans: A randomized clinical trial. Psychol Serv. 2015 Aug;12(3):199-212. doi: 10.1037/ser0000032. PMID: 26213789.",44509,2019
sautter2015_CAPS_B_0_ITT,Psychotherapy,PTSD,114,B,PTSD,,21,,PTSD Family Education,PTSD Family Education,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Couple,In Person,56,Structured Clinical Interview,CAPS,CAPS,ITT,All available observations used,General linear mixed models with time flexibly modeled; t tests or Fisher's exact tests for PTSD diagnostic change comparisons,End of Treatment,0,,72.59,,SE,3.79,,,-10.34,,,,Treatment effect,,,,,,p=0.01,,,,,,,,,,,,,,Veteran,,1,,,"Veterans: 1.75%
Partners: 98.25%",,,,Medium,"Sautter FJ, Glynn SM, Cretu JB, et al. Efficacy of structured approach therapy in reducing PTSD in returning veterans: A randomized clinical trial. Psychol Serv. 2015 Aug;12(3):199-212. doi: 10.1037/ser0000032. PMID: 26213789.",44509,2019
sautter2015_CAPS_B_12_ITT,Psychotherapy,PTSD,114,B,PTSD,,20,,PTSD Family Education,PTSD Family Education,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Couple,In Person,56,Structured Clinical Interview,CAPS,CAPS,ITT,All available observations used,General linear mixed models with time flexibly modeled; t tests or Fisher's exact tests for PTSD diagnostic change comparisons,Assessment at 3 to <6 Months,12,,71.93,,SE,3.86,,,-11,,,,Treatment effect,,,,,,p=0.01,,,,,,,,CAPS <45,0.0714,,,,,Veteran,,1,,,"Veterans: 1.75%
Partners: 98.25%",,,,Medium,"Sautter FJ, Glynn SM, Cretu JB, et al. Efficacy of structured approach therapy in reducing PTSD in returning veterans: A randomized clinical trial. Psychol Serv. 2015 Aug;12(3):199-212. doi: 10.1037/ser0000032. PMID: 26213789.",44509,2019
sautter2015_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,114,B,PTSD,,28,(Veterans only),PTSD Family Education,PTSD Family Education,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Couple,In Person,56,Structured Clinical Interview,CAPS,CAPS,ITT,All available observations used,General linear mixed models with time flexibly modeled; t tests or Fisher's exact tests for PTSD diagnostic change comparisons,Baseline,,,82.93,,SE,3.37,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,,"Veterans: 1.75%
Partners: 98.25%",,,,Medium,"Sautter FJ, Glynn SM, Cretu JB, et al. Efficacy of structured approach therapy in reducing PTSD in returning veterans: A randomized clinical trial. Psychol Serv. 2015 Aug;12(3):199-212. doi: 10.1037/ser0000032. PMID: 26213789.",44509,2019
sautter2015_PCL_A_0_NA,Psychotherapy,PTSD,114,A,PTSD,,,,Structured Approach Therapy,Structured Approach Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Couple,In Person,58,Self report,PCL,PCL-M,,,General linear mixed models with time flexibly modeled; t tests or Fisher's exact tests for PTSD diagnostic change comparisons,End of Treatment,0,,42.16,2.38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,,"Veterans: 1.75%
Partners: 98.25%",,,,Medium,"Sautter FJ, Glynn SM, Cretu JB, et al. Efficacy of structured approach therapy in reducing PTSD in returning veterans: A randomized clinical trial. Psychol Serv. 2015 Aug;12(3):199-212. doi: 10.1037/ser0000032. PMID: 26213789.",44509,2019
sautter2015_PCL_A_12_NA,Psychotherapy,PTSD,114,A,PTSD,,,,Structured Approach Therapy,Structured Approach Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Couple,In Person,58,Self report,PCL,PCL-M,,,General linear mixed models with time flexibly modeled; t tests or Fisher's exact tests for PTSD diagnostic change comparisons,Assessment at 3 to <6 Months,12,,39.54,2.48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,,"Veterans: 1.75%
Partners: 98.25%",,,,Medium,"Sautter FJ, Glynn SM, Cretu JB, et al. Efficacy of structured approach therapy in reducing PTSD in returning veterans: A randomized clinical trial. Psychol Serv. 2015 Aug;12(3):199-212. doi: 10.1037/ser0000032. PMID: 26213789.",44509,2019
sautter2015_PCL_A_Baseline_NA,Psychotherapy,PTSD,114,A,PTSD,,,,Structured Approach Therapy,Structured Approach Therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Couple,In Person,58,Self report,PCL,PCL-M,,,General linear mixed models with time flexibly modeled; t tests or Fisher's exact tests for PTSD diagnostic change comparisons,Baseline,,,60.84,,SE,2.12,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,,"Veterans: 1.75%
Partners: 98.25%",,,,Medium,"Sautter FJ, Glynn SM, Cretu JB, et al. Efficacy of structured approach therapy in reducing PTSD in returning veterans: A randomized clinical trial. Psychol Serv. 2015 Aug;12(3):199-212. doi: 10.1037/ser0000032. PMID: 26213789.",44509,2019
sautter2015_PCL_B_0_NA,Psychotherapy,PTSD,114,B,PTSD,,,,PTSD Family Education,PTSD Family Education,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Couple,In Person,56,Self report,PCL,PCL-M,,,General linear mixed models with time flexibly modeled; t tests or Fisher's exact tests for PTSD diagnostic change comparisons,End of Treatment,0,,53.91,2.48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,,"Veterans: 1.75%
Partners: 98.25%",,,,Medium,"Sautter FJ, Glynn SM, Cretu JB, et al. Efficacy of structured approach therapy in reducing PTSD in returning veterans: A randomized clinical trial. Psychol Serv. 2015 Aug;12(3):199-212. doi: 10.1037/ser0000032. PMID: 26213789.",44509,2019
sautter2015_PCL_B_12_NA,Psychotherapy,PTSD,114,B,PTSD,,,,PTSD Family Education,PTSD Family Education,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Couple,In Person,56,Self report,PCL,PCL-M,,,General linear mixed models with time flexibly modeled; t tests or Fisher's exact tests for PTSD diagnostic change comparisons,Assessment at 3 to <6 Months,12,,51.77,2.53,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,,"Veterans: 1.75%
Partners: 98.25%",,,,Medium,"Sautter FJ, Glynn SM, Cretu JB, et al. Efficacy of structured approach therapy in reducing PTSD in returning veterans: A randomized clinical trial. Psychol Serv. 2015 Aug;12(3):199-212. doi: 10.1037/ser0000032. PMID: 26213789.",44509,2019
sautter2015_PCL_B_Baseline_NA,Psychotherapy,PTSD,114,B,PTSD,,,,PTSD Family Education,PTSD Family Education,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Couple,In Person,56,Self report,PCL,PCL-M,,,General linear mixed models with time flexibly modeled; t tests or Fisher's exact tests for PTSD diagnostic change comparisons,Baseline,,,60.81,,SE,2.17,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,,"Veterans: 1.75%
Partners: 98.25%",,,,Medium,"Sautter FJ, Glynn SM, Cretu JB, et al. Efficacy of structured approach therapy in reducing PTSD in returning veterans: A randomized clinical trial. Psychol Serv. 2015 Aug;12(3):199-212. doi: 10.1037/ser0000032. PMID: 26213789.",44509,2019
saygin2002_TOP-8_A_0_Comp,Pharmacotherapy,PTSD,60,A,PTSD,,30,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,TOP-8,TOP-8,Completer,,General linear mixed models with time flexibly modeled; t tests or Fisher's exact tests for PTSD diagnostic change comparisons,End of Treatment,0,,5.23,3.24,,,,,-14.04,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7593,,0.2407,Natural or manmade disasters,,High,"Saygin MZ, Sungur MZ, Sabol EU, et al. Nefazodone versus sertraline in the treatment of posttraumatic stress disorder. Klinik Psikofarmakol B√ºlteni. 2002 Jan;12(1):1-5.",24668,2019
saygin2002_TOP-8_A_Baseline_Comp,Pharmacotherapy,PTSD,60,A,PTSD,,30,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,TOP-8,TOP-8,Completer,,General linear mixed models with time flexibly modeled; t tests or Fisher's exact tests for PTSD diagnostic change comparisons,Baseline,,,19.27,3.89,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7593,,0.2407,Natural or manmade disasters,,High,"Saygin MZ, Sungur MZ, Sabol EU, et al. Nefazodone versus sertraline in the treatment of posttraumatic stress disorder. Klinik Psikofarmakol B√ºlteni. 2002 Jan;12(1):1-5.",24668,2019
saygin2002_TOP-8_B_0_Comp,Pharmacotherapy,PTSD,60,B,PTSD,,24,,Nefazodone,Nefazodone,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,TOP-8,TOP-8,Completer,,General linear mixed models with time flexibly modeled; t tests or Fisher's exact tests for PTSD diagnostic change comparisons,End of Treatment,0,,4.35,2.94,,,,,-11.4,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7593,,0.2407,Natural or manmade disasters,,High,"Saygin MZ, Sungur MZ, Sabol EU, et al. Nefazodone versus sertraline in the treatment of posttraumatic stress disorder. Klinik Psikofarmakol B√ºlteni. 2002 Jan;12(1):1-5.",24668,2019
saygin2002_TOP-8_B_Baseline_Comp,Pharmacotherapy,PTSD,60,B,PTSD,,30,,Nefazodone,Nefazodone,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,TOP-8,TOP-8,Completer,,General linear mixed models with time flexibly modeled; t tests or Fisher's exact tests for PTSD diagnostic change comparisons,Baseline,,,15.75,3.48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7593,,0.2407,Natural or manmade disasters,,High,"Saygin MZ, Sungur MZ, Sabol EU, et al. Nefazodone versus sertraline in the treatment of posttraumatic stress disorder. Klinik Psikofarmakol B√ºlteni. 2002 Jan;12(1):1-5.",24668,2019
schacht2017_CAPS_A_0_ITT,Psychotherapy,PTSD,58,A,PTSD+SUD,Not integrated,23,,PE with incentive,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS,ITT,Ignored,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",End of Treatment,0,,48.09,24.26,,,,,-24.2,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS (frequency ≥1 and severity ≥2),,,≥15-point reduction on CAPS total score,0.7826,,Community,,,1,0.7931,,0.2069,Mixed,"child sexual assault, child physical assault, intimate partner violence, other (unexpected death of loved one)",Medium,"Schacht RL, Brooner RK, King VL, et al. Incentivizing attendance to prolonged exposure for PTSD with opioid use disorder patients: a randomized controlled trial. J Consult Clin Psychol. 2017 Jul;85(7):689-701. doi: 10.1037/ccp0000208. PMID: 28414485",47904,2019
schacht2017_CAPS_A_12_ITT,Psychotherapy,PTSD,58,A,PTSD+SUD,Not integrated,23,,PE with incentive,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS,ITT,Ignored,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",Assessment at 3 to <6 Months,12,,46.13,20.84,,,,,-26.16,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS (frequency ≥1 and severity ≥2),,,≥15-point reduction on CAPS total score,0.7391,,Community,,,1,0.7931,,0.2069,Mixed,"child sexual assault, child physical assault, intimate partner violence, other (unexpected death of loved one)",Medium,"Schacht RL, Brooner RK, King VL, et al. Incentivizing attendance to prolonged exposure for PTSD with opioid use disorder patients: a randomized controlled trial. J Consult Clin Psychol. 2017 Jul;85(7):689-701. doi: 10.1037/ccp0000208. PMID: 28414485",47904,2019
schacht2017_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,58,A,PTSD+SUD,Not integrated,28,,PE with incentive,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,28,Structured Clinical Interview,CAPS,CAPS,ITT,Ignored,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",Baseline,,,72.29,18.78,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7931,,0.2069,Mixed,"child sexual assault, child physical assault, intimate partner violence, other (unexpected death of loved one)",Medium,"Schacht RL, Brooner RK, King VL, et al. Incentivizing attendance to prolonged exposure for PTSD with opioid use disorder patients: a randomized controlled trial. J Consult Clin Psychol. 2017 Jul;85(7):689-701. doi: 10.1037/ccp0000208. PMID: 28414485",47904,2019
schacht2017_CAPS_B_0_ITT,Psychotherapy,PTSD,58,B,PTSD+SUD,Not integrated,27,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,Ignored,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",End of Treatment,0,,58.33,23.41,,,,,-14.44,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS (frequency ≥1 and severity ≥2),,,≥15-point reduction on CAPS total score,0.4815,,Community,,,1,0.7931,,0.2069,Mixed,"child sexual assault, child physical assault, intimate partner violence, other (unexpected death of loved one)",Medium,"Schacht RL, Brooner RK, King VL, et al. Incentivizing attendance to prolonged exposure for PTSD with opioid use disorder patients: a randomized controlled trial. J Consult Clin Psychol. 2017 Jul;85(7):689-701. doi: 10.1037/ccp0000208. PMID: 28414485",47904,2019
schacht2017_CAPS_B_12_ITT,Psychotherapy,PTSD,58,B,PTSD+SUD,Not integrated,24,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,Ignored,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",Assessment at 3 to <6 Months,12,,58.54,23.98,,,,,-14.23,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS (frequency ≥1 and severity ≥2),,,≥15-point reduction on CAPS total score,0.375,,Community,,,1,0.7931,,0.2069,Mixed,"child sexual assault, child physical assault, intimate partner violence, other (unexpected death of loved one)",Medium,"Schacht RL, Brooner RK, King VL, et al. Incentivizing attendance to prolonged exposure for PTSD with opioid use disorder patients: a randomized controlled trial. J Consult Clin Psychol. 2017 Jul;85(7):689-701. doi: 10.1037/ccp0000208. PMID: 28414485",47904,2019
schacht2017_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,58,B,PTSD+SUD,Not integrated,30,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,Ignored,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",Baseline,,,72.77,15.52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7931,,0.2069,Mixed,"child sexual assault, child physical assault, intimate partner violence, other (unexpected death of loved one)",Medium,"Schacht RL, Brooner RK, King VL, et al. Incentivizing attendance to prolonged exposure for PTSD with opioid use disorder patients: a randomized controlled trial. J Consult Clin Psychol. 2017 Jul;85(7):689-701. doi: 10.1037/ccp0000208. PMID: 28414485",47904,2019
schneier2012_CAPS_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,37,A,PTSD,,13,,PE + paroxetine,Prolonged Exposure (PE) + paroxetine,Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Structured Clinical Interview,CAPS,CAPS,ITT,Assumption of missing at random,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",End of Treatment,0,,21.5,19.9,,,,,-51.1,,,,,,,,,,,,,,,,,,,,,CAPS ≤20 and CGI-C score of 1 (very much improved),0.4211,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5405,,0.4595,Terrorism/political violence/forced displacement,,Medium,"Schneier FR, Neria Y, Pavlicova M, et al. Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial. Am J Psychiatry. 2012 Jan;169(1):80-8. doi: 10.1176/appi.ajp.2011.11020321. PMID: 21908494.",37261,2019
schneier2012_CAPS_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,37,A,PTSD,,19,,PE + paroxetine,Prolonged Exposure (PE) + paroxetine,Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,19,Structured Clinical Interview,CAPS,CAPS,ITT,Assumption of missing at random,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",Baseline,,,72.6,12.9,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS ≤20 and CGI-C score of 1 (very much improved),,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5405,,0.4595,Terrorism/political violence/forced displacement,,Medium,"Schneier FR, Neria Y, Pavlicova M, et al. Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial. Am J Psychiatry. 2012 Jan;169(1):80-8. doi: 10.1176/appi.ajp.2011.11020321. PMID: 21908494.",37261,2019
schneier2012_CAPS_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,37,B,PTSD,,13,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS,ITT,Assumption of missing at random,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",End of Treatment,0,,35.6,31.3,,,,,-29.8,,,,,Cohen's d,1.12,,,,,,,,,,,,,,,CAPS ≤20 and CGI-C score of 1 (very much improved),0.1667,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5405,,0.4595,Terrorism/political violence/forced displacement,,Medium,"Schneier FR, Neria Y, Pavlicova M, et al. Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial. Am J Psychiatry. 2012 Jan;169(1):80-8. doi: 10.1176/appi.ajp.2011.11020321. PMID: 21908494.",37261,2019
schneier2012_CAPS_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,37,B,PTSD,,18,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS,ITT,Assumption of missing at random,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",Baseline,,,65.4,12.8,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS ≤20 and CGI-C score of 1 (very much improved),,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5405,,0.4595,Terrorism/political violence/forced displacement,,Medium,"Schneier FR, Neria Y, Pavlicova M, et al. Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial. Am J Psychiatry. 2012 Jan;169(1):80-8. doi: 10.1176/appi.ajp.2011.11020321. PMID: 21908494.",37261,2019
schneier2015_CAPS_A_0_Comp,Pharmacotherapy,PTSD,38,A,PTSD,,11,,Mirtazapine augmentation,Mirtazapine,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS,Completer,linear mixed effect models with missing data treated as ignorable nonresponse,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS score < 20,0.6364,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6389,,0.3611,Mixed,"rape/sexual assault, community/school violence",Medium,"Schneier FR, Campeas R, Carcamo J, et al. Combined mirtazapine and SSRI treatment of PTSD: a placebo-controlled trial. Depress Anxiety. 2015 Aug;32(8):570-9. doi: 10.1002/da.22384. PMID: 26115513.",44165,2019
schneier2015_CAPS_A_0_ITT,Pharmacotherapy,PTSD,38,A,PTSD,,18,,Mirtazapine augmentation,Mirtazapine,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS,ITT,linear mixed effect models with missing data treated as ignorable nonresponse,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS score < 20,0.3889,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6389,,0.3611,Mixed,"rape/sexual assault, community/school violence",Medium,"Schneier FR, Campeas R, Carcamo J, et al. Combined mirtazapine and SSRI treatment of PTSD: a placebo-controlled trial. Depress Anxiety. 2015 Aug;32(8):570-9. doi: 10.1002/da.22384. PMID: 26115513.",44165,2019
schneier2015_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,38,A,PTSD,,11,,Mirtazapine augmentation,Mirtazapine,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS,Completer,linear mixed effect models with missing data treated as ignorable nonresponse,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS score < 20,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6389,,0.3611,Mixed,"rape/sexual assault, community/school violence",Medium,"Schneier FR, Campeas R, Carcamo J, et al. Combined mirtazapine and SSRI treatment of PTSD: a placebo-controlled trial. Depress Anxiety. 2015 Aug;32(8):570-9. doi: 10.1002/da.22384. PMID: 26115513.",44165,2019
schneier2015_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,38,A,PTSD,,18,,Mirtazapine augmentation,Mirtazapine,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS,ITT,linear mixed effect models with missing data treated as ignorable nonresponse,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS score < 20,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6389,,0.3611,Mixed,"rape/sexual assault, community/school violence",Medium,"Schneier FR, Campeas R, Carcamo J, et al. Combined mirtazapine and SSRI treatment of PTSD: a placebo-controlled trial. Depress Anxiety. 2015 Aug;32(8):570-9. doi: 10.1002/da.22384. PMID: 26115513.",44165,2019
schneier2015_CAPS_B_0_Comp,Pharmacotherapy,PTSD,38,B,PTSD,,9,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,linear mixed effect models with missing data treated as ignorable nonresponse,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS score < 20,0.2222,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6389,,0.3611,Mixed,"rape/sexual assault, community/school violence",Medium,"Schneier FR, Campeas R, Carcamo J, et al. Combined mirtazapine and SSRI treatment of PTSD: a placebo-controlled trial. Depress Anxiety. 2015 Aug;32(8):570-9. doi: 10.1002/da.22384. PMID: 26115513.",44165,2019
schneier2015_CAPS_B_0_ITT,Pharmacotherapy,PTSD,38,B,PTSD,,18,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,ITT,linear mixed effect models with missing data treated as ignorable nonresponse,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS score < 20,0.1111,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6389,,0.3611,Mixed,"rape/sexual assault, community/school violence",Medium,"Schneier FR, Campeas R, Carcamo J, et al. Combined mirtazapine and SSRI treatment of PTSD: a placebo-controlled trial. Depress Anxiety. 2015 Aug;32(8):570-9. doi: 10.1002/da.22384. PMID: 26115513.",44165,2019
schneier2015_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,38,B,PTSD,,9,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,linear mixed effect models with missing data treated as ignorable nonresponse,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS score < 20,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6389,,0.3611,Mixed,"rape/sexual assault, community/school violence",Medium,"Schneier FR, Campeas R, Carcamo J, et al. Combined mirtazapine and SSRI treatment of PTSD: a placebo-controlled trial. Depress Anxiety. 2015 Aug;32(8):570-9. doi: 10.1002/da.22384. PMID: 26115513.",44165,2019
schneier2015_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,38,B,PTSD,,18,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,ITT,linear mixed effect models with missing data treated as ignorable nonresponse,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS score < 20,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6389,,0.3611,Mixed,"rape/sexual assault, community/school violence",Medium,"Schneier FR, Campeas R, Carcamo J, et al. Combined mirtazapine and SSRI treatment of PTSD: a placebo-controlled trial. Depress Anxiety. 2015 Aug;32(8):570-9. doi: 10.1002/da.22384. PMID: 26115513.",44165,2019
schneier2015_PCL_A_0_ITT,Pharmacotherapy,PTSD,38,A,PTSD,,,,Mirtazapine augmentation,Mirtazapine,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Self report,PCL,PCL,ITT,,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",End of Treatment,0,,33.2,18.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6389,,0.3611,Mixed,"rape/sexual assault, community/school violence",Medium,"Schneier FR, Campeas R, Carcamo J, et al. Combined mirtazapine and SSRI treatment of PTSD: a placebo-controlled trial. Depress Anxiety. 2015 Aug;32(8):570-9. doi: 10.1002/da.22384. PMID: 26115513.",44165,2019
schneier2015_PCL_A_Baseline_ITT,Pharmacotherapy,PTSD,38,A,PTSD,,,,Mirtazapine augmentation,Mirtazapine,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,18,Self report,PCL,PCL,ITT,,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",Baseline,,,58.9,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6389,,0.3611,Mixed,"rape/sexual assault, community/school violence",Medium,"Schneier FR, Campeas R, Carcamo J, et al. Combined mirtazapine and SSRI treatment of PTSD: a placebo-controlled trial. Depress Anxiety. 2015 Aug;32(8):570-9. doi: 10.1002/da.22384. PMID: 26115513.",44165,2019
schneier2015_PCL_B_0_ITT,Pharmacotherapy,PTSD,38,B,PTSD,,,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Self report,PCL,PCL,ITT,,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",End of Treatment,0,,39.2,18.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6389,,0.3611,Mixed,"rape/sexual assault, community/school violence",Medium,"Schneier FR, Campeas R, Carcamo J, et al. Combined mirtazapine and SSRI treatment of PTSD: a placebo-controlled trial. Depress Anxiety. 2015 Aug;32(8):570-9. doi: 10.1002/da.22384. PMID: 26115513.",44165,2019
schneier2015_PCL_B_Baseline_ITT,Pharmacotherapy,PTSD,38,B,PTSD,,,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Self report,PCL,PCL,ITT,,"Linear mixed-effects model and t-test for change in mean score, chi-square or likelihood ratio or Fisher's exact test for diagnostic change and clinically meaningful response",Baseline,,,60.0,10.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6389,,0.3611,Mixed,"rape/sexual assault, community/school violence",Medium,"Schneier FR, Campeas R, Carcamo J, et al. Combined mirtazapine and SSRI treatment of PTSD: a placebo-controlled trial. Depress Anxiety. 2015 Aug;32(8):570-9. doi: 10.1002/da.22384. PMID: 26115513.",44165,2019
schnurr2003_CAPS_A_0_Comp,Psychotherapy,PTSD,360,A,PTSD,,106,,Trauma-focused group therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,180,Structured Clinical Interview,CAPS,CAPS,Completer,SAS PROC MIXED with Satterthwaite option,Mixed linear model using SAS PROC MIXED,End of Treatment,0,,72.55,,SE,1.85,,,-7.42,,,,,,,,,,p<0.001,,,,,,,,,,,Decrease of ≥10 points on CAPS,0.49,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.",23438,2019
schnurr2003_CAPS_A_0_ITT,Psychotherapy,PTSD,360,A,PTSD,,162,,Trauma-focused group therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,180,Structured Clinical Interview,CAPS,CAPS,ITT,SAS PROC MIXED with Satterthwaite option,Mixed linear model using SAS PROC MIXED,End of Treatment,0,,72.79,,SE,1.51,,,-7.62,,,,,,,,,,p<0.001,,,,,,,,,,,Decrease of ≥10 points on CAPS,0.447,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.",23438,2019
schnurr2003_CAPS_A_52_Comp,Psychotherapy,PTSD,360,A,PTSD,,106,,Trauma-focused group therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,180,Structured Clinical Interview,CAPS,CAPS,Completer,SAS PROC MIXED with Satterthwaite option,Mixed linear model using SAS PROC MIXED,Assessment at ≥12 Months,52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Decrease of ≥10 points on CAPS,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.",23438,2019
schnurr2003_CAPS_A_52_ITT,Psychotherapy,PTSD,360,A,PTSD,,162,,Trauma-focused group therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,180,Structured Clinical Interview,CAPS,CAPS,ITT,SAS PROC MIXED with Satterthwaite option,Mixed linear model using SAS PROC MIXED,Assessment at ≥12 Months,52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Decrease of ≥10 points on CAPS,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.",23438,2019
schnurr2003_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,360,A,PTSD,,106,,Trauma-focused group therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,180,Structured Clinical Interview,CAPS,CAPS,Completer,SAS PROC MIXED with Satterthwaite option,Mixed linear model using SAS PROC MIXED,Baseline,,,79.97,,SE,1.91,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.",23438,2019
schnurr2003_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,360,A,PTSD,,162,,Trauma-focused group therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,180,Structured Clinical Interview,CAPS,CAPS,ITT,SAS PROC MIXED with Satterthwaite option,Mixed linear model using SAS PROC MIXED,Baseline,,,80.41,,SE,1.45,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.",23438,2019
schnurr2003_CAPS_B_0_Comp,Psychotherapy,PTSD,360,B,PTSD,,111,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,180,Structured Clinical Interview,CAPS,CAPS,Completer,SAS PROC MIXED with Satterthwaite option,Mixed linear model using SAS PROC MIXED,End of Treatment,0,,76.49,,SE,1.8,,,-4.91,,,,,,,,,,p<0.05,,,,,,,,,,,Decrease of ≥10 points on CAPS,0.38,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.",23438,2019
schnurr2003_CAPS_B_0_ITT,Psychotherapy,PTSD,360,B,PTSD,,163,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,180,Structured Clinical Interview,CAPS,CAPS,ITT,SAS PROC MIXED with Satterthwaite option,Mixed linear model using SAS PROC MIXED,End of Treatment,0,,74.82,,SE,1.49,,,-7.19,,,,,,,,,,p<0.001,,,,,,,,,,,Decrease of ≥10 points on CAPS,0.432,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.",23438,2019
schnurr2003_CAPS_B_52_Comp,Psychotherapy,PTSD,360,B,PTSD,,111,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,180,Structured Clinical Interview,CAPS,CAPS,Completer,SAS PROC MIXED with Satterthwaite option,Mixed linear model using SAS PROC MIXED,Assessment at ≥12 Months,52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Decrease of ≥10 points on CAPS,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.",23438,2019
schnurr2003_CAPS_B_52_ITT,Psychotherapy,PTSD,360,B,PTSD,,163,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,180,Structured Clinical Interview,CAPS,CAPS,ITT,SAS PROC MIXED with Satterthwaite option,Mixed linear model using SAS PROC MIXED,Assessment at ≥12 Months,52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Decrease of ≥10 points on CAPS,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.",23438,2019
schnurr2003_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,360,B,PTSD,,111,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,180,Structured Clinical Interview,CAPS,CAPS,Completer,SAS PROC MIXED with Satterthwaite option,Mixed linear model using SAS PROC MIXED,Baseline,,,81.4,,SE,1.67,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.",23438,2019
schnurr2003_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,360,B,PTSD,,163,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,180,Structured Clinical Interview,CAPS,CAPS,ITT,SAS PROC MIXED with Satterthwaite option,Mixed linear model using SAS PROC MIXED,Baseline,,,82.01,,SE,1.44,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.",23438,2019
schnurr2003_PCL_A_0_Comp,Psychotherapy,PTSD,360,A,PTSD,,,,Trauma-focused group therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,180,Self report,PCL,PCL,Completer,,Mixed linear model using SAS PROC MIXED,End of Treatment,0,,58.44,,SE,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.",23438,2019
schnurr2003_PCL_A_0_ITT,Psychotherapy,PTSD,360,A,PTSD,,,,Trauma-focused group therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,180,Self report,PCL,PCL,ITT,,Mixed linear model using SAS PROC MIXED,End of Treatment,0,,58.78,,SE,0.89,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.",23438,2019
schnurr2003_PCL_A_Baseline_Comp,Psychotherapy,PTSD,360,A,PTSD,,,,Trauma-focused group therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,180,Self report,PCL,PCL,Completer,,Mixed linear model using SAS PROC MIXED,Baseline,,,61.37,,SE,1.19,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.",23438,2019
schnurr2003_PCL_A_Baseline_ITT,Psychotherapy,PTSD,360,A,PTSD,,,,Trauma-focused group therapy,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,180,Self report,PCL,PCL,ITT,,Mixed linear model using SAS PROC MIXED,Baseline,,,61.84,,SE,0.91,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.",23438,2019
schnurr2003_PCL_B_0_Comp,Psychotherapy,PTSD,360,B,PTSD,,,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,180,Self report,PCL,PCL,Completer,,Mixed linear model using SAS PROC MIXED,End of Treatment,0,,60.99,,SE,1.18,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.",23438,2019
schnurr2003_PCL_B_0_ITT,Psychotherapy,PTSD,360,B,PTSD,,,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,180,Self report,PCL,PCL,ITT,,Mixed linear model using SAS PROC MIXED,End of Treatment,0,,60.00,,SE,0.88,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.",23438,2019
schnurr2003_PCL_B_Baseline_Comp,Psychotherapy,PTSD,360,B,PTSD,,,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,180,Self report,PCL,PCL,Completer,,Mixed linear model using SAS PROC MIXED,Baseline,,,62.41,,SE,1.14,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.",23438,2019
schnurr2003_PCL_B_Baseline_ITT,Psychotherapy,PTSD,360,B,PTSD,,,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,180,Self report,PCL,PCL,ITT,,Mixed linear model using SAS PROC MIXED,Baseline,,,62.60,,SE,0.94,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Low,"Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.",23438,2019
schnurr2007_CAPS_A_0_Comp,Psychotherapy,PTSD,284,A,PTSD,,87,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,141,Structured Clinical Interview,CAPS,CAPS,Completer,,Mixed linear model using SAS PROC MIXED,End of Treatment,0,,,,,,,,,,,,,Cohen's d,1.15,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to CAPS and CAPS score ≤45,0.4699,,≥10-point decrease from baseline CAPS score,0.747,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_CAPS_A_0_ITT,Psychotherapy,PTSD,284,A,PTSD,,141,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,141,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,Mixed linear model using SAS PROC MIXED,End of Treatment,0,,52.9,,95% CI,47.7,58,,-24.7,,,,,Cohen's d,0.8,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to CAPS and CAPS score ≤45,0.3901,,≥10-point decrease from baseline CAPS score,0.7021,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_CAPS_A_12_Comp,Psychotherapy,PTSD,284,A,PTSD,,87,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,141,Structured Clinical Interview,CAPS,CAPS,Completer,,Mixed linear model using SAS PROC MIXED,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS and CAPS score ≤45,0.4286,,≥10-point decrease from baseline CAPS score,0.8333,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_CAPS_A_12_ITT,Psychotherapy,PTSD,284,A,PTSD,,141,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,141,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,Mixed linear model using SAS PROC MIXED,Assessment at 3 to <6 Months,12,,49.7,,95% CI,44.7,54.7,,-27.9,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS and CAPS score ≤45,0.3901,,≥10-point decrease from baseline CAPS score,0.7801,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_CAPS_A_26_Comp,Psychotherapy,PTSD,284,A,PTSD,,87,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,141,Structured Clinical Interview,CAPS,CAPS,Completer,,Mixed linear model using SAS PROC MIXED,Assessment at 6 to <12 Months,26,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS and CAPS score ≤45,0.4643,,≥10-point decrease from baseline CAPS score,0.7262,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_CAPS_A_26_ITT,Psychotherapy,PTSD,284,A,PTSD,,141,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,141,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,Mixed linear model using SAS PROC MIXED,Assessment at 6 to <12 Months,26,,50.4,,95% CI,45,54.7,,-27.2,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS and CAPS score ≤45,0.3972,,≥10-point decrease from baseline CAPS score,0.6879,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,284,A,PTSD,,87,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,141,Structured Clinical Interview,CAPS,CAPS,Completer,,Mixed linear model using SAS PROC MIXED,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,284,A,PTSD,,141,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,141,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,Mixed linear model using SAS PROC MIXED,Baseline,,,77.6,,95% CI,74.8,80.4,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_CAPS_B_0_Comp,Psychotherapy,PTSD,284,B,PTSD,,112,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,143,Structured Clinical Interview,CAPS,CAPS,Completer,,Mixed linear model using SAS PROC MIXED,End of Treatment,0,,,,,,,,,,,,,Cohen's d,0.67,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to CAPS and CAPS score ≤45,0.1982,,≥10-point decrease from baseline CAPS score,0.5946,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_CAPS_B_0_ITT,Psychotherapy,PTSD,284,B,PTSD,,143,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,143,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,Mixed linear model using SAS PROC MIXED,End of Treatment,0,,60.1,,95% CI,55.3,64.8,,-17.8,,,,,Cohen's d,0.62,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to CAPS and CAPS score ≤45,0.2028,,≥10-point decrease from baseline CAPS score,0.5874,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_CAPS_B_12_Comp,Psychotherapy,PTSD,284,B,PTSD,,112,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,143,Structured Clinical Interview,CAPS,CAPS,Completer,,Mixed linear model using SAS PROC MIXED,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS and CAPS score ≤45,0.283,,≥10-point decrease from baseline CAPS score,0.717,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_CAPS_B_12_ITT,Psychotherapy,PTSD,284,B,PTSD,,143,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,143,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,Mixed linear model using SAS PROC MIXED,Assessment at 3 to <6 Months,12,,56.0,,95% CI,50.5,61.5,,-21.9,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS and CAPS score ≤45,0.2797,,≥10-point decrease from baseline CAPS score,0.7133,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_CAPS_B_26_Comp,Psychotherapy,PTSD,284,B,PTSD,,112,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,143,Structured Clinical Interview,CAPS,CAPS,Completer,,Mixed linear model using SAS PROC MIXED,Assessment at 6 to <12 Months,26,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS and CAPS score ≤45,0.3429,,≥10-point decrease from baseline CAPS score,0.6857,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_CAPS_B_26_ITT,Psychotherapy,PTSD,284,B,PTSD,,143,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,143,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,Mixed linear model using SAS PROC MIXED,Assessment at 6 to <12 Months,26,,54.5,,95% CI,49.3,59.7,,-23.4,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS and CAPS score ≤45,0.3287,,≥10-point decrease from baseline CAPS score,0.6853,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,284,B,PTSD,,112,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,143,Structured Clinical Interview,CAPS,CAPS,Completer,,Mixed linear model using SAS PROC MIXED,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,284,B,PTSD,,143,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,143,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,Mixed linear model using SAS PROC MIXED,Baseline,,,77.9,,95% CI,75.1,80.6,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_PCL_A_0_ITT,Psychotherapy,PTSD,284,A,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,141,Self report,PCL,PCL,ITT,Multiple imputation,Mixed linear model using SAS PROC MIXED,End of Treatment,0,,41.6,,95% CI,38.4,44.9,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_PCL_A_12_ITT,Psychotherapy,PTSD,284,A,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,141,Self report,PCL,PCL,ITT,Multiple imputation,Mixed linear model using SAS PROC MIXED,Assessment at 3 to <6 Months,12,,43.5,,95% CI,40.2,46.7,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_PCL_A_26_ITT,Psychotherapy,PTSD,284,A,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,141,Self report,PCL,PCL,ITT,Multiple imputation,Mixed linear model using SAS PROC MIXED,Assessment at 6 to <12 Months,26,,44.6,,95% CI,41.2,48.1,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_PCL_A_Baseline_ITT,Psychotherapy,PTSD,284,A,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,141,Self report,PCL,PCL,ITT,Multiple imputation,Mixed linear model using SAS PROC MIXED,Baseline,,,58.2,,95% CI,56,60.3,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_PCL_B_0_ITT,Psychotherapy,PTSD,284,B,PTSD,,,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,143,Self report,PCL,PCL,ITT,Multiple imputation,Mixed linear model using SAS PROC MIXED,End of Treatment,0,,48.9,,95% CI,45.8,52,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_PCL_B_12_ITT,Psychotherapy,PTSD,284,B,PTSD,,,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,143,Self report,PCL,PCL,ITT,Multiple imputation,Mixed linear model using SAS PROC MIXED,Assessment at 3 to <6 Months,12,,48.8,,95% CI,45.3,52.4,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_PCL_B_26_ITT,Psychotherapy,PTSD,284,B,PTSD,,,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,143,Self report,PCL,PCL,ITT,Multiple imputation,Mixed linear model using SAS PROC MIXED,Assessment at 6 to <12 Months,26,,48.5,,95% CI,45.2,51.8,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2007_PCL_B_Baseline_ITT,Psychotherapy,PTSD,284,B,PTSD,,,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,143,Self report,PCL,PCL,ITT,Multiple imputation,Mixed linear model using SAS PROC MIXED,Baseline,,,57.1,,95% CI,55,59.2,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.0246,0.9754,0,1,,0,Mixed,"combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)",Medium,"Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.",29137,2020
schnurr2013_PDS_A_0_ITT,Collaborative care,PTSD,195,A,PTSD,,68,,Three Component Model,Three Component Model,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,N,No,No,Yes,Individual,Phone,96,Self report,PDS,PDS,ITT,Imputed using multivariate imputation by chained equations,Generalized linear mixed model with Wald tests for significance of treatment effect.,End of Treatment,0,,30.2,10.3,,,,,-3,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0872,,0.9128,Mixed,"combat-related, rape/sexual assault, accidents, natural or manmade disaster, community/school violence",Medium,"Schnurr PP, Friedman MJ, Oxman TE, et al. RESPECT-PTSD: re-engineering systems for the primary care treatment of PTSD, a randomized controlled trial. J Gen Intern Med. 2013 Jan;28(1):32-40. doi: 10.1007/s11606-012-2166-6. PMID: 22865017.",39174,2019
schnurr2013_PDS_A_Baseline_ITT,Collaborative care,PTSD,195,A,PTSD,,91,,Three Component Model,Three Component Model,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,N,No,No,Yes,Individual,Phone,96,Self report,PDS,PDS,ITT,Imputed using multivariate imputation by chained equations,Generalized linear mixed model with Wald tests for significance of treatment effect.,Baseline,,,33.2,8.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0872,,0.9128,Mixed,"combat-related, rape/sexual assault, accidents, natural or manmade disaster, community/school violence",Medium,"Schnurr PP, Friedman MJ, Oxman TE, et al. RESPECT-PTSD: re-engineering systems for the primary care treatment of PTSD, a randomized controlled trial. J Gen Intern Med. 2013 Jan;28(1):32-40. doi: 10.1007/s11606-012-2166-6. PMID: 22865017.",39174,2019
schnurr2013_PDS_B_0_ITT,Collaborative care,PTSD,195,B,Control,,78,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,99,Self report,PDS,PDS,ITT,Imputed using multivariate imputation by chained equations,Generalized linear mixed model with Wald tests for significance of treatment effect.,End of Treatment,0,,29.9,10.8,,,,,-4.1,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0872,,0.9128,Mixed,"combat-related, rape/sexual assault, accidents, natural or manmade disaster, community/school violence",Medium,"Schnurr PP, Friedman MJ, Oxman TE, et al. RESPECT-PTSD: re-engineering systems for the primary care treatment of PTSD, a randomized controlled trial. J Gen Intern Med. 2013 Jan;28(1):32-40. doi: 10.1007/s11606-012-2166-6. PMID: 22865017.",39174,2019
schnurr2013_PDS_B_Baseline_ITT,Collaborative care,PTSD,195,B,Control,,96,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,99,Self report,PDS,PDS,ITT,Imputed using multivariate imputation by chained equations,Generalized linear mixed model with Wald tests for significance of treatment effect.,Baseline,,,34,9.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.0872,,0.9128,Mixed,"combat-related, rape/sexual assault, accidents, natural or manmade disaster, community/school violence",Medium,"Schnurr PP, Friedman MJ, Oxman TE, et al. RESPECT-PTSD: re-engineering systems for the primary care treatment of PTSD, a randomized controlled trial. J Gen Intern Med. 2013 Jan;28(1):32-40. doi: 10.1007/s11606-012-2166-6. PMID: 22865017.",39174,2019
schoorl2013_CAPS_A_0_ITT,Nonpharmacologic cognitive,PTSD,102,A,PTSD,,38,,Attentional Bias Modification,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,Technology Alone,48,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Repeated measures linear model,End of Treatment,0,,65.1,23.3,,,,,-15.6,,,,,Cohen's d,0.66,,,,,,,,,,,,,,,,,,Community,,,1,0.7549,,0.2451,Mixed,"other (childhood trauma unspecified, adult trauma unspecified)",Medium,"Schoorl M, Putman P, Van Der Does W. Attentional bias modification in posttraumatic stress disorder: a randomized controlled trial. Psychother Psychosom. 2013;82(2):99-105. doi: 10.1159/000341920. PMID: 23295710",41171,2019
schoorl2013_CAPS_A_3_ITT,Nonpharmacologic cognitive,PTSD,102,A,PTSD,,34,,Attentional Bias Modification,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,Technology Alone,48,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Repeated measures linear model,Assessment at <3 Months,3,,64.3,24.1,,,,,-16.4,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7549,,0.2451,Mixed,"other (childhood trauma unspecified, adult trauma unspecified)",Medium,"Schoorl M, Putman P, Van Der Does W. Attentional bias modification in posttraumatic stress disorder: a randomized controlled trial. Psychother Psychosom. 2013;82(2):99-105. doi: 10.1159/000341920. PMID: 23295710",41171,2019
schoorl2013_CAPS_A_Baseline_ITT,Nonpharmacologic cognitive,PTSD,102,A,PTSD,,48,,Attentional Bias Modification,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,Technology Alone,48,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Repeated measures linear model,Baseline,,,80.7,16.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7549,,0.2451,Mixed,"other (childhood trauma unspecified, adult trauma unspecified)",Medium,"Schoorl M, Putman P, Van Der Does W. Attentional bias modification in posttraumatic stress disorder: a randomized controlled trial. Psychother Psychosom. 2013;82(2):99-105. doi: 10.1159/000341920. PMID: 23295710",41171,2019
schoorl2013_CAPS_B_0_ITT,Nonpharmacologic cognitive,PTSD,102,B,Control,,38,,Attentional Bias,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Technology Alone,54,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Repeated measures linear model,End of Treatment,0,,70.4,21.7,,,,,-10.1,,,,,Cohen's d,0.46,,,,,,,,,,,,,,,,,,Community,,,1,0.7549,,0.2451,Mixed,"other (childhood trauma unspecified, adult trauma unspecified)",Medium,"Schoorl M, Putman P, Van Der Does W. Attentional bias modification in posttraumatic stress disorder: a randomized controlled trial. Psychother Psychosom. 2013;82(2):99-105. doi: 10.1159/000341920. PMID: 23295710",41171,2019
schoorl2013_CAPS_B_3_ITT,Nonpharmacologic cognitive,PTSD,102,B,Control,,38,,Attentional Bias,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Technology Alone,54,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Repeated measures linear model,Assessment at <3 Months,3,,66.9,24.1,,,,,-13.6,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7549,,0.2451,Mixed,"other (childhood trauma unspecified, adult trauma unspecified)",Medium,"Schoorl M, Putman P, Van Der Does W. Attentional bias modification in posttraumatic stress disorder: a randomized controlled trial. Psychother Psychosom. 2013;82(2):99-105. doi: 10.1159/000341920. PMID: 23295710",41171,2019
schoorl2013_CAPS_B_Baseline_ITT,Nonpharmacologic cognitive,PTSD,102,B,Control,,54,,Attentional Bias,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Technology Alone,54,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Repeated measures linear model,Baseline,,,80.5,18.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7549,,0.2451,Mixed,"other (childhood trauma unspecified, adult trauma unspecified)",Medium,"Schoorl M, Putman P, Van Der Does W. Attentional bias modification in posttraumatic stress disorder: a randomized controlled trial. Psychother Psychosom. 2013;82(2):99-105. doi: 10.1159/000341920. PMID: 23295710",41171,2019
schoorl2013_Self_A_3_NA,Nonpharmacologic cognitive,PTSD,102,A,PTSD,,,,Attentional Bias Modification,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,Technology Alone,48,Self report,Self-Rating Inventory for Post-traumatic Stress Disorder,Self-Rating Inventory for Post-traumatic Stress Disorder,,,Repeated measures linear model,Assessment at <3 Months,3,,57.2,13.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7549,,0.2451,Mixed,"other (childhood trauma unspecified, adult trauma unspecified)",Medium,"Schoorl M, Putman P, Van Der Does W. Attentional bias modification in posttraumatic stress disorder: a randomized controlled trial. Psychother Psychosom. 2013;82(2):99-105. doi: 10.1159/000341920. PMID: 23295710",41171,2019
schoorl2013_Self_A_Baseline_NA,Nonpharmacologic cognitive,PTSD,102,A,PTSD,,,,Attentional Bias Modification,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,Yes,No,No,No,Individual,Technology Alone,48,Self report,Self-Rating Inventory for Post-traumatic Stress Disorder,Self-Rating Inventory for Post-traumatic Stress Disorder,,,Repeated measures linear model,Baseline,,,62.1,9.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7549,,0.2451,Mixed,"other (childhood trauma unspecified, adult trauma unspecified)",Medium,"Schoorl M, Putman P, Van Der Does W. Attentional bias modification in posttraumatic stress disorder: a randomized controlled trial. Psychother Psychosom. 2013;82(2):99-105. doi: 10.1159/000341920. PMID: 23295710",41171,2019
schoorl2013_Self_B_3_NA,Nonpharmacologic cognitive,PTSD,102,B,Control,,,,Attentional Bias,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Technology Alone,54,Self report,Self-Rating Inventory for Post-traumatic Stress Disorder,Self-Rating Inventory for Post-traumatic Stress Disorder,,,Repeated measures linear model,Assessment at <3 Months,3,,58.6,11.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7549,,0.2451,Mixed,"other (childhood trauma unspecified, adult trauma unspecified)",Medium,"Schoorl M, Putman P, Van Der Does W. Attentional bias modification in posttraumatic stress disorder: a randomized controlled trial. Psychother Psychosom. 2013;82(2):99-105. doi: 10.1159/000341920. PMID: 23295710",41171,2019
schoorl2013_Self_B_Baseline_NA,Nonpharmacologic cognitive,PTSD,102,B,Control,,,,Attentional Bias,Attention bias modification (ABM),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Technology Alone,54,Self report,Self-Rating Inventory for Post-traumatic Stress Disorder,Self-Rating Inventory for Post-traumatic Stress Disorder,,,Repeated measures linear model,Baseline,,,63.9,8.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7549,,0.2451,Mixed,"other (childhood trauma unspecified, adult trauma unspecified)",Medium,"Schoorl M, Putman P, Van Der Does W. Attentional bias modification in posttraumatic stress disorder: a randomized controlled trial. Psychother Psychosom. 2013;82(2):99-105. doi: 10.1159/000341920. PMID: 23295710",41171,2019
seo2010_CAPS_A_0_ITT,Pharmacotherapy,PTSD,40,A,PTSD,,20,,Mirtazapine,Mirtazapine,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,Repeated measures linear model,End of Treatment,0,,68.70,26.02,,,,,-38.05,,,,,,,,,,p<0.001,,,,,,,,,,,≥30% reduction in CAPS-2 total score,0.7,,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing accident)",Medium,"Seo H-J, Jung Y-E, Bahk W-M, et al. A comparison of mirtazapine and paroxetine for the treatment of patients with posttraumatic stress disorder: a randomized open-label trial. Clin Psychopharmacol Neurosci. 2010;8(2):84-9.",35572,2019
seo2010_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,40,A,PTSD,,20,,Mirtazapine,Mirtazapine,No,Not Applicable,Yes,Antidepressant: Other,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,Repeated measures linear model,Baseline,,,106.75,4.34,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% reduction in CAPS-2 total score,,,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing accident)",Medium,"Seo H-J, Jung Y-E, Bahk W-M, et al. A comparison of mirtazapine and paroxetine for the treatment of patients with posttraumatic stress disorder: a randomized open-label trial. Clin Psychopharmacol Neurosci. 2010;8(2):84-9.",35572,2019
seo2010_CAPS_B_0_ITT,Pharmacotherapy,PTSD,40,B,PTSD,,20,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,Repeated measures linear model,End of Treatment,0,,64.65,16.19,,,,,-39.55,,,,,,,,,,p<0.001,,,,,,,,,,,≥30% reduction in CAPS-2 total score,0.85,,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing accident)",Medium,"Seo H-J, Jung Y-E, Bahk W-M, et al. A comparison of mirtazapine and paroxetine for the treatment of patients with posttraumatic stress disorder: a randomized open-label trial. Clin Psychopharmacol Neurosci. 2010;8(2):84-9.",35572,2019
seo2010_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,40,B,PTSD,,20,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,Repeated measures linear model,Baseline,,,104.20,7.38,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% reduction in CAPS-2 total score,,,Community,,,1,0.7,,0.3,Mixed,"rape/sexual assault, accidents, community/school violence, other (witnessing accident)",Medium,"Seo H-J, Jung Y-E, Bahk W-M, et al. A comparison of mirtazapine and paroxetine for the treatment of patients with posttraumatic stress disorder: a randomized open-label trial. Clin Psychopharmacol Neurosci. 2010;8(2):84-9.",35572,2019
shapiro2015_IES_A_0_NA,Psychotherapy,PTSD,17,A,PTSD,,8,,EMDR for Recent Trauma Episode,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,8,Self report,IES,IES-R,,,Repeated measures ANOVA for between-group mean score change,End of Treatment,0,,21.25,15.53,,,,,-20.38,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.941,,0.059,Terrorism/political violence/forced displacement,,High,"Shapiro E, Laub B. Early EMDR intervention following a community critical incident: a randomized clinical trial. Journal of EMDR Practice and Research. 2015 Feb;9(1):17-27. doi: 10.1891/1933-3196.9.1.17",47811,2019
shapiro2015_IES_A_12_NA,Psychotherapy,PTSD,17,A,PTSD,,8,,EMDR for Recent Trauma Episode,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,8,Self report,IES,IES-R,,,Repeated measures ANOVA for between-group mean score change,Assessment at 3 to <6 Months,12,,15.5,12.62,,,,,-26.13,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.941,,0.059,Terrorism/political violence/forced displacement,,High,"Shapiro E, Laub B. Early EMDR intervention following a community critical incident: a randomized clinical trial. Journal of EMDR Practice and Research. 2015 Feb;9(1):17-27. doi: 10.1891/1933-3196.9.1.17",47811,2019
shapiro2015_IES_A_Baseline_NA,Psychotherapy,PTSD,17,A,PTSD,,8,,EMDR for Recent Trauma Episode,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,8,Self report,IES,IES-R,,,Repeated measures ANOVA for between-group mean score change,Baseline,,,41.63,11.46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.941,,0.059,Terrorism/political violence/forced displacement,,High,"Shapiro E, Laub B. Early EMDR intervention following a community critical incident: a randomized clinical trial. Journal of EMDR Practice and Research. 2015 Feb;9(1):17-27. doi: 10.1891/1933-3196.9.1.17",47811,2019
shapiro2015_IES_B_0_NA,Psychotherapy,PTSD,17,B,Control,,9,,Waitlist/Delayed Treatment,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,9,Self report,IES,IES-R,,,Repeated measures ANOVA for between-group mean score change,End of Treatment,0,,42.61,14.84,,,,,-1.67,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.941,,0.059,Terrorism/political violence/forced displacement,,High,"Shapiro E, Laub B. Early EMDR intervention following a community critical incident: a randomized clinical trial. Journal of EMDR Practice and Research. 2015 Feb;9(1):17-27. doi: 10.1891/1933-3196.9.1.17",47811,2019
shapiro2015_IES_B_12_NA,Psychotherapy,PTSD,17,B,Control,,5,,Waitlist/Delayed Treatment,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,9,Self report,IES,IES-R,,,Repeated measures ANOVA for between-group mean score change,Assessment at 3 to <6 Months,12,,24.4,14.74,,,,,-19.88,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.941,,0.059,Terrorism/political violence/forced displacement,,High,"Shapiro E, Laub B. Early EMDR intervention following a community critical incident: a randomized clinical trial. Journal of EMDR Practice and Research. 2015 Feb;9(1):17-27. doi: 10.1891/1933-3196.9.1.17",47811,2019
shapiro2015_IES_B_Baseline_NA,Psychotherapy,PTSD,17,B,Control,,9,,Waitlist/Delayed Treatment,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,9,Self report,IES,IES-R,,,Repeated measures ANOVA for between-group mean score change,Baseline,,,44.28,17.54,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.941,,0.059,Terrorism/political violence/forced displacement,,High,"Shapiro E, Laub B. Early EMDR intervention following a community critical incident: a randomized clinical trial. Journal of EMDR Practice and Research. 2015 Feb;9(1):17-27. doi: 10.1891/1933-3196.9.1.17",47811,2019
shemesh2011_PDS_A_0_ITT,Psychotherapy,PTSD,60,A,PTSD,,23,,CBT using imaginal exposure,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PDS,PDS,ITT,,Repeated-measures ANOVA,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.3333,,0.6667,Illness/medical procedure,,High,"Shemesh E, Annunziato RA, Weatherley BD, et al. A randomized controlled trial for the safety and promise of cognitive-behavioral therapy using imaginal exposure in patients with posttraumatic stress disorder resulting from cardiovascular illness. J Clin Psychiatry. 2011 Feb;72(2):168-74. doi: 10.4088/JCP.09m05116blu. PMID: 20441725",34244,2019
shemesh2011_PDS_A_Baseline_ITT,Psychotherapy,PTSD,60,A,PTSD,,23,,CBT using imaginal exposure,Imaginal exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Self report,PDS,PDS,ITT,,Repeated-measures ANOVA,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.3333,,0.6667,Illness/medical procedure,,High,"Shemesh E, Annunziato RA, Weatherley BD, et al. A randomized controlled trial for the safety and promise of cognitive-behavioral therapy using imaginal exposure in patients with posttraumatic stress disorder resulting from cardiovascular illness. J Clin Psychiatry. 2011 Feb;72(2):168-74. doi: 10.4088/JCP.09m05116blu. PMID: 20441725",34244,2019
shemesh2011_PDS_B_0_ITT,Psychotherapy,PTSD,60,B,Control,,28,,Control,Education,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,30,Self report,PDS,PDS,ITT,,Repeated-measures ANOVA,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.3333,,0.6667,Illness/medical procedure,,High,"Shemesh E, Annunziato RA, Weatherley BD, et al. A randomized controlled trial for the safety and promise of cognitive-behavioral therapy using imaginal exposure in patients with posttraumatic stress disorder resulting from cardiovascular illness. J Clin Psychiatry. 2011 Feb;72(2):168-74. doi: 10.4088/JCP.09m05116blu. PMID: 20441725",34244,2019
shemesh2011_PDS_B_Baseline_ITT,Psychotherapy,PTSD,60,B,Control,,28,,Control,Education,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,30,Self report,PDS,PDS,ITT,,Repeated-measures ANOVA,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.3333,,0.6667,Illness/medical procedure,,High,"Shemesh E, Annunziato RA, Weatherley BD, et al. A randomized controlled trial for the safety and promise of cognitive-behavioral therapy using imaginal exposure in patients with posttraumatic stress disorder resulting from cardiovascular illness. J Clin Psychiatry. 2011 Feb;72(2):168-74. doi: 10.4088/JCP.09m05116blu. PMID: 20441725",34244,2019
shestatsky1988_IES_A_0_Comp,Pharmacotherapy,PTSD,13,A,PTSD,,6,,Phenelzine,Phenelzine,No,Not Applicable,Yes,Antidepressant: MAOI,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,IES,IES,Completer,,Repeated-measures ANOVA,End of Treatment,0,,31.7,13.93,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.4,0.6,,,,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement, other (accident with death of son)",High,"Shestatsky M, Greenberg D, Lerer B. A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res. 1988 May;24(2):149-55. doi: 10.1016/0165-1781(88)90057-1. PMID: 3406235.",00758,2019
shestatsky1988_IES_A_0_ITT,Pharmacotherapy,PTSD,13,A,PTSD,,10,,Phenelzine,Phenelzine,No,Not Applicable,Yes,Antidepressant: MAOI,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,IES,IES,ITT,,Repeated-measures ANOVA,End of Treatment,0,,33.0,11.8,,,,,-1,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.4,0.6,,,,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement, other (accident with death of son)",High,"Shestatsky M, Greenberg D, Lerer B. A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res. 1988 May;24(2):149-55. doi: 10.1016/0165-1781(88)90057-1. PMID: 3406235.",00758,2019
shestatsky1988_IES_A_Baseline_Comp,Pharmacotherapy,PTSD,13,A,PTSD,,6,,Phenelzine,Phenelzine,No,Not Applicable,Yes,Antidepressant: MAOI,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,IES,IES,Completer,,Repeated-measures ANOVA,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.4,0.6,,,,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement, other (accident with death of son)",High,"Shestatsky M, Greenberg D, Lerer B. A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res. 1988 May;24(2):149-55. doi: 10.1016/0165-1781(88)90057-1. PMID: 3406235.",00758,2019
shestatsky1988_IES_A_Baseline_ITT,Pharmacotherapy,PTSD,13,A,PTSD,,10,,Phenelzine,Phenelzine,No,Not Applicable,Yes,Antidepressant: MAOI,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,IES,IES,ITT,,Repeated-measures ANOVA,Baseline,,,34.0,11.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.4,0.6,,,,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement, other (accident with death of son)",High,"Shestatsky M, Greenberg D, Lerer B. A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res. 1988 May;24(2):149-55. doi: 10.1016/0165-1781(88)90057-1. PMID: 3406235.",00758,2019
shestatsky1988_IES_B_0_Comp,Pharmacotherapy,PTSD,13,B,Control,,6,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,13,Self report,IES,IES,Completer,,Repeated-measures ANOVA,End of Treatment,0,,31.5,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.4,0.6,,,,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement, other (accident with death of son)",High,"Shestatsky M, Greenberg D, Lerer B. A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res. 1988 May;24(2):149-55. doi: 10.1016/0165-1781(88)90057-1. PMID: 3406235.",00758,2019
shestatsky1988_IES_B_0_ITT,Pharmacotherapy,PTSD,13,B,Control,,10,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,13,Self report,IES,IES,ITT,,Repeated-measures ANOVA,End of Treatment,0,,30.0,12,,,,,-6,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.4,0.6,,,,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement, other (accident with death of son)",High,"Shestatsky M, Greenberg D, Lerer B. A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res. 1988 May;24(2):149-55. doi: 10.1016/0165-1781(88)90057-1. PMID: 3406235.",00758,2019
shestatsky1988_IES_B_Baseline_Comp,Pharmacotherapy,PTSD,13,B,Control,,6,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,13,Self report,IES,IES,Completer,,Repeated-measures ANOVA,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.4,0.6,,,,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement, other (accident with death of son)",High,"Shestatsky M, Greenberg D, Lerer B. A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res. 1988 May;24(2):149-55. doi: 10.1016/0165-1781(88)90057-1. PMID: 3406235.",00758,2019
shestatsky1988_IES_B_Baseline_ITT,Pharmacotherapy,PTSD,13,B,Control,,10,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,13,Self report,IES,IES,ITT,,Repeated-measures ANOVA,Baseline,,,36.0,19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.4,0.6,,,,Mixed,"combat-related, accidents, terrorism/political violence/forced displacement, other (accident with death of son)",High,"Shestatsky M, Greenberg D, Lerer B. A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res. 1988 May;24(2):149-55. doi: 10.1016/0165-1781(88)90057-1. PMID: 3406235.",00758,2019
simon2008_SPRINT_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,25,A,PTSD,,9,,PE + paroxetine controlled release,Prolonged Exposure (PE) + paroxetine,Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,SPRINT,SPRINT,ITT,LOCF,Repeated-measures ANOVA,End of Treatment,0,,13.78,,,,,,-2.33,5.24,,,,,,,,,,,,,,,,,,,,SPRINT score <6,0.3333,,Community,,,1,0.5652,,0.4348,Mixed,"rape/sexual assault, intimate partner violence, accidents, illness/medical procedure, other (exposure to war)",Medium,"Simon NM, Connor KM, Lang AJ, et al. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy. J Clin Psychiatry. 2008 Mar;69(3):400-5. PMID: 18348595.",30521,2019
simon2008_SPRINT_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,25,A,PTSD,,9,,PE + paroxetine controlled release,Prolonged Exposure (PE) + paroxetine,Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,SPRINT,SPRINT,ITT,LOCF,Repeated-measures ANOVA,Baseline,,,16.11,8.99,,,,,,,,,,,,,,,,,,,,,,,,,,SPRINT score <6,,,Community,,,1,0.5652,,0.4348,Mixed,"rape/sexual assault, intimate partner violence, accidents, illness/medical procedure, other (exposure to war)",Medium,"Simon NM, Connor KM, Lang AJ, et al. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy. J Clin Psychiatry. 2008 Mar;69(3):400-5. PMID: 18348595.",30521,2019
simon2008_SPRINT_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,25,B,PTSD,,14,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,14,Self report,SPRINT,SPRINT,ITT,LOCF,Repeated-measures ANOVA,End of Treatment,0,,12.43,,,,,,-4.57,7.24,,,,,,,,,,,,,,,,,,,,SPRINT score <6,0.1429,,Community,,,1,0.5652,,0.4348,Mixed,"rape/sexual assault, intimate partner violence, accidents, illness/medical procedure, other (exposure to war)",Medium,"Simon NM, Connor KM, Lang AJ, et al. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy. J Clin Psychiatry. 2008 Mar;69(3):400-5. PMID: 18348595.",30521,2019
simon2008_SPRINT_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,25,B,PTSD,,14,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,14,Self report,SPRINT,SPRINT,ITT,LOCF,Repeated-measures ANOVA,Baseline,,,17.00,7.65,,,,,,,,,,,,,,,,,,,,,,,,,,SPRINT score <6,,,Community,,,1,0.5652,,0.4348,Mixed,"rape/sexual assault, intimate partner violence, accidents, illness/medical procedure, other (exposure to war)",Medium,"Simon NM, Connor KM, Lang AJ, et al. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy. J Clin Psychiatry. 2008 Mar;69(3):400-5. PMID: 18348595.",30521,2019
sloan2004_PDS_A_4_Comp,Psychotherapy,PTSD,51,A,PTSD,,26,,Written emotional disclosure,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Written,28,Self report,PDS,PDS,Completer,,Repeated-measures ANOVA,Assessment at <3 Months,4,,11.5,9.9,,,,,-6.1,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, accidents, child sexual abuse, community/school violence, other (witness to murder)",Medium,"Sloan DM, Marx BP. A closer examination of the structured written disclosure procedure. J Consult Clin Psychol. 2004 Apr;72(2):165-75. doi: 10.1037/0022-006X.72.2.165. PMID: 15065952.",28170,2019
sloan2004_PDS_A_Baseline_Comp,Psychotherapy,PTSD,51,A,PTSD,,26,,Written emotional disclosure,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Written,28,Self report,PDS,PDS,Completer,,Repeated-measures ANOVA,Baseline,,,17.6,6.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, accidents, child sexual abuse, community/school violence, other (witness to murder)",Medium,"Sloan DM, Marx BP. A closer examination of the structured written disclosure procedure. J Consult Clin Psychol. 2004 Apr;72(2):165-75. doi: 10.1037/0022-006X.72.2.165. PMID: 15065952.",28170,2019
sloan2004_PDS_B_4_Comp,Psychotherapy,PTSD,51,B,Control,,23,,Control writing condition,Control writing,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Written,23,Self report,PDS,PDS,Completer,,Repeated-measures ANOVA,Assessment at <3 Months,4,,18.4,7.1,,,,,1.8,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, accidents, child sexual abuse, community/school violence, other (witness to murder)",Medium,"Sloan DM, Marx BP. A closer examination of the structured written disclosure procedure. J Consult Clin Psychol. 2004 Apr;72(2):165-75. doi: 10.1037/0022-006X.72.2.165. PMID: 15065952.",28170,2019
sloan2004_PDS_B_Baseline_Comp,Psychotherapy,PTSD,51,B,Control,,23,,Control writing condition,Control writing,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Written,23,Self report,PDS,PDS,Completer,,Repeated-measures ANOVA,Baseline,,,16.6,5.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Mixed,"rape/sexual assault, accidents, child sexual abuse, community/school violence, other (witness to murder)",Medium,"Sloan DM, Marx BP. A closer examination of the structured written disclosure procedure. J Consult Clin Psychol. 2004 Apr;72(2):165-75. doi: 10.1037/0022-006X.72.2.165. PMID: 15065952.",28170,2019
sloan2007_PDS_A_4_Comp,Psychotherapy,PTSD,85,A,PTSD,,28,,Written disclosure focused on emotional expression,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Written,28,Self report,PDS,PDS,Completer,,3 (condition) X 2 (Time) repeated-measures ANOVA with Scheffe post hoc tests,Assessment at <3 Months,4,,8.5,7.5,,,,,-12.2,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8049,,0.1951,Mixed,"rape/sexual assault, community/school violence, accidents, other (witness to murder)",Medium,"Sloan DM, Marx BP, Epstein EM, et al. Does altering the writing instructions influence outcome associated with written disclosure? Behav Ther. 2007 Jun;38(2):155-68. doi: 10.1016/j.beth.2006.06.005. PMID: 17499082.",32045,2019
sloan2007_PDS_A_Baseline_Comp,Psychotherapy,PTSD,85,A,PTSD,,28,,Written disclosure focused on emotional expression,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Written,28,Self report,PDS,PDS,Completer,,3 (condition) X 2 (Time) repeated-measures ANOVA with Scheffe post hoc tests,Baseline,,,20.7,9.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8049,,0.1951,Mixed,"rape/sexual assault, community/school violence, accidents, other (witness to murder)",Medium,"Sloan DM, Marx BP, Epstein EM, et al. Does altering the writing instructions influence outcome associated with written disclosure? Behav Ther. 2007 Jun;38(2):155-68. doi: 10.1016/j.beth.2006.06.005. PMID: 17499082.",32045,2019
sloan2007_PDS_B_4_Comp,Psychotherapy,PTSD,85,B,PTSD,,27,,Written disclosure focused on insight and cognitive assimilation,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Written,27,Self report,PDS,PDS,Completer,,3 (condition) X 2 (Time) repeated-measures ANOVA with Scheffe post hoc tests,Assessment at <3 Months,4,,14.8,10.9,,,,,-2.7,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8049,,0.1951,Mixed,"rape/sexual assault, community/school violence, accidents, other (witness to murder)",Medium,"Sloan DM, Marx BP, Epstein EM, et al. Does altering the writing instructions influence outcome associated with written disclosure? Behav Ther. 2007 Jun;38(2):155-68. doi: 10.1016/j.beth.2006.06.005. PMID: 17499082.",32045,2019
sloan2007_PDS_B_Baseline_Comp,Psychotherapy,PTSD,85,B,PTSD,,27,,Written disclosure focused on insight and cognitive assimilation,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Written,27,Self report,PDS,PDS,Completer,,3 (condition) X 2 (Time) repeated-measures ANOVA with Scheffe post hoc tests,Baseline,,,17.5,9.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8049,,0.1951,Mixed,"rape/sexual assault, community/school violence, accidents, other (witness to murder)",Medium,"Sloan DM, Marx BP, Epstein EM, et al. Does altering the writing instructions influence outcome associated with written disclosure? Behav Ther. 2007 Jun;38(2):155-68. doi: 10.1016/j.beth.2006.06.005. PMID: 17499082.",32045,2019
sloan2007_PDS_C_4_Comp,Psychotherapy,PTSD,85,C,Control,,27,,Control writing condition,Control writing,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Written,27,Self report,PDS,PDS,Completer,,3 (condition) X 2 (Time) repeated-measures ANOVA with Scheffe post hoc tests,Assessment at <3 Months,4,,16.4,5.9,,,,,-0.9,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8049,,0.1951,Mixed,"rape/sexual assault, community/school violence, accidents, other (witness to murder)",Medium,"Sloan DM, Marx BP, Epstein EM, et al. Does altering the writing instructions influence outcome associated with written disclosure? Behav Ther. 2007 Jun;38(2):155-68. doi: 10.1016/j.beth.2006.06.005. PMID: 17499082.",32045,2019
sloan2007_PDS_C_Baseline_Comp,Psychotherapy,PTSD,85,C,Control,,27,,Control writing condition,Control writing,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Written,27,Self report,PDS,PDS,Completer,,3 (condition) X 2 (Time) repeated-measures ANOVA with Scheffe post hoc tests,Baseline,,,17.3,5.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8049,,0.1951,Mixed,"rape/sexual assault, community/school violence, accidents, other (witness to murder)",Medium,"Sloan DM, Marx BP, Epstein EM, et al. Does altering the writing instructions influence outcome associated with written disclosure? Behav Ther. 2007 Jun;38(2):155-68. doi: 10.1016/j.beth.2006.06.005. PMID: 17499082.",32045,2019
sloan2011_PSS-I_A_4_Comp,Psychotherapy,PTSD,47,A,PTSD,,21,,Written emotional disclosure,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Written,24,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Repeated measures ANOVA; effect sizes calculated using r effect size,Assessment at <3 Months,4,,16,8.2,,,,,-8.8,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.3333,,,,,Community,,,1,,,,Mixed,"rape/sexual assault, community/school violence, accidents, combat-related, other (witness to a murder)",High,"Sloan DM, Marx BP, Greenberg EM. A test of written emotional disclosure as an intervention for posttraumatic stress disorder. Behav Res Ther. 2011 Apr;49(4):299-304. doi: 10.1016/j.brat.2011.02.001. PMID: 21367400.",36171,2019
sloan2011_PSS-I_A_Baseline_Comp,Psychotherapy,PTSD,47,A,PTSD,,21,,Written emotional disclosure,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Written,24,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Repeated measures ANOVA; effect sizes calculated using r effect size,Baseline,,,24.8,5.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"rape/sexual assault, community/school violence, accidents, combat-related, other (witness to a murder)",High,"Sloan DM, Marx BP, Greenberg EM. A test of written emotional disclosure as an intervention for posttraumatic stress disorder. Behav Res Ther. 2011 Apr;49(4):299-304. doi: 10.1016/j.brat.2011.02.001. PMID: 21367400.",36171,2019
sloan2011_PSS-I_B_4_Comp,Psychotherapy,PTSD,47,B,Control,,21,,Control writing condition,Control writing,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,,23,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Repeated measures ANOVA; effect sizes calculated using r effect size,Assessment at <3 Months,4,,15,7.2,,,,,-10.2,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.22,,,,,Community,,,1,,,,Mixed,"rape/sexual assault, community/school violence, accidents, combat-related, other (witness to a murder)",High,"Sloan DM, Marx BP, Greenberg EM. A test of written emotional disclosure as an intervention for posttraumatic stress disorder. Behav Res Ther. 2011 Apr;49(4):299-304. doi: 10.1016/j.brat.2011.02.001. PMID: 21367400.",36171,2019
sloan2011_PSS-I_B_Baseline_Comp,Psychotherapy,PTSD,47,B,Control,,21,,Control writing condition,Control writing,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,,23,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Repeated measures ANOVA; effect sizes calculated using r effect size,Baseline,,,25.2,5.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,,,,Mixed,"rape/sexual assault, community/school violence, accidents, combat-related, other (witness to a murder)",High,"Sloan DM, Marx BP, Greenberg EM. A test of written emotional disclosure as an intervention for posttraumatic stress disorder. Behav Res Ther. 2011 Apr;49(4):299-304. doi: 10.1016/j.brat.2011.02.001. PMID: 21367400.",36171,2019
sloan2012_CAPS_A_0_ITT,Psychotherapy,PTSD,46,A,PTSD,,22,,Written exposure therapy,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,ITT,No missing data,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,End of Treatment,0,,,,,,,,,,,,,Standardized mean gain,3.18,95% CI,2.2,4.16,"p=""significant""",,,,,,,,Not meeting criteria for PTSD according to CAPS,0.9545,,≥12 point decrease in CAPS score,0.9545,,Community,,,1,0.65,,0.35,Accidents,,Low,"Sloan DM, Marx BP, Bovin MJ, et al. Written exposure as an intervention for PTSD: a randomized clinical trial with motor vehicle accident survivors. Behav Res Ther. 2012 Oct;50(10):627-35. doi: 10.1016/j.brat.2012.07.001. PMID: 22863540.",39268,2019
sloan2012_CAPS_A_12_ITT,Psychotherapy,PTSD,46,A,PTSD,,22,,Written exposure therapy,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,ITT,No missing data,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,1,,≥12 point decrease in CAPS score,1,,Community,,,1,0.65,,0.35,Accidents,,Low,"Sloan DM, Marx BP, Bovin MJ, et al. Written exposure as an intervention for PTSD: a randomized clinical trial with motor vehicle accident survivors. Behav Res Ther. 2012 Oct;50(10):627-35. doi: 10.1016/j.brat.2012.07.001. PMID: 22863540.",39268,2019
sloan2012_CAPS_A_26_ITT,Psychotherapy,PTSD,46,A,PTSD,,22,,Written exposure therapy,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,ITT,No missing data,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 6 to <12 Months,26,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,1,,≥12 point decrease in CAPS score,1,,Community,,,1,0.65,,0.35,Accidents,,Low,"Sloan DM, Marx BP, Bovin MJ, et al. Written exposure as an intervention for PTSD: a randomized clinical trial with motor vehicle accident survivors. Behav Res Ther. 2012 Oct;50(10):627-35. doi: 10.1016/j.brat.2012.07.001. PMID: 22863540.",39268,2019
sloan2012_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,46,A,PTSD,,22,,Written exposure therapy,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Structured Clinical Interview,CAPS,CAPS,ITT,No missing data,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Baseline,,,73.57,,95% CI,68.15,78.99,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.65,,0.35,Accidents,,Low,"Sloan DM, Marx BP, Bovin MJ, et al. Written exposure as an intervention for PTSD: a randomized clinical trial with motor vehicle accident survivors. Behav Res Ther. 2012 Oct;50(10):627-35. doi: 10.1016/j.brat.2012.07.001. PMID: 22863540.",39268,2019
sloan2012_CAPS_B_0_ITT,Psychotherapy,PTSD,46,B,Control,,24,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,24,Structured Clinical Interview,CAPS,CAPS,ITT,No missing data,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,End of Treatment,0,,,,,,,,,,,,,Standardized mean gain,-0.14,95% CI,-0.39,0.12,p=NS,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.125,,≥12 point decrease in CAPS score,0.0833,,Community,,,1,0.65,,0.35,Accidents,,Low,"Sloan DM, Marx BP, Bovin MJ, et al. Written exposure as an intervention for PTSD: a randomized clinical trial with motor vehicle accident survivors. Behav Res Ther. 2012 Oct;50(10):627-35. doi: 10.1016/j.brat.2012.07.001. PMID: 22863540.",39268,2019
sloan2012_CAPS_B_12_ITT,Psychotherapy,PTSD,46,B,Control,,24,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,24,Structured Clinical Interview,CAPS,CAPS,ITT,No missing data,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.3333,,≥12 point decrease in CAPS score,0.4583,,Community,,,1,0.65,,0.35,Accidents,,Low,"Sloan DM, Marx BP, Bovin MJ, et al. Written exposure as an intervention for PTSD: a randomized clinical trial with motor vehicle accident survivors. Behav Res Ther. 2012 Oct;50(10):627-35. doi: 10.1016/j.brat.2012.07.001. PMID: 22863540.",39268,2019
sloan2012_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,46,B,Control,,24,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,24,Structured Clinical Interview,CAPS,CAPS,ITT,No missing data,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.65,,0.35,Accidents,,Low,"Sloan DM, Marx BP, Bovin MJ, et al. Written exposure as an intervention for PTSD: a randomized clinical trial with motor vehicle accident survivors. Behav Res Ther. 2012 Oct;50(10):627-35. doi: 10.1016/j.brat.2012.07.001. PMID: 22863540.",39268,2019
sloan2018a_CAPS_A_12_Comp,Psychotherapy,PTSD,126,A,PTSD,,58,,Written exposure therapy,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,Completer,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 3 to <6 Months,12,,26.36,13,,,,,-9.74,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-5,0.4483,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018a_CAPS_A_12_ITT,Psychotherapy,PTSD,126,A,PTSD,,60,,Written exposure therapy,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,ITT,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 3 to <6 Months,12,,26.63,13,,,,,-9.47,,,,,Cohen's d,0.82,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-5,0.45,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018a_CAPS_A_24_Comp,Psychotherapy,PTSD,126,A,PTSD,,56,,Written exposure therapy,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,Completer,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 3 to <6 Months,24,,25.25,12.32,,,,,-10.85,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-5,0.5714,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018a_CAPS_A_24_ITT,Psychotherapy,PTSD,126,A,PTSD,,57,,Written exposure therapy,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,ITT,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 3 to <6 Months,24,,25.23,13.2,,,,,-10.87,,,,,Cohen's d,0.97,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-5,0.5614,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018a_CAPS_A_36_Comp,Psychotherapy,PTSD,126,A,PTSD,,53,,Written exposure therapy,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,Completer,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 6 to <12 Months,36,,23.47,13.54,,,,,-12.63,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-5,0.5094,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018a_CAPS_A_36_ITT,Psychotherapy,PTSD,126,A,PTSD,,55,,Written exposure therapy,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,ITT,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 6 to <12 Months,36,,23.26,13.33,,,,,-12.84,,,,Change from baseline,Cohen's d,1.08,,,,p=0.001,,,,,,,,Not meeting criteria for PTSD according to CAPS-5,0.5185,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018a_CAPS_A_6_Comp,Psychotherapy,PTSD,126,A,PTSD,,59,,Written exposure therapy,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,Completer,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at <3 Months,6,,30.19,11.73,,,,,-5.91,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-5,0.3051,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018a_CAPS_A_6_ITT,Psychotherapy,PTSD,126,A,PTSD,,62,,Written exposure therapy,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,ITT,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at <3 Months,6,,30.90,11.7,,,,,-5.2,,,,,Cohen's d,0.51,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-5,0.2903,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018a_CAPS_A_60_ITT,Psychotherapy,PTSD,126,A,PTSD,,57,,Written exposure therapy,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,ITT,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at ≥12 Months,60,,21.11,13.47,,,,,-14.93,12.83,,,,Cohen's d,1.23,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to CAPS-5,0.6842,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018a_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,126,A,PTSD,,59,,Written exposure therapy,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,Completer,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Baseline,,,36.10,8.81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018a_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,126,A,PTSD,,63,,Written exposure therapy,Written Exposure Therapy (WET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,ITT,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Baseline,,,36.10,8.91,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018a_CAPS_B_12_Comp,Psychotherapy,PTSD,126,B,PTSD,,37,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,Completer,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 3 to <6 Months,12,,22.95,13.73,,,,,-13.78,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-5,0.5676,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018a_CAPS_B_12_ITT,Psychotherapy,PTSD,126,B,PTSD,,52,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,ITT,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 3 to <6 Months,12,,24.81,13.86,,,,,-12.29,,,,Change from baseline,Cohen's d,1.13,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-5,0.5,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018a_CAPS_B_24_Comp,Psychotherapy,PTSD,126,B,PTSD,,34,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,Completer,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 3 to <6 Months,24,,18.97,16.12,,,,,-17.76,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-5,0.6765,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018a_CAPS_B_24_ITT,Psychotherapy,PTSD,126,B,PTSD,,49,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,ITT,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 3 to <6 Months,24,,20.92,16.3,,,,,-16.18,,,,,Cohen's d,1.38,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-5,0.6122,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018a_CAPS_B_36_Comp,Psychotherapy,PTSD,126,B,PTSD,,37,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,Completer,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 6 to <12 Months,36,,19.89,15.36,,,,,-16.84,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-5,0.6757,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018a_CAPS_B_36_ITT,Psychotherapy,PTSD,126,B,PTSD,,51,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,ITT,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 6 to <12 Months,36,,21.37,15.28,,,,,-15.73,,,,,Cohen's d,1.25,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to CAPS-5,0.6078,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018a_CAPS_B_6_Comp,Psychotherapy,PTSD,126,B,PTSD,,37,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,Completer,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at <3 Months,6,,33.32,12.74,,,,,-3.41,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-5,0.2432,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018a_CAPS_B_6_ITT,Psychotherapy,PTSD,126,B,PTSD,,54,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,ITT,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at <3 Months,6,,32.94,12.94,,,,,-4.16,,,,Change from baseline,Cohen's d,0.38,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS-5,0.2778,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018a_CAPS_B_60_ITT,Psychotherapy,PTSD,126,B,PTSD,,53,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,ITT,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at ≥12 Months,60,,19.04,14.65,,,,,-17.74,13.67,,,,Cohen's d,1.38,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to CAPS-5,0.7358,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018a_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,126,B,PTSD,,37,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,Completer,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Baseline,,,36.73,9.41,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018a_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,126,B,PTSD,,63,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,63,Structured Clinical Interview,CAPS,CAPS-5,ITT,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Baseline,,,37.10,10.07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.2619,0.7381,0.4762,,0.5278,Mixed,"combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence",Medium,"Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.",49592,2020
sloan2018b_CAPS_A_0_ITT,Psychotherapy,PTSD,198,A,PTSD,,74,,Group CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,98,Structured Clinical Interview,CAPS,CAPS-5,ITT,Models,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,End of Treatment,0,,32.7,12.3,,,,,-7.1,,,,,Effect size (d),0.63,,,,,,,,,,,,PTSD diagnostic status was established according to the DSM-5 diagnostic algorithm,0.293,,CAPS-5 Reliable Change Index ( ≥13 point reduction),0.227,,Veteran,0,1,0,0,,1,Mixed,Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one),Medium,"Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.",51291,2020
sloan2018b_CAPS_A_12_ITT,Psychotherapy,PTSD,198,A,PTSD,,78,,Group CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,98,Structured Clinical Interview,CAPS,CAPS-5,ITT,Models,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 3 to <6 Months,12,,32.1,14.2,,,,,-7.7,,,,,Effect size (d),0.63,,,,,,,,,,,,PTSD diagnostic status was established according to the DSM-5 diagnostic algorithm,0.346,,CAPS-5 Reliable Change Index ( ≥13 point reduction),0.333,,Veteran,0,1,0,0,,1,Mixed,Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one),Medium,"Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.",51291,2020
sloan2018b_CAPS_A_26_ITT,Psychotherapy,PTSD,198,A,PTSD,,66,,Group CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,98,Structured Clinical Interview,CAPS,CAPS-5,ITT,Models,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 6 to <12 Months,26,,31.8,13.2,,,,,-8,,,,,Effect size (d),0.72,,,,,,,,,,,,PTSD diagnostic status was established according to the DSM-5 diagnostic algorithm,0.288,,CAPS-5 Reliable Change Index ( ≥13 point reduction),0.273,,Veteran,0,1,0,0,,1,Mixed,Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one),Medium,"Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.",51291,2020
sloan2018b_CAPS_A_52_ITT,Psychotherapy,PTSD,198,A,PTSD,,,,Group CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,98,Structured Clinical Interview,CAPS,CAPS-5,ITT,Models,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at ≥12 Months,52,,28.8,13.5,,,,,-11,,,,,Effect size (d),0.97,,,,,,,,,,,,PTSD diagnostic status was established according to the DSM-5 diagnostic algorithm,0.465,,CAPS-5 Reliable Change Index ( ≥13 point reduction),0.383,,Veteran,0,1,0,0,,1,Mixed,Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one),Medium,"Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.",51291,2020
sloan2018b_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,198,A,PTSD,,98,,Group CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,98,Structured Clinical Interview,CAPS,CAPS-5,ITT,Models,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Baseline,,,39.8,9.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one),Medium,"Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.",51291,2020
sloan2018b_CAPS_B_0_ITT,Psychotherapy,PTSD,198,B,PTSD,,88,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,100,Structured Clinical Interview,CAPS,CAPS-5,ITT,Models,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,End of Treatment,0,,34.2,12.3,,,,,-5.2,,,,,Effect size (d),0.48,,,,,,,,,,,,PTSD diagnostic status was established according to the DSM-5 diagnostic algorithm,0.227,,CAPS-5 Reliable Change Index ( ≥13 point reduction),0.227,,Veteran,0,1,0,0,,1,Mixed,Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one),Medium,"Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.",51291,2020
sloan2018b_CAPS_B_12_ITT,Psychotherapy,PTSD,198,B,PTSD,,86,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,100,Structured Clinical Interview,CAPS,CAPS-5,ITT,Models,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 3 to <6 Months,12,,32.1,13.8,,,,,-7.3,,,,,Effect size (d),0.61,,,,,,,,,,,,PTSD diagnostic status was established according to the DSM-5 diagnostic algorithm,0.279,,CAPS-5 Reliable Change Index ( ≥13 point reduction),0.279,,Veteran,0,1,0,0,,1,Mixed,Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one),Medium,"Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.",51291,2020
sloan2018b_CAPS_B_26_ITT,Psychotherapy,PTSD,198,B,PTSD,,82,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,100,Structured Clinical Interview,CAPS,CAPS-5,ITT,Models,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 6 to <12 Months,26,,31.7,14.6,,,,,-7.7,,,,,Effect size (d),0.61,,,,,,,,,,,,PTSD diagnostic status was established according to the DSM-5 diagnostic algorithm,0.321,,CAPS-5 Reliable Change Index ( ≥13 point reduction),0.309,,Veteran,0,1,0,0,,1,Mixed,Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one),Medium,"Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.",51291,2020
sloan2018b_CAPS_B_52_ITT,Psychotherapy,PTSD,198,B,PTSD,,,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,100,Structured Clinical Interview,CAPS,CAPS-5,ITT,Models,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at ≥12 Months,52,,31.9,14.7,,,,,-7.5,,,,,Effect size (d),0.61,,,,,,,,,,,,PTSD diagnostic status was established according to the DSM-5 diagnostic algorithm,0.337,,CAPS-5 Reliable Change Index ( ≥13 point reduction),0.303,,Veteran,0,1,0,0,,1,Mixed,Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one),Medium,"Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.",51291,2020
sloan2018b_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,198,B,PTSD,,100,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,100,Structured Clinical Interview,CAPS,CAPS-5,ITT,Models,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Baseline,,,39.4,9.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one),Medium,"Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.",51291,2020
sloan2018b_PCL_A_0_ITT,Psychotherapy,PTSD,198,A,PTSD,,,,Group CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,98,Self report,PCL,PCL-5,ITT,Models,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,End of Treatment,0,,40.4,15.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one),Medium,"Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.",51291,2020
sloan2018b_PCL_A_12_ITT,Psychotherapy,PTSD,198,A,PTSD,,,,Group CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,98,Self report,PCL,PCL-5,ITT,Models,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 3 to <6 Months,12,,39.6,16.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one),Medium,"Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.",51291,2020
sloan2018b_PCL_A_26_ITT,Psychotherapy,PTSD,198,A,PTSD,,,,Group CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,98,Self report,PCL,PCL-5,ITT,Models,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 6 to <12 Months,26,,40.3,15.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one),Medium,"Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.",51291,2020
sloan2018b_PCL_A_52_ITT,Psychotherapy,PTSD,198,A,PTSD,,,,Group CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,98,Self report,PCL,PCL-5,ITT,Models,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at ≥12 Months,52,,36.9,17.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one),Medium,"Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.",51291,2020
sloan2018b_PCL_A_Baseline_ITT,Psychotherapy,PTSD,198,A,PTSD,,,,Group CBT,Trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,98,Self report,PCL,PCL-5,ITT,Models,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Baseline,,,47.5,13.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one),Medium,"Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.",51291,2020
sloan2018b_PCL_B_0_ITT,Psychotherapy,PTSD,198,B,PTSD,,,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,100,Self report,PCL,PCL-5,ITT,Models,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,End of Treatment,0,,44.9,13.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one),Medium,"Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.",51291,2020
sloan2018b_PCL_B_12_ITT,Psychotherapy,PTSD,198,B,PTSD,,,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,100,Self report,PCL,PCL-5,ITT,Models,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 3 to <6 Months,12,,42.9,15.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one),Medium,"Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.",51291,2020
sloan2018b_PCL_B_26_ITT,Psychotherapy,PTSD,198,B,PTSD,,,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,100,Self report,PCL,PCL-5,ITT,Models,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at 6 to <12 Months,26,,44.2,16.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one),Medium,"Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.",51291,2020
sloan2018b_PCL_B_52_ITT,Psychotherapy,PTSD,198,B,PTSD,,,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,100,Self report,PCL,PCL-5,ITT,Models,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Assessment at ≥12 Months,52,,41.7,17.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one),Medium,"Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.",51291,2020
sloan2018b_PCL_B_Baseline_ITT,Psychotherapy,PTSD,198,B,PTSD,,,,Group PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In person,100,Self report,PCL,PCL-5,ITT,Models,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Baseline,,,49.3,11.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one),Medium,"Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.",51291,2020
smajkic2001_PSS_A_0_Comp,Pharmacotherapy,PTSD,40,A,PTSD,,15,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Self report,PSS,PSS,Completer,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,End of Treatment,0,,31.6,,,,,,-10.3,,,,,,,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to PSS,0,,,,,Community,,,1,0.5625,,0.4375,Terrorism/political violence/forced displacement,,High,"Smajkic A, Weine SM, Djuric-Bijedic Z, et al. Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms. J Trauma. Stress. 2001 Jul;14(3):445-52. doi: 10.1023/A:1011177420069. PMID: 11534876.",16085,2019
smajkic2001_PSS_A_Baseline_Comp,Pharmacotherapy,PTSD,40,A,PTSD,,15,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Self report,PSS,PSS,Completer,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Baseline,,,41.9,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS,,,,,,Community,,,1,0.5625,,0.4375,Terrorism/political violence/forced displacement,,High,"Smajkic A, Weine SM, Djuric-Bijedic Z, et al. Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms. J Trauma. Stress. 2001 Jul;14(3):445-52. doi: 10.1023/A:1011177420069. PMID: 11534876.",16085,2019
smajkic2001_PSS_B_0_Comp,Pharmacotherapy,PTSD,40,B,PTSD,,12,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Self report,PSS,PSS,Completer,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,End of Treatment,0,,26.3,,,,,,-11,,,,,,,,,,p<0.001,,,,,,,,Not meeting criteria for PTSD according to PSS,0,,,,,Community,,,1,0.5625,,0.4375,Terrorism/political violence/forced displacement,,High,"Smajkic A, Weine SM, Djuric-Bijedic Z, et al. Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms. J Trauma. Stress. 2001 Jul;14(3):445-52. doi: 10.1023/A:1011177420069. PMID: 11534876.",16085,2019
smajkic2001_PSS_B_Baseline_Comp,Pharmacotherapy,PTSD,40,B,PTSD,,12,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Self report,PSS,PSS,Completer,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Baseline,,,37.3,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS,,,,,,Community,,,1,0.5625,,0.4375,Terrorism/political violence/forced displacement,,High,"Smajkic A, Weine SM, Djuric-Bijedic Z, et al. Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms. J Trauma. Stress. 2001 Jul;14(3):445-52. doi: 10.1023/A:1011177420069. PMID: 11534876.",16085,2019
smajkic2001_PSS_C_0_Comp,Pharmacotherapy,PTSD,40,C,PTSD,,5,,Venlafaxine,Venlafaxine,No,Not Applicable,Yes,Antidepressant: SNRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PSS,PSS,Completer,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,End of Treatment,0,,26.6,,,,,,-11.2,,,,,,,,,,p<0.05,,,,,,,,Not meeting criteria for PTSD according to PSS,0,,,,,Community,,,1,0.5625,,0.4375,Terrorism/political violence/forced displacement,,High,"Smajkic A, Weine SM, Djuric-Bijedic Z, et al. Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms. J Trauma. Stress. 2001 Jul;14(3):445-52. doi: 10.1023/A:1011177420069. PMID: 11534876.",16085,2019
smajkic2001_PSS_C_Baseline_Comp,Pharmacotherapy,PTSD,40,C,PTSD,,5,,Venlafaxine,Venlafaxine,No,Not Applicable,Yes,Antidepressant: SNRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PSS,PSS,Completer,,Hierarchical linear modeling with random slopes and random intercept model; effect sizes for condition x time interaction as correlations (converted from t ratios); endpoint between-group effect sizes with Hedges' g.,Baseline,,,37.8,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS,,,,,,Community,,,1,0.5625,,0.4375,Terrorism/political violence/forced displacement,,High,"Smajkic A, Weine SM, Djuric-Bijedic Z, et al. Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms. J Trauma. Stress. 2001 Jul;14(3):445-52. doi: 10.1023/A:1011177420069. PMID: 11534876.",16085,2019
smyth2008_PSS-I_A_0_NA,Psychotherapy,PTSD,25,A,PTSD,,13,,Expressive writing,Written narrative exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Written,10,Structured Clinical Interview,PSS-I,PSS-I,,,Change score from baseline,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.56,,0.44,Mixed,"combat-related, rape/sexual assault",High,"Smyth JM, Hockemeyer JR, Tulloch H. Expressive writing and post-traumatic stress disorder: effects on trauma symptoms, mood states, and cortisol reactivity. Br J Health Psychol. 2008 Feb;13(1):85-93. doi: 10.1348/135910707X250866. PMID: 18230238.",30627,2019
smyth2008_PSS-I_A_Baseline_NA,Psychotherapy,PTSD,25,A,PTSD,,15,,Expressive writing,Written narrative exposure,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Written,10,Structured Clinical Interview,PSS-I,PSS-I,,,Change score from baseline,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.56,,0.44,Mixed,"combat-related, rape/sexual assault",High,"Smyth JM, Hockemeyer JR, Tulloch H. Expressive writing and post-traumatic stress disorder: effects on trauma symptoms, mood states, and cortisol reactivity. Br J Health Psychol. 2008 Feb;13(1):85-93. doi: 10.1348/135910707X250866. PMID: 18230238.",30627,2019
smyth2008_PSS-I_B_0_NA,Psychotherapy,PTSD,25,B,Control,,8,,Emotionally neutral writing,Control writing,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,15,Structured Clinical Interview,PSS-I,PSS-I,,,Change score from baseline,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.56,,0.44,Mixed,"combat-related, rape/sexual assault",High,"Smyth JM, Hockemeyer JR, Tulloch H. Expressive writing and post-traumatic stress disorder: effects on trauma symptoms, mood states, and cortisol reactivity. Br J Health Psychol. 2008 Feb;13(1):85-93. doi: 10.1348/135910707X250866. PMID: 18230238.",30627,2019
smyth2008_PSS-I_B_Baseline_NA,Psychotherapy,PTSD,25,B,Control,,10,,Emotionally neutral writing,Control writing,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,15,Structured Clinical Interview,PSS-I,PSS-I,,,Change score from baseline,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.56,,0.44,Mixed,"combat-related, rape/sexual assault",High,"Smyth JM, Hockemeyer JR, Tulloch H. Expressive writing and post-traumatic stress disorder: effects on trauma symptoms, mood states, and cortisol reactivity. Br J Health Psychol. 2008 Feb;13(1):85-93. doi: 10.1348/135910707X250866. PMID: 18230238.",30627,2019
sonne2016_HTQ_A_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,207,A,PTSD,,85,,Sertraline + CBT,Sertraline + trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,109,Self report,HTQ,HTQ,Completer,,Change score from baseline,End of Treatment,0,,3.02,,SE,0.06,,SE 0.06,0.22,,,,,,,,,,p<0.01,,,,,,,,,,,,,,Community,,,1,0.401,,0.599,Terrorism/political violence/forced displacement,,Medium,"Sonne C, Carlsson JM, Bech P, et al. Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study. BMC Psychiatry. 2016 Nov 8;16(1):383. doi: 10.1186/s12888-016-1081-5. PMID: 27825327.",45853,2019
sonne2016_HTQ_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,207,A,PTSD,,109,,Sertraline + CBT,Sertraline + trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,109,Self report,HTQ,HTQ,ITT,Full Information Maximum Likelihood,Change score from baseline,End of Treatment,0,,3.02,,SE,0.06,,SE 0.06,0.22,,,,,Effect size,0.54,,,,p<0.01,,,,,,,,,,,,,,Community,,,1,0.401,,0.599,Terrorism/political violence/forced displacement,,Medium,"Sonne C, Carlsson JM, Bech P, et al. Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study. BMC Psychiatry. 2016 Nov 8;16(1):383. doi: 10.1186/s12888-016-1081-5. PMID: 27825327.",45853,2019
sonne2016_HTQ_A_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,207,A,PTSD,,85,,Sertraline + CBT,Sertraline + trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,109,Self report,HTQ,HTQ,Completer,,Change score from baseline,Baseline,,,3.24,,SE,0.04,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.401,,0.599,Terrorism/political violence/forced displacement,,Medium,"Sonne C, Carlsson JM, Bech P, et al. Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study. BMC Psychiatry. 2016 Nov 8;16(1):383. doi: 10.1186/s12888-016-1081-5. PMID: 27825327.",45853,2019
sonne2016_HTQ_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,207,A,PTSD,,109,,Sertraline + CBT,Sertraline + trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,109,Self report,HTQ,HTQ,ITT,Full Information Maximum Likelihood,Change score from baseline,Baseline,,,3.24,,SE,0.04,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.401,,0.599,Terrorism/political violence/forced displacement,,Medium,"Sonne C, Carlsson JM, Bech P, et al. Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study. BMC Psychiatry. 2016 Nov 8;16(1):383. doi: 10.1186/s12888-016-1081-5. PMID: 27825327.",45853,2019
sonne2016_HTQ_B_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,207,B,PTSD,,69,,Venlafaxine + CBT,Venlafaxine plus trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,Yes,Antidepressant: SNRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,98,Self report,HTQ,HTQ,Completer,,Change score from baseline,End of Treatment,0,,3.06,,SE,0.07,,SE 0.06,-0.15,,,,,,,,,,p=0.01,,,,,,,,,,,,,,Community,,,1,0.401,,0.599,Terrorism/political violence/forced displacement,,Medium,"Sonne C, Carlsson JM, Bech P, et al. Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study. BMC Psychiatry. 2016 Nov 8;16(1):383. doi: 10.1186/s12888-016-1081-5. PMID: 27825327.",45853,2019
sonne2016_HTQ_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,207,B,PTSD,,98,,Venlafaxine + CBT,Venlafaxine plus trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,Yes,Antidepressant: SNRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,98,Self report,HTQ,HTQ,ITT,Full Information Maximum Likelihood,Change score from baseline,End of Treatment,0,,3.05,,SE,0.06,,SE 0.06,-0.13,,,,,Effect size,0.32,,,,p=0.02,,,,,,,,,,,,,,Community,,,1,0.401,,0.599,Terrorism/political violence/forced displacement,,Medium,"Sonne C, Carlsson JM, Bech P, et al. Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study. BMC Psychiatry. 2016 Nov 8;16(1):383. doi: 10.1186/s12888-016-1081-5. PMID: 27825327.",45853,2019
sonne2016_HTQ_B_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,207,B,PTSD,,69,,Venlafaxine + CBT,Venlafaxine plus trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,Yes,Antidepressant: SNRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,98,Self report,HTQ,HTQ,Completer,,Change score from baseline,Baseline,,,3.21,,SE,0.05,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.401,,0.599,Terrorism/political violence/forced displacement,,Medium,"Sonne C, Carlsson JM, Bech P, et al. Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study. BMC Psychiatry. 2016 Nov 8;16(1):383. doi: 10.1186/s12888-016-1081-5. PMID: 27825327.",45853,2019
sonne2016_HTQ_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,207,B,PTSD,,98,,Venlafaxine + CBT,Venlafaxine plus trauma-focused cognitive behavioral therapy (TF-CBT),Yes,TF,Yes,Antidepressant: SNRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,98,Self report,HTQ,HTQ,ITT,Full Information Maximum Likelihood,Change score from baseline,Baseline,,,3.18,,SE,0.04,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.401,,0.599,Terrorism/political violence/forced displacement,,Medium,"Sonne C, Carlsson JM, Bech P, et al. Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study. BMC Psychiatry. 2016 Nov 8;16(1):383. doi: 10.1186/s12888-016-1081-5. PMID: 27825327.",45853,2019
spence2011_PCL_A_0_ITT,Other mixed,PTSD,44,A,PTSD,,21,,Internet-delivered CBT,Internet-delivered CBT,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,23,Self report,PCL,PCL-C,ITT,BOCF,"ANCOVA for mean scores, chi-square for diagnostic change",End of Treatment,0,,44.78,17.29,,,,,-16,,,,,Cohen's d,1.18,95% CI,-2.92,8.26,,,,,,,,,PCL <44,,,,,,Community,,,1,0.8095,,0.1905,Mixed,"rape/sexual assault, accidents, community/school violence, other (not specified)",Medium,"Spence J, Titov N, Dear BF, et al. Randomized controlled trial of internet-delivered cognitive behavioral therapy for posttraumatic stress disorder. Depress Anxiety. 2011 Jul;28(7):541-50. doi: 10.1002/da.20835. PMID: 21721073.",37944,2019
spence2011_PCL_A_12_ITT,Other mixed,PTSD,44,A,PTSD,,19,,Internet-delivered CBT,Internet-delivered CBT,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,23,Self report,PCL,PCL-C,ITT,BOCF,"ANCOVA for mean scores, chi-square for diagnostic change",Assessment at 3 to <6 Months,12,,43.17,17.89,,,,,-17.61,,,,,Cohen's d,1.24,95% CI,-2.86,8.55,,,,,,,,,PCL <44,0.6087,,,,,Community,,,1,0.8095,,0.1905,Mixed,"rape/sexual assault, accidents, community/school violence, other (not specified)",Medium,"Spence J, Titov N, Dear BF, et al. Randomized controlled trial of internet-delivered cognitive behavioral therapy for posttraumatic stress disorder. Depress Anxiety. 2011 Jul;28(7):541-50. doi: 10.1002/da.20835. PMID: 21721073.",37944,2019
spence2011_PCL_A_Baseline_ITT,Other mixed,PTSD,44,A,PTSD,,23,,Internet-delivered CBT,Internet-delivered CBT,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,23,Self report,PCL,PCL-C,ITT,BOCF,"ANCOVA for mean scores, chi-square for diagnostic change",Baseline,,,60.78,10.03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8095,,0.1905,Mixed,"rape/sexual assault, accidents, community/school violence, other (not specified)",Medium,"Spence J, Titov N, Dear BF, et al. Randomized controlled trial of internet-delivered cognitive behavioral therapy for posttraumatic stress disorder. Depress Anxiety. 2011 Jul;28(7):541-50. doi: 10.1002/da.20835. PMID: 21721073.",37944,2019
spence2011_PCL_B_0_ITT,Other mixed,PTSD,44,B,Control,,19,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,21,Self report,PCL,PCL-C,ITT,BOCF,"ANCOVA for mean scores, chi-square for diagnostic change",End of Treatment,0,,51.79,12.51,,,,,-5.21,,,,,Cohen's d,0.49,95% CI,-3.87,6.82,,,,,,,,,PCL <44,,,,,,Community,,,1,0.8095,,0.1905,Mixed,"rape/sexual assault, accidents, community/school violence, other (not specified)",Medium,"Spence J, Titov N, Dear BF, et al. Randomized controlled trial of internet-delivered cognitive behavioral therapy for posttraumatic stress disorder. Depress Anxiety. 2011 Jul;28(7):541-50. doi: 10.1002/da.20835. PMID: 21721073.",37944,2019
spence2011_PCL_B_Baseline_ITT,Other mixed,PTSD,44,B,Control,,19,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,21,Self report,PCL,PCL-C,ITT,BOCF,"ANCOVA for mean scores, chi-square for diagnostic change",Baseline,,,57,9.69,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8095,,0.1905,Mixed,"rape/sexual assault, accidents, community/school violence, other (not specified)",Medium,"Spence J, Titov N, Dear BF, et al. Randomized controlled trial of internet-delivered cognitive behavioral therapy for posttraumatic stress disorder. Depress Anxiety. 2011 Jul;28(7):541-50. doi: 10.1002/da.20835. PMID: 21721073.",37944,2019
spence2014_IES_A_0_NA,Other mixed,PTSD,125,A,PTSD,,,,"Non-exposure, internet-delivered CBT",Internet-delivered CBT,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,66,Self report,IES,IES-R,,,"Mixed effects model, chi-squared for diagnostic change",End of Treatment,0,,26.65,16.77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.864,,0.136,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)",Medium,"Spence J, Titov N, Johnston L, et al. Internet-based trauma-focused cognitive behavioural therapy for PTSD with and without exposure components: a randomised controlled trial. J Affect Disord. 2014 Jun;162:73-80. doi: 10.1016/j.jad.2014.03.009. PMID: 24767009.",42408,2019
spence2014_IES_A_12_NA,Other mixed,PTSD,125,A,PTSD,,,,"Non-exposure, internet-delivered CBT",Internet-delivered CBT,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,66,Self report,IES,IES-R,,,"Mixed effects model, chi-squared for diagnostic change",Assessment at 3 to <6 Months,12,,22.69,14.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.864,,0.136,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)",Medium,"Spence J, Titov N, Johnston L, et al. Internet-based trauma-focused cognitive behavioural therapy for PTSD with and without exposure components: a randomised controlled trial. J Affect Disord. 2014 Jun;162:73-80. doi: 10.1016/j.jad.2014.03.009. PMID: 24767009.",42408,2019
spence2014_IES_A_Baseline_NA,Other mixed,PTSD,125,A,PTSD,,,,"Non-exposure, internet-delivered CBT",Internet-delivered CBT,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,66,Self report,IES,IES-R,,,"Mixed effects model, chi-squared for diagnostic change",Baseline,,,46.23,14.66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.864,,0.136,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)",Medium,"Spence J, Titov N, Johnston L, et al. Internet-based trauma-focused cognitive behavioural therapy for PTSD with and without exposure components: a randomised controlled trial. J Affect Disord. 2014 Jun;162:73-80. doi: 10.1016/j.jad.2014.03.009. PMID: 24767009.",42408,2019
spence2014_IES_B_0_NA,Other mixed,PTSD,125,B,PTSD,,,,Internet-delivered CBT,Internet-delivered CBT,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,59,Self report,IES,IES-R,,,"Mixed effects model, chi-squared for diagnostic change",End of Treatment,0,,32.23,21.56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.864,,0.136,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)",Medium,"Spence J, Titov N, Johnston L, et al. Internet-based trauma-focused cognitive behavioural therapy for PTSD with and without exposure components: a randomised controlled trial. J Affect Disord. 2014 Jun;162:73-80. doi: 10.1016/j.jad.2014.03.009. PMID: 24767009.",42408,2019
spence2014_IES_B_12_NA,Other mixed,PTSD,125,B,PTSD,,,,Internet-delivered CBT,Internet-delivered CBT,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,59,Self report,IES,IES-R,,,"Mixed effects model, chi-squared for diagnostic change",Assessment at 3 to <6 Months,12,,26.61,21.91,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.864,,0.136,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)",Medium,"Spence J, Titov N, Johnston L, et al. Internet-based trauma-focused cognitive behavioural therapy for PTSD with and without exposure components: a randomised controlled trial. J Affect Disord. 2014 Jun;162:73-80. doi: 10.1016/j.jad.2014.03.009. PMID: 24767009.",42408,2019
spence2014_IES_B_Baseline_NA,Other mixed,PTSD,125,B,PTSD,,,,Internet-delivered CBT,Internet-delivered CBT,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,59,Self report,IES,IES-R,,,"Mixed effects model, chi-squared for diagnostic change",Baseline,,,51.27,15.71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.864,,0.136,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)",Medium,"Spence J, Titov N, Johnston L, et al. Internet-based trauma-focused cognitive behavioural therapy for PTSD with and without exposure components: a randomised controlled trial. J Affect Disord. 2014 Jun;162:73-80. doi: 10.1016/j.jad.2014.03.009. PMID: 24767009.",42408,2019
spence2014_PSS-I_A_0_ITT,Other mixed,PTSD,125,A,PTSD,,58,,"Non-exposure, internet-delivered CBT",Internet-delivered CBT,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,66,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Imputed, LOCF for PTSD diagnosis","Mixed effects model, chi-squared for diagnostic change",End of Treatment,0,,14.43,9.31,,,,,-17.55,,,,,Cohen's d,1.89,95% CI,1.47,2.29,,,,,,,,,Not meeting criteria for PTSD according to the PSS-I,0.3788,,,,,Community,,,1,0.864,,0.136,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)",Medium,"Spence J, Titov N, Johnston L, et al. Internet-based trauma-focused cognitive behavioural therapy for PTSD with and without exposure components: a randomised controlled trial. J Affect Disord. 2014 Jun;162:73-80. doi: 10.1016/j.jad.2014.03.009. PMID: 24767009.",42408,2019
spence2014_PSS-I_A_12_ITT,Other mixed,PTSD,125,A,PTSD,,51,,"Non-exposure, internet-delivered CBT",Internet-delivered CBT,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,66,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Imputed, LOCF for PTSD diagnosis","Mixed effects model, chi-squared for diagnostic change",Assessment at 3 to <6 Months,12,,13.02,10.89,,,,,-18.96,,,,,Cohen's d,1.88,95% CI,1.46,2.28,p<0.001,,,,,,,,Not meeting criteria for PTSD according to the PSS-I,0.4394,,,,,Community,,,1,0.864,,0.136,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)",Medium,"Spence J, Titov N, Johnston L, et al. Internet-based trauma-focused cognitive behavioural therapy for PTSD with and without exposure components: a randomised controlled trial. J Affect Disord. 2014 Jun;162:73-80. doi: 10.1016/j.jad.2014.03.009. PMID: 24767009.",42408,2019
spence2014_PSS-I_A_Baseline_ITT,Other mixed,PTSD,125,A,PTSD,,66,,"Non-exposure, internet-delivered CBT",Internet-delivered CBT,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,66,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Imputed, LOCF for PTSD diagnosis","Mixed effects model, chi-squared for diagnostic change",Baseline,,,31.98,9.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.864,,0.136,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)",Medium,"Spence J, Titov N, Johnston L, et al. Internet-based trauma-focused cognitive behavioural therapy for PTSD with and without exposure components: a randomised controlled trial. J Affect Disord. 2014 Jun;162:73-80. doi: 10.1016/j.jad.2014.03.009. PMID: 24767009.",42408,2019
spence2014_PSS-I_B_0_ITT,Other mixed,PTSD,125,B,PTSD,,52,,Internet-delivered CBT,Internet-delivered CBT,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,59,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Imputed, LOCF for PTSD diagnosis","Mixed effects model, chi-squared for diagnostic change",End of Treatment,0,,17.1,12.57,,,,,-14.56,,,,,Cohen's d,1.31,95% CI,0.9,1.69,,,,,,,,,Not meeting criteria for PTSD according to the PSS-I,0.322,,,,,Community,,,1,0.864,,0.136,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)",Medium,"Spence J, Titov N, Johnston L, et al. Internet-based trauma-focused cognitive behavioural therapy for PTSD with and without exposure components: a randomised controlled trial. J Affect Disord. 2014 Jun;162:73-80. doi: 10.1016/j.jad.2014.03.009. PMID: 24767009.",42408,2019
spence2014_PSS-I_B_12_ITT,Other mixed,PTSD,125,B,PTSD,,48,,Internet-delivered CBT,Internet-delivered CBT,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,59,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Imputed, LOCF for PTSD diagnosis","Mixed effects model, chi-squared for diagnostic change",Assessment at 3 to <6 Months,12,,15.69,13.38,,,,,-15.97,,,,,Cohen's d,1.37,95% CI,0.96,1.77,p<0.001,,,,,,,,Not meeting criteria for PTSD according to the PSS-I,0.339,,,,,Community,,,1,0.864,,0.136,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)",Medium,"Spence J, Titov N, Johnston L, et al. Internet-based trauma-focused cognitive behavioural therapy for PTSD with and without exposure components: a randomised controlled trial. J Affect Disord. 2014 Jun;162:73-80. doi: 10.1016/j.jad.2014.03.009. PMID: 24767009.",42408,2019
spence2014_PSS-I_B_Baseline_ITT,Other mixed,PTSD,125,B,PTSD,,59,,Internet-delivered CBT,Internet-delivered CBT,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,Yes,No,Individual,Technology Assisted,59,Structured Clinical Interview,PSS-I,PSS-I,ITT,"Imputed, LOCF for PTSD diagnosis","Mixed effects model, chi-squared for diagnostic change",Baseline,,,31.66,9.55,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.864,,0.136,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)",Medium,"Spence J, Titov N, Johnston L, et al. Internet-based trauma-focused cognitive behavioural therapy for PTSD with and without exposure components: a randomised controlled trial. J Affect Disord. 2014 Jun;162:73-80. doi: 10.1016/j.jad.2014.03.009. PMID: 24767009.",42408,2019
spivak2006_CAPS_A_0_Comp,Pharmacotherapy,PTSD,40,A,PTSD,,11,,Reboxetine,Reboxetine,No,Not Applicable,Yes,Antidepressant: SNRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,,"Mixed effects model, chi-squared for diagnostic change",End of Treatment,0,,39,15.6,,,,,-35.3,16,,,,,,,,,p<0.001,,,,,,,,,,,,,,Community,,,1,0.475,,0.525,Accidents,,Medium,"Spivak B, Strous RD, Shaked G, et al. Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial. J Clin Psychopharmacol. 2006 Apr;26(2):152-6. doi: 10.1097/01.jcp.0000203195.65710.f0. PMID: 16633143.",1548487,2019
spivak2006_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,40,A,PTSD,,11,,Reboxetine,Reboxetine,No,Not Applicable,Yes,Antidepressant: SNRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,,"Mixed effects model, chi-squared for diagnostic change",Baseline,,,74.4,19.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.475,,0.525,Accidents,,Medium,"Spivak B, Strous RD, Shaked G, et al. Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial. J Clin Psychopharmacol. 2006 Apr;26(2):152-6. doi: 10.1097/01.jcp.0000203195.65710.f0. PMID: 16633143.",1548487,2019
spivak2006_CAPS_B_0_Comp,Pharmacotherapy,PTSD,40,B,PTSD,,17,,Fluvoxamine,Fluvoxamine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,,"Mixed effects model, chi-squared for diagnostic change",End of Treatment,0,,36,17.5,,,,,-45,17,,,,,,,,,p<0.001,,,,,,,,,,,,,,Community,,,1,0.475,,0.525,Accidents,,Medium,"Spivak B, Strous RD, Shaked G, et al. Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial. J Clin Psychopharmacol. 2006 Apr;26(2):152-6. doi: 10.1097/01.jcp.0000203195.65710.f0. PMID: 16633143.",1548487,2019
spivak2006_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,40,B,PTSD,,17,,Fluvoxamine,Fluvoxamine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,,"Mixed effects model, chi-squared for diagnostic change",Baseline,,,81.2,11.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.475,,0.525,Accidents,,Medium,"Spivak B, Strous RD, Shaked G, et al. Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial. J Clin Psychopharmacol. 2006 Apr;26(2):152-6. doi: 10.1097/01.jcp.0000203195.65710.f0. PMID: 16633143.",1548487,2019
spivak2006_TOP-8_A_0_NA,Pharmacotherapy,PTSD,40,A,PTSD,,,,Reboxetine,Reboxetine,No,Not Applicable,Yes,Antidepressant: SNRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,TOP-8,TOP-8,,,"Mixed effects model, chi-squared for diagnostic change",End of Treatment,0,,9.2,2.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.475,,0.525,Accidents,,Medium,"Spivak B, Strous RD, Shaked G, et al. Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial. J Clin Psychopharmacol. 2006 Apr;26(2):152-6. doi: 10.1097/01.jcp.0000203195.65710.f0. PMID: 16633143.",1548487,2019
spivak2006_TOP-8_A_Baseline_NA,Pharmacotherapy,PTSD,40,A,PTSD,,,,Reboxetine,Reboxetine,No,Not Applicable,Yes,Antidepressant: SNRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,TOP-8,TOP-8,,,"Mixed effects model, chi-squared for diagnostic change",Baseline,,,18.2,3.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.475,,0.525,Accidents,,Medium,"Spivak B, Strous RD, Shaked G, et al. Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial. J Clin Psychopharmacol. 2006 Apr;26(2):152-6. doi: 10.1097/01.jcp.0000203195.65710.f0. PMID: 16633143.",1548487,2019
spivak2006_TOP-8_B_0_NA,Pharmacotherapy,PTSD,40,B,PTSD,,,,Fluvoxamine,Fluvoxamine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,TOP-8,TOP-8,,,"Mixed effects model, chi-squared for diagnostic change",End of Treatment,0,,8.8,3.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.475,,0.525,Accidents,,Medium,"Spivak B, Strous RD, Shaked G, et al. Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial. J Clin Psychopharmacol. 2006 Apr;26(2):152-6. doi: 10.1097/01.jcp.0000203195.65710.f0. PMID: 16633143.",1548487,2019
spivak2006_TOP-8_B_Baseline_NA,Pharmacotherapy,PTSD,40,B,PTSD,,,,Fluvoxamine,Fluvoxamine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,TOP-8,TOP-8,,,"Mixed effects model, chi-squared for diagnostic change",Baseline,,,19.1,3.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.475,,0.525,Accidents,,Medium,"Spivak B, Strous RD, Shaked G, et al. Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial. J Clin Psychopharmacol. 2006 Apr;26(2):152-6. doi: 10.1097/01.jcp.0000203195.65710.f0. PMID: 16633143.",1548487,2019
stappenbeck2015a_PCL_A_0_Comp,Psychotherapy,PTSD+SUD,80,A,PTSD+SUD,Not integrated,31,,Cognitive Restructuring,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,31,Self report,PCL,Adapted PCL-C,Completer,Generalized estimating equation models using maximum likelihood estimation,"Mixed effects model, chi-squared for diagnostic change",End of Treatment,0,,3.1,1.8,,,,,-0.8,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.269,0.731,0.487,,0.513,,,Medium,"Stappenbeck CA, Luterek JA, Kaysen DL, et al. A controlled examination of two coping skills for daily alcohol use and PTSD symptom severity among dually diagnosed individuals. Behav Res Ther. 2015a Mar;66:8-17. doi: 10.1016/j.brat.2014.12.013. PMID: 25617814.",43808,2020
stappenbeck2015a_PCL_A_Baseline_Comp,Psychotherapy,PTSD+SUD,80,A,PTSD+SUD,Not integrated,31,,Cognitive Restructuring,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,31,Self report,PCL,Adapted PCL-C,Completer,Generalized estimating equation models using maximum likelihood estimation,"Mixed effects model, chi-squared for diagnostic change",Baseline,,,3.9,1.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.269,0.731,0.487,,0.513,,,Medium,"Stappenbeck CA, Luterek JA, Kaysen DL, et al. A controlled examination of two coping skills for daily alcohol use and PTSD symptom severity among dually diagnosed individuals. Behav Res Ther. 2015a Mar;66:8-17. doi: 10.1016/j.brat.2014.12.013. PMID: 25617814.",43808,2020
stappenbeck2015a_PCL_B_0_Comp,Psychotherapy,PTSD+SUD,80,B,PTSD+SUD,Not integrated,27,,Experiential Acceptance,Experiential Acceptance,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,29,Self report,PCL,Adapted PCL-C,Completer,Generalized estimating equation models using maximum likelihood estimation,"Mixed effects model, chi-squared for diagnostic change",End of Treatment,0,,2.7,1.4,,,,,-0.5,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.269,0.731,0.487,,0.513,,,Medium,"Stappenbeck CA, Luterek JA, Kaysen DL, et al. A controlled examination of two coping skills for daily alcohol use and PTSD symptom severity among dually diagnosed individuals. Behav Res Ther. 2015a Mar;66:8-17. doi: 10.1016/j.brat.2014.12.013. PMID: 25617814.",43808,2020
stappenbeck2015a_PCL_B_Baseline_Comp,Psychotherapy,PTSD+SUD,80,B,PTSD+SUD,Not integrated,27,,Experiential Acceptance,Experiential Acceptance,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,29,Self report,PCL,Adapted PCL-C,Completer,Generalized estimating equation models using maximum likelihood estimation,"Mixed effects model, chi-squared for diagnostic change",Baseline,,,3.2,1.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.269,0.731,0.487,,0.513,,,Medium,"Stappenbeck CA, Luterek JA, Kaysen DL, et al. A controlled examination of two coping skills for daily alcohol use and PTSD symptom severity among dually diagnosed individuals. Behav Res Ther. 2015a Mar;66:8-17. doi: 10.1016/j.brat.2014.12.013. PMID: 25617814.",43808,2020
stappenbeck2015a_PCL_C_0_Comp,Psychotherapy,PTSD+SUD,80,C,Control,Not integrated,20,,Attention control,Attention control,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,20,Self report,PCL,Adapted PCL-C,Completer,Generalized estimating equation models using maximum likelihood estimation,"Mixed effects model, chi-squared for diagnostic change",End of Treatment,0,,3.4,1.3,,,,,-0.6,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.269,0.731,0.487,,0.513,,,Medium,"Stappenbeck CA, Luterek JA, Kaysen DL, et al. A controlled examination of two coping skills for daily alcohol use and PTSD symptom severity among dually diagnosed individuals. Behav Res Ther. 2015a Mar;66:8-17. doi: 10.1016/j.brat.2014.12.013. PMID: 25617814.",43808,2020
stappenbeck2015a_PCL_C_Baseline_Comp,Psychotherapy,PTSD+SUD,80,C,Control,Not integrated,20,,Attention control,Attention control,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,20,Self report,PCL,Adapted PCL-C,Completer,Generalized estimating equation models using maximum likelihood estimation,"Mixed effects model, chi-squared for diagnostic change",Baseline,,,4.0,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.269,0.731,0.487,,0.513,,,Medium,"Stappenbeck CA, Luterek JA, Kaysen DL, et al. A controlled examination of two coping skills for daily alcohol use and PTSD symptom severity among dually diagnosed individuals. Behav Res Ther. 2015a Mar;66:8-17. doi: 10.1016/j.brat.2014.12.013. PMID: 25617814.",43808,2020
stecker2014_PCL_A_12_Comp,Psychotherapy,PTSD,300,A,PTSD,,123,,Brief CBT by telephone,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Phone,143,Self report,PCL,PCL-M,Completer,,"Mixed effects model, chi-squared for diagnostic change",Assessment at 3 to <6 Months,12,,49.7,15.2,,,,,-9.5,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.1277,,0.8723,,,High,"Stecker T, McHugo GJ, Xie HY, et al. RCT of a brief phone-based CBT intervention to improve PTSD treatment utilization by returning service members. Psychiatr Serv. 2014 Oct;65(10):1232-7. doi: 10.1176/appi.ps.201300433. PMID: 24933496.",44566,2020
stecker2014_PCL_A_26_Comp,Psychotherapy,PTSD,300,A,PTSD,,123,,Brief CBT by telephone,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Phone,143,Self report,PCL,PCL-M,Completer,,"Mixed effects model, chi-squared for diagnostic change",Assessment at 6 to <12 Months,26,,49.8,15.2,,,,,-9.4,,,,,,,,,,p<0.05,,,,,,,,,,,,,,Mixed,,,0,0.1277,,0.8723,,,High,"Stecker T, McHugo GJ, Xie HY, et al. RCT of a brief phone-based CBT intervention to improve PTSD treatment utilization by returning service members. Psychiatr Serv. 2014 Oct;65(10):1232-7. doi: 10.1176/appi.ps.201300433. PMID: 24933496.",44566,2020
stecker2014_PCL_A_4_Comp,Psychotherapy,PTSD,300,A,PTSD,,123,,Brief CBT by telephone,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Phone,143,Self report,PCL,PCL-M,Completer,,"Mixed effects model, chi-squared for diagnostic change",Assessment at <3 Months,4,,51.3,13.6,,,,,-7.9,,,,,,,,,,p<0.05,,,,,,,,,,,,,,Mixed,,,0,0.1277,,0.8723,,,High,"Stecker T, McHugo GJ, Xie HY, et al. RCT of a brief phone-based CBT intervention to improve PTSD treatment utilization by returning service members. Psychiatr Serv. 2014 Oct;65(10):1232-7. doi: 10.1176/appi.ps.201300433. PMID: 24933496.",44566,2020
stecker2014_PCL_A_Baseline_Comp,Psychotherapy,PTSD,300,A,PTSD,,123,,Brief CBT by telephone,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Phone,143,Self report,PCL,PCL-M,Completer,,"Mixed effects model, chi-squared for diagnostic change",Baseline,,,59.2,11.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.1277,,0.8723,,,High,"Stecker T, McHugo GJ, Xie HY, et al. RCT of a brief phone-based CBT intervention to improve PTSD treatment utilization by returning service members. Psychiatr Serv. 2014 Oct;65(10):1232-7. doi: 10.1176/appi.ps.201300433. PMID: 24933496.",44566,2020
stecker2014_PCL_B_12_Comp,Psychotherapy,PTSD,300,B,Control,,151,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,157,Self report,PCL,PCL-M,Completer,,"Mixed effects model, chi-squared for diagnostic change",Assessment at 3 to <6 Months,12,,52.8,14.2,,,,,-6.9,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.1277,,0.8723,,,High,"Stecker T, McHugo GJ, Xie HY, et al. RCT of a brief phone-based CBT intervention to improve PTSD treatment utilization by returning service members. Psychiatr Serv. 2014 Oct;65(10):1232-7. doi: 10.1176/appi.ps.201300433. PMID: 24933496.",44566,2020
stecker2014_PCL_B_26_Comp,Psychotherapy,PTSD,300,B,Control,,151,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,157,Self report,PCL,PCL-M,Completer,,"Mixed effects model, chi-squared for diagnostic change",Assessment at 6 to <12 Months,26,,48.9,15.1,,,,,-10.8,,,,,,,,,,p<0.05,,,,,,,,,,,,,,Mixed,,,0,0.1277,,0.8723,,,High,"Stecker T, McHugo GJ, Xie HY, et al. RCT of a brief phone-based CBT intervention to improve PTSD treatment utilization by returning service members. Psychiatr Serv. 2014 Oct;65(10):1232-7. doi: 10.1176/appi.ps.201300433. PMID: 24933496.",44566,2020
stecker2014_PCL_B_4_Comp,Psychotherapy,PTSD,300,B,Control,,151,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,157,Self report,PCL,PCL-M,Completer,,"Mixed effects model, chi-squared for diagnostic change",Assessment at <3 Months,4,,55.0,13.1,,,,,-4.7,,,,,,,,,,p<0.05,,,,,,,,,,,,,,Mixed,,,0,0.1277,,0.8723,,,High,"Stecker T, McHugo GJ, Xie HY, et al. RCT of a brief phone-based CBT intervention to improve PTSD treatment utilization by returning service members. Psychiatr Serv. 2014 Oct;65(10):1232-7. doi: 10.1176/appi.ps.201300433. PMID: 24933496.",44566,2020
stecker2014_PCL_B_Baseline_Comp,Psychotherapy,PTSD,300,B,Control,,151,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,157,Self report,PCL,PCL-M,Completer,,"Mixed effects model, chi-squared for diagnostic change",Baseline,,,59.7,11.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.1277,,0.8723,,,High,"Stecker T, McHugo GJ, Xie HY, et al. RCT of a brief phone-based CBT intervention to improve PTSD treatment utilization by returning service members. Psychiatr Serv. 2014 Oct;65(10):1232-7. doi: 10.1176/appi.ps.201300433. PMID: 24933496.",44566,2020
stein2002_CAPS_A_0_ITT,Pharmacotherapy,PTSD,19,A,PTSD,,7,,Olanzapine augmentation,Olanzapine augmentation,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Mixed effects model, chi-squared for diagnostic change",End of Treatment,0,,71.3,,,,,,-14.8,14.16,,,,,,,,,,,,,,,,,,,,"CGI severity score ""much improved"" or ""very much improved"" relative to baseline",0.3,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Stein MB, Kline NA, Matloff JL. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry. 2002 Oct;159(10):1777-9. doi: 10.1176/appi.ajp.159.10.1777. PMID: 12359687.",24689,2019
stein2002_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,19,A,PTSD,,10,,Olanzapine augmentation,Olanzapine augmentation,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Mixed effects model, chi-squared for diagnostic change",Baseline,,,86.1,22.1,,,,,,,,,,,,,,,,,,,,,,,,,,"CGI severity score ""much improved"" or ""very much improved"" relative to baseline",,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Stein MB, Kline NA, Matloff JL. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry. 2002 Oct;159(10):1777-9. doi: 10.1176/appi.ajp.159.10.1777. PMID: 12359687.",24689,2019
stein2002_CAPS_B_0_ITT,Pharmacotherapy,PTSD,19,B,PTSD,,7,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,9,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Mixed effects model, chi-squared for diagnostic change",End of Treatment,0,,81.33,,,,,,-2.67,10.55,,,,,,,,,,,,,,,,,,,,"CGI severity score ""much improved"" or ""very much improved"" relative to baseline",0.1111,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Stein MB, Kline NA, Matloff JL. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry. 2002 Oct;159(10):1777-9. doi: 10.1176/appi.ajp.159.10.1777. PMID: 12359687.",24689,2019
stein2002_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,19,B,PTSD,,9,,Placebo augmentation,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,9,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,"Mixed effects model, chi-squared for diagnostic change",Baseline,,,84.0,16.2,,,,,,,,,,,,,,,,,,,,,,,,,,"CGI severity score ""much improved"" or ""very much improved"" relative to baseline",,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Stein MB, Kline NA, Matloff JL. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry. 2002 Oct;159(10):1777-9. doi: 10.1176/appi.ajp.159.10.1777. PMID: 12359687.",24689,2019
steinert2016_HTQ_A_0_Comp,Psychotherapy,PTSD,86,A,PTSD,,52,,Resource-oriented trauma therapy combined with EMDR,Resource-oriented trauma therapy combined with Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Self report,HTQ,HTQ - PTSD scale (Indochinese version),Completer,Listwise deletion,General linear regression models for continuous outcomes; binary logistic regression for categorical outcomes; Bonferroni-corrected alpha=0.01; adjusted odds ratios and Cohen's d effect sizes.,End of Treatment,0,Baseline adjusted,1.39,,95% CI,1.23,1.54,,,,,,,Cohen's d,4.43,,,,,,,,,,,,Not meeting criteria for PTSD according to HTQ for DSM-IV,0.9592,,,,,Community,,,1,0.6071,,0.3929,Mixed,"intimate partner violence, accidents, rape/sexual assault, combat-related, community/school violence, other (trafficking)",Medium,"Steinert C, Bumke PJ, Hollekamp RL, et al. Treating post-traumatic stress disorder by resource activation in Cambodia. World Psychiatry. 2016 Jun;15(2):183-5. doi: 10.1002/wps.20303. PMID: 27265714.",45144,2019
steinert2016_HTQ_A_Baseline_Comp,Psychotherapy,PTSD,86,A,PTSD,,52,,Resource-oriented trauma therapy combined with EMDR,Resource-oriented trauma therapy combined with Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Self report,HTQ,HTQ - PTSD scale (Indochinese version),Completer,Listwise deletion,General linear regression models for continuous outcomes; binary logistic regression for categorical outcomes; Bonferroni-corrected alpha=0.01; adjusted odds ratios and Cohen's d effect sizes.,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6071,,0.3929,Mixed,"intimate partner violence, accidents, rape/sexual assault, combat-related, community/school violence, other (trafficking)",Medium,"Steinert C, Bumke PJ, Hollekamp RL, et al. Treating post-traumatic stress disorder by resource activation in Cambodia. World Psychiatry. 2016 Jun;15(2):183-5. doi: 10.1002/wps.20303. PMID: 27265714.",45144,2019
steinert2016_HTQ_B_0_Comp,Psychotherapy,PTSD,86,B,Control,,32,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,33,Self report,HTQ,HTQ - PTSD scale (Indochinese version),Completer,Listwise deletion,General linear regression models for continuous outcomes; binary logistic regression for categorical outcomes; Bonferroni-corrected alpha=0.01; adjusted odds ratios and Cohen's d effect sizes.,End of Treatment,0,Baseline adjusted,2.86,,95% CI,2.66,3.06,,,,,,,Cohen's d,0.52,,,,,,,,,,,,Not meeting criteria for PTSD according to HTQ for DSM-IV,0.7586,,,,,Community,,,1,0.6071,,0.3929,Mixed,"intimate partner violence, accidents, rape/sexual assault, combat-related, community/school violence, other (trafficking)",Medium,"Steinert C, Bumke PJ, Hollekamp RL, et al. Treating post-traumatic stress disorder by resource activation in Cambodia. World Psychiatry. 2016 Jun;15(2):183-5. doi: 10.1002/wps.20303. PMID: 27265714.",45144,2019
steinert2016_HTQ_B_Baseline_Comp,Psychotherapy,PTSD,86,B,Control,,32,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,33,Self report,HTQ,HTQ - PTSD scale (Indochinese version),Completer,Listwise deletion,General linear regression models for continuous outcomes; binary logistic regression for categorical outcomes; Bonferroni-corrected alpha=0.01; adjusted odds ratios and Cohen's d effect sizes.,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.6071,,0.3929,Mixed,"intimate partner violence, accidents, rape/sexual assault, combat-related, community/school violence, other (trafficking)",Medium,"Steinert C, Bumke PJ, Hollekamp RL, et al. Treating post-traumatic stress disorder by resource activation in Cambodia. World Psychiatry. 2016 Jun;15(2):183-5. doi: 10.1002/wps.20303. PMID: 27265714.",45144,2019
stenmark2013_CAPS_A_0_Comp,Psychotherapy,PTSD,81,A,PTSD,,33,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,51,Structured Clinical Interview,CAPS,CAPS,Completer,Mixed effects model using available data (no imputation),"Mixed-effect model for CAPS, chi-square for PTSD diagnosis",End of Treatment,0,,,,,,,,,,,,Refugees,Hedges' g,1.37,95% CI,0.7,2.04,,Asylum Seekers,Hedges' g,0.9,95% CI,0.06,1.74,,Not meeting criteria for PTSD according to CAPS,0.4242,,,,,Community,,,1,0.3086,,0.6914,,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",46540,2019
stenmark2013_CAPS_A_26_Comp,Psychotherapy,PTSD,81,A,PTSD,,33,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,51,Structured Clinical Interview,CAPS,CAPS,Completer,Mixed effects model using available data (no imputation),"Mixed-effect model for CAPS, chi-square for PTSD diagnosis",Assessment at 6 to <12 Months,26,,,,,,,,,,,,Refugees,Hedges' g,1.53,95% CI,0.85,2.22,,Asylum Seekers,Hedges' g,0.93,95% CI,0.09,1.77,,Not meeting criteria for PTSD according to CAPS,0.4545,,CAPS score decrease by ≥2 SD of pre-test score,0.6061,,Community,,,1,0.3086,,0.6914,,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",46540,2019
stenmark2013_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,81,A,PTSD,,51,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,51,Structured Clinical Interview,CAPS,CAPS,Completer,Mixed effects model using available data (no imputation),"Mixed-effect model for CAPS, chi-square for PTSD diagnosis",Baseline,,,83.7,15.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.3086,,0.6914,,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",46540,2019
stenmark2013_CAPS_B_0_Comp,Psychotherapy,PTSD,81,B,Control,,21,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,30,Structured Clinical Interview,CAPS,CAPS,Completer,Mixed effects model using available data (no imputation),"Mixed-effect model for CAPS, chi-square for PTSD diagnosis",End of Treatment,0,,,,,,,,,,,,Refugees,Hedges' g,0.42,95% CI,0.33,1.16,,Asylum Seekers,Hedges' g,0.82,95% CI,0.28,1.91,,Not meeting criteria for PTSD according to CAPS,0,,,,,Community,,,1,0.3086,,0.6914,,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",46540,2019
stenmark2013_CAPS_B_26_Comp,Psychotherapy,PTSD,81,B,Control,,21,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,30,Structured Clinical Interview,CAPS,CAPS,Completer,Mixed effects model using available data (no imputation),"Mixed-effect model for CAPS, chi-square for PTSD diagnosis",Assessment at 6 to <12 Months,26,,,,,,,,,,,,Refugees,Hedges' g,0.57,95% CI,0.19,1.33,,Asylum Seekers,Hedges' g,0.31,95% CI,0.75,1.36,,Not meeting criteria for PTSD according to CAPS,0.1905,,CAPS score decrease by ≥2 SD of pre-test score,0.0476,,Community,,,1,0.3086,,0.6914,,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",46540,2019
stenmark2013_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,81,B,Control,,30,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,30,Structured Clinical Interview,CAPS,CAPS,Completer,Mixed effects model using available data (no imputation),"Mixed-effect model for CAPS, chi-square for PTSD diagnosis",Baseline,,,83.67,16.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.3086,,0.6914,,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",46540,2019
suris2013a_CAPS_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,A,PTSD,,27,,Sirolimus + trauma memory reactivation,Sirolimus + imaginal exposure (experimental paradigm),Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,ITT,,"T-tests, ANOVA for continuous variables, Fisher's exact test for response",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,20 point reduction in CAPS total score,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",41233,2019
suris2013a_CAPS_A_12_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,A,PTSD,,27,,Sirolimus + trauma memory reactivation,Sirolimus + imaginal exposure (experimental paradigm),Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,ITT,,"T-tests, ANOVA for continuous variables, Fisher's exact test for response",Assessment at 3 to <6 Months,12,,55.26,22.96,,,,,-16.87,,,,,,,,,,,,,,,,,,,,,20 point reduction in CAPS total score,0.4444,,Veteran,0,1,0,0,,1,Combat-related,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",41233,2019
suris2013a_CAPS_A_4_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,A,PTSD,,27,,Sirolimus + trauma memory reactivation,Sirolimus + imaginal exposure (experimental paradigm),Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,ITT,,"T-tests, ANOVA for continuous variables, Fisher's exact test for response",Assessment at <3 Months,4,,58.27,22.96,,,,,-13.86,,,,,,,,,,,,,,,,,,,,,20 point reduction in CAPS total score,0.4074,,Veteran,0,1,0,0,,1,Combat-related,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",41233,2019
suris2013a_CAPS_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,A,PTSD,,27,,Sirolimus + trauma memory reactivation,Sirolimus + imaginal exposure (experimental paradigm),Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,ITT,,"T-tests, ANOVA for continuous variables, Fisher's exact test for response",Baseline,,,72.13,15.27,,,,,,,,,,,,,,,,,,,,,,,,,,20 point reduction in CAPS total score,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",41233,2019
suris2013a_CAPS_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,B,PTSD,,24,,Placebo + trauma memory reactivation,Imaginal exposure (experimental paradigm) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,ITT,,"T-tests, ANOVA for continuous variables, Fisher's exact test for response",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,20 point reduction in CAPS total score,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",41233,2019
suris2013a_CAPS_B_12_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,B,PTSD,,24,,Placebo + trauma memory reactivation,Imaginal exposure (experimental paradigm) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,ITT,,"T-tests, ANOVA for continuous variables, Fisher's exact test for response",Assessment at 3 to <6 Months,12,,62.63,17.6,,,,,-8,,,,,,,,,,,,,,,,,,,,,20 point reduction in CAPS total score,0.2917,,Veteran,0,1,0,0,,1,Combat-related,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",41233,2019
suris2013a_CAPS_B_4_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,B,PTSD,,24,,Placebo + trauma memory reactivation,Imaginal exposure (experimental paradigm) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,ITT,,"T-tests, ANOVA for continuous variables, Fisher's exact test for response",Assessment at <3 Months,4,,64.54,17.88,,,,,-6.09,,,,,,,,,,,,,,,,,,,,,20 point reduction in CAPS total score,0.1667,,Veteran,0,1,0,0,,1,Combat-related,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",41233,2019
suris2013a_CAPS_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,B,PTSD,,24,,Placebo + trauma memory reactivation,Imaginal exposure (experimental paradigm) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,ITT,,"T-tests, ANOVA for continuous variables, Fisher's exact test for response",Baseline,,,70.63,16.37,,,,,,,,,,,,,,,,,,,,,,,,,,20 point reduction in CAPS total score,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",41233,2019
suris2013a_PCL_A_0_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,A,PTSD,,,,Sirolimus + trauma memory reactivation,Sirolimus + imaginal exposure (experimental paradigm),Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL,,,"T-tests, ANOVA for continuous variables, Fisher's exact test for response",End of Treatment,0,LSM 51.39,,2.02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",41233,2019
suris2013a_PCL_A_16_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,A,PTSD,,,,Sirolimus + trauma memory reactivation,Sirolimus + imaginal exposure (experimental paradigm),Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL,,,"T-tests, ANOVA for continuous variables, Fisher's exact test for response",Assessment at 3 to <6 Months,16,LSM 54.98,,1.99,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",41233,2019
suris2013a_PCL_A_26_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,A,PTSD,,,,Sirolimus + trauma memory reactivation,Sirolimus + imaginal exposure (experimental paradigm),Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL,,,"T-tests, ANOVA for continuous variables, Fisher's exact test for response",Assessment at 6 to <12 Months,26,LSM 50.52,,1.97,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",41233,2019
suris2013a_PCL_A_8_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,A,PTSD,,,,Sirolimus + trauma memory reactivation,Sirolimus + imaginal exposure (experimental paradigm),Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL,,,"T-tests, ANOVA for continuous variables, Fisher's exact test for response",Assessment at <3 Months,8,LSM 52.71,,1.98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",41233,2019
suris2013a_PCL_A_Baseline_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,A,PTSD,,,,Sirolimus + trauma memory reactivation,Sirolimus + imaginal exposure (experimental paradigm),Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL,,,"T-tests, ANOVA for continuous variables, Fisher's exact test for response",Baseline,,LSM 65.53,,1.67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",41233,2019
suris2013a_PCL_B_0_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,B,PTSD,,,,Placebo + trauma memory reactivation,Imaginal exposure (experimental paradigm) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Self report,PCL,PCL,,,"T-tests, ANOVA for continuous variables, Fisher's exact test for response",End of Treatment,0,,57.89,2.18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",41233,2019
suris2013a_PCL_B_16_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,B,PTSD,,,,Placebo + trauma memory reactivation,Imaginal exposure (experimental paradigm) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Self report,PCL,PCL,,,"T-tests, ANOVA for continuous variables, Fisher's exact test for response",Assessment at 3 to <6 Months,16,,55.22,2.15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",41233,2019
suris2013a_PCL_B_26_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,B,PTSD,,,,Placebo + trauma memory reactivation,Imaginal exposure (experimental paradigm) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Self report,PCL,PCL,,,"T-tests, ANOVA for continuous variables, Fisher's exact test for response",Assessment at 6 to <12 Months,26,,56.22,2.17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",41233,2019
suris2013a_PCL_B_8_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,B,PTSD,,,,Placebo + trauma memory reactivation,Imaginal exposure (experimental paradigm) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Self report,PCL,PCL,,,"T-tests, ANOVA for continuous variables, Fisher's exact test for response",Assessment at <3 Months,8,,59.35,2.24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",41233,2019
suris2013a_PCL_B_Baseline_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,B,PTSD,,,,Placebo + trauma memory reactivation,Imaginal exposure (experimental paradigm) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Self report,PCL,PCL,,,"T-tests, ANOVA for continuous variables, Fisher's exact test for response",Baseline,,,65.40,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.",41233,2019
suris2013b_CAPS_A_0_ITT,Psychotherapy,PTSD,129,A,PTSD,,45,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,75,Structured Clinical Interview,CAPS,CAPS,ITT,,Generalized linear mixed model,End of Treatment,0,LSM 64.97,,3.27,,,,,-20.1,,,,,Cohen's d,1.02,95% CI,0.73,1.3,,,,,,,,,,,,,,,Veteran,0,1,0,0.8488,,0.1512,MST,,High,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",87369,2019
suris2013b_CAPS_A_16_ITT,Psychotherapy,PTSD,129,A,PTSD,,46,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,75,Structured Clinical Interview,CAPS,CAPS,ITT,,Generalized linear mixed model,Assessment at 3 to <6 Months,16,LSM 63.96,,3.26,,,,,-21.11,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,0.8488,,0.1512,MST,,High,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",87369,2019
suris2013b_CAPS_A_26_ITT,Psychotherapy,PTSD,129,A,PTSD,,48,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,75,Structured Clinical Interview,CAPS,CAPS,ITT,,Generalized linear mixed model,Assessment at 6 to <12 Months,26,LSM 59.47,,3.23,,,,,-25.6,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,0.8488,,0.1512,MST,,High,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",87369,2019
suris2013b_CAPS_A_8_ITT,Psychotherapy,PTSD,129,A,PTSD,,47,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,75,Structured Clinical Interview,CAPS,CAPS,ITT,,Generalized linear mixed model,Assessment at <3 Months,8,LSM 64.05,,3.13,,,,,-21.02,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,0.8488,,0.1512,MST,,High,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",87369,2019
suris2013b_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,129,A,PTSD,,52,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,75,Structured Clinical Interview,CAPS,CAPS,ITT,,Generalized linear mixed model,Baseline,,LSM 85.07,,2.69,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.8488,,0.1512,MST,,High,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",87369,2019
suris2013b_CAPS_B_0_ITT,Psychotherapy,PTSD,129,B,Control,,44,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,57,Structured Clinical Interview,CAPS,CAPS,ITT,,Generalized linear mixed model,End of Treatment,0,LSM 68.64,,3.61,,,,,-15.17,,,,,Cohen's d,0.8,95% CI,0.52,1.08,,,,,,,,,,,,,,,Veteran,0,1,0,0.8488,,0.1512,MST,,High,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",87369,2019
suris2013b_CAPS_B_16_ITT,Psychotherapy,PTSD,129,B,Control,,43,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,57,Structured Clinical Interview,CAPS,CAPS,ITT,,Generalized linear mixed model,Assessment at 3 to <6 Months,16,LSM 66.35,,3.47,,,,,-17.46,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,0.8488,,0.1512,MST,,High,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",87369,2019
suris2013b_CAPS_B_26_ITT,Psychotherapy,PTSD,129,B,Control,,42,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,57,Structured Clinical Interview,CAPS,CAPS,ITT,,Generalized linear mixed model,Assessment at 6 to <12 Months,26,LSM 61.38,,3.54,,,,,-22.43,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,0.8488,,0.1512,MST,,High,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",87369,2019
suris2013b_CAPS_B_8_ITT,Psychotherapy,PTSD,129,B,Control,,42,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,57,Structured Clinical Interview,CAPS,CAPS,ITT,,Generalized linear mixed model,Assessment at <3 Months,8,LSM 68.15,,3.71,,,,,-15.66,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,0.8488,,0.1512,MST,,High,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",87369,2019
suris2013b_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,129,B,Control,,34,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,57,Structured Clinical Interview,CAPS,CAPS,ITT,,Generalized linear mixed model,Baseline,,LSM 83.81,,3.29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.8488,,0.1512,MST,,High,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",87369,2019
suris2013b_PCL_A_12_NA,Psychotherapy,PTSD,129,A,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,75,Self report,PCL,PCL,,,Generalized linear mixed model,Assessment at 3 to <6 Months,12,,51.07,13.81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.8488,,0.1512,MST,,High,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",87369,2019
suris2013b_PCL_A_4_NA,Psychotherapy,PTSD,129,A,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,75,Self report,PCL,PCL,,,Generalized linear mixed model,Assessment at <3 Months,4,,49.62,13.14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.8488,,0.1512,MST,,High,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",87369,2019
suris2013b_PCL_A_Baseline_NA,Psychotherapy,PTSD,129,A,PTSD,,,,CPT,Cognitive Processing Therapy (CPT),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,75,Self report,PCL,PCL,,,Generalized linear mixed model,Baseline,,,57.19,10.61,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.8488,,0.1512,MST,,High,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",87369,2019
suris2013b_PCL_B_12_NA,Psychotherapy,PTSD,129,B,Control,,,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,57,Self report,PCL,PCL,,,Generalized linear mixed model,Assessment at 3 to <6 Months,12,,54.13,11.23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.8488,,0.1512,MST,,High,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",87369,2019
suris2013b_PCL_B_4_NA,Psychotherapy,PTSD,129,B,Control,,,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,57,Self report,PCL,PCL,,,Generalized linear mixed model,Assessment at <3 Months,4,,55.00,11.85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.8488,,0.1512,MST,,High,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",87369,2019
suris2013b_PCL_B_Baseline_NA,Psychotherapy,PTSD,129,B,Control,,,,PCT,Present Centered Therapy (PCT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,57,Self report,PCL,PCL,,,Generalized linear mixed model,Baseline,,,60.83,10.26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.8488,,0.1512,MST,,High,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",87369,2019
suris2017_PCL_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,A,PTSD,,26,,Dexamethasone + brief trauma memory reactivation task,Dexamethasone + imaginal exposure (experimental paradigm),Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,26,Self report,PCL,PCL,ITT,,Generalized linear mixed models for differences over the course of the study (through 6 months post-treatment); Wilcoxon two-sample rank sum tests to compare baseline to separate followup time points,End of Treatment,0,,47.40,11.21,,,,,-8.95,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",49780,2019
suris2017_PCL_A_12_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,A,PTSD,,26,,Dexamethasone + brief trauma memory reactivation task,Dexamethasone + imaginal exposure (experimental paradigm),Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,26,Self report,PCL,PCL,ITT,,Generalized linear mixed models for differences over the course of the study (through 6 months post-treatment); Wilcoxon two-sample rank sum tests to compare baseline to separate followup time points,Assessment at 3 to <6 Months,12,,46.46,13.5,,,,,-10.57,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",49780,2019
suris2017_PCL_A_26_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,A,PTSD,,26,,Dexamethasone + brief trauma memory reactivation task,Dexamethasone + imaginal exposure (experimental paradigm),Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,26,Self report,PCL,PCL,ITT,,Generalized linear mixed models for differences over the course of the study (through 6 months post-treatment); Wilcoxon two-sample rank sum tests to compare baseline to separate followup time points,Assessment at 6 to <12 Months,26,,47.07,12.92,,,,,-8.53,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",49780,2019
suris2017_PCL_A_4_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,A,PTSD,,26,,Dexamethasone + brief trauma memory reactivation task,Dexamethasone + imaginal exposure (experimental paradigm),Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,26,Self report,PCL,PCL,ITT,,Generalized linear mixed models for differences over the course of the study (through 6 months post-treatment); Wilcoxon two-sample rank sum tests to compare baseline to separate followup time points,Assessment at <3 Months,4,,49.6,13.02,,,,,-6.85,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",49780,2019
suris2017_PCL_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,A,PTSD,,26,,Dexamethasone + brief trauma memory reactivation task,Dexamethasone + imaginal exposure (experimental paradigm),Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,26,Self report,PCL,PCL,ITT,,Generalized linear mixed models for differences over the course of the study (through 6 months post-treatment); Wilcoxon two-sample rank sum tests to compare baseline to separate followup time points,Baseline,,,56.35,10.98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",49780,2019
suris2017_PCL_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,B,Control,,28,,Placebo + brief trauma memory reactivation task,Imaginal exposure (experimental paradigm),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,28,Self report,PCL,PCL,ITT,,Generalized linear mixed models for differences over the course of the study (through 6 months post-treatment); Wilcoxon two-sample rank sum tests to compare baseline to separate followup time points,End of Treatment,0,,51.45,14.94,,,,,-3.94,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",49780,2019
suris2017_PCL_B_12_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,B,Control,,28,,Placebo + brief trauma memory reactivation task,Imaginal exposure (experimental paradigm),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,28,Self report,PCL,PCL,ITT,,Generalized linear mixed models for differences over the course of the study (through 6 months post-treatment); Wilcoxon two-sample rank sum tests to compare baseline to separate followup time points,Assessment at 3 to <6 Months,12,,51.94,12.23,,,,,-3.96,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",49780,2019
suris2017_PCL_B_26_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,B,Control,,28,,Placebo + brief trauma memory reactivation task,Imaginal exposure (experimental paradigm),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,28,Self report,PCL,PCL,ITT,,Generalized linear mixed models for differences over the course of the study (through 6 months post-treatment); Wilcoxon two-sample rank sum tests to compare baseline to separate followup time points,Assessment at 6 to <12 Months,26,,48.41,12.98,,,,,-4.58,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",49780,2019
suris2017_PCL_B_4_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,B,Control,,28,,Placebo + brief trauma memory reactivation task,Imaginal exposure (experimental paradigm),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,28,Self report,PCL,PCL,ITT,,Generalized linear mixed models for differences over the course of the study (through 6 months post-treatment); Wilcoxon two-sample rank sum tests to compare baseline to separate followup time points,Assessment at <3 Months,4,,52.24,11.25,,,,,-2.33,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",49780,2019
suris2017_PCL_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,54,B,Control,,,,Placebo + brief trauma memory reactivation task,Imaginal exposure (experimental paradigm),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,28,Self report,PCL,PCL,ITT,,Generalized linear mixed models for differences over the course of the study (through 6 months post-treatment); Wilcoxon two-sample rank sum tests to compare baseline to separate followup time points,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Suris A, Link-Malcolm J, Chard K, et al. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. PMID: 23325750.",49780,2019
talbot2014_CAPS_A_26_NA,Psychotherapy,PTSD,45,A,PTSD,,,,CBT for insomnia,Cognitive Behavioral Therapy for Insomnia (CBT-I),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,29,Structured Clinical Interview,CAPS,CAPS (excluding sleep symptoms B2 and D1),,,Generalized linear mixed models for differences over the course of the study (through 6 months post-treatment); Wilcoxon two-sample rank sum tests to compare baseline to separate followup time points,Assessment at 6 to <12 Months,26,,,,,,,mean decrease 27.5,,,,,,Cohen's d,1.23,,,,p<0.001,,,,,,,,,,,,,,Mixed,,0.2,0.8,0.6889,,0.3111,,,Low,"Talbot LS, Maguen S, Metzler TJ, et al. Cognitive behavioral therapy for insomnia in posttraumatic stress disorder: a randomized controlled trial. Sleep. 2014 Feb 1;37(3):327-41. doi: 10.5665/sleep.3408. PMID: 24497661.",42060,2020
talbot2014_CAPS_A_Baseline_NA,Psychotherapy,PTSD,45,A,PTSD,,29,,CBT for insomnia,Cognitive Behavioral Therapy for Insomnia (CBT-I),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,29,Structured Clinical Interview,CAPS,CAPS (excluding sleep symptoms B2 and D1),,,Generalized linear mixed models for differences over the course of the study (through 6 months post-treatment); Wilcoxon two-sample rank sum tests to compare baseline to separate followup time points,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.2,0.8,0.6889,,0.3111,,,Low,"Talbot LS, Maguen S, Metzler TJ, et al. Cognitive behavioral therapy for insomnia in posttraumatic stress disorder: a randomized controlled trial. Sleep. 2014 Feb 1;37(3):327-41. doi: 10.5665/sleep.3408. PMID: 24497661.",42060,2020
talbot2014_CAPS_B_0_NA,Psychotherapy,PTSD,45,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,16,Structured Clinical Interview,CAPS,CAPS (excluding sleep symptoms B2 and D1),,,Generalized linear mixed models for differences over the course of the study (through 6 months post-treatment); Wilcoxon two-sample rank sum tests to compare baseline to separate followup time points,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.2,0.8,0.6889,,0.3111,,,Low,"Talbot LS, Maguen S, Metzler TJ, et al. Cognitive behavioral therapy for insomnia in posttraumatic stress disorder: a randomized controlled trial. Sleep. 2014 Feb 1;37(3):327-41. doi: 10.5665/sleep.3408. PMID: 24497661.",42060,2020
talbot2014_CAPS_B_Baseline_NA,Psychotherapy,PTSD,45,B,Control,,16,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,16,Structured Clinical Interview,CAPS,CAPS (excluding sleep symptoms B2 and D1),,,Generalized linear mixed models for differences over the course of the study (through 6 months post-treatment); Wilcoxon two-sample rank sum tests to compare baseline to separate followup time points,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.2,0.8,0.6889,,0.3111,,,Low,"Talbot LS, Maguen S, Metzler TJ, et al. Cognitive behavioral therapy for insomnia in posttraumatic stress disorder: a randomized controlled trial. Sleep. 2014 Feb 1;37(3):327-41. doi: 10.5665/sleep.3408. PMID: 24497661.",42060,2020
talbot2014_PCL_A_0_NA,Psychotherapy,PTSD,45,A,PTSD,,,,CBT for insomnia,Cognitive Behavioral Therapy for Insomnia (CBT-I),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,29,Self report,PCL,PCL (excluding sleep items #2 and #13,,,Generalized linear mixed models for differences over the course of the study (through 6 months post-treatment); Wilcoxon two-sample rank sum tests to compare baseline to separate followup time points,End of Treatment,0,,32.96,1.65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.2,0.8,0.6889,,0.3111,,,Low,"Talbot LS, Maguen S, Metzler TJ, et al. Cognitive behavioral therapy for insomnia in posttraumatic stress disorder: a randomized controlled trial. Sleep. 2014 Feb 1;37(3):327-41. doi: 10.5665/sleep.3408. PMID: 24497661.",42060,2020
talbot2014_PCL_A_Baseline_NA,Psychotherapy,PTSD,45,A,PTSD,,,,CBT for insomnia,Cognitive Behavioral Therapy for Insomnia (CBT-I),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,29,Self report,PCL,PCL (excluding sleep items #2 and #13,,,Generalized linear mixed models for differences over the course of the study (through 6 months post-treatment); Wilcoxon two-sample rank sum tests to compare baseline to separate followup time points,Baseline,,,43.69,,SE,1.85,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.2,0.8,0.6889,,0.3111,,,Low,"Talbot LS, Maguen S, Metzler TJ, et al. Cognitive behavioral therapy for insomnia in posttraumatic stress disorder: a randomized controlled trial. Sleep. 2014 Feb 1;37(3):327-41. doi: 10.5665/sleep.3408. PMID: 24497661.",42060,2020
talbot2014_PCL_B_0_NA,Psychotherapy,PTSD,45,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,16,Self report,PCL,PCL (excluding sleep items #2 and #13,,,Generalized linear mixed models for differences over the course of the study (through 6 months post-treatment); Wilcoxon two-sample rank sum tests to compare baseline to separate followup time points,End of Treatment,0,,39.43,2.87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.2,0.8,0.6889,,0.3111,,,Low,"Talbot LS, Maguen S, Metzler TJ, et al. Cognitive behavioral therapy for insomnia in posttraumatic stress disorder: a randomized controlled trial. Sleep. 2014 Feb 1;37(3):327-41. doi: 10.5665/sleep.3408. PMID: 24497661.",42060,2020
talbot2014_PCL_B_Baseline_NA,Psychotherapy,PTSD,45,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,16,Self report,PCL,PCL (excluding sleep items #2 and #13,,,Generalized linear mixed models for differences over the course of the study (through 6 months post-treatment); Wilcoxon two-sample rank sum tests to compare baseline to separate followup time points,Baseline,,,43.69,,SE,1.85,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.2,0.8,0.6889,,0.3111,,,Low,"Talbot LS, Maguen S, Metzler TJ, et al. Cognitive behavioral therapy for insomnia in posttraumatic stress disorder: a randomized controlled trial. Sleep. 2014 Feb 1;37(3):327-41. doi: 10.5665/sleep.3408. PMID: 24497661.",42060,2020
tarrier1999a_CAPS_A_0_Comp,Psychotherapy,PTSD,72,A,PTSD,,29,,Imaginal exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,35,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,End of Treatment,0,,48.24,30.25,,,,,-22.9,,,,,Effect size,0.9,,,,p<0.05,,,,,,,,Not meeting criteria for PTSD according to CAPS for DSM-III,0.5862,,Assessor-rated CAPS Global Severity scale as 0 or 1,0.4138,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5806,treatment completers only,0.4194,Mixed,"accidents, other (crime, not specified)",Medium,"Tarrier N, Pilgrim H, Sommerfield C, et al. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol. 1999 Feb;67(1):13-8. doi: 10.1037//0022-006X.67.1.13. PMID: 10028204.",09173,2019
tarrier1999a_CAPS_A_26_Comp,Psychotherapy,PTSD,72,A,PTSD,,27,,Imaginal exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,35,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,Assessment at 6 to <12 Months,26,,52.11,23.78,,,,,-19.03,,,,,,,,,,p<0.05,,,,,,,,Not meeting criteria for PTSD according to CAPS for DSM-III,0.5185,,Assessor-rated CAPS Global Severity scale as 0 or 1,0.2593,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.5806,treatment completers only,0.4194,Mixed,"accidents, other (crime, not specified)",Medium,"Tarrier N, Pilgrim H, Sommerfield C, et al. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol. 1999 Feb;67(1):13-8. doi: 10.1037//0022-006X.67.1.13. PMID: 10028204.",09173,2019
tarrier1999a_CAPS_A_52_Comp,Psychotherapy,PTSD,72,A,PTSD,,25,,Imaginal exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,35,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,Assessment at ≥12 Months,52,,45.16,28.26,,,,,-25.98,,,,,Effect size,0.88,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS for DSM-III,,,,,,Community,,,1,0.5806,treatment completers only,0.4194,Mixed,"accidents, other (crime, not specified)",Medium,"Tarrier N, Pilgrim H, Sommerfield C, et al. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol. 1999 Feb;67(1):13-8. doi: 10.1037//0022-006X.67.1.13. PMID: 10028204.",09173,2019
tarrier1999a_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,72,A,PTSD,,35,,Imaginal exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,35,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,Baseline,,,71.14,18.98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5806,treatment completers only,0.4194,Mixed,"accidents, other (crime, not specified)",Medium,"Tarrier N, Pilgrim H, Sommerfield C, et al. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol. 1999 Feb;67(1):13-8. doi: 10.1037//0022-006X.67.1.13. PMID: 10028204.",09173,2019
tarrier1999a_CAPS_B_0_Comp,Psychotherapy,PTSD,72,B,PTSD,,33,,Cognitive therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,End of Treatment,0,,50.82,23.99,,,,,-26.94,,,,,Effect size,1.3,,,,p<0.05,,,,,,,,Not meeting criteria for PTSD according to CAPS for DSM-III,0.4242,,Assessor-rated CAPS Global Severity scale as 0 or 1,0.3333,,Community,,,1,0.5806,treatment completers only,0.4194,Mixed,"accidents, other (crime, not specified)",Medium,"Tarrier N, Pilgrim H, Sommerfield C, et al. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol. 1999 Feb;67(1):13-8. doi: 10.1037//0022-006X.67.1.13. PMID: 10028204.",09173,2019
tarrier1999a_CAPS_B_26_Comp,Psychotherapy,PTSD,72,B,PTSD,,29,,Cognitive therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,Assessment at 6 to <12 Months,26,,50.21,24.37,,,,,-27.55,,,,,,,,,,p<0.05,,,,,,,,Not meeting criteria for PTSD according to CAPS for DSM-III,0.4828,,Assessor-rated CAPS Global Severity scale as 0 or 1,0.3448,,Community,,,1,0.5806,treatment completers only,0.4194,Mixed,"accidents, other (crime, not specified)",Medium,"Tarrier N, Pilgrim H, Sommerfield C, et al. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol. 1999 Feb;67(1):13-8. doi: 10.1037//0022-006X.67.1.13. PMID: 10028204.",09173,2019
tarrier1999a_CAPS_B_52_Comp,Psychotherapy,PTSD,72,B,PTSD,,29,,Cognitive therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,Assessment at ≥12 Months,52,,52.48,24.09,,,,,-25.28,,,,,Effect size,1.06,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS for DSM-III,,,,,,Community,,,1,0.5806,treatment completers only,0.4194,Mixed,"accidents, other (crime, not specified)",Medium,"Tarrier N, Pilgrim H, Sommerfield C, et al. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol. 1999 Feb;67(1):13-8. doi: 10.1037//0022-006X.67.1.13. PMID: 10028204.",09173,2019
tarrier1999a_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,72,B,PTSD,,37,,Cognitive therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,Baseline,,,77.76,14.95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5806,treatment completers only,0.4194,Mixed,"accidents, other (crime, not specified)",Medium,"Tarrier N, Pilgrim H, Sommerfield C, et al. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol. 1999 Feb;67(1):13-8. doi: 10.1037//0022-006X.67.1.13. PMID: 10028204.",09173,2019
tarrier1999a_Penn_A_0_NA,Psychotherapy,PTSD,72,A,PTSD,,,,Imaginal exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,35,Self report,Penn Inventory,Penn Inventory,,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,End of Treatment,0,,34.43,14.69,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5806,treatment completers only,0.4194,Mixed,"accidents, other (crime, not specified)",Medium,"Tarrier N, Pilgrim H, Sommerfield C, et al. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol. 1999 Feb;67(1):13-8. doi: 10.1037//0022-006X.67.1.13. PMID: 10028204.",09173,2019
tarrier1999a_Penn_A_26_NA,Psychotherapy,PTSD,72,A,PTSD,,,,Imaginal exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,35,Self report,Penn Inventory,Penn Inventory,,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,Assessment at 6 to <12 Months,26,,41.78,12.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5806,treatment completers only,0.4194,Mixed,"accidents, other (crime, not specified)",Medium,"Tarrier N, Pilgrim H, Sommerfield C, et al. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol. 1999 Feb;67(1):13-8. doi: 10.1037//0022-006X.67.1.13. PMID: 10028204.",09173,2019
tarrier1999a_Penn_A_52_NA,Psychotherapy,PTSD,72,A,PTSD,,,,Imaginal exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,35,Self report,Penn Inventory,Penn Inventory,,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,Assessment at ≥12 Months,52,,41.04,14.08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5806,treatment completers only,0.4194,Mixed,"accidents, other (crime, not specified)",Medium,"Tarrier N, Pilgrim H, Sommerfield C, et al. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol. 1999 Feb;67(1):13-8. doi: 10.1037//0022-006X.67.1.13. PMID: 10028204.",09173,2019
tarrier1999a_Penn_A_Baseline_NA,Psychotherapy,PTSD,72,A,PTSD,,,,Imaginal exposure therapy,Exposure therapy,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,35,Self report,Penn Inventory,Penn Inventory,,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,Baseline,,,47.28,10.96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5806,treatment completers only,0.4194,Mixed,"accidents, other (crime, not specified)",Medium,"Tarrier N, Pilgrim H, Sommerfield C, et al. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol. 1999 Feb;67(1):13-8. doi: 10.1037//0022-006X.67.1.13. PMID: 10028204.",09173,2019
tarrier1999a_Penn_B_0_NA,Psychotherapy,PTSD,72,B,PTSD,,,,Cognitive therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Self report,Penn Inventory,Penn Inventory,,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,End of Treatment,0,,36.09,15.46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5806,treatment completers only,0.4194,Mixed,"accidents, other (crime, not specified)",Medium,"Tarrier N, Pilgrim H, Sommerfield C, et al. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol. 1999 Feb;67(1):13-8. doi: 10.1037//0022-006X.67.1.13. PMID: 10028204.",09173,2019
tarrier1999a_Penn_B_26_NA,Psychotherapy,PTSD,72,B,PTSD,,,,Cognitive therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Self report,Penn Inventory,Penn Inventory,,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,Assessment at 6 to <12 Months,26,,37.24,15.76,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5806,treatment completers only,0.4194,Mixed,"accidents, other (crime, not specified)",Medium,"Tarrier N, Pilgrim H, Sommerfield C, et al. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol. 1999 Feb;67(1):13-8. doi: 10.1037//0022-006X.67.1.13. PMID: 10028204.",09173,2019
tarrier1999a_Penn_B_52_NA,Psychotherapy,PTSD,72,B,PTSD,,,,Cognitive therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Self report,Penn Inventory,Penn Inventory,,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,Assessment at ≥12 Months,52,,38.39,15.12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5806,treatment completers only,0.4194,Mixed,"accidents, other (crime, not specified)",Medium,"Tarrier N, Pilgrim H, Sommerfield C, et al. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol. 1999 Feb;67(1):13-8. doi: 10.1037//0022-006X.67.1.13. PMID: 10028204.",09173,2019
tarrier1999a_Penn_B_Baseline_NA,Psychotherapy,PTSD,72,B,PTSD,,,,Cognitive therapy,Cognitive Therapy for PTSD (CT-PTSD),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Self report,Penn Inventory,Penn Inventory,,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,Baseline,,,46.52,12.98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5806,treatment completers only,0.4194,Mixed,"accidents, other (crime, not specified)",Medium,"Tarrier N, Pilgrim H, Sommerfield C, et al. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol. 1999 Feb;67(1):13-8. doi: 10.1037//0022-006X.67.1.13. PMID: 10028204.",09173,2019
taylor2003a_CAPS_A_0_Comp,Mixed: Psychotherapy & CIH,PTSD,60,A,PTSD,,15,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,22,Structured Clinical Interview,CAPS,CAPS subscales,Completer,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,No longer meeting DSM-IV-TR criteria for PTSD,0.8667,,≥2 standard deviation reduction in score from baseline,,,Community,0,0,1,0.75,,0.25,Mixed,"rape/sexual assault, accidents, community/school violence",Medium,"Taylor S, Thordarson DS, Maxfield L, et al. Comparative efficacy, speed, and adverse effects of three PTSD treatments: exposure therapy, EMDR, and relaxation training. J Consult Clin Psychol. 2003a Apr;71(2):330-8. doi: 10.1037/0022-006X.71.2.330. PMID: 12699027.",25484,2020
taylor2003a_CAPS_A_12_Comp,Mixed: Psychotherapy & CIH,PTSD,60,A,PTSD,,15,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,22,Structured Clinical Interview,CAPS,CAPS subscales,Completer,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,No longer meeting DSM-IV-TR criteria for PTSD,0.8667,,≥2 standard deviation reduction in score from baseline,,,Community,0,0,1,0.75,,0.25,Mixed,"rape/sexual assault, accidents, community/school violence",Medium,"Taylor S, Thordarson DS, Maxfield L, et al. Comparative efficacy, speed, and adverse effects of three PTSD treatments: exposure therapy, EMDR, and relaxation training. J Consult Clin Psychol. 2003a Apr;71(2):330-8. doi: 10.1037/0022-006X.71.2.330. PMID: 12699027.",25484,2020
taylor2003a_CAPS_A_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,60,A,PTSD,,22,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,22,Structured Clinical Interview,CAPS,CAPS subscales,Completer,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.75,,0.25,Mixed,"rape/sexual assault, accidents, community/school violence",Medium,"Taylor S, Thordarson DS, Maxfield L, et al. Comparative efficacy, speed, and adverse effects of three PTSD treatments: exposure therapy, EMDR, and relaxation training. J Consult Clin Psychol. 2003a Apr;71(2):330-8. doi: 10.1037/0022-006X.71.2.330. PMID: 12699027.",25484,2020
taylor2003a_CAPS_B_0_Comp,Mixed: Psychotherapy & CIH,PTSD,60,B,PTSD,,15,,Relaxation training,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,19,Structured Clinical Interview,CAPS,CAPS subscales,Completer,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,No longer meeting DSM-IV-TR criteria for PTSD,0.4,,≥2 standard deviation reduction in score from baseline,,,Community,0,0,1,0.75,,0.25,Mixed,"rape/sexual assault, accidents, community/school violence",Medium,"Taylor S, Thordarson DS, Maxfield L, et al. Comparative efficacy, speed, and adverse effects of three PTSD treatments: exposure therapy, EMDR, and relaxation training. J Consult Clin Psychol. 2003a Apr;71(2):330-8. doi: 10.1037/0022-006X.71.2.330. PMID: 12699027.",25484,2020
taylor2003a_CAPS_B_12_Comp,Mixed: Psychotherapy & CIH,PTSD,60,B,PTSD,,15,,Relaxation training,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,19,Structured Clinical Interview,CAPS,CAPS subscales,Completer,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,No longer meeting DSM-IV-TR criteria for PTSD,0.4667,,≥2 standard deviation reduction in score from baseline,,,Community,0,0,1,0.75,,0.25,Mixed,"rape/sexual assault, accidents, community/school violence",Medium,"Taylor S, Thordarson DS, Maxfield L, et al. Comparative efficacy, speed, and adverse effects of three PTSD treatments: exposure therapy, EMDR, and relaxation training. J Consult Clin Psychol. 2003a Apr;71(2):330-8. doi: 10.1037/0022-006X.71.2.330. PMID: 12699027.",25484,2020
taylor2003a_CAPS_B_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,60,B,PTSD,,19,,Relaxation training,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,19,Structured Clinical Interview,CAPS,CAPS subscales,Completer,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.75,,0.25,Mixed,"rape/sexual assault, accidents, community/school violence",Medium,"Taylor S, Thordarson DS, Maxfield L, et al. Comparative efficacy, speed, and adverse effects of three PTSD treatments: exposure therapy, EMDR, and relaxation training. J Consult Clin Psychol. 2003a Apr;71(2):330-8. doi: 10.1037/0022-006X.71.2.330. PMID: 12699027.",25484,2020
taylor2003a_CAPS_C_0_Comp,Mixed: Psychotherapy & CIH,PTSD,60,C,PTSD,,15,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,19,Structured Clinical Interview,CAPS,CAPS subscales,Completer,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,No longer meeting DSM-IV-TR criteria for PTSD,0.6,,≥2 standard deviation reduction in score from baseline,,,Community,0,0,1,0.75,,0.25,Mixed,"rape/sexual assault, accidents, community/school violence",Medium,"Taylor S, Thordarson DS, Maxfield L, et al. Comparative efficacy, speed, and adverse effects of three PTSD treatments: exposure therapy, EMDR, and relaxation training. J Consult Clin Psychol. 2003a Apr;71(2):330-8. doi: 10.1037/0022-006X.71.2.330. PMID: 12699027.",25484,2020
taylor2003a_CAPS_C_12_Comp,Mixed: Psychotherapy & CIH,PTSD,60,C,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,19,Structured Clinical Interview,CAPS,CAPS subscales,Completer,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,No longer meeting DSM-IV-TR criteria for PTSD,0.6667,,≥2 standard deviation reduction in score from baseline,,,Community,0,0,1,0.75,,0.25,Mixed,"rape/sexual assault, accidents, community/school violence",Medium,"Taylor S, Thordarson DS, Maxfield L, et al. Comparative efficacy, speed, and adverse effects of three PTSD treatments: exposure therapy, EMDR, and relaxation training. J Consult Clin Psychol. 2003a Apr;71(2):330-8. doi: 10.1037/0022-006X.71.2.330. PMID: 12699027.",25484,2020
taylor2003a_CAPS_C_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,60,C,PTSD,,19,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,19,Structured Clinical Interview,CAPS,CAPS subscales,Completer,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.75,,0.25,Mixed,"rape/sexual assault, accidents, community/school violence",Medium,"Taylor S, Thordarson DS, Maxfield L, et al. Comparative efficacy, speed, and adverse effects of three PTSD treatments: exposure therapy, EMDR, and relaxation training. J Consult Clin Psychol. 2003a Apr;71(2):330-8. doi: 10.1037/0022-006X.71.2.330. PMID: 12699027.",25484,2020
taylor2008_PCL-C_A_0_ITT,Pharmacotherapy,PTSD,13,A,PTSD,,13,,Prazosin,Prazosin,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PCL-C,PCL-C,ITT,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,End of Treatment,0,,51,14,,,,,-7,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8462,,0.1538,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence",High,"Taylor FB, Martin P, Thompson C, et al. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study. Biol Psychiatry. 2008 Mar 15;63(6):629-32. doi: 10.1016/j.biopsych.2007.07.001. PMID: 17868655.",1548486,2019
taylor2008_PCL-C_A_Baseline_ITT,Pharmacotherapy,PTSD,13,A,PTSD,,13,,Prazosin,Prazosin,No,Not Applicable,Yes,Antiadrenergic,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PCL-C,PCL-C,ITT,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,Baseline,,,58,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8462,,0.1538,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence",High,"Taylor FB, Martin P, Thompson C, et al. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study. Biol Psychiatry. 2008 Mar 15;63(6):629-32. doi: 10.1016/j.biopsych.2007.07.001. PMID: 17868655.",1548486,2019
taylor2008_PCL-C_B_0_ITT,Pharmacotherapy,PTSD,13,B,Control,,13,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,13,Self report,PCL-C,PCL-C,ITT,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,End of Treatment,0,,55,15,,,,,-1,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8462,,0.1538,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence",High,"Taylor FB, Martin P, Thompson C, et al. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study. Biol Psychiatry. 2008 Mar 15;63(6):629-32. doi: 10.1016/j.biopsych.2007.07.001. PMID: 17868655.",1548486,2019
taylor2008_PCL-C_B_Baseline_ITT,Pharmacotherapy,PTSD,13,B,Control,,13,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,13,Self report,PCL-C,PCL-C,ITT,,Repeated measures ANOVA (baseline through 6-month followup); ANCOVA (12-month followup); chi-squared for dichotomous outcomes,Baseline,,,56,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8462,,0.1538,Mixed,"child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence",High,"Taylor FB, Martin P, Thompson C, et al. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study. Biol Psychiatry. 2008 Mar 15;63(6):629-32. doi: 10.1016/j.biopsych.2007.07.001. PMID: 17868655.",1548486,2019
terheide2016_CAPS_A_0_Comp,Psychotherapy,PTSD,72,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,Completer,Listwise deletion,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.3636,,≥10-point improvement on CAPS,,,Community,,,1,0.2778,,0.7222,Mixed,"terrorism/political violence/forced displacement, community/school violence",Low,"Ter Heide FJJ, Mooren TM, Van de Schoot R, et al. Eye Movement Desensitisation and Reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial. Br J Psychiatry. 2016 Oct;209(4):311-8. doi: 10.1192/bjp.bp.115.167775. PMID: 26892849.",45021,2019
terheide2016_CAPS_A_0_ITT,Psychotherapy,PTSD,72,A,PTSD,,32,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using Bayesian statistics,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,unimputed,67.38,23.16,,,,,-7.31,,,,,,,,,,,,,,,,,,,,,≥10-point improvement on CAPS,,,Community,,,1,0.2778,,0.7222,Mixed,"terrorism/political violence/forced displacement, community/school violence",Low,"Ter Heide FJJ, Mooren TM, Van de Schoot R, et al. Eye Movement Desensitisation and Reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial. Br J Psychiatry. 2016 Oct;209(4):311-8. doi: 10.1192/bjp.bp.115.167775. PMID: 26892849.",45021,2019
terheide2016_CAPS_A_12_Comp,Psychotherapy,PTSD,72,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,Completer,Listwise deletion,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.1875,,≥10-point improvement on CAPS,0.4063,,Community,,,1,0.2778,,0.7222,Mixed,"terrorism/political violence/forced displacement, community/school violence",Low,"Ter Heide FJJ, Mooren TM, Van de Schoot R, et al. Eye Movement Desensitisation and Reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial. Br J Psychiatry. 2016 Oct;209(4):311-8. doi: 10.1192/bjp.bp.115.167775. PMID: 26892849.",45021,2019
terheide2016_CAPS_A_12_ITT,Psychotherapy,PTSD,72,A,PTSD,,32,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using Bayesian statistics,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Assessment at 3 to <6 Months,12,unimputed,69.94,25.07,,,,unimputed,-4.75,,,,unimputed,Cohen's d,0.19,95% CI,-0.16,0.54,p=NS,,,,,,,,,,,≥10-point improvement on CAPS,,,Community,,,1,0.2778,,0.7222,Mixed,"terrorism/political violence/forced displacement, community/school violence",Low,"Ter Heide FJJ, Mooren TM, Van de Schoot R, et al. Eye Movement Desensitisation and Reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial. Br J Psychiatry. 2016 Oct;209(4):311-8. doi: 10.1192/bjp.bp.115.167775. PMID: 26892849.",45021,2019
terheide2016_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,72,A,PTSD,,36,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using Bayesian statistics,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,unimputed,74.69,18.01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.2778,,0.7222,Mixed,"terrorism/political violence/forced displacement, community/school violence",Low,"Ter Heide FJJ, Mooren TM, Van de Schoot R, et al. Eye Movement Desensitisation and Reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial. Br J Psychiatry. 2016 Oct;209(4):311-8. doi: 10.1192/bjp.bp.115.167775. PMID: 26892849.",45021,2019
terheide2016_CAPS_B_0_Comp,Psychotherapy,PTSD,72,B,PTSD,,,,Stabilization,Stabilization,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,Completer,Listwise deletion,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.3103,,≥10-point improvement on CAPS,,,Community,,,1,0.2778,,0.7222,Mixed,"terrorism/political violence/forced displacement, community/school violence",Low,"Ter Heide FJJ, Mooren TM, Van de Schoot R, et al. Eye Movement Desensitisation and Reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial. Br J Psychiatry. 2016 Oct;209(4):311-8. doi: 10.1192/bjp.bp.115.167775. PMID: 26892849.",45021,2019
terheide2016_CAPS_B_0_ITT,Psychotherapy,PTSD,72,B,PTSD,,29,,Stabilization,Stabilization,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using Bayesian statistics,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,unimputed,68.86,26.93,,,,unimputed,-9.39,,,,,,,,,,,,,,,,,,,,,≥10-point improvement on CAPS,,,Community,,,1,0.2778,,0.7222,Mixed,"terrorism/political violence/forced displacement, community/school violence",Low,"Ter Heide FJJ, Mooren TM, Van de Schoot R, et al. Eye Movement Desensitisation and Reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial. Br J Psychiatry. 2016 Oct;209(4):311-8. doi: 10.1192/bjp.bp.115.167775. PMID: 26892849.",45021,2019
terheide2016_CAPS_B_12_Comp,Psychotherapy,PTSD,72,B,PTSD,,,,Stabilization,Stabilization,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,Completer,Listwise deletion,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Assessment at 3 to <6 Months,12,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.2903,,≥10-point improvement on CAPS,0.4194,,Community,,,1,0.2778,,0.7222,Mixed,"terrorism/political violence/forced displacement, community/school violence",Low,"Ter Heide FJJ, Mooren TM, Van de Schoot R, et al. Eye Movement Desensitisation and Reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial. Br J Psychiatry. 2016 Oct;209(4):311-8. doi: 10.1192/bjp.bp.115.167775. PMID: 26892849.",45021,2019
terheide2016_CAPS_B_12_ITT,Psychotherapy,PTSD,72,B,PTSD,,31,,Stabilization,Stabilization,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using Bayesian statistics,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Assessment at 3 to <6 Months,12,unimputed,69.55,25.05,,,,unimputed,-8.7,,,,unimputed,Cohen's d,0.3,95% CI,-0.06,0.66,p=NS,,,,,,,,,,,≥10-point improvement on CAPS,,,Community,,,1,0.2778,,0.7222,Mixed,"terrorism/political violence/forced displacement, community/school violence",Low,"Ter Heide FJJ, Mooren TM, Van de Schoot R, et al. Eye Movement Desensitisation and Reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial. Br J Psychiatry. 2016 Oct;209(4):311-8. doi: 10.1192/bjp.bp.115.167775. PMID: 26892849.",45021,2019
terheide2016_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,72,B,PTSD,,36,,Stabilization,Stabilization,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using Bayesian statistics,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,unimputed,78.25,18.34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.2778,,0.7222,Mixed,"terrorism/political violence/forced displacement, community/school violence",Low,"Ter Heide FJJ, Mooren TM, Van de Schoot R, et al. Eye Movement Desensitisation and Reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial. Br J Psychiatry. 2016 Oct;209(4):311-8. doi: 10.1192/bjp.bp.115.167775. PMID: 26892849.",45021,2019
terheide2016_HTQ_A_12_ITT,Psychotherapy,PTSD,72,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Self report,HTQ,HTQ,ITT,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Assessment at 3 to <6 Months,12,,2.73,0.63,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.2778,,0.7222,Mixed,"terrorism/political violence/forced displacement, community/school violence",Low,"Ter Heide FJJ, Mooren TM, Van de Schoot R, et al. Eye Movement Desensitisation and Reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial. Br J Psychiatry. 2016 Oct;209(4):311-8. doi: 10.1192/bjp.bp.115.167775. PMID: 26892849.",45021,2019
terheide2016_HTQ_A_2_ITT,Psychotherapy,PTSD,72,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Self report,HTQ,HTQ,ITT,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Assessment at <3 Months,2,,2.63,0.57,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.2778,,0.7222,Mixed,"terrorism/political violence/forced displacement, community/school violence",Low,"Ter Heide FJJ, Mooren TM, Van de Schoot R, et al. Eye Movement Desensitisation and Reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial. Br J Psychiatry. 2016 Oct;209(4):311-8. doi: 10.1192/bjp.bp.115.167775. PMID: 26892849.",45021,2019
terheide2016_HTQ_A_Baseline_ITT,Psychotherapy,PTSD,72,A,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Self report,HTQ,HTQ,ITT,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,,2.86,0.45,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.2778,,0.7222,Mixed,"terrorism/political violence/forced displacement, community/school violence",Low,"Ter Heide FJJ, Mooren TM, Van de Schoot R, et al. Eye Movement Desensitisation and Reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial. Br J Psychiatry. 2016 Oct;209(4):311-8. doi: 10.1192/bjp.bp.115.167775. PMID: 26892849.",45021,2019
terheide2016_HTQ_B_12_ITT,Psychotherapy,PTSD,72,B,PTSD,,,,Stabilization,Stabilization,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,37,Self report,HTQ,HTQ,ITT,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Assessment at 3 to <6 Months,12,unimputed,2.76,0.62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.2778,,0.7222,Mixed,"terrorism/political violence/forced displacement, community/school violence",Low,"Ter Heide FJJ, Mooren TM, Van de Schoot R, et al. Eye Movement Desensitisation and Reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial. Br J Psychiatry. 2016 Oct;209(4):311-8. doi: 10.1192/bjp.bp.115.167775. PMID: 26892849.",45021,2019
terheide2016_HTQ_B_2_ITT,Psychotherapy,PTSD,72,B,PTSD,,,,Stabilization,Stabilization,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,37,Self report,HTQ,HTQ,ITT,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Assessment at <3 Months,2,unimputed,2.79,0.62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.2778,,0.7222,Mixed,"terrorism/political violence/forced displacement, community/school violence",Low,"Ter Heide FJJ, Mooren TM, Van de Schoot R, et al. Eye Movement Desensitisation and Reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial. Br J Psychiatry. 2016 Oct;209(4):311-8. doi: 10.1192/bjp.bp.115.167775. PMID: 26892849.",45021,2019
terheide2016_HTQ_B_Baseline_ITT,Psychotherapy,PTSD,72,B,PTSD,,,,Stabilization,Stabilization,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,37,Self report,HTQ,HTQ,ITT,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,unimputed,2.90,0.51,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.2778,,0.7222,Mixed,"terrorism/political violence/forced displacement, community/school violence",Low,"Ter Heide FJJ, Mooren TM, Van de Schoot R, et al. Eye Movement Desensitisation and Reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial. Br J Psychiatry. 2016 Oct;209(4):311-8. doi: 10.1192/bjp.bp.115.167775. PMID: 26892849.",45021,2019
thorp2019_CAPS_A_0_ITT,Mixed: Psychotherapy & CIH,PTSD,87,A,PTSD,,29,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,41,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,48.48,24.59,,,,,-17.59,,,,,Cohen's d,0.89,,,,,,,,,,,,CAPS for DSM-IV-TR using 1/2 rule,,,15-point change on CAPS,,,Veteran,0,1,0,0,,1,Mixed,"combat-related, natural or manmade disasters",Medium,"Thorp S, Glassman LH. A randomized controlled trial of prolonged exposure therapy versus relaxation training for older veterans with military-related PTSD. J Anxiety Disord. 2019 May;64:45-54. doi: 10.1016/j.janxdis.2019.02.003. PMID: 30978622.",51843,2020
thorp2019_CAPS_A_26_ITT,Mixed: Psychotherapy & CIH,PTSD,87,A,PTSD,,20,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,41,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Assessment at 6 to <12 Months,26,,52.10,21.67,,,,,-13.97,,,,,,,,,,,,,,,,,,CAPS for DSM-IV-TR using 1/2 rule,0.42,,15-point change on CAPS,0.5,,Veteran,0,1,0,0,,1,Mixed,"combat-related, natural or manmade disasters",Medium,"Thorp S, Glassman LH. A randomized controlled trial of prolonged exposure therapy versus relaxation training for older veterans with military-related PTSD. J Anxiety Disord. 2019 May;64:45-54. doi: 10.1016/j.janxdis.2019.02.003. PMID: 30978622.",51843,2020
thorp2019_CAPS_A_Baseline_ITT,Mixed: Psychotherapy & CIH,PTSD,87,A,PTSD,,41,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,41,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,,66.07,14.84,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"combat-related, natural or manmade disasters",Medium,"Thorp S, Glassman LH. A randomized controlled trial of prolonged exposure therapy versus relaxation training for older veterans with military-related PTSD. J Anxiety Disord. 2019 May;64:45-54. doi: 10.1016/j.janxdis.2019.02.003. PMID: 30978622.",51843,2020
thorp2019_CAPS_B_0_ITT,Mixed: Psychotherapy & CIH,PTSD,87,B,PTSD,,38,,Relaxation training,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,46,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,62.79,17.8,,,,,-10.21,,,,,,,,,,,,,,,,,,CAPS for DSM-IV-TR using 1/2 rule,,,15-point change on CAPS,,,Veteran,0,1,0,0,,1,Mixed,"combat-related, natural or manmade disasters",Medium,"Thorp S, Glassman LH. A randomized controlled trial of prolonged exposure therapy versus relaxation training for older veterans with military-related PTSD. J Anxiety Disord. 2019 May;64:45-54. doi: 10.1016/j.janxdis.2019.02.003. PMID: 30978622.",51843,2020
thorp2019_CAPS_B_26_ITT,Mixed: Psychotherapy & CIH,PTSD,87,B,PTSD,,26,,Relaxation training,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,46,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Assessment at 6 to <12 Months,26,,61.58,17.29,,,,,-11.42,,,,,,,,,,,,,,,,,,CAPS for DSM-IV-TR using 1/2 rule,0.2308,,15-point change on CAPS,0.3462,,Veteran,0,1,0,0,,1,Mixed,"combat-related, natural or manmade disasters",Medium,"Thorp S, Glassman LH. A randomized controlled trial of prolonged exposure therapy versus relaxation training for older veterans with military-related PTSD. J Anxiety Disord. 2019 May;64:45-54. doi: 10.1016/j.janxdis.2019.02.003. PMID: 30978622.",51843,2020
thorp2019_CAPS_B_Baseline_ITT,Mixed: Psychotherapy & CIH,PTSD,87,B,PTSD,,46,,Relaxation training,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,46,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,,73.00,14.66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"combat-related, natural or manmade disasters",Medium,"Thorp S, Glassman LH. A randomized controlled trial of prolonged exposure therapy versus relaxation training for older veterans with military-related PTSD. J Anxiety Disord. 2019 May;64:45-54. doi: 10.1016/j.janxdis.2019.02.003. PMID: 30978622.",51843,2020
thorp2019_PCL_A_0_ITT,Mixed: Psychotherapy & CIH,PTSD,87,A,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,41,Self report,PCL,PCL-S,ITT,Imputation,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,47.00,18.91,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"combat-related, natural or manmade disasters",Medium,"Thorp S, Glassman LH. A randomized controlled trial of prolonged exposure therapy versus relaxation training for older veterans with military-related PTSD. J Anxiety Disord. 2019 May;64:45-54. doi: 10.1016/j.janxdis.2019.02.003. PMID: 30978622.",51843,2020
thorp2019_PCL_A_26_ITT,Mixed: Psychotherapy & CIH,PTSD,87,A,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,41,Self report,PCL,PCL-S,ITT,Imputation,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Assessment at 6 to <12 Months,26,,58.37,13.77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"combat-related, natural or manmade disasters",Medium,"Thorp S, Glassman LH. A randomized controlled trial of prolonged exposure therapy versus relaxation training for older veterans with military-related PTSD. J Anxiety Disord. 2019 May;64:45-54. doi: 10.1016/j.janxdis.2019.02.003. PMID: 30978622.",51843,2020
thorp2019_PCL_A_Baseline_ITT,Mixed: Psychotherapy & CIH,PTSD,87,A,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,41,Self report,PCL,PCL-S,ITT,Imputation,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,,57.46,12.66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"combat-related, natural or manmade disasters",Medium,"Thorp S, Glassman LH. A randomized controlled trial of prolonged exposure therapy versus relaxation training for older veterans with military-related PTSD. J Anxiety Disord. 2019 May;64:45-54. doi: 10.1016/j.janxdis.2019.02.003. PMID: 30978622.",51843,2020
thorp2019_PCL_B_0_ITT,Mixed: Psychotherapy & CIH,PTSD,87,B,PTSD,,,,Relaxation training,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,46,Self report,PCL,PCL-S,ITT,Imputation,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,58.13,12.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"combat-related, natural or manmade disasters",Medium,"Thorp S, Glassman LH. A randomized controlled trial of prolonged exposure therapy versus relaxation training for older veterans with military-related PTSD. J Anxiety Disord. 2019 May;64:45-54. doi: 10.1016/j.janxdis.2019.02.003. PMID: 30978622.",51843,2020
thorp2019_PCL_B_26_ITT,Mixed: Psychotherapy & CIH,PTSD,87,B,PTSD,,,,Relaxation training,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,46,Self report,PCL,PCL-S,ITT,Imputation,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Assessment at 6 to <12 Months,26,,58.31,10.88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"combat-related, natural or manmade disasters",Medium,"Thorp S, Glassman LH. A randomized controlled trial of prolonged exposure therapy versus relaxation training for older veterans with military-related PTSD. J Anxiety Disord. 2019 May;64:45-54. doi: 10.1016/j.janxdis.2019.02.003. PMID: 30978622.",51843,2020
thorp2019_PCL_B_Baseline_ITT,Mixed: Psychotherapy & CIH,PTSD,87,B,PTSD,,,,Relaxation training,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,46,Self report,PCL,PCL-S,ITT,Imputation,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,,60.16,11.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"combat-related, natural or manmade disasters",Medium,"Thorp S, Glassman LH. A randomized controlled trial of prolonged exposure therapy versus relaxation training for older veterans with military-related PTSD. J Anxiety Disord. 2019 May;64:45-54. doi: 10.1016/j.janxdis.2019.02.003. PMID: 30978622.",51843,2020
tripodi2019_PCL_A_0_Comp,Psychotherapy,PTSD+SUD,40,A,PTSD+SUD,Integrated,15,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,20,Self report,PCL,PCL-C,Completer,None (no missing data),Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,34.33,11.2,,,,,-19.54,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,,,Medium,"Tripodi SJ, Mennicke AM, McCarter SA, et al. Evaluating seeking safety for women in prison: a randomized controlled trial. Res Soc Work Pract. 2019 Mar;29(3):281-90. doi: 10.1177/1049731517706550.",,2020
tripodi2019_PCL_A_16_Comp,Psychotherapy,PTSD+SUD,40,A,PTSD+SUD,Integrated,13,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,20,Self report,PCL,PCL-C,Completer,None (no missing data),Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Assessment at 3 to <6 Months,16,,30.46,6.8,,,,,-23.41,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,,,Medium,"Tripodi SJ, Mennicke AM, McCarter SA, et al. Evaluating seeking safety for women in prison: a randomized controlled trial. Res Soc Work Pract. 2019 Mar;29(3):281-90. doi: 10.1177/1049731517706550.",,2020
tripodi2019_PCL_A_Baseline_Comp,Psychotherapy,PTSD+SUD,40,A,PTSD+SUD,Integrated,15,,Seeking Safety,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,20,Self report,PCL,PCL-C,Completer,None (no missing data),Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,,53.87,14.95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,,,Medium,"Tripodi SJ, Mennicke AM, McCarter SA, et al. Evaluating seeking safety for women in prison: a randomized controlled trial. Res Soc Work Pract. 2019 Mar;29(3):281-90. doi: 10.1177/1049731517706550.",,2020
tripodi2019_PCL_B_0_Comp,Psychotherapy,PTSD+SUD,40,B,Control,Not integrated,18,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Mixed,In person,20,Self report,PCL,PCL-C,Completer,None (no missing data),Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,46.17,12.98,,,,,-13.66,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,,,Medium,"Tripodi SJ, Mennicke AM, McCarter SA, et al. Evaluating seeking safety for women in prison: a randomized controlled trial. Res Soc Work Pract. 2019 Mar;29(3):281-90. doi: 10.1177/1049731517706550.",,2020
tripodi2019_PCL_B_16_Comp,Psychotherapy,PTSD+SUD,40,B,Control,Not integrated,16,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Mixed,In person,20,Self report,PCL,PCL-C,Completer,None (no missing data),Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Assessment at 3 to <6 Months,16,,41.81,12.3,,,,,-18.02,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,,,Medium,"Tripodi SJ, Mennicke AM, McCarter SA, et al. Evaluating seeking safety for women in prison: a randomized controlled trial. Res Soc Work Pract. 2019 Mar;29(3):281-90. doi: 10.1177/1049731517706550.",,2020
tripodi2019_PCL_B_Baseline_Comp,Psychotherapy,PTSD+SUD,40,B,Control,Not integrated,18,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Mixed,In person,20,Self report,PCL,PCL-C,Completer,None (no missing data),Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,,59.83,15.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,1,,0,,,Medium,"Tripodi SJ, Mennicke AM, McCarter SA, et al. Evaluating seeking safety for women in prison: a randomized controlled trial. Res Soc Work Pract. 2019 Mar;29(3):281-90. doi: 10.1177/1049731517706550.",,2020
tucker2001_CAPS_A_0_ITT,Pharmacotherapy,PTSD,323,A,PTSD,,151,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,151,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,38.8,,,,,SEM 2.0,-35.5,,,,,,,,,,,,,,,,,,,,,CGI-I score of 1 or 2,0.588,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,,0.0684,0.9316,0.658,,0.342,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, seeing someone hurt or die)",Medium,"Tucker PM, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62(11):860-8. PMID: 11775045.",24214,2019
tucker2001_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,323,A,PTSD,,151,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,151,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,,74.3,,SEM,1.4,,,,,,,,,,,,,,,,,,,,,,,,CGI-I score of 1 or 2,,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,,0.0684,0.9316,0.658,,0.342,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, seeing someone hurt or die)",Medium,"Tucker PM, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62(11):860-8. PMID: 11775045.",24214,2019
tucker2001_CAPS_B_0_ITT,Pharmacotherapy,PTSD,323,B,Control,,156,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,156,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,48.5,,,,,SEM 2.0,-24.7,,,,,,,,,,,,,,,,,,,,,CGI-I score of 1 or 2,0.38,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,,0.0684,0.9316,0.658,,0.342,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, seeing someone hurt or die)",Medium,"Tucker PM, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62(11):860-8. PMID: 11775045.",24214,2019
tucker2001_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,323,B,Control,,156,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,156,Structured Clinical Interview,CAPS,CAPS-2,ITT,LOCF,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,,73.2,,SEM,1.3,,,,,,,,,,,,,,,,,,,,,,,,CGI-I score of 1 or 2,,Additional definitions of Clinically Meaningful Response reported in the study,Mixed,,0.0684,0.9316,0.658,,0.342,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, seeing someone hurt or die)",Medium,"Tucker PM, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62(11):860-8. PMID: 11775045.",24214,2019
tucker2001_DTS_A_0_NA,Pharmacotherapy,PTSD,323,A,PTSD,,,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,151,Self report,DTS,DTS,,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.0684,0.9316,0.658,,0.342,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, seeing someone hurt or die)",Medium,"Tucker PM, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62(11):860-8. PMID: 11775045.",24214,2019
tucker2001_DTS_A_Baseline_NA,Pharmacotherapy,PTSD,323,A,PTSD,,,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,151,Self report,DTS,DTS,,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,,73.1,,SEM,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.0684,0.9316,0.658,,0.342,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, seeing someone hurt or die)",Medium,"Tucker PM, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62(11):860-8. PMID: 11775045.",24214,2019
tucker2001_DTS_B_0_NA,Pharmacotherapy,PTSD,323,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,156,Self report,DTS,DTS,,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.0684,0.9316,0.658,,0.342,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, seeing someone hurt or die)",Medium,"Tucker PM, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62(11):860-8. PMID: 11775045.",24214,2019
tucker2001_DTS_B_Baseline_NA,Pharmacotherapy,PTSD,323,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,156,Self report,DTS,DTS,,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,,73.6,,SEM,1.8,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.0684,0.9316,0.658,,0.342,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, seeing someone hurt or die)",Medium,"Tucker PM, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62(11):860-8. PMID: 11775045.",24214,2019
tucker2001_TOP-8_A_0_NA,Pharmacotherapy,PTSD,323,A,PTSD,,,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,151,Structured Clinical Interview,TOP-8,TOP-8,,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.0684,0.9316,0.658,,0.342,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, seeing someone hurt or die)",Medium,"Tucker PM, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62(11):860-8. PMID: 11775045.",24214,2019
tucker2001_TOP-8_A_Baseline_NA,Pharmacotherapy,PTSD,323,A,PTSD,,,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,151,Structured Clinical Interview,TOP-8,TOP-8,,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,,18.3,,SEM,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.0684,0.9316,0.658,,0.342,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, seeing someone hurt or die)",Medium,"Tucker PM, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62(11):860-8. PMID: 11775045.",24214,2019
tucker2001_TOP-8_B_0_NA,Pharmacotherapy,PTSD,323,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,156,Structured Clinical Interview,TOP-8,TOP-8,,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.0684,0.9316,0.658,,0.342,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, seeing someone hurt or die)",Medium,"Tucker PM, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62(11):860-8. PMID: 11775045.",24214,2019
tucker2001_TOP-8_B_Baseline_NA,Pharmacotherapy,PTSD,323,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,156,Structured Clinical Interview,TOP-8,TOP-8,,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,,18.2,,SEM,4.6,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,0.0684,0.9316,0.658,,0.342,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, seeing someone hurt or die)",Medium,"Tucker PM, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62(11):860-8. PMID: 11775045.",24214,2019
tucker2003_CAPS_A_0_ITT,Pharmacotherapy,PTSD,59,A,PTSD,,25,,Citalopram,Citalopram,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,60.28,26.15,,,,,-30.72,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Community,,,1,0.7414,,0.2586,Mixed,"rape/sexual assault, combat-related, natural or manmade disasters, accidents, terrorism/political violence/forced displacement, community/school violence",Medium,"Tucker P, Potter-Kimball R, Wyatt DB, et al. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo. Psychopharmacol Bull. 2003 Summer;37(3):135-49.  PMID: 14608246.",26085,2019
tucker2003_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,59,A,PTSD,,25,,Citalopram,Citalopram,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,,91,10.58,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7414,,0.2586,Mixed,"rape/sexual assault, combat-related, natural or manmade disasters, accidents, terrorism/political violence/forced displacement, community/school violence",Medium,"Tucker P, Potter-Kimball R, Wyatt DB, et al. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo. Psychopharmacol Bull. 2003 Summer;37(3):135-49.  PMID: 14608246.",26085,2019
tucker2003_CAPS_B_0_ITT,Pharmacotherapy,PTSD,59,B,PTSD,,23,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,42.09,29.09,,,,,-41.82,,,,,,,,,,p<0.001,,,,,,,,,,,,,,Community,,,1,0.7414,,0.2586,Mixed,"rape/sexual assault, combat-related, natural or manmade disasters, accidents, terrorism/political violence/forced displacement, community/school violence",Medium,"Tucker P, Potter-Kimball R, Wyatt DB, et al. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo. Psychopharmacol Bull. 2003 Summer;37(3):135-49.  PMID: 14608246.",26085,2019
tucker2003_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,59,B,PTSD,,23,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,,83.91,17.28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7414,,0.2586,Mixed,"rape/sexual assault, combat-related, natural or manmade disasters, accidents, terrorism/political violence/forced displacement, community/school violence",Medium,"Tucker P, Potter-Kimball R, Wyatt DB, et al. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo. Psychopharmacol Bull. 2003 Summer;37(3):135-49.  PMID: 14608246.",26085,2019
tucker2003_CAPS_C_0_ITT,Pharmacotherapy,PTSD,59,C,Control,,10,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,55.50,29.07,,,,,-38.7,,,,,,,,,,p=0.003,,,,,,,,,,,,,,Community,,,1,0.7414,,0.2586,Mixed,"rape/sexual assault, combat-related, natural or manmade disasters, accidents, terrorism/political violence/forced displacement, community/school violence",Medium,"Tucker P, Potter-Kimball R, Wyatt DB, et al. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo. Psychopharmacol Bull. 2003 Summer;37(3):135-49.  PMID: 14608246.",26085,2019
tucker2003_CAPS_C_Baseline_ITT,Pharmacotherapy,PTSD,59,C,Control,,10,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,,94.20,11.93,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7414,,0.2586,Mixed,"rape/sexual assault, combat-related, natural or manmade disasters, accidents, terrorism/political violence/forced displacement, community/school violence",Medium,"Tucker P, Potter-Kimball R, Wyatt DB, et al. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo. Psychopharmacol Bull. 2003 Summer;37(3):135-49.  PMID: 14608246.",26085,2019
tucker2003_IES_A_0_NA,Pharmacotherapy,PTSD,59,A,PTSD,,,,Citalopram,Citalopram,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Self report,IES,IES,,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,24.65,17.09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7414,,0.2586,Mixed,"rape/sexual assault, combat-related, natural or manmade disasters, accidents, terrorism/political violence/forced displacement, community/school violence",Medium,"Tucker P, Potter-Kimball R, Wyatt DB, et al. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo. Psychopharmacol Bull. 2003 Summer;37(3):135-49.  PMID: 14608246.",26085,2019
tucker2003_IES_A_Baseline_NA,Pharmacotherapy,PTSD,59,A,PTSD,,,,Citalopram,Citalopram,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,25,Self report,IES,IES,,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,,50.04,15.96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7414,,0.2586,Mixed,"rape/sexual assault, combat-related, natural or manmade disasters, accidents, terrorism/political violence/forced displacement, community/school violence",Medium,"Tucker P, Potter-Kimball R, Wyatt DB, et al. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo. Psychopharmacol Bull. 2003 Summer;37(3):135-49.  PMID: 14608246.",26085,2019
tucker2003_IES_B_0_NA,Pharmacotherapy,PTSD,59,B,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Self report,IES,IES,,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,17.16,16.41,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7414,,0.2586,Mixed,"rape/sexual assault, combat-related, natural or manmade disasters, accidents, terrorism/political violence/forced displacement, community/school violence",Medium,"Tucker P, Potter-Kimball R, Wyatt DB, et al. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo. Psychopharmacol Bull. 2003 Summer;37(3):135-49.  PMID: 14608246.",26085,2019
tucker2003_IES_B_Baseline_NA,Pharmacotherapy,PTSD,59,B,PTSD,,,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Self report,IES,IES,,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,,46.26,18.45,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7414,,0.2586,Mixed,"rape/sexual assault, combat-related, natural or manmade disasters, accidents, terrorism/political violence/forced displacement, community/school violence",Medium,"Tucker P, Potter-Kimball R, Wyatt DB, et al. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo. Psychopharmacol Bull. 2003 Summer;37(3):135-49.  PMID: 14608246.",26085,2019
tucker2003_IES_C_0_NA,Pharmacotherapy,PTSD,59,C,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,10,Self report,IES,IES,,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,20.57,20.31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7414,,0.2586,Mixed,"rape/sexual assault, combat-related, natural or manmade disasters, accidents, terrorism/political violence/forced displacement, community/school violence",Medium,"Tucker P, Potter-Kimball R, Wyatt DB, et al. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo. Psychopharmacol Bull. 2003 Summer;37(3):135-49.  PMID: 14608246.",26085,2019
tucker2003_IES_C_Baseline_NA,Pharmacotherapy,PTSD,59,C,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,10,Self report,IES,IES,,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,,53.80,10.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7414,,0.2586,Mixed,"rape/sexual assault, combat-related, natural or manmade disasters, accidents, terrorism/political violence/forced displacement, community/school violence",Medium,"Tucker P, Potter-Kimball R, Wyatt DB, et al. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo. Psychopharmacol Bull. 2003 Summer;37(3):135-49.  PMID: 14608246.",26085,2019
tucker2007_CAPS_A_0_Comp,Pharmacotherapy,PTSD,40,A,PTSD,,14,,Topiramate,Topiramate,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,35.6,,,,,,-52.7,,,,,,,,,,,,,,,,,,,,,CAPS score <20,0.4211,,Community,,,1,0.7895,,0.2105,Mixed,"child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (non-specified)",Medium,"Tucker P, Trautman RP, Wyatt DB, et al. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2007 Feb;68(2):201-6. PMID: 17335317.",31122,2019
tucker2007_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,40,A,PTSD,,19,,Topiramate,Topiramate,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,,88.3,13.8,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS score <20,,,Community,,,1,0.7895,,0.2105,Mixed,"child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (non-specified)",Medium,"Tucker P, Trautman RP, Wyatt DB, et al. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2007 Feb;68(2):201-6. PMID: 17335317.",31122,2019
tucker2007_CAPS_B_0_Comp,Pharmacotherapy,PTSD,40,B,Control,,16,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,End of Treatment,0,,49.1,,,,,,-42,,,,,,,,,,,,,,,,,,,,,CAPS score <20,0.2105,,Community,,,1,0.7895,,0.2105,Mixed,"child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (non-specified)",Medium,"Tucker P, Trautman RP, Wyatt DB, et al. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2007 Feb;68(2):201-6. PMID: 17335317.",31122,2019
tucker2007_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,40,B,Control,,19,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,20,Structured Clinical Interview,CAPS,CAPS,Completer,,Bayesian latent growth modeling for PTSD severity change using ITT sample (linear and quadratic slopes); chi-square for proportions with PTSD diagnosis and severity change using completer sample; Cohen's d effect size calculated as the difference between the slopes divided by the square root of the slope‚Äôs variance,Baseline,,,91.1,13.7,,,,,,,,,,,,,,,,,,,,,,,,,,CAPS score <20,,,Community,,,1,0.7895,,0.2105,Mixed,"child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (non-specified)",Medium,"Tucker P, Trautman RP, Wyatt DB, et al. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2007 Feb;68(2):201-6. PMID: 17335317.",31122,2019
tuerk2018_CAPS_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,A,PTSD,,14,,PE + Yohimbine,Prolonged Exposure (PE) + yohimbine,Yes,TF,Yes,Supplement,No,Not Applicable,No,No,No,No,No,Individual,In Person,14,Structured Clinical Interview,CAPS,CAPS,ITT,Hierarchical linear modeling,Hierarchical linear modeling with Sidak corrections for multiple comparisons; non-parametric chi-squared tests for dichotomous variables.,End of Treatment,0,,29.78,19.74,,,,,-37,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD,,,≥1 standard deviation improvement on PCL-M,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Tuerk PW, Wangelin BC, Powers MB, et al. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn. Behav. Ther. 2018 Sep;47(5):351-71. doi: 10.1080/16506073.2018.1432679. PMID: 29448886.",50114,2019
tuerk2018_CAPS_A_12_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,A,PTSD,,12,,PE + Yohimbine,Prolonged Exposure (PE) + yohimbine,Yes,TF,Yes,Supplement,No,Not Applicable,No,No,No,No,No,Individual,In Person,14,Structured Clinical Interview,CAPS,CAPS,ITT,Hierarchical linear modeling,Hierarchical linear modeling with Sidak corrections for multiple comparisons; non-parametric chi-squared tests for dichotomous variables.,Assessment at 3 to <6 Months,12,,35.00,18.51,,,,,-31.78,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD,,,≥1 standard deviation improvement on PCL-M,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Tuerk PW, Wangelin BC, Powers MB, et al. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn. Behav. Ther. 2018 Sep;47(5):351-71. doi: 10.1080/16506073.2018.1432679. PMID: 29448886.",50114,2019
tuerk2018_CAPS_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,A,PTSD,,14,,PE + Yohimbine,Prolonged Exposure (PE) + yohimbine,Yes,TF,Yes,Supplement,No,Not Applicable,No,No,No,No,No,Individual,In Person,14,Structured Clinical Interview,CAPS,CAPS,ITT,Hierarchical linear modeling,Hierarchical linear modeling with Sidak corrections for multiple comparisons; non-parametric chi-squared tests for dichotomous variables.,Baseline,,,66.78,22.65,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD,,,≥1 standard deviation improvement on PCL-M,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Tuerk PW, Wangelin BC, Powers MB, et al. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn. Behav. Ther. 2018 Sep;47(5):351-71. doi: 10.1080/16506073.2018.1432679. PMID: 29448886.",50114,2019
tuerk2018_CAPS_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,B,PTSD,,12,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,12,Structured Clinical Interview,CAPS,CAPS,ITT,Hierarchical linear modeling,Hierarchical linear modeling with Sidak corrections for multiple comparisons; non-parametric chi-squared tests for dichotomous variables.,End of Treatment,0,,26.89,21.35,,,,,-41.69,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD,,,≥1 standard deviation improvement on PCL-M,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Tuerk PW, Wangelin BC, Powers MB, et al. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn. Behav. Ther. 2018 Sep;47(5):351-71. doi: 10.1080/16506073.2018.1432679. PMID: 29448886.",50114,2019
tuerk2018_CAPS_B_12_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,B,PTSD,,12,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,12,Structured Clinical Interview,CAPS,CAPS,ITT,Hierarchical linear modeling,Hierarchical linear modeling with Sidak corrections for multiple comparisons; non-parametric chi-squared tests for dichotomous variables.,Assessment at 3 to <6 Months,12,,28.86,16.38,,,,,-39.72,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD,,,≥1 standard deviation improvement on PCL-M,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Tuerk PW, Wangelin BC, Powers MB, et al. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn. Behav. Ther. 2018 Sep;47(5):351-71. doi: 10.1080/16506073.2018.1432679. PMID: 29448886.",50114,2019
tuerk2018_CAPS_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,B,PTSD,,12,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,12,Structured Clinical Interview,CAPS,CAPS,ITT,Hierarchical linear modeling,Hierarchical linear modeling with Sidak corrections for multiple comparisons; non-parametric chi-squared tests for dichotomous variables.,Baseline,,,68.58,11.8,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD,,,≥1 standard deviation improvement on PCL-M,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Tuerk PW, Wangelin BC, Powers MB, et al. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn. Behav. Ther. 2018 Sep;47(5):351-71. doi: 10.1080/16506073.2018.1432679. PMID: 29448886.",50114,2019
tuerk2018_PCL_A_0_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,A,PTSD,,,,PE + Yohimbine,Prolonged Exposure (PE) + yohimbine,Yes,TF,Yes,Supplement,No,Not Applicable,No,No,No,No,No,Individual,In Person,14,Self report,PCL,PCL-M,,,Hierarchical linear modeling with Sidak corrections for multiple comparisons; non-parametric chi-squared tests for dichotomous variables.,End of Treatment,0,,30.20,9.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Tuerk PW, Wangelin BC, Powers MB, et al. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn. Behav. Ther. 2018 Sep;47(5):351-71. doi: 10.1080/16506073.2018.1432679. PMID: 29448886.",50114,2019
tuerk2018_PCL_A_12_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,A,PTSD,,,,PE + Yohimbine,Prolonged Exposure (PE) + yohimbine,Yes,TF,Yes,Supplement,No,Not Applicable,No,No,No,No,No,Individual,In Person,14,Self report,PCL,PCL-M,,,Hierarchical linear modeling with Sidak corrections for multiple comparisons; non-parametric chi-squared tests for dichotomous variables.,Assessment at 3 to <6 Months,12,,37.56,14.34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Tuerk PW, Wangelin BC, Powers MB, et al. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn. Behav. Ther. 2018 Sep;47(5):351-71. doi: 10.1080/16506073.2018.1432679. PMID: 29448886.",50114,2019
tuerk2018_PCL_A_Baseline_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,A,PTSD,,,,PE + Yohimbine,Prolonged Exposure (PE) + yohimbine,Yes,TF,Yes,Supplement,No,Not Applicable,No,No,No,No,No,Individual,In Person,14,Self report,PCL,PCL-M,,,Hierarchical linear modeling with Sidak corrections for multiple comparisons; non-parametric chi-squared tests for dichotomous variables.,Baseline,,,62.14,12.11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Tuerk PW, Wangelin BC, Powers MB, et al. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn. Behav. Ther. 2018 Sep;47(5):351-71. doi: 10.1080/16506073.2018.1432679. PMID: 29448886.",50114,2019
tuerk2018_PCL_B_0_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,B,PTSD,,,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,12,Self report,PCL,PCL-M,,,Hierarchical linear modeling with Sidak corrections for multiple comparisons; non-parametric chi-squared tests for dichotomous variables.,End of Treatment,0,,32.44,14.46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Tuerk PW, Wangelin BC, Powers MB, et al. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn. Behav. Ther. 2018 Sep;47(5):351-71. doi: 10.1080/16506073.2018.1432679. PMID: 29448886.",50114,2019
tuerk2018_PCL_B_12_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,B,PTSD,,,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,12,Self report,PCL,PCL-M,,,Hierarchical linear modeling with Sidak corrections for multiple comparisons; non-parametric chi-squared tests for dichotomous variables.,Assessment at 3 to <6 Months,12,,30.86,11.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Tuerk PW, Wangelin BC, Powers MB, et al. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn. Behav. Ther. 2018 Sep;47(5):351-71. doi: 10.1080/16506073.2018.1432679. PMID: 29448886.",50114,2019
tuerk2018_PCL_B_Baseline_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,26,B,PTSD,,,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,12,Self report,PCL,PCL-M,,,Hierarchical linear modeling with Sidak corrections for multiple comparisons; non-parametric chi-squared tests for dichotomous variables.,Baseline,,,63.42,8.36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,Medium,"Tuerk PW, Wangelin BC, Powers MB, et al. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn. Behav. Ther. 2018 Sep;47(5):351-71. doi: 10.1080/16506073.2018.1432679. PMID: 29448886.",50114,2019
tylee2017_PCL_A_0_NA,Psychotherapy,PTSD,30,A,PTSD,,,,Reconsolidation of traumatic memories,Reconsolidation of Traumatic Memories (RTM),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Self report,PCL,PCL-M,,,Repeated-measures ANOVA with Greenhouse-Geisser correction as needed; post-hoc tests with family-wise Bonferroni correction,End of Treatment,0,,29.9,11.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"combat-related, other (not specified)",High,"Tylee DS, Gray R, Glatt SJ, et al. Evaluation of the reconsolidation of traumatic memories protocol for the treatment of PTSD: a randomized, wait-list-controlled trial. J Mil Veteran Fam Health. 2017;3(1):21-33. doi: 10.3138/jmvfh.4120.",49612,2019
tylee2017_PCL_A_Baseline_NA,Psychotherapy,PTSD,30,A,PTSD,,,,Reconsolidation of traumatic memories,Reconsolidation of Traumatic Memories (RTM),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Self report,PCL,PCL-M,,,Repeated-measures ANOVA with Greenhouse-Geisser correction as needed; post-hoc tests with family-wise Bonferroni correction,Baseline,,,64.9,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"combat-related, other (not specified)",High,"Tylee DS, Gray R, Glatt SJ, et al. Evaluation of the reconsolidation of traumatic memories protocol for the treatment of PTSD: a randomized, wait-list-controlled trial. J Mil Veteran Fam Health. 2017;3(1):21-33. doi: 10.3138/jmvfh.4120.",49612,2019
tylee2017_PCL_B_0_NA,Psychotherapy,PTSD,30,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,15,Self report,PCL,PCL-M,,,Repeated-measures ANOVA with Greenhouse-Geisser correction as needed; post-hoc tests with family-wise Bonferroni correction,End of Treatment,0,,67.6,8.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"combat-related, other (not specified)",High,"Tylee DS, Gray R, Glatt SJ, et al. Evaluation of the reconsolidation of traumatic memories protocol for the treatment of PTSD: a randomized, wait-list-controlled trial. J Mil Veteran Fam Health. 2017;3(1):21-33. doi: 10.3138/jmvfh.4120.",49612,2019
tylee2017_PCL_B_Baseline_NA,Psychotherapy,PTSD,30,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,15,Self report,PCL,PCL-M,,,Repeated-measures ANOVA with Greenhouse-Geisser correction as needed; post-hoc tests with family-wise Bonferroni correction,Baseline,,,68.0,9.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"combat-related, other (not specified)",High,"Tylee DS, Gray R, Glatt SJ, et al. Evaluation of the reconsolidation of traumatic memories protocol for the treatment of PTSD: a randomized, wait-list-controlled trial. J Mil Veteran Fam Health. 2017;3(1):21-33. doi: 10.3138/jmvfh.4120.",49612,2019
tylee2017_PSS-I_A_0_Comp,Psychotherapy,PTSD,30,A,PTSD,,15,,Reconsolidation of traumatic memories,Reconsolidation of Traumatic Memories (RTM),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Repeated-measures ANOVA with Greenhouse-Geisser correction as needed; post-hoc tests with family-wise Bonferroni correction,End of Treatment,0,,9.7,8.3,,,,,-27.6,,,,,Hedges' g,3.59,,,,p<0.001,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"combat-related, other (not specified)",High,"Tylee DS, Gray R, Glatt SJ, et al. Evaluation of the reconsolidation of traumatic memories protocol for the treatment of PTSD: a randomized, wait-list-controlled trial. J Mil Veteran Fam Health. 2017;3(1):21-33. doi: 10.3138/jmvfh.4120.",49612,2019
tylee2017_PSS-I_A_Baseline_Comp,Psychotherapy,PTSD,30,A,PTSD,,15,,Reconsolidation of traumatic memories,Reconsolidation of Traumatic Memories (RTM),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Repeated-measures ANOVA with Greenhouse-Geisser correction as needed; post-hoc tests with family-wise Bonferroni correction,Baseline,,,37.3,6.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"combat-related, other (not specified)",High,"Tylee DS, Gray R, Glatt SJ, et al. Evaluation of the reconsolidation of traumatic memories protocol for the treatment of PTSD: a randomized, wait-list-controlled trial. J Mil Veteran Fam Health. 2017;3(1):21-33. doi: 10.3138/jmvfh.4120.",49612,2019
tylee2017_PSS-I_B_0_Comp,Psychotherapy,PTSD,30,B,Control,,15,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,15,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Repeated-measures ANOVA with Greenhouse-Geisser correction as needed; post-hoc tests with family-wise Bonferroni correction,End of Treatment,0,,38.9,8.1,,,,,0.2,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"combat-related, other (not specified)",High,"Tylee DS, Gray R, Glatt SJ, et al. Evaluation of the reconsolidation of traumatic memories protocol for the treatment of PTSD: a randomized, wait-list-controlled trial. J Mil Veteran Fam Health. 2017;3(1):21-33. doi: 10.3138/jmvfh.4120.",49612,2019
tylee2017_PSS-I_B_Baseline_Comp,Psychotherapy,PTSD,30,B,Control,,15,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,15,Structured Clinical Interview,PSS-I,PSS-I,Completer,,Repeated-measures ANOVA with Greenhouse-Geisser correction as needed; post-hoc tests with family-wise Bonferroni correction,Baseline,,,38.7,6.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Mixed,"combat-related, other (not specified)",High,"Tylee DS, Gray R, Glatt SJ, et al. Evaluation of the reconsolidation of traumatic memories protocol for the treatment of PTSD: a randomized, wait-list-controlled trial. J Mil Veteran Fam Health. 2017;3(1):21-33. doi: 10.3138/jmvfh.4120.",49612,2019
ulmer2011_PCL_A_0_Comp,Psychotherapy,PTSD,22,A,PTSD,,9,,Sleep intervention for PTSD,Cognitive Behavioral Therapy for Insomnia (CBT-I) + Imagery Rehearsal Training (IRT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PCL,PCL-M,Completer,,ITT: linear mixed-effects models (PROC MIXED in SAS); Cohen's d effect size,End of Treatment,0,,44,,SE,4.99,,,,,,,,,,,,,,,,,,,,,,,,PCL-M ≤49,0.5,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.3182,,0.6818,,,High,"Ulmer CS, Edinger JD, Calhoun PS. A multi-component cognitive-behavioral intervention for sleep disturbance in veterans with PTSD: a pilot study. J Clin Sleep Med. 2011 Feb 15;7(1):57-68.  PMID: 21344046.",36068,2019
ulmer2011_PCL_A_0_ITT,Psychotherapy,PTSD,22,A,PTSD,,9,,Sleep intervention for PTSD,Cognitive Behavioral Therapy for Insomnia (CBT-I) + Imagery Rehearsal Training (IRT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PCL,PCL-M,ITT,linear mixed-effects models,ITT: linear mixed-effects models (PROC MIXED in SAS); Cohen's d effect size,End of Treatment,0,,45.25,,SE,3.51,,,-17.83,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3182,,0.6818,,,High,"Ulmer CS, Edinger JD, Calhoun PS. A multi-component cognitive-behavioral intervention for sleep disturbance in veterans with PTSD: a pilot study. J Clin Sleep Med. 2011 Feb 15;7(1):57-68.  PMID: 21344046.",36068,2019
ulmer2011_PCL_A_Baseline_Comp,Psychotherapy,PTSD,22,A,PTSD,,9,,Sleep intervention for PTSD,Cognitive Behavioral Therapy for Insomnia (CBT-I) + Imagery Rehearsal Training (IRT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PCL,PCL-M,Completer,,ITT: linear mixed-effects models (PROC MIXED in SAS); Cohen's d effect size,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3182,,0.6818,,,High,"Ulmer CS, Edinger JD, Calhoun PS. A multi-component cognitive-behavioral intervention for sleep disturbance in veterans with PTSD: a pilot study. J Clin Sleep Med. 2011 Feb 15;7(1):57-68.  PMID: 21344046.",36068,2019
ulmer2011_PCL_A_Baseline_ITT,Psychotherapy,PTSD,22,A,PTSD,,13,,Sleep intervention for PTSD,Cognitive Behavioral Therapy for Insomnia (CBT-I) + Imagery Rehearsal Training (IRT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,13,Self report,PCL,PCL-M,ITT,linear mixed-effects models,ITT: linear mixed-effects models (PROC MIXED in SAS); Cohen's d effect size,Baseline,,,63.08,12.47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3182,,0.6818,,,High,"Ulmer CS, Edinger JD, Calhoun PS. A multi-component cognitive-behavioral intervention for sleep disturbance in veterans with PTSD: a pilot study. J Clin Sleep Med. 2011 Feb 15;7(1):57-68.  PMID: 21344046.",36068,2019
ulmer2011_PCL_B_0_Comp,Psychotherapy,PTSD,22,B,Control,,9,,Usual care,Electronic sleep diary,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Written,9,Self report,PCL,PCL-M,Completer,,ITT: linear mixed-effects models (PROC MIXED in SAS); Cohen's d effect size,End of Treatment,0,,66.22,,SE,3.51,,,,,,,,,,,,,,,,,,,,,,,,PCL-M ≤49,0,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.3182,,0.6818,,,High,"Ulmer CS, Edinger JD, Calhoun PS. A multi-component cognitive-behavioral intervention for sleep disturbance in veterans with PTSD: a pilot study. J Clin Sleep Med. 2011 Feb 15;7(1):57-68.  PMID: 21344046.",36068,2019
ulmer2011_PCL_B_0_ITT,Psychotherapy,PTSD,22,B,Control,,9,,Usual care,Electronic sleep diary,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Written,9,Self report,PCL,PCL-M,ITT,linear mixed-effects models,ITT: linear mixed-effects models (PROC MIXED in SAS); Cohen's d effect size,End of Treatment,0,,66.08,,SE,2.99,,,2.64,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3182,,0.6818,,,High,"Ulmer CS, Edinger JD, Calhoun PS. A multi-component cognitive-behavioral intervention for sleep disturbance in veterans with PTSD: a pilot study. J Clin Sleep Med. 2011 Feb 15;7(1):57-68.  PMID: 21344046.",36068,2019
ulmer2011_PCL_B_Baseline_Comp,Psychotherapy,PTSD,22,B,Control,,9,,Usual care,Electronic sleep diary,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Written,9,Self report,PCL,PCL-M,Completer,,ITT: linear mixed-effects models (PROC MIXED in SAS); Cohen's d effect size,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3182,,0.6818,,,High,"Ulmer CS, Edinger JD, Calhoun PS. A multi-component cognitive-behavioral intervention for sleep disturbance in veterans with PTSD: a pilot study. J Clin Sleep Med. 2011 Feb 15;7(1):57-68.  PMID: 21344046.",36068,2019
ulmer2011_PCL_B_Baseline_ITT,Psychotherapy,PTSD,22,B,Control,,9,,Usual care,Electronic sleep diary,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Written,9,Self report,PCL,PCL-M,ITT,linear mixed-effects models,ITT: linear mixed-effects models (PROC MIXED in SAS); Cohen's d effect size,Baseline,,,63.44,11.66,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.3182,,0.6818,,,High,"Ulmer CS, Edinger JD, Calhoun PS. A multi-component cognitive-behavioral intervention for sleep disturbance in veterans with PTSD: a pilot study. J Clin Sleep Med. 2011 Feb 15;7(1):57-68.  PMID: 21344046.",36068,2019
vandenberg2015_CAPS_A_0_ITT,Psychotherapy,PTSD,155,A,PTSD,,53,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Logistic generalized estimating equation analyses with exchangeable correlation structure for dichotomous outcomes; linear mixed models for continuous variables; Cohen's d between-group effect sizes using estimated data from linear mixed model,End of Treatment,0,,37.8,,95% CI,31.2,44.3,,-31.8,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.566,,CAPS ≤20,0.283,,Community,,,1,0.5419,,0.4581,Mixed,"rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)",Low,"van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.",43279,2019
vandenberg2015_CAPS_A_26_ITT,Psychotherapy,PTSD,155,A,PTSD,,53,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Logistic generalized estimating equation analyses with exchangeable correlation structure for dichotomous outcomes; linear mixed models for continuous variables; Cohen's d between-group effect sizes using estimated data from linear mixed model,Assessment at 6 to <12 Months,26,,36.7,,95% CI,30.1,43.4,,-32.9,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.585,,CAPS ≤20,0.264,,Community,,,1,0.5419,,0.4581,Mixed,"rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)",Low,"van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.",43279,2019
vandenberg2015_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,155,A,PTSD,,53,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Logistic generalized estimating equation analyses with exchangeable correlation structure for dichotomous outcomes; linear mixed models for continuous variables; Cohen's d between-group effect sizes using estimated data from linear mixed model,Baseline,,,69.6,14.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5419,,0.4581,Mixed,"rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)",Low,"van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.",43279,2019
vandenberg2015_CAPS_B_0_ITT,Psychotherapy,PTSD,155,B,PTSD,,55,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,55,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Logistic generalized estimating equation analyses with exchangeable correlation structure for dichotomous outcomes; linear mixed models for continuous variables; Cohen's d between-group effect sizes using estimated data from linear mixed model,End of Treatment,0,,40.3,,95% CI,33.6,47.1,,-31.8,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.6,,CAPS ≤20,0.164,,Community,,,1,0.5419,,0.4581,Mixed,"rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)",Low,"van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.",43279,2019
vandenberg2015_CAPS_B_26_ITT,Psychotherapy,PTSD,155,B,PTSD,,55,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,55,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Logistic generalized estimating equation analyses with exchangeable correlation structure for dichotomous outcomes; linear mixed models for continuous variables; Cohen's d between-group effect sizes using estimated data from linear mixed model,Assessment at 6 to <12 Months,26,,38.8,,95% CI,31.9,45.6,,-33.3,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.564,,CAPS ≤20,0.145,,Community,,,1,0.5419,,0.4581,Mixed,"rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)",Low,"van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.",43279,2019
vandenberg2015_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,155,B,PTSD,,55,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,55,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Logistic generalized estimating equation analyses with exchangeable correlation structure for dichotomous outcomes; linear mixed models for continuous variables; Cohen's d between-group effect sizes using estimated data from linear mixed model,Baseline,,,72.1,17.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5419,,0.4581,Mixed,"rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)",Low,"van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.",43279,2019
vandenberg2015_CAPS_C_0_ITT,Psychotherapy,PTSD,155,C,Control,,47,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,47,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Logistic generalized estimating equation analyses with exchangeable correlation structure for dichotomous outcomes; linear mixed models for continuous variables; Cohen's d between-group effect sizes using estimated data from linear mixed model,End of Treatment,0,,56.5,,95% CI,49.5,63.6,,-11.6,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.277,,CAPS ≤20,0.064,,Community,,,1,0.5419,,0.4581,Mixed,"rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)",Low,"van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.",43279,2019
vandenberg2015_CAPS_C_26_ITT,Psychotherapy,PTSD,155,C,Control,,47,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,47,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Logistic generalized estimating equation analyses with exchangeable correlation structure for dichotomous outcomes; linear mixed models for continuous variables; Cohen's d between-group effect sizes using estimated data from linear mixed model,Assessment at 6 to <12 Months,26,,51.9,,95% CI,44.9,58.9,,-16.2,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.319,,CAPS ≤20,0.064,,Community,,,1,0.5419,,0.4581,Mixed,"rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)",Low,"van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.",43279,2019
vandenberg2015_CAPS_C_Baseline_ITT,Psychotherapy,PTSD,155,C,Control,,47,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,47,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Logistic generalized estimating equation analyses with exchangeable correlation structure for dichotomous outcomes; linear mixed models for continuous variables; Cohen's d between-group effect sizes using estimated data from linear mixed model,Baseline,,,68.1,15.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5419,,0.4581,Mixed,"rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)",Low,"van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.",43279,2019
vandenberg2015_PSS-SR_A_0_NA,Psychotherapy,PTSD,155,A,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Self report,PSS-SR,PSS-SR,,,Logistic generalized estimating equation analyses with exchangeable correlation structure for dichotomous outcomes; linear mixed models for continuous variables; Cohen's d between-group effect sizes using estimated data from linear mixed model,End of Treatment,0,,16.1,,95% CI,13.1,19.1,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5419,,0.4581,Mixed,"rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)",Low,"van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.",43279,2019
vandenberg2015_PSS-SR_A_26_NA,Psychotherapy,PTSD,155,A,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Self report,PSS-SR,PSS-SR,,,Logistic generalized estimating equation analyses with exchangeable correlation structure for dichotomous outcomes; linear mixed models for continuous variables; Cohen's d between-group effect sizes using estimated data from linear mixed model,Assessment at 6 to <12 Months,26,,16.4,,95% CI,13.4,19.4,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5419,,0.4581,Mixed,"rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)",Low,"van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.",43279,2019
vandenberg2015_PSS-SR_A_Baseline_NA,Psychotherapy,PTSD,155,A,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,53,Self report,PSS-SR,PSS-SR,,,Logistic generalized estimating equation analyses with exchangeable correlation structure for dichotomous outcomes; linear mixed models for continuous variables; Cohen's d between-group effect sizes using estimated data from linear mixed model,Baseline,,,28.5,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5419,,0.4581,Mixed,"rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)",Low,"van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.",43279,2019
vandenberg2015_PSS-SR_B_0_NA,Psychotherapy,PTSD,155,B,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,55,Self report,PSS-SR,PSS-SR,,,Logistic generalized estimating equation analyses with exchangeable correlation structure for dichotomous outcomes; linear mixed models for continuous variables; Cohen's d between-group effect sizes using estimated data from linear mixed model,End of Treatment,0,,16.1,,95% CI,12.9,19.2,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5419,,0.4581,Mixed,"rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)",Low,"van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.",43279,2019
vandenberg2015_PSS-SR_B_26_NA,Psychotherapy,PTSD,155,B,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,55,Self report,PSS-SR,PSS-SR,,,Logistic generalized estimating equation analyses with exchangeable correlation structure for dichotomous outcomes; linear mixed models for continuous variables; Cohen's d between-group effect sizes using estimated data from linear mixed model,Assessment at 6 to <12 Months,26,,16.2,,95% CI,13,19.3,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5419,,0.4581,Mixed,"rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)",Low,"van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.",43279,2019
vandenberg2015_PSS-SR_B_Baseline_NA,Psychotherapy,PTSD,155,B,PTSD,,,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,55,Self report,PSS-SR,PSS-SR,,,Logistic generalized estimating equation analyses with exchangeable correlation structure for dichotomous outcomes; linear mixed models for continuous variables; Cohen's d between-group effect sizes using estimated data from linear mixed model,Baseline,,,30.3,7.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5419,,0.4581,Mixed,"rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)",Low,"van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.",43279,2019
vandenberg2015_PSS-SR_C_0_NA,Psychotherapy,PTSD,155,C,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,47,Self report,PSS-SR,PSS-SR,,,Logistic generalized estimating equation analyses with exchangeable correlation structure for dichotomous outcomes; linear mixed models for continuous variables; Cohen's d between-group effect sizes using estimated data from linear mixed model,End of Treatment,0,,25.8,,95% CI,22.5,28.9,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5419,,0.4581,Mixed,"rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)",Low,"van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.",43279,2019
vandenberg2015_PSS-SR_C_26_NA,Psychotherapy,PTSD,155,C,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,47,Self report,PSS-SR,PSS-SR,,,Logistic generalized estimating equation analyses with exchangeable correlation structure for dichotomous outcomes; linear mixed models for continuous variables; Cohen's d between-group effect sizes using estimated data from linear mixed model,Assessment at 6 to <12 Months,26,,24.1,,95% CI,20.9,27.4,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5419,,0.4581,Mixed,"rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)",Low,"van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.",43279,2019
vandenberg2015_PSS-SR_C_Baseline_NA,Psychotherapy,PTSD,155,C,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,47,Self report,PSS-SR,PSS-SR,,,Logistic generalized estimating equation analyses with exchangeable correlation structure for dichotomous outcomes; linear mixed models for continuous variables; Cohen's d between-group effect sizes using estimated data from linear mixed model,Baseline,,,27.7,8.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5419,,0.4581,Mixed,"rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)",Low,"van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.",43279,2019
vandenderen2018_IES_A_0_Comp,Psychotherapy,PTSD,85,A,PTSD,,17,,EMDR + CBT,Eye Movement Desensitization and Reprocessing (EMDR) + cognitive behavioral therapy (CBT) without a trauma focus,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Self report,IES,IES (Dutch version),Completer,missing items on scales replaced by average scores on the observed items if >50% of items were answered; if <50% of items were answered or scale completely missing then score was not imputed.,Multilevel analysis with time nested in participants and participants nested in victims; Cohen's d statistics for effect size,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IES (Dutch version) score at end of treatment >2 standard deviations below the mean of the baseline sample (IES <23),0.2353,,Community,,,1,0.7412,,0.2588,Other (homicidally bereaved),,High,"van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.",49818,2019
vandenderen2018_IES_A_0_ITT,Psychotherapy,PTSD,85,A,PTSD,,20,,EMDR + CBT,Eye Movement Desensitization and Reprocessing (EMDR) + cognitive behavioral therapy (CBT) without a trauma focus,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Self report,IES,IES (Dutch version),ITT,missing items on scales replaced by average scores on the observed items if >50% of items were answered; if <50% of items were answered or scale completely missing then score was not imputed.,Multilevel analysis with time nested in participants and participants nested in victims; Cohen's d statistics for effect size,End of Treatment,0,,31.51,17.36,,,,,-16.44,,,,,Cohen's d,1.2,95% CI,0.5,1.89,,,,,,,,,,,,,,,Community,,,1,0.7412,,0.2588,Other (homicidally bereaved),,High,"van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.",49818,2019
vandenderen2018_IES_A_26_Comp,Psychotherapy,PTSD,85,A,PTSD,,17,,EMDR + CBT,Eye Movement Desensitization and Reprocessing (EMDR) + cognitive behavioral therapy (CBT) without a trauma focus,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Self report,IES,IES (Dutch version),Completer,missing items on scales replaced by average scores on the observed items if >50% of items were answered; if <50% of items were answered or scale completely missing then score was not imputed.,Multilevel analysis with time nested in participants and participants nested in victims; Cohen's d statistics for effect size,Assessment at 6 to <12 Months,26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7412,,0.2588,Other (homicidally bereaved),,High,"van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.",49818,2019
vandenderen2018_IES_A_26_ITT,Psychotherapy,PTSD,85,A,PTSD,,20,,EMDR + CBT,Eye Movement Desensitization and Reprocessing (EMDR) + cognitive behavioral therapy (CBT) without a trauma focus,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Self report,IES,IES (Dutch version),ITT,missing items on scales replaced by average scores on the observed items if >50% of items were answered; if <50% of items were answered or scale completely missing then score was not imputed.,Multilevel analysis with time nested in participants and participants nested in victims; Cohen's d statistics for effect size,Assessment at 6 to <12 Months,26,,35.21,19.51,,,,,-12.74,,,,,Cohen's d,0.84,95% CI,0.11,1.56,,,,,,,,,,,,,,,Community,,,1,0.7412,,0.2588,Other (homicidally bereaved),,High,"van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.",49818,2019
vandenderen2018_IES_A_Baseline_Comp,Psychotherapy,PTSD,85,A,PTSD,,17,,EMDR + CBT,Eye Movement Desensitization and Reprocessing (EMDR) + cognitive behavioral therapy (CBT) without a trauma focus,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Self report,IES,IES (Dutch version),Completer,missing items on scales replaced by average scores on the observed items if >50% of items were answered; if <50% of items were answered or scale completely missing then score was not imputed.,Multilevel analysis with time nested in participants and participants nested in victims; Cohen's d statistics for effect size,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7412,,0.2588,Other (homicidally bereaved),,High,"van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.",49818,2019
vandenderen2018_IES_A_Baseline_ITT,Psychotherapy,PTSD,85,A,PTSD,,20,,EMDR + CBT,Eye Movement Desensitization and Reprocessing (EMDR) + cognitive behavioral therapy (CBT) without a trauma focus,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,20,Self report,IES,IES (Dutch version),ITT,missing items on scales replaced by average scores on the observed items if >50% of items were answered; if <50% of items were answered or scale completely missing then score was not imputed.,Multilevel analysis with time nested in participants and participants nested in victims; Cohen's d statistics for effect size,Baseline,,,47.95,9.41,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7412,,0.2588,Other (homicidally bereaved),,High,"van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.",49818,2019
vandenderen2018_IES_B_0_Comp,Psychotherapy,PTSD,85,B,PTSD,,13,,CBT + EMDR,Cognitive behavioral therapy (CBT) + Eye Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Self report,IES,IES (Dutch version),Completer,missing items on scales replaced by average scores on the observed items if >50% of items were answered; if <50% of items were answered or scale completely missing then score was not imputed.,Multilevel analysis with time nested in participants and participants nested in victims; Cohen's d statistics for effect size,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IES (Dutch version) score at end of treatment >2 standard deviations below the mean of the baseline sample (IES <23),0.5385,,Community,,,1,0.7412,,0.2588,Other (homicidally bereaved),,High,"van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.",49818,2019
vandenderen2018_IES_B_0_ITT,Psychotherapy,PTSD,85,B,PTSD,,22,,CBT + EMDR,Cognitive behavioral therapy (CBT) + Eye Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Self report,IES,IES (Dutch version),ITT,missing items on scales replaced by average scores on the observed items if >50% of items were answered; if <50% of items were answered or scale completely missing then score was not imputed.,Multilevel analysis with time nested in participants and participants nested in victims; Cohen's d statistics for effect size,End of Treatment,0,,21.51,15.7,,,,,-23.26,,,,,Cohen's d,1.61,95% CI,0.87,2.35,,,,,,,,,,,,,,,Community,,,1,0.7412,,0.2588,Other (homicidally bereaved),,High,"van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.",49818,2019
vandenderen2018_IES_B_26_Comp,Psychotherapy,PTSD,85,B,PTSD,,13,,CBT + EMDR,Cognitive behavioral therapy (CBT) + Eye Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Self report,IES,IES (Dutch version),Completer,missing items on scales replaced by average scores on the observed items if >50% of items were answered; if <50% of items were answered or scale completely missing then score was not imputed.,Multilevel analysis with time nested in participants and participants nested in victims; Cohen's d statistics for effect size,Assessment at 6 to <12 Months,26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7412,,0.2588,Other (homicidally bereaved),,High,"van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.",49818,2019
vandenderen2018_IES_B_26_ITT,Psychotherapy,PTSD,85,B,PTSD,,22,,CBT + EMDR,Cognitive behavioral therapy (CBT) + Eye Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Self report,IES,IES (Dutch version),ITT,missing items on scales replaced by average scores on the observed items if >50% of items were answered; if <50% of items were answered or scale completely missing then score was not imputed.,Multilevel analysis with time nested in participants and participants nested in victims; Cohen's d statistics for effect size,Assessment at 6 to <12 Months,26,,22.9,16.57,,,,,-21.87,,,,,Cohen's d,0.86,95% CI,0.13,1.6,,,,,,,,,,,,,,,Community,,,1,0.7412,,0.2588,Other (homicidally bereaved),,High,"van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.",49818,2019
vandenderen2018_IES_B_Baseline_Comp,Psychotherapy,PTSD,85,B,PTSD,,13,,CBT + EMDR,Cognitive behavioral therapy (CBT) + Eye Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Self report,IES,IES (Dutch version),Completer,missing items on scales replaced by average scores on the observed items if >50% of items were answered; if <50% of items were answered or scale completely missing then score was not imputed.,Multilevel analysis with time nested in participants and participants nested in victims; Cohen's d statistics for effect size,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7412,,0.2588,Other (homicidally bereaved),,High,"van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.",49818,2019
vandenderen2018_IES_B_Baseline_ITT,Psychotherapy,PTSD,85,B,PTSD,,22,,CBT + EMDR,Cognitive behavioral therapy (CBT) + Eye Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,22,Self report,IES,IES (Dutch version),ITT,missing items on scales replaced by average scores on the observed items if >50% of items were answered; if <50% of items were answered or scale completely missing then score was not imputed.,Multilevel analysis with time nested in participants and participants nested in victims; Cohen's d statistics for effect size,Baseline,,,44.77,13.54,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7412,,0.2588,Other (homicidally bereaved),,High,"van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.",49818,2019
vandenderen2018_IES_C_0_ITT,Psychotherapy,PTSD,85,C,Control,,43,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,43,Self report,IES,IES (Dutch version),ITT,missing items on scales replaced by average scores on the observed items if >50% of items were answered; if <50% of items were answered or scale completely missing then score was not imputed.,Multilevel analysis with time nested in participants and participants nested in victims; Cohen's d statistics for effect size,End of Treatment,0,,25.32,20.29,,,,,-20.98,,,,,Cohen's d,-0.04,95% CI,-0.49,0.41,,,,,,,,,,,,IES (Dutch version) score at end of treatment >2 standard deviations below the mean of the baseline sample (IES <23),0.0233,,Community,,,1,0.7412,,0.2588,Other (homicidally bereaved),,High,"van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.",49818,2019
vandenderen2018_IES_C_Baseline_Comp,Psychotherapy,PTSD,85,C,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,43,Self report,IES,IES (Dutch version),Completer,missing items on scales replaced by average scores on the observed items if >50% of items were answered; if <50% of items were answered or scale completely missing then score was not imputed.,Multilevel analysis with time nested in participants and participants nested in victims; Cohen's d statistics for effect size,Baseline,,,46.3,13.38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7412,,0.2588,Other (homicidally bereaved),,High,"van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.",49818,2019
vandenderen2018_IES_C_Baseline_ITT,Psychotherapy,PTSD,85,C,Control,,43,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,43,Self report,IES,IES (Dutch version),ITT,missing items on scales replaced by average scores on the observed items if >50% of items were answered; if <50% of items were answered or scale completely missing then score was not imputed.,Multilevel analysis with time nested in participants and participants nested in victims; Cohen's d statistics for effect size,Baseline,,,46.3,13.38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7412,,0.2588,Other (homicidally bereaved),,High,"van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.",49818,2019
vanderkolk1994_CAPS_A_0_Comp,Pharmacotherapy,PTSD,64,A,PTSD,,21,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,33,Structured Clinical Interview,CAPS,CAPS,Completer,,Multilevel analysis with time nested in participants and participants nested in victims; Cohen's d statistics for effect size,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.4844,0.5156,0.3438,,0.6562,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement",Medium,"Van der Kolk BA, Dreyfuss D, Michaels MJ, et al. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry. 1994;55(12):517-22. PMID: 7814344.",05244,2019
vanderkolk1994_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,64,A,PTSD,,33,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,33,Structured Clinical Interview,CAPS,CAPS,Completer,,Multilevel analysis with time nested in participants and participants nested in victims; Cohen's d statistics for effect size,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.4844,0.5156,0.3438,,0.6562,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement",Medium,"Van der Kolk BA, Dreyfuss D, Michaels MJ, et al. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry. 1994;55(12):517-22. PMID: 7814344.",05244,2019
vanderkolk1994_CAPS_B_0_Comp,Pharmacotherapy,PTSD,64,B,Control,,27,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,Completer,,Multilevel analysis with time nested in participants and participants nested in victims; Cohen's d statistics for effect size,End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.4844,0.5156,0.3438,,0.6562,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement",Medium,"Van der Kolk BA, Dreyfuss D, Michaels MJ, et al. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry. 1994;55(12):517-22. PMID: 7814344.",05244,2019
vanderkolk1994_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,64,B,Control,,31,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,31,Structured Clinical Interview,CAPS,CAPS,Completer,,Multilevel analysis with time nested in participants and participants nested in victims; Cohen's d statistics for effect size,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0,0.4844,0.5156,0.3438,,0.6562,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement",Medium,"Van der Kolk BA, Dreyfuss D, Michaels MJ, et al. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry. 1994;55(12):517-22. PMID: 7814344.",05244,2019
vanderkolk2007_CAPS_A_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,88,A,PTSD,,24,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANCOVA (omnibus and pairwise) for continuous measures, Pearson chi-squared for categorical outcomes",End of Treatment,0,,28.37,19.66,,,,,-41.03,,,,,,,,,,,,,,,,,,CAPS score ≤50 and per-item frequency ≥1 + intensity ≥2 and per-item total severity score ≥4,0.875,,CAPS score <20,0.2917,,Community,,,1,0.8295,,0.1705,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)",Medium,"Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.",29236,2019
vanderkolk2007_CAPS_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,88,A,PTSD,,29,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,ITT,early termination assessment or LOCF,"ANCOVA (omnibus and pairwise) for continuous measures, Pearson chi-squared for categorical outcomes",End of Treatment,0,,32.55,22.5,,,,,-34.85,,,,,,,,,,,,,,,,,,CAPS score ≤50 and per-item frequency ≥1 + intensity ≥2 and per-item total severity score ≥4,0.7586,,CAPS score <20,0.2759,,Community,,,1,0.8295,,0.1705,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)",Medium,"Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.",29236,2019
vanderkolk2007_CAPS_A_26_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,88,A,PTSD,,21,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANCOVA (omnibus and pairwise) for continuous measures, Pearson chi-squared for categorical outcomes",Assessment at 6 to <12 Months,26,,25.67,21.17,,,,,-46,,,,,,,,,,,,,,,,,,CAPS score ≤50 and per-item frequency ≥1 + intensity ≥2 and per-item total severity score ≥4,0.9048,,CAPS score <20,0.5714,,Community,,,1,0.8295,,0.1705,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)",Medium,"Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.",29236,2019
vanderkolk2007_CAPS_A_26_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,88,A,PTSD,,24,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,ITT,early termination assessment or LOCF,"ANCOVA (omnibus and pairwise) for continuous measures, Pearson chi-squared for categorical outcomes",Assessment at 6 to <12 Months,26,,25.79,21.61,,,,,-45.9,,,,,,,,,,,,,,,,,,CAPS score ≤50 and per-item frequency ≥1 + intensity ≥2 and per-item total severity score ≥4,0.875,,CAPS score <20,0.5833,,Community,,,1,0.8295,,0.1705,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)",Medium,"Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.",29236,2019
vanderkolk2007_CAPS_A_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,88,A,PTSD,,24,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANCOVA (omnibus and pairwise) for continuous measures, Pearson chi-squared for categorical outcomes",Baseline,,,69.4,12.7,,,,,,,,,,,,,,,,,,,,,,,CAPS score ≤50 and per-item frequency ≥1 + intensity ≥2 and per-item total severity score ≥4,,,CAPS score <20,,,Community,,,1,0.8295,,0.1705,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)",Medium,"Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.",29236,2019
vanderkolk2007_CAPS_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,88,A,PTSD,,29,,EMDR,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,ITT,early termination assessment or LOCF,"ANCOVA (omnibus and pairwise) for continuous measures, Pearson chi-squared for categorical outcomes",Baseline,,,71.7,11.9,,,,,,,,,,,,,,,,,,,,,,,CAPS score ≤50 and per-item frequency ≥1 + intensity ≥2 and per-item total severity score ≥4,,,CAPS score <20,,,Community,,,1,0.8295,,0.1705,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)",Medium,"Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.",29236,2019
vanderkolk2007_CAPS_B_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,88,B,PTSD,,26,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANCOVA (omnibus and pairwise) for continuous measures, Pearson chi-squared for categorical outcomes",End of Treatment,0,,38.69,20.3,,,,,-35.01,,,,,,,,,,,,,,,,,,CAPS score ≤50 and per-item frequency ≥1 + intensity ≥2 and per-item total severity score ≥4,0.8077,,CAPS score <20,0.1538,,Community,,,1,0.8295,,0.1705,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)",Medium,"Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.",29236,2019
vanderkolk2007_CAPS_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,88,B,PTSD,,30,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,early termination assessment or LOCF,"ANCOVA (omnibus and pairwise) for continuous measures, Pearson chi-squared for categorical outcomes",End of Treatment,0,,42.67,22.11,,,,,-31.03,,,,,,,,,,,,,,,,,,CAPS score ≤50 and per-item frequency ≥1 + intensity ≥2 and per-item total severity score ≥4,0.7333,,CAPS score <20,0.1333,,Community,,,1,0.8295,,0.1705,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)",Medium,"Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.",29236,2019
vanderkolk2007_CAPS_B_26_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,88,B,PTSD,,18,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANCOVA (omnibus and pairwise) for continuous measures, Pearson chi-squared for categorical outcomes",Assessment at 6 to <12 Months,26,,41.22,15.7,,,,,-34.7,,,,,,,,,,,,,,,,,,CAPS score ≤50 and per-item frequency ≥1 + intensity ≥2 and per-item total severity score ≥4,0.7222,,CAPS score <20,0,,Community,,,1,0.8295,,0.1705,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)",Medium,"Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.",29236,2019
vanderkolk2007_CAPS_B_26_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,88,B,PTSD,,26,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,early termination assessment or LOCF,"ANCOVA (omnibus and pairwise) for continuous measures, Pearson chi-squared for categorical outcomes",Assessment at 6 to <12 Months,26,,42.12,15.83,,,,,-33.8,,,,,,,,,,,,,,,,,,CAPS score ≤50 and per-item frequency ≥1 + intensity ≥2 and per-item total severity score ≥4,0.7308,,CAPS score <20,0,,Community,,,1,0.8295,,0.1705,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)",Medium,"Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.",29236,2019
vanderkolk2007_CAPS_B_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,88,B,PTSD,,26,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANCOVA (omnibus and pairwise) for continuous measures, Pearson chi-squared for categorical outcomes",Baseline,,,73.7,13.4,,,,,,,,,,,,,,,,,,,,,,,CAPS score ≤50 and per-item frequency ≥1 + intensity ≥2 and per-item total severity score ≥4,,,CAPS score <20,,,Community,,,1,0.8295,,0.1705,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)",Medium,"Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.",29236,2019
vanderkolk2007_CAPS_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,88,B,PTSD,,30,,Fluoxetine,Fluoxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,CAPS,CAPS,ITT,early termination assessment or LOCF,"ANCOVA (omnibus and pairwise) for continuous measures, Pearson chi-squared for categorical outcomes",Baseline,,,75.9,15.6,,,,,,,,,,,,,,,,,,,,,,,CAPS score ≤50 and per-item frequency ≥1 + intensity ≥2 and per-item total severity score ≥4,,,CAPS score <20,,,Community,,,1,0.8295,,0.1705,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)",Medium,"Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.",29236,2019
vanderkolk2007_CAPS_C_0_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,88,C,Control,,26,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANCOVA (omnibus and pairwise) for continuous measures, Pearson chi-squared for categorical outcomes",End of Treatment,0,,39.81,18.76,,,,,-30.49,,,,,,,,,,,,,,,,,,CAPS score ≤50 and per-item frequency ≥1 + intensity ≥2 and per-item total severity score ≥4,0.6538,,CAPS score <20,0.1154,,Community,,,1,0.8295,,0.1705,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)",Medium,"Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.",29236,2019
vanderkolk2007_CAPS_C_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,88,C,Control,,29,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,ITT,early termination assessment or LOCF,"ANCOVA (omnibus and pairwise) for continuous measures, Pearson chi-squared for categorical outcomes",End of Treatment,0,,43.55,22.6,,,,,-30.95,,,,,,,,,,,,,,,,,,CAPS score ≤50 and per-item frequency ≥1 + intensity ≥2 and per-item total severity score ≥4,0.5862,,CAPS score <20,0.1034,,Community,,,1,0.8295,,0.1705,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)",Medium,"Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.",29236,2019
vanderkolk2007_CAPS_C_Baseline_Comp,Mixed: Psychotherapy & pharmacotherapy,PTSD,88,C,Control,,26,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,Completer,,"ANCOVA (omnibus and pairwise) for continuous measures, Pearson chi-squared for categorical outcomes",Baseline,,,70.3,13,,,,,,,,,,,,,,,,,,,,,,,CAPS score ≤50 and per-item frequency ≥1 + intensity ≥2 and per-item total severity score ≥4,,,CAPS score <20,,,Community,,,1,0.8295,,0.1705,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)",Medium,"Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.",29236,2019
vanderkolk2007_CAPS_C_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,88,C,Control,,29,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,29,Structured Clinical Interview,CAPS,CAPS,ITT,early termination assessment or LOCF,"ANCOVA (omnibus and pairwise) for continuous measures, Pearson chi-squared for categorical outcomes",Baseline,,,74.5,12.5,,,,,,,,,,,,,,,,,,,,,,,CAPS score ≤50 and per-item frequency ≥1 + intensity ≥2 and per-item total severity score ≥4,,,CAPS score <20,,,Community,,,1,0.8295,,0.1705,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)",Medium,"Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.",29236,2019
vanderkolk2014_CAPS_A_0_Comp,Mixed: Psychotherapy & CIH,PTSD,76,A,PTSD,,31,,Yoga + supportive therapy,Yoga,Yes,Non-TF,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Group,In Person,,Structured Clinical Interview,CAPS,CAPS severity,Completer,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,End of Treatment,0,,49.48,25.16,,,,,-24.45,,,,,Cohen's d,-1.07,,,,p<0.001,,,,,,,,CAPS <45,0.5161,,,,,Community,,,1,1,,0,,,Medium,"van der Kolk BA, Stone L, West J, et al. Yoga as an adjunctive treatment for posttraumatic stress disorder: a randomized controlled trial. J Clin Psychiatry. 2014 Jun;75(6):e559-65. doi: 10.4088/JCP.13m08561. PMID: 25004196.",42647,2019
vanderkolk2014_CAPS_A_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,76,A,PTSD,,32,,Yoga + supportive therapy,Yoga,Yes,Non-TF,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Group,In Person,,Structured Clinical Interview,CAPS,CAPS severity,Completer,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Baseline,,,73.94,20.83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,,,Medium,"van der Kolk BA, Stone L, West J, et al. Yoga as an adjunctive treatment for posttraumatic stress disorder: a randomized controlled trial. J Clin Psychiatry. 2014 Jun;75(6):e559-65. doi: 10.4088/JCP.13m08561. PMID: 25004196.",42647,2019
vanderkolk2014_CAPS_B_0_Comp,Mixed: Psychotherapy & CIH,PTSD,76,B,Control,,29,,Women's health education + supportive therapy,Women's health education plus Supportive Therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In Person,,Structured Clinical Interview,CAPS,CAPS severity,Completer,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,End of Treatment,0,,63.49,25.48,,,,,-13.17,,,,,Cohen's d,-0.66,,,,p<0.01,,,,,,,,CAPS <45,0.2069,,,,,Community,,,1,1,,0,,,Medium,"van der Kolk BA, Stone L, West J, et al. Yoga as an adjunctive treatment for posttraumatic stress disorder: a randomized controlled trial. J Clin Psychiatry. 2014 Jun;75(6):e559-65. doi: 10.4088/JCP.13m08561. PMID: 25004196.",42647,2019
vanderkolk2014_CAPS_B_Baseline_Comp,Mixed: Psychotherapy & CIH,PTSD,76,B,Control,,32,,Women's health education + supportive therapy,Women's health education plus Supportive Therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In Person,,Structured Clinical Interview,CAPS,CAPS severity,Completer,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Baseline,,,76.66,20.83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,,,Medium,"van der Kolk BA, Stone L, West J, et al. Yoga as an adjunctive treatment for posttraumatic stress disorder: a randomized controlled trial. J Clin Psychiatry. 2014 Jun;75(6):e559-65. doi: 10.4088/JCP.13m08561. PMID: 25004196.",42647,2019
vanderkolk2014_DTS_A_0_NA,Mixed: Psychotherapy & CIH,PTSD,76,A,PTSD,,,,Yoga + supportive therapy,Yoga,Yes,Non-TF,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Group,In Person,,Self report,DTS,DTS,,,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,End of Treatment,0,,51.49,24.09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,,,Medium,"van der Kolk BA, Stone L, West J, et al. Yoga as an adjunctive treatment for posttraumatic stress disorder: a randomized controlled trial. J Clin Psychiatry. 2014 Jun;75(6):e559-65. doi: 10.4088/JCP.13m08561. PMID: 25004196.",42647,2019
vanderkolk2014_DTS_A_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,76,A,PTSD,,,,Yoga + supportive therapy,Yoga,Yes,Non-TF,No,Not Applicable,Yes,Yoga,No,No,No,No,No,Group,In Person,,Self report,DTS,DTS,,,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Baseline,,,65.17,23.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,,,Medium,"van der Kolk BA, Stone L, West J, et al. Yoga as an adjunctive treatment for posttraumatic stress disorder: a randomized controlled trial. J Clin Psychiatry. 2014 Jun;75(6):e559-65. doi: 10.4088/JCP.13m08561. PMID: 25004196.",42647,2019
vanderkolk2014_DTS_B_0_NA,Mixed: Psychotherapy & CIH,PTSD,76,B,Control,,,,Women's health education + supportive therapy,Women's health education plus Supportive Therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In Person,,Self report,DTS,DTS,,,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,End of Treatment,0,,63.75,28.81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,,,Medium,"van der Kolk BA, Stone L, West J, et al. Yoga as an adjunctive treatment for posttraumatic stress disorder: a randomized controlled trial. J Clin Psychiatry. 2014 Jun;75(6):e559-65. doi: 10.4088/JCP.13m08561. PMID: 25004196.",42647,2019
vanderkolk2014_DTS_B_Baseline_NA,Mixed: Psychotherapy & CIH,PTSD,76,B,Control,,,,Women's health education + supportive therapy,Women's health education plus Supportive Therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Group,In Person,,Self report,DTS,DTS,,,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Baseline,,,73.06,25.86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,,,Medium,"van der Kolk BA, Stone L, West J, et al. Yoga as an adjunctive treatment for posttraumatic stress disorder: a randomized controlled trial. J Clin Psychiatry. 2014 Jun;75(6):e559-65. doi: 10.4088/JCP.13m08561. PMID: 25004196.",42647,2019
vanderkolk2016_CAPS_A_0_Comp,Complementary and integrative health (CIH),PTSD,52,A,PTSD,,22,,Neurofeedback + TAU,Neurofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,28,Structured Clinical Interview,CAPS,CAPS,Completer,,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,End of Treatment,0,,44.12,,95% CI,34.92,53.31,,-36.86,,,,,,,,,,,,,,,,,,CAPS score ≤45,,,,,,Community,,,1,0.8571,,0.1429,Mixed,"child other abuse, rape/sexual assault, intimate partner violence, other (not specified)",Medium,"Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.",46581,2019
vanderkolk2016_CAPS_A_0_ITT,Complementary and integrative health (CIH),PTSD,52,A,PTSD,,22,,Neurofeedback + TAU,Neurofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,28,Structured Clinical Interview,CAPS,CAPS,ITT,missing at random (screened for patterns of missingness),Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,End of Treatment,0,,42.95,,95% CI,34.1,51.8,,-36.5,,,,,,,,,,,,,,,,,,CAPS score ≤45,0.7273,,,,,Community,,,1,0.8571,,0.1429,Mixed,"child other abuse, rape/sexual assault, intimate partner violence, other (not specified)",Medium,"Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.",46581,2019
vanderkolk2016_CAPS_A_4_Comp,Complementary and integrative health (CIH),PTSD,52,A,PTSD,,19,,Neurofeedback + TAU,Neurofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,28,Structured Clinical Interview,CAPS,CAPS,Completer,,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Assessment at <3 Months,4,,40.23,,95% CI,30.51,49.95,,-40.75,,-49.11,-32.47,,d,-2.38,,,,,,,,,,,,CAPS score ≤45,,,,,,Community,,,1,0.8571,,0.1429,Mixed,"child other abuse, rape/sexual assault, intimate partner violence, other (not specified)",Medium,"Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.",46581,2019
vanderkolk2016_CAPS_A_4_ITT,Complementary and integrative health (CIH),PTSD,52,A,PTSD,,19,,Neurofeedback + TAU,Neurofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,28,Structured Clinical Interview,CAPS,CAPS,ITT,missing at random (screened for patterns of missingness),Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Assessment at <3 Months,4,,39.1,,95% CI,29.69,48.51,,-40.35,,-48.67,-32.12,,d,-2.33,,,,"p=""significant""",,,,,,,,CAPS score ≤45,0.5789,,,,,Community,,,1,0.8571,,0.1429,Mixed,"child other abuse, rape/sexual assault, intimate partner violence, other (not specified)",Medium,"Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.",46581,2019
vanderkolk2016_CAPS_A_Baseline_Comp,Complementary and integrative health (CIH),PTSD,52,A,PTSD,,22,,Neurofeedback + TAU,Neurofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,28,Structured Clinical Interview,CAPS,CAPS,Completer,,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Baseline,,,80.89,,95% CI,73.64,88.31,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8571,,0.1429,Mixed,"child other abuse, rape/sexual assault, intimate partner violence, other (not specified)",Medium,"Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.",46581,2019
vanderkolk2016_CAPS_A_Baseline_ITT,Complementary and integrative health (CIH),PTSD,52,A,PTSD,,28,,Neurofeedback + TAU,Neurofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,28,Structured Clinical Interview,CAPS,CAPS,ITT,missing at random (screened for patterns of missingness),Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Baseline,,,79.45,,95% CI,72.86,86.04,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8571,,0.1429,Mixed,"child other abuse, rape/sexual assault, intimate partner violence, other (not specified)",Medium,"Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.",46581,2019
vanderkolk2016_CAPS_B_0_Comp,Complementary and integrative health (CIH),PTSD,52,B,Control,,22,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,24,Structured Clinical Interview,CAPS,CAPS,Completer,,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,End of Treatment,0,,65.68,,95% CI,56.48,74.88,,-9.5,,,,,,,,,,,,,,,,,,CAPS score ≤45,,,,,,Community,,,1,0.8571,,0.1429,Mixed,"child other abuse, rape/sexual assault, intimate partner violence, other (not specified)",Medium,"Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.",46581,2019
vanderkolk2016_CAPS_B_0_ITT,Complementary and integrative health (CIH),PTSD,52,B,Control,,22,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,24,Structured Clinical Interview,CAPS,CAPS,ITT,missing at random (screened for patterns of missingness),Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,End of Treatment,0,,66.49,,95% CI,57.39,75.6,,-9.75,,,,,,,,,,,,,,,,,,CAPS score ≤45,0.3182,,,,,Community,,,1,0.8571,,0.1429,Mixed,"child other abuse, rape/sexual assault, intimate partner violence, other (not specified)",Medium,"Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.",46581,2019
vanderkolk2016_CAPS_B_4_Comp,Complementary and integrative health (CIH),PTSD,52,B,Control,,19,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,24,Structured Clinical Interview,CAPS,CAPS,Completer,,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Assessment at <3 Months,4,,64.68,,95% CI,54.96,74.39,,-10.5,,-18.83,-2.19,,d,-2.38,,,,,,,,,,,,CAPS score ≤45,,,,,,Community,,,1,0.8571,,0.1429,Mixed,"child other abuse, rape/sexual assault, intimate partner violence, other (not specified)",Medium,"Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.",46581,2019
vanderkolk2016_CAPS_B_4_ITT,Complementary and integrative health (CIH),PTSD,52,B,Control,,19,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,24,Structured Clinical Interview,CAPS,CAPS,ITT,missing at random (screened for patterns of missingness),Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Assessment at <3 Months,4,,65.46,,95% CI,55.83,75.1,,-10.78,,-19.1,-2.48,,d,-0.62,,,,"p=""significant""",,,,,,,,CAPS score ≤45,0.1053,,,,,Community,,,1,0.8571,,0.1429,Mixed,"child other abuse, rape/sexual assault, intimate partner violence, other (not specified)",Medium,"Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.",46581,2019
vanderkolk2016_CAPS_B_Baseline_Comp,Complementary and integrative health (CIH),PTSD,52,B,Control,,22,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,24,Structured Clinical Interview,CAPS,CAPS,Completer,,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Baseline,,,75.18,,95% CI,67.84,82.51,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8571,,0.1429,Mixed,"child other abuse, rape/sexual assault, intimate partner violence, other (not specified)",Medium,"Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.",46581,2019
vanderkolk2016_CAPS_B_Baseline_ITT,Complementary and integrative health (CIH),PTSD,52,B,Control,,24,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,24,Structured Clinical Interview,CAPS,CAPS,ITT,missing at random (screened for patterns of missingness),Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Baseline,,,76.24,,95% CI,69.13,83.36,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8571,,0.1429,Mixed,"child other abuse, rape/sexual assault, intimate partner violence, other (not specified)",Medium,"Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.",46581,2019
vanderkolk2016_DTS_A_0_ITT,Complementary and integrative health (CIH),PTSD,52,A,PTSD,,,,Neurofeedback + TAU,Neurofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,28,Self report,DTS,DTS,ITT,missing at random (screened for patterns of missingness),Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,End of Treatment,0,,44.19,,95% CI,35.76,52.63,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8571,,0.1429,Mixed,"child other abuse, rape/sexual assault, intimate partner violence, other (not specified)",Medium,"Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.",46581,2019
vanderkolk2016_DTS_A_4_ITT,Complementary and integrative health (CIH),PTSD,52,A,PTSD,,,,Neurofeedback + TAU,Neurofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,28,Self report,DTS,DTS,ITT,missing at random (screened for patterns of missingness),Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Assessment at <3 Months,4,,36.5,,95% CI,27.4,45.6,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8571,,0.1429,Mixed,"child other abuse, rape/sexual assault, intimate partner violence, other (not specified)",Medium,"Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.",46581,2019
vanderkolk2016_DTS_A_Baseline_ITT,Complementary and integrative health (CIH),PTSD,52,A,PTSD,,,,Neurofeedback + TAU,Neurofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In person,28,Self report,DTS,DTS,ITT,missing at random (screened for patterns of missingness),Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Baseline,,,67.28,,95% CI,57.55,77,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8571,,0.1429,Mixed,"child other abuse, rape/sexual assault, intimate partner violence, other (not specified)",Medium,"Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.",46581,2019
vanderkolk2016_DTS_B_0_ITT,Complementary and integrative health (CIH),PTSD,52,B,Control,,,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,24,Self report,DTS,DTS,ITT,missing at random (screened for patterns of missingness),Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,End of Treatment,0,,58.21,,95% CI,49.26,67.16,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8571,,0.1429,Mixed,"child other abuse, rape/sexual assault, intimate partner violence, other (not specified)",Medium,"Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.",46581,2019
vanderkolk2016_DTS_B_4_ITT,Complementary and integrative health (CIH),PTSD,52,B,Control,,,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,24,Self report,DTS,DTS,ITT,missing at random (screened for patterns of missingness),Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Assessment at <3 Months,4,,56.62,,95% CI,47.09,66.15,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8571,,0.1429,Mixed,"child other abuse, rape/sexual assault, intimate partner violence, other (not specified)",Medium,"Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.",46581,2019
vanderkolk2016_DTS_B_Baseline_ITT,Complementary and integrative health (CIH),PTSD,52,B,Control,,,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,24,Self report,DTS,DTS,ITT,missing at random (screened for patterns of missingness),Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Baseline,,,62.97,,95% CI,52.47,73.48,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.8571,,0.1429,Mixed,"child other abuse, rape/sexual assault, intimate partner violence, other (not specified)",Medium,"Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.",46581,2019
vangelderen2020_CAPS_A_0_ITT,Other mixed,PTSD,43,A,PTSD,,19,,Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR),Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,22,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,End of Treatment,0,,40.70,,95% CI,36.65,44.74,,-2.12,,,,,,,,,,,,,,,,,,Not fulfilling criteria for PTSD according to CAPS-5,,,≥10 point decrease in CAPS-5 score,,,Veteran,0,1,0,0.023,,0.977,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence, terrorism/political violence/forced displacement, other (""severe human suffering"", ""death caused to someone else"", ""explosion or fire"")",Low,"van Gelderen MJ, Nijdam MJ, Haagen JFG, et al. Interactive Motion-Assisted Exposure Therapy for Veterans with Treatment-Resistant Posttraumatic Stress Disorder: A Randomized Controlled Trial. Psychotherapy & Psychosomatics. 2020 Mar 23:1-13. doi: https://dx.doi.org/10.1159/000505977. PMID: 32203971.",,2020
vangelderen2020_CAPS_A_10_ITT,Other mixed,PTSD,43,A,PTSD,,20,,Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR),Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,22,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Assessment at <3 Months,10,,35.97,,95% CI,31.67,40.26,,-6.85,,,,,,,,,,,,,,,,,,Not fulfilling criteria for PTSD according to CAPS-5,0.1,,≥10 point decrease in CAPS-5 score,0.45,,Veteran,0,1,0,0.023,,0.977,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence, terrorism/political violence/forced displacement, other (""severe human suffering"", ""death caused to someone else"", ""explosion or fire"")",Low,"van Gelderen MJ, Nijdam MJ, Haagen JFG, et al. Interactive Motion-Assisted Exposure Therapy for Veterans with Treatment-Resistant Posttraumatic Stress Disorder: A Randomized Controlled Trial. Psychotherapy & Psychosomatics. 2020 Mar 23:1-13. doi: https://dx.doi.org/10.1159/000505977. PMID: 32203971.",,2020
vangelderen2020_CAPS_A_6_ITT,Other mixed,PTSD,43,A,PTSD,,18,,Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR),Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,22,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Assessment at <3 Months,6,,38.29,,95% CI,33.67,42.91,,-4.53,,,,,,,,,,,,,,,,,,Not fulfilling criteria for PTSD according to CAPS-5,,,≥10 point decrease in CAPS-5 score,,,Veteran,0,1,0,0.023,,0.977,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence, terrorism/political violence/forced displacement, other (""severe human suffering"", ""death caused to someone else"", ""explosion or fire"")",Low,"van Gelderen MJ, Nijdam MJ, Haagen JFG, et al. Interactive Motion-Assisted Exposure Therapy for Veterans with Treatment-Resistant Posttraumatic Stress Disorder: A Randomized Controlled Trial. Psychotherapy & Psychosomatics. 2020 Mar 23:1-13. doi: https://dx.doi.org/10.1159/000505977. PMID: 32203971.",,2020
vangelderen2020_CAPS_A_Baseline_ITT,Other mixed,PTSD,43,A,PTSD,,22,,Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR),Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,22,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Baseline,,,42.82,,95% CI,39.45,46.19,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.023,,0.977,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence, terrorism/political violence/forced displacement, other (""severe human suffering"", ""death caused to someone else"", ""explosion or fire"")",Low,"van Gelderen MJ, Nijdam MJ, Haagen JFG, et al. Interactive Motion-Assisted Exposure Therapy for Veterans with Treatment-Resistant Posttraumatic Stress Disorder: A Randomized Controlled Trial. Psychotherapy & Psychosomatics. 2020 Mar 23:1-13. doi: https://dx.doi.org/10.1159/000505977. PMID: 32203971.",,2020
vangelderen2020_CAPS_B_0_ITT,Other mixed,PTSD,43,B,Control,,20,,Non-specific treatment component control,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,21,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,End of Treatment,0,,43.79,,95% CI,39.74,47.84,,-2.88,,,,,,,,,,,,,,,,,,Not fulfilling criteria for PTSD according to CAPS-5,,,≥10 point decrease in CAPS-5 score,,,Veteran,0,1,0,0.023,,0.977,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence, terrorism/political violence/forced displacement, other (""severe human suffering"", ""death caused to someone else"", ""explosion or fire"")",Low,"van Gelderen MJ, Nijdam MJ, Haagen JFG, et al. Interactive Motion-Assisted Exposure Therapy for Veterans with Treatment-Resistant Posttraumatic Stress Disorder: A Randomized Controlled Trial. Psychotherapy & Psychosomatics. 2020 Mar 23:1-13. doi: https://dx.doi.org/10.1159/000505977. PMID: 32203971.",,2020
vangelderen2020_CAPS_B_10_ITT,Other mixed,PTSD,43,B,Control,,20,,Non-specific treatment component control,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,21,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Assessment at <3 Months,10,,44.04,,95% CI,40.91,47.17,,-2.63,,,,,,,,,,,,,,,,,,Not fulfilling criteria for PTSD according to CAPS-5,0.1,,≥10 point decrease in CAPS-5 score,0,,Veteran,0,1,0,0.023,,0.977,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence, terrorism/political violence/forced displacement, other (""severe human suffering"", ""death caused to someone else"", ""explosion or fire"")",Low,"van Gelderen MJ, Nijdam MJ, Haagen JFG, et al. Interactive Motion-Assisted Exposure Therapy for Veterans with Treatment-Resistant Posttraumatic Stress Disorder: A Randomized Controlled Trial. Psychotherapy & Psychosomatics. 2020 Mar 23:1-13. doi: https://dx.doi.org/10.1159/000505977. PMID: 32203971.",,2020
vangelderen2020_CAPS_B_6_ITT,Other mixed,PTSD,43,B,Control,,20,,Non-specific treatment component control,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,21,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Assessment at <3 Months,6,,44.08,,95% CI,40.71,47.45,,-2.59,,,,,,,,,,,,,,,,,,Not fulfilling criteria for PTSD according to CAPS-5,,,≥10 point decrease in CAPS-5 score,,,Veteran,0,1,0,0.023,,0.977,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence, terrorism/political violence/forced displacement, other (""severe human suffering"", ""death caused to someone else"", ""explosion or fire"")",Low,"van Gelderen MJ, Nijdam MJ, Haagen JFG, et al. Interactive Motion-Assisted Exposure Therapy for Veterans with Treatment-Resistant Posttraumatic Stress Disorder: A Randomized Controlled Trial. Psychotherapy & Psychosomatics. 2020 Mar 23:1-13. doi: https://dx.doi.org/10.1159/000505977. PMID: 32203971.",,2020
vangelderen2020_CAPS_B_Baseline_ITT,Other mixed,PTSD,43,B,Control,,21,,Non-specific treatment component control,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,21,Structured Clinical Interview,CAPS,CAPS-5,ITT,Multiple imputation,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Baseline,,,46.67,,95% CI,44.15,49.18,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.023,,0.977,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence, terrorism/political violence/forced displacement, other (""severe human suffering"", ""death caused to someone else"", ""explosion or fire"")",Low,"van Gelderen MJ, Nijdam MJ, Haagen JFG, et al. Interactive Motion-Assisted Exposure Therapy for Veterans with Treatment-Resistant Posttraumatic Stress Disorder: A Randomized Controlled Trial. Psychotherapy & Psychosomatics. 2020 Mar 23:1-13. doi: https://dx.doi.org/10.1159/000505977. PMID: 32203971.",,2020
vangelderen2020_PCL_A_0_ITT,Other mixed,PTSD,43,A,PTSD,,,,Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR),Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,22,Self report,PCL,PCL-5,ITT,Multiple imputation,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,End of Treatment,0,,55.39,,95% CI,50.29,60.48,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.023,,0.977,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence, terrorism/political violence/forced displacement, other (""severe human suffering"", ""death caused to someone else"", ""explosion or fire"")",Low,"van Gelderen MJ, Nijdam MJ, Haagen JFG, et al. Interactive Motion-Assisted Exposure Therapy for Veterans with Treatment-Resistant Posttraumatic Stress Disorder: A Randomized Controlled Trial. Psychotherapy & Psychosomatics. 2020 Mar 23:1-13. doi: https://dx.doi.org/10.1159/000505977. PMID: 32203971.",,2020
vangelderen2020_PCL_A_10_ITT,Other mixed,PTSD,43,A,PTSD,,,,Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR),Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,22,Self report,PCL,PCL-5,ITT,Multiple imputation,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Assessment at <3 Months,10,,49.53,,95% CI,43.37,55.69,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.023,,0.977,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence, terrorism/political violence/forced displacement, other (""severe human suffering"", ""death caused to someone else"", ""explosion or fire"")",Low,"van Gelderen MJ, Nijdam MJ, Haagen JFG, et al. Interactive Motion-Assisted Exposure Therapy for Veterans with Treatment-Resistant Posttraumatic Stress Disorder: A Randomized Controlled Trial. Psychotherapy & Psychosomatics. 2020 Mar 23:1-13. doi: https://dx.doi.org/10.1159/000505977. PMID: 32203971.",,2020
vangelderen2020_PCL_A_6_ITT,Other mixed,PTSD,43,A,PTSD,,,,Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR),Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,22,Self report,PCL,PCL-5,ITT,Multiple imputation,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Assessment at <3 Months,6,,53.00,,95% CI,47.92,58.09,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.023,,0.977,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence, terrorism/political violence/forced displacement, other (""severe human suffering"", ""death caused to someone else"", ""explosion or fire"")",Low,"van Gelderen MJ, Nijdam MJ, Haagen JFG, et al. Interactive Motion-Assisted Exposure Therapy for Veterans with Treatment-Resistant Posttraumatic Stress Disorder: A Randomized Controlled Trial. Psychotherapy & Psychosomatics. 2020 Mar 23:1-13. doi: https://dx.doi.org/10.1159/000505977. PMID: 32203971.",,2020
vangelderen2020_PCL_A_Baseline_ITT,Other mixed,PTSD,43,A,PTSD,,,,Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR),Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,22,Self report,PCL,PCL-5,ITT,Multiple imputation,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Baseline,,,53.98,,95% CI,50.06,57.89,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.023,,0.977,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence, terrorism/political violence/forced displacement, other (""severe human suffering"", ""death caused to someone else"", ""explosion or fire"")",Low,"van Gelderen MJ, Nijdam MJ, Haagen JFG, et al. Interactive Motion-Assisted Exposure Therapy for Veterans with Treatment-Resistant Posttraumatic Stress Disorder: A Randomized Controlled Trial. Psychotherapy & Psychosomatics. 2020 Mar 23:1-13. doi: https://dx.doi.org/10.1159/000505977. PMID: 32203971.",,2020
vangelderen2020_PCL_B_0_ITT,Other mixed,PTSD,43,B,Control,,,,Non-specific treatment component control,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,21,Self report,PCL,PCL-5,ITT,Multiple imputation,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,End of Treatment,0,,51.87,,95% CI,47.46,56.29,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.023,,0.977,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence, terrorism/political violence/forced displacement, other (""severe human suffering"", ""death caused to someone else"", ""explosion or fire"")",Low,"van Gelderen MJ, Nijdam MJ, Haagen JFG, et al. Interactive Motion-Assisted Exposure Therapy for Veterans with Treatment-Resistant Posttraumatic Stress Disorder: A Randomized Controlled Trial. Psychotherapy & Psychosomatics. 2020 Mar 23:1-13. doi: https://dx.doi.org/10.1159/000505977. PMID: 32203971.",,2020
vangelderen2020_PCL_B_10_ITT,Other mixed,PTSD,43,B,Control,,,,Non-specific treatment component control,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,21,Self report,PCL,PCL-5,ITT,Multiple imputation,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Assessment at <3 Months,10,,52.98,,95% CI,48.25,57.72,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.023,,0.977,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence, terrorism/political violence/forced displacement, other (""severe human suffering"", ""death caused to someone else"", ""explosion or fire"")",Low,"van Gelderen MJ, Nijdam MJ, Haagen JFG, et al. Interactive Motion-Assisted Exposure Therapy for Veterans with Treatment-Resistant Posttraumatic Stress Disorder: A Randomized Controlled Trial. Psychotherapy & Psychosomatics. 2020 Mar 23:1-13. doi: https://dx.doi.org/10.1159/000505977. PMID: 32203971.",,2020
vangelderen2020_PCL_B_6_ITT,Other mixed,PTSD,43,B,Control,,,,Non-specific treatment component control,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,21,Self report,PCL,PCL-5,ITT,Multiple imputation,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Assessment at <3 Months,6,,51.79,,95% CI,47.44,56.14,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.023,,0.977,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence, terrorism/political violence/forced displacement, other (""severe human suffering"", ""death caused to someone else"", ""explosion or fire"")",Low,"van Gelderen MJ, Nijdam MJ, Haagen JFG, et al. Interactive Motion-Assisted Exposure Therapy for Veterans with Treatment-Resistant Posttraumatic Stress Disorder: A Randomized Controlled Trial. Psychotherapy & Psychosomatics. 2020 Mar 23:1-13. doi: https://dx.doi.org/10.1159/000505977. PMID: 32203971.",,2020
vangelderen2020_PCL_B_Baseline_ITT,Other mixed,PTSD,43,B,Control,,,,Non-specific treatment component control,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,21,Self report,PCL,PCL-5,ITT,Multiple imputation,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Baseline,,,53.57,,95% CI,50.44,56.7,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.023,,0.977,Mixed,"combat-related, accidents, illness/medical procedure, community/school violence, terrorism/political violence/forced displacement, other (""severe human suffering"", ""death caused to someone else"", ""explosion or fire"")",Low,"van Gelderen MJ, Nijdam MJ, Haagen JFG, et al. Interactive Motion-Assisted Exposure Therapy for Veterans with Treatment-Resistant Posttraumatic Stress Disorder: A Randomized Controlled Trial. Psychotherapy & Psychosomatics. 2020 Mar 23:1-13. doi: https://dx.doi.org/10.1159/000505977. PMID: 32203971.",,2020
vantwoutfrank2019_PCL_A_0_NA,Other mixed,PTSD,20,A,PTSD,,,,Transcranial direct current stimulation + Virtual reality exposure,Transcranial direct current stimulation (tDCS) + Virtual reality exposure (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,,Self report,PCL,PCL-5,,Linear mixed models,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,End of Treatment,0,,32.5,16.3,,,,,-9.33,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"van 't Wout-Frank M, Shea MT, Larson VC, et al. Combined transcranial direct current stimulation with virtual reality exposure for posttraumatic stress disorder: feasibility and pilot results. Brain Stimul. 2019 Jan - Feb;12(1):41-3. doi: 10.1016/j.brs.2018.09.011. PMID: 30266416.",,2020
vantwoutfrank2019_PCL_A_4_NA,Other mixed,PTSD,20,A,PTSD,,,,Transcranial direct current stimulation + Virtual reality exposure,Transcranial direct current stimulation (tDCS) + Virtual reality exposure (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,,Self report,PCL,PCL-5,,Linear mixed models,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Assessment at <3 Months,4,,29.0,13.4,,,,,-12.83,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"van 't Wout-Frank M, Shea MT, Larson VC, et al. Combined transcranial direct current stimulation with virtual reality exposure for posttraumatic stress disorder: feasibility and pilot results. Brain Stimul. 2019 Jan - Feb;12(1):41-3. doi: 10.1016/j.brs.2018.09.011. PMID: 30266416.",,2020
vantwoutfrank2019_PCL_A_Baseline_NA,Other mixed,PTSD,20,A,PTSD,,,,Transcranial direct current stimulation + Virtual reality exposure,Transcranial direct current stimulation (tDCS) + Virtual reality exposure (VRET),Yes,TF,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,,Self report,PCL,PCL-5,,Linear mixed models,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Baseline,,,41.83,10.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"van 't Wout-Frank M, Shea MT, Larson VC, et al. Combined transcranial direct current stimulation with virtual reality exposure for posttraumatic stress disorder: feasibility and pilot results. Brain Stimul. 2019 Jan - Feb;12(1):41-3. doi: 10.1016/j.brs.2018.09.011. PMID: 30266416.",,2020
vantwoutfrank2019_PCL_B_0_NA,Other mixed,PTSD,20,B,PTSD,,,,Sham transcranial direct current stimulation + Virtual reality exposure,Virtual reality exposure (VRET) plus sham,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,,Self report,PCL,PCL-5,,Linear mixed models,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,End of Treatment,0,,35.8,16.2,,,,,-8.53,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"van 't Wout-Frank M, Shea MT, Larson VC, et al. Combined transcranial direct current stimulation with virtual reality exposure for posttraumatic stress disorder: feasibility and pilot results. Brain Stimul. 2019 Jan - Feb;12(1):41-3. doi: 10.1016/j.brs.2018.09.011. PMID: 30266416.",,2020
vantwoutfrank2019_PCL_B_4_NA,Other mixed,PTSD,20,B,PTSD,,,,Sham transcranial direct current stimulation + Virtual reality exposure,Virtual reality exposure (VRET) plus sham,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,,Self report,PCL,PCL-5,,Linear mixed models,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Assessment at <3 Months,4,,35.3,19.6,,,,,-9.03,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"van 't Wout-Frank M, Shea MT, Larson VC, et al. Combined transcranial direct current stimulation with virtual reality exposure for posttraumatic stress disorder: feasibility and pilot results. Brain Stimul. 2019 Jan - Feb;12(1):41-3. doi: 10.1016/j.brs.2018.09.011. PMID: 30266416.",,2020
vantwoutfrank2019_PCL_B_Baseline_NA,Other mixed,PTSD,20,B,PTSD,,,,Sham transcranial direct current stimulation + Virtual reality exposure,Virtual reality exposure (VRET) plus sham,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,,Self report,PCL,PCL-5,,Linear mixed models,Hierarchical linear and nonlinear modeling with restricted maximum likelihood estimation to conduct multilevel regression analyses; Cohen's d,Baseline,,,44.33,15.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,Combat-related,,High,"van 't Wout-Frank M, Shea MT, Larson VC, et al. Combined transcranial direct current stimulation with virtual reality exposure for posttraumatic stress disorder: feasibility and pilot results. Brain Stimul. 2019 Jan - Feb;12(1):41-3. doi: 10.1016/j.brs.2018.09.011. PMID: 30266416.",,2020
vera2011_CAPS_A_0_Comp,Psychotherapy,PTSD,14,A,PTSD,,5,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,7,Structured Clinical Interview,CAPS,CAPS (Spanish version),Completer,Mixed-effects regression models,Mixed-effects regression with both linear and quadratic trends for time and baseline scores as covariate,End of Treatment,0,,36.2,23.61,,,,,-17,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS for DSM-IV,0.4,,15-point decrease in CAPS score,0.4,,Community,,,1,0,,1,,,High,"Vera M, Reyes-Rabanillo ML, Juarbe D, et al. Prolonged exposure for the treatment of Spanish-speaking Puerto Ricans with posttraumatic stress disorder: a feasibility study. BMC Res. Notes. 2011 Oct 17;4:415. doi: 10.1186/1756-0500-4-415. PMID: 22005187.",38256,2019
vera2011_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,14,A,PTSD,,5,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,7,Structured Clinical Interview,CAPS,CAPS (Spanish version),Completer,Mixed-effects regression models,Mixed-effects regression with both linear and quadratic trends for time and baseline scores as covariate,Baseline,,,53.2,8.81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0,,1,,,High,"Vera M, Reyes-Rabanillo ML, Juarbe D, et al. Prolonged exposure for the treatment of Spanish-speaking Puerto Ricans with posttraumatic stress disorder: a feasibility study. BMC Res. Notes. 2011 Oct 17;4:415. doi: 10.1186/1756-0500-4-415. PMID: 22005187.",38256,2019
vera2011_CAPS_B_0_Comp,Psychotherapy,PTSD,14,B,Control,,7,,Usual care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,7,Structured Clinical Interview,CAPS,CAPS (Spanish version),Completer,Mixed-effects regression models,Mixed-effects regression with both linear and quadratic trends for time and baseline scores as covariate,End of Treatment,0,,76.14,22.2,,,,,2.85,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS for DSM-IV,0,,15-point decrease in CAPS score,0.143,,Community,,,1,0,,1,,,High,"Vera M, Reyes-Rabanillo ML, Juarbe D, et al. Prolonged exposure for the treatment of Spanish-speaking Puerto Ricans with posttraumatic stress disorder: a feasibility study. BMC Res. Notes. 2011 Oct 17;4:415. doi: 10.1186/1756-0500-4-415. PMID: 22005187.",38256,2019
vera2011_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,14,B,Control,,7,,Usual care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,7,Structured Clinical Interview,CAPS,CAPS (Spanish version),Completer,Mixed-effects regression models,Mixed-effects regression with both linear and quadratic trends for time and baseline scores as covariate,Baseline,,,73.29,18.42,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0,,1,,,High,"Vera M, Reyes-Rabanillo ML, Juarbe D, et al. Prolonged exposure for the treatment of Spanish-speaking Puerto Ricans with posttraumatic stress disorder: a feasibility study. BMC Res. Notes. 2011 Oct 17;4:415. doi: 10.1186/1756-0500-4-415. PMID: 22005187.",38256,2019
villarreal2016_CAPS_A_0_ITT,Pharmacotherapy,PTSD,80,A,PTSD,,29,,Quetiapine,Quetiapine,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,42,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed-effects regression with both linear and quadratic trends for time and baseline scores as covariate,End of Treatment,0,,53.85,26.4,,,,,-21.55,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,,,High,"Villarreal G, Hamner MB, Ca√±ive JM, et al. Efficacy of quetiapine monotherapy in posttraumatic stress disorder: a randomized, placebo-controlled trial. Am J Psychiatry. 2016 Dec;173(12):1205-12. doi: 10.1176/appi.ajp.2016.15070967. PMID: 27418378.",45102,2019
villarreal2016_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,80,A,PTSD,,42,,Quetiapine,Quetiapine,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,42,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed-effects regression with both linear and quadratic trends for time and baseline scores as covariate,Baseline,,,75.40,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,,,High,"Villarreal G, Hamner MB, Ca√±ive JM, et al. Efficacy of quetiapine monotherapy in posttraumatic stress disorder: a randomized, placebo-controlled trial. Am J Psychiatry. 2016 Dec;173(12):1205-12. doi: 10.1176/appi.ajp.2016.15070967. PMID: 27418378.",45102,2019
villarreal2016_CAPS_B_0_ITT,Pharmacotherapy,PTSD,80,B,Control,,18,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,38,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed-effects regression with both linear and quadratic trends for time and baseline scores as covariate,End of Treatment,0,,65.66,20.8,,,,,-4.94,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,,,High,"Villarreal G, Hamner MB, Ca√±ive JM, et al. Efficacy of quetiapine monotherapy in posttraumatic stress disorder: a randomized, placebo-controlled trial. Am J Psychiatry. 2016 Dec;173(12):1205-12. doi: 10.1176/appi.ajp.2016.15070967. PMID: 27418378.",45102,2019
villarreal2016_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,80,B,Control,,38,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,38,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,Mixed-effects regression with both linear and quadratic trends for time and baseline scores as covariate,Baseline,,,70.60,11.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,,,High,"Villarreal G, Hamner MB, Ca√±ive JM, et al. Efficacy of quetiapine monotherapy in posttraumatic stress disorder: a randomized, placebo-controlled trial. Am J Psychiatry. 2016 Dec;173(12):1205-12. doi: 10.1176/appi.ajp.2016.15070967. PMID: 27418378.",45102,2019
villarreal2016_DTS_A_0_NA,Pharmacotherapy,PTSD,80,A,PTSD,,,,Quetiapine,Quetiapine,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,42,Self report,DTS,DTS,,,Mixed-effects regression with both linear and quadratic trends for time and baseline scores as covariate,End of Treatment,0,,63.82,35.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,,,High,"Villarreal G, Hamner MB, Ca√±ive JM, et al. Efficacy of quetiapine monotherapy in posttraumatic stress disorder: a randomized, placebo-controlled trial. Am J Psychiatry. 2016 Dec;173(12):1205-12. doi: 10.1176/appi.ajp.2016.15070967. PMID: 27418378.",45102,2019
villarreal2016_DTS_A_Baseline_NA,Pharmacotherapy,PTSD,80,A,PTSD,,,,Quetiapine,Quetiapine,No,Not Applicable,Yes,Antipsychotic,No,Not Applicable,No,No,No,No,No,Individual,In Person,42,Self report,DTS,DTS,,,Mixed-effects regression with both linear and quadratic trends for time and baseline scores as covariate,Baseline,,,91.38,22.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,,,High,"Villarreal G, Hamner MB, Ca√±ive JM, et al. Efficacy of quetiapine monotherapy in posttraumatic stress disorder: a randomized, placebo-controlled trial. Am J Psychiatry. 2016 Dec;173(12):1205-12. doi: 10.1176/appi.ajp.2016.15070967. PMID: 27418378.",45102,2019
villarreal2016_DTS_B_0_NA,Pharmacotherapy,PTSD,80,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,38,Self report,DTS,DTS,,,Mixed-effects regression with both linear and quadratic trends for time and baseline scores as covariate,End of Treatment,0,,73.73,29.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,,,High,"Villarreal G, Hamner MB, Ca√±ive JM, et al. Efficacy of quetiapine monotherapy in posttraumatic stress disorder: a randomized, placebo-controlled trial. Am J Psychiatry. 2016 Dec;173(12):1205-12. doi: 10.1176/appi.ajp.2016.15070967. PMID: 27418378.",45102,2019
villarreal2016_DTS_B_Baseline_NA,Pharmacotherapy,PTSD,80,B,Control,,,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,38,Self report,DTS,DTS,,,Mixed-effects regression with both linear and quadratic trends for time and baseline scores as covariate,Baseline,,,84.47,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,,,High,"Villarreal G, Hamner MB, Ca√±ive JM, et al. Efficacy of quetiapine monotherapy in posttraumatic stress disorder: a randomized, placebo-controlled trial. Am J Psychiatry. 2016 Dec;173(12):1205-12. doi: 10.1176/appi.ajp.2016.15070967. PMID: 27418378.",45102,2019
wagner2007_PCL_A_0_ITT,Psychotherapy,PTSD,8,A,PTSD,,4,,Behavioral Activation,Behavioral activation (BA),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,4,Self report,PCL,PCL-C,ITT,,Residualized change scores,End of Treatment,0,,36.5,13.5,,,,,-17.7,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.625,,0.375,Accidents,,High,"Wagner AW, Zatzick DF, Ghesquiere A, et al. Behavioral activation as an early intervention for posttraumatic stress disorder and depression among physically injured trauma survivors. Cogn Behav Pract. 2007 Nov;14(4):341-9. doi: 10.1016/j.cbpra.2006.05.002.",32469,2019
wagner2007_PCL_A_Baseline_ITT,Psychotherapy,PTSD,8,A,PTSD,,4,,Behavioral Activation,Behavioral activation (BA),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,4,Self report,PCL,PCL-C,ITT,,Residualized change scores,Baseline,,,54.2,17.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.625,,0.375,Accidents,,High,"Wagner AW, Zatzick DF, Ghesquiere A, et al. Behavioral activation as an early intervention for posttraumatic stress disorder and depression among physically injured trauma survivors. Cogn Behav Pract. 2007 Nov;14(4):341-9. doi: 10.1016/j.cbpra.2006.05.002.",32469,2019
wagner2007_PCL_B_0_ITT,Psychotherapy,PTSD,8,B,Control,,4,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,4,Self report,PCL,PCL-C,ITT,,Residualized change scores,End of Treatment,0,,57.7,21.3,,,,,2.2,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.625,,0.375,Accidents,,High,"Wagner AW, Zatzick DF, Ghesquiere A, et al. Behavioral activation as an early intervention for posttraumatic stress disorder and depression among physically injured trauma survivors. Cogn Behav Pract. 2007 Nov;14(4):341-9. doi: 10.1016/j.cbpra.2006.05.002.",32469,2019
wagner2007_PCL_B_Baseline_ITT,Psychotherapy,PTSD,8,B,Control,,4,,TAU,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,4,Self report,PCL,PCL-C,ITT,,Residualized change scores,Baseline,,,55.5,11.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.625,,0.375,Accidents,,High,"Wagner AW, Zatzick DF, Ghesquiere A, et al. Behavioral activation as an early intervention for posttraumatic stress disorder and depression among physically injured trauma survivors. Cogn Behav Pract. 2007 Nov;14(4):341-9. doi: 10.1016/j.cbpra.2006.05.002.",32469,2019
wagner2019_CAPS_A_0_ITT,Psychotherapy,PTSD,80,A,PTSD,,30,,Behavioral activation,Behavioral activation (BA),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,42,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation (mixed-effects regression model),Residualized change scores,End of Treatment,0,,54.40,22.98,,,,,-21.48,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,Other (military-related),,High,"Wagner AW, Jakupcak M, Kowalski HM, et al. Behavioral activation as a treatment for posttraumatic stress disorder among returning veterans: a randomized trial. Psychiatr Serv. 2019 Oct 1;70(10):867-73. doi: 10.1176/appi.ps.201800572. PMID: 31337325.",52288,2020
wagner2019_CAPS_A_12_ITT,Psychotherapy,PTSD,80,A,PTSD,,28,,Behavioral activation,Behavioral activation (BA),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,42,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation (mixed-effects regression model),Residualized change scores,Assessment at 3 to <6 Months,12,,56.25,25.43,,,,,-19.63,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,Other (military-related),,High,"Wagner AW, Jakupcak M, Kowalski HM, et al. Behavioral activation as a treatment for posttraumatic stress disorder among returning veterans: a randomized trial. Psychiatr Serv. 2019 Oct 1;70(10):867-73. doi: 10.1176/appi.ps.201800572. PMID: 31337325.",52288,2020
wagner2019_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,80,A,PTSD,,42,,Behavioral activation,Behavioral activation (BA),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,42,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation (mixed-effects regression model),Residualized change scores,Baseline,,,75.88,15.15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,Other (military-related),,High,"Wagner AW, Jakupcak M, Kowalski HM, et al. Behavioral activation as a treatment for posttraumatic stress disorder among returning veterans: a randomized trial. Psychiatr Serv. 2019 Oct 1;70(10):867-73. doi: 10.1176/appi.ps.201800572. PMID: 31337325.",52288,2020
wagner2019_CAPS_B_0_ITT,Psychotherapy,PTSD,80,B,PTSD,,24,,Standard care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,38,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation (mixed-effects regression model),Residualized change scores,End of Treatment,0,,70.13,25.68,,,,,-11.87,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,Other (military-related),,High,"Wagner AW, Jakupcak M, Kowalski HM, et al. Behavioral activation as a treatment for posttraumatic stress disorder among returning veterans: a randomized trial. Psychiatr Serv. 2019 Oct 1;70(10):867-73. doi: 10.1176/appi.ps.201800572. PMID: 31337325.",52288,2020
wagner2019_CAPS_B_12_ITT,Psychotherapy,PTSD,80,B,PTSD,,25,,Standard care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,38,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation (mixed-effects regression model),Residualized change scores,Assessment at 3 to <6 Months,12,,64.60,28.3,,,,,-17.4,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,Other (military-related),,High,"Wagner AW, Jakupcak M, Kowalski HM, et al. Behavioral activation as a treatment for posttraumatic stress disorder among returning veterans: a randomized trial. Psychiatr Serv. 2019 Oct 1;70(10):867-73. doi: 10.1176/appi.ps.201800572. PMID: 31337325.",52288,2020
wagner2019_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,80,B,PTSD,,38,,Standard care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,38,Structured Clinical Interview,CAPS,CAPS,ITT,Imputation (mixed-effects regression model),Residualized change scores,Baseline,,,82.00,15.72,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,Other (military-related),,High,"Wagner AW, Jakupcak M, Kowalski HM, et al. Behavioral activation as a treatment for posttraumatic stress disorder among returning veterans: a randomized trial. Psychiatr Serv. 2019 Oct 1;70(10):867-73. doi: 10.1176/appi.ps.201800572. PMID: 31337325.",52288,2020
wagner2019_PCL_A_0_ITT,Psychotherapy,PTSD,80,A,PTSD,,,,Behavioral activation,Behavioral activation (BA),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,42,Self report,PCL,PCL-M,ITT,Imputation (mixed-effects regression model),Residualized change scores,End of Treatment,0,,44.17,12.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,Other (military-related),,High,"Wagner AW, Jakupcak M, Kowalski HM, et al. Behavioral activation as a treatment for posttraumatic stress disorder among returning veterans: a randomized trial. Psychiatr Serv. 2019 Oct 1;70(10):867-73. doi: 10.1176/appi.ps.201800572. PMID: 31337325.",52288,2020
wagner2019_PCL_A_12_ITT,Psychotherapy,PTSD,80,A,PTSD,,,,Behavioral activation,Behavioral activation (BA),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,42,Self report,PCL,PCL-M,ITT,Imputation (mixed-effects regression model),Residualized change scores,Assessment at 3 to <6 Months,12,,47.90,13.44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,Other (military-related),,High,"Wagner AW, Jakupcak M, Kowalski HM, et al. Behavioral activation as a treatment for posttraumatic stress disorder among returning veterans: a randomized trial. Psychiatr Serv. 2019 Oct 1;70(10):867-73. doi: 10.1176/appi.ps.201800572. PMID: 31337325.",52288,2020
wagner2019_PCL_A_Baseline_ITT,Psychotherapy,PTSD,80,A,PTSD,,,,Behavioral activation,Behavioral activation (BA),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,42,Self report,PCL,PCL-M,ITT,Imputation (mixed-effects regression model),Residualized change scores,Baseline,,,58.95,7.75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,Other (military-related),,High,"Wagner AW, Jakupcak M, Kowalski HM, et al. Behavioral activation as a treatment for posttraumatic stress disorder among returning veterans: a randomized trial. Psychiatr Serv. 2019 Oct 1;70(10):867-73. doi: 10.1176/appi.ps.201800572. PMID: 31337325.",52288,2020
wagner2019_PCL_B_0_ITT,Psychotherapy,PTSD,80,B,PTSD,,,,Standard care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,38,Self report,PCL,PCL-M,ITT,Imputation (mixed-effects regression model),Residualized change scores,End of Treatment,0,,52.56,12.99,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,Other (military-related),,High,"Wagner AW, Jakupcak M, Kowalski HM, et al. Behavioral activation as a treatment for posttraumatic stress disorder among returning veterans: a randomized trial. Psychiatr Serv. 2019 Oct 1;70(10):867-73. doi: 10.1176/appi.ps.201800572. PMID: 31337325.",52288,2020
wagner2019_PCL_B_12_ITT,Psychotherapy,PTSD,80,B,PTSD,,,,Standard care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,38,Self report,PCL,PCL-M,ITT,Imputation (mixed-effects regression model),Residualized change scores,Assessment at 3 to <6 Months,12,,51.36,15.06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,Other (military-related),,High,"Wagner AW, Jakupcak M, Kowalski HM, et al. Behavioral activation as a treatment for posttraumatic stress disorder among returning veterans: a randomized trial. Psychiatr Serv. 2019 Oct 1;70(10):867-73. doi: 10.1176/appi.ps.201800572. PMID: 31337325.",52288,2020
wagner2019_PCL_B_Baseline_ITT,Psychotherapy,PTSD,80,B,PTSD,,,,Standard care,Treatment as usual (TAU),No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,38,Self report,PCL,PCL-M,ITT,Imputation (mixed-effects regression model),Residualized change scores,Baseline,,,58.97,8.09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0625,,0.9375,Other (military-related),,High,"Wagner AW, Jakupcak M, Kowalski HM, et al. Behavioral activation as a treatment for posttraumatic stress disorder among returning veterans: a randomized trial. Psychiatr Serv. 2019 Oct 1;70(10):867-73. doi: 10.1176/appi.ps.201800572. PMID: 31337325.",52288,2020
wahbeh2016_PCL_A_0_Comp,Complementary and integrative health (CIH),PTSD,114,A,PTSD,,27,,Mindfulness meditation,Mindfulness,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL,Completer,Linear mixed model (assumes data missing at random),Linear mixed model; post hoc paired-arm comparisons and within-arm pre-post changes; false discovery rate correction; mixed model ANOVAs with a priori pairwise comparisons using significance of p=0.05; effect sizes with partial eta-squared and Cohen's d.,End of Treatment,0,,50.71,13.91,,,,,-5.54,,,,,Cohen's d,0.47,,,,p=0.02,,,,,,,,,,,Decrease of 6 to 10 points on PCL-C (RCI 1.00 to 1.96),0.1111,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.0588,,0.9412,Other (not specified),,High,"Wahbeh H, Goodrich E, Goy E, et al. Mechanistic pathways of mindfulness meditation in combat veterans with posttraumatic stress disorder. J Clin Psychol. 2016 Apr;72(4):365-83. doi: 10.1002/jclp.22255. PMID: 26797725.",48070,2019
wahbeh2016_PCL_A_Baseline_Comp,Complementary and integrative health (CIH),PTSD,114,A,PTSD,,27,,Mindfulness meditation,Mindfulness,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL,Completer,Linear mixed model (assumes data missing at random),Linear mixed model; post hoc paired-arm comparisons and within-arm pre-post changes; false discovery rate correction; mixed model ANOVAs with a priori pairwise comparisons using significance of p=0.05; effect sizes with partial eta-squared and Cohen's d.,Baseline,,,56.25,9.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0588,,0.9412,Other (not specified),,High,"Wahbeh H, Goodrich E, Goy E, et al. Mechanistic pathways of mindfulness meditation in combat veterans with posttraumatic stress disorder. J Clin Psychol. 2016 Apr;72(4):365-83. doi: 10.1002/jclp.22255. PMID: 26797725.",48070,2019
wahbeh2016_PCL_B_0_Comp,Complementary and integrative health (CIH),PTSD,114,B,PTSD,,25,,Slow breathing (RESPeRATE biofeedback device),Biofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL,Completer,Linear mixed model (assumes data missing at random),Linear mixed model; post hoc paired-arm comparisons and within-arm pre-post changes; false discovery rate correction; mixed model ANOVAs with a priori pairwise comparisons using significance of p=0.05; effect sizes with partial eta-squared and Cohen's d.,End of Treatment,0,,54.18,12.05,,,,,-0.3,,,,,,,,,,p=0.59,,,,,,,,,,,Decrease of 6 to 10 points on PCL-C (RCI 1.00 to 1.96),0.16,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.0588,,0.9412,Other (not specified),,High,"Wahbeh H, Goodrich E, Goy E, et al. Mechanistic pathways of mindfulness meditation in combat veterans with posttraumatic stress disorder. J Clin Psychol. 2016 Apr;72(4):365-83. doi: 10.1002/jclp.22255. PMID: 26797725.",48070,2019
wahbeh2016_PCL_B_Baseline_Comp,Complementary and integrative health (CIH),PTSD,114,B,PTSD,,25,,Slow breathing (RESPeRATE biofeedback device),Biofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL,Completer,Linear mixed model (assumes data missing at random),Linear mixed model; post hoc paired-arm comparisons and within-arm pre-post changes; false discovery rate correction; mixed model ANOVAs with a priori pairwise comparisons using significance of p=0.05; effect sizes with partial eta-squared and Cohen's d.,Baseline,,,54.5,11.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0588,,0.9412,Other (not specified),,High,"Wahbeh H, Goodrich E, Goy E, et al. Mechanistic pathways of mindfulness meditation in combat veterans with posttraumatic stress disorder. J Clin Psychol. 2016 Apr;72(4):365-83. doi: 10.1002/jclp.22255. PMID: 26797725.",48070,2019
wahbeh2016_PCL_C_0_Comp,Complementary and integrative health (CIH),PTSD,114,C,PTSD,,25,,Mindfulness meditation + slow breathing,Mindfulness meditation + slow breathing,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL,Completer,Linear mixed model (assumes data missing at random),Linear mixed model; post hoc paired-arm comparisons and within-arm pre-post changes; false discovery rate correction; mixed model ANOVAs with a priori pairwise comparisons using significance of p=0.05; effect sizes with partial eta-squared and Cohen's d.,End of Treatment,0,,46.91,10.96,,,,,-5.1,,,,,,,,,,p=0.006,,,,,,,,,,,Decrease of 6 to 10 points on PCL-C (RCI 1.00 to 1.96),0.1,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.0588,,0.9412,Other (not specified),,High,"Wahbeh H, Goodrich E, Goy E, et al. Mechanistic pathways of mindfulness meditation in combat veterans with posttraumatic stress disorder. J Clin Psychol. 2016 Apr;72(4):365-83. doi: 10.1002/jclp.22255. PMID: 26797725.",48070,2019
wahbeh2016_PCL_C_Baseline_Comp,Complementary and integrative health (CIH),PTSD,114,C,PTSD,,25,,Mindfulness meditation + slow breathing,Mindfulness meditation + slow breathing,No,Not Applicable,No,Not Applicable,Yes,Meditation,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL,Completer,Linear mixed model (assumes data missing at random),Linear mixed model; post hoc paired-arm comparisons and within-arm pre-post changes; false discovery rate correction; mixed model ANOVAs with a priori pairwise comparisons using significance of p=0.05; effect sizes with partial eta-squared and Cohen's d.,Baseline,,,52,10.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0588,,0.9412,Other (not specified),,High,"Wahbeh H, Goodrich E, Goy E, et al. Mechanistic pathways of mindfulness meditation in combat veterans with posttraumatic stress disorder. J Clin Psychol. 2016 Apr;72(4):365-83. doi: 10.1002/jclp.22255. PMID: 26797725.",48070,2019
wahbeh2016_PCL_D_0_Comp,Complementary and integrative health (CIH),PTSD,114,D,Control,,25,,Sitting quietly,Sitting quietly,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Self report,PCL,PCL,Completer,Linear mixed model (assumes data missing at random),Linear mixed model; post hoc paired-arm comparisons and within-arm pre-post changes; false discovery rate correction; mixed model ANOVAs with a priori pairwise comparisons using significance of p=0.05; effect sizes with partial eta-squared and Cohen's d.,End of Treatment,0,,51.55,12.06,,,,,-3.8,,,,,,,,,,p=0.04,,,,,,,,,,,Decrease of 6 to 10 points on PCL-C (RCI 1.00 to 1.96),0.12,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.0588,,0.9412,Other (not specified),,High,"Wahbeh H, Goodrich E, Goy E, et al. Mechanistic pathways of mindfulness meditation in combat veterans with posttraumatic stress disorder. J Clin Psychol. 2016 Apr;72(4):365-83. doi: 10.1002/jclp.22255. PMID: 26797725.",48070,2019
wahbeh2016_PCL_D_Baseline_Comp,Complementary and integrative health (CIH),PTSD,114,D,Control,,25,,Sitting quietly,Sitting quietly,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,,Self report,PCL,PCL,Completer,Linear mixed model (assumes data missing at random),Linear mixed model; post hoc paired-arm comparisons and within-arm pre-post changes; false discovery rate correction; mixed model ANOVAs with a priori pairwise comparisons using significance of p=0.05; effect sizes with partial eta-squared and Cohen's d.,Baseline,,,55.3,9.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.0588,,0.9412,Other (not specified),,High,"Wahbeh H, Goodrich E, Goy E, et al. Mechanistic pathways of mindfulness meditation in combat veterans with posttraumatic stress disorder. J Clin Psychol. 2016 Apr;72(4):365-83. doi: 10.1002/jclp.22255. PMID: 26797725.",48070,2019
walters2020_CAPS_A_0_ITT,Psychotherapy,PTSD,23,A,PTSD,,7,,IRT + CBT-I,Cognitive Behavioral Therapy for Insomnia (CBT-I) + Imagery Rehearsal Training (IRT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,12,Structured Clinical Interview,CAPS,CAPS-IV,ITT,Complete case (pairwise deletion),Linear mixed model; post hoc paired-arm comparisons and within-arm pre-post changes; false discovery rate correction; mixed model ANOVAs with a priori pairwise comparisons using significance of p=0.05; effect sizes with partial eta-squared and Cohen's d.,End of Treatment,0,,37.57,20.97,,,,,-15.76,,,,,,,,,,p<0.05,,,,,,,,,,,,,,Mixed,0.1778,0.8222,0,0.1739,,0.8261,Combat-related,,High,"Walters EM, Jenkins MM, Nappi CM, et al. The impact of prolonged exposure on sleep and enhancing treatment outcomes with evidence-based sleep interventions: a pilot study. Psychol Trauma. 2020 Feb;12(2):175-85. doi: 10.1037/tra0000478. PMID: 31246050.",,2020
walters2020_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,23,A,PTSD,,12,,IRT + CBT-I,Cognitive Behavioral Therapy for Insomnia (CBT-I) + Imagery Rehearsal Training (IRT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,12,Structured Clinical Interview,CAPS,CAPS-IV,ITT,Complete case (pairwise deletion),Linear mixed model; post hoc paired-arm comparisons and within-arm pre-post changes; false discovery rate correction; mixed model ANOVAs with a priori pairwise comparisons using significance of p=0.05; effect sizes with partial eta-squared and Cohen's d.,Baseline,,,53.33,19.38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.1778,0.8222,0,0.1739,,0.8261,Combat-related,,High,"Walters EM, Jenkins MM, Nappi CM, et al. The impact of prolonged exposure on sleep and enhancing treatment outcomes with evidence-based sleep interventions: a pilot study. Psychol Trauma. 2020 Feb;12(2):175-85. doi: 10.1037/tra0000478. PMID: 31246050.",,2020
walters2020_CAPS_B_0_ITT,Psychotherapy,PTSD,23,B,PTSD,,8,,Supportive care therapy,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,11,Structured Clinical Interview,CAPS,CAPS-IV,ITT,Complete case (pairwise deletion),Linear mixed model; post hoc paired-arm comparisons and within-arm pre-post changes; false discovery rate correction; mixed model ANOVAs with a priori pairwise comparisons using significance of p=0.05; effect sizes with partial eta-squared and Cohen's d.,End of Treatment,0,,52.38,18.52,,,,,-8.98,,,,,,,,,,p>0.05,,,,,,,,,,,,,,Mixed,0.1778,0.8222,0,0.1739,,0.8261,Combat-related,,High,"Walters EM, Jenkins MM, Nappi CM, et al. The impact of prolonged exposure on sleep and enhancing treatment outcomes with evidence-based sleep interventions: a pilot study. Psychol Trauma. 2020 Feb;12(2):175-85. doi: 10.1037/tra0000478. PMID: 31246050.",,2020
walters2020_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,23,B,PTSD,,11,,Supportive care therapy,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,11,Structured Clinical Interview,CAPS,CAPS-IV,ITT,Complete case (pairwise deletion),Linear mixed model; post hoc paired-arm comparisons and within-arm pre-post changes; false discovery rate correction; mixed model ANOVAs with a priori pairwise comparisons using significance of p=0.05; effect sizes with partial eta-squared and Cohen's d.,Baseline,,,61.36,19.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.1778,0.8222,0,0.1739,,0.8261,Combat-related,,High,"Walters EM, Jenkins MM, Nappi CM, et al. The impact of prolonged exposure on sleep and enhancing treatment outcomes with evidence-based sleep interventions: a pilot study. Psychol Trauma. 2020 Feb;12(2):175-85. doi: 10.1037/tra0000478. PMID: 31246050.",,2020
walters2020_PCL_A_0_ITT,Psychotherapy,PTSD,23,A,PTSD,,,,IRT + CBT-I,Cognitive Behavioral Therapy for Insomnia (CBT-I) + Imagery Rehearsal Training (IRT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,12,Self report,PCL,PCL,ITT,Complete case (pairwise deletion),Linear mixed model; post hoc paired-arm comparisons and within-arm pre-post changes; false discovery rate correction; mixed model ANOVAs with a priori pairwise comparisons using significance of p=0.05; effect sizes with partial eta-squared and Cohen's d.,End of Treatment,0,,34.43,16.15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.1778,0.8222,0,0.1739,,0.8261,Combat-related,,High,"Walters EM, Jenkins MM, Nappi CM, et al. The impact of prolonged exposure on sleep and enhancing treatment outcomes with evidence-based sleep interventions: a pilot study. Psychol Trauma. 2020 Feb;12(2):175-85. doi: 10.1037/tra0000478. PMID: 31246050.",,2020
walters2020_PCL_A_Baseline_ITT,Psychotherapy,PTSD,23,A,PTSD,,,,IRT + CBT-I,Cognitive Behavioral Therapy for Insomnia (CBT-I) + Imagery Rehearsal Training (IRT),Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,12,Self report,PCL,PCL,ITT,Complete case (pairwise deletion),Linear mixed model; post hoc paired-arm comparisons and within-arm pre-post changes; false discovery rate correction; mixed model ANOVAs with a priori pairwise comparisons using significance of p=0.05; effect sizes with partial eta-squared and Cohen's d.,Baseline,,,39.75,14.58,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.1778,0.8222,0,0.1739,,0.8261,Combat-related,,High,"Walters EM, Jenkins MM, Nappi CM, et al. The impact of prolonged exposure on sleep and enhancing treatment outcomes with evidence-based sleep interventions: a pilot study. Psychol Trauma. 2020 Feb;12(2):175-85. doi: 10.1037/tra0000478. PMID: 31246050.",,2020
walters2020_PCL_B_0_ITT,Psychotherapy,PTSD,23,B,PTSD,,,,Supportive care therapy,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,11,Self report,PCL,PCL,ITT,Complete case (pairwise deletion),Linear mixed model; post hoc paired-arm comparisons and within-arm pre-post changes; false discovery rate correction; mixed model ANOVAs with a priori pairwise comparisons using significance of p=0.05; effect sizes with partial eta-squared and Cohen's d.,End of Treatment,0,,40.38,14.17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.1778,0.8222,0,0.1739,,0.8261,Combat-related,,High,"Walters EM, Jenkins MM, Nappi CM, et al. The impact of prolonged exposure on sleep and enhancing treatment outcomes with evidence-based sleep interventions: a pilot study. Psychol Trauma. 2020 Feb;12(2):175-85. doi: 10.1037/tra0000478. PMID: 31246050.",,2020
walters2020_PCL_B_Baseline_ITT,Psychotherapy,PTSD,23,B,PTSD,,,,Supportive care therapy,Supportive counseling,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,11,Self report,PCL,PCL,ITT,Complete case (pairwise deletion),Linear mixed model; post hoc paired-arm comparisons and within-arm pre-post changes; false discovery rate correction; mixed model ANOVAs with a priori pairwise comparisons using significance of p=0.05; effect sizes with partial eta-squared and Cohen's d.,Baseline,,,45.80,16.73,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,0.1778,0.8222,0,0.1739,,0.8261,Combat-related,,High,"Walters EM, Jenkins MM, Nappi CM, et al. The impact of prolonged exposure on sleep and enhancing treatment outcomes with evidence-based sleep interventions: a pilot study. Psychol Trauma. 2020 Feb;12(2):175-85. doi: 10.1037/tra0000478. PMID: 31246050.",,2020
wang2012_CAPS_A_0_Comp,Other mixed,PTSD,138,A,PTSD,,63,,Electroacupuncture,Acupuncture,No,Not Applicable,No,Not Applicable,Yes,Acupuncture,No,No,No,No,No,Individual,In Person,69,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,End of Treatment,0,,27.3,17.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5814,,0.4186,Natural or manmade disasters,,Medium,"Wang Y, Hu YP, Wang WC, et al. Clinical studies on treatment of earthquake-caused posttraumatic stress disorder using electroacupuncture. Evid Based Complement Alternat Med. 2012;2012:431279. doi: 10.1155/2012/431279. PMID: 23049609.",40245,2019
wang2012_CAPS_A_12_Comp,Other mixed,PTSD,138,A,PTSD,,63,,Electroacupuncture,Acupuncture,No,Not Applicable,No,Not Applicable,Yes,Acupuncture,No,No,No,No,No,Individual,In Person,69,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,Assessment at 3 to <6 Months,12,,20.4,15.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5814,,0.4186,Natural or manmade disasters,,Medium,"Wang Y, Hu YP, Wang WC, et al. Clinical studies on treatment of earthquake-caused posttraumatic stress disorder using electroacupuncture. Evid Based Complement Alternat Med. 2012;2012:431279. doi: 10.1155/2012/431279. PMID: 23049609.",40245,2019
wang2012_CAPS_A_26_Comp,Other mixed,PTSD,138,A,PTSD,,63,,Electroacupuncture,Acupuncture,No,Not Applicable,No,Not Applicable,Yes,Acupuncture,No,No,No,No,No,Individual,In Person,69,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,Assessment at 6 to <12 Months,26,,15.9,14.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5814,,0.4186,Natural or manmade disasters,,Medium,"Wang Y, Hu YP, Wang WC, et al. Clinical studies on treatment of earthquake-caused posttraumatic stress disorder using electroacupuncture. Evid Based Complement Alternat Med. 2012;2012:431279. doi: 10.1155/2012/431279. PMID: 23049609.",40245,2019
wang2012_CAPS_A_Baseline_Comp,Other mixed,PTSD,138,A,PTSD,,63,,Electroacupuncture,Acupuncture,No,Not Applicable,No,Not Applicable,Yes,Acupuncture,No,No,No,No,No,Individual,In Person,69,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5814,,0.4186,Natural or manmade disasters,,Medium,"Wang Y, Hu YP, Wang WC, et al. Clinical studies on treatment of earthquake-caused posttraumatic stress disorder using electroacupuncture. Evid Based Complement Alternat Med. 2012;2012:431279. doi: 10.1155/2012/431279. PMID: 23049609.",40245,2019
wang2012_CAPS_B_0_Comp,Other mixed,PTSD,138,B,PTSD,,64,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,69,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,End of Treatment,0,,31.2,18.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5814,,0.4186,Natural or manmade disasters,,Medium,"Wang Y, Hu YP, Wang WC, et al. Clinical studies on treatment of earthquake-caused posttraumatic stress disorder using electroacupuncture. Evid Based Complement Alternat Med. 2012;2012:431279. doi: 10.1155/2012/431279. PMID: 23049609.",40245,2019
wang2012_CAPS_B_12_Comp,Other mixed,PTSD,138,B,PTSD,,64,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,69,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,Assessment at 3 to <6 Months,12,,26.3,19.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5814,,0.4186,Natural or manmade disasters,,Medium,"Wang Y, Hu YP, Wang WC, et al. Clinical studies on treatment of earthquake-caused posttraumatic stress disorder using electroacupuncture. Evid Based Complement Alternat Med. 2012;2012:431279. doi: 10.1155/2012/431279. PMID: 23049609.",40245,2019
wang2012_CAPS_B_26_Comp,Other mixed,PTSD,138,B,PTSD,,64,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,69,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,Assessment at 6 to <12 Months,26,,21.8,18.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5814,,0.4186,Natural or manmade disasters,,Medium,"Wang Y, Hu YP, Wang WC, et al. Clinical studies on treatment of earthquake-caused posttraumatic stress disorder using electroacupuncture. Evid Based Complement Alternat Med. 2012;2012:431279. doi: 10.1155/2012/431279. PMID: 23049609.",40245,2019
wang2012_CAPS_B_Baseline_Comp,Other mixed,PTSD,138,B,PTSD,,64,,Paroxetine,Paroxetine,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,69,Structured Clinical Interview,CAPS,CAPS,Completer,,ANOVA,Baseline,,,66.8,21.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.5814,,0.4186,Natural or manmade disasters,,Medium,"Wang Y, Hu YP, Wang WC, et al. Clinical studies on treatment of earthquake-caused posttraumatic stress disorder using electroacupuncture. Evid Based Complement Alternat Med. 2012;2012:431279. doi: 10.1155/2012/431279. PMID: 23049609.",40245,2019
watson1997_M-PTSD_A_0_NA,Complementary and integrative health (CIH),PTSD,90,A,PTSD,,,,Relaxation Instruction,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,30,Self report,M-PTSD,M-PTSD,,,Type 1 mixed ANOVA,End of Treatment,0,,124.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,High,"Watson CG, Tuorila JR, Vickers KS, et al. The efficacies of three relaxation regimens in the treatment of PTSD in Vietnam War veterans. J Clin Psychol. 1997 Dec;53(8):917-23. doi: 10.1002/(SICI)1097-4679(199712)53:8<917::AID-JCLP17>3.0.CO;2-N. PMID: 9403395.",09969,2019
watson1997_M-PTSD_A_Baseline_NA,Complementary and integrative health (CIH),PTSD,90,A,PTSD,,,,Relaxation Instruction,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,30,Self report,M-PTSD,M-PTSD,,,Type 1 mixed ANOVA,Baseline,,,128.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,High,"Watson CG, Tuorila JR, Vickers KS, et al. The efficacies of three relaxation regimens in the treatment of PTSD in Vietnam War veterans. J Clin Psychol. 1997 Dec;53(8):917-23. doi: 10.1002/(SICI)1097-4679(199712)53:8<917::AID-JCLP17>3.0.CO;2-N. PMID: 9403395.",09969,2019
watson1997_M-PTSD_B_0_NA,Complementary and integrative health (CIH),PTSD,90,B,PTSD,,,,Relaxation Instruction with deep breathing exercise,Relaxation with deep breathing exercise,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,30,Self report,M-PTSD,M-PTSD,,,Type 1 mixed ANOVA,End of Treatment,0,,129.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,High,"Watson CG, Tuorila JR, Vickers KS, et al. The efficacies of three relaxation regimens in the treatment of PTSD in Vietnam War veterans. J Clin Psychol. 1997 Dec;53(8):917-23. doi: 10.1002/(SICI)1097-4679(199712)53:8<917::AID-JCLP17>3.0.CO;2-N. PMID: 9403395.",09969,2019
watson1997_M-PTSD_B_Baseline_NA,Complementary and integrative health (CIH),PTSD,90,B,PTSD,,,,Relaxation Instruction with deep breathing exercise,Relaxation with deep breathing exercise,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,30,Self report,M-PTSD,M-PTSD,,,Type 1 mixed ANOVA,Baseline,,,129.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,High,"Watson CG, Tuorila JR, Vickers KS, et al. The efficacies of three relaxation regimens in the treatment of PTSD in Vietnam War veterans. J Clin Psychol. 1997 Dec;53(8):917-23. doi: 10.1002/(SICI)1097-4679(199712)53:8<917::AID-JCLP17>3.0.CO;2-N. PMID: 9403395.",09969,2019
watson1997_M-PTSD_C_0_NA,Complementary and integrative health (CIH),PTSD,90,C,PTSD,,,,Relaxation instruction with deep breathing and biofeedback,Relaxation with deep breathing and biofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,30,Self report,M-PTSD,M-PTSD,,,Type 1 mixed ANOVA,End of Treatment,0,,121.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,High,"Watson CG, Tuorila JR, Vickers KS, et al. The efficacies of three relaxation regimens in the treatment of PTSD in Vietnam War veterans. J Clin Psychol. 1997 Dec;53(8):917-23. doi: 10.1002/(SICI)1097-4679(199712)53:8<917::AID-JCLP17>3.0.CO;2-N. PMID: 9403395.",09969,2019
watson1997_M-PTSD_C_Baseline_NA,Complementary and integrative health (CIH),PTSD,90,C,PTSD,,,,Relaxation instruction with deep breathing and biofeedback,Relaxation with deep breathing and biofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,30,Self report,M-PTSD,M-PTSD,,,Type 1 mixed ANOVA,Baseline,,,122.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,High,"Watson CG, Tuorila JR, Vickers KS, et al. The efficacies of three relaxation regimens in the treatment of PTSD in Vietnam War veterans. J Clin Psychol. 1997 Dec;53(8):917-23. doi: 10.1002/(SICI)1097-4679(199712)53:8<917::AID-JCLP17>3.0.CO;2-N. PMID: 9403395.",09969,2019
watson1997_PTSD_A_0_Comp,Complementary and integrative health (CIH),PTSD,90,A,PTSD,,30,,Relaxation Instruction,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,PTSD Interview,PTSD Interview,Completer,,Type 1 mixed ANOVA,End of Treatment,0,,95,,,,,,-0.4,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,High,"Watson CG, Tuorila JR, Vickers KS, et al. The efficacies of three relaxation regimens in the treatment of PTSD in Vietnam War veterans. J Clin Psychol. 1997 Dec;53(8):917-23. doi: 10.1002/(SICI)1097-4679(199712)53:8<917::AID-JCLP17>3.0.CO;2-N. PMID: 9403395.",09969,2019
watson1997_PTSD_A_Baseline_Comp,Complementary and integrative health (CIH),PTSD,90,A,PTSD,,30,,Relaxation Instruction,Relaxation,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,PTSD Interview,PTSD Interview,Completer,,Type 1 mixed ANOVA,Baseline,,,95.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,High,"Watson CG, Tuorila JR, Vickers KS, et al. The efficacies of three relaxation regimens in the treatment of PTSD in Vietnam War veterans. J Clin Psychol. 1997 Dec;53(8):917-23. doi: 10.1002/(SICI)1097-4679(199712)53:8<917::AID-JCLP17>3.0.CO;2-N. PMID: 9403395.",09969,2019
watson1997_PTSD_B_0_Comp,Complementary and integrative health (CIH),PTSD,90,B,PTSD,,30,,Relaxation Instruction with deep breathing exercise,Relaxation with deep breathing exercise,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,PTSD Interview,PTSD Interview,Completer,,Type 1 mixed ANOVA,End of Treatment,0,,97.8,,,,,,-0.3,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,High,"Watson CG, Tuorila JR, Vickers KS, et al. The efficacies of three relaxation regimens in the treatment of PTSD in Vietnam War veterans. J Clin Psychol. 1997 Dec;53(8):917-23. doi: 10.1002/(SICI)1097-4679(199712)53:8<917::AID-JCLP17>3.0.CO;2-N. PMID: 9403395.",09969,2019
watson1997_PTSD_B_Baseline_Comp,Complementary and integrative health (CIH),PTSD,90,B,PTSD,,30,,Relaxation Instruction with deep breathing exercise,Relaxation with deep breathing exercise,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,PTSD Interview,PTSD Interview,Completer,,Type 1 mixed ANOVA,Baseline,,,98.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,High,"Watson CG, Tuorila JR, Vickers KS, et al. The efficacies of three relaxation regimens in the treatment of PTSD in Vietnam War veterans. J Clin Psychol. 1997 Dec;53(8):917-23. doi: 10.1002/(SICI)1097-4679(199712)53:8<917::AID-JCLP17>3.0.CO;2-N. PMID: 9403395.",09969,2019
watson1997_PTSD_C_0_Comp,Complementary and integrative health (CIH),PTSD,90,C,PTSD,,30,,Relaxation instruction with deep breathing and biofeedback,Relaxation with deep breathing and biofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,PTSD Interview,PTSD Interview,Completer,,Type 1 mixed ANOVA,End of Treatment,0,,89.4,,,,,,-1.1,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,High,"Watson CG, Tuorila JR, Vickers KS, et al. The efficacies of three relaxation regimens in the treatment of PTSD in Vietnam War veterans. J Clin Psychol. 1997 Dec;53(8):917-23. doi: 10.1002/(SICI)1097-4679(199712)53:8<917::AID-JCLP17>3.0.CO;2-N. PMID: 9403395.",09969,2019
watson1997_PTSD_C_Baseline_Comp,Complementary and integrative health (CIH),PTSD,90,C,PTSD,,30,,Relaxation instruction with deep breathing and biofeedback,Relaxation with deep breathing and biofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,30,Structured Clinical Interview,PTSD Interview,PTSD Interview,Completer,,Type 1 mixed ANOVA,Baseline,,,90.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0,,1,,,High,"Watson CG, Tuorila JR, Vickers KS, et al. The efficacies of three relaxation regimens in the treatment of PTSD in Vietnam War veterans. J Clin Psychol. 1997 Dec;53(8):917-23. doi: 10.1002/(SICI)1097-4679(199712)53:8<917::AID-JCLP17>3.0.CO;2-N. PMID: 9403395.",09969,2019
watts2012_CAPS_A_0_NA,Nonpharmacologic biological,PTSD,20,A,PTSD,,,,rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,,,"Mann-Whitney test for continuous outcomes, Fisher exact tests for proportions",End of Treatment,0,,53.9,15.3,,,,,-27.7,,,,,,,,,,p<0.0001,,,,,,,,,,,,,,Veteran,,1,,0.1,,0.9,Mixed,"combat-related, rape/sexual assault, community/school violence, other (multiple trauma)",Medium,"Watts BV, Landon B, Groft A, et al. A sham controlled study of repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Brain Stimul. 2012 Jan;5(1):38-43. doi: 10.1016/j.brs.2011.02.002. PMID: 22264669.",38446,2019
watts2012_CAPS_A_4_NA,Nonpharmacologic biological,PTSD,20,A,PTSD,,,,rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,,,"Mann-Whitney test for continuous outcomes, Fisher exact tests for proportions",Assessment at <3 Months,4,,63.9,,,,,,-17.7,,,,,,,,,,p=0.001,,,,,,,,,,,,,,Veteran,,1,,0.1,,0.9,Mixed,"combat-related, rape/sexual assault, community/school violence, other (multiple trauma)",Medium,"Watts BV, Landon B, Groft A, et al. A sham controlled study of repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Brain Stimul. 2012 Jan;5(1):38-43. doi: 10.1016/j.brs.2011.02.002. PMID: 22264669.",38446,2019
watts2012_CAPS_A_8_NA,Nonpharmacologic biological,PTSD,20,A,PTSD,,,,rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,,,"Mann-Whitney test for continuous outcomes, Fisher exact tests for proportions",Assessment at <3 Months,8,,64.2,,,,,,-17.4,,,,,,,,,,p=0.001,,,,,,,,,,,,,,Veteran,,1,,0.1,,0.9,Mixed,"combat-related, rape/sexual assault, community/school violence, other (multiple trauma)",Medium,"Watts BV, Landon B, Groft A, et al. A sham controlled study of repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Brain Stimul. 2012 Jan;5(1):38-43. doi: 10.1016/j.brs.2011.02.002. PMID: 22264669.",38446,2019
watts2012_CAPS_A_Baseline_NA,Nonpharmacologic biological,PTSD,20,A,PTSD,,10,,rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,,,"Mann-Whitney test for continuous outcomes, Fisher exact tests for proportions",Baseline,,,81.6,9.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.1,,0.9,Mixed,"combat-related, rape/sexual assault, community/school violence, other (multiple trauma)",Medium,"Watts BV, Landon B, Groft A, et al. A sham controlled study of repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Brain Stimul. 2012 Jan;5(1):38-43. doi: 10.1016/j.brs.2011.02.002. PMID: 22264669.",38446,2019
watts2012_CAPS_B_0_NA,Nonpharmacologic biological,PTSD,20,B,Control,,,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,,,"Mann-Whitney test for continuous outcomes, Fisher exact tests for proportions",End of Treatment,0,,61.7,11.1,,,,,-10.6,,,,,,,,,,p=0.09,,,,,,,,,,,,,,Veteran,,1,,0.1,,0.9,Mixed,"combat-related, rape/sexual assault, community/school violence, other (multiple trauma)",Medium,"Watts BV, Landon B, Groft A, et al. A sham controlled study of repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Brain Stimul. 2012 Jan;5(1):38-43. doi: 10.1016/j.brs.2011.02.002. PMID: 22264669.",38446,2019
watts2012_CAPS_B_Baseline_NA,Nonpharmacologic biological,PTSD,20,B,Control,,10,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Structured Clinical Interview,CAPS,CAPS,,,"Mann-Whitney test for continuous outcomes, Fisher exact tests for proportions",Baseline,,,72.3,12.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.1,,0.9,Mixed,"combat-related, rape/sexual assault, community/school violence, other (multiple trauma)",Medium,"Watts BV, Landon B, Groft A, et al. A sham controlled study of repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Brain Stimul. 2012 Jan;5(1):38-43. doi: 10.1016/j.brs.2011.02.002. PMID: 22264669.",38446,2019
watts2012_PCL_A_0_NA,Nonpharmacologic biological,PTSD,20,A,PTSD,,,,rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Self report,PCL,PCL,,,"Mann-Whitney test for continuous outcomes, Fisher exact tests for proportions",End of Treatment,0,,48.7,9.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.1,,0.9,Mixed,"combat-related, rape/sexual assault, community/school violence, other (multiple trauma)",Medium,"Watts BV, Landon B, Groft A, et al. A sham controlled study of repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Brain Stimul. 2012 Jan;5(1):38-43. doi: 10.1016/j.brs.2011.02.002. PMID: 22264669.",38446,2019
watts2012_PCL_A_Baseline_NA,Nonpharmacologic biological,PTSD,20,A,PTSD,,,,rTMS,Transcranial magnetic stimualtion (TMS),No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In Person,10,Self report,PCL,PCL,,,"Mann-Whitney test for continuous outcomes, Fisher exact tests for proportions",Baseline,,,64.9,6.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.1,,0.9,Mixed,"combat-related, rape/sexual assault, community/school violence, other (multiple trauma)",Medium,"Watts BV, Landon B, Groft A, et al. A sham controlled study of repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Brain Stimul. 2012 Jan;5(1):38-43. doi: 10.1016/j.brs.2011.02.002. PMID: 22264669.",38446,2019
watts2012_PCL_B_0_NA,Nonpharmacologic biological,PTSD,20,B,Control,,,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,PCL,PCL,,,"Mann-Whitney test for continuous outcomes, Fisher exact tests for proportions",End of Treatment,0,,54.8,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.1,,0.9,Mixed,"combat-related, rape/sexual assault, community/school violence, other (multiple trauma)",Medium,"Watts BV, Landon B, Groft A, et al. A sham controlled study of repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Brain Stimul. 2012 Jan;5(1):38-43. doi: 10.1016/j.brs.2011.02.002. PMID: 22264669.",38446,2019
watts2012_PCL_B_Baseline_NA,Nonpharmacologic biological,PTSD,20,B,Control,,,,Sham rTMS,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,PCL,PCL,,,"Mann-Whitney test for continuous outcomes, Fisher exact tests for proportions",Baseline,,,57.3,3.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,,1,,0.1,,0.9,Mixed,"combat-related, rape/sexual assault, community/school violence, other (multiple trauma)",Medium,"Watts BV, Landon B, Groft A, et al. A sham controlled study of repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Brain Stimul. 2012 Jan;5(1):38-43. doi: 10.1016/j.brs.2011.02.002. PMID: 22264669.",38446,2019
wells2012_IES_A_0_NA,Psychotherapy,PTSD,20,A,PTSD,,,,Metacognitive therapy,Metacognitive Therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,IES,IES,,,Mixed-model ANOVA and independent t-test for change in mean score,End of Treatment,0,,20.5,18.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.55,,0.45,Mixed,"rape/sexual assault, community/school violence, accidents",Medium,"Wells A, Colbear JS. Treating posttraumatic stress disorder with metacognitive therapy: a preliminary controlled trial. J Clin Psychol. 2012 Apr;68(4):373-81. doi: 10.1002/jclp.20871. PMID: 24469928.",38376,2019
wells2012_IES_A_Baseline_NA,Psychotherapy,PTSD,20,A,PTSD,,,,Metacognitive therapy,Metacognitive Therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,IES,IES,,,Mixed-model ANOVA and independent t-test for change in mean score,Baseline,,,53.2,12.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.55,,0.45,Mixed,"rape/sexual assault, community/school violence, accidents",Medium,"Wells A, Colbear JS. Treating posttraumatic stress disorder with metacognitive therapy: a preliminary controlled trial. J Clin Psychol. 2012 Apr;68(4):373-81. doi: 10.1002/jclp.20871. PMID: 24469928.",38376,2019
wells2012_IES_B_0_NA,Psychotherapy,PTSD,20,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,10,Self report,IES,IES,,,Mixed-model ANOVA and independent t-test for change in mean score,End of Treatment,0,,54.8,12.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.55,,0.45,Mixed,"rape/sexual assault, community/school violence, accidents",Medium,"Wells A, Colbear JS. Treating posttraumatic stress disorder with metacognitive therapy: a preliminary controlled trial. J Clin Psychol. 2012 Apr;68(4):373-81. doi: 10.1002/jclp.20871. PMID: 24469928.",38376,2019
wells2012_IES_B_Baseline_NA,Psychotherapy,PTSD,20,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,10,Self report,IES,IES,,,Mixed-model ANOVA and independent t-test for change in mean score,Baseline,,,56.2,10.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.55,,0.45,Mixed,"rape/sexual assault, community/school violence, accidents",Medium,"Wells A, Colbear JS. Treating posttraumatic stress disorder with metacognitive therapy: a preliminary controlled trial. J Clin Psychol. 2012 Apr;68(4):373-81. doi: 10.1002/jclp.20871. PMID: 24469928.",38376,2019
wells2012_PDS_A_0_ITT,Psychotherapy,PTSD,20,A,PTSD,,9,,Metacognitive therapy,Metacognitive Therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,PDS,PDS,ITT,LOCF,Mixed-model ANOVA and independent t-test for change in mean score,End of Treatment,0,,16.8,16.4,,,,,-15.9,13.25,,,,,,,,,,,,,,,,,,,,"RCI of 8, cutoff <22 on the PDS",0.7778,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.55,,0.45,Mixed,"rape/sexual assault, community/school violence, accidents",Medium,"Wells A, Colbear JS. Treating posttraumatic stress disorder with metacognitive therapy: a preliminary controlled trial. J Clin Psychol. 2012 Apr;68(4):373-81. doi: 10.1002/jclp.20871. PMID: 24469928.",38376,2019
wells2012_PDS_A_12_ITT,Psychotherapy,PTSD,20,A,PTSD,,8,,Metacognitive therapy,Metacognitive Therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,PDS,PDS,ITT,LOCF,Mixed-model ANOVA and independent t-test for change in mean score,Assessment at 3 to <6 Months,12,,11.9,16.7,,,,,-20.8,,,,,,,,,,,,,,,,,,,,,"RCI of 8, cutoff <22 on the PDS",0.875,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.55,,0.45,Mixed,"rape/sexual assault, community/school violence, accidents",Medium,"Wells A, Colbear JS. Treating posttraumatic stress disorder with metacognitive therapy: a preliminary controlled trial. J Clin Psychol. 2012 Apr;68(4):373-81. doi: 10.1002/jclp.20871. PMID: 24469928.",38376,2019
wells2012_PDS_A_26_ITT,Psychotherapy,PTSD,20,A,PTSD,,8,,Metacognitive therapy,Metacognitive Therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,PDS,PDS,ITT,LOCF,Mixed-model ANOVA and independent t-test for change in mean score,Assessment at 6 to <12 Months,26,,9.1,12.1,,,,,-23.6,,,,,,,,,,,,,,,,,,,,,"RCI of 8, cutoff <22 on the PDS",0.75,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.55,,0.45,Mixed,"rape/sexual assault, community/school violence, accidents",Medium,"Wells A, Colbear JS. Treating posttraumatic stress disorder with metacognitive therapy: a preliminary controlled trial. J Clin Psychol. 2012 Apr;68(4):373-81. doi: 10.1002/jclp.20871. PMID: 24469928.",38376,2019
wells2012_PDS_A_Baseline_ITT,Psychotherapy,PTSD,20,A,PTSD,,10,,Metacognitive therapy,Metacognitive Therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,PDS,PDS,ITT,LOCF,Mixed-model ANOVA and independent t-test for change in mean score,Baseline,,,32.7,7.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.55,,0.45,Mixed,"rape/sexual assault, community/school violence, accidents",Medium,"Wells A, Colbear JS. Treating posttraumatic stress disorder with metacognitive therapy: a preliminary controlled trial. J Clin Psychol. 2012 Apr;68(4):373-81. doi: 10.1002/jclp.20871. PMID: 24469928.",38376,2019
wells2012_PDS_B_0_ITT,Psychotherapy,PTSD,20,B,Control,,10,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,10,Self report,PDS,PDS,ITT,LOCF,Mixed-model ANOVA and independent t-test for change in mean score,End of Treatment,0,,34.1,4.7,,,,,-3.2,4.94,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.55,,0.45,Mixed,"rape/sexual assault, community/school violence, accidents",Medium,"Wells A, Colbear JS. Treating posttraumatic stress disorder with metacognitive therapy: a preliminary controlled trial. J Clin Psychol. 2012 Apr;68(4):373-81. doi: 10.1002/jclp.20871. PMID: 24469928.",38376,2019
wells2012_PDS_B_Baseline_ITT,Psychotherapy,PTSD,20,B,Control,,10,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,10,Self report,PDS,PDS,ITT,LOCF,Mixed-model ANOVA and independent t-test for change in mean score,Baseline,,,37.3,5.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.55,,0.45,Mixed,"rape/sexual assault, community/school violence, accidents",Medium,"Wells A, Colbear JS. Treating posttraumatic stress disorder with metacognitive therapy: a preliminary controlled trial. J Clin Psychol. 2012 Apr;68(4):373-81. doi: 10.1002/jclp.20871. PMID: 24469928.",38376,2019
wells2015_IES_A_0_Comp,Psychotherapy,PTSD,32,A,PTSD,,,,Metacognitive therapy,Metacognitive Therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,IES,IES,Completer,,ANCOVA and Hedges' g for change in mean score,End of Treatment,0,,9.90,9.69,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.375,,0.625,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (fire)",Medium,"Wells A, Walton D, Lovell K, et al. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder. Cognit Ther Res. 2015 February;39(1):70-80. doi: 10.1007/s10608-014-9636-6.",50330,2019
wells2015_IES_A_Baseline_Comp,Psychotherapy,PTSD,32,A,PTSD,,,,Metacognitive therapy,Metacognitive Therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,IES,IES,Completer,,ANCOVA and Hedges' g for change in mean score,Baseline,,,53.30,8.87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.375,,0.625,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (fire)",Medium,"Wells A, Walton D, Lovell K, et al. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder. Cognit Ther Res. 2015 February;39(1):70-80. doi: 10.1007/s10608-014-9636-6.",50330,2019
wells2015_IES_B_0_Comp,Psychotherapy,PTSD,32,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,IES,IES,Completer,,ANCOVA and Hedges' g for change in mean score,End of Treatment,0,,23.70,16.28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.375,,0.625,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (fire)",Medium,"Wells A, Walton D, Lovell K, et al. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder. Cognit Ther Res. 2015 February;39(1):70-80. doi: 10.1007/s10608-014-9636-6.",50330,2019
wells2015_IES_B_Baseline_Comp,Psychotherapy,PTSD,32,B,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,IES,IES,Completer,,ANCOVA and Hedges' g for change in mean score,Baseline,,,51.20,8.16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.375,,0.625,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (fire)",Medium,"Wells A, Walton D, Lovell K, et al. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder. Cognit Ther Res. 2015 February;39(1):70-80. doi: 10.1007/s10608-014-9636-6.",50330,2019
wells2015_IES_C_0_Comp,Psychotherapy,PTSD,32,C,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,10,Self report,IES,IES,Completer,,ANCOVA and Hedges' g for change in mean score,End of Treatment,0,,51.30,13.43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.375,,0.625,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (fire)",Medium,"Wells A, Walton D, Lovell K, et al. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder. Cognit Ther Res. 2015 February;39(1):70-80. doi: 10.1007/s10608-014-9636-6.",50330,2019
wells2015_IES_C_Baseline_Comp,Psychotherapy,PTSD,32,C,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,10,Self report,IES,IES,Completer,,ANCOVA and Hedges' g for change in mean score,Baseline,,,52.30,12.98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.375,,0.625,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (fire)",Medium,"Wells A, Walton D, Lovell K, et al. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder. Cognit Ther Res. 2015 February;39(1):70-80. doi: 10.1007/s10608-014-9636-6.",50330,2019
wells2015_PDS_A_0_Comp,Psychotherapy,PTSD,32,A,PTSD,,10,,Metacognitive therapy,Metacognitive Therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,PDS,PDS,Completer,No missing data for treatment completers,ANCOVA and Hedges' g for change in mean score,End of Treatment,0,,10.4,6.98,,,,SE 2.20,-26.8,,,,,Hedges' g,3.52,,,,p<0.0005,,,,,,,,Not meeting criteria for PTSD according to SCID-I/P,0.9,,≥10-point improvement on IES and total score <32,1,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.375,,0.625,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (fire)",Medium,"Wells A, Walton D, Lovell K, et al. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder. Cognit Ther Res. 2015 February;39(1):70-80. doi: 10.1007/s10608-014-9636-6.",50330,2019
wells2015_PDS_A_12_Comp,Psychotherapy,PTSD,32,A,PTSD,,10,,Metacognitive therapy,Metacognitive Therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,PDS,PDS,Completer,No missing data for treatment completers,ANCOVA and Hedges' g for change in mean score,Assessment at 3 to <6 Months,12,,14.5,16.2,,,,,-22.7,,,,,Hedges' g,1.23,,,,,,,,,,,,Not meeting criteria for PTSD according to SCID-I/P,,,≥10-point improvement on IES and total score <32,0.8,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.375,,0.625,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (fire)",Medium,"Wells A, Walton D, Lovell K, et al. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder. Cognit Ther Res. 2015 February;39(1):70-80. doi: 10.1007/s10608-014-9636-6.",50330,2019
wells2015_PDS_A_Baseline_Comp,Psychotherapy,PTSD,32,A,PTSD,,11,,Metacognitive therapy,Metacognitive Therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,PDS,PDS,Completer,No missing data for treatment completers,ANCOVA and Hedges' g for change in mean score,Baseline,,,37.2,8.93,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.375,,0.625,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (fire)",Medium,"Wells A, Walton D, Lovell K, et al. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder. Cognit Ther Res. 2015 February;39(1):70-80. doi: 10.1007/s10608-014-9636-6.",50330,2019
wells2015_PDS_B_0_Comp,Psychotherapy,PTSD,32,B,PTSD,,10,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,PDS,PDS,Completer,No missing data for treatment completers,ANCOVA and Hedges' g for change in mean score,End of Treatment,0,,18.3,13.31,,,,SE 4.61,-14.5,,,,,Hedges' g,0.91,,,,p=0.01,,,,,,,,Not meeting criteria for PTSD according to SCID-I/P,0.7,,≥10-point improvement on IES and total score <32,0.7,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.375,,0.625,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (fire)",Medium,"Wells A, Walton D, Lovell K, et al. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder. Cognit Ther Res. 2015 February;39(1):70-80. doi: 10.1007/s10608-014-9636-6.",50330,2019
wells2015_PDS_B_12_Comp,Psychotherapy,PTSD,32,B,PTSD,,10,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,PDS,PDS,Completer,No missing data for treatment completers,ANCOVA and Hedges' g for change in mean score,Assessment at 3 to <6 Months,12,,16.5,9.47,,,,,-16.3,,,,,Hedges' g,1.08,,,,,,,,,,,,Not meeting criteria for PTSD according to SCID-I/P,,,≥10-point improvement on IES and total score <32,0.7,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.375,,0.625,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (fire)",Medium,"Wells A, Walton D, Lovell K, et al. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder. Cognit Ther Res. 2015 February;39(1):70-80. doi: 10.1007/s10608-014-9636-6.",50330,2019
wells2015_PDS_B_Baseline_Comp,Psychotherapy,PTSD,32,B,PTSD,,11,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,11,Self report,PDS,PDS,Completer,No missing data for treatment completers,ANCOVA and Hedges' g for change in mean score,Baseline,,,32.8,8.85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.375,,0.625,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (fire)",Medium,"Wells A, Walton D, Lovell K, et al. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder. Cognit Ther Res. 2015 February;39(1):70-80. doi: 10.1007/s10608-014-9636-6.",50330,2019
wells2015_PDS_C_0_Comp,Psychotherapy,PTSD,32,C,Control,,10,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,10,Self report,PDS,PDS,Completer,No missing data for treatment completers,ANCOVA and Hedges' g for change in mean score,End of Treatment,0,,39.2,8.85,,,,SE 0.75,0.9,,,,,,,,,,p=NS,,,,,,,,Not meeting criteria for PTSD according to SCID-I/P,,,≥10-point improvement on IES and total score <32,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.375,,0.625,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (fire)",Medium,"Wells A, Walton D, Lovell K, et al. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder. Cognit Ther Res. 2015 February;39(1):70-80. doi: 10.1007/s10608-014-9636-6.",50330,2019
wells2015_PDS_C_Baseline_Comp,Psychotherapy,PTSD,32,C,Control,,10,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,10,Self report,PDS,PDS,Completer,No missing data for treatment completers,ANCOVA and Hedges' g for change in mean score,Baseline,,,38.3,8.74,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.375,,0.625,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence, other (fire)",Medium,"Wells A, Walton D, Lovell K, et al. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder. Cognit Ther Res. 2015 February;39(1):70-80. doi: 10.1007/s10608-014-9636-6.",50330,2019
whitworth2019b_PDS_A_0_Comp,Complementary and integrative health (CIH),PTSD,22,A,PTSD,,9,,Resistance training,Exercise,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In person,11,Self report,PDS,PDS-5,Completer,,ANCOVA and Hedges' g for change in mean score,End of Treatment,0,,25.6,16.7,,,,,-12.2,,,,,Cohen's d,-0.87,,,,,,,,,,,,,,,,,,Community,0,,1,0.818,,0.182,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, other (unspecified type of child abuse, unspecified ""other"")",Medium,"Whitworth JW, Nosrat S, SantaBarbara NJ, et al. High intensity resistance training improves sleep quality and anxiety in individuals who screen positive for posttraumatic stress disorder: a randomized controlled feasibility trial. Ment Health Phys Act. 2019b;16:43-9. doi: 10.1016/j.mhpa.2019.04.001.",52118,2020
whitworth2019b_PDS_A_Baseline_Comp,Complementary and integrative health (CIH),PTSD,22,A,PTSD,,9,,Resistance training,Exercise,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In person,11,Self report,PDS,PDS-5,Completer,,ANCOVA and Hedges' g for change in mean score,Baseline,,,37.8,10.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,,1,0.818,,0.182,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, other (unspecified type of child abuse, unspecified ""other"")",Medium,"Whitworth JW, Nosrat S, SantaBarbara NJ, et al. High intensity resistance training improves sleep quality and anxiety in individuals who screen positive for posttraumatic stress disorder: a randomized controlled feasibility trial. Ment Health Phys Act. 2019b;16:43-9. doi: 10.1016/j.mhpa.2019.04.001.",52118,2020
whitworth2019b_PDS_B_0_Comp,Complementary and integrative health (CIH),PTSD,22,B,Control,,10,,Attention control,Attention control,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,11,Self report,PDS,PDS-5,Completer,,ANCOVA and Hedges' g for change in mean score,End of Treatment,0,,30.9,15,,,,,-12.4,,,,,Cohen's d,-1,,,,,,,,,,,,,,,,,,Community,0,,1,0.818,,0.182,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, other (unspecified type of child abuse, unspecified ""other"")",Medium,"Whitworth JW, Nosrat S, SantaBarbara NJ, et al. High intensity resistance training improves sleep quality and anxiety in individuals who screen positive for posttraumatic stress disorder: a randomized controlled feasibility trial. Ment Health Phys Act. 2019b;16:43-9. doi: 10.1016/j.mhpa.2019.04.001.",52118,2020
whitworth2019b_PDS_B_Baseline_Comp,Complementary and integrative health (CIH),PTSD,22,B,Control,,10,,Attention control,Attention control,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,11,Self report,PDS,PDS-5,Completer,,ANCOVA and Hedges' g for change in mean score,Baseline,,,43.3,8.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,,1,0.818,,0.182,Mixed,"combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, other (unspecified type of child abuse, unspecified ""other"")",Medium,"Whitworth JW, Nosrat S, SantaBarbara NJ, et al. High intensity resistance training improves sleep quality and anxiety in individuals who screen positive for posttraumatic stress disorder: a randomized controlled feasibility trial. Ment Health Phys Act. 2019b;16:43-9. doi: 10.1016/j.mhpa.2019.04.001.",52118,2020
whitworth2019c_PDS_A_0_Comp,Complementary and integrative health (CIH),PTSD,30,A,PTSD,,12,,High-intensity resistance exercise,Exercise,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In person,15,Self report,PDS,PDS-5,Completer,,ANCOVA and Hedges' g for change in mean score,End of Treatment,0,,17.08,11.12,,,,,-22.17,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.733,,0.267,Mixed,"rape/sexual assault, community/school violence, other (""sudden or unexpected loss of a child or spouse"")",Medium,"Whitworth JW, Nosrat S, SantaBarbara NJ, et al. Feasibility of Resistance Exercise for Posttraumatic Stress and Anxiety Symptoms: A Randomized Controlled Pilot Study. Journal of Traumatic Stress. 2019 Dec;32(6):977-84. doi: https://dx.doi.org/10.1002/jts.22464. PMID: 31743507.",1548217,2020
whitworth2019c_PDS_A_Baseline_Comp,Complementary and integrative health (CIH),PTSD,30,A,PTSD,,15,,High-intensity resistance exercise,Exercise,No,Not Applicable,No,Not Applicable,Yes,Other physical activity and recreational therapies,No,No,No,No,No,Individual,In person,15,Self report,PDS,PDS-5,Completer,,ANCOVA and Hedges' g for change in mean score,Baseline,,,39.25,11.69,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.733,,0.267,Mixed,"rape/sexual assault, community/school violence, other (""sudden or unexpected loss of a child or spouse"")",Medium,"Whitworth JW, Nosrat S, SantaBarbara NJ, et al. Feasibility of Resistance Exercise for Posttraumatic Stress and Anxiety Symptoms: A Randomized Controlled Pilot Study. Journal of Traumatic Stress. 2019 Dec;32(6):977-84. doi: https://dx.doi.org/10.1002/jts.22464. PMID: 31743507.",1548217,2020
whitworth2019c_PDS_B_0_Comp,Complementary and integrative health (CIH),PTSD,30,B,Control,,12,,Time-matched control,Psychoeducation,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,15,Self report,PDS,PDS-5,Completer,,ANCOVA and Hedges' g for change in mean score,End of Treatment,0,,25.50,14.73,,,,,-15.42,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.733,,0.267,Mixed,"rape/sexual assault, community/school violence, other (""sudden or unexpected loss of a child or spouse"")",Medium,"Whitworth JW, Nosrat S, SantaBarbara NJ, et al. Feasibility of Resistance Exercise for Posttraumatic Stress and Anxiety Symptoms: A Randomized Controlled Pilot Study. Journal of Traumatic Stress. 2019 Dec;32(6):977-84. doi: https://dx.doi.org/10.1002/jts.22464. PMID: 31743507.",1548217,2020
whitworth2019c_PDS_B_Baseline_Comp,Complementary and integrative health (CIH),PTSD,30,B,Control,,15,,Time-matched control,Psychoeducation,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,15,Self report,PDS,PDS-5,Completer,,ANCOVA and Hedges' g for change in mean score,Baseline,,,40.92,8.68,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.733,,0.267,Mixed,"rape/sexual assault, community/school violence, other (""sudden or unexpected loss of a child or spouse"")",Medium,"Whitworth JW, Nosrat S, SantaBarbara NJ, et al. Feasibility of Resistance Exercise for Posttraumatic Stress and Anxiety Symptoms: A Randomized Controlled Pilot Study. Journal of Traumatic Stress. 2019 Dec;32(6):977-84. doi: https://dx.doi.org/10.1002/jts.22464. PMID: 31743507.",1548217,2020
yeh2011_CAPS_A_0_Comp,Pharmacotherapy,PTSD,35,A,PTSD,,14,,Topiramate,Topiramate,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,CAPS,CAPS,Completer,,ANCOVA and Hedges' g for change in mean score,End of Treatment,0,,21.85,21.38,,,,,-57.79,,,,,,,,,,,,,,,,,,,,,≥30% improvement on CAPS and CAPS subscales,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6774,,0.3226,,,Medium,"Yeh MS, Mari JJ, Costa MC, et al. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD. CNS Neurosci Ther. 2011 Oct;17(5):305-10. doi: 10.1111/j.1755-5949.2010.00188.x. PMID: 21554564.",35220,2019
yeh2011_CAPS_A_0_ITT,Pharmacotherapy,PTSD,35,A,PTSD,,14,,Topiramate,Topiramate,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANCOVA and Hedges' g for change in mean score,End of Treatment,0,,30.41,30.9,,,,,-48.35,,,,,,,,,,,,,,,,,,,,,≥30% improvement on CAPS and CAPS subscales,0.8235,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6774,,0.3226,,,Medium,"Yeh MS, Mari JJ, Costa MC, et al. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD. CNS Neurosci Ther. 2011 Oct;17(5):305-10. doi: 10.1111/j.1755-5949.2010.00188.x. PMID: 21554564.",35220,2019
yeh2011_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,35,A,PTSD,,14,,Topiramate,Topiramate,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,CAPS,CAPS,Completer,,ANCOVA and Hedges' g for change in mean score,Baseline,,,79.64,12.03,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% improvement on CAPS and CAPS subscales,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6774,,0.3226,,,Medium,"Yeh MS, Mari JJ, Costa MC, et al. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD. CNS Neurosci Ther. 2011 Oct;17(5):305-10. doi: 10.1111/j.1755-5949.2010.00188.x. PMID: 21554564.",35220,2019
yeh2011_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,35,A,PTSD,,17,,Topiramate,Topiramate,No,Not Applicable,Yes,Mood Stabilizer,No,Not Applicable,No,No,No,No,No,Individual,In Person,17,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANCOVA and Hedges' g for change in mean score,Baseline,,,78.76,12.64,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% improvement on CAPS and CAPS subscales,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6774,,0.3226,,,Medium,"Yeh MS, Mari JJ, Costa MC, et al. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD. CNS Neurosci Ther. 2011 Oct;17(5):305-10. doi: 10.1111/j.1755-5949.2010.00188.x. PMID: 21554564.",35220,2019
yeh2011_CAPS_B_0_Comp,Pharmacotherapy,PTSD,35,B,Control,,12,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS,Completer,,ANCOVA and Hedges' g for change in mean score,End of Treatment,0,,31.91,28.22,,,,,-32.42,,,,,,,,,,,,,,,,,,,,,≥30% improvement on CAPS and CAPS subscales,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6774,,0.3226,,,Medium,"Yeh MS, Mari JJ, Costa MC, et al. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD. CNS Neurosci Ther. 2011 Oct;17(5):305-10. doi: 10.1111/j.1755-5949.2010.00188.x. PMID: 21554564.",35220,2019
yeh2011_CAPS_B_0_ITT,Pharmacotherapy,PTSD,35,B,Control,,12,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANCOVA and Hedges' g for change in mean score,End of Treatment,0,,35.78,33.76,,,,,-30.36,,,,,,,,,,,,,,,,,,,,,≥30% improvement on CAPS and CAPS subscales,0.6428,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6774,,0.3226,,,Medium,"Yeh MS, Mari JJ, Costa MC, et al. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD. CNS Neurosci Ther. 2011 Oct;17(5):305-10. doi: 10.1111/j.1755-5949.2010.00188.x. PMID: 21554564.",35220,2019
yeh2011_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,35,B,Control,,12,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS,Completer,,ANCOVA and Hedges' g for change in mean score,Baseline,,,64.33,22,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% improvement on CAPS and CAPS subscales,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6774,,0.3226,,,Medium,"Yeh MS, Mari JJ, Costa MC, et al. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD. CNS Neurosci Ther. 2011 Oct;17(5):305-10. doi: 10.1111/j.1755-5949.2010.00188.x. PMID: 21554564.",35220,2019
yeh2011_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,35,B,Control,,14,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,18,Structured Clinical Interview,CAPS,CAPS,ITT,LOCF,ANCOVA and Hedges' g for change in mean score,Baseline,,,66.14,22.63,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% improvement on CAPS and CAPS subscales,,Additional definitions of Clinically Meaningful Response reported in the study,Community,,,1,0.6774,,0.3226,,,Medium,"Yeh MS, Mari JJ, Costa MC, et al. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD. CNS Neurosci Ther. 2011 Oct;17(5):305-10. doi: 10.1111/j.1755-5949.2010.00188.x. PMID: 21554564.",35220,2019
yehuda2014_CAPS_A_0_Comp,Psychotherapy,PTSD,52,A,PTSD,,,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA,End of Treatment,0,,,,,,,,-23,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS for DSM-IV,0.44,,,,,Veteran,0,1,0,0.1081,,0.8919,Combat-related,,High,"Yehuda R, Pratchett LC, Elmes MW, et al. Glucocorticoid-related predictors and correlates of post-traumatic stress disorder treatment response in combat veterans. Interface Focus. 2014 Oct 6;4(5):20140048. doi: 10.1098/rsfs.2014.0048. PMID: 25285201.",42868,2019
yehuda2014_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,52,A,PTSD,,25,,PE,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,37,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1081,,0.8919,Combat-related,,High,"Yehuda R, Pratchett LC, Elmes MW, et al. Glucocorticoid-related predictors and correlates of post-traumatic stress disorder treatment response in combat veterans. Interface Focus. 2014 Oct 6;4(5):20140048. doi: 10.1098/rsfs.2014.0048. PMID: 25285201.",42868,2019
yehuda2014_CAPS_B_0_Comp,Psychotherapy,PTSD,52,B,Control,,,,Minimal attention,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,15,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA,End of Treatment,0,,,,,,,,-14,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to CAPS for DSM-IV,0.1667,,,,,Veteran,0,1,0,0.1081,,0.8919,Combat-related,,High,"Yehuda R, Pratchett LC, Elmes MW, et al. Glucocorticoid-related predictors and correlates of post-traumatic stress disorder treatment response in combat veterans. Interface Focus. 2014 Oct 6;4(5):20140048. doi: 10.1098/rsfs.2014.0048. PMID: 25285201.",42868,2019
yehuda2014_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,52,B,Control,,12,,Minimal attention,Minimal attention,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,Phone,15,Structured Clinical Interview,CAPS,CAPS,Completer,,Repeated measures ANOVA,Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.1081,,0.8919,Combat-related,,High,"Yehuda R, Pratchett LC, Elmes MW, et al. Glucocorticoid-related predictors and correlates of post-traumatic stress disorder treatment response in combat veterans. Interface Focus. 2014 Oct 6;4(5):20140048. doi: 10.1098/rsfs.2014.0048. PMID: 25285201.",42868,2019
yehuda2015_CAPS_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,24,A,PTSD,,11,,Hydrocortisone + PE,Hydrocortisone prior to Prolonged Exposure (PE),Yes,TF,Yes,Steroids,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using maximum likelihood model,"Latent growth curve modeling for change in scores, multiple regression analysis for responders",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting diagnostic criteria for PTSD according to CAPS,0.5455,,,,,Veteran,0,1,0,,,,Mixed,"combat-related, accidents, other (interpersonal violence)",Low,"Yehuda R, Bierer LM, Pratchett LC, et al. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome. Psychoneuroendocrinology. 2015 Jan;51:589-97. doi: 10.1016/j.psyneuen.2014.08.004. PMID: 25212409.",42838,2019
yehuda2015_CAPS_A_6_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,24,A,PTSD,,,,Hydrocortisone + PE,Hydrocortisone prior to Prolonged Exposure (PE),Yes,TF,Yes,Steroids,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using maximum likelihood model,"Latent growth curve modeling for change in scores, multiple regression analysis for responders",Assessment at <3 Months,6,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting diagnostic criteria for PTSD according to CAPS,,,,,,Veteran,0,1,0,,,,Mixed,"combat-related, accidents, other (interpersonal violence)",Low,"Yehuda R, Bierer LM, Pratchett LC, et al. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome. Psychoneuroendocrinology. 2015 Jan;51:589-97. doi: 10.1016/j.psyneuen.2014.08.004. PMID: 25212409.",42838,2019
yehuda2015_CAPS_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,24,A,PTSD,,12,,Hydrocortisone + PE,Hydrocortisone prior to Prolonged Exposure (PE),Yes,TF,Yes,Steroids,No,Not Applicable,No,No,No,No,No,Individual,In Person,12,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using maximum likelihood model,"Latent growth curve modeling for change in scores, multiple regression analysis for responders",Baseline,,,73.4,12.7,,,,,,,,,,,,,,,,,,,,,,,Not meeting diagnostic criteria for PTSD according to CAPS,,,,,,Veteran,0,1,0,,,,Mixed,"combat-related, accidents, other (interpersonal violence)",Low,"Yehuda R, Bierer LM, Pratchett LC, et al. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome. Psychoneuroendocrinology. 2015 Jan;51:589-97. doi: 10.1016/j.psyneuen.2014.08.004. PMID: 25212409.",42838,2019
yehuda2015_CAPS_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,24,B,PTSD,,5,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,12,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using maximum likelihood model,"Latent growth curve modeling for change in scores, multiple regression analysis for responders",End of Treatment,0,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting diagnostic criteria for PTSD according to CAPS,,,,,,Veteran,0,1,0,,,,Mixed,"combat-related, accidents, other (interpersonal violence)",Low,"Yehuda R, Bierer LM, Pratchett LC, et al. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome. Psychoneuroendocrinology. 2015 Jan;51:589-97. doi: 10.1016/j.psyneuen.2014.08.004. PMID: 25212409.",42838,2019
yehuda2015_CAPS_B_6_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,24,B,PTSD,,,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,12,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using maximum likelihood model,"Latent growth curve modeling for change in scores, multiple regression analysis for responders",Assessment at <3 Months,6,,,,,,,,,,,,,,,,,,,,,,,,,,Not meeting diagnostic criteria for PTSD according to CAPS,,,,,,Veteran,0,1,0,,,,Mixed,"combat-related, accidents, other (interpersonal violence)",Low,"Yehuda R, Bierer LM, Pratchett LC, et al. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome. Psychoneuroendocrinology. 2015 Jan;51:589-97. doi: 10.1016/j.psyneuen.2014.08.004. PMID: 25212409.",42838,2019
yehuda2015_CAPS_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,24,B,PTSD,,12,,PE + placebo,Prolonged Exposure (PE) + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,12,Structured Clinical Interview,CAPS,CAPS,ITT,Imputed using maximum likelihood model,"Latent growth curve modeling for change in scores, multiple regression analysis for responders",Baseline,,,74.9,18.1,,,,,,,,,,,,,,,,,,,,,,,Not meeting diagnostic criteria for PTSD according to CAPS,,,,,,Veteran,0,1,0,,,,Mixed,"combat-related, accidents, other (interpersonal violence)",Low,"Yehuda R, Bierer LM, Pratchett LC, et al. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome. Psychoneuroendocrinology. 2015 Jan;51:589-97. doi: 10.1016/j.psyneuen.2014.08.004. PMID: 25212409.",42838,2019
yuen2015_CAPS_A_0_ITT,Psychotherapy,PTSD,74,A,PTSD,,23,,PE via telehealth,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,36,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,"Repeated measures t-tests, Hedges' g effect sizes; chi-squared for categorical outcomes; margin of noninferiority set at -0.42 for Hedge's g",End of Treatment,0,,35.91,17.66,,,,,-29.36,,,,,Hedges' g,1.9,,,,p<0.01,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.46,,,,,Veteran,0,1,0,0.019,,0.981,Combat-related,,Medium,"Yuen EK, Gros DF, Price M, et al. Randomized controlled trial of home-based telehealth versus in-person prolonged exposure for combat-related PTSD in veterans: preliminary results. J Clin Psychol. 2015 Jun;71(6):500-12. doi: 10.1002/jclp.22168. PMID: 25809565.",44639,2019
yuen2015_CAPS_A_Baseline_ITT,Psychotherapy,PTSD,74,A,PTSD,,23,,PE via telehealth,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,36,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,"Repeated measures t-tests, Hedges' g effect sizes; chi-squared for categorical outcomes; margin of noninferiority set at -0.42 for Hedge's g",Baseline,,,65.27,11.69,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.019,,0.981,Combat-related,,Medium,"Yuen EK, Gros DF, Price M, et al. Randomized controlled trial of home-based telehealth versus in-person prolonged exposure for combat-related PTSD in veterans: preliminary results. J Clin Psychol. 2015 Jun;71(6):500-12. doi: 10.1002/jclp.22168. PMID: 25809565.",44639,2019
yuen2015_CAPS_B_0_ITT,Psychotherapy,PTSD,74,B,PTSD,,29,,PE in-person,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,38,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,"Repeated measures t-tests, Hedges' g effect sizes; chi-squared for categorical outcomes; margin of noninferiority set at -0.42 for Hedge's g",End of Treatment,0,,38.33,22.25,,,,,-30.09,,,,,Hedges' g,1.51,,,,p<0.01,,,,,,,,Not meeting criteria for PTSD according to CAPS,0.4,,,,,Veteran,0,1,0,0.019,,0.981,Combat-related,,Medium,"Yuen EK, Gros DF, Price M, et al. Randomized controlled trial of home-based telehealth versus in-person prolonged exposure for combat-related PTSD in veterans: preliminary results. J Clin Psychol. 2015 Jun;71(6):500-12. doi: 10.1002/jclp.22168. PMID: 25809565.",44639,2019
yuen2015_CAPS_B_Baseline_ITT,Psychotherapy,PTSD,74,B,PTSD,,29,,PE in-person,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,38,Structured Clinical Interview,CAPS,CAPS,ITT,Multiple imputation,"Repeated measures t-tests, Hedges' g effect sizes; chi-squared for categorical outcomes; margin of noninferiority set at -0.42 for Hedge's g",Baseline,,,68.42,14.73,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.019,,0.981,Combat-related,,Medium,"Yuen EK, Gros DF, Price M, et al. Randomized controlled trial of home-based telehealth versus in-person prolonged exposure for combat-related PTSD in veterans: preliminary results. J Clin Psychol. 2015 Jun;71(6):500-12. doi: 10.1002/jclp.22168. PMID: 25809565.",44639,2019
yuen2015_PCL_A_0_ITT,Psychotherapy,PTSD,74,A,PTSD,,,,PE via telehealth,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,36,Self report,PCL,PCL-M,ITT,,"Repeated measures t-tests, Hedges' g effect sizes; chi-squared for categorical outcomes; margin of noninferiority set at -0.42 for Hedge's g",End of Treatment,0,,43.41,18.43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.019,,0.981,Combat-related,,Medium,"Yuen EK, Gros DF, Price M, et al. Randomized controlled trial of home-based telehealth versus in-person prolonged exposure for combat-related PTSD in veterans: preliminary results. J Clin Psychol. 2015 Jun;71(6):500-12. doi: 10.1002/jclp.22168. PMID: 25809565.",44639,2019
yuen2015_PCL_A_Baseline_ITT,Psychotherapy,PTSD,74,A,PTSD,,,,PE via telehealth,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,36,Self report,PCL,PCL-M,ITT,,"Repeated measures t-tests, Hedges' g effect sizes; chi-squared for categorical outcomes; margin of noninferiority set at -0.42 for Hedge's g",Baseline,,,62.20,13.75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.019,,0.981,Combat-related,,Medium,"Yuen EK, Gros DF, Price M, et al. Randomized controlled trial of home-based telehealth versus in-person prolonged exposure for combat-related PTSD in veterans: preliminary results. J Clin Psychol. 2015 Jun;71(6):500-12. doi: 10.1002/jclp.22168. PMID: 25809565.",44639,2019
yuen2015_PCL_B_0_ITT,Psychotherapy,PTSD,74,B,PTSD,,,,PE in-person,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,38,Self report,PCL,PCL-M,ITT,,"Repeated measures t-tests, Hedges' g effect sizes; chi-squared for categorical outcomes; margin of noninferiority set at -0.42 for Hedge's g",End of Treatment,0,,42.59,18.32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.019,,0.981,Combat-related,,Medium,"Yuen EK, Gros DF, Price M, et al. Randomized controlled trial of home-based telehealth versus in-person prolonged exposure for combat-related PTSD in veterans: preliminary results. J Clin Psychol. 2015 Jun;71(6):500-12. doi: 10.1002/jclp.22168. PMID: 25809565.",44639,2019
yuen2015_PCL_B_Baseline_ITT,Psychotherapy,PTSD,74,B,PTSD,,,,PE in-person,Prolonged Exposure (PE),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,38,Self report,PCL,PCL-M,ITT,,"Repeated measures t-tests, Hedges' g effect sizes; chi-squared for categorical outcomes; margin of noninferiority set at -0.42 for Hedge's g",Baseline,,,61.17,10.93,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Veteran,0,1,0,0.019,,0.981,Combat-related,,Medium,"Yuen EK, Gros DF, Price M, et al. Randomized controlled trial of home-based telehealth versus in-person prolonged exposure for combat-related PTSD in veterans: preliminary results. J Clin Psychol. 2015 Jun;71(6):500-12. doi: 10.1002/jclp.22168. PMID: 25809565.",44639,2019
yurtsever2018_IES_A_0_Comp,Psychotherapy,PTSD,63,A,PTSD,,18,,EMDR Group Traumatic Episode Protocol,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,28,Self report,IES,IES-R,Completer,Excluded,Repeated measures ANOVA for change in mean score; independent samples t-test for between-group comparison at each time point; chi-square test for diagnostic change,End of Treatment,0,,48.22,17.34,,,,SE 4.81,-14.22,,,,,,,,,,p<0.05,,,,,,,,Not meeting criteria for PTSD according to MINI,0.5556,,,,,Community,,,1,0.766,,0.234,Terrorism/political violence/forced displacement,,Medium,"Yurtsever A, Konuk E, Akyüz T, et al. An Eye Movement Desensitization and Reprocessing (EMDR) group intervention for Syrian refugees with post-traumatic stress symptoms: results of a randomized controlled trial. Front Psychol. 2018 Jun 12;9:493. doi: 10.3389/fpsyg.2018.00493. PMID: 29946275.",51112,2019
yurtsever2018_IES_A_4_Comp,Psychotherapy,PTSD,63,A,PTSD,,18,,EMDR Group Traumatic Episode Protocol,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,28,Self report,IES,IES-R,Completer,Excluded,Repeated measures ANOVA for change in mean score; independent samples t-test for between-group comparison at each time point; chi-square test for diagnostic change,Assessment at <3 Months,4,,51.94,16.78,,,,SE 4.10,-10.5,,,,,,,,,,p<0.05,,,,,,,,Not meeting criteria for PTSD according to MINI,0.6111,,,,,Community,,,1,0.766,,0.234,Terrorism/political violence/forced displacement,,Medium,"Yurtsever A, Konuk E, Akyüz T, et al. An Eye Movement Desensitization and Reprocessing (EMDR) group intervention for Syrian refugees with post-traumatic stress symptoms: results of a randomized controlled trial. Front Psychol. 2018 Jun 12;9:493. doi: 10.3389/fpsyg.2018.00493. PMID: 29946275.",51112,2019
yurtsever2018_IES_A_Baseline_Comp,Psychotherapy,PTSD,63,A,PTSD,,28,,EMDR Group Traumatic Episode Protocol,Eye Movement Desensitization and Reprocessing (EMDR),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,28,Self report,IES,IES-R,Completer,Excluded,Repeated measures ANOVA for change in mean score; independent samples t-test for between-group comparison at each time point; chi-square test for diagnostic change,Baseline,,,62.44,9.05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.766,,0.234,Terrorism/political violence/forced displacement,,Medium,"Yurtsever A, Konuk E, Akyüz T, et al. An Eye Movement Desensitization and Reprocessing (EMDR) group intervention for Syrian refugees with post-traumatic stress symptoms: results of a randomized controlled trial. Front Psychol. 2018 Jun 12;9:493. doi: 10.3389/fpsyg.2018.00493. PMID: 29946275.",51112,2019
yurtsever2018_IES_B_0_Comp,Psychotherapy,PTSD,63,B,Control,,29,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,29,Self report,IES,IES-R,Completer,Excluded,Repeated measures ANOVA for change in mean score; independent samples t-test for between-group comparison at each time point; chi-square test for diagnostic change,End of Treatment,0,,59.1,17.37,,,,SE 3.18,-3.35,,,,,,,,,,p>0.05,,,,,,,,Not meeting criteria for PTSD according to MINI,0.1034,,,,,Community,,,1,0.766,,0.234,Terrorism/political violence/forced displacement,,Medium,"Yurtsever A, Konuk E, Akyüz T, et al. An Eye Movement Desensitization and Reprocessing (EMDR) group intervention for Syrian refugees with post-traumatic stress symptoms: results of a randomized controlled trial. Front Psychol. 2018 Jun 12;9:493. doi: 10.3389/fpsyg.2018.00493. PMID: 29946275.",51112,2019
yurtsever2018_IES_B_4_Comp,Psychotherapy,PTSD,63,B,Control,,29,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,29,Self report,IES,IES-R,Completer,Excluded,Repeated measures ANOVA for change in mean score; independent samples t-test for between-group comparison at each time point; chi-square test for diagnostic change,Assessment at <3 Months,4,,58.83,15.41,,,,SE 2.35,-3.62,,,,,,,,,,p>0.05,,,,,,,,Not meeting criteria for PTSD according to MINI,0.069,,,,,Community,,,1,0.766,,0.234,Terrorism/political violence/forced displacement,,Medium,"Yurtsever A, Konuk E, Akyüz T, et al. An Eye Movement Desensitization and Reprocessing (EMDR) group intervention for Syrian refugees with post-traumatic stress symptoms: results of a randomized controlled trial. Front Psychol. 2018 Jun 12;9:493. doi: 10.3389/fpsyg.2018.00493. PMID: 29946275.",51112,2019
yurtsever2018_IES_B_Baseline_Comp,Psychotherapy,PTSD,63,B,Control,,32,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,29,Self report,IES,IES-R,Completer,Excluded,Repeated measures ANOVA for change in mean score; independent samples t-test for between-group comparison at each time point; chi-square test for diagnostic change,Baseline,,,62.45,1.227,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.766,,0.234,Terrorism/political violence/forced displacement,,Medium,"Yurtsever A, Konuk E, Akyüz T, et al. An Eye Movement Desensitization and Reprocessing (EMDR) group intervention for Syrian refugees with post-traumatic stress symptoms: results of a randomized controlled trial. Front Psychol. 2018 Jun 12;9:493. doi: 10.3389/fpsyg.2018.00493. PMID: 29946275.",51112,2019
zalta2019_PCL_A_0_NA,Nonpharmacologic biological,PTSD,15,A,PTSD,,9,,Re-timer,Re-timer,No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,9,Self report,PCL,PCL-5,,,Repeated measures ANOVA for change in mean score; independent samples t-test for between-group comparison at each time point; chi-square test for diagnostic change,End of Treatment,0,,28.00,14.41,,,,,-15.11,,,,,,,,,,,,,,,,,,,,,10-point change on PCL-5,0.6667,,Community,0,0,1,0.5333,,0.4667,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence",Medium,"Zalta AK, Bravo K, Valdespino‐Hayden Z, et al. A placebo‐controlled pilot study of a wearable morning bright light treatment for probable PTSD. Depress Anxiety. 2019 Jul;36(7):617-24. doi: 10.1002/da.22897. PMID: 30995350.",52251,2020
zalta2019_PCL_A_Baseline_NA,Nonpharmacologic biological,PTSD,15,A,PTSD,,9,,Re-timer,Re-timer,No,Not Applicable,No,Not Applicable,No,Not Applicable,Yes,No,No,No,No,Individual,In person,9,Self report,PCL,PCL-5,,,Repeated measures ANOVA for change in mean score; independent samples t-test for between-group comparison at each time point; chi-square test for diagnostic change,Baseline,,,43.11,12.77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.5333,,0.4667,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence",Medium,"Zalta AK, Bravo K, Valdespino‐Hayden Z, et al. A placebo‐controlled pilot study of a wearable morning bright light treatment for probable PTSD. Depress Anxiety. 2019 Jul;36(7):617-24. doi: 10.1002/da.22897. PMID: 30995350.",52251,2020
zalta2019_PCL_B_0_NA,Nonpharmacologic biological,PTSD,15,B,Control,,6,,Placebo Re-timer,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,6,Self report,PCL,PCL-5,,,Repeated measures ANOVA for change in mean score; independent samples t-test for between-group comparison at each time point; chi-square test for diagnostic change,End of Treatment,0,,31.67,17.26,,,,,-2.5,,,,,,,,,,,,,,,,,,,,,10-point change on PCL-5,0.3333,,Community,0,0,1,0.5333,,0.4667,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence",Medium,"Zalta AK, Bravo K, Valdespino‐Hayden Z, et al. A placebo‐controlled pilot study of a wearable morning bright light treatment for probable PTSD. Depress Anxiety. 2019 Jul;36(7):617-24. doi: 10.1002/da.22897. PMID: 30995350.",52251,2020
zalta2019_PCL_B_Baseline_NA,Nonpharmacologic biological,PTSD,15,B,Control,,6,,Placebo Re-timer,Sham,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In person,6,Self report,PCL,PCL-5,,,Repeated measures ANOVA for change in mean score; independent samples t-test for between-group comparison at each time point; chi-square test for diagnostic change,Baseline,,,34.17,15.33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.5333,,0.4667,Mixed,"combat-related, rape/sexual assault, accidents, community/school violence",Medium,"Zalta AK, Bravo K, Valdespino‐Hayden Z, et al. A placebo‐controlled pilot study of a wearable morning bright light treatment for probable PTSD. Depress Anxiety. 2019 Jul;36(7):617-24. doi: 10.1002/da.22897. PMID: 30995350.",52251,2020
zang2013_IES_A_0_Comp,Psychotherapy,PTSD,22,A,PTSD,,11,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,11,Self report,IES,IES-R,Completer,,Repeated measures ANOVA for change in mean score; independent samples t-test for between-group comparison at each time point; chi-square test for diagnostic change,End of Treatment,0,,26,,,,,,-22,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.7727,,0.2273,Natural or manmade disasters,,Low,"Zang Y, Hunt NC, Cox T. A randomised controlled pilot study: the effectiveness of narrative exposure therapy with adult survivors of the Sichuan earthquake. BMC Psychiatry. 2013 Jan 31;13:41. doi: 10.1186/1471-244X-13-41. PMID: 23363689.",46041,2020
zang2013_IES_A_2_Comp,Psychotherapy,PTSD,22,A,PTSD,,11,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,11,Self report,IES,IES-R,Completer,,Repeated measures ANOVA for change in mean score; independent samples t-test for between-group comparison at each time point; chi-square test for diagnostic change,Assessment at <3 Months,2,,24.5,,,,,,-23.5,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.7727,,0.2273,Natural or manmade disasters,,Low,"Zang Y, Hunt NC, Cox T. A randomised controlled pilot study: the effectiveness of narrative exposure therapy with adult survivors of the Sichuan earthquake. BMC Psychiatry. 2013 Jan 31;13:41. doi: 10.1186/1471-244X-13-41. PMID: 23363689.",46041,2020
zang2013_IES_A_Baseline_Comp,Psychotherapy,PTSD,22,A,PTSD,,11,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In person,11,Self report,IES,IES-R,Completer,,Repeated measures ANOVA for change in mean score; independent samples t-test for between-group comparison at each time point; chi-square test for diagnostic change,Baseline,,,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.7727,,0.2273,Natural or manmade disasters,,Low,"Zang Y, Hunt NC, Cox T. A randomised controlled pilot study: the effectiveness of narrative exposure therapy with adult survivors of the Sichuan earthquake. BMC Psychiatry. 2013 Jan 31;13:41. doi: 10.1186/1471-244X-13-41. PMID: 23363689.",46041,2020
zang2013_IES_B_0_Comp,Psychotherapy,PTSD,22,B,Control,,11,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,11,Self report,IES,IES-R,Completer,,Repeated measures ANOVA for change in mean score; independent samples t-test for between-group comparison at each time point; chi-square test for diagnostic change,End of Treatment,0,,47,,,,,,-0.5,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.7727,,0.2273,Natural or manmade disasters,,Low,"Zang Y, Hunt NC, Cox T. A randomised controlled pilot study: the effectiveness of narrative exposure therapy with adult survivors of the Sichuan earthquake. BMC Psychiatry. 2013 Jan 31;13:41. doi: 10.1186/1471-244X-13-41. PMID: 23363689.",46041,2020
zang2013_IES_B_Baseline_Comp,Psychotherapy,PTSD,22,B,Control,,11,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,11,Self report,IES,IES-R,Completer,,Repeated measures ANOVA for change in mean score; independent samples t-test for between-group comparison at each time point; chi-square test for diagnostic change,Baseline,,,47.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,0,1,0.7727,,0.2273,Natural or manmade disasters,,Low,"Zang Y, Hunt NC, Cox T. A randomised controlled pilot study: the effectiveness of narrative exposure therapy with adult survivors of the Sichuan earthquake. BMC Psychiatry. 2013 Jan 31;13:41. doi: 10.1186/1471-244X-13-41. PMID: 23363689.",46041,2020
zang2014_IES_A_0_ITT,Psychotherapy,PTSD,30,A,PTSD,,10,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,IES,IES-R,ITT,,ANCOVA and paired t-tests for score changes,End of Treatment,0,,17,6.72,,,,,-33.9,,-37.95,-29.85,,Hedges' g,3.65,,,,p<0.001,,,,,,,,,,,,,,Community,,,1,0.9,,0.1,Natural or manmade disasters,,Medium,"Zang Y, Hunt NC, Cox T. Adapting narrative exposure therapy for Chinese earthquake survivors: a pilot randomised controlled feasibility study. BMC Psychiatry. 2014 Oct 3;14:262. doi: 10.1186/s12888-014-0262-3. PMID: 25927297.",46042,2019
zang2014_IES_A_1_ITT,Psychotherapy,PTSD,30,A,PTSD,,10,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,IES,IES-R,ITT,,ANCOVA and paired t-tests for score changes,Assessment at <3 Months,1,,16.1,6.85,,,,,-34.8,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.9,,0.1,Natural or manmade disasters,,Medium,"Zang Y, Hunt NC, Cox T. Adapting narrative exposure therapy for Chinese earthquake survivors: a pilot randomised controlled feasibility study. BMC Psychiatry. 2014 Oct 3;14:262. doi: 10.1186/s12888-014-0262-3. PMID: 25927297.",46042,2019
zang2014_IES_A_12_ITT,Psychotherapy,PTSD,30,A,PTSD,,10,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,IES,IES-R,ITT,,ANCOVA and paired t-tests for score changes,Assessment at 3 to <6 Months,12,,12.7,9.59,,,,,-38.2,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.9,,0.1,Natural or manmade disasters,,Medium,"Zang Y, Hunt NC, Cox T. Adapting narrative exposure therapy for Chinese earthquake survivors: a pilot randomised controlled feasibility study. BMC Psychiatry. 2014 Oct 3;14:262. doi: 10.1186/s12888-014-0262-3. PMID: 25927297.",46042,2019
zang2014_IES_A_Baseline_ITT,Psychotherapy,PTSD,30,A,PTSD,,10,,NET,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,IES,IES-R,ITT,,ANCOVA and paired t-tests for score changes,Baseline,,,50.9,10.65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.9,,0.1,Natural or manmade disasters,,Medium,"Zang Y, Hunt NC, Cox T. Adapting narrative exposure therapy for Chinese earthquake survivors: a pilot randomised controlled feasibility study. BMC Psychiatry. 2014 Oct 3;14:262. doi: 10.1186/s12888-014-0262-3. PMID: 25927297.",46042,2019
zang2014_IES_B_0_ITT,Psychotherapy,PTSD,30,B,PTSD,,10,,NET-Revised,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,IES,IES-R,ITT,,ANCOVA and paired t-tests for score changes,End of Treatment,0,,16.9,4.93,,,,,-35.2,,-43.93,-26.47,,Hedges' g,4.62,,,,p<0.001,,,,,,,,,,,,,,Community,,,1,0.9,,0.1,Natural or manmade disasters,,Medium,"Zang Y, Hunt NC, Cox T. Adapting narrative exposure therapy for Chinese earthquake survivors: a pilot randomised controlled feasibility study. BMC Psychiatry. 2014 Oct 3;14:262. doi: 10.1186/s12888-014-0262-3. PMID: 25927297.",46042,2019
zang2014_IES_B_12_ITT,Psychotherapy,PTSD,30,B,PTSD,,10,,NET-Revised,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,IES,IES-R,ITT,,ANCOVA and paired t-tests for score changes,Assessment at 3 to <6 Months,12,,12.7,6.48,,,,,-39.4,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.9,,0.1,Natural or manmade disasters,,Medium,"Zang Y, Hunt NC, Cox T. Adapting narrative exposure therapy for Chinese earthquake survivors: a pilot randomised controlled feasibility study. BMC Psychiatry. 2014 Oct 3;14:262. doi: 10.1186/s12888-014-0262-3. PMID: 25927297.",46042,2019
zang2014_IES_B_2_ITT,Psychotherapy,PTSD,30,B,PTSD,,10,,NET-Revised,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,IES,IES-R,ITT,,ANCOVA and paired t-tests for score changes,Assessment at <3 Months,2,,16.5,4.81,,,,,-35.6,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.9,,0.1,Natural or manmade disasters,,Medium,"Zang Y, Hunt NC, Cox T. Adapting narrative exposure therapy for Chinese earthquake survivors: a pilot randomised controlled feasibility study. BMC Psychiatry. 2014 Oct 3;14:262. doi: 10.1186/s12888-014-0262-3. PMID: 25927297.",46042,2019
zang2014_IES_B_Baseline_ITT,Psychotherapy,PTSD,30,B,PTSD,,10,,NET-Revised,Narrative Exposure Therapy (NET),Yes,TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,10,Self report,IES,IES-R,ITT,,ANCOVA and paired t-tests for score changes,Baseline,,,52.1,9.06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.9,,0.1,Natural or manmade disasters,,Medium,"Zang Y, Hunt NC, Cox T. Adapting narrative exposure therapy for Chinese earthquake survivors: a pilot randomised controlled feasibility study. BMC Psychiatry. 2014 Oct 3;14:262. doi: 10.1186/s12888-014-0262-3. PMID: 25927297.",46042,2019
zang2014_IES_C_0_ITT,Psychotherapy,PTSD,30,C,Control,,10,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,10,Self report,IES,IES-R,ITT,,ANCOVA and paired t-tests for score changes,End of Treatment,0,,54.7,10.81,,,,,-2.1,,-3.66,-0.54,,Hedges' g,3.04,,,,p<0.05,,,,,,,,,,,,,,Community,,,1,0.9,,0.1,Natural or manmade disasters,,Medium,"Zang Y, Hunt NC, Cox T. Adapting narrative exposure therapy for Chinese earthquake survivors: a pilot randomised controlled feasibility study. BMC Psychiatry. 2014 Oct 3;14:262. doi: 10.1186/s12888-014-0262-3. PMID: 25927297.",46042,2019
zang2014_IES_C_Baseline_ITT,Psychotherapy,PTSD,30,C,Control,,10,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,10,Self report,IES,IES-R,ITT,,ANCOVA and paired t-tests for score changes,Baseline,,,56.8,10.91,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.9,,0.1,Natural or manmade disasters,,Medium,"Zang Y, Hunt NC, Cox T. Adapting narrative exposure therapy for Chinese earthquake survivors: a pilot randomised controlled feasibility study. BMC Psychiatry. 2014 Oct 3;14:262. doi: 10.1186/s12888-014-0262-3. PMID: 25927297.",46042,2019
ziemba2014_CAPS_A_0_Comp,Psychotherapy,PTSD,18,A,PTSD,,7,,Telemedicine-administered CBT,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,,Structured Clinical Interview,CAPS,CAPS,Completer,,"None (small sample size ""prevented the ability to demonstrate statistical significance of the results"")",End of Treatment,0,,72,,,,,,-23,,,,,,,,,,,,,,,,,,,,,≥15-point change in total CAPS score,,,Mixed,,,0,0.9,,0.1,,,Medium,"Ziemba SJ, Bradley NS, Landry L-AP, et al. Posttraumatic stress disorder treatment for Operation Enduring Freedom/Operation Iraqi Freedom combat veterans through a civilian community-based telemedicine network. Telemed J E Health. 2014 May;20(5):446-50. doi: 10.1089/tmj.2013.0312. PMID: 24617961.",46063,2019
ziemba2014_CAPS_A_Baseline_Comp,Psychotherapy,PTSD,18,A,PTSD,,7,,Telemedicine-administered CBT,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,Video,,Structured Clinical Interview,CAPS,CAPS,Completer,,"None (small sample size ""prevented the ability to demonstrate statistical significance of the results"")",Baseline,,,95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.9,,0.1,,,Medium,"Ziemba SJ, Bradley NS, Landry L-AP, et al. Posttraumatic stress disorder treatment for Operation Enduring Freedom/Operation Iraqi Freedom combat veterans through a civilian community-based telemedicine network. Telemed J E Health. 2014 May;20(5):446-50. doi: 10.1089/tmj.2013.0312. PMID: 24617961.",46063,2019
ziemba2014_CAPS_B_0_Comp,Psychotherapy,PTSD,18,B,PTSD,,6,,Face-to-face-administered CBT,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,Completer,,"None (small sample size ""prevented the ability to demonstrate statistical significance of the results"")",End of Treatment,0,,68,,,,,,-22,,,,,,,,,,,,,,,,,,,,,≥15-point change in total CAPS score,,,Mixed,,,0,0.9,,0.1,,,Medium,"Ziemba SJ, Bradley NS, Landry L-AP, et al. Posttraumatic stress disorder treatment for Operation Enduring Freedom/Operation Iraqi Freedom combat veterans through a civilian community-based telemedicine network. Telemed J E Health. 2014 May;20(5):446-50. doi: 10.1089/tmj.2013.0312. PMID: 24617961.",46063,2019
ziemba2014_CAPS_B_Baseline_Comp,Psychotherapy,PTSD,18,B,PTSD,,6,,Face-to-face-administered CBT,Cognitive behavioral therapy (CBT) without a trauma focus,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Individual,In Person,,Structured Clinical Interview,CAPS,CAPS,Completer,,"None (small sample size ""prevented the ability to demonstrate statistical significance of the results"")",Baseline,,,90,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mixed,,,0,0.9,,0.1,,,Medium,"Ziemba SJ, Bradley NS, Landry L-AP, et al. Posttraumatic stress disorder treatment for Operation Enduring Freedom/Operation Iraqi Freedom combat veterans through a civilian community-based telemedicine network. Telemed J E Health. 2014 May;20(5):446-50. doi: 10.1089/tmj.2013.0312. PMID: 24617961.",46063,2019
zlotnick1997_Crim_A_0_NA,Psychotherapy,PTSD,46,A,PTSD,,,,Group affect management therapy,Affect management therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,23,Self report,Crime-Related Post-Traumatic Stress Scale,Crime-Related Post-Traumatic Stress Scale,,,ANCOVA,End of Treatment,0,,26.29,19.88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,High,"Zlotnick C, Shea MT, Rosen KH, et al. An affect-management group for women with posttraumatic stress disorder and histories of childhood sexual abuse. J Trauma Stress. 1997 Jul;10(3):425-36. doi: 10.1023/A:1024841321156. PMID: 9246650.",13731,2019
zlotnick1997_Crim_A_Baseline_NA,Psychotherapy,PTSD,46,A,PTSD,,,,Group affect management therapy,Affect management therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,23,Self report,Crime-Related Post-Traumatic Stress Scale,Crime-Related Post-Traumatic Stress Scale,,,ANCOVA,Baseline,,,33.53,18.88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,High,"Zlotnick C, Shea MT, Rosen KH, et al. An affect-management group for women with posttraumatic stress disorder and histories of childhood sexual abuse. J Trauma Stress. 1997 Jul;10(3):425-36. doi: 10.1023/A:1024841321156. PMID: 9246650.",13731,2019
zlotnick1997_Crim_B_0_NA,Psychotherapy,PTSD,46,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,23,Self report,Crime-Related Post-Traumatic Stress Scale,Crime-Related Post-Traumatic Stress Scale,,,ANCOVA,End of Treatment,0,,51.43,24.19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,High,"Zlotnick C, Shea MT, Rosen KH, et al. An affect-management group for women with posttraumatic stress disorder and histories of childhood sexual abuse. J Trauma Stress. 1997 Jul;10(3):425-36. doi: 10.1023/A:1024841321156. PMID: 9246650.",13731,2019
zlotnick1997_Crim_B_Baseline_NA,Psychotherapy,PTSD,46,B,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,23,Self report,Crime-Related Post-Traumatic Stress Scale,Crime-Related Post-Traumatic Stress Scale,,,ANCOVA,Baseline,,,46.88,21.16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,High,"Zlotnick C, Shea MT, Rosen KH, et al. An affect-management group for women with posttraumatic stress disorder and histories of childhood sexual abuse. J Trauma Stress. 1997 Jul;10(3):425-36. doi: 10.1023/A:1024841321156. PMID: 9246650.",13731,2019
zlotnick1997_DTS_A_0_Comp,Psychotherapy,PTSD,46,A,PTSD,,16,,Group affect management therapy,Affect management therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,23,Self report,DTS,DTS,Completer,,ANCOVA,End of Treatment,0,,45.76,34.12,,,,,-21.12,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DTS and CAPS-1,0.875,,,,,Community,,,1,1,,0,Child sexual abuse,,High,"Zlotnick C, Shea MT, Rosen KH, et al. An affect-management group for women with posttraumatic stress disorder and histories of childhood sexual abuse. J Trauma Stress. 1997 Jul;10(3):425-36. doi: 10.1023/A:1024841321156. PMID: 9246650.",13731,2019
zlotnick1997_DTS_A_Baseline_Comp,Psychotherapy,PTSD,46,A,PTSD,,16,,Group affect management therapy,Affect management therapy,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Group,In Person,23,Self report,DTS,DTS,Completer,,ANCOVA,Baseline,,,66.88,22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,High,"Zlotnick C, Shea MT, Rosen KH, et al. An affect-management group for women with posttraumatic stress disorder and histories of childhood sexual abuse. J Trauma Stress. 1997 Jul;10(3):425-36. doi: 10.1023/A:1024841321156. PMID: 9246650.",13731,2019
zlotnick1997_DTS_B_0_Comp,Psychotherapy,PTSD,46,B,Control,,17,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,23,Self report,DTS,DTS,Completer,,ANCOVA,End of Treatment,0,,73.06,29.86,,,,,-1.63,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to DTS and CAPS-1,0.4118,,,,,Community,,,1,1,,0,Child sexual abuse,,High,"Zlotnick C, Shea MT, Rosen KH, et al. An affect-management group for women with posttraumatic stress disorder and histories of childhood sexual abuse. J Trauma Stress. 1997 Jul;10(3):425-36. doi: 10.1023/A:1024841321156. PMID: 9246650.",13731,2019
zlotnick1997_DTS_B_Baseline_Comp,Psychotherapy,PTSD,46,B,Control,,17,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,,,23,Self report,DTS,DTS,Completer,,ANCOVA,Baseline,,,74.69,25.83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,1,,0,Child sexual abuse,,High,"Zlotnick C, Shea MT, Rosen KH, et al. An affect-management group for women with posttraumatic stress disorder and histories of childhood sexual abuse. J Trauma Stress. 1997 Jul;10(3):425-36. doi: 10.1023/A:1024841321156. PMID: 9246650.",13731,2019
zlotnick2009_CAPS_A_0_ITT,Psychotherapy,PTSD+SUD,49,A,PTSD+SUD,Integrated,27,,Seeking Safety + TAU,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In person,27,Structured Clinical Interview,CAPS,CAPS-I,ITT,Listwise deletion,ANCOVA,End of Treatment,0,,57.0,23.7,,,,,-12.4,,,,,,,,,,p≤0.01,,,,,,,,Not fulfilling DSM-IV criteria for PTSD on CAPS-I,0.3704,,,,,Community,0,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",High,"Zlotnick C, Johnson JE, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009 Dec;40(4):325-36. doi: 10.1016/j.beth.2008.09.004. PMID: 19892078.",32555,2020
zlotnick2009_CAPS_A_12_ITT,Psychotherapy,PTSD+SUD,49,A,PTSD+SUD,Integrated,23,,Seeking Safety + TAU,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In person,27,Structured Clinical Interview,CAPS,CAPS-I,ITT,Listwise deletion,ANCOVA,Assessment at 3 to <6 Months,12,,50.9,32,,,,,-18.5,,,,,,,,,,p≤0.01,,,,,,,,Not fulfilling DSM-IV criteria for PTSD on CAPS-I,,,,,,Community,0,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",High,"Zlotnick C, Johnson JE, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009 Dec;40(4):325-36. doi: 10.1016/j.beth.2008.09.004. PMID: 19892078.",32555,2020
zlotnick2009_CAPS_A_26_ITT,Psychotherapy,PTSD+SUD,49,A,PTSD+SUD,Integrated,23,,Seeking Safety + TAU,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In person,27,Structured Clinical Interview,CAPS,CAPS-I,ITT,Listwise deletion,ANCOVA,Assessment at 6 to <12 Months,26,,45.9,30.7,,,,,-23.5,,,,,,,,,,p≤0.01,,,,,,,,Not fulfilling DSM-IV criteria for PTSD on CAPS-I,0.53,,,,,Community,0,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",High,"Zlotnick C, Johnson JE, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009 Dec;40(4):325-36. doi: 10.1016/j.beth.2008.09.004. PMID: 19892078.",32555,2020
zlotnick2009_CAPS_A_Baseline_ITT,Psychotherapy,PTSD+SUD,49,A,PTSD+SUD,Integrated,27,,Seeking Safety + TAU,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In person,27,Structured Clinical Interview,CAPS,CAPS-I,ITT,Listwise deletion,ANCOVA,Baseline,,,69.4,16.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",High,"Zlotnick C, Johnson JE, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009 Dec;40(4):325-36. doi: 10.1016/j.beth.2008.09.004. PMID: 19892078.",32555,2020
zlotnick2009_CAPS_B_0_ITT,Psychotherapy,PTSD+SUD,49,B,SUD,Not integrated,22,,TAU for substance use,Treatment as usual (TAU) for substance use,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In person,22,Structured Clinical Interview,CAPS,CAPS-I,ITT,Listwise deletion,ANCOVA,End of Treatment,0,,52.5,24.6,,,,,-11.9,,,,,,,,,,p≤0.05,,,,,,,,Not fulfilling DSM-IV criteria for PTSD on CAPS-I,0.2727,,,,,Community,0,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",High,"Zlotnick C, Johnson JE, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009 Dec;40(4):325-36. doi: 10.1016/j.beth.2008.09.004. PMID: 19892078.",32555,2020
zlotnick2009_CAPS_B_12_ITT,Psychotherapy,PTSD+SUD,49,B,SUD,Not integrated,21,,TAU for substance use,Treatment as usual (TAU) for substance use,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In person,22,Structured Clinical Interview,CAPS,CAPS-I,ITT,Listwise deletion,ANCOVA,Assessment at 3 to <6 Months,12,,51.5,24.6,,,,,-12.9,,,,,,,,,,p≤0.01,,,,,,,,Not fulfilling DSM-IV criteria for PTSD on CAPS-I,,,,,,Community,0,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",High,"Zlotnick C, Johnson JE, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009 Dec;40(4):325-36. doi: 10.1016/j.beth.2008.09.004. PMID: 19892078.",32555,2020
zlotnick2009_CAPS_B_26_ITT,Psychotherapy,PTSD+SUD,49,B,SUD,Not integrated,21,,TAU for substance use,Treatment as usual (TAU) for substance use,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In person,22,Structured Clinical Interview,CAPS,CAPS-I,ITT,Listwise deletion,ANCOVA,Assessment at 6 to <12 Months,26,,46.7,28.3,,,,,-17.7,,,,,,,,,,p≤0.01,,,,,,,,Not fulfilling DSM-IV criteria for PTSD on CAPS-I,0.53,,,,,Community,0,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",High,"Zlotnick C, Johnson JE, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009 Dec;40(4):325-36. doi: 10.1016/j.beth.2008.09.004. PMID: 19892078.",32555,2020
zlotnick2009_CAPS_B_Baseline_ITT,Psychotherapy,PTSD+SUD,49,B,SUD,Not integrated,22,,TAU for substance use,Treatment as usual (TAU) for substance use,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In person,22,Structured Clinical Interview,CAPS,CAPS-I,ITT,Listwise deletion,ANCOVA,Baseline,,,64.4,21.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",High,"Zlotnick C, Johnson JE, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009 Dec;40(4):325-36. doi: 10.1016/j.beth.2008.09.004. PMID: 19892078.",32555,2020
zlotnick2009_TSC-40_A_0_ITT,Psychotherapy,PTSD+SUD,49,A,PTSD+SUD,Integrated,,,Seeking Safety + TAU,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In person,27,Self report,TSC-40,TSC-40,ITT,Listwise deletion,ANCOVA,End of Treatment,0,,6.4,3.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",High,"Zlotnick C, Johnson JE, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009 Dec;40(4):325-36. doi: 10.1016/j.beth.2008.09.004. PMID: 19892078.",32555,2020
zlotnick2009_TSC-40_A_12_ITT,Psychotherapy,PTSD+SUD,49,A,PTSD+SUD,Integrated,,,Seeking Safety + TAU,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In person,27,Self report,TSC-40,TSC-40,ITT,Listwise deletion,ANCOVA,Assessment at 3 to <6 Months,12,,6.7,3.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",High,"Zlotnick C, Johnson JE, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009 Dec;40(4):325-36. doi: 10.1016/j.beth.2008.09.004. PMID: 19892078.",32555,2020
zlotnick2009_TSC-40_A_26_ITT,Psychotherapy,PTSD+SUD,49,A,PTSD+SUD,Integrated,,,Seeking Safety + TAU,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In person,27,Self report,TSC-40,TSC-40,ITT,Listwise deletion,ANCOVA,Assessment at 6 to <12 Months,26,,5.9,2.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",High,"Zlotnick C, Johnson JE, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009 Dec;40(4):325-36. doi: 10.1016/j.beth.2008.09.004. PMID: 19892078.",32555,2020
zlotnick2009_TSC-40_A_Baseline_ITT,Psychotherapy,PTSD+SUD,49,A,PTSD+SUD,Integrated,,,Seeking Safety + TAU,Seeking Safety,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In person,27,Self report,TSC-40,TSC-40,ITT,Listwise deletion,ANCOVA,Baseline,,,9.3,3.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",High,"Zlotnick C, Johnson JE, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009 Dec;40(4):325-36. doi: 10.1016/j.beth.2008.09.004. PMID: 19892078.",32555,2020
zlotnick2009_TSC-40_B_0_ITT,Psychotherapy,PTSD+SUD,49,B,SUD,Not integrated,,,TAU for substance use,Treatment as usual (TAU) for substance use,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In person,22,Self report,TSC-40,TSC-40,ITT,Listwise deletion,ANCOVA,End of Treatment,0,,5.6,3.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",High,"Zlotnick C, Johnson JE, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009 Dec;40(4):325-36. doi: 10.1016/j.beth.2008.09.004. PMID: 19892078.",32555,2020
zlotnick2009_TSC-40_B_12_ITT,Psychotherapy,PTSD+SUD,49,B,SUD,Not integrated,,,TAU for substance use,Treatment as usual (TAU) for substance use,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In person,22,Self report,TSC-40,TSC-40,ITT,Listwise deletion,ANCOVA,Assessment at 3 to <6 Months,12,,7.4,3.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",High,"Zlotnick C, Johnson JE, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009 Dec;40(4):325-36. doi: 10.1016/j.beth.2008.09.004. PMID: 19892078.",32555,2020
zlotnick2009_TSC-40_B_26_ITT,Psychotherapy,PTSD+SUD,49,B,SUD,Not integrated,,,TAU for substance use,Treatment as usual (TAU) for substance use,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In person,22,Self report,TSC-40,TSC-40,ITT,Listwise deletion,ANCOVA,Assessment at 6 to <12 Months,26,,6.7,3.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",High,"Zlotnick C, Johnson JE, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009 Dec;40(4):325-36. doi: 10.1016/j.beth.2008.09.004. PMID: 19892078.",32555,2020
zlotnick2009_TSC-40_B_Baseline_ITT,Psychotherapy,PTSD+SUD,49,B,SUD,Not integrated,,,TAU for substance use,Treatment as usual (TAU) for substance use,Yes,Non-TF,No,Not Applicable,No,Not Applicable,No,No,No,No,No,Mixed,In person,22,Self report,TSC-40,TSC-40,ITT,Listwise deletion,ANCOVA,Baseline,,,8.2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,0,,1,1,,0,Mixed,"rape/sexual assault, community/school violence",High,"Zlotnick C, Johnson JE, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009 Dec;40(4):325-36. doi: 10.1016/j.beth.2008.09.004. PMID: 19892078.",32555,2020
zoellner2017_PSS-I_A_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,42,A,PTSD,,,,Methylene blue + imaginal exposure,Imaginal exposure (experimental paradigm) followed by methylene blue,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Structured Clinical Interview,PSS-I,PSS-I,ITT,Mixed effects model with missing data treated as ignorable and randomly missing,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",End of Treatment,0,,17.10,10.57,,,,,-14.97,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.7,,PSS-I ≤23 and CGI-I ≤3 (determined using RCI cutoff c),0.7,,Community,,,1,0.7143,,0.2857,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.",48582,2019
zoellner2017_PSS-I_A_4_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,42,A,PTSD,,,,Methylene blue + imaginal exposure,Imaginal exposure (experimental paradigm) followed by methylene blue,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Structured Clinical Interview,PSS-I,PSS-I,ITT,Mixed effects model with missing data treated as ignorable and randomly missing,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",Assessment at <3 Months,4,,10.33,3.77,,,,,-21.74,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.8889,,PSS-I ≤23 and CGI-I ≤3 (determined using RCI cutoff c),1,,Community,,,1,0.7143,,0.2857,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.",48582,2019
zoellner2017_PSS-I_A_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,42,A,PTSD,,15,,Methylene blue + imaginal exposure,Imaginal exposure (experimental paradigm) followed by methylene blue,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Structured Clinical Interview,PSS-I,PSS-I,ITT,Mixed effects model with missing data treated as ignorable and randomly missing,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",Baseline,,,32.07,6.17,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,,,PSS-I ≤23 and CGI-I ≤3 (determined using RCI cutoff c),,,Community,,,1,0.7143,,0.2857,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.",48582,2019
zoellner2017_PSS-I_B_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,42,B,PTSD,,,,Placebo + imaginal exposure,Imaginal exposure + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,16,Structured Clinical Interview,PSS-I,PSS-I,ITT,Mixed effects model with missing data treated as ignorable and randomly missing,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",End of Treatment,0,,14.67,9.27,,,,,-16.71,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.6667,,PSS-I ≤23 and CGI-I ≤3 (determined using RCI cutoff c),0.8667,,Community,,,1,0.7143,,0.2857,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.",48582,2019
zoellner2017_PSS-I_B_4_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,42,B,PTSD,,,,Placebo + imaginal exposure,Imaginal exposure + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,16,Structured Clinical Interview,PSS-I,PSS-I,ITT,Mixed effects model with missing data treated as ignorable and randomly missing,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",Assessment at <3 Months,4,,13.33,9.15,,,,,-18.05,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.6667,,PSS-I ≤23 and CGI-I ≤3 (determined using RCI cutoff c),0.9333,,Community,,,1,0.7143,,0.2857,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.",48582,2019
zoellner2017_PSS-I_B_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,42,B,PTSD,,16,,Placebo + imaginal exposure,Imaginal exposure + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,16,Structured Clinical Interview,PSS-I,PSS-I,ITT,Mixed effects model with missing data treated as ignorable and randomly missing,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",Baseline,,,31.38,6.88,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,,,PSS-I ≤23 and CGI-I ≤3 (determined using RCI cutoff c),,,Community,,,1,0.7143,,0.2857,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.",48582,2019
zoellner2017_PSS-I_C_0_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,42,C,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,11,Structured Clinical Interview,PSS-I,PSS-I,ITT,Mixed effects model with missing data treated as ignorable and randomly missing,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",End of Treatment,0,,29.60,8.4,,,,,-3.13,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.1,,PSS-I ≤23 and CGI-I ≤3 (determined using RCI cutoff c),0.1,,Community,,,1,0.7143,,0.2857,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.",48582,2019
zoellner2017_PSS-I_C_4_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,42,C,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,11,Structured Clinical Interview,PSS-I,PSS-I,ITT,Mixed effects model with missing data treated as ignorable and randomly missing,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",Assessment at <3 Months,4,,28.33,7.43,,,,,-4.4,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,0.1111,,PSS-I ≤23 and CGI-I ≤3 (determined using RCI cutoff c),0.2222,,Community,,,1,0.7143,,0.2857,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.",48582,2019
zoellner2017_PSS-I_C_Baseline_ITT,Mixed: Psychotherapy & pharmacotherapy,PTSD,42,C,Control,,11,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,11,Structured Clinical Interview,PSS-I,PSS-I,ITT,Mixed effects model with missing data treated as ignorable and randomly missing,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",Baseline,,,32.73,7.24,,,,,,,,,,,,,,,,,,,,,,,Not meeting criteria for PTSD according to PSS-I,,,PSS-I ≤23 and CGI-I ≤3 (determined using RCI cutoff c),,,Community,,,1,0.7143,,0.2857,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.",48582,2019
zoellner2017_PSS-SR_A_0_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,42,A,PTSD,,,,Methylene blue + imaginal exposure,Imaginal exposure (experimental paradigm) followed by methylene blue,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Self report,PSS-SR,PSS-SR,,,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",End of Treatment,0,,16.00,12.06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7143,,0.2857,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.",48582,2019
zoellner2017_PSS-SR_A_4_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,42,A,PTSD,,,,Methylene blue + imaginal exposure,Imaginal exposure (experimental paradigm) followed by methylene blue,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Self report,PSS-SR,PSS-SR,,,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",Assessment at <3 Months,4,,9.44,8.09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7143,,0.2857,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.",48582,2019
zoellner2017_PSS-SR_A_Baseline_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,42,A,PTSD,,,,Methylene blue + imaginal exposure,Imaginal exposure (experimental paradigm) followed by methylene blue,Yes,TF,Yes,Other pharmacotherapy,No,Not Applicable,No,No,No,No,No,Individual,In Person,15,Self report,PSS-SR,PSS-SR,,,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",Baseline,,,32.53,7.83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7143,,0.2857,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.",48582,2019
zoellner2017_PSS-SR_B_0_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,42,B,PTSD,,,,Placebo + imaginal exposure,Imaginal exposure + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,16,Self report,PSS-SR,PSS-SR,,,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",End of Treatment,0,,15.13,9.49,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7143,,0.2857,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.",48582,2019
zoellner2017_PSS-SR_B_4_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,42,B,PTSD,,,,Placebo + imaginal exposure,Imaginal exposure + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,16,Self report,PSS-SR,PSS-SR,,,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",Assessment at <3 Months,4,,12.73,8.16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7143,,0.2857,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.",48582,2019
zoellner2017_PSS-SR_B_Baseline_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,42,B,PTSD,,,,Placebo + imaginal exposure,Imaginal exposure + placebo,Yes,TF,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,16,Self report,PSS-SR,PSS-SR,,,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",Baseline,,,29.88,7.28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7143,,0.2857,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.",48582,2019
zoellner2017_PSS-SR_C_0_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,42,C,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,11,Self report,PSS-SR,PSS-SR,,,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",End of Treatment,0,,35.11,6.03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7143,,0.2857,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.",48582,2019
zoellner2017_PSS-SR_C_4_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,42,C,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,11,Self report,PSS-SR,PSS-SR,,,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",Assessment at <3 Months,4,,31.67,8.12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7143,,0.2857,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.",48582,2019
zoellner2017_PSS-SR_C_Baseline_NA,Mixed: Psychotherapy & pharmacotherapy,PTSD,42,C,Control,,,,Waitlist,Waitlist,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,11,Self report,PSS-SR,PSS-SR,,,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",Baseline,,,35.36,7.84,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.7143,,0.2857,Mixed,"combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)",Medium,"Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.",48582,2019
zohar2002_CAPS_A_0_Comp,Pharmacotherapy,PTSD,42,A,PTSD,,17,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Structured Clinical Interview,CAPS,CAPS-2,Completer,,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",End of Treatment,0,,,,,,,,-26.4,6.6,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 total severity score,0.4118,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.88,,0.12,Mixed,"combat-related, accidents, other (captivity)",Medium,"Zohar J, Amital D, Miodownik C, et al. Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol. 2002;22(2):190-5. doi: 10.1097/00004714-200204000-00013. PMID: 11910265.",24564,2019
zohar2002_CAPS_A_0_ITT,Pharmacotherapy,PTSD,42,A,PTSD,,23,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Structured Clinical Interview,CAPS,CAPS-2,ITT,,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",End of Treatment,0,,72.5,,,,,,-18.7,6.7,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 total severity score,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.88,,0.12,Mixed,"combat-related, accidents, other (captivity)",Medium,"Zohar J, Amital D, Miodownik C, et al. Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol. 2002;22(2):190-5. doi: 10.1097/00004714-200204000-00013. PMID: 11910265.",24564,2019
zohar2002_CAPS_A_Baseline_Comp,Pharmacotherapy,PTSD,42,A,PTSD,,17,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Structured Clinical Interview,CAPS,CAPS-2,Completer,,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 total severity score,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.88,,0.12,Mixed,"combat-related, accidents, other (captivity)",Medium,"Zohar J, Amital D, Miodownik C, et al. Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol. 2002;22(2):190-5. doi: 10.1097/00004714-200204000-00013. PMID: 11910265.",24564,2019
zohar2002_CAPS_A_Baseline_ITT,Pharmacotherapy,PTSD,42,A,PTSD,,23,,Sertraline,Sertraline,No,Not Applicable,Yes,Antidepressant: SSRI,No,Not Applicable,No,No,No,No,No,Individual,In Person,23,Structured Clinical Interview,CAPS,CAPS-2,ITT,,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",Baseline,,,91.2,13.3,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 total severity score,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.88,,0.12,Mixed,"combat-related, accidents, other (captivity)",Medium,"Zohar J, Amital D, Miodownik C, et al. Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol. 2002;22(2):190-5. doi: 10.1097/00004714-200204000-00013. PMID: 11910265.",24564,2019
zohar2002_CAPS_B_0_Comp,Pharmacotherapy,PTSD,42,B,Control,,15,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,19,Structured Clinical Interview,CAPS,CAPS-2,Completer,,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",End of Treatment,0,,,,,,,,-14.8,6.1,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 total severity score,0.3333,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.88,,0.12,Mixed,"combat-related, accidents, other (captivity)",Medium,"Zohar J, Amital D, Miodownik C, et al. Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol. 2002;22(2):190-5. doi: 10.1097/00004714-200204000-00013. PMID: 11910265.",24564,2019
zohar2002_CAPS_B_0_ITT,Pharmacotherapy,PTSD,42,B,Control,,19,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,19,Structured Clinical Interview,CAPS,CAPS-2,ITT,,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",End of Treatment,0,,79.8,,,,,,-13.5,6.6,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 total severity score,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.88,,0.12,Mixed,"combat-related, accidents, other (captivity)",Medium,"Zohar J, Amital D, Miodownik C, et al. Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol. 2002;22(2):190-5. doi: 10.1097/00004714-200204000-00013. PMID: 11910265.",24564,2019
zohar2002_CAPS_B_Baseline_Comp,Pharmacotherapy,PTSD,42,B,Control,,15,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,19,Structured Clinical Interview,CAPS,CAPS-2,Completer,,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",Baseline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 total severity score,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.88,,0.12,Mixed,"combat-related, accidents, other (captivity)",Medium,"Zohar J, Amital D, Miodownik C, et al. Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol. 2002;22(2):190-5. doi: 10.1097/00004714-200204000-00013. PMID: 11910265.",24564,2019
zohar2002_CAPS_B_Baseline_ITT,Pharmacotherapy,PTSD,42,B,Control,,19,,Placebo,Placebo,No,Not Applicable,No,Not Applicable,No,Not Applicable,No,No,Yes,No,No,Individual,In Person,19,Structured Clinical Interview,CAPS,CAPS-2,ITT,,"Mixed effects models for continuous outcomes and generalized linear mixed models for binary outcomes, effect size d calculated using on-average difference divided by pooled SD",Baseline,,,93.3,11.7,,,,,,,,,,,,,,,,,,,,,,,,,,≥30% decrease in CAPS-2 total severity score,,Additional definitions of Clinically Meaningful Response reported in the study,Veteran,0,1,0,0.88,,0.12,Mixed,"combat-related, accidents, other (captivity)",Medium,"Zohar J, Amital D, Miodownik C, et al. Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol. 2002;22(2):190-5. doi: 10.1097/00004714-200204000-00013. PMID: 11910265.",24564,2019
zucker2009_Deta_A_0_NA,Complementary and integrative health (CIH),PTSD,45,A,PTSD,,,,Respiratory sinus arrhythmia biofeedback,Biofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,,Self report,Detailed Assessment of Posttraumatic Stress - Posttraumatic Stress Total subscale,Detailed Assessment of Posttraumatic Stress - Posttraumatic Stress Total subscale,,,Repeated measures ANOVA with paired t-tests,End of Treatment,0,,71.78,15.41,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.447,,0.553,,,High,"Zucker TL, Samuelson KW, Muench F, et al. The effects of respiratory sinus arrhythmia biofeedback on heart rate variability and posttraumatic stress disorder symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2009;34(2):135-43. doi: 10.1007/s10484-009-9085-2. PMID: 19396540.",33842,2019
zucker2009_Deta_A_Baseline_NA,Complementary and integrative health (CIH),PTSD,45,A,PTSD,,,,Respiratory sinus arrhythmia biofeedback,Biofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,,Self report,Detailed Assessment of Posttraumatic Stress - Posttraumatic Stress Total subscale,Detailed Assessment of Posttraumatic Stress - Posttraumatic Stress Total subscale,,,Repeated measures ANOVA with paired t-tests,Baseline,,,88.00,12.57,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.447,,0.553,,,High,"Zucker TL, Samuelson KW, Muench F, et al. The effects of respiratory sinus arrhythmia biofeedback on heart rate variability and posttraumatic stress disorder symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2009;34(2):135-43. doi: 10.1007/s10484-009-9085-2. PMID: 19396540.",33842,2019
zucker2009_Deta_B_0_NA,Complementary and integrative health (CIH),PTSD,45,B,PTSD,,,,Progressive muscle relaxation,Progressive muscle relaxation (PMR),No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,,Self report,Detailed Assessment of Posttraumatic Stress - Posttraumatic Stress Total subscale,Detailed Assessment of Posttraumatic Stress - Posttraumatic Stress Total subscale,,,Repeated measures ANOVA with paired t-tests,End of Treatment,0,,73.63,16.86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.447,,0.553,,,High,"Zucker TL, Samuelson KW, Muench F, et al. The effects of respiratory sinus arrhythmia biofeedback on heart rate variability and posttraumatic stress disorder symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2009;34(2):135-43. doi: 10.1007/s10484-009-9085-2. PMID: 19396540.",33842,2019
zucker2009_Deta_B_Baseline_NA,Complementary and integrative health (CIH),PTSD,45,B,PTSD,,,,Progressive muscle relaxation,Progressive muscle relaxation (PMR),No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,,Self report,Detailed Assessment of Posttraumatic Stress - Posttraumatic Stress Total subscale,Detailed Assessment of Posttraumatic Stress - Posttraumatic Stress Total subscale,,,Repeated measures ANOVA with paired t-tests,Baseline,,,87.84,11.74,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.447,,0.553,,,High,"Zucker TL, Samuelson KW, Muench F, et al. The effects of respiratory sinus arrhythmia biofeedback on heart rate variability and posttraumatic stress disorder symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2009;34(2):135-43. doi: 10.1007/s10484-009-9085-2. PMID: 19396540.",33842,2019
zucker2009_PCL_A_0_Comp,Complementary and integrative health (CIH),PTSD,45,A,PTSD,,19,,Respiratory sinus arrhythmia biofeedback,Biofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL-C,Completer,,Repeated measures ANOVA with paired t-tests,End of Treatment,0,,38.53,10.03,,,,,-14.06,,,,,,,,,,p<0.01,,,,,,,,,,,,,,Community,,,1,0.447,,0.553,,,High,"Zucker TL, Samuelson KW, Muench F, et al. The effects of respiratory sinus arrhythmia biofeedback on heart rate variability and posttraumatic stress disorder symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2009;34(2):135-43. doi: 10.1007/s10484-009-9085-2. PMID: 19396540.",33842,2019
zucker2009_PCL_A_Baseline_Comp,Complementary and integrative health (CIH),PTSD,45,A,PTSD,,19,,Respiratory sinus arrhythmia biofeedback,Biofeedback,No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL-C,Completer,,Repeated measures ANOVA with paired t-tests,Baseline,,,52.59,11.86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.447,,0.553,,,High,"Zucker TL, Samuelson KW, Muench F, et al. The effects of respiratory sinus arrhythmia biofeedback on heart rate variability and posttraumatic stress disorder symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2009;34(2):135-43. doi: 10.1007/s10484-009-9085-2. PMID: 19396540.",33842,2019
zucker2009_PCL_B_0_Comp,Complementary and integrative health (CIH),PTSD,45,B,PTSD,,19,,Progressive muscle relaxation,Progressive muscle relaxation (PMR),No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL-C,Completer,,Repeated measures ANOVA with paired t-tests,End of Treatment,0,,44.32,13.59,,,,,-9.52,,,,,,,,,,p<0.01,,,,,,,,,,,,,,Community,,,1,0.447,,0.553,,,High,"Zucker TL, Samuelson KW, Muench F, et al. The effects of respiratory sinus arrhythmia biofeedback on heart rate variability and posttraumatic stress disorder symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2009;34(2):135-43. doi: 10.1007/s10484-009-9085-2. PMID: 19396540.",33842,2019
zucker2009_PCL_B_Baseline_Comp,Complementary and integrative health (CIH),PTSD,45,B,PTSD,,19,,Progressive muscle relaxation,Progressive muscle relaxation (PMR),No,Not Applicable,No,Not Applicable,Yes,Relaxation,No,No,No,No,No,Individual,In Person,,Self report,PCL,PCL-C,Completer,,Repeated measures ANOVA with paired t-tests,Baseline,,,53.84,10.18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Community,,,1,0.447,,0.553,,,High,"Zucker TL, Samuelson KW, Muench F, et al. The effects of respiratory sinus arrhythmia biofeedback on heart rate variability and posttraumatic stress disorder symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2009;34(2):135-43. doi: 10.1007/s10484-009-9085-2. PMID: 19396540.",33842,2019
